PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chu, TY; Weng, X; Law, COK; Kong, HK; Lau, J; Li, S; Pham, HQ; Wang, R; Zhang, L; Kao, RYT; Lau, KF; Ngo, JCK; Lau, TCK				Chu, Tinyi; Weng, Xing; Law, Carmen Oi Kwan; Kong, Hoi-Kuan; Lau, Jeffrey; Li, Sheila; Hoa Quynh Pham; Wang, Rui; Zhang, Liang; Kao, Richard Y. T.; Lau, Kwok-Fai; Ngo, Jacky Chi Ki; Lau, Terrence Chi Kong			The ribosomal maturation factor P from Mycobacterium smegmatis facilitates the ribosomal biogenesis by binding to the small ribosomal protein S12	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome assembly; crystal structure; mycobacteria; protein-protein interaction; protein complex; RimP; ribosomal maturation factor P; ribosomal biogenesis; MSMEG 2624; Mycobacterium smegmatis; small ribosomal protein S12; RpsL; tuberculosis; bacterial translation		The ribosomal maturation factor P (RimP) is a highly conserved protein in bacteria and has been shown to be important in ribosomal assembly in Escherichia coli. Because of its central importance in bacterial metabolism, RimP represents a good potential target for drug design to combat human pathogens such as Mycobacterium tuberculosis. However, to date, the only RimP structure available is the NMR structure of the ortholog in another bacterial pathogen, Streptococcus pneumoniae. Here, we report a 2.2 angstrom resolution crystal structure of MSMEG_2624, the RimP ortholog in the close M. tuberculosis relative Mycobacterium smegmatis, and using in vitro binding assays, we show that MSMEG_2624 interacts with the small ribosomal protein S12, also known as RpsL. Further analyses revealed that the conserved residues in the linker region between the N- and C-terminal domains of MSMEG_2624 are essential for binding to RpsL. However, neither of the two domains alone was sufficient to form strong interactions with RpsL. More importantly, the linker region was essential for in vivo ribosomal biogenesis. Our study provides critical mechanistic insights into the role of RimP in ribosome biogenesis. We anticipate that the MSMEG_2624 crystal structure has the potential to be used for drug design to manage M. tuberculosis infections.	[Chu, Tinyi; Weng, Xing; Law, Carmen Oi Kwan; Kong, Hoi-Kuan; Lau, Jeffrey; Li, Sheila; Hoa Quynh Pham; Wang, Rui; Zhang, Liang; Lau, Terrence Chi Kong] City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China; [Kao, Richard Y. T.] Univ Hong Kong, Dept Microbiol, Hong Kong, Peoples R China; [Lau, Kwok-Fai; Ngo, Jacky Chi Ki] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China	City University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Lau, TCK (corresponding author), City Univ Hong Kong, Dept Biomed Sci, Kowloon, Hong Kong, Peoples R China.; Ngo, JCK (corresponding author), Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China.	jackyngo@cuhk.edu.hk; chiklau@cityu.edu.hk	Ngo, Jacky C/O-8093-2017; Lau, Terrence/ABB-7900-2021	Ngo, Jacky C/0000-0002-6004-7041; Lau, Terrence/0000-0002-7505-7306; PHAM, Quynh Hoa/0000-0001-6165-3628; Lau, Kwok-Fai/0000-0002-0193-1152; ZHANG, Liang/0000-0003-3100-8593; Chu, Tinyi/0000-0003-3369-6692; WANG, Rui/0000-0003-3830-4133	General Research Fund (GRF) [11101518, 9042616, 21101917]; Health and Medical Research Fund (HMRF) Grant [15140342]	General Research Fund (GRF); Health and Medical Research Fund (HMRF) Grant	This work was supported by General Research Fund (GRF) 11101518, 9042616, and 21101917 and Health and Medical Research Fund (HMRF) Grant 15140342. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bunner AE, 2010, J MOL BIOL, V398, P1, DOI 10.1016/j.jmb.2010.02.036; Bylund GO, 1998, J BACTERIOL, V180, P73, DOI 10.1128/JB.180.1.73-82.1998; CHAMPNEY WS, 1977, MOL GEN GENET, V152, P259, DOI 10.1007/BF00693079; Chang J, 2008, FEMS IMMUNOL MED MIC, V53, P26, DOI 10.1111/j.1574-695X.2008.00394.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DeLano W. L., 2015, PYMOL MOL GRAPH SYST; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Kerrien S, 2012, NUCLEIC ACIDS RES, V40, pD841, DOI 10.1093/nar/gkr1088; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P520; Ness SR, 2004, STRUCTURE, V12, P1753, DOI 10.1016/j.str.2004.07.018; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; Nord S, 2009, J MOL BIOL, V386, P742, DOI 10.1016/j.jmb.2008.12.076; Sashital DG, 2014, ELIFE, V3, DOI 10.7554/eLife.04491; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization (WHO), 2016, WHO GLOB TUB REP 201; Yu LP, 2001, J MOL BIOL, V311, P593, DOI 10.1006/jmbi.2001.4894	22	10	10	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					372	378		10.1074/jbc.RA118.002298	http://dx.doi.org/10.1074/jbc.RA118.002298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409901	Green Published, hybrid			2022-12-26	WOS:000455105500038
J	Yin, WJ; Song, Y; Chang, X				Yin, Weijie; Song, Yan; Chang, Xing			Single-cell RNA-Seq analysis identifies a noncoding interleukin 4 (IL-4) RNA that post-transcriptionally up-regulates IL-4 production in T helper cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; post-transcriptional regulation; T helper cells; long noncoding RNA (long ncRNA; lncRNA); transcriptomics; adaptive immunity; alternative promoter; IL4; single-cell RNA-Seq; type 2 T helper cells	CYTOKINE GENE-EXPRESSION; TRANSCRIPTION FACTOR; FOLLICULAR-HELPER; TH2 CELLS; GENERATION; T(H)2; DIFFERENTIATION; ACCESSIBILITY; BIMODALITY; INSIGHTS	High-throughput sequencing has revealed a tremendous complexity of cellular transcriptomes, which is partly due to the generation of multiple alternative transcripts from a single gene locus. Because alternative transcripts often have low abundance in bulk cells, the functions of most of these transcripts and their relationship with their canonical counterparts remain unclear. Here we applied single-cell RNA-Seq to analyze the transcriptome complexity of in vitro-differentiated, murine type 2 T helper (Th2) cells. We found that cytokine gene transcripts contribute most of the intercellular heterogeneity, with a group of universal cytokines, including interleukins 1a, 2, 3, and 16, being bimodally expressed. At the single-cell level, use of alternative promoters prevalently generated alternative transcripts. For instance, although undetectable in bulk cells, a noncoding RNA isoform of IL-4 (IL4nc), which was driven by an intronic promoter in the IL-4 locus, was predominantly expressed in a subset of Th2 cells. IL4nc displayed distinct temporal expression patterns compared with the canonical IL-4 mRNA and post-transcriptionally promoted the production of IL-4 protein in Th2 cells. In conclusion, our findings reveal a mechanism whereby minor noncanonical transcripts post-transcriptionally regulate expression of their cognate canonical genes.	[Yin, Weijie; Chang, Xing] Chinese Acad Sci, Univ Chinese Acad Sci, Key Lab Tissue Microenvironm & Tumor, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Song, Yan] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; University of California System; University of California San Diego	Chang, X (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Key Lab Tissue Microenvironm & Tumor, Shanghai Inst Nutr & Hlth,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China.	changxing@sibs.ac.cn		Chang, Xing/0000-0002-5072-9225	Ministry of Science and Technology of the People's Republic of China [2014CB943600, 2018YFA0107500]; National Natural Science Foundation of China [31370858, 81671552]; Science and Technology Commission of Shanghai Municipality [17ZR449700]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Grants 2014CB943600 and 2018YFA0107500 from the Ministry of Science and Technology of the People's Republic of China, Grants 31370858 and 81671552 from the National Natural Science Foundation of China, and Grant 17ZR449700 from the Science and Technology Commission of Shanghai Municipality. The authors declare that they have no conflicts of interest with the contents of this article.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Bancroft AJ, 2000, EUR J IMMUNOL, V30, P2083, DOI 10.1002/1521-4141(200007)30:7&lt;2083::AID-IMMU2083&gt;3.0.CO;2-3; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Guo LY, 2004, IMMUNITY, V20, P193, DOI 10.1016/S1074-7613(04)00025-1; Guo LY, 2002, P NATL ACAD SCI USA, V99, P10623, DOI 10.1073/pnas.162360199; Ho IC, 2002, CELL, V109, pS109, DOI 10.1016/S0092-8674(02)00705-5; Kang SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003410; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kubo M, 2017, ALLERGOL INT, V66, P377, DOI 10.1016/j.alit.2017.04.006; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Licona-Limon P, 2013, NAT IMMUNOL, V14, P536, DOI 10.1038/ni.2617; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahata B, 2014, CELL REP, V7, P1130, DOI 10.1016/j.celrep.2014.04.011; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; OJEDA G, 1995, CELL IMMUNOL, V164, P265, DOI 10.1006/cimm.1995.1170; Onodera CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043511; Paul WE, 2015, CYTOKINE, V75, P3, DOI 10.1016/j.cyto.2015.01.038; Proserpio V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0957-5; Quinn JJ, 2016, NAT REV GENET, V17, P47, DOI 10.1038/nrg.2015.10; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; SWAIN SL, 1990, J IMMUNOL, V145, P3796; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Wang J, 2009, CANCER INFORM, V7, P199; Yamane H, 2005, J EXP MED, V202, P793, DOI 10.1084/jem.20051304; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	41	2	2	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					290	298		10.1074/jbc.RA118.004111	http://dx.doi.org/10.1074/jbc.RA118.004111			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30404921	Green Published, hybrid			2022-12-26	WOS:000455105500031
J	Nielsen, MI; Stegmayr, J; Grant, OC; Yang, Z; Nilsson, UJ; Boos, I; Carlsson, MC; Woods, RJ; Unverzagt, C; Leffler, H; Wandall, HH				Nielsen, Mathias Ingemann; Stegmayr, John; Grant, Oliver C.; Yang, Zhang; Nilsson, Ulf J.; Boos, Irene; Carlsson, Michael C.; Woods, Robert J.; Unverzagt, Carlo; Leffler, Hakon; Wandall, Hans H.			Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						galectin; glycobiology; sialic acid; molecular genetics; carbohydrate-binding protein; glycoprotein; GalNAc; genetic engineering; glycan; LacNAc; glycation; glycolipid	HUMAN SERUM GLYCOPROTEINS; TERMINAL DOMAIN; HIGH-AFFINITY; N-GLYCANS; CHO-CELLS; LECTIN; RECOGNITION; APOPTOSIS; ADHESION; LIGANDS	Galectins compose a protein family defined by a conserved sequence motif conferring affinity for -galactose-containing glycans. Moreover, galectins gain higher affinity and fine-tune specificity by glycan interactions at sites adjacent to their -galactoside-binding site, as revealed by extensive testing against panels of purified glycans. However, in cells, galectins bind glycans on glycoproteins and glycolipids in the context of other cellular components, such as at the cell surface. Because of difficulties in characterizing natural cellular environments, we currently lack a detailed understanding of galectin-binding specificities in the cellular context. To address this challenge, we used a panel of genetically stable glycosylation mutated CHO cells that express defined glycans to evaluate the binding affinities of 10 different carbohydrate-recognition domains in galectins to N-glycans and mucin-type O-glycans. Using flow cytometry, we measured the cell-surface binding of the galectins. Moreover, we used fluorescence anisotropy to determine the galectin affinities to recombinant erythropoietin used as a reporter glycoprotein produced by the glycoengineered cells and to synthetic N-glycans with defined branch structures. We found that all galectins, apart from galectin-8N, require complex N-glycans for high-affinity binding. Galectin-8N targeted both N- and O-linked glycans with high affinity, preferring 2,3-sialylated N-acetyllactosamine (LacNAc) structures. Furthermore, we found that 2,3-sialylation suppresses high-affinity binding of select galectins, including galectin-2, -3, -4N, and -7. Structural modeling provided a basis for interpreting the observed binding preferences. These results underscore the power of a glycoengineered platform to dissect the glycan-binding specificities of carbohydrate-binding proteins.	[Nielsen, Mathias Ingemann; Yang, Zhang; Carlsson, Michael C.; Wandall, Hans H.] Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark; [Stegmayr, John; Carlsson, Michael C.; Leffler, Hakon] Lund Univ, Div Microbiol Immunol & Glycobiol MIG, Dept Lab Med, Fac Med, S-22100 Lund, Sweden; [Grant, Oliver C.; Woods, Robert J.] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, 220 Riverbend Rd, Athens, GA 30602 USA; [Nilsson, Ulf J.] Lund Univ, Ctr Anal & Synth, Dept Chem, S-22100 Lund, Sweden; [Boos, Irene; Unverzagt, Carlo] Univ Bayreuth, Bioorgan Chem, Gebaude NW 1, D-95440 Bayreuth, Germany	University of Copenhagen; Lund University; University System of Georgia; University of Georgia; Lund University; University of Bayreuth	Wandall, HH (corresponding author), Univ Copenhagen, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Fac Hlth & Med Sci, DK-2200 Copenhagen N, Denmark.	hhw@sund.ku.dk	Boos, Irene/K-3382-2015; Leffler, Hakon/A-2416-2019; Nilsson, Ulf J./L-3219-2014; Yang, Zhang/I-8934-2016	Boos, Irene/0000-0002-8244-4312; Nilsson, Ulf J./0000-0001-5815-9522; Stegmayr, John/0000-0002-8167-9259; Yang, Zhang/0000-0002-4756-5813; Carlsson, Michael/0000-0001-8567-2284; Wandall, Hans H./0000-0003-0240-9232; Woods, Robert/0000-0002-2400-6293; Grant, Oliver/0000-0003-4835-5161; Nielsen, Mathias Alexander Ingemann/0000-0002-6823-5354	European Research Council (ERC) [772735]; Danish Research Councils (Sapere Aude); Danish Research Council of Independent Research; Danish Research Councils for Strategic Research; Lundbeck Foundation; Agnes and Poul Friis Foundation; Vera og Carl Johan Michaelsens Legat; Danish National Research Foundation [DNRF 107]; University of Copenhagen [CDO2016]	European Research Council (ERC)(European Research Council (ERC)European Commission); Danish Research Councils (Sapere Aude); Danish Research Council of Independent Research; Danish Research Councils for Strategic Research; Lundbeck Foundation(Lundbeckfonden); Agnes and Poul Friis Foundation; Vera og Carl Johan Michaelsens Legat; Danish National Research Foundation(Danmarks Grundforskningsfond); University of Copenhagen	This work was in part supported by the European Research Council (ERC Consolidator Grant, EU project 772735), Danish Research Councils (Sapere Aude), the Danish Research Council of Independent Research, the Danish Research Councils for Strategic Research, Programme of Excellence 2016 Grant CDO2016 from the University of Copenhagen, The Lundbeck Foundation, Agnes and Poul Friis Foundation, Vera og Carl Johan Michaelsens Legat, and Danish National Research Foundation Grant DNRF 107. U. J. N. and H. L. are shareholders in Galecto Biotech, AB, a company that develops galectin inhibitors. H. H. W. is a shareholder and has a consultancy arrangement with Go-Therapeutics, who have provided consulting fees not related to this study.	Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Bohari MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep39556; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Bum-Erdene K, 2015, FEBS J, V282, P3348, DOI 10.1111/febs.13348; Carlsson MC, 2013, J BIOL CHEM, V288, P28398, DOI 10.1074/jbc.M113.487793; Carlsson MC, 2012, BBA-GEN SUBJECTS, V1820, P1366, DOI 10.1016/j.bbagen.2012.01.007; Carlsson MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026560; Carlsson S, 2007, GLYCOBIOLOGY, V17, P906, DOI 10.1093/glycob/cwm059; Carlsson S, 2007, GLYCOBIOLOGY, V17, P663, DOI 10.1093/glycob/cwm026; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Chen WS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11302; Cooper D, 2012, ANN NY ACAD SCI, V1253, P181, DOI 10.1111/j.1749-6632.2011.06291.x; COOPER DNW, 1991, J CELL BIOL, V115, P1437, DOI 10.1083/jcb.115.5.1437; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Delaine T, 2016, CHEMBIOCHEM, V17, P1759, DOI 10.1002/cbic.201600285; Duda K, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku251; Earl LA, 2010, J BIOL CHEM, V285, P2242, DOI 10.1074/jbc.M109.066191; Grant OC, 2016, GLYCOBIOLOGY, V26, P1027, DOI 10.1093/glycob/cww094; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ideo H, 2011, J BIOL CHEM, V286, P11346, DOI 10.1074/jbc.M110.195925; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lee JH, 2001, J BIOL CHEM, V276, P13924, DOI 10.1074/jbc.M010046200; LEFFLER H, 1986, J BIOL CHEM, V261, P119; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Lin YH, 2017, J BIOL CHEM, V292, P17845, DOI 10.1074/jbc.M117.802793; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Mehta-D'souza P, 2015, METHODS MOL BIOL, V1207, P105, DOI 10.1007/978-1-4939-1396-1_7; MERKLE RK, 1988, J BIOL CHEM, V263, P16143; Noll AJ, 2016, GLYCOBIOLOGY, V26, P655, DOI 10.1093/glycob/cww002; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Peterson K, 2018, J MED CHEM, V61, P1164, DOI 10.1021/acs.jmedchem.7b01626; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Rawley O., 2015, BLOOD, V118, P2234; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Saravanan C, 2009, J CELL SCI, V122, P3684, DOI 10.1242/jcs.045674; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Sorme P, 2005, J AM CHEM SOC, V127, P1737, DOI 10.1021/ja043475p; Sorme P, 2004, ANAL BIOCHEM, V334, P36, DOI 10.1016/j.ab.2004.06.042; STANLEY P, 1980, J CELL BIOL, V85, P60, DOI 10.1083/jcb.85.1.60; Stegmayr J, 2016, J BIOL CHEM, V291, P13318, DOI 10.1074/jbc.M116.721464; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Thiemann S, 2016, ANNU REV IMMUNOL, V34, P243, DOI 10.1146/annurev-immunol-041015-055402; Thode C, 2015, J INVEST DERMATOL, V135, P238, DOI 10.1038/jid.2014.284; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Varki A., 2017, ESSENTIALS GLYCOBIOL, P469; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; Vespa GNR, 1999, J IMMUNOL, V162, P799; WARNOCK DE, 1993, J BIOL CHEM, V268, P10145; WOO HJ, 1990, J BIOL CHEM, V265, P7097; Woods Group, 2005, GLYCAM WEB; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Yang Z, 2015, NAT BIOTECHNOL, V33, P842, DOI 10.1038/nbt.3280; ZHOU Q, 1990, ARCH BIOCHEM BIOPHYS, V281, P27, DOI 10.1016/0003-9861(90)90408-Q; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	67	38	39	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20249	20262		10.1074/jbc.RA118.004636	http://dx.doi.org/10.1074/jbc.RA118.004636			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385505	Green Published, hybrid			2022-12-26	WOS:000454685900030
J	Turner, R; Brennan, SO; Ashby, LV; Dickerhof, N; Hamzah, MR; Pearson, JF; Stamp, LK; Kettle, AJ				Turner, Rufus; Brennan, Stephen O.; Ashby, Louisa V.; Dickerhof, Nina; Hamzah, Melanie R.; Pearson, John F.; Stamp, Lisa K.; Kettle, Anthony J.			Conjugation of urate-derived electrophiles to proteins during normal metabolism and inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						uric acid; oxidative stress; neutrophil; NADPH oxidase; myeloperoxidase; post-translational modification (PTM); biomarker; uratylation; protein adduct; lysine modification	URIC-ACID; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; LIPID-PEROXIDATION; OXIDATIVE STRESS; AMERICAN-COLLEGE; REDOX REACTIONS; FREE-RADICALS; MYELOPEROXIDASE; ANTIOXIDANT	Urate is often viewed as an antioxidant. Here, we present an alternative perspective by showing that, when oxidized, urate propagates oxidative stress. Oxidation converts urate to the urate radical and the electrophilic products dehydrourate, 5-hydroxyisourate, and urate hydroperoxide, which eventually break down to allantoin. We investigated whether urate-derived electrophiles are intercepted by nucleophilic amino acid residues to form stable adducts on proteins. When urate was oxidized in the presence of various peptides and proteins, two adducts derived from urate (M-r 167 Da) were detected and had mass additions of 140 and 166 Da, occurring mainly on lysine residues and N-terminal amines. The adduct with a 140-Da mass addition was detected more frequently and was stable. Dehydrourate (M-r 166 Da) also formed transient adducts with cysteine residues. Urate-derived adducts were detected on human serum albumin in plasma of healthy donors. Basal adduct levels increased when neutrophils were added to plasma and stimulated, and relied on the NADPH oxidase, myeloperoxidase, hydrogen peroxide, and superoxide. Adducts of oxidized urate on serum albumin were elevated in plasma and synovial fluid from individuals with gout and rheumatoid arthritis. We propose that rather than acting as an antioxidant, urate's conversion to electrophiles contributes to oxidative stress. The addition of urate-derived electrophiles to nucleophilic amino acid residues, a process we call oxidative uratylation, will leave a footprint on proteins that could alter their function when critical sites are modified.	[Turner, Rufus; Ashby, Louisa V.; Dickerhof, Nina; Hamzah, Melanie R.; Kettle, Anthony J.] Univ Otago Christchurch, Ctr Free Radical Res, POB 4345, Christchurch 8011, New Zealand; [Turner, Rufus; Brennan, Stephen O.; Ashby, Louisa V.; Dickerhof, Nina; Hamzah, Melanie R.; Kettle, Anthony J.] Univ Otago Christchurch, Dept Pathol & Biomed Sci, POB 4345, Christchurch 8011, New Zealand; [Pearson, John F.] Univ Otago Christchurch, Biostat & Computat Biol Unit, POB 4345, Christchurch 8011, New Zealand; [Stamp, Lisa K.] Univ Otago Christchurch, Dept Med, POB 4345, Christchurch 8011, New Zealand	University of Otago; University of Otago; University of Otago; University of Otago	Kettle, AJ (corresponding author), Univ Otago Christchurch, Ctr Free Radical Res, POB 4345, Christchurch 8011, New Zealand.; Kettle, AJ (corresponding author), Univ Otago Christchurch, Dept Pathol & Biomed Sci, POB 4345, Christchurch 8011, New Zealand.	tony.kettle@otago.ac.nz	Brennan, Stephen/AAW-9929-2020; Ashby, Louisa/GRN-9388-2022	Ashby, Louisa/0000-0001-8247-096X; Kettle, Tony/0000-0002-8218-7766; Dickerhof, Nina/0000-0003-2269-4595	Manatu Hauora Health Research Council of New Zealand	Manatu Hauora Health Research Council of New Zealand	This work was supported by grants from the Manatu Hauora Health Research Council of New Zealand. The authors declare that they have no conflicts of interest with the contents of this article.	ALLISON WS, 1964, J BIOL CHEM, V239, P2140; AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; ARUOMA OI, 1989, FEBS LETT, V244, P76, DOI 10.1016/0014-5793(89)81166-4; Ashby MT, 2008, J DENT RES, V87, P900, DOI 10.1177/154405910808701003; BECKER BF, 1993, FREE RADICAL BIO MED, V14, P615, DOI 10.1016/0891-5849(93)90143-I; BEERS RF, 1952, J BIOL CHEM, V195, P133; Brennan SO, 2016, CLIN CHIM ACTA, V457, P125, DOI 10.1016/j.cca.2016.04.014; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Cantu-Medellin N, 2013, REDOX BIOL, V1, P353, DOI 10.1016/j.redox.2013.05.002; Carvalho LAC, 2017, J BIOL CHEM, V292, P8705, DOI 10.1074/jbc.M116.767657; CROW JP, 1995, BIOCHEMISTRY-US, V34, P3544, DOI 10.1021/bi00011a008; Dickerhof N, 2017, J CYST FIBROS, V16, P214, DOI 10.1016/j.jcf.2016.10.012; Domazou AS, 2012, FREE RADICAL BIO MED, V52, P1929, DOI 10.1016/j.freeradbiomed.2012.02.045; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; FREI B, 1989, P NATL ACAD SCI USA, V86, P6377, DOI 10.1073/pnas.86.16.6377; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Fridovich I., 1985, HDB METHODS OXYGEN R, P51; Gersch C, 2009, NUCLEOS NUCLEOT NUCL, V28, P118, DOI 10.1080/15257770902736400; Kahn K, 1998, BIOCHEMISTRY-US, V37, P11651, DOI 10.1021/bi980446g; Kanbay M, 2016, EUR J INTERN MED, V29, P3, DOI 10.1016/j.ejim.2015.11.026; Kand'ar R, 2011, J CHROMATOGR B, V879, P2834, DOI 10.1016/j.jchromb.2011.08.007; KETTLE AJ, 1992, J BIOL CHEM, V267, P8319; Kettle AJ, 1997, REDOX REP, V3, P3, DOI 10.1080/13510002.1997.11747085; Kettle AJ, 2007, BIOCHEMISTRY-US, V46, P4888, DOI 10.1021/bi602587k; Kettle AJ, 2016, RSC METALLOBIO SER, V4, P272; Kettle AJ, 2011, FREE RADICAL BIO MED, V51, P2190, DOI 10.1016/j.freeradbiomed.2011.09.019; KITTRIDGE KJ, 1984, FEBS LETT, V170, P162, DOI 10.1016/0014-5793(84)81391-5; Li M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19520; Li X, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2376; MAPLES KR, 1988, J BIOL CHEM, V263, P1709; Meotti FC, 2011, J BIOL CHEM, V286, P12901, DOI 10.1074/jbc.M110.172460; Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Paganoni S, 2017, NEUROTHERAPEUTICS, V14, P148, DOI 10.1007/s13311-016-0497-4; Patricio ES, 2015, CHEM RES TOXICOL, V28, P1556, DOI 10.1021/acs.chemrestox.5b00132; Peskin AV, 2006, FREE RADICAL BIO MED, V40, P45, DOI 10.1016/j.freeradbiomed.2005.08.019; Ramazzina I, 2006, NAT CHEM BIOL, V2, P144, DOI 10.1038/nchembio768; Santos CXC, 1999, ARCH BIOCHEM BIOPHYS, V372, P285, DOI 10.1006/abbi.1999.1491; Santus R, 2001, FREE RADICAL RES, V35, P129, DOI 10.1080/10715760100300671; Sautin YY, 2008, NUCLEOS NUCLEOT NUCL, V27, P608, DOI 10.1080/15257770802138558; Seet RCS, 2011, STROKE, V42, P2326, DOI 10.1161/STROKEAHA.111.618835; SEGAL AW, 1980, J CELL BIOL, V85, P42, DOI 10.1083/jcb.85.1.42; Seidel A, 2014, J BIOL CHEM, V289, P21937, DOI 10.1074/jbc.M113.544957; SIMIC MG, 1989, J AM CHEM SOC, V111, P5778, DOI 10.1021/ja00197a042; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Stamp LK, 2014, RHEUMATOLOGY, V53, P1958, DOI 10.1093/rheumatology/keu218; Stamp LK, 2012, RHEUMATOLOGY, V51, P1796, DOI 10.1093/rheumatology/kes193; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; Tiden AK, 2011, J BIOL CHEM, V286, P37578, DOI 10.1074/jbc.M111.266981; Tipton PA, 2006, NAT CHEM BIOL, V2, P124, DOI 10.1038/nchembio0306-124; Turner R, 2012, J CHROMATOGR B, V891, P85, DOI 10.1016/j.jchromb.2012.02.009; VOLK KJ, 1989, ANAL CHEM, V61, P1709, DOI 10.1021/ac00190a024; VOLK KJ, 1990, J PHARMACEUT BIOMED, V8, P205, DOI 10.1016/0731-7085(90)80028-N; WILLSON RL, 1985, PHILOS T R SOC B, V311, P545, DOI 10.1098/rstb.1985.0163; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; Yakubenko VP, 2018, BLOOD, V132, P78, DOI 10.1182/blood-2017-10-810176	58	7	7	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19886	19898		10.1074/jbc.RA118.005237	http://dx.doi.org/10.1074/jbc.RA118.005237			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385504	hybrid, Green Published			2022-12-26	WOS:000454294900032
J	Hutabarat, M; Wibowo, N; Obermayer-Pietsch, B; Huppertz, B				Hutabarat, Martina; Wibowo, Noroyono; Obermayer-Pietsch, Barbara; Huppertz, Berthold			Impact of vitamin D and vitamin D receptor on the trophoblast survival capacity in preeclampsia	PLOS ONE			English	Article							AUTOPHAGY	Background Preeclampsia and intra-uterine growth restriction (IUGR) are major health problems during pregnancy affecting both mother and child. Defective placental development and failure of trophoblast differentiation during pregnancy are important aspects in the pathogenesis of both syndromes. Recent studies have shown that autophagy is involved in the trophoblast survival capacity. As vitamin D has a central role in many cellular processes, we studied the relation of vitamin D and autophagy in those processes of preeclampsia and IUGR. Methods Serum and placental samples from four groups of cases; normal term, IUGR, early-onset and late-onset preeclampsia, were analyzed for 25(OH)D vitamin D, sFLT1, PGF, LGALS13 in serum and vitamin D receptor (VDR), MAP1LC3B and BECN1 in placental tissues. Results There was a significant difference in the sFLT1/PGF ratio in preeclamptic cases compared to controls and IUGR. There was a significant difference between these groups in the MAP1LC3B/BECN1 ratio as marker of the trophoblast survival capacity with a significantly reduced ratio in villous trophoblast of early-onset preeclampsia. Maternal vitamin D deficiency was found in all pathological pregnancies combined with significantly reduced staining levels of placental VDR in IUGR. Finally, there was a strong and significant negative correlation between the survival capacity (MAP1LC3B/BECN1) and both maternal vitamin D and placental VDR in the preeclampsia groups. Conclusion Vitamin D and intracellular VDR are strongly related to the trophoblast survival capacity in preeclampsia.	[Hutabarat, Martina] Univ Indonesia, Postgrad Dept, Doctorate Program, Fac Med, Jakarta, Indonesia; [Wibowo, Noroyono] Univ Indonesia, Div Maternal Fetal Med, Dept Obstet & Gynecol, Fac Med, Jakarta, Indonesia; [Obermayer-Pietsch, Barbara] Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria; [Huppertz, Berthold] Med Univ Graz, Dept Cell Biol Histol & Embryol, Gottfried Schatz Res Ctr, Graz, Austria	University of Indonesia; University of Indonesia; Medical University of Graz; Medical University of Graz	Hutabarat, M (corresponding author), Univ Indonesia, Postgrad Dept, Doctorate Program, Fac Med, Jakarta, Indonesia.	martina.hutabarata28@yahoo.com	Huppertz, Berthold/I-2331-2019	Huppertz, Berthold/0000-0003-4814-2158; Wibowo, Noroyono/0000-0003-3995-6870				Achkar M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.009; Adhami F, 2007, AUTOPHAGY, V3, P42, DOI 10.4161/auto.3412; American College of Obstetricians and Gynecologist, 2011, VIT D SCREEN SUPPL P, V495, P1; American College of Obstetricians and Gynecologists, 2013, TASK FORC HYP PREGN; Bildirici I, 2012, PLACENTA, V33, P591, DOI 10.1016/j.placenta.2012.04.011; Bodnar LM, 2014, EPIDEMIOLOGY, V25, P207, DOI 10.1097/EDE.0000000000000039; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; Burton GJ, 2005, TOPICAL ENDOCRINOL, P2; Chafetz I, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.025; Chauhan SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.025; Christakos S, 2010, ENDOCRIN METAB CLIN, V39, P243, DOI 10.1016/j.ecl.2010.02.002; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; Demirovic D, 2013, EXP GERONTOL, V48, P94, DOI 10.1016/j.exger.2012.02.005; Erez O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181468; Food and Nutrition Board, 2010, DIET REF INT VIT D C; Gizurarson S, 2016, FETAL DIAGN THER, V39, P56, DOI 10.1159/000381914; Herraiz I, 2018, FETAL DIAGN THER, V43, P81, DOI 10.1159/000477903; Hossein-nezhad A, 2013, MAYO CLIN PROC, V88, P720, DOI 10.1016/j.mayocp.2013.05.011; Hung TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040957; Huppertz B, 2008, FETAL DIAGN THER, V24, P230, DOI 10.1159/000151344; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Huppertz B, 2015, J REPROD IMMUNOL, V108, P26, DOI 10.1016/j.jri.2014.11.003; Huppertz B, 2011, PREGNANCY HYPERTENS, V1, P79, DOI 10.1016/j.preghy.2010.10.003; Hutabarat M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186909; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Bao KLN, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060759; Kourtis N, 2011, EMBO J, V30, P2520, DOI 10.1038/emboj.2011.162; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Murthi P, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00043; Nakashima A, 2013, AUTOPHAGY, V9, P303, DOI 10.4161/auto.22927; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Redman C., 2017, PREGNANCY HYPERTENS, V7, P58, DOI [10.1016/j.preghy.2016.10.011, DOI 10.1016/J.PREGHY.2016.10.011]; Signorelli P, 2011, PLACENTA, V32, P482, DOI 10.1016/j.placenta.2011.03.005; Staff AC, 2013, PLACENTA, V34, pS73, DOI 10.1016/j.placenta.2012.11.022; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Tamblyn JA, 2015, J ENDOCRINOL, V224, pR107, DOI 10.1530/JOE-14-0642; Tavera-Mendoza L, 2006, EMBO REP, V7, P180, DOI 10.1038/sj.embor.7400594; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; Urrutia RP, 2012, CURR OPIN OBSTET GYN, V24, P57, DOI 10.1097/GCO.0b013e3283505ab3; Vanherwegen A-S, 2017, MOL CELL ENDOCRINOL, P1; Vayssiere C, 2015, EUR J OBSTET GYN R B, V193, P10, DOI 10.1016/j.ejogrb.2015.06.021; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838	44	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206725	10.1371/journal.pone.0206725	http://dx.doi.org/10.1371/journal.pone.0206725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408071	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300032
J	Kim, JH; Jang, SJ; Yun, JW; Jung, MH; Woo, SH				Kim, Jin Hyun; Jang, Si Jung; Yun, Jeong Won; Jung, Myeong Hee; Woo, Seung Hoon			Effects of pepsin and pepstatin on reflux tonsil hypertrophy in vitro	PLOS ONE			English	Article							HELICOBACTER-PYLORI; ALLERGIC RHINITIS; APOPTOSIS; PREVALENCE; CHILDREN; LYMPHOCYTES; DISORDERS; DISEASE; CELLS	There is evidence that pepsin can aggravate tonsil hypertrophy. Pepstatin is a potent inhibitor of pepsin activity and could protect patients against reflux tonsil hypertrophy by inhibiting pepsin. We examined the effects of pepstatin on the development of tonsil hypertrophy to investigate pepsin's role in the pathogenesis of tonsil lesions. We investigated whether pepstatin suppresses pepsin-mediated lymphocyte proliferation in tonsil hypertrophy. Forty-nine children with tonsil hypertrophy and twenty-two adults with tonsillitis were recruited to the study prior to surgery. Tonsil tissue from each patient was harvested and assessed for changes in the number of lymphocytes and macrophages in the presence of pepsin and pepstatin. We found that the proportions of CD4- and CD14-positive cells were significantly lower (p < 0.05), but that the proportions of CD19- and CD68-positive cells were significantly higher (p < 0.05), in children than in adults. There were significantly more CD4-positive cells after pepsin treatment, but these numbers were reduced by pepstatin. The levels of both interleukin-2 (IL-2) and interferon gamma (IFN-gamma) increased significantly in response to pepsin, but were reduced when pepsin was inhibited by pepstatin. The level of IL-10 is reduced in pepsin-treated CD4 cells and the level is restored by pepstatin. IL-2 blocking reduced the increased CD4 cell number by pepsin. But, an additive or a synergic effect is not founded in combined with IL-2 blocking and pepstatin. Pepsin-positive cells did not co-localize with CD20 and CD45 cells, but they were found surrounding CD20- and CD45-positive hypertrophic tonsil cells. Pepsin-positive cells co-localized with CD68-positive cells. It is probable that pepsin from extraesophageal reflux aggravates tonsil hypertrophy and pepstatin exerts a protective effect by inhibiting pepsin activity.	[Kim, Jin Hyun; Jang, Si Jung; Jung, Myeong Hee] Gyeongsang Natl Univ Hosp, Biomed Res Inst, Jinju, South Korea; [Kim, Jin Hyun; Woo, Seung Hoon] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea; [Yun, Jeong Won; Woo, Seung Hoon] Gyeongsang Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Jinju, South Korea; [Woo, Seung Hoon] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA	Gyeongsang National University; Gyeongsang National University Hospital; Gyeongsang National University; Gyeongsang National University; Gyeongsang National University Hospital; University of California System; University of California Irvine	Woo, SH (corresponding author), Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea.; Woo, SH (corresponding author), Gyeongsang Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Jinju, South Korea.; Woo, SH (corresponding author), Univ Calif Irvine, Beckman Laser Inst, Irvine, CA 92697 USA.	lesaby@hanmail.net		woo, seung hoon/0000-0001-7560-1140	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2016R1A2B4013000]; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012K1A4A3053142]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (2016R1A2B4013000) to SHW. The research was also supported by the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012K1A4A3053142) to SHW.	Borthwick NJ, 2000, INT IMMUNOL, V12, P1005, DOI 10.1093/intimm/12.7.1005; Choi KY, 2018, CLIN EXP OTORHINOLAR, V11, P210, DOI 10.21053/ceo.2017.01109; GAW AJ, 1995, ALIMENT PHARM THERAP, V9, P167; Huang SW, 2001, ANN ALLERG ASTHMA IM, V87, P350, DOI 10.1016/S1081-1206(10)62251-X; Johnston N, 2016, ANN NY ACAD SCI, V1381, P5, DOI 10.1111/nyas.13080; Kawabata I, 1996, ACTA OTO-LARYNGOL, P60; Kim JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152336; Kim MJ, 2018, CLIN EXP OTORHINOLAR, V11, P199, DOI 10.21053/ceo.2018.00115; Koufman JA, 2000, OTOLARYNG HEAD NECK, V123, P385, DOI 10.1067/mhn.2000.109935; Kraus J, 2014, ACTA OTO-LARYNGOL, V134, P88, DOI 10.3109/00016489.2013.840924; Kucera Tomas, 2004, Biomedical Papers (Olomouc), V148, P225; Kuki K, 1996, ACTA OTO-LARYNGOL, P68; Lack G, 2001, J ALLERGY CLIN IMMUN, V108, pS9, DOI 10.1067/mai.2001.115562; Lopez-Gonzalez MA, 1999, EUR J PEDIATR, V158, P469, DOI 10.1007/s004310051122; Moon JH, 2018, CLIN EXP OTORHINOLAR, V11, P146, DOI 10.21053/ceo.2017.00647; Onal M, 2015, INT J PEDIATR OTORHI, V79, P191, DOI 10.1016/j.ijporl.2014.12.005; Rathmell JC, 2002, CELL, V109, pS97, DOI 10.1016/S0092-8674(02)00704-3; Roberts AL, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-3; Roberts NB, 2006, ALIMENT PHARM THER, V24, P2, DOI 10.1111/j.1365-2036.2006.03038.x; Roberts NB, 2003, J ENZYM INHIB MED CH, V18, P209, DOI 10.1080/1475636031000076888; Sadeghi-Shabestari M, 2011, INT J PEDIATR OTORHI, V75, P589, DOI 10.1016/j.ijporl.2011.01.026; Simark-Mattsson C, 2002, SCAND J IMMUNOL, V55, P606, DOI 10.1046/j.1365-3083.2002.01095.x; Stapleton A, 2008, INT J PEDIATR OTORHI, V72, P409, DOI 10.1016/j.ijporl.2007.11.003; Steigerwald-Mullen P, 2000, J VIROL, V74, P6748, DOI 10.1128/JVI.74.15.6748-6759.2000; SUGIYAMA M, 1982, INT J PEDIATR OTORHI, V4, P193, DOI 10.1016/0165-5876(82)90001-5; UMEZAWA H, 1970, J ANTIBIOT, V23, P259, DOI 10.7164/antibiotics.23.259; WALKER V, 1979, GUT, V20, P977, DOI 10.1136/gut.20.11.977; Xue XC, 2014, J MED VIROL, V86, P963, DOI 10.1002/jmv.23894; Yilmaz T, 2006, OTOLARYNG HEAD NECK, V134, P772, DOI 10.1016/j.otohns.2006.02.002	29	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207090	10.1371/journal.pone.0207090	http://dx.doi.org/10.1371/journal.pone.0207090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408092	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300074
J	Chen, D; Luo, WG; Zeng, QS; Cui, BX				Chen, Dian; Luo, Wugan; Zeng, Qingshuo; Cui, Benxin			The lead ores circulation in Central China during the early Western Han Dynasty: A case study with bronze vessels from the Gejiagou site	PLOS ONE			English	Article							PROVINCE	This study first publishes lead isotope data of bronze vessels from Central China in Western Han Dynasty and attempts to find out the lead ores circulation of this time by taking bronzes from the Gejiagou site (Nanyang City, Henan Province) as an example. The elemental concentrations suggest the lead should be introduced on purpose and indicate the provenance information of lead ores. All the lead isotope ratios conform to the characteristics of common lead and most of them are similar to Nanyang local lead ores. The lead of another two bronzes, NY9 and NY13, should be imported from southern China. Combined with the historical background of early Western Han Dynasty, the wider range of the lead ore circulation may be an indicator for, as the loose policy, economic prosperity and transportation improvement.	[Chen, Dian; Luo, Wugan] Univ Chinese Acad Sci, Dept Archaeometry, Beijing, Peoples R China; [Chen, Dian; Luo, Wugan] Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origin, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Zeng, Qingshuo; Cui, Benxin] Inst Cultural Rel Res Nanyang City, Nanyang, Henan, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Luo, WG (corresponding author), Univ Chinese Acad Sci, Dept Archaeometry, Beijing, Peoples R China.; Luo, WG (corresponding author), Chinese Acad Sci, Key Lab Vertebrate Evolut & Human Origin, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China.	xiahua@ucas.ac.cn	Chen, Dian/AAI-7650-2020; Chen, Dian/AAP-9506-2020	Chen, Dian/0000-0002-5502-6254; Luo, Wugan/0000-0002-4893-8853				Bao MJ, 1996, ARCHAEOLOGY, V03, P99; Cattin F, 2011, J ARCHAEOL SCI, V38, P1221, DOI 10.1016/j.jas.2010.12.016; Charalambous A, 2014, J ARCHAEOL SCI, V46, P205, DOI 10.1016/j.jas.2014.03.006; Chen TM, 2008, SCI TECHNOLOGY ARCHA, P160; Chen WQ, 2005, PRELIMINARY STUDY EC; Doe B. R., 1970, LEAD ISOTOPES MINERA; Duan Shi-gang, 2010, Journal of Mineralogy and Petrology, V30, P69; Figueiredo E, 2007, NUCL INSTRUM METH A, V580, P725, DOI 10.1016/j.nima.2007.05.135; Gale N., 2000, MODERN ANAL METHODS; Ge J, 2003, GEOLOGY CHEM MINERAL, P213; Han RP, 2007, HIST SCI TECHNOLOGY, P115; Hunan Provincial Museum, 1978, ARCHEOLOGY, p[297, 364]; Li X. C., 1992, ARCHAEOLOGY, V5, P464; Liang T, 2008, DIZHI XUEBAO, V7, P967; Lv C, 2014, RES SOURCE W E ZHOU; Ma DZ, 2007, CULTURAL RELICS, P4; Mu D, 2018, ARCHAEOL ANTHROP SCI, P1; Mu D, 2014, J ARCHAEOL SCI, V52, P515, DOI 10.1016/j.jas.2014.09.021; Tian X, 2008, BRONZE VESSELS CHIN; Wang Y, 2012, PRELIMINARY STUDY BR; Wang ZJ., 1994, HIST MANUSCRIPT TRAN; White William Charles, 1956, BRONZE CULTURE ANCIE; Xu LB, 2010, STUDY MINERALIZATION; Xu Q, 2017, RES VASSAL STATES NA; YIN H, 1978, GEOCHIMICA, P270; [应汉龙 YING HanLong], 2006, [矿床地质, Mineral Deposits], V25, P135; Yu YX., 2017, PRELIMINARY STUDY BR; Yunnan Provincial Museum, 1959, EXC REP SHIZH ANC CE; Zhang J., 2017, CULTURAL RELICS SO C, V2, P94; Zhang J, 2009, ACTA PETROL SIN, V25, P2833; Zhang ZQ, 1978, CULTURAL RELICS, P31; Zhou SC, 2014, J CHINESE HIST GEOGR, V03, P57; Zhu BQ, 1995, J GEOCHEM EXPLOR, V55, P171, DOI 10.1016/0375-6742(95)00011-9	33	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205866	10.1371/journal.pone.0205866	http://dx.doi.org/10.1371/journal.pone.0205866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403700	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500030
J	Pederson, DB; Dong, YQ; Blue, LB; Smith, SV; Cao, M				Pederson, Daniel B.; Dong, Yuqing; Blue, Levi B.; Smith, Sara, V; Cao, Min			Water-soluble cranberry extract inhibits Vibrio cholerae biofilm formation possibly through modulating the second messenger 3 ', 5 ' - Cyclic diguanylate level	PLOS ONE			English	Article							O1 EL-TOR; C-DI-GMP; SIGNAL-TRANSDUCTION SYSTEMS; URINARY-TRACT-INFECTIONS; RUGOSE COLONY MORPHOLOGY; VPS BIOSYNTHESIS GENES; BIOACTIVE COMPOUNDS; POLYSACCHARIDE PRODUCTION; PORPHYROMONAS-GINGIVALIS; PSEUDOMONAS-AERUGINOSA	Quorum sensing (QS) and nucleotide-based second messengers are vital signaling systems that regulate bacterial physiology in response to changing environments. Disrupting bacterial signal transduction is a promising direction to combat infectious diseases, and QS and the second messengers are undoubtedly potential targets. In Vibrio cholerae, both QS and the second messenger 3', 5'-cyclic diguanylate (c-di-GMP) play a central role in controlling motility, motile-to-sessile life transition, and virulence. In this study, we found that water-soluble extract from the North American cranberry could significantly inhibit V. cholerae biofilm formation during the development/maturation stage by reducing the biofilm matrix production and secretion. The anti-biofilm effect by water-soluble cranberry extract was possibly through modulating the intracellular c-di-GMP level and was independent of QS and the QS master regulator HapR. Our results suggest an opportunity to explore more functional foods to fight stubborn infections through interference with the bacterial signaling systems.	[Pederson, Daniel B.; Dong, Yuqing; Blue, Levi B.; Smith, Sara, V; Cao, Min] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Dong, Yuqing; Cao, Min] Clemson Univ, Inst Engaged Aging, Clemson, SC 29634 USA	Clemson University; Clemson University	Cao, M (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.; Cao, M (corresponding author), Clemson Univ, Inst Engaged Aging, Clemson, SC 29634 USA.	mcao@clemson.edu		Cao, Min/0000-0003-1592-8111				ALBERT MJ, 1993, LANCET, V341, P704; Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Babu J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/590384; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Beyhan S, 2007, MOL MICROBIOL, V63, P995, DOI 10.1111/j.1365-2958.2006.05568.x; Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; Bodet C, 2008, CRIT REV FOOD SCI, V48, P672, DOI 10.1080/10408390701636211; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Burger O, 2002, CRIT REV FOOD SCI, V42, P279, DOI 10.1080/10408390209351916; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; Conner JG, 2017, CURR OPIN MICROBIOL, V36, P20, DOI 10.1016/j.mib.2017.01.002; Cote J, 2010, CRIT REV FOOD SCI, V50, P872, DOI 10.1080/10408390903042069; Cote J, 2010, CRIT REV FOOD SCI, V50, P666, DOI 10.1080/10408390903044107; Daglia M, 2012, CURR OPIN BIOTECH, V23, P174, DOI 10.1016/j.copbio.2011.08.007; DAHLBACK B, 1981, ARCH MICROBIOL, V128, P267, DOI 10.1007/BF00422527; Dinh J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103290; Feldman M, 2009, CURR MICROBIOL, V59, P469, DOI 10.1007/s00284-009-9462-3; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Harjai K, 2014, INDIAN J MED RES, V139, P446; Hollenbeck EC, 2014, BIOPHYS J, V107, P2245, DOI 10.1016/j.bpj.2014.10.015; Howell AB, 2005, PHYTOCHEMISTRY, V66, P2281, DOI 10.1016/j.phytochem.2005.05.022; Howell AB, 2007, MOL NUTR FOOD RES, V51, P732, DOI 10.1002/mnfr.200700038; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Jones CJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005068; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; Kim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145844; Koo H, 2006, CARIES RES, V40, P20, DOI 10.1159/000088901; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Labrecque J, 2006, J ANTIMICROB CHEMOTH, V58, P439, DOI 10.1093/jac/dkl220; Leshem R, 2011, INVEST OPHTH VIS SCI, V52, P4929, DOI 10.1167/iovs.10-5335; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Liu Z, 2007, INFECT IMMUN, V75, P122, DOI 10.1128/IAI.01190-06; Lutz C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00375; Maisuria VB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30169; Nakayama S, 2011, J AM CHEM SOC, V133, P4856, DOI 10.1021/ja1091062; Opoku-Temeng C, 2016, CHEM COMMUN, V52, P9327, DOI 10.1039/c6cc03439j; Pappas E, 2009, CRIT REV FOOD SCI, V49, P741, DOI 10.1080/10408390802145377; Prabu GR, 2006, J APPL MICROBIOL, V101, P487, DOI 10.1111/j.1365-2672.2006.02912.x; RAMAMURTHY T, 1993, LANCET, V341, P703, DOI 10.1016/0140-6736(93)90480-5; Rampioni G, 2014, BIOORG CHEM, V55, P60, DOI 10.1016/j.bioorg.2014.04.005; Rane HS, 2014, J ANTIMICROB CHEMOTH, V69, P428, DOI 10.1093/jac/dkt398; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shikuma NJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002719; Slobodnikova L, 2016, MOLECULES, V21, DOI 10.3390/molecules21121717; Srivastava D, 2013, MOL MICROBIOL, V90, P1262, DOI 10.1111/mmi.12432; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; Steinberg D, 2004, J ANTIMICROB CHEMOTH, V54, P86, DOI 10.1093/jac/dkh254; Tapiainen T, 2012, EUR J CLIN MICROBIOL, V31, P655, DOI 10.1007/s10096-011-1355-2; Thelin KH, 1996, INFECT IMMUN, V64, P2853, DOI 10.1128/IAI.64.7.2853-2856.1996; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Ulrey RK, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-499; van der Mei H.C., 1991, MICROBIAL CELL SURFA; Vance RE, 2003, INFECT IMMUN, V71, P2571, DOI 10.1128/IAI.71.5.2571-2576.2003; Walker EB, 1997, J FAM PRACTICE, V45, P167; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Wojnicz D, 2016, INT J FOOD SCI NUTR, V67, P1005, DOI 10.1080/09637486.2016.1211996; Yamanaka A, 2007, J PERIODONTAL RES, V42, P589, DOI 10.1111/j.1600-0765.2007.00982.x; Yamanaka A, 2004, ORAL MICROBIOL IMMUN, V19, P150, DOI 10.1111/j.0902-0055.2004.00130.x; Yildiz FH, 2004, MOL MICROBIOL, V53, P497, DOI 10.1111/j.1365-2958.2004.04154.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028; Yildiz FH, 2001, J BACTERIOL, V183, P1716, DOI 10.1128/JB.183.5.1716-1726.2001; Zhu J, 2003, DEV CELL, V5, P647, DOI 10.1016/S1534-5807(03)00295-8; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	71	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207056	10.1371/journal.pone.0207056	http://dx.doi.org/10.1371/journal.pone.0207056			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403745	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500099
J	Kohn, JR; Hilliard, ME; Lyons, SK; Fox, KA; Kushner, JA				Kohn, Jaden R.; Hilliard, Marisa E.; Lyons, Sarah K.; Fox, Karin A.; Kushner, Jake A.			Identifying and addressing gaps in reproductive health education for adolescent girls with type 1 diabetes	PLOS ONE			English	Article							CONGENITAL-ANOMALIES; GLYCEMIC CONTROL; PRECONCEPTION CARE; MENSTRUAL-CYCLE; EARLY-PREGNANCY; UNITED-STATES; WOMEN; OUTCOMES; RISK; MALFORMATIONS	Aims Adolescent girls with diabetes are at risk for adverse pregnancy outcomes due to age, risk-taking behavior, poor glycemic control, and lack of knowledge. Our aims were to assess attitudes and behaviors related to reproductive health education (RHE) among diabetes healthcare providers and adolescent girls with diabetes, and to pilot a brief clinic-based RHE intervention. Methods We surveyed 29 providers and 50 adolescent girls with type 1 diabetes about RHE experiences, attitudes, and behaviors. We piloted the RHE intervention with 9 adolescent-parent dyads. Results 50% of providers were very uncomfortable discussing pregnancy or contraception. Most (72%) did not proactively initiate RHE; common barriers included insufficient time and subject knowledge. Fewer than 10% recommended long-acting reversible contraceptives. A minority (10%) of adolescents had discussed pregnancy or contraception with a provider. RHE sessions lasted a median of 16 (range 13-24) minutes, and there were promising trends for changes in adolescents' self-efficacy and intentions to use contraception and seek preconception counseling and in their knowledge of reproductive health. Conclusion Adolescent girls with diabetes rarely receive education on pregnancy and contraception due to provider discomfort, limited knowledge, and limited time. RHE using easily-accessible materials with an educator may help address this gap in care.	[Kohn, Jaden R.] Baylor Coll Med, Houston, TX 77030 USA; [Hilliard, Marisa E.; Lyons, Sarah K.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Hilliard, Marisa E.; Lyons, Sarah K.] Texas Childrens Hosp, Houston, TX 77030 USA; [Fox, Karin A.] Baylor Coll Med, Dept Obstet & Gynaecol, Div Maternal Fetal Med, Houston, TX 77030 USA; [Kushner, Jake A.] Baylor Coll Med, McNair Med Inst, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Kohn, JR (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	jrskohn@gmail.com	Kushner, Jake A/AAF-5049-2022; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Lyons, Sarah/0000-0002-3686-0112	Albert Schweitzer Fellowship; National Institute of Health [K12 KD097696, 1R01AG040110]; Robert and Janice McNair Foundation; Diabetes Research Center of the Baylor College of Medicine [DRC - P30DK079638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK097696] Funding Source: NIH RePORTER	Albert Schweitzer Fellowship; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Janice McNair Foundation; Diabetes Research Center of the Baylor College of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Kohn's work on this project was supported by funds from the Albert Schweitzer Fellowship (http://www.schweitzerfellowship.org/).Dr. Hilliard's work on this project was supported in part by funds from the National Institute of Health [K12 KD097696 (PI: B Anderson)]. Dr. Kushner's work on this project was supported in part by funds from: the Robert and Janice McNair Foundation (http://www.mcnairfoundation.org/), the National Institute of Health [1R01AG040110], and the Diabetes Research Center of the Baylor College of Medicine [DRC - P30DK079638]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althabe F, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S8; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS137, DOI 10.2337/dc18-S013; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS13, DOI 10.2337/dc18-S002; American Diabetes Association, 2018, DIAB REPR HLTH GIRLS; [Anonymous], 2014, COUNT IT KEY DAT; Barata DS, 2013, DIABETES CARE, V36, pE70, DOI 10.2337/dc12-2248; Bayer LL, 2013, J ADOLESCENT HEALTH, V52, pS54, DOI 10.1016/j.jadohealth.2012.09.022; Bell R, 2012, DIABETOLOGIA; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Charron-Prochownik D, 2006, DIABETES EDUCATOR, V32, P235, DOI 10.1177/0145721706286895; Charron-Prochownik D, 2006, AM J HEALTH BEHAV, V30, P208, DOI 10.5993/AJHB.30.2.10; Charron-Prochownik D, 2008, DIABETES CARE, V31, P1327, DOI 10.2337/dc07-1266; Charron-Prochownik D, 2006, PEDIATR DIABETES, V7, P267, DOI 10.1111/j.1399-5448.2006.00197.x; Charron-Prochownik D, 2013, DIABETES CARE, V36, P3870, DOI 10.2337/dc13-0355; Clements MA, 2016, PEDIATR DIABETES, V17, P327, DOI 10.1111/pedi.12295; Codner E, 2012, PEDIATR DIABETES, V13, P108, DOI 10.1111/j.1399-5448.2011.00825.x; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575; Finer LB, 2014, AM J PUBLIC HEALTH, V104, pS43, DOI 10.2105/AJPH.2013.301416; Fischl AFR, 2010, DIABETES CARE, V33, P701, DOI 10.2337/dc09-1821; Gaete X, 2010, FERTIL STERIL, V94, P1822, DOI 10.1016/j.fertnstert.2009.08.039; Goldner Whitney S, 2004, Diabetes Technol Ther, V6, P473, DOI 10.1089/1520915041705875; Goldstuck Norman D, 2013, ISRN Obstet Gynecol, V2013, P814062, DOI 10.1155/2013/814062; Hamilton BE, 2017, 002 NAT CTR HLTH STA; Hillard Paula J Adams, 2015, Adolesc Med State Art Rev, V26, P382; Hilliard ME, 2011, DIABETES RES CLIN PR, V94, P39, DOI 10.1016/j.diabres.2011.05.027; Hilliard ME, 2011, ARCH PEDIAT ADOL MED, V165, P624, DOI 10.1001/archpediatrics.2011.86; Jovanovic L, 2006, ENDOCRIN METAB CLIN, V35, P79, DOI 10.1016/j.ecl.2005.09.008; KITZMILLER JL, 1991, JAMA-J AM MED ASSOC, V265, P731, DOI 10.1001/jama.265.6.731; Kost K, 2016, TEENAGE PREGNANCIES; MILLER E, 1981, NEW ENGL J MED, V304, P1331, DOI 10.1056/NEJM198105283042204; MILLS JL, 1979, DIABETES, V28, P292, DOI 10.2337/diabetes.28.4.292; Ozdemirci S, 2016, J MATERN-FETAL NEO M, V29, P3391, DOI 10.3109/14767058.2015.1130814; Ray JG, 2001, QJM-INT J MED, V94, P435, DOI 10.1093/qjmed/94.8.435; Rybak TM, 2017, J PEDIATR PSYCHOL, V42, P40, DOI 10.1093/jpepsy/jsw071; Schwarz EB, 2010, DIABETES EDUCATOR, V36, P489, DOI 10.1177/0145721710365171; Suris JC, 2004, ARCH DIS CHILD, V89, P938, DOI 10.1136/adc.2003.045369; WILLHOITE MB, 1993, DIABETES CARE, V16, P450, DOI 10.2337/diacare.16.2.450; YLINEN K, 1984, BRIT MED J, V289, P345, DOI 10.1136/bmj.289.6441.345	39	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206102	10.1371/journal.pone.0206102	http://dx.doi.org/10.1371/journal.pone.0206102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399169	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000007
J	Krzyzanowska-Berkowska, P; Czajor, K; Helemejko, I; Iskander, DR				Krzyzanowska-Berkowska, Patrycja; Czajor, Karolina; Helemejko, Iwona; Iskander, D. Robert			Relationship between the rate of change in lamina cribrosa depth and the rate of retinal nerve fiber layer thinning following glaucoma surgery	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAOCULAR-PRESSURE REDUCTION; PRELAMINAR TISSUE; THICKNESS; DISPLACEMENT; TRABECULECTOMY; PROGRESSION; REVERSAL	Purpose To assess whether lamina cribrosa depth (LCD) reduction and the rate of change in LCD over time (Delta LCD/Delta t) is associated with retinal nerve fiber layer (RNFL) thickness and the rate of RNFL thinning over time (Delta RNFL/Delta t) to test the hypothesis that, in a long term, RNFL thinning occurs irrespectively to the displacement of the lamina cribrosa following glaucoma surgery. Methods Twenty-nine primary open-angle glaucoma patients underwent glaucoma surgery. Sixteen patients underwent trabeculectomy and 13 patients undertook non-penetrating deep sclerectomy. Images of optic nerve head using spectral-domain optical coherence tomography (SD-OCT) with enhanced depth imaging technology were obtained preoperatively, at one-, three-, six-month and follow-up postoperative visit from 12 to 29 months after surgery (1pv, 3pv, 6pv, and FUpv, respectively). Correspondingly, measurements of the circumpapillary RNFL thickness were acquired. Results Intraocular pressure decreased from 24.0 +/- 8.9 to 10.9 +/- 3.9mmHg at 6pv (P<0.001) and to 12.7 +/- 4.4mmHg at FUpv (P<0.001). LCD was reduced from 465.3 +/- 136.4 mu m to 402.9 +/- 126.4 mu m at 1pv (P<0.001) and maintained similar position at 6pv (394.3 +/- 118.4 mu m; P = 0.170 with respect to 1pv). A significant decrease in the LCD was noted at FUpv (342.8 +/- 90.3 mu m, P<0.001) with respect to 6pv. RNFL thickness increased significantly to 64.9 +/- 19.8 mu m at 1pv (P = 0.005) and subsequently decreased to baseline level at 3pv. Further statistically significant decrease in RNFL thickness with respect to previous visit was found at 6pv and at FUpv (56.4 +/- 15.6 mu m and 55.0 +/- 14.0 mu m, P = 0.023 and P = 0.045, respectively). A thinner RNFL thickness at FUpv was not related to the LCD at FUpv (P = 0.129) but was correlated with Delta LCD/Delta t at FUpv (P = 0.003). The Delta RNFL/Delta t at FUpv was statistically significantly correlated with Delta LCD/Delta t at FUpv (P<0.001). Conclusions This is the first study that considers direct correlation between the rate of change in LCD with the rate of RNFL thinning over time. A thinner RNFL thickness following glaucoma surgery was associated with the rate of LCD reduction, not with position of the lamina cribrosa at the FUpv.	[Krzyzanowska-Berkowska, Patrycja; Czajor, Karolina; Helemejko, Iwona] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland; [Iskander, D. Robert] Wroclaw Univ Sci & Technol, Fac Fundamental Problems Technol, Dept Biomed Engn, Wroclaw, Poland	Wroclaw Medical University; Wroclaw University of Science & Technology	Krzyzanowska-Berkowska, P (corresponding author), Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland.	patrycja.krzyzanowska-berkowska@umed.wroc.pl	Iskander, D Robert/E-3576-2017	Iskander, D Robert/0000-0002-5962-6206; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534; Czajor, Karolina/0000-0002-4230-6134	Wroclaw Medical University Research Grant [ST-861]	Wroclaw Medical University Research Grant	This research was funded by the Wroclaw Medical University Research Grant number ST-861 to PKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin A, 2003, OPHTHALMOLOGY, V110, P1506, DOI 10.1016/S0161-6420(03)00493-7; Barrancos C, 2014, EYE, V28, P58, DOI 10.1038/eye.2013.238; Chang PT, 2007, OPHTHALMOLOGY, V114, P2252, DOI 10.1016/j.ophtha.2007.02.012; Ederer F, 2001, AM J OPHTHALMOL, V132, P311; Kadziauskiene A, 2018, OPHTHALMOLOGY; Kim YW, 2017, J GLAUCOMA, V26, P753, DOI 10.1097/IJG.0000000000000728; Krzyzanowska-Berkowska P, 2018, GRAEF ARCH CLIN EXP, V256, P791, DOI 10.1007/s00417-018-3920-1; Lanzagorta-Aresti A, 2017, BRIT J OPHTHALMOL, V101, P290, DOI 10.1136/bjophthalmol-2015-307428; LEE EJ, 2012, OPHTHALMOLOGY, V119; Lee EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168678; Lee EJ, 2015, OPHTHALMOLOGY, V122, P2234, DOI 10.1016/j.ophtha.2015.07.020; Lee EJ, 2015, OPHTHALMOLOGY, V122, P721, DOI 10.1016/j.ophtha.2014.10.007; Lee EJ, 2013, OPHTHALMOLOGY, V120, P553, DOI 10.1016/j.ophtha.2012.08.047; Lee EJ, 2011, AM J OPHTHALMOL, V152, P87, DOI 10.1016/j.ajo.2011.01.024; Lee SH, 2016, INVEST OPHTH VIS SCI, V57, P5006, DOI 10.1167/iovs.15-18982; Leung CKS, 2010, INVEST OPHTH VIS SCI, V51, P217, DOI 10.1167/iovs.09-3468; Mansberger SL, 2017, AM J OPHTHALMOL, V174, P1, DOI 10.1016/j.ajo.2016.10.020; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Quigley HA, 2015, PROG BRAIN RES, V220, P59, DOI 10.1016/bs.pbr.2015.04.003; Quigley HA, 2013, CELL TISSUE RES, V353, P231, DOI 10.1007/s00441-013-1603-0; Raghu N, 2012, EYE, V26, P1131, DOI 10.1038/eye.2012.115; Rebolleda G, 2007, OPHTHALMOLOGY, V114, P488, DOI 10.1016/j.ophtha.2006.06.051; Reis ASC, 2012, INVEST OPHTH VIS SCI, V53, P5819, DOI 10.1167/iovs.12-9924; Saeedi O, 2014, BRIT J OPHTHALMOL, V98, P976, DOI 10.1136/bjophthalmol-2013-304433; SOGANO S, 1993, OPHTHALMOLOGY, V100, P1253; Waisbourd M, 2016, GRAEF ARCH CLIN EXP, V254, P1159, DOI 10.1007/s00417-016-3321-2; Wu ZC, 2017, AM J OPHTHALMOL, V181, P106, DOI 10.1016/j.ajo.2017.06.017	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206040	10.1371/journal.pone.0206040	http://dx.doi.org/10.1371/journal.pone.0206040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399148	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000006
J	Broncel, A; Bocian, R; Klos-Wojtczak, P; Konopacki, J				Broncel, Adam; Bocian, Renata; Klos-Wojtczak, Paulina; Konopacki, Jan			Medial septal cholinergic mediation of hippocampal theta rhythm induced by vagal nerve stimulation	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; LONG-TERM; ELECTRICAL-STIMULATION; DENTATE GYRUS; NEURONS; MEMORY; ORGANIZATION; OSCILLATION; MODULATION; MECHANISMS	Background Electrical vagal nerve stimulation (VNS) has been used for years to treat patients with drug-resistant epilepsy. This technique also remains under investigation as a specific treatment of patients with Alzheimer's disease. Recently we discovered that VNS induced hippocampal formation (HPC) type II theta rhythm, which is involved in memory consolidation. In the present study, we have extended our previous observation and addressed the neuronal substrate and pharmacological profile of HPC type II theta rhythm induced by VNS in anesthetized rats. Methods Male Wistar rats were implanted with a VNS cuff electrode around the left vagus nerve, a tungsten microelectrode for recording the HPC field activity, and a medial septal (MS) cannula for the injection of a local anesthetic, procaine, and muscarinic agents. A direct, brief effect of VNS on the HPC field potential was evaluated before and after medial-septal drug injection. Results Medial septal injection of local anesthetic, procaine, reversibly abolished VNS-induced HPC theta rhythm. With the use of cholinergic muscarinic agonist and antagonists, we demonstrated that medial septal M1 receptors are involved in the mediation of the VNS effect on HPC theta field potential. Conclusion The MS cholinergic M1 receptor mechanism integrates not only central inputs from the brainstem synchronizing pathway, which underlies the production of HPC type II theta rhythm, but also the input from the vagal afferents in the brain stem.	[Broncel, Adam; Klos-Wojtczak, Paulina] Res Dept, Neuromed, Lodz, Poland; [Bocian, Renata; Klos-Wojtczak, Paulina; Konopacki, Jan] Univ Lodz, Fac Biol & Environm Protect, Dept Neurobiol, Lodz, Poland	University of Lodz	Konopacki, J (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Neurobiol, Lodz, Poland.	jan.konopacki@biol.uni.lodz.pl	Broncel, Adam/AAA-9480-2022	Bocian, Renata/0000-0003-0335-4923; Konopacki, Jan/0000-0003-2814-0550	Regional Operational Programme for Lodzkie Voivodeship [RPLD.01.02.02-10-0067/17-00]	Regional Operational Programme for Lodzkie Voivodeship	This work was supported by grant from Regional Operational Programme for Lodzkie Voivodeship for 2014-2020 (grant number: RPLD.01.02.02-10-0067/17-00).	Aalbers M, 2011, EXP NEUROL, V230, P167, DOI 10.1016/j.expneurol.2011.04.014; Ben-Menachem E, 2002, LANCET NEUROL, V1, P477, DOI 10.1016/S1474-4422(02)00220-X; Biggio F, 2009, INT J NEUROPSYCHOPH, V12, P1209, DOI 10.1017/S1461145709000200; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; BLAND BH, 1986, PROG NEUROBIOL, V26, P1, DOI 10.1016/0301-0082(86)90019-5; BLAND BH, 1993, PROG NEUROBIOL, V41, P157, DOI 10.1016/0301-0082(93)90007-F; Bland BH, 1998, NEUROSCI BIOBEHAV R, V22, P259, DOI 10.1016/S0149-7634(97)00013-4; Bland BH, 1999, J NEUROSCI, V19, P3223; Bland BH, 2006, HIPPOCAMPUS, V16, P673, DOI 10.1002/hipo.20210; Bland Brian H., 2000, P115; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Boyce R, 2016, SCIENCE, V352, P812, DOI 10.1126/science.aad5252; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Broncel A, 2017, ACTA NEUROBIOL EXP, V77, P1; Broncel A, 2017, BRAIN RES, V1675, P41, DOI 10.1016/j.brainres.2017.08.030; BRUNELLO N, 1981, J PHARMACOL EXP THER, V219, P489; BUNO W, 1978, BRAIN RES BULL, V3, P21, DOI 10.1016/0361-9230(78)90057-6; BUZSAKI G, 1983, BRAIN RES REV, V6, P139, DOI 10.1016/0165-0173(83)90037-1; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Castle M, 2005, NEUROSCIENCE, V134, P657, DOI 10.1016/j.neuroscience.2005.04.031; Clark KB, 1999, NAT NEUROSCI, V2, P94, DOI 10.1038/4600; Crooks R, 2012, HIPPOCAMPUS, V22, P1567, DOI 10.1002/hipo.20999; DASILVA FHL, 1990, PHYSIOL REV, V70, P453, DOI 10.1152/physrev.1990.70.2.453; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; DeGiorgio CM, 2000, EPILEPSIA, V41, P1195, DOI 10.1111/j.1528-1157.2000.tb00325.x; FIBIGER HC, 1982, BRAIN RES REV, V4, P327, DOI 10.1016/0165-0173(82)90011-X; Ghacibeh GA, 2006, COGN BEHAV NEUROL, V19, P119, DOI 10.1097/01.wnn.0000213908.34278.7d; GILAD GM, 1987, BRAIN RES, V436, P311, DOI 10.1016/0006-8993(87)91675-1; Golebiewski H, 2002, BRAIN RES BULL, V58, P323, DOI 10.1016/S0361-9230(02)00797-9; Goutagny R, 2008, NEUROSCIENCE, V152, P849, DOI 10.1016/j.neuroscience.2007.12.014; HALSELL CB, 1992, J COMP NEUROL, V317, P57, DOI 10.1002/cne.903170105; Hasselmo ME, 2002, NEURAL NETWORKS, V15, P689, DOI 10.1016/S0893-6080(02)00057-6; Hord ED, 2003, J PAIN, V4, P530, DOI 10.1016/j.jpain.2003.08.001; Howland Robert H, 2014, Curr Behav Neurosci Rep, V1, P64; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Kang D, 2015, J NEUROPHYSIOL, V114, P2797, DOI 10.1152/jn.00542.2015; Klos-Wojtczak P, 2017, ACTA NEUROBIOL EXP, V77; Knight J, 2006, BRAIN RES, V1072, P36, DOI 10.1016/j.brainres.2005.12.020; Konopacki J, 1998, NEUROSCI BIOBEHAV R, V22, P311, DOI 10.1016/S0149-7634(97)00017-1; Krahl SE, 2004, J PSYCHIATR RES, V38, P237, DOI 10.1016/j.jpsychires.2003.11.005; Krahl SE, 2003, EPILEPSY RES, V56, P1, DOI 10.1016/S0920-1211(03)00122-0; Larsen LE, 2016, NEUROTHERAPEUTICS, V13, P592, DOI 10.1007/s13311-016-0432-8; Larsen LE, 2016, BRAIN STIMUL, V9, P124, DOI 10.1016/j.brs.2015.09.009; LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7; Leung LS, 1998, NEUROSCI BIOBEHAV R, V22, P275; Li SM, 2007, SYNAPSE, V61, P412, DOI 10.1002/syn.20388; Lopes da Silva F.H., 1992, INDUCED RHYTHMS BRAI, P83; Manta S, 2013, INT J NEUROPSYCHOPH, V16, P459, DOI 10.1017/S1461145712000387; Manta Stella, 2009, J Psychiatry Neurosci, V34, P272; MCNAUGHTON N, 1980, NEUROSCI LETT, V18, P67, DOI 10.1016/0304-3940(80)90214-1; MONMAUR P, 1991, BRAIN RES, V544, P150, DOI 10.1016/0006-8993(91)90898-6; Murphy D, 1998, BRAIN RES BULL, V45, P631, DOI 10.1016/S0361-9230(97)00462-0; ODDIE SD, 1994, HIPPOCAMPUS, V4, P454, DOI 10.1002/hipo.450040408; Oddie SD, 1998, NEUROSCI BIOBEHAV R, V22, P221, DOI 10.1016/S0149-7634(97)00003-1; Oddie SD, 1997, BEHAV BRAIN RES, V88, P169, DOI 10.1016/S0166-4328(97)02290-0; Oddie SD, 1996, J NEUROSCI, V16, P1948; Paton JFR, 2000, NEUROSCIENCE, V95, P141; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; Paxinos G., 2014, RAT BRAIN STEREOTAXI; Pena DF, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00327; PETSCHE H, 1965, ELECTROEN CLIN NEURO, V19, P25, DOI 10.1016/0013-4694(65)90004-0; Peyron C, 1996, J COMP NEUROL, V364, P402; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Raedt R, 2011, J NEUROCHEM, V117, P461, DOI 10.1111/j.1471-4159.2011.07214.x; Rizzo P, 2003, SLEEP, V26, P607, DOI 10.1093/sleep/26.5.607; Roosevelt RW, 2006, BRAIN RES, V1119, P124, DOI 10.1016/j.brainres.2006.08.048; Sainsbury RS, 1998, NEUROSCI BIOBEHAV R, V22, P237, DOI 10.1016/S0149-7634(97)00011-0; Sainsbury RS, 1985, ELECT ACTIVITY ARCHI, P11; Shapiro ML, 1983, SOC NEUR ABSTR, V13, P87; Sjogren MJC, 2002, J CLIN PSYCHIAT, V63, P972, DOI 10.4088/JCP.v63n1103; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Smucny J, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00043; SMYTHE JW, 1992, NEUROSCI BIOBEHAV R, V16, P289, DOI 10.1016/S0149-7634(05)80203-9; STERIADE M, 1990, ELECTROEN CLIN NEURO, V76, P481, DOI 10.1016/0013-4694(90)90001-Z; STEWART M, 1989, J NEUROPHYSIOL, V61, P982, DOI 10.1152/jn.1989.61.5.982; STORMMATHISEN J, 1978, NEUROSCI LETT, V9, P65, DOI 10.1016/0304-3940(78)90049-6; Straube A, 2015, J HEADACHE PAIN, V16, DOI 10.1186/s10194-015-0543-3; TERHORST GJ, 1989, NEUROSCIENCE, V31, P785; Ura H, 2013, BRAIN RES, V1492, P63, DOI 10.1016/j.brainres.2012.11.024; Van Bockstaele EJ, 1999, SYNAPSE, V34, P154, DOI 10.1002/(SICI)1098-2396(199911)34:2<154::AID-SYN8>3.0.CO;2-C; VANDERWOLF CH, 1986, BRAIN RES, V374, P342, DOI 10.1016/0006-8993(86)90428-2; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; VERTES RP, 1981, J NEUROPHYSIOL, V46, P1140, DOI 10.1152/jn.1981.46.5.1140; Vertes RP, 1997, NEUROSCIENCE, V81, P893; Watson BO, 2015, DAEDALUS-US, V144, P67, DOI 10.1162/DAED_a_00318; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Xiang YX, 2015, NEURAL REGEN RES, V10, P576, DOI 10.4103/1673-5374.155430; Yamaguchi Yoko, 2004, Journal of Integrative Neuroscience, V3, P143, DOI 10.1142/S0219635204000488; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021; Zuo YT, 2007, PHYSIOL BEHAV, V90, P583, DOI 10.1016/j.physbeh.2006.11.009	91	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206532	10.1371/journal.pone.0206532	http://dx.doi.org/10.1371/journal.pone.0206532			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395575	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400030
J	Higgins, LE; Myers, JE; Sibley, CP; Johnstone, ED; Heazell, AEP				Higgins, Lucy E.; Myers, Jenny E.; Sibley, Colin P.; Johnstone, Edward D.; Heazell, Alexander E. P.			Antenatal placental assessment in the prediction of adverse pregnancy outcome after reduced fetal movement	PLOS ONE			English	Article							MIDDLE CEREBRAL-ARTERY; DOPPLER WAVE-FORMS; REFERENCE RANGES; GROWTH-FACTOR; PULSATILITY INDEX; UMBILICAL ARTERY; BIRTH-WEIGHT; SERIAL MEASUREMENTS; PERINATAL MORBIDITY; UTERINE ARTERIES	Objective To assess the value of in utero placental assessment in predicting adverse pregnancy outcome after reported reduced fetal movements (RFM). Method A non-interventional prospective cohort study of women (N = 300) with subjective RFM at >= 28 weeks' gestation in singleton non-anomalous pregnancies at a UK tertiary maternity hospital. Clinical, sonographic (fetal weight, placental size and maternal, fetal and placental arterial Doppler) and biochemical (maternal serum hCG, hPL, progesterone, PIGF and sFlt-1) assessment was conducted. Multiple logistic regression identified combinations of measurements (models) most predictive of adverse pregnancy outcome (perinatal mortality, birth weight <10th centile, five minute Apgar score <7, umbilical arterial pH <7.1 or base excess <-10, neonatal intensive care admission). Models were compared by test performance characteristics (ROC curve, sensitivity, specificity, positive/negative predictive value, positive/negative likelihood ratios) against baseline care (estimated fetal weight centile, amniotic fluid index and gestation at presentation). Results 61 (20.6%) pregnancies ended in adverse outcome. Models incorporating PIGF/sFlt-1 ratio and umbilical artery free loop Doppler impedance demonstrated modest improvement in ROC area for adverse outcome (baseline care 0.69 vs. proposed models 0.73-0.76, p<0.05). However, there was little improvement in other test characteristics (baseline vs. best proposed model: sensitivity 21.7% [95% confidence interval 13.1-33.6] vs. 35.8%% [24.4-49.3], specificity 96.6% [93.4-98.3] vs. 94.7% [90.7-97.0], PPV 61.9% [40.9-79.3] vs. 63.3% [45.5-78.1], NPV 82.8% [77.9-86.8] vs. 85.2% [80.0-89.2], positive LR 6.3 [2.814.6] vs. 6.7 [3.4-3.3], negative LR 0.81 [0.71-0.93] vs. 0.68 [0.55-0.83]) and wide confidence intervals. Negative post-test probability remained high (16.7% vs. 14.0%). Conclusion Antenatal placental assessment may improve identification of RFM pregnancies at highest risk of adverse pregnancy outcome but further work is required to understand and refine currently available outcome definitions and diagnostic techniques to improve clinical utility.	[Higgins, Lucy E.; Myers, Jenny E.; Sibley, Colin P.; Johnstone, Edward D.; Heazell, Alexander E. P.] Univ Manchester, Fac Biol Med & Hlth, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Higgins, Lucy E.; Myers, Jenny E.; Sibley, Colin P.; Johnstone, Edward D.; Heazell, Alexander E. P.] Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Higgins, LE (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.; Higgins, LE (corresponding author), Manchester Univ NHS Fdn Trust, St Marys Hosp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	lucy.higgins@manchester.ac.uk		Myers, Jenny/0000-0003-0913-2096; Higgins, Lucy/0000-0003-0993-497X	NIHR Manchester Biomedical Research Centre pump-prime fellowship [HIGLa899]; Action Medical Research Training Fellowship [GN2136]; National Institute of Health Research Clinical Scientist fellowships [CS-13-009, CS-011-020]; Tommy's -the Baby Charity	NIHR Manchester Biomedical Research Centre pump-prime fellowship; Action Medical Research Training Fellowship; National Institute of Health Research Clinical Scientist fellowships; Tommy's -the Baby Charity	LH was supported by an NIHR Manchester Biomedical Research Centre pump-prime fellowship (HIGLa899; https://www.manchesterbrc.nihr.ac.uk) and an Action Medical Research Training Fellowship (GN2136; https://www.action.org.uk).AEPH and JM are supported by National Institute of Health Research Clinical Scientist fellowships (respectively CS-13-009 and CS-011-020; https://www.nihr.ac.uk).The study was supported by Tommy's -the Baby Charity (https://www.tommys.org).The funders had no role in the design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings represent the views of the authors, not the funders.	Acharya G, 2005, ULTRASOUND OBST GYN, V26, P162, DOI 10.1002/uog.1902; Acharya G, 2005, AM J OBSTET GYNECOL, V192, P937, DOI 10.1016/j.ajog.2004.09.019; Babovic I, 2011, CLIN EXP OBSTET GYN, V38, P43; Bahlmann F, 2002, J PERINAT MED, V30, P490, DOI 10.1515/JPM.2002.077; Benton SJ, 2016, PLACENTA, V42, P1, DOI 10.1016/j.placenta.2016.03.010; Campbell S, 2000, ACTA OBSTET GYN SCAN, V79, P631, DOI 10.1034/j.1600-0412.2000.079008631.x; Chaiworapongsa T, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.01.016; Clark DE, 1998, BIOL REPROD, V59, P1540, DOI 10.1095/biolreprod59.6.1540; Dutton PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039784; Ebbing C, 2007, ULTRASOUND OBST GYN, V30, P287, DOI 10.1002/uog.4088; Espinoza J, 2007, J MATERN-FETAL NEO M, V20, P495, DOI 10.1080/14767050701413022; Figueras F, 2007, ARCH DIS CHILD-FETAL, V92, P277, DOI 10.1136/adc.2006.108621; Figueras F, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014835; Flenady V, 2011, LANCET, V377, P1703, DOI 10.1016/S0140-6736(11)60064-0; Flenady V, 2009, AUST NZ J OBSTET GYN, V49, P358, DOI 10.1111/j.1479-828X.2009.01026.x; Gomez O, 2008, ULTRASOUND OBST GYN, V32, P128, DOI 10.1002/uog.5315; Griffin M, 2015, ULTRASOUND OBST GYN, V46, P182, DOI 10.1002/uog.14860; Heazell AEP, 2015, PLACENTA, V36, pS20, DOI 10.1016/j.placenta.2014.12.017; Heazell AEP, 2008, ACTA OBSTET GYN SCAN, V87, P331, DOI 10.1080/00016340801902034; Heazell AEP, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-95; Heidweiller-Schreurs CAV, 2018, ULTRASOUND OBST GYN, V51, P313, DOI 10.1002/uog.18809; Higgins L, FEMINA2 MENDELEY DAT, DOI [10.17632/vsxsjhp6n3.1, DOI 10.17632/VSXSJHP6N3.1]; Higgins LE, 2016, PLACENTA, V42, P51, DOI 10.1016/j.placenta.2016.04.010; Higgins LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129117; Hrynaszkiewicz I, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c181; Joern H, 1997, ULTRASOUND MED BIOL, V23, P1179, DOI 10.1016/S0301-5629(97)00085-9; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Khan KS, 2001, BRIT J OBSTET GYNAEC, V108, P562; Kingdom JCP, 1997, ULTRASOUND OBST GYN, V9, P271, DOI 10.1046/j.1469-0705.1997.09040271.x; Knight HE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002000; Kurdi W, 2004, EUR J OBSTET GYN R B, V117, P20, DOI 10.1016/j.ejogrb.2003.10.038; Kurmanavicius J, 1997, ULTRASOUND OBST GYN, V10, P112, DOI 10.1046/j.1469-0705.1997.10020112.x; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; MacDorman MF, 2006, NATL VITAL STAT REPO, V60; Magann EF, 2000, OBSTET GYNECOL, V96, P737, DOI 10.1016/S0029-7844(00)01020-6; McCarthy CM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0964-2; McCowan LME, 2005, BJOG-INT J OBSTET GY, V112, P1026, DOI 10.1111/j.1471-0528.2005.00656.x; Ministry of Health, 2012, FET INF DEATHS 2008; Morales-Rosello J, 2014, ULTRASOUND OBST GYN, V43, P303, DOI 10.1002/uog.13319; O'Sullivan O, 2009, J OBSTET GYNAECOL, V29, P705, DOI 10.3109/01443610903229598; Oros D, 2011, ULTRASOUND OBST GYN, V37, P191, DOI 10.1002/uog.7738; Pagani G, 2014, PLACENTA, V35, P606, DOI 10.1016/j.placenta.2014.04.020; Pagani G, 2014, ULTRASOUND OBST GYN, V43, P548, DOI 10.1002/uog.13220; Palacio M, 2004, ULTRASOUND OBST GYN, V24, P647, DOI 10.1002/uog.1761; Platt MW, 2016, ARCH DIS CHILD-FETAL, V101, P4, DOI 10.1136/archdischild-2015-309271; Prefumo F, 2004, OBSTET GYNECOL, V103, P764, DOI 10.1097/01.AOG.0000118310.51730.2d; Prior T, 2014, OBSTET GYNECOL, V123, P1263, DOI 10.1097/AOG.0000000000000292; Rizzo G, 2009, J ULTRAS MED, V28, P1615, DOI 10.7863/jum.2009.28.12.1615; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Shibata E, 2005, J CLIN ENDOCR METAB, V90, P4895, DOI 10.1210/jc.2004-1955; Smith GCS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001274; Smith GCS, 2010, CLIN OBSTET GYNECOL, V53, P597, DOI 10.1097/GRF.0b013e3181eb64a6; Smith V, 2014, MIDWIFERY, V30, P43, DOI 10.1016/j.midw.2013.02.006; SONESSON SE, 1993, J CLIN ULTRASOUND, V21, P317, DOI 10.1002/jcu.1870210505; Toal M, 2008, J OBSTET GYNAECOL CA, V30, P198, DOI 10.1016/S1701-2163(16)32756-6; Ukah UV, 2017, HYPERTENSION, V70, P1228, DOI 10.1161/HYPERTENSIONAHA.117.10150; Unterscheider J, 2013, AM J OBSTET GYNECOL, V208, DOI [10. 1016/j. ajog. 2013. 02. 007, DOI 10.1016/J.AJ0G.2013.02.007]; Warrander LK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034851; Whitworth M, 2011, REDUCED FETAL MOVEME; Winje BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039259; Zeisler H, 2016, NEW ENGL J MED, V374, P13, DOI 10.1056/NEJMoa1414838; Zeitlin J., 2013, EUROPEAN PERINATAL H	62	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206533	10.1371/journal.pone.0206533	http://dx.doi.org/10.1371/journal.pone.0206533			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395584	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400031
J	Iesu, E; Franchi, F; Cavicchi, FZ; Pozzebon, S; Fontana, V; Mendoza, M; Nobilel, L; Scolletta, S; Vincent, JL; Creteur, J; Taccone, FS				Iesu, Enrica; Franchi, Federico; Cavicchi, Federica Zama; Pozzebon, Selene; Fontana, Vito; Mendoza, Manuel; Nobilel, Leda; Scolletta, Sabino; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio Silvio			Acute liver dysfunction after cardiac arrest	PLOS ONE			English	Article							INTERNATIONAL LIAISON COMMITTEE; AMERICAN-HEART-ASSOCIATION; ACUTE KIDNEY INJURY; HYPOXIC HEPATITIS; INTENSIVE-CARE; FAILURE; RESUSCITATION; CARDIOPULMONARY; PROGNOSTICATION; STATEMENT	Few data are available regarding hypoxic hepatitis (HH) and acute liver failure (ALF) in patients resuscitated from cardiac arrest (CA). The aim of this study was to describe the occurrence of these complications and their association with outcome. All adult patients admitted to the Department of Intensive Care following CA were considered for inclusion in this retrospective study. Exclusion criteria were early death (<24 hours) or missing biological data. We retrieved data concerning CA characteristics and markers of liver function. ALF was defined as a bilirubin >1.2 mg/dL and an international normalized ratio >= 1.5. HH was defined as an aminotransferase level >1000 IU/L. Neurological outcome was assessed at 3 months and an unfavourable neurological outcome was defined as a Cerebral Performance Categories (CPC) score of 3-5. A total of 374 patients (age 62 [52-74] years; 242 male) were included. ALF developed in 208 patients (56%) and HH in 27 (7%); 24 patients developed both conditions. Patients with HH had higher mortality (89% vs. 51% vs. 45%, respectively) and greater rates of unfavourable neurological outcome (93% vs. 60% vs. 59%, respectively) compared to those with ALF without HH (n = 184) and those without ALF or HH (n = 163; p = 0.03). Unwitnessed arrest, non-shockable initial rhythm, lack of bystander cardiopulmonary resuscitation, high adrenaline doses and the development of acute kidney injury were independent predictors of unfavourable neurological outcome; HH (OR: 16.276 [95% Cls: 2.625-81.345; p = 0.003), but not ALF, was also a significant risk-factor for unfavourable outcome. Although ALF occurs frequently after CA, HH is a rare complication. Only HH is significantly associated with poor neurological outcome in this setting.	[Iesu, Enrica; Franchi, Federico; Cavicchi, Federica Zama; Pozzebon, Selene; Fontana, Vito; Mendoza, Manuel; Nobilel, Leda; Vincent, Jean-Louis; Creteur, Jacques; Taccone, Fabio Silvio] Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium; [Franchi, Federico; Pozzebon, Selene; Scolletta, Sabino] Univ Siena, Dept Med Biotechnol, Anesthesia & Intens Care Unit, Siena, Italy; [Mendoza, Manuel] Hosp Univ Tarragona Joan XXIII, Dept Intens Care, Tarragona, Spain	Universite Libre de Bruxelles; University of Siena; Universitat Rovira i Virgili; Hospital Universitari De Tarragona Joan XXIII	Taccone, FS (corresponding author), Univ Libre Bruxelles, Erasme Hosp, Dept Intens Care, Brussels, Belgium.	ftaccone@ulb.ac.be		Vincent, Jean-Louis/0000-0001-6011-6951				Beitler JR, 2017, AM J RESP CRIT CARE, V195, P1198, DOI 10.1164/rccm.201609-1771OC; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Champigneulle B, 2016, RESUSCITATION, V103, P60, DOI 10.1016/j.resuscitation.2016.03.021; Dragancea I, 2013, RESUSCITATION, V84, P337, DOI 10.1016/j.resuscitation.2012.09.015; Fuhrmann V, 2011, INTENS CARE MED, V37, P1302, DOI 10.1007/s00134-011-2248-7; Fuhrmann V, 2009, INTENS CARE MED, V35, P1397, DOI 10.1007/s00134-009-1508-2; Hadem J, 2012, CLIN GASTROENTEROL H, V10, P664, DOI 10.1016/j.cgh.2012.02.016; Henrion J, 2012, LIVER INT, V32, P1039, DOI 10.1111/j.1478-3231.2011.02655.x; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; JENNETT B, 1975, LANCET, V1, P480; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; McDowell Torres Dawn, 2010, Gastroenterol Hepatol (N Y), V6, P444; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nobile L, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1528-6; Nolan JP, 2008, RESUSCITATION, V79, P350, DOI 10.1016/j.resuscitation.2008.09.017; Oh SH, 2015, AM J EMERG MED, V33, P1166, DOI 10.1016/j.ajem.2015.05.008; Ortiortiz AB, 2017, MINERVA ANESTESIOL, V83, P255, DOI 10.23736/S0375-9393.16.11442-7; Perkins GD, 2016, RESUSCITATION, V108, P75, DOI 10.1016/j.resuscitation.2016.08.029; Raurich JM, 2011, J ANESTH, V25, P50, DOI 10.1007/s00540-010-1058-3; Roberts BW, 2013, CRIT CARE MED, V41, P1492, DOI 10.1097/CCM.0b013e31828a39e9; Sandroni C, 2016, MINERVA ANESTESIOL, V82, P989; Saner FH, 2009, EUR J MED RES, V14, P541; Sintek MA, 2015, J CARD FAIL, V21, P868, DOI 10.1016/j.cardfail.2015.06.383; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Studer W, 2002, RESUSCITATION, V53, P201, DOI 10.1016/S0300-9572(02)00007-2; Taccone FS, 2014, CRIT CARE, V18, DOI 10.1186/cc13696; Tujjar O, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0900-2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	29	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206655	10.1371/journal.pone.0206655	http://dx.doi.org/10.1371/journal.pone.0206655			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395574	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400039
J	Gyawali, B; Hansen, MRH; Povlsen, MB; Neupane, D; Andersen, PK; McLachlan, CS; Sandbaek, A; Vaidya, A; Kallestrup, P				Gyawali, Bishal; Hansen, Martin Rune Hassan; Povlsen, Mia Buhl; Neupane, Dinesh; Andersen, Peter Krogh; McLachlan, Craig Steven; Sandbaek, Annelli; Vaidya, Abhinav; Kallestrup, Per			Awareness, prevalence, treatment, and control of type 2 diabetes in a semi-urban area of Nepal: Findings from a cross-sectional study conducted as a part of COBIN-D trial	PLOS ONE			English	Article							COMMUNITY-BASED INTERVENTION; RISK-FACTORS; URBAN-POPULATION; PROJECTIONS; PROTOCOL; DISEASE; NORTH	Background Type 2 diabetes is an escalating public health problem in Nepal. The current study aims to assess the prevalence, associated factors, awareness, treatment, and control of type 2 diabetes in a semi-urban area of Nepal. Methods A population-based cross-sectional survey was conducted including 2,310 adults aged 25 years or above from a semi-urban area of Lekhnath Municipality of Nepal, during October 2016 to April 2017 using the World Health Organization (WHO) STEPS approach. Data on demographics, behavioral risk factors, blood pressure, anthropometric measurements (weight, height, waist and hip circumference), and fasting blood glucose were collected by face-to-face interviews during a door-to-door visit. Participants were considered to have type 2 diabetes if they had previously been diagnosed by a physician and/or were on antidiabetic medications and/or had fasting blood glucose >= 7.0 mmol/L. Participants were classified as being aware of their diabetes conditions if they had earlier been told that they had type 2 diabetes. Treatment of diabetes among those aware was if participants received any kind of medication treatment or counseling, and control of diabetes among those treated was defined as fasting blood glucose level was <7.0 mmol/L. Odds Ratio (OR) with 95% Confidence Interval (CI) was used to determine the strength of association. Results The prevalence of type 2 diabetes was 11.7% (95% CI: 10.5-13.1). Among type 2 diabetes participants, 65% were aware of their disease, 94% of those who were aware received treatment, and 21% of the treated subjects had their diabetes under control. Factors significantly associated with type 2 diabetes were older age (OR = 3.2 for age group 45-54 years, OR = 3.8 for age group 55-64 years), Janajati ethnicity (OR = 1.4), abdominal obesity (OR = 2.3), being overweight or obese (OR = 1.4), and hypertension (OR = 2.0), while protective factors included being a female (OR = 0.4), medium physical activity (OR = 0.3), high physical activity (OR = 0.2), and not having family history of diabetes (OR = 0.3). Conclusions The study revealed a high prevalence of type 2 diabetes among adults. Older age, male gender, Janajati ethnicity, abdominal obesity, overweight or obesity, hypertension, low physical activity, and family history of diabetes were associated with type 2 diabetes. Immediate public health and individual measures are warranted to reduce further burden of type 2 diabetes.	[Gyawali, Bishal; Hansen, Martin Rune Hassan; Povlsen, Mia Buhl; Andersen, Peter Krogh; Sandbaek, Annelli; Kallestrup, Per] Aarhus Univ, Dept Publ Hlth, Aarhus C, Denmark; [Hansen, Martin Rune Hassan] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Neupane, Dinesh] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Dept Epidemiol, Baltimore, MD USA; [McLachlan, Craig Steven] Univ New South Wales, Rural Clin Sch, Sydney, NSW, Australia; [Vaidya, Abhinav] Kathmandu Med Coll, Dept Community Med, Kathmandu, Nepal; [Vaidya, Abhinav] Teaching Hosp, Kathmandu, Nepal	Aarhus University; National Research Centre for the Working Environment; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of New South Wales Sydney	Gyawali, B (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus C, Denmark.	bishalforu@hotmail.com	McLachlan, Craig S/E-5340-2013; Kallestrup, Per/AAA-8313-2022	Kallestrup, Per/0000-0001-6041-4510; McLachlan, Craig/0000-0001-9843-8980; Gyawali, Bishal/0000-0002-8315-1925; Sandbaek, Annelli/0000-0003-1647-2646; Hansen, Martin Rune Hassan/0000-0001-9681-2393	Aarhus University scholarship; International Center for Occupational and Environmental Medicine and Public Health, Clinic of Occupational and Environmental Medicine, Odense University Hospital, Odense, Demark	Aarhus University scholarship; International Center for Occupational and Environmental Medicine and Public Health, Clinic of Occupational and Environmental Medicine, Odense University Hospital, Odense, Demark	This study is funded by an Aarhus University scholarship. The authors would also like to thank International Center for Occupational and Environmental Medicine and Public Health, Clinic of Occupational and Environmental Medicine, Odense University Hospital, Odense, Demark for partial funding. There was no additional external funding received for this study.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Anjana RM, 2011, DIABETOLOGIA, V54, P3022, DOI 10.1007/s00125-011-2291-5; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Bhandari GP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-23; Bhowmik B, 2013, DIABETES METAB J, V37, P46, DOI 10.4093/dmj.2013.37.1.46; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chiu M, 2011, DIABETES CARE, V34, P1741, DOI 10.2337/dc10-2300; Chowdhury MAB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0197-3; Chowdhury MAB, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2413-y; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Fletcher Barbara, 2002, J Cardiovasc Nurs, V16, P17; Gupta A, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000048; Gyawali B, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2954-3; Gyawali B, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31704; Gyawali B, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29088; Hajian-Tilaki KO, 2007, OBES REV, V8, P3, DOI 10.1111/j.1467-789X.2006.00235.x; Health Management Information System (HMIS), 2010, ETHN GROUP; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu Gang, 2005, Metabolic Syndrome and Related Disorders, V3, P35, DOI 10.1089/met.2005.3.35; Hu MQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10797-x; International Diabetes Federation, 2014, DIABETES ATLAS 6 EDI; Irazola V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183953; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Laakso M, 2001, J INTERN MED, V249, P225, DOI 10.1046/j.1365-2796.2001.00789.x; LEVITT NS, 1993, DIABETES CARE, V16, P601, DOI 10.2337/diacare.16.4.601; LIU XL, 2016, SCI REP UK, V6; Neupane D, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1412-3; Oli N, 2013, EPIDEMIOLOGY RES INT, V2013, P13, DOI DOI 10.1155/2013/329156; Ono Kazuo, 2007, Nepal Med Coll J, V9, P154; Rahman MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118365; RAMACHANDRAN A, 1988, BRIT MED J, V297, P587, DOI 10.1136/bmj.297.6648.587; Ramachandran A, 2008, DIABETES CARE, V31, P893, DOI 10.2337/dc07-1207; Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573; Ravikumar P, 2011, DIABETES METAB, V37, P216, DOI 10.1016/j.diabet.2010.10.004; Riley L, 2016, AM J PUBLIC HEALTH, V106, P74, DOI 10.2105/AJPH.2015.302962; Sasaki H, 2005, DIABETES RES CLIN PR, V67, P167, DOI 10.1016/j.diabres.2004.06.012; Shera AS, 1999, DIABETES RES CLIN PR, V44, P49, DOI 10.1016/S0168-8227(99)00017-0; Shrestha UK, 2006, DIABETIC MED, V23, P1130, DOI 10.1111/j.1464-5491.2006.01953.x; Supiyev A, 2016, DIABETES RES CLIN PR, V112, P6, DOI 10.1016/j.diabres.2015.11.011; Vaidya A, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-39; Vashitha Aditya, 2012, Asian Pacific Journal of Tropical Disease, pS173; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103594; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, WHO STEPWISE APPR CH; World Health Organization, 2016, GLOB REP DIAB; Xu Y, 2013, JAMA-J AM MED ASSOC, V310, P948, DOI 10.1001/jama.2013.168118; Yue JQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153791	51	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206491	10.1371/journal.pone.0206491	http://dx.doi.org/10.1371/journal.pone.0206491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388140	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800034
J	Semlali, A; Almutairi, M; Rouabhia, M; Parine, NR; Al Amri, A; Al-Numair, NS; Hawsawi, YM; Alanazi, MS				Semlali, Abdelhabib; Almutairi, Mikhlid; Rouabhia, Mahmoud; Parine, Narasimha Reddy; Al Amri, Abdullah; Al-Numair, Nouf S.; Hawsawi, Yousef M.; Alanazi, Mohammad Saud			Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; SIGNALING PATHWAY; POLYMORPHISMS; SUSCEPTIBILITY; ACTIVATION	Herein, we evaluated the association of the Toll-like receptor 6 (TLR6) single nucleotide polymorphisms (SNPs) rs3796508 (Va1327Met) and rs5743810 (Ser249Pro) with breast cancer (BC) susceptibility in Saudi Arabian women, using in silico analysis. We found no significant differences in genotypic and allelic frequencies for rs3796508 between the BC patients (n = 127) and healthy individuals (n = 116). However, 86% of the BC patients, versus 98% of the healthy controls, carried the rs5743810 Pro allele (OR = 0.103, CI = 0.0360.293, P= 0.00001). Advanced analysis based on the comparison of the estrogen receptor (ER)-positive and -negative patients with the healthy controls indicated a significant association between rs5743810 allelic frequency and BC risk protection (OR = 0.100, CI = 0.034-0.297, P= 0.00001 for ER + BC cases; OR = 0.102, CI = 0.033-0.318, P= 0.00001 for ER BC cases). Furthermore, rs5743810 was associated with BC risk protection at either above or below 48 years of age at diagnosis (OR = 0.101, CI = 0.022-0.455, P= 0.00037 for age <48 years; OR = 0.120, CI = 0.028-0.519, P= 0.00087 for age >48 years). Such associations were not found for rs3796508. In silico analysis indicated that these SNPs had neutral effects within the TLR6 structure, confirming the protective role of rs5743810. Our findings therefore suggest a strong association between rs5743810 and protection against BC risk in Saudi Arabian women. Importantly, the rs5743810 Pro allele could be a potential BC diagnostic biomarker in this ethnic population.	[Semlali, Abdelhabib; Rouabhia, Mahmoud; Al Amri, Abdullah] Univ Laval, Fac Med Dentaire, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada; [Semlali, Abdelhabib; Parine, Narasimha Reddy; Alanazi, Mohammad Saud] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh, Saudi Arabia; [Almutairi, Mikhlid] King Saud Univ, Coll Sci, Zool Dept, Riyadh, Saudi Arabia; [Al-Numair, Nouf S.; Hawsawi, Yousef M.] King Faisal Specialist Hosp & Res Ctr, Res Ctr, Dept Genet, Riyadh, Saudi Arabia; [Al-Numair, Nouf S.] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	Laval University; King Saud University; King Saud University; King Faisal Specialist Hospital & Research Center; Alfaisal University	Semlali, A (corresponding author), Univ Laval, Fac Med Dentaire, Dept Stomatol, Grp Rech Ecol Buccale, Quebec City, PQ, Canada.; Semlali, A (corresponding author), King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh, Saudi Arabia.	asemlali@ksu.edu.sa	Hawsawi, Yousef/K-8070-2019; Alamri, Abdullah M/C-3108-2012; Semlali, Abdelhabib/AAP-7043-2020; almutairi, mikhlid/AAE-1530-2020	Hawsawi, Yousef/0000-0003-1901-697X; Alamri, Abdullah M/0000-0002-3045-1350; Semlali, Abdelhabib/0000-0002-1643-0377; PARINE, NARASIMHA REDDY/0000-0002-0765-9022; Rouabhia, Mahmoud/0000-0003-2205-8281; Al-Numair, Nouf/0000-0002-2729-856X				Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Albeshan SM, 2018, CLIN BREAST CANCER, V18, pE381, DOI 10.1016/j.clbc.2017.07.006; Alrashidi Ali Ghannam, 2017, Asian Pac J Cancer Prev, V18, P2755, DOI 10.22034/APJCP.2017.18.10.2755; Basith S, 2012, ARCH PHARM RES, V35, P1297, DOI 10.1007/s12272-012-0802-7; Beklen A, 2008, ORAL MICROBIOL IMMUN, V23, P425, DOI 10.1111/j.1399-302X.2008.00448.x; Bhatelia K, 2014, CELL SIGNAL, V26, P2350, DOI 10.1016/j.cellsig.2014.07.035; Bhide MR, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-21; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Chan M, 2012, BREAST CANCER RES TR, V136, P209, DOI 10.1007/s10549-012-2234-y; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Cotterchio M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125273; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Gonzalez-Perez A, 2011, AM J HUM GENET, V88, P440, DOI 10.1016/j.ajhg.2011.03.004; Gupta AK, 2004, J CUTAN MED SURG, V8, P338, DOI 10.1007/s10227-005-0023-5; Hein A, 2017, GEBURTSH FRAUENHEILK, V77, P651, DOI 10.1055/s-0042-113189; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hong J, 2010, J BIOL CHEM, V285, P39447, DOI 10.1074/jbc.M110.132522; Jang JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118008; Kazma R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051680; Ke X, 2015, CHINESE J CANCER RES, V27, P181, DOI 10.3978/j.issn.1000-9604.2015.03.07; Kohailan M, 2016, ONCOTARGETS THER, V9, P7187, DOI 10.2147/OTT.S109650; Korak T, 2017, INT J CLIN EXP PATHO, V10, P2181; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kutikhin AG, 2011, HUM IMMUNOL, V72, P1095, DOI 10.1016/j.humimm.2011.07.307; Liu SZ, 2015, SAUDI J GASTROENTERO, V21, P95, DOI 10.4103/1319-3767.153832; Mauldin IS, 2015, INT J CANCER, V137, P1386, DOI 10.1002/ijc.29515; Morgan ME, 2014, MUCOSAL IMMUNOL, V7, P1266, DOI 10.1038/mi.2014.16; Park SJ, 2010, J AGR FOOD CHEM, V58, P4701, DOI 10.1021/jf100484r; Resler AJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-219; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rogers EN, 2013, GENES IMMUN, V14, P347, DOI 10.1038/gene.2013.22; Semlali A, 2017, ONCOTARGETS THER, V10, P2325, DOI 10.2147/OTT.S121618; Semlali A, 2017, ONCOTARGETS THER, V10, P1207, DOI 10.2147/OTT.S112165; Semlali A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052614; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Yates CM, 2013, J MOL BIOL, V425, P3949, DOI 10.1016/j.jmb.2013.07.012; Yu Hui, 2011, Zhonghua Yi Xue Za Zhi, V91, P129	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0203376	10.1371/journal.pone.0203376	http://dx.doi.org/10.1371/journal.pone.0203376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388713	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800005
J	Tsai, YS; Kung, PT; Ku, MC; Wang, YH; Tsai, WC				Tsai, Yi-Shiun; Kung, Pei-Tseng; Ku, Ming-Chou; Wang, Yeuh-Hsin; Tsai, Wen-Chen			Effects of pay for performance on risk incidence of infection and of revision after total knee arthroplasty in type 2 diabetic patients: A nationwide matched cohort study	PLOS ONE			English	Article							PERIPROSTHETIC JOINT INFECTION; FOR-PERFORMANCE; TOTAL HIP; GLYCEMIC CONTROL; HEMOGLOBIN A1C; HEALTH-CARE; OUTCOMES; REPLACEMENT; MELLITUS; PROGRAM	As the world's population ages, the number of people receiving total knee arthroplasty (TKA) has been on the rise. Although patients with diabetes mellitus are known to face greater risks of TKA postoperative infection and revision TKA owing to diabetic complications, studies on whether such patients' participation in pay for performance (P4P) programs influences the incidence rates of TKA postoperative infection or revision TKA are still lacking. This study examined the 2002-2012 data of Taiwan's National Health Insurance Research Database to conduct a retrospective cohort analysis of diabetic patients over 50 years old who have received TKA. To reduce any selection bias between patients joining and not joining the P4P program, propensity score matching was applied. The Cox proportional hazards model was used to examine the influence of the P4P program on TKA postoperative infection and revision TKA, and the results indicate that joining P4P lowered the risk of postoperative infection (HR = 0.91, 95% CI: 0.77-1.08), however, which was not statistically significant, and significantly lowered the risk of revision TKA (HR = 0.53, 95% CI: 0.39-0.72). Being younger and male, having multiple comorbid conditions or greater diabetic severity, receiving care at regional or public hospitals, and not having a diagnosis of degenerative or rheumatoid arthritis were identified as factors for higher risk of TKA postoperative infection for patients with diabetes. As for the risk of revision TKA, postoperative infection and being younger were identified as factors for a significantly higher risk (p < 0.05).	[Tsai, Yi-Shiun] Feng Yuan Hosp, Dept Orthoped, Minist Hlth & Welf, Taichung, Taiwan; [Tsai, Yi-Shiun; Wang, Yeuh-Hsin; Tsai, Wen-Chen] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Kung, Pei-Tseng] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan; [Kung, Pei-Tseng] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Ku, Ming-Chou] Chang Bing Show Chwan Mem Hosp, Dept Orthoped, Changhua, Taiwan	China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chang Bing Show Chwan Memorial Hospital	Tsai, WC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.	wtsai@mail.cmu.edu.tw	Tsai, Wen-Chen/O-3095-2015	Tsai, Wen-Chen/0000-0002-9684-0789	China Medical University [CMU106-ASIA-13]; Asia University	China Medical University(China Medical University); Asia University	This study was supported by the grant (CMU106-ASIA-13) from China Medical University and Asia University. http://www.cmu.edu.tw/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers DC, 1997, J BONE JOINT SURG AM, V79A, P278, DOI 10.2106/00004623-199702000-00018; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Chang CH, 2010, DIABETIC MED, V27, P636, DOI 10.1111/j.1464-5491.2010.03007.x; Chen TT, 2011, HEALTH SERV RES, V46, P47, DOI 10.1111/j.1475-6773.2010.01182.x; Chen YC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004197; Chong W-C, 2013, TAIWAN GONG GONG WEI, V32, P615; Chrastil J, 2015, J ARTHROPLASTY, V30, P1197, DOI 10.1016/j.arth.2015.01.040; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Daines BK, 2015, J AM ACAD ORTHOP SUR, V23, P356, DOI 10.5435/JAAOS-D-12-00170; de Bruin SR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-272; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Eka A, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.09.26; Everhart JS, 2013, CLIN ORTHOP RELAT R, V471, P3112, DOI 10.1007/s11999-013-2923-9; Funnel MM, 2009, DIABETES CARE, V32, pS87, DOI 10.2337/dc09-S087; de Tejada MGS, 2010, VALUE HEALTH, V13, P447, DOI 10.1111/j.1524-4733.2009.00685.x; Greene J, 2013, HEALTH SERV RES, V48, P1415, DOI 10.1111/1475-6773.12033; Heck DA, 1998, MED CARE, V36, P661, DOI 10.1097/00005650-199805000-00006; Hsu CC, 2014, DIABETES RES CLIN PR, V106, pS328, DOI 10.1016/S0168-8227(14)70738-7; Huang Jin, 2013, J Evid Based Med, V6, P173, DOI 10.1111/jebm.12052; Katz JN, 2007, ARTHRITIS RHEUM, V56, P568, DOI 10.1002/art.22333; Khan M, 2016, BONE JOINT J, V98B, P105, DOI [10.1302/0301-620X.98B1.36293, 10.1302/0301-620X.9881.36293]; King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746; Kremers HM, 2015, J ARTHROPLASTY, V30, P439, DOI 10.1016/j.arth.2014.10.009; Kremers HM, 2013, CLIN ORTHOP RELAT R, V471, P206, DOI 10.1007/s11999-012-2508-z; Kumar A, 2015, J CHIN MED ASSOC, V78, P538, DOI 10.1016/j.jcma.2015.06.005; Kunutsor SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150866, 10.1371/journal.pone.0151537]; Kurtz SM, 2008, J ARTHROPLASTY, V23, P984, DOI 10.1016/j.arth.2007.10.017; Kurtz SM, 2007, J BONE JOINT SURG AM, V89A, P144, DOI 10.2106/JBJS.G.00587; Lai CL, 2013, J CHIN MED ASSOC, V76, P102, DOI 10.1016/j.jcma.2012.06.024; Lee TT, 2010, AM J MANAG CARE, V16, P65; Leta TH, 2015, ACTA ORTHOP, V86, P48, DOI 10.3109/17453674.2014.964097; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Meehan JP, 2014, J BONE JOINT SURG AM, V96A, P529, DOI 10.2106/JBJS.M.00545; Namba RS, 2013, J ARTHROPLASTY, V28, P122, DOI 10.1016/j.arth.2013.04.050; Namba RS, 2013, J BONE JOINT SURG AM, V95A, P775, DOI 10.2106/JBJS.L.00211; Ohmann C, 2010, J BONE JOINT SURG AM, V92A, P629, DOI 10.2106/JBJS.H.01436; Pan CC, 2017, AM J MANAG CARE, V23, pE57; Patel A, 2015, BONE JOINT J, V97B, P1076, DOI 10.1302/0301-620X.97B8.35170; Qasim SN, 2017, SICOT-J, V3, DOI 10.1051/sicotj/2016038; Schett G, 2013, DIABETES CARE, V36, P403, DOI 10.2337/dc12-0924; Schrama JC, 2010, ARTHRIT CARE RES, V62, P473, DOI 10.1002/acr.20036; Sheng PY, 2006, J BONE JOINT SURG AM, V88A, P1425, DOI 10.2106/JBJS.E.00737; Stiehl JB, 2006, INT ORTHOP, V30, P190, DOI 10.1007/s00264-005-0053-z; Tan ECH, 2014, QUAL LIFE RES, V23, P689, DOI 10.1007/s11136-013-0502-x; Tayton ER, 2016, BONE JOINT J, V98B, P334, DOI 10.1302/0301-620X.98B3.36775; Vaghela P, 2009, DIABETES CARE, V32, P427, DOI 10.2337/dc08-1999; Willems S, 2005, PATIENT EDUC COUNS, V56, P139, DOI 10.1016/j.pec.2004.02.011; Yang Z, 2014, BONE JOINT J, V96B, P1637, DOI 10.1302/0301-620X.96B12.34378; Yen SM, 2016, AM J MANAG CARE, V22, pE18; Young BA, 2008, AM J MANAG CARE, V14, P15; Yu HC, 2014, HEALTH POLICY PLANN, V29, P732, DOI 10.1093/heapol/czt056; Yuan SP, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/575124; Zhu Y, 2015, J HOSP INFECT, V89, P82, DOI 10.1016/j.jhin.2014.10.008	56	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206797	10.1371/journal.pone.0206797	http://dx.doi.org/10.1371/journal.pone.0206797			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388167	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800061
J	Ali, N; Perveen, R; Rahman, S; Mahmood, S; Rahman, S; Islam, S; Haque, T; Sumon, A; Kathak, RR; Molla, NH; Islam, F; Mohanto, NC; Nurunnabi, SM; Ahmed, S; Rahman, M				Ali, Nurshad; Perveen, Rasheda; Rahman, Shahnaz; Mahmood, Shakil; Rahman, Sadaqur; Islam, Shiful; Haque, Tangigul; Sumon, Abu Hasan; Kathak, Rahanuma Raihanu; Molla, Noyan Hossain; Islam, Farjana; Mohanto, Nayan Chandra; Nurunnabi, Shaikh Mirja; Ahmed, Shamim; Rahman, Mustafizur			Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC SYNDROME; RISK-FACTOR; ASSOCIATION; GOUT; HYPERTENSION; ADOLESCENTS; HEALTH	Background and objectives Recent studies have shown that hyperuricemia is commonly associated with dyslipidemia, cardiovascular diseases, hypertension and metabolic syndrome. Elevated serum uric acid has been demonstrated to be associated with obesity in the adult population in many countries; however, there is still a lack of evidence for the Bangladeshi population. The aims of this study were to evaluate the prevalence of hyperuricemia and determine the relationship between serum uric acid (SUA) and obesity among the Bangladeshi adults. Methods In this cross-sectional study, blood samples were collected from 260 adults (142 males and 118 females) and analyzed for SUA and lipid profile. All participants were categorized as underweight (n = 11), normal (n = 66), overweight (n = 120) and obese (n = 63) according to the body mass index (BMI) scale for the Asian population. Based on SUA concentration the participants were stratified into four quartiles (Q1: < 232 mu mol/L, Q2: 232-291 mu mol/L, Q3: 292-345 mu mol/L and Q4: > 345 mu mol/L). Results The mean age and BMI of the participants were 32.5 +/- 13.3 years and 24.9 +/- 3.8 kg/m(2), respectively. The average level of SUA was 294 +/- 90 mu mol/L with a significant difference between males and females (p < 0.001). Overall, the estimated prevalence of hyperuricemia was 9.3% with 8.4% in male and 10.2% in female participants. There were significant increases in the prevalence of obesity (17.4%, 22.2%, 28.6% and 31.8%, respectively, p < 0.01 for trend) across the SUA quartiles. A multiple logistic regression analysis revealed that SUA quartiles were independently associated with the presence of obesity (p < 0.01). Conclusion Present study indicates a significant positive relationship between SUA and obesity among the Bangladeshi adults. Therefore, routine measurement of SUA is recommended in obese individuals to prevent hyperuricemia and its related complications.	[Ali, Nurshad; Rahman, Sadaqur; Islam, Shiful; Haque, Tangigul; Sumon, Abu Hasan; Kathak, Rahanuma Raihanu; Molla, Noyan Hossain; Mohanto, Nayan Chandra; Nurunnabi, Shaikh Mirja; Ahmed, Shamim] Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh; [Perveen, Rasheda; Rahman, Shahnaz; Mahmood, Shakil; Rahman, Mustafizur] Gono Univ, Gonoshasthaya Samaj Vittik Med Coll, Dept Biochem & Mol Biol, Dhaka, Bangladesh; [Islam, Farjana] Bangabandhu Sheikh Mujibur Rahman Sci & Technol U, Dept Biochem & Mol Biol, Gopalganj, Bangladesh	Shahjalal University of Science & Technology (SUST); Bangabandhu Sheikh Mujibur Rahman Science & Technology University	Ali, N (corresponding author), Shahjalal Univ Sci & Technol, Dept Biochem & Mol Biol, Sylhet, Bangladesh.	nur_rubd@yahoo.com	Haque, Tangigul/AAU-8514-2020; Islam, Shiful/AAX-7442-2021; Ali, Nurshad/R-7452-2018; ISLAM, FARJANA/R-1573-2019; Mohanto, Nayan Chandra/GLR-0463-2022	Islam, Shiful/0000-0002-1826-6777; Ali, Nurshad/0000-0003-1649-0887; ISLAM, FARJANA/0000-0001-8274-2021; Mohanto, Nayan Chandra/0000-0002-5803-1534; Haque, Tangigul/0000-0002-7181-8104; Kathak, Rahanuma Raihanu/0000-0002-0220-1442	Gonoshasthaya Samaj Vittik Medical College, Gono University, Savar, Dhaka, Bangladesh	Gonoshasthaya Samaj Vittik Medical College, Gono University, Savar, Dhaka, Bangladesh	This work did not receive any external funding. It was supported internally with a small fund from Gonoshasthaya Samaj Vittik Medical College, Gono University, Savar, Dhaka 1344, Bangladesh.	Al-Arfaj AS, 2001, RHEUMATOL INT, V20, P61, DOI 10.1007/s002960000076; Ali N, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4617-9; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bindler RC, 2014, J PEDIATR ENDOCR MET, V27, P467, DOI 10.1515/jpem-2013-0255; Chen MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep40009; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; Dai XY, 2013, EUR J EPIDEMIOL, V28, P669, DOI 10.1007/s10654-013-9829-4; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Desai RJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193622; Duan Y, 2015, NUTR HOSP, V31, P2407, DOI 10.3305/nh.2015.31.6.8734; Essa SA, 2015, JOURNAL OF BABYLON U, V23; FABREGAT I, 1987, BIOCHEM BIOPH RES CO, V146, P920, DOI 10.1016/0006-291X(87)90618-8; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; Haq AU, 2009, J POSTGRADUATE MED I, V23; Huda N, 2014, TOXICOL APPL PHARM, V281, P11, DOI 10.1016/j.taap.2014.09.011; Jaipakdee J, 2013, SE ASIAN J TROP MED, V44, P512; Kanwar G., 2016, INT J HEALTHCARE SCI, V4, P52; Li-ying Chen, 2007, Journal of Zhejiang University-Science B, V8, P593, DOI 10.1631/jzus.2007.130593; Liu R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/762820; Lohsoonthorn V, 2006, ARCH MED RES, V37, P883, DOI 10.1016/j.arcmed.2006.03.008; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Matsuura F, 1998, METABOLISM, V47, P929, DOI 10.1016/S0026-0495(98)90346-8; Miao ZM, 2009, INFLAMM RES, V58, P659, DOI 10.1007/s00011-009-0031-9; Nagahama K, 2004, HYPERTENS RES, V27, P227, DOI 10.1291/hypres.27.227; Nakanishi N, 2001, METABOLISM, V50, P621, DOI 10.1053/meta.2001.24196; Ogura T, 2004, METABOLISM, V53, P448, DOI 10.1016/j.metabol.2003.11.017; Oyama C, 2006, TOHOKU J EXP MED, V209, P257, DOI 10.1620/tjem.209.257; Perlstein TS, 2006, HYPERTENSION, V48, P1031, DOI 10.1161/01.HYP.0000248752.08807.4c; Rathmann W, 2007, EUR J EPIDEMIOL, V22, P439, DOI 10.1007/s10654-007-9132-3; Remedios C, 2012, OBES SURG, V22, P945, DOI 10.1007/s11695-012-0655-7; Sari I, 2009, RHEUMATOL INT, V29, P869, DOI 10.1007/s00296-008-0806-2; Schlesinger N, 2005, CURR PHARM DESIGN, V11, P4133, DOI 10.2174/138161205774913273; Sivakumar K, 2014, INT J SCI STUDY, V2, P1; Sui XM, 2008, METABOLISM, V57, P845, DOI 10.1016/j.metabol.2008.01.030; Tanaka K, 2015, ENVIRON HEALTH PREV, V20, P347, DOI 10.1007/s12199-015-0473-3; Terkeltaub RA, 2003, NEW ENGL J MED, V349, P1647, DOI 10.1056/NEJMcp030733; Uaratanawong S, 2011, CLIN RHEUMATOL, V30, P887, DOI 10.1007/s10067-011-1699-0; Wang HG, 2014, IRAN J PUBLIC HEALTH, V43, P1503; *WHO INT ASS STUD, 2000, AS PAC PERSP RED OB, P22; Wortmann RL, 2002, CURR OPIN RHEUMATOL, V14, P281, DOI 10.1097/00002281-200205000-00015; Yang C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192396; You LL, 2014, J ATHEROSCLER THROMB, V21, P355, DOI 10.5551/jat.20529; Zhang JX, 2014, J CLIN HYPERTENS, V16, P569, DOI 10.1111/jch.12353; Zhu CL, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/5438157; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	46	104	107	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206850	10.1371/journal.pone.0206850	http://dx.doi.org/10.1371/journal.pone.0206850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383816	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600101
J	Perdomo-Pantoja, A; Mejia-Perez, SI; Reynoso-Noveron, N; Gomez-Flores-Ramos, L; Soto-Reyes, E; Sanchez-Correa, TE; Guerra-Calderas, L; Castro-Hernandez, C; Vidal-Millan, S; Sanchez-Corona, J; Taja-Chayeb, L; Gutierrez, O; Cacho-Diaz, B; Alvarez-Gomez, RM; Gomez-Amador, JL; Ostrosky-Wegman, P; Corone, T; Herrera-Montalvo, LA; Wegman-Ostrosky, T				Perdomo-Pantoja, Alexander; Iliana Mejia-Perez, Sonia; Reynoso-Noveron, Nancy; Gomez-Flores-Ramos, Liliana; Soto-Reyes, Ernesto; Estefania Sanchez-Correa, Thalia; Guerra-Calderas, Lissania; Castro-Hernandez, Clementina; Vidal-Millan, Silvia; Sanchez-Corona, Jose; Taja-Chayeb, Lucia; Gutierrez, Olga; Cacho-Diaz, Bernardo; Maria Alvarez-Gomez, Rosa; Luis Gomez-Amador, Juan; Ostrosky-Wegman, Patricia; Corone, Teresa; Alonso Herrera-Montalvo, Luis; Wegman-Ostrosky, Talia			Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ESSENTIAL-HYPERTENSION; GLIOBLASTOMA; CANCER; RISK; INHIBITORS; EXPRESSION; SURVIVAL; GLIOMA; POLYMORPHISMS	Introduction Renin-angiotensin system (RAS) in brain cancer represents a scarcely explored field in neuro-oncology. Recently, some pre- and clinical studies have reported that RAS components play a relevant role in the development and behavior of gliomas. The angiotensinogen (AGT) rs5050 genetic variant has been identified as a crucial regulator of the transcription of AGT mRNA, which makes it a logical and promising target of research. The aim of this study was to determine the relationship between the AGT rs5050 genetic variant in blood with prognosis in astrocytoma. Methods A prospective pilot study was performed on forty-eight astrocytoma patients, who received the standard-of-care treatment. Blood samples were taken prior to surgery and DNA was sequenced using Ion Torrent next-generation sequencing and analyzed by Ion Reporter software. Descriptive, bivariate, multivariate, and survival analyses were performed using SPSS v21, STATA 12 and GraphPad Prism 7. Results Median follow-up was 41 months (range 1-48). Survival analysis showed a significant difference between the rs5050 genotypes (p = .05). We found lower survival rates in individuals with the GG-genotype of rs5050 AGT compared to patients with the TT- and TG-genotype (2 months vs. 11.5 months, respectively [p = .01]). In bivariate and multivariate analyses, GG-genotype was negatively associated with survival. Conclusions In patients with astrocytoma, AGT rs5050 GG-genotype was associated with poor prognosis. We propose this germline genetic variant as a complementary biomarker, which can be detected practically and safely in blood samples or saliva.	[Perdomo-Pantoja, Alexander] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Baltimore, MD 21205 USA; [Perdomo-Pantoja, Alexander; Iliana Mejia-Perez, Sonia; Estefania Sanchez-Correa, Thalia; Luis Gomez-Amador, Juan] Inst Nacl Neurol & Neurocirugra Manuel Velasco Su, Dept Neurocirugra, Mexico City, DF, Mexico; [Reynoso-Noveron, Nancy; Gomez-Flores-Ramos, Liliana; Soto-Reyes, Ernesto; Guerra-Calderas, Lissania; Vidal-Millan, Silvia; Taja-Chayeb, Lucia; Gutierrez, Olga; Maria Alvarez-Gomez, Rosa; Alonso Herrera-Montalvo, Luis; Wegman-Ostrosky, Talia] Inst Nacl Cancerol, Direcc Invest, Mexico City, DF, Mexico; [Castro-Hernandez, Clementina; Alonso Herrera-Montalvo, Luis] UNAM INCAN, Inst Invest Biomed, Unidad Invest Biomed Canc, Mexico City, DF, Mexico; [Sanchez-Corona, Jose] IMSS, Ctr Invest Biomed Occidente, Guadalajara, Jalisco, Mexico; [Cacho-Diaz, Bernardo] Inst Nacl Cancerol, Unidad Neurooncol, Mexico City, DF, Mexico; [Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico; [Corone, Teresa] Inst Nacl Neurol & Neurocirugia Manuel Velasco Su, Lab Clin Enfermedades Neurodegenerat, Mexico City, DF, Mexico	Johns Hopkins University; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico	Wegman-Ostrosky, T (corresponding author), Inst Nacl Cancerol, Direcc Invest, Mexico City, DF, Mexico.	taliaw@gmail.com	Pérez, Sonia Mejía/AAP-9785-2021; Wegman-Ostrosky, Talia/AAV-7521-2020; Corona, Teresa/AAU-8333-2021; Herrera, Luis/GOV-3311-2022; Gómez-Flores-Ramos, Liliana/GRS-0459-2022; Perdomo-Pantoja, Alexander/N-9161-2019	Pérez, Sonia Mejía/0000-0002-5929-6761; Wegman-Ostrosky, Talia/0000-0002-3207-6697; Corona, Teresa/0000-0002-9324-229X; Perdomo-Pantoja, Alexander/0000-0002-4981-8132; Soto-Reyes, Ernesto/0000-0002-4219-6406; Gutierrez, Olga/0000-0002-5493-6774; Gomez Flores Ramos, Liliana/0000-0002-4617-639X; Cacho-Diaz, Bernardo/0000-0001-9289-5312; Sanchez Correa, Thalia/0000-0001-9133-6746; Sanchez Corona, Jose/0000-0001-5693-5786	Consejo Nacional de Ciencia y Tecnologia (CONACYT) (Mexico) [Salud-2013-01-202720]	Consejo Nacional de Ciencia y Tecnologia (CONACYT) (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia (CONACYT) (Mexico) (Salud-2013-01-202720).	Ager EI, 2008, CARCINOGENESIS, V29, P1675, DOI 10.1093/carcin/bgn171; Aldape K, 2015, ACTA NEUROPATHOL, V129, P829, DOI 10.1007/s00401-015-1432-1; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andreotti G, 2010, CARCINOGENESIS, V31, P614, DOI 10.1093/carcin/bgp321; Arrieta O, 2008, BRIT J CANCER, V99, P160, DOI 10.1038/sj.bjc.6604431; Balam-Ortiz E, 2011, AM J MED SCI, V342, P205, DOI 10.1097/MAJ.0b013e3182121020; Birney E, 2015, NATURE, V526, P52, DOI 10.1038/526052a; Carpentier AF, 2012, EUR J NEUROL, V19, P1337, DOI 10.1111/j.1468-1331.2012.03766.x; Celerier J, 2002, HYPERTENSION, V39, P224, DOI 10.1161/hy0202.103441; Clere N, 2010, INT J CANCER, V127, P2279, DOI 10.1002/ijc.25234; Coate L, 2010, J CLIN ONCOL, V28, P4029, DOI 10.1200/JCO.2009.27.2336; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Crowley SD, 2012, EXP CELL RES, V318, P1049, DOI 10.1016/j.yexcr.2012.02.023; Delgado-Lopez PD, 2016, CLIN TRANSL ONCOL, V18, P1062, DOI 10.1007/s12094-016-1497-x; Friis S, 2001, CANCER-AM CANCER SOC, V92, P2462, DOI 10.1002/1097-0142(20011101)92:9<2462::AID-CNCR1596>3.0.CO;2-L; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; Ishigami T, 1997, HYPERTENSION, V30, P1325, DOI 10.1161/01.HYP.30.6.1325; Januel E, 2015, EUR J NEUROL, V22, P1304, DOI 10.1111/ene.12746; Juillerat-Jeanneret L, 2004, BRIT J CANCER, V90, P1059, DOI 10.1038/sj.bjc.6601646; KARNOFSKY DA, 1950, AM J MED, V8, P767, DOI 10.1016/0002-9343(50)90102-1; Kasl Rebecca A, 2016, Surg Neurol Int, V7, pS282, DOI 10.4103/2152-7806.181985; Kast RE, 2013, ONCOTARGET, V4, P502, DOI 10.18632/oncotarget.969; Kawai T, 2017, PHARMACOL RES, V125, P4, DOI 10.1016/j.phrs.2017.05.008; Kourilsky A, 2016, J NEUROL, V263, P524, DOI 10.1007/s00415-015-8016-9; Ladd AMGZ, 2007, BREAST CANCER RES TR, V101, P299, DOI 10.1007/s10549-006-9290-0; Lanz TV, 2010, J CLIN INVEST, V120, P2782, DOI 10.1172/JCI41709; Leung PS, 2003, REGUL PEPTIDES, V116, P61, DOI 10.1016/S0167-0115(03)00192-7; Levin VA, 2017, J NEURO-ONCOL, V134, P325, DOI 10.1007/s11060-017-2528-3; Lian MX, 2015, J RENIN-ANGIO-ALDO S, V16, P443, DOI 10.1177/1470320313495910; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Morishita R, 1996, HYPERTENSION, V27, P502, DOI 10.1161/01.HYP.27.3.502; National Center of Biotechnology Information, 2016, 1000 GENOMES BROWSER; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Perdomo-Pantoja A, 2018, J NEURO-ONCOL, V138, P1, DOI 10.1007/s11060-018-2789-5; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Preusser M, 2014, NAT REV NEUROL, V10, P681, DOI 10.1038/nrneurol.2014.208; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sugimoto M, 2007, CARCINOGENESIS, V28, P2036, DOI 10.1093/carcin/bgm074; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Urup T, 2016, MOL ONCOL, V10, P1160, DOI 10.1016/j.molonc.2016.05.005; Vasku A, 2009, INT J COLORECTAL DIS, V24, P289, DOI 10.1007/s00384-008-0553-6; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wegman-Ostrosky T, 2015, J RENIN-ANGIO-ALDO S, V16, P227, DOI 10.1177/1470320313496858; Wolf G, 2002, KIDNEY INT, V61, P1986, DOI 10.1046/j.1523-1755.2002.00365.x; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Xavier-Magalhaes Ana, 2013, CNS Oncol, V2, P495, DOI 10.2217/cns.13.48; Yanai K, 1996, J BIOL CHEM, V271, P15981, DOI 10.1074/jbc.271.27.15981; Zhao YY, 1999, HYPERTENSION, V33, P108, DOI 10.1161/01.HYP.33.1.108	51	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206590	10.1371/journal.pone.0206590	http://dx.doi.org/10.1371/journal.pone.0206590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383794	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600069
J	Zivotic, M; Tampe, B; Muller, G; Muller, C; Lipkovski, A; Xu, XB; Nyamsuren, G; Zeisberg, M; Markovic-Lipkovski, J				Zivotic, Maja; Tampe, Bjorn; Mueller, Gerhard; Mueller, Claudia; Lipkovski, Aleksandar; Xu, Xingbo; Nyamsuren, Gunsmaa; Zeisberg, Michael; Markovic-Lipkovski, Jasmina			Modulation of NCAM/FGFR1 signaling suppresses EMT program in human proximal tubular epithelial cells	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; STRUCTURAL BASIS; KIDNEY FIBROSIS; CYCLE ARREST; NCAM; ADHESION; FGFR; ACTIVATION; EXPRESSION; RECEPTORS	Neural cell adhesion molecule (NCAM) and fibroblast growth factor receptor 1 (FGFR1) cross-talk have been involved in epithelial-to-mesenchymal transition (EMT) process during carcinogenesis. Since EMT also contributes to maladaptive repair and parenchymal damage during renal fibrosis, we became encouraged to explore the role of NCAM/FGFR1 signaling as initiating or driving forces of EMT program in cultured human proximal tubular epithelial cells (TECs). TECs stimulated with TGF-beta 1 (10ng/mL) was used as an established in vitro EMT model. TGF-beta 1 downstream effectors were detected in vitro, as well as in 50 biopsies of different human kidney diseases to explore their in vivo correlation. NCAM/FGFR1 signaling and its modulation by FGFR1 inhibitor PD173074 (100nM) were analyzed by light microscopy, immunolabeling, qRT-PCR and scratch assays. Morphological changes associated with EMT appeared 48h after TGF-beta 1 treatment and was clearly apparent after 72 hours, followed by loss of CDH1 (encoding E-Cadherin) and transcriptional induction of SNAI1 (SNAIL), SNAI2 (SLUG), TWIST1, MMP2, MMP9, CDH2 (N-Cadherin), ITGA5 (integrin-alpha 5), ITGB1 (integrin-beta 1), ACTA2 (alpha-SMA) and S100A4 (FSP1). Moreover, at the early stage of EMT program (24 hours upon TGF-beta 1 exposure), transcriptional induction of several NCAM isoforms along with FGFR1 was observed, implicating a mechanistic link between NCAM/FGFR1 signaling and induction of EMT. These assumptions were further supported by the inhibition of the EMT program after specific blocking of FGFR1 signaling by PD173074. Finally, there was evidence for an in vivo TGF-beta 1 pathway activation in diseased human kidneys and correlation with impaired renal excretory functions. Collectively, NCAM/FGFR1 signaling appears to be involved in the initial phase of TGF-beta 1 initiated EMT which can be effectively suppressed by application of FGFR inhibitor.	[Zivotic, Maja; Markovic-Lipkovski, Jasmina] Univ Belgrade, Inst Pathol, Fac Med, Belgrade, Serbia; [Tampe, Bjorn; Mueller, Gerhard; Mueller, Claudia; Nyamsuren, Gunsmaa; Zeisberg, Michael] Georg August Univ, Univ Med Ctr, Dept Nephrol & Rheumatol, Gottingen, Germany; [Lipkovski, Aleksandar] Univ Belgrade, Fac Math, Belgrade, Serbia; [Xu, Xingbo] Georg August Univ, Dept Cardiol & Pneumol, Univ Med Ctr, Gottingen, Germany	University of Belgrade; University of Gottingen; University of Belgrade; University of Gottingen	Zivotic, M (corresponding author), Univ Belgrade, Inst Pathol, Fac Med, Belgrade, Serbia.	majajoker@gmail.com	Tampe, Björn/ABA-6091-2021; Lipkovski, Aleksandar/AAI-3517-2020; Zivotic, Maja/N-9508-2017	Tampe, Björn/0000-0002-4357-9863; Zivotic, Maja/0000-0002-5833-6661; Xu, Xingbo/0000-0002-8249-5507	Ministry of Education, Science and Technological Development of the Republic of Serbia [OI 175047]; Alexander von Humboldt Foundation [3.4-IP-DEU/1019337]	Ministry of Education, Science and Technological Development of the Republic of Serbia; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	Financial support for research was provided by Ministry of Education, Science and Technological Development of the Republic of Serbia (Project No. OI 175047), as well as by Alexander von Humboldt Foundation (Project No. 3.4-IP-DEU/1019337). The funders had no role in the study design, in the collection, analysis and interpretation of data, in the writing of the report and in the decision to submit article for publication.	Abbate M, 1999, AM J PHYSIOL-RENAL, V277, pF454, DOI 10.1152/ajprenal.1999.277.3.F454; [Anonymous], 2002, KDOQI CLIN PRACT GUI, P44; Buchmaier BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068301; Cavallaro U, 2001, NAT CELL BIOL, V3, P650, DOI 10.1038/35083041; Colombo N, 2011, ECANCERMEDICALSCIENC, V5, DOI 10.3332/ecancer.2011.226; Di Marco GS, 2014, NEPHROL DIAL TRANSPL, V29, P2028, DOI 10.1093/ndt/gfu190; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Kanda T, 2003, ARCH ORAL BIOL, V48, P213, DOI 10.1016/S0003-9969(02)00204-2; Kiselyov VV, 2005, J NEUROCHEM, V94, P1169, DOI 10.1111/j.1471-4159.2005.03284.x; Kiselyov VV, 2003, STRUCTURE, V11, P691, DOI 10.1016/S0969-2126(03)00096-0; Kochoyan A, 2008, PROTEIN SCI, V17, P1698, DOI 10.1110/ps.035964.108; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lei J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100075; Loeffler I, 2015, CELLS-BASEL, V4, P631, DOI 10.3390/cells4040631; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Markovic-Lipkovski J, 2007, NEPHROL DIAL TRANSPL, V22, P1558, DOI 10.1093/ndt/gfm006; Markovic-Lipkovski J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137028; Meng XM, 2015, ONCOTARGET, V6, P36984, DOI 10.18632/oncotarget.6100; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Metsuyanim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006709; Nguyen PT, 2013, BRIT J CANCER, V109, P2248, DOI 10.1038/bjc.2013.550; Shima H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01702-7; SUN XQ, 2017, J ADV TRANSPORT, DOI DOI 10.1155/2017/; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Thannickal VJ, 1998, BIOCHEM BIOPH RES CO, V251, P437, DOI 10.1006/bbrc.1998.9443; Tomlinson DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038972; Vansthertem D, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/193259; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Ye TH, 2014, BREAST CANCER RES TR, V143, P435, DOI 10.1007/s10549-013-2829-y; Zecchini S, 2011, EMBO MOL MED, V3, P480, DOI 10.1002/emmm.201100152; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0033-x; Zivotic M, 2015, PEDIATR NEPHROL, V30, P79, DOI 10.1007/s00467-014-2893-5	38	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206786	10.1371/journal.pone.0206786	http://dx.doi.org/10.1371/journal.pone.0206786			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383875	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600097
J	Lynch, JM; Li, B; Katoli, P; Xiang, CX; Leehy, B; Rangaswamy, N; Saenz-Vash, V; Wang, YK; Lei, H; Nicholson, TB; Meredith, E; Rice, DS; Prasanna, G; Chen, A				Lynch, Jeffrey M.; Li, Bing; Katoli, Parvaneh; Xiang, Chuanxi; Leehy, Barrett; Rangaswamy, Nalini; Saenz-Vash, Veronica; Wang, Y. Karen; Lei, Hong; Nicholson, Thomas B.; Meredith, Erik; Rice, Dennis S.; Prasanna, Ganesh; Chen, Amy			Binding of a glaucoma-associated myocilin variant to the B-crystallin chaperone impedes protein clearance in trabecular meshwork cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; aggregation; cell biology; aging; crystallin; CRISPR; Cas; genetic disease; secretion; glaucoma; myocilin	OPEN-ANGLE GLAUCOMA; ENDOPLASMIC-RETICULUM STRESS; OLFACTOMEDIN-HOMOLOGY DOMAIN; HEAT-SHOCK PROTEINS; TARGETING SIGNAL 1; GENE-EXPRESSION; MOUSE MODEL; ER STRESS; MICROARRAY ANALYSIS; CHEMICAL CHAPERONE	Myocilin (MYOC) was discovered more than 20 years ago and is the gene whose mutations are most commonly observed in individuals with glaucoma. Despite extensive research efforts, the function of WT MYOC has remained elusive, and how mutant MYOC is linked to glaucoma is unclear. Mutant MYOC is believed to be misfolded within the endoplasmic reticulum, and under normal physiological conditions misfolded MYOC should be retro-translocated to the cytoplasm for degradation. To better understand mutant MYOC pathology, we CRISPR-engineered a rat to have a MYOC Y435H substitution that is the equivalent of the pathological human MYOC Y437H mutation. Using this engineered animal model, we discovered that the chaperone B-crystallin (CRYAB) is a MYOC-binding partner and that co-expression of these two proteins increases protein aggregates. Our results suggest that the misfolded mutant MYOC aggregates with cytoplasmic CRYAB and thereby compromises protein clearance mechanisms in trabecular meshwork cells, and this process represents the primary mode of mutant MYOC pathology. We propose a model by which mutant MYOC causes glaucoma, and we propose that therapeutic treatment of patients having a MYOC mutation may focus on disrupting the MYOC-CRYAB complexes.	[Lynch, Jeffrey M.; Li, Bing; Katoli, Parvaneh; Xiang, Chuanxi; Leehy, Barrett; Rangaswamy, Nalini; Rice, Dennis S.; Prasanna, Ganesh; Chen, Amy] Novartis Inst BioMed Res, Ophthalmol, 22 Windsor St, Cambridge, MA 02139 USA; [Saenz-Vash, Veronica; Wang, Y. Karen] Novartis Inst BioMed Res, Analyt Sci & Imaging, Cambridge, MA 02139 USA; [Lei, Hong] Novartis Inst BioMed Res, Lab Anim Serv, Cambridge, MA 02139 USA; [Nicholson, Thomas B.] Novartis Inst BioMed Res, Chem Biol & Therapeut, Cambridge, MA 02139 USA; [Meredith, Erik] Novartis Inst BioMed Res, Global Dev Chem, Cambridge, MA 02139 USA	Novartis; Novartis; Novartis; Novartis; Novartis	Lynch, JM (corresponding author), Novartis Inst BioMed Res, Ophthalmol, 22 Windsor St, Cambridge, MA 02139 USA.	jeffrey.lynch@novartis.com		Lynch, Jeff/0000-0002-4042-7872	Novartis Institutes for BioMedical Research	Novartis Institutes for BioMedical Research	This work was supported by Novartis Institutes for BioMedical Research. Authors are all employees of Novartis Institutes for BioMedical Research (NIBR) and receive salary. As NIBR is a publicly traded pharmaceutical company, the authors may hold stock.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Alward WLM, 1998, NEW ENGL J MED, V338, P1022, DOI 10.1056/NEJM199804093381503; Alward WLM, 2000, EYE, V14, P429, DOI 10.1038/eye.2000.127; Andley UP, 2007, PROG RETIN EYE RES, V26, P78, DOI 10.1016/j.preteyeres.2006.10.003; Anholt RRH, 2013, TRENDS MOL MED, V19, P586, DOI 10.1016/j.molmed.2013.06.005; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; Brubaker RF, 1998, EYES AQUEOUS HUMOR S, P234; Bui BV, 2004, J PHYSIOL-LONDON, V555, P153, DOI 10.1113/jphysiol.2003.052738; Caballero M, 2001, BIOCHEM BIOPH RES CO, V282, P662, DOI 10.1006/bbrc.2001.4624; Chis R, 2012, AM J PHYSIOL-HEART C, V303, pH967, DOI 10.1152/ajpheart.00040.2012; Chou TH, 2014, INVEST OPHTH VIS SCI, V55, P5602, DOI 10.1167/iovs.14-14793; Donegan RK, 2015, HUM MOL GENET, V24, P2111, DOI 10.1093/hmg/ddu730; Ecroyd H, 2010, PROTEIN SCI ENG, P189; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Elgersma Y, 1996, J BIOL CHEM, V271, P26375, DOI 10.1074/jbc.271.42.26375; Faucher M, 2002, HUM MOL GENET, V11, P2077, DOI 10.1093/hmg/11.18.2077; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P532; Glembotski CC, 2007, CIRC RES, V101, P975, DOI 10.1161/CIRCRESAHA.107.161273; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gould DB, 2006, MOL CELL BIOL, V26, P8427, DOI 10.1128/MCB.01127-06; Hagemann TL, 2009, HUM MOL GENET, V18, P1190, DOI 10.1093/hmg/ddp013; Hamanaka T, 2017, INVEST OPHTH VIS SCI, V58, P2818, DOI 10.1167/iovs.16-20646; Hewitt AW, 2008, HUM MUTAT, V29, P207, DOI 10.1002/humu.20634; Hill SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130888; Ishibashi T, 2002, INVEST OPHTH VIS SCI, V43, P3691; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Jobling AI, 2001, INVEST OPHTH VIS SCI, V42, P1829; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Johnson DH, 2000, ARCH OPHTHALMOL-CHIC, V118, P974; Johnson M, 2017, EXP EYE RES, V158, P94, DOI 10.1016/j.exer.2016.01.017; JOHNSON WG, 1980, AM J HUM GENET, V32, P374; Jones-Odeh E, 2015, EYE, V29, P1270, DOI 10.1038/eye.2015.158; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Kore RA, 2016, BBA-MOL CELL RES, V1863, P368, DOI 10.1016/j.bbamcr.2015.11.027; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lametschwandtner G, 1998, J BIOL CHEM, V273, P33635, DOI 10.1074/jbc.273.50.33635; Li C, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/3/037005; Liton P, 2006, MOL VIS, V12, P774; Lundvall A, 2011, J GLAUCOMA, V20, P7, DOI 10.1097/IJG.0b013e3181d1d1ef; Lutjen-Drecoll E, 1998, INVEST OPHTH VIS SCI, V39, P517; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Maezawa I, 2008, J NEUROCHEM, V104, P457, DOI 10.1111/j.1471-4159.2007.04972.x; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Malmos KG, 2017, AMYLOID, V24, P1, DOI 10.1080/13506129.2017.1304905; Massaad CA, 2009, P NATL ACAD SCI USA, V106, P13576, DOI 10.1073/pnas.0902714106; Meyer A, 1996, HUM GENET, V98, P567, DOI 10.1007/s004390050260; Mirzaei M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12858-7; Miyara N, 2008, JPN J OPHTHALMOL, V52, P84, DOI 10.1007/s10384-007-0507-5; Morissette J, 1998, NAT GENET, V19, P319, DOI 10.1038/1203; Nag A, 2017, OPHTHALMOLOGY, V124, P547, DOI 10.1016/j.ophtha.2016.11.018; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Oliveira AO, 2016, HUM MOL GENET, V25, P1677, DOI 10.1093/hmg/ddw028; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Patel HR, 2014, J PHYS CHEM LETT, V5, P1864, DOI 10.1021/jz5001775; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Piri N, 2007, BRAIN RES, V1141, P1, DOI 10.1016/j.brainres.2006.11.095; Piri N, 2013, MOL NEUROBIOL, V48, P819, DOI 10.1007/s12035-013-8470-2; Polansky JR, 2000, EYE, V14, P503, DOI 10.1038/eye.2000.137; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROCKEN C, 1992, VIRCHOWS ARCH A, V421, P339, DOI 10.1007/BF01660981; Scheier B, 1996, MOL CELL ENDOCRINOL, V123, P187, DOI 10.1016/S0303-7207(96)03922-6; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Shen XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095838, 10.1371/journal.pone.0092845]; Shepard AR, 2007, HUM MOL GENET, V16, P609, DOI 10.1093/hmg/ddm001; Shepard AR, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Snider EJ, 2018, J TISSUE ENG REGEN M, V12, P695, DOI 10.1002/term.2488; Souzeau E, 2013, OPHTHALMOLOGY, V120, P1135, DOI 10.1016/j.ophtha.2012.11.029; Steele MR, 2006, INVEST OPHTH VIS SCI, V47, P977, DOI 10.1167/iovs.05-0865; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stothert AR, 2014, HUM MOL GENET, V23, P6470, DOI 10.1093/hmg/ddu367; Sunden SLF, 1996, GENOME RES, V6, P862, DOI 10.1101/gr.6.9.862; SWINKELS BW, 1992, FEBS LETT, V305, P133, DOI 10.1016/0014-5793(92)80880-P; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Wirtz MK, 2008, MOL VIS, V14, P774; Yam GHT, 2007, INVEST OPHTH VIS SCI, V48, P1683, DOI 10.1167/iovs.06-0943; Young TK, 2012, MOL VIS, V18, P3064; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhuo YH, 2008, MOL VIS, V14, P1533; Zillig M, 2005, INVEST OPHTH VIS SCI, V46, P223, DOI 10.1167/iovs.04-0988; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	92	6	6	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20137	20156		10.1074/jbc.RA118.004325	http://dx.doi.org/10.1074/jbc.RA118.004325			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389787	Green Published, hybrid			2022-12-26	WOS:000454685900022
J	de Castro, AA; Legaspi, JC; Tavares, WD; Meagher, RL; Miller, N; Kanga, L; Haseeb, M; Serrao, JE; Wilcken, CF; Zanuncio, JC				de Castro, Ancideriton Antonio; Legaspi, Jesusa Crisostomo; Tavares, Wagner de Souza; Meagher, Robert L., Jr.; Miller, Neil; Kanga, Lambert; Haseeb, Muhammad; Serrao, Jose Eduardo; Wilcken, Carlos Frederico; Zanuncio, Jose Cola			Lethal and behavioral effects of synthetic and organic insecticides on Spodoptera exigua and its predator Podisus maculiventris	PLOS ONE			English	Article							REDUCED-RISK INSECTICIDES; BEET ARMYWORM LEPIDOPTERA; CHRYSOPERLA-CARNEA; BIOLOGICAL-CONTROL; NATURAL ENEMIES; NOCTUIDAE; RESISTANCE; AZADIRACHTIN; HETEROPTERA; PESTICIDES	Background The beet armyworm, Spodoptera exigua (Lepidoptera: Noctuidae), is a key insect pest of edible vegetables around the world and it is resistant to insecticide of different classes. Insecticides that are effective to this pest and selective to predator stinkbugs are required for the integrated management of S. exigua. Methods The toxicity of four commercial insecticide formulations azadirachtin + pyrethrin, spinosad, pyrethrin and chlorantraniliprole was tested on the target pest and their side effect were evaluated on the spined soldier bug, Podisus maculiventris (Heteroptera: Pentatomidae) through different bioassays. Results Spinosad and chlorantraniliprole were more toxic to S. exigua than to the predator P. maculiventris but opposite results were obtained for pyrethrin and azadirachtin + pyrethrin in contact toxicity bioassay. Chlorantraniliprole was the most toxic to S. exigua in oral toxicity bioassay, followed by spinosad, pyrethrin and azadirachtin + pyrethrin. Spinosad in oral toxicity bioassay was the most toxic to P. maculiventris, followed by pyrethrin, azadirachtin + pyrethrin and chlorantraniliprole. Spinosad caused irritability to the predator while pyrethrin to the pest. The insecticide repellency was not observed over the tested insect species. The synthetic insecticide chlorantraniliprole was less toxic than the natural pyrethrin, azadirachtin + pyrethrin and spinosad to the predator. Conclusions This work provides useful information on the combination of commercial insecticides with the predator P. maculiventris to controlling S. exigua in integrated pest management (IPM) programs.	[de Castro, Ancideriton Antonio; Zanuncio, Jose Cola] Univ Fed Vicosa, Dept Entomol BIOAGRO, Vicosa, MG, Brazil; [de Castro, Ancideriton Antonio; Legaspi, Jesusa Crisostomo; Tavares, Wagner de Souza; Miller, Neil] Florida A&M Univ, USDA ARS, CMAVE, Ctr Biol Control, Tallahassee, FL 32307 USA; [Tavares, Wagner de Souza] Univ Fed Vicosa, Dept Fitotecnia BIOAGRO, Vicosa, MG, Brazil; [Meagher, Robert L., Jr.] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Kanga, Lambert; Haseeb, Muhammad] Florida A&M Univ, Ctr Biol Control, Coll Agr & Food Sci, Tallahassee, FL 32307 USA; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Wilcken, Carlos Frederico] Univ Estadual Paulista Julio de Mesquite Filho, Fac Ciencias Agron, Dept Protecao Vegetal, Botucatu, SP, Brazil	Universidade Federal de Vicosa; State University System of Florida; Florida A&M University; United States Department of Agriculture (USDA); Universidade Federal de Vicosa; United States Department of Agriculture (USDA); State University System of Florida; Florida A&M University; Universidade Federal de Vicosa; Universidade Estadual Paulista	Tavares, WD (corresponding author), Florida A&M Univ, USDA ARS, CMAVE, Ctr Biol Control, Tallahassee, FL 32307 USA.; Tavares, WD (corresponding author), Univ Fed Vicosa, Dept Fitotecnia BIOAGRO, Vicosa, MG, Brazil.	wagnermaias@yahoo.com.br	Wilcken, Carlos F/D-1596-2012	Wilcken, Carlos F/0000-0001-9875-4158; Tavares, Wagner/0000-0002-8394-6808	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); "Programa Cooperativo sobre Protecao Florestal (PROTEF)" of the "Instituto de Pesquisas e Estudos Florestais (IPEF)"	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); "Programa Cooperativo sobre Protecao Florestal (PROTEF)" of the "Instituto de Pesquisas e Estudos Florestais (IPEF)"	We thank "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)", "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)", "Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)", and "Programa Cooperativo sobre Protecao Florestal (PROTEF)" of the "Instituto de Pesquisas e Estudos Florestais (IPEF)" for scholarship and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbes K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138411; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Ahmad M, 2010, CROP PROT, V29, P1428, DOI 10.1016/j.cropro.2010.07.025; Balusu RR, 2012, PEST MANAG SCI, V68, P573, DOI 10.1002/ps.2297; Biondi A, 2012, PEST MANAG SCI, V68, P1523, DOI 10.1002/ps.3396; Biondi A, 2012, CHEMOSPHERE, V87, P803, DOI 10.1016/j.chemosphere.2011.12.082; Bueno AD, 2017, CIENC RURAL, V47, DOI 10.1590/0103-8478cr20160829; Campos MR, 2011, CROP PROT, V30, P1535, DOI 10.1016/j.cropro.2011.08.013; Cordeiro EMG, 2010, CHEMOSPHERE, V81, P1352, DOI 10.1016/j.chemosphere.2010.08.021; Correa AS, 2011, CROP PROT, V30, P1655, DOI 10.1016/j.cropro.2011.08.022; de Castro AA, 2013, CHEMOSPHERE, V93, P1043, DOI 10.1016/j.chemosphere.2013.05.075; De Castro AA, 2012, ECOTOXICOLOGY, V21, P96, DOI [10.1007/s10646-011-0769-z, DOI 10.1007/S10646-011-0769-Z]; de Castro AA, 2015, BIOCONTROL, V60, P231, DOI 10.1007/s10526-014-9639-y; DECLERCQ P, 1994, J ECON ENTOMOL, V87, P76, DOI 10.1093/jee/87.1.76; Desneux N, 2004, ENTOMOL EXP APPL, V112, P227, DOI 10.1111/j.0013-8703.2004.00198.x; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Evans SC, 2010, ECOTOXICOLOGY, V19, P1249, DOI 10.1007/s10646-010-0509-9; Fernandes MES, 2016, CHEMOSPHERE, V156, P45, DOI 10.1016/j.chemosphere.2016.04.115; Gontijo PC, 2014, J PEST SCI, V87, P711, DOI 10.1007/s10340-014-0611-5; Gradish AE, 2010, PEST MANAG SCI, V66, P142, DOI 10.1002/ps.1846; Greenberg SM, 2001, ANN ENTOMOL SOC AM, V94, P566, DOI 10.1603/0013-8746(2001)094[0566:FALHOS]2.0.CO;2; Guedes NMP, 2009, B ENTOMOL RES, V99, P393, DOI 10.1017/S0007485309006610; HAYNES KF, 1988, ANNU REV ENTOMOL, V33, P149, DOI 10.1146/annurev.en.33.010188.001053; He YX, 2012, ECOTOXICOLOGY, V21, P1291, DOI 10.1007/s10646-012-0883-6; Kraiss H, 2008, PEST MANAG SCI, V64, P660, DOI 10.1002/ps.1541; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Lai T, 2001, J PEST SCI, V84, P381; Lai TC, 2011, PESTIC BIOCHEM PHYS, V101, P198, DOI 10.1016/j.pestbp.2011.09.006; Lai TC, 2011, PEST MANAG SCI, V67, P1468, DOI 10.1002/ps.2201; Lefebvre M, 2011, CHEMOSPHERE, V84, P25, DOI 10.1016/j.chemosphere.2011.02.090; Liu TX, 1999, J ECON ENTOMOL, V92, P1266, DOI 10.1093/jee/92.6.1266; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Maxwell EM, 2006, FLA ENTOMOL, V89, P117, DOI 10.1653/0015-4040(2006)89[117:EOSRII]2.0.CO;2; Medina P, 2004, J ECON ENTOMOL, V97, P43, DOI 10.1603/0022-0493-97.1.43; Mohaghegh J, 2000, BIOCONTROL SCI TECHN, V10, P33, DOI 10.1080/09583150029369; Mohaghegh J, 2001, J APPL ENTOMOL, V125, P131, DOI 10.1046/j.1439-0418.2001.00519.x; Moscardini VF, 2014, BIOCONTROL, V59, P503, DOI 10.1007/s10526-014-9588-5; Moulton JK, 2000, PEST MANAG SCI, V56, P842, DOI 10.1002/1526-4998(200010)56:10<842::AID-PS212>3.0.CO;2-H; Mourao SA, 2014, FLA ENTOMOL, V97, P555, DOI 10.1653/024.097.0229; Nauen R, 2006, PEST MANAG SCI, V62, P690, DOI 10.1002/ps.1254; Osorio A, 2008, PEST MANAG SCI, V64, P1001, DOI 10.1002/ps.1594; Pereira RR, 2011, J STORED PROD RES, V47, P161; Pezzini DT, 2015, BIOCONTROL SCI TECHN, V25, P1024, DOI 10.1080/09583157.2015.1027659; Powell M, 2014, PLANT DIS, V98, P1639, DOI 10.1094/PDIS-12-13-1261-RE; Qi BY, 2001, BIOL CONTROL, V22, P185, DOI 10.1006/bcon.2001.0965; Robertson J. L., 1992, PESTICIDE BIOASSAYS; Roy A, 2006, BIOL PHARM BULL, V29, P191, DOI 10.1248/bpb.29.191; RUBERSON JR, 1994, FLA ENTOMOL, V77, P440, DOI 10.2307/3495698; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; Saeed S, 2010, J PEST SCI, V83, P165, DOI 10.1007/s10340-009-0283-8; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; Stecca CD, 2017, SEMIN-CIENC AGRAR, V38, P3469, DOI 10.5433/1679-0359.2017v38n6p3469; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Taylor JE, 2008, CROP PROT, V27, P268, DOI 10.1016/j.cropro.2007.05.014; THEILING KM, 1988, AGR ECOSYST ENVIRON, V21, P191, DOI 10.1016/0167-8809(88)90088-6; Tillman PG, 2004, J ECON ENTOMOL, V97, P800, DOI 10.1603/0022-0493(2004)097[0800:COSOPE]2.0.CO;2; Vinuela E, 2000, BIOCONTROL SCI TECHN, V10, P165, DOI 10.1080/09583150029305; Zanuncio JC, 2014, EKOLOJI, V23, P98, DOI 10.5053/ekoloji.2014.9112; Zheng XL, 2011, J ENTOMOL RES SOC, V13, P39; Zhu GP, 2013, PEST MANAG SCI, V69, P483, DOI 10.1002/ps.3394	61	11	11	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206789	10.1371/journal.pone.0206789	http://dx.doi.org/10.1371/journal.pone.0206789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408828	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300038
J	Asami, T; Nakamura, R; Takaishi, M; Yoshida, H; Yoshimi, A; Whitford, TJ; Hirayasu, Y				Asami, Takeshi; Nakamura, Ryota; Takaishi, Masao; Yoshida, Haruhisa; Yoshimi, Asuka; Whitford, Thomas J.; Hirayasu, Yoshio			Smaller volumes in the lateral and basal nuclei of the amygdala in patients with panic disorder	PLOS ONE			English	Article							FACIAL AFFECT; RECOGNITION; REDUCTION; ANXIETY; CORTEX; FMRI	The amygdala plays an important functional role in fear and anxiety. Abnormalities in the amygdala are believed to be involved in the neurobiological basis of panic disorder (PD). Previous structural neuroimaging studies have found global volumetric and morphological abnormalities in the amygdala in patients with PD. Very few studies, however, have explored for structural abnormalities in various amygdala sub-regions, which consist of various sub-nuclei, each with different functions. This study aimed to evaluate for volumetric abnormalities in the amygdala sub-nuclei, in order to provide a better understanding neurobiological basis of PD. Thirty-eight patients with PD and 38 matched healthy control (HC) participants underwent structural MRI scanning. The volume of the whole amygdala, as well as its consistent sub-nuclei, were calculated using FreeSurfer software. Relative volumes of these amygdala sub-regions were compared between the two groups. Results showed significantly smaller volumes in the right lateral and basal nuclei in the patients with PD compared with the HC. Lateral and basal nuclei are thought to play crucial role for processing sensory information related with anxiety and fear. Our results suggest that these particular amygdala sub-regions play a role in the development of PD symptoms.	[Asami, Takeshi; Nakamura, Ryota; Takaishi, Masao; Yoshida, Haruhisa; Yoshimi, Asuka; Hirayasu, Yoshio] Yokohama City Univ, Dept Psychiat, Grad Sch Med, Yokohama, Kanagawa, Japan; [Whitford, Thomas J.] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Hirayasu, Yoshio] Heian Hosp, Urasoe, Okinawa, Japan	Yokohama City University; University of New South Wales Sydney	Asami, T (corresponding author), Yokohama City Univ, Dept Psychiat, Grad Sch Med, Yokohama, Kanagawa, Japan.	t_asami@yokohama-cu.ac.jp		Nakamura, Ryota/0000-0003-1803-413X	Ministry of Health, Labor and Welfare (Kokoro) [200400762A, 200500806A, 200632005A]; JSPS KAKENHI [JP25861023, JP17K10313]; SENSHIN Medical Research Foundation of Japan	Ministry of Health, Labor and Welfare (Kokoro); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); SENSHIN Medical Research Foundation of Japan	This study was supported by grants from the Ministry of Health, Labor and Welfare (Kokoro 200400762A, 200500806A, and 200632005A, B) (Y.H.), and JSPS KAKENHI Grant Numbers JP25861023 and JP17K10313 (T.A.), and a grant from SENSHIN Medical Research Foundation (T.A.) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami T, 2008, PSYCHIAT CLIN NEUROS, V62, P322, DOI 10.1111/j.1440-1819.2008.01800.x; Asami T, 2018, J AFFECT DISORDERS, V240, P199, DOI 10.1016/j.jad.2018.07.064; Asami T, 2009, PSYCHIAT RES-NEUROIM, V173, P128, DOI 10.1016/j.pscychresns.2008.10.004; Chechko N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005537; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fujiwara A, 2011, PSYCHIAT CLIN NEUROS, V65, P365, DOI 10.1111/j.1440-1819.2011.02219.x; Gorman JM, 2000, AM J PSYCHIAT, V157, P493, DOI 10.1176/appi.ajp.157.4.493; Hayano F, 2009, PSYCHIAT CLIN NEUROS, V63, P266, DOI 10.1111/j.1440-1819.2009.01960.x; Hollingshead AB, 1965, 2 FACTOR INDEX SOCIA; Hortensius R, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0376; Kim JE, 2017, J NERV MENT DIS, V205, P714, DOI 10.1097/NMD.0000000000000696; Lai CH, 2015, J AFFECT DISORDERS, V186, P1, DOI 10.1016/j.jad.2015.07.022; Massana G, 2003, NEUROIMAGE, V19, P80, DOI 10.1016/S1053-8119(03)00036-3; Nash JR, 2008, BRIT J PSYCHIAT, V193, P229, DOI 10.1192/bjp.bp.107.041186; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Pillay SS, 2007, J ANXIETY DISORD, V21, P381, DOI 10.1016/j.janxdis.2006.04.001; Pillay SS, 2006, J AFFECT DISORDERS, V94, P173, DOI 10.1016/j.jad.2006.04.007; Sakai Y, 2005, NEUROREPORT, V16, P927, DOI 10.1097/00001756-200506210-00010; Santos M, 2015, EUR J PHARMACOL, V759, P127, DOI 10.1016/j.ejphar.2015.03.039; Saygin ZM, 2017, NEUROIMAGE, V155, P370, DOI 10.1016/j.neuroimage.2017.04.046; Sobanski T, 2010, PSYCHOL MED, V40, P1879, DOI 10.1017/S0033291709991930; Sobanski T, 2017, WORLD J PSYCHIATR, V7, P12, DOI 10.5498/wjp.v7.i1.12; Tuescher O, 2011, J ANXIETY DISORD, V25, P251, DOI 10.1016/j.janxdis.2010.09.010; Uchida RR, 2003, BRAZ J MED BIOL RES, V36, P925, DOI 10.1590/S0100-879X2003000700014; Whalen P.J., 2009, HUMAN AMYGDALA; Yoon SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152690	27	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207163	10.1371/journal.pone.0207163	http://dx.doi.org/10.1371/journal.pone.0207163			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403747	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500103
J	Elliott, SM; Erickson, ML; Krall, AL; Adams, BA				Elliott, Sarah M.; Erickson, Melinda L.; Krall, Aliesha L.; Adams, Byron A.			Concentrations of pharmaceuticals and other micropollutants in groundwater downgradient from large on-site wastewater discharges	PLOS ONE			English	Article							ORGANIC CONTAMINANTS; TREATMENT SYSTEMS; SEPTIC SYSTEMS; DOMESTIC WELLS; NEW-YORK; FATE; EFFLUENT; CHEMICALS; REMOVAL	Large subsurface treatment systems (LSTS) and rapid infiltration basins (RIB) are preferred onsite wastewater treatments compared to direct discharge of treated wastewater to streams and adjacent facilities. Discharge of these wastewater treatments may result in contaminant loading to aquifers that also serve as drinking water sources downgradient from the discharge site. Until recently, few studies have characterized the contribution of micropollutants (e.g. pharmaceuticals, fragrances, flame retardants, etc.) to receiving aquifers. We conducted a pilot project to characterize the occurrence of micropollutants in groundwater downgradient from 7 on-site treatment systems in Minnesota, USA: 5 community LSTS and 2 municipal RIB. One downgradient monitoring well was sampled three times at each facility over one year. Of 223 micropollutants analyzed, 35 were detected. Total sample concentrations ranged from 90 to 4,039 ng/L. Sulfamethoxazole (antibiotic) was detected in all samples at concentrations from 7 to 965 ng/L. Other pharmaceuticals (0.12-1,000 ng/L), organophosphorus flame retardants (10-500 ng/L), and other anthropogenic chemicals (4-775 ng/L) were also detected. The numbers and concentrations of micropollutants detected were inversely related to dissolved oxygen and depth to water. Ratios of pharmaceutical concentrations to human-health screening values were <0.10 for most samples. However, concentrations of carbamazepine and sulfamethoxazole exceeded screening values at two sites. Study results illustrate that large on-site wastewater systems designed to discharge to permeable soil or shallow groundwater effectively deliver pharmaceuticals and other micropollutants to groundwater aquifers and could contribute micropollutants to drinking water via water supply wells.	[Elliott, Sarah M.; Erickson, Melinda L.; Krall, Aliesha L.] US Geol Survey, Mounds View, MN 55112 USA; [Adams, Byron A.] Minnesota Pollut Control Agcy, St Paul, MN USA	United States Department of the Interior; United States Geological Survey	Elliott, SM (corresponding author), US Geol Survey, Mounds View, MN 55112 USA.	selliott@usgs.gov		Diekoff, Aliesha/0000-0003-2521-5043	State of Minnesota Clean Water fund via the Minnesota Pollution Control Agency; USGS Cooperative Matching Fund	State of Minnesota Clean Water fund via the Minnesota Pollution Control Agency; USGS Cooperative Matching Fund	Funding for this study was provided by the State of Minnesota Clean Water fund via the Minnesota Pollution Control Agency and the USGS Cooperative Matching Fund.; Funding for this study was provided by the State of Minnesota Clean Water Fund via the Minnesota Pollution Control Agency and the USGS Cooperative Matching Fund. We would like to thank the facility owners and operators for their cooperation and participation in this study. We thank our colleague Patrick Phillips, whose comprehensive review greatly improved this manuscript. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	[Anonymous], 2007, 20075021 US GEOL SUR, DOI DOI 10.3133/SIR20075021; [Anonymous], 2000, 4500NO3F SM; Barber LB, 2009, ENVIRON SCI TECHNOL, V43, P4843, DOI 10.1021/es803292v; Barnes KK, 2008, SCI TOTAL ENVIRON, V402, P192, DOI 10.1016/j.scitotenv.2008.04.028; Blum KM, 2017, SCI TOTAL ENVIRON, V575, P265, DOI 10.1016/j.scitotenv.2016.09.135; Brausch JM, 2011, CHEMOSPHERE, V82, P1518, DOI 10.1016/j.chemosphere.2010.11.018; Bremer JE, 2012, HYDROL EARTH SYST SC, V16, P2453, DOI 10.5194/hess-16-2453-2012; Byron Adams, 2011, BEST MANAGEMENT PRAC; Carrara C, 2008, ENVIRON SCI TECHNOL, V42, P2805, DOI 10.1021/es070344q; Conn KE, 2006, ENVIRON SCI TECHNOL, V40, P7358, DOI 10.1021/es0605117; Conn KE, 2010, ENVIRON ENG SCI, V27, P347, DOI 10.1089/ees.2009.0364; Elliott SM, 2016, CHEM EMERGING CONCER, DOI [10.5066/F7M906RN, DOI 10.5066/F7M906RN]; Valdes ME, 2014, SCI TOTAL ENVIRON, V472, P389, DOI 10.1016/j.scitotenv.2013.10.124; Fairbairn DJ, 2016, SCI TOTAL ENVIRON, V551, P605, DOI 10.1016/j.scitotenv.2016.02.056; Ferrell GM, 2014, J ENVIRON HEALTH, V76, P18; Ferrey M, 2011, WASTEWATER TREATMENT; Fisher IJ, 2016, MAR POLLUT BULL, V107, P509, DOI 10.1016/j.marpolbul.2016.04.038; Foreman W.T., 2012, BOOK B, V5, DOI DOI 10.3133/TM5B9; Furlong E. T., 2014, US GEOLOGICAL SURVEY, V5, P49, DOI [10.3133/tm5B10, DOI 10.3133/TM5B10]; Garcia SN, 2013, CHEMOSPHERE, V92, P38, DOI 10.1016/j.chemosphere.2013.03.007; Godfrey E, 2007, GROUND WATER, V45, P263, DOI 10.1111/j.1745-6584.2006.00288.x; Hinkle S. R., 2005, 20055055 US GEOL SUR; Hobbs H. C., 1982, S 01 GEOLOGIC MAP MI; Lapworth DJ, 2012, ENVIRON POLLUT, V163, P287, DOI 10.1016/j.envpol.2011.12.034; Li WC, 2014, ENVIRON POLLUT, V187, P193, DOI 10.1016/j.envpol.2014.01.015; Minnesota Department of Health, 2017, MINN WELL IND MWI; Phillips PJ, 2015, SCI TOTAL ENVIRON, V512, P43, DOI 10.1016/j.scitotenv.2014.12.067; Schaider LA, 2017, ENVIRON SCI TECHNOL, V51, P7304, DOI 10.1021/acs.est.6b04778; Schaider LA, 2016, SCI TOTAL ENVIRON, V547, P470, DOI 10.1016/j.scitotenv.2015.12.081; Diaz-Cruz MS, 2008, CHEMOSPHERE, V72, P333, DOI 10.1016/j.chemosphere.2008.02.031; Standard Methods Online, 1997, 4500FC SM; Subedi B, 2015, WATER RES, V72, P28, DOI 10.1016/j.watres.2014.10.049; Suchomel A., 2015, PHARM WATER SCREENIN; Swartz CH, 2006, ENVIRON SCI TECHNOL, V40, P4894, DOI 10.1021/es052595+; United States Environmental Protection Agency (USEPA), 1994, 2007 USEPA; United States Environmental Protection Agency (USEPA), 1993, 3501 USEPA; USEPA, 2013, ANN REP 2013 DEC WAS; USEPA, 1999, CLASS 5 UND INJ CONT, V16; USEPA, 2012, CAS STUD IND CLUST D; USEPA, 1997, 3001 US EPA; USGS, US GEOLOGICAL SURVEY, V9; Vatovec C, 2016, SCI TOTAL ENVIRON, V572, P906, DOI 10.1016/j.scitotenv.2016.07.199; Verstraeten IM, 2005, GROUND WATER MONIT R, V25, P107, DOI 10.1111/j.1745-6592.2005.0015.x; Zaugg S.D., 2006, DETERMINATION WASTEW, DOI 10.3133/tm5B4	44	20	20	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206004	10.1371/journal.pone.0206004	http://dx.doi.org/10.1371/journal.pone.0206004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403721	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500045
J	Lee, LM; Le, HH; Jean, FR				Lee, Lee-Min; Hoang-Hiep Le; Jean, Fu-Rong			Improved model adaptation approach for recognition of reduced-frame-rate continuous speech	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS	In distributed speech recognition applications, the front-end device that stands for any hand-held electronic device like smartphones and personal digital assistants (PDAs) captures the speech signal, extracts the speech features, and then sends the speech-feature vector sequence to the back-end server for decoding. Since the front-end mobile device has limited computation capacity, battery power and bandwidth, there exists a feasible strategy of reducing the frame rate of the speech-feature vector sequence to alleviate the drawback. Previously, we proposed a method for adjusting the transition probabilities of the hidden Markov model to enable it to address the degradation of recognition accuracy caused by the frame-rate mismatch between the input and the original model. The previous model adaptation method is referred to as the adapting-then-connecting approach that adapts each model individually and then connects the adapted models to form a word network for speech recognition. We have found that this model adaption approach introduces transitions that skip too many states and increase the number of insertion errors. In this study, we propose an improved model adaptation approach denoted as the connecting-then-adapting approach that first connects the individual models to form a word network and then adapts the connected network for speech recognition. This new approach calculates the transition matrix of a connected model, adapts the transition matrix of the connected model according to the frame rate, and then creates a transition arc for each transition probability. The new approach can better align the speech feature sequence with the states in the word network and therefore reduce the number of insertion errors. We conducted experiments to investigate the effectiveness of our new approach and analyzed the results with respect to insertion, deletion, and substitution errors. The experimental results indicate that the proposed new method obtains a better recognition rate than the old method.	[Lee, Lee-Min; Hoang-Hiep Le] Da Yeh Univ, Dept Elect Engn, Changhua, Taiwan; [Hoang-Hiep Le] Saigon Univ, Fac Elect Telecommun, Ho Chi Minh City, Vietnam; [Jean, Fu-Rong] Natl Taipei Univ Technol, Dept Elect Engn, Taipei, Taiwan	Da Yeh University; Saigon University; National Taipei University of Technology	Jean, FR (corresponding author), Natl Taipei Univ Technol, Dept Elect Engn, Taipei, Taiwan.	frjean@ntut.edu.tw			Ministry of Science and Technology, Taiwan [MOST 104-2221-E-212-009]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was financially supported by Ministry of Science and Technology, Taiwan, under contract number MOST 104-2221-E-212-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, ISCA TUTORIAL RES WO; [Anonymous], 2003, 201108 ETSI ES; Deng HQ, 2007, 2007 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING, VOLS 1 AND 2, P591, DOI 10.1109/ASRU.2007.4430179; ETSI, 2003, 202211 ETSI ES; Lee LM, 2017, ELECTRON LETT, V53, P962, DOI 10.1049/el.2017.0458; Lee LM, 2010, ELECTRON LETT, V46, P723, DOI 10.1049/el.2010.0942; Lee LM, 2013, IEEE T CYBERNETICS, V43, P2114, DOI 10.1109/TCYB.2013.2240450; Peinado A, 2006, SPEECH RECOGNITION D; Tan Z-H, 2005, 2005 IEEE 7 WORKSH M; Tan ZH, 2005, SPEECH COMMUN, V47, P220, DOI 10.1016/j.specom.2005.05.007; Tan ZH, 2008, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84800-143-5; Young S, 1989, CUEDFINFENGTR38, V38; Young S., 2006, HTK BOOK HTK VERSION	13	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206916	10.1371/journal.pone.0206916	http://dx.doi.org/10.1371/journal.pone.0206916			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403736	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500082
J	Challa, GS; Li, WL				Challa, Ghana Shyam; Li, Wanlong			De novo assembly of wheat root transcriptomes and transcriptional signature of longitudinal differentiation	PLOS ONE			English	Article							RESPONSIVE GENES; DRAFT GENOME; ARABIDOPSIS; STRESS; IDENTIFICATION; ALGORITHM; REVEALS; PROTEIN; SYSTEM; SHOOT	Hidden underground, root systems constitute an important part of the plant for its development, nourishment and sensing the soil environment around it, but we know very little about its genetic regulation in crop plants like wheat. In the present study, we de novo assembled the root transcriptomes in reference cultivar Chinese Spring from RNA-seq reads generated by the 454-GS-FLX and HiSeq platforms. The FLX reads were assembled into 24,986 transcripts with completeness of 54.84%, and the HiSeq reads were assembled into 91,543 high-confidence protein-coding transcripts, 2,404 low-confidence protein-coding transcripts, and 13,181 non-coding transcripts with the completeness of >90%. Combining the FLX and HiSeq assemblies, we assembled a root transcriptome of 92,335 ORF-containing transcripts. Approximately 7% of the coding transcripts and similar to 2% non-coding transcripts are not present in the current wheat genome assembly. Functional annotation of both assemblies showed similar gene ontology patterns and that similar to 7% coding and >5% non-coding transcripts are root-specific. Transcription quantification identified 1,728 differentially expressed transcripts between root tips and maturation zone, and functional annotation of these transcripts captured a transcriptional signature of longitudinal development of wheat root. With the transcriptomic resources developed, this study provided the first view of wheat root transcriptome under different developmental zones and laid a foundation for molecular studies of wheat root development and growth using a reverse genetic approach.	[Challa, Ghana Shyam; Li, Wanlong] South Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA; [Li, Wanlong] South Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA	South Dakota State University; South Dakota State University	Li, WL (corresponding author), South Dakota State Univ, Dept Biol & Microbiol, Brookings, SD 57007 USA.; Li, WL (corresponding author), South Dakota State Univ, Dept Plant Sci, Brookings, SD 57007 USA.	Wanlong.li@sdstate.edu	Challa, Ghana/AAG-5407-2019	Challa, Ghana/0000-0002-0047-1799; Li, Wanlong/0000-0001-5886-1426	USDA-NIFA project [20186701427360]; South Dakota State University; South Dakota Agricultural Experiment Station	USDA-NIFA project; South Dakota State University; South Dakota Agricultural Experiment Station	This research is supported by a USDA-NIFA project (20186701427360 to Wl) and Research/Scholarship Support Fund from South Dakota State University. GSC was partly supported by a graduate research assistantship from South Dakota Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Zhengzhi Zhang for technical assistance. GSC was partly supported by a graduate research assistantship from South Dakota Agricultural Experiment Station.	Akhunov ED, 2013, PLANT PHYSIOL, V161, P252, DOI 10.1104/pp.112.205161; Bansal V, 2008, BIOINFORMATICS, V24, pI153, DOI 10.1093/bioinformatics/btn298; Bedada G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-995; Bedre R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3017-3; Benkova E, 2009, PLANT MOL BIOL, V69, P383, DOI 10.1007/s11103-008-9393-6; Biselli C, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00037; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Camilios-Neto D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-378; Cantu D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-492; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Choe S, 1999, PLANT PHYSIOL, V119, P897, DOI 10.1104/pp.119.3.897; Choulet F, 2014, SCIENCE, V345, DOI 10.1126/science.1249721; Chu Z, 2017, BMC PLANT BIOL, V17, P224, DOI [10.1186/s12870-017-1166-4, DOI 10.1186/S12870-017-1166-4]; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Engstrom EM, 2011, PLANT PHYSIOL, V155, P735, DOI 10.1104/pp.110.168757; Feng YL, 2016, J GENET, V95, P957, DOI 10.1007/s12041-016-0724-0; Fitzelle KJ, 2001, J EXP BOT, V52, P265, DOI 10.1093/jexbot/52.355.265; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Gibbs DJ, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592316.2014.970406; Hochholdinger F, 2008, CURR OPIN PLANT BIOL, V11, P70, DOI 10.1016/j.pbi.2007.10.002; Hofstad AN, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.05.0032; Hu L, 2018, PLANT SCI, V272, P276, DOI 10.1016/j.plantsci.2018.03.036; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hussey SG, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-173; Jaillais Y, 2016, CURR OPIN PLANT BIOL, V33, P92, DOI 10.1016/j.pbi.2016.06.014; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kataoka T, 2004, PLANT PHYSIOL, V136, P4198, DOI 10.1104/pp.104.045625; Khan Z, 2009, BIOINFORMATICS, V25, P1609, DOI 10.1093/bioinformatics/btp275; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Krasileva KV, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r66; Kumar RR, 2015, OMICS, V19, P632, DOI 10.1089/omi.2015.0097; Kyndt T, 2012, J EXP BOT, V63, P2141, DOI 10.1093/jxb/err435; Leach LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-276; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074478; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu J, 2015, PLANT BIOTECHNOL J, V13, P319, DOI 10.1111/pbi.12336; Liu W, 2015, INT J MOL SCI, V16, P20657, DOI 10.3390/ijms160920657; Liu YJ, 2018, PLANTA, V247, P1307, DOI 10.1007/s00425-018-2848-3; Lohse M, 2014, PLANT CELL ENVIRON, V37, P1250, DOI 10.1111/pce.12231; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Lu D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4767; Ma J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00592; Nole-Wilson S, 2005, PLANT MOL BIOL, V57, P613, DOI 10.1007/s11103-005-0955-6; Oono Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-77; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pearce S, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0831-3; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Petricka JJ, 2012, ANNU REV PLANT BIOL, V63, P563, DOI 10.1146/annurev-arplant-042811-105501; Pingault L, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0601-9; Powell JJ, 2017, ANN BOT-LONDON, V119, P853, DOI 10.1093/aob/mcw207; Rangan P, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4154-z; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; Reeksting BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086399; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rosado A, 2006, PLANT PHYSIOL, V142, P1113, DOI 10.1104/pp.106.085191; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Seifert F, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0782-8; SMITH DL, 1995, PLANT CELL, V7, P735, DOI 10.1105/tpc.7.6.735; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; The International Wheat Genome Sequencing Consortium, 2014, SCIENCE, V345, DOI [10.1371/journal.pone.0083530, DOI 10.1371/JOURNAL.PONE.0083530]; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Xing PY, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/7305684; Yang LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120691; Zhang C, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4002-1; Zhang Q, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030782; Zhang SJ, 2014, J BIOTECHNOL, V189, P48, DOI 10.1016/j.jbiotec.2014.08.032; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	73	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205582	10.1371/journal.pone.0205582	http://dx.doi.org/10.1371/journal.pone.0205582			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395610	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400008
J	Mubin, N; Pahari, S; Owais, M; Zubair, S				Mubin, Nida; Pahari, Susanta; Owais, Mohammad; Zubair, Swaleha			Mycobacterium tuberculosis host cell interaction: Role of latency associated protein Acr-1 in differential modulation of macrophages	PLOS ONE			English	Article							DENDRITIC CELLS; CYTOKINE PRODUCTION; SECRETION SYSTEM; NONREPLICATING PERSISTENCE; ALPHA-CRYSTALLIN; HYPOXIC RESPONSE; FLOW-CYTOMETRY; T-CELLS; INFECTION; GROWTH	Mycobacterium tuberculosis (M.tb) contrives intracellular abode as a strategy to combat antibody onslaught. Additionally, to thrive against hostile ambiance inside host macrophages, the pathogen inhibits phago-lysosomal fusion. Finally, to further defy host cell offensives, M.tb opts for dormant phase, where it turns off or slows down most of its metabolic process as an added stratagem. While M.tb restrains most of its metabolic activities during dormancy, surprisingly latency-associated alpha-crystallin protein (Acr-1) is expressed most prominently during this phase. Interestingly, several previous studies described the potential of Acr-1 to induce the robust immuno-prophylactic response in the immunized host. It is intriguing to comprehend the apparent discrepancy that the microbe M.tb overexpresses a protein that has the potential to prime host immune system against the pathogen itself. Keeping this apparent ambiguity into consideration, it is imperative to unravel intricacies involved in the exploitation of Acr-1 by M.tb during its interaction with host immune cells. The present study suggests that Acr-1 exhibits diverse role in the maturation of macrophages (M Phi s) and related immunological responses. The early encounter of bone marrow derived immune cells (pre-exposure during differentiation to M Phi s) with Acr-1 (AcrM Phi pre), results in hampering of their function. The pre-exposure of naive M Phi s with Acr-1 induces the expression of TIM-3 and IL-10. In contrast, exposure of fully differentiated M Phi s to Acr-1 results in their down-modulation and induces the phosphorylation of STAT-1 and STAT-4 in host M Phi s. Furthermore, Acr-1 mediated activation of M Phi s results in the induction of Th1 and Th17 phenotype by activated T lymphocyte.	[Mubin, Nida; Owais, Mohammad] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Mol Immunol Lab, Aligarh, Uttar Pradesh, India; [Pahari, Susanta] CSIR Inst Microbial Technol, Immunol Lab, Chandigarh, India; [Zubair, Swaleha] Aligarh Muslim Univ, Dept Comp Sci, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Aligarh Muslim University	Owais, M (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Mol Immunol Lab, Aligarh, Uttar Pradesh, India.; Zubair, S (corresponding author), Aligarh Muslim Univ, Dept Comp Sci, Aligarh, Uttar Pradesh, India.	mdowais2012@gmail.com; swalehazubair@yahoo.com	Pahari, Susanta/GLU-0379-2022	Pahari, Susanta/0000-0001-6577-3387; Mohammad, Owais/0000-0001-7377-7388				Abdallah AM, 2008, J IMMUNOL, V181, P7166, DOI 10.4049/jimmunol.181.10.7166; Abebe M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/678570; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Bekmurzayeva A, 2013, TUBERCULOSIS, V93, P381, DOI 10.1016/j.tube.2013.03.003; Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033; de Chastellier C, 2009, IMMUNOBIOLOGY, V214, P526, DOI 10.1016/j.imbio.2008.12.005; DENIS M, 1990, INT J IMMUNOPHARMACO, V12, P721, DOI 10.1016/0192-0561(90)90034-K; FELS AOS, 1986, J APPL PHYSIOL, V60, P353, DOI 10.1152/jappl.1986.60.2.353; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Ganguly N, 2008, IMMUNOL CELL BIOL, V86, P98, DOI 10.1038/sj.icb.7100117; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; GIMMI CD, 1993, P NATL ACAD SCI USA, V90, P6586, DOI 10.1073/pnas.90.14.6586; Hickman SP, 2002, J IMMUNOL, V168, P4636, DOI 10.4049/jimmunol.168.9.4636; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Langlois RA, 2007, IMMUNOL RES, V39, P128, DOI 10.1007/s12026-007-0077-0; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Marin ND, 2010, TUBERCULOSIS, V90, P252, DOI 10.1016/j.tube.2010.05.003; Mazurek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042515; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MOSMANN TR, 1989, J IMMUNOL METHODS, V116, P151, DOI 10.1016/0022-1759(89)90198-1; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mukamolova GV, 2010, AM J RESP CRIT CARE, V181, P174, DOI 10.1164/rccm.200905-0661OC; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Ocana-Guzman R, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00229; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; Pahari S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00193; Pahari S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00906; Pahari S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39492; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Pozzi LAM, 2005, J IMMUNOL, V175, P2071, DOI 10.4049/jimmunol.175.4.2071; Qiao D, 2011, SCAND J IMMUNOL, V73, P330, DOI 10.1111/j.1365-3083.2011.02512.x; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Salgame P, 2005, CURR OPIN IMMUNOL, V17, P374, DOI 10.1016/j.coi.2005.06.006; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Siddiqui KF, 2015, CLIN EXP IMMUNOL, V181, P286, DOI 10.1111/cei.12634; Siddiqui KF, 2011, CRIT REV MICROBIOL, V37, P349, DOI 10.3109/1040841X.2011.606425; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Sugawara I, 2004, TOHOKU J EXP MED, V202, P41, DOI 10.1620/tjem.202.41; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Weischenfeldt Joachim, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot5080; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	48	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206459	10.1371/journal.pone.0206459	http://dx.doi.org/10.1371/journal.pone.0206459			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395609	gold, Green Submitted, Green Published			2022-12-26	WOS:000449291400025
J	Siemann, LA; Huntsberger, CJ; Leavitt, JS; Smolowitz, RJ				Siemann, Liese A.; Huntsberger, Carl J.; Leavitt, Jasper S.; Smolowitz, Ronald J.			Summering on the bank: Seasonal distribution and abundance of monkfish on Georges Bank	PLOS ONE			English	Article							GROUNDFISH; LOPHIUS; FISHERY	The American monkfish is an important commercial species that is widely distributed across a range of depths and temperatures from North Carolina to southern Nova Scotia, including on Georges Bank. We examined changes in the seasonal distribution and relative abundance of monkfish in the scallop access areas in Closed Area I and Closed Area II on Georges Bank using catch data from a three-year seasonal scallop dredge survey. Over the course of the survey, more than 6,000 monkfish were caught and measured, and clear seasonal changes in monkfish abundance were documented. Monkfish catch peaked in the summer and early fall when they were caught across the entire survey area, while they were caught only in deeper waters at the edges of the bank in the winter. Monkfish relative abundance was modeled using a generalized linear mixed model with a Tweedie distribution, and the final model, with month, depth, and bottom temperature as fixed effects, effectively explained the seasonal shifts in the location and relative abundance of monkfish observed during this study. The results suggest that monkfish movements are driven by seasonal changes in bottom temperature. Management measures for monkfish are determined primarily based on data collected during the Northeast Fisheries Science Center bottom trawl surveys, yet this survey catches few monkfish, adding uncertainty to stock assessments. Our research indicates that increasing the use of dredge surveys to collect data on monkfish would be a positive step toward improving monkfish assessments. If monkfish movements are impacted by changes in thermal habitat, their distributions may shift in response to climate change, increasing the need for improved monkfish assessment strategies to effectively manage the species in the future.	[Siemann, Liese A.; Huntsberger, Carl J.; Leavitt, Jasper S.; Smolowitz, Ronald J.] Coonamessett Farm Fdn Inc, East Falmouth, MA 02536 USA; [Huntsberger, Carl J.] Univ Maine, Darling Marine Ctr, Walpole, ME USA; [Leavitt, Jasper S.] Trent Univ, Dept Biol, Peterborough, ON, Canada	University of Maine System; University of Maine Orono; Trent University	Siemann, LA (corresponding author), Coonamessett Farm Fdn Inc, East Falmouth, MA 02536 USA.	lsiemann@cfarm.org			NOAA Sea Scallop Research Set-Aside [NA11NMF4540027, NA12NMF4540034, NA13NMF4540011]	NOAA Sea Scallop Research Set-Aside	This study was funded by the NOAA Sea Scallop Research Set-Aside grants NA11NMF4540027, NA12NMF4540034, and NA13NMF4540011 (https://www.nefsc.noaa.gov/coopresearch/rsa_program.html).The funders had no role in study design.; We would like to thank our colleagues at CFF for their participation in the bycatch study over the years. We are grateful to the vessel owners, operators, and crew members who made this project possible. We also thank A. Richards and two anonymous reviewers whose comments improved the manuscript. This study was funded by the NOAA Sea Scallop Research SetAside grants NA11NMF4540027, NA12NMF4540034, and NA13NMF4540011. The funder provided support in the form of salaries for authors [L.A.S, C.J.H., and J.S.L.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Coonamessett Farm Foundation, Inc is a non-profit scientific research foundation.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Almeida Frank P., 1995, North American Journal of Fisheries Management, V15, P14, DOI 10.1577/1548-8675(1995)015<0014:LWRASM>2.3.CO;2; Balcom N., 1997, NA56FKO109 NOAA NE R; Bigelow A. F., 2002, BIGELOW SCHROEDERS F; Bivand R., 2015, RGDAL BINDINGS GEOSP, P1; Bjornstad ON, 2013, NCF SPATIAL NONPARAM, V1, P1; Cadrin S, 2016, NA13NMF4540091; Chikarmane HM, 2000, BIOL BULL, V199, P227, DOI 10.2307/1542912; Comeau LA, 2002, ICES J MAR SCI, V59, P333, DOI 10.1006/jmsc.2001.1153; Farina AC, 2008, ICES J MAR SCI, V65, P1272, DOI 10.1093/icesjms/fsn140; Haring P, 2008, ICES J MAR SCI, V65, P1370, DOI 10.1093/icesjms/fsn131; Hasbrouk E, 2013, NA12NMF4540095; He P., 2010, BEHAV MARINE FISHES; HE PG, 1993, ICES MAR SC, V196, P183; Jacobson L, 2014, 201413 TRANSB RES AS; JEAN Y, 1965, J FISH RES BOARD CAN, V22, P621, DOI 10.1139/f65-052; Mountain D.G., 1992, ICES MAR SCI S, P424; MURAWSKI SA, 1988, CAN J FISH AQUAT SCI, V45, P1720, DOI 10.1139/f88-204; New England Fishery Management Council, 1998, MONKF FISH MAN PLAN; New England Fishery Management Council, 2011, APP C EFH DES MAP RE; New England Fishery Management Council, 2016, OMN ESS FISH HAB AM, V2; New England Fishery Management Council, 2016, MONKF FISH MAN PLAN; New England Fishery Management Council, 1998, AM 11 NE MULT FISH M, V1; New England Fishery Management Council. Appendix A, 2014, APP A EFH DES METH U; Northeast Fisheries Science Center, 2014, 1406 NEFSC; Northeast Fisheries Science Center, 2010, 50 NE REG STOCK ASS, P15; Northeast Fisheries Science Center, 2013, 1323 NEFSC; O'Driscoll RL, 2000, 2000083 CAN STOCK AS; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P589, DOI 10.1139/f94-061; PERRY RI, 1994, CAN J FISH AQUAT SCI, V51, P1401, DOI 10.1139/f94-140; R Core Team, 2013, R LANG ENV STAT COMP; Richards RA, 2008, ICES J MAR SCI, V65, P1291, DOI 10.1093/icesjms/fsn108; Rountree RA, 2006, 2006Q01 ICES CM; Ryer CH, 2006, FISH RES, V81, P242, DOI 10.1016/j.fishres.2006.07.001; SCOTT J S, 1982, Journal of Northwest Atlantic Fishery Science, V3, P29; Sherwood G, 2013, NA07NMF4540023; Shono H, 2008, FISH RES, V93, P154, DOI 10.1016/j.fishres.2008.03.006; Smolowitz R, 2012, N AM J FISH MANAGE, V32, P65, DOI 10.1080/02755947.2012.661386; Speiss A.-J., 2014, QPCR MODELLING ANAL; Stefansson G, 1996, ICES J MAR SCI, V53, P577, DOI 10.1006/jmsc.1996.0079; Steimle F. W., 1999, NMFSNE127; SWARTZMAN G, 1992, CAN J FISH AQUAT SCI, V49, P1366, DOI 10.1139/f92-152; Tracy HC, 1906, INLAND FISH ANN REPT, V36, P38; Tweedie M.C.K., 1984, STAT APPL NEW DIRECT, P579; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206829	10.1371/journal.pone.0206829	http://dx.doi.org/10.1371/journal.pone.0206829			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395622	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400058
J	Apremont, V; Cambon-Bonavita, MA; Cueff-Gauchard, V; Francois, D; Pradillon, F; Corbari, L; Zbinden, M				Apremont, Vincent; Cambon-Bonavita, Marie-Anne; Cueff-Gauchard, Valerie; Francois, David; Pradillon, Florence; Corbari, Laure; Zbinden, Magali			Gill chamber and gut microbial communities of the hydrothermal shrimp Rimicaris chacei Williams and Rona 1986: A possible symbiosis	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; STABLE-ISOTOPE APPROACH; SP-NOV.; GEN. NOV.; TROPHIC ECOLOGY; EXOCULATA GUT; VENT FIELDS; SEA; BACTERIA; DIVERSITY	Rimicaris chacei Williams and Rona 1986, formerly named as Chorocaris chacei, is a caridean shrimp living in deep-sea hydrothermal ecosystems. This shrimp is endemic to the Mid Atlantic Ridge (MAR) and lives at the periphery of aggregates of its well-known congeneric R. exoculata Williams and Rona 1986. Contrasting with the very dense and mobile clusters formed by R. exoculata, R. chacei lives in small groups of several individuals that are not very mobile. Although devoid of the characteristic hypertrophied cephalothorax of R. exoculata, which harbors the ectosymbionts, a microbial community has also been reported in the cephalothorax of R. chacei. Previous data on morphology, behavior and isotopic values indicate a diet based on a combination of feeding on its epibiotic bacteria and scavenging or occasional predation. In this study, our objective was to describe, for the first time, the distribution, morphology and phylogeny of the microbial communities associated with R. chacei. This species is significantly less studied than R. exoculata, but nevertheless represents the only other known example of symbiosis in crustaceans of MAR hydrothermal vent sites. Microbial communities have been observed at the same locations as in R. exoculata (mouthparts, branchiostegites and digestive tract). However, in R. chacei, the surfaces occupied by the bacteria are smaller. The main lineages are affiliated to Epsilon and Gammaproteobacteria in the cephalothorax and to Deferribacteres, Mollicutes, Epsilon and Gammaproteobacteria in the digestive tract. Comparison with the well-described bacterial communities of R. exoculata and hypotheses about the role of these communities in R. chacei are discussed.	[Apremont, Vincent; Cambon-Bonavita, Marie-Anne; Cueff-Gauchard, Valerie; Francois, David] Univ Brest, IFREMER, CNRS, Lab Microbiol Environm Extremes, Plouzane, France; [Apremont, Vincent; Zbinden, Magali] Sorbonne Univ, Unite Biol ORganismes & Ecosyst Aquat BOREA, MNHN, CNRS,IRD Equipe Adaptat Milieux Extremes AMEX, 7 Quai St Bernard, Paris, France; [Pradillon, Florence] Ifremer Ctr Bretagne, ZI Pointe Diable, Lab Environm Profond, REM EEP LEP, Plouzane, France; [Corbari, Laure] UPMC, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite ISYEB,UMR 7205,CNRS,MNHN,EPH, Paris, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Zbinden, M (corresponding author), Sorbonne Univ, Unite Biol ORganismes & Ecosyst Aquat BOREA, MNHN, CNRS,IRD Equipe Adaptat Milieux Extremes AMEX, 7 Quai St Bernard, Paris, France.	magali.zbinden@upmc.fr	Cueff, Valerie/AAW-9258-2021; Pradillon, Florence/AAM-2992-2020	Pradillon, Florence/0000-0002-6473-6290; Cueff-Gauchard, Valerie/0000-0001-6969-642X; Cambon-Bonavita, Marie-Anne/0000-0002-4076-0472	Ifremer REMIMA program; European Union Seventh Framework Program under the MIDAS project [603418]; Pierre and Marie Curie-Sorbonne Universite; Pierre and Marie Curie-Sorbonne Universities	Ifremer REMIMA program; European Union Seventh Framework Program under the MIDAS project; Pierre and Marie Curie-Sorbonne Universite; Pierre and Marie Curie-Sorbonne Universities	This work was supported by the Ifremer REMIMA program, the European Union Seventh Framework Program under the MIDAS project [grant agreement no 603418], and Pierre and Marie Curie-Sorbonne Universite for V.A.'s PhD thesis grant and functional support (data collection and analyses).; This work was supported by the Ifremer REMIMA program, the European Union Seventh Framework Program under the MIDAS project [grant agreement no 603418], and Pierre and Marie Curie-Sorbonne Universities for V.A.'s PhD thesis grant and functional support. The authors thank the chief scientists of the MoMARdream-Naut 2007, BioBaz 2013 and BICOSE 2014 (http://dx.doi.org/10.17600/14000100) cuises (F. Gaill, F. Lallier and M.A. Cambon-Bonavita), the captains and crews of the R/V Pourquoi pas?, the ROV Victor 6000 and Nautile submersible teams for their efficiency. SEM observations were performed at the Electronic Microscopy Platform of the National Museum of Natural History, Paris, with the help of Caroline Dalle. TEM observations were performed at the electronic microscopy platform of the Institute of Biology Paris-Seine (IBPS), with the help of G. Toutirais and M. Trichet. X-ray microanalyses were performed at Ifremer Brest with the help of Nicolas Gayet. We thank Helen McCombie-Boudry of the Bureau de Traduction of Universite de Bretagne Occidentale for revising the English of this paper.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Aruga S, 2002, INT J SYST EVOL MICR, V52, P1309, DOI 10.1099/00207713-52-4-1309; Assie A, 2016, THESIS; Baker Maria C., 2010, P161, DOI 10.1002/9781444325508.ch9; Boden R, 2011, J BACTERIOL, V193, P7001, DOI 10.1128/JB.06267-11; BOWMAN JP, 1993, INT J SYST BACTERIOL, V43, P735, DOI 10.1099/00207713-43-4-735; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brinkhoff T, 1997, APPL ENVIRON MICROB, V63, P3789, DOI 10.1128/AEM.63.10.3789-3796.1997; CASANOVA B, 1993, CAH BIOL MAR, V34, P573; Colaco A, 2002, DEEP-SEA RES PT I, V49, P395, DOI 10.1016/S0967-0637(01)00060-7; Corbari L., 2008, BIOGEOSCI DISCUSS, V5, P1825, DOI DOI 10.5194/BGD-5-1825-2008; Corbari L, 2008, AQUAT BIOL, V1, P225, DOI 10.3354/ab00024; Cowart DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172543; Desbruyeres D, 2001, DEEP-SEA RES PT I, V48, P1325, DOI 10.1016/S0967-0637(00)00083-2; Dubilier N, 2008, NAT REV MICROBIOL, V6, P725, DOI 10.1038/nrmicro1992; Durand L, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv101; Durand L, 2010, FEMS MICROBIOL ECOL, V71, P291, DOI 10.1111/j.1574-6941.2009.00806.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FIALAMEDIONI A, 1986, MAR BIOL, V92, P65, DOI 10.1007/BF00392747; Gebruk AV, 1997, ADV MAR BIOL, V32, P93; GEBRUK AV, 1993, MAR ECOL PROG SER, V98, P247, DOI 10.3354/meps098247; Gebruk AV, 2000, J MAR BIOL ASSOC UK, V80, P485, DOI 10.1017/S0025315400002186; Goffredi SK, 2010, ENV MICROBIOL REP, V2, P479, DOI 10.1111/j.1758-2229.2010.00136.x; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Greene AC, 1997, INT J SYST BACTERIOL, V47, P505, DOI 10.1099/00207713-47-2-505; Guri M, 2012, ISME J, V6, P597, DOI 10.1038/ismej.2011.133; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Hernandez-Avila I, 2016, LARVAL DISPERSAL LIF; Hugler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016018; Inagaki F, 2004, INT J SYST EVOL MICR, V54, P1477, DOI 10.1099/ijs.0.03042-0; Jan C, 2014, ENVIRON MICROBIOL, V16, P2723, DOI 10.1111/1462-2920.12406; JANNASCH HW, 1985, PROC R SOC SER B-BIO, V225, P277, DOI 10.1098/rspb.1985.0062; Kanagawa T, 2000, APPL ENVIRON MICROB, V66, P5043, DOI 10.1128/AEM.66.11.5043-5052.2000; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Knittel K, 2005, INT J SYST EVOL MICR, V55, P781, DOI 10.1099/ijs.0.63362-0; Komai T, 2008, J SHELLFISH RES, V27, P21, DOI 10.2983/0730-8000(2008)27[21:TROTHV]2.0.CO;2; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lin XJ, 2006, APPL ENVIRON MICROB, V72, P2679, DOI 10.1128/AEM.72.4.2679-2690.2006; Macpherson E, 2005, ZOOSYSTEMA, V27, P709; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; Martins I, 2008, ECOL MODEL, V217, P59, DOI 10.1016/j.ecolmodel.2008.05.008; Mino S, 2014, INT J SYST EVOL MICR, V64, P3195, DOI 10.1099/ijs.0.065094-0; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; Nye V, 2012, J MAR BIOL ASSOC UK, V92, P1057, DOI 10.1017/S0025315411002001; Petersen JM, 2010, ENVIRON MICROBIOL, V12, P2204, DOI 10.1111/j.1462-2920.2009.02129.x; POLZ MF, 1995, P NATL ACAD SCI USA, V92, P7232, DOI 10.1073/pnas.92.16.7232; Polz MF, 1998, LIMNOL OCEANOGR, V43, P1631, DOI 10.4319/lo.1998.43.7.1631; Pond DW, 1997, MAR ECOL PROG SER, V156, P167, DOI 10.3354/meps156167; Ponsard J, 2013, ISME J, V7, P96, DOI 10.1038/ismej.2012.87; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Rieley G, 1999, MAR BIOL, V133, P495, DOI 10.1007/s002270050489; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; SEGONZAC M, 1993, CAH BIOL MAR, V34, P535; Stahl D. A., 1991, NUCL ACID TECHNIQUES; Streit K, 2015, DEEP-SEA RES PT I, V100, P13, DOI 10.1016/j.dsr.2015.02.003; Takai K, 2003, INT J SYST EVOL MICR, V53, P839, DOI 10.1099/ijs.0.02479-0; Tanaka N, 2011, INT J SYST EVOL MICR, V61, P412, DOI 10.1099/ijs.0.020263-0; Tavormina PL, 2015, INT J SYST EVOL MICR, V65, P251, DOI 10.1099/ijs.0.062927-0; Teixeira S, 2013, MOL ECOL, V22, P4663, DOI 10.1111/mec.12419; Unz R.F., 2015, BERGEYS MANUAL SYSTE, P1, DOI [10.1002/9781118960608.gbm01005, DOI 10.1002/9781118960608.GBM01005]; Vereshchaka AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129975; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Zbinden M, 2004, MAR ECOL PROG SER, V284, P237, DOI 10.3354/meps284237; Zbinden M, 2003, FEMS MICROBIOL ECOL, V46, P23, DOI 10.1016/S0168-6496(03)00176-4; Zbinden M, 2008, J EXP MAR BIOL ECOL, V359, P131, DOI 10.1016/j.jembe.2008.03.009	70	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206084	10.1371/journal.pone.0206084	http://dx.doi.org/10.1371/journal.pone.0206084			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388125	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800020
J	Burke, LC; Ezeribe, HO; Kwon, AY; Dockery, D; Lyons, PJ				Burke, Linnea C.; Ezeribe, Hazel O.; Kwon, Anna Y.; Dockery, Donnel; Lyons, Peter J.			Carboxypeptidase O is a lipid droplet-associated enzyme able to cleave both acidic and polar C-terminal amino acids	PLOS ONE			English	Article							MEMBRANE CURVATURE; PROTEIN; METALLOCARBOXYPEPTIDASES; CHOLESTEROL; INSIGHTS; INVADOLYSIN; MECHANISM; DOMAINS; MEMBERS; FAMILY	Carboxypeptidase O (CPO) is a member of the M14 family of metallocarboxypeptidases with a preference for the cleavage of C-terminal acidic amino acids. CPO is largely expressed in the small intestine, although it has been detected in other tissues such as the brain and ovaries. CPO does not contain a prodomain, nor is it strongly regulated by pH, and hence appears to exist as a constitutively active enzyme. The goal of this study was to investigate the intracellular distribution and activity of CPO in order to predict physiological substrates and function. The distribution of CPO, when expressed in MDCK cells, was analyzed by immunofluorescence microscopy. Soon after addition of nutrient-rich media, CPO was found to associate with lipid droplets, causing an increase in lipid droplet quantity. As media became depleted, CPO moved to a broader ER distribution, no longer impacting lipid droplet numbers. Membrane cholesterol levels played a role in the distribution and in vitro enzymatic activity of CPO, with cholesterol enrichment leading to decreased lipid droplet association and enzymatic activity. The ability of CPO to cleave C-terminal amino acids within the early secretory pathway (in vivo) was examined using Gaussia luciferase as a substrate, C-terminally tagged with variants of an ER retention signal. While no effect of cholesterol was observed, these data show that CPO does function as an active enzyme within the ER where it removes C-terminal glutamates and aspartates, as well as a number of polar amino acids.	[Burke, Linnea C.; Ezeribe, Hazel O.; Kwon, Anna Y.; Dockery, Donnel; Lyons, Peter J.] Andrews Univ, Dept Biol, Berrien Springs, MI 49104 USA	Andrews University	Lyons, PJ (corresponding author), Andrews Univ, Dept Biol, Berrien Springs, MI 49104 USA.	lyons@andrews.edu		Lyons, Peter/0000-0001-5214-5445	Andrews University	Andrews University	This work was supported by Faculty Research Grants from Andrews University (PJL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Area-Gomez E, 2017, FASEB J, V31, P864, DOI 10.1096/fj.201601309; Browman DT, 2006, J CELL SCI, V119, P3149, DOI 10.1242/jcs.03060; Chen Z, 1997, BIOPHYS J, V73, P267, DOI 10.1016/S0006-3495(97)78067-6; CHRISTIANSON DW, 1989, ACCOUNTS CHEM RES, V22, P62, DOI 10.1021/ar00158a003; Cobbe N, 2009, J CELL SCI, V122, P3414, DOI 10.1242/jcs.044610; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Di Cara F, 2013, J CELL SCI, V126, P4769, DOI 10.1242/jcs.133306; Dong W, 1999, NEUROSCIENCE, V89, P1301, DOI 10.1016/S0306-4522(98)00381-9; Fernandez D, 2010, BIOCHIMIE, V92, P1484, DOI 10.1016/j.biochi.2010.05.002; Fricker LD, 1999, TRENDS BIOCHEM SCI, V24, P390, DOI 10.1016/S0968-0004(99)01448-6; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Fujimoto M, 2011, INT REV CEL MOL BIO, V292, P73, DOI 10.1016/B978-0-12-386033-0.00002-5; Fujimoto T, 2001, J CELL BIOL, V152, P1079, DOI 10.1083/jcb.152.5.1079; Garcia-Guerrero MC, 2018, P NATL ACAD SCI USA, V115, pE3932, DOI 10.1073/pnas.1803685115; Henderson MJ, 2014, MOL BIOL CELL, V25, P2828, DOI 10.1091/mbc.E14-06-1141; Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Korkhov VM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-59; LANGE Y, 1980, J BIOL CHEM, V255, P9331; Lezin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023457; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Lyons PJ, 2006, PROTEINS, V63, P1069, DOI 10.1002/prot.20946; Lyons PJ, 2011, J BIOL CHEM, V286, P39023, DOI 10.1074/jbc.M111.265819; Matthews KW, 2004, MOL IMMUNOL, V40, P785, DOI 10.1016/j.molimm.2003.10.002; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Novikova EG, 1999, BIOCHEM BIOPH RES CO, V256, P564, DOI 10.1006/bbrc.1999.0378; Novikova EG, 1999, J BIOL CHEM, V274, P28887, DOI 10.1074/jbc.274.41.28887; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ostermeyer AG, 2001, J CELL BIOL, V152, P1071, DOI 10.1083/jcb.152.5.1071; Paladino S, 2014, NAT CHEM BIOL, V10, P350, DOI [10.1038/NCHEMBIO.1495, 10.1038/nchembio.1495]; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Reeves VL, 2012, ADV EXP MED BIOL, V729, P3, DOI 10.1007/978-1-4614-1222-9_1; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Ryu YS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5507; Sanglas L, 2008, MOL CELL, V31, P598, DOI 10.1016/j.molcel.2008.05.031; Shah A, 2015, NUCLEIC ACIDS RES, V43, pD335, DOI 10.1093/nar/gku1131; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; Szmola R, 2011, J BIOL CHEM, V286, P1819, DOI 10.1074/jbc.M110.187369; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Ventura S, 1997, BIOL CHEM, V378, P161; Wang L, 2009, J BONE MINER RES, V24, P265, DOI [10.1359/jbmr.081014, 10.1359/JBMR.081014]; Waugh MG, 2011, J LIPID RES, V52, P582, DOI 10.1194/jlr.D012807; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Wojcikiewicz RJH, 2009, CELL CALCIUM, V46, P147, DOI 10.1016/j.ceca.2009.05.002; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Yang ST, 2016, CHEM PHYS LIPIDS, V199, P136, DOI 10.1016/j.chemphyslip.2016.05.003	48	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206824	10.1371/journal.pone.0206824	http://dx.doi.org/10.1371/journal.pone.0206824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388170	Green Published, gold			2022-12-26	WOS:000449289800064
J	Fletcher, JM				Fletcher, Jason M.			Spousal concordance in telomere length: New evidence from older adults in the US	PLOS ONE			English	Article							ASSOCIATION; MORTALITY; HEALTH; LIFE; COHORT; BLOOD	Telomere length (TL) has been associated with a range of aging outcomes as well as mortality. Recent research has shown both high heritability (similar to 70%) of TL as well as moderate spousal similarity (r similar to 0.3) using European datasets. This paper explores the level of spousal concordance in telomere length in the Health and Retirement Study, a national sample of adults in the US. The results show that the spousal correlations are lower (r similar to 0.11). Regression-based associations in TL in the US are low (beta similar to 0.08) and also vary by the number of times respondents have been married, where spouses married a single time have higher associations in TL (beta similar to.12) than spouses married more once (beta similar to 0.03). I also find variation in spousal TL association levels based on husband's education level. These findings suggest the possibility of both assortative mating patterns related to telomere length as well as likelihood of shared environmental factors that cause TL similarity in people who are socially connected.	[Fletcher, Jason M.] Univ Wisconsin, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison	Fletcher, JM (corresponding author), Univ Wisconsin, Madison, WI 53715 USA.	Jason.fletcher@wisc.edu			National Institute of Aging [P30 AG017266]; NATIONAL INSTITUTE ON AGING [P30AG017266] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute of Aging (P30 AG017266 to JF.) The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Bischoff C, 2006, EPIDEMIOLOGY, V17, P190, DOI 10.1097/01.ede.0000199436.55248.10; Broer L, 2013, EUR J HUM GENET, V21, P1163, DOI 10.1038/ejhg.2012.303; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Domingue BW, 2014, P NATL ACAD SCI USA, V111, P7996, DOI 10.1073/pnas.1321426111; Faul JD, 2016, BIODEMOGR SOC BIOL, V62, P73, DOI 10.1080/19485565.2015.1120645; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Hjelmborg JB, 2015, J MED GENET, V52, P297, DOI 10.1136/jmedgenet-2014-102736; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Shaffer JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048318; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	16	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0202388	10.1371/journal.pone.0202388	http://dx.doi.org/10.1371/journal.pone.0202388			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383762	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600004
J	Gyselaers, W; Vonck, S; Staelens, AS; Lanssens, D; Tomsin, K; Oben, J; Dreesen, P; Bruckers, L				Gyselaers, Wilfried; Vonck, Sharona; Staelens, Anneleen Simone; Lanssens, Dorien; Tomsin, Kathleen; Oben, Jolien; Dreesen, Pauline; Bruckers, Liesbeth			Body fluid volume homeostasis is abnormal in pregnancies complicated with hypertension and/or poor fetal growth	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; MATERNAL PLASMA-VOLUME; ANALYSIS BIA; BIOIMPEDANCE; WATER; PREECLAMPSIA; CARDIOGRAPHY; RELIABILITY; WOMEN; HEMODYNAMICS	Objectives To evaluate body water volumes and cardiac output in each trimester of pregnancies complicated with hypertension and/or poor fetal growth, relative to uncomplicated pregnancy. Methods In this semi-longitudinal cohort study, a standardised non-invasive maternal hemodynamics assessment in first, second or third trimester was performed in 1068 women with uncomplicated pregnancy (UP), 75 with early onset (EPE) and 117 with late onset preeclampsia (LPE), 139 with gestational hypertension (GH), 129 with small for gestational age (SGA) neonates and 43 with essential hypertension (EH). Women with hypertension or SGA were included prior to onset of symptoms or at diagnosis of disease; 46% of women (758/1631) were assessed in. 2 trimesters. Impedance cardiography and spectrum analysis were used to measure cardiac output, total body water (TBW), extracellular (ECW) and intracellular water (ICW). A linear mixed model was used for inter-trimestrial comparison of parity-, age-and BMI-corrected values within and between groups. Results For all pregnancies, TBW is higher in each consecutive trimester, mainly due to increasing fraction of ECW (ECW%). Compared to first trimester UP, ECW and ECW% are higher in EPE whereas TBW, ECW and ICW are lower in SGA. Compared to inter-trimestrial differences in UP, abnormal changes for body water volumes are observed in GH, EPE and LPE and for CO in EPE and LPE. Changes in EH are not different from UP. Conclusions This study is the first to show that concomitant gestational changes of ECW and CO are different from UP already in preclinical stages of pregnancies complicated with hypertension and/or poor fetal growth, except EH. This finding highlights the relevance of early gestational assessment of maternal body fluid status in pregnancies at risk for hypertension or poor fetal growth.	[Gyselaers, Wilfried; Vonck, Sharona; Lanssens, Dorien; Dreesen, Pauline] Hasselt Univ, Fac Med & Life Sci, Diepenbeek, Belgium; [Gyselaers, Wilfried; Vonck, Sharona; Staelens, Anneleen Simone; Lanssens, Dorien; Tomsin, Kathleen; Oben, Jolien; Dreesen, Pauline] Ziekenhu Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium; [Gyselaers, Wilfried] Hasselt Univ, Dept Physiol, Diepenbeek, Belgium; [Bruckers, Liesbeth] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Diepenbeek, Belgium	Hasselt University; Hasselt University; Hasselt University	Gyselaers, W (corresponding author), Hasselt Univ, Fac Med & Life Sci, Diepenbeek, Belgium.; Gyselaers, W (corresponding author), Ziekenhu Oost Limburg, Dept Obstet & Gynaecol, Genk, Belgium.; Gyselaers, W (corresponding author), Hasselt Univ, Dept Physiol, Diepenbeek, Belgium.	wilfried.gyselaers@zol.be	Vonck, Sharona/AAM-9019-2021; Dreesen, Pauline/AFR-6703-2022	Dreesen, Pauline/0000-0003-4165-6121	IWT -Instituut voor Innovatie door Wetenschap en Technologie/FWO - Fonds voor Wetenschappelijk Onderzoek [131581]	IWT -Instituut voor Innovatie door Wetenschap en Technologie/FWO - Fonds voor Wetenschappelijk Onderzoek	This work was supported by IWT -Instituut voor Innovatie door Wetenschap en Technologie/FWO - Fonds voor Wetenschappelijk Onderzoek (http://www.fwo.be/en/) grant no. 131581 to SV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandstad A, 2014, MIL MED, V179, P208, DOI 10.7205/MILMED-D-12-00545; Brown CM, 2014, DRUGS, V74, P283, DOI 10.1007/s40265-014-0187-7; Brown MA, 2018, HYPERTENSION, V72, P24, DOI 10.1161/HYPERTENSIONAHA.117.10803; de Castro JAC, 2018, J BODYW MOV THER, V22, P134, DOI 10.1016/j.jbmt.2017.04.010; Chumlea WC, 2001, KIDNEY INT, V59, P2250, DOI 10.1046/j.1523-1755.2001.00741.x; da Silva EG, 2010, HYPERTENS PREGNANCY, V29, P357, DOI 10.3109/10641950903116523; De Haas S, 2017, ULTRASOUND OBST GYN, V49, P177, DOI 10.1002/uog.17360; de Haas S, 2016, ULTRASOUND OBSTET GY; Duvekot J J, 1994, Obstet Gynecol Surv, V49, pS1, DOI 10.1097/00006254-199412011-00001; DUVEKOT JJ, 1995, OBSTET GYNECOL, V85, P361, DOI 10.1016/0029-7844(94)00417-C; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fellahi JL, 2014, J CARDIOTHOR VASC AN, V28, P755, DOI 10.1053/j.jvca.2013.12.026; Ghezzi F, 2001, EUR J OBSTET GYN R B, V98, P171, DOI 10.1016/S0301-2115(01)00330-X; Gyselaers W, 2015, ULTRASOUND OBST GYN, V45, P421, DOI 10.1002/uog.13427; Caceres DI, 2014, NUTR HOSP, V30, P1359, DOI 10.3305/nh.2014.30.6.7934; Jaffrin MY, 2008, MED ENG PHYS, V30, P1257, DOI 10.1016/j.medengphy.2008.06.009; JaqueFortunato SV, 1996, SEMIN PERINATOL, V20, P340, DOI 10.1016/S0146-0005(96)80027-9; Kent E, 2013, OBSTET GYNECOL, V121, P46, DOI [http://10.1097/AOG.0b013e31827a0052, 10.1097/AOG.0b013e31827a0052]; Kreimeier U, 2000, CRIT CARE, V4, pS3, DOI 10.1186/cc968; Larciprete G, 2003, ACTA DIABETOL, V40, pS225, DOI 10.1007/s00592-003-0072-4; Loenneke JP, 2013, CLIN PHYSIOL FUNCT I, V33, P405, DOI 10.1111/cpf.12045; LUKASKI HC, 1994, AM J CLIN NUTR, V59, P578, DOI 10.1093/ajcn/59.3.578; Malbrain MLNG, 2014, ANAESTH INTENSIVE TH, V46, P381, DOI 10.5603/AIT.2014.0061; Martinez EE, 2017, J PEDIATR-US, V190, P56, DOI 10.1016/j.jpeds.2017.07.045; McLaughlin K, 2018, HYPERTENSION, V71, P550, DOI 10.1161/HYPERTENSIONAHA.117.10606; Metsaars WP, 2006, HYPERTENS PREGNANCY, V25, P143, DOI 10.1080/10641950600912927; Oben J, 2014, J MATERN-FETAL NEO M, V27, P1646, DOI 10.3109/14767058.2013.871700; SALAS SP, 1993, OBSTET GYNECOL, V81, P1029; Sergi G, 2017, AGING CLIN EXP RES, V29, P591, DOI 10.1007/s40520-016-0622-6; Sonek J, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.10.024; Staelens AS, 2016, EUR J OBSTET GYN R B, V204, P69, DOI 10.1016/j.ejogrb.2016.07.502; Stott D, 2017, ULTRASOUND OBST GYN, V49, P761, DOI 10.1002/uog.17340; Strain GW, 2008, OBESITY, V16, P1953, DOI 10.1038/oby.2008.321; Tay J, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.02.007; Tomsin K, 2012, J OBSTET GYNAECOL, V32, P630, DOI 10.3109/01443615.2012.673036; Tomsin K, 2013, CLIN EXP PHARMACOL P, V40, P438, DOI 10.1111/1440-1681.12105; Trutschnigg B, 2008, APPL PHYSIOL NUTR ME, V33, P1232, DOI 10.1139/H08-122; Valensise H, 2000, AM J CLIN NUTR, V72, P780; Valensise H, 2003, ACTA DIABETOL, V40, pS216, DOI 10.1007/s00592-003-0070-6; Valensise H, 2008, HYPERTENSION, P52; VANOPPEN AC, 1995, AM J OBSTET GYNECOL, V173, P923, DOI 10.1016/0002-9378(95)90367-4; Vinayagam D, 2018, ULTRASOUND OBST GYN, V51, P665, DOI 10.1002/uog.17504; Vonck S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115594; Weng CW, 2015, ANALYST, V140, P6619, DOI 10.1039/c5an01251a; Widen EM, 2014, EUR J CLIN NUTR, V68, P643, DOI 10.1038/ejcn.2014.40	45	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206257	10.1371/journal.pone.0206257	http://dx.doi.org/10.1371/journal.pone.0206257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383796	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600034
J	Shah, K; Patel, S; Mirza, S; Rawal, RM				Shah, Kanisha; Patel, Shanaya; Mirza, Sheefa; Rawal, Rakesh M.			A multi-gene expression profile panel for predicting liver metastasis: An algorithmic approach	PLOS ONE			English	Article							LUNG-CANCER METASTASIS; CATENIN EXPRESSION; E-CADHERIN; GENE; SURVIVAL; BONE; CARCINOMA; RISK; MICROARRAY; SIGNATURE	Background & aim Liver metastasis has been found to affect outcome in prostate, pancreatic and colorectal cancers, but its role in lung cancer is unclear. The 5 year survival rate remains extensively low owing to intrinsic resistance to conventional therapy which can be attributed to the genetic modulators involved in the pathogenesis of the disease. Thus, this study aims to generate a model for early diagnosis and timely treatment of liver metastasis in lung cancer patients. Methods mRNA expression of 15 genes was quantified by real time PCR on lung cancer specimens with (n = 32) and without (n = 30) liver metastasis and their normal counterparts. Principal Component analysis, linear discriminant analysis and hierarchical clustering were conducted to obtain a predictive model. The accuracy of the models was tested by performing Receiver Operating Curve analysis. Results The expression profile of all the 15 genes were subjected to PCA and LDA analysis and 5 models were generated. ROC curve analysis was performed for all the models and the individual genes. It was observed that out of the 15 genes only 8 genes showed significant sensitivity and specificity. Another model consisting of the selected eight genes was generated showing a specificity and sensitivity of 90.0 and 96.87 respectively (p <0.0001). Moreover, hierarchical clustering showed that tumors with a greater fold change lead to poor prognosis. Conclusion Our study led to the generation of a concise, biologically relevant multi-gene panel that significantly and non-invasively predicts liver metastasis in lung cancer patients.	[Shah, Kanisha; Patel, Shanaya; Mirza, Sheefa; Rawal, Rakesh M.] Gujarat Canc Res Inst, Dept Canc Biol, Div Med Chem & Pharmacogen, Ahmadabad, Gujarat, India; [Shah, Kanisha; Mirza, Sheefa; Rawal, Rakesh M.] Gujarat Univ, Dept Life Sci, Ahmadabad, Gujarat, India; [Patel, Shanaya] Ahmedabad Univ, Dept Biol & Life Sci, Ahmadabad, Gujarat, India	The Gujarat Cancer & Research Institute; Gujarat University; Ahmedabad University	Rawal, RM (corresponding author), Gujarat Canc Res Inst, Dept Canc Biol, Div Med Chem & Pharmacogen, Ahmadabad, Gujarat, India.; Rawal, RM (corresponding author), Gujarat Univ, Dept Life Sci, Ahmadabad, Gujarat, India.	rakeshrawal.gu@gmail.com	Patel, Shanaya/GLR-0269-2022; Mirza, Sheefa/AAQ-8232-2021; Shah, Kanisha/AGH-2542-2022	Patel, Shanaya/0000-0001-9879-0466; Rawal, Rakesh/0000-0002-7985-1187; Mirza, Sheefa/0000-0003-0870-0901; Shah, Kanisha/0000-0002-7252-1847	Gujarat Cancer Society [RE/74/14]; Gujarat Cancer & Research Institute	Gujarat Cancer Society; Gujarat Cancer & Research Institute	The study was supported by The Gujarat Cancer & Research Institute and Gujarat Cancer Society (RE/74/14). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bast RC, 2011, GYNECOL ONCOL, V121, P429, DOI 10.1016/j.ygyno.2011.04.032; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Borczuk AC, 2004, AM J RESP CRIT CARE, V170, P167, DOI 10.1164/rccm.200401-066OC; Canel M, 2013, J CELL SCI, V126, P393, DOI 10.1242/jcs.100115; Casimiro S, 2009, MOL CELL ENDOCRINOL, V310, P71, DOI 10.1016/j.mce.2009.07.004; Choi N, 2006, J THORAC ONCOL, V1, P622; Comamala M, 2011, BRIT J CANCER, V104, P989, DOI 10.1038/bjc.2011.34; D'Amico TA, 1999, J THORAC CARDIOV SUR, V117, P736, DOI 10.1016/S0022-5223(99)70294-1; D'Amico TA, 2001, ANN THORAC SURG, V72, P1144, DOI 10.1016/S0003-4975(01)02979-4; Dat L, 2012, INT J ONCOL, V40, P1455, DOI 10.3892/ijo.2012.1348; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Huang HL, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0463-x; Hugh TJ, 1999, INT J CANCER, V82, P504, DOI 10.1002/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim KY, 2015, CANCER RES TREAT, V47, P242, DOI 10.4143/crt.2014.066; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Liu HY, 2006, PLOS MED, V3, P1090, DOI 10.1371/journal.pmed.0030232; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Mojarad EN, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.22324v2; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; O'Brien TJ, 2001, TUMOR BIOL, V22, P348, DOI 10.1159/000050638; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Roy I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090400; Sarrio D, 2003, INT J CANCER, V106, P208, DOI 10.1002/ijc.11197; Shah K, 2017, META GENE, V11, P26, DOI 10.1016/j.mgene.2016.11.001; Sone S, 2007, CANCER METAST REV, V26, P685, DOI 10.1007/s10555-007-9081-z; Stenbygaard LE, 1999, ACTA ONCOL, V38, P993; STRAUSS GM, 1995, J CLIN ONCOL, V13, P1265, DOI 10.1200/JCO.1995.13.5.1265; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tamura T, 2015, MOL CLIN ONCOL, V3, P217, DOI 10.3892/mco.2014.410; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206400	10.1371/journal.pone.0206400	http://dx.doi.org/10.1371/journal.pone.0206400			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383826	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600047
J	Roenn, CP; Li, M; Schack, VR; Forster, IC; Holm, R; Toustrup-Jensen, MS; Andersen, JP; Petrou, S; Vilsen, B				Roenn, Christian P.; Li, Melody; Schack, Vivien R.; Forster, Ian C.; Holm, Rikke; Toustrup-Jensen, Mads S.; Andersen, Jens P.; Petrou, Steven; Vilsen, Bente			Functional consequences of the CAPOS mutation E818K of Na+,K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme mechanism; membrane enzyme; membrane transport; mutant; Na; K plus -ATPase; neurological disease; site-directed mutagenesis; sodium transport; potassium transport; ATP1A3; electrophysiology; Na plus site; Na; K plus -pump; P-type ATPase	NEUROLOGICAL DISEASE MUTATIONS; SENSORINEURAL HEARING-LOSS; 4TH TRANSMEMBRANE SEGMENT; NA,K-ATPASE ALPHA-SUBUNIT; DE-NOVO MUTATIONS; ALTERNATING HEMIPLEGIA; CEREBELLAR-ATAXIA; NA+ AFFINITY; VOLTAGE-DEPENDENCE; CRYSTAL-STRUCTURE	The cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome is caused by the single mutation E818K of the 3-isoform of Na+,K+-ATPase. Here, using biochemical and electrophysiological approaches, we examined the functional characteristics of E818K, as well as of E818Q and E818A mutants. We found that these amino acid substitutions reduce the apparent Na+ affinity at the cytoplasmic-facing sites of the pump protein and that this effect is more pronounced for the lysine and glutamine substitutions (3-4-fold) than for the alanine substitution. The electrophysiological measurements indicated a more conspicuous, approximate to 30-fold reduction of apparent Na+ affinity for the extracellular-facing sites in the CAPOS mutant, which was related to an accelerated transition between the phosphoenzyme intermediates E1P and E2P. The apparent affinity for K+ activation of the ATPase activity was unaffected by these substitutions, suggesting that primarily the Na+-specific site III is affected. Furthermore, the apparent affinities for ATP and vanadate were WT-like in E818K, indicating a normal E-1-E-2 equilibrium of the dephosphoenzyme. Proton-leak currents were not increased in E818K. However, the CAPOS mutation caused a weaker voltage dependence of the pumping rate and a stronger inhibition by cytoplasmic K+ than the WT enzyme, which together with the reduced Na+ affinity of the cytoplasmic-facing sites precluded proper pump activation under physiological conditions. The functional deficiencies could be traced to the participation of Glu-818 in an intricate hydrogen-bonding/salt-bridge network, connecting it to key residues involved in Na+ interaction at site III.	[Roenn, Christian P.; Schack, Vivien R.; Holm, Rikke; Toustrup-Jensen, Mads S.; Andersen, Jens P.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark; [Li, Melody; Forster, Ian C.; Petrou, Steven] Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia	Aarhus University; Florey Institute of Neuroscience & Mental Health	Vilsen, B (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	bv@biomed.au.dk		Toustrup-Jensen, Mads Schak/0000-0003-2064-5861; Petrou, Steven/0000-0002-4960-6375; Andersen, Jens Peter/0000-0003-0654-4300; Vilsen, Bente/0000-0002-4727-9382; Forster, Ian/0000-0003-3087-9952; Schack, Vivien/0000-0002-1365-3938				Aguiar PD, 2004, NEURON, V43, P169, DOI 10.1016/j.neuron.2004.06.028; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chang IJ, 2018, AM J MED GENET A, V176, P235, DOI 10.1002/ajmg.a.38502; Cornelius F, 2011, J BIOL CHEM, V286, P29882, DOI 10.1074/jbc.M111.259663; Dard R, 2015, DEV MED CHILD NEUROL, V57, P1183, DOI 10.1111/dmcn.12927; De Fusco M, 2003, NAT GENET, V33, P192, DOI 10.1038/ng1081; Demos MK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-15; Rodriguez AD, 2017, PEDIATR NEUROL, V71, P60, DOI 10.1016/j.pediatrneurol.2017.01.009; Han KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16676-9; Hayashida T, 2018, BRAIN DEV-JPN, V40, P576, DOI 10.1016/j.braindev.2018.03.004; Heimer G, 2015, J CHILD NEUROL, V30, P1749, DOI 10.1177/0883073815579708; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Holm R, 2016, BBA-BIOENERGETICS, V1857, P1807, DOI 10.1016/j.bbabio.2016.08.009; Holm R, 2015, J BIOL CHEM, V290, P9801, DOI 10.1074/jbc.M114.625509; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaneko M, 2014, NAT GENET, V46, P144, DOI 10.1038/ng.2850; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Li M, 2015, NEUROBIOL DIS, V77, P88, DOI 10.1016/j.nbd.2015.02.002; Maas RPPWM, 2016, PEDIATR NEUROL, V59, P71, DOI 10.1016/j.pediatrneurol.2016.02.010; McLean WJ, 2009, JARO-J ASSOC RES OTO, V10, P37, DOI 10.1007/s10162-008-0152-9; Meier S, 2010, J GEN PHYSIOL, V135, P115, DOI 10.1085/jgp.200910301; Meyer DJ, 2017, J GEN PHYSIOL, V149, P1009, DOI 10.1085/jgp.201711827; Mitchell TJ, 2014, BIOPHYS J, V106, P2555, DOI 10.1016/j.bpj.2014.04.053; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; NAKAO M, 1986, NATURE, V323, P628, DOI 10.1038/323628a0; Nicolaides P, 1996, J MED GENET, V33, P419, DOI 10.1136/jmg.33.5.419; Paciorkowski AR, 2015, EPILEPSIA, V56, P422, DOI 10.1111/epi.12914; Panagiotakaki E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0335-5; Petrou S, 1997, FEBS LETT, V411, P339, DOI 10.1016/S0014-5793(97)00700-X; Poulsen H, 2010, NATURE, V467, P99, DOI 10.1038/nature09309; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; Rosewich H, 2014, NEUROLOGY, V83, P861, DOI 10.1212/WNL.0000000000000735; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; SAGAR A, 1994, J GEN PHYSIOL, V103, P869, DOI 10.1085/jgp.103.5.869; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; Tranebjaerg L, 2018, HUM GENET, V137, P111, DOI 10.1007/s00439-017-1862-z; Vedovato N, 2014, J GEN PHYSIOL, V143, P449, DOI 10.1085/jgp.201311148; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; WANG XY, 1995, AM J PHYSIOL-CELL PH, V268, pC590, DOI 10.1152/ajpcell.1995.268.3.C590; Yaragatupalli S, 2009, P NATL ACAD SCI USA, V106, P15507, DOI 10.1073/pnas.0903752106	49	8	9	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					269	280		10.1074/jbc.RA118.004591	http://dx.doi.org/10.1074/jbc.RA118.004591			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409907	Green Published, hybrid			2022-12-26	WOS:000455105500029
J	Gupta, D; Lacayo, AA; Greene, SM; Leahy, JL; Jetton, TL				Gupta, Dhananjay; Lacayo, Adam A.; Greene, Shane M.; Leahy, John L.; Jetton, Thomas L.			-Cell mass restoration by 7 nicotinic acetylcholine receptor activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (-cell); cholinergic receptor; autoimmune disease; diabetes; STAT3; ion channel; nicotinic acetylcholine receptors (nAChR); islet; pancreatic islet	VAGUS NERVE; INSULIN; EXPRESSION; APOPTOSIS; SYSTEM; DEATH; INFLAMMATION; SECRETION; PATHWAYS; GROWTH	Although it is well-established how nutrients, growth factors, and hormones impact functional -cell mass (BCM), the influence of the central nervous system in this regard, and especially in the context of islet immune modulation, has been understudied. Here we investigated the expression and activity of pancreatic islet 7 nicotinic acetylcholine receptor (7nAChR) in islet anti-inflammatory and prosurvival signaling. Systemic administration of 7nAChR agonists in mice improved glucose tolerance and curtailed streptozotocin-induced hyperglycemia by retaining BCM, in part through maintaining Pdx1 and MafA expression and reducing apoptosis. 7nAChR activation of mouse islets ex vivo led to reduced inflammatory drive through a JAK2-STAT3 pathway that couples with CREB/Irs2/Akt survival signaling. Because the vagus nerve conveys anti-inflammatory signals to immune cells of the spleen and other nonneural tissues in the viscera by activating 7nAChR agonists, our study suggests a novel role for -cell 7nAChR that functions to maintain -cell survival and mass homeostasis through modulating islet cytokine and phosphatidylinositol 3-kinase-dependent signaling pathways. Exploiting these pathways may have therapeutic potential for the treatment of autoimmune diabetes.	[Gupta, Dhananjay; Lacayo, Adam A.; Greene, Shane M.; Leahy, John L.; Jetton, Thomas L.] Univ Vermont, Div Endocrinol Diabet & Metab, Dept Med, Larner Coll Med, Burlington, VT 05446 USA	University of Vermont	Jetton, TL (corresponding author), Univ Vermont, Dept Med, Larner Coll Med, Colchester Res Facil, 360 South Pk Dr, Colchester, VT 05446 USA.	tjetton@uvm.edu			Juvenile Diabetes Research Foundation (JDRF), United States of America [17-2013-399, 27-2008-669]	Juvenile Diabetes Research Foundation (JDRF), United States of America	This work was supported by Research Awards 17-2013-399 and 27-2008-669 from the Juvenile Diabetes Research Foundation (JDRF), United States of America (to T.L.J.).	Ali MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134648; Andersson AK, 2005, MOL CELL ENDOCRINOL, V240, P50, DOI 10.1016/j.mce.2005.06.001; Bending D, 2012, INT IMMUNOL, V24, P339, DOI 10.1093/intimm/dxs049; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Delbro DS, 2012, AUTON NEUROSCI-BASIC, V167, P75, DOI 10.1016/j.autneu.2011.11.006; Downs AM, 2014, NEUROSCIENCE, V266, P178, DOI 10.1016/j.neuroscience.2014.02.011; Drago J, 2003, CELL MOL LIFE SCI, V60, P1267, DOI 10.1007/s00018-003-2259-9; Edvell A, 1998, AM J PHYSIOL-ENDOC M, V274, pE1034, DOI 10.1152/ajpendo.1998.274.6.E1034; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Fujimoto K, 2009, DIABETES OBES METAB, V11, P30, DOI 10.1111/j.1463-1326.2009.01121.x; Ganic E, 2016, CELL REP, V14, P1991, DOI 10.1016/j.celrep.2016.02.002; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; George JA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00419; Imai J, 2008, SCIENCE, V322, P1250, DOI 10.1126/science.1163971; Jetton TL, 2008, AM J PHYSIOL-ENDOC M, V294, pE679, DOI 10.1152/ajpendo.00569.2007; Jetton TL, 2005, DIABETES, V54, P2294, DOI 10.2337/diabetes.54.8.2294; Kiba T, 2002, DIGESTION, V66, P79, DOI 10.1159/000065594; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Klee P, 2016, ENDOCRINOLOGY, V157, P3800, DOI 10.1210/en.2015-2057; KOLB H, 1987, DIABETES METAB REV, V3, P751, DOI 10.1002/dmr.5610030308; Koopman FA, 2015, ORAL DIS, V21, P858, DOI 10.1111/odi.12354; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Lausier J, 2010, AM J PHYSIOL-ENDOC M, V299, pE786, DOI 10.1152/ajpendo.00202.2010; Mabley JG, 2002, J PHARMACOL EXP THER, V300, P876, DOI 10.1124/jpet.300.3.876; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Mellado-Gil J, 2011, DIABETES, V60, P525, DOI 10.2337/db09-1305; Mundinger TO, 2016, DIABETOLOGIA, V59, P2058, DOI 10.1007/s00125-016-4026-0; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Rodriguez-Diaz R, 2011, NAT MED, V17, P888, DOI 10.1038/nm.2371; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2009, NEURON, V64, P28, DOI 10.1016/j.neuron.2009.09.039; Saravia F, 2003, TRENDS IMMUNOL, V24, P574, DOI 10.1016/j.it.2003.09.010; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; Walker DP, 2006, BIOORGAN MED CHEM, V14, P8219, DOI 10.1016/j.bmc.2006.09.019; WOODS SC, 1974, PHYSIOL REV, V54, P596, DOI 10.1152/physrev.1974.54.3.596; Xu TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051217; Yamamoto J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01869-7; Yoshikawa H, 2005, METABOLISM, V54, P247, DOI 10.1016/j.metabol.2004.08.020; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang B, 2012, ACTA BIOCH BIOPH SIN, V44, P207, DOI 10.1093/abbs/gmr121; Zumsteg U, 2000, DIABETES, V49, P39, DOI 10.2337/diabetes.49.1.39	45	15	16	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20295	20306		10.1074/jbc.RA118.004617	http://dx.doi.org/10.1074/jbc.RA118.004617			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30397183	Green Published, hybrid			2022-12-26	WOS:000454685900034
J	Cui, L; Wang, GB; Yang, DB; Nahiyoon, SA; Yan, XJ; Yuan, HZ				Cui, Li; Wang, Guobin; Yang, Daibin; Nahiyoon, Shahzad Ali; Yan, Xiaojing; Yuan, Huizhu			Biocidal radiuses of abamectin, thiamethoxam and sulfoxaflor droplets controlling against wheat aphid (Sitobion avenae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS; HELIOTHIS-VIRESCENS; SIZE; INSECTICIDE; DEPOSITS; DENSITY; LARVAE; LEPIDOPTERA; PERMETHRIN; BIFENTHRIN	Spraying insecticide is a common practice in the control against pest insects. However, little attention has been paid to the biocidal radius of droplets. Therefore, in this study, we investigated the biocidal radiuses of abamectin, thiamethoxam and sulfoxaflor droplets controlling against wheat aphid (Sitobion avenae). The mortality of S. avenae showed a droplet density dependent process that can be described by an exponential model. Calculated mortality limit (A(2)) varied with the concentration of insecticides. Although similar LD50 values were observed in abamectin (13.77 ng aphid(-1)) and sulfoxaflor (14.52 ng aphid(-1)) against S. avenae, sulfoxaflor had a larger biocidal radius (r(50)) than abamectin due to its translocation ability at the same concentration. And sulfoxaflor had a relatively larger biocidal radius than thiamethoxam (LD50 = 68.42 ng aphid(-1)) because it is more toxic to S. avenae. The ratio of r(50)/VMD was introduced to estimate the potential of droplets. Droplets generated by the air atomizing nozzle (VMD = 43 mu m) had higher value of r(50)/VMD than the centrifugal atomizing nozzle (VMD = 153 mu m). Our results indicated that the mortality limit can be reached at a concentration of an insecticide. The biocidal radius of a droplet is different from its actual size. The LD50 and translocation ability of insecticides contributed to their biocidal radius. Ratio of r(50)/VMD is an indicator of droplets' insecticidal potential. Smaller droplets generated by the air atomizing nozzle have higher insecticidal potential.	[Cui, Li; Wang, Guobin; Yang, Daibin; Nahiyoon, Shahzad Ali; Yan, Xiaojing; Yuan, Huizhu] Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops, Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Ministry of Agriculture & Rural Affairs	Yan, XJ; Yuan, HZ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Key Lab Integrated Pest Management Crops, Minist Agr, Beijing, Peoples R China.	xjyan@ippcaas.cn; hzhyuan@ippcaas.cn	Wang, Guobin/AEJ-1468-2022	Wang, Guobin/0000-0002-8657-8705; Yuan, huizhu/0000-0001-5576-3222	National Key R&D Program of China [2016YFD0200700]; National Natural Science Foundation of China [31371969]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key R&D Program of China (2016YFD0200700) to XY, the National Natural Science Foundation of China (31371969) to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A. J., 1987, ASPECTS APPLIED BIOL, V14, P257; ALM SR, 1987, J ECON ENTOMOL, V80, P517, DOI 10.1093/jee/80.2.517; BRYANT JE, 1988, J ECON ENTOMOL, V81, P130, DOI 10.1093/jee/81.1.130; Chen YZ, 2013, PEST MANAG SCI, V69, P938, DOI 10.1002/ps.3455; FISHER RW, 1976, J ECON ENTOMOL, V69, P438, DOI 10.1093/jee/69.4.438; HEWITT AJ, 1993, CROP PROT, V12, P59, DOI 10.1016/0261-2194(93)90021-A; HIMEL CM, 1969, J ECON ENTOMOL, V62, P916, DOI 10.1093/jee/62.4.916; Kwon DH, 2010, J ASIA-PAC ENTOMOL, V13, P229, DOI 10.1016/j.aspen.2010.02.002; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; MBOOB SS, 1975, PLANT PATHOL, V24, P158, DOI 10.1111/j.1365-3059.1975.tb01884.x; MUNTHALI DC, 1982, PESTIC SCI, V13, P60, DOI 10.1002/ps.2780130109; Nauen R, 2008, PEST MANAG SCI, V64, P1082, DOI 10.1002/ps.1660; OMAR D, 1991, PESTIC SCI, V32, P439, DOI 10.1002/ps.2780320406; Pozo OJ, 2003, J CHROMATOGR A, V992, P133, DOI 10.1016/S0021-9673(03)00325-X; Salt DW, 1996, PESTIC SCI, V48, P77, DOI 10.1002/(SICI)1096-9063(199609)48:1&lt;77::AID-PS444&gt;3.0.CO;2-5; SALYANI M, 1988, T ASAE, V31, P1680; Salyani M, 2003, AM SOC TEST MATER, V1449, P221, DOI 10.1520/STP11209S; Salyani M, 1989, SPRAY DROPLET SIZE E, P263; Sharkey A. J., 1987, Aspects of Applied Biology, P267; Simon AL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46497; SMITH DB, 1977, J ECON ENTOMOL, V70, P437, DOI 10.1093/jee/70.4.437; Sparks TC, 2013, PESTIC BIOCHEM PHYS, V107, P1, DOI 10.1016/j.pestbp.2013.05.014; Stelinski L. L., 2012, J ASTM INT, V9, P1, DOI DOI 10.1520/STP104310); WOFFORD JT, 1987, J ECON ENTOMOL, V80, P460, DOI 10.1093/jee/80.2.460; WOMAC AR, 1994, PESTIC SCI, V40, P77, DOI 10.1002/ps.2780400113; Zhu HP, 2011, COMPUT ELECTRON AGR, V76, P38, DOI 10.1016/j.compag.2011.01.003; Zhu YM, 2011, J AGR FOOD CHEM, V59, P2950, DOI 10.1021/jf102765x	27	2	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0205598	10.1371/journal.pone.0205598	http://dx.doi.org/10.1371/journal.pone.0205598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408038	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300009
J	El-Matary, W; Deora, V; Grover, K				El-Matary, Wael; Deora, Vini; Grover, Kanika			Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective	PLOS ONE			English	Article							PREVENTION TRIALS; PARTICIPATION	Background The aim of this study was to determine the proportion of patients' caregivers willing to participate in clinical research and examine the possible barriers against recruitment to clinical research in children with inflammatory bowel disease. Methods In a cross-sectional study, caregivers and children with inflammatory bowel disease were surveyed via a questionnaire that addressed parents' willingness to participate in clinical studies and factors influencing their willingness to participate. Results A total of 118 caregivers to children with inflammatory bowel disease [median age 14.5, IQR: 12.0-15.8 years, 60 boys, 61 (52%) with Crohn's disease] who were followed for a median duration of 1.73 years (IQR 0.4-3.6 years) completed the survey. One hundred and four (88.2%) caregivers answered "Definitely" or "Probably" to participate in clinical research while 14 (11.8%) were "Neutral" or "Probably" unwilling to participate (P<0.001). Patients were less likely to participate in clinical research if they had longer disease duration (P = 0.019), or were in clinical relapse (P = 0.03). Parents' education, income, age of children at diagnosis, money incentive, disease relapse and medications at the time of the survey did not have any significant effect on willingness to participate. Conclusions The majority of children with inflammatory bowel disease and their caregivers are willing to participate in clinical research.	[El-Matary, Wael; Deora, Vini; Grover, Kanika] Univ Manitoba, Dept Pediat & Child Hlth, Sect Pediat Gastroenterol, Winnipeg, MB, Canada; [El-Matary, Wael; Deora, Vini; Grover, Kanika] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada	University of Manitoba; University of Manitoba	El-Matary, W (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Sect Pediat Gastroenterol, Winnipeg, MB, Canada.; El-Matary, W (corresponding author), Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.	welmatary@hsc.mb.ca		EL-MATARY, WAEL/0000-0001-6417-7583	Children's Hospital Research Institute of Manitoba [318810]	Children's Hospital Research Institute of Manitoba	The study was funded by a grant from The Children's Hospital Research Institute of Manitoba: grant number: 318810 (http://chrim.ca/) to WEM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Costenbader KH, 2007, ARTHRIT RHEUM-ARTHR, V57, P49, DOI 10.1002/art.22480; Dev AT, 2008, BMC HEALTH SERV RES, V8, P1, DOI 10.1186/1472-6963-8-208; Ding EL, 2007, ARCH INTERN MED, V167, P905, DOI 10.1001/archinte.167.9.905; El-Matary W, 2014, J PEDIATR GASTR NUTR, V59, P763, DOI 10.1097/MPG.0000000000000525; Ghione S, 2018, AM J GASTROENTEROL, V113, P265, DOI 10.1038/ajg.2017.228; Halpern SD, 2004, ARCH INTERN MED, V164, P801, DOI 10.1001/archinte.164.7.801; Hoberman A, 2013, JAMA PEDIATR, V167, P561, DOI 10.1001/jamapediatrics.2013.1050; Levine A, 2014, J PEDIATR GASTR NUTR, V58, P795, DOI 10.1097/MPG.0000000000000239; Madeson SM, 2002, J INT MED, V251, P156; Ordas I, 2012, LANCET, V380, P1606, DOI 10.1016/S0140-6736(12)60150-0; Ravikoff JE, 2012, INFLAMM BOWEL DIS, V18, P2092, DOI 10.1002/ibd.22872	12	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206965	10.1371/journal.pone.0206965	http://dx.doi.org/10.1371/journal.pone.0206965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408097	Green Submitted, gold, Green Published			2022-12-26	WOS:000449512300056
J	Kubesch, A; Quenstedt, L; Saleh, M; Ruschenbaum, S; Schwarzkopf, K; Martinez, Y; Welsch, C; Zeuzem, S; Wetzel, TM; Lange, CM				Kubesch, Alica; Quenstedt, Leonie; Saleh, Maged; Rueschenbaum, Sabrina; Schwarzkopf, Katharina; Martinez, Yolanda; Welsch, Christoph; Zeuzem, Stefan; Wetzel, Tania M.; Lange, Christian M.			Vitamin D deficiency is associated with hepatic decompensation and inflammation in patients with liver cirrhosis: A prospective cohort study	PLOS ONE			English	Article							D-RECEPTOR; INFECTED PATIENTS; SEVERE FIBROSIS; DISEASE	Background Vitamin D is required to maintain the integrity of the intestinal barrier and inhibits inflammatory signaling pathways. Objective Vitamin D deficiency might be involved in cirrhosis-associated systemic inflammation and risk of hepatic decompensation in patients with liver cirrhosis. Methods Outpatients of the Hepatology Unit of the University Hospital Frankfurt with advanced liver fibrosis and cirrhosis were prospectively enrolled. 25-hydroxyvitamin D (25(OH)D-3) serum concentrations were quantified and associated with markers of systemic inflammation / intestinal bacterial translocation and hepatic decompensation. Results A total of 338 patients with advanced liver fibrosis or cirrhosis were included. Of those, 51 patients (15%) were hospitalized due to hepatic decompensation during follow-up. Overall, 72 patients (21%) had severe vitamin D deficiency. However, patients receiving vitamin D supplements had significantly higher 25(OH) D3 serum levels compared to patients without supplements (37 ng/mL vs. 16 ng/ml, P<0.0001). Uni- and multivariate analyses revealed an independent association of severe vitamin D deficiency with the risk of hepatic decompensation during follow-up (multivariate P = 0.012; OR = 3.25, 95% CI = 1.30-8.2), together with MELD score, low hemoglobin concentration, low coffee consumption, and presence of diabetes. Of note, serum levels of C-reactive protein, IL-6 and soluble CD14 were significantly higher in patients with versus without severe vitamin D deficiency, and serum levels of soluble CD14 levels declined in patients with de novo supplementation of vitamin D (median 2.15 vs. 1.87 ng/mL, P = 0.002). Conclusions In this prospective cohort study, baseline vitamin D levels were inversely associated with liver-cirrhosis related systemic inflammation and the risk of hepatic decompensation.	[Kubesch, Alica; Quenstedt, Leonie; Saleh, Maged; Rueschenbaum, Sabrina; Schwarzkopf, Katharina; Martinez, Yolanda; Welsch, Christoph; Zeuzem, Stefan; Wetzel, Tania M.; Lange, Christian M.] Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Kubesch, A (corresponding author), Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.	Alica.Kubesch@kgu.de	Welsch, Christoph/AAF-6785-2020; Zeuzem, Stefan/AAE-7435-2019	Welsch, Christoph/0000-0002-1823-4863; 	Deutsche Forschungsgemeinschaft [LA 2806/2-1, LA 2806/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (LA 2806/2-1 and LA 2806/5-1 to CML). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthakrishnan AN, 2012, GASTROENTEROLOGY, V142, P482, DOI 10.1053/j.gastro.2011.11.040; Bischoff-Ferrari H, 2011, INT J VITAM NUTR RES, V81, P264, DOI 10.1024/0300-9831/a000072; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Bucharles S, 2012, J RENAL NUTR, V22, P284, DOI 10.1053/j.jrn.2011.07.001; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Farnik H, 2013, HEPATOLOGY, V58, P1270, DOI 10.1002/hep.26488; Holick MF, 2017, REV ENDOCR METAB DIS, V18, P153, DOI 10.1007/s11154-017-9424-1; Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007; Lange CM, 2013, J HEPATOL, V59, P504, DOI 10.1016/j.jhep.2013.04.032; Lange CM, 2011, J HEPATOL, V54, P887, DOI 10.1016/j.jhep.2010.08.036; Liu WC, 2013, J CLIN INVEST, V123, P3983, DOI 10.1172/JCI65842; Moore KP, 2003, HEPATOLOGY, V38, P258, DOI 10.1053/jhep.2003.50315; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Petta S, 2010, HEPATOLOGY, V51, P1158, DOI 10.1002/hep.23489; Raftery T, 2015, UNITED EUR GASTROENT, V3, P294, DOI 10.1177/2050640615572176; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Stokes CS, 2013, LIVER INT, V33, P338, DOI 10.1111/liv.12106; Terrier B, 2011, J HEPATOL, V55, P756, DOI 10.1016/j.jhep.2011.01.041; Trepo E, 2013, J HEPATOL, V59, P344, DOI 10.1016/j.jhep.2013.03.024; Villa E, 2012, GASTROENTEROLOGY, V143, P1253, DOI 10.1053/j.gastro.2012.07.018; Wang J, 2016, NAT GENET, V48, P1396, DOI 10.1038/ng.3695	23	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207162	10.1371/journal.pone.0207162	http://dx.doi.org/10.1371/journal.pone.0207162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408125	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300087
J	Nshimyumukiza, L; Lieffers, JRL; Ekwaru, JP; Ohinmaa, A; Veugelers, PJ				Nshimyumukiza, Leon; Lieffers, Jessica R. L.; Ekwaru, John Paul; Ohinmaa, Arto; Veugelers, Paul J.			Temporal changes in diet quality and the associated economic burden in Canada	PLOS ONE			English	Article							HEALTHY EATING INDEX; STOP HYPERTENSION SCORE; CHRONIC DISEASE RISK; COST-OF-ILLNESS; PHYSICAL INACTIVITY; CONSUMPTION; UPDATE; METAANALYSIS; OUTCOMES; SMOKING	A high-quality diet is associated with a reduced of risk of chronic disease and all-cause mortality. In this study, we assessed changes in diet quality and the associated economic burden in the Canadian population between 2004 and 2015. We used a prevalence-based cost-of-illness approach. We first calculated the diet quality using the Healthy Eating Index-Canada-2010 (HEI-C-2010) and 24-hour recall data from the Canadian Community Health Surveys (CCHS) on nutrition (CCHS 2004 cycle 2.2 and the CCHS-NU 2015). We then retrieved relative risks of HEI-2010 quintiles for chronic diseases from meta-analyses. Based on the proportions of the population following diets of varying qualities and these relative risks, we computed the population-attributable fractions and attributable costs (direct health care and indirect costs) by survey year (2004 and 2015) as well as by age and sex group. Costs were estimated in 2017 Canadian dollars for comparison purposes. We observed that on average the diet quality of Canadians improved between 2004 and 2015: the proportion of the Canadian population that did not eat a diet of high quality decreased from 83% to 76%. This improvement in diet quality translated in a decrease in economic burden of $133 million, down from $13.21 billion in 2004 to $13.08 billion in 2015. The economic burden decreased by $219 million among males but increased by $86 million among females. It also decreased among people under the age of 65 years ($333 million) but increased among those over 65 years ($200 million). Our findings suggest that, despite some temporal improvements, the diet of the majority of Canadians is of poor quality resulting in a high attributable economic burden. Policy and decision makers are encouraged to expand nutrition programs and policies and to specifically target the elderly in order to prevent chronic diseases and reduce health care costs.	[Nshimyumukiza, Leon; Ekwaru, John Paul; Ohinmaa, Arto; Veugelers, Paul J.] Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada; [Nshimyumukiza, Leon] Univ Laval, Fac Med, Dept Family & Emergency Med, Quebec City, PQ, Canada; [Lieffers, Jessica R. L.] Univ Saskatchewan, Coll Pharm & Nutr, Saskatoon, SK, Canada	University of Alberta; Laval University; University of Saskatchewan	Veugelers, PJ (corresponding author), Univ Alberta, Sch Publ Hlth, Populat Hlth Intervent Res Unit, Edmonton, AB, Canada.	paul.veugelers@ulberta.ca	Nshimyumukiza, Léon/H-1694-2011	Nshimyumukiza, Léon/0000-0003-2707-5099; Veugelers, Paul/0000-0001-8996-0822	Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates (AI) [201300671]; Social Science and Humanities Research Council (SSHRC); Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation (CFI); Statistics Canada	Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates (AI); Social Science and Humanities Research Council (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Statistics Canada	This research was funded through the Collaborative Research and Innovation Opportunities (CRIO) Team program from Alberta Innovates (AI) (grant number 201300671 to PJV and AO). All interpretations and opinions in the present study are those of the authors. This research was also supported by funds to the Canadian Research Data Centre Network (CRDCN) from the Social Science and Humanities Research Council (SSHRC), the Canadian Institute for Health Research (CIHR), the Canadian Foundation for Innovation (CFI) and Statistics Canada. Although the research and analysis are based on data from Statistics Canada, the opinions expressed do not represent the views of Statistics Canada or the Canadian Research Data Centre Network (CRDCN).	Abdullah MMH, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.28646; Abdullah MMH, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070793; BARNARD ND, 1995, PREV MED, V24, P646, DOI 10.1006/pmed.1995.1100; Boshuizen HC, 2009, VALUE HEALTH, V12, P1210, DOI 10.1111/j.1524-4733.2009.00590.x; Canada Health, 2007, EATING WELL CANADAS; Canada Statistics, 2012, CAN YB 2011; Canadian Institute for Health Information (CIHI), 2017, NAT HLTH EXP TRENDS; Candari C., 2017, ASSESSING EC COSTS U; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Ekwaru JP, 2017, PUBLIC HEALTH NUTR, V20, P515, DOI 10.1017/S1368980016002846; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Garriguet Didier, 2009, Health Rep, V20, P41; Guenther PM, 2008, J AM DIET ASSOC, V108, P1896, DOI 10.1016/j.jada.2008.08.016; Guenther PM, 2013, J ACAD NUTR DIET, V113, P569, DOI 10.1016/j.jand.2012.12.016; Gyles C, 2010, FOOD NUTR RES, P54; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Health Canada, 2017, CANUCS CANADIAN NIRI; Health Canada, 2006, CANADIAN COMMUNITY H; Health Canada, 2002, EC BURD ILLN CAN 199; IHME, 2016, COUNTR PROF CAN TOP; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S; Jessri M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080910; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Johnson JA, 2006, DIABETES CARE, V29, P2403, DOI 10.2337/dc06-0735; KENNEDY ET, 1995, J AM DIET ASSOC, V95, P1103, DOI 10.1016/S0002-8223(95)00300-2; Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021; Krueger H, 2013, CHRON DIS INJ CAN, V33, P236; Krueger H, 2017, CAN J PUBLIC HEALTH, V108, pE152, DOI [10.17269/CJPH.108.5721, 10.17269/cjph.108.5721]; Krueger H, 2015, CAN J PUBLIC HEALTH, V106, pE171, DOI 10.17269/cjph.106.4994; Lieffere JRL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196333; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Moshfegh A, 2008, AM J CLIN NUTR, V88, P234; NCI, 2018, HLTH EAT IND CHOOS M; NCI, HLTH EAT IND SAS COD; Nishida C, 2004, PUBLIC HEALTH NUTR, V7, P245, DOI 10.1079/PHN2003592; Ocke MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013; Public Health Agency of Canada, 2014, EC BURD ILLN CAN 200; RAMAGEMORIN PL, 2013, HEALTH REP, V24, P3; Reedy J, 2018, J ACAD NUTR DIET, V118, P1622, DOI 10.1016/j.jand.2018.05.019; Reedy J, 2014, J NUTR, V144, P881, DOI 10.3945/jn.113.189407; SAS institute Inc, SURVEYFREQ PROC; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Schwingshackl L, 2018, J ACAD NUTR DIET, V118, P74, DOI 10.1016/j.jand.2017.08.024; Schwingshackl L, 2015, J ACAD NUTR DIET, V115, P780, DOI 10.1016/j.jand.2014.12.009; Statistics Canada, 2013, SURVEY METHODOLOGY; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Tarricone R, 2006, HEALTH POLICY, V77, P51, DOI 10.1016/j.healthpol.2005.07.016; The Secretariat for the Intersectoral Healthy Living Network, 2005, INT PAN CAN HLTH LIV; Veugelers PJ, 2010, CAN J PUBLIC HEALTH, V101, pS5, DOI 10.1007/BF03405617	50	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206877	10.1371/journal.pone.0206877	http://dx.doi.org/10.1371/journal.pone.0206877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408076	Green Submitted, gold, Green Published			2022-12-26	WOS:000449512300047
J	Oishi, K; Kanahara, N; Takase, M; Oda, Y; Nakata, Y; Niitsu, T; Ishikawa, M; Sato, Y; Iyo, M				Oishi, Kengo; Kanahara, Nobuhisa; Takase, Masayuki; Oda, Yasunori; Nakata, Yusuke; Niitsu, Tomihisa; Ishikawa, Masatomo; Sato, Yasunori; Iyo, Masaomi			Vulnerable combinations of functional dopaminergic polymorphisms to late-onset treatment resistant schizophrenia	PLOS ONE			English	Article							SUPERSENSITIVITY PSYCHOSIS; RECEPTOR GENE; ANTIPSYCHOTICS; ASSOCIATION; SYMPTOMS; DISORDER; PATHWAY; ALLELE	Background A significant portion of patients with schizophrenia who respond to initial antipsychotic treatment acquire treatment resistance. One of the possible pathogeneses of treatment-resistant schizophrenia (TRS) is antipsychotic-induced dopamine supersensitivity psychosis (Ai-DSP). Patients with this disease progression might share some genetic vulnerabilities, and thus determining individuals with higher risks of developing Ai-DSP could contribute to preventing iatrogenic development of TRS. Therefore, we decided to examine whether combinations of functional single nucleotide polymorphisms (SNPs) known to affect dopaminergic functions are related to Ai-DSP development. Methods In this case-control study, 357 Japanese participants diagnosed with schizophrenia or schizoaffective disorder were recruited and divided into two groups, those with and without Ai-DSP. As functional SNPs, we examined rs10770141 of the tyrosine hydroxylase gene, rs4680 of the catechol-O-methyltransferase gene, and rs1799732 and rs1800497 of the DRD2 genes, which are known to possess strong directional ties to dopamine synthesis, dopamine degradation and post-synaptic DRD2 prevalence, respectively. Results Among the 357 Japanese patients with schizophrenia or schizoaffective disorder, 130 were classified as Ai-DSP(+) and the other 227 as Ai-DSP(-). Significantly higher proportions of Ai-DSP(+) patients were found to have the SNP combinations of rs10770141/rs4680 (57.9%, OR2.654, 95% CI1.036-6.787, P = 0.048) and rs10770141/rs4680/rs1800497 (64.3%, OR4.230, 95% CI1.306-13.619, P = 0.029). However, no single SNP was associated with Ai-DSP. Conclusions We preliminarily found that carrying particular combinations of functional SNPs, which are related to relatively higher dopamine synthesis and dopamine degradation and lower naive DRD2, might indicate vulnerability to development of Ai-DSP. However, further studies are needed to validate the present results.	[Oishi, Kengo; Takase, Masayuki; Oda, Yasunori; Nakata, Yusuke; Niitsu, Tomihisa; Ishikawa, Masatomo; Iyo, Masaomi] Chiba Univ, Dept Psychiat, Grad Sch Med, Chuo Ku, Chiba, Chiba, Japan; [Kanahara, Nobuhisa] Chiba Univ, Div Med Treatment & Rehabil, Ctr Forens Mental Hlth, Chuo Ku, Chiba, Chiba, Japan; [Takase, Masayuki] Zucker Hillside Hosp, Glen Oaks, NY USA; [Sato, Yasunori] Chiba Univ, Dept Global Clin Res, Grad Sch Med, Chuou Ku, Chiba, Chiba, Japan	Chiba University; Chiba University; Northwell Health; Chiba University	Oishi, K (corresponding author), Chiba Univ, Dept Psychiat, Grad Sch Med, Chuo Ku, Chiba, Chiba, Japan.	kengo.oishi@chiba-u.jp		Oishi, Kengo/0000-0002-0132-7270; Sato, Yasunori/0000-0002-7189-5126	SENSHIN Medical Research Foundation	SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation)	This study was partly funded by SENSHIN Medical Research Foundation, whereas the rest was fully supported by the internal fund. There was no additional external funding received for this study.	Agid O, 2011, J CLIN PSYCHIAT, V72, P1439, DOI 10.4088/JCP.09m05785yel; Arinami T, 1997, HUM MOL GENET, V6, P577, DOI 10.1093/hmg/6.4.577; Austin SF, 2015, SCHIZOPHR RES, V168, P84, DOI 10.1016/j.schres.2015.07.021; Bhakta SG, 2012, SCHIZOPHR RES, V140, P192, DOI 10.1016/j.schres.2012.06.026; Bychkov E, 2007, J NEUROCHEM, V102, P699, DOI 10.1111/j.1471-4159.2007.04586.x; CHOUINARD G, 1991, SCHIZOPHR RES, V5, P21, DOI 10.1016/0920-9964(91)90050-2; CHOUINARD G, 1978, LANCET, V2, P99; Chouinard G, 2008, PSYCHOTHER PSYCHOSOM, V77, P69, DOI 10.1159/000112883; Chouinard G, 2017, PSYCHOTHER PSYCHOSOM, V86, P189, DOI 10.1159/000477313; Farrell MS, 2015, MOL PSYCHIATR, V20, P555, DOI 10.1038/mp.2015.16; Goff DC, 2017, AM J PSYCHIAT, V174, P840, DOI 10.1176/appi.ajp.2017.16091016; Horiguchi M, 2014, PSYCHIAT CLIN NEUROS, V68, P456, DOI 10.1111/pcn.12157; Iyo M, 2013, J CLIN PSYCHOPHARM, V33, P398, DOI 10.1097/JCP.0b013e31828ea95c; Kimura H, 2016, J PSYCHOPHARMACOL, V30, P795, DOI 10.1177/0269881116655978; Kimura H, 2014, SCHIZOPHR RES, V155, P52, DOI 10.1016/j.schres.2014.02.022; Lally J, 2016, PSYCHOL MED, V46, P3231, DOI 10.1017/S0033291716002014; Lawford BR, 2013, J PSYCHOPHARMACOL, V27, P343, DOI 10.1177/0269881112463469; Li DW, 2006, HUM GENET, V120, P22, DOI 10.1007/s00439-006-0190-5; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Miura I, 2016, PSYCHONEUROENDOCRINO, V72, P1, DOI 10.1016/j.psyneuen.2016.06.002; Murray RM, 2016, BRIT J PSYCHIAT, V209, P363, DOI 10.1192/bjp.bp.116.182683; Noble EP, 2003, AM J MED GENET B, V116B, P103, DOI 10.1002/ajmg.b.10005; Pohjalainen T, 1998, MOL PSYCHIATR, V3, P256, DOI 10.1038/sj.mp.4000350; Seeman MV, 2014, PROG NEURO-PSYCHOPH, V48, P155, DOI 10.1016/j.pnpbp.2013.10.003; Sheitman BB, 1998, J PSYCHIATR RES, V32, P143, DOI 10.1016/S0022-3956(97)00052-6; Silvestri S, 2000, PSYCHOPHARMACOLOGY, V152, P174, DOI 10.1007/s002130000532; Suzuki T, 2015, PSYCHIAT RES, V227, P278, DOI 10.1016/j.psychres.2015.02.021; Tachibana M, 2016, ASIAN J PSYCHIATR, V24, P28, DOI 10.1016/j.ajp.2016.08.014; Tadokoro S, 2012, SCHIZOPHRENIA BULL, V38, P1012, DOI 10.1093/schbul/sbr006; The National Center for Biotechnology Information, DAT SHORT GEN VAR DB; Wang C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23191-y; Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19; Yamanaka H, 2016, SCHIZOPHR RES, V170, P252, DOI 10.1016/j.schres.2016.01.013; Yin J, 2017, CURR NEUROPHARMACOL, V15, P174, DOI 10.2174/1570159X14666160606093602	34	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207133	10.1371/journal.pone.0207133	http://dx.doi.org/10.1371/journal.pone.0207133			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408108	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300081
J	Walker, JW; Han, BA; Ott, IM; Drake, JM				Walker, Joseph W.; Han, Barbara A.; Ott, Isabel M.; Drake, John M.			Transmissibility of emerging viral zoonoses	PLOS ONE			English	Article							INFECTIOUS-DISEASES; VIRUS TRANSMISSION; EMERGENCE; EPIDEMIOLOGY; RNA	Effective public health research and preparedness requires an accurate understanding of which virus species possess or are at risk of developing human transmissibility. Unfortunately, our ability to identify these viruses is limited by gaps in disease surveillance and an incomplete understanding of the process of viral adaptation. By fitting boosted regression trees to data on 224 human viruses and their associated traits, we developed a model that predicts the human transmission ability of zoonotic viruses with over 84% accuracy. This model identifies several viruses that may have an undocumented capacity for transmission between humans. Viral traits that predicted human transmissibility included infection of non-human primates, the absence of a lipid envelope, and detection in the human nervous system and respiratory tract. This predictive model can be used to prioritize high-risk viruses for future research and surveillance, and could inform an integrated early warning system for emerging infectious diseases.	[Walker, Joseph W.; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Walker, Joseph W.; Drake, John M.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA; [Han, Barbara A.] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Ott, Isabel M.] Univ Georgia, Coll Vet Med, Southeastern Cooperat Wildlife Dis Study, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Cary Institute of Ecosystem Studies; University System of Georgia; University of Georgia	Walker, JW (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.; Walker, JW (corresponding author), Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.	jw14128@uga.edu	Han, Barbara A/H-9363-2015	Han, Barbara A/0000-0002-9948-3078; Ott, Isabel/0000-0002-7134-0956	University of Georgia Center for Undergraduate Research Opportunities; NSF DEB EEID Program [1717282]	University of Georgia Center for Undergraduate Research Opportunities; NSF DEB EEID Program	Authors Walker and Ott were supported by assistantships from the University of Georgia Center for Undergraduate Research Opportunities (curo.uga.edu) and NSF DEB EEID Program Grant #1717282. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Berger Stephen A, 2005, Int J Health Geogr, V4, P10, DOI 10.1186/1476-072X-4-10; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Calattini S, 2007, EMERG INFECT DIS, V13, P1314, DOI 10.3201/eid1309.061162; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053; Friedman Jerome, 2009, ELEMENTS STAT LEARNI, V2nd; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Geoghegan JL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006215; Geoghegan JL, 2016, P NATL ACAD SCI USA, V113, P4170, DOI 10.1073/pnas.1521582113; Halliday J, 2012, PHILOS T R SOC B, V367, P2872, DOI 10.1098/rstb.2011.0362; Han BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004815; Han BA, 2016, EMBO REP, V17, P785, DOI 10.15252/embr.201642534; Han BA, 2015, P NATL ACAD SCI USA, V112, P7039, DOI 10.1073/pnas.1501598112; Hastie T, 2013, ECOGRAPHY, V36, P864, DOI 10.1111/j.1600-0587.2013.00321.x; Herfst S, 2017, CURR OPIN VIROL, V22, P22, DOI 10.1016/j.coviro.2016.11.006; Holmes E., 2009, EVOLUTION EMERGENCE; Holmes EC, 2010, P NATL ACAD SCI USA, V107, P1742, DOI 10.1073/pnas.0906193106; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; ICTV, 2017, VIR TAX CLASS NOM VI; Jepsen JR, 2009, EMERG INFECT DIS, V15, P2040, DOI 10.3201/eid1512.090514; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Lancaster T, 1996, J ECONOMETRICS, V71, P145, DOI 10.1016/0304-4076(94)01698-4; Lim ES, 2014, VIROLOGY, V454, P25, DOI 10.1016/j.virol.2014.01.018; Lloyd-Smith JO, 2009, SCIENCE, V326, P1362, DOI 10.1126/science.1177345; Lucas W., 2010, ELS, DOI [10.1002/9780470015902.a0001091.pub2, DOI 10.1002/9780470015902.A0001091.PUB2]; Mahieux R, 2011, VIRUSES-BASEL, V3, P1074, DOI 10.3390/v3071074; MORSE SS, 1990, J INFECT DIS, V162, P1, DOI 10.1093/infdis/162.1.1; Oberste MS, 2009, EMERG INFECT DIS, V15, P640, DOI 10.3201/eid1504.081428; Olival K. J, 2017, NATURE, V451, P990; Payungporn S, 2008, EMERG INFECT DIS, V14, P902, DOI 10.3201/eid1406.071270; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45; Ridgeway G, 2017, GBM GEN BOOSTED REGR; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; Siedner MJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001804; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Tomley FM, 2009, PHILOS T R SOC B, V364, P2637, DOI 10.1098/rstb.2009.0133; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059; Woolhouse MEJ, 2016, EMERG INFECT DIS, V22, P2037, DOI 10.3201/eid2212.160123; Yang LH, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0163-2	47	18	18	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206926	10.1371/journal.pone.0206926	http://dx.doi.org/10.1371/journal.pone.0206926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403733	Green Submitted, gold, Green Published			2022-12-26	WOS:000449379500083
J	Allegre, L; Le Teuff, I; Leprince, S; Warembourg, S; Taillades, H; Garric, X; Letouzey, V; Huberlant, S				Allegre, Lucie; Le Teuff, Isabelle; Leprince, Salome; Warembourg, Sophie; Taillades, Hubert; Garric, Xavier; Letouzey, Vincent; Huberlant, Stephanie			A new bioabsorbable polymer film to prevent peritoneal adhesions validated in a post-surgical animal model	PLOS ONE			English	Article							POSTOPERATIVE ABDOMINAL ADHESIONS; SMALL-BOWEL OBSTRUCTION; INTRAABDOMINAL ADHESION; CARBOXYMETHYLCELLULOSE MEMBRANE; BIORESORBABLE MEMBRANE; HOSPITAL READMISSIONS; BARRIER; SURGERY; EFFICACY; MULTICENTER	Background Peritoneal adhesions are a serious surgical postoperative complication. The aim of this study is to investigate, in a rat model, the anti-adhesive effects of a bioabsorbable film of polymer combining polyethylene glycol and polylactic acid. Materials and methods Sixty-three animals were randomized into five groups according to the anti-adhesion treatment: Hyalobarrier (R), Seprafilm (R), Polymer A (PA), Polymer B (PB), and control. The rats were euthanized on days 5 and 12 to evaluate the extent, severity and degree of adhesions and histopathological changes. Three animals were euthanized at day 2 in PA, PB and control groups to observe the in vivo elimination. Results Macroscopic adhesion formation was significantly lower in the PA group than in the control group at day 5 (median adhesion score 0 +/- 0 vs 9.6 +/- 0.5 p = 0.002) and at day 12 (0 +/- 0 vs 7.3 +/- 4 p = 0.02). Furthermore, median adhesion score at day 5 was significantly lower in the PA group than in the Seprafilm group (0 +/- 0 vs 4.2 +/- 3.9 p = 0.03). Residence time of PA seems longer than PB. Conclusion The PA bioabsorbable film seems efficient in preventing the formation of peritoneal adhesions.	[Allegre, Lucie; Le Teuff, Isabelle; Warembourg, Sophie; Letouzey, Vincent; Huberlant, Stephanie] Univ Hosp Nimes, Dept Gynecol & Obstet, Nimes, France; [Allegre, Lucie; Le Teuff, Isabelle; Leprince, Salome; Warembourg, Sophie; Garric, Xavier; Letouzey, Vincent; Huberlant, Stephanie] Univ Montpellier I, CNRS UMR 5247, Max Mousseron Inst Biomol, Dept Artificial Polymers, Montpellier, France; [Taillades, Hubert] Univ Montpellier, Surg & Expt Dept, Montpellier, France	Universite de Montpellier; CHU de Nimes; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Universite de Montpellier	Allegre, L (corresponding author), Univ Hosp Nimes, Dept Gynecol & Obstet, Nimes, France.; Allegre, L (corresponding author), Univ Montpellier I, CNRS UMR 5247, Max Mousseron Inst Biomol, Dept Artificial Polymers, Montpellier, France.	allegrelucie@gmail.com	Garric, Xavier/ABE-6895-2021	Allegre, Lucie/0000-0003-0384-0657	Societe d'Acceleration de Transfet de Technologie SATT	Societe d'Acceleration de Transfet de Technologie SATT	LA and SL received funding by Societe d'Acceleration de Transfet de Technologie SATT. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahmad G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001298.pub4; Arslan E, 2014, INT J SURG, V12, P120, DOI 10.1016/j.ijsu.2013.11.010; Beck DE, 2003, DIS COLON RECTUM, V46, P1310, DOI 10.1007/s10350-004-6739-2; Becker JM, 1996, J AM COLL SURGEONS, V183, P297; Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556; Cohen Z, 2005, DIS COLON RECTUM, V48, P1130, DOI 10.1007/s10350-004-0954-8; De Iaco PA, 2001, SURGERY, V130, P60, DOI 10.1067/msy.2001.115102; DIZEREGA GS, 1994, FERTIL STERIL, V61, P219; Duron JJ, 2007, COLORECTAL DIS, V9, P14, DOI 10.1111/j.1463-1318.2007.01343.x; Ellis H, 1999, LANCET, V353, P1476, DOI 10.1016/S0140-6736(98)09337-4; Farag S, 2017, J MINIM INVASIVE GYN; Fazio VW, 2006, DIS COLON RECTUM, V49, P1, DOI 10.1007/s10350-005-0268-5; Ferland R, 2001, HUM REPROD, V16, P2718, DOI 10.1093/humrep/16.12.2718; Fortin CN, 2015, HUM REPROD UPDATE, V21, P536, DOI 10.1093/humupd/dmv021; Fredriksson F, 2016, BRIT J SURG, V103, P284, DOI 10.1002/bjs.10072; Garric X, 2008, J MATER SCI-MATER M, V19, P1645, DOI 10.1007/s10856-007-3232-1; Hindocha A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011254.pub2; Hinoki A, 2016, BRIT J SURG, V103, P692, DOI 10.1002/bjs.10122; Hong M-K, 2017, JSLS, V21; Hwang HJ, 2013, INT J COLORECTAL DIS, V28, P1117, DOI 10.1007/s00384-013-1679-8; Kumar S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005080.pub2; Kusuki I, 2014, SURG LAPARO ENDO PER, V24, pE13, DOI 10.1097/SLE.0b013e31828f6ec1; Kusunoki M, 2005, SURG TODAY, V35, P940, DOI 10.1007/s00595-005-3061-0; Leach RE, 1998, FERTIL STERIL, V69, P415, DOI 10.1016/S0015-0282(97)00573-6; Li J, 2017, MAT SCI ENG C-MATER, V78, P988, DOI 10.1016/j.msec.2017.04.017; Liu Z, 2017, MED SCI MONITOR, V23, P5363, DOI 10.12659/MSM.904669; Lower AM, 2000, BRIT J OBSTET GYNAEC, V107, P855, DOI 10.1111/j.1471-0528.2000.tb11083.x; Mettler L, 2004, FERTIL STERIL, V82, P398, DOI 10.1016/j.fertnstert.2003.12.046; Ntagiopoulos PG, 2015, INT ORTHOP, V39, P697, DOI 10.1007/s00264-014-2530-8; Ozel H, 2005, WOUND REPAIR REGEN, V13, P358, DOI 10.1111/j.1067-1927.2005.130402.x; Parrish Lawrence C, 2009, J Oral Sci, V51, P383; Pfeifer S, 2013, FERTIL STERIL, V99, P1550, DOI 10.1016/j.fertnstert.2013.02.031; Pouly JL, 2012, GYNECOL OBSTET FERTI, V40, P419, DOI 10.1016/j.gyobfe.2011.10.001; Rodgers K, 1998, FERTIL STERIL, V69, P403, DOI 10.1016/S0015-0282(97)00574-8; Saffer EM, 2011, CURR MED CHEM, V18, P5676; Takagi K, 2013, INT J MED SCI, V10, P467, DOI 10.7150/ijms.5607; Tang CL, 2003, DIS COLON RECTUM, V46, P1200, DOI 10.1007/s10350-004-6716-9; ten Broek RPG, 2012, GYNECOL SURG, V9, P29, DOI 10.1007/s10397-011-0698-0; ten Broek RPG, 2014, LANCET, V384, P581, DOI 10.1016/S0140-6736(14)61358-1; ten Broek RPG, 2014, LANCET, V383, P48, DOI 10.1016/S0140-6736(13)61687-6; ten Broek RPG, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5588; Turgut A, 2013, GYNECOL OBSTET INVES, V75, P281, DOI 10.1159/000349893; Verma SK, 2016, MATER TODAY-PROC, V3, P1949, DOI 10.1016/j.matpr.2016.04.096; Vieille P, 2015, J INVEST SURG, V28, P109, DOI 10.3109/08941939.2014.981324; Vrijland WW, 2002, ANN SURG, V235, P193, DOI 10.1097/00000658-200202000-00006; Yang B, 2012, INT J NANOMED, V7, P547, DOI 10.2147/IJN.S26141; Yeo Y, 2008, EUR J PHARM BIOPHARM, V68, P57, DOI 10.1016/j.ejpb.2007.03.027; Yu L, 2011, BIOMACROMOLECULES, V12, P1290, DOI 10.1021/bm101572j; Zhang Z, 2011, BIOMATERIALS, V32, P4725, DOI 10.1016/j.biomaterials.2011.03.046	49	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0202285	10.1371/journal.pone.0202285	http://dx.doi.org/10.1371/journal.pone.0202285			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395571	Green Published, gold			2022-12-26	WOS:000449291400004
J	Barberia, I; Oliva, R; Bourdin, P; Slater, M				Barberia, Itxaso; Oliva, Ramon; Bourdin, Pierre; Slater, Mel			Virtual mortality and near-death experience after a prolonged exposure in a shared virtual reality may lead to positive life-attitude changes	PLOS ONE			English	Article							TERROR MANAGEMENT THEORY; IMPLICIT ASSOCIATION TEST; INTERGROUP CONTACT THEORY; COLLETT-LESTER FEAR; SELF-ESTEEM; SYMBOLIC IMMORTALITY; CULTURAL WORLDVIEW; NEGATIVE AFFECT; CARDIAC-ARREST; PANAS SCALES	Mortality is an obvious if uncomfortable part of the human condition, yet it is impossible to study its impact on anyone who experiences it. Reports of phenomena associated with death such as out-of-the-body (OBE) and near death experiences (NDE) can only be studied post-hoc, since it is impossible to design a scientific study where an experimental group experiences death (and returns) and a control group does not. Yet NDEs seem to have a profound influence on the subsequent lives of people and are therefore worthy of study. Terror Management Theory, which argues that death anxiety contributes to in-group solidarity and hostility to out-groups, relies on studies that manipulate opinions and cannot be based on experiential evidence. Here we introduce a potential methodology that uses immersive virtual reality (VR) for the study of mortality and NDEs. Participants are embodied in alternate bodies in a beautiful island along with two companions. They explore the island and carry out tasks together. The mechanism of embodiment produces strong illusions of ownership over their life-sized virtual bodies. Over time each participant witnesses the death of the two companions and then her own death-which includes the reported features of an NDE (OBE, life review, the tunnel leading to white light) followed by a period of observation of the continuing activities in the virtual world on an external screen. Fifteen female participants experienced 6 sessions in the island, each starting as a child and gradually maturing, and eventually ageing and dying. Sixteen control subjects formed a waiting group. We introduce this as a methodology for the study of these issues, and present promising results, suggesting that those who experienced the island report life attitude changes, becoming more concerned with others and more interested in global rather than material issues compared to the control group. The results are based on a small sample size, and should be considered as indicative of the possibilities of this new methodology as a way forward for future studies in this field.	[Barberia, Itxaso; Oliva, Ramon; Bourdin, Pierre; Slater, Mel] Univ Barcelona, Dept Clin Psychol & Psychobiol, Event Lab, Barcelona, Spain; [Barberia, Itxaso] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Bourdin, Pierre] Univ Oberta Catalunya, Comp Sci Multimedia & Telecommun Dept, Barcelona, Spain	University of Barcelona; University of Barcelona; UOC Universitat Oberta de Catalunya	Slater, M (corresponding author), Univ Barcelona, Dept Clin Psychol & Psychobiol, Event Lab, Barcelona, Spain.	melslater@ub.edu	BARBERIA, ITXASO/L-8477-2014; Slater, Mel/M-5210-2014; Bourdin, Pierre/Y-4958-2019	BARBERIA, ITXASO/0000-0003-3045-2289; Slater, Mel/0000-0002-6223-0050; Bourdin, Pierre/0000-0002-8745-3787	University of Barcelona by the University of California Riverside as sub-project of "The Immortality Project" - John Templeton Foundation [35279]	University of Barcelona by the University of California Riverside as sub-project of "The Immortality Project" - John Templeton Foundation	This research was supported at the University of Barcelona by the University of California Riverside as sub-project 35279 of "The Immortality Project" funded by the John Templeton Foundation.	Abeyta AA, 2014, MOTIV EMOTION, V38, P523, DOI 10.1007/s11031-014-9400-y; Abuín Manuel R., 2014, Clínica y Salud, V25, P131, DOI 10.1016/j.clysa.2014.06.001; Agrillo C, 2011, REV GEN PSYCHOL, V15, P1, DOI 10.1037/a0021992; Anzellotti F, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-2; Arndt J, 1997, PSYCHOL SCI, V8, P379, DOI 10.1111/j.1467-9280.1997.tb00429.x; Banakou D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00601; Banakou D, 2014, P NATL ACAD SCI USA, V111, P17678, DOI 10.1073/pnas.1414936111; Banakou D, 2013, P NATL ACAD SCI USA, V110, P12846, DOI 10.1073/pnas.1306779110; Bergstrom I, 2017, IEEE T VIS COMPUT GR, V23, P1332, DOI 10.1109/TVCG.2017.2657138; Blackmore SJ, 1982, BODY INVESTIGATION O, DOI [10.1177/1088868309352321, DOI 10.1177/1088868309352321]; Blanke O, 2015, NEURON, V88, P145, DOI 10.1016/j.neuron.2015.09.029; Blanke O, 2009, NEUROLOGY OF CONSCIOUSNESS: COGNITIVE NEUROSCIENCE AND NEUROPATHOLOGY, P303, DOI 10.1016/B978-0-12-374168-4.00023-X; Bostrom N, 2003, PHILOS QUART, V53, P243, DOI 10.1111/1467-9213.00309; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bourdin P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169343; Bradley KI, 2012, DEATH STUD, V36, P819, DOI 10.1080/07481187.2011.605987; Brey P., 1999, Ethics and Information Technology, V1, P5, DOI 10.1023/A:1010069907461; Burke BL, 2010, PERS SOC PSYCHOL REV, V14, P155, DOI 10.1177/1088868309352321; Carpenter B., 2016, J STAT SOFTWARE, V20; Cassol H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193001; de Rivera JLG., 2012, LSB 50 LISTADO SINTO; Dechesne M, 2003, J PERS SOC PSYCHOL, V84, P722, DOI 10.1037/0022-3514.84.4.722; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Fairchild KM, 1993, VIRT REAL ANN INT S; FLORIAN V, 1983, J PERS SOC PSYCHOL, V44, P600, DOI 10.1037/0022-3514.44.3.600; Florian V, 1998, J PERS SOC PSYCHOL, V74, P725, DOI 10.1037/0022-3514.74.3.725; Gillian N, 2014, J MACH LEARN RES, V15, P3483; GREENBERG J, 1992, J PERS SOC PSYCHOL, V63, P212, DOI 10.1037/0022-3514.63.2.212; Greenberg J, 1997, ADV EXP SOC PSYCHOL, V29, P61, DOI 10.1016/S0065-2601(08)60016-7; GREENBERG J, 1994, J PERS SOC PSYCHOL, V67, P627, DOI 10.1037/0022-3514.67.4.627; GREENBERG J, 1990, J PERS SOC PSYCHOL, V58, P308, DOI 10.1037/0022-3514.58.2.308; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; GREYSON B, 1992, PSYCHIATRY, V55, P95; Greyson B., 2004, J NEAR DEATH STUD, V23, P41; Harmon-Jones E, 1997, J PERS SOC PSYCHOL, V72, P24, DOI 10.1037/0022-3514.72.1.24; Hasler BS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174965; Huddy L, 2007, AM J POLIT SCI, V51, P63, DOI 10.1111/j.1540-5907.2007.00237.x; Klemenc-Ketis Z, 2013, INT J BEHAV MED, V20, P7, DOI 10.1007/s12529-011-9209-y; Kokkinara E, 2014, PERCEPTION, V43, P43, DOI 10.1068/p7545; Lester D, 2003, DEATH STUD, V27, P81, DOI 10.1080/07481180302873; Madary M, 2016, FRONT ROBOT AI, V3, DOI 10.3389/frobt.2016.00003; Martin-Albo J, 2007, SPAN J PSYCHOL, V10, P458, DOI 10.1017/S1138741600006727; Meister L, 2015, TRENDS COGN SCI, V19, P6, DOI 10.1016/j.tics.2014.11.001; Moody R. A, 2001, LIFE LIFE 25 ANNIVER; Pan X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146837; Parnia S, 2007, RESUSCITATION, V74, P215, DOI 10.1016/j.resuscitation.2007.01.020; Parnia S, 2001, RESUSCITATION, V48, P149, DOI 10.1016/S0300-9572(00)00328-2; Paul LA, 2015, PHILOS PHENOMEN RES, V91, P760, DOI 10.1111/phpr.12249; Paul L. A., 2014, TRANSFORMATIVE EXPER, DOI DOI 10.1093/ACPROF:OSO/9780198717959.001.0001; Peck TC, 2013, CONSCIOUS COGN, V22, P779, DOI 10.1016/j.concog.2013.04.016; Persinger MA, 2010, NEUROQUANTOLOGY, V8; Petkova VI, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00035; Pettigrew TF, 1998, ANNU REV PSYCHOL, V49, P65, DOI 10.1146/annurev.psych.49.1.65; Pettigrew TF, 2006, J PERS SOC PSYCHOL, V90, P751, DOI 10.1037/0022-3514.90.5.751; Rosenberg M, 1989, SOC ADOLESCENT SELF; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; ROSENBLATT A, 1989, J PERS SOC PSYCHOL, V57, P681, DOI 10.1037/0022-3514.57.4.681; Royse D, 2018, OMEGA-J DEATH DYING; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Sandin B, 1999, PSICOTHEMA, V11, P37; Sandin B., 2008, ESTRES PSICOSOCIAL C, P275; Schmeichel BJ, 2009, J PERS SOC PSYCHOL, V96, P1077, DOI 10.1037/a0015091; Seinfeld S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19987-7; Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381; Skarbez R, 2017, IEEE T VIS COMPUT GR, V23, P1322, DOI 10.1109/TVCG.2017.2657158; Slater M, 2000, PRESENCE-TELEOP VIRT, V9, P413, DOI 10.1162/105474600566925; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010564; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Tomas-Sabado J, 2007, DEATH STUD, V31, P249, DOI 10.1080/07481180601152625; van der Hoort B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020195; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	73	15	15	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0203358	10.1371/journal.pone.0203358	http://dx.doi.org/10.1371/journal.pone.0203358			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395568	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400005
J	Hacisalihoglu, G; Kantanka, S; Miller, N; Gustin, JL; Settles, AM				Hacisalihoglu, Gokhan; Kantanka, Sarfo; Miller, Nathan; Gustin, Jeffery L.; Settles, A. Mark			Modulation of early maize seedling performance via priming under sub-optimal temperatures	PLOS ONE			English	Article							MEAN GERMINATION TIME; ZEA-MAYS-L; SPRING MAIZE; SWEET CORN; ENHANCES GERMINATION; GROWTH; EMERGENCE; SEEDS; STRESS; VIGOR	Seeds planted in early spring frequently experience low temperature stress in the soil during germination and early plant growth. Seed pretreatments such as priming have been shown to ameliorate the negative effects of cold soil in some crops. However, the potential beneficial effects of priming have not been widely investigated for Zea mays (maize). To investigate seed priming effects, 24 diverse maize inbred lines were primed using a synthetic solid matrix, Micro-Cel E, and then exposed to 10 degrees C soil conditions. Six DSLR cameras captured time lapsed images of emerging seedlings. Manual scoring was used to determine treatment effects on three seedling emergence metrics. Chilling substantially reduced total emergence for two of 24 genotypes evaluated. For these genotypes, priming provided protection allowing nearly full emergence. Priming significantly reduced mean emergence time and increased the emergence uniformity of chilling sensitive genotypes. The results suggest that the cold sensitive genotypes may benefit from priming pretreatment. Kernel density, weight, oil, protein, and starch traits, as determined by single-kernel near infrared spectroscopy, were not correlated with seedling emergence traits supporting a conclusion that early seedling performance cannot be determined from these maize kernel characteristics.	[Hacisalihoglu, Gokhan; Kantanka, Sarfo] Florida A&M Univ, Dept Biol Sci, Tallahassee, FL USA; [Miller, Nathan] Univ Wisconsin, Dept Bot, Madison, WI USA; [Gustin, Jeffery L.; Settles, A. Mark] Univ Florida, Hort Sci Dept, Gainesville, FL 32611 USA	State University System of Florida; Florida A&M University; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida	Settles, AM (corresponding author), Univ Florida, Hort Sci Dept, Gainesville, FL 32611 USA.	settles@ufl.edu		Hacisalihoglu, Gokhan/0000-0001-9608-9668	National Science Foundation [1444456]	National Science Foundation(National Science Foundation (NSF))	This research was funded by the National Science Foundation award 1444456 to A.M.S.	Afzal I, 2008, SEED SCI TECHNOL, V36, P497, DOI 10.15258/sst.2008.36.2.26; Afzal I, 2015, SEED SCI TECHNOL, V43, P238, DOI 10.15258/sst.2015.43.2.02; Afzal I, 2012, SEED SCI TECHNOL, V40, P271, DOI 10.15258/sst.2012.40.2.13; Azanza F, 1996, EUPHYTICA, V87, P7, DOI 10.1007/BF00022959; Bakhtavar MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124441; BRADFORD KJ, 1986, HORTSCIENCE, V21, P1105; Chen K, 2010, SEED SCI TECHNOL, V38, P36, DOI 10.15258/sst.2010.38.1.04; COHN MA, 1978, AM J BOT, V65, P50, DOI 10.2307/2442553; Fox J., 2019, R COMPANION APPL REG, V.; Frascaroli E, 2013, THEOR APPL GENET, V126, P733, DOI 10.1007/s00122-012-2014-4; GRAVEN LM, 1990, J PROD AGRIC, V3, P445, DOI 10.2134/jpa1990.0445; Greaves JA, 1996, J EXP BOT, V47, P307, DOI 10.1093/jxb/47.3.307; Guan YJ, 2009, J ZHEJIANG UNIV-SC B, V10, P427, DOI 10.1631/jzus.B0820373; Gustin JL, 2013, J AGR FOOD CHEM, V61, P10872, DOI 10.1021/jf403790v; Hacisalihoglu G, 2010, SEED SCI TECHNOL, V38, P214, DOI 10.15258/sst.2010.38.1.21; Hacisalihoglu G, 2008, ACTA AGR SCAND B-S P, V58, P280, DOI 10.1080/09064710701706218; Hacisalihoglu G, 2007, HORTTECHNOLOGY, V17, P480, DOI 10.21273/HORTTECH.17.4.480; Hotchkiss JR, 1997, HORTSCIENCE, V32, P719, DOI 10.21273/HORTSCI.32.4.719; Hu GQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42082; Imran M, 2013, EUR J AGRON, V49, P141, DOI 10.1016/j.eja.2013.04.001; Imran S, 2013, INT J AGRIC BIOL, V15, P1251; Khan AS, 2010, PROFES 10, P131; Leipner Joerg, 2009, P291, DOI 10.1007/978-0-387-79418-1_15; Li Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01153; Matthews S, 2006, SEED SCI TECHNOL, V34, P339, DOI 10.15258/sst.2006.34.2.09; Pallaoro DS, 2016, J SEED SCI, V38, P148, DOI 10.1590/2317-1545v38n2161132; PARERA CA, 1992, J AM SOC HORTIC SCI, V117, P400, DOI 10.21273/JASHS.117.3.400; Pommel B, 2002, EUR J AGRON, V16, P263, DOI 10.1016/S1161-0301(01)00130-7; R Core, 2017, R LANG ENV STAT COMP; Rehman HU, 2015, J INTEGR AGR, V14, P1745, DOI 10.1016/S2095-3119(14)61000-5; Spielbauer G, 2009, CEREAL CHEM, V86, P556, DOI 10.1094/CCHEM-86-5-0556; Taylor AG, 1998, SEED SCI RES, V8, P245, DOI 10.1017/S0960258500004141; Trimble L, 2016, CROP SCI, V56, P1927, DOI 10.2135/cropsci2015.02.0117; Verheul MJ, 1996, EUR J AGRON, V5, P31, DOI 10.1016/S1161-0301(96)02007-2; Wang T, 2011, SEED SCI TECHNOL, V39, P318, DOI 10.15258/sst.2011.39.2.05; Yadav PV, 2012, J CROP IMPROV, V26, P140, DOI 10.1080/15427528.2011.618330; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245	37	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206861	10.1371/journal.pone.0206861	http://dx.doi.org/10.1371/journal.pone.0206861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395595	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400061
J	Kuwabara, J; Kuwahara, K; Kuwabara, Y; Yasuno, S; Nakagawa, Y; Ueshima, K; Kimura, T				Kuwabara, Junko; Kuwahara, Koichiro; Kuwabara, Yoshihiro; Yasuno, Shinji; Nakagawa, Yasuaki; Ueshima, Kenji; Kimura, Takeshi			Cross-sectional study of the association between day-to-day home blood pressure variability and visceral fat area measured using the dual impedance method	PLOS ONE			English	Article							BY-DAY VARIABILITY; HEART-RATE; CARDIOVASCULAR RISK; STROKE RISK; FINN-HOME; JAPANESE; OHASAMA; HYPERTENSION; METAANALYSIS; POPULATION	Background The blood pressure (BP) variability (BPV) is a predictor of cardiovascular disease, independently of the BP itself. In addition, visceral fat accumulation can trigger atherosclerotic disease through various mechanisms. Methods and results We examined the association between fat accumulation and day-to-day BPV in 61 adult hypertensive patients. Visceral fat area (VFA) was measured using the dual bioelectrical impedance analysis method. Participants were divided into three groups based on VFA. The standard deviation (SD) in home systolic BP (SBP) for 7 consecutive days was significantly lower in the high VFA tertile (low VFA, 8.40 +/- 4.15 mmHg; intermediate VFA, 8.47 +/- 2.80 mmHg; and high VFA, 5.84 +/- 2.37 mmHg, p of One-way ANOVA = 0.017, p for trend = 0.0126). A similar association was observed between the coefficient of variance (CV) of home SBP and the VFA tertile. Multiple-regression analysis adjusted for age, sex, antihypertensive drug, diabetes, habitual drinking, and SBP level also showed a significant association between the VFA tertile and the SD or CV of home SBP. The adjusted coefficient of regression for the SD of home SBP was -3.28 (95%CI: -5.60 to -0.97, p = 0.008) and the CV of home SBP was -2.51 (95%CI: -4.31 to -0.71, p = 0.008) for the highest VFA tertile as compared to the lowest VFA tertile. Conclusions These results show for the first time negative correlation between VFA and day-to-day BPV. The degree of obesity should be taken into account when evaluating the value of BPV.	[Kuwabara, Junko; Nakagawa, Yasuaki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan; [Kuwahara, Koichiro] Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan; [Kuwabara, Yoshihiro; Ueshima, Kenji] Kyoto Univ Hosp, Ctr Accessing Early Promising Treatment, Kyoto, Japan; [Yasuno, Shinji] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept EBM Res, Kyoto, Japan	Kyoto University; Shinshu University; Kyoto University; Kyoto University	Kuwahara, K (corresponding author), Shinshu Univ, Sch Med, Dept Cardiovasc Med, Matsumoto, Nagano, Japan.	kkuwah@shinshu-u.ac.jp	Kuwahara, Koichiro/AFK-1723-2022	Kuwahara, Koichiro/0000-0003-2670-7170; Kuwabara, Yoshihiro/0000-0003-4161-2970				Asayama K, 2013, HYPERTENSION, V61, P61, DOI 10.1161/HYPERTENSIONAHA.111.00138; Black HR, 1997, ARCH INTERN MED, V157, P2413; Engeli S, 2005, HYPERTENSION, V45, P356, DOI 10.1161/01.HYP.0000154361.47683.d3; Enomoto M, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00003; GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560; Hashimoto T, 2012, AM J HYPERTENS, V25, P883, DOI 10.1038/ajh.2012.62; Ida M, 2013, OBESITY, V21, pE350, DOI 10.1002/oby.20300; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Johansson JK, 2010, J HYPERTENS, V28, P1836, DOI 10.1097/HJH.0b013e32833b6c8a; Kalil GZ, 2012, HYPERTENS RES, V35, P4, DOI 10.1038/hr.2011.173; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kato T, 2010, AM J HYPERTENS, V23, P980, DOI 10.1038/ajh.2010.94; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Matsui Y, 2012, HYPERTENSION, V59, P1132, DOI 10.1161/HYPERTENSIONAHA.111.189217; Muntner P, 2014, J CLIN HYPERTENS, V16, P323, DOI 10.1111/jch.12290; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Ohkubo T, 2004, J HYPERTENS, V22, P1099, DOI 10.1097/00004872-200406000-00009; Oikawa T, 2006, J HYPERTENS, V24, P1737, DOI 10.1097/01.hjh.0000242397.53214.27; Parati G, 2012, CURR HYPERTENS REP, V14, P421, DOI 10.1007/s11906-012-0290-7; Park KS, 2016, J DIABETES COMPLICAT, V30, P343, DOI 10.1016/j.jdiacomp.2015.10.014; Sakamaki K, 2016, INTERNAL MED, V55, P1691, DOI 10.2169/internalmedicine.55.6088; Shimamoto K, 2014, HYPERTENS RES, V37, P256, DOI [10.1038/hr.2014.20, 10.1038/hr.2014.18]; Sone H, 2003, LANCET, V361, P85, DOI 10.1016/S0140-6736(03)12151-4; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; Ushigome E, 2013, J DIABETES INVEST, V4, P399, DOI 10.1111/jdi.12052; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Yagi S, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-27; Yamakage H, 2014, ENDOCR J, V61, P807, DOI 10.1507/endocrj.EJ14-0092; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263	30	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206945	10.1371/journal.pone.0206945	http://dx.doi.org/10.1371/journal.pone.0206945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395594	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400070
J	Ouyang, JQ; Tian, YJ; Jiang, CX; Yang, QF; Wang, HJ; Li, Q				Ouyang, Jingqi; Tian, Yajing; Jiang, Chunxian; Yang, Qunfang; Wang, Haijian; Li, Qing			Laboratory assays on the effects of a novel acaricide, SYP-9625 on Tetranychus cinnabarinus (Boisduval) and its natural enemy, Neoseiulus californicus (McGregor)	PLOS ONE			English	Article								Objective Tetranychus cinnabarinus (Boisduval) is an agricultural mite pest threatens crops throughout the world, causing serious economic loses. Exploring the effects of acaricides on predatory mites is crucial for the combination of biological and chemical control of T. cinnabarinus. Neoseiulus californicus (McGregor) is one of the principal natural enemies of T. cinnabarinus, which can be applied in protected agriculture. In this study, the effects of sublethal concentrations of a new acaricide, SYP-9625 on two mite species, and the effects of the application concentration on predatory mite, N. californicus were assessed. The aim of the present study was to evaluate the effect of SYP-9625 on life parameters and predation capacity of N. californicus based on the concentration-response bioassay of T. cinnabarinus to explor the application of the new acaricide with natural enemy N. californicus. Method All of the experiments were conducted under laboratory conditions [25 +/- 1 degrees C, 16: 8 h (L: D) and 75 +/- 5% RH]. The sublethal concentrations LC10 (0.375 mu g/mL) and the LC30 (0.841 mu g/mL) against T. cinnabarinus and the application concentration (100 mu g/mL) against N. californicus were used to evaluate the effects of SYP-9625 on population parameters of N. californicus based on an age-stage, two-sex life table and its predation capacity by functional response. Result cinnabarinus females treated with LC30 exhibited significantly reduced net reproductive rates (R-0 = 11.02) in their offspring compared with females treated with LC10 (R-0 = 14.96) and untreated females (R-0 = 32.74). However, the intrinsic rate of increase (r(m)) and the finite rate of increase (lambda) of N. californicus indicated that the application concentration of SYP-9625 had no significant negative effect on N. californicus eggs (r(m) = 0.277, lambda = 1.319) compared to the control (r(m) = 0.292, lambda = 1.338). Additionally, most population parameters of N. californicus showed a dose-dependent manner with the increase of the concentration of SYP-9625 against T. cinnabarinus. SYP-9625 also stimulated the control efficiency of N. californicus against immobile stages including eggs and larvae. Conclusion This study demonstrated that sublethal concentrations of SYP-9625 can inhibit the population growth of T. cinnabarinus. In addition, the sublethal concentrations and the application concentration showed no effect on the population growth of N. californicus. These two advantages described above showed great commercial potential of this new acaricide based on population parameters of the two mite species and predation capacity of the predatory mite under laboratory conditions.	[Ouyang, Jingqi; Tian, Yajing; Jiang, Chunxian; Yang, Qunfang; Wang, Haijian; Li, Qing] Sichuan Agr Univ, Coll Agron, Dept Plant Protect, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University	Li, Q (corresponding author), Sichuan Agr Univ, Coll Agron, Dept Plant Protect, Chengdu, Sichuan, Peoples R China.	liq8633@163.com			Sichuan innovation team	Sichuan innovation team	Our work was supported by the modern agricultural industry technology http://www.scnycxtd.com/of Sichuan innovation team. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinejad M, 2014, EXP APPL ACAROL, V64, P361, DOI 10.1007/s10493-014-9830-y; Amano Hiroshi, 2004, Journal of the Acarological Society of Japan, V13, P65, DOI 10.2300/acari.13.65; [Anonymous], 1959, CAN ENTOMOL, V7, P385; Bostanian NJ, 2006, PEST MANAG SCI, V62, P334, DOI 10.1002/ps.1171; Canlas LJ, 2006, SYSTEMATIC APPL ACAR, V2, P167; CHI H, 1988, ENVIRON ENTOMOL, V17, P26, DOI 10.1093/ee/17.1.26; CHI H, 1990, J ECON ENTOMOL, V83, P1143, DOI 10.1093/jee/83.4.1143; Chi H., 2012, TWOSEX MSCHART COMPU; Chi H, 1985, 2 NEW METHODS STUDY; Claver MA, 2003, J APPL ENTOMOL, V127, P18, DOI 10.1046/j.1439-0418.2003.00654.x; Cloyd RA, 2006, HORTSCIENCE, V41, P707, DOI 10.21273/HORTSCI.41.3.707; Dejan M, ACARICIDES BIOL PROF, P39; Duso C, 2008, BIOL CONTROL, V47, P16, DOI 10.1016/j.biocontrol.2008.06.011; Elzen GW, 2001, J ECON ENTOMOL, V94, P55, DOI 10.1603/0022-0493-94.1.55; Fraulo AB, 2007, EXP APPL ACAROL, V43, P109, DOI 10.1007/s10493-007-9109-7; Ghaderi S, 2013, ENTOMOL GEN, V34, P225; [宫亚军 Gong Yajun], 2013, [农药, Agrochemicals], V52, P225; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Hamedi N, 2011, EXP APPL ACAROL, V53, P29, DOI 10.1007/s10493-010-9382-8; Holling C. S., 1965, Mem ent Soc Canada Ottawa, Vno. 45, P1; Huang YB, 2013, J APPL ENTOMOL, V137, P327, DOI 10.1111/jen.12002; JULIANO SA, 1985, EVOLUTION, V39, P212, DOI 10.1111/j.1558-5646.1985.tb04096.x; Korenko S, 2016, BIOCONTROL, V5, P1; Li DX, 2006, J APPL ENTOMOL, V130, P314, DOI 10.1111/j.1439-0418.2006.01056.x; Li DX, 2007, BIOCONTROL, V52, P41, DOI 10.1007/s10526-006-9015-7; Li Qing, 2014, Acta Phytophylacica Sinica, V41, P257; Lopez L, 2015, J ECON ENTOMOL, V108, P1047, DOI 10.1093/jee/tov033; Marafeli PP, 2014, BRAZ J BIOL, V74, P691, DOI 10.1590/bjb.2014.0079; Marcic D, 2007, EXP APPL ACAROL, V42, P121, DOI 10.1007/s10493-007-9082-1; Martinou AF, 2014, CHEMOSPHERE, V96, P167, DOI 10.1016/j.chemosphere.2013.10.024; Martinou AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144413; Mollaloo MG, 2017, SUBLETHAL EFFECTS PY, V1, P1; Musa A, 2017, EXP APPL ACAROL, V71, P211, DOI 10.1007/s10493-017-0118-x; Ochiai N, 2007, EXP APPL ACAROL, V43, P181, DOI 10.1007/s10493-007-9115-9; Park JJ, 2011, EXP APPL ACAROL, V54, P243, DOI 10.1007/s10493-011-9435-7; Pekar S, 2012, PEST MANAG SCI, V68, P1438, DOI 10.1002/ps.3397; Poletti M, 2007, BIOL CONTROL, V40, P30, DOI 10.1016/j.biocontrol.2006.09.001; Rashidi F, 2018, J EC ENTOMOLOGY; tutan O, 2014, TURKISH J AGR FOREST, V1, P19; Walzer A, 1999, BIOCONTROL, V43, P457, DOI 10.1023/A:1009980401662; Wang L, 2016, PESTICIDE BIOCH PHYS, V102; Wang S, 1971, SYSTEMATIC APPL ACAR, V4, P481; WILLIAMS FM, 1985, CAN ENTOMOL, V117, P631, DOI 10.4039/Ent117631-5; Yorulmaz-Salman S, 2014, PEST MANAG SCI, V70, P819, DOI 10.1002/ps.3623; Yu H, 2016, J AGR FOOD CHEM, V51; Zanuncio TV, 2003, CROP PROT, V22, P941, DOI 10.1016/S0261-2194(03)00094-2	46	10	11	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0199269	10.1371/journal.pone.0199269	http://dx.doi.org/10.1371/journal.pone.0199269			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395569	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400001
J	Villanueva, PJ; Martinez, A; Baca, ST; DeJesus, RE; Larragoity, M; Contreras, L; Gutierrez, DA; Varela-Ramirez, A; Aguilera, RJ				Villanueva, Pauline J.; Martinez, Alberto; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J.			Pyronaridine exerts potent cytotoxicity on human breast and hematological cancer cells through induction of apoptosis	PLOS ONE			English	Article							MEDIATED MULTIDRUG-RESISTANCE; DNA-BINDING; ANTITUMOR-ACTIVITY; DERIVATIVES; QUINACRINE; COMPLEXES; AGENTS; LINES	The potent antimalarial drug pyronaridine (PND) was tested for its potential as an anticancer drug. After exposing cancerous (17) and non-cancerous (2) cells to PND for 72 hr, PND was found to exhibit consistent and potent cytotoxic activity at low micromolar (mu M) concentrations that ranged from 1.6 mu M to 9.4 mu M. Moreover, PND exerted a significant selective cytotoxicity index (SCI) on five out of seven breast cancer cell lines tested, with favorable values of 2.5 to 4.4, as compared with the non-cancerous breast MCF-10A cell line. By using the same comparison, PND exhibited a significant SCI on three out of four leukemia/lymphoma cell lines with promising values of 3.3 to 3.5. One breast cancer and one leukemia cell line were tested further in order to determine the likely mode of action of PND. PND was found to consistently elicit phosphatidylserine externalization, mitochondrial depolarization, and DNA fragmentation, in both the triple negative MDA-MB-231 breast cancer and HL-60 leukemia cell lines. In addition, PND treatment altered cell cycle progression in both cancer cells. Subsequent DNA mobility-shift assays, UV-Visible spectroscopic titrations, and circular dichroism (CD) experiments revealed that PND intercalates with DNA. The findings presented in this study indicates that PND induces apoptosis and interfered with cell cycle progression of cancer cell lines and these results indicate that this drug has the potential as a repurposed drug for cancer therapy.	[Villanueva, Pauline J.; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J.] Univ Texas El Paso, Cytometry Screening & Imaging Core Facil, El Paso, TX 79968 USA; [Villanueva, Pauline J.; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J.] Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA; [Villanueva, Pauline J.; Baca, Sarah T.; DeJesus, Rebecca E.; Larragoity, Manuel; Contreras, Lisett; Gutierrez, Denisse A.; Varela-Ramirez, Armando; Aguilera, Renato J.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Martinez, Alberto] CUNY, Chem Dept, New York City Coll Technol, Brooklyn, NY 11210 USA	University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; University of Texas System; University of Texas El Paso; City University of New York (CUNY) System	Aguilera, RJ (corresponding author), Univ Texas El Paso, Cytometry Screening & Imaging Core Facil, El Paso, TX 79968 USA.; Aguilera, RJ (corresponding author), Univ Texas El Paso, Border Biomed Res Ctr, El Paso, TX 79968 USA.; Aguilera, RJ (corresponding author), Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA.	raguilera@utep.edu	Varela-Ramirez, Armando/ABI-4315-2020	Varela-Ramirez, Armando/0000-0002-2071-4874; Gutierrez, Denisse/0000-0001-5421-2242; Villanueva, Paulina/0000-0003-1195-2480; Aguilera, Renato/0000-0003-3765-2793; Contreras, Lisett/0000-0002-7433-8413	National Institute of General Medical Sciences-Support of Competitive Research grant [1SC3GM103713-03]; PSC-CUNY [60106-00 48]; National Institute on Minority Health and Health Disparities, a component of National Institutes of Health [5G12MD007592]; NIGMS RISE training grant [R25 GM069621-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM069621] Funding Source: NIH RePORTER	National Institute of General Medical Sciences-Support of Competitive Research grant; PSC-CUNY; National Institute on Minority Health and Health Disparities, a component of National Institutes of Health; NIGMS RISE training grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work was provided by the National Institute of General Medical Sciences-Support of Competitive Research grant 1SC3GM103713-03 to RJA, and PSC-CUNY # 60106-00 48 to AM. This work was also supported by grant 5G12MD007592 to the Border Biomedical Research Center (BBRC) at UTEP from the National Institute on Minority Health and Health Disparities, a component of National Institutes of Health. PJV, RED, and ML were supported by NIGMS RISE training grant R25 GM069621-15.	Auparakkitanon S, 2006, ANTIMICROB AGENTS CH, V50, P2197, DOI 10.1128/AAC.00119-06; BALDINI G, 1981, BIOPHYS J, V36, P465, DOI 10.1016/S0006-3495(81)84746-7; Boyer R., 2006, BIOCH LAB MODERN THE; CHAVALITSHEWINKOON P, 1993, ANTIMICROB AGENTS CH, V37, P403, DOI 10.1128/AAC.37.3.403; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Contreras L, 2018, CELL ONCOL, V41, P623, DOI 10.1007/s13402-018-0397-1; Croft SL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-270; Ehsanian R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-13; Fox K., 1977, DRUG DNA INTERACTION; Gupta S, 2009, J CELL MOL MED, V13, P1004, DOI 10.1111/j.1582-4934.2009.00697.x; Ke W, 2011, MED ONCOL, V1, P35; Kennea NL, 2005, CELL DEATH DIFFER, V12, P1439, DOI 10.1038/sj.cdd.4401641; Keyhani J, 1998, IMMUNOL LETT, V62, P81, DOI 10.1016/S0165-2478(98)00019-4; Lang XL, 2013, BIOORGAN MED CHEM, V21, P4170, DOI 10.1016/j.bmc.2013.05.008; Lema Carolina, 2011, Curr Cell Biochem, V1, P1; Martinez A, 2010, J INORG BIOCHEM, V104, P967, DOI 10.1016/j.jinorgbio.2010.05.002; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Nunes LM, 2014, AAPS J, V16, P872, DOI 10.1208/s12248-014-9617-4; Oldham ED, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-014-0072-1; Paulikova H, 2012, BIOORGAN MED CHEM, V20, P7139, DOI 10.1016/j.bmc.2012.09.068; Qi J, 2004, BIOCHEM BIOPH RES CO, V319, P1124, DOI 10.1016/j.bbrc.2004.05.099; Qi J, 2002, ACTA PHARMACOL SIN, V23, P544; Robles-Escajeda E, 2016, CELL ONCOL, V39, P265, DOI 10.1007/s13402-016-0272-x; Robles-Escajeda E, 2013, CELL BIOL TOXICOL, V29, P431, DOI 10.1007/s10565-013-9264-z; Robles-Escajeda E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073508; Salem O, 2015, J CHEM SCI, V127, P931, DOI 10.1007/s12039-015-0851-9; Santiago-Vazquez Yahaira, 2016, Clin Cancer Drugs, V3, P138; Seong CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103564; Shahabuddin MS, 2009, J PHOTOCH PHOTOBIO B, V94, P13, DOI 10.1016/j.jphotobiol.2008.09.001; Shaik N, 2009, INORG CHEM, V48, P1577, DOI 10.1021/ic801925k; Valdez B, VIOLET EXCITED NIMDA; Varela-Ramirez A, 2017, NUCLEIC ACIDS RES, V45, P6217, DOI 10.1093/nar/gkx222; Varela-Ramirez A, 2011, CELL BIOL TOXICOL, V27, P159, DOI 10.1007/s10565-010-9178-y; Wang Y, 2017, NANOMED-NANOTECHNOL, V13, P1785, DOI 10.1016/j.nano.2017.01.014; WEISBLUM B, 1972, P NATL ACAD SCI USA, V69, P629, DOI 10.1073/pnas.69.3.629	37	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206467	10.1371/journal.pone.0206467	http://dx.doi.org/10.1371/journal.pone.0206467			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395606	Green Published, gold			2022-12-26	WOS:000449291400026
J	Khalil, ISM; Tabak, AF; Abou Seif, M; Klingner, A; Sitti, M				Khalil, Islam S. M.; Tabak, Ahmet Fatih; Abou Seif, Mohamed; Klingner, Anke; Sitti, Metin			Controllable switching between planar and helical flagellar swimming of a soft robotic sperm	PLOS ONE			English	Article							PROPULSION; MICROROBOTS; MICROSWIMMERS	Sperm cells undergo a wide variety of swimming patterns by a beating flagellum to maintain high speed regardless of the rheological and physical properties of the background fluid. In this work, we develop and control a soft robotic sperm that undergoes controllable switching between swimming modes like biological sperm cells. The soft robotic sperm consists of a magnetic head and an ultra-thin flexible flagellum, and is actuated using external magnetic fields. We observe that out-of-plane wobbling of the head results in helical wave propagation along the flagellum, whereas in-plane wobbling achieves planar wave propagation. Our theoretical predictions and experimental results show the ability of the soft robotic sperm to change its swimming speed by tuning the beating frequency of its flagellum and the propulsion pattern. The average speed of the soft robotic sperm increases by factors of 2 and 1.2 in fluids with viscosity of 1 Pa.s and 5 Pa.s at relatively low actuation frequencies, respectively, when they switch between planar to helical flagellar propulsion.	[Khalil, Islam S. M.; Abou Seif, Mohamed] German Univ Cairo, Mechatron Dept, New Cairo, Egypt; [Klingner, Anke] German Univ Cairo, Phys Dept, New Cairo, Egypt; [Tabak, Ahmet Fatih; Sitti, Metin] Max Planck Inst Intelligent Syst, Phys Intelligence Dept, Stuttgart, Germany	Egyptian Knowledge Bank (EKB); German University in Cairo; Egyptian Knowledge Bank (EKB); German University in Cairo; Max Planck Society	Khalil, ISM (corresponding author), German Univ Cairo, Mechatron Dept, New Cairo, Egypt.	islam.shoukry@guc.edu.eg	Sitti, Metin/AGP-6288-2022; Tabak, Ahmet Fatih/R-9187-2018	Tabak, Ahmet Fatih/0000-0003-3311-6942; Sitti, Metin/0000-0001-8249-3854; Khalil, Islam/0000-0003-0617-088X	German University in Cairo; DAAD-BMBF; Science and Technology Development Fund in Egypt [23016]; Max Planck Society	German University in Cairo; DAAD-BMBF(Federal Ministry of Education & Research (BMBF)Deutscher Akademischer Austausch Dienst (DAAD)); Science and Technology Development Fund in Egypt(Science and Technology Development Fund (STDF)); Max Planck Society(Max Planck Society)	This study was funded by the German University in Cairo and the DAAD-BMBF funding project. The authors also acknowledge the funding from the Science and Technology Development Fund in Egypt (No. 23016). A.F.T. and M.S. were supported by the Max Planck Society.	Abbott JJ, 2009, INT J ROBOT RES, V28, P1434, DOI 10.1177/0278364909341658; Alouges F, 2015, SOFT ROBOT, V2, P117, DOI 10.1089/soro.2015.0007; Bell DJ, 2007, IEEE INT CONF ROBOT, P1128, DOI 10.1109/ROBOT.2007.363136; BRENNEN C, 1977, ANNU REV FLUID MECH, V9, P339, DOI 10.1146/annurev.fl.09.010177.002011; Cicconofri G, 2016, EUR PHYS J E, V39, DOI 10.1140/epje/i2016-16072-y; Diller E, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4874306; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Ghosh A, 2009, NANO LETT, V9, P2243, DOI 10.1021/nl900186w; GRAY J, 1955, J EXP BIOL, V32, P802; Hamed Y, 2018, P IEEE INT C BIOM RO, P61; Huang HW, 2017, IEEE ROBOT AUTOM LET, V2, P727, DOI 10.1109/LRA.2017.2651167; Huang HW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12263; KANEKO T, 1975, J PHYS D APPL PHYS, V8, P1927, DOI 10.1088/0022-3727/8/16/003; Kantsler V, 2014, ELIFE, V3, DOI 10.7554/eLife.02403; Khalil ISM, 2018, ADV SCI, V5, DOI 10.1002/advs.201700461; Khalil ISM, 2017, IEEE INT C INT ROBOT, P1907; Khalil ISM, 2017, IEEE ROBOT AUTOM LET, V2, P927, DOI 10.1109/LRA.2017.2654546; Khalil ISM, 2016, APPL PHYS LETT, V109, DOI 10.1063/1.4958737; Khalil ISM, 2014, IEEE INT C INT ROBOT, P4686, DOI 10.1109/IROS.2014.6943228; Li GJ, 2015, J FLUID MECH, V784, DOI 10.1017/jfm.2015.595; Lum GZ, 2016, P NATL ACAD SCI USA, V113, pE6007, DOI 10.1073/pnas.1608193113; Maier AM, 2016, NANO LETT, V16, P906, DOI 10.1021/acs.nanolett.5b03716; Medina-Sanchez M, 2016, NANO LETT, V16, P555, DOI 10.1021/acs.nanolett.5b04221; Nelson BJ, 2010, ANNU REV BIOMED ENG, V12, P55, DOI 10.1146/annurev-bioeng-010510-103409; Pak OS, 2011, SOFT MATTER, V7, P8169, DOI 10.1039/c1sm05503h; Palagi S, 2016, NAT MATER, V15, P647, DOI [10.1038/NMAT4569, 10.1038/nmat4569]; Peyer KE, 2013, NANOSCALE, V5, P1259, DOI 10.1039/c2nr32554c; Servant A, 2015, ADV MATER, V27, P2981, DOI 10.1002/adma.201404444; Sitti M., 2017, MOBILE MICROROBOTICS; Sitti M, 2015, P IEEE, V103, P205, DOI 10.1109/JPROC.2014.2385105; Thomson WT, 1981, THEORY OF VIBRATION; Wang J, 2012, ACS NANO, V6, P5745, DOI 10.1021/nn3028997; Williams B. J., 2014, NAT COMMUN, V5, P1, DOI DOI 10.1038/NC0MMS4081; Woolley DM, 2001, J EXP BIOL, V204, P1333; Ye Z, 2014, IEEE T ROBOT, V30, P3, DOI 10.1109/TRO.2013.2280058; Yu TS, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2349585; Zhang L, 2014, APPL PHYS LETT, V94	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206456	10.1371/journal.pone.0206456	http://dx.doi.org/10.1371/journal.pone.0206456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388132	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800033
J	Liu, Y; Zupan, NJ; Shiyanbola, OO; Swearingen, R; Carlson, JN; Jacobson, NA; Mahoney, JE; Klein, R; Bjelland, TD; Smith, MA				Liu, Yao; Zupan, Nicholas J.; Shiyanbola, Olayinka O.; Swearingen, Rebecca; Carlson, Julia N.; Jacobson, Nora A.; Mahoney, Jane E.; Klein, Ronald; Bjelland, Timothy D.; Smith, Maureen A.			Factors influencing patient adherence with diabetic eye screening in rural communities: A qualitative study	PLOS ONE			English	Article							IMPROVING PRIMARY-CARE; PERCEIVED BARRIERS; RETINOPATHY; ACCESS; TELEOPHTHALMOLOGY; DISPARITIES	Objective Diabetic retinopathy remains the leading cause of blindness among working-age U.S. adults largely due to low screening rates. Rural populations face particularly greater challenges to screening because they are older, poorer, less insured, and less likely to receive guideline-concordant care than those in urban areas. Current patient education efforts may not fully address multiple barriers to screening faced by rural patients. We sought to characterize contextual factors affecting rural patient adherence with diabetic eye screening guidelines. Research design and methods We conducted semi-structured interviews with 29 participants (20 adult patients with type 2 diabetes and 9 primary care providers) in a rural, multi-payer health system. Both inductive and directed content analysis were performed. Results Factors influencing rural patient adherence with diabetic eye screening were categorized as environmental, social, and individual using the Ecological Model of Health. Major themes included limited access to and infrequent use of healthcare, long travel distances to obtain care, poverty and financial tradeoffs, trusting relationships with healthcare providers, family members' struggles with diabetes, anxiety about diabetes complications, and the burden of diabetes management. Conclusions Significant barriers exist for rural patients that affect their ability to adhere with yearly diabetic eye screening. Many studies emphasize patient education to increase adherence, but current patient education strategies fail to address major environmental, social, and individual barriers. Addressing these factors, leveraging patient trust in their healthcare providers, and strategies targeted specifically to environmental barriers such as long travel distances (e.g. teleophthalmology) may fill crucial gaps in diabetic eye screening in rural communities.	[Liu, Yao; Zupan, Nicholas J.; Swearingen, Rebecca; Carlson, Julia N.; Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA; [Liu, Yao; Swearingen, Rebecca; Smith, Maureen A.] Univ Wisconsin, Hlth Innovat Program, Sch Med & Publ Hlth, Madison, WI 53726 USA; [Shiyanbola, Olayinka O.] Univ Wisconsin, Sch Pharm, Dept Social & Adm Sci, 425 N Charter St, Madison, WI 53706 USA; [Jacobson, Nora A.] Univ Wisconsin, Sch Med & Publ Hlth, Inst Clin & Translat Res, Madison, WI USA; [Mahoney, Jane E.] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA; [Bjelland, Timothy D.] Mile Bluff Med Ctr, Mauston, WI USA; [Smith, Maureen A.] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI USA; [Smith, Maureen A.] Univ Wisconsin, Dept Family Med & Community Hlth, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Liu, Y (corresponding author), Univ Wisconsin, Dept Ophthalmol & Visual Sci, Sch Med & Publ Hlth, Madison, WI 53726 USA.; Liu, Y (corresponding author), Univ Wisconsin, Hlth Innovat Program, Sch Med & Publ Hlth, Madison, WI 53726 USA.	liu463@wisc.edu		LIU, YAO/0000-0002-0700-0148; Shiyanbola, Olayinka/0000-0002-6018-2104; Carlson, Julia/0000-0002-5187-2744	National Eye Institute [K23 EY026518]; Wisconsin Partnership Program New Investigator Award; National Center for Advancing Translational Sciences [UL1TR000427]; Research to Prevent Blindness, Inc.; University of Wisconsin (UW) School of Medicine and Public Health; University of Wisconsin Health Innovation Program; Institute for Clinical and Translational Research, University of Wisconsin, Madison (US); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K23EY026518] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wisconsin Partnership Program New Investigator Award; National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); University of Wisconsin (UW) School of Medicine and Public Health; University of Wisconsin Health Innovation Program; Institute for Clinical and Translational Research, University of Wisconsin, Madison (US); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute K23 EY026518 (Yao Liu) nei.nih.gov; Wisconsin Partnership Program New Investigator Award (Yao Liu) www.med.wisc.edu/wisconsin-partnership-program/; National Center for Advancing Translational Sciences UL1TR000427, ncats.nih.gov; Research to Prevent Blindness, Inc., rpbusa.org; University of Wisconsin (UW) School of Medicine and Public Health, www.med.wisc.edu; University of Wisconsin Health Innovation Program; and Institute for Clinical and Translational Research, University of Wisconsin, Madison (US). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Rezwan, 2013, W V Med J, V109, P6; [Anonymous], 2018, JUN COUNT WISC MAD; Baker RS, 2005, OPHTHAL EPIDEMIOL, V12, P1, DOI 10.1080/09286580590921330; Baker RS, 1998, OPHTHALMOLOGY, V105, P1373, DOI 10.1016/S0161-6420(98)98015-0; Basch CE, 1999, AM J PUBLIC HEALTH, V89, P1878, DOI 10.2105/AJPH.89.12.1878; Beverly EA, 2012, DIABETES CARE, V35, P1466, DOI [10.2337/dc11-2422, 10.2337/dc12-0661]; Birt L, 2016, QUAL HEALTH RES, V26, P1802, DOI 10.1177/1049732316654870; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1775, DOI 10.1001/jama.288.14.1775; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Centers for Disease Control and Prevention, 2021, NAT DIAB STAT REP; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Chin EK, 2014, TELEMED E-HEALTH, V20, P102, DOI 10.1089/tmj.2013.0042; Cummings DM, 2001, J RURAL HEALTH, V17, P25, DOI 10.1111/j.1748-0361.2001.tb00251.x; Dansky KH, 1998, J RURAL HEALTH, V14, P129, DOI 10.1111/j.1748-0361.1998.tb00614.x; Das T, 2016, INDIAN J OPHTHALMOL, V64, P84, DOI 10.4103/0301-4738.178151; Delorme C, 1998, CAN FAM PHYSICIAN, V44, P1473; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Fathy C, 2016, SEMIN OPHTHALMOL, V31, P364, DOI 10.3109/08820538.2016.1154170; Furler J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-214; George SM, 2017, AMIA ANN S P, V2016, P590; Goins RT, 2005, J RURAL HEALTH, V21, P206, DOI 10.1111/j.1748-0361.2005.tb00084.x; Goncalves MR, 2017, ANN FAM MED, V15, P383, DOI 10.1370/afm.2086; Grisolia ABD, 2017, ARQ BRAS OFTALMOL, V80, P401, DOI 10.5935/0004-2749.20170099; Hale NL, 2010, J COMMUN HEALTH, V35, P365, DOI 10.1007/s10900-010-9259-0; Hartnett ME, 2005, ARCH OPHTHALMOL-CHIC, V123, P387, DOI 10.1001/archopht.123.3.387; Hill Jacqueline, 2013, Perm J, V17, P67, DOI 10.7812/TPP/12-099; Hipwell AE, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005498; Hussey P, 2003, HEALTH POLICY, V66, P215, DOI 10.1016/S0168-8510(03)00050-2; Krishna S, 2010, J RURAL HEALTH, V26, P3, DOI 10.1111/j.1748-0361.2009.00259.x; Krumeich A, 2001, HEALTH EDUC RES, V16, P121, DOI 10.1093/her/16.2.121; Lee PP, 2003, OPHTHALMOLOGY, V110, P1952, DOI 10.1016/S0161-6420(03)00817-0; LEESE GP, 1993, BRIT MED J, V306, P187, DOI 10.1136/bmj.306.6871.187; Levin Klaus, 2013, J Diabetes Sci Technol, V7, P587; Liu Y, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0911-2; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Miller TA, 2013, DIABET METAB SYND OB, V6, P421, DOI 10.2147/DMSO.S36368; Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21; National Institutes of Health, 2015, NAT EYE I EYE DIS ST; Probst JC, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-40; Rathi S, 2017, OPHTHALMOLOGY, V124, P1729, DOI 10.1016/j.ophtha.2017.05.026; Rosati R, 2017, J HEALTH CARE POOR U, V28, P635, DOI 10.1353/hpu.2017.0064; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sheppler CR, 2014, OPHTHALMOLOGY, V121, P1212, DOI 10.1016/j.ophtha.2013.12.016; Sofaer S, 1999, HEALTH SERV RES, V34, P1101; The C Change Program, 2018, INNOVATIVE APPROACHE; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; U.S. Census Bureau, QUICKFACTS JUNEAU CO; Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038; Wiggins MN, 2013, CAN J OPHTHALMOL, V48, P265, DOI 10.1016/j.jcjo.2013.03.011; Zahnd WE, 2009, AM J HEALTH BEHAV, V33, P550; Zhang XP, 2007, AM J PREV MED, V33, P318, DOI 10.1016/j.amepre.2007.05.002; Zwarenstein M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-87	52	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206742	10.1371/journal.pone.0206742	http://dx.doi.org/10.1371/journal.pone.0206742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388172	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800055
J	Wada, Y; Matsumoto, K; Suzuki, T; Saito, T; Kanazawa, N; Tachibana, S; Iseri, K; Sugiyama, M; Iyoda, M; Shibata, T				Wada, Yukihiro; Matsumoto, Kei; Suzuki, Taihei; Saito, Tomohiro; Kanazawa, Nobuhiro; Tachibana, Shohei; Iseri, Ken; Sugiyama, Motonori; Iyoda, Masayuki; Shibata, Takanori			Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy	PLOS ONE			English	Article							IMMUNOGLOBULIN-A NEPHROPATHY; ABERRANTLY GLYCOSYLATED IGA1; STEROID PULSE THERAPY; OXFORD CLASSIFICATION; RENAL-DISEASE; RISK-FACTORS; PROGRESSION; CHILDREN; JAPAN; AUTOANTIBODIES	Introduction Galactose-deficient IgA1 (Gd-IgA1) is a critical pathogenic factor for IgA nephropathy (IgAN), but its value as a disease-specific biomarker remains controversial. We aimed to clarify the clinical significance of Gd-IgA1 in patients with IgAN. Methods We retrospectively reviewed 111 patients who were diagnosed with IgAN based on the findings of renal biopsies (RB) at Showa University Hospital since 2007. Serum Gd-IgA1 (s-Gd-IgA1) at the time of RB was compared among 111 IgAN patients, 18 Henoch-Schonlein purpura nephritis (HSPN) patients, 29 lupus nephritis (LN) patients, 28 ANCA-associated vasculitis (AAV) patients, and 13 minimal change disease (MCD) patients using ELISA with an anti-human Gd-IgA1-specific monoclonal antibody (KM55). We also immunohistochemically stained paraffin-embedded sections for mesangial Gd-IgA1 (m-Gd-IgA1) deposition using KM55. Results Although levels of s-Gd-IgA1 were comparable among IgAN and HSPN, s-Gd-IgA1 levels were significantly elevated in patients with IgAN compared with LN, AAV and MCD (IgAN vs. HSPN, LN, AAV, and MCD: 16.2 +/- 9.1 vs. 14.2 +/- 10.8, p = 0.263; 12.7 +/- 9.4, p = 0.008; 13.1 +/- 7.3, p = 0.059; and 8.2 +/- 4.8 mu g/mL, p<0.001, respectively). Mesangial-Gd-IgA1 deposition was specifically detected in IgAN or HSPN. The increase in s-Gd-IgA1 significantly correlated with m-Gd-IgA1 positivity in patients with IgAN, and s-Gd-IgA1 elevation and m-Gd-IgA1 deposition were evident in patients with histopathologically advanced IgAN. Moreover, s-Gd-IgA1 levels were significantly higher in IgAN patients with glomerular sclerosis and tubulo-interstitial lesions. Mesangial-Gd-IgA1 intensity negatively correlated with eGFR in IgAN. Multivariate analysis selected s-Gd-IgA1 elevation as a significant risk factor for a 30%-reduction in eGFR in IgAN (HR, 1.37; 95% CI, 1.02-1.89; p = 0.038). Conclusions Although IgAN and HSPN remain difficult to differentiate, s-Gd-IgA1 elevation and m-Gd-IgA1 deposition are reliable diagnostic factors that reflect IgAN severity. Serum-Gd-IgA1 could serve as a predictor of renal outcomes in IgAN. Thus, Gd-IgA1 could be significant biomarker for patients with IgAN.	[Wada, Yukihiro; Matsumoto, Kei; Suzuki, Taihei; Saito, Tomohiro; Kanazawa, Nobuhiro; Tachibana, Shohei; Iseri, Ken; Sugiyama, Motonori; Iyoda, Masayuki; Shibata, Takanori] Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan	Showa University	Wada, Y (corresponding author), Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan.	yukihiro@med.showa-u.ac.jp	Iseri, Ken/K-6376-2019; Saito, Tomohiro/AAD-6724-2021	Iseri, Ken/0000-0002-6610-2451; Wada, Yukihiro/0000-0001-5996-8735				Berthelot L, 2018, NEPHROL DIAL TRANSPL, V33, P1579, DOI 10.1093/ndt/gfx300; Berthelot L, 2015, KIDNEY INT, V88, P815, DOI 10.1038/ki.2015.158; Berthoux F, 2012, J AM SOC NEPHROL, V23, P1579, DOI 10.1681/ASN.2012010053; Camilla R, 2011, CLIN J AM SOC NEPHRO, V6, P1903, DOI 10.2215/CJN.11571210; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Coppo R, 2005, J NEPHROL, V18, P503; Coppo R, 2017, J NEPHROL, V30, P339, DOI 10.1007/s40620-016-0360-z; Coppo R, 2017, PEDIATR NEPHROL, V32, P139, DOI 10.1007/s00467-016-3469-3; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Hastings MC, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/315467; Hastings MC, 2010, CLIN J AM SOC NEPHRO, V5, P2069, DOI 10.2215/CJN.03270410; Heineke MH, 2017, AUTOIMMUN REV, V16, P1246, DOI 10.1016/j.autrev.2017.10.009; Hihara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158154; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Imai H, 2012, CLIN EXP NEPHROL, V16, P195, DOI 10.1007/s10157-011-0552-8; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Jiang MJ, 2015, INT J CLIN EXP MED, V8, P7861; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Kawamura T, 2013, J NEPHROL, V26, P350, DOI 10.5301/jn.5000151; Kim M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147394; Kiryluk K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006609; Kiryluk K, 2014, J CLIN INVEST, V124, P2325, DOI 10.1172/JCI74475; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Moldoveanu Z, 2007, KIDNEY INT, V71, P1148, DOI 10.1038/sj.ki.5002185; Murakoshi M, 2017, CLIN EXP NEPHROL, V21, P1068, DOI 10.1007/s10157-017-1408-7; Nakata J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089707; no author, 2011, Nihon Jinzo Gakkai Shi, V53, P123; Pillebout E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188718; Placzek WJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190967; Razminia M, 2004, CATHETER CARDIO INTE, V63, P419, DOI 10.1002/ccd.20217; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Sanders JT, 2017, INT J NEPHROL, V2017, DOI 10.1155/2017/8210641; Shimozato S, 2008, NEPHROL DIAL TRANSPL, V23, P1931, DOI 10.1093/ndt/gfm913; Sun Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166700; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2018, KIDNEY INT, V93, P700, DOI 10.1016/j.kint.2017.10.019; Suzuki H, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/7806438; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki K, 2003, KIDNEY INT, V63, P2286, DOI 10.1046/j.1523-1755.63.6s.2.x; Suzuki Y, 2014, CLIN EXP NEPHROL, V18, P770, DOI 10.1007/s10157-013-0921-6; Tomino Y, 2016, KIDNEY RES CLIN PRAC, V35, P197, DOI 10.1016/j.krcp.2016.09.001; Wada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111728; Wada Y, 2013, CLIN EXP NEPHROL, V17, P73, DOI 10.1007/s10157-012-0660-0; Yanagawa H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098081; Yasutake J, 2015, NEPHROL DIAL TRANSPL, V30, P1315, DOI 10.1093/ndt/gfv221; Zhao N, 2012, KIDNEY INT, V82, P790, DOI 10.1038/ki.2012.197	49	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206865	10.1371/journal.pone.0206865	http://dx.doi.org/10.1371/journal.pone.0206865			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388165	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800067
J	Walsh, TK; Joussen, N; Tian, K; McGaughran, A; Anderson, CJ; Qiu, XH; Ahn, SJ; Bird, L; Pavlidi, N; Vontas, J; Ryu, J; Rasool, A; Macedo, IB; Tay, WT; Zhang, YJ; Whitehouse, MEA; Silvie, PJ; Downes, S; Nemec, L; Heckel, DG				Walsh, Thomas K.; Joussen, Nicole; Tian, Kai; McGaughran, Angela; Anderson, Craig J.; Qiu, Xinghui; Ahn, Seung-Joon; Bird, Lisa; Pavlidi, Nena; Vontas, John; Ryu, Jaeeun; Rasool, Akhtar; Macedo, Isabella Barony; Tay, Wee Tek; Zhang, Yongjun; Whitehouse, Mary E. A.; Silvie, Pierre Jean; Downes, Sharon; Nemec, Lori; Heckel, David G.			Multiple recombination events between two cytochrome P450 loci contribute to global pyrethroid resistance in Helicoverpa armigera	PLOS ONE			English	Article							HUBNER LEPIDOPTERA; FENVALERATE RESISTANCE; METABOLIC RESISTANCE; NERVE INSENSITIVITY; HELIOTHIS-ZEA; NOCTUIDAE; POPULATIONS; EXPRESSION; ALIGNMENT; NORTH	The cotton bollworm, Helicoverpa armigera (Hubner) is one of the most serious insect pest species to evolve resistance against many insecticides from different chemical classes. This species has evolved resistance to the pyrethroid insecticides across its native range and is becoming a truly global pest after establishing in South America and having been recently recorded in North America. A chimeric cytochrome P450 gene, CYP337B3, has been identified as a resistance mechanism for resistance to fenvalerate and cypermethrin. Here we show that this resistance mechanism is common around the world with at least eight different alleles. It is present in South America and has probably introgressed into its closely related native sibling species, Helicoverpa zea. The different alleles of CYP337B3 are likely to have arisen independently in different geographic locations from selection on existing diversity. The alleles found in Brazil are those most commonly found in Asia, suggesting a potential origin for the incursion of H. armigera into the Americas.	[Walsh, Thomas K.; McGaughran, Angela; Anderson, Craig J.; Ryu, Jaeeun; Tay, Wee Tek] Commonwealth Sci & Ind Res Org, Black Mt Labs, Acton, ACT, Australia; [Joussen, Nicole; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany; [Tian, Kai; Qiu, Xinghui] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [McGaughran, Angela] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Anderson, Craig J.] Univ Stirling, Biol & Environm Sci, Stirling, Scotland; [Ahn, Seung-Joon] Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Suwon, South Korea; [Bird, Lisa] Tamworth Agr Inst, New South Wales Dept Primary Ind, Calala, NSW, Australia; [Pavlidi, Nena] Univ Crete, Dept Biol, Rethimnon, Greece; [Vontas, John] Agr Univ Athens, Lab Pesticide Sci, Athens, Greece; [Rasool, Akhtar] Natl Inst Biotechnol & Genet Engn, Insect Mol Biol Lab, Faisalabad, Pakistan; [Macedo, Isabella Barony] Univ Fed Minas Gera, Fac Farm, Belo Horizonte, MG, Brazil; [Zhang, Yongjun] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China; [Whitehouse, Mary E. A.; Downes, Sharon; Nemec, Lori] Australian Cotton Res Inst, Narrabri, NSW, Australia; [Silvie, Pierre Jean] Ctr Cooperat Int Rech Agron Dev, Agroecol & Intensificat Durable Cultures Annuelle, Montpellier, France; [Ahn, Seung-Joon] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Rasool, Akhtar] Univ Swat, Ctr Anim Sci & Fisheries, Odigram, Khyber Pakhtunk, Pakistan	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Melbourne; University of Stirling; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; NSW Department of Primary Industries; University of Crete; Agricultural University of Athens; Pakistan Institute of Engineering & Applied Science; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; CIRAD; Oregon State University	Heckel, DG (corresponding author), Max Planck Inst Chem Ecol, Dept Entomol, Jena, Germany.	heckel@ice.mpg.de	Walsh, Thomas K/C-1263-2009; Tay, Wee Tek/C-1818-2008; McGaughran, Angela/C-5916-2014; Heckel, David G/K-2138-2013; Vontas, John/X-5112-2018; Tay, Wee Tek/GPF-6142-2022; Downes, Sharon Joy/C-1770-2008; Anderson, Craig/K-2050-2013	Walsh, Thomas K/0000-0001-8425-0135; Tay, Wee Tek/0000-0002-8451-0811; McGaughran, Angela/0000-0002-3429-8699; Heckel, David G/0000-0001-8991-2150; Vontas, John/0000-0002-8704-2574; Tay, Wee Tek/0000-0002-8451-0811; Downes, Sharon Joy/0000-0002-3729-1732; Ahn, Seung-Joon/0000-0002-5980-106X; Whitehouse, Mary/0000-0001-9911-8356; Anderson, Craig/0000-0002-2832-9313	Commonwealth Science and Industry Research Organisation, Land and Water, Health and Biosecurity, Agriculture; Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft DFG, Germany [JO 855/1-1]	Commonwealth Science and Industry Research Organisation, Land and Water, Health and Biosecurity, Agriculture; Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft DFG, Germany(German Research Foundation (DFG))	Financial support in Australia (to TKW) was provided by the Commonwealth Science and Industry Research Organisation, Land and Water, Health and Biosecurity, Agriculture. In Germany financial support (to DGH) was provided by the Max-Planck-Gesellschaft. NJ was supported by a grant from the Deutsche Forschungsgemeinschaft DFG, Germany; JO 855/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson CJ, 2016, MOL ECOL, V25, P5296, DOI 10.1111/mec.13841; Anderson CJ, 2018, P NATL ACAD SCI USA, V115, P5034, DOI 10.1073/pnas.1718831115; [Anonymous], 2014, TRACER V1 6; Arnemann J, 2015, THESIS; Arnemann JA, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028292; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Behere GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053448; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; DALY JC, 1992, B ENTOMOL RES, V82, P5, DOI 10.1017/S0007485300051439; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Duangkaew P, 2011, ARCH INSECT BIOCHEM, V76, P236, DOI 10.1002/arch.20413; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; Feng HQ, 2005, J INSECT BEHAV, V18, P335, DOI 10.1007/s10905-005-3694-2; Feyereisen R, 2011, BBA-PROTEINS PROTEOM, V1814, P19, DOI 10.1016/j.bbapap.2010.06.012; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; FORRESTER NW, 1993, B ENTOMOL RES, pR1; Gunning RV, 1996, J ECON ENTOMOL, V89, P816, DOI 10.1093/jee/89.4.816; GUNNING RV, 1984, J ECON ENTOMOL, V77, P1283, DOI 10.1093/jee/77.5.1283; GUNNING RV, 1991, PESTIC SCI, V33, P473, DOI 10.1002/ps.2780330410; Gunning RV, 1999, PESTIC BIOCHEM PHYS, V63, P50, DOI 10.1006/pest.1998.2388; Gunning RV, 1996, PESTIC BIOCHEM PHYS, V54, P12, DOI 10.1006/pest.1996.0004; Han YC, 2015, PESTIC BIOCHEM PHYS, V121, P129, DOI 10.1016/j.pestbp.2014.12.004; HARDWICK D. F., 1965, Memoirs of the Entomology Society of Canada; Hayden J, 2015, FLORIDA DEP AGR CONS; Head DJ, 1998, INSECT MOL BIOL, V7, P191, DOI 10.1046/j.1365-2583.1998.72061.x; Heckel David G., 2010, P239; Heckel DG, 1998, PHILOS T ROY SOC B, V353, P1713, DOI 10.1098/rstb.1998.0323; Hohenlohe PA, 2010, INT J PLANT SCI, V171, P1059, DOI 10.1086/656306; Joussen N, 2012, P NATL ACAD SCI USA, V109, P15206, DOI 10.1073/pnas.1202047109; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Leite NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113286; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; McCaffery AR, 1998, PHILOS T R SOC B, V353, P1735, DOI 10.1098/rstb.1998.0326; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nadeau NJ, 2012, PHILOS T R SOC B, V367, P343, DOI 10.1098/rstb.2011.0198; Newcomb RD, 2005, J MOL EVOL, V60, P207, DOI 10.1007/s00239-004-0104-x; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Olson-Manning CF, 2012, NAT REV GENET, V13, P867, DOI 10.1038/nrg3322; PEARCE SL, 2017, BMC BIOL, V15; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Pittendrigh B, 1997, INSECT BIOCHEM MOLEC, V27, P507, DOI 10.1016/S0965-1748(97)00025-8; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Ranasinghe C, 1998, PESTIC SCI, V54, P195, DOI 10.1002/(SICI)1096-9063(1998110)54:3&lt;195::AID-PS813&gt;3.0.CO;2-8; Ranasinghe C, 1999, INSECT BIOCHEM MOLEC, V29, P145, DOI 10.1016/S0965-1748(98)00118-0; Ranasinghe C, 1999, INSECT MOL BIOL, P8, DOI DOI 10.1111/J.1365-2583.2008.00809.X; Rasool A, 2014, INSECT BIOCHEM MOLEC, V53, P54, DOI 10.1016/j.ibmb.2014.07.006; Rinkevich FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052761; Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595; Tay WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080134; Tennessen JA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-127; Wee CW, 2008, INSECT MOL BIOL, V17, P351, DOI 10.1111/j.1365-2583.2008.00809.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wood HM, 2008, MOL ECOL, V17, P3123, DOI 10.1111/j.1365-294X.2008.03755.x	62	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0197760	10.1371/journal.pone.0197760	http://dx.doi.org/10.1371/journal.pone.0197760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383872	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600001
J	Yang, H; Li, L; Hu, H; Wu, YL; Xia, H; Liu, Y; Tan, SD				Yang, Hui; Li, Lin; Hu, Hai; Wu, Yanlan; Xia, Hui; Liu, Yu; Tan, Shudong			A coastline generalization method that considers buffer consistency	PLOS ONE			English	Article							ROBUST LINE SIMPLIFICATION; GENERATION; ALGORITHMS; REMOVAL	Coastlines are the boundary between the ocean and land and are an important line feature in spatial data. Coastlines must be adapted via map generalization when they are stored in multi-scale spatial databases. This article presents a new method of coastline generalization that considers the buffer consistency from the original coastline to the generalized coastlines. This method uses the geographical distance field to identify the feature points and bends that influence the buffer consistency from the original coastline to the generalized coastline, and the process is also used to simplify the bends and maintain the concave and convex characteristics in the generalization. This method is compared to the bend-simplification method, and the results indicate that the proposed method can preserve the shape characteristics of coastlines. Moreover, the seaward buffer boundaries from the original coastline to the generalized coastline are consistent when the distance is greater than the tolerance of the coastline generalization.	[Yang, Hui; Li, Lin; Hu, Hai; Xia, Hui; Liu, Yu] Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China; [Li, Lin] Wuhan Univ, Collaborat Innovat Ctr Geospatial Technol, Wuhan, Hubei, Peoples R China; [Wu, Yanlan] Anhui Univ, Sch Resources & Environm Engn, Hefei, Anhui, Peoples R China; [Tan, Shudong] NMDIS, Tianjin, Peoples R China	Wuhan University; Wuhan University; Anhui University	Li, L (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan, Hubei, Peoples R China.; Li, L (corresponding author), Wuhan Univ, Collaborat Innovat Ctr Geospatial Technol, Wuhan, Hubei, Peoples R China.	lilin@whu.edu.cn			National Key Technology R&D Program of the Ministry of Science and Technology of China [2012BAB16B01]; National Natural Science Foundation of China [41571395, 41471328, 41271443]; Scientific and Technological Leading Talent Fund of National Administration of Surveying, Mapping and Geo-information(2014) of China	National Key Technology R&D Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Leading Talent Fund of National Administration of Surveying, Mapping and Geo-information(2014) of China	The article was supported by the National Key Technology R&D Program of the Ministry of Science and Technology of China (No. 2012BAB16B01 and url is http://program.most.gov.cn/), the National Natural Science Foundation of China (No. 41571395, No. 41471328, No. 41271443 and url is http://www.nsfc.gov.cn/), and the Scientific and Technological Leading Talent Fund of National Administration of Surveying, Mapping and Geo-information(2014) of China to Professor Lin Li (url is http://www.nasg.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai TH, 2017, INT J GEOGR INF SCI, V31, P297, DOI 10.1080/13658816.2016.1197399; Ai TH, 2014, MAR GEOD, V37, P167, DOI 10.1080/01490419.2014.903215; Bose P, 2006, J DISCRET ALGORITHMS, V4, P554, DOI 10.1016/j.jda.2005.06.008; Buchin K., 2011, P 19 ACM SIGSP INT C, P261, DOI DOI 10.1145/2093973.2094009; Christensen A. H., 1999, CARTOGR GEOGR INF SC, V26, P19, DOI DOI 10.1559/152304099782424893; Corcoran P, 2011, INT J GEOGR INF SCI, V25, P1659, DOI 10.1080/13658816.2010.545062; De Berg M., 1998, CARTOGR GEOGR INF SC, V25, P243; Douglas D.H., 1973, CARTOGRAPHICA INT J, V10, P112, DOI [10.3138/FM57-6770-U75U-7727, DOI 10.3138/FM57-6770-U75U-7727]; Ebisch K, 2002, COMPUT GEOSCI-UK, V28, P995, DOI 10.1016/S0098-3004(02)00009-2; Ferrero S, 2009, APPL GEOMAT, V1, P49, DOI 10.1007/s12518-009-0007-z; Gokgoz T, 2015, ISPRS INT GEO-INF, V4, P2185, DOI 10.3390/ijgi4042185; Gorman GJ, 2007, COMPUT GEOSCI-UK, V33, P666, DOI 10.1016/j.cageo.2006.09.007; Guilbert E, 2008, INT J GEOGR INF SCI, V22, P847, DOI 10.1080/13658810701689846; Guilbert E, 2007, MAR GEOD, V30, P169, DOI 10.1080/01490410701296697; He Z, 2016, CARTOGRAPHY, P152; Hu H, 2014, COMPUT GEOSCI-UK, V73, P81, DOI 10.1016/j.cageo.2014.08.011; Jiang B, 2013, ANN ASSOC AM GEOGR, V103, P844, DOI 10.1080/00045608.2013.765773; Lewin S, 2010, PATTERN RECOGN LETT, V31, P447, DOI 10.1016/j.patrec.2009.10.001; Li ZL, 2007, CARTOGR J, V44, P80, DOI 10.1179/000870407X173913; LI ZL, 1992, INT J GEOGR INF SYST, V6, P373, DOI 10.1080/02693799208901921; Liu PC, 2016, CARTOGR GEOGR INF SC, V43, P454, DOI 10.1080/15230406.2015.1088799; Luscher P., 2008, HEADWAY SPATIAL DATA, P449; McMaster Robert B., 1992, RESOURCE PUBLICATION, DOI PNR61; McNamara DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047207; MULLER JC, 1990, CARTOGR GEOGR INFORM, V17, P141, DOI 10.1559/152304090783813817; Pallero JLG, 2015, COMPUT GEOSCI-UK, V83, P146, DOI 10.1016/j.cageo.2015.07.011; Pallero JLG, 2013, COMPUT GEOSCI-UK, V61, P152, DOI 10.1016/j.cageo.2013.08.011; Perkal J, 1966, ATTEMPT OBJECTIVE GE; PilleWiyer W., 1966, CARTOGR J, V3, P10, DOI DOI 10.1179/CAJ.1966.3.1.10; Raposo P, 2013, CARTOGR GEOGR INF SC, V40, P427, DOI 10.1080/15230406.2013.803707; Saalfeld A., 1999, CARTOGR GEOGR INF SC, V26, P7, DOI [10.1559/152304099782424901, DOI 10.1559/152304099782424901]; Shi SZ, 2013, GISCI REMOTE SENS, V50, P473, DOI 10.1080/15481603.2013.820060; Shi WZ, 2006, CARTOGR J, V43, P27, DOI 10.1179/000870406X93490; SNYDER JP, 1984, MAP PROJECTIONS USED, P90; Song XM, 2013, SENSOR LETT, V11, P1015, DOI 10.1166/sl.2013.2895; Stum AK, 2017, T GIS, V21, P1061, DOI 10.1111/tgis.12270; Tong XH, 2015, T GIS, V19, P780, DOI 10.1111/tgis.12130; Touya G, 2010, LECT NOTES COMPUT SC, V6292, P264, DOI 10.1007/978-3-642-15300-6_19; VISVALINGAM M, 1993, CARTOGR J, V30, P46; Visvalingam M., 1990, Computer Graphics Forum, V9, P213, DOI 10.1111/j.1467-8659.1990.tb00398.x; Wang Z., 1998, CARTOGR GEOGR INFORM, V25, P3, DOI DOI 10.1559/152304098782441750; Wu ST, 2003, XVI BRAZILIAN SYMPOSIUM ON COMPUTER GRAPHICS AND IMAGE PROCESSING, PROCEEDINGS, P60, DOI 10.1109/SIBGRA.2003.1240992; YanLan Wu, 2015, 27TH INTERNATIONAL C; Yu J, 2013, INT CONF GEOINFORM; Zhang SK, 2016, J NAVIGATION, V69, P729, DOI 10.1017/S0373463315000831	45	1	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206565	10.1371/journal.pone.0206565	http://dx.doi.org/10.1371/journal.pone.0206565			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383812	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600066
J	Inglis, S; Kanczler, JM; Oreffo, ROC				Inglis, Stefanie; Kanczler, Janos M.; Oreffo, Richard O. C.			3D human bone marrow stromal and endothelial cell spheres promote bone healing in an osteogenic niche	FASEB JOURNAL			English	Article						coculture; bone drill defect; cell construct; organotypic culture; ex vivo	MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; IN-VITRO; PROGENITOR CELLS; MULTICELLULAR SPHEROIDS; CULTURE-SYSTEM; DIFFERENTIATION; ANGIOGENESIS; REGENERATION; COCULTURE	The current study used an ex vivo [embryonic day (E)18] chick femur defect model to examine the bone regenerative capacity of implanted 3-dimensional (3D) skeletal-endothelial cell constructs. Human bone marrow stromal cell (HBMSC) and HUVEC spheroids were implanted within a bone defect site to determine the osteogenic potential of the skeletal-endothelial cell unit. Cells were pelleted as co- or monocell spheroids and placed within 1-mm-drill defects in the mid-diaphysis of E18 chick femurs and cultured organotypically for 10 d. Micro-computed tomography analysis revealed significantly (P = 0.0001) increased levels of bone volume (BV) and BV/tissue volume ratio in all cell-pellet groups compared with the sham defect group. The highest increase was seen in BV in femurs containing the HUVEC and HBMSC monocell constructs. Type II collagen expression was particularly pronounced within the cell spheres containing HBMSCs and HUVECs, and CD31-positive cell clusters were prominent within HUVEC-implanted defects. These studies demonstrate the importance of the 3D osteogenic-endothelial niche interaction in bone regeneration. Elucidating the component cell interactions in the osteogenic-vascular niche and the role of exogenous factors in driving these osteogenic processes will aid the development of better bone reparative strategies.Inglis, S., Kanczler, J. M., Oreffo, R. O. C. 3D human bone marrow stromal and endothelial cell spheres promote bone healing in an osteogenic niche.	[Inglis, Stefanie; Kanczler, Janos M.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci,Southampton Gen Hosp, Southampton, Hants, England	University of Southampton	Oreffo, ROC (corresponding author), Univ Southampton, Southampton Gen Hosp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci,Univ Orthopaed, MP887,CF86,Tremona Rd,IDS Bldg, Southampton SO16 6YD, Hants, England.	roco@soton.ac.uk	; Oreffo, Richard/A-4615-2011	Kanczler, Janos/0000-0001-7249-0414; Oreffo, Richard/0000-0001-5995-6726	Biotechnology and Biological Sciences Research Council (LOLA) [BB/G010579/1]; BBSRC [BB/G010579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (LOLA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank the doctors and nurses at the Princess Anne Maternity Hospital for providing human umbilical cords, Dr. Gry Hulsart Billstrom (Department of Surgical Sciences, Uppsala University, Uppsala, Sweden) for expert advice on mu CT imaging, Dr. David Johnston of the Biomedical Imaging Unit at Southampton General Hospital for confocal imaging, and members of the Bone and Joint research group for their help. This work was supported by the Biotechnology and Biological Sciences Research Council (LOLA Grant BB/G010579/1). The authors declare no conflicts of interest.	Akiyama M, 2006, CELL TRANSPLANT, V15, P521, DOI 10.3727/000000006783981765; BRUDER SP, 1989, CONNECT TISSUE RES, V20, P65, DOI 10.3109/03008208909023875; Carano RAD, 2003, DRUG DISCOV TODAY, V8, P980, DOI 10.1016/S1359-6446(03)02866-6; Einhorn TA, 2005, J ORTHOP TRAUMA, V19, pS4, DOI 10.1097/00005131-200511101-00002; El-Serafi AT, 2011, EUR CELLS MATER, V21, P558, DOI 10.22203/eCM.v021a42; Ferrera D, 2002, BONE, V30, P718, DOI 10.1016/S8756-3282(02)00691-9; Finkenzeller G, 2009, CELL PROLIFERAT, V42, P498, DOI 10.1111/j.1365-2184.2009.00610.x; Freeman FE, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0210-2; Freeman FE, 2015, TISSUE ENG PT A, V21, P1320, DOI [10.1089/ten.TEA.2014.0249, 10.1089/ten.tea.2014.0249]; Futrega K, 2017, TISSUE ENG PART C-ME, V23, P200, DOI 10.1089/ten.tec.2016.0329; Giblin JP, 2008, BLOOD, V112, P957, DOI 10.1182/blood-2007-12-130740; Goerke SM, 2015, MICROVASC RES, V98, P40, DOI 10.1016/j.mvr.2014.12.001; Goerke SM, 2012, TISSUE ENG PT A, V18, P2395, DOI [10.1089/ten.TEA.2012.0147, 10.1089/ten.tea.2012.0147]; Gomez-Barrena E, 2011, J CELL MOL MED, V15, P1266, DOI 10.1111/j.1582-4934.2011.01265.x; Inglis S, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-015-0270-3; Jahn K, 2010, EUR CELLS MATER, V20, P149; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jeon S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07049-3; Kanczler JM, 2008, EUR CELLS MATER, V15, P100, DOI 10.22203/eCM.v015a08; Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Langen UH, 2017, NAT CELL BIOL, V19, P189, DOI 10.1038/ncb3476; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Metzger W, 2017, MAT SCI ENG C-MATER, V73, P310, DOI 10.1016/j.msec.2016.12.087; Ong LJY, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa8858; Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rao RR, 2015, TISSUE ENG PT A, V21, P530, DOI [10.1089/ten.tea.2013.0740, 10.1089/ten.TEA.2013.0740]; Rossi MID, 2005, BRAZ J MED BIOL RES, V38, P1455, DOI 10.1590/S0100-879X2005001000002; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Saleh F A, 2011, Eur Cell Mater, V22, P242; Sandell L., 1999, FRONT BIOSCI-LANDMRK, V4, P731; Sasaki JI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129266; van der Stok J, 2014, EUR CELLS MATER, V27, P137, DOI 10.22203/eCM.v027a11; Walser R, 2013, EUR CELLS MATER, V26, P222, DOI 10.22203/eCM.v026a16; Whyte JL, 2011, STEM CELL RES, V6, P238, DOI 10.1016/j.scr.2011.02.001	37	14	14	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3279	3290		10.1096/fj.201801114R	http://dx.doi.org/10.1096/fj.201801114R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30403537	Green Published, hybrid			2022-12-26	WOS:000459794800017
J	Kim, MK; Song, JY; Koh, DI; Kim, JY; Hatano, M; Jeon, BN; Kim, MY; Cho, SY; Kim, KS; Hur, MW				Kim, Min-Kyeong; Song, Ji-Yang; Koh, Dong-In; Kim, Jin Young; Hatano, Masahiko; Jeon, Bu-Nam; Kim, Min-Young; Cho, Su-Yeon; Kim, Kyung-Sup; Hur, Man-Wook			Reciprocal negative regulation between the tumor suppressor protein p53 and B cell CLL/lymphoma 6 (BCL6) via control of caspase-1 expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						p53; caspase 1 (CASP1); proteolysis; E1A binding protein p300 (P300); post-translational modification (PTM); acetylation; acetylation; BCL6; caspase-1; p300; p53; memory B cell; lymphocyte; cancer development; lymphoma	GENE; MUTATIONS; APOPTOSIS; TRANSCRIPTION; SENESCENCE; LYMPHOMA; PATHWAY; CYCLE	Even in the face of physiological DNA damage or expression of the tumor suppressor protein p53, B cell CLL/lymphoma 6 (BCL6) increases proliferation and antagonizes apoptotic responses in B cells. BCL6 represses TP53 transcription and also appears to inactivate p53 at the protein level, and additional findings have suggested negative mutual regulation between BCL6 and p53. Here, using Bcl6(-/-) knockout mice, HEK293A and HCT116 p53(-/-) cells, and site-directed mutagenesis, we found that BCL6 interacts with p53 and thereby inhibits acetylation of Lys-132 in p53 by E1A-binding protein p300 (p300), a modification that normally occurs upon DNA damage-induced cellular stress and whose abrogation by BCL6 diminished transcriptional activation of p53 target genes, including that encoding caspase-1. Conversely, we also found that BCL6 protein is degraded via p53-induced, caspase-mediated proteolytic cleavage, and the formation of a BCL6-p53-caspase-1 complex. Our results suggest that p53 may block oncogenic transformation by decreasing BCL6 stability via caspase-1 up-regulation, whereas aberrant BCL6 expression inactivates transactivation of p53 target genes, either by inhibiting p53 acetylation by p300 or repressing TP53 gene transcription. These findings have implications for B cell development and lymphomagenesis.	[Kim, Min-Kyeong; Song, Ji-Yang; Koh, Dong-In; Jeon, Bu-Nam; Kim, Min-Young; Cho, Su-Yeon; Kim, Kyung-Sup; Hur, Man-Wook] Yonsei Univ, Brain Korea 21 Plus Project Med Sci, Severance Biomed Res Inst, Dept Biochem & Mol Biol,Sch Med, 50 Yonsei Ro, Seoul 03722, South Korea; [Kim, Jin Young] Korea Basic Sci Inst, Biomed Om Grp, 162 Yoengudanji Ro, Ochang 28119, Chungbuk, South Korea; [Hatano, Masahiko] Chiba Univ, Grad Sch Med, Dept Biomed Sci, Chuo Ku, 1-8-1 Inohana, Chiba, Chiba 2600856, Japan	Yonsei University; Korea Basic Science Institute (KBSI); Chiba University	Hur, MW (corresponding author), Yonsei Univ, Sch Med, Dept Biochem & Mol Biol, 50-1 Yonsei Ro, Seoul 03722, South Korea.	mwhur2@yuhs.ac		Hur, Man-Wook/0000-0002-3416-1334; Kim, Kyung-sup/0000-0001-8483-8537	JeonRack-HooSok Grant [2016R1E1A1A02921938]; Do-Yak Research Grant [2011-0028817]; Medical Research Center Research Grant from the National Research Foundation of Korea (NRF) of the Korean Government (Ministry of Science, ICT and Future Planning (MSIP)) [2011-0030086]	JeonRack-HooSok Grant; Do-Yak Research Grant; Medical Research Center Research Grant from the National Research Foundation of Korea (NRF) of the Korean Government (Ministry of Science, ICT and Future Planning (MSIP))	This work was supported by JeonRack-HooSok Grant 2016R1E1A1A02921938 (to M.-W.H.), Do-Yak Research Grant 2011-0028817 (to M.-W.H.), and Medical Research Center Research Grant 2011-0030086 (to M.-W.H.) from the National Research Foundation of Korea (NRF) of the Korean Government (Ministry of Science, ICT and Future Planning (MSIP)). The authors declare that they have no conflicts of interest with the contents of this article.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; Basso K, 2010, ADV IMMUNOL, V105, P193, DOI 10.1016/S0065-2776(10)05007-8; Bellido M, 2002, HAEMATOLOGICA, V87, P908; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Chan WM, 2006, MOL CANCER RES, V4, P15, DOI 10.1158/1541-7786.MCR-05-0097; Ding HF, 2000, J BIOL CHEM, V275, P38905, DOI 10.1074/jbc.M004714200; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gaidano G, 1997, AM J HEMATOL, V56, P206, DOI 10.1002/(SICI)1096-8652(199712)56:4<206::AID-AJH2>3.0.CO;2-0; Gupta S, 2001, J BIOL CHEM, V276, P10585, DOI 10.1074/jbc.C100025200; Hu Wenwei, 2012, Genes Cancer, V3, P199, DOI 10.1177/1947601912454734; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Koh DI, 2014, P NATL ACAD SCI USA, V111, P15078, DOI 10.1073/pnas.1318780111; Kubbutat MHG, 1998, MOL MED TODAY, V4, P250, DOI 10.1016/S1357-4310(98)01260-X; Kusam S, 2004, ONCOGENE, V23, P839, DOI 10.1038/sj.onc.1207065; Lan Q, 2009, BLOOD, V114, P264, DOI 10.1182/blood-2009-01-198697; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lavrik IN, 2005, J CLIN INVEST, V115, P2665, DOI 10.1172/JCI26252; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; Martinez-Climent JA, 2003, BLOOD, V101, P3109, DOI 10.1182/blood-2002-07-2119; MIURA M, 1993, CELL, V75, P653, DOI 10.1016/0092-8674(93)90486-A; Nicholson DW, 1999, CELL DEATH DIFFER, V6, P1028, DOI 10.1038/sj.cdd.4400598; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Ranuncolo SM, 2008, J BIOL CHEM, V283, P22565, DOI 10.1074/jbc.M803490200; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Saito M, 2007, CANCER CELL, V12, P280, DOI 10.1016/j.ccr.2007.08.011; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Scott AM, 2007, CELL DEATH DIFFER, V14, P23, DOI 10.1038/sj.cdd.4402026; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	41	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					299	313		10.1074/jbc.RA118.004204	http://dx.doi.org/10.1074/jbc.RA118.004204			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409904	Green Published, hybrid			2022-12-26	WOS:000455105500032
J	Chen, CY; Anderson, NC; Becker, S; Schicht, M; Stoddard, C; Brauer, L; Paulsen, F; Grabel, L				Chen, Christopher Y.; Anderson, Nickesha C.; Becker, Sandy; Schicht, Martin; Stoddard, Christopher; Braeuer, Lars; Paulsen, Friedrich; Grabel, Laura			Examining the role of the surfactant family member SFTA3 in interneuron specification	PLOS ONE			English	Article							MEDIAL GANGLIONIC EMINENCE; SONIC HEDGEHOG; PROGENITORS; PROTEIN; EXPRESSION; NEURONS	The transcription factor NKX2.1, expressed at high levels in the medial ganglionic eminence (MGE), is a master regulator of cortical interneuron progenitor development. To identify gene candidates with expression profiles similar to NKX2.1, previous transcriptome analysis of human embryonic stem cell (hESC)-derived MGE-like progenitors revealed SFTA3 as the strongest candidate. Quantitative real-time PCR analysis of hESC-derived NKX2.1-positive progenitors and transcriptome data available from the Allen Institute for Brain Science revealed comparable expression patterns for NKX2.1 and SFTA3 during interneuron differentiation in vitro and demonstrated high SFTA3 expression in the human MGE. Although SFTA3 has been well studied in the lung, the possible role of this surfactant protein in the MGE during embryonic development remains unexamined. To determine if SFTA3 plays a role in MGE specification, SFTA3-/- and NKX2.1 -/- hESC lines were generated using custom designed CRISPRs. We show that NKX2.1 KOs have a significantly diminished capacity to differentiate into MGE interneuron subtypes. SFTA3 KOs also demonstrated a somewhat reduced ability to differentiate down the MGE-like lineage, although not as severe relative to NKX2.1 deficiency. These results suggest NKX2.1 and SFTA3 are co-regulated genes, and that deletion of SFTA3 does not lead to a major change in the specification of MGE derivatives.	[Chen, Christopher Y.; Anderson, Nickesha C.; Becker, Sandy; Grabel, Laura] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA; [Schicht, Martin; Braeuer, Lars; Paulsen, Friedrich] Friedrich Alexander Univ Erlangen Numberg FAU, Inst Funct & Clin Anat, Erlangen, Germany; [Stoddard, Christopher] Univ Connecticut Hlth, Genome Sci, Farmington, CT USA	Wesleyan University; University of Erlangen Nuremberg; University of Connecticut	Chen, CY (corresponding author), Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA.	cychen@wesleyan.edu		Schicht, Martin/0000-0001-5155-5477; Paulsen, Friedrich/0000-0002-0527-0953; Anderson, Nickesha Camille/0000-0003-4168-0703	Connecticut Regenerative Medicine Research Fund [13-SCC-WES-01]	Connecticut Regenerative Medicine Research Fund	This work was supported by 13-SCC-WES-01 from the Connecticut Regenerative Medicine Research Fund to L. Grabel.	Anderson SA, 2001, DEVELOPMENT, V128, P353; ANDERSON SA, 1995, NEUROSCIENCE, V67, P7, DOI 10.1016/0306-4522(95)00051-J; Banda E, 2015, STEM CELLS DEV, V24, P1022, DOI 10.1089/scd.2014.0415; Barnett CP, 2012, AM J MED GENET A, V158A, P3168, DOI 10.1002/ajmg.a.35456; Butt SJB, 2008, NEURON, V59, P722, DOI 10.1016/j.neuron.2008.07.031; Carre A, 2009, HUM MOL GENET, V18, P2266, DOI 10.1093/hmg/ddp162; Chen CY, 2016, STEM CELL REV REP, V12, P744, DOI 10.1007/s12015-016-9676-2; Diler Ebru, 2014, BMC Res Notes, V7, P851, DOI 10.1186/1756-0500-7-851; Du TG, 2008, DEVELOPMENT, V135, P1559, DOI 10.1242/dev.015123; Germain ND, 2013, STEM CELLS DEV, V22, P1477, DOI 10.1089/scd.2012.0264; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Herriges MJ, 2017, GENE DEV, V31, P889, DOI 10.1101/gad.298018.117; Herriges MJ, 2014, GENE DEV, V28, P1363, DOI 10.1101/gad.238782.114; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Machold R, 2003, NEURON, V39, P937, DOI 10.1016/S0896-6273(03)00561-0; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Rausch F, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2513-0; Schicht M, 2014, EUR RESPIR J, V44, P447, DOI 10.1183/09031936.00179813; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Sussel L, 1999, DEVELOPMENT, V126, P3359; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; Xu Q, 2005, DEVELOPMENT, V132, P4987, DOI 10.1242/dev.02090; Xu Q, 2004, J NEUROSCI, V24, P2612, DOI 10.1523/JNEUROSCI.5667-03.2004; Xu Q, 2010, NEURON, V65, P328, DOI 10.1016/j.neuron.2010.01.004	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0198703	10.1371/journal.pone.0198703	http://dx.doi.org/10.1371/journal.pone.0198703			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408033	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300001
J	Finotelli, P; Dipasquale, O; Costantini, I; Pini, A; Baglio, F; Baselli, G; Dulio, P; Cercignani, M				Finotelli, Paolo; Dipasquale, Ottavia; Costantini, Isa; Pini, Alessia; Baglio, Francesca; Baselli, Giuseppe; Dulio, Paolo; Cercignani, Mara			Exploring resting-state functional connectivity invariants across the lifespan in healthy people by means of a recently proposed graph theoretical model	PLOS ONE			English	Article							AGE-RELATED-CHANGES; YOUNG ADULTHOOD; CORTEX; NETWORK; PRECUNEUS; ATTENTION; ANATOMY; CORE	In this paper we investigate the changes in the functional connectivity intensity, and some related properties, in healthy people, across the life span and at resting state. For the explicit computation of the functional connectivity we exploit a recently proposed model, that bases not only on the correlations data provided by the acquisition equipment, but also on different parameters, such as the anatomical distances between nodes and their degrees. The leading purpose of the paper is to show that the proposed approach is able to recover the main aspects of resting state condition known from the available literature, as well as to suggest new insights, perspectives and speculations from a neurobiological point of view. Our study involves 133 subjects, both males and females of different ages, with no evidence of neurological diseases or systemic disorders. First, we show how the model applies to the sample, where the subjects are grouped into 28 different groups (14 of males and 14 of females), according to their age. This leads to the construction of two graphs (one for males and one for females), that can be realistically interpreted as representative of the neural network during the resting state. Second, following the idea that the brain network is better understood by focusing on specific nodes having a kind of centrality, we refine the two output graphs by introducing a new metric that favours the selection of nodes having higher degrees. As a third step, we extensively comment and discuss the obtained results. In particular, it is remarkable that, despite a great overlapping exists between the outcomes concerning males and females, some intriguing differences appear. This motivates a deeper local investigation, which represents the fourth part of the paper, carried out through a thorough statistical analysis. As a result, we are enabled to support that, for two special age groups, a few links contribute in differentiating the behaviour of males and females. In addition, we performed an average-based comparison between the proposed model and the traditional statistical correlation-based approach, then discussing and commenting the main outlined discrepancies.	[Finotelli, Paolo; Pini, Alessia; Dulio, Paolo] Politecn Milan, Dept Math, Milan, Italy; [Dipasquale, Ottavia; Costantini, Isa; Baglio, Francesca] Fdn Don Carlo Gnocchi, IRCCS, MRI Lab, Milan, Italy; [Baselli, Giuseppe] Politecn Milan, Dept Elect Informat & Bioengn, Milan, Italy; [Cercignani, Mara] Santa Lucia Fdn, Neuroimaging Lab, Rome, Italy; [Dipasquale, Ottavia] Kings Coll London, London, England; [Costantini, Isa] Univ Nice Sophia Antipolis, Nice, France; [Cercignani, Mara] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Falmer, England; [Pini, Alessia] Univ Cattolica Sacro Cuore, Milan, Italy	Polytechnic University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus; Polytechnic University of Milan; IRCCS Santa Lucia; University of London; King's College London; UDICE-French Research Universities; Universite Cote d'Azur; University of Brighton; University of Sussex; Catholic University of the Sacred Heart	Finotelli, P (corresponding author), Politecn Milan, Dept Math, Milan, Italy.	paolo.finotelli@polimi.it	baglio, francesca/AAX-6298-2020; Finotelli, Paolo/AGG-0659-2022; Baglio, Francesca/K-2808-2016; Pini, Alessia/F-7257-2018	baglio, francesca/0000-0002-6145-5274; Baglio, Francesca/0000-0002-6145-5274; Pini, Alessia/0000-0001-9235-3062; Cercignani, Mara/0000-0002-4550-2456	Italian Ministry of Health "Ricerca Corrente - IRCCS" Program	Italian Ministry of Health "Ricerca Corrente - IRCCS" Program	This research was supported by the financial contribution of Italian Ministry of Health "Ricerca Corrente - IRCCS" Program. Reference: fbaglio@dongnocchi.it.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Albert Neil B, 2009, Commun Integr Biol, V2, P530; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Beckmann C. F, MED IMAGING IEEE T, V23, P137; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2011, BIOL PSYCHIAT, V69, p200S; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHARTRAND G., 1977, INTRO GRAPH THEORY; Davey J. M, 2016, NEUROIMAGE, V137; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dudoit S, 2008, SPRINGER SER STAT, P1; Ferreira LK, 2016, CEREB CORTEX, V26, P3851, DOI 10.1093/cercor/bhv190; Finotelli P, 2015, ARCH ITALIENNES BIOL, V153; Finotelli P, 2016, ARCH ITALIENNES BIOL; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; Gogtay N, 2010, BRAIN COGNITION, V72, P6, DOI 10.1016/j.bandc.2009.08.009; Goldstein RZ, 2007, AM J PSYCHIAT, V164, P43, DOI 10.1176/appi.ajp.164.1.43; Greicius MD, 2009, CEREBRAL CORTEX; Greicius MD, 2003, P NATL ACAD SCI; Griffanti L, 2014, NEUROIMAGE, V95, P232, DOI 10.1016/j.neuroimage.2014.03.034; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hjelmervik H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103492; HOLM S, 1979, SCAND J STAT, V6, P65; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johnson R.A., 2002, APPL MULTIVARIATE ST, V5; Kaiser M, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.036103; Lin P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46088; Lin P, 2016, BRAIN IMAGING BEHAV, V10, P212, DOI 10.1007/s11682-015-9384-6; Lin P, 2011, CEREB CORTEX, V21, P821, DOI 10.1093/cercor/bhq151; Makris N, 2007, CEREB CORTEX, V17, P1364, DOI 10.1093/cercor/bhl047; Pesarin F., 2010, PERMUTATION TESTS CO; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2007, NEUROIMAGE, V37; Raichle ME, 2001, PNAS, V98; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Schlee W, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-16; Sheline YI, 2013, BIOL PSYCHIAT, V74, P340, DOI 10.1016/j.biopsych.2012.11.028; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2004, NEUROSCIENTIST, V10, P372, DOI 10.1177/1073858404263960; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; VANDENHEUVEL MP, 2009, HUMAN BRAIN MAPPING; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Xu JP, 2015, SCI REP-UK, V5, DOI 10.1038/srep18883; Xu X, 2015, ANAL METHODS-UK, V7, P4111, DOI 10.1039/c5ay00699f; Zhang CS, 2016, J ALTERN COMPLEM MED, V22, P174, DOI 10.1089/acm.2014.0212	52	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206567	10.1371/journal.pone.0206567	http://dx.doi.org/10.1371/journal.pone.0206567			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408067	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000449512300023
J	Mizoguchi, M; Ishida, Y; Nosaka, M; Kimura, A; Kuninaka, Y; Yahata, T; Nanjo, S; Toujima, S; Minami, S; Ino, K; Mukaida, N; Kondo, T				Mizoguchi, Mika; Ishida, Yuko; Nosaka, Mizuho; Kimura, Akihiko; Kuninaka, Yumi; Yahata, Tamaki; Nanjo, Sakiko; Toujima, Saori; Minami, Sawako; Ino, Kazuhiko; Mukaida, Naofumi; Kondo, Toshikazu			Prevention of lipopolysaccharide-induced preterm labor by the lack of CX3CL1-CX3CR1 interaction in mice	PLOS ONE			English	Article							FRACTALKINE RECEPTOR CX(3)CR1; THERAPEUTIC TARGETS; AMNIOTIC-FLUID; TERM; INFLAMMATION; EXPRESSION; CHEMOKINE; DELIVERY; BIRTH; CELLS	Preterm labor (PTL) is the most common cause of neonatal death and long-term adverse outcome. The pharmacological agents for PTL prevention are palliative and frequently fail to prevent PTL and improve neonatal outcome. It is essential to fully understand the molecular mechanisms of PTL in order to develop novel therapeutic methods against PTL. Several lines of evidence indicate some chemokines are expressed in gestational tissues during labor or PTL. To reveal the pathophysiological roles of the CX3CL1-CX3CR1 axis in PTL, we performed present study using LPS-induced PTL mice model in CX3CR1-deficient (Cx3cr1(-/-)) mice. We indicated that PTL was suppressed in Cx3cr1( -/-) mice and immunoneutralization of CX3CL1 in WT mice. From immunohistochemical and the gene expression analyses, the CX3CL1-CX3CR1 axis has detrimental roles in PTL through intrauterine recruitment of macrophages and the enhancement of macrophage-derived inflammatory mediators. Thus, the CX3CL1-CX3CR1 axis may be a good molecular target for preventing PTL.	[Mizoguchi, Mika; Ishida, Yuko; Nosaka, Mizuho; Kimura, Akihiko; Kuninaka, Yumi; Yahata, Tamaki; Kondo, Toshikazu] Wakayama Med Univ, Dept Forens Med, Wakayama, Japan; [Mizoguchi, Mika; Yahata, Tamaki; Nanjo, Sakiko; Toujima, Saori; Minami, Sawako; Ino, Kazuhiko] Wakayama Med Univ, Dept Obstet & Gynecol, Wakayama, Japan; [Mukaida, Naofumi] Kanazawa Univ, Canc Res Inst, Div Mol Bioregulat, Kanazawa, Ishikawa, Japan	Wakayama Medical University; Wakayama Medical University; Kanazawa University	Kondo, T (corresponding author), Wakayama Med Univ, Dept Forens Med, Wakayama, Japan.	kondot@wakayama-med.ac.jp	Yahata, Tamaki/O-2540-2018; Mukaida, Naofumi/D-7623-2011	Mukaida, Naofumi/0000-0002-4193-1851; Kondo, Toshikazu/0000-0002-5059-8309				American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics, 2003, Obstet Gynecol, V102, P1445; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Blanc W A, 1981, Monogr Pathol, P67; Borna S, 2007, J OBSTET GYNAECOL RE, V33, P631, DOI 10.1111/j.1447-0756.2007.00623.x; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Cook DN, 2001, MOL CELL BIOL, V21, P3159, DOI 10.1128/MCB.21.9.3159-3165.2001; Demirci EK, 2016, CELL ADHES MIGR, V10, P189, DOI 10.1080/19336918.2015.1089378; Ebert T, 2014, DIABETIC MED, V31, P1014, DOI 10.1111/dme.12451; Feng LL, 1999, KIDNEY INT, V56, P612, DOI 10.1046/j.1523-1755.1999.00604.x; Filipovich Y, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.014; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Furuichi K, 2006, AM J PATHOL, V169, P372, DOI 10.2353/ajpath.2006.060043; Gomaa MF, 2017, J MATERN-FETAL NEO M, V30, P1782, DOI 10.1080/14767058.2016.1224840; Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Hamilton S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095505; Hamilton SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056946; Haram K, 2003, ACTA OBSTET GYN SCAN, V82, P687, DOI 10.1034/j.1600-0412.2003.00218.x; Hassan SS, 2006, AM J OBSTET GYNECOL, V195, P778, DOI 10.1016/j.ajog.2006.06.021; Hirsch E, 2006, AM J OBSTET GYNECOL, V194, P1334, DOI 10.1016/j.ajog.2005.11.004; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Inui M, 2011, J IMMUNOL, V186, P423, DOI 10.4049/jimmunol.1000043; Ishida Y, 2008, J IMMUNOL, V181, P4208, DOI 10.4049/jimmunol.181.6.4208; Ishida Y, 2008, J IMMUNOL, V180, P569, DOI 10.4049/jimmunol.180.1.569; Julia V, 2012, ALLERGY, V67, P1106, DOI 10.1111/j.1398-9995.2012.02870.x; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Karjalainen MK, 2015, J IMMUNOL, V195, P2187, DOI 10.4049/jimmunol.1501174; Keelan JA, 1999, AM J OBSTET GYNECOL, V181, P1530, DOI 10.1016/S0002-9378(99)70400-X; Khanprakob T, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007748.pub2; Kobayashi A, 2015, EUR J PHARMACOL, V766, P63, DOI 10.1016/j.ejphar.2015.09.039; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S6; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Li HN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27914; Li ZY, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.470; Liu WM, 2016, ARCH IMMUNOL THER EX, V64, P371, DOI 10.1007/s00005-016-0395-9; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Mittal P, 2010, J PERINAT MED, V38, P617, DOI [10.1515/JPM.2010.097, 10.1515/jpm.2010.097]; Mohan Aarthi R, 2004, Semin Fetal Neonatal Med, V9, P437, DOI 10.1016/j.siny.2004.08.001; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Mukaida N, 2003, AM J PHYSIOL-LUNG C, V284, pL566, DOI 10.1152/ajplung.00233.2002; Murphy SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.043; Nagamatsu T, 2010, REPROD SCI, V17, P209, DOI 10.1177/1933719109349962; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Nosaka M, 2015, INT J LEGAL MED, V129, P1021, DOI 10.1007/s00414-015-1147-9; Nosaka M, 2011, J CLIN INVEST, V121, P2911, DOI 10.1172/JCI40782; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Puchner K, 2011, IN VIVO, V25, P141; Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rueda CM, 2016, J IMMUNOL, V196, P3706, DOI 10.4049/jimmunol.1502613; Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072; Shimoya K, 2003, MOL HUM REPROD, V9, P97, DOI 10.1093/molehr/gag009; Shynlova O, 2014, J CELL MOL MED, V18, P1816, DOI 10.1111/jcmm.12307; Shynlova O, 2013, REPROD SCI, V20, P154, DOI 10.1177/1933719112446084; Siwetz M, 2015, AM J PATHOL, V185, P1334, DOI 10.1016/j.ajpath.2015.01.019; Slater DM, 1999, MOL HUM REPROD, V5, P880, DOI 10.1093/molehr/5.9.880; Sykes L, 2014, REPRODUCTION, V148, pR29, DOI 10.1530/REP-13-0587; Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629; Toda A, 2016, AM J PATHOL, V186, P616, DOI 10.1016/j.ajpath.2015.11.004; Tower CL, 2014, IMMUNOTHERAPY-UK, V6, P901, DOI [10.2217/IMT.14.70, 10.2217/imt.14.70]; Wakabayashi A, 2013, MOL HUM REPROD, V19, P718, DOI 10.1093/molehr/gat057; Walker KF, 2016, LANCET, V387, P2068, DOI 10.1016/S0140-6736(16)00590-0; Xu Y, 2016, J IMMUNOL, V196, P2476, DOI 10.4049/jimmunol.1502055	67	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207085	10.1371/journal.pone.0207085	http://dx.doi.org/10.1371/journal.pone.0207085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399192	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000044
J	Musa, SM; Czachur, MV; Shiels, HA				Musa, Syafiq M.; Czachur, Molly, V; Shiels, Holly A.			Oviparous elasmobranch development inside the egg case in 7 key stages	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; CARCHARODON-CARCHARIAS; FUNCTIONAL-MORPHOLOGY; CLEARNOSE SKATE; PECTORAL FINS; WHITE SHARK; CHONDRICHTHYES; PLACENTATION; CAPSULES; BIOLOGY	Embryological stages of oviparous elasmobranch during development can be difficult to identify, requiring magnification and/or fixation of an anaesthetized embryo. These restrictions are poorly suited for monitoring the development of living elasmobranchs inside their egg cases. There are two major aims of this study. The first was to observe elasmobranch embryonic development non-invasively and produce a non-invasive developmental key for identifying the life stages for an elasmobranch inside the egg case. To this end, 7 key developmental stages were identified for the greater spotted catshark, Scyliorhinus stellaris, and are provided here with diagrams from multiple perspectives to demonstrate the key features of each stage. The physiological and ecological relevance of each stage are discussed in terms of structure and function for embryonic survival in the harsh intertidal zone. Also discussed is the importance of the egg case membrane and the protective embryonic jelly. The second aim of the study was to understand the applicability of the 7 developmental stages from S. stellaris to other oviparous elasmobranchs. Thus, changes in embryonic body size and egg yolk volume at each stage were measured and compared with those of the closely related, lesser spotted catshark, Scyliorhinus canicula. We find nearly identical growth patterns and yolk consumption patterns in both species across the 7 developmental stages. Thus, although the 7 developmental stages have been constructed in reference to the greater spotted catshark, we suggest that it can be applied to other oviparous elasmobranch species with only minor modification.	[Musa, Syafiq M.; Czachur, Molly, V; Shiels, Holly A.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Musa, Syafiq M.] Univ Kebangsaan Malaysia, Sch Environm & Nat Resource Sci, Fac Sci & Technol, Bangi, Selangor, Malaysia; [Czachur, Molly, V] Stellenbosch Univ, Dept Bot & Zool, Stellenbosch, South Africa	University of Manchester; Universiti Kebangsaan Malaysia; Stellenbosch University	Shiels, HA (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.	holly.shiels@manchester.ac.uk	Musa, Syafiq/AAF-9567-2019	Musa, Syafiq/0000-0001-9170-2646	Ministry of Higher Education (KPT, Malaysia); Universiti Kebangsaan Malaysia (UKM); University of Manchester Sustainability Summer Studentship; Higher Education Innovation Fund through The University of Manchester's Knowledge and Innovation hub for Environmental stability	Ministry of Higher Education (KPT, Malaysia); Universiti Kebangsaan Malaysia (UKM); University of Manchester Sustainability Summer Studentship; Higher Education Innovation Fund through The University of Manchester's Knowledge and Innovation hub for Environmental stability	S.M.M. is supported by the Ministry of Higher Education (KPT, Malaysia) and Universiti Kebangsaan Malaysia (UKM). M.V.C. was a summer intern student from University of Bangor, UK supported by a University of Manchester Sustainability Summer Studentship. The project was funded by the Higher Education Innovation Fund through The University of Manchester's Knowledge and Innovation hub for Environmental stability, and by the Ministry of Higher Education (KPT, Malaysia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, OVERVIEW WORLD ELASM, DOI DOI 10.7554/eLife.02199; BALLARD WW, 1993, J EXP ZOOL, V267, P318, DOI 10.1002/jez.1402670309; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; CASTRO JI, 1993, J MORPHOL, V218, P257, DOI 10.1002/jmor.1052180304; Compagno LJ, 2001, FAO SPECIES CATALOGU; Compagno LJV., 1984, FAO FISH SYNOP, P20; COX DL, 1993, ENVIRON BIOL FISH, V38, P117, DOI 10.1007/BF00842908; Dulvy NK, 1386, P ROY SOC LOND B BIO, V264, P1309; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; HAMLETT WC, 1985, J SUBMICR CYTOL PATH, V17, P31; HAMLETT WC, 1984, TISSUE CELL, V16, P613, DOI 10.1016/0040-8166(84)90035-1; Hamlett WC, 1999, SHARKS, SKATES, AND RAYS, P398; HAMLETT WC, 1993, J EXP ZOOL, V266, P347, DOI 10.1002/jez.1402660504; Hamlett William C., 2005, P395; Harahush BK, 2007, J FISH BIOL, V71, P1007, DOI 10.1111/j.1095-8649.2007.01569.x; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hoff GR, 2009, J FISH BIOL, V74, P483, DOI 10.1111/j.1095-8649.2008.02138.x; Johnson MS, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow003; Koob Thomas J., 1998, Bulletin of the Mount Desert Island Biological Laboratory, V37, P117; KOOB TJ, 1987, J EXP MAR BIOL ECOL, V113, P155, DOI 10.1016/0022-0981(87)90162-6; Last PR, 1994, SHARKS RAYS AUSTR, P135; LECHENAULT H, 1993, ENVIRON BIOL FISH, V38, P241, DOI 10.1007/BF00842920; Leonard JBK, 1999, J EXP ZOOL, V283, P13, DOI 10.1002/(SICI)1097-010X(19990101)283:1<13::AID-JEZ3>3.0.CO;2-S; Lingham-Soliar T, 2005, J MORPHOL, V264, P233, DOI 10.1002/jmor.10328; Lingham-Soliar T, 2005, J MORPHOL, V263, P1, DOI 10.1002/jmor.10207; LUER CA, 1985, ENVIRON BIOL FISH, V13, P161, DOI 10.1007/BF00000926; Luer CA, 2007, ENVIRON BIOL FISH, V80, P239, DOI 10.1007/s10641-007-9219-4; McLaughlin DM, 2005, J MAR BIOL ASSOC UK, V85, P1185, DOI 10.1017/S0025315405012282; MCLAUGHLIN RH, 1971, ECOL MONOGR, V41, P271, DOI 10.2307/1948494; Mellinger J., 1986, INDO PACIFIC FISH BI, P310; Onimaru K, 2018, DEV DYNAM, V247, P712, DOI 10.1002/dvdy.24623; Orton JH, 1926, NATURE, V118, P732, DOI 10.1038/118732a0; Pimentel MS, 2014, J EXP BIOL, V217, P2062, DOI 10.1242/jeb.092635; Reynolds JD, 2005, P ROY SOC B-BIOL SCI, V272, P2337, DOI 10.1098/rspb.2005.3281; Rodda KR, 2008, J FISH BIOL, V72, P961, DOI 10.1111/j.1095-8649.2007.01777.x; Rodda KR, 2000, THESIS; Rombough PJ, 1998, J EXP BIOL, V201, P1763; ROMBOUGH PJ, 1989, COMP BIOCHEM PHYS A, V92, P279, DOI 10.1016/0300-9629(89)90564-1; Rosa R, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1738; Serena F., 2005, FIELD IDENTIFICATION, P97; Stevenson C, 2007, CORAL REEFS, V26, P47, DOI 10.1007/s00338-006-0158-x; Wilga CD, 2001, J MORPHOL, V249, P195, DOI 10.1002/jmor.1049; Wilga CD, 2000, J EXP BIOL, V203, P2261	44	12	13	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206984	10.1371/journal.pone.0206984	http://dx.doi.org/10.1371/journal.pone.0206984			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399186	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000039
J	Klassen, S; Weed, J; Evans, D				Klassen, Sarah; Weed, Jonathan; Evans, Damian			Semi-supervised machine learning approaches for predicting the chronology of archaeological sites: A case study of temples from medieval Angkor, Cambodia	PLOS ONE			English	Article								Archaeologists often need to date and group artifact types to discern typologies, chronologies, and classifications. For over a century, statisticians have been using classification and clustering techniques to infer patterns in data that can be defined by algorithms. In the case of archaeology, linear regression algorithms are often used to chronologically date features and sites, and pattern recognition is used to develop typologies and classifications. However, archaeological data is often expensive to collect, and analyses are often limited by poor sample sizes and datasets. Here we show that recent advances in computation allow archaeologists to use machine learning based on much of the same statistical theory to address more complex problems using increased computing power and larger and incomplete datasets. This paper approaches the problem of predicting the chronology of archaeological sites through a case study of medieval temples in Angkor, Cambodia. For this study, we have a large dataset of temples with known architectural elements and artifacts; however, less than ten percent of the sample of temples have known dates, and much of the attribute data is incomplete. Our results suggest that the algorithms can predict dates for temples from 821-1150 CE with a 49-66-year average absolute error. We find that this method surpasses traditional supervised and unsupervised statistical approaches for under-specified portions of the dataset and is a promising new method for anthropological inquiry.	[Klassen, Sarah] Arizona State Univ, Sch Social Change & Human Evolut, Tempe, AZ 85281 USA; [Weed, Jonathan] MIT, Dept Math, Cambridge, MA 02139 USA; [Evans, Damian] Ecole Francaise Extreme Orient, Paris, France	Arizona State University; Arizona State University-Tempe; Massachusetts Institute of Technology (MIT); UDICE-French Research Universities; PSL Research University Paris; Ecole Francaise d'Extreme-Orient (EFEO)	Klassen, S (corresponding author), Arizona State Univ, Sch Social Change & Human Evolut, Tempe, AZ 85281 USA.	sarah.e.klassen@gmail.com	Klassen, Sarah/AAA-5622-2020	Evans, Damian/0000-0003-0320-4319	National Science Foundation Dissertation Improvement Grant [1638137]; Rust Family Foundation; Graduate Research Support Grant, Graduate and Professional Student Association (GPSA); Office of Graduate Education; Office of the Vice President for Research and Economic Affairs; National Science Foundation [DGE-1122374]; Australian Government, Department of Education and Training; ASU College of Liberal Arts and Sciences Graduate Dissertation Completion Fellowship; Dartmouth College General Fellowship for Graduate Research; Australian Research Council; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [639828]; APSARA National Authority	National Science Foundation Dissertation Improvement Grant(National Science Foundation (NSF)); Rust Family Foundation; Graduate Research Support Grant, Graduate and Professional Student Association (GPSA); Office of Graduate Education; Office of the Vice President for Research and Economic Affairs; National Science Foundation(National Science Foundation (NSF)); Australian Government, Department of Education and Training(Australian GovernmentDepartment of Industry, Innovation and Science); ASU College of Liberal Arts and Sciences Graduate Dissertation Completion Fellowship; Dartmouth College General Fellowship for Graduate Research; Australian Research Council(Australian Research Council); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); APSARA National Authority	The survey of temple sites in Cambodia was funded by the National Science Foundation Dissertation Improvement Grant (1638137), the Rust Family Foundation, the Graduate Research Support Grant, Graduate and Professional Student Association (GPSA), the Office of Graduate Education, and the Office of the Vice President for Research and Economic Affairs. Fellowship support was provided for the authors from the National Science Foundation Graduate Research Fellowship (DGE-1122374), the Endeavour Fellowship from the Australian Government, Department of Education and Training, the ASU College of Liberal Arts and Sciences Graduate Dissertation Completion Fellowship, and the Dartmouth College General Fellowship for Graduate Research. This research has also benefited from funding from the Australian Research Council and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 639828).; This project was generously founded from multiple sources. The survey of temple sites in Cambodia was funded by the National Science Foundation Dissertation Improvement Grant (1638137), the Rust Family Foundation, the Graduate Research Support Grant, Graduate and Professional Student Association (GPSA), the Office of Graduate Education, and the Office of the Vice President for Research and Economic Affairs. Fellowship support was provided for the authors from the National Science Foundation Graduate Research Fellowship (DGE-1122374), the Endeavour Fellowship from the Australian Government, Department of Education and Training, the ASU College of Liberal Arts and Sciences Graduate Dissertation Completion Fellowship, and the Dartmouth College General Fellowship for Graduate Research. This research has also benefited from funding from the Australian Research Council and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 639828). As well as support and permissions from the APSARA National Authority.	Alpaydin E, 2014, ADAPT COMPUT MACH LE, P1; [Anonymous], 2007, MAKERS MODELS DECORA; B?ty Pierre., 2005, EXTENSION AEROPORT S; Belkin M, 2006, J MACH LEARN RES, V7, P2399; Blum A., 1998, Proceedings of the Eleventh Annual Conference on Computational Learning Theory, P92, DOI 10.1145/279943.279962; Chapelle O., 2010, SEMISUPERVISED LEARN; Cowley D., 2016, AARGNEWS, V53, P11; de Sa V., 1993, P NIPS 93 NEUR INF P; Dougherty C, 2015, NEW YORK TIMES; Evans D, 2007, P NATL ACAD SCI USA, V104, P14277, DOI 10.1073/pnas.0702525104; Evans D, 2016, J ARCHAEOL SCI, V74, P164, DOI 10.1016/j.jas.2016.05.009; Evans D, 2015, ANTIQUITY, V89, P1402, DOI 10.15184/aqy.2015.157; Evans DH, 2013, P NATL ACAD SCI USA, V110, P12595, DOI 10.1073/pnas.1306539110; Gansell AR, 2014, J ARCHAEOL SCI, V44, P194, DOI 10.1016/j.jas.2013.11.005; Guyon I, 2010, IEEE IJCNN; Hardy M. A., 1993, REGRESSION DUMMY VAR; Hare Timothy S., 1996, ANCIENT MESOAM, V7, P281, DOI DOI 10.1017/S0956536100001474; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Horr C, 2014, ACM J COMPUT CULT HE, V7, DOI 10.1145/2533988; Horr C., 2009, NEW PARADIGMS AUTOMA; KOHLER TA, 1987, J ANTHROPOL ARCHAEOL, V6, P1, DOI 10.1016/0278-4165(87)90015-8; Lustig, 2009, POWER PRAGMATISM POL; Lustig E, 2007, J SOUTHEAST ASIAN ST, V38, P1, DOI 10.1017/S0022463406000919; Mavroeidis D., 2007, ECML PKDD2007 DISCOV; Oonk S, 2015, J ARCHAEOL SCI, V59, P80, DOI 10.1016/j.jas.2015.04.002; Pottier C., 2009, ASEANIE, V24, P61; Pottier C., 1999, UFR ORIENT MONDE ARA; Salazar A., 2012, STAT PATTERN RECOGNI, V4; Shennan S., 1997, QUANTIFYING ARCHAEOL; Tian Q, 2004, 2004 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXP (ICME), VOLS 1-3, P1019, DOI 10.1109/ICME.2004.1394376; van der Maaten, 2006, P COMP APPL QUANT ME, P112; Zhu X., 2003, P INT C MACH LEARN I, V3; Zhu X, 2009, MORGAN CLAYPOOL, DOI DOI 10.1007/978-3-031-01548-9	33	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205649	10.1371/journal.pone.0205649	http://dx.doi.org/10.1371/journal.pone.0205649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395642	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400009
J	Zhu, TF; Corraze, G; Plagnes-Juan, E; Skiba-Cassy, S				Zhu, Tengfei; Corraze, Genevieve; Plagnes-Juan, Elisabeth; Skiba-Cassy, Sandrine			Circulating miRNA measurements are reflective of cholesterol-based changes in rainbow trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							IN-VIVO; MICRORNA FUNCTION; CANCER-DETECTION; BODY-FLUIDS; HOMEOSTASIS; EXPRESSION; PLASMA; GENES; METABOLISM; BIOMARKERS	MicroRNAs (miRNAs) are a class of small non-coding RNAs which are known to posttranscriptionally regulate the expression of most genes in both animals and plants. Meanwhile, studies have shown that numbers of miRNAs are present in body fluids including the plasma. Despite the mode of action of these circulating miRNAs still remains unknown, they have been found to be promising biomarkers for disease diagnosis, prognosis and response to treatment. In order to evaluate the potential of miRNAs as non-invasive biomarkers in aquaculture, a time-course experiment was implemented to investigate the postprandial regulation of miRNAs levels in liver and plasma as well as the hepatic expression of genes involved in cholesterol metabolism. We showed that miR-1, miR-33a, miR-122, miR-128 and miR-223 were expressed in the liver of rainbow trout and present at detectable level in the plasma. We also demonstrated that hepatic expression of miR-1, miR-122 and miR-128 were regulated by feed intake and reached their highest levels 12 hours after the meal. Interestingly, we observed that circulating levels of miR-128 and miR-223 are subjected to postprandial regulations similar to that observed in their hepatic counterparts. Statistical correlations were observed between liver and plasma for miR-128 and miR-223 and between hepatic and circulating miR-122, miR-128 and miR-223 and expression of genes related to cholesterol synthesis and efflux or glucose phosphorylation. These results demonstrated that circulating miR-122, miR-128 and miR-223 are potential biomarkers of cholesterol metabolism in rainbow trout.	[Zhu, Tengfei; Corraze, Genevieve; Plagnes-Juan, Elisabeth; Skiba-Cassy, Sandrine] Univ Pau & Pays Adour, INRA, UPPA E2S, UMR 1419,Nutr Metab Aquaculture, St Pee Sur Nivelle, France	INRAE; Universite de Pau et des Pays de l'Adour	Skiba-Cassy, S (corresponding author), Univ Pau & Pays Adour, INRA, UPPA E2S, UMR 1419,Nutr Metab Aquaculture, St Pee Sur Nivelle, France.	sandrine.skiba@inra.fr			China Scholarship Council (CSC) [201406330071]	China Scholarship Council (CSC)(China Scholarship Council)	T. Zhu gratefully acknowledges the financial assistance provided by the China Scholarship Council (CSC, File No. 201406330071) for his doctoral fellowship.	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.301; Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Barbier O, 2009, MOL CELL BIOCHEM, V326, P3, DOI 10.1007/s11010-008-0001-5; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Bommer GT, 2011, CELL METAB, V13, P241, DOI 10.1016/j.cmet.2011.02.004; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chang TY, 2009, AM J PHYSIOL-ENDOC M, V297, pE1, DOI 10.1152/ajpendo.90926.2008; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Cheng YH, 2010, CLIN SCI, V119, P87, DOI 10.1042/CS20090645; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Drakaki A, 2009, CURR GENOMICS, V10, P35, DOI 10.2174/138920209787581299; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Etheridge A, 2011, MUTAT RES-FUND MOL M, V717, P85, DOI 10.1016/j.mrfmmm.2011.03.004; Fox J, 2016, RCMDR R COMMANDER R; Friedman M, 1996, J AGR FOOD CHEM, V44, P6, DOI 10.1021/jf9400167; Gerin I, 2010, J BIOL CHEM, V285, P33652, DOI 10.1074/jbc.M110.152090; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hanke M, 2010, UROL ONCOL-SEMIN ORI, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Heckmann LH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-250; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Iwakawa HO, 2015, TRENDS CELL BIOL, V25, P651, DOI 10.1016/j.tcb.2015.07.011; Juanchich A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2505-9; Kortner TM, 2014, BRIT J NUTR, V111, P2089, DOI 10.1017/S0007114514000373; Kortner TM, 2013, BRIT J NUTR, V109, P593, DOI 10.1017/S0007114512002024; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Latasa MJ, 2000, P NATL ACAD SCI USA, V97, P10619, DOI 10.1073/pnas.180306597; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leaver MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-299; Li TG, 2013, HEPATOLOGY, V58, P1111, DOI 10.1002/hep.26427; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lu TT, 2001, J BIOL CHEM, V276, P37735, DOI 10.1074/jbc.R100035200; Ma H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039649; Mennigen JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-70; Mennigen JA, 2014, COMP BIOCHEM PHYS B, V169, P16, DOI 10.1016/j.cbpb.2013.12.002; Mennigen JA, 2013, J EXP BIOL, V216, P1597, DOI 10.1242/jeb.082248; Mennigen JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038604; Mishima Y, 2012, DEV GROWTH DIFFER, V54, P55, DOI 10.1111/j.1440-169X.2011.01306.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; Naylor RL, 2009, P NATL ACAD SCI USA, V106, P15103, DOI 10.1073/pnas.0905235106; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; PRINTZ RL, 1993, ANNU REV NUTR, V13, P463, DOI 10.1146/annurev.nu.13.070193.002335; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Salem M, 2010, MAR BIOTECHNOL, V12, P410, DOI 10.1007/s10126-009-9232-z; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shenoy A, 2014, NAT REV MOL CELL BIO, V15, P565, DOI 10.1038/nrm3854; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Thorgaard GH, 2002, COMP BIOCHEM PHYS B, V133, P609, DOI 10.1016/S1096-4959(02)00167-7; Tocher DR, 2008, AQUACULTURE, V280, P21, DOI 10.1016/j.aquaculture.2008.04.034; Turchini G. M., 2010, FISH OIL REPLACEMENT; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2014, P NATL ACAD SCI USA, V111, P14518, DOI 10.1073/pnas.1215767111; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wagner J, 2013, ARTERIOSCL THROM VAS, V33, P1392, DOI 10.1161/ATVBAHA.112.300741; Wang J, 2015, J LIPID RES, V56, P319, DOI 10.1194/jlr.M054544; Wang L, 2013, MOL CELL BIOL, V33, P1956, DOI 10.1128/MCB.01580-12; Watanabe T, 2005, FEBS LETT, V579, P318, DOI 10.1016/j.febslet.2004.11.067; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhong D, 2013, CELL SIGNAL, V25, P1429, DOI 10.1016/j.cellsig.2013.03.003; Zhu TF, 2018, AM J PHYSIOL-REG I, V314, pR58, DOI 10.1152/ajpregu.00179.2017; Zhu TF, 2014, AQUACULTURE, V428, P290, DOI 10.1016/j.aquaculture.2014.03.027; Zhu X, 2015, MAR BIOTECHNOL, V17, P180, DOI 10.1007/s10126-014-9606-8	83	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206727	10.1371/journal.pone.0206727	http://dx.doi.org/10.1371/journal.pone.0206727			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395627	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400044
J	McSweeney, L; Spence, S; Anderson, J; Wrieden, W; Haighton, C				McSweeney, Lorraine; Spence, Suzanne; Anderson, Julie; Wrieden, Wendy; Haighton, Catherine			Parental perceptions of onsite hospital food outlets in a large hospital in the North East of England: A qualitative interview study	PLOS ONE			English	Article							VENDING MACHINES; ENVIRONMENT; HEALTH; NUTRITION; POLICY	Background Addressing the increasing obesity rates in children living in the United Kingdom has become a priority. A public health level approach as opposed to an individual approach is potentially one way forward. The wider food environment should be designed so that the 'healthier choice' is the easiest choice; this includes public sector settings such as hospitals. Many hospital outlets sell and promote food and drinks high in sugar, fat and salt undermining health messages developed by the UK National Health Service. Financial incentives have been provided to encourage hospitals to promote healthier food choices; however, few outlets have complied with the targets. The aim of this qualitative interview study was to determine the dietary perceptions and needs of parents whose children attend a large children's hospital in the North East of England and to identify potential barriers and facilitators to eating healthily in a hospital setting. Methods Eighteen parents whose children attended the hospital as an in- or out-patient were recruited through either ward research nurses, information posters or a parent hospital Facebook page to participate in a one-to-one in-depth interview. Results Parents reported a lack of affordable healthy options for sale both for themselves and visiting children. Although parents wanted to see more healthy options available for sale they did not feel it was appropriate to ban or restrict sales of any food types. Parents of frequent or long-term in-patients found it difficult to adequately feed themselves. Conclusions The ways in which visitors and staff can be encouraged to choose the healthier option in an NHS hospital setting warrants further investigation. The use of 'nudge theory', which has gained particular momentum in areas such as health promotion, may be a tool which can be utilised by hospitals to facilitate the promotion of healthy eating.	[McSweeney, Lorraine; Spence, Suzanne; Wrieden, Wendy] Newcastle Univ, Human Nutr Res Ctr, William Leech Bldg,Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England; [Anderson, Julie] Royal Victoria Infirm, Child Hlth Res Strategy, Childrens Serv, Clin Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Haighton, Catherine] Northumbria Univ, Social Work Educ & Community Wellbeing, Coach Lane Campus West, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Northumbria University	McSweeney, L (corresponding author), Newcastle Univ, Human Nutr Res Ctr, William Leech Bldg,Framlington Pl, Newcastle Upon Tyne, Tyne & Wear, England.	lorraine.mcsweeney@ncl.ac.uk	McSweeney, Lorraine/O-1226-2015; Haighton, Catherine/H-1528-2015	McSweeney, Lorraine/0000-0003-1044-6201; Haighton, Catherine/0000-0002-8061-0428; Spence, Suzanne/0000-0002-7089-7197	Fuse The Centre for Translational Research, the Medical Research Council (UK) [BH163208]	Fuse The Centre for Translational Research, the Medical Research Council (UK)	Funded by Fuse The Centre for Translational Research on behalf of the Medical Research Council (UK) BH163208: LM.	Bell C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-492; Benjamin J, 2014, 7 THINGS EVERYONE SH; Button K, 2017, TAKING PULSE HOSP FO; Center Training and Research Translation, 2013, HLTH FOOD ENV PRIC I; Center Training and Research Translation, 2013, KAIS PERM CAF MEN LA; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Department of Health, 2014, HOSP FOOD STAND PAN; Department of Health, 2016, TOOLK SUPP DEV HOSP; Eneli IU, 2014, AM J PUBLIC HEALTH, V104, P1822, DOI 10.2105/AJPH.2014.302002; Gorton D, 2010, NEW ZEAL MED J, V123, P43; Grech A, 2015, OBES REV, V16, P1030, DOI 10.1111/obr.12311; HM Government, 2016, CHILDH OB PLAN ACT; Johnson EJ, 2012, MARKET LETT, V23, P487, DOI 10.1007/s11002-012-9186-1; Lawrence S, 2009, PEDIATRICS, V123, pS287, DOI 10.1542/peds.2008-2780G; Lesser LI, 2012, ACAD PEDIATR, V12, P62, DOI 10.1016/j.acap.2011.09.004; Local Government Association, 2013, CHANG BEH PUBL HLTH, DOI [10.1093/pubmed/fdt067, DOI 10.1093/PUBMED/FDT067]; MALHOTRA A, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F3932; McDonald CM, 2006, ARCH PEDIAT ADOL MED, V160, P900, DOI 10.1001/archpedi.160.9.900; Moran A, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150541; NHS England, 2016, COMM QUAL INN CQUIN; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Pope C, 1995, BMJ-BRIT MED J, V311, P42; Public Health England, 2016, CHILD OBESITY; QSR International, 2011, NVIVO 9; Quigley M, 2013, MED LAW REV, V21, P588, DOI 10.1093/medlaw/fwt022; Ritchie J, 2012, FRAMEWORK APPROACH Q; Saghai Y, 2013, J MED ETHICS, V39, P487, DOI 10.1136/medethics-2012-100727; Sahud HB, 2006, PEDIATRICS, V118, P2290, DOI 10.1542/peds.2006-1228; Sustain the alliance for better food and farming, 2016, NEW HLTH HOSP FOOD L; Sustain the alliance for better food and farming, 2017, SUSTAIN ALLIANCE BET; Swinburn B, 2013, OBES REV, V14, P24, DOI 10.1111/obr.12073; Thomas S.S., 2017, 2017 IEEE S SER COMP, P1, DOI DOI 10.1109/TENCONSPRING.2017.8070003; van Kleef E, 2012, BMC PUBLIC HEALTH, V12, P1, DOI [10.1186/1471-2458-12-1, DOI 10.1186/1471-2458-12-1]; Winston CP, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120335	35	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0205416	10.1371/journal.pone.0205416	http://dx.doi.org/10.1371/journal.pone.0205416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388187	Green Accepted, Green Published, gold			2022-12-26	WOS:000449289800013
J	Yulianto, I; Booth, H; Ningtias, P; Kartawijaya, T; Santos, J; Sarmintohadi; Kleinertz, S; Campbell, SJ; Palm, HW; Hammer, C				Yulianto, Irfan; Booth, Hollie; Ningtias, Prayekti; Kartawijaya, Tasrif; Santos, Juan; Sarmintohadi; Kleinertz, Sonja; Campbell, Stuart J.; Palm, Harry W.; Hammer, Cornelius			Practical measures for sustainable shark fisheries: Lessons learned from an Indonesian targeted shark fishery	PLOS ONE			English	Article							LONGLINE FISHERIES; EXTINCTION RISK; MARINE; MANAGEMENT; CONSEQUENCES; POPULATIONS; ECOSYSTEMS; RECOVERY; WORLD; CATCH	Overfishing is a major threat to the survival of shark species, primarily driven by international trade in high-value fins, as well as meat, liver oil, skin and cartilage. The Convention on the International Trade in Endangered Species of Wild Fauna and Flora (CITES) aims to ensure that commercial trade does not threaten wild species, and several shark species have recently been listed on CITES as part of international efforts to ensure that trade does not threaten their survival. However, as international trade regulations alone will be insufficient to reduce overexploitation of sharks, they must be accompanied by practical fisheries management measures to reduce fishing mortality. To examine which management measures might be practical in the context of a targeted shark fishery, we collected data from 52 vessels across 595 fishing trips from January 2014 to December 2015 at Tanjung Luar fishing port in East Lombok, Indonesia. We recorded 11,920 landed individuals across 42 species, a high proportion of which were threatened and regulated species. Catch per unit effort depended primarily on the number of hooks and type of fishing gear used, and to a lesser degree on month, boat engine power, number of sets and fishing ground. The most significant factors influencing the likelihood of catching threatened and regulated species were month, fishing ground, engine power and hook number. We observed significant negative relationships between standardised catch per unit effort and several indicators of fishing effort, suggesting diminishing returns above relatively low levels of fishing effort. Our results suggest that management measures focusing on fishing effort controls, gear restrictions and modifications and spatiotemporal closures could have significant benefits for the conservation of shark species, and may help to improve the overall sustainability of the Tanjung Luar shark fishery. These management measures may also be applicable to shark fisheries in other parts of Indonesia and beyond, as sharks increasingly become the focus of global conservation efforts.	[Yulianto, Irfan; Booth, Hollie; Ningtias, Prayekti; Kartawijaya, Tasrif] Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia; [Yulianto, Irfan; Kleinertz, Sonja] Bogor Agr Univ, Fac Fisheries & Marine Sci, Bogor, Indonesia; [Santos, Juan; Hammer, Cornelius] Thuenen Inst, Inst Balt Sea Fisheries, Rostock, Germany; [Sarmintohadi] Minist Marine Affairs & Fisheries, Directorate Marine Conservat Areas & Biodivers, Jakarta, Indonesia; [Kleinertz, Sonja; Palm, Harry W.] Univ Rostock, Dept Aquaculture & Sea Ranching, Rostock, Germany; [Campbell, Stuart J.] Rare Indonesia, Bogor, Indonesia	Wildlife Conservation Society - Indonesia; Bogor Agricultural University; Johann Heinrich von Thunen Institute; Ministry of Marine Affairs and Fisheries; University of Rostock	Yulianto, I (corresponding author), Wildlife Conservat Soc Indonesia Program, Bogor, Indonesia.; Yulianto, I (corresponding author), Bogor Agr Univ, Fac Fisheries & Marine Sci, Bogor, Indonesia.	iyulianto@wcs.org	Yulianto, Irfan/AAE-6672-2021	Booth, Hollie/0000-0003-4339-820X; Campbell, Stuart/0000-0002-1158-3200; Yulianto, Irfan/0000-0003-4116-9171	Darwin Initiative [2805]	Darwin Initiative	Data collection of this study was funded by the Darwin Initiative (grant number 2805). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLOBAL PRIORITIES CO; [Anonymous], 2018, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2018-2.RLTS.T2478A50349982.EN; [Anonymous], 590 FAO; Barker MJ, 2005, AQUAT CONSERV, V15, P325, DOI 10.1002/aqc.660; Beer A. J. E., 2015, THESIS; Booth H, THESIS; Burnham K P, 2003, MODEL SELECT MULTIMO; Cartamil D, 2011, FISH RES, V108, P393, DOI 10.1016/j.fishres.2011.01.020; CHRISTENSEN J., 2014, HIST PERSPECTIVES FI; Clarke S., 2014, SPC FISH NEWSL, V145, P49; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Cohen D., 2006, SEMISTRUCTURED INTER; Costello C, 2016, P NATL ACAD SCI USA, V113, P5125, DOI 10.1073/pnas.1520420113; Damalas D, 2007, FISH RES, V84, P233, DOI 10.1016/j.fishres.2006.11.001; Davidson LNK, 2016, FISH FISH, V17, P438, DOI 10.1111/faf.12119; Dharmadi, 2015, AFR J MAR SCI, V37, P249, DOI 10.2989/1814232X.2015.1045431; Doherty PD, 2014, ECOL EVOL, V4, P2375, DOI 10.1002/ece3.1104; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; FOX WW, 1970, T AM FISH SOC, V99, P80, DOI 10.1577/1548-8659(1970)99<80:AESMFO>2.0.CO;2; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jaiteh VF, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00043; Jaiteh VF, 2017, MAR POLICY, DOI [10.1016/j.marpol.2017.08.014, DOI 10.1016/J.MARPOL.2017.08.014]; Kumoru L., 2003, 176 M STAND COMM TUN; Lack M, 2011, FUTURE SHARKS REV AC, P44; Lestari W.P., 2017, SOCIOECONOMIC STUDY; McClenachan L, 2016, CURR BIOL, V26, P1640, DOI 10.1016/j.cub.2016.05.026; Ministry of Marine Affairs and Fisheries, 2015, NAT PLAN ACT SHARKS; Neubert K, 2016, MAR POLLUT BULL, V110, P747, DOI 10.1016/j.marpolbul.2016.02.075; Oh BZL, 2017, CONSERV BIOL, V31, P635, DOI 10.1111/cobi.12868; Palm HW, 2017, FISHES-BASEL, V2, DOI 10.3390/fishes2020008; Palm HW, 2011, PARASITOL RES MG, V2, P223, DOI 10.1007/978-3-642-21396-0_12; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Purwanto P, 2014, INDONESIAN FISHERIES, V20, P59, DOI /10.15578/ifrj.20.2.2014.59-67; Satria A, 2004, MAR POLICY, V28, P437, DOI 10.1016/j.marpol.2003.11.001; Schaefer MB., 1954, B IATTC BOL CIAT, V1, P23; Sembiring A, 2015, FISH RES, V164, P130, DOI 10.1016/j.fishres.2014.11.003; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Skud BE, 1984, MANIPULATION FIXED G; Speed CW, 2018, BIOL CONSERV, V220, P308, DOI 10.1016/j.biocon.2018.01.010; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; Vincent ACJ, 2014, FISH FISH, V15, P563, DOI 10.1111/faf.12035; Ward-Paige CA, 2017, GLOBAL ENVIRON CHANG, V47, P174, DOI 10.1016/j.gloenvcha.2017.09.005; West Nusa Tenggara Provincial Government, 2017, MAN ZON PLAN LUN MAR; White W.T., 2006, EC IMPORTANT SHARKS	47	15	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206437	10.1371/journal.pone.0206437	http://dx.doi.org/10.1371/journal.pone.0206437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388159	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800031
J	Braun, DP; Phillips, ID; Nanayakkara, L; Wissel, B				Braun, David P.; Phillips, Iain D.; Nanayakkara, Lushani; Wissel, Bjorn			Diet characterization and a preliminary investigation into trophic niche placement for an endangered lake sturgeon (Acipenser fulvescens) population in the Saskatchewan River, SK, Canada	PLOS ONE			English	Article							ISOTOPE MIXING MODELS; FEEDING ECOLOGY; SPATIAL VARIABILITY; NORTHERN ONTARIO; STABLE-ISOTOPES; RESTORATION; HABITAT; CHIRONOMIDAE; RAFINESQUE; DELTA-C-13	All Canadian lake sturgeon (Acipenser fulvescens) populations are listed under the Committee on the Status of Endangered Wildlife in Canada (COSEWIC) due to their complex life history, loss of habitat and negative interactions with anthropomorphic activities. Lake sturgeon diets vary considerably across their range and depend on the local benthic invertebrate fauna, substrata, and competition with congener species. Hence, determining population-specific prey assemblages is a vital contribution to effective conservation efforts. We used carbon and nitrogen stable isotopes to identify lake sturgeon prey preferences for juvenile (<100 cm) and adult (> 100 cm) age classes and their trophic niche in the Saskatchewan River, SK, Canada. In this system, lake sturgeon were the top predator within the benthic food web with no direct competition for preferred prey items from congener species. Their diet was dominated by crayfish (49.1 +/- 6.4%) and snails (36.3 +/- 5.5%), with no significant differences between age classes. Furthermore, lake sturgeon favoured deep rocky pools throughout the river; a habitat where crayfish and snails are typically found. Therefore, conservation efforts should be directed at preserving these habitats for the residing benthic invertebrate community, and the lake sturgeon's ability to access them.	[Braun, David P.; Nanayakkara, Lushani; Wissel, Bjorn] Univ Regina, Dept Biol, Regina, SK, Canada; [Phillips, Iain D.] Water Secur Agcy, Saskatoon, SK, Canada; [Braun, David P.] Fisheries & Oceans Canada, Regina, SK, Canada	University of Regina; Fisheries & Oceans Canada	Braun, DP (corresponding author), Univ Regina, Dept Biol, Regina, SK, Canada.; Braun, DP (corresponding author), Fisheries & Oceans Canada, Regina, SK, Canada.	david.braun@dfo-mpo.gc.ca	Phillips, Iain/L-3116-2019	Phillips, Iain/0000-0003-0955-3771	Water Security Agency (WSA); Institute of Environmental Change and Society (IECS)	Water Security Agency (WSA); Institute of Environmental Change and Society (IECS)	Project funding was provided by the Water Security Agency (WSA) and the Institute of Environmental Change and Society (IECS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacker TM, 2017, ENVIRON BIOL FISH, V100, P1301, DOI 10.1007/s10641-017-0643-9; Bajkov A., 1930, CANADIAN FISHERIES M, V1930, P43; Barth CC, 2013, J APPL ICHTHYOL, V29, P721, DOI 10.1111/jai.12193; Barth CC, 2011, T AM FISH SOC, V140, P1629, DOI 10.1080/00028487.2011.641881; Beamesderfer RCP, 1997, ENVIRON BIOL FISH, V48, P407, DOI 10.1023/A:1007310916515; Beamish FWH, 1998, CAN FIELD NAT, V112, P459; BIRSTEIN VJ, 1993, CONSERV BIOL, V7, P773, DOI 10.1046/j.1523-1739.1993.740773.x; Block D., 2001, THESIS; BOVBJERG RV, 1953, PHYSIOL ZOOL, V26, P173, DOI 10.1086/physzool.26.2.30154514; Braun D, 2014, J APPL ICHTHYOL, V30, P1174, DOI 10.1111/jai.12627; Canadian Council on Animal Care, 2005, GUID CAR US FISH RES; Chiasson WB, 1997, CAN J FISH AQUAT SCI, V54, P2866, DOI 10.1139/cjfas-54-12-2866; Coker RE, 1921, 893 US BUR FISH; Committee on the Status of Endangered Wildlife (COSEWIC), CW69144842007EPDF CO; Cooper Ryan N, 2012, Aquat Biosyst, V8, P6, DOI 10.1186/2046-9063-8-6; Dillon R.T., 2004, ECOLOGY FRESHWATER M; DONALD DB, 1977, CAN J ZOOL, V55, P1038, DOI 10.1139/z77-132; Edmunds G.F., 1976, MAYFLIES N CENTRAL A; Finlay JC, 1999, LIMNOL OCEANOGR, V44, P1198, DOI 10.4319/lo.1999.44.5.1198; Fry B., 2008, STABLE ISOTOPE ECOLO; Garvey JE, 2003, ECOLOGY, V84, P3339, DOI 10.1890/02-0444; Guilbard F, 2007, AM FISH S S, V56, P85; Gustafson L, 2007, OECOLOGIA, V152, P140, DOI 10.1007/s00442-006-0633-7; Harkness W.J.K., 1961, LAKE STURGEON HIST I; Haugen GN, 1969, ALBERTA FISH WILDLIF, V4, P6; Haxton T, 2003, CAN FIELD NAT, V117, P541, DOI 10.22621/cfn.v117i4.822; HERSHEY AE, 1987, OECOLOGIA, V73, P236, DOI 10.1007/BF00377513; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jackson JR, 2002, J APPL ICHTHYOL, V18, P439, DOI 10.1046/j.1439-0426.2002.00394.x; Johnson DH, 1963, THESIS; Kauffman JB, 1997, FISHERIES, V22, P12, DOI 10.1577/1548-8446(1997)022&lt;0012:AEPORA&gt;2.0.CO;2; Kennedy WA, 1967, FISH RES BOARD CAN B, P161; Langhorne AL, 2001, CAN MANUSCR REP FISH; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Layman CA, 2012, BIOL REV, V87, P545, DOI 10.1111/j.1469-185X.2011.00208.x; Ledger ME, 2013, NAT CLIM CHANGE, V3, P223, DOI [10.1038/nclimate1684, 10.1038/NCLIMATE1684]; MAGNIN E, 1970, Naturaliste Canadien (Quebec), V97, P73; McCutchan JM, 2003, OIKOS, V102, P225; McKinney RA, 1999, HYDROBIOLOGIA, V412, P17, DOI 10.1023/A:1003887913402; Merritt R. W., 2008, INTRO AQUATIC INSECT; Miller MJ, 2004, ECOLOGY FUNCTIONAL M; MOMOT WT, 1984, J CRUSTACEAN BIOL, V4, P35, DOI 10.2307/1547894; Moon DN, 1998, J FRESHWATER ECOL, V13, P317, DOI 10.1080/02705060.1998.9663624; Moore JW, 2008, ECOL LETT, V11, P470, DOI 10.1111/j.1461-0248.2008.01163.x; Mosindy T, ASSESSMENT LAKE STUR; Nilo P, 2006, T AM FISH SOC, V135, P1044, DOI 10.1577/T05-279.1; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PECKARSKY BL, 1990, FRESHWATER MACROINVE; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Peterson DL, 2007, REV FISH BIOL FISHER, V17, P59, DOI 10.1007/s11160-006-9018-6; Phillips DL, 2002, OECOLOGIA, V130, P114, DOI 10.1007/s004420100786; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1, DOI 10.1146/annurev.en.31.010186.000245; Pollock MS, 2015, ENVIRON REV, V23, P30, DOI 10.1139/er-2014-0037; Quinones-Rivera ZJ, 2015, J GREAT LAKES RES, V41, P144, DOI 10.1016/j.jglr.2015.05.005; ROELL MJ, 1993, T AM FISH SOC, V122, P46, DOI 10.1577/1548-8659(1993)122<0046:TBOPOS>2.3.CO;2; Roseman EF, 2011, J APPL ICHTHYOL, V27, P66, DOI 10.1111/j.1439-0426.2011.01829.x; Sandilands AP, 1987, ONTARIO FISHERIES TE, V23; Saskatchewan Watershed Authority, 2010, FISH SPEC SASK; Scott W.B., 1973, B FISH RES BOARD CAN; Stelzer RS, 2008, T AM FISH SOC, V137, P1018, DOI 10.1577/T07-214.1; Swanson HK, 2015, ECOLOGY, V96, P318, DOI 10.1890/14-0235.1; Thorp J.H., 1991, ECOLOGY CLASSIFICATI; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Vecsei P, 2004, STURGEONS PADDLEFISH, P103; Webb J. M., 2002, THESIS; Werner RG, 2005, CONTRIBUTING FACTORS; Wetzel R.G., 2001, LIMNOLOGY LAKE RIVER, DOI DOI 10.1046/J.1529-8817.2001.37602.X; Wishingrad V, 2014, T AM FISH SOC, V143, P1555, DOI 10.1080/00028487.2014.954052; [No title captured]	72	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206313	10.1371/journal.pone.0206313	http://dx.doi.org/10.1371/journal.pone.0206313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383784	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600036
J	dos Santos, MCT; Scheller, D; Schulte, C; Mesa, IR; Colman, P; Bujac, SR; Bell, R; Berteau, C; Perez, LT; Lachmann, I; Berg, D; Maetzler, W; da Costa, AN				dos Santos, Marcia Cristina T.; Scheller, Dieter; Schulte, Claudia; Mesa, Irene R.; Colman, Peter; Bujac, Sarah R.; Bell, Rosie; Berteau, Caroline; Perez, Luis Tosar; Lachmann, Ingolf; Berg, Daniela; Maetzler, Walter; da Costa, Andre Nogueira			Evaluation of cerebrospinal fluid proteins as potential biomarkers for early stage Parkinson's disease diagnosis	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CSF BIOMARKERS; S100B PROTEIN; PROGRESSION; RECOMMENDATIONS; ASSOCIATIONS; VALIDATION; DISCOVERY; ACCURACY	Cerebrospinal fluid (CSF) has often been used as the source of choice for biomarker discovery with the goal to support the diagnosis of neurodegenerative diseases. For this study, we selected 15 CSF protein markers which were identified in previously published clinical investigations and proposed as potential biomarkers for PD diagnosis. We aimed at investigating and confirming their suitability for early stage diagnosis of the disease. The current study was performed in a two-fold confirmatory approach. Firstly, the CSF protein markers were analysed in confirmatory cohort I comprising 80 controls and 80 early clinical PD patients. Through univariate analysis we found significant changes of six potential biomarkers (alpha-syn, DJ-1, A beta 42, S100 beta, p-Tau and t-Tau). In order to increase robustness of the observations for potential patient differentiation, we developed-based on a machine learning approach-an algorithm which enabled identifying a panel of markers which would improve clinical diagnosis. Based on that model, a panel comprised of alpha-syn, S100 beta and UCHL1 were suggested as promising candidates. Secondly, we aimed at replicating our observations in an independent cohort (confirmatory cohort II) comprising 30 controls and 30 PD patients. The univariate analysis demonstrated A beta 42 as the only reproducible potential biomarker. Taking into account both technical and clinical aspects, these observations suggest that the large majority of the investigated CSF proteins currently proposed as potential biomarkers lack robustness and reproducibility in supporting diagnosis in the early clinical stages of PD.	[dos Santos, Marcia Cristina T.; Bell, Rosie; Berteau, Caroline; da Costa, Andre Nogueira] UCB Biopharma SPRL, Translat Med, Braine Lalleud, Belgium; [Scheller, Dieter] Consultancy Neuropharm, Neuss, Germany; [Schulte, Claudia; Berg, Daniela; Maetzler, Walter] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Bra Res, Tubingen, Germany; [Schulte, Claudia; Berg, Daniela; Maetzler, Walter] German Ctr Neurodegenerat Dis, Tubingen, Germany; [Mesa, Irene R.; Colman, Peter; Bujac, Sarah R.] UCB Pharma SA, Exploratory Stat, Global Exploratory Dev, Slough, Berks, England; [Perez, Luis Tosar] UCB Biopharma SPRL, Non Clin Dev, Bioanalyt Sci, Braine Lalleud, Belgium; [Lachmann, Ingolf] Analyt Jena, Res & Dev, Jena, Germany; [Berg, Daniela; Maetzler, Walter] Christian Albrechts Univ Kiel, Dept Neurol, Kiel, Germany; [Bell, Rosie] Univ Cambridge, Ctr Misfolding Dis, Cambridge, England; [Berteau, Caroline] Univ Leeds, Leeds Inst Biomed & Clin Sci, Leeds, W Yorkshire, England	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); UCB Pharma SA; University of Kiel; University of Cambridge; University of Leeds	da Costa, AN (corresponding author), UCB Biopharma SPRL, Translat Med, Braine Lalleud, Belgium.	andre.dacosta@ucb.com	Berg, Daniela/A-8728-2019; Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020	Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Schulte, Claudia/0000-0003-4006-1265; Bell, Rosie/0000-0002-1744-7066	German Federal Ministry for Education and Research (BMBF) within the BioPharma initiative Neuroallianz; UCB Pharma GmbH (Monheim, Germany); Hertie Institute; DZNE; UCB Biopharma SPRL; Consultancy Neuropharm; UCB Pharma SA; Analytik Jena	German Federal Ministry for Education and Research (BMBF) within the BioPharma initiative Neuroallianz; UCB Pharma GmbH (Monheim, Germany)(UCB Pharma SA); Hertie Institute; DZNE(Helmholtz Association); UCB Biopharma SPRL; Consultancy Neuropharm; UCB Pharma SA(UCB Pharma SA); Analytik Jena	This work was supported by grants from the German Federal Ministry for Education and Research (BMBF) within the BioPharma initiative Neuroallianz, project D13 B and by UCB Pharma GmbH (Monheim, Germany). The D13B study supports the investigation of biomarkers in prodromal and clinical phases of Parkinson's disease, and supports specifically the TREND study of the Neurology Department of the University of Tubingen, Germany. Samples were obtained from the Neuro-Biobank of the University of Tuebingen, Germany. This biobank is supported by the local University, the Hertie Institute and the DZNE. UCB Biopharma SPRL, Consultancy Neuropharm, UCB Pharma SA and Analytik Jena provided support in the form of salaries for authors MCTDS, RB, CB, ANDC, DS, IRM, PC, SRB, LTP and IL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aasly JO, 2012, NEUROLOGY, V78, P55, DOI 10.1212/WNL.0b013e31823ed101; Adler CH, 2014, NEUROLOGY, V83, P406, DOI 10.1212/WNL.0000000000000641; Algarni MA, 2016, EXPERT REV NEUROTHER, V16, P187, DOI 10.1586/14737175.2016.1135056; Bernhard FP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150552; Bernhardt D, 2016, PARKINSONISM RELAT D, V33, P84, DOI 10.1016/j.parkreldis.2016.09.016; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Buddhala C, 2015, NEUROBIOL AGING, V36, P476, DOI 10.1016/j.neurobiolaging.2014.07.043; Carvalho DZ, 2015, NEUROSCI LETT, V608, P57, DOI 10.1016/j.neulet.2015.10.010; Chahine Lama M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS99, DOI 10.1016/S1353-8020(13)70025-7; Chen YC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002672; Cristina M, 2016, BIOANALYSIS, V8, P2497, DOI 10.4155/bio-2016-0166; Fahn S., 1987, RECENT DEV PARKINSON, VVol. 2, P153; Gelpi E, 2014, MOVEMENT DISORD, V29, P1010, DOI 10.1002/mds.25776; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Grunblatt E, 2004, J NEURAL TRANSM, V111, P1543, DOI 10.1007/s00702-004-0212-1; Gwinn K, 2017, BIOMARK MED, V11, P451, DOI 10.2217/bmm-2016-0370; Herbert MK, 2014, PARKINSONISM RELAT D, V20, P112, DOI 10.1016/j.parkreldis.2013.09.003; Heywood WE, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0059-y; Huertas I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174644; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jani D, 2016, AAPS J, V18, P1, DOI 10.1208/s12248-015-9820-y; JIMENEZJIMENEZ FJ, 2014, FRONT CELL NEUROSCI, V8; Kang JH, 2016, ACTA NEUROPATHOL, V131, P935, DOI 10.1007/s00401-016-1552-2; Khandelwal PJ, 2011, J NEUROIMMUNOL, V238, P1, DOI 10.1016/j.jneuroim.2011.07.002; Kordower JH, 2013, BRAIN, V136, P2419, DOI 10.1093/brain/awt192; Lewczuk P, 2006, J NEURAL TRANSM, V113, P1075, DOI 10.1007/s00702-006-0511-9; Lindqvist D, 2013, BRAIN BEHAV IMMUN, V33, P183, DOI 10.1016/j.bbi.2013.07.007; Maarouf CL, 2013, BIOMARK INSIGHTS, V8, P19, DOI 10.4137/BMI.S11422; Maetzler W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088604; Maetzler W, 2011, MOVEMENT DISORD, V26, P176, DOI 10.1002/mds.23358; Majbour NK, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0072-9; Marek K, 2011, PROG NEUROBIOL, V95, P629, DOI 10.1016/j.pneurobio.2011.09.005; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P399, DOI 10.1002/mds.23462; Meissner WG, 2011, NAT REV DRUG DISCOV, V10, P377, DOI 10.1038/nrd3430; Miller DB, 2015, METABOLISM, V64, pS40, DOI 10.1016/j.metabol.2014.10.030; Mollenhauer B, 2017, NEUROLOGY, V89, P1959, DOI [10.1212/WNL.0000000000004609, 10.1212/wnl.0000000000004609]; Mollenhauer Brit, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS76, DOI 10.1016/S1353-8020(13)70020-8; Noelker C, 2011, MOL DIAGN THER, V15, P83, DOI 10.2165/11534870-000000000-00000; O'Bryant SE, 2014, J ALZHEIMERS DIS, V42, P1325, DOI 10.3233/JAD-141041; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Parnetti L, 2014, MOVEMENT DISORD, V29, P1019, DOI 10.1002/mds.25772; Parnetti L, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00053; Poewe W, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.13, 10.1111/ene.14108]; Qiang JK, 2013, ANN NEUROL, V74, P119, DOI 10.1002/ana.23872; Rochester L, 2017, NEUROLOGY, V88, P1501, DOI 10.1212/WNL.0000000000003840; Rosenthal LS, 2016, MOVEMENT DISORD, V31, P915, DOI 10.1002/mds.26438; Schaf DV, 2005, PARKINSONISM RELAT D, V11, P39, DOI 10.1016/j.parkreldis.2004.07.002; Shi M, 2015, MOL CELL PROTEOMICS, V14, P544, DOI 10.1074/mcp.M114.040576; Shi M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.09.015; Shi M, 2011, ANN NEUROL, V69, P570, DOI 10.1002/ana.22311; Steiner J, 2011, CLIN CHEM LAB MED, V49, P409, DOI 10.1515/CCLM.2011.083; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Trojanowski JQ, 1998, J NEUROPATH EXP NEUR, V57, P643, DOI 10.1097/00005072-199806000-00010; Wang Z, 2016, J NEUROL SCI, V371, P137, DOI 10.1016/j.jns.2016.10.035; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Yardan T, 2011, J PAK MED ASSOC, V61, P276; Yu SY, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-113	57	21	21	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206536	10.1371/journal.pone.0206536	http://dx.doi.org/10.1371/journal.pone.0206536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383831	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600061
J	Kachelmeier, A; Shola, T; Meier, WB; Johnson, A; Jiang, MY; Steyger, PS				Kachelmeier, Allan; Shola, Tsering; Meier, William B.; Johnson, Anastasiya; Jiang, Meiyan; Steyger, Peter S.			Simplified, automated methods for assessing pixel intensities of fluorescently-tagged drugs in cells	PLOS ONE			English	Article								Assessing the cytoplasmic uptake of fluorescently-tagged drugs in heterogeneous cell types currently involves time-consuming manual segmentation of confocal microscopy images. We developed a set of methods that incorporate map algebra techniques to facilitate and expedite image segmentation, particularly of the parenchyma of intermediate cells in the stria vascularis of the inner ear. Map algebra is used to apply a convolution kernel to pixel neighborhoods to create a masking image to select pixels in the original image for further operations. Here, we describe the utility of integrated intensity-based, percentile-based, and local autocorrelation-based methods to automate segmentation of images into putative morphological regions for pixel intensity analysis. Integrated intensity-based methods are variants of watershed segmentation tools that determine morphological boundaries from rates of change in integrated pixel intensity. Percentile- and local autocorrelation-based methods evolved out of the process of developing map algebra- and integrated intensity-based tools. We identified several simplifications that are surprisingly effective for image segmentation and pixel intensity analysis. These methods were empirically validated on three levels: first, the algorithms were developed based on iterations of inspected results; second, algorithms were tested for various types of robustness; and third, developed algorithms were validated against results from manually-segmented images. We conclude the key to automated segmentation is supervision of output data.	[Kachelmeier, Allan; Shola, Tsering; Meier, William B.; Johnson, Anastasiya; Jiang, Meiyan; Steyger, Peter S.] Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA; [Steyger, Peter S.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Steyger, PS (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97201 USA.; Steyger, PS (corresponding author), VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Portland, OR 97239 USA.	steygerp@ohsu.edu	Steyger, Peter S./B-9147-2011	Steyger, Peter S./0000-0002-6103-5237	National Institute of Deafness and Other Communication Disorders (NIH-NIDCD) [R01 DC004555, R01 DC012588, P30 DC005983]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004555, P30DC005983, R01DC012588] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders (NIH-NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Deafness and Other Communication Disorders (NIH-NIDCD) grants R01 DC004555 to PSS, R01 DC012588 to PSS and P30 DC005983, with illustration drafts and figure formatting by Karen Thiebes, Simplified Science Publishing, LLC. Funding agencies had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; ARGANDACARRERAS I, 2017, BIOINFORMATICS, V4, P4; BIOINFORMATICS BTQ, 1946, PUBMED; BLACK FO, 1993, OTOLARYNG CLIN N AM, V26, P713; CANNY JF, 1983, FINDING EDGES AND LI, V145; DAI CF, 2014, PUBMED, V1; Galison P., 1997, PRESS; HIEL H, 1993, AUDIOLOGY, V32, P78; HIJMANS RJ, R PACKAGE VERSION, P2; Koo JW, 2015, PUBMED, V7, DOI 10.1126/scitranslmed.aac5546; LI HZ, 2011, SCI REP UK, V1, P20260; Meijering E, 2012, IEEE SIGNAL PROC MAG, V29, P140, DOI 10.1109/MSP.2012.2204190; MOSALIGANTI KR, 2012, PLOS COMPUTATIONAL B, V12, P14; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; R Core Team, 2018, R LANG ENV STAT COMP; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Stegmaier J, 2016, DEV CELL, V36, P225, DOI 10.1016/j.devcel.2015.12.028; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Tomlin CD, 1990, ENGLEWOOD CLIFFS; VALMIANSKI I, 2014, REV SCI INSTRUM, V4, P3; VISSER E, NEUROIMAGE, P479; Wang Q, 2009, JARO-J ASSOC RES OTO, V10, P205, DOI 10.1007/s10162-009-0160-4	23	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206628	10.1371/journal.pone.0206628	http://dx.doi.org/10.1371/journal.pone.0206628			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383813	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600076
J	Lawrenz, B; Sibal, J; Garrido, N; Abu, E; Jean, A; Melado, L; Fatemi, HM				Lawrenz, Barbara; Sibal, Junard; Garrido, Nicolas; Abu, Emmanuel; Jean, Alliza; Melado, Laura; Fatemi, Human M.			Inter-assay variation and reproducibility of progesterone measurements during ovarian stimulation for IVF	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH-RATES; SERUM PROGESTERONE; ANTAGONIST CYCLES; FOLLICULAR PHASE; EMBRYO-TRANSFER; PREGNANCY; ELEVATION	In recent years there is increasing evidence that elevated progesterone levels during ovarian stimulation for IVF / ICSI have a negative impact on the ART-outcome. However, different progesterone assays were used in the previous studies and different assays might produce varying results. This retrospective study evaluated the reproducibility and reliability of different progesterone assays with a special focus on progesterone levels below 1.5 ng/ml, as this range is crucial for early detection of progesterone rise during ovarian stimulation for IVF. A total of 413 blood samples were categorized in different progesterone ranges and whether they were retrieved on the day of final oocyte maturation and the results were compared regarding their reproducibility and reliability. To compare the reproducibility between the different progesterone assays, the Intraclass Correlation Coefficient (ICC) was calculated and interpretation of the ICC results was done according to Cicchetti, ranging from poor to excellent. The correlation of the assays was excellent when all samples were compared including samples retrieved on day of final oocyte maturation, however in the ranges of progesterone levels 1.0 ng/ml to < 1.5 ng/ml, 0.8 ng/ml to < 1.0 ng/ml and < 0.8 ng/ml, the ICC varied between poor and excellent. The assays " gen III" and " Architect" showed an excellent reproducibility of progesterone results throughout all ranges of progesterone levels. This analysis demonstrates, that different progesterone assays have a limited reproducibility and that the results depend on the assay used and the range of progesterone level. This fact leads to two important conclusions. Firstly the limited reproducibility might lead to substantially different treatment decisions in ovarian stimulation treatment for IVF and secondly critical interpretation of thresholds, provided by meta-analysis, is crucial despite the risk that the so far gained clinical experience might become irrelevant and has to be adjusted to the results, obtained by each assay.	[Lawrenz, Barbara; Sibal, Junard; Abu, Emmanuel; Jean, Alliza; Melado, Laura; Fatemi, Human M.] IVIRMA Middle East Fertil Clin, Abu Dhabi, U Arab Emirates; [Lawrenz, Barbara] Womens Univ Hosp Tuebingen, Obstet Dept, Tubingen, Germany; [Garrido, Nicolas] IVI Valencia, IVI Fdn, Valencia, Spain	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Valencia	Lawrenz, B (corresponding author), IVIRMA Middle East Fertil Clin, Abu Dhabi, U Arab Emirates.; Lawrenz, B (corresponding author), Womens Univ Hosp Tuebingen, Obstet Dept, Tubingen, Germany.	barbara.lawrenz@ivirma.com	Lawrenz, Barbara/AAH-3399-2020; fatemi, human/AAH-3250-2020; Garrido, Nicolas/ABG-3235-2020	Garrido, Nicolas/0000-0001-8271-5218; Lawrenz, Barbara/0000-0001-6209-4223				Bosch E, 2003, FERTIL STERIL, V80, P1444, DOI 10.1016/j.fertnstert.2003.07.002; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Connell MT, 2016, FERTIL STERIL, V106, P584, DOI 10.1016/j.fertnstert.2016.04.024; EDELSTEIN MC, 1990, FERTIL STERIL, V54, P853; FANCHIN R, 1993, FERTIL STERIL, V59, P1090; GIVENS CR, 1994, FERTIL STERIL, V62, P1011; Huang B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145895; Kilicdag EB, 2010, ARCH GYNECOL OBSTET, V281, P747, DOI 10.1007/s00404-009-1248-0; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kyrou D, 2011, FERTIL STERIL, V96, P1112, DOI 10.1016/j.fertnstert.2011.08.029; Lawrenz B, 2016, HUM REPROD, V31, P2554, DOI 10.1093/humrep/dew213; Lawrenz B, 2018, FERTIL STERIL, V109, P577, DOI 10.1016/j.fertnstert.2018.02.128; Patton PE, 2014, FERTIL STERIL, V101, P1629, DOI 10.1016/j.fertnstert.2014.02.037; Racca A., 2018, HUM REPROD; Santos-Ribeiro S, 2014, HUM REPROD, V29, P1698, DOI 10.1093/humrep/deu151; Ubaldi F, 1996, HUM REPROD, V11, P1405; Ubaldi F, 1995, HUM REPROD, V10, P3091, DOI 10.1093/oxfordjournals.humrep.a135864; Ubaldi F, 1997, FERTIL STERIL, V67, P521, DOI 10.1016/S0015-0282(97)80080-5; Venetis CA, 2013, HUM REPROD UPDATE, V19, P433, DOI 10.1093/humupd/dmt014; Xu B, 2012, FERTIL STERIL, V97, P1321, DOI 10.1016/j.fertnstert.2012.03.014	20	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206098	10.1371/journal.pone.0206098	http://dx.doi.org/10.1371/journal.pone.0206098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383804	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600027
J	Perez-Brumer, A; Nunn, A; Hsiang, E; Oldenburg, C; Bender, M; Beauchamps, L; Mena, L; MacCarthy, S				Perez-Brumer, Amaya; Nunn, Amy; Hsiang, Elaine; Oldenburg, Catherine; Bender, Melverta; Beauchamps, Laura; Mena, Leandro; MacCarthy, Sarah			"We don't treat your kind": Assessing HIV health needs holistically among transgender people in Jackson, Mississippi	PLOS ONE			English	Article							SOCIAL SUPPORT; RISK; WOMEN; DETERMINANTS; DEPRESSION; PREVALENCE; HIV/AIDS	HIV disproportionately impacts transgender communities and the majority of new infections occur in the Southern United States. Yet, limited data exists on contextual realities of HIV vulnerability and healthcare needs among transgender individuals in the Deep South. Addressing this gap in the literature, we assess the health needs, including barriers and facilitators to accessing healthcare, including and beyond HIV, from the perspective of transgender men and women in Mississippi. Between June-August 2014, in-depth, semi-structured qualitative interviews (n = 14) were conducted with adult transgender persons at an LGBT healthcare setting in Jackson, Mississippi. In-depth interviews lasted between 60-90 minutes and followed semi-structured format (themes probed: HIV vulnerability, healthcare needs, and availability of gender-affirming medical care). Audio files were transcribed verbatim and analyzed using Dedoose (v.6.1.18). Among participants (mean age = 23.3 years, standard deviation = 4.98), 43% identified as a transgender man or on a transmasculine spectrum, 43% as Black, and 21% self-reported living with HIV. HIV-related services were frequently described as the primary gateway to accessing healthcare needs. Nonetheless, participants' primary health concerns were: gender affirmation processes (hormones, silicone, binding/packing); mental health; and drug/alcohol use. Stigma and discrimination were commonly reported in healthcare settings and health-related information was primarily attained through social networks and online resources. Results highlight gender identity alongside race and pervasive marginalization as key social determinants of transgender health in Mississippi. As Mississippi is one of several states actively debating transgender access to public accommodations, findings underscore the need to treat transgender health as a holistic and multidimensional construct, including, but moving beyond, HIV prevention and care.	[Perez-Brumer, Amaya] Columbia Univ, Dept Sociomed Sci, New York, NY 10032 USA; [Nunn, Amy] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, Providence, RI 02912 USA; [Nunn, Amy] Brown Univ, Sch Publ Hlth, Rhode Isl Publ Hlth Inst, Providence, RI 02912 USA; [Hsiang, Elaine] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Oldenburg, Catherine] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA; [Oldenburg, Catherine] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA USA; [Oldenburg, Catherine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bender, Melverta; Beauchamps, Laura; Mena, Leandro] Univ Mississippi, Med Ctr, Div Infect Dis, Jackson, MS 39216 USA; [Mena, Leandro] John D Bower Sch Populat Hlth, Dept Populat Hlth Sci, Jackson, MS USA; [MacCarthy, Sarah] RAND Corp, Santa Monica, CA USA	Columbia University; Brown University; Brown University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Mississippi; University of Mississippi Medical Center; RAND Corporation	Perez-Brumer, A (corresponding author), Columbia Univ, Dept Sociomed Sci, New York, NY 10032 USA.	agp2133@cumc.columbia.edu	Perez-Brumer, Amaya/AAF-6336-2021	Perez-Brumer, Amaya/0000-0003-2441-4358	National Institute of Child Health & Human Development T32 grant [R25MH83620]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH083620] Funding Source: NIH RePORTER	National Institute of Child Health & Human Development T32 grant; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	APB is supported by a National Institute of Child Health & Human Development T32 grant R25MH83620.	[Anonymous], 2008, CLOS GAP GEN HLTH EQ; Baral SD, 2013, LANCET INFECT DIS, V13, P214, DOI 10.1016/S1473-3099(12)70315-8; Benotsch EG, 2013, DRUG ALCOHOL DEPEN, V132, P391, DOI 10.1016/j.drugalcdep.2013.02.027; Borkan J., 1999, DOING QUALITATIVE RE, V2nd ed., P179; Bowen GA, 2008, QUAL RES, V8, P137, DOI 10.1177/1468794107085301; Bradford J, 2013, AM J PUBLIC HEALTH, V103, P1820, DOI 10.2105/AJPH.2012.300796; Budge SL, 2013, J CONSULT CLIN PSYCH, V81, P545, DOI 10.1037/a0031774; Committee on the Future of Atmospheric Chemistry Research Board on Atmospheric Sciences and Climate Division on Earth and Life Studies and National Academies of Sciences Engineering and Medicine, 2016, FUTURE ATMOSPHERIC C, DOI 10.17226/23573; Conron KJ, 2012, AM J PUBLIC HEALTH, V102, P118, DOI 10.2105/AJPH.2011.300315; Coulter RWS, 2015, DRUG ALCOHOL DEPEN, V154, P251, DOI 10.1016/j.drugalcdep.2015.07.006; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [https://doi.org/10.2307/1229039, DOI 10.2307/1229039]; Garofalo R, 2006, J ADOLESCENT HEALTH, V38, P230, DOI 10.1016/j.jadohealth.2005.03.023; Gates G, 2011, MANY PEOPLE ARE LESB; Grant JM, 2010, NATL TRANSGENDER DIS; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Herbst JH, 2008, AIDS BEHAV, V12, P1, DOI 10.1007/s10461-007-9299-3; Hrostowski S, 2015, SOC WORK HEALTH CARE, V54, P474, DOI 10.1080/00981389.2015.1030057; Hughto JMW, 2015, SOC SCI MED, V147, P222, DOI 10.1016/j.socscimed.2015.11.010; Mathews T J, 2012, Natl Vital Stat Rep, V60, P1; Nemoto T, 2011, AM J PUBLIC HEALTH, V101, P1980, DOI 10.2105/AJPH.2010.197285; Truong N, 2016, GLOB PUBLIC HEALTH, V11, P937, DOI 10.1080/17441692.2016.1142593; Palys T., 2008, SAGE ENCY QUALITATIV, P697, DOI DOI 10.4135/9781412963909.N349; Pega F, 2015, AM J PUBLIC HEALTH, V105, pE58, DOI 10.2105/AJPH.2014.302373; Perez-Brumer A, 2015, BEHAV MED, V41, P164, DOI 10.1080/08964289.2015.1028322; Poteat T, 2014, CURR OPIN HIV AIDS, V9, P168, DOI 10.1097/COH.0000000000000030; Reif SS, 2014, AIDS CARE, V26, P351, DOI 10.1080/09540121.2013.824535; Reisner S.L., 2014, DISCRIMINATION HLTH; Reisner SL, 2014, LGBT HEALTH, V1, P177, DOI 10.1089/lgbt.2014.0009; Rood BA, 2015, LGBT HEALTH, V2, P270, DOI 10.1089/lgbt.2013.0048; Rowe C, 2015, DRUG ALCOHOL DEPEN, V147, P160, DOI 10.1016/j.drugalcdep.2014.11.023; Safer JD, 2016, CURR OPIN ENDOCRINOL, V23, P168, DOI 10.1097/MED.0000000000000227; Sevelius JM, 2014, ANN BEHAV MED, V47, P5, DOI 10.1007/s12160-013-9565-8; Sevelius JM, 2013, SEX ROLES, V68, P675, DOI 10.1007/s11199-012-0216-5; Torres CG, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0505-6; Unites States Census Bureau, MISS 2015 QUICKF	35	26	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0202389	10.1371/journal.pone.0202389	http://dx.doi.org/10.1371/journal.pone.0202389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383751	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600005
J	Petriglieri, F; Nierychlo, M; Nielsen, PH; Mcllroy, SJ				Petriglieri, Francesca; Nierychlo, Marta; Nielsen, Per Halkjaemr; Mcllroy, Simon Jon			In situ visualisation of the abundant Chloroflexi populations in full-scale anaerobic digesters and the fate of immigrating species	PLOS ONE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; GEN. NOV.; FILAMENTOUS BACTERIA; HYBRIDIZATION; ANAEROLINEAE; IDENTIFICATION; CALDILINEA; BULKING; MEMBER	Anaerobic digestion is a key process for the conversion of waste organics to biogas for energy and is reliant on the synergistic activities of complex microbial communities. Members of the phylum Chloroflexi are often found to be abundant in these systems, yet little is known of their role, with most members yet to be cultured or identified. The aim of this study was to characterize the Chloroflexi communities present in full-scale anaerobic digesters receiving excess sludge from wastewater treatment plants. The core genus-level-phylotypes were identified from extensive 16S rRNA gene amplicon sequencing surveys of 19 full-scale systems over a 6 year period. The T78 and Leptolinea, and the RB349 and SJA-170, were found to be the most abundant genera of mesophilic and thermophilic digesters, respectively. With the exception of Leptolinea, these phylotypes are known only by their 16S rRNA gene sequence, and their morphology and metabolic potentials are not known. Fluorescence in situ hybridisation (FISH) probes were designed for these phylotypes, with their application revealing a similar thin filamentous morphology, indicating a possible role for these organisms in maintaining floc structure. The new FISH probes provide a useful tool for future efforts to characterize these organisms in situ. FISH also suggests that immigrating Chloroflexi species die off in the anaerobic digester environment and their high abundance in anaerobic digesters, observed with DNA based sequencing surveys, was quite possibly due to the persistence of their DNA after their death. This observation is important for the interpretation of popular DNA-based sequencing methods applied for the characterisation of communities with substantial immigration rates, such as anaerobic digesters.	[Petriglieri, Francesca; Nierychlo, Marta; Nielsen, Per Halkjaemr; Mcllroy, Simon Jon] Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark	Aalborg University	Mcllroy, SJ (corresponding author), Aalborg Univ, Ctr Microbial Communities, Dept Chem & Biosci, Aalborg, Denmark.	s.mcilroy@uq.edu.au	Nielsen, Per Halkjær/T-6796-2018; McIlroy, Simon Jon/P-4785-2017	Nielsen, Per Halkjær/0000-0002-6402-1877; Nierychlo, Marta/0000-0003-1756-3726; McIlroy, Simon Jon/0000-0003-3749-8730; Petriglieri, Francesca/0000-0002-1676-7690	Danish Council for Independent Research [4093-00127A]; Villum foundation [VKR 022796]; Innovation Fund Denmark (NomiGas) [1305-00018B]; Aalborg University	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Villum foundation(Villum Fonden); Innovation Fund Denmark (NomiGas); Aalborg University	Danish Council for Independent Research (grant no. 4093-00127A), the Villum foundation (grant no. VKR 022796), the Innovation Fund Denmark (NomiGas, grant no. 1305-00018B) and Aalborg University.	Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Appels L, 2011, RENEW SUST ENERG REV, V15, P4295, DOI 10.1016/j.rser.2011.07.121; Ariesyady HD, 2007, WATER RES, V41, P1554, DOI 10.1016/j.watres.2006.12.036; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Daims H, 2006, ENVIRON MICROBIOL, V8, P200, DOI 10.1111/j.1462-2920.2005.00880.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; Ganidi N, 2009, BIORESOURCE TECHNOL, V100, P5546, DOI 10.1016/j.biortech.2009.06.024; Hao LP, 2018, ISME J, V12, P2225, DOI 10.1038/s41396-018-0187-9; Kirkegaard RH, 2016, ISME J, V10, P2352, DOI 10.1038/ismej.2016.43; Kirkegaard RH, 2017, SCI REP, V7, P1; Kragelund C, 2008, MICROBIOL-SGM, V154, P886, DOI 10.1099/mic.0.2007/011684-0; Kragelund C, 2011, FEMS MICROBIOL ECOL, V76, P451, DOI 10.1111/j.1574-6941.2011.01065.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Martiny AC, 2013, ISME J, V7, P830, DOI 10.1038/ismej.2012.160; McIlroy SJ, 2011, ENVIRON MICROBIOL, V13, P33, DOI 10.1111/j.1462-2920.2010.02306.x; McIlroy SJ, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax016; McIlroy SJ, 2016, ISME J, V10, P2223, DOI 10.1038/ismej.2016.14; Mei R, 2016, SCI REP-UK, V6, DOI 10.1038/srep34090; Nelson MC, 2011, BIORESOURCE TECHNOL, V102, P3730, DOI 10.1016/j.biortech.2010.11.119; Nierychlo M., 2015, HYDROCARBON AND LIPI, P115; Riviere D, 2009, ISME J, V3, P700, DOI 10.1038/ismej.2009.2; Sekiguchi Y, 2003, INT J SYST EVOL MICR, V53, P1843, DOI 10.1099/ijs.0.02699-0; Speirs L, 2009, APPL ENVIRON MICROB, V75, P2446, DOI 10.1128/AEM.02310-08; Speirs LBM, 2011, ENV MICROBIOL REP, V3, P159, DOI 10.1111/j.1758-2229.2010.00201.x; Stahl D.A., 1991, NUCL ACID TECHNIQUES, P205; Stokholm-Bjerregaard M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00718; Sun L, 2016, INT J SYST EVOL MICR, V66, P988, DOI 10.1099/ijsem.0.000822; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Weiland P, 2010, APPL MICROBIOL BIOT, V85, P849, DOI 10.1007/s00253-009-2246-7; Xia Y, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0524-z; Yamada T, 2005, APPL ENVIRON MICROB, V71, P7493, DOI 10.1128/AEM.71.11.7493-7503.2005; Yamada T, 2007, INT J SYST EVOL MICR, V57, P2299, DOI 10.1099/ijs.0.65098-0; Yamada T, 2006, INT J SYST EVOL MICR, V56, P1331, DOI 10.1099/ijs.0.64169-0; Yilmaz LS, 2011, APPL ENVIRON MICROB, V77, P1118, DOI 10.1128/AEM.01733-10	40	18	18	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206255	10.1371/journal.pone.0206255	http://dx.doi.org/10.1371/journal.pone.0206255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383873	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600033
J	Tewolde, FT; Shiina, K; Maruo, T; Takagaki, M; Kozai, T; Yamori, W				Tewolde, Fasil Tadesse; Shiina, Kouta; Maruo, Toru; Takagaki, Michiko; Kozai, Toyoki; Yamori, Wataru			Supplemental LED inter-lighting compensates for a shortage of light for plant growth and yield under the lack of sunshine	PLOS ONE			English	Article							TOMATO PLANTS; TEMPERATURE-ACCLIMATION; CHLOROPHYLL CONTENT; PHYSIOLOGICAL-ROLE; SOLAR-RADIATION; PHOTOSYSTEM-I; PHOTOSYNTHESIS; LEAVES; QUALITY; GREENHOUSE	Supplemental lighting can enhance yield when sunlight is limited, as in winter. As the effect of frequent cloudy or rainy days in other seasons on plant growth and yield remains unclear, we investigated the effect on tomato (Solanum lycopersicum) and compensation by supplemental LED inter-lighting. Plants were grown under 30% shade cloth on 0%, 40%, or 60% of days. Lower leaves were illuminated with red and blue LED inter-lighting modules from right after first anthesis, or not illuminated. Shading during 40% and 60% of days diminished daily light integral (DLI) by 26% and 40%, respectively, and reduced shoot dry weight by 22.0% and 23.3%, yield by 18.5% and 23.3%, and fruit soluble solids content by 12.3% and 9.3%. In contrast, supplemental inter-lighting improved the light distribution within plants and compensated DLI, and maintained similar yield and soluble solids content in both shade treatments as in the control. These results clearly show that supplemental LED inter-lighting could efficiently compensate for a shortage of light for plant growth, photosynthesis and thus yield under the lack of sunshine.	[Tewolde, Fasil Tadesse; Maruo, Toru; Takagaki, Michiko] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Tewolde, Fasil Tadesse; Maruo, Toru; Takagaki, Michiko; Yamori, Wataru] Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan; [Tewolde, Fasil Tadesse] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Shiina, Kouta] JA Zen Noh, Kashiwa, Chiba, Japan; [Kozai, Toyoki] Japan Plant Factory Assoc, Kashiwa, Chiba, Japan; [Yamori, Wataru] Univ Tokyo, Fac Sci, Dept Biol Sci, Tokyo, Japan	Chiba University; Chiba University; Ethiopian Institute of Agricultural Research (EIAR); University of Tokyo	Yamori, W (corresponding author), Chiba Univ, Ctr Environm Hlth & Field Sci, Kashiwa, Chiba, Japan.; Yamori, W (corresponding author), Univ Tokyo, Fac Sci, Dept Biol Sci, Tokyo, Japan.	wataru.yamori@bs.s.u-tokyo.ac.jp	Yamori, Wataru/C-5680-2011	Yamori, Wataru/0000-0001-7215-4736	Japan Society for the Promotion of Science (JSPS) [16H06552, 18H02185]; JA Zen-noh	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JA Zen-noh	This study was partly supported by Japan Society for the Promotion of Science (JSPS) [KAKENHI Grant Number: 16H06552 and 18H02185 (to W.Y.)]. JA Zen-noh provided support in the form of salaries for authors KS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	ACOCK B, 1978, J EXP BOT, V29, P815, DOI 10.1093/jxb/29.4.815; Adams SR, 2001, ANN BOT-LONDON, V88, P869, DOI 10.1006/anbo.2001.1524; Alton PB, 2008, AGR FOREST METEOROL, V148, P1641, DOI 10.1016/j.agrformet.2008.05.014; Bartoli CG, 2006, J EXP BOT, V57, P1621, DOI 10.1093/jxb/erl005; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; COCKSHULL KE, 1992, J HORTIC SCI, V67, P11, DOI 10.1080/00221589.1992.11516215; Dorais M, 2003, CAN GREENH C OCT 9 2; FAO, 2012, FAOSTAT DAT COLL; FISCHER RA, 1978, ANNU REV PLANT PHYS, V29, P277, DOI 10.1146/annurev.pp.29.060178.001425; Foyer C. H., 1993, ANTIOXIDANTS HIGHER, P31; Frantz JM, 2000, J AM SOC HORTIC SCI, V125, P694, DOI 10.21273/JASHS.125.6.694; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Ghosh PK, 2004, BIORESOURCE TECHNOL, V95, P85, DOI 10.1016/j.biortech.2004.02.012; GIACOMELLI GA, 1994, ACTA HORTIC, P77, DOI 10.17660/ActaHortic.1994.361.6; GINIGER MS, 1988, T ASAE, V31, P1176; Goto Eiji, 2003, Environment Control in Biology, V41, P121; Gunnlaugsson E., 2006, P 5 INT S ART LIGHT, V711, P71, DOI [10.17660/ActaHortic.2006.711.6, DOI 10.17660/ACTAH0RTIC.2006.711.6]; Hanan J., 1998, GREENHOUSES ADV TECH; Hao X, 2012, ACTA HORTIC, V956, P335, DOI 10.17660/ActaHortic.2012.956.38; Heuvelink E, 2006, ACTA HORTIC, P25, DOI 10.17660/ActaHortic.2006.711.1; HISATOMI T, 1978, J JPN SOC HORTIC SCI, V46, P487, DOI 10.2503/jjshs.46.487; Hovi T, 2004, SCI HORTIC-AMSTERDAM, V102, P283, DOI 10.1016/j.scienta.2004.04.003; Hovi-Pekkanen T, 2008, SCI HORTIC-AMSTERDAM, V116, P152, DOI 10.1016/j.scienta.2007.11.010; Imai T, 1999, FREE RADICAL RES, V31, pS171, DOI 10.1080/10715769900301471; JMA, 2014, DAT SOL INFR RAD; Joshi J, 2017, HORTSCIENCE, V52, P831, DOI [10.21273/HORTSCI11822-17, 10.]; Liu XiaoYing, 2012, African Journal of Biotechnology, V11, P6169; Lu Na, 2012, Environmental Control in Biology, V50, P63; Lu Na, 2012, Environmental Control in Biology, V50, P1; Mao LZ, 2007, PHOTOSYNTHETICA, V45, P601, DOI 10.1007/s11099-007-0103-4; Marcelis LFM, 2006, ACTA HORTIC, P97, DOI 10.17660/ActaHortic.2006.711.9; MCAVOY RJ, 1988, SCI HORTIC-AMSTERDAM, V35, P161, DOI 10.1016/0304-4238(88)90109-4; MCAVOY RJ, 1989, J HORTIC SCI, V64, P331, DOI 10.1080/14620316.1989.11515961; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Merrill B. F., 2016, HDB PHOTOSYNTHESIS; Monostori I, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00605; NAIDU RA, 1984, PHYSIOL PLANT PATHOL, V25, P191, DOI 10.1016/0048-4059(84)90057-2; NOVOA R, 1981, PLANT SOIL, V58, P177, DOI 10.1007/BF02180053; Okano K, 2001, JARQ-JPN AGR RES Q, V35, P177, DOI 10.6090/jarq.35.177; Pettersen RI, 2010, SCI HORTIC-AMSTERDAM, V125, P77, DOI 10.1016/j.scienta.2010.02.006; Sandri Miguel Angelo, 2003, Hortic. Bras., V21, P642, DOI 10.1590/S0102-05362003000400013; Stanhill G, 2001, AGR FOREST METEOROL, V107, P255, DOI 10.1016/S0168-1923(00)00241-0; Takai T, 2010, FIELD CROP RES, V115, P165, DOI 10.1016/j.fcr.2009.10.019; Tewolde FT, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00448; Trouwborst G, 2010, PHYSIOL PLANTARUM, V138, P289, DOI 10.1111/j.1399-3054.2009.01333.x; Wada T, 2006, J JPN SOC HORTIC SCI, V75, P51, DOI 10.2503/jjshs.75.51; Wang H, 2007, SCI HORTIC-AMSTERDAM, V112, P66, DOI 10.1016/j.scienta.2006.12.007; Wang KC, 2012, ATMOS CHEM PHYS, V12, P9581, DOI 10.5194/acp-12-9581-2012; Wild M, 2005, SCIENCE, V308, P847, DOI 10.1126/science.1103215; Xu HL, 1997, PHOTOSYNTHETICA, V33, P113, DOI 10.1023/A:1022135507700; Yamori W, 2005, PLANT CELL ENVIRON, V28, P536, DOI 10.1111/j.1365-3040.2004.01299.x; Yamori W., 2013, J PLANT BIOCH PHYSL, V1, P113; Yamori W, 2016, J PLANT RES, V129, P379, DOI 10.1007/s10265-016-0816-1; Yamori W, 2016, ANNU REV PLANT BIOL, V67, P81, DOI 10.1146/annurev-arplant-043015-112002; Yamori W, 2016, SCI REP-UK, V6, DOI 10.1038/srep20147; Yamori W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13908; Yamori W, 2010, PLANT PHYSIOL, V152, P388, DOI 10.1104/pp.109.145862; Yamori W, 2009, PLANT CELL PHYSIOL, V50, P203, DOI 10.1093/pcp/pcn189; Zhang G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01110	59	16	17	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206592	10.1371/journal.pone.0206592	http://dx.doi.org/10.1371/journal.pone.0206592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383825	Green Published, gold			2022-12-26	WOS:000449027600070
J	Cui, WC; Li, XH; Hull, L; Xiao, M				Cui, Wanchang; Li, XiangHong; Hull, Lisa; Xiao, Mang			Measuring radiation-induced DNA damage in Cryptococcus neoformans and Saccharomyces cerevisiae using long range quantitative PCR	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; GEL-ELECTROPHORESIS; REPAIR; CELLS; NUCLEAR; CHROMATIN; RESTORE	DNA damage has been considered to be the universal critical lesion in cells after exposure to ionizing radiation. Measuring radiation-induced DNA damage is important to understand the mechanisms of radiation-induced toxicity and monitor DNA damage repairs. Currently the most widely used methods to measure DNA damage are pulsed-field gel electrophoresis (PFGF) and single-cell gel electrophoresis (also known as the comet assay), both of which are technically challenging and time consuming. Long range quantitative polymerase chain reaction (LR-QPCR) has been used successfully to measure nuclear and mitochondrial DNA damage in mammalian and several model organism cells. The principle of this assay is that DNA lesions will slow down or block the progression of DNA polymerase. Therefore, the amplification efficiency of DNA with fewer lesions will be higher than DNA with more lesions under the same reaction condition. Here, we developed the LR-QPCR assay primers and reaction conditions to quantify DNA damage in Cryptococcus neoformans (C. neoformans) and Saccharomyces cerevisiae (S. cerevisiae) after gamma ray exposure. Under these conditions, long DNA targets of C. neoformans H99 and S. cerevisiae BY4741 (17.6 and 16.4 kb for nuclear DNA and 15.3 and 14.6 kb for mitochondrial DNA) were quantitatively amplified using extracted DNA templates, respectively. Two short mitochondrial DNA targets of these two species (207 bp and 154 bp) were also quantitatively amplified and used to monitor the number of mitochondria. Using the LR-QPCR method, we showed that the frequency of radiation-induced mitochondrial and nuclear DNA lesions had a significant linear correlation with the radiation doses (from 500 Gy to 3000 Gy) in both species. Furthermore, the faster disappearance of DNA damage detected in C. neoformans H99S strain compared to H99 strain may help to explain the different radiation sensitivity of these two strains. In summary, we developed a simple, sensitive method to measure radiation-induced DNA damage, which can greatly facilitate the study of radiation-induced toxicity and can be widely used as a dosimetry in radiation-induced cell damage.	[Cui, Wanchang; Li, XiangHong; Hull, Lisa; Xiao, Mang] Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Xiao, M (corresponding author), Uniformed Serv Univ Hlth Sci, Radiat Countermeasures Program, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA.	mang.xiao@usuhs.edu		Cui, Wanchang/0000-0001-6408-8601	DEFENSE THREAT REDUCTION AGENCY [HDTRA-1-15-1-7335]	DEFENSE THREAT REDUCTION AGENCY(United States Department of DefenseDefense Threat Reduction Agency)	The work was supported by DEFENSE THREAT REDUCTION AGENCY (htip://www.dtra.mil) Grant HDTRA-1-15-1-7335 awarded to Mang Xiao (MX). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blasiak J, 2013, INT J MOL SCI, V14, P2996, DOI 10.3390/ijms14022996; BLOK J, 1973, Current Topics in Radiation Research Quarterly, V9, P165; Cao J, 2006, TOXICOL SCI, V91, P476, DOI 10.1093/toxsci/kfj153; Crnich CJ, 2014, J CLIN MICROBIOL, V52, P2027, DOI 10.1128/JCM.03466-13; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Furda A, 2014, METHODS MOL BIOL, V1105, P419, DOI 10.1007/978-1-62703-739-6_31; Gonzalez B, 1997, YEAST, V13, P1347, DOI 10.1002/(SICI)1097-0061(199711)13:14<1347::AID-YEA176>3.0.CO;2-O; GOVAN HL, 1990, NUCLEIC ACIDS RES, V18, P3823, DOI 10.1093/nar/18.13.3823; Hall EJ, 2006, RADIOBIOLOGY RADIOLO; HUTCHINSON F, 1966, CANCER RES, V26, P2045; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jia HY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05737; Jung KW, 2016, MBIO, V7, DOI [10.1128/mBio.01483-16, 10.1128/mbio.01483-16]; KALINOWSKI DP, 1992, NUCLEIC ACIDS RES, V20, P3485, DOI 10.1093/nar/20.13.3485; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; Kawashima Y, 2017, GENES CELLS, V22, P84, DOI 10.1111/gtc.12457; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007; Mseddi F, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-5; Polo SE, 2015, DNA REPAIR, V36, P114, DOI 10.1016/j.dnarep.2015.09.014; Rodriguez RA, 2013, J APPL MICROBIOL, V114, P1854, DOI 10.1111/jam.12169; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Senoo T, 2016, J MICROBIOL METH, V127, P77, DOI 10.1016/j.mimet.2016.05.023; Sharma A, 2017, P NATL ACAD SCI USA, V114, pE9253, DOI 10.1073/pnas.1713608114; Singh Gyanesh, 2015, F1000Res, V4, P176, DOI 10.12688/f1000research.6665.1; Soria G, 2012, MOL CELL, V46, P722, DOI 10.1016/j.molcel.2012.06.002; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207071	10.1371/journal.pone.0207071	http://dx.doi.org/10.1371/journal.pone.0207071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408089	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300073
J	Gielbert, A; Thorne, JK; Plater, JM; Thorne, L; Griffiths, PC; Simmons, MM; Cassar, CA				Gielbert, Adriana; Thorne, Jemma K.; Plater, Jane M.; Thorne, Leigh; Griffiths, Peter C.; Simmons, Marion M.; Cassar, Claire A.			Molecular characterisation of atypical BSE prions by mass spectrometry and changes following transmission to sheep and transgenic mouse models	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; TRUNCATED FORMS; GREAT-BRITAIN; LIQUID-CHROMATOGRAPHY; VARIANT CJD; PROTEIN; MICE; SCRAPIE; STRAIN; CATTLE	The prion hypothesis proposes a causal relationship between the misfolded prion protein (PrPSc) molecular entity and the disease transmissible spongiform encephalopathy (TSE). Variations in the conformation of PrPSc are associated with different forms of TSE and different risks to animal and human health. Since the discovery of atypical forms of bovine spongiform encephalopathy (BSE) in 2003, scientists have progressed the molecular characterisation of the associated PrPSc in order to better understand these risks, both in cattle as the natural host and following experimental transmission to other species. Here we report the development of a mass spectrometry based assay for molecular characterisation of bovine proteinase K (PK) treated PrPSc (PrPres) by quantitative identification of its N-terminal amino acid profiles (N-TAAPs) and tryptic peptides. We have applied the assay to classical, H-type and L-type BSE prions purified from cattle, transgenic (Tg) mice expressing the bovine (Tg110 and Tg1896) or ovine (TgEM16) prion protein gene, and sheep brain. We determined that, for classical BSE in cattle, the G96 N-terminal cleavage site dominated, while the range of cleavage sites was wider following transmission to Tg mice and sheep. For L-BSE in cattle and Tg bovinised mice, a C-terminal shift was identified in the N-TAAP distribution compared to classical BSE, consistent with observations by Western blot (WB). For L-BSE transmitted to sheep, both N-TAAP and tryptic peptide profiles were found to be changed compared to cattle, but less so following transmission to Tg ovinised mice. Relative abundances of aglycosyl peptides were found to be significantly different between the atypical BSE forms in cattle as well as in other hosts. The enhanced resolution provided by molecular analysis of PrPres using mass spectrometry has improved insight into the molecular changes following transmission of atypical BSE to other species.	[Gielbert, Adriana; Thorne, Jemma K.; Plater, Jane M.; Thorne, Leigh; Griffiths, Peter C.; Simmons, Marion M.; Cassar, Claire A.] Anim & Plant Hlth Agcy Weybridge, Addlestone, Surrey, England	Animal & Plant Health Agency UK	Gielbert, A (corresponding author), Anim & Plant Hlth Agcy Weybridge, Addlestone, Surrey, England.	janine.gielbert@apha.gov.uk	Gielbert, Adriana/C-5188-2011	Gielbert, Adriana/0000-0003-1597-9373	Department for Environment, Food and Rural Affairs (Defra), UK	Department for Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA))	This work was funded by the Department for Environment, Food and Rural Affairs (Defra), UK (Grants SE2020 to AG and SE1961 to MMS), https://WWW.gov.uk/goermment/organisations/department-ervironment-food-rural-affairs.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank former and current staff of the Animal Services Unit and the Pathology Department for their contribution to and expertise in generating experimental classical and atypical BSE infections, and to James Hope and John Spiropoulos for helpful discussions and critical reading of the manuscript. We are grateful to the Department for Environment, Food and Rural Affairs (Defra), UK, for funding this work (Grants SE2020 and SE1961).	[Anonymous], 2009, PREP MOR SENS BIOASS; Arnold ME, 2007, J GEN VIROL, V88, P3198, DOI 10.1099/vir.0.82987-0; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Bencsik A, 2013, J NEUROPATH EXP NEUR, V72, P211, DOI 10.1097/NEN.0b013e318285c7f9; Beringue V, 2008, EMERG INFECT DIS, V14, P1898, DOI 10.3201/eid1412.080941; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Beringue V, 2006, PLOS PATHOG, V2, P956, DOI 10.1371/journal.ppat.0020112; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2007, PRION, V1, P61, DOI 10.4161/pri.1.1.3828; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Chen SG, 2000, ARCH VIROL, P209; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Corda E, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0194-2; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Espinosa JC, 2007, J VIROL, V81, P835, DOI 10.1128/JVI.01356-06; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gielbert A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00007; Gielbert A, 2013, ANAL BIOCHEM, V436, P36, DOI 10.1016/j.ab.2013.01.015; Gielbert A, 2009, J MASS SPECTROM, V44, P384, DOI 10.1002/jms.1516; Green R, 2005, J COMP PATHOL, V132, P117, DOI 10.1016/j.jcpa.2004.08.002; Griffiths PC, 2013, J GEN VIROL, V94, P2577, DOI 10.1099/vir.0.051581-0; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; HOPE J, 1988, NATURE, V336, P390, DOI 10.1038/336390a0; Howells LC, 2008, BIOMARKERS, V13, P393, DOI [10.1080/13547500801903719, 10.1080/13547500801903719 ]; Jacobs JG, 2011, J GEN VIROL, V92, P222, DOI 10.1099/vir.0.026153-0; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Jeffrey M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0269-x; Konold T, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0243-2; Konold T, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-22; Langeveld JPM, 2011, J CLIN MICROBIOL, V49, P3026, DOI 10.1128/JCM.01102-11; Levavasseur E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172428; MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632; Mestre-Frances N, 2012, EMERG INFECT DIS, V18, P142, DOI 10.3201/eid1801.111092; Moreno JA, 2017, METHODS MOL BIOL, V1658, P219, DOI 10.1007/978-1-4939-7244-9_16; Nicot S, 2014, J INFECT DIS, V209, P950, DOI 10.1093/infdis/jit596; OIE, NUMB REP CAS BOV SPO; Okada H, 2015, VET RES, V46, DOI 10.1186/s13567-015-0211-2; Onisko B, 2007, J AM SOC MASS SPECTR, V18, P1070, DOI 10.1016/j.jasms.2007.03.009; Onisko BC, 2007, RAPID COMMUN MASS SP, V21, P4023, DOI 10.1002/rcm.3310; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; Pan T, 2001, J BIOL CHEM, V276, P37284, DOI 10.1074/jbc.M107358200; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Priem J, 2014, J VIROL, V88, P2903, DOI 10.1128/JVI.02446-13; Priemer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067599; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Requena JR, 2016, PRION, V10, P165, DOI 10.1080/19336896.2016.1175801; Sajnani G, 2008, J MOL BIOL, V382, P88, DOI 10.1016/j.jmb.2008.06.070; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Silva CJ, 2011, ANAL CHEM, V83, P1609, DOI 10.1021/ac102527w; Simmons MM, 2016, VET RES, V47, DOI 10.1186/s13567-016-0394-1; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Stack MJ, 2013, VET REC, V172, P70, DOI 10.1136/vr.101158; Stack MJ, 2009, VET REC, V165, P605, DOI 10.1136/vr.165.20.605-c; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Tang Y, 2014, APPL ENVIRON MICROB, V80, P478, DOI 10.1128/AEM.02472-13; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Torres JM, 2011, EMERG INFECT DIS, V17, P1636, DOI 10.3201/eid1709.101403; Watts JC, 2014, J BIOL CHEM, V289, P19841, DOI 10.1074/jbc.R114.550707; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; WILESMITH JW, 1988, VET REC, V123, P638	68	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206505	10.1371/journal.pone.0206505	http://dx.doi.org/10.1371/journal.pone.0206505			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408075	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300021
J	Wu, P; Arris, D; Grayson, M; Hung, CN; Ruparel, S				Wu, Ping; Arris, Dominic; Grayson, Max; Hung, Chia-Nung; Ruparel, Shivani			Characterization of sensory neuronal subtypes innervating mouse tongue	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; TRIGEMINAL GANGLION; NEUROPATHIC PAIN; ORAL MUCOSITIS; MERKEL CELLS; NERVE INJURY; RAT; RECEPTORS; HEAD; MOUTH	The tongue is uniquely exposed to water-soluble environmental chemicals that may lead to injury or tumorigenesis. However, comparatively little research has focused on the molecular and functional organization of trigeminal ganglia (TG) afferent neurons innervating the tongue. The current study identified and characterized lingual sensory neurons based on a neuronal subtype classification previously characterized in the dorsal root ganglion (DRG) neurons. We employed immunohistochemistry on transgenic reporter mouse lines as well as single-cell PCR of known markers of neuronal subtypes to characterize neuronal subtypes innervating the tongue. Markers expressed in retrogradely labeled TG neurons were evaluated for the proportion of neurons expressing each marker, intensity of expression, and overlapping genes. We found that tongue-innervating sensory neurons primarily expressed CGRP, TRPV1, TrkC, 5HT3A and Parvalbumin. These markers correspond to peptidergic and a subgroup of non-peptidergic C-nociceptors, peptidergic A nociceptors, proprioceptors and myelinated low-threshold mechanoreceptors (LTMRs). Interestingly, as reported previously, we also found several differences between TG and DRG neurons indicating the need for single-cell sequencing of neuronal types based on tissue type within all TG as well as DRG neurons.	[Wu, Ping; Arris, Dominic; Grayson, Max; Ruparel, Shivani] Univ Texas Hlth San Antonio, Dept Endodont, San Antonio, TX 78229 USA; [Hung, Chia-Nung] Univ Texas Hlth San Antonio, Dept Mol Med, San Antonio, TX USA; [Hung, Chia-Nung] Tunghai Univ, Dept Life Sci, Taichung, Taiwan	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Tunghai University	Ruparel, S (corresponding author), Univ Texas Hlth San Antonio, Dept Endodont, San Antonio, TX 78229 USA.	ruparels@uthscsa.edu			Palliative Care Pilot Award by the American Cancer Society; Institute of Integration of Medicine and Science (IIMS/CTSA); NIH [R01DE027223]; National Institute of Dental and Craniofacial Research; Cancer Prevention Research Institute of Texas [RP150600]; Office of Vice President of Research of UT Health at San Antonio; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE027223] Funding Source: NIH RePORTER	Palliative Care Pilot Award by the American Cancer Society; Institute of Integration of Medicine and Science (IIMS/CTSA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Cancer Prevention Research Institute of Texas; Office of Vice President of Research of UT Health at San Antonio; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by funds provided by the Palliative Care Pilot Award by the American Cancer Society (SR), the pilot project award (SR) by the Institute of Integration of Medicine and Science (IIMS/CTSA) and the NIH R01DE027223 (SR) by the National Institute of Dental and Craniofacial Research.; We would like to thank Dr. Xinzhong Dong (John Hopkins University Medical School, Baltimore, MD) for kindly providing MRGPRA3cre/+ and NPY2R-TdTomato reporter mice; Dr. Qin Liu (Washington University, St. Louis, MO) for kindly providing MRGPRD-GFP mice; and Dr. Yu Shin Kim (UTMB, Galveston, TX) for kindly providing trkCcre-ER/+ mouse line that was generated in Dr. David Ginty's laboratory (Harvard Medical School, Boston, MA). Single-cell gene expression analysis was performed by Bioanalytic and Single-cell core (BASiC) at UT Health at San Antonio. The BASiC core is supported by the Cancer Prevention Research Institute of Texas (RP150600) and the Office of Vice President of Research of UT Health at San Antonio. We thank Dr. Nameer Kirma for his advice on technical optimization of the technique. We also thank Jacob Boyd for his input on generating heatmaps with Graph Pad prism software.	Abe M, 2007, J DERMATOL, V34, P340, DOI 10.1111/j.1346-8138.2007.00284.x; ADATIA AK, 1971, J ANAT, V110, P215; Arcourt A, 2017, NEURON, V93, P179, DOI 10.1016/j.neuron.2016.11.027; Bae JY, 2018, J COMP NEUROL, V526, P2204, DOI 10.1002/cne.24476; Bai L, 2015, CELL, V163, P1783, DOI 10.1016/j.cell.2015.11.060; Balasubramaniam R, 2009, AUST DENT J, V54, P293, DOI 10.1111/j.1834-7819.2009.01153.x; Barettino D, 1999, BBA-GENE STRUCT EXPR, V1446, P24, DOI 10.1016/S0167-4781(99)00056-1; Batalla A, 2016, CUTIS, V98, pE3; Chang WP, 2016, P NATL ACAD SCI USA, V113, pE5491, DOI 10.1073/pnas.1610176113; Chaplin JM, 1999, HEAD NECK-J SCI SPEC, V21, P531, DOI 10.1002/(SICI)1097-0347(199909)21:6<531::AID-HED6>3.0.CO;2-M; Charalambous M, 2018, EUR J ONCOL NURS, V34, P89, DOI 10.1016/j.ejon.2018.04.003; Chen CL, 2013, PROSTATE, V73, P813, DOI 10.1002/pros.22625; Chen WL, 2014, EUR J NEUROSCI, V39, P1439, DOI 10.1111/ejn.12516; Chodroff L, 2016, MOL PAIN, V12, DOI 10.1177/1744806916666841; Cobo JL., 2017, JPRAS OPEN, V12, P9, DOI [10.1016/j.jpra.2017.01.005, DOI 10.1016/J.JPRA.2017.01.005]; COOPER S, 1953, J PHYSIOL-LONDON, V122, P193, DOI 10.1113/jphysiol.1953.sp004991; Corder G, 2010, J PAIN, V11, P388, DOI 10.1016/j.jpain.2009.09.008; de Nooij JC, 2013, NEURON, V77, P1055, DOI 10.1016/j.neuron.2013.01.015; Drage LA, 1999, MAYO CLIN PROC, V74, P223, DOI 10.4065/74.3.223; DUC C, 1994, EUR J NEUROSCI, V6, P264, DOI 10.1111/j.1460-9568.1994.tb00269.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; Dutta M, 2013, J NEPAL MED ASSOC, V52, P277, DOI 10.31729/jnma.585; Elitt CM, 2008, BRAIN RES, V1230, P80, DOI 10.1016/j.brainres.2008.06.119; EMESON RB, 1989, NATURE, V341, P76, DOI 10.1038/341076a0; EPSTEIN JB, 1993, ORAL ONCOL, V29B, P191, DOI 10.1016/0964-1955(93)90022-7; Ferreira WA, 2018, TOXINS, V10, DOI 10.3390/toxins10010012; FITZGERALD MJT, 1979, J ANAT, V128, P523; Santos JMG, 2018, INSIGHTS IMAGING, V9, P559, DOI 10.1007/s13244-018-0630-5; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GRINSPAN D, 1995, INT J DERMATOL, V34, P483, DOI 10.1111/j.1365-4362.1995.tb00617.x; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; Han L, 2013, NAT NEUROSCI, V16, P174, DOI 10.1038/nn.3289; Henry MA, 2006, PAIN, V124, P222, DOI 10.1016/j.pain.2006.05.028; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hockley JRF, 2019, GUT, V68, P633, DOI 10.1136/gutjnl-2017-315631; Kanazawa T, 2014, BRAIN RES BULL, V106, P17, DOI 10.1016/j.brainresbull.2014.04.015; KEEFE FJ, 1986, HEAD NECK-J SCI SPEC, V8, P169, DOI 10.1002/hed.2890080308; Keller MK, 2018, ORAL DIS, V24, P1107, DOI 10.1111/odi.12858; Kilinc E, 2017, NEUROPHARMACOLOGY, V116, P160, DOI 10.1016/j.neuropharm.2016.12.024; Kim YS, 2016, NEURON, V91, P1085, DOI 10.1016/j.neuron.2016.07.044; Lee SL, 1999, NEUROREPORT, V10, P2847, DOI 10.1097/00001756-199909090-00027; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Liu Q, 2009, CELL, V139, P1353, DOI 10.1016/j.cell.2009.11.034; Lorenzo LE, 2014, J NEUROSCI, V34, P8300, DOI 10.1523/JNEUROSCI.0159-14.2014; Loyd DR, 2011, PAIN, V152, P2267, DOI 10.1016/j.pain.2011.06.002; Luo PF, 2006, EUR J NEUROSCI, V23, P3269, DOI 10.1111/j.1460-9568.2006.04858.x; Ma FY, 2004, J NEUROCHEM, V90, P431, DOI 10.1111/j.1471-4159.2004.02492.x; Marable DR, 2016, ORAL DIS, V22, P140, DOI 10.1111/odi.12399; Martos-Fernandez Miriam, 2014, J Clin Exp Dent, V6, pe193, DOI 10.4317/jced.51375; Matsuo K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134659; Medici T, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0232-9; Menni S, 2004, J EUR ACAD DERMATOL, V18, P737, DOI 10.1111/j.1468-3083.2004.01032.x; Mercadante S, 2015, SUPPORT CARE CANCER, V23, P3249, DOI 10.1007/s00520-015-2720-y; Nakagawa T, 2007, NEUROSCIENCE, V147, P445, DOI 10.1016/j.neuroscience.2007.03.045; Neeb L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017360; Nguyen MQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185543; Parada CA, 2001, NEUROSCIENCE, V102, P937, DOI 10.1016/S0306-4522(00)00523-6; Patil MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198601; Prato V, 2017, CELL REP, V21, P3102, DOI 10.1016/j.celrep.2017.11.066; Price TJ, 2005, NEUROSCI LETT, V389, P94, DOI 10.1016/j.neulet.2005.07.029; Renn CL, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-61; Ruparel NB, 2008, PAIN, V135, P271, DOI 10.1016/j.pain.2007.06.005; Ruparel S, 2012, PAIN, V153, P2031, DOI 10.1016/j.pain.2012.04.027; Sakurai K, 2013, CELL REP, V5, P87, DOI 10.1016/j.celrep.2013.08.051; SAXENA A, 1995, INDIAN J MED RES, V102, P28; Schurmans S, 1997, P NATL ACAD SCI USA, V94, P10415, DOI 10.1073/pnas.94.19.10415; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; SHERIF MF, 1991, HISTOL HISTOPATHOL, V6, P549; Sugawara S, 2017, EUR J ORAL SCI, V125, P444, DOI 10.1111/eos.12382; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P383, DOI 10.1679/aohc.68.383; Thiagarajan Magesh Karuppur, 2011, Indian J Dent Res, V22, P843, DOI 10.4103/0970-9290.94682; Toyoshima K, 1999, J COMP NEUROL, V406, P129, DOI 10.1002/(SICI)1096-9861(19990329)406:1<129::AID-CNE8>3.0.CO;2-P; Tsagogiorgas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043525; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Verweij JP, 2017, J CRANIOFAC SURG, V28, P496, DOI 10.1097/SCS.0000000000003354; Waroquier D, 2009, CONTACT DERMATITIS, V60, P106, DOI 10.1111/j.1600-0536.2008.01352.x; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yom SS, 2006, ORAL SURG ORAL MED O, V101, P761, DOI 10.1016/j.tripleo.2005.10.068; Zeitz KP, 2002, J NEUROSCI, V22, P1010, DOI 10.1523/JNEUROSCI.22-03-01010.2002; Zur KB, 2004, CLIN ANAT, V17, P88, DOI 10.1002/ca.10166; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	82	11	11	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207069	10.1371/journal.pone.0207069	http://dx.doi.org/10.1371/journal.pone.0207069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408082	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300072
J	Blugan, G; Mata-Osoro, G; Fecht, S; Janczak-Rusch, J; Kuebler, J				Blugan, Gurdial; Mata-Osoro, Gustavo; Fecht, Simon; Janczak-Rusch, Jolanta; Kuebler, Jakob			Torsional shear strength of steel joined with high performance aerospace adhesives at cryogenic and elevated temperatures	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; AUTOMOTIVE INDUSTRY; COMPOSITE; BEHAVIOR; ALLOY	Pure torsional shear tests of joints glued with two different aerospace grade adhesives were performed using a specifically designed and constructed torsional shear test equipment. The developed test equipment allows for measuring of pure torsional shear strength under cryogenic and at elevated temperature conditions. The adhesives Hysol EA 9321 and 3M Scotch-Weld EC-9323-2 B/A were used to join steel torsional shear test specimens. Torsional shear tests were performed from -180 degrees C to 150 degrees C. In addition torsional shear fatigue tests were also performed at various loads and the effect of cryogenic aging (cyclic cooling and warming) on the torsional strength of the joints was investigated. The results showed that both sets of adhesive joints achieved three times higher torsional shear strength at -180 degrees C compared to room temperature.	[Blugan, Gurdial; Mata-Osoro, Gustavo; Kuebler, Jakob] Empa, Swiss Fed Labs Mat Sci & Technol, Lab High Performance Ceram, Dubendorf, Switzerland; [Fecht, Simon] Fraunhofer Inst Mfg Technol & Adv Mat IFAM, Dept Adhes Bonding Technol, Bremen, Germany; [Janczak-Rusch, Jolanta] Empa, Lab Joining Technol & Corros, Swiss Fed Labs Mat Sci & Technol, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Fraunhofer Gesellschaft; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Blugan, G (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Lab High Performance Ceram, Dubendorf, Switzerland.	gurdial.blugan@empa.ch	, Janczak/I-9454-2014	, Janczak/0000-0002-9161-5822; Kuebler, Jakob/0000-0003-1331-0721	European Community [609188]	European Community(European Commission)	The research leading to these results has received funding from the European Community's 7th Frame-work Programme FP7 2007-2013 under the grant agreement No. 609188. ADMACOM (Advanced Manufacturing Routes for Metal/Composite Components for Aerospace). G.B., G.O.-M., J. J.-R. and J.K. all received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banea MD, 2010, P I MECH ENG L-J MAT, V224, P51, DOI 10.1243/14644207JMDA283; Blugan G, 2007, CERAM INT, V33, P1033, DOI 10.1016/j.ceramint.2006.03.010; Da Silva LFM, 2005, J ADHES SCI TECHNOL, V19, P109, DOI 10.1163/1568561053148449; Ferraris M, 2010, COMPOS PART B-ENG, V41, P182, DOI 10.1016/j.compositesb.2009.10.008; Goglio L, 2016, INT J ADHES ADHES, V70, P46, DOI 10.1016/j.ijadhadh.2016.05.006; Gorjan L, 2016, CERAM INT, V42, P15739, DOI 10.1016/j.ceramint.2016.07.035; Gorjan L, 2015, MATER DESIGN, V88, P889, DOI 10.1016/j.matdes.2015.09.067; Huveners EMP, 2007, GLASS PERFROMANCE DA, V2007, P367; Jung HC, 2011, J NUCL MATER, V417, P383, DOI 10.1016/j.jnucmat.2010.12.082; Kang SG, 2007, COMPOS STRUCT, V78, P440, DOI 10.1016/j.compstruct.2005.11.005; Melcher RJ, 2007, COMPOS SCI TECHNOL, V67, P501, DOI 10.1016/j.compscitech.2006.08.026; Moszner F, 2017, INT J APPL CERAM TEC, V14, P703, DOI 10.1111/ijac.12689; Murakami S, 2016, INT J ADHES ADHES, V67, P86, DOI 10.1016/j.ijadhadh.2015.12.030; Pethrick RA, 2015, P I MECH ENG L-J MAT, V229, P349, DOI 10.1177/1464420714522981; RENTON WJ, 1976, EXP MECH, V16, P409, DOI 10.1007/BF02410348; Roumagnac P, 2012, QUASISTATIC CONSTITU, P79; Silva MRG, 2016, LAT AM J SOLIDS STRU, V13, P835, DOI 10.1590/1679-78252762	17	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206981	10.1371/journal.pone.0206981	http://dx.doi.org/10.1371/journal.pone.0206981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403732	Green Published, gold			2022-12-26	WOS:000449379500087
J	Gebresillassie, BM; Belachew, SA; Tefera, YG; Abebe, TB; Mekuria, AB; Haile, KT; Erku, DA				Gebresillassie, Begashaw Melaku; Belachew, Sewunet Admasu; Tefera, Yonas Getaye; Abebe, Tamrat Befekadu; Mekuria, Abebe Basazn; Haile, Kaleab Taye; Erku, Daniel Asfaw			Evaluating patients', physicians' and pharmacy professionals' perception and concern regarding generic medicines in Gondar town, northwest Ethiopia: A multi-stakeholder, cross-sectional survey	PLOS ONE			English	Article							EUROPEAN COUNTRIES; PATIENTS ATTITUDES; SUBSTITUTION; POLICIES; BELIEFS; DRUGS; THINK	Background Generic medicine prescribing has become common practice in many countries. However, data regarding the perceptions of stakeholders (patients, prescribers and dispensers) regarding generic medicines in Ethiopia is scarce. The present survey aimed to investigate the perception of patients, physicians and pharmacy professionals regarding generic medicines in Ethiopia. Methods A quantitative cross-sectional survey was conducted in Gondar town, Northwest Ethiopia between January 1 and February 1, 2017. The questionnaire, comprised of 5-point Likert scale items on perception and concerns regarding generic medicine, was administered to patients, physicians and pharmacy professionals working in the community drug retail outlets. Frequencies, percentages, and median were calculated using Statistical Package for the Social Sciences (SPSS) software version 21.0 for Windows to describe different variables. Results The survey was completed by 612 participants. More than half of patients, 56% (n = 219) knew about the term brand and generic medicines and 38.7% (n =151) of patients agreed/ strongly agreed that brand medicines are more effective. Nearly half, 47% (n = 184) of patients agreed that they should have the option of choosing between generic and brand medicines and 61.4% (n = 240) of patients believed that cost should be considered before a medicineis prescribed. The majority of physicians 70.6% (n = 101) indicated a very low generic medicine prescription rate. 56% (n = 130) of physicians and 87.2% (n = 68) of pharmacy professionals agreed that they need a standard guideline to both prescribers and pharmacists on brand substitution process. Furthermore, 39.9% (n = 57) of the physicians and 87.2% (n = 68) of pharmacy professionals agreed that drug advertisements by the manufacturers would influence their prescribing/dispensing practice. Conclusions Overall, our findings demonstrate a knowledge gap among patients towards the perception of generics, perceiving generics are less effective and inferior in quality compared to their branded equivalents. The majority of physicians reported a very low generic medicine prescribing rate and the majority pharmacy professionals' dispensing practice was influenced by drug advertisements. Hence, a customized educational program should be developed and implemented to patients, prescribers and dispensers so as to boost the acceptability of generic medicines and increase generic prescribing and/or substitution.	[Gebresillassie, Begashaw Melaku; Belachew, Sewunet Admasu; Tefera, Yonas Getaye; Abebe, Tamrat Befekadu; Erku, Daniel Asfaw] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Clin Pharm Dept, Gondar, Ethiopia; [Mekuria, Abebe Basazn] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Pharmacol Dept, Gondar, Ethiopia; [Haile, Kaleab Taye] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Pharmaceut & Social Pharm Dept, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Gebresillassie, BM (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Clin Pharm Dept, Gondar, Ethiopia.	begashaw531@gmail.com	Erku, Daniel/AAC-1508-2020; Taye, Kaleab/GWQ-5270-2022	Erku, Daniel/0000-0002-8878-0317; Taye, Kaleab/0000-0002-6655-1521; Tefera, Yonas Getaye/0000-0002-9205-9442; Abebe, Tamrat Befekadu/0000-0002-9367-7592; Admasu Belachew, Sewunet/0000-0002-1050-8188				Ali Eskinder Eshetu, 2014, Value Health Reg Issues, V4, P37, DOI 10.1016/j.vhri.2014.06.005; Ali SM, 2013, J MED MARK DEVICE DI, V13, P1; Andersson K, 2005, PHARMACOEPIDEM DR S, V14, P341, DOI 10.1002/pds.1055; Auta A, 2014, MED PRIN PRACT, V23, P53, DOI 10.1159/000355473; Babar ZUD, 2011, RES SOC ADMIN PHARM, V7, P294, DOI 10.1016/j.sapharm.2010.06.004; Bangalee V, 2015, AFR HEALTH SCI, V15, P281, DOI 10.4314/ahs.v15i1.37; Barnett I., 2010, POOR HOUSEHOLDS EXPE; Beecroft Grahame, 2007, Aust New Zealand Health Policy, V4, P7, DOI 10.1186/1743-8462-4-7; Cameron A, 2009, LANCET, V373, P632; Colgan S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008915; Dunne S, 2014, PATIENT, V7, P177, DOI 10.1007/s40271-013-0042-z; Dunne SS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0415-3; El-Dahiyat Faris, 2013, J Pharm Policy Pract, V6, P3, DOI 10.1186/2052-3211-6-3; Federal Democratic Republic of Ethiopia Ministry of Health, HLTH SECT DEV PROGR; Federman AD, 2007, MED CARE, V45, P109, DOI 10.1097/01.mlr.0000250293.24939.2e; FMOH/WHO, DRUG FIN ETH 2007; Garuoliene K, 2011, EXPERT REV PHARM OUT, V11, P343, DOI [10.1586/ERP.11.24, 10.1586/erp.11.24]; Generic Pharmaceutical Association, 2012, 1 TRILL 10 YEARS GEN; Giralt AN, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000172; Heikkila R, 2007, HEALTH POLICY, V82, P366, DOI 10.1016/j.healthpol.2006.10.006; Himmel W, 2005, INT J CLIN PHARM TH, V43, P472; HOWLAND RH, 2009, J PSYCHOSOC NURS MEN, V47, P17; Iosifescu A, 2008, PATIENT EDUC COUNS, V73, P377, DOI 10.1016/j.pec.2008.07.012; Johnson RE, 1997, MED CARE, V35, P1119, DOI 10.1097/00005650-199711000-00004; Johnston A, 2011, BRIT J CLIN PHARMACO, V72, P727, DOI 10.1111/j.1365-2125.2011.03987.x; Kaplan WA, 2012, HEALTH POLICY, V106, P211, DOI 10.1016/j.healthpol.2012.04.015; King DR, 2002, CROAT MED J, V43, P462; Kumar R, 2014, GABI J, V3, P63, DOI 10.5639/gabij.2014.0302.019; Laing R, 2010, WORLD HLTH REP, V35, P210; Ministry of Health and Ministry of Industry, 2015, NAT STRAT PLAN ACT P; Mohammed R., 2017, SUDAN MED MONITOR, V12, P19; Ngo SNT, 2013, EPILEPSY BEHAV, V26, P64, DOI 10.1016/j.yebeh.2012.10.032; Palagyi M, 2008, BRATISL MED J, V109, P324; Patel A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-297; Rathe J, 2013, EUR J CLIN PHARMACOL, V69, P1827, DOI 10.1007/s00228-013-1539-z; Shrank WH, 2011, ANN PHARMACOTHER, V45, P31, DOI 10.1345/aph.1P389; Shrank WH, 2009, HEALTH AFFAIR, V28, P546, DOI 10.1377/hlthaff.28.2.546; Suleman S, 2016, ETHIOP J HEALTH SCI, V26, P259, DOI 10.4314/ejhs.v26i3.9; Suleman S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003345; Valles JA, 2003, HEALTH POLICY, V65, P269, DOI 10.1016/S0168-8510(03)00018-6; Vogler S, 2012, GABI J, V1, P93, DOI 10.5639/gabij.2012.0102.020; WHO, 2015, GEN DRUGS	42	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0204146	10.1371/journal.pone.0204146	http://dx.doi.org/10.1371/journal.pone.0204146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403668	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500007
J	Mitchell, SB; Iwabuchi, S; Kawano, H; Yuen, TMT; Koh, JY; Ho, KWD; Harata, NC				Mitchell, Sara B.; Iwabuchi, Sadahiro; Kawano, Hiroyuki; Yuen, Tsun Ming Tom; Koh, Jin-Young; Ho, K. W. David; Harata, N. Charles			Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a	PLOS ONE			English	Article							KNOCK-IN MOUSE; SUBTLE MICROSTRUCTURAL CHANGES; FLUORESCENT CERAMIDE ANALOG; DYT1 DYSTONIA; ENDOPLASMIC-RETICULUM; SYNAPTIC PLASTICITY; MEMBRANE-PROTEINS; SECRETORY PATHWAY; MESSENGER-RNAS; TORSINA	Autosomal-dominant, early-onset DYT1 dystonia is associated with an in-frame deletion of a glutamic acid codon (Delta E) in the TOR1A gene. The gene product, torsinA, is an evolutionarily conserved AAA+ ATPase. The fact that constitutive secretion from patient fibroblasts is suppressed indicates that the Delta E-torsinA protein influences the cellular secretory machinery. However, which component is affected remains unclear. Prompted by recent reports that abnormal protein trafficking through the Golgi apparatus, the major protein-sorting center of the secretory pathway, is sometimes associated with a morphological change in the Golgi, we evaluated the influence of Delta E-torsinA on this organelle. Specifically, we examined its structure by confocal microscopy, in cultures of striatal, cerebral cortical and hippocampal neurons obtained from wild-type, heterozygous and homozygous Delta E-torsinA knock-in mice. In live neurons, the Golgi was assessed following uptake of a fluorescent ceramide analog, and in fixed neurons it was analyzed by immuno-fluorescence staining for the Golgi-marker GM130. Neither staining method indicated genotype-specific differences in the size, staining intensity, shape or localization of the Golgi. Moreover, no genotype-specific difference was observed as the neurons matured in vitro. These results were supported by a lack of genotype-specific differences in GM130 expression levels, as assessed by Western blotting. The Golgi was also disrupted by treatment with brefeldin A, but no genotype-specific differences were found in the immuno-fluorescence staining intensity of GM130. Overall, our results demonstrate that the Delta E torsinA protein does not drastically influence Golgi morphology in neurons, irrespective of genotype, brain region (among those tested), or maturation stage in culture. While it remains possible that functional changes in the Golgi exist, our findings imply that any such changes are not severe enough to influence its morphology to a degree detectable by light microscopy.	[Mitchell, Sara B.; Iwabuchi, Sadahiro; Kawano, Hiroyuki; Yuen, Tsun Ming Tom; Koh, Jin-Young; Ho, K. W. David; Harata, N. Charles] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA; [Yuen, Tsun Ming Tom] Univ Iowa, Dept Chem & Biochem Engn, Coll Engn, Iowa City, IA USA; [Ho, K. W. David; Harata, N. Charles] Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA; [Harata, N. Charles] Univ Iowa, Iowa Neurosci Inst, Carver Coll Med, Iowa City, IA 52242 USA; [Iwabuchi, Sadahiro] Kanazawa Univ, Grad Sch Med Sci, Dept Integrat Med Longev, Kanazawa, Ishikawa, Japan; [Koh, Jin-Young] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Mol Otolaryngol & Renal Res Labs, Carver Coll Med, Iowa City, IA 52242 USA; [Koh, Jin-Young] Univ Iowa, Coll Engn, Dept Biomed Engn, Iowa City, IA 52242 USA; [Ho, K. W. David] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Kanazawa University; University of Iowa; University of Iowa; State University System of Florida; University of Florida	Harata, NC (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA 52242 USA.; Harata, NC (corresponding author), Univ Iowa, Med Scientist Training Program, Carver Coll Med, Iowa City, IA 52242 USA.; Harata, NC (corresponding author), Univ Iowa, Iowa Neurosci Inst, Carver Coll Med, Iowa City, IA 52242 USA.	charles-harata@uiowa.edu	Iwabuchi, Sadahiro/AAD-4455-2022; Ho, Kwo Wei David/I-9751-2019	Ho, Kwo Wei David/0000-0003-2085-2107; Mitchell, Sara/0000-0001-7628-9945; Koh, Jin-Young/0000-0002-6785-0515; Harata, N. Charles/0000-0003-3287-4549	Department of Defense [W81XWH-14-1-0301]; Dystonia Medical Research Foundation; Edward Mallinckrodt, Jr. Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Dystonia Medical Research Foundation; Edward Mallinckrodt, Jr. Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by Department of Defense (W81XWH-14-1-0301, NCH), http://cdmrp.army.mil/funding/prmrp.shtml; Dystonia Medical Research Foundation (NCH), http://www.dystonia-foundation.org/; Edward Mallinckrodt, Jr. Foundation (NCH), http://www.emallinckrodtfoundation.org/.	Albanese A, 2013, MOVEMENT DISORD, V28, P863, DOI 10.1002/mds.25475; ALCALDE J, 1992, J CELL BIOL, V116, P69, DOI 10.1083/jcb.116.1.69; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Allen_ Mouse_ Brain_ Atlas, 2009, TOR1A SAG SECT; Arthur CP, 2010, NEUROSCIENCE, V167, P135, DOI 10.1016/j.neuroscience.2010.01.056; Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Augood SJ, 1998, ANN NEUROL, V43, P669, DOI 10.1002/ana.410430518; Bankaitis VA, 2012, CURR BIOL, V22, pR414, DOI 10.1016/j.cub.2012.03.004; Bexiga MG, 2013, INT J MOL SCI, V14, P18670, DOI 10.3390/ijms140918670; Brandizzi F, 2013, NAT REV MOL CELL BIO, V14, P382, DOI 10.1038/nrm3588; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bressman SB, 2013, MOVEMENT DISORD, V28, P906, DOI 10.1002/mds.25528; BROWN A, 1995, NAT GENET, V10, P301, DOI 10.1038/ng0795-301; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Carbon M, 2010, BRAIN, V133, P690, DOI 10.1093/brain/awq017; Charlesworth G, 2013, BRAIN, V136, P2017, DOI 10.1093/brain/awt138; Clarke JH, 2009, J COMP NEUROL, V517, P296, DOI 10.1002/cne.22161; Condon KH, 2013, J NEUROSCI, V33, P3799, DOI 10.1523/JNEUROSCI.1930-11.2013; Cookson MR, 2005, NEURON, V48, P875, DOI 10.1016/j.neuron.2005.12.006; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cox DJ, 2013, J COMP NEUROL, V521, P1954, DOI 10.1002/cne.23292; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Duchen L W, 1976, Adv Neurol, V14, P353; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Egner A, 2006, HDB BIOL CONFOCAL MI, P404, DOI DOI 10.1007/978-0-387-45524-2_20; Fuchs T, 2013, NAT GENET, V45, P88, DOI 10.1038/ng.2496; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2009, J NEUROCHEM, V109, P1596, DOI 10.1111/j.1471-4159.2009.06095.x; Grundmann K, 2012, NEUROBIOL DIS, V47, P61, DOI 10.1016/j.nbd.2012.03.024; GUO LF, 1995, CELL, V81, P233, DOI 10.1016/0092-8674(95)90333-X; HALL RD, 1974, BRAIN RES, V66, P23, DOI 10.1016/0006-8993(74)90076-6; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HARRIS KM, 1993, NEUROSCIENCE, V53, P495, DOI 10.1016/0306-4522(93)90214-Z; Hedreen J C, 1988, Adv Neurol, V50, P123; Hewett JW, 2008, HUM MOL GENET, V17, P1436, DOI 10.1093/hmg/ddn032; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hewett JW, 2006, NEUROBIOL DIS, V22, P98, DOI 10.1016/j.nbd.2005.10.012; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Horton AC, 2003, J NEUROSCI, V23, P6188; Ishida R, 2015, FEBS J, V282, P2232, DOI 10.1111/febs.13271; Iwabuchi S, 2014, JOVE-J VIS EXP, DOI 10.3791/50557; Iwabuchi S, 2014, J NEUROSCI METH, V223, P92, DOI 10.1016/j.jneumeth.2013.12.003; Iwabuchi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080793; Iwabuchi S, 2013, NEUROSCI LETT, V548, P61, DOI 10.1016/j.neulet.2013.05.047; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kakazu Y, 2012, SYNAPSE, V66, P807, DOI 10.1002/syn.21571; Kakazu Y, 2012, SYNAPSE, V66, P453, DOI 10.1002/syn.21534; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Klein C, 1998, HUM MOL GENET, V7, P1133, DOI 10.1093/hmg/7.7.1133; Klumperman J, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005181; Koh JY, 2013, NEUROSCIENCE, V253, P316, DOI 10.1016/j.neuroscience.2013.08.060; Koh JY, 2015, JOVE-J VIS EXP, DOI 10.3791/51879; KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315, DOI 10.1091/mbc.6.10.1315; Lisauskas T, 2012, TRAFFIC, V13, P416, DOI 10.1111/j.1600-0854.2011.01318.x; Manganelli F, 2017, NEUROLOGY, V88, P2132, DOI 10.1212/WNL.0000000000003992; Martella G, 2014, NEUROBIOL DIS, V65, P124, DOI 10.1016/j.nbd.2014.01.016; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; Martin JN, 2009, NEUROSCIENCE, V164, P563, DOI 10.1016/j.neuroscience.2009.07.068; Martinez Harryl D, 2011, Genes Cancer, V2, P956, DOI 10.1177/1947601912436422; Matsuki T, 2010, CELL, V143, P826, DOI 10.1016/j.cell.2010.10.029; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; Nakamura N, 2010, J PHARMACOL SCI, V112, P255, DOI 10.1254/jphs.09R03CR; Neefjes J, 2014, TRENDS NEUROSCI, V37, P66, DOI 10.1016/j.tins.2013.11.006; Neychev VK, 2011, NEUROBIOL DIS, V42, P185, DOI 10.1016/j.nbd.2011.01.026; Ozelius LJ, 2011, NEUROBIOL DIS, V42, P127, DOI 10.1016/j.nbd.2010.12.012; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267; PAGANO RE, 1989, J CELL BIOL, V109, P2067, DOI 10.1083/jcb.109.5.2067; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; PAWLEY J B, 2006, HDB BIOL CONFOCAL MI, V3, DOI [10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; Prudente CN, 2014, NEUROSCIENCE, V260, P23, DOI 10.1016/j.neuroscience.2013.11.062; Rendon WO, 2013, HISTOCHEM CELL BIOL, V139, P671, DOI 10.1007/s00418-012-1059-4; Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47; ROSENWALD AG, 1993, ADV LIPID RES, V26, P101; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Roy E, 2012, HUM MOL GENET, V21, P1481, DOI 10.1093/hmg/ddr584; Ryan SD, 2012, J CELL BIOL, V196, P727, DOI 10.1083/jcb.201107096; Ryan SD, 2012, MOL BIOL CELL, V23, P553, DOI 10.1091/mbc.E11-06-0573; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sciaky N, 1997, J CELL BIOL, V139, P1137, DOI 10.1083/jcb.139.5.1137; Sciamanna G, 2012, J NEUROSCI, V32, P11991, DOI 10.1523/JNEUROSCI.0041-12.2012; Sciamanna G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024261; Sengupta D, 2011, ANNU REV CELL DEV BI, V27, P57, DOI 10.1146/annurev-cellbio-100109-104003; Shamseldin HE, 2016, HUM GENET, V135, P245, DOI 10.1007/s00439-015-1632-8; Simpson JC, 2012, NAT CELL BIOL, V14, P764, DOI 10.1038/ncb2510; Song CH, 2014, NEUROBIOL DIS, V62, P372, DOI 10.1016/j.nbd.2013.10.003; Song CH, 2013, NEUROBIOL DIS, V54, P362, DOI 10.1016/j.nbd.2013.01.008; Standaert DG, 2011, NEUROBIOL DIS, V42, P148, DOI 10.1016/j.nbd.2011.01.012; Tanabe LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032245; Tanabe LM, 2009, NAT REV NEUROL, V5, P598, DOI 10.1038/nrneurol.2009.160; Terasaki M, 2001, CURR PROTOC CELL BIO, DOI [10.1002/2015.06.014, DOI 10.1002/2015.06.014]; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Ulug AM, 2011, P NATL ACAD SCI USA, V108, P6638, DOI 10.1073/pnas.1016445108; Vitry S, 2010, AM J PATHOL, V177, P2984, DOI 10.2353/ajpath.2010.100447; Walker RH, 2001, BRAIN RES, V900, P348, DOI 10.1016/S0006-8993(01)02302-2; Walter M, 2010, NEUROBIOL DIS, V38, P192, DOI 10.1016/j.nbd.2009.12.019; Wei JH, 2015, CELL, V162, P287, DOI 10.1016/j.cell.2015.06.014; Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024539; You XT, 2015, NAT NEUROSCI, V18, P603, DOI 10.1038/nn.3975; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018357; Zhou W, 2014, CURR BIOL, V24, P1227, DOI 10.1016/j.cub.2014.04.008; Ziefer P, 2002, MOL BRAIN RES, V101, P132, DOI 10.1016/S0169-328X(02)00176-6	114	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206123	10.1371/journal.pone.0206123	http://dx.doi.org/10.1371/journal.pone.0206123			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403723	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500052
J	Spada, TC; Silva, JMRD; Francisco, LS; Marcal, LJ; Antonangelo, L; Zanetta, DMT; Yu, L; Burdmann, EA				Spada, Tania C.; Silva, Jose M. R. D.; Francisco, Lucila S.; Marcal, Lia J.; Antonangelo, Leila; Zanetta, Dirce M. T.; Yu, Luis; Burdmann, Emmanuel A.			High intensity resistance training causes muscle damage and increases biomarkers of acute kidney injury in healthy individuals	PLOS ONE			English	Article							EXERCISE-INDUCED RHABDOMYOLYSIS; PHYSICAL-ACTIVITY; ANAEROBIC CAPACITY; KNOWLEDGE; RECOVERY; SEPSIS; PANEL	Purpose High-intensity interval resistance training (HIIRT) is an increasingly popular exercise program that provides positive results with short sessions. This study aimed to evaluate whether an HIIRT session causes muscle and kidney damage. Methods Fifty-eight healthy volunteers (median age 24 years, 50% women) participated in this study and performed a HIIRT session. The Borg CR10 scale for pain (CR1OP) and blood and urine samples were collected before (baseline) and 2 and 24 hours after the HIIRT session. Blood samples were analyzed for serum creatinine (SCr), creatine kinase (CK) and myoglobin. Urine samples were assessed for creatinine, neutrophil gelatinase-associated lipocalin, interleukin 18, calbindin, microalbuminuria, trefoil factor-3 and beta-2 microglobulin. Results CR10P had a significant increase at 2 and 24 hours post-workout, and CK increased significantly at 2 hours and increased further at 24 hours. Myoglobin increased significantly at 2 hours and remained elevated at 24 hours. SCr increased modestly but significantly at 24 hours only in men. Three men met the KDIGO diagnostic criteria for acute kidney injury. The urinary kidney injury biomarkers increased significantly at 2 hours and returned to the baseline values 24 hours after HIIRT. Conclusions A single HIIRT session caused early and significant elevations in CK, myoglobin, SCr, microalbuminuria and urinary biomarkers indicative of kidney tubular injury, suggesting the occurrence of muscle and kidney damage.	[Spada, Tania C.; Yu, Luis; Burdmann, Emmanuel A.] Univ Sao Paulo, Med Sch, Div Nephrol, Sao Paulo, Brazil; [Spada, Tania C.; Yu, Luis; Burdmann, Emmanuel A.] Univ Sao Paulo, Med Sch, LIM 12, Sao Paulo, Brazil; [Spada, Tania C.; Yu, Luis; Burdmann, Emmanuel A.] Hosp Clin Sao Paulo, Sao Paulo, Brazil; [Silva, Jose M. R. D.] Sao Paulo State Univ, Sch Sci, Bauru, Brazil; [Francisco, Lucila S.] Univ Guarulhos, Div Sports, Guarulhos, Brazil; [Marcal, Lia J.; Antonangelo, Leila] Univ Sao Paulo, Med Sch, Hosp Clin, Dept Pathol,Clin Lab, Sao Paulo, Brazil; [Marcal, Lia J.; Antonangelo, Leila] Univ Sao Paulo, Med Sch, Hosp Clin, LIM 3, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Guarulhos; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Burdmann, EA (corresponding author), Univ Sao Paulo, Med Sch, Div Nephrol, Sao Paulo, Brazil.; Burdmann, EA (corresponding author), Univ Sao Paulo, Med Sch, LIM 12, Sao Paulo, Brazil.; Burdmann, EA (corresponding author), Hosp Clin Sao Paulo, Sao Paulo, Brazil.	burdmann@usp.br	Burdmann, Emmanuel/AAY-1966-2020; Antonangelo, Leila/H-9998-2012; Yu, Luis/E-8735-2012; Zanetta, Dirce M T/G-4950-2013; Burdmann, Emmanuel/B-7023-2009	Antonangelo, Leila/0000-0002-8634-5100; Burdmann, Emmanuel/0000-0002-7644-8579; Yu, Luis/0000-0001-9102-0063; Zanetta, Dirce Maria/0000-0002-7273-5087	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq - National Counsel of Technological and Scientific Development), Brazil [CNPq 133977/2015-3, CNPq 305858/2013-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation), Sao Paulo, Brazil [FAPESP 2014/19286-4]	"Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq - National Counsel of Technological and Scientific Development), Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation), Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Tania C. Spada was a recipient of a master degree grant, CNPq 133977/2015-3, from "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq - National Counsel of Technological and Scientific Development), Brazil from 2015 to 2017. Emmanuel A. Burdmann is a recipient of the following research grants: CNPq 305858/2013-0 from "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq - National Counsel of Technological and Scientific Development), Brazil and FAPESP 2014/19286-4 from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Sao Paulo Research Foundation), Sao Paulo, Brazil. There was no specific funding for this study. The authors declare that they have no other relevant financial interests.	Aalborg C, 2016, TIDSSKR NORSKE LAEGE, V136, P1532, DOI 10.4045/tidsskr.15.1207; Almada C, 2013, J PHYSIOL BIOCHEM, V69, P85, DOI 10.1007/s13105-012-0191-x; An RP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168175; Apeland Terje, 2017, BMJ Open Sport Exerc Med, V3, pe000241, DOI 10.1136/bmjsem-2017-000241; Argyropoulos CP, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00073; Arulkumaran N, 2017, CRIT CARE MED, V45, pE821, DOI 10.1097/CCM.0000000000002381; Astor BC, 2011, AM J NEPHROL, V34, P291, DOI 10.1159/000330699; Bhakthavatsalam R K, 2016, Indian J Nephrol, V26, P449; Bird Stephen R, 2016, BMJ Open Sport Exerc Med, V2, pe000143, DOI 10.1136/bmjsem-2016-000143; Borg G., 2000, ESCALAS BORG DOR ESF; Cervellin G, 2017, CLIN BIOCHEM, V50, P656, DOI 10.1016/j.clinbiochem.2017.02.016; Charlton JR, 2014, NEPHROL DIAL TRANSPL, V29, P1301, DOI 10.1093/ndt/gft510; Chugh Atul, 2007, J Clin Hypertens (Greenwich), V9, P196, DOI 10.1111/j.1524-6175.2007.06445.x; Coons SJ, 2009, CLIN THER, V31, P2572, DOI 10.1016/j.clinthera.2009.11.035; Deferrari G, 2018, NEPHROL DIAL TRANSPL, V33, P813, DOI 10.1093/ndt/gfx210; Dieterle F, 2010, NAT BIOTECHNOL, V28, P463, DOI 10.1038/nbt.1622; Du TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080271; Endre ZH, 2014, NEPHRON CLIN PRACT, V127, P101, DOI 10.1159/000363678; Fardal H, 2016, TIDSSKR NORSKE LAEGE, V136, P1537, DOI 10.4045/tidsskr.16.0042; Feng MC, 2016, J CLIN LAB ANAL, V30, P1037, DOI 10.1002/jcla.21977; Foster C, 2015, J SPORT SCI MED, V14, P747; Gibala MJ, 2008, EXERC SPORT SCI REV, V36, P58, DOI 10.1097/JES.0b013e318168ec1f; Gleason Patrick T, 2017, Curr Treat Options Cardiovasc Med, V19, P79, DOI 10.1007/s11936-017-0578-7; Pitanga FJG, 2017, SAO PAULO MED J, V135, P391, DOI 10.1590/1516-3180.2017.0023190317; Henstridge DC, 2016, J APPL PHYSIOL, V120, P683, DOI 10.1152/japplphysiol.00811.2015; Hoffmann D, 2010, TOXICOLOGY, V277, P49, DOI 10.1016/j.tox.2010.08.013; Honda S, 2017, INTERNAL MED, V56, P1175, DOI 10.2169/internalmedicine.56.7636; Huynh A, 2016, INTERN MED J, V46, P602, DOI 10.1111/imj.13055; Kashani K, 2017, CLIN CHEM LAB MED, V55, P1074, DOI 10.1515/cclm-2016-0973; Kirwan JP, 2017, CLEV CLIN J MED, V84, pS15, DOI 10.3949/ccjm.84.s1.03; Lazzeri C, 2012, SCAND CARDIOVASC J, V46, P324, DOI 10.3109/14017431.2012.702919; Mansour SG, 2017, AM J KIDNEY DIS, V70, P252, DOI 10.1053/j.ajkd.2017.01.045; Nejat M, 2012, KIDNEY INT, V81, P1254, DOI 10.1038/ki.2012.23; Paoli A, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-237; Pennemans V, 2013, CLIN CHEM LAB MED, V51, P1795, DOI 10.1515/cclm-2013-0157; Rinnert M, 2010, CELL TISSUE RES, V339, P639, DOI 10.1007/s00441-009-0913-8; SHAIKH Q A, 1991, JPMA (Journal of the Pakistan Medical Association), V41, P314; Shephard RJ, 2016, J SPORT MED PHYS FIT, V56, P1060; Smith LP, 2014, SOC SCI MED, V120, P126, DOI 10.1016/j.socscimed.2014.09.010; Tabata I, 1996, MED SCI SPORT EXER, V28, P1327, DOI 10.1097/00005768-199610000-00018; Warburton DER, 2017, CURR OPIN CARDIOL, V32, P541, DOI 10.1097/HCO.0000000000000437; Zhao CH, 2017, NEUROPSYCH DIS TREAT, V13, P91, DOI 10.2147/NDT.S124630	42	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0205791	10.1371/journal.pone.0205791	http://dx.doi.org/10.1371/journal.pone.0205791			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399190	gold, Green Submitted, Green Published			2022-12-26	WOS:000449374000003
J	Lenton, GK; Bishop, PJ; Saxby, DJ; Doyle, TLA; Pizzolato, C; Billing, D; Lloyd, DG				Lenton, Gavin K.; Bishop, Peter J.; Saxby, David J.; Doyle, Tim L. A.; Pizzolato, Claudio; Billing, Daniel; Lloyd, David G.			Tibiofemoral joint contact forces increase with load magnitude and walking speed but remain almost unchanged with different types of carried load	PLOS ONE			English	Article							UNITED-STATES MILITARY; KNEE OSTEOARTHRITIS; MUSCULOSKELETAL MODEL; IN-VIVO; GAIT; OPTIMIZATION; PREDICTION; MOMENTS; BIOMECHANICS; SIMULATION	Musculoskeletal injuries (MSI) in the military reduce soldier capability and impose substantial costs. Characterizing biomechanical surrogates of MSI during commonly performed military tasks (e.g., load carriage) is necessary for evaluating the effectiveness of possible interventions to reduce MSI risk. This study determined the effects of body-borne load distribution, load magnitude, and walking speed on tibiofemoral contact forces. Twenty-one Australian Army Reserve soldiers completed a treadmill walking protocol in an unloaded condition and wearing four armor types (standard-issue and three prototypes) with two load configurations (15 and 30 kg) for a total of 8 armor x load ensembles. In each ensemble, participants completed a 5-minute warm-up, and then walked for 10 minutes at both moderate (1.53 m.s(-1)) and fast (1.81 m.s(-1)) speeds. During treadmill walking, three-dimensional kinematics, ground reaction forces, and muscle activity from nine lower-limb muscles were collected in the final minute of each speed. These data were used as inputs into a neuromusculoskeletal model, which estimated medial, lateral and total tibiofemoral contact forces. Repeated measures analyses of variance revealed no differences for any variables between armor types, but peak medial compartment contact forces increased when progressing from moderate to fast walking and with increased load (p<0.001). Acute exposure to load carriage increased estimated tibiofemoral contact forces 10.1 and 19.9% with 15 and 30kg of carried load, respectively, compared to unloaded walking. These results suggest that soldiers carrying loads in excess of 15 kg for prolonged periods could be at greater risk of knee MSI than those with less exposure.	[Lenton, Gavin K.; Bishop, Peter J.; Saxby, David J.; Pizzolato, Claudio; Lloyd, David G.] Griffith Univ, Gold Coast Orthopaed Res Engn & Educ Alliance, Menzies Hlth Inst Queensland, Sch Allied Hlth Sci, Southport, Qld, Australia; [Doyle, Tim L. A.] Macquarie Univ, Dept Hlth Profess, Fac Med & Hlth Sci, N Ryde, NSW, Australia; [Billing, Daniel] Def Sci & Technol Grp, Land Div, Fishermans Bend, Vic, Australia	Griffith University; Macquarie University; Defence Science & Technology	Lenton, GK (corresponding author), Griffith Univ, Gold Coast Orthopaed Res Engn & Educ Alliance, Menzies Hlth Inst Queensland, Sch Allied Hlth Sci, Southport, Qld, Australia.	g.lenton@griffith.edu.au	Lloyd, David Gavin/AAH-6066-2020; Lenton, Gavin/Q-9460-2019; Pizzolato, Claudio/R-6215-2019; Doyle, Timothy/F-9553-2014; Saxby, David John/T-4036-2019	Lloyd, David Gavin/0000-0002-0824-9682; Lenton, Gavin/0000-0001-7703-7440; Pizzolato, Claudio/0000-0002-0292-2776; Doyle, Timothy/0000-0002-1227-6835; Saxby, David John/0000-0002-0874-7518	Defence Science and Technology Group	Defence Science and Technology Group	Defence Science and Technology Group contributed funding to support this research. They had no involvement into the study design, in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication.	Alvim F, 2015, J APPL BIOMECH, V31, P383, DOI 10.1123/jab.2014-0178; Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennell KL, 2011, ANN RHEUM DIS, V70, P1770, DOI 10.1136/ard.2010.147082; Besier TF., 2011, ANTERIOR KNEE PAIN P, P269; Bowersock CD, 2017, J SPORT SCI, V35, P2005, DOI 10.1080/02640414.2016.1249904; Brown TN, 2018, J BIOMECH, V69, P97, DOI 10.1016/j.jbiomech.2018.01.003; Brown TN, 2014, J BIOMECH, V47, P3494, DOI 10.1016/j.jbiomech.2014.09.002; BUFF HU, 1988, J BIOMECH, V21, P17, DOI 10.1016/0021-9290(88)90187-X; Burr DB, 1998, J BIOMECH, V31, P337, DOI 10.1016/S0021-9290(98)00016-5; Cameron KL, 2011, ARTHRITIS RHEUM-US, V63, P2974, DOI 10.1002/art.30498; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Devaprakash D, 2016, J ELECTROMYOGR KINES, V31, P126, DOI 10.1016/j.jelekin.2016.10.001; Fregly BJ, 2012, J ORTHOP RES, V30, P503, DOI 10.1002/jor.22023; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Harrington ME, 2007, J BIOMECH, V40, P595, DOI 10.1016/j.jbiomech.2006.02.003; Knarr B, 2016, COMPUT METHOD BIOMEC, V19, P320, DOI 10.1080/10255842.2015.1018193; LaFiandra M, 2004, MED SCI SPORT EXER, V36, P460, DOI 10.1249/01.MSS.0000117113.77904.46; Lenton GK, 2017, GAIT POSTURE, V54, P318, DOI 10.1016/j.gaitpost.2017.04.002; Lloyd DG, 2003, J BIOMECH, V36, P765, DOI 10.1016/S0021-9290(03)00010-1; Lloyd R, 2000, ERGONOMICS, V43, P1331, DOI 10.1080/001401300421770; Lynn SK, 2007, KNEE, V14, P22, DOI 10.1016/j.knee.2006.09.002; Malcolm P, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0014-8; Mantoan A, 2015, SOURCE CODE BIOL MED, V10, DOI 10.1186/s13029-015-0044-4; Meyer AJ, 2013, J ORTHOP RES, V31, P921, DOI 10.1002/jor.22304; Modenese L, 2016, J BIOMECH, V49, P141, DOI 10.1016/j.jbiomech.2015.11.006; Nindl Bradley C, 2013, US Army Med Dep J, P5; Pizzolato C, 2015, J BIOMECH, V48, P3929, DOI 10.1016/j.jbiomech.2015.09.021; Rajagopal A, 2016, IEEE T BIO-MED ENG, V63, P2068, DOI 10.1109/TBME.2016.2586891; Ramsay JW, 2016, J BIOMECH, V49, P3868, DOI 10.1016/j.jbiomech.2016.10.022; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; Robertson DGE, 2003, J ELECTROMYOGR KINES, V13, P569, DOI 10.1016/S1050-6411(03)00080-4; Sartori M, 2014, J BIOMECH, V47, P3613, DOI 10.1016/j.jbiomech.2014.10.009; Saxby DJ, 2016, GAIT POSTURE, V49, P78, DOI 10.1016/j.gaitpost.2016.06.014; Seay J.F, 2015, STUDIES MECHANOBIOLO, P1; Sharpe SR, 2008, J BIOMECH, V41, P968, DOI 10.1016/j.jbiomech.2007.12.018; Sherman SL, 2014, CLIN SPORT MED, V33, P389, DOI 10.1016/j.csm.2014.03.008; Showery JE, 2016, J ARTHROPLASTY, V31, P2108, DOI 10.1016/j.arth.2016.03.026; Silder A, 2013, J BIOMECH, V46, P2522, DOI 10.1016/j.jbiomech.2013.06.020; Winby CR, 2013, CLIN BIOMECH, V28, P1014, DOI 10.1016/j.clinbiomech.2013.09.006; Winby CR, 2009, J BIOMECH, V42, P2294, DOI 10.1016/j.jbiomech.2009.06.019; Young AJ, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00004	44	17	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206859	10.1371/journal.pone.0206859	http://dx.doi.org/10.1371/journal.pone.0206859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395591	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400060
J	Aguila, E; Lopez-Ortega, M; Robledo, LMG				Aguila, Emma; Lopez-Ortega, Mariana; Gutierrez Robledo, Luis Miguel			Non-contributory pension programs and frailty of older adults: Evidence from Mexico	PLOS ONE			English	Article							INSTRUMENTAL ACTIVITIES; CASH TRANSFERS; HEALTH; PEOPLE; PARTICIPATION	Non-contributory pension programs in the developing world seek to provide older adults with an income that may improve their health and wellbeing in old age by enabling access to health care and better nutrition. There is no previous evidence of the effects of non-contributory pensions on frailty, a comprehensive measure of health and well-being of the oldest old. We aimed to estimate the effects of non-contributory pension programs on frailty of older adults in the state of Yucatan, Mexico. We use rich panel data, including objective markers and self-reported assessments of health and well-being, for 944 adults at least 70 years of age in two communities of Yucatan, Mexico. The first wave was collected in 2008; the second wave was collected in 2010, 18 months after implementation of a monthly state pension in one community and 12 months after a federal pension paid every two months in the other. We found the state pension led to a statistically significant decrease in the severity of frailty for women, but the federal pension was associated with an increase. We found no statistically significant change in the frailty index for men in either community. Among explanations for these findings are monthly payments being more likely to be spent on health care, medicines, and more regular food expenditures, enabling women who previously lacked independent means of support to increase their longer-term health. The federal program paid every two months led to irregular patterns of food expenditure and increased ownership of durable goods but had no effects on health care utilization, subsequently leading to deterioration in longer-term health for women.	[Aguila, Emma] Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA 90007 USA; [Aguila, Emma] RAND, Santa Monica, CA 90401 USA; [Lopez-Ortega, Mariana] Natl Inst Hlth, Natl Inst Geriatr, Res Dept, Mexico City, DF, Mexico; [Gutierrez Robledo, Luis Miguel] Natl Inst Hlth, Natl Inst Geriatr, Off Director Gen, Mexico City, DF, Mexico	University of Southern California; RAND Corporation	Aguila, E (corresponding author), Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA 90007 USA.; Aguila, E (corresponding author), RAND, Santa Monica, CA 90401 USA.	eaguilav@usc.edu	Aguila, Emma/S-6518-2016	Aguila, Emma/0000-0001-7953-1469	State of Yucatan; National Institute on Aging and various units at the RAND Corporation [R01AG035008, P01AG022481, R21AG033312, P30AG017265]; NATIONAL INSTITUTE ON AGING [P30AG017265] Funding Source: NIH RePORTER	State of Yucatan; National Institute on Aging and various units at the RAND Corporation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by funding from the State of Yucatan and by Grants R01AG035008, P01AG022481, R21AG033312, and P30AG017265 from the National Institute on Aging and various units at the RAND Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPOR, 2016, STAND DEF FIN DISP C; Aguila E., 2014, NONCONTRIBUTORY PENS; Aguila E., 2011, LIVING LONGER MEXICO; Aguila E, 2015, DEV TESTING INFORMED; Aguila E, 2017, AM ECON REV, V107, P430, DOI 10.1257/aer.p20171147; Aguila E, 2016, J AGING SOC POLICY, V28, P325, DOI 10.1080/08959420.2016.1158384; Aguila E, 2015, P NATL ACAD SCI USA, V112, P70, DOI 10.1073/pnas.1414453112; Aguilar-Navarro S, 2012, J FRALITY AGING, V1, P112; Aguilar-Navarro SG, 2015, SALUD PUBLICA MEXICO, V57, pS62; Alencar MA, 2015, TOP GERIATR REHABIL, V31, P105, DOI 10.1097/TGR.0000000000000055; Ali, 2010, WPS5292 WORLD BANK, V5292, P1; Alonso J, 2016, EFFECT NONCONTRIBUTO; Amuedo-Dorantes C, 2015, SOUTH ECON J, V81, P782, DOI 10.1002/soej.12003; Angel JL, 2017, GERONTOLOGIST, V57, P153, DOI 10.1093/geront/gnw136; [Anonymous], NONCONTRIBUTORY PENS; [Anonymous], [No title captured]; Barrientos A., 2003, NONCONTRIBUTORY PENS; Behrman JR, 2013, DEMOGRAPHY, V50, P1363, DOI 10.1007/s13524-013-0199-z; Bergman H, 2007, J GERONTOL A-BIOL, V62, P731, DOI 10.1093/gerona/62.7.731; Bitran R, 2003, 33359 WORLD BANK, P1; Bouillon K, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-64; Cameron C., 2005, MICROECONOMETRICS US, P1056; Case A, 1998, ECON J, V108, P1330, DOI 10.1111/1468-0297.00345; Coady D., 2004, TARGETING TRANSFERS; COCKERHAM WC, 1983, J GERONTOL, V38, P349, DOI 10.1093/geronj/38.3.349; CONSAR, 2012, DISP CAR GEN MAT OP; Consejo Nacional de Evaluacion de la Politica de Desarrollo Social (CONEVAL), 2015, LIN BIEN MEX; Consejo Nacional de Poblacion C, 2016, DAT AB IND MARG; Consejo Nacional de Poblacion (CONAPO), 2012, DAT PROYECC; Crimmins E, 2008, DR012 U MICH SURV RE; de Oliveira PR, 2017, J ECON STUD, V44, P183, DOI 10.1108/JES-04-2015-0059; Delgado G, 2000, TD 0734 PRINCIPAIS R; Demakakos P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068632; Feeney K., 2017, CASH TRANSFERS ADULT; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Galiani S, 2016, LABOUR ECON, V38, P47, DOI 10.1016/j.labeco.2015.11.003; Giraldo Rodriguez L, 2010, ENVEJECIMIENTO VULNE, P315; Robledo LMG, 2012, CURR GERIATR REP, V1, P183, DOI 10.1007/s13670-012-0028-z; Hevia de la Jara Felipe, 2009, Sociológica (Méx.), V24, P43; HOLM S, 1979, SCAND J STAT, V6, P65; Instituto Nacional de Estadistica y Geografia INEGI, 2017, IND OC EMPL CUART TR; Juarez L, 2015, ECON DEV CULT CHANGE, V63, P685, DOI 10.1086/681668; Juarez L, 2009, J PUBLIC ECON, V93, P454, DOI 10.1016/j.jpubeco.2008.10.002; Kassouf AL, 2012, SSRN ELECT J; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Lang PO, 2009, GERONTOLOGY, V55, P539, DOI 10.1159/000211949; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lee JS, 2001, J NUTR, V131, P765, DOI 10.1093/jn/131.3.765; Levy D, 2010, J DEV EFFECT, V2, P421, DOI 10.1080/19439342.2010.519783; Lloyd-Sherlock P, 2014, J DEV STUD, V50, P1570, DOI 10.1080/00220388.2014.936399; Lloyd-Sherlock P, 2012, DEV CHANGE, V43, P1049, DOI 10.1111/j.1467-7660.2012.01790.x; Lund F., 2002, J INT DEV, V14, P681, DOI [10.1002/jid.918, DOI 10.1002/JID.918]; Newson L, 2012, FINANCING SOCIAL PEN; Organisation for Economic Co-operation and Development (OECD), 2015, PPPS EXCH RAT PURCH; Pongiglione B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130747; Salinas-Rodriguez A, 2014, 5 3IE; Smith JP, 1999, J ECON PERSPECT, V13, P145, DOI 10.1257/jep.13.2.145; SPECTOR WD, 1987, J CHRON DIS, V40, P481, DOI 10.1016/0021-9681(87)90004-X; Steffick DE, 2000, DOCUMENTATION AFFECT; Perez-Zepeda MU, 2016, REV INVEST CLIN, V68, P92; United Nations, 2015, STESASERA390 UN; Vogel I., 2012, REV USE THEORY CHANG, DOI [10.1242/dev.080515, DOI 10.1242/DEV.080515]; Willmore L, 2007, WORLD DEV, V35, P24, DOI 10.1016/j.worlddev.2006.09.008	64	10	10	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206792	10.1371/journal.pone.0206792	http://dx.doi.org/10.1371/journal.pone.0206792			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388177	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800059
J	Weissberg, D; Mubiru, F; Kambugu, A; Fehr, J; Kiragga, A; von Braun, A; Baumann, A; Kaelin, M; Sekaggya-Wiltshire, C; Kamya, M; Castelnuovo, B				Weissberg, Dana; Mubiru, Frank; Kambugu, Andrew; Fehr, Jan; Kiragga, Agnes; von Braun, Amrei; Baumann, Anna; Kaelin, Marisa; Sekaggya-Wiltshire, Christine; Kamya, Moses; Castelnuovo, Barbara			Ten years of antiretroviral therapy: Incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort	PLOS ONE			English	Article							CLINICAL-DISEASE PROGRESSION; SUB-SAHARAN AFRICA; CD4 CELL COUNTS; POPULATION-LEVEL; INCOME COUNTRIES; AIDS MORTALITY; VIRAL FAILURE; UNITED-STATES; HIV; ADULTS	Background Despite increased antiretroviral therapy (ART) coverage and the raised CD4 threshold for starting ART, opportunistic infections (OIs) are still one of the leading causes of death in sub-Saharan Africa. There are few studies from resource-limited settings on long-term reporting of OIs other than tuberculosis. Methods Patients starting ART between April 2004 and April 2005 were enrolled and followed-up for 10 years in Kampala, Uganda. We report incidences, patterns and risk factors using Cox proportional hazards models of OIs among all patients and among patients with CD4 cell counts >200 cells/mu L. Results Of the 559 patients starting ART, 164 patients developed a total of 241 OIs during 10 years of follow-up. The overall incidence was highest for oral candidiasis (25.4, 95% confidence interval (CI): 20.5-31.6 per 1000 person-years of follow-up), followed by tuberculosis (15.3, 95% CI: 11.7-20.1), herpes zoster (12.3, 95% CI: 9.1-16.6) and cryptococcal meningitis (3.0, 95% CI: 1.7-5.5). Incidence rates for all OIs were highest in the first year after ART initiation and decreased with the increase of the current CD4 cell count. Factors independently associated with development of OIs were baseline nevirapine-based regimens, time-varying higher viral load, time-varying lower CD4 cell count and time-varying lower hemoglobin. In patients developing OIs at a current CD4 cell count >200 cells/mu L, factors independently associated with OI development were time-varying increase in viral load and time-varying decrease in hemoglobin, whereas a baseline CD4 cell count <50 cells/mu L was protective. Conclusion We report high early incidences of OIs, decreasing with increasing CD4 cell count and time spent on ART. Ongoing HIV replication and anemia were strong predictors for OI development independent of the CD4 cell count. Our findings support the recommendation for early initiation of ART and suggest close monitoring for OIs among patients recently started on ART, with low CD4 cell count, high viral load and anemia.	[Weissberg, Dana; Mubiru, Frank; Kambugu, Andrew; Kiragga, Agnes; Baumann, Anna; Kaelin, Marisa; Sekaggya-Wiltshire, Christine; Castelnuovo, Barbara] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda; [Weissberg, Dana; Fehr, Jan; von Braun, Amrei; Baumann, Anna; Kaelin, Marisa] Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland; [Fehr, Jan] Univ Zurich, Dept Publ Hlth, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Kamya, Moses] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	Makerere University; University of Zurich; University Zurich Hospital; University of Zurich; Makerere University	Weissberg, D (corresponding author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, Kampala, Uganda.; Weissberg, D (corresponding author), Univ Zurich, Univ Hosp Zurich, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	dana.weissberg@gmail.com	Fehr, Jan S/V-7499-2017	Fehr, Jan S/0000-0003-1113-9895; Sekaggya-Wiltshire, Christine/0000-0001-9247-2950; Castelnuovo, Barbara/0000-0001-7756-5032				Aaron L, 2004, CLIN MICROBIOL INFEC, V10, P388, DOI 10.1111/j.1469-0691.2004.00758.x; Anastos K, 2004, JAIDS-J ACQ IMM DEF, V35, P383, DOI 10.1097/00126334-200404010-00008; Anglaret X, 2012, CLIN INFECT DIS, V54, P714, DOI 10.1093/cid/cir898; Auld AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054665; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Barbara C, 2015, JAIDS-J ACQ IMM DEF, V70, pE174, DOI 10.1097/QAI.0000000000000820; Berhane K, 2004, JAIDS-J ACQ IMM DEF, V37, P1245, DOI 10.1097/01.qai.0000134759.01684.27; Buchacz K, 2016, J INFECT DIS, V214, P862, DOI 10.1093/infdis/jiw085; Castelnuovo B, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20773; Castelnuovo B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142722; Castelnuovo B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051631; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Coelho LE, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1462-x; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; De Beaudrap P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-179; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Fangman John J W, 2005, Curr Hematol Rep, V4, P95; Fenner L, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21327; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Floyd S, 2012, TROP MED INT HEALTH, V17, pe84, DOI 10.1111/j.1365-3156.2012.03032.x; Furrer H, 2016, J INFECT DIS, V214, P830, DOI 10.1093/infdis/jiw086; GIORGI JV, 1993, ANN NY ACAD SCI, V677, P126, DOI 10.1111/j.1749-6632.1993.tb38771.x; Hennessey KA, 2000, AIDS RES HUM RETROV, V16, P103, DOI 10.1089/088922200309449; Iroezindu MO, 2016, ANN MED HEALTH SCI R, V6, P4, DOI 10.4103/2141-9248.180234; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kaplan JE, 2000, CLIN INFECT DIS, V30, pS5, DOI 10.1086/313843; Keiser O, 2008, TROP MED INT HEALTH, V13, P870, DOI 10.1111/j.1365-3156.2008.02078.x; Kowalska JD, 2007, AIDS RES HUM RETROV, V23, P1183, DOI 10.1089/aid.2006.0292; Lawn SD, 2005, LANCET INFECT DIS, V5, P361, DOI 10.1016/S1473-3099(05)70140-7; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Low A, 2016, CLIN INFECT DIS, V62, P1595, DOI 10.1093/cid/ciw125; Maduna PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121843; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mocroft A, 2007, AIDS, V21, P1867, DOI 10.1097/QAD.0b013e328270b877; Mocroft A, 2011, ANTIVIR THER, V16, P329, DOI 10.3851/IMP1746; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; Moore RD, 1996, ANN INTERN MED, V124, P633, DOI 10.7326/0003-4819-124-7-199604010-00003; Moore RD, 2002, J ACQ IMMUN DEF SYND, V29, P54, DOI 10.1097/00042560-200201010-00007; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Nesheim SR, 2007, PEDIATRICS, V120, P100, DOI 10.1542/peds.2006-2052; Nwaka S, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-11; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pathmanathan I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173309; Reekie J, 2011, AIDS, V25, P2259, DOI 10.1097/QAD.0b013e32834cdb4b; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Rubaihayo J, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0927-7; RUEGG CL, 1990, ANN NY ACAD SCI, V616, P307; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Siedner MJ, 2015, CLIN INFECT DIS, V60, P1120, DOI 10.1093/cid/ciu1137; Siika A, 2018, CLIN INFECT DIS, V66, pS140, DOI 10.1093/cid/cix1142; Srasuebkul P, 2009, CLIN INFECT DIS, V48, P940, DOI 10.1086/597354; Uganda Ministry of Health, 2003, NAT ANT TREATM CAR G; UNAIDS, 2016, UNAIDS REP GLOB AIDS; Van Rie A, 2011, JAIDS-J ACQ IMM DEF, V56, P349, DOI 10.1097/QAI.0b013e3181f9fb39; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; Wheeler D A, 1999, AIDS Read, V9, P347; WHO, 2016, GLOB TUB REP; World Health Organisation, 2017, SCALING UP ANTIRETRO; World Health Organisation, 2017, HLTH STAT INF SYST E	62	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206796	10.1371/journal.pone.0206796	http://dx.doi.org/10.1371/journal.pone.0206796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383836	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000449027600098
J	Hirota, A; Nakajima-Koyama, M; Ashida, Y; Nishida, E				Hirota, Akira; Nakajima-Koyama, May; Ashida, Yuhei; Nishida, Eisuke			The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; neurodifferentiation; nucleosome remodeling deacetylase (NuRD); p53; protein degradation; chromodomain helicase DNA-binding protein 4 (CHD4); lineage specification; methyl-CpG binding domain protein 3 (MBD3)	HISTONE DEACETYLASE; NURD; PLURIPOTENCY; EXPRESSION; MI-2-BETA; GENE; SPECIFICITY; COMMITMENT; INDUCTION; BRACHYURY	Lineage specification of the three germ layers occurs during early embryogenesis and is critical for normal development. The nucleosome remodeling and deacetylase (NuRD) complex is a repressive chromatin modifier that plays a role in lineage commitment. However, the role of chromodomain helicase DNA-binding protein 4 (CHD4), one of the core subunits of the NuRD complex, in neural lineage commitment is poorly understood. Here, we report that the CHD4/NuRD complex plays a critical role in neural differentiation of mouse embryonic stem cells (ESCs). We found that RNAi-mediated Chd4 knockdown suppresses neural differentiation, as did knockdown of methyl-CpG-binding domain protein Mbd3, another NuRD subunit. Chd4 and Mbd3 knockdowns similarly affected changes in global gene expression during neural differentiation and up-regulated several mesendodermal genes. However, inhibition of mesendodermal genes by knocking out the master regulators of mesendodermal lineages, Brachyury and Eomes, through a CRISPR/Cas9 approach could not restore the impaired neural differentiation caused by the Chd4 knockdown, suggesting that CHD4 controls neural differentiation by not repressing other lineage differentiation processes. Notably, Chd4 knockdown increased the acetylation levels of p53, resulting in increased protein levels of p53. Double knockdown of Chd4 and p53 restored the neural differentiation rate. Furthermore, overexpression of BCL2, a downstream factor of p53, partially rescued the impaired neural differentiation caused by the Chd4 knockdown. Our findings reveal that the CHD4/NuRD complex regulates neural differentiation of ESCs by down-regulating p53.	[Hirota, Akira; Nakajima-Koyama, May; Ashida, Yuhei; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Nakajima-Koyama, May; Nishida, Eisuke] AMED CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan	Kyoto University	Nakajima-Koyama, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.; Nakajima-Koyama, M (corresponding author), AMED CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan.; Nishida, E (corresponding author), RIKEN Ctr Biosyst Dynam Res, Lab Mol Biol Aging, Chuou Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	mnakajima.m07@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp		Hirota, Akira/0000-0003-3301-089X				Allen HF, 2013, CELL MOL LIFE SCI, V70, P3513, DOI 10.1007/s00018-012-1256-2; Aloia L, 2014, GENE DEV, V28, P182, DOI 10.1101/gad.228510.113; Amaya M, 2013, BLOOD, V121, P3493, DOI 10.1182/blood-2012-11-466227; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Costello I, 2011, NAT CELL BIOL, V13, P1084, DOI 10.1038/ncb2304; Faial T, 2015, DEVELOPMENT, V142, P2121, DOI 10.1242/dev.117838; Gomez-del Arco P, 2016, CELL METAB, V23, P881, DOI 10.1016/j.cmet.2016.04.008; Hassig CA, 1998, P NATL ACAD SCI USA, V95, P3519, DOI 10.1073/pnas.95.7.3519; Hemann MT, 2006, CELL DEATH DIFFER, V13, P1256, DOI 10.1038/sj.cdd.4401962; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hosokawa H, 2013, P NATL ACAD SCI USA, V110, P4691, DOI 10.1073/pnas.1220865110; Huang CY, 2017, GENE DEV, V31, P241, DOI 10.1101/gad.292169.116; Huang CY, 2010, CELL RES, V20, P154, DOI 10.1038/cr.2010.5; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Iwafuchi-Doi M, 2012, DEVELOPMENT, V139, P3926, DOI 10.1242/dev.085936; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kalisz M, 2012, DEV BIOL, V362, P94, DOI 10.1016/j.ydbio.2011.11.017; Kamiya D, 2011, NATURE, V470, P503, DOI 10.1038/nature09726; Kashiwagi M, 2007, DEVELOPMENT, V134, P1571, DOI 10.1242/dev.001750; Knock E, 2015, NEURAL DEV, V10, DOI 10.1186/s13064-015-0040-z; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Lolas M, 2014, P NATL ACAD SCI USA, V111, P4478, DOI 10.1073/pnas.1402612111; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nitarska J, 2016, CELL REP, V17, P1683, DOI 10.1016/j.celrep.2016.10.022; O'Shaughnessy-Kirwan A, 2015, DEVELOPMENT, V142, P2586, DOI 10.1242/dev.125450; Polo SE, 2010, EMBO J, V29, P3130, DOI 10.1038/emboj.2010.188; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Spruijt CG, 2010, MOL BIOSYST, V6, P1700, DOI 10.1039/c004108d; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Thornton SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110498; Trouillas M, 2008, CELL DEATH DIFFER, V15, P1450, DOI 10.1038/cdd.2008.63; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wilson SI, 2001, NAT NEUROSCI, V4, P1161, DOI 10.1038/nn747; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Yoshida T, 2008, GENE DEV, V22, P1174, DOI 10.1101/gad.1642808; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; Zhao HX, 2017, J BIOL CHEM, V292, P8507, DOI 10.1074/jbc.M116.770248	43	5	5	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					195	209		10.1074/jbc.RA118.004086	http://dx.doi.org/10.1074/jbc.RA118.004086			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409903	hybrid, Green Published			2022-12-26	WOS:000455105500023
J	Li, FF; Lang, YE; Ji, ZL; Xia, ZQ; Han, YW; Cheng, YT; Liu, GM; Sun, F; Zhao, YH; Gao, MJ; Chen, ZY; Wu, YL; Li, WX; Cao, ZJ				Li, Fangfang; Lang, Yange; Ji, Zhenglin; Xia, Zhiqiang; Han, Yuewen; Cheng, Yuting; Liu, Gaomin; Sun, Fang; Zhao, Yonghui; Gao, Minjun; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian			A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						peptides; infection; dengue virus (DENV); hepatitis C virus (HCV); virus entry; antiviral agent; antiviral mechanism; antiviral peptide; dengue virus; scorpion venom peptide; Zika virus; herpes simplex virus; membrane fusion; endosome	INHIBITORY-ACTIVITY; VIRUS-INFECTION; HOST-CELLS; BIOAVAILABILITY; ACIDIFICATION; REPLICATION; EXPRESSION; TARGETS	Viral infections still threaten human health all over the world, and many people die from viral diseases every year. However, there are no effective vaccines or drugs for preventing or managing most viral diseases. Thus, the discovery and development of broad-spectrum antiviral agents remain urgent. Here, we expressed and purified a venom peptide, Ev37, from the scorpion Euscorpiops validus in a prokaryotic system. We found that rEv37 can inhibit dengue virus type 2 (DENV-2), hepatitis C virus (HCV), Zika virus (ZIKV), and herpes simplex virus type 1 (HSV-1) infections in a dose-dependent manner at noncytotoxic concentrations, but that it has no effect on Sendai virus (SeV) and adenovirus (AdV) infections in vitro. Furthermore, rEv37 alkalized acidic organelles to prevent low pH-dependent fusion of the viral membrane-endosomal membrane, which mainly blocks the release of the viral genome from the endosome to the cytoplasm and then restricts viral late entry. Taken together, our results indicate that the scorpion venom peptide Ev37 is a broad-spectrum antiviral agent with a specific molecular mechanism against viruses undergoing low pH-dependent fusion activation during entry into host cells. We conclude that Ev37 is a potential candidate for development as an antiviral drug.	[Li, Fangfang; Lang, Yange; Ji, Zhenglin; Xia, Zhiqiang; Han, Yuewen; Cheng, Yuting; Liu, Gaomin; Sun, Fang; Zhao, Yonghui; Gao, Minjun; Chen, Zongyun; Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, State Key Lab Virol, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Wu, Yingliang; Li, Wenxin; Cao, Zhijian] Wuhan Univ, Biodrug Res Ctr, Wuhan 430072, Hubei, Peoples R China; [Cao, Zhijian] Wuhan Univ, Hubei Prov Engn & Technol Res, Ctr Fluorinated Pharmaceut, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Cao, ZJ (corresponding author), Wuhan Univ, State Key Lab Virol, Modern Virol Res Ctr, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	zjcao@whu.edu.cn						Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; Carballar-Lejarazu R, 2008, CELL MOL LIFE SCI, V65, P3081, DOI 10.1007/s00018-008-8250-8; Cheng G, 2008, P NATL ACAD SCI USA, V105, P3088, DOI 10.1073/pnas.0712380105; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; El-Bitar AMH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0276-6; FAN DP, 1978, CELL, V15, P985, DOI 10.1016/0092-8674(78)90282-9; Feng J, 2013, PROTEIN EXPRES PURIF, V88, P127, DOI 10.1016/j.pep.2012.12.004; Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100; da Mata ECG, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-016-0089-0; Hong W, 2013, BIOMATERIALS, V34, P3511, DOI 10.1016/j.biomaterials.2013.01.075; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Huang S, 1999, J VIROL, V73, P2798, DOI 10.1128/JVI.73.4.2798-2802.1999; Jones JC, 2006, J VIROL, V80, P11960, DOI 10.1128/JVI.01678-06; Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084; Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002; Li ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097539; Lin LT, 2015, J HEPATOL, V62, P541, DOI 10.1016/j.jhep.2014.10.040; Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3; Marvin SA, 2012, BIOL CELL, V104, P188, DOI 10.1111/boc.201100096; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346; Nicola AV, 2016, TRAFFIC, V17, P965, DOI 10.1111/tra.12408; Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008; Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005; Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108; Shan C, 2018, J VIROL, V92, DOI 10.1128/JVI.01002-18; Sinha S, 2003, ANTIMICROB AGENTS CH, V47, P494, DOI 10.1128/AAC.47.2.494-500.2003; Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Wiethoff CM, 2005, J VIROL, V79, P1992, DOI 10.1128/JVI.79.4.1992-2000.2005; Yacoub Sophie, 2016, F1000Res, V5, DOI 10.12688/f1000research.6233.1; Yang DQ, 2012, J BONE MINER RES, V27, P1695, DOI 10.1002/jbmr.1623; Zeng XC, 2012, PEPTIDES, V33, P44, DOI 10.1016/j.peptides.2011.11.012; Zeng ZY, 2018, THERANOSTICS, V8, P199, DOI 10.7150/thno.21425; Zeng ZY, 2016, TOXINS, V8, DOI 10.3390/toxins8050124; Zhao ZH, 2012, J BIOL CHEM, V287, P30181, DOI 10.1074/jbc.M112.370312	39	16	16	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					182	194		10.1074/jbc.RA118.005015	http://dx.doi.org/10.1074/jbc.RA118.005015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30404919	Green Published, hybrid			2022-12-26	WOS:000455105500022
J	Li, J; Chen, T; Huang, XH; Zhao, YS; Wang, B; Yin, YY; Cui, Y; Zhao, YN; Zhang, RP; Wang, XJ; Wang, YC; Dai, JW				Li, Jing; Chen, Tong; Huang, Xiahe; Zhao, Yunshan; Wang, Bin; Yin, Yanyun; Cui, Yi; Zhao, Yannan; Zhang, Ruiping; Wang, Xiujie; Wang, Yingchun; Dai, Jianwu			Substrate-independent immunomodulatory characteristics of mesenchymal stem cells in three-dimensional culture	PLOS ONE			English	Article							MSCS; DIFFERENTIATION; TOPOGRAPHY; CD73	Mesenchymal stem cells (MSCs) play important roles in tissue regeneration, and multi-lineage differentiation and immunomodulation are two major characteristics of MSCs that are utilized in stem cell therapy. MSCs in vivo have a markedly different three-dimensional (3D) niche compared to the traditional two-dimensional (2D) culture in vitro. A 3D scaffold is predicted to provide an artificial 3D environment similar to the in vivo environment. Significant changes in MSC differentiation are shown to be occurred when under 3D culture. However, the immunomodulatory characteristics of MSCs under 3D culture remain unknown. In this study, 3D culture systems were constructed using different substrates to evaluate the common immunomodulatory characteristics of MSCs. Compared to the MSCs under 2D culture, the MSCs under 3D culture, which had higher stemness and maintained cell phenotype, showed altered immunophenotypic pattern. Gene expression profile analysis at mRNA and protein level detected by gene chip and protein chip, respectively, further revealed the difference between 3D cultured MSCs and 2D cultured MSCs, which was mainly concentrated in the immunoregulation related aspects. Moreover, the immunoregulatory role of 3D culture was confirmed by our immunosuppressive experiments. These findings demonstrated that the immunomodulatory capacities of MSCs were enhanced by the 3D geometry of substrates.	[Li, Jing] Chinese Peoples Liberat Army Gen Hosp, Lab Translat Med, Beijing, Peoples R China; [Li, Jing; Wang, Bin; Yin, Yanyun; Cui, Yi; Zhao, Yannan; Dai, Jianwu] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Chen, Tong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Tong; Wang, Xiujie] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing, Peoples R China; [Huang, Xiahe; Wang, Yingchun] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China; [Zhao, Yunshan] Chinese Peoples Liberat Army Gen Hosp, Inst Gen Surg, Beijing, Peoples R China; [Zhang, Ruiping] Shanxi Med Univ, Clin Med Sch 1, Dept Radiol, Taiyuan, Shanxi, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese People's Liberation Army General Hospital; Shanxi Medical University	Dai, JW (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	jwdai@genetics.ac.cn	Chen, Tong/AAC-3555-2022; Zhang, Rui/GXN-3801-2022	Chen, Tong/0000-0003-3134-3113; 	Ministry of Science and Technology of China [2011CB965001, 2011CB710905]; "Strategic Priority Research Program of the Chinese Academy of Sciences" (Chinese Academy of Sciences) [XDA01030000]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA01030000]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); "Strategic Priority Research Program of the Chinese Academy of Sciences" (Chinese Academy of Sciences); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the Ministry of Science and Technology of China (http://www.most.gov.cn/eng/; 2011CB965001 and 2011CB710905; JW D); the "Strategic Priority Research Program of the Chinese Academy of Sciences" (the Chinese Academy of Sciences, http://english.cas.cn/; XDA01030000; JW D). JW D: substantial contribution to conception and design, financial support, analysis and interpretation of data, final approval of the version to be published.; This work was supported by grants from the Ministry of Science and Technology of China (2011CB965001 and 2011CB710905) and the "Strategic Priority Research Program of the Chinese Academy of Sciences" (XDA01030000).	Ansari S, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5974-8; Ansari S, 2017, ACTA BIOMATER, V60, P181, DOI 10.1016/j.actbio.2017.07.017; Bassi G, 2015, TISSUE ENG PT A, V21, P767, DOI [10.1089/ten.tea.2014.0269, 10.1089/ten.TEA.2014.0269]; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Brisevac D, 2012, NEUROCHEM INT, V61, P681, DOI 10.1016/j.neuint.2012.06.017; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; DelaRosa O, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/865601; Fiedler J, 2013, BIOMATERIALS, V34, P8851, DOI 10.1016/j.biomaterials.2013.08.010; Furman BD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4591; Gao LY, 2014, MOL CELL PROTEOMICS, V13, P204, DOI 10.1074/mcp.M113.033803; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Han SF, 2012, J GENET GENOMICS, V39, P633, DOI 10.1016/j.jgg.2012.08.006; Harvey A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079283; Heuts DPHM, 2012, CHEMBIOCHEM, V13, P2384, DOI 10.1002/cbic.201200426; Jones E, 2015, METHODS MOL BIOL, V1235, P105, DOI 10.1007/978-1-4939-1785-3_10; Karaoz E, 2011, J CELL PHYSIOL, V226, P1367, DOI 10.1002/jcp.22468; Lee MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184111; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Ng CP, 2014, BIOMATERIALS, V35, P4046, DOI 10.1016/j.biomaterials.2014.01.081; Pandolfi L, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5856-0; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2013, STEM CELLS, V31, P2042, DOI 10.1002/stem.1400; Regulski MJ, 2017, WOUNDS, V29, P20; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rubtsov Y, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/6516854; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Tsimbouri P, 2014, J CELL BIOCHEM, V115, P380, DOI 10.1002/jcb.24673; Valles G, 2015, BIOMATERIALS, V37, P124, DOI 10.1016/j.biomaterials.2014.10.028; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002; Wei JS, 2014, BIOMATERIALS, V35, P7724, DOI 10.1016/j.biomaterials.2014.05.060; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wu YN, 2014, NANOMED-NANOTECHNOL, V10, P1507, DOI 10.1016/j.nano.2014.04.002; Wu YN, 2017, TISSUE ENG PT A, V23, P43, DOI [10.1089/ten.TEA.2016.0123, 10.1089/ten.tea.2016.0123]; Yang X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11666-3; Yeh HY, 2012, BIOMATERIALS, V33, P8943, DOI 10.1016/j.biomaterials.2012.08.069	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206811	10.1371/journal.pone.0206811	http://dx.doi.org/10.1371/journal.pone.0206811			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408051	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300039
J	Dubey, S; Kallubai, M; Sarkar, A; Subramanyam, R				Dubey, Shreya; Kallubai, Monika; Sarkar, Arijit; Subramanyam, Rajagopal			Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin	PLOS ONE			English	Article							COMPARATIVE BINDING MECHANISM; PLASMA-PROTEINS; ACID-BINDING; STABILITY; NANOPARTICLES	Withania somnifera (Ashwagandha) is an efficient medicinal plant known in Ayurveda and Chinese medicine since ancient times, whose extracts are consumed orally as food supplement or as a health tonic owing to its several restorative properties for various CNS disorders, inflammation, tumour, stress, rheumatism etc. In this study, we have analyzed the binding interaction of four derivatives of Withania somnifera (Withanolide A, Withanolide B, Withanoside IV and Withanoside V) with HSA because of their important pharmacological properties. To unravel the binding between derivatives of Withania somnifera and HSA, fluorescence spectroscopy was used. Binding studies were further studied by molecular docking and dynamics and results confirmed greater stability upon binding of derivatives with HSA. Circular dichroism data illustrated change in the secondary structure of protein upon interaction with these derivatives, particularly the helical structure was increased and beta-sheets and random coils were decreased. Furthermore, morphological and topological changes were observed using AFM and TEM upon binding of ligands with HSA indicating that HSA-withnoside/withanolide complexes were formed. All the results cumulatively demonstrate strong binding of withanosides and withanolides derivatives with serum albumin, which should further be explored to study the pharmacokinetics and pharmacodynamics of these derivatives.	[Dubey, Shreya; Kallubai, Monika; Sarkar, Arijit; Subramanyam, Rajagopal] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Gachibowli, Telangana, India	University of Hyderabad	Subramanyam, R (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Gachibowli, Telangana, India.	srgsl@uohyd.ernet.in	SARKAR, ARIJIT/Q-7733-2019	SARKAR, ARIJIT/0000-0002-3447-1295; Subramanyam, Rajagopal/0000-0003-3872-8390	Science and Engineering Research Board [SB/EMEQ-064/2014]; CSIR; UGC-Kothari	Science and Engineering Research Board; CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC-Kothari	This work was supported by Science and Engineering Research Board (SB/EMEQ-064/2014 dated 14-07-2015). SD and MK acknowledge CSIR and UGC-Kothari for fellowship.; We thank Bioinformatics facility, School of Life Sciences, University of Hyderabad for computer facility. SD and MK acknowledges CSIR and UGC-Kothari for fellowship.	CARTER DC, 1989, SCIENCE, V244, P1195, DOI 10.1126/science.2727704; Chanphai P, 2017, COLLOID SURFACE B, V150, P168, DOI 10.1016/j.colsurfb.2016.11.037; Chuang VTG, 2006, CHIRALITY, V18, P159, DOI 10.1002/chir.20237; Curry S, 1999, BBA-MOL CELL BIOL L, V1441, P131, DOI 10.1016/S1388-1981(99)00148-1; Dhar N, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01031; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; GLOTTER E, 1991, NAT PROD REP, V8, P415, DOI 10.1039/np9910800415; Gokara M, 2017, J BIOMOL STRUCT DYN, V35, P2280, DOI 10.1080/07391102.2016.1216895; Gokara M, 2015, J BIOMOL STRUCT DYN, V33, P196, DOI 10.1080/07391102.2013.868321; Gokara M, 2014, J BIOMOL STRUCT DYN, V32, P1290, DOI 10.1080/07391102.2013.817953; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Hein KL, 2010, J STRUCT BIOL, V171, P353, DOI 10.1016/j.jsb.2010.03.014; Huang J, 2010, CHEM COMMUN, V46, P6684, DOI 10.1039/c0cc01041c; Kallubai M, 2019, J BIOMOL STRUCT DYN, V37, P623, DOI 10.1080/07391102.2018.1433554; Kallubai M, 2015, MOL BIOSYST, V11, P1172, DOI 10.1039/c4mb00635f; Li SS, 2016, RSC ADV, V6, P85811, DOI 10.1039/c6ra17508b; Magasanik B., 1995, 2 COMPONENT SIGNAL T, P1; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Neelam S, 2010, J PHYS CHEM B, V114, P3005, DOI 10.1021/jp910156k; Nerusu A, 2017, ACS OMEGA, V2, P6514, DOI 10.1021/acsomega.7b00577; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Radibratovic M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167973; Rapaport DC, 1998, COMPUT PHYS, P1, DOI [10.1063/1.4822471, DOI 10.1063/1.4822471]; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V94, P8, DOI 10.1016/j.jphotobiol.2008.09.002; Subramanyam R, 2009, J PHOTOCH PHOTOBIO B, V95, P81, DOI 10.1016/j.jphotobiol.2009.01.002; Sudhamalla B, 2010, J PHYS CHEM B, V114, P9054, DOI 10.1021/jp102730p; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Sun YE, 2017, J FOOD DRUG ANAL, V25, P385, DOI 10.1016/j.jfda.2016.08.013; Varshney A, 2010, CHIRALITY, V22, P77, DOI 10.1002/chir.20709; Verma SK., 2011, ASIAN J PHARM CLIN R, V4, P1; Yadav SA, 2018, J BIOMOL STRUCT DYN, V36, P810, DOI 10.1080/07391102.2017.1300106; Yamasaki K, 2000, AAPS PharmSciTech, V1, pE12, DOI 10.1208/pt010212; Yeggoni DPR, 2016, J BIOMOL STRUCT DYN, V34, P2023, DOI 10.1080/07391102.2015.1104264; Yeggoni DP, 2017, RSC ADV, V7, P5002, DOI 10.1039/c6ra25671f; Yeggoni DP, 2016, J PHOTOCH PHOTOBIO B, V160, P248, DOI 10.1016/j.jphotobiol.2016.04.012; Yeggoni DP, 2016, RSC ADV, V6, P40225, DOI 10.1039/c6ra06837e; Yeggoni DP, 2015, J BIOMOL STRUCT DYN, V33, P1336, DOI 10.1080/07391102.2014.947326; Yeggoni DP, 2014, MOL BIOSYST, V10, P3101, DOI 10.1039/c4mb00408f; Yuan LX, 2017, SPECTROCHIM ACTA A, V173, P584, DOI 10.1016/j.saa.2016.10.023; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0200053	10.1371/journal.pone.0200053	http://dx.doi.org/10.1371/journal.pone.0200053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403672	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500003
J	Karawita, H; Perera, P; Gunawardane, P; Dayawansa, N				Karawita, Hasitha; Perera, Priyan; Gunawardane, Pabasara; Dayawansa, Nihal			Habitat preference and den characterization of Indian Pangolin (Manis crassicaudata) in a tropical lowland forested landscape of southwest Sri Lanka	PLOS ONE			English	Article							POTOHAR PLATEAU; PAKISTAN; PENTADACTYLA; KNOWLEDGE; ABUNDANCE; DIET	The Indian pangolin (Manis crassicaudata) is under threat due to hunting for local consumption and illegal trafficking of scales and meat. The dearth of scientific studies on the ecology of the M. crassicaudata has impaired accurate assessments of its conservation needs. This study investigated the habitat preference and burrow characteristics of M. crassicaudata in a tropical lowland rainforest in southwest Sri Lanka. A total of 75 burrows (54 feeding burrows and 21 resting burrows) of M. crassicaudata in four different habitat types i.e. secondary forest, Pine-dominated forest, rubber cultivations and tea-dominated home gardens bordering forest were observed using fixed-width transects in order to characterize resting and feeding burrows of this species. The highest density of resting burrows was recorded from the secondary forest (4ha(-1)), followed by rubber cultivations (2.5ha(-1)) while no resting burrows were recorded in the Pine-dominated forest and the tea-dominated home gardens bordering forest. Feeding burrows were more abundant in the Pine-dominated forest (5.7ha(-)(1)). The burrow depth, burrow opening height, and width were significantly larger in resting burrows compared to feeding burrows. Resting burrows were located at higher elevations (75-100m) with moderately high slopes (45 degrees-60 degrees), dense canopy cover (>75%) and away from human habitation. Feeding burrows showed a greater variability in terms of associated environmental features. The study further revealed that Indian pangolins exclusively prefer habitats with rocks and boulders under which they dig resting burrows while the location of feeding burrows largely overlaps with the distribution of prey species. The resting burrow design consisted of a bending tunnel that initially slopes downward and then gradually inclines at an angle between 20 and 30 degrees, leading to the resting chamber. Our study high-lights the importance of conserving fragmented secondary natural forests in changing landscapes of the southwest lowlands of Sri Lanka as these habitats appear to be critical to sustaining populations of M. crassicaudata.	[Karawita, Hasitha; Perera, Priyan; Gunawardane, Pabasara] Univ Sri Jayewardenepura, Dept Forestry & Environm Sci, Nugegoda, Sri Lanka; [Perera, Priyan] Zool Soc London, IUCN SSC Pangolin Specialist Grp, London, England; [Dayawansa, Nihal] Univ Colombo, Dept Zool & Environm Sci, Colombo 07, Sri Lanka	University Sri Jayewardenepura; Zoological Society of London; University of Colombo	Perera, P (corresponding author), Univ Sri Jayewardenepura, Dept Forestry & Environm Sci, Nugegoda, Sri Lanka.; Perera, P (corresponding author), Zool Soc London, IUCN SSC Pangolin Specialist Grp, London, England.	priyan@sjp.ac.lk	Perera, Priyan/K-2352-2012	Perera, Priyan/0000-0002-9452-4790	University of Sri Jayewardenepura, Sri Lanka [ASP/SCI/2015/07]	University of Sri Jayewardenepura, Sri Lanka	This research was fully funded by the University of Sri Jayewardenepura, Sri Lanka under the research grant ASP/SCI/2015/07.	Albert CH, 2010, ECOGRAPHY, V33, P1028, DOI 10.1111/j.1600-0587.2010.06421.x; [Anonymous], 1999, WALKERS MAMMALS WORL; [Anonymous], [No title captured]; [Anonymous], [No title captured]; Baillie J., 2014, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2014-2.RLTS.T12761A45221874.en, DOI 10.2305/IUCN.UK.2014-2.RLTS.T12761A45221874.EN]; Bart J, 1995, AUK, V112, P758; Bhandari N., 2014, Nepalese Journal of Zoology, V2, P18; Chakkaravarthy QA, 2012, P 3 SEM SMALL MAMM I, P50; Challender Daniel W.S., 2011, Traffic Bulletin, V23, P92; Cochran WG., 1963, SAMPLING TECHNIQUES; Etikan I., 2016, AM J THEORETICAL APP, V5, P1, DOI [10.11648/j.ajtas.20160501.11, DOI 10.11648/J.AJTAS.20160501.11]; Irshad N, 2015, ANIM BIOL, V65, P57, DOI 10.1163/15707563-00002462; Mahmood T, 2015, J ANIM PLANT SCI, V25, P1311; Mahmood T, 2014, RUSS J ECOL+, V45, P70, DOI 10.1134/S1067413614010081; Mahmood T, 2013, PAK J ZOOL, V45, P1533; Nash HC, 2016, BIOL CONSERV, V196, P189, DOI 10.1016/j.biocon.2016.02.025; Newton Peter, 2008, Endangered Species Research, V6, P41, DOI 10.3354/esr00127; Perera P, 2017, COMMUNITY ECOL, V18, P175, DOI 10.1556/168.2017.18.2.7; Perera P., 2017, J TROP FOR ENV, V7, P1; Phillips W., 1981, MANUAL MAMMALS SRI L, VVolume 2; Prater S.H., 1980, BOOK INDIAN ANIMALS; Prater SH, 1965, BOOK INDIAN ANIMALS, V2; Punyawardena BV, 2003, AGROECOLOGICAL REGIO; SPSS I, 2009, PASW STAT 18; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; THAPA P, 2014, AM J ZOOL RES, V2, P16, DOI DOI 10.12691/AJZR-2-1-3; Trageser SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175450; Weerakoon D.K., 2012, NATL RED LIST, P134; Wu SB, 2003, MAMMALIA, V67, P493; Yang CW, 2007, ZOO BIOL, V26, P223, DOI 10.1002/zoo.20134	30	19	20	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206082	10.1371/journal.pone.0206082	http://dx.doi.org/10.1371/journal.pone.0206082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403703	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500051
J	Nam, JY; Choi, Y; Jung, MK; Shin, J; Cho, KH; Kim, W; Park, EC				Nam, Jin Young; Choi, Young; Jung, Mo Kyung; Shin, Jaeyong; Cho, Kyoung Hee; Kim, Woorim; Park, Eun-Cheol			The effect of neonatal hypothyroidism and low family income on intellectual disability: A population-based cohort study	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MENTAL-RETARDATION; CONGENITAL HYPOTHYROIDISM; CHILDREN; ASSOCIATION; ADOLESCENTS; PREVALENCE; PREGNANCY; INFANTS; HEALTH	Background To investigate relationships among neonatal hypothyroidism, family income, and intellectual disability, as well as the combined effects of neonatal hypothyroidism and low family income on intellectual disability. Methods Data were extracted from the National Health Insurance Service-National Sample Cohort from 2002 to 2011. This retrospective study included 91,247 infants. The presence of intellectual disability was based on the disability evaluation system in Korea. Newborn hypothyroidism was identified from diagnosis and prescription codes. Family income was determined from average monthly insurance premiums. Cox proportional hazards models were used to calculate adjusted hazard ratios. Results Of the 91,247 infants, 208 were considered to have intellectual disability (29.18 cases per 100,000 person-year). The risk of intellectual disability was higher in infants with hypothyroidism than in those without hypothyroidism (hazard ratio = 5.28, P: < .0001). The risk of intellectual disability was higher in infants with low family income than in those with high family income (hazard ratio = 2.32, P. < .0001). The risk of intellectual disability was higher in infants with hypothyroidism and low family income than in those without hypothyroidism and with high family income (hazard ratio = 36.05, P. < .0001). Conclusions Neonatal hypothyroidism and low family income were associated with the risk of intellectual disability in Korea. Additionally, neonatal hypothyroidism and low family income significantly increased the risk of intellectual disability. Public health policymakers should consider providing additional resources for alleviating neonatal hypothyroidism among low-income families.	[Nam, Jin Young; Choi, Young; Kim, Woorim] Yonsei Univ, Grad Sch, Dept Publ Hlth, Seoul, South Korea; [Nam, Jin Young; Choi, Young; Shin, Jaeyong; Cho, Kyoung Hee; Kim, Woorim; Park, Eun-Cheol] Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea; [Jung, Mo Kyung] Bundang Cha Med Ctr, Dept Pediat, Gyeonggi Do, South Korea; [Shin, Jaeyong; Park, Eun-Cheol] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, EC (corresponding author), Yonsei Univ, Coll Med, Inst Hlth Serv Res, Seoul, South Korea.; Park, EC (corresponding author), Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	ecpark@yuhs.ac	Park, Eun-Cheol/O-5644-2019; Shin, Jaeyong/AAA-5394-2022	Park, Eun-Cheol/0000-0002-2306-5398; Shin, Jaeyong/0000-0002-2955-6382; Nam, Jin Young/0000-0003-0540-8753				[Anonymous], 1985, J Pediatr, V107, P915; Badawi N, 2000, BRIT J OBSTET GYNAEC, V107, P798, DOI 10.1111/j.1471-0528.2000.tb13344.x; Blackburn C, 2007, CHILD CARE HLTH DEV, V33, P291, DOI 10.1111/j.1365-2214.2006.00646.x; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Brosco JP, 2006, ARCH PEDIAT ADOL MED, V160, P302, DOI 10.1001/archpedi.160.3.302; Camp BW, 1998, EARLY HUM DEV, V50, P159, DOI 10.1016/S0378-3732(97)00034-9; Centers for Disease Control and Prevention, 1942, FACTS DEV DIS 2015; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Cochran WG., 1963, SAMPLING TECHNIQUES; Counts D, 2009, PEDIATR REV, V30, P251, DOI 10.1542/pir.30-7-251; Duyme M, 1999, P NATL ACAD SCI USA, V96, P8790, DOI 10.1073/pnas.96.15.8790; Emerson E, 2003, J INTELL DISABIL RES, V47, P385, DOI 10.1046/j.1365-2788.2003.00498.x; GRANT DB, 1992, ACTA MED AUST, V19, P54; Grosse SD, 2011, ARCH DIS CHILD, V96, P374, DOI 10.1136/adc.2010.190280; Gruters A, 2012, NAT REV ENDOCRINOL, V8, P104, DOI 10.1038/nrendo.2011.160; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hackman DA, 2009, TRENDS COGN SCI, V13, P65, DOI 10.1016/j.tics.2008.11.003; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hair NL, 2015, JAMA PEDIATR, V169, P822, DOI 10.1001/jamapediatrics.2015.1475; Haveman R, 1995, J ECON LIT, V33, P1829; Kliegman RM, 2015, NELSON ESSENTIALS PE; KUOTAI T, 1988, AM J MENT RETARD, V93, P193; Kwon J, 2009, J KOREAN MED ASSOC, V52, P601, DOI 10.5124/jkma.2009.52.6.601; LaFranchi SH, 2011, J CLIN ENDOCR METAB, V96, P2959, DOI 10.1210/jc.2011-1175; Larson K, 2010, MATERN CHILD HLTH J, V14, P332, DOI 10.1007/s10995-009-0477-y; Lee J, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv319; Leonard H, 2005, SOC SCI MED, V60, P1499, DOI 10.1016/j.socscimed.2004.08.014; Leonard H, 2002, MENT RETARD DEV D R, V8, P117, DOI 10.1002/mrdd.10031; Leonard H, 2006, ANN EPIDEMIOL, V16, P448, DOI 10.1016/j.annepidem.2005.05.002; Maulik PK, 2011, RES DEV DISABIL, V32, P419, DOI 10.1016/j.ridd.2010.12.018; Pratt HD, 2007, PRIMARY CARE, V34, P375, DOI 10.1016/j.pop.2007.04.010; Schalock R., 2021, INTELLECTUAL DISABIL; Spencer N, 1999, J EPIDEMIOL COMMUN H, V53, P495, DOI 10.1136/jech.53.8.495; Tang M, 2003, INT J EPIDEMIOL, V32, P381, DOI 10.1093/ije/dyg075; WHO Regional Office for Europe, 1948, DEF INT DIS 2016	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205955	10.1371/journal.pone.0205955	http://dx.doi.org/10.1371/journal.pone.0205955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403688	Green Submitted, gold, Green Published			2022-12-26	WOS:000449379500035
J	Poche, RM; Poche, D; Franckowiak, G; Somers, DJ; Briley, LN; Tseveenjav, B; Polyakova, L				Poche, Richard M.; Poche, David; Franckowiak, Greg; Somers, Daniel J.; Briley, Lindsay N.; Tseveenjav, Batchimeg; Polyakova, Larisa			Field evaluation of low-dose warfarin baits to control wild pigs (Sus scrofa) in North Texas	PLOS ONE			English	Article							NAMADGI-NATIONAL-PARK; FERAL SWINE DAMAGE; HOME-RANGE; SOUTHERN TEXAS; HABITAT USE; VERTEBRATE PESTS; BOAR; HOGS; POPULATION; REPRODUCTION	Wild pigs (Sus scrofa) are a highly detrimental invasive species that occupy a rapidly expanding range within the United States. In Australia, field trials evaluating baits containing 0.09% warfarin resulted in wild pig population reduction >95%. The objective of this study was to conduct an EPA-approved field trial to evaluate the use of bait containing low-dose warfarin (0.01% and 0.005%) in reducing wild pig numbers in Texas. An 8-week field test was conducted in the panhandle similar to 100 km southeast of Amarillo. Two similar to 8 km(2) treatment plots were selected and each presented with either 0.01% or 0.005% warfarin baits. One control plot (similar to 8 km(2)) was presented placebo. The baits were delivered using 30 species-specific feeders per plot (n = 90) that kept wildlife from accessing the toxicant. Pig movements and feed consumption were monitored during pre-treatment, treatment, and post-treatment periods. All pigs with VHF transmitters within the 0.005% warfarin-treated plot (n = 14) succumbed to the warfarin (100% mortality). Overall, 35 wild pigs were found dead from warfarin toxicosis, within both treatment plots. Total feed consumption by wild pigs was reduced by similar to 97.8% and similar to 96.2% for the 0.005% and 0.01% warfarin baited plots, respectively, indicating the absence of pigs was a result of toxic bait consumption. Results of 97 systematic searches of the treatment plots indicated no warfarin-induced non-target wildlife fatalities. Warfarin residues in wild pig livers averaged 3.69 mg/kg (n = 13) and 2.89 mg/kg (n = 9) for pigs recovered within the 0.005% plot and 0.01% warfarin plot, respectively. This study is the first efficacy field evaluation of a wild pig toxicant conducted in the US. The results suggest low-dose warfarin bait, presented in species-specific feeders, can effectively reduce wild pig numbers and pose minimal risk to non-target wildlife and domestic animals. A product containing warfarin may provide another management tool in reducing wild pig problems.	[Poche, Richard M.; Poche, David; Franckowiak, Greg; Somers, Daniel J.; Briley, Lindsay N.; Tseveenjav, Batchimeg; Polyakova, Larisa] Genesis Labs Inc, Wellington, CO 80549 USA; [Somers, Daniel J.; Briley, Lindsay N.] Oregon Dept Fish & Wildlife, Roseburg, OR USA		Poche, D (corresponding author), Genesis Labs Inc, Wellington, CO 80549 USA.	davidp@genesislabs.com		Franckowiak, Gregory/0000-0003-1425-8638	Scimetrics Limited Corp. (Wellington, Colorado); Genesis Laboratories, Inc.Wellington, Colorado USA	Scimetrics Limited Corp. (Wellington, Colorado); Genesis Laboratories, Inc.Wellington, Colorado USA	This study was funded by Scimetrics Limited Corp. (Wellington, Colorado; http://www.kaputproducts.com/).The funder provided support in the form of research materials, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional funding was provided by Genesis Laboratories, Inc. Wellington, Colorado USA in the form of salaries to all authors (RMP, DP, GF, DJS, LNB, BT, and LP). No additional external funding was received for this study. The specific roles of these authors are articulated in the 'author contributions' section.	Anderson A, 2016, CROP PROT, V89, P89, DOI 10.1016/j.cropro.2016.06.023; BABER DW, 1986, J MAMMAL, V67, P512, DOI 10.2307/1381283; Ballari SA, 2014, MAMMAL REV, V44, P124, DOI 10.1111/mam.12015; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; BOMFORD M, 1995, WILDLIFE SOC B, V23, P249; Brook RK, 2014, WILDLIFE SOC B, V38, P486, DOI 10.1002/wsb.424; Campbell TA, 2010, SOUTHWEST NAT, V55, P564, DOI 10.1894/TAL-15.1; Campbell TA, 2010, J WILDLIFE MANAGE, V74, P337, DOI 10.2193/2009-131; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CHOQUENOT D, 1990, J WILDLIFE MANAGE, V54, P353, DOI 10.2307/3809054; Cowled B, 2004, PROJECT INVESTIGATES; Cowled BD, 2008, WILDLIFE RES, V35, P651, DOI 10.1071/WR07072; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; DARDAILLON M, 1988, Z SAUGETIERKD, V53, P22; Dexter N, 1999, WILDLIFE RES, V26, P755, DOI 10.1071/WR98075; Eason CT, 2009, RE EVALUATION POTENT; Engeman R, 2014, ENVIRON SCI POLLUT R, V21, P7689, DOI 10.1007/s11356-014-2727-9; ENGEMAN RM, 1984, NEW ENGL J MED, V311, P257; EPA, 2017, NOT PEST KAP FER HOG; EPA, 1995, R E D FACTS SOD FLUO; Fagerstone KA, 1983, VERTEBRATE PEST CONT; FIFRA, 2008, FIFRA FED INS FUNG R; Fogarty E. P., 2007, THESIS; Forbes SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113681; Franckowiak GA, 2018, AM MIDL NAT, V179, P28, DOI 10.1674/0003-0031-179.1.28; Friebel Brad A., 2009, Human-Wildlife Conflicts, V3, P49; Galetti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141459; Hayes R, 2009, SOUTHEAST NAT, V8, P411, DOI 10.1656/058.008.0304; Hone J, 1982, SCI B, V89; ILSE LM, 1995, J MAMMAL, V76, P784, DOI 10.2307/1382747; Intermountain Healthcare, 2018, WARF COUM DOS GUID 1; Jolley DB, 2010, J MAMMAL, V91, P519, DOI 10.1644/09-MAMM-A-129.1; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Killian G, 2006, AM J REPROD IMMUNOL, V55, P378, DOI 10.1111/j.1600-0897.2006.00379.x; Kreeger TJ, 2012, HDB WILDLIFE CHEM IM, P158; Lapidge S, 2012, USDA NATL WILDLIFE C, P1158; Lapidge S, 2009, P WILDL DAMAGE MANAG, V13, P49; Lashley MA, 2018, ECOLOGY, V99, P491, DOI 10.1002/ecy.2027; LINK KP, 1959, CIRCULATION, V19, P97, DOI 10.1161/01.CIR.19.1.97; Littin KE, 2004, NEW ZEAL VET J, V52, P1, DOI 10.1080/00480169.2004.36384; Lowe S., 2000, ALIENS INVASIVE SPEC, V12, P12; Massei G, 2018, PEST MANAG SCI, V74, P853, DOI 10.1002/ps.4763; Massei Giovanna, 2011, Human-Wildlife Interactions, V5, P79; MAYER J, 2009, WILD PIGS BIOL DAMAG; Mayer J. J., 2014, SRNLSTI201400292; MCILROY JC, 1989, AUST WILDLIFE RES, V16, P353; MCILROY JC, 1989, AUST WILDLIFE RES, V16, P195; McIlroy JC., 1995, IBEX JME, V3, P241; Meehan AP., 1984, RATS MICE THEIR BIOL; Nogueira SLG, 2009, BIODIVERS CONSERV, V18, P3677, DOI 10.1007/s10531-009-9680-9; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; OBRIEN PH, 1990, AUST WILDLIFE RES, V17, P101; Pedersen K, 2017, ZOONOSES PUBLIC HLTH, V64, P647, DOI 10.1111/zph.12359; Pedersen K, 2017, J FOOD PROTECT, V80, P1239, DOI [10.4315/0362-028x.jfp-17-016, 10.4315/0362-028X.JFP-17-016]; Peine J.D., 1990, Proceedings of the Vertebrate Pest Conference, V14, P221; Pimentel David, 2007, P2; Poche R, 2008, DEV NOVEL FERAL HOG; Poche R M., 2018, VERT PEST C; Poche RM, 2018, WILD PIG C SCI MAN S; Poche RM, 2012, OUTLOOKS PEST MANAGE, V23, P132, DOI DOI 10.1564/23JUN11; Poche RM, 2000, PESTICIDES WILDLIFE, V771, P181; Ruiz-Fons F, 2017, TRANSBOUND EMERG DIS, V64, P68, DOI 10.1111/tbed.12369; Sales LP, 2017, J ANIM ECOL, V86, P1214, DOI 10.1111/1365-2656.12721; Salmon TP, 2006, PEST MANAG SCI, V62, P678, DOI 10.1002/ps.1224; SAUNDERS G, 1990, AUST WILDLIFE RES, V17, P525; Schlichting PE, 2016, WILDLIFE SOC B, V40, P487, DOI 10.1002/wsb.662; Schneider BS, 1982, PB83153924 EPA; Seward N. W., 2004, Sheep & Goat Research Journal, V19, P34; Snow NP, 2017, WILDLIFE SOC B, V41, P256, DOI 10.1002/wsb.775; Snow NP, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150039, 10.1371/journal.pone.0146712]; Snow NP, 2018, WILD PIG C SCI MAN S; Taylor RB, 1998, J MAMMAL, V79, P1325, DOI 10.2307/1383024; THIJSSEN HHW, 1995, PESTIC SCI, V43, P73, DOI 10.1002/ps.2780430112; Thomas M., 1999, Science for Conservation, P49; United States Environmental Protection Agency (EPA), 1991, RER EL DOC WARF ITS; United States Federal Drug Administration, HIGHL PRESCR INF COU	77	7	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206070	10.1371/journal.pone.0206070	http://dx.doi.org/10.1371/journal.pone.0206070			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403690	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500048
J	Walker, BL; Newhall, KA				Walker, Benjamin L.; Newhall, Katherine A.			Inferring information flow in spike-train data sets using a trial-shuffle method	PLOS ONE			English	Article							EFFECTIVE CONNECTIVITY; CORTICAL-NEURONS; TRANSFER ENTROPY; CAUSALITY	Understanding information processing in the brain requires the ability to determine the functional connectivity between the different regions of the brain. We present a method using transfer entropy to extract this flow of information between brain regions from spike-train data commonly obtained in neurological experiments. Transfer entropy is a statistical measure based in information theory that attempts to quantify the information flow from one process to another, and has been applied to find connectivity in simulated spike-train data. Due to statistical error in the estimator, inferring functional connectivity requires a method for determining significance in the transfer entropy values. We discuss the issues with numerical estimation of transfer entropy and resulting challenges in determining significance before presenting the trial-shuffle method as a viable option. The trial-shuffle method, for spike-train data that is split into multiple trials, determines significant transfer entropy values independently for each individual pair of neurons by comparing to a created baseline distribution using a rigorous statistical test. This is in contrast to either globally comparing all neuron transfer entropy values or comparing pairwise values to a single baseline value. In establishing the viability of this method by comparison to several alternative approaches in the literature, we find evidence that preserving the inter-spike-interval timing is important. We then use the trial-shuffle method to investigate information flow within a model network as we vary model parameters. This includes investigating the global flow of information within a connectivity network divided into two well-connected subnetworks, going beyond local transfer of information between pairs of neurons.	[Walker, Benjamin L.; Newhall, Katherine A.] Univ North Carolina Chapel Hill, Dept Math, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Newhall, KA (corresponding author), Univ North Carolina Chapel Hill, Dept Math, Chapel Hill, NC 27599 USA.	knewhall@unc.edu	Newhall, Katie/I-2634-2019	Newhall, Katie/0000-0003-3594-0441	National Institute of Health Big Data to Knowledge [1T32 CA201159-01]; University of North Carolina at Chapel Hill Junior Faculty Development Award	National Institute of Health Big Data to Knowledge; University of North Carolina at Chapel Hill Junior Faculty Development Award	BLW was supported by the National Institute of Health Big Data to Knowledge grant number 1T32 CA201159-01. BLW and KAN were supported by the University of North Carolina at Chapel Hill Junior Faculty Development Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer M, 2007, IEEE T CONTR SYST T, V15, P12, DOI 10.1109/TCST.2006.883234; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Gourevitch B, 2007, J NEUROPHYSIOL, V97, P2533, DOI 10.1152/jn.01106.2006; GRANGER CWJ, 1988, J ECONOMETRICS, V39, P199, DOI 10.1016/0304-4076(88)90045-0; GREEN JD, 1958, NATURE, V182, P962, DOI 10.1038/182962a0; Humphrey DR, 1990, EXTRACELLULAR SINGLE, P1, DOI [10.1385/0-89603-185-3:1, DOI 10.1385/0-89603-185-3:1]; Ito SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027431; Izhikevich E. M., 2003, IEEE T NEURAL NETWOR, V14, P6; Kaiser A, 2002, PHYSICA D, V166, P43, DOI 10.1016/S0167-2789(02)00432-3; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Li ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070894; Lindner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-119; Nigam S, 2016, J NEUROSCI, V36, P670, DOI 10.1523/JNEUROSCI.2177-15.2016; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Orlandi JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098842; Rivlin-Etzion M, 2006, J NEUROPHYSIOL, V95, P3245, DOI 10.1152/jn.00055.2005; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sellers KK, 2016, CELL REP, V16, P2864, DOI 10.1016/j.celrep.2016.08.055; Timme NM, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004858; Ver Steeg G., 2012, P 21 INT C WORLD WID, P509, DOI DOI 10.1145/2187836.2187906; Vicente R, 2011, J COMPUT NEUROSCI, V30, P45, DOI 10.1007/s10827-010-0262-3; Wibral M, 2014, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-54474-3; Woo J, 2009, IEEE T BIO-MED ENG, V56, P1348, DOI 10.1109/TBME.2008.2005782	26	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206977	10.1371/journal.pone.0206977	http://dx.doi.org/10.1371/journal.pone.0206977			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403739	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500086
J	Wang, YH; Gao, J; Sun, MF; Chen, JP; Zhang, X; Chen, Y; Chen, DH				Wang, Yong-Hui; Gao, Jin; Sun, Ming-Fa; Chen, Jian-Ping; Zhang, Xiang; Chen, Yuan; Chen, De-Hua			Impacts of soil salinity on Bt protein concentration in square of transgenic Bt cotton	PLOS ONE			English	Article							CRY1AC EXPRESSION; PEPTIDASE ACTIVITIES; MULTIPLE CROPS; NITROGEN; STRESS; METABOLISM; LEVEL; ACCUMULATION; LEPIDOPTERA; SENESCENCE	Insect-resistance of transgenic Bacillus thuringiensis (Bt) cotton varies among plants organs and with different environmental conditions. The objective of this study was to examine the influence of soil salinity on Bt protein concentration in cotton squares and to elucidate the potential mechanism of Bt efficacy reduction. Two cotton cultivars (NuCOTN 33B and CCRI 07, salt-sensitive and salt-tolerant) were subjected to salinity stress under four natural saline levels in field conditions in 2015 and 2016 and seven regimes of soil salinity ranged from 0.5 to 18.8 dS m(-1) in greenhouse conditions in 2017. Results of field studies revealed that Bt protein content was not significantly changed at 7.13 dS m(-1) salinity, but exhibited a significant drop at the 10.41 and 14.1 6 dS m(-1) salinity. The greenhouse experiments further showed similar trends that significant declines of the insecticidal protein contents in squares were detected when soil salinity exceeded 9.1 dS m(-1). Meanwhile, high salinity resulted in significant reduction in contents of soluble protein and total nitrogen, activities of nitrate reductase (NR), glutamine synthetase (GS) and glutamic-pyruvic transaminase (GPT), but increased amino acid content, activities of protease and peptidase in cotton squares. High salinity also decreased root vigor (RV), root total absorption area (RTA) and root active absorption area (RAA). The extent of decrease of Bt protein content was more pronounced in NuCOTN 33B than CCRI 07, and CCRIO7 exhibited stronger enzymes activities involved in square protein synthesis and higher levels of RV, RTA and RAA. Therefore, the results of our present study indicated that insecticidal protein expression in cotton squares were significantly affected by higher salinity (equal to or higher than 9.1 dS m(-1)), reduced protein synthesis and increased protein degradation in squares and reduced metabolic activities in roots might lead to the decrease of Bt protein content in squares.	[Wang, Yong-Hui; Gao, Jin; Sun, Ming-Fa; Chen, Jian-Ping] Minist Agr, Observat & Expt Stn Saline Land Costal Area, Inst Agr Sci Jiangsu Coastal Area, Yancheng, Peoples R China; [Wang, Yong-Hui; Zhang, Xiang; Chen, Yuan; Chen, De-Hua] Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China	Ministry of Agriculture & Rural Affairs; Yangzhou University	Chen, DH (corresponding author), Yangzhou Univ, Key Lab Crop Genet & Physiol Jiangsu Prov, Yangzhou, Jiangsu, Peoples R China.	cdh@yzu.edu.cn		Wang, Yonghui/0000-0003-2219-7281	National Natural Science Foundation of China [31501267]; National Key Research and Development Program of China [2016YFD0101421]; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Natural Science Foundation of Jiangsu Province [BK20181210]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	We are grateful for financial support from the National Natural Science Foundation of China (31501267), the National Key Research and Development Program of China (2016YFD0101421), the Priority Academic Program Development of Jiangsu Higher Education Institution (PAPD) and Natural Science Foundation of Jiangsu Province (BK20181210).	Adamczyk John J. Jr., 2001, Journal of Insect Science (Tucson), V1, P1; Ashraf M, 2000, FIELD CROP RES, V66, P115, DOI 10.1016/S0378-4290(00)00064-2; Benedict JH, 1996, J ECON ENTOMOL, V89, P230, DOI 10.1093/jee/89.1.230; Blaise D, 2011, CURR SCI INDIA, V101, P783; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARRASCO P, 1990, PLANT PHYSIOL, V92, P1070, DOI 10.1104/pp.92.4.1070; Chen DH, 2005, FIELD CROP RES, V92, P1, DOI 10.1016/j.fcr.2003.11.005; Chen Song, 1997, Jiangsu Journal of Agricultural Sciences, V13, P154; Chen WP, 2010, PLANT SOIL, V326, P61, DOI 10.1007/s11104-008-9881-0; Chen Y, 2012, J INTEGR AGR, V11, P1836, DOI 10.1016/S2095-3119(12)60188-9; Ding Y, 2006, ANN APPL BIOL, V149, P111, DOI 10.1111/j.1744-7348.2006.00080.x; Gore J., 2004, Journal of Cotton Science, V8, P223; Higbie SM, 2010, INT J AGRON, V2010, DOI 10.1155/2010/643475; Imtiazb M., 2018, J PLANT NUTR, V41, P1; Iqbal A, 2013, INT J AGRIC BIOL, V15, P1181; Jiang LJ, 2006, ENVIRON EXP BOT, V55, P315, DOI 10.1016/j.envexpbot.2005.01.003; Khan A, 2017, ENVIRON SCI POLLUT R, V24, P14551, DOI 10.1007/s11356-017-8920-x; Khan Taqi Ahmed, 2011, Journal of Agrobiology, V28, P97, DOI 10.2478/v10146-011-0011-x; Kong XS, 2008, TECHNIQUES PLANT PHY; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Kumari A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00537; Li M, 2014, THESIS; Li MY, 2013, J INTEGR AGR, V12, P436, DOI [10.1016/S2095-3119(13)60244-0, 10.1016/s2095-3119(13)60244-0]; Li Yuan, 2017, Acta Agronomica Sinica, V43, P1658; Liu RX, 2008, AGR WATER MANAGE, V95, P1261, DOI 10.1016/j.agwat.2008.05.002; Liu RX, 2015, AGRON J, V107, P2038, DOI 10.2134/agronj14.0567; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Luo J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176883; Luo Z, 2008, CROP PROT, V27, P1485, DOI 10.1016/j.cropro.2008.06.006; Mahon R., 2002, AUST COTTON GROWER, V22, P18; Manjunatha R, 2009, KARNATAKA J AGR SCI, V13, P67; Martins CM, 2008, ANN APPL BIOL, V152, P255, DOI 10.1111/j.1744-7348.2007.00214.x; Meng S, 2016, ENVIRON EXP BOT, V123, P78, DOI 10.1016/j.envexpbot.2015.11.005; Millar AA, 1996, AUST J PLANT PHYSIOL, V23, P341, DOI 10.1071/PP9960341; Miller AJ, 2005, PLANT SOIL, V274, P1, DOI 10.1007/s11104-004-0965-1; Mokhele B, 2012, CAN J PLANT SCI, V92, P399, DOI [10.4141/CJPS2011-135, 10.4141/cjps2011-135]; NELSON D W, 1972, Journal of Environmental Quality, V1, P423; OAKS A, 1980, PLANTA, V148, P477, DOI [10.1007/BF00552663, 10.1007/BF02395318]; Olsen KM, 2000, J ECON ENTOMOL, V93, P1293, DOI 10.1603/0022-0493-93.4.1293; Ramesh Kumar, 2013, Annals of Agri Bio Research, V18, P39; Rochester IJ, 2006, J COTTON SCI, V10, P252; SETLOW P, 1975, J BACTERIOL, V122, P642, DOI 10.1128/JB.122.2.642-649.1975; Shah JM, 2017, J INTEGR AGR, V16, P190, DOI [10.1016/S2095-3119(15)61308-9, 10.1016/s2095-3119(15)61308-9]; Shen Ping, 2010, Cotton Science, V22, P393; Siddiqui MH, 2010, AGR SCI CHINA, V9, P671, DOI 10.1016/S1671-2927(09)60142-5; SILBERBUSH M, 1987, COMMUN SOIL SCI PLAN, V18, P65, DOI 10.1080/00103628709367803; Stam M, 1997, ANN BOT-LONDON, V79, P3, DOI 10.1006/anbo.1996.0295; TONHAZY NE, 1950, ARCH BIOCHEM, V28, P36; Vance CP, 1981, PLANT PHYSIOL, V67, P1198; Wang XQ, 2008, PLANTA, V228, P167, DOI 10.1007/s00425-008-0727-z; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu L.H., 1998, CHINESE J SOIL SCI, V29, P136, DOI [10.19336/j.cnki.trtb.1998.03.015, DOI 10.19336/J.CNKI.TRTB.1998.03.015]; Xin CS, 2008, CHIN AGR SCI B, V24, P188; Xu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138268; YEMM EW, 1955, ANALYST, V80, P209, DOI 10.1039/an9558000209; Zhang HJ, 2012, J AGRON CROP SCI, V198, P27, DOI 10.1111/j.1439-037X.2011.00481.x; Zhang L. N., 2010, BIODIVERS SCI, V18, P142; Zhang LX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003608; Zhang X, 2017, FRONT PLANT SCI, V8, DOI [10.1016/S1671-2927(09)60142-5, DOI 10.1016/S1671-2927(09)60142-5]; Zouhaier B, 2016, J PLANT RES, V129, P423, DOI 10.1007/s10265-016-0791-6	62	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207013	10.1371/journal.pone.0207013	http://dx.doi.org/10.1371/journal.pone.0207013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403755	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500093
J	Zink, IC; Browder, JA; Lirman, D; Serafy, JE				Zink, Ian C.; Browder, Joan A.; Lirman, Diego; Serafy, Joseph E.			Pink shrimp Farfantepenaeus duorarum spatiotemporal abundance trends along an urban, subtropical shoreline slated for restoration	PLOS ONE			English	Article							SUBMERGED AQUATIC VEGETATION; WATER CANAL DISCHARGE; CROSS-SHELF TRANSPORT; WESTERN BISCAYNE BAY; FRESH-WATER; SPATIAL DISTRIBUTIONS; PENAEUS-DUORARUM; LARVAL TRANSPORT; COASTAL LAGOON; SEAGRASS BEDS	The Biscayne Bay Coastal Wetlands (BBCW) project of the Comprehensive Everglades Restoration Plan (CERP) aims to reduce point-source freshwater discharges and spread freshwater flow along the mainland shoreline of southern Biscayne Bay. These actions will be taken to approximate conditions in the coastal wetlands and bay that existed prior to construction of canals and water control structures. An increase in pink shrimp (Farfantepenaeus duorarum) density to >= 2 individuals m(-2) during the wet season (i.e., August-October) along the mainland shoreline was previously proposed as an indication of BBCW success. This study examined pre-BBCW baseline densities and compared them with the proposed target. Densities were monitored by seasonal (wet, dry) throw-trapping (1 m(2) replicated in triplicate) at 47 sites along similar to 22 km of the southwestern Biscayne Bay coastline over 10 years (2007-2016). Densities varied across years and were most often higher in dry seasons. Quantile regression revealed density limitation by four habitat attributes: water temperature (degrees C), depth (m), salinity (ppt), and submerged aquatic vegetation (SAV: % cover). Procrustean analyses that tested for concordance between the spatial and temporal distributions of shrimp densities and habitat metrics found that water temperature, water depth, and salinity explained similar to 28%, 28%, and 22% of density variability, respectively. No significant relationship with SAV was observed. Hierarchical clustering was used to identify spatially and temporally similar groupings of pink shrimp densities by sites or season-years. Significant groupings were then investigated with respect to potentially limiting habitat attributes. Six site and four year-season clusters were identified. Although habitat attributes significantly differed among spatial clusters, within-cluster median pink shrimp densities did not correlate with within-cluster minima, maxima, medians, or standard deviations of habitat attributes. Overall, pink shrimp density ((X) over bar = 0.86, SD = 1.32 shrimp m(-2)) was significantly lower (t((alpha= 0.)(10)(,2),)(939)= -26.53, P <0.0001) than the 2 shrimp m(-2) CERP Interim Goal target. Pink shrimp density corresponded significantly with salinity and appeared limited to density < 2 shrimp m-(2) by salinity < similar to 18 ppt. Salinity is an environmental attribute that will be directly influenced by CERP implementation.	[Zink, Ian C.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Zink, Ian C.; Browder, Joan A.; Serafy, Joseph E.] NOAA, Protected Resources & Biodivers Div, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL 33149 USA; [Lirman, Diego; Serafy, Joseph E.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Marine Biol & Ecol Dept, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of Miami; National Oceanic Atmospheric Admin (NOAA) - USA; University of Miami	Zink, IC (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Cooperat Inst Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.; Zink, IC (corresponding author), NOAA, Protected Resources & Biodivers Div, Southeast Fisheries Sci Ctr, Natl Marine Fisheries Serv, Miami, FL 33149 USA.	ian.zink@noaa.gov		Zink, Ian/0000-0003-3788-8528	National Park Service; U.S. Army Corps of Engineers under the Comprehensive Everglades Restoration Plan	National Park Service; U.S. Army Corps of Engineers under the Comprehensive Everglades Restoration Plan	Various work orders to the National Marine Fisheries Service Southeast Fisheries Science Center from the US Army Corps of Engineers, Jacksonville, Florida, to Joan Browder and Joseph Serafy helped support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study used monitoring data collected over a substantial period by many individuals; without their efforts, this study would not have been possible. We also thank the National Park Service for its support of this research. This study was conducted during pursuit of the PhD degree of I. Zink; he would like to thank committee members D. Die and J. Luo for their comments and suggestions during review of earlier versions of this manuscript. The authors would also like to thank two anonymous reviewers for their suggestions prior to submission of the manuscript for publication. Funding from the U.S. Army Corps of Engineers under the Comprehensive Everglades Restoration Plan supported this study.	Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Allen D. M., 1970, 614 USFWS USDOI BUR; ALLEN DM, 1980, B MAR SCI, V30, P21; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 1958, LIMNOL OCEANOGR, V3, P346; Arbour JH, 2014, METHODS ECOL EVOL, V5, P16, DOI 10.1111/2041-210X.12128; Ault Jerald S., 1999, North American Journal of Fisheries Management, V19, P696, DOI 10.1577/1548-8675(1999)019<0696:AESSDT>2.0.CO;2; Ault JS, 1999, CAN J FISH AQUAT SCI, V56, P4; BERKELEY SA, 1984, FISHERIES ASSESSMENT; Blanco-Martinez Z, 2017, MAR FRESHWATER RES, V68, P581, DOI 10.1071/MF15207; Brook IM, 1982, OCEANOL ACTA, P63; Browder JA, 2005, WETLANDS, V25, P854, DOI 10.1672/0277-5212(2005)025[0854:BBCEM]2.0.CO;2; Browder JA, 2005, BISCAYNE BAY COAST 1; Browder JA, 2009, ECOL INDIC, V9, pS17, DOI 10.1016/j.ecolind.2008.10.007; BRUSHER HA, 1976, FISH B-NOAA, V74, P158; Bryan DR, 2015, ENVIRON BIOL FISH, V98, P2263, DOI 10.1007/s10641-015-0445-x; Caccia VG, 2005, MAR POLLUT BULL, V50, P1416, DOI 10.1016/j.marpolbul.2005.08.002; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Cade BS, 1999, ECOLOGY, V80, P311, DOI 10.1890/0012-9658(1999)080[0311:EEOLFW]2.0.CO;2; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; Costello TJ, 1966, ANN REPORT BUREAU CO, P15; Costello TJ, 1986, NMFSSEFSC161 NOAA US; Criales MM, 2007, MAR ECOL PROG SER, V345, P167, DOI 10.3354/meps06916; Criales MM, 2015, MAR COAST FISH, V7, P148, DOI 10.1080/19425120.2014.1001541; Criales MM, 2011, J EXP MAR BIOL ECOL, V409, P283, DOI 10.1016/j.jembe.2011.09.007; Criales MM, 2011, J CRUSTACEAN BIOL, V31, P26, DOI 10.1651/10-3291.1; Criales MM, 2010, B MAR SCI, V86, P53; Criales MM, 2000, B MAR SCI, V67, P773; Criales MM, 2006, FISH B-NOAA, V104, P60; Criales MM, 2005, MAR ECOL PROG SER, V286, P231, DOI 10.3354/meps286231; Criales MM, 2003, ESTUAR COAST SHELF S, V57, P457, DOI 10.1016/S0272-7714(02)00374-8; CUMMINGS WILLIAM C., 1961, TRANS AMER FISH SOC, V90, P462, DOI 10.1577/1548-8659(1961)90[462:MASOTP]2.0.CO;2; Davis Jr JH, 1943, FLA GEOL SURV B, V25; DeLaune RD, 2003, ESTUAR COAST SHELF S, V58, P653, DOI 10.1016/S0272-7714(03)00177-X; Diaz G. B., 2001, THESIS; Eldred B., 1962, P 1 NAT COAST SHALL, P411; Eldred B, 1961, FLORIDA STATE BOARD, V3; Farfante I. P., 1969, Fishery Bulletin Fish and Wildlife Service US, V67, P461; Lisboa FJG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101238; GORE RH, 1981, ESTUAR COAST SHELF S, V12, P485, DOI 10.1016/S0302-3524(81)80007-2; Halley RB, 1977, AAPG BULL, V64, P519; Hovel KA, 2002, MAR ECOL PROG SER, V243, P11, DOI 10.3354/meps243011; Ingle RM, 1957, P GULF CARIB FISH I, P6; Irlandi E, 1997, B MAR SCI, V61, P869; JACKSON DA, 1995, ECOSCIENCE, V2, P297, DOI 10.1080/11956860.1995.11682297; Johnson DR, 2002, METAANALYSIS SYNTHES; JONES AC, 1970, B MAR SCI, V20, P634; KENNEDY F S JR, 1981, Journal of Crustacean Biology, V1, P474, DOI 10.2307/1548125; Kinne O., 1964, Oceanography and Marine Biology, V2, P281; KINNE OTTO, 1967, AMER ASS ADVAN SCI PUBL, V83, P525; KOENKER R, 1994, BIOMETRIKA, V81, P673; Koenker R., 2010, ADDITIVE MODELS QUAN, P23, DOI [10.1186/1475-2875-9-330, DOI 10.1186/1475-2875-9-330]; Kohout F. A., 1967, P488; Kohout FA, 1967, THESIS; Kushlan JA, 1981, T AM FISH SCO, V110; Lancaster J, 2006, FRESHWATER BIOL, V51, P783, DOI 10.1111/j.1365-2427.2006.01518.x; Langevin CD, 2003, GROUND WATER, V41, P758, DOI 10.1111/j.1745-6584.2003.tb02417.x; Legendre P., 2012, NUMERICAL ECOLOGY; Lirman D, 2008, HYDROBIOLOGIA, V596, P105, DOI 10.1007/s10750-007-9061-x; Lirman D, 2014, ESTUAR COAST, V37, P1243, DOI 10.1007/s12237-014-9769-6; Lirman D, 2003, ESTUARIES, V26, P131, DOI 10.1007/BF02691700; Lirman D, 2003, AQUAT CONSERV, V13, P121, DOI 10.1002/aqc.552; Lirman D., 2016, 4 ANN REPORT IBBEAM; Lirman D, 2008, J COASTAL RES, V24, P135, DOI 10.2112/04-0428.1; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCGILL R, 1978, AM STAT, V32, P12, DOI 10.2307/2683468; McManus LC, 2014, ECOL INDIC, V44, P173, DOI 10.1016/j.ecolind.2014.03.006; Minello TJ, 1998, AM FISH S S, V22, P43; MURPHEY PL, 1995, MAR ECOL PROG SER, V121, P91, DOI 10.3354/meps121091; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Perez-Castaneda R, 2005, ICES J MAR SCI, V62, P14, DOI 10.1016/j.icesjms.2004.10.005; Perez-Castaneda R, 2010, J MAR BIOL ASSOC UK, V90, P445, DOI 10.1017/S0025315409990865; Perez-Farfante I., 1970, 599 US FISH WILDL SE; Perez-Farfante I, 1997, MEMOIRS MUSEUM NATL, V175; PEREZFARFANTE I, 1988, 64 NOAA NMFS; Pitre ST, 2001, THESIS; RCOVER, 2004, PERF MEAS SO COAST S; RECOVER, 2005, APP REC TEAMS REC IN; RECOVER, 2008, SO EST PERF MEAS SAL; Robblee MB, 2008, GREAT EV EC REST PLA, P364; Robblee RB, 1991, FLORIDA BAY ADJACENT; Roth BM, 2008, MAR ECOL PROG SER, V359, P185, DOI 10.3354/meps07380; ROZAS LP, 1995, ESTUARIES, V18, P579, DOI 10.2307/1352378; Rubec PJ, 2016, MAR COAST FISH, V8, P232, DOI 10.1080/19425120.2015.1084408; Santos R. M., 2014, THESIS; Santos RO, 2011, MAR ECOL PROG SER, V427, P233, DOI 10.3354/meps08996; Scharf FS, 1998, ECOLOGY, V79, P448, DOI 10.1890/0012-9658(1998)079[0448:IERFTE]2.0.CO;2; Schneider J.J., 1969, TIDAL RELATIONS S BI; Serafy JE, 1997, MAR ECOL PROG SER, V160, P161, DOI 10.3354/meps160161; Serafy JE, 2007, B MAR SCI, V80, P609; Shaler NS, 1895, B MUS COMP ZOOL HARV, V16, P139; Sheridan P, 2003, B MAR SCI, V72, P37; Sklar FH, 1998, ENVIRON MANAGE, V22, P547, DOI 10.1007/s002679900127; Smith HM., 1896, REPORT COMMISSIONER, P169; Sokal RR, 1995, BIOMETRY; Stabenau B. E., 2011, PARK SCI, V28, P26; Stabenau E, 2015, B MAR SCI, V91, P433, DOI 10.5343/bms.2015.1017; Stalker JC, 2009, ESTUAR COAST, V32, P694, DOI 10.1007/s12237-009-9155-y; Tabb DC, 1962, TECH SER, V37; Taylor WP, 1934, ECOLOGY, V15, P374, DOI 10.2307/1932352; Thomson JD, 1996, ECOLOGY, V77, P1698, DOI 10.2307/2265776; USACE, 2014, BISC BAY COAST WETL; USACE SFWMD, 2011, CENTR SO FLOR PROJ C, V1; Wachnicka A, 2016, CHANGES SPATIAL TEMP; Wang JD, 2003, B MAR SCI, V72, P695; Wang JD, 1988, EFFECTS FRESHWATER C; Wang JD, 1980, MATH MODELING ESTUAR, P157; WILLIAMS AB, 1960, BIOL BULL, V119, P560, DOI 10.2307/1539268; WILLIAMS AUSTIN B., 1955, BULL MARINE SCI GULF AND CARIBBEAN, V5, P116; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Yokel BJ, 1983, THESIS; Zein-Eldin Z. P., 1964, Proceedings of the Gulf and Caribbean Fisheries Institute, V16, P121; Zink IC, 2017, ECOL INDIC, V81, P1, DOI 10.1016/j.ecolind.2017.05.046; Zink IC, 2017, NEARSHORE SALINITY J	117	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0198539	10.1371/journal.pone.0198539	http://dx.doi.org/10.1371/journal.pone.0198539			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403667	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500001
J	Hurt, CP; Lein, DH; Smith, CR; Curtis, JR; Westfall, AO; Cortis, J; Rice, C; Willig, JH				Hurt, Christopher P.; Lein, Donald H., Jr.; Smith, Christian R.; Curtis, Jeffrey R.; Westfall, Andrew O.; Cortis, Jonathan; Rice, Clayton; Willig, James H.			Assessing a novel way to measure step count while walking using a custom mobile phone application	PLOS ONE			English	Article							GAIT SPEED; ACCURACY; HEALTH	Introduction Walking speed has been associated with many clinical outcomes (e.g., frailty, mortality, joint replacement need, etc.). Accurately measuring walking speed (stride length x step count/time) typically requires significant clinician/staff time or a gait lab with specialized equipment (i.e., electronic timers or motion capture). In the present study, our goal was to measure "step count" via smartphones through novel software and to compare with step tracking software that come standard with iOS and Android smartphones as a first step in walking speed measurement. Methods A separate calibration and validation data collection was performed. Individuals in the calibration collection (n = 5) walked 20m at normal and slow speed (<1.0 m/s). Appropriate settings for the novel mobile application were chosen to measure step count. Individuals in the validation (n = 52) collection walked at 6m, 10m, and 20m at normal and slow walking speeds. We compared step difference (absolute difference) from observed step counts to native step tracking software and our novel software derived step counts. We used generalized estimated equation adjusted (participant level) negative binomial regression models of absolute step difference from observed step counts, to determine optimal settings (calibration) and subsequently to gauge performance of the shake algorithm settings and native step tracking software across different distances and speeds (validation). Results For iOS/iPhone 6, when compared to observed step count, the shake service (software driven approach) significantly outperformed the embedded native step tracking software across all distances at slow speed, and for short distance (6m) at normal speed. On the Android phone, the shake service outperformed the native step tracking software at slow speed at 6 meters and 20 meters, while its performance eclipsed the native step tracking software only at 20 meters at normal speed. Discussion Our software based approach outperformed native step tracking software across various speeds and distances and carries the advantage of having adjustable measurement parameters that can be further optimized for specific medical conditions. Such software applications will provide an effective way to capture standardized data across multiple commercial smartphone devices, facilitating the future capture of walking speed and other clinically important performance parameters that will influence clinical and home care in the era of value based care.	[Hurt, Christopher P.; Lein, Donald H., Jr.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA; [Smith, Christian R.] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Curtis, Jeffrey R.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Westfall, Andrew O.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Cortis, Jonathan; Rice, Clayton] CGI Grp Inc, Montreal, PQ, Canada; [Willig, James H.] Univ Alabama Birmingham, Div Infect Dis, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Hurt, CP (corresponding author), Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA.	cphurt@uab.edu		Lein, Jr, Donld/0000-0001-9297-2760; Hurt, Christopher/0000-0001-8861-9876	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD071866] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD071866] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		An HS, 2017, EUR J SPORT SCI, V17, P360, DOI 10.1080/17461391.2016.1255261; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Danova T, 2014, BUSINESS INSIDER; Duncan MJ, 2018, J SPORT SCI, V36, P1695, DOI 10.1080/02640414.2017.1409855; EVANS AL, 1991, MED BIOL ENG COMPUT, V29, P102, DOI 10.1007/BF02446305; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; FRIEDMAN PJ, 1988, AGE AGEING, V17, P227, DOI 10.1093/ageing/17.4.227; Fritz S, 2009, J GERIATR PHYS THER, V32, P2, DOI 10.1519/00139143-200932020-00002; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; Hurt CP, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0007-7; Inzitari Marco, 2017, Rev Esp Geriatr Gerontol, V52, P35, DOI 10.1016/j.regg.2015.12.010; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Learmonth YC, 2016, PHYS THER REV, V21, P160, DOI 10.1080/10833196.2016.1263415; Leong JY, 2017, J SPORT SCI, V35, P14, DOI 10.1080/02640414.2016.1154592; Lewis ZH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1947-3; Lyons EJ, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6967; Najafi B, 2009, GAIT POSTURE, V29, P261, DOI 10.1016/j.gaitpost.2008.09.002; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Perrin, 2017, TECH ADOPTION CLIMBS; Rose M, 2008, J CLIN EPIDEMIOL, V61, P17, DOI 10.1016/j.jclinepi.2006.06.025; Schoneburg B, 2013, MOVEMENT DISORD, V28, P1474, DOI 10.1002/mds.25613; Smith A, 2015, US SMARTPHONE USE 20; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Weinstein RS, 2014, AM J MED, V127, P183, DOI 10.1016/j.amjmed.2013.09.032	27	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206828	10.1371/journal.pone.0206828	http://dx.doi.org/10.1371/journal.pone.0206828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399162	gold, Green Published, Green Submitted			2022-12-26	WOS:000449374000023
J	Fortes, LS; Costa, MC; Ferreira, MEC; Nascimento, JRA; Fiorese, L; Lima, DRAA; Cyrino, ES				Fortes, Leonardo S.; Costa, Manoel C.; Ferreira, Maria E. C.; Nascimento-Junior, Jose R. A.; Fiorese, Lenamar; Lima-Junior, Dalton R. A. A.; Cyrino, Edilson S.			Frequency of resistance training does not affect inhibitory control or improve strength in well-trained young adults	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; OLDER WOMEN; EXERCISE; SYSTEMS	The objective of the current study was to compare the effects of resistance training frequency on cognitive inhibitory control in young adults with previous experience in the modality. Male participants (N= 36) were randomly placed into one of three experimental groups. Participants performed resistance training 1 (F1), 2 (F2), and 3 (F3) times per week for 24 weeks. The three groups performed exercises of equal intensity, volume-load, and rest duration. Cognitive inhibitory control (via Stroop test) was tested 72 h before (pre-experiment) and 72 h after (post-experiment) the resistance training program. No time vs. group interaction effects were noted for accuracy (F-(4,F-29) = 3.57, p = 0.18) or response time (F-(4,F-29) = 2.61, p = 0.06) on the Stroop test. These results indicate that increased resistance training frequency, when volume-load is kept constant, does not appear to potentiate cognitive inhibitory control.	[Fortes, Leonardo S.; Lima-Junior, Dalton R. A. A.] Univ Fed Pernambuco, Grad Program Phys Educ, Recife, PE, Brazil; [Costa, Manoel C.] Univ Pernambuco, Super Sch Phys Educ, Recife, PE, Brazil; [Ferreira, Maria E. C.] Univ Fed Juiz de Fora, Grad Program Phys Educ, Juiz De Fora, Brazil; [Nascimento-Junior, Jose R. A.] Fed Univ Vale Sao Francisco, Grad Program Phys Educ, Petrolina, Brazil; [Fiorese, Lenamar] Univ Estadual Maringa, Grad Program Phys Educ, Maringa, Parana, Brazil; [Cyrino, Edilson S.] Univ Estadual Londrina, Grad Program Phys Educ, Londrina, Brazil	Universidade Federal de Pernambuco; Universidade de Pernambuco (UPE); Universidade Federal de Juiz de Fora; Universidade Estadual de Maringa; Universidade Estadual de Londrina	Fortes, LS (corresponding author), Univ Fed Pernambuco, Grad Program Phys Educ, Recife, PE, Brazil.	leodesousafortes@hotmail.com	do Nascimento, José Roberto Andrade/L-2068-2017; de Lima-Junior, Dalton/E-9792-2019; da Cunha Costa, Manoel/I-4632-2014; Fortes, Leonardo de Sousa/Q-3378-2016; Fiorese, Lenamar/AAW-3972-2020; CYRINO, EDILSON/F-7196-2012; Ferreira, Maria Elisa Caputo/D-3496-2019	do Nascimento, José Roberto Andrade/0000-0003-3836-6967; de Lima-Junior, Dalton/0000-0003-1542-604X; da Cunha Costa, Manoel/0000-0001-8815-8846; Fortes, Leonardo de Sousa/0000-0002-0778-769X; CYRINO, EDILSON/0000-0001-9016-8779; Ferreira, Maria Elisa Caputo/0000-0002-3294-7560; Fiorese, Lenamar/0000-0003-1610-7534				Bruce J, 2016, APPL NEUROPSYCH-ADUL, V23, P336, DOI 10.1080/23279095.2015.1064002; Brush CJ, 2016, J SPORT EXERCISE PSY, V38, P396, DOI 10.1123/jsep.2016-0027; Chupel MU, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00377; Deslandes A, 2009, NEUROPSYCHOBIOLOGY, V59, P191, DOI 10.1159/000223730; Fonseca RM, 2014, J STRENGTH COND RES, V28, P3085, DOI 10.1519/JSC.0000000000000539; Hanson NJ, 2018, EXP BRAIN RES, V236, P1643, DOI 10.1007/s00221-018-5247-x; Huang T, 2014, SCAND J MED SCI SPOR, V24, P1, DOI 10.1111/sms.12069; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Portugal EMM, 2013, NEUROPSYCHOBIOLOGY, V68, P1, DOI 10.1159/000350946; Northey JM, 2018, BR J SPORTS MED; Parsons TD, 2011, STUD HEALTH TECHNOL, V163, P433, DOI 10.3233/978-1-60750-706-2-433; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Ribeiro AS, 2017, J STRENGTH COND RES, V31, P1888, DOI 10.1519/JSC.0000000000001653; Ribeiro AS, 2016, EXP GERONTOL, V79, P8, DOI 10.1016/j.exger.2016.03.007; Schoenfeld BJ, 2018, SPORTS MED; Schoenfeld BJ, 2016, J SPORT SCI MED, V15, P715; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Weinberg L, 2014, ACTA PSYCHOL, V153, P13, DOI 10.1016/j.actpsy.2014.06.011	19	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206784	10.1371/journal.pone.0206784	http://dx.doi.org/10.1371/journal.pone.0206784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388181	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800057
J	Zanetti, SP; Talso, M; Palmisano, F; Longo, F; Gallioli, A; Fontana, M; De Lorenzis, E; Sampogna, G; Boeri, L; Albo, G; Trinchieri, A; Montanari, E				Zanetti, Stefano Paolo; Talso, Michele; Palmisano, Franco; Longo, Fabrizio; Gallioli, Andrea; Fontana, Matteo; De Lorenzis, Elisa; Sampogna, Gianluca; Boeri, Luca; Albo, Giancarlo; Trinchieri, Alberto; Montanari, Emanuele			Comparison among the available stone treatment techniques from the first European Association of Urology Section of Urolithiasis (EULIS) Survey: Do we have a Queen?	PLOS ONE			English	Article							RETROGRADE INTRARENAL SURGERY; MICROPERCUTANEOUS NEPHROLITHOTOMY MICROPERC; PERCUTANEOUS NEPHROLITHOTOMY; KIDNEY-STONES; 2 CM; MANAGEMENT; RIRS	Purpose The miniaturization of instruments has had an impact on stone management. The aims of this study were to highlight surgeon preferences among Retrograde Intra Renal Surgery (RIRS), Regular, Mini-, UltraMini- and Micro- Percutaneous Nephrolithotomy (PCNL) for urolithiasis and to compare the effectiveness and safety of these techniques in a real-life setting. Methods A 12-item survey regarding endourological techniques was conducted through Survey Monkey among attendees of the 2013 European Association of Urology Section of Urolithiasis meeting. We asked responders to share data from the last 5 cases they performed for each technique. Procedures were stratified according to stone size and the centres' surgical volume. Techniques were compared in terms of effectiveness and safety. Analyses were performed on the overall group and a subgroup of 1-2 cm stones. Results We collected data from a total of 420 procedures by 30, out of 78, urologists who received the survey (response rate 38%): 140 RIRS, 141 Regular-PCNL (>20 Ch), 67 Mini-PCNL (14-20 Ch), 28 UltraMini-PCNL (11-13 Ch) and 44 Micro-PCNL (4,8-8 Ch). Techniques choice was influenced by stone size and the centre's surgical volume. Effectiveness and safety outcomes were influenced by stone size, independently of the technique. The stone-free rate was significantly lower in Micro-PCNL compared to Regular-PCNL. This was not confirmed for 1-2 cm stones. All techniques presented a lower complication rate than Regular-PCNL, with Mini-PCNL being the most protective technique compared to Regular-PCNL. Conclusions Stone size seems to drive treatment choice. Miniaturized PCNL techniques are widely employed for 1-2 cm stones, in particular in higher surgical volume centres. Mini-PCNL and RIRS are growing in popularity for stones > 2 cm. Mini-PCNL seems to be a good compromise, being the most effective and safe procedure among PCNL techniques. RIRS is characterized by satisfactory stone-free and low complication rates.	[Zanetti, Stefano Paolo; Palmisano, Franco; Longo, Fabrizio; Gallioli, Andrea; Fontana, Matteo; De Lorenzis, Elisa; Sampogna, Gianluca; Boeri, Luca; Albo, Giancarlo; Montanari, Emanuele] Univ Milan, IRCCS Ca Granda Osped Maggiore Policlin, Dept Urol, Milan, Italy; [Talso, Michele] ASST Vimercate Hosp MB, Dept Urol, Vimercate, MB, Italy; [Trinchieri, Alberto] Presidio Osped Alessandro Manzoni, Dept Urol, Lecce, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ospedale di Vimercate	Zanetti, SP (corresponding author), Univ Milan, IRCCS Ca Granda Osped Maggiore Policlin, Dept Urol, Milan, Italy.	stefano.p.zanetti@gmail.com	Sampogna, Gianluca/AAJ-3673-2020; Trinchieri, Alberto/AAH-6934-2019; Gallioli, Andrea/AHC-7277-2022; Boeri, Luca/AAC-4848-2022; MONTANARI, EMANUELE/I-8034-2015	Sampogna, Gianluca/0000-0003-0403-7110; Gallioli, Andrea/0000-0002-3316-5691; de lorenzis, elisa/0000-0002-5961-9874; MONTANARI, EMANUELE/0000-0002-3586-666X; Palmisano, Franco/0000-0002-0197-9033; Fontana, Matteo/0000-0002-7017-6576				Aboumarzouk OM, 2012, J ENDOUROL, V26, P1257, DOI 10.1089/end.2012.0217; Akman T, 2012, BJU INT, V109, P1384, DOI 10.1111/j.1464-410X.2011.10691.x; Al-Qahtani SM, 2012, ADV UROL, V2012, DOI 10.1155/2012/543537; Breda A, 2014, CURR OPIN UROL, V24, P179, DOI 10.1097/MOU.0000000000000030; De S, 2016, EUR UROL, V69, pE85, DOI 10.1016/j.eururo.2015.12.046; Emiliani E, 2017, CENT EUR J UROL, V70, P69, DOI 10.5173/ceju.2017.930; Ganpule A, 2016, BJU INT, V117, P478, DOI 10.1111/bju.13263; Kandemir A, 2017, WORLD J UROL, V35, P1771, DOI 10.1007/s00345-017-2058-9; Kukreja R, 2004, J ENDOUROL, V18, P715, DOI 10.1089/end.2004.18.715; Mishra S, 2011, BJU INT, V108, P896, DOI 10.1111/j.1464-410X.2010.09936.x; Sabnis RB, 2013, BJU INT, V112, P355, DOI 10.1111/bju.12164; Sorokin I, 2017, WORLD J UROL, V35, P1301, DOI 10.1007/s00345-017-2008-6; Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041; Wilhelm K, 2015, WORLD J UROL, V33, P2131, DOI 10.1007/s00345-015-1585-5; Yamaguchi A, 2011, J ENDOUROL, V25, P933, DOI 10.1089/end.2010.0606; Zanetti SP, 2016, ARCH ITAL UROL ANDRO, V88, P212, DOI 10.4081/aiua.2016.3.212	16	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0205159	10.1371/journal.pone.0205159	http://dx.doi.org/10.1371/journal.pone.0205159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388123	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800012
J	Chia, SY; Tanga, CM; Khamis, FM; Mohamed, SA; Salifu, D; Sevgan, S; Fiaboe, KKM; Niassy, S; van Loon, JJA; Dicke, M; Ekesi, S				Chia, Shaphan Yong; Tanga, Chrysantus Mbi; Khamis, Fathiya M.; Mohamed, Samira A.; Salifu, Daisy; Sevgan, Subramanian; Fiaboe, Komi K. M.; Niassy, Saliou; van Loon, Joop J. A.; Dicke, Marcel; Ekesi, Sunday			Threshold temperatures and thermal requirements of black soldier fly Hermetia illucens: Implications for mass production	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; BACTROCERA-INVADENS DIPTERA; DIFFERENT LIFE STAGES; DEPENDENT DEVELOPMENT; FLIES DIPTERA; DEMOGRAPHIC PARAMETERS; CONSTANT TEMPERATURES; SPODOPTERA-EXIGUA; IMMATURE STAGES; HISTORY TRAITS	Efforts to recycle organic wastes using black soldier fly (BSF) Hermetia illucens into high-nutrient biomass that constitutes a sustainable fat (biodiesel) and high-quality protein ingredient in animal feeds have recently gained momentum worldwide. However, there is little information on the most suitable rearing conditions for growth, development and survivor-ship of these flies, which is a prerequisite for mass production technologies. We evaluated the physiological requirements for growth and reproduction of H. illucens on two diets [spent grains supplemented with brewers' yeast (D1) and un-supplemented (D2)]. Development rates at nine constant temperatures (10-42 degrees C) were fitted to temperature-dependent linear and non-linear day-degree models. Thereafter, life history table parameters were determined within a range of favourable temperatures. The thermal maximum (TM) estimates for larval, pre-pupal and pupal development using non-linear model ranged between 37.2 +/- 0.3 and 44.0 +/- 2.3 degrees C. The non-linear and linear day-degree model estimations of lower developmental temperature threshold for larvae were 11.7 +/- 0.9 and 12.3 +/- 1.4 degrees C for D1, and 10.4 +/- 1.7 and 11.7 +/- 3.0 degrees C for D2, respectively. The estimated thermal constant of immature life stages development of BSF was higher for the larval stage (250 +/- 25 DD for D1 and 333 +/- 51 for D2) than the other stages evaluated. Final larval wet weight was higher on D1 compared to D2. The population growth rate was most favourable at 30-degree celsius (degrees C) with higher intrinsic rate of natural increase (r(m) = 0.127 for D1 and 0.122 for D2) and shorter doubling time (5.5 days for D1 and 5.7 days for D2) compared to the other temperatures. These results are valuable for the optimization of commercial mass rearing procedures of BSF under various environmental conditions and prediction of population dynamics patterns using computer simulation models.	[Chia, Shaphan Yong; Khamis, Fathiya M.; van Loon, Joop J. A.; Dicke, Marcel] Wageningen Univ, Lab Entomol, Plant Sci Grp, Wageningen, Netherlands; [Chia, Shaphan Yong; Tanga, Chrysantus Mbi; Mohamed, Samira A.; Salifu, Daisy; Sevgan, Subramanian; Fiaboe, Komi K. M.; Niassy, Saliou; Ekesi, Sunday] Icipe, Nairobi, Kenya	Wageningen University & Research; International Centre of Insect Physiology & Ecology (ICIPE)	Tanga, CM (corresponding author), Icipe, Nairobi, Kenya.	ctanga@icipe.org	, Subramanian/H-8531-2014; Chia, Shaphan/ABF-6414-2020; Ekesi, Sunday/P-8944-2019; Chia, Shaphan/ABG-7238-2020; Chia, Shaphan/U-6856-2019; Dicke, Marcel/B-2300-2010; van Loon, Joop J.A./B-3744-2009	, Subramanian/0000-0003-4447-0744; Chia, Shaphan/0000-0001-7489-3233; Dicke, Marcel/0000-0001-8565-8896; van Loon, Joop J.A./0000-0002-4260-0501	Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) [ILIPA - W 08.250.202]; Federal Ministry for Economic Cooperation and Development (BMZ) [ENTONUTRI - 81194993]; Canadian International Development Research Centre (IDRC); Australian Centre for International Agricultural Research (ACIAR) through the International Centre of Insect Physiology and Ecology (icipe) [107839-001]; UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO); Federal Ministry for Economic Cooperation and Development (BMZ); Canadian International Development Research Centre (IDRC); Australian Centre for International Agricultural Research (ACIAR) through the International Centre of Insect Physiology and Ecology (icipe); UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	This research was financially supported by the Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) (ILIPA - W 08.250.202), Federal Ministry for Economic Cooperation and Development (BMZ) (ENTONUTRI - 81194993), the Canadian International Development Research Centre (IDRC) and the Australian Centre for International Agricultural Research (ACIAR) (INSFEED - Cultivate Grant No: 107839-001) through the International Centre of Insect Physiology and Ecology (icipe). We also gratefully acknowledge the icipe core funding provided by UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany, and the Kenyan Government. The views expressed herein do not necessarily reflect the official opinion of the donors.	Amalraj DD, 2005, MEM I OSWALDO CRUZ, V100, P893, DOI 10.1590/S0074-02762005000800012; Andreadis SS, 2013, J PEST SCI, V86, P409, DOI 10.1007/s10340-013-0490-1; Arnold H., 2013, EDIBLE INSECTS FUTUR, V171, P1; Baek S, 2014, J PEST SCI, V87, P331, DOI 10.1007/s10340-013-0546-2; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Barragan-Fonseca KB, 2017, J INSECTS FOOD FEED, V3, P105, DOI 10.3920/JIFF2016.0055; BELLOWS TS, 1992, ANNU REV ENTOMOL, V37, P587, DOI 10.1146/annurev.en.37.010192.003103; Berger D, 2008, FUNCT ECOL, V22, P523, DOI 10.1111/j.1365-2435.2008.01392.x; BIRCH LC, 1948, J ANIM ECOL, V17, P15, DOI 10.2307/1605; Bonso NK., 2013, THESIS, P84; BOOTH DC, 1984, ENVIRON ENTOMOL, V13, P421, DOI 10.1093/ee/13.2.421; Brevault T, 2000, ENTOMOL EXP APPL, V94, P25, DOI 10.1023/A:1003952909411; Briere JF, 1998, ENVIRON ENTOMOL, V27, P94, DOI 10.1093/ee/27.1.94; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; Cammack JA, 2017, INSECTS, V8, DOI 10.3390/insects8020056; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Carey JR, 1993, APPL DEMOGRAPHIC BIO; CHURCHILLSTANLAND C, 1986, J ECON ENTOMOL, V79, P614, DOI 10.1093/jee/79.3.614; Diamantidis AD, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.33; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dixon AFG, 2009, FUNCT ECOL, V23, P257, DOI 10.1111/j.1365-2435.2008.01489.x; Duyck PF, 2002, B ENTOMOL RES, V92, P461, DOI 10.1079/BER2002188; Efron B., 1993, INTRO BOOTSTRAP, P436, DOI [10.1007/978-1-4899-4541-9, DOI 10.1007/978-1-4899-4541-9]; Ekesi S, 2007, ANN ENTOMOL SOC AM, V100, P562, DOI 10.1603/0013-8746(2007)100[562:ATASRO]2.0.CO;2; Fand BB, 2014, CROP PROT, V55, P98, DOI 10.1016/j.cropro.2013.10.020; Fletcher BS, 1989, FRUIT FLIES THEIR BI; FOULY AH, 1995, ENVIRON ENTOMOL, V24, P870, DOI 10.1093/ee/24.4.870; Gabre RA, 2005, ACTA OECOL, V27, P179, DOI 10.1016/j.actao.2004.12.002; Golizadeh Ali, 2009, Journal of Asia-Pacific Entomology, V12, P207, DOI 10.1016/j.aspen.2009.05.002; Goulson D, 2005, J APPL ECOL, V42, P795, DOI 10.1111/j.1365-2664.2005.01078.x; Hansen DL, 1999, ENTOMOL EXP APPL, V93, P269, DOI 10.1023/A:1003948313507; Harnden LM, 2016, FORENSIC SCI INT, V266, P109, DOI 10.1016/j.forsciint.2016.05.007; Hodek I., 1996, ECOLOGY COCCINELLIDA, P464, DOI 10.1007/978-94-017-1349-8; Hoffmann KH, 1985, ENV PHYSL BIOCH INSE, P33, DOI [DOI 10.1007/978-3-642-70020-0_2, 10.1007/978-3-642-70020-0_2]; Holmes LA, 2016, J INSECTS FOOD FEED, V2, P255, DOI 10.3920/JIFF2016.0008; Holmes LA, 2013, ENVIRON ENTOMOL, V42, P370, DOI 10.1603/EN12255; Honek A, 1990, TEMPERATURE DEV TIME; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; KARLSSON B, 1990, FUNCT ECOL, V4, P609, DOI 10.2307/2389728; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; Khanamani M, 2013, INT J ACAROL, V39, P638, DOI 10.1080/01647954.2013.861867; KRAINACKER DA, 1987, OECOLOGIA, V73, P583, DOI 10.1007/BF00379420; Lalander CH, 2015, AGRON SUSTAIN DEV, V35, P261, DOI 10.1007/s13593-014-0235-4; Lalander CH, 2014, AGRON SUSTAIN DEV, P1; Liu XF, 2009, SCI RES ESSAYS, V4, P467; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Makkar HPS, 2014, ANIM FEED SCI TECH, V197, P1, DOI 10.1016/j.anifeedsci.2014.07.008; Marshall S. A., 2015, Journal of the Entomological Society of Ontario, V146, P51; Mehrparvar M, 2007, EUR J ENTOMOL, V104, P631, DOI 10.14411/eje.2007.078; Nedved Oldrich, 2012, P54; Newton G. L, 2005, BLACK SOLDIER FLY HE; Nguyen TTX, 2013, J MED ENTOMOL, V50, P898, DOI 10.1603/ME12260; Park HH, 2014, J ASIA-PAC ENTOMOL, V17, P83, DOI 10.1016/j.aspen.2013.11.003; Portilla M JAM, 2014, LIFE TABLES TOOLS EV; R Core Team, 2020, R LANG ENV STAT COMP; Richards DR, 1998, ANN ENTOMOL SOC AM, V91, P632, DOI 10.1093/aesa/91.5.632; Roy S., 2016, P ZOOLOGICAL SOC, P1; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Rwomushana I, 2008, J APPL ENTOMOL, V132, P832, DOI 10.1111/j.1439-0418.2008.01318.x; Salum JK, 2014, J APPL ENTOMOL, V138, P441, DOI 10.1111/jen.12044; Sanchez-Muros MJ, 2014, J CLEAN PROD, V65, P16, DOI 10.1016/j.jclepro.2013.11.068; Saska P, 2013, J APPL ECOL, V50, P181, DOI 10.1111/1365-2664.12023; Schneider J. C., 2009, PRINCIPLES PROCEDURE, P97; SHARP JL, 1983, J ECON ENTOMOL, V76, P302, DOI 10.1093/jee/76.2.302; SHEPPARD DC, 1994, BIORESOURCE TECHNOL, V50, P275, DOI 10.1016/0960-8524(94)90102-3; SINGH P, 1982, NEW ZEAL ENTOMOL, V7, P304, DOI 10.1080/00779962.1982.9722404; Smith R., 2016, ANN RES REV BIOL, V9, P1, DOI [10.9734/ARRB/2016/22973, DOI 10.9734/ARRB/2016/22973]; Sorensen JG, 2001, J INSECT PHYSIOL, V47, P1301, DOI 10.1016/S0022-1910(01)00119-6; Souissi R, 1997, ENTOMOL EXP APPL, V85, P113, DOI 10.1023/A:1003045312404; Sripontan Y., 2017, KHON KAEN AGR J, V45, P179; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P59, DOI 10.1111/j.1749-7345.2006.00073.x; SUMMERS CG, 1984, ENVIRON ENTOMOL, V13, P236, DOI 10.1093/ee/13.1.236; Tanga C.M, 2018, PLOS ONE, V13; Tanga CM, 2015, ZOOKEYS, P467, DOI 10.3897/zookeys.540.9906; Tchuinkam T, 2011, B ENTOMOL RES, V101, P259, DOI 10.1017/S0007485310000349; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; Tomberlin JK, 2002, ANN ENTOMOL SOC AM, V95, P379, DOI 10.1603/0013-8746(2002)095[0379:SLHTOB]2.0.CO;2; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; VALICENTE FH, 1995, BIOL CONTROL, V5, P449, DOI 10.1006/bcon.1995.1054; Vantomme P., 2012, SUMMARY REPORT TECHN; Vargas RI, 2000, ANN ENTOMOL SOC AM, V93, P75, DOI 10.1603/0013-8746(2000)093[0075:CDOTHF]2.0.CO;2; VARGAS RI, 1989, ANN ENTOMOL SOC AM, V82, P55, DOI 10.1093/aesa/82.1.55; Vargas RI, 1996, ANN ENTOMOL SOC AM, V89, P64, DOI 10.1093/aesa/89.1.64; VARGAS RI, 1994, J ECON ENTOMOL, V87, P91, DOI 10.1093/jee/87.1.91; Vasicek A, 2002, PESQUI AGROPECU BRAS, V37, P407, DOI 10.1590/S0100-204X2002000300023; Vayssieres JF, 2008, ENVIRON ENTOMOL, V37, P307, DOI 10.1603/0046-225X(2008)37[307:DOISAC]2.0.CO;2; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P475, DOI 10.1093/aesa/77.5.475; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	89	58	58	30	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206097	10.1371/journal.pone.0206097	http://dx.doi.org/10.1371/journal.pone.0206097			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383771	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600026
J	Mestre, C; Otero, C; Diaz-Douton, F; Gautier, J; Pujol, J				Mestre, Clara; Otero, Caries; Diaz-Douton, Fernando; Gautier, Josselin; Pujol, Jaume			An automated and objective cover test to measure heterophoria	PLOS ONE			English	Article							INTEREXAMINER REPEATABILITY; OCULAR DOMINANCE; EYE-MOVEMENTS; RELIABILITY; EXPERIENCE; DISPARITY	Heterophoria is the relative deviation of the eyes in absence of fusional vergence. Fusional vergence can be deprived by, for example, occluding one eye while the other fixates a visual target. Then, the occluded eye will presumably deviate from its initial position by an amount that corresponds to the heterophoria. Its assessment in clinical practice is crucial for the diagnosis of non-strabismic binocular dysfunctions such as convergence insufficiency. Traditional clinical methods, like the cover test or the modified Thorington test, suffer from practitioner's subjectivity, impossibility to observe the occluding eye or unusual viewing conditions. These limitations could be overcome by using eye tracking systems to measure objectively the heterophoria. The main purpose of this study was to compare the performance of an automated and objective method to measure near heterophoria using an eye-tracker with two conventional methods: the cover-uncover test and the modified Thorington test. The eye tracking method gave us the possibility to measure the heterophoria as the deviation of the occluded eye (mimicking the cover test) or as the deviations of the occluded and fixating eyes (adhering to the theoretical definition of heterophoria). The latter method provided smaller results than the former, although on average the differences might not be clinically relevant. The proposed objective method exhibited considerably better repeatability than the two conventional clinical methods. It showed better agreement with the modified Thorington test than with the cover-uncover test, and a similar level of agreement was obtained between the two clinical methods. To conclude, the use of eye-trackers to measure heterophoria provides objective and more repeatable measures. As eye-trackers become common tools in clinical settings, their use to measure heterophoria should be the new gold standard.	[Mestre, Clara; Otero, Caries; Diaz-Douton, Fernando; Pujol, Jaume] Univ Politecn Cataluna, Davalor Res Ctr, Terrassa, Spain; [Diaz-Douton, Fernando] Univ Politecn Cataluna, Ctr Sensors Instruments & Syst Dev CD6, Terrassa, Spain; [Gautier, Josselin] Inria, Sophia Antipolis, France	Universitat Politecnica de Catalunya; Universitat Politecnica de Catalunya; Inria	Mestre, C (corresponding author), Univ Politecn Cataluna, Davalor Res Ctr, Terrassa, Spain.	clara.mestre@upc.edu	Douton, Fernando Diaz/K-1368-2017; Otero, Carles/AAB-7719-2021	Douton, Fernando Diaz/0000-0003-3699-015X; Mestre Ferrer, Clara/0000-0003-0053-550X; Otero, Carles/0000-0002-8092-8778; Pujol, Jaume/0000-0003-0811-9244	Spanish Ministry of Economy and Competitiveness [DPI2014-56850-R]; European Union; Generalitat de Catalunya; Davalor Salud, S.L.	Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Davalor Salud, S.L.	This research was supported by the Spanish Ministry of Economy and Competitiveness under grant DPI2014-56850-R, the European Union, and by Davalor Salud, S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Harold Bedell for insightful discussions and his valuable comments. The authors would like to thank all the subjects that participated in this study. CM and CO thank the Generalitat de Catalunya for their awarded PhD studentship.	Anderson HA, 2010, OPTOMETRY VISION SCI, V87, P168, DOI 10.1097/OPX.0b013e3181d1d954; Antona B, 2011, Binocul Vis Strabolog Q Simms Romano, V26, P91; Babinsky E, 2015, INVEST OPHTH VIS SCI, V56, P1406, DOI 10.1167/iovs.14-14649; BARNARD NAS, 1995, OPHTHAL PHYSL OPT, V15, P413, DOI 10.1016/0275-5408(95)00053-G; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cebrian JL, 2014, OPTOMETRY VISION SCI, V91, P786, DOI 10.1097/OPX.0000000000000297; Ciuffreda K. J., 1992, J BEHAV OPTOMETRY, V3, P3; Fogt N, 2000, OPTOMETRY VISION SCI, V77, P670, DOI 10.1097/00006324-200012000-00014; Griffin JR, 1982, BINOCULAR ANOMALIES; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; HIRSCH M J, 1948, Am J Optom Arch Am Acad Optom, V25, P407; Hrynchak PK, 2010, OPHTHAL PHYSL OPT, V30, P304, DOI 10.1111/j.1475-1313.2010.00723.x; Jaschinski W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170190; Jaschinski W, 2016, J EYE MOVEMENT RES, V9, DOI 10.16910/jemr.9.4.2; Jaschinski W, 2010, OPHTHAL PHYSL OPT, V30, P379, DOI 10.1111/j.1475-1313.2010.00753.x; Johansson J, 2015, J VISION, V15, DOI 10.1167/15.9.21; Johns HA, 2004, OPTOMETRY VISION SCI, V81, P939; Li JR, 2010, INVEST OPHTH VIS SCI, V51, P6875, DOI 10.1167/iovs.10-5549; LUDVIGH E, 1949, AM J OPHTHALMOL, V32, P649, DOI 10.1016/0002-9394(49)91415-4; MORRIS F M, 1960, Am J Optom Arch Am Acad Optom, V37, P327; NORTH RV, 1993, OPHTHAL PHYSL OPT, V13, P239, DOI 10.1111/j.1475-1313.1993.tb00465.x; PELI E, 1983, AM J OPTOM PHYS OPT, V60, P712; Pickwell D, 1989, BINOCULAR VISION ANO, P15; PICKWELL LD, 1973, BRIT J PHYSIOL OPT, V28, P23; Rainey BB, 1998, OPTOMETRY VISION SCI, V75, P719, DOI 10.1097/00006324-199810000-00016; Rice ML, 2008, J AAPOS, V12, P365, DOI 10.1016/j.jaapos.2008.01.017; Sanker N, 2012, CLIN EXP OPTOM, V95, P638, DOI 10.1111/j.1444-0938.2012.00785.x; Scheiman M., 2014, CLIN MANAGEMENT BINO; Schroeder TL, 1996, OPTOMETRY VISION SCI, V73, P389, DOI 10.1097/00006324-199606000-00006; Schroth V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138871; Svede A, 2015, PERCEPTION, V44, P1110, DOI 10.1177/0301006615596886; Troyer ME, 2017, OPHTHAL PHYSL OPT, V37, P7, DOI 10.1111/opo.12342; van Rijn LJ, 1998, VISION RES, V38, P2973, DOI 10.1016/S0042-6989(98)00079-0; Von Noorden G. K., 2002, BINOCULAR VISION OCU, V6th; Wong EPF, 2002, OPTOMETRY VISION SCI, V79, P370, DOI 10.1097/00006324-200206000-00010; Zhou D, 2017, CURR EYE RES, V42, P1155, DOI 10.1080/02713683.2017.1297464	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206674	10.1371/journal.pone.0206674	http://dx.doi.org/10.1371/journal.pone.0206674			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383846	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600082
J	Tepper, PG; Mardekian, J; Masseria, C; Phatak, H; Kamble, S; Abdulsattar, Y; Petkun, W; Lip, GYH				Tepper, Ping G.; Mardekian, Jack; Masseria, Cristina; Phatak, Hemant; Kamble, Shital; Abdulsattar, Younos; Petkun, William; Lip, Gregory Y. H.			Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban	PLOS ONE			English	Article							ORAL ANTICOAGULANTS; STROKE PREVENTION; WARFARIN; SAFETY; EFFICACY; METAANALYSIS; MORTALITY; THERAPY; EVENTS; TRIALS	Limited real-world data are available regarding the comparative safety of non-vitamin K antagonist oral anticoagulants (NOACs). The objective of this retrospective claims observational cohort study was to compare the risk of bleeding among non-valvular atrial fibrillation (NVAF) patients prescribed apixaban, dabigatran, or rivaroxaban. NVAF patients aged. 18 years with a 1-year baseline period were included if they were new initiators of NOACs or switched from warfarin to a NOAC. Cox proportional hazards modelling was used to estimate the adjusted hazard ratios of any bleeding, clinically relevant non-major (CRNM) bleeding, and major inpatient bleeding within 6 months of treatment initiation for rivaroxaban and dabigatran compared to apixaban. Among 60,227 eligible patients, 8,785 were prescribed apixaban, 20,963 dabigatran, and 30,529 rivaroxaban. Compared to dabigatran or rivaroxaban patients, apixaban patients were more likely to have greater proportions of baseline comorbidities and higher CHA(2)DS(2)-VASc and HAS-BLED scores. After adjusting for baseline clinical and demographic characteristics, patients prescribed rivaroxaban were more likely to experience any bleeding (HR: 1.35, 95% confidence interval [CI]: 1.26-1.45), CRNM bleeding (HR: 1.38, 95% CI: 1.27-1.49), and major inpatient bleeding (HR: 1.43, 95% CI: 1.17-1.74), compared to patients prescribed apixaban. Dabigatran patients had similar bleeding risks as apixaban patients. In conclusion, NVAF patients treated with rivaroxaban appeared to have an increased risk of any bleeding, CRNM bleeding, and major inpatient bleeding, compared to apixaban patients. There was no significant difference in any bleeding, CRNM bleeding, or inpatient major bleeding risks between patients treated with dabigatran and apixaban.	[Tepper, Ping G.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Mardekian, Jack; Masseria, Cristina; Abdulsattar, Younos] Pfizer Inc, Dept Outcomes & Evidence, New York, NY USA; [Phatak, Hemant; Kamble, Shital] Bristol Myers Squibb, Dept Global Hlth Econ & Outcomes Res, Princeton, NJ USA; [Petkun, William] Bristol Myers Squibb, Dept Global Med Affairs, Princeton, NJ USA; [Lip, Gregory Y. H.] Univ Birmingham, City Hosp, Inst Cardiovasc Sci, Birmingham, W Midlands, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pfizer; Bristol-Myers Squibb; Bristol-Myers Squibb; University of Birmingham	Tepper, PG (corresponding author), Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA.	ping@pganalytics.com			Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	This study was funded by Bristol-Myers Squibb and Pfizer who provided support in the form of salaries for authors HO, SK, WP and JM, CM and YA respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abraham NS, 2017, GASTROENTEROLOGY, V152, P1014, DOI 10.1053/j.gastro.2016.12.018; Abraham NS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1857; Adeboyeje G, 2016, CIRCULATION CARDI S2, V9, pA2, DOI DOI 10.1161/CIRCOUTCOMES.115.002510; Benjamin EJ, 2009, CIRCULATION, V119, P606, DOI 10.1161/CIRCULATIONAHA.108.825380; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cunningham A, 2011, PHARMACOEPIDEM DR S, V20, P560, DOI 10.1002/pds.2109; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Gallego P, 2013, THROMB HAEMOSTASIS, V110, P1189, DOI 10.1160/TH13-07-0556; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Halperin JL, 2014, CIRCULATION, V130, P138, DOI 10.1161/CIRCULATIONAHA.113.005008; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Hernandez I, 2015, JAMA INTERN MED, V175, P18, DOI 10.1001/jamainternmed.2014.5398; Hylek EM, 2014, THROMB HAEMOSTASIS, V111, P783, DOI 10.1160/TH13-12-1032; Laliberte F, 2014, CURR MED RES OPIN, V30, P1317, DOI 10.1185/03007995.2014.907140; Lauffenburger JC, 2015, AM J CARDIOL, V115, P1095, DOI 10.1016/j.amjcard.2015.01.539; Lauffenburger JC, 2013, PHARMACOEPIDEM DR S, V22, P899, DOI 10.1002/pds.3458; Lip GYH, 2016, THROMB HAEMOSTASIS, V116, P975, DOI 10.1160/TH16-05-0403; Lip GYH, 2012, J AM COLL CARDIOL, V60, P738, DOI 10.1016/j.jacc.2012.03.019; Lip GYH, 2010, AM J MED, V123, P484, DOI 10.1016/j.amjmed.2009.12.013; Marini C, 2005, STROKE, V36, P1115, DOI 10.1161/01.STR.0000166053.83476.4a; Noseworthy PA, 2016, CHEST, V150, P1302, DOI 10.1016/j.chest.2016.07.013; Patel MR, 2010, NEW ENGL J MED, V362, P886, DOI 10.1056/NEJMoa0907272; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Roldan V, 2013, CHEST, V143, P179, DOI 10.1378/chest.12-0608; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Seeger JD, 2015, THROMB HAEMOSTASIS, V114, P1277, DOI 10.1160/TH15-06-0497; Skjoth F, 2014, THROMB HAEMOSTASIS, V111, P981, DOI 10.1160/TH14-02-0118; Villines TC, 2015, THROMB HAEMOSTASIS, V114, P1290, DOI 10.1160/TH15-06-0453; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003725	32	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205989	10.1371/journal.pone.0205989	http://dx.doi.org/10.1371/journal.pone.0205989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383768	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600023
J	Frazier, NM; Brand, T; Gordan, JD; Grandis, J; Jura, N				Frazier, Nicole Michael; Brand, Toni; Gordan, John D.; Grandis, Jennifer; Jura, Natalia			Overexpression-mediated activation of MET in the Golgi promotes HER3/ERBB3 phosphorylation	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SCATTER FACTOR-RECEPTOR; C-MET; LUNG-CANCER; TYROSINE KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; GENE AMPLIFICATION; CRYSTAL-STRUCTURE; PROGNOSTIC-SIGNIFICANCE; NUCLEAR MET	Ligand-dependent oligomerization of receptor tyrosine kinases (RTKs) results in their activation through highly specific conformational changes in the extracellular and intracellular receptor domains. These conformational changes are unique for each RTK subfamily, limiting cross-activation between unrelated RTKs. The proto-oncogene MET receptor tyrosine kinase overcomes these structural constraints and phosphorylates unrelated RTKs in numerous cancer cell lines. The molecular basis for these interactions is unknown. We investigated the mechanism by which MET phosphorylates the human epidermal growth factor receptor-3 (HER3 or ERBB3), a catalytically impaired RTK whose phosphorylation by MET has been described as an essential component of drug resistance to inhibitors targeting EGFR and HER2. We find that in untransformed cells, HER3 is not phosphorylated by MET in response to ligand stimulation, but rather to increasing levels of MET expression, which results in ligand-independent MET activation. Phosphorylation of HER3 by its canonical coreceptors, EGFR and HER2, is achieved by engaging an allosteric site on the HER3 kinase domain, but this site is not required when HER3 is phosphorylated by MET. We also observe that HER3 preferentially interacts with MET during its maturation along the secretory pathway, before MET is post translationally processed by cleavage within its extracellular domain. This results in accumulation of phosphorylated HER3 in the Golgi apparatus. We further show that in addition to HER3, MET phosphorylates other RTKs in the Golgi, suggesting that this mechanism is not limited to HER3 phosphorylation. These data demonstrate a link between MET overexpression and its aberrant activation in the Golgi endomembranes and suggest that non-canonical interactions between MET and other RTKs occur during maturation of receptors. Our study highlights a novel aspect of MET signaling in cancer that would not be accessible to inhibition by therapeutic antibodies.	[Frazier, Nicole Michael; Jura, Natalia] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Brand, Toni; Grandis, Jennifer] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94113 USA; [Gordan, John D.] Univ Calif San Francisco, Div Hematol & Oncol, San Francisco, CA 94158 USA; [Jura, Natalia] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jura, N (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	natalia.jura@ucsf.edu		Frazier, Nicole/0000-0002-9499-1938	National Institute of General Medical Sciences [R01 GM109176]; Susan G. Komen Foundation [CCR14299947]; Lung Cancer Research Foundation; National Institute of Dental and Craniofacial Research [R01 DE023685]; NATIONAL CANCER INSTITUTE [R35CA231998, R01CA098372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007810, R01GM109176] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Lung Cancer Research Foundation; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Moasser for insightful discussions and members of the Jura lab for valuable discussions and input on experimental design and execution. This work was supported partially by the grant from the National Institute of General Medical Sciences to N.J. (R01 GM109176), Susan G. Komen Foundation Career Catalyst Research Grant to N.J. (CCR14299947), Lung Cancer Research Foundation Grant to N.J. and the grant from National Institute of Dental and Craniofacial Research to J.G. (R01 DE023685).	Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Beji A, 2012, CLIN CANCER RES, V18, P956, DOI 10.1158/1078-0432.CCR-11-1186; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Bougherara H, 2009, MOL CANCER RES, V7, P1525, DOI 10.1158/1541-7786.MCR-09-0138; Casadevall D, 2015, ONCOTARGET, V6, P16215, DOI 10.18632/oncotarget.3976; Chen R, 2013, J CELL BIOCHEM, V114, P816, DOI 10.1002/jcb.24420; Chirgadze DY, 1999, NAT STRUCT BIOL, V6, P72; Choudhary C, 2009, MOL CELL, V36, P326, DOI 10.1016/j.molcel.2009.09.019; Christensen JG, 2005, CANCER LETT, V225, P1, DOI 10.1016/j.canlet.2004.09.044; Cignetto S, 2016, MOL ONCOL, V10, P938, DOI 10.1016/j.molonc.2016.03.004; Citores L, 2007, J CELL PHYSIOL, V212, P148, DOI 10.1002/jcp.21014; Coleman DT, 2016, ONCOTARGET, V7, P32664, DOI 10.18632/oncotarget.8706; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Dieras V, 2015, ANN ONCOL, V26, P1904, DOI 10.1093/annonc/mdv263; Dimou A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107677; Du ZQ, 2016, MOL CANCER THER, V15, P1227, DOI 10.1158/1535-7163.MCT-15-0745; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Favelyukis S, 2001, NAT STRUCT BIOL, V8, P1058, DOI 10.1038/nsb721; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gherardi E, 2003, P NATL ACAD SCI USA, V100, P12039, DOI 10.1073/pnas.2034936100; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kataoka Y, 2012, INVEST NEW DRUG, V30, P1352, DOI 10.1007/s10637-011-9699-0; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Kermorgant S, 2003, J BIOL CHEM, V278, P28921, DOI 10.1074/jbc.M302116200; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; KIM HH, 1994, J BIOL CHEM, V269, P24747; Kim KH, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.17; Kim SM, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.48; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Lefebvre J, 2012, FASEB J, V26, P1387, DOI 10.1096/fj.11-197723; Li AN, 2015, LUNG CANCER, V90, P375, DOI 10.1016/j.lungcan.2015.10.021; Li YQ, 2015, ONCOTARGET, V6, P13309, DOI 10.18632/oncotarget.3751; Liu SY, 2016, ONCOTARGET, V7, P11251, DOI 10.18632/oncotarget.7081; Liu XD, 2011, CLIN CANCER RES, V17, P7127, DOI 10.1158/1078-0432.CCR-11-1157; Mazot P, 2011, ONCOGENE, V30, P2017, DOI 10.1038/onc.2010.595; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Menting JG, 2013, NATURE, V493, P241, DOI 10.1038/nature11781; MONDINO A, 1991, MOL CELL BIOL, V11, P6084, DOI 10.1128/MCB.11.12.6084; PARK M, 1987, P NATL ACAD SCI USA, V84, P6379, DOI 10.1073/pnas.84.18.6379; PONZETTO C, 1993, MOL CELL BIOL, V13, P4600, DOI 10.1128/MCB.13.8.4600; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; RODRIGUES GA, 1994, ONCOGENE, V9, P2019; Rosen LS, 2017, CLIN CANCER RES, V23, P1910, DOI 10.1158/1078-0432.CCR-16-1418; Ruco LP, 1996, J PATHOL, V180, P266, DOI 10.1002/(SICI)1096-9896(199611)180:3<266::AID-PATH658>3.0.CO;2-Q; Schmidt-Arras DE, 2005, MOL CELL BIOL, V25, P3690, DOI 10.1128/MCB.25.9.3690-3703.2005; Seiwert TY, 2009, CANCER RES, V69, P3021, DOI 10.1158/0008-5472.CAN-08-2881; Shah MA, 2017, JAMA ONCOL, V3, P620, DOI 10.1001/jamaoncol.2016.5580; Shah MA, 2016, ONCOLOGIST, V21, P1085, DOI 10.1634/theoncologist.2016-0038; Shi PY, 2016, CANCER LETT, V380, P494, DOI 10.1016/j.canlet.2016.07.021; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Song ZB, 2017, CLIN LUNG CANCER, V18, P213, DOI 10.1016/j.cllc.2016.09.011; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Steinway SN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128159; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Tabone-Eglinger S, 2008, CLIN CANCER RES, V14, P2285, DOI 10.1158/1078-0432.CCR-07-4102; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; TEMPEST PR, 1988, BRIT J CANCER, V58, P3, DOI 10.1038/bjc.1988.150; Tey SK, 2017, CANCER LETT, V411, P150, DOI 10.1016/j.canlet.2017.09.047; Xie YQ, 2014, MOL ENDOCRINOL, V28, P1629, DOI 10.1210/me.2014-1078; Yan SC, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0296-y; Yun C, 2015, MOL CARCINOGEN, V54, P1700, DOI 10.1002/mc.22241; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; ZHU H, 1994, J BIOL CHEM, V269, P29943; Zhu LY, 2016, J CELL SCI, V129, P4238, DOI 10.1242/jcs.191684	69	18	18	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1936	1950		10.1038/s41388-018-0537-0	http://dx.doi.org/10.1038/s41388-018-0537-0			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30390071	Green Accepted			2022-12-26	WOS:000461164400011
J	Kadima, J; Patterson, E; Mburu, M; Blat, C; Nyanduko, M; Bukusi, EA; Cohen, C; Oyaro, P; Abuogi, L				Kadima, Julie; Patterson, Elizabeth; Mburu, Margaret; Blat, Cinthia; Nyanduko, Margaret; Bukusi, Elizabeth Anne; Cohen, Craig; Oyaro, Patrick; Abuogi, Lisa			Adoption of routine virologic testing and predictors of virologic failure among HIV - infected children on antiretroviral treatment in western Kenya	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; SUB-SAHARAN AFRICA; VIRAL SUPPRESSION; DRUG-RESISTANCE; SOUTH-AFRICA; THERAPY; ADOLESCENTS; ACCUMULATION; METAANALYSIS; MUTATIONS	Background Access to routine virologic monitoring, critical to ensuring treatment success, remains limited in low- and middle-income countries. We report on implementation of routine viral load (VL) monitoring and risk factors for virologic failure among HIV-infected children on antiretroviral treatment (ART) in Western Kenya. Methods Routine VL testing was introduced in western Kenya in November 2013. We performed a case-control study among 1190 HIV-infected children <= 15 years on ART who underwent routine VL testing June 2014-May 2015. A random sample of 98 cases (virologic failure define as VL>1000 cps/mL) and 201 controls (VL<1000 cps/mL) from five facilities in three high HIV prevalence counties in Kenya were followed for a minimum of 12 months. Data from patient charts were analyzed using logistic regression to determine factors associated with failure to attain virologic suppression at initial routine and subsequent VL testing among cases. Results Overall, 1190 (94%) children with a median age of 8 years underwent routine VL testing of whom (37%) had virological failure. Among the 299 cases and controls, WHO stage, base-line CD4 count and time since ART initiation were not associated with virologic failure during the follow-up period. In multivariable analysis, unsuppressed children at initial test were more likely to be male (adjusted Odds Ratio (aOR) 2.1, 95% Confidence Interval (Cl) 2.1-3.6) and have had an ART regimen change (aOR 2.0, Cl 1.0-3.7) than controls. Of the two-thirds of children 201/299 who had a subsequent VL performed, VL suppression was greater among those suppressed at initial test 126/135 (93.3%) compared to children with virologic failure 15/66 (22.7%, p<0.0001). Among those failing at first test who achieved viral suppression in follow up, 12/15 (80%) were on a protease inhibitor (PI)-based regimen. In the multivariable analysis of children with subsequent VL testing, children on Pl-based 2nd line regimens were 10-fold more likely to achieve viral suppression than children on first-line NNRTI-based ART (adjusted Odds Ratio [aOR] 0.1; 95%Cl 0.0-0.4). Conclusion Coverage of initial routine viral load testing among children on ART in western Kenya is high. However, subsequent testing and virologic suppression are low in children with virologic failure on initial routine viral load test. There is an urgent need to improve management and viral load monitoring of children living with HIV experiencing treatment failure to ensure improved long-term outcomes.	[Kadima, Julie; Mburu, Margaret; Bukusi, Elizabeth Anne; Oyaro, Patrick] Kenya Med Res Inst KEMRI, Family AIDS Care & Educ Serv FACES, Kisumu, Kenya; [Patterson, Elizabeth] Univ Colorado, Sch Med, Aurora, CO USA; [Blat, Cinthia; Cohen, Craig] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Nyanduko, Margaret] Univ Nairobi, Sch Med, Nairobi, Kenya; [Abuogi, Lisa] Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA	Kenya Medical Research Institute; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California San Francisco; University of Nairobi; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Abuogi, L (corresponding author), Univ Colorado Denver, Dept Pediat, Aurora, CO 80045 USA.	lisa.abuogi@ucdenver.edu			U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA) [PS001913]; FOGARTY INTERNATIONAL CENTER [D43TW009783] Funding Source: NIH RePORTER	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreement [PS001913] from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA). This funding provided full support for the following authors: JK, PO and partial support for EAB, CC, and LA. No funding bodies had any role in study design, data collection and analysis. CDC reviews all manuscripts under this funding mechanism and contributes minor revisions as well as approval to publish.	Abrams EJ, 2015, J INT AIDS SOC, V18, P7, DOI 10.7448/IAS.18.7.20296; Adetunji Adedotun A, 2013, J Int Assoc Provid AIDS Care, V12, P236, DOI 10.1177/1545109712463733; Aibibula W, 2017, AIDS BEHAV, V21, P754, DOI 10.1007/s10461-016-1605-5; Bain-Brickley D, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009513; Barth RE, 2010, LANCET INFECT DIS, V10, P155, DOI 10.1016/S1473-3099(09)70328-7; Boender TS, 2016, J ANTIMICROB CHEMOTH, V71, P2918, DOI 10.1093/jac/dkw218; Boender TS, 2016, J ANTIMICROB CHEMOTH; Boerma RS, 2016, CLIN INFECT DIS, V63, P1645, DOI 10.1093/cid/ciw645; Chohan BH, 2015, AIDS RES HUM RETROV, V31, P783, DOI [10.1089/aid.2014.0370, 10.1089/AID.2014.0370]; Council KMoHNAC, 2016, KEN AIDS RESP PROGR; Crowell CS, 2015, AIDS, V29, P295, DOI 10.1097/QAD.0000000000000528; Crowell CS, 2017, PEDIAT INFECT DIS J; Davies MA, 2015, J INT AIDS SOC, V18, P1, DOI 10.7448/IAS.18.7.20745; Fatti G, 2014, AIDS CARE, V26, P448, DOI 10.1080/09540121.2013.855699; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, UNAIDS FACTSH 2016; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2016, FACTSH CHILDR HIV; Lecher S, 2016, MMWR-MORBID MORTAL W, V65, P1332, DOI 10.15585/mmwr.mm6547a2; Lewis Kulzer Jayne, 2012, J Int AIDS Soc, V15, P8, DOI 10.1186/1758-2652-15-8; Luzuriaga K, 2014, J INFECT DIS, V210, P1529, DOI 10.1093/infdis/jiu297; Medicine Sans Frontiers, 2017, MAK VIR LOAD ROUT SU; Mossoro-Kpinde CD, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006282; Muri L, 2017, AIDS, V31, P61, DOI 10.1097/QAD.0000000000001273; NASCOP, 2016, KEN HIV COUNT PROF; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; Penazzato M, 2015, J INT AIDS SOC, V18, P30, DOI 10.7448/IAS.18.7.20270; Rewari BB, 2010, JAIDS-J ACQ IMM DEF, V55, P610, DOI 10.1097/QAI.0b013e3181f43a31; Roberts T, 2016, CLIN INFECT DIS; Rossouw TM, 2016, HIV MED; Rutherford GW, 2014, AIDS, V28, pS161, DOI 10.1097/QAD.0000000000000236; Shiau S, 2013, J PEDIATR-US, V162, P1138, DOI 10.1016/j.jpeds.2012.11.025; Sigaloff KCE, 2012, AIDS RES HUM RETROV, V28, P171, DOI 10.1089/aid.2011.0136; Sigaloff KCE, 2011, LANCET INFECT DIS, V11, P769, DOI 10.1016/S1473-3099(11)70141-4; UNAIDS, 2015, AIDS CHANG EV MDG6 1; UNAIDS, 2014, 90 90 90 AMB TREATM; Vreeman RC, 2008, PEDIATR INFECT DIS J, V27, P686, DOI 10.1097/INF.0b013e31816dd325; Waruru A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158881; WHO TECHNICAL REPORT, 2014, AIDS MED DIAGNOSTICS	39	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0200242	10.1371/journal.pone.0200242	http://dx.doi.org/10.1371/journal.pone.0200242			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412576	Green Submitted, gold, Green Published			2022-12-26	WOS:000449772600002
J	Chen, J; LeBlanc, ARH; Jin, LY; Huang, T; Reisz, RR				Chen, Jun; LeBlanc, Aaron R. H.; Jin, Liyong; Huang, Timothy; Reisz, Robert R.			Tooth development, histology, and enamel microstructure in Changchunsaurus parvus: Implications for dental evolution in ornithopod dinosaurs	PLOS ONE			English	Article							SERRATED TEETH; ATTACHMENT; PERIODONTIUM; WEAR	The great diversity of dinosaurian tooth shapes and sizes, and in particular, the amazing dental complexity in derived ornithischians has attracted a lot of attention. However, the evolution of dental batteries in hadrosaurids and ceratopsids is difficult to understand without a broader comparative framework. Here we describe tooth histology and development in the "middle" Cretaceous ornithischian dinosaur Changchunsaurus parvus, a small herbivore that has been characterized as an early ornithopod, or even as a more basal ornithischian. We use this taxon to show how a "typical" ornithischian dentition develops, copes with wear, and undergoes tooth replacement. Although in most respects the histological properties of their teeth are similar to those of other dinosaurs, we show that, as in other more derived ornithischians, in C. parvus the pulp chamber is not invaded fully by the newly developing replacement tooth until eruption is nearly complete. This allowed C. parvus to maintain an uninterrupted shearing surface along a single tooth row, while undergoing continuous tooth replacement. Our histological sections also show that the replacement foramina on the lingual surfaces of the jaws are likely the entry points for an externally placed dental lamina, a feature found in many other ornithischian dinosaurs. Surprisingly, our histological analysis also revealed the presence of wavy enamel, the phylogenetically earliest occurrence of this type of tissue. This contradicts previous interpretations that this peculiar type of enamel arose in association with more complex hadrosauroid dentitions. In view of its early appearance, we suggest that wavy enamel may have evolved in association with a shearing-type dentition in a roughly symmetrically-enameled crown, although its precise function still remains somewhat of a mystery.	[Chen, Jun; Jin, Liyong; Huang, Timothy; Reisz, Robert R.] Jilin Univ, Int Ctr Future Sci, Dinosaur Evolut Res Ctr, Changchun, Jilin, Peoples R China; [Chen, Jun] Minist Educ, Key Lab Evolut Past Life & Environm Northeast Asi, Changchun, Jilin, Peoples R China; [LeBlanc, Aaron R. H.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Reisz, Robert R.] Univ Toronto Mississauga, Dept Biol, Mississauga, ON, Canada	Jilin University; University of Alberta; University of Toronto; University Toronto Mississauga	Chen, J (corresponding author), Jilin Univ, Int Ctr Future Sci, Dinosaur Evolut Res Ctr, Changchun, Jilin, Peoples R China.; Chen, J (corresponding author), Minist Educ, Key Lab Evolut Past Life & Environm Northeast Asi, Changchun, Jilin, Peoples R China.; LeBlanc, ARH (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	cj@jlu.edu.cn; arl@ualberta.ca		Reisz, Robert/0000-0002-7454-1649; LeBlanc, Aaron/0000-0002-2497-1296	Izaak Walton Killam Postdoctoral Fellowship from the Killam Trustees	Izaak Walton Killam Postdoctoral Fellowship from the Killam Trustees	We thank the Chinese National Infrastructure of Mineral Rock and Fossil Specimen Resources (YK 201202-7) for support of specimen collection. A. R. H. LeBlanc is supported by an Izaak Walton Killam Postdoctoral Fellowship from the Killam Trustees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLER WL, 1992, PALEOBIOLOGY, V18, P161, DOI 10.1017/S0094837300013956; [Anonymous], 1840, ODONTOGRAPHY TREATIS; Baron MG, 2017, NATURE, V543, P501, DOI 10.1038/nature21700; Berkovitz B, 2017, TEETH NONMAMMALIAN V; Boyd C. A., 2015, PEERJ, V3, P1; Bramble K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16056-3; Brink KS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12338; BUFFETAUT E, 1986, NATURWISSENSCHAFTEN, V73, P326, DOI 10.1007/BF00451481; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031556; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Caldwell MW, 2007, ZOOL J LINN SOC-LOND, V149, P687, DOI 10.1111/j.1096-3642.2007.00280.x; D'Emic MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069235; Dumont M, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0753-6; Edmund A. G., 1957, Contributions of the Royal Ontario Museum of Zoology, VNo. 48, P1; Edmund A.G., 1960, CONTR LIFE SCI DIV R, V52, P1, DOI DOI 10.5962/BHL.TITLE.52196; Erickson GM, 1996, J MORPHOL, V228, P189, DOI 10.1002/(SICI)1097-4687(199605)228:2<189::AID-JMOR7>3.0.CO;2-0; Erickson GM, 1996, P NATL ACAD SCI USA, V93, P14623, DOI 10.1073/pnas.93.25.14623; Erickson GM, 2017, P NATL ACAD SCI USA, V114, P540, DOI 10.1073/pnas.1613716114; Erickson GM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500055; Erickson Gregory M., 2014, P422; Erickson GM, 2012, SCIENCE, V338, P98, DOI 10.1126/science.1224495; Fong RKM, 2016, J MORPHOL, V277, P916, DOI 10.1002/jmor.20545; Garcia RA, 2016, CRETACEOUS RES, V57, P248, DOI 10.1016/j.cretres.2015.09.006; Godefroit P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13160-2; He YM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24283-5; Horner JR, 2004, DINOSAURIA, P325; Hwang SH, 2005, J MORPHOL, V266, P208, DOI 10.1002/jmor.10372; Hwang SH, 2011, BIOL REV, V86, P183, DOI 10.1111/j.1469-185X.2010.00142.x; Hwang SH, 2010, LETHAIA, V43, P307, DOI 10.1111/j.1502-3931.2009.00194.x; Jin LY, 2010, J VERTEBR PALEONTOL, V30, P196, DOI 10.1080/02724630903412372; KVAM THORVALD, 1960, ACTA ODONTOL SCAND, V18, P67, DOI 10.3109/00016356009026092; LeBlanc ARH, 2017, J VERTEBR PALEONTOL, V37, DOI 10.1080/02724634.2017.1354006; LeBlanc ARH, 2017, J ANAT, V231, P869, DOI 10.1111/joa.12686; LeBlanc ARH, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0721-1; LeBlanc AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065351; McIntosh JE, 2002, MICROSC RES TECHNIQ, V59, P449, DOI 10.1002/jemt.10222; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P413; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; OSTROM JH, 1966, EVOLUTION, V20, P290, DOI 10.1111/j.1558-5646.1966.tb03367.x; Ostrom JH., 1961, B AM MUS NAT HIST, V122, P1; Reid REH., 1996, GEOLOGY STUDIES, V41, P25; Sander P. Martin, 1999, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V38, P1; Schwarz D, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2015.1008134; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sereno PC, 2012, ZOOKEYS, P1, DOI [10.3897/zookeys.226.2840, 10.3897/zookeys.223.2840]; Stokosa K, 2005, LIFE O PAST, P163; Strickson E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28904; Suarez CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15653-6; TENCATE AR, 1972, ANAT REC, V173, P69, DOI 10.1002/ar.1091730106; THULBORN RA, 1978, LETHAIA, V11, P185, DOI 10.1111/j.1502-3931.1978.tb01226.x; THULBORN RA, 1971, J ZOOL, V164, P165; Wang CC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15202; WEISHAMPEL D B, 1983, Acta Palaeontologica Polonica, V28, P271; Zan Shu-Qin, 2005, Vertebrata Palasiatica, V43, P182; Zanno LE, 2011, HIST BIOL, V23, P317, DOI 10.1080/08912963.2010.543952	57	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205206	10.1371/journal.pone.0205206	http://dx.doi.org/10.1371/journal.pone.0205206			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403689	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500013
J	Wu, PF; Dai, GJ; Chen, FX; Chen, L; Zhang, T; Xie, KZ; Wang, JY; Zhan, GX				Wu, Pengfei; Dai, Guojun; Chen, Fuxiang; Chen, Lan; Zhang, Tao; Xie, Kaizhou; Wang, Jinyu; Zhan, Genxi			Transcriptome profile analysis of leg muscle tissues between slow- and fast-growing chickens	PLOS ONE			English	Article							GENE-EXPRESSION; MEAT QUALITY; VESTIGIAL-LIKE; GROWTH TRAITS; INSULIN; ASSOCIATION; DIFFERENTIATION; PROLIFERATION; POLYMORPHISMS; DEPOSITION	Chicken is widely favored by consumers because of some unique features. The leg muscles occupy an important position in the market. However, the specific mechanism for regulating muscle growth speed is not clear. In this experiment, we used Jinghai yellow chickens with different body weights at 300 days as research subjects. The chickens were divided into fast- and slow-growing groups, and we collected leg muscles after slaughtering for use in RNA-seq. After comparing the two groups, 87 differentially expressed genes (DEGs) were identified (fold change >= 2 and FDR < 0.05). The fast-growing group had 42 up-regulated genes and 45 down-regulated genes among these DEGs compared to the slow-growing group. Six items were significantly enriched in the biological process: embryo development ending in birth or egg hatching, chordate embryonic development, embryonic skeletal system development, and embryo development as well as responses to ketones and the sulfur compound biosynthetic process. Two significantly enriched pathways were found in the KEGG pathway analysis (P-value < 0.05): the insulin signaling pathway and the adipocytokine signaling pathway. This study provides a theoretical basis for the molecular mechanism of chicken growth and for improving the production of Jinghai yellow chicken.	[Wu, Pengfei; Dai, Guojun; Chen, Fuxiang; Chen, Lan; Zhang, Tao; Xie, Kaizhou; Wang, Jinyu; Zhan, Genxi] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Wu, Pengfei; Dai, Guojun; Chen, Fuxiang; Chen, Lan; Zhang, Tao; Xie, Kaizhou; Wang, Jinyu; Zhan, Genxi] Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Zhan, GX (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.; Zhan, GX (corresponding author), Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou, Jiangsu, Peoples R China.	gxzhang@yzu.edu.cn		Wu, Pengfei/0000-0002-8660-3464	Natural Science Foundation in Jiangsu province [BK20181453]; Scientific and Technological Innovation Cultivated Foundation of Yangzhou University [2016CXJ069]; China Agriculture Research System [CARS-41]; Jiangsu Agriculture Research System [JATS[2018]303]; Priority Academic Program Development of Jiangsu Higher Education institutions	Natural Science Foundation in Jiangsu province(Natural Science Foundation of Jiangsu Province); Scientific and Technological Innovation Cultivated Foundation of Yangzhou University; China Agriculture Research System; Jiangsu Agriculture Research System; Priority Academic Program Development of Jiangsu Higher Education institutions	This study was financially supported by the Natural Science Foundation in Jiangsu province (BK20181453), the Scientific and Technological Innovation Cultivated Foundation of Yangzhou University (#2016CXJ069), China Agriculture Research System (CARS-41), Jiangsu Agriculture Research System (JATS[2018]303), and the Priority Academic Program Development of Jiangsu Higher Education institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla BA, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00262; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, POULTRY SCI, V93, P16, DOI [10.3382/ps.2013-03464, DOI 10.3382/PS.2013-03464]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai X, 2017, J HENAN AGR SCI; Blasco A, 2018, MEAT SCI, V145, P178, DOI 10.1016/j.meatsci.2018.06.030; Bonnet A, 2010, MECH DEVELOP, V127, P120, DOI 10.1016/j.mod.2009.10.001; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Cao JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02373-8; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; D'Andre HC, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-43; Dall'Olio S, 2018, MEAT SCI, V136, P44, DOI 10.1016/j.meatsci.2017.09.012; Davis RVN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122525; Demeure O, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-36; Dransfield E, 1999, POULTRY SCI, V78, P743, DOI 10.1093/ps/78.5.743; Dushyanth K, 2016, ANIM BIOTECHNOL, V27, P269, DOI 10.1080/10495398.2016.1182541; Gao X., 2017, ARCH TOXICOL, P1; Ghosh M, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0341-1; Henchion M, 2014, MEAT SCI, V98, P561, DOI 10.1016/j.meatsci.2014.06.007; Honda M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07149-0; Hu YN, 2018, ENVIRON POLLUT, V234, P667, DOI 10.1016/j.envpol.2017.12.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Islam F, 2017, J CELLULAR PHYSL, V233; Islam F, 2017, HUM GENET, V136, P321, DOI 10.1007/s00439-017-1760-4; Islam F, 2017, MOL CARCINOGEN, V56, P238, DOI 10.1002/mc.22488; Ismail I, 2017, KOREAN J FOOD SCI AN, V37, P873, DOI [10.5851/kosfa.2017.37.6.87, 10.5851/kosfa.2017.37.6.873]; Jin SH, 2016, POULTRY SCI, V95, P1492, DOI 10.3382/ps/pew081; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Khavandi M, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0818-1; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Li MZ, 2008, PROG NAT SCI-MATER, V18, P387, DOI 10.1016/j.pnsc.2007.10.011; Li YB, 2016, CHIN J NAT MEDICINES, V14, P813, DOI 10.1016/S1875-5364(16)30098-X; Lindberg J, 2010, GENOMICS, V95, P1, DOI 10.1016/j.ygeno.2009.08.010; Liu LX, 2016, GENETICS MOL RES, V15; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200; Mansur RB, 2016, J PSYCHIATR RES, V74, P63, DOI 10.1016/j.jpsychires.2015.12.003; Ouyang HJ, 2015, INT J MOL SCI, V16, P16242, DOI 10.3390/ijms160716242; Park W, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11379-7; Pathak SK, 2017, FUNCT INTEGR GENOMIC, V17, P607, DOI 10.1007/s10142-017-0558-8; Paumard-Rigal S, 1998, DEV GENES EVOL, V208, P440, DOI 10.1007/s004270050201; Peng J, 2017, J MOL ENDOCRINOL; Poirier S, 2014, J BIOL CHEM, V289, P18736, DOI 10.1074/jbc.M114.563650; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; Rao S, 2016, MOL REPROD DEV, V83, P61, DOI 10.1002/mrd.22591; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Schmidt CJ, 2009, POULTRY SCI, V88, P2610, DOI 10.3382/ps.2009-00055; Shu JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183118; Sibut V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-112; Simon E, 2016, DEV GENES EVOL, V226, P297, DOI 10.1007/s00427-016-0546-3; Slawinska A, 2013, J APPL GENET, V54, P489, DOI 10.1007/s13353-013-0161-1; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Teber ET, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S69; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tu Y, 2015, J POULTRY SCI; Vigneri R, 2016, J ENDOCRINOL INVEST, V39, P1365, DOI 10.1007/s40618-016-0508-7; Waern K, 2011, METHODS MOL BIOL, V759, P125, DOI 10.1007/978-1-61779-173-4_8; Wang AQ, 2015, INT J MOL SCI, V16, P22904, DOI 10.3390/ijms160922904; Wang GQ, 2017, POULTRY SCI, V96, P3687, DOI 10.3382/ps/pex184; Wang Guoqing, 2017, BMC Obes, V4, P14, DOI 10.1186/s40608-017-0150-8; Wang H, 2017, PHYSIOL BEHAV, P182; Wang LJ, 2013, MOL BIOL REP, V40, P417, DOI 10.1007/s11033-012-2076-z; Wu QM, 2016, ASIAN PAC J TROP MED, V9, P872, DOI 10.1016/j.apjtm.2016.07.014; Xiong H, 2018, J ETHNOPHARMACOL, V211, P366, DOI 10.1016/j.jep.2017.10.004; Xue Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173824; Yang J, 2017, CELL SIGNAL, V38, P192, DOI 10.1016/j.cellsig.2017.07.012; Yi B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162631; Yuan ZQ, 2014, BIOCHEM BIOPH RES CO, V454, P554, DOI 10.1016/j.bbrc.2014.10.117; Zhang GX, 2014, MOL BIOL REP, V41, P7331, DOI 10.1007/s11033-014-3619-2; Zhang R, 2018, BRIT POULTRY SCI, V59, P63, DOI 10.1080/00071668.2017.1390212; Zuo JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124873	74	13	13	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206131	10.1371/journal.pone.0206131	http://dx.doi.org/10.1371/journal.pone.0206131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403718	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500053
J	Esquirol, L; Peat, TS; Wilding, M; Hartley, CJ; Newman, J; Scott, C				Esquirol, Lygie; Peat, Thomas S.; Wilding, Matthew; Hartley, Carol J.; Newman, Janet; Scott, Colin			A novel decarboxylating amidohydrolase involved in avoiding metabolic dead ends during cyanuric acid catabolism in Pseudomonas sp strain ADP	PLOS ONE			English	Article							RAY-DIFFRACTION ANALYSIS; IV SECRETION SYSTEM; ALLOPHANATE HYDROLASE; AMIDASE DOMAIN; CRYSTALLIZATION; REVEALS; VIRB8; REFINEMENT; SEQUENCE; COMPLEX	Cyanuric acid is a common environmental contaminant and a metabolic intermediate in the catabolism of s-triazine compounds, including atrazine and other herbicides. Cyanuric acid is catabolized via a number of bacterial pathways, including one first identified in Pseudomonas sp. strain ADP, which is encoded by a single, five-gene operon (atzDGEHF) found on a self-transmissible plasmid. The discovery of two of the five genes (atzG and atzH) was reported in 2018 and although the function of atzG was determined, the role of atzH was unclear. Here, we present the first in vitro reconstruction of the complete, five-protein cyanuric acid catabolism pathway, which indicates that AtzH may be an amidase responsible for converting 1,3-dicarboxprea (the AtzE product) to allophanate (the AtzF substrate). We have solved the AtzH structure (a DUF3225 protein from the NTF2 superfamily) and used it to predict the substrate-binding pocket. Site-directed mutagenesis experiments suggest that two residues (Tyr22 and Arg46) are needed for catalysis. We also show that atzH homologs are commonly found in Proteobacteria associated with homologs of the atzG and atzE genes. The genetic context of these atzG-atzE-atzH clusters imply that they have a role in the catabolism of nitrogenous compounds. Moreover, their presence in many genomes in the absence of homologs of atzD and atzF suggests that the atzG-atzE-atzH cluster may pre-date the evolution of the cyanuric acid catabolism operon.	[Esquirol, Lygie; Hartley, Carol J.; Scott, Colin] CSIRO Land & Water, Biocatalysis & Synthet Biol Team, Canberra, ACT, Australia; [Esquirol, Lygie; Wilding, Matthew] Australian Natl Univ, Res Sch Chem, Canberra, ACT, Australia; [Peat, Thomas S.; Wilding, Matthew; Newman, Janet] CSIRO Biomed Mfg, Melbourne, Vic, Australia; [Scott, Colin] CSIRO Land & Water, Synthet Biol Future Sci Platform, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Scott, C (corresponding author), CSIRO Land & Water, Biocatalysis & Synthet Biol Team, Canberra, ACT, Australia.; Scott, C (corresponding author), CSIRO Land & Water, Synthet Biol Future Sci Platform, Canberra, ACT, Australia.	colin.scott@csiro.au	Wilding, Matthew A/D-4173-2012; Hartley, Carol J/C-2255-2008; Peat, Thomas S/F-9817-2010; Newman, Janet M/D-1857-2011; Scott, Colin/A-4682-2009	Wilding, Matthew A/0000-0002-3921-7771; Hartley, Carol J/0000-0002-1927-8040; Peat, Thomas S/0000-0002-6488-0831; Newman, Janet M/0000-0003-2666-3219; Scott, Colin/0000-0001-6110-6982; Esquirol, Lygie/0000-0002-4887-3260	CSIRO (Commonwealth Scientific and Industrial Reasearch Organisation)	CSIRO (Commonwealth Scientific and Industrial Reasearch Organisation)	CSIRO (Commonwealth Scientific and Industrial Reasearch Organisation) is the sole funder of the work (paying the salaries of the authors and operating for the project), and that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2007, J MOL BIOL, V368, P450, DOI 10.1016/j.jmb.2007.02.028; Arand M, 2003, EMBO J, V22, P2583, DOI 10.1093/emboj/cdg275; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balotra S, 2015, APPL ENVIRON MICROB, V81, P470, DOI 10.1128/AEM.02783-14; Balotra S, 2014, ACTA CRYSTALLOGR F, V70, P310, DOI 10.1107/S2053230X13034705; Cameron SM, 2011, ACS CATAL, V1, P1075, DOI 10.1021/cs200295n; Cheng G, 2005, APPL ENVIRON MICROB, V71, P4437, DOI 10.1128/AEM.71.8.4437-4445.2005; Eberhardt RY, 2013, BMC BIOINFORMATICS, V14; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Esquirol L, 2018, J BIOL CHEM; Esquirol L, 2018, J BIOL CHEM, V293, P7880, DOI 10.1074/jbc.RA118.001996; Esquirol L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192736; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Goessweiner-Mohr N, 2013, J BIOL CHEM, V288, P2018, DOI 10.1074/jbc.M112.428847; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Holliday GL, 2009, J MOL BIOL, V390, P560, DOI 10.1016/j.jmb.2009.05.015; (JCSG) JCfSG, 2007, CRYST STRUCT UNCH PR; Kim SW, 1997, BIOCHEMISTRY-US, V36, P14030, DOI 10.1021/bi971546+; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; MANDELBAUM RT, 1995, APPL ENVIRON MICROB, V61, P1451, DOI 10.1128/AEM.61.4.1451-1457.1995; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasako M, 1998, BIOCHEMISTRY-US, V37, P9931, DOI 10.1021/bi980321b; Newman J, 2010, CRYST GROWTH DES, V10, P2785, DOI 10.1021/cg1004209; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Parkhurst JM, 2016, J APPL CRYSTALLOGR, V49, P1912, DOI 10.1107/S1600576716013595; Peat TS, 2013, MOL MICROBIOL, V88, P1149, DOI 10.1111/mmi.12249; Porter CJ, 2012, MOL MICROBIOL, V83, P275, DOI 10.1111/j.1365-2958.2011.07930.x; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Robinson SL, 2018, ENV MICROBIOL; Rosa N, 2015, J BIOMOL SCREEN, V20, P898, DOI 10.1177/1087057115584059; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Sultana A, 2004, EMBO J, V23, P1911, DOI 10.1038/sj.emboj.7600201; Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102; Udikovic-Kolic N, 2012, APPL MICROBIOL BIOT, V96, P1175, DOI 10.1007/s00253-012-4495-0; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Watson AA, 2005, ACTA CRYSTALLOGR F, V61, P1094, DOI 10.1107/S1744309105037991; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5; Zhao J, 2018, BIOSCIENCE REPORTS, V38, P12	45	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206949	10.1371/journal.pone.0206949	http://dx.doi.org/10.1371/journal.pone.0206949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399173	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000034
J	Robinson, RJ; Eddingsaas, NC; DiFrancesco, AG; Jayasekera, S; Hensel, EC				Robinson, Risa J.; Eddingsaas, Nathan C.; DiFrancesco, A. Gary; Jayasekera, Shehan; Hensel, Edward C., Jr.			A framework to investigate the impact of topography and product characteristics on electronic cigarette emissions	PLOS ONE			English	Article							NICOTINE; AEROSOL; FORMALDEHYDE; LIQUID	Significance Protocols for testing and reporting emissions of Harmful and Potentially Harmful Constituents (HPHCs) from electronic cigarettes (e-cigs) are lacking. The premise of this study is that multi-path relationships may be developed to describe interactions between product characteristics, use behavior and emissions to develop appropriate protocols for tobacco product regulatory compliance testing. Methods This study proposes a framework consisting of three component terms: HPHC mass concentration, HPHC mass ratio and total particulate mass (TPM) concentration. The framework informs experiments to investigate dependence of aerosol emissions from five electronic cigarettes spanning several design generations and three e-liquids for six repeated trials at each of ten flow conditions. Results Results are reported for TPM concentration as a function of flow conditions spanning the range of natural environment topography observed in prior studies. An empirical correlation describing TPM concentration as a function of flow conditions and coil power setting (6, 7.5 and 10 watts) for the Innokin iTaste MVP 2.0 vaporizer with Innokin iClear 30 dual coil tank is presented. Additional results document the impact of flow conditions and wick and coil design on TPM concentration through comparison of the Innokin iClear 30 (upper coil, capillary action wick) and the Innokin iClear X.I (lower coil, gravity fed wick) operated at 7.5 watts. The impact of e-liquid on TPM concentration is illustrated by comparing emissions from an NJOY Vape Pen filled with AVAIL Arctic Blast, Tobacco Row, and Mardi Gras e-liquids. TPM concentration is shown to depend upon flow conditions across a range of e-cigarette product designs including cig-a-like, pen-style, box-mod and emergent disposable-cartridge style devices. Conclusions A framework provides a foundation for reporting emissions across a variety of e-cigs, e-liquids and research laboratories. The study demonstrates TPM concentration is a function of topography behavior (i.e. puff flow rate and puff duration) for varying device operating power and product characteristics.	[Robinson, Risa J.; DiFrancesco, A. Gary; Jayasekera, Shehan; Hensel, Edward C., Jr.] Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA; [Eddingsaas, Nathan C.] Rochester Inst Technol, Sch Chem & Mat Sci, Rochester, NY 14623 USA	Rochester Institute of Technology; Rochester Institute of Technology	Robinson, RJ (corresponding author), Rochester Inst Technol, Dept Mech Engn, Rochester, NY 14623 USA.	rjreme@rit.edu	Hensel, Edward/Q-6753-2019	Hensel, Edward/0000-0002-2682-0766; Robinson, Risa/0000-0001-8488-5448	Rochester Institute of Technology	Rochester Institute of Technology	This work was internally funded by Rochester Institute of Technology.	Baassiri M, 2017, AEROSOL SCI TECH, V51, P1231, DOI 10.1080/02786826.2017.1341040; El-Hellani A, 2016, NICOTINE CARBONYL EM; El-Hellani A, 2015, CHEM RES TOXICOL, V28, P1532, DOI 10.1021/acs.chemrestox.5b00107; Farsalinos KE, 2017, FOOD CHEM TOXICOL, V109, P90, DOI 10.1016/j.fct.2017.08.044; Farsalinos KE, 2015, INT J ENV RES PUB HE, V12, P9046, DOI 10.3390/ijerph120809046; Farsalinos KE, 2015, ADDICTION, V110, P1352, DOI 10.1111/add.12942; Goniewicz ML, 2014, ADDICTION, V109, P500, DOI 10.1111/add.12410; Goniewicz ML, 2013, NICOTINE TOB RES, V15, P158, DOI 10.1093/ntr/nts103; Goniewicz ML, 2014, TOB CONTROL, V23, P133, DOI 10.1136/tobaccocontrol-2012-050859; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kim KH, 2016, ANAL METHODS-UK, V8, P2305, DOI 10.1039/c5ay03385c; Korzun T, 2018, ACS OMEGA, V3, P30, DOI 10.1021/acsomega.7b01521; Kosmider L, 2014, CARBONYL COMPOUNDS E, DOI [10.1093/ntr/ntu078, DOI 10.1093/NTR/NTU078]; KoSmider L, 2017, COMPENSATORY PUFFING, DOI DOI 10.1093/NTENTX162; Kosmider L., 2016, INFLUENCE ELECT CIGA; Margham J, 2016, CHEM RES TOXICOL, V29, P1662, DOI 10.1021/acs.chemrestox.6b00188; Pagano DT, 2015, DETERMINATION NICOTI; Pankow JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173055; Robinson RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164038; Robinson R J, 2015, PLoS One, V10, pe0129296, DOI 10.1371/journal.pone.0129296; Sala C, 2017, EUR J MASS SPECTROM, V23, P64, DOI 10.1177/1469066717699078; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Talih S, 2017, CHEM RES TOXICOL, V30, P1791, DOI 10.1021/acs.chemrestox.7b00212; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Tayyarah R, 2014, REGUL TOXICOL PHARM, V70, P704, DOI 10.1016/j.yrtph.2014.10.010; Trehy ML, 2011, J LIQ CHROMATOGR R T, V34, P1442, DOI 10.1080/10826076.2011.572213	26	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206341	10.1371/journal.pone.0206341	http://dx.doi.org/10.1371/journal.pone.0206341			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395620	Green Submitted, gold, Green Published			2022-12-26	WOS:000449291400020
J	Bielinski, M; Lesiewska, N; Bielinska, J; Liebert, A; Mieczkowski, A; Soponska-Brzoszczyk, P; Brzoszczyk, B; Klopocka, M; Borkowska, A				Bielinski, Maciej; Lesiewska, Natalia; Bielinska, Joanna; Liebert, Ariel; Mieczkowski, Artur; Soponska-Brzoszczyk, Pauline; Brzoszczyk, Bartosz; Klopocka, Maria; Borkowska, Aline			Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation	PLOS ONE			English	Article							QUALITY-OF-LIFE; CROHNS-DISEASE; DEPRESSIVE SYMPTOMS; ULCERATIVE-COLITIS; BIPOLAR DISORDER; HOSPITAL ANXIETY; ACTIVITY INDEX; TERM OUTCOMES; RISK-FACTORS; TEMPS	Psychiatric disorders are significantly common complications among patients suffering from inflammatory bowel diseases (IBD). Affective temperament is a concept of core personality traits, which can decribe the vulnerability to mood disorders, therefore its evaluation might convey useful information about patients' mental status in autoimmune disorders. The aim of the study was to evaluate the affective temperament in patients with Crohn's disease (CD) and ulcerative colitis (UC) as characteristic features of these diseases, but also in the clinical course and the severity of anxiety and depression. Due to our knowledge this is the first study of this kind. The study enrolled 130 patients with IBD, including 68 with CD and 62 with UC. We used TEMPS-A to evaluate affective temperament and HADS scales to assess the intensity of depressive and anxiety symptoms. Harvey Bradshaw scale, Crohn's Disease Activity Index (CDAI) and Mayo Score were used to evaluate clinical severity of the diseases. We observed significantly higher prevalence of depressive, cyclothymic and anxiety temperaments in CD patients compared to the control group. Harvey Bradshaw scale, CDAI and Mayo Self Report showed statistically significant outcomes, including significant positive correlations with depressive, cyclothymic and anxiety subscales of TEMPS-A, and negative correlation with the hyperthymic temperament in CD subjects. Our findings indicate significant differences between CD and UC due to temperament traits, and suggest distinct pathogenesis of mood disorders in IBD.	[Bielinski, Maciej; Lesiewska, Natalia; Mieczkowski, Artur; Borkowska, Aline] Nicolaus Copernicus Univ, Chair & Dept Clin Neuropsychol, Torun, Poland; [Bielinski, Maciej; Lesiewska, Natalia; Bielinska, Joanna; Liebert, Ariel; Mieczkowski, Artur; Soponska-Brzoszczyk, Pauline; Klopocka, Maria; Borkowska, Aline] Coll Med, Bydgoszcz, Poland; [Bielinska, Joanna; Liebert, Ariel; Klopocka, Maria] Nicolaus Copernicus Univ, Inst Gastroenterol Nursing, Torun, Poland; [Soponska-Brzoszczyk, Pauline] Nicolaus Copernicus Univ, Dept Obstet & Gynecol, Torun, Poland; [Brzoszczyk, Bartosz] Dr Jan Biziel Univ Hosp 2, Dept Urol, Bydgoszcz, Poland	Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University; Nicolaus Copernicus University	Bielinski, M (corresponding author), Nicolaus Copernicus Univ, Chair & Dept Clin Neuropsychol, Torun, Poland.; Bielinski, M (corresponding author), Coll Med, Bydgoszcz, Poland.	bielinskim@gmail.com	Kłopocka, Maria/I-2199-2014	Kłopocka, Maria/0000-0003-2149-5826; Borkowska, Alina/0000-0001-7305-0242	Collegium Medicum's (NCU) scientific units	Collegium Medicum's (NCU) scientific units	The research was made from funds for the statutory activities of Collegium Medicum's (NCU) scientific units. This research was not supported by external financing.; The research was made from funds for the statutory activities of Collegium Medicum's (NCU) scientific units. All authors declare no conflict of interests connected with this manuscript.	Aguiar FA, 2013, J AFFECT DISORDERS, V148, P53; Akiskal H.S., 1992, AM PSYCHIATR PRESS R, V11, P43; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P3, DOI 10.1016/j.jad.2004.12.001; Akiskal HS, 2005, J AFFECT DISORDERS, V85, P1, DOI 10.1016/j.jad.2004.12.003; AKISKAL HS, 1995, ARCH GEN PSYCHIAT, V52, P114; Ananthakrishnan AN, 2013, AM J GASTROENTEROL, V108, P594, DOI 10.1038/ajg.2012.471; Asik M, 2015, J AFFECT DISORDERS, V185, P214, DOI 10.1016/j.jad.2015.06.043; Bernstein CN, 2016, DIGEST DIS, V34, P58, DOI 10.1159/000442929; BEST WR, 1979, GASTROENTEROLOGY, V77, P843; Best WR, 2006, INFLAMM BOWEL DIS, V12, P304, DOI 10.1097/01.MIB.0000215091.77492.2a; Bielinska J., 2017, MED RES J, V2, P6; Borkowska A, 2010, J AFFECT DISORDERS, V123, P36, DOI 10.1016/j.jad.2009.09.024; Mella LFB, 2010, REV BRAS PSIQUIATR, V32, P257, DOI 10.1590/S1516-44462010005000021; Caspi A, 2010, AM J PSYCHIAT, V167, P509, DOI 10.1176/appi.ajp.2010.09101452; Coates MD, 2017, ALIMENT PHARM THER, V46, P569, DOI 10.1111/apt.14226; Dembinska-Krajewski D, 2014, J PSYCHIAT POL, V48, P261; Eory A, 2014, EUR J GEN PRACT, V20, P247, DOI 10.3109/13814788.2013.868431; Evans L, 2005, J AFFECT DISORDERS, V85, P153, DOI 10.1016/j.jad.2003.10.015; Evertsz FB, 2017, J CONSULT CLIN PSYCH, V85, P918, DOI 10.1037/ccp0000227; Gois C, 2011, J AFFECT DISORDERS, V134, P52, DOI 10.1016/j.jad.2011.05.021; Gonda X, 2006, J AFFECT DISORDERS, V91, P125, DOI 10.1016/j.jad.2005.12.048; Goodwin FK, 2007, MANIC DEPRESSIVE ILL; Greenwood TA, 2012, BIOL PSYCHIAT, V72, P303, DOI 10.1016/j.biopsych.2012.01.018; Gulamhusein AF, 2016, AM J GASTROENTEROL, V111, P705, DOI 10.1038/ajg.2016.55; GUYATT HL, 1991, T ROY SOC TROP MED H, V85, P778, DOI 10.1016/0035-9203(91)90453-6; Hall PA, 2008, PSYCHOSOM MED, V70, P837, DOI 10.1097/PSY.0b013e31817bb8e5; HARVEY RF, 1980, LANCET, V1, P1134; Hong JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084564; Ishak WW, 2017, INFLAMM BOWEL DIS, V23, P798, DOI 10.1097/MIB.0000000000001060; Jaffe C. L., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P47; Janke KH, 2005, INFLAMM BOWEL DIS, V11, P272, DOI 10.1097/01.MIB.0000160809.38611.f7; Janowski K, 2008, BRIT J DERMATOL, V158, P633, DOI 10.1111/j.1365-2133.2007.08381.x; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Karam EG, 2010, WORLD PSYCHIATRY, V9, P103; Kesebir S, 2013, J AFFECT DISORDERS, V148, P352, DOI 10.1016/j.jad.2012.12.023; Kim MC, 2016, GUT LIVER, V10, P399, DOI 10.5009/gnl15188; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; Litaiem N, 2013, J AFFECT DISORDERS, V151, P321, DOI 10.1016/j.jad.2013.05.099; Lonnfors S, 2014, J CROHNS COLITIS, V8, P1281, DOI 10.1016/j.crohns.2014.03.005; Lucendo AJ, 2014, EUR J GASTROEN HEPAT, V26, P1399, DOI 10.1097/MEG.0000000000000226; Marrie RA, 2017, J PSYCHOSOM RES, V101, P17, DOI 10.1016/j.jpsychores.2017.07.015; Martin-Subero M, 2016, CNS SPECTRUMS, V21, P184, DOI 10.1017/S1092852915000449; Mendlowicz MV, 2005, J AFFECT DISORDERS, V85, P147, DOI 10.1016/j.jad.2004.01.012; Nasiri S, 2017, SEMIN PEDIATR SURG, V26, P398, DOI 10.1053/j.sempedsurg.2017.10.010; Panara AJ, 2014, ALIMENT PHARM THER, V39, P802, DOI 10.1111/apt.12669; Primas C, 2013, J CROHNS COLITIS, V7, P630, DOI DOI 10.1016/J.CR0HNS.2013.05.001; Ramsey M, 2017, CLIN TRANSL GASTROEN, V8, DOI 10.1038/ctg.2017.54; Rezvani A, 2014, INT J RHEUM DIS, V17, P34, DOI 10.1111/1756-185X.12033; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Serafini G, 2014, CNS NEUROL DISORD-DR, V13, P1708; Simoes CC, 2018, BMJ CASE REP; Stern AF, 2014, OCCUP MED-OXFORD, V64, P393, DOI 10.1093/occmed/kqu024; Vazquez GH, 2018, HARVARD REV PSYCHIAT, V26, P8, DOI 10.1097/HRP.0000000000000153; Verma S, 2001, DIGEST DIS SCI, V46, P865, DOI 10.1023/A:1010725106411; Vermeire S, 2010, CLIN GASTROENTEROL H, V8, P357, DOI 10.1016/j.cgh.2010.01.001; von Zerssen D, 1998, J AFFECT DISORDERS, V51, P1; Walker JR, 2008, AM J GASTROENTEROL, V103, P1989, DOI 10.1111/j.1572-0241.2008.01980.x; Wichowicz HM, 2011, PSYCHIATR POL, V45, P505; Yildirim Tulay, 2017, J Phys Ther Sci, V29, P394, DOI 10.1589/jpts.29.394	59	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205606	10.1371/journal.pone.0205606	http://dx.doi.org/10.1371/journal.pone.0205606			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383791	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600020
J	Frisch, K; Smage, SB; Johansen, R; Duesund, H; Brevik, OJ; Nylund, A				Frisch, Kathleen; Smage, Sverre Bang; Johansen, Renate; Duesund, Henrik; Brevik, Oyvind Jakobsen; Nylund, Are			Pathology of experimentally induced mouthrot caused by Tenacibaculum maritimum in Atlantic salmon smolts	PLOS ONE			English	Article							FLEXIBACTER-MARITIMUS; BRITISH-COLUMBIA; MARINE FISH; IDENTIFICATION; STOMATITIS; BACTERIA; FEATURES; CANADA; SALAR	Mouthrot, caused by Tenacibaculum maritimum is a significant disease of farmed Atlantic salmon, Salmo salar on the West Coast of North America. Smolts recently transferred into saltwater are the most susceptible and affected fish die with little internal or external clinical signs other than the characteristic small (usually <5 mm) yellow plaques that are present inside the mouth. The mechanism by which these smolts die is unknown. This study investigated the microscopic pathology (histology and scanning electron microscopy) of bath infected smolts with Western Canadian T. maritimum isolates TmarCan15-1, TmarCan16-1 and TmarCan16-5 and compared the findings to what is seen in a natural outbreak of mouthrot. A real-time RT-PCR assay based on the outer membrane protein A specific for T. maritimum was designed and used to investigate the tissue tropism of the bacteria. The results from this showed that T. maritimum is detectable internally by real-time RT-PCR. This combined with the fact that the bacteria can be isolated from the kidney suggests that T. maritimum becomes systemic. The pathology in the infected smolts is primarily mouth lesions, including damaged tissues surrounding the teeth; the disease is similar to periodontal disease in mammals. The pathological changes are focal, severe, and occur very rapidly with little associated inflammation. Skin lesions are more common in experimentally infected smolts than in natural outbreaks, but this could be an artefact of the challenge dose, handling and tank used during the experiments.	[Frisch, Kathleen; Smage, Sverre Bang; Duesund, Henrik; Brevik, Oyvind Jakobsen] Cermaq Grp As, Oslo, Norway; [Frisch, Kathleen; Smage, Sverre Bang; Nylund, Are] Univ Bergen, Dept Biol, Fish Dis Res Grp, Bergen, Norway; [Johansen, Renate] PHARMAQ Analyt AS, Oslo, Norway	University of Bergen	Frisch, K (corresponding author), Cermaq Grp As, Oslo, Norway.; Frisch, K (corresponding author), Univ Bergen, Dept Biol, Fish Dis Res Grp, Bergen, Norway.	kathleen.frisch@cermaq.com			Research Council of Norway (Norges Forskningsrad) [251805]; Cermaq Group AS	Research Council of Norway (Norges Forskningsrad)(Research Council of Norway); Cermaq Group AS	The study was partially funded by the Research Council of Norway (Norges Forskningsrad) (Project number 251805, https://www.forskningsradet.no/prosjektbanken/#/project/NFR/251805/Sprak= en). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Cermaq Group AS received this funding. Cermaq Group AS provided support in the form of salaries for authors [KF, SS, OB, HD], and also played a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. One of the authors [AN] is employed by the University of Bergen (UiB) and another author [RJ] is employed by Pharmaq Analytiq AS; however neither UiB nor Pharmaq Analytiq AS had a role in study design, data collection or decision to publish. The specific roles of these authors are articulated in the "author contributions" section.	Andersen L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-198; Apablaza P, 2017, J AQUAT ANIM HEALTH, V29, P143, DOI 10.1080/08997659.2017.1339643; Avendano-Herrera R, 2016, TRANSBOUND EMERG DIS, V63, P121, DOI 10.1111/tbed.12464; Avendano-Herrera R, 2006, DIS AQUAT ORGAN, V71, P255, DOI 10.3354/dao071255; Baxa D. V., 1988, REP USA MAR BIOL I K, V10, P1; BURCHARD RP, 1990, APPL ENVIRON MICROB, V56, P2529, DOI 10.1128/AEM.56.8.2529-2534.1990; Chen M. F., 1995, Journal of Aquatic Animal Health, V7, P318, DOI 10.1577/1548-8667(1995)007&lt;0318:IACOMF&gt;2.3.CO;2; Dalsgaard I., 1993, Annual Review of Fish Diseases, V3, P127, DOI 10.1016/0959-8030(93)90032-7; FRELIER PF, 1994, DIS AQUAT ORGAN, V18, P227, DOI 10.3354/dao018227; Fringuelli E, 2012, J FISH DIS, V35, P579, DOI 10.1111/j.1365-2761.2012.01377.x; Frisch K, 2018, J FISH DIS, V41, P1247, DOI 10.1111/jfd.12818; Frisch K, 2018, J FISH DIS, V41, P131, DOI 10.1111/jfd.12687; Handlinger J, 1997, J FISH DIS, V20, P159, DOI 10.1046/j.1365-2761.1997.00288.x; Hicks BD, 1989, BRIT COLUMBIA SALMON, P1; HIKIDA M, 1979, B JPN SOC SCI FISH, V45, P421; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Kent Michael L., 2002, P61, DOI 10.1079/9780851994437.0061; Kent ML, 1992, CAN SPEC PUBL FISH A, V116, P1; Koziel J, 2013, CELL TISSUE RES, V351, P325, DOI 10.1007/s00441-012-1355-2; MAGARINOS B, 1995, DIS AQUAT ORGAN, V21, P103, DOI 10.3354/dao021103; Marty GD, 2007, BIOTECHNIQUES, V42, P716, DOI 10.2144/000112488; Morrison DB, 2013, CAN VET J, V54, P1160; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Ostland VE, 1999, J AQUAT ANIM HEALTH, V11, P35, DOI 10.1577/1548-8667(1999)011&lt;0035:FMAWAB&gt;2.0.CO;2; Perez-Pascual D, 2017, FRONTIERS MICROBIOLO, V8, P1166, DOI [10.3389/fmicb.2017.01166, DOI 10.3389/FMICB.2017.01166]; Rahman T, 2014, FISH PATHOL, V49, P121, DOI 10.3147/jsfp.49.121; Smage SB, 2018, AQUACULTURE, V495, P858, DOI 10.1016/j.aquaculture.2018.06.063; Smage SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187476; Smage SB, 2016, AQUACULTURE, V464, P178, DOI 10.1016/j.aquaculture.2016.06.030; Smage SB, 2016, ANTON LEEUW INT J G, V109, P273, DOI 10.1007/s10482-015-0630-0; Soltani M, 1996, AQUACULTURE, V140, P259, DOI 10.1016/0044-8486(95)01157-9; Suzuki M, 2001, INT J SYST EVOL MICR, V51, P1639, DOI 10.1099/00207713-51-5-1639; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Tunsjo HS, 2009, MICROB PATHOGENESIS, V47, P134, DOI 10.1016/j.micpath.2009.06.005; van Gelderen R, 2009, J FISH DIS, V32, P727, DOI 10.1111/j.1365-2761.2009.01032.x; van Gelderen R, 2011, DIS AQUAT ORGAN, V95, P125, DOI 10.3354/dao02329; van Gelderen R, 2010, DIS AQUAT ORGAN, V91, P121, DOI 10.3354/dao02219; Vilar P, 2012, J FISH DIS, V35, P437, DOI 10.1111/j.1365-2761.2012.01360.x	38	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206951	10.1371/journal.pone.0206951	http://dx.doi.org/10.1371/journal.pone.0206951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383870	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600105
J	Gould, NJ; Lorencatto, F; During, C; Rowley, M; Glidewell, L; Walwyn, R; Michie, S; Foy, R; Stanworth, SJ; Grimshaw, JM; Francis, JJ				Gould, Natalie J.; Lorencatto, Fabiana; During, Camilla; Rowley, Megan; Glidewell, Liz; Walwyn, Rebecca; Michie, Susan; Foy, Robbie; Stanworth, Simon J.; Grimshaw, Jeremy M.; Francis, Jill J.			How do hospitals respond to feedback about blood transfusion practice? A multiple case study investigation	PLOS ONE			English	Article							IMPLEMENTATION	National clinical audits play key roles in improving care and driving system-wide change. However, effects of audit and feedback depend upon both reach (e.g. relevant staff receiving the feedback) and response (e.g. staff regulating their behaviour accordingly). This study aimed to investigate which hospital staff initially receive feedback and formulate a response, how feedback is disseminated within hospitals, and how responses are enacted (including barriers and enablers to enactment). Using a multiple case study approach, we purposively sampled four UK hospitals for variation in infrastructure and resources. We conducted semi-structured interviews with staff from transfusion-related roles and observed Hospital Transfusion Committee meetings. Interviews and analysis were based on the Theoretical Domains Framework of behaviour change. We coded interview transcripts into theoretical domains, then inductively identified themes within each domain to identify barriers and enablers. We also analysed data to identify which staff currently receive feedback and how dissemination is managed within the hospital. Members of the hospital's transfusion team initially received feedback in all cases, and were primarily responsible for disseminating and responding, facilitated through the Hospital Transfusion Committee. At each hospital, key individuals involved in prescribing transfusions reported never having received feedback from a national audit. Whether audits were discussed and actions explicitly agreed in Committee meetings varied between hospitals. Key enablers of action across all cases included clear lines of responsibility and strategies to remind staff about recommendations. Barriers included difficulties disseminating to relevant staff and needing to amend feedback to make it appropriate for local use. Appropriate responses by hospital staff to feedback about blood transfusion practice depend upon supportive infrastructures and role clarity. Hospitals could benefit from support to disseminate feedback systematically, particularly to frontline staff involved in the behaviours being audited, and practical tools to support strategic decision-making (e.g. action-planning around local response to feedback).	[Gould, Natalie J.; Lorencatto, Fabiana; During, Camilla; Francis, Jill J.] City Univ London, Sch Hlth Sci, London, England; [Lorencatto, Fabiana; Michie, Susan] UCL, Ctr Behav Change, London, England; [Rowley, Megan] Royal Infirm Edinburgh NHS Trust, Scottish Natl Blood Transfus Serv, Edinburgh, Midlothian, Scotland; [Glidewell, Liz; Foy, Robbie] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Glidewell, Liz] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Walwyn, Rebecca] Univ Leeds, Clin Trials Res Unit, Leeds, W Yorkshire, England; [Stanworth, Simon J.] NHS Blood & Transplant, Transfus Med, Oxford, England; [Stanworth, Simon J.] Oxford Univ Hosp NHS Fdn Trust, Dept Haematol, Oxford, England; [Stanworth, Simon J.] Univ Oxford, Radcliffe Dept Med, Oxford, England; [Grimshaw, Jeremy M.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON, Canada	City University London; University of London; University College London; Royal Infirmary of Edinburgh; University of Edinburgh; University of Leeds; University of York - UK; University of Leeds; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Francis, JJ (corresponding author), City Univ London, Sch Hlth Sci, London, England.	jill.francis.1@city.ac.uk	Francis, Jill/AHE-6998-2022; Glidewell, Liz/G-7338-2011	Glidewell, Liz/0000-0003-2519-2654; Foy, Robbie/0000-0003-0605-7713; Francis, Jill/0000-0001-5784-8895	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-1210-12010]	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR))	This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (Grant Reference Number RP-PG-1210-12010) led by Dr Simon J Stanworth. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	[Anonymous], 1998, SELF REGULATION BEHA, DOI DOI 10.1017/CBO9781139174794; Baxter P, 2008, QUAL REP, V13, P544; Brehaut JC, 2016, ANN INTERN MED, V164, P435, DOI 10.7326/M15-2248; Christina V, 2016, J NURS MANAGE, V24, P1080, DOI 10.1111/jonm.12409; D'Lima DM, 2015, J HEALTH SERV RES PO, V20, P26, DOI 10.1177/1355819614557299; Dyson J., 2011, Journal of Infection Prevention, V12, P17, DOI 10.1177/1757177410384300; Francis JJ, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18250; Francis JJ, 2014, BRIT J HEALTH PSYCH, V19, P274, DOI 10.1111/bjhp.12066; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Francis JJ, 2009, BRIT J HEALTH PSYCH, V14, P625, DOI 10.1348/135910708X397025; Glidewell L, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-118; Gould NJ, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0092-1; Graham-Rowe E, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0309-2; Grol R, 2004, MED J AUSTRALIA, V180, pS57, DOI 10.5694/j.1326-5377.2004.tb05948.x; Hartley S, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0614-8; Ivers N, 2012, COCHRANE LIB, V7; Ivers NM, 2016, LANCET, V388, P547, DOI 10.1016/S0140-6736(16)31256-9; Ivers NM, 2014, IMPLEMENT SCI, V9, DOI [10.1186/1748-5908-9-14, 10.1186/1748-5908-9-51]; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Patey A, 2012, IMPLEMENT SCI, V7, P1; Sinuff T, 2015, BMJ QUAL SAF; Tuti T, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0590-z; Vahidi RG, 2013, J PAKISTAN MED STUDE, V3	23	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206676	10.1371/journal.pone.0206676	http://dx.doi.org/10.1371/journal.pone.0206676			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383792	Green Published, Green Accepted, gold			2022-12-26	WOS:000449027600083
J	Handgraaf, HJM; Mulder, BGS; Feshtali, SS; Boogerd, LSF; van der Valk, MJM; Sarasqueta, AF; Swijnenburg, RJ; Bonsing, BA; Vahrmeijer, AL; Mieog, JSD				Handgraaf, H. J. M.; Mulder, B. G. Sibinga; Feshtali, S. Shahbazi; Boogerd, L. S. F.; van der Valk, M. J. M.; Sarasqueta, A. Farina; Swijnenburg, R. J.; Bonsing, B. A.; Vahrmeijer, A. L.; Mieog, J. S. D.			Staging laparoscopy with ultrasound and near-infrared fluorescence imaging to detect occult metastases of pancreatic and periampullary cancer	PLOS ONE			English	Article							TUMOR-SIZE; HEAD; ADENOCARCINOMA; MALIGNANCIES; DIAGNOSIS; CA-19-9; YIELD	Introduction Up to 38% of pancreatic and periampullary cancer patients undergoing curative intended surgery turn out to have incurable disease. Therefore, staging laparoscopy (SL) prior to laparotomy is advised to spare patients the morbidity, inconvenience and expense of futile major surgery. The aim of this study was to assess the added value of SL with laparoscopic ultrasonography (LUS) and laparoscopic near-infrared fluorescence imaging (LFI). Methods All patients undergoing curative intended surgery of pancreatic or periampullary cancer were included prospectively in this single arm study. Patients received an intravenous infusion of 10 mg indocyanine green (ICG) one or two days prior to surgery to allow LFI. Suspect lesions were analyzed via biopsy or resection. Follow-up visits after surgery occurred every three months. Results A total of 25 patients were included. Suspect lesions were identified in 7 patients: liver metastases (n = 2; identified by inspection, LUS, and LFI), peritoneal metastases (n = 1; identified by inspection only), and benign lesions (n = 4; identified by inspection or LUS). Quality of LFI was good in 67% (10/15) of patients dosed one day and 89% (8/9) dosed two days prior to surgery. A futile laparotomy was averted in 3 patients (12%). Following SL the primary tumor was resected in 20 patients. Two patients (10%) developed metastases within 3 months after resection. Conclusions Despite current preoperative imaging modalities metastases are still identified during surgery. This study shows limited added value of LUS during SL in patients with pancreatic or periampullary cancer. LFI was of added value due to its high negative predictive value in case of suspect hepatic lesions identified by inspection.	[Handgraaf, H. J. M.; Mulder, B. G. Sibinga; Boogerd, L. S. F.; van der Valk, M. J. M.; Swijnenburg, R. J.; Bonsing, B. A.; Vahrmeijer, A. L.; Mieog, J. S. D.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands; [Feshtali, S. Shahbazi] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Sarasqueta, A. Farina] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mieog, JSD (corresponding author), Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands.	j.s.d.mieog@lumc.nl	Vahrmeijer, Alexander/AFK-4657-2022; Vahrmeijer, Alexander/AAG-3329-2022; Handgraaf, Henricus/P-3059-2014	Vahrmeijer, Alexander/0000-0001-9370-0011; Vahrmeijer, Alexander/0000-0001-9370-0011; Handgraaf, Henricus/0000-0002-5114-3584; Farina Sarasqueta, Arantza/0000-0002-4307-1568; Farina Sarasqueta, Aranzazu/0000-0002-6173-592X; Swijnenburg, Rutger-Jan/0000-0002-3980-4634	Dutch Cancer Society [UL2015-7665]	Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the Bas Mulder Award (grant UL2015-7665) from the Dutch Cancer Society (https://www.kwf.nl/english/Pages/The-organisation.aspx).	A'Hern RP, 2001, STAT MED, V20, P859, DOI 10.1002/sim.721; Alexakis N, 2015, EJSO-EUR J SURG ONC, V41, P265, DOI 10.1016/j.ejso.2014.09.006; Allen VB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009323.pub3; Boogerd LSF, 2017, SURG ENDOSC, V31, P952, DOI 10.1007/s00464-016-5007-6; De Rosa A, 2016, HPB, V18, P13, DOI 10.1016/j.hpb.2015.10.004; de Werra C, 2015, INT J SURG, V21, pS55, DOI 10.1016/j.ijsu.2015.04.091; Fujioka S, 2008, INT SURG, V93, P324; Garcea G, 2012, PANCREAS, V41, P233, DOI 10.1097/MPA.0b013e31822432ee; Gaujoux S, 2010, WORLD J GASTRO SURG, V2, P283, DOI 10.4240/wjgs.v2.i9.283; Grossjohann HS, 2010, SCAND J GASTROENTERO, V45, P917, DOI 10.3109/00365521003702718; Handgraaf HJM, 2017, EJSO-EUR J SURG ONC, V43, P1463, DOI 10.1016/j.ejso.2017.04.016; Handgraaf HJM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/890230; Holzapfel K, 2011, ABDOM IMAGING, V36, P179, DOI 10.1007/s00261-010-9633-5; Hori Y, 2008, SURG ENDOSC, V22, P1353, DOI [10.1007/s00464-008-9759-5, 10.1007/s00464-008-9757-7]; Hsu CP, 2018, ASIAN J SURG, V41, P115, DOI 10.1016/j.asjsur.2016.11.009; Kim HW, 2017, SURGERY, V161, P1579, DOI 10.1016/j.surg.2016.12.038; Levy Jordan, 2016, HPB Surg, V2016, P8092109, DOI 10.1155/2016/8092109; Lin LZ, 2016, MED ULTRASON, V18, P163, DOI 10.11152/mu.2013.2066.182.ceu; Maithel SK, 2008, ANN SURG ONCOL, V15, P3512, DOI 10.1245/s10434-008-0134-5; Stefanidis D, 2006, ANN ONCOL, V17, P189, DOI 10.1093/annonc/mdj013; van der Vorst JR, 2013, CANCER-AM CANCER SOC, V119, P3411, DOI 10.1002/cncr.28203; Velanovich V, 2000, J GASTROINTEST SURG, V4, P542, DOI 10.1016/S1091-255X(00)80099-2; Yokoyama N, 2012, CANCER-AM CANCER SOC, V118, P2813, DOI 10.1002/cncr.26594	23	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205960	10.1371/journal.pone.0205960	http://dx.doi.org/10.1371/journal.pone.0205960			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383818	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600022
J	Tian, YY; Zhao, JZ; Ren, PF; Wang, B; Zhao, CZ; Shi, C; Wei, B; Ma, J; Guo, YJ				Tian, Yingying; Zhao, Jiuzhou; Ren, Pengfei; Wang, Bo; Zhao, Chengzhi; Shi, Chao; Wei, Bing; Ma, Jie; Guo, Yongjun			Different subtypes of EGFR exon19 mutation can affect prognosis of patients with non-small cell lung adenocarcinoma	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; GROWTH-FACTOR RECEPTOR; 1ST-LINE GEFITINIB THERAPY; PHASE-II TRIAL; CANCER PATIENTS; NSCLC PATIENTS; EFFICACY; TKI; CHEMOTHERAPY; METAANALYSIS	Aims In this study, we determined whether different subtypes of epidermal growth factor receptor (EGFR) exon19 mutation are associated with the therapeutic effect of EGFR-tyrosine kinase inhibitors (TKIs) on advanced non-small cell lung adenocarcinoma. Methods A total of 122 patients with stage III or IV non-small cell lung adenocarcinoma were retrospectively reviewed. Clinical characteristics of these patients, including progression-free survival (PFS) outcome for EGFR-TKI treatment, were analyzed. Results According to the mutation pattern, we classified the in-frame deletions detected on EGFR Exon19 into three different types: codon deletion (CD), with a deletion of one or more original codons; codon substitution and skipping (CSS), with a deletion of one or two nucleotides but the residues could be translated into a new amino acid without changing following amino acid sequence; CD or CSS plus single nucleotide variant (SNV) (CD/CSS+SNV), exclude CD or CSS, there's another SNV nearby the deletion region. The clinical characteristics of three groups were analyzed and as a result, no significant difference was found. By comparing the average number of missing bases and amino acids of the three mutation subtypes, it could be discovered that the number of missing bases and amino acids of the three mutation subtypes is diverse, and group CSS> group CD> group CD/CSS+SNV. Finally, survival analysis was performed between three groups of patients. The median PFS of group CD, group CSS and group CD/CSS+SNV was 11 months, 9 months and 14 months respectively. There was a distinct difference in the PFS between group CSS and group CD/CSS+SNV (P = 0.035<0.05), and the PFS of group CD/CSS+SNV was longer. Conclusions Different mutation subtypes of EGFR exon19 can predict the therapeutic effect of EGFR-TKIs on advanced non-small cell lung adenocarcinoma.	[Tian, Yingying; Zhao, Jiuzhou; Ren, Pengfei; Wang, Bo; Zhao, Chengzhi; Shi, Chao; Wei, Bing; Ma, Jie; Guo, Yongjun] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Mol Pathol, Zhengzhou, Henan, Peoples R China; [Tian, Yingying] Zhengzhou Univ, Sch Pharmaceut Sci, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Guo, YJ (corresponding author), Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Mol Pathol, Zhengzhou, Henan, Peoples R China.	yongjunguo@hotmail.com		Guo, Yongjun/0000-0003-1641-2969; Tian, Yingying/0000-0001-9445-414X				[Anonymous], 1986, NOBEL LECT, P1981; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Choi YW, 2018, AM J CLIN ONCOL-CANC, V41, P385, DOI 10.1097/COC.0000000000000282; Haspinger ER, 2015, CRIT REV ONCOL HEMAT, V94, P213, DOI 10.1016/j.critrevonc.2014.11.005; He YY, 2014, CLIN LUNG CANCER, V15, P441, DOI 10.1016/j.cllc.2014.06.006; Helland A, 2011, J THORAC ONCOL, V6, P947, DOI 10.1097/JTO.0b013e31820db209; Kuiper JL, 2015, CLIN LUNG CANCER, V16, P60, DOI 10.1016/j.cllc.2014.07.008; Lee JK, 2014, JAMA-J AM MED ASSOC, V311, P1430, DOI 10.1001/jama.2014.3314; Liu J J, 2016, Zhonghua Zhong Liu Za Zhi, V38, P211, DOI 10.3760/cma.j.issn.0253-3766.2016.03.010; Prudkin Ludmila, 2006, Ann Diagn Pathol, V10, P306, DOI 10.1016/j.anndiagpath.2006.06.011; Su J, 2017, ONCOTARGET, V8, P111246, DOI 10.18632/oncotarget.22768; Sun W, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0193-6; Sunaga N, 2007, LUNG CANCER, V56, P383, DOI 10.1016/j.lungcan.2007.01.025; Sutani A, 2006, BRIT J CANCER, V95, P1483, DOI 10.1038/sj.bjc.6603466; Sutiman N, 2017, J THORAC ONCOL, V12, P529, DOI 10.1016/j.jtho.2016.11.2225; Tamura K, 2008, BRIT J CANCER, V98, P907, DOI 10.1038/sj.bjc.6604249; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsim S, 2010, RESP MED, V104, P1767, DOI 10.1016/j.rmed.2010.08.005; Wang H, 2014, J CANCER RES CLIN, V140, P1901, DOI 10.1007/s00432-014-1709-0; Wang HJ, 2018, CANCER BIOL THER, V19, P687, DOI 10.1080/15384047.2018.1450115; Wei B, 2017, PATHOL RES PRACT, V213, P749, DOI 10.1016/j.prp.2017.04.007; Wei WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168795; Zhang CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173524; Zhang Xiaozhu, 2008, Int J Med Sci, V5, P209; Zhang YC, 2014, IEEE INT CONF ELECTR, P9; Zhou J, 2018, THORAC CANCER, V9, P228, DOI 10.1111/1759-7714.12568; Zhou Juan, 2016, Asian Pac J Cancer Prev, V17, P965	28	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0201682	10.1371/journal.pone.0201682	http://dx.doi.org/10.1371/journal.pone.0201682			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383772	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600002
J	Pena-Cardena, A; Grande, R; Sanchez, J; Tabashnik, BE; Bravo, A; Soberon, M; Gomez, I				Pena-Cardena, Arlen; Grande, Ricardo; Sanchez, Jorge; Tabashnik, Bruce E.; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel			The C-terminal protoxin region of Bacillus thuringiensis Cry1Ab toxin has a functional role in binding to GPI-anchored receptors in the insect midgut	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; bacterial toxin; glycosylphosphatidylinositol (GPI anchor); aminopeptidase; cadherin; alkaline phosphatase; aminopeptidase; Bacillus thuringiensis; C-terminal region; Cry toxin	EUROPEAN CORN-BORER; MANDUCA-SEXTA; DOMAIN-II; DELTA-ENDOTOXIN; BT COTTON; ALKALINE-PHOSPHATASE; IRREVERSIBLE BINDING; LOOP 2; RESISTANCE; CADHERIN	Bacillus thuringiensis Cry toxins are used worldwide for controlling insects. Cry1Ab is produced as a 130-kDa protoxin that is activated by proteolytic removal of an inert 500 amino-acid-long C-terminal region, enabling the activated toxin to bind to insect midgut receptor proteins, leading to its membrane insertion and pore formation. It has been proposed that the C-terminal region is only involved in toxin crystallization, but its role in receptor binding is undefined. Here we show that the C-terminal region of Cry1Ab protoxin provides additional binding sites for alkaline phosphatase (ALP) and aminopeptidase N (APN) insect receptors. ELISA, ligand blot, surface plasmon resonance, and pulldown assays revealed that the Cry1Ab C-terminal region binds to both ALP and APN but not to cadherin. Thus, the C-terminal region provided a higher binding affinity of the protoxin to the gut membrane that correlated with higher toxicity of protoxin than activated toxin. Moreover, Cry1Ab domain II loop 2 or 3 mutations reduced binding of the protoxin to cadherin but not to ALP or APN, supporting the idea that protoxins have additional binding sites. These results imply that two different regions mediate the binding of Cry1Ab protoxin to membrane receptors, one located in domain II-III of the toxin and another in its C-terminal region, suggesting an active role of the C-terminal protoxin fragment in the mode of action of Cry toxins. These results suggest that future manipulations of the C-terminal protoxin region could alter the specificity and increase the toxicity of B. thuringiensis proteins.	[Pena-Cardena, Arlen; Sanchez, Jorge; Bravo, Alejandra; Soberon, Mario; Gomez, Isabel] Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico; [Grande, Ricardo] Univ Nacl Autonoma Mexico, Unidad Secuenciac Mas & Bioinformat, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University of Arizona	Gomez, I (corresponding author), Univ Nacl Autonoma Mexico, Dept Microbiol Mol, Inst Biotecnol, Ave Univ 2001, Cuernavaca 62210, Morelos, Mexico.	isabelg@ibt.unam.mx	de la Parra, Maria Alejandra Bravo/R-6740-2017		Consejo Nacional de Ciencia y Tecnologia [Fronteras 008]; PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica-Universidad Nacional Autonoma de Mexico) [IN202718, IN213514]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica-Universidad Nacional Autonoma de Mexico)	This work was supported in part by Consejo Nacional de Ciencia y Tecnologia Fronteras 008 and PAPIIT-UNAM (Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica-Universidad Nacional Autonoma de Mexico) IN202718 and IN213514.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Adegawa S, 2017, BBA-PROTEINS PROTEOM, V1865, P220, DOI 10.1016/j.bbapap.2016.11.011; Anilkumar KJ, 2008, APPL ENVIRON MICROB, V74, P462, DOI 10.1128/AEM.01612-07; Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266; Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938; Bravo A, 2013, MICROB BIOTECHNOL, V6, P17, DOI 10.1111/j.1751-7915.2012.00342.x; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; CHOMA CT, 1990, EUR J BIOCHEM, V189, P523, DOI 10.1111/j.1432-1033.1990.tb15518.x; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042; deMaagd RA, 1996, APPL ENVIRON MICROB, V62, P1537, DOI 10.1128/AEM.62.5.1537-1543.1996; Dively GP, 2018, P NATL ACAD SCI USA, V115, P3320, DOI 10.1073/pnas.1720692115; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Evdokimov AG, 2014, PROTEIN SCI, V23, P1491, DOI 10.1002/pro.2536; Fabrick JA, 2007, INSECT BIOCHEM MOLEC, V37, P97, DOI 10.1016/j.ibmb.2006.10.010; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p; Gomez I, 2014, BIOCHEM J, V459, P383, DOI 10.1042/BJ20131408; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135; Jenkins J L, 2000, Genet Eng (N Y), V22, P33; Jimenez-Juarez N, 2007, J BIOL CHEM, V282, P21222, DOI 10.1074/jbc.M701314200; Lee MK, 2000, MOL MICROBIOL, V38, P289, DOI 10.1046/j.1365-2958.2000.02109.x; LERECLUS D, 1995, BIO-TECHNOL, V13, P67, DOI 10.1038/nbt0195-67; Li XM, 2018, CELL CHEM BIOL, V25, P1, DOI 10.1016/j.chembiol.2018.01.003; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Meza R, 1996, FEMS MICROBIOL LETT, V145, P333, DOI 10.1111/j.1574-6968.1996.tb08597.x; Nicolia A, 2014, CRIT REV BIOTECHNOL, V34, P77, DOI 10.3109/07388551.2013.823595; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Rajamohan F, 1996, J BIOL CHEM, V271, P2390, DOI 10.1074/jbc.271.5.2390; RAJAMOHAN F, 1995, J BACTERIOL, V177, P2276, DOI 10.1128/jb.177.9.2276-2282.1995; Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Sellman BR, 1997, MOL MICROBIOL, V25, P429, DOI 10.1046/j.1365-2958.1997.4541820.x; Siqueira HAA, 2004, PEST MANAG SCI, V60, P1189, DOI 10.1002/ps.935; Smedley DP, 1996, MICROBIOL-SGM, V142, P1617, DOI 10.1099/13500872-142-7-1617; Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974; Tabashnik BE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005646; Tabashnik BE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15107; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; THOMAS WE, 1983, J CELL SCI, V60, P181; Torres-Quintero MC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22740-9; Wan P, 2008, ENVIRON ENTOMOL, V37, P1043, DOI 10.1603/0046-225X(2008)37[1043:PDOSLL]2.0.CO;2; WOLFERSBERGER MG, 1993, ARCH INSECT BIOCHEM, V24, P139, DOI 10.1002/arch.940240304; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103	53	19	20	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20263	20272		10.1074/jbc.RA118.005101	http://dx.doi.org/10.1074/jbc.RA118.005101			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385510	Green Published, hybrid			2022-12-26	WOS:000454685900031
J	Cooper, N; Cant, I; White, MD; Meyer, GF				Cooper, Natalia; Cant, Iain; White, Mark D.; Meyer, Georg F.			Perceptual assessment of environmental stability modulates postural sway	PLOS ONE			English	Article							MOTION; EXPECTATION; RESPONSES; YOUNG; BASE	We actively maintain postural equilibrium in everyday life, and, although we are unaware of the underlying processing, there is increasing evidence for cortical involvement in this postural control. Converging evidence shows that we make appropriate use of 'postural anchors', for example static objects in the environment, to stabilise our posture. Visually evoked postural responses (VEPR) that are caused when we counteract the illusory perception of self-motion in space (vection) are modulated in the presence of postural anchors and therefore provide a convenient behavioural measure. The aim of this study is to evaluate the factors influencing visual appraisal of the suitability of postural anchors. We are specifically interested in the effect of perceived 'reality' in VR the expected 'stability' of visual anchors. To explore the effect of 'reality' we introduced an accommodation-vergence conflict. We show that VEPR are appropriately modulated only when virtual visual 'anchors' are rendered such that vergence and accommodation cues are consistent. In a second experiment we directly test whether cognitive assessment of the likely stability of real perceptual anchors (we contrast a 'teapot on a stand' and a 'helium balloon') affects VEPR. We show that the perceived positional stability of environmental anchors modulate postural responses. Our results confirm previous findings showing that postural sway is modulated by the configuration of the environment and further show that an assessment of the stability and reality of the environment plays an important role in this process. On this basis we propose design guidelines for VR systems, in particular we argue that accommodation-vergence conflicts should be minimised and that high quality motion tracking and rendering are essential for high fidelity VR.	[Cooper, Natalia] Natl Res Council Canada, Construct Res Ctr, Ottawa, ON, Canada; [Cant, Iain] Hartree Ctr Sci Tech Daresbury, Virtual Engn Ctr, Keckwick Lane, Warrington, Cheshire, England; [White, Mark D.] Univ Liverpool, Sch Engn, Brownlow Hill, Liverpool, Merseyside, England; [Meyer, Georg F.] Univ Liverpool, Psychol Sci, Liverpool, Merseyside, England	National Research Council Canada; University of Liverpool; University of Liverpool	Meyer, GF (corresponding author), Univ Liverpool, Psychol Sci, Liverpool, Merseyside, England.	georg@liverpool.ac.uk	White, Mark/AAG-8761-2020	White, Mark/0000-0002-8611-9525; Meyer, Georg/0000-0002-3739-1653	ESRC [ES/J500094/1]	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was funded by ESRC Case award (North West DTC ES/J500094/1) to GFM, MW & NC, funder website http://www.esrc.ac.uk/.The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.; This study was funded by ESRC Case award (North West DTC ES/J500094/1) to GFM, MW and NC, funder website http://www.esrc.ac.uk/.The funders had no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Allum JHJ, 1998, GAIT POSTURE, V8, P214, DOI 10.1016/S0966-6362(98)00027-7; Bacsi AM, 2005, EXP BRAIN RES, V160, P22, DOI 10.1007/s00221-004-1982-2; Banks MS, 2013, HEAD AND HELMET MOUN, VXVIII; Bardy BG, 1996, EXP BRAIN RES, V111, P271; Bergeron M, 2015, ADV MED, V2015; Bernhard ER, 2011, COMPELLING SELF MOTI; Berthoz A, 1979, Prog Brain Res, V50, P197; Blumle A, 2006, EXP BRAIN RES, V173, P357, DOI 10.1007/s00221-006-0384-z; Bronstein AM, 1997, EXP BRAIN RES, V113, P243, DOI 10.1007/BF02450322; Caudron S, 2008, EXP BRAIN RES, V184, P53, DOI 10.1007/s00221-007-1079-9; Cenciarini M, 2006, J NEUROPHYSIOL, V95, P2733, DOI 10.1152/jn.00856.2004; Dakin CJ, 2010, J NEUROPHYSIOL, V103, P1048, DOI 10.1152/jn.00881.2009; Day BL, 2016, J PHYSIOL-LONDON, V594, P5661, DOI 10.1113/JP271813; Dichgans J, 1978, HDB SENSORY PHYSL, P755, DOI DOI 10.1007/978-3-642-46354-9_25; DIJKSTRA TMH, 1994, BIOL CYBERN, V71, P489, DOI 10.1007/BF00198467; Efron B., 1994, INTRO BOOTSTRAP; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Field A., 2009, DISCOPERING STAT USI; Guerraz M, 2005, J COGNITIVE NEUROSCI, V17, P463, DOI 10.1162/0898929053279540; Guerraz M, 2001, PERCEPT PSYCHOPHYS, V63, P47, DOI 10.3758/BF03200502; Guerraz M, 2001, COGNITIVE BRAIN RES, V11, P259, DOI 10.1016/S0926-6410(00)00080-X; Guerraz M, 2008, NEUROSCI LETT, V443, P12, DOI 10.1016/j.neulet.2008.07.053; Hassall CD, 2014, J MOTOR BEHAV, V46, P381, DOI 10.1080/00222895.2014.918021; Hoffman DM, 2008, J VISION, V8, DOI 10.1167/8.3.33; HOWARD IP, 1994, PERCEPTION, V23, P745, DOI 10.1068/p230745; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; James William, 2013, PRINCIPLES PSYCHOL; Kapoula Z, 2006, EXP BRAIN RES, V173, P438, DOI 10.1007/s00221-006-0382-1; Kapoula Z, 2011, PSYCHOL AESTHET CREA, V5, P186, DOI 10.1037/a0022087; Kavounoudias A, 2001, J PHYSIOL-LONDON, V532, P869, DOI 10.1111/j.1469-7793.2001.0869e.x; Kouzaki M, 2008, EXP BRAIN RES, V188, P153, DOI 10.1007/s00221-008-1426-5; Lambooij M, 2010, J SOC INF DISPLAY, V18, P931, DOI 10.1889/JSID18.11.931; Lambooij M, 2009, J IMAGING SCI TECHN, V53, DOI 10.2352/J.ImagingSci.Technol.2009.53.3.030201; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; Mahboobin A, 2005, EXP BRAIN RES, V167, P260, DOI 10.1007/s00221-005-0053-7; Matheron E, 2007, NEUROSCI LETT, V423, P236, DOI 10.1016/j.neulet.2007.07.016; Meldrum D, 2015, ARCH PHYS MED REHAB, V96, P1319, DOI 10.1016/j.apmr.2015.02.032; Melzer I, 2001, GERONTOLOGY, V47, P189, DOI 10.1159/000052797; Mergner T, 2005, EXP BRAIN RES, V167, P535, DOI 10.1007/s00221-005-0065-3; Meyer GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067651; Palm HG, 2009, GAIT POSTURE, V30, P328, DOI 10.1016/j.gaitpost.2009.05.023; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Riecke BE, 2006, ACM T APPL PERCEPT, V3, P194, DOI [10.1145/1166087.1166091., DOI 10.1145/1166087.1166091, 10.1145/1166087.1166091]; Shibata T, 2011, PROC SPIE, V7863, DOI 10.1117/12.872347; Slater M, 1999, PRESENCE-TELEOP VIRT, V8, P560, DOI 10.1162/105474699566477; Slobounov S, 2006, BIOL PSYCHOL, V72, P188, DOI 10.1016/j.biopsycho.2005.10.005; Streepey JW, 2007, EXP BRAIN RES, V176, P182, DOI 10.1007/s00221-006-0677-2; VANASTEN WNJC, 1988, EXP BRAIN RES, V73, P371, DOI 10.1007/BF00248230; Villard SJ, 2008, HUM FACTORS, V50, P332, DOI 10.1518/001872008X250728; Witmer BG, 1998, PRESENCE-TELEOP VIRT, V7, P225, DOI 10.1162/105474698565686	50	7	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206218	10.1371/journal.pone.0206218	http://dx.doi.org/10.1371/journal.pone.0206218			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ8VH	30412590	Green Published, Green Submitted, gold			2022-12-26	WOS:000449772600012
J	Borel, AL; Coumes, S; Reche, F; Ruckly, S; Pepin, JL; Tamisier, R; Wion, N; Arvieux, C				Borel, Anne-Laure; Coumes, Sandrine; Reche, Fabian; Ruckly, Stephane; Pepin, Jean-Louis; Tamisier, Renaud; Wion, Nelly; Arvieux, Catherine			Waist, neck circumferences, waist-to-hip ratio: Which is the best cardiometabolic risk marker in women with severe obesity? The SOON cohort	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; HEIGHT RATIO; ANTHROPOMETRIC INDEXES; INSULIN-RESISTANCE; DIABETES-MELLITUS; ABDOMINAL OBESITY; ADIPOSE-TISSUE	A centralized deposit of adiposity increases the risk of cardiometabolic diseases. Several anthropometric markers can be used to characterize fat distribution. In the case of severe obesity, several markers, such as hip and waist circumference, are prone to measurement error. Conversely, neck circumference is easy to obtain. The aim was to determine the best surrogate marker of obesity-related cardiometabolic diseases from: body mass index (BMI), waist, hip and neck circumferences and waist-to-hip ratio. Methods Data from women (n = 305, aged 43 [34; 53] years-old, BMI 44.2 [40.8; 48.2] kg/m(2)) included in the Severe Obesity Outcome Network (SOON) cohort were analyzed (i) to evaluate collinearity between the different anthropometric markers, (ii) to compare the association of markers with hypertension, type 2 diabetes, obstructive sleep apnea syndrome (OSAS) and other cardiometabolic risks. Results Hip, waist and neck circumferences correlated with BMI with respectively less collinearity (r = 0.70, r = 0.59 and r = 0.37, respectively, p<0.001) whereas waist-to-hip ratio was not correlated (r = 0.11, p = 0.072). Waist and neck circumferences were significantly associated with hypertension, type 2 diabetes and OSAS in univariate logistic regressions, waist-to-hip ratio with hypertension and type 2 diabetes. Hip circumference was inversely correlated with type 2 diabetes (OR 0.970 (95CI: 0.948; 0.991) p = 0.006). BMI was only linked to OSAS (OR 1.092 (95CI: 1.043; 1.143) p<0.001). Neck circumference was the only marker significantly associated with all cardiometabolic risk markers (HOMA-IR, apnea-hypopnea index, Log Triglycerides/HDL-c, alanin-aminotransferase, aspartate-aminotransferase, gamma-glutamyl transpeptidase). Conclusions Neck circumference appears the most appropriate anthropometric marker to identify the fat distribution associated with high cardiometabolic risk in women with severe obesity.	[Borel, Anne-Laure; Pepin, Jean-Louis; Tamisier, Renaud] Univ Grenoble Alpes, Hypoxia PathoPhysiol Lab, INSERM, U1042, Grenoble, France; [Borel, Anne-Laure; Coumes, Sandrine; Wion, Nelly] Grenoble Alpes Univ Hosp, Pole DIGIDUNE, Dept Nutr, Grenoble, France; [Reche, Fabian; Arvieux, Catherine] Grenoble Alpes Univ Hosp, Pole DIGIDUNE, Dept Digest Surg, Grenoble, France; [Ruckly, Stephane] ICUREsearch, Paris, France; [Pepin, Jean-Louis; Tamisier, Renaud] Grenoble Univ Hosp, Pole Thorax & Vaisseaux, Physiol Sleep & Exercise Clin, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Borel, AL (corresponding author), Univ Grenoble Alpes, Hypoxia PathoPhysiol Lab, INSERM, U1042, Grenoble, France.; Borel, AL (corresponding author), Grenoble Alpes Univ Hosp, Pole DIGIDUNE, Dept Nutr, Grenoble, France.	alborel@chu-grenoble.fr	Tamisier, Renaud/M-6858-2014; Arvieux, Catherine/AAQ-3128-2021	Tamisier, Renaud/0000-0003-1128-6529; Pepin, Jean Louis/0000-0003-3832-2358; Borel, Anne-Laure/0000-0002-7368-172X	Fond AGIR pour les maladies chroniques; Agence Regionale pour la Sante Rhone-Alpes	Fond AGIR pour les maladies chroniques; Agence Regionale pour la Sante Rhone-Alpes	This research was funded by the Fond AGIR pour les maladies chroniques and Agence Regionale pour la Sante Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahbab S, 2013, MED SCI MONITOR, V19, P111, DOI 10.12659/MSM.883776; Assyov Y, 2017, ENDOCR RES, V42, P6, DOI 10.3109/07435800.2016.1155598; Banhiran W, 2014, SLEEP BREATH, V18, P151, DOI 10.1007/s11325-013-0863-y; Ben-Noun LL, 2004, AM J HYPERTENS, V17, P409, DOI 10.1016/j.amjhyper.2004.02.005; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; BURSTEIN M, 1960, CLIN CHIM ACTA, V5, P609, DOI 10.1016/0009-8981(60)90075-9; Chiu H-Y, 2016, SLEEP MED REV; Cho Nam H, 2015, Sci Rep, V5, P18565, DOI 10.1038/srep18565; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Cizza G, 2014, METAB SYNDR RELAT D, V12, P231, DOI 10.1089/met.2013.0093; Dai YN, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0218-3; Dalton M, 2003, J INTERN MED, V254, P555, DOI 10.1111/j.1365-2796.2003.01229.x; DAVIES RJO, 1990, EUR RESPIR J, V3, P509; Caixexa JAD, 2015, SLEEP BREATH, V19, P231, DOI 10.1007/s11325-014-1001-1; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2011, J AM COLL CARDIOL, V57, P1887, DOI 10.1016/j.jacc.2010.10.063; Drapeau V, 2007, OBES SURG, V17, P905, DOI 10.1007/s11695-007-9168-1; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gupta A, 2017, MAYO CLIN PROC, V92, P536, DOI 10.1016/j.mayocp.2016.12.023; Hajian-Tilaki K, 2014, J RES HEALTH SCI, V14, P276; HEADY J A, 1956, Lancet, V271, P569, DOI 10.1016/S0140-6736(56)92049-9; Huang BX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118071; Jamar G, 2013, INT J CLIN PRACT, V67, P217, DOI 10.1111/ijcp.12041; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; Lemieux I, 2006, DIABETES CARE, V29, P1417, DOI 10.2337/dc06-0441; Li Q, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0060-z; Liang J, 2013, DIABETES CARE, V36, pE145, DOI 10.2337/dc13-1114; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Marfell- Jones AS, 2012, INTERNATIONAL STANDA; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Neeland IJ, 2018, CIRCULATION, V137, P1391, DOI 10.1161/CIRCULATIONAHA.117.029617; Neeland IJ, 2015, J AM COLL CARDIOL, V65, P2150, DOI 10.1016/j.jacc.2015.01.061; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Perea V, 2013, SURG OBES RELAT DIS, V9, P648, DOI 10.1016/j.soard.2012.05.010; Picon PX, 2007, ARQ BRAS ENDOCRINOL, V51, P443, DOI 10.1590/S0004-27302007000300013; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Preis SR, 2013, DIABETES CARE, V36, pE3, DOI 10.2337/dc12-0738; Preis SR, 2010, J CLIN ENDOCR METAB, V95, P3701, DOI 10.1210/jc.2009-1779; Roca-Rivada A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12214; Rosenquist KJ, 2013, DIABETES CARE, V36, pE153, DOI 10.2337/dc13-0379; Smith JD, 2012, J CLIN ENDOCRINOL ME; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Sperling LS, 2015, J AM COLL CARDIOL, V66, P1050, DOI 10.1016/j.jacc.2015.06.1328; Vallianou NG, 2013, DIABETES-METAB RES, V29, P90, DOI 10.1002/dmrr.2369; Zazai R, 2014, OBES SURG, V24, P777, DOI 10.1007/s11695-013-1141-6; Zen V, 2012, AM J CARDIOVASC DIS, V2, P323; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhou D, 2014, PREV MED, V67, P35, DOI 10.1016/j.ypmed.2014.06.025	50	31	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206617	10.1371/journal.pone.0206617	http://dx.doi.org/10.1371/journal.pone.0206617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408116	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300027
J	Meda, IB; Dumont, A; Kouanda, S; Ridde, V				Meda, Ivlabehire Bertrand; Dumont, Alexandre; Kouanda, Seni; Ridde, Valery			Impact of fee subsidy policy on perinatal health in a low-resource setting: A quasi-experimental study	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; INTERRUPTED TIME-SERIES; FACILITY-BASED DELIVERY; MATERNAL HEALTH; USER FEES; SERVICE UTILIZATION; NEONATAL HEALTH; RELATIVE RISKS; CHILD SURVIVAL; CARE	Background A national subsidy policy was introduced in 2007 in Burkina Faso to improve financial accessibility to facility-based delivery. In this article, we estimated the effects of reducing user fees on institutional delivery and neonatal mortality, immediately and three years after the introduction of the policy. Methods The study was based on a quasi-experimental design. We used data obtained from the 2010 Demographic and Health Survey, including survival information for 32,102 live-born infants born to 12,474 women. We used a multilevel Poisson regression model with robust variances to control for secular trends in outcomes between the period before the introduction of the policy (1 January, 2007) and the period after. In sensitivity analyses, we used two different models according to the different definitions of the period "before" and the period "after". Results Immediately following its introduction, the subsidy policy was associated with increases in institutional deliveries by 4% (RR = 1.04, 95% CI: 0.98-1.10) in urban areas and by 12% (RR = 1.12, 95% CI: 1.04-1.20) in rural areas. The results showed similar patterns in sensitivity analyses. This effect was particularly marked among rural clusters with low institutional delivery rates at baseline (RR = 1.44, 95% CI: 1.33-1.55). It was persistent for 42 months after the introduction of the policy but these increases were not statistically significant. At 42 months, the delivery rates had increased by 26% in rural areas (RR = 1.26; 95% CI: 0.86-1.86) and 13% (RR = 1.13; 95% CI: 0.88-1.46) in urban areas. There was no evidence of a significant decrease in neonatal mortality rates. Conclusion The delivery subsidy implemented in Burkina Faso is associated with short-term increases in health facility deliveries. This policy has been particularly beneficial for rural households.	[Meda, Ivlabehire Bertrand; Kouanda, Seni] Inst Rech Sci Sante IRSS CNRST, Dept Biomed & Sante Publ, Ouagadougou, Burkina Faso; [Meda, Ivlabehire Bertrand] ESPUM, Montreal, PQ, Canada; [Meda, Ivlabehire Bertrand; Ridde, Valery] IRSPUM, Montreal, PQ, Canada; [Meda, Ivlabehire Bertrand; Kouanda, Seni] IASP, Ouagadougou, Burkina Faso; [Dumont, Alexandre; Ridde, Valery] Univ Paris Sorbonne Cites, ERL INSERM SAGESUD, CEPED, IRD,Univ Paris Descartes,IRD French Inst Res Sust, Paris, France	Universite de Montreal; Universite de Montreal; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD)	Meda, IB (corresponding author), Inst Rech Sci Sante IRSS CNRST, Dept Biomed & Sante Publ, Ouagadougou, Burkina Faso.; Meda, IB (corresponding author), ESPUM, Montreal, PQ, Canada.; Meda, IB (corresponding author), IRSPUM, Montreal, PQ, Canada.; Meda, IB (corresponding author), IASP, Ouagadougou, Burkina Faso.	medabert@yahoo.fr	ridde, valery/AAV-1016-2020; Ridde, Valery/AAD-2736-2019	Ridde, Valery/0000-0001-9299-8266; Meda, Ivlabehire Bertrand/0000-0002-9717-3770	Canadian Institutes of Health Research (CIHR) [ROH-115213]; World Health Organization (WHO) [SPHQ10-RTG-14]; Quebec Health Research Fund (FRQS); University of Montreal Public Health Research Institute (IRSPUM); University of Montreal Hospital Research Centre (CRCHUM); International Development Research Centre (IDRC) [107473-99906075-058]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); World Health Organization (WHO)(World Health Organization); Quebec Health Research Fund (FRQS); University of Montreal Public Health Research Institute (IRSPUM); University of Montreal Hospital Research Centre (CRCHUM); International Development Research Centre (IDRC)	This work was supported by the Canadian Institutes of Health Research (CIHR), which funded the program [ROH-115213] to VR. This research project is part of the project "Community research studies and interventions for health equity in Burkina Faso". IBM also benefited from scholarships provided by the World Health Organization (WHO) [SPHQ10-RTG-14], the Quebec Health Research Fund (FRQS), the University of Montreal Public Health Research Institute (IRSPUM), the University of Montreal Hospital Research Centre (CRCHUM) and the International Development Research Centre (IDRC) [107473-99906075-058]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2009, AM J EPIDEMIOL, V169, P1140, DOI 10.1093/aje/kwp015; Belaid L, 2015, HEALTH POLICY PLANN, V30, P309, DOI 10.1093/heapol/czu012; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; De Allegri M, 2012, J PUBLIC HEALTH POL, V33, P439, DOI 10.1057/jphp.2012.27; Dzakpasu S, 2014, HEALTH POLICY PLANN, V29, P137, DOI 10.1093/heapol/czs142; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; French B, 2008, STAT MED, V27, P5005, DOI 10.1002/sim.3340; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Ganaba R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0875-2; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Hatt LE, 2013, J HEALTH POPUL NUTR, V31, P67; Nguyen HT, 2018, HEALTH POLICY PLANN, V33, P948, DOI 10.1093/heapol/czy077; Institut National de la Statistique et de la Demographie (INSD) ICF International, 2012, THE BURKINA FASO DEM; Kouanda S, 2016, INT J GYNECOL OBSTET, V135, pS39, DOI 10.1016/j.ijgo.2016.08.009; Lagarde M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009094; Lagarde M, 2012, HEALTH POLICY PLANN, V27, P76, DOI 10.1093/heapol/czr004; Lamichhane P, 2017, HEALTH POLICY PLANN, V32, P1427, DOI 10.1093/heapol/czx124; Langlois EV, 2016, HEALTH POLICY PLANN, V31, P462, DOI 10.1093/heapol/czv088; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Leone T, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009692; McKinnon B, 2015, SOC SCI MED, V135, P117, DOI 10.1016/j.socscimed.2015.05.003; McKinnon B, 2015, HEALTH POLICY PLANN, V30, P432, DOI 10.1093/heapol/czu027; Meda IB, 2013, SANTE MATERNELLE ACC, P163; Mosley WH, 2003, B WORLD HEALTH ORGAN, V81, P140; Philibert A, 2017, HEALTH POLICY PLANN, V32, P405, DOI 10.1093/heapol/czw142; Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI, VI; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, VII; Ravit M, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000558; Richard F, 2010, AM J PUBLIC HEALTH, V100, P1845, DOI 10.2105/AJPH.2009.179689; Ridde V, 2011, HLTH POLICY PLAN S2, V26, pii30, DOI DOI 10.1093/HEAP0L/CZR060; Ridde V, 2013, EVAL PROGRAM PLANN, V36, P145, DOI 10.1016/j.evalprogplan.2012.09.005; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Rutstein SO, 2004, DHS COMP REPORTS, V6; Serumaga B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d108; Stanton ME, 2013, J HEALTH POPUL NUTR, V31, P1; TALJAARD M, 2014, IMPLEMENT SCI, V0009; UNICEF, 2015, MON SIT CHILDR WOM D; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Witter S, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0412-y; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	44	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206978	10.1371/journal.pone.0206978	http://dx.doi.org/10.1371/journal.pone.0206978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408129	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300061
J	Verwimp, C; Ruttink, T; Muylle, H; Van Glabeke, S; Cnops, G; Quataert, P; Honnay, O; Roldan-Ruiz, I				Verwimp, Christophe; Ruttink, Tom; Muylle, Hilde; Van Glabeke, Sabine; Cnops, Gerda; Quataert, Paul; Honnay, Olivier; Roldan-Ruiz, Isabel			Temporal changes in genetic diversity and forage yield of perennial ryegrass in monoculture and in combination with red clover in swards	PLOS ONE			English	Article							NEXT-GENERATION; INTRASPECIFIC VARIABILITY; GRASSLAND MIXTURES; SPECIES-DIVERSITY; TOOLKIT; MARKERS; SAMPLES	Agricultural grasslands are often cultivated as mixtures of grasses and legumes, and an extensive body of literature is available regarding interspecific interactions, and how these relate to yield and agronomic performance. However, knowledge of the impact of intraspecific diversity on grassland functioning is scarce. We investigated these effects during a 4-year field trial established with perennial ryegrass (Lolium perenne) and red clover (Trifolium pratense). We simulated different levels of intraspecific functional diversity by sowing single cultivars or by combining cultivars with contrasting growth habits, in monospecific or bispecific settings (i.e. perennial ryegrass whether or not in combination with red clover). Replicate field plots were established for seven seed compositions. We determined yield parameters and monitored differences in genetic diversity in the ryegrass component among seed compositions, and temporal changes in the genetic composition and genetic diversity at the within plot level. The composition of cultivars of both species affected the yield and species abundance. In general, the presence of clover had a positive effect on the yield. The cultivar composition of the ryegrass component had a significant effect on the yield, both in monoculture, and in combination with clover. For the genetic analyses, we validated empirically that genotyping-by-sequencing of pooled samples (pool-GBS) is a suitable method for accurate measurement of population allele frequencies, and obtained a dataset of 22,324 SNPs with complete data. We present a method to investigate the temporal dynamics of cultivars in seed mixtures grown under field conditions, and show how cultivar abundances vary during subsequent years. We screened the SNP panel for outlier loci, putatively under selection during the cultivation period, but none were detected.	[Verwimp, Christophe; Ruttink, Tom; Muylle, Hilde; Van Glabeke, Sabine; Cnops, Gerda; Roldan-Ruiz, Isabel] Res Inst Agr Fisheries & Food, Plant Sci Unit, Melle, Belgium; [Verwimp, Christophe; Honnay, Olivier] Univ Leuven, Dept Biol Plant Conservat & Populat Biol, Heverlee, Belgium; [Quataert, Paul] Res Inst Nat & Forest, Brussels, Belgium; [Roldan-Ruiz, Isabel] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Zwijnaarde, Belgium	Institute For Agricultural & Fisheries Research; KU Leuven; Research Institute for Nature & Forest; Ghent University	Roldan-Ruiz, I (corresponding author), Res Inst Agr Fisheries & Food, Plant Sci Unit, Melle, Belgium.; Roldan-Ruiz, I (corresponding author), Univ Ghent, Dept Plant Biotechnol & Bioinformat, Zwijnaarde, Belgium.	isabel.roldan-ruiz@ilvo.vlaanderen.be	Honnay, Olivier/AAH-8625-2019	Honnay, Olivier/0000-0002-4287-8511; Roldan-Ruiz, Isabel/0000-0001-7340-3386; Ruttink, Tom/0000-0002-1012-9399; Quataert, Paul/0000-0002-6894-9402	Research Institute for Agriculture, Fisheries and Food (ILVO); European Community [244983]	Research Institute for Agriculture, Fisheries and Food (ILVO); European Community(European Commission)	The authors thank the Research Institute for Agriculture, Fisheries and Food (ILVO), and the European Community (FP7-Multisward 244983) for funding.	Albert CH, 2011, PERSPECT PLANT ECOL, V13, P217, DOI 10.1016/j.ppees.2011.04.003; Anderson EC, 2014, MOL ECOL, V23, P502, DOI 10.1111/mec.12609; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Ashraf BH, 2016, THEOR APPL GENET, V129, P45, DOI 10.1007/s00122-015-2607-9; Auzanneau J, 2007, THEOR APPL GENET, V115, P837, DOI 10.1007/s00122-007-0612-3; Barot S, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0418-x; Belanger S, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2014.10.0073; Belanger S, 2016, THEOR APPL GENET, V129, P1393, DOI 10.1007/s00122-016-2711-5; Bell N, 2018, J BIOGEOGR, V45, P177, DOI 10.1111/jbi.13120; Bolaric S, 2005, PLANT BREEDING, V124, P161, DOI 10.1111/j.1439-0523.2004.01032.x; Boller B, 2016, PERFORMANCE DIPLOID, P15, DOI [10.1007/978-3-319-28932-8_2, DOI 10.1007/978-3-319-28932-8_2]; Brophy C, 2017, J ECOL, V105, P1210, DOI 10.1111/1365-2745.12754; Byrne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057438; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Clavin D, 2017, GRASS FORAGE SCI, V72, P414, DOI 10.1111/gfs.12249; Corander J, 2013, MOL ECOL, V22, P2931, DOI 10.1111/mec.12174; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De Keersmaecker W, 2016, J APPL ECOL, V53, P430, DOI 10.1111/1365-2664.12595; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Eriksen J, 2014, GRASS FORAGE SCI, V69, P241, DOI 10.1111/gfs.12025; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522; Finn JA, 2013, J APPL ECOL, V50, P365, DOI 10.1111/1365-2664.12041; Fracassetti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140462; Fu YB, 2014, G3-GENES GENOM GENET, V4, P891, DOI 10.1534/g3.114.010942; Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360; Gordon A., 2010, FASTQ A SHORT UNPUB; Hart SP, 2016, ECOL LETT, V19, P825, DOI 10.1111/ele.12618; Herten K, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0514-3; Hoban S, 2016, AM NAT, V188, P379, DOI 10.1086/688018; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Humphreys M, 2010, HANDB PLANT BREED, V5, P211, DOI 10.1007/978-1-4419-0760-8_10; Husse S, 2016, FIELD CROP RES, V194, P1, DOI 10.1016/j.fcr.2016.04.021; Lee JM, 2017, GRASS FORAGE SCI, V72, P382, DOI 10.1111/gfs.12243; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; Luscher A, 2014, GRASS FORAGE SCI, V69, P206, DOI 10.1111/gfs.12124; Manzanares C, 2016, MOL BIOL EVOL, V33, P870, DOI 10.1093/molbev/msv335; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mimee B, 2015, MOL ECOL RESOUR, V15, P1356, DOI 10.1111/1755-0998.12412; OJIMA DS, 1993, WATER AIR SOIL POLL, V70, P95, DOI 10.1007/BF01104990; Phelan P, 2015, CRIT REV PLANT SCI, V34, P281, DOI 10.1080/07352689.2014.898455; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Poland JA, 2012, PLANT GENOME-US, V5, P92, DOI 10.3835/plantgenome2012.05.0005; Raineri E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-239; Reheul D, 2010, HANDB PLANT BREED, V5, P1, DOI 10.1007/978-1-4419-0760-8_1; Rellstab C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080422; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Roldan-Ruiz I, 2001, THEOR APPL GENET, V103, P1138, DOI 10.1007/s001220100571; Roldan-Ruiz I, 2000, MOL BREEDING, V6, P125, DOI 10.1023/A:1009680614564; Saracutu O, 2010, SUSTAINABLE USE OF GENETIC DIVERSITY IN FORAGE AND TURF BREEDING, P155, DOI 10.1007/978-90-481-8706-5_22; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Suter M, 2015, GLOBAL CHANGE BIOL, V21, P2424, DOI 10.1111/gcb.12880; Tange O., 2018, USENIX MAGAZINE, V36, P42; Thorogood D, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01331; Van Minnebruggen A, 2015, GRASS FORAGE SCI, V70, P507, DOI 10.1111/gfs.12138; van Rooijen NM, 2015, ECOSYSTEMS, V18, P1383, DOI 10.1007/s10021-015-9905-6; Violle C, 2012, TRENDS ECOL EVOL, V27, P244, DOI 10.1016/j.tree.2011.11.014	66	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206571	10.1371/journal.pone.0206571	http://dx.doi.org/10.1371/journal.pone.0206571			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408053	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300024
J	Bezerra, IC; da Silva, RM; Oliveira, CP; Brasil, CCP; Vasconcelos, MGF; Mamede, MV; de Oliveira, MTP				Bezerra, Indara Cavalcante; da Silva, Raimunda Magalhaes; Oliveira, Cleoneide Paulo; Praca Brasil, Christina Cesar; Ferreira Vasconcelos, Mardenia Gomes; Mamede, Marli Vilela; Pinheiro de Oliveira, Marnewton Tadeu			Mastectomized women's perception of breast cancer early detection	PLOS ONE			English	Article								Background A third of new cases of breast cancer could be detected early, which would prevent more serious consequences, such as mastectomy and death. Access to the subjectivity of mastectomized patients becomes relevant to elucidate failures in early detection of breast cancer and thus improve the cancer care network. Given that, the present study aimed to identify mastectomized women's perception of the quality of care provided by the cancer care network for the early detection and diagnosis of breast cancer. Methods Qualitative study carried out at a public outpatient cancer center in the city of Fortaleza, Ceara, Northeastern Brazil, to analyze the perceptions of 26 women who had undergone mastectomy after breast cancer based on Symbolic Interactionism. Results The thematic analysis showed how women (re)structure their lives in the face of the structural and social aspects of coping with breast. Two essential themes emerged: "Contradictions regarding access to primary health care services and obstacles to the organization of SUS formal care network services" and "The informal and private health care network increase quality care coverage". Conclusions The absence of effective measures in Primary Health Care and patients' 'pilgrimage' in the formal health care network have delayed early detection breast cancer.	[Bezerra, Indara Cavalcante; da Silva, Raimunda Magalhaes; Praca Brasil, Christina Cesar] Univ Fortaleza, Programa Posgrad Saude Colet, Fortaleza, Ceara, Brazil; [Oliveira, Cleoneide Paulo] Ctr Univ Estacio Sa, Dept Fisioterapia, Fortaleza, Ceara, Brazil; [Ferreira Vasconcelos, Mardenia Gomes] Univ Estadual Ceara, Programa Posgrad Saude Colet, Fortaleza, Ceara, Brazil; [Mamede, Marli Vilela] Univ Sao Paulo, Dept Enfermagem, Ribeirao Preto, SP, Brazil; [Pinheiro de Oliveira, Marnewton Tadeu] Hosp Sao Camilo Cura DArs, Dept Tumores Cutaneos, Fortaleza, Ceara, Brazil	Universidade Fortaleza; Universidade Estadual do Ceara; Universidade de Sao Paulo	Bezerra, IC (corresponding author), Univ Fortaleza, Programa Posgrad Saude Colet, Fortaleza, Ceara, Brazil.	indaracavalcante@yahoo.com	Brasil, Christina/ABC-7161-2020	Brasil, Christina/0000-0002-7741-5349; Mamede, Marli Villela/0000-0002-6478-8680; CAVALCANTE BEZERRA, INDARA/0000-0003-0647-2490				Abraido-Lanza AF, 2015, HEALTH EDUC BEHAV, V42, P633, DOI 10.1177/1090198115580975; Acioli GG, 2006, SAUDE BRASIL CARTOGR; AKERMAN M., 2015, PRATICAS AVALIACAO S; [Anonymous], 2015, MAM RASTR CANC MAM M; Azevedo RF, 2010, REV BRAS ENFERM, V63, P1067, DOI 10.1590/S0034-71672010000600031; Batiston AP, 2009, COGITARE ENFERM, V14, P59; Blumer H, 1969, SYMBOLIC INTERCTIONI; Boyle P, 2008, WORLD CANC REPORT; Carter MJ, 2016, CURR SOCIOL, V64, P931, DOI 10.1177/0011392116638396; Carvalho Virgínia Donizete de, 2010, Psicol. cienc. prof., V30, P146; Chetlen A, 2016, CLIN IMAG, V40, P279, DOI 10.1016/j.clinimag.2015.05.017; Costa Juliana Pessoa, 2014, Saúde debate, V38, P733, DOI 10.5935/0103-1104.20140067; de Sant'Ana RS, 2016, EINSTEIN-SAO PAULO, V14, P324, DOI 10.1590/S1679-45082016AO3708; Deandrea S, 2016, PREV MED, V91, P250, DOI 10.1016/j.ypmed.2016.08.021; Fregnani JH, 2017, CANC MAMA POLITICAS; Goncalves Livia Magalhaes, 2013, THESIS; Horlate VA, 2012, REV BRAS CANCEROL, V58, P67; Instituto Nacional de Cancer, 2016, CANC MAM; Instituto Nacional de Cancer (Brasil), 2017, CANC MAM; Juliani C M, 1999, Rev Esc Enferm USP, V33, P323; Kotepui M, 2015, HEALTH EXPECT, V18, P3069, DOI 10.1111/hex.12292; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Minayo MCS, 2013, DESAFIO CONHECIMENTO, V13th; Ministerio da Saude (BR), 2013, CONTR CANC COL UT MA; Norsa'adah B, 2012, ASIAN PAC J CANCER P, V13, P3723, DOI 10.7314/APJCP.2012.13.8.3723; Nunes Altacílio Aparecido, 2012, Rev. bras. educ. med., V36, P27, DOI 10.1590/S0100-55022012000200004; Oliveira Evangelina Xavier Gouveia de, 2011, Ciênc. saúde coletiva, V16, P3649; Oliveira I.A., 2017, THESIS; Oshiro ML, 2014, REV BRAS CANCEROL, V60, P15; Paim JS, 2013, CAD SAUDE PUBLICA, V29, P1927, DOI 10.1590/0102-311X00099513; Peppercorn J, 2015, BREAST CANCER RES TR, V153, P659, DOI 10.1007/s10549-015-3566-1; PORTO M. A. T., 2013, REV BRASILEIRA CANC, V59, P331; Rego IKP, 2013, REV BRASILEIRA CANC, V59, P379; Rezende M.L.G., 2010, THESIS; Rezende Vera Lucia, 2010, Paidéia (Ribeirão Preto), V20, P229, DOI 10.1590/S0103-863X2010000200010; Sano H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180819; Sharma K, 2012, J ONCOL, V2012, DOI 10.1155/2012/121873; Shirazi M, 2015, J RELIG HEALTH, V54, P153, DOI 10.1007/s10943-013-9793-z; Silva GAE, 2013, REV SAUDE PUBL, V51, P1; Souza A, 2008, REV PSICOL POLITICA, V8, P157; Talib Z, 2016, BREAST J, V22, P330, DOI 10.1111/tbj.12618; Turrini RN, 2008, CAD SAUDE PUBLICA, V24, P663, DOI 10.1590/S0102-311X2008000300020; Thuler LCS, 2012, ABC CANC ABORDAGENS; Torres LGL, 2008, THESIS; Trufelli DC, 2008, REV ASSOC MED BRAS, V54, P72, DOI 10.1590/S0104-42302008000100024	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206405	10.1371/journal.pone.0206405	http://dx.doi.org/10.1371/journal.pone.0206405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403717	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500065
J	Calderon-Gutierrez, F; Sanchez-Ortiz, CA; Huato-Soberanis, L				Calderon-Gutierrez, Fernando; Sanchez-Ortiz, Carlos A.; Huato-Soberanis, Leonardo			Ecological patterns in anchialine caves	PLOS ONE			English	Article							YUCATAN PENINSULA; CENOTE AEROLITO; COZUMEL ISLAND; CLIMATE-CHANGE; MARINE CAVES; BIODIVERSITY; CRUSTACEA; RECORDS; SPONGE; SEA	Anchialine caves are characterized by high levels of endemism and extreme conditions. However, few ecological studies have been conducted in these ecosystems. This study integrates biotic and abiotic parameters of two sets of cave systems with contrasting high and low species richness. Seven ecological patterns are used to explain the expected species richness and density in an anchialine cave. In addition, the population size for conspicuous macrofauna was estimated. The high impact that single-events have on anchialine fauna are also reported. These findings reinforce the conclusions of previous studies of the high extinction risk of anchialine cave fauna, and substantiate the necessity of ad hoc conservation strategies for anchialine caves.	[Calderon-Gutierrez, Fernando; Sanchez-Ortiz, Carlos A.] Univ Autonoma Baja California Sur, Dept Acad Ciencias Marinas & Costeras, La Paz, Baja Calif Sur, Mexico; [Huato-Soberanis, Leonardo] Ctr Invest Biol Noroeste CIBNOR, Programa Ecol Pesquera, La Paz, Baja Calif Sur, Mexico; [Calderon-Gutierrez, Fernando] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Universidad Autonoma de Baja California; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Texas A&M University System	Sanchez-Ortiz, CA (corresponding author), Univ Autonoma Baja California Sur, Dept Acad Ciencias Marinas & Costeras, La Paz, Baja Calif Sur, Mexico.	csanchez@uabcs.mx	Calderón-Gutiérrez, Fernando/AAA-7718-2021; Sanchez, Carlos/AAJ-4644-2020	Calderón-Gutiérrez, Fernando/0000-0002-3181-4280; Sanchez, Carlos/0000-0001-7199-1268	Consejo Nacional de Ciencia y Tecnologia [334824]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Consejo Nacional de Ciencia y Tecnologia - http://conacyt.gob.mx/ supported Fernando Calderon-Gutierrez with a scholarship with the grant 334824. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Alcocer J, 1999, REV BIOL TROP, V47, P19; Alvarez F, 2008, CRUSTACEOS MEXICO ES, P379; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Bautista F, 2011, TROP SUBTROP AGROECO, V13, P7; Bishop RE, 2015, J CRUSTACEAN BIOL, V35, P511, DOI 10.1163/1937240X-00002335; Botosaneanu Lazare, 2002, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V72, P101; Brankovits D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01776-x; Bribiesca-Contreras G, 2013, MOL ECOL RESOUR, V13, P1137, DOI 10.1111/1755-0998.12098; Brusca RC, 2003, INVERTEBRATES; Bussotti S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122632; Calderon-Gutierrez F, 2014, ECHINODERMS ECOLOGY, P167; Calderon-Gutierrez F, 2017, REG STUD MAR SCI, V9, P43, DOI 10.1016/j.rsma.2016.11.001; Calderon-Gutierrez Fernando, 2012, Natura Croatica, V21, P21; Chavez-Solis EM, 2018, J CRUSTACEAN BIOL, V38, P1, DOI 10.1093/jcbiol/rux098; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Delworth TL, 2016, NAT GEOSCI, V9, P509, DOI [10.1038/ngeo2738, 10.1038/NGEO2738]; Dematteis G., 1975, MANUAL ESPELEOLOGIA; Ereskovsky AV, 2016, J MAR BIOL ASSOC UK, V96, P391, DOI 10.1017/S0025315415001071; Field M., 2002, LEXICON CAVE KARST T; Frontana-Uribe SC, 2011, J CAVE KARST STUD, V73, P1, DOI 10.4311/jcks2009lsc0107; Gabriel JJ, 2009, J PALEOLIMNOL, V42, P199, DOI 10.1007/s10933-008-9271-x; Garcia-Cubas A., 2007, CATALOGO ILUSTRADO M, V1; Garcia-Cubas A., 2004, Catalogo ilustrado de moluscos gasteropodos del Golfo de Mexico y mar Caribe; Gerovasileiou V, 2015, MEDITERR MAR SCI, V16, P245, DOI 10.12681/mms.1069; Gerovasileiou V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183707; Gerovasileiou V, 2016, MAR ECOL-EVOL PERSP, V37, P239, DOI 10.1111/maec.12268; Gerovasileiou V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039873; Gibert J, 2009, FRESHWATER BIOL, V54, P930, DOI 10.1111/j.1365-2427.2009.02201.x; Gomez Lopez P., 1984, Anales del Instituto de Ciencias del Mar y Limnologia Universidad Nacional Autonoma de Mexico, V11, P65; Gonzalez BC, 2018, ZOOL SCR, V47, P106, DOI 10.1111/zsc.12258; Gonzalez Brett C., 2012, Natura Croatica, V21, P51; Gonzalez BC, 2011, HYDROBIOLOGIA, V677, P149, DOI 10.1007/s10750-011-0932-9; Gulden B, 2016, WORLDS LONGEST CAVES; HART CW, 1985, P BIOL SOC WASH, V98, P288; Hernandez-Diaz YQ, 2013, REV MEX BIODIVERS, V84, P676, DOI 10.7550/rmb.30737; Hoenemann M, 2013, J CRUSTACEAN BIOL, V33, P603, DOI 10.1163/1937240X-00002179; Hoffman A., 1986, MANUAL BIOESPELEOLOG; Humphreys W. F., 1999, Records of the Western Australian Museum, V19, P469; Iliffe T.M., 2002, HYDROGEOLOGY BIOL PO, P99; Iliffe TM, 2001, MAR TECHNOL SOC J, V35, P36, DOI 10.4031/002533201788001901; Iliffe TM, 1992, DIVERSIDAD BIOL RESE, VII, P382; Kelley K.N., 2011, SPELEOGENESIS EVOLUT, V11, P32; KENSLEY B, 1988, J CRUSTACEAN BIOL, V8, P688, DOI 10.2307/1548704; Kornicker LS, 2007, ZOOTAXA, V1565; Laguarda-Figueras A, 2005, REV BIOL TROP, V53, P109; Lehnert Helmut, 1993, Acta Biologica Benrodis, V5, P35; Longphuirt SN, 2016, BIOL ENVIRON, V116B, P295, DOI [10.3318/BIOE.2016.21, 10.3318/bioe.2016.21]; Lugo-Hubp J.J., 1992, REV MEXICANA CIENCIA, V10, P143; Mejia-Orti LM, 2017, CRUSTACEANA, V90, P381, DOI 10.1163/15685403-00003657; Mejia-Ortiz LM, 2008, BIODIVERSIDAD ACUATI; Mejia-Ortiz LM., 2006, NACD, V39, P11; Mercado-Salas NF, 2013, AQUAT CONSERV, V23, P939, DOI 10.1002/aqc.2350; Miloslavich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011916; Montefalcone M, 2018, MAR ENVIRON RES, V137, P98, DOI 10.1016/j.marenvres.2018.02.022; Neiber MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019627; Olesen J, 2017, EUR J TAXON, V316, P1, DOI 10.5852/ejt.2017.316; Ortiz M, 2015, REV MEX BIODIVERS, V86, P332, DOI 10.1016/j.rmb.2015.04.008; Parravicini V, 2010, ESTUAR COAST SHELF S, V86, P276, DOI 10.1016/j.ecss.2009.11.004; Perez-Moreno JL, 2016, INT J SPELEOL, V45, P149, DOI 10.5038/1827-806X.45.2.1954; Pohlman JW, 2011, HYDROBIOLOGIA, V677, P33, DOI 10.1007/s10750-011-0624-5; Pohlman JW, 1997, MAR ECOL PROG SER, V155, P17, DOI 10.3354/meps155017; Rubio F, 2016, J MOLLUS STUD, V82, P169, DOI 10.1093/mollus/eyv049; Ruhl HA, 2007, ECOLOGY, V88, P1250, DOI 10.1890/06-0890; Salinas JG, 1985, METODOS QUIMICOS ANA; Schmitter-Soto JJ, 2002, HYDROBIOLOGIA, V467, P215, DOI 10.1023/A:1014923217206; Scotti G., 2017, J MAR SCI RES DEV, V7, P1, DOI DOI 10.4172/2155-9910.1000238; Simon KS, 2007, J CAVE KARST STUD, V69, P279; Sket B, 1996, TRENDS ECOL EVOL, V11, P221, DOI 10.1016/0169-5347(96)20031-X; Solis-Marin FA, 2007, BIODIVERSIDAD ACUATI, P187; Solis-Marin FA, 2010, ECHINODERMS: DURHAM, P259; Solis-Marin FA, 2010, REV MEX BIODIVERS, V81, P663; STOCK JH, 1986, STYGOLOGIA, V2, P90; STOESSELL RK, 1995, GROUND WATER, V33, P366, DOI 10.1111/j.1745-6584.1995.tb00291.x; Suarez-Morales E, 2005, B MAR SCI, V77, P409; Suarez-Morales E., 1998, REV SOC MEXICANA HIS, V48, P37; Suarez-Morales E, 2017, B MAR SCI, V93, P863, DOI 10.5343/bms.2017.1012; Suarez-Morales E, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.671.12052; Talamante Olmo Torres, 2012, Natura Croatica, V21, P95; Telesh IV, 2010, MAR POLLUT BULL, V61, P149, DOI 10.1016/j.marpolbul.2010.02.008; Pisanty DT, 2010, CAH BIOL MAR, V51, P177; Vacelet J, 1996, BIOSYST ECOL SER, P299; Volkmer-Ribeiro Cecilia, 2010, Neotropical Biology and Conservation, V5, P53, DOI 10.4013/nbc.2010.51.08; Voros J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170945; WoRMS Editorial Board, 2017, WORLD REGISTER MARIN, DOI 10.14284/170; Yanez-Mendoza G, 2011, MANUAL BUCEO SUBTERR; Yanez-Mendoza G., 2007, BIODIVERSIDAD ACUATI, P49	87	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0202909	10.1371/journal.pone.0202909	http://dx.doi.org/10.1371/journal.pone.0202909			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403661	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500004
J	Quan, TP; Hope, R; Clark, T; Moroney, R; Butcher, L; Knight, P; Crook, D; Hopkins, S; Peto, TEA; Johnso, AP; Walker, AS				Phuong Quan, T.; Hope, Russell; Clark, Tiphanie; Moroney, Ruth; Butcher, Lisa; Knight, Peter; Crook, Derrick; Hopkins, Susan; Peto, Timothy E. A.; Johnso, Alan P.; Walker, A. Sarah			Using linked electronic health records to report healthcare-associated infections	PLOS ONE			English	Article							SURVEILLANCE	Background Reporting of strategic healthcare-associated infections (HCAls) to Public Health England is mandatory for all acute hospital trusts in England, via a web-based HCAI Data Capture System (HCAI-DCS). Aim Investigate the feasibility of automating the current, manual, HCAI reporting using linked electronic health records (linked-EHR), and assess its level of accuracy. Methods All data previously submitted through the HCAI-DCS by the Oxford University Hospitals infection control (IC) team for methicillin-resistant and methicillin-susceptible Staphylococcus aureus (MRSA, MSSA), Clostridium difficile, and Escherichia coli, through March 2017 were downloaded and compared to outputs created from linked-EHR, with detailed comparisons between 2013-2017. Findings Total MRSA, MSSA, E. coli and C. difficile cases entered by the IC team vs linked-EHR were 428 vs 432, 795 vs 816, 2454 vs 2450 and 3365 vs 3393 respectively. From 2013-2017, most discrepancies (32/37 (86%)) were likely due to IC recording errors. Patient and specimen identifiers were completed for >98% of cases by both methods, with very high agreement (>97%). Fields relating to the patient at the time the specimen was taken were complete to a similarly high level (>99% IC, >97% linked-EHR), and agreement was fairly good (>80%) except for the main and treatment specialties (57% and 54% respectively) and the patient category (55%). Optional, organism-specific data-fields were less complete, by both methods. Where comparisons were possible, agreement was reasonably high (mostly 70-90%). Conclusion Basic factual information, such as demographic data, is almost-certainly better automated, and many other data fields can potentially be populated successfully from linked-EHR. Manual data collection is time-consuming and inefficient; automated electronic data collection would leave healthcare professionals free to focus on clinical rather than administrative work.	[Phuong Quan, T.; Crook, Derrick; Peto, Timothy E. A.; Johnso, Alan P.; Walker, A. Sarah] Univ Oxford, NIHR, Hlth Protect Res Unit Healthcare Associated Infec, Oxford, England; [Phuong Quan, T.; Knight, Peter; Crook, Derrick; Peto, Timothy E. A.; Walker, A. Sarah] Univ Oxford, Nuffield Dept Med, Oxford, England; [Hope, Russell; Crook, Derrick; Hopkins, Susan; Johnso, Alan P.] Publ Hlth England, Natl Infect Serv, London, England; [Clark, Tiphanie; Moroney, Ruth; Butcher, Lisa; Knight, Peter] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Knight, Peter; Crook, Derrick; Peto, Timothy E. A.; Walker, A. Sarah] NIHR Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; Public Health England; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Quan, TP (corresponding author), Univ Oxford, NIHR, Hlth Protect Res Unit Healthcare Associated Infec, Oxford, England.; Quan, TP (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	phuong.quan@ndm.ox.ac.uk	Hope, Russell/CAF-3297-2022; Walker, Sarah/HDM-8717-2022	Hope, Russell/0000-0003-2838-6833; Quan, Thai/0000-0001-8566-1817; Hopkins, Susan/0000-0001-5179-5702; peto, tim/0000-0003-3477-8307; Crook, Derrick/0000-0002-0590-2850	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford; Public Health England (PHE); NIHR Oxford Biomedical Research Centre	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford; Public Health England (PHE); NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Healthcare Associated Infections and Antimicrobial Resistance at University of Oxford in partnership with Public Health England (PHE); and supported by the NIHR Oxford Biomedical Research Centre. TPQ is based at University of Oxford. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England.	Alvarez LG, 2011, J HOSP INFECT, V79, P231, DOI 10.1016/j.jhin.2011.06.016; Finney JM, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-7; Freeman R, 2013, J HOSP INFECT, V84, P106, DOI 10.1016/j.jhin.2012.11.031; Johnson AP, 2012, J ANTIMICROB CHEMOTH, V67, P802, DOI 10.1093/jac/dkr561; Public Health England, 2017, LAB SURV STAPH AUR B; Public Health England, 2015, VOL SURV CLOSTR DIFF; Public Health England, 2016, MAND ENH MRSA MSSA E; Russo PL, 2018, J HOSP INFECT, V99, P1, DOI 10.1016/j.jhin.2017.09.002; Wilson APR, 2012, J ANTIMICROB CHEMOTH, V67, pI23, DOI 10.1093/jac/dks198	9	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206860	10.1371/journal.pone.0206860	http://dx.doi.org/10.1371/journal.pone.0206860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403746	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500077
J	Ruedenauer, FA; Wohrle, C; Spaethe, J; Leonhardt, SD				Ruedenauer, Fabian A.; Woehrle, Christine; Spaethe, Johannes; Leonhardt, Sara D.			Do honeybees (Apis mellifera) differentiate between different pollen types?	PLOS ONE			English	Article							PROBOSCIS EXTENSION REFLEX; SUCROSE RESPONSIVENESS; NUTRITIONAL CONTENT; JUVENILE-HORMONE; FLOWER CONSTANCY; BEE; DISCRIMINATION; BUMBLEBEES; PROTEIN; ODORS	Bees receive nectar and pollen as reward for pollinating plants. Pollen of different plant species varies widely in nutritional composition. In order to select pollen of appropriate nutritional quality, bees would benefit if they could distinguish different pollen types. Whether they rely on visual, olfactory and/or chemotactile cues to distinguish between different pollen types, has however been little studied. In this study, we examined whether and how Apis mellifera workers differentiate between almond and apple pollen. We used differential proboscis extension response conditioning with olfactory and chemotactile stimulation, in light and darkness, and in summer and winter bees. We found that honeybees were only able to differentiate between different pollen types, when they could use both chemotactile and olfactory cues. Visual cues further improved learning performance. Summer bees learned faster than winter bees. Our results thus highlight the importance of multisensory information for pollen discrimination.	[Ruedenauer, Fabian A.; Woehrle, Christine; Leonhardt, Sara D.] Univ Wurzburg, Dept Anim Ecol & Trop Biol, Biozentrum, Wurzburg, Germany; [Spaethe, Johannes] Univ Wurzburg, Dept Behav Physiol & Sociobiol, Biozentrum, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Leonhardt, SD (corresponding author), Univ Wurzburg, Dept Anim Ecol & Trop Biol, Biozentrum, Wurzburg, Germany.	sara.leonhardt@uni-wuerzburg.de	Leonhardt, Sara/AAI-6901-2020	Leonhardt, Sara/0000-0002-8154-9569; Ruedenauer, Fabian A./0000-0002-2509-0554	Deutsche Forschungsgemeinschaft (DFG) [LE 2750/5-1, SP1380/1-1]; University of Wuerzburg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, LE 2750/5-1 to SDL and SP1380/1-1 to JS) and the University of Wuerzburg in the funding programme Open Access Publishing. The DFG also provided the salary for FAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Leonie Lichtenstein for advice on the experimental setup and the handling of bees and Dirk Ahrens-Lagast for keeping and managing the honeybee colonies. We are further grateful to Simon Sprecher and an anonymous reviewer whose comments greatly improved the presentation of our study. Funding was provided by the Deutsche Forschungsgemeinschaft (DFG project: LE 2750/5-1) and the University of Wuerzburg in the funding programme Open Access Publishing.	Alaux C, 2010, BIOL LETTERS, V6, P562, DOI 10.1098/rsbl.2009.0986; Almeida-Muradian LB, 2005, J FOOD COMPOS ANAL, V18, P105, DOI 10.1016/j.jfca.2003.10.008; Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; Archer CR, 2014, FUNCT ECOL, V28, P913, DOI 10.1111/1365-2435.12226; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Chittka L, 1997, ISRAEL J PLANT SCI, V45, P169, DOI 10.1080/07929978.1997.10676682; Cook SM, 2005, PHYSIOL ENTOMOL, V30, P164, DOI 10.1111/j.1365-3032.2005.00445.x; de Brito Sanchez MG, 2011, CHEM SENSES, V36, P675, DOI 10.1093/chemse/bjr040; de GROOT A. P., 1953, PHYSIOL COMPARATA ET OECOL, V3, P197; Deisig N, 2002, LEARN MEMORY, V9, P112, DOI 10.1101/lm.41002; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; DIETZ A, 1971, ANN ENTOMOL SOC AM, V64, P919, DOI 10.1093/aesa/64.4.919; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Estevinho LM, 2012, INT J FOOD SCI TECH, V47, P429, DOI 10.1111/j.1365-2621.2011.02859.x; FEWELL JH, 1992, BEHAV ECOL SOCIOBIOL, V30, P387, DOI 10.1007/BF00176173; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; GOULSON D, 2003, BUMBLEBEES THEIR BEH; HUANG ZY, 1995, J COMP PHYSIOL B, V165, P18, DOI 10.1007/BF00264682; Human H, 2006, PHYTOCHEMISTRY, V67, P1486, DOI 10.1016/j.phytochem.2006.05.023; KATSUMATA T, 1975, Journal of the Faculty of Agriculture Iwate University, V12, P275; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; Kevan PG, 2001, J EXP BIOL, V204, P2571; Laloi D, 1999, ANN SOC ENTOMOL FR, V35, P154; Laska M, 1999, CHEM SENSES, V24, P429, DOI 10.1093/chemse/24.4.429; Leadbeater E, 2014, BEHAV ECOL SOCIOBIOL, V68, P1145, DOI 10.1007/s00265-014-1725-8; Manning R, 2001, BEE WORLD, V82, P60, DOI 10.1080/0005772X.2001.11099504; MCCALL C, 1992, AM J BOT, V79, P434, DOI 10.2307/2445156; MENZEL R, 1976, J COMP PHYSIOL, V108, P11, DOI 10.1007/BF00625437; Muth F, 2017, ANIM BEHAV, V126, P123, DOI 10.1016/j.anbehav.2017.01.010; Muth F, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0628; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Nicholls E, 2017, FUNCT ECOL, V31, P76, DOI 10.1111/1365-2435.12778; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pacini E, 2005, FLORA, V200, P399, DOI 10.1016/j.flora.2005.02.006; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pernal SF, 2001, BEHAV ECOL SOCIOBIOL, V51, P53, DOI 10.1007/s002650100412; Pernal SF, 2002, ANIM BEHAV, V63, P369, DOI 10.1006/anbe.2001.1904; PHAMDELEGUE MH, 1990, CR ACAD SCI III-VIE, V310, P527; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ray S, 1997, J APICULT RES, V36, P108, DOI 10.1080/00218839.1997.11100936; Ray S, 1999, DEV PSYCHOBIOL, V34, P21, DOI 10.1002/(SICI)1098-2302(199901)34:1<21::AID-DEV4>3.3.CO;2-B; Reinhard J, 2004, J EXP BIOL, V207, P4371, DOI 10.1242/jeb.01306; Riessberger U, 1997, APIDOLOGIE, V28, P411, DOI 10.1051/apido:19970608; Roger N, 2017, J INSECT PHYSIOL, V96, P128, DOI 10.1016/j.jinsphys.2016.11.002; Roulston TH, 2000, PLANT SYST EVOL, V222, P187, DOI 10.1007/BF00984102; Ruedenauer FA, 2017, J EXP BIOL, V220, P1435, DOI 10.1242/jeb.153122; Ruedenauer FA, 2016, BEHAV ECOL SOCIOBIOL, V70, P1209, DOI 10.1007/s00265-016-2129-8; Ruedenauer FA, 2015, J EXP BIOL, V218, P2233, DOI 10.1242/jeb.118554; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2003, APIDOLOGIE, V34, P67, DOI 10.1051/apido:2002050; SCHWARZ R, 1955, Z VERGL PHYSIOL, V37, P180, DOI 10.1007/BF00298308; SMITH BH, 1991, J COMP PSYCHOL, V105, P345, DOI 10.1037/0735-7036.105.4.345; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; Szymas B, 2003, APIDOLOGIE, V34, P97, DOI 10.1051/apido:2003012; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; TOGASAWA YOSHIHISA, 1967, NIPPON NOGEIKAGAKU KAISHI [J AGR CHEM SOC JAP], V41, P178; TOGASAWA YOSHIHISA, 1967, NIPPON NOGEIKAGAKU KAISHI [J AGR CHEM SOC JAP], V41, P184; VARESCHI E, 1971, Z VERGL PHYSIOL, V75, P143; von Frisch K, 1921, ZOOL JB ZOOL PHYSL, V38, P1; Wang TH, 2013, J AGR FOOD CHEM, V61, P5009, DOI 10.1021/jf400695w; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2004, CHEM SENSES, V29, P127, DOI 10.1093/chemse/bjh016; Wright GA, 2004, P ROY SOC B-BIOL SCI, V271, P147, DOI 10.1098/rspb.2003.2590; Wright GA, 2002, J CHEM ECOL, V28, P721, DOI 10.1023/A:1015232608858	69	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205821	10.1371/journal.pone.0205821	http://dx.doi.org/10.1371/journal.pone.0205821			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403699	Green Submitted, gold, Green Published			2022-12-26	WOS:000449379500025
J	Lynch, JM; Dolman, AJ; Guo, CY; Dolan, K; Xiang, CX; Reda, S; Li, B; Prasanna, G				Lynch, Jeffrey M.; Dolman, Andrew J.; Guo, Chenying; Dolan, Katie; Xiang, Chuanxi; Reda, Samir; Li, Bing; Prasanna, Ganesh			Mutant myocilin impacts sarcomere ultrastructure in mouse gastrocnemius muscle	PLOS ONE			English	Article							REGULATORY PHOSPHORYLATION SITE; OPEN-ANGLE GLAUCOMA; CREATINE-KINASE; M-BAND; ER STRESS; PROTEIN; GENE; MUTATIONS; TIGR; IDENTIFICATION	Myocilin (MYOC) is the gene with mutations most common in glaucoma. In the eye, MYOC is in trabecular meshwork, ciliary body, and retina. Other tissues with high MYOC transcript levels are skeletal muscle and heart. To date, the function of wild-type MYOC remains unknown and how mutant MYOC causes high intraocular pressure and glaucoma is ambiguous. By investigating mutant MYOC in a non-ocular tissue we hoped to obtain novel insight into mutant MYOC pathology. For this study, we utilized a transgenic mouse expressing human mutant MYOC Y437H protein and we examined its skeletal (gastrocnemius) muscle phenotype. Electron micrographs showed that sarcomeres in the skeletal muscle of mutant CMV-MYOC-Y437H mice had multiple M-bands. Western blots of soluble muscle lysates from transgenics indicated a decrease in two M-band proteins, myomesin 1 (MYOM1) and muscle creatine kinase (CKM). Immunoprecipitation identified CKM as a MYOC binding partner. Our results suggest that binding of mutant MYOC to CKM is changing sarcomere ultrastructure and this may adversely impact muscle function. We speculate that a person carrying the mutant MYOC mutation will likely have a glaucoma phenotype and may also have undiagnosed muscle ailments or vice versa, both of which will have to be monitored and treated.	[Lynch, Jeffrey M.; Dolman, Andrew J.; Guo, Chenying; Dolan, Katie; Xiang, Chuanxi; Reda, Samir; Li, Bing; Prasanna, Ganesh] Novartis Inst BioMed Res, Ophthalmol, Cambridge, MA 02139 USA	Novartis	Lynch, JM (corresponding author), Novartis Inst BioMed Res, Ophthalmol, Cambridge, MA 02139 USA.	jeffrey.lynch@novartis.com		Lynch, Jeff/0000-0002-4042-7872	Novartis Institutes for BioMedical Research (NIBR)	Novartis Institutes for BioMedical Research (NIBR)	Research funding was provided by Novartis Institutes for BioMedical Research (NIBR). NIBR provided support in the form of salaries for authors (JL, AD, CG, KD, CX, SR, BL, GP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Agarkova I, 2005, TRENDS CELL BIOL, V15, P477, DOI 10.1016/j.tcb.2005.07.001; Alessio HM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/950516; Alward WLM, 2002, ARCH OPHTHALMOL-CHIC, V120, P1189; Bertoncini P, 2005, J MOL BIOL, V348, P1127, DOI 10.1016/j.jmb.2005.03.040; Bittner RE, 1999, NAT GENET, V23, P141, DOI 10.1038/13770; Dordea AC, 2016, EXP EYE RES, V147, P50, DOI 10.1016/j.exer.2016.04.012; EDMAN AC, 1988, J ULTRA MOL STRUCT R, V100, P1, DOI 10.1016/0889-1605(88)90054-7; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Gentry B, 2011, MUSCLE NERVE, V43, P49, DOI 10.1002/mus.21796; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Guo CY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196529; Hornemann T, 2003, J MOL BIOL, V332, P877, DOI 10.1016/S0022-2836(03)00921-5; Hu LYR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/714197; Joe MK, 2003, BIOCHEM BIOPH RES CO, V312, P592, DOI 10.1016/j.bbrc.2003.10.162; Joe MK, 2012, J BIOL CHEM, V287, P13216, DOI 10.1074/jbc.M111.224063; Johnson DH, 2000, ARCH OPHTHALMOL-CHIC, V118, P974; Katzemich A, 2012, J CELL SCI, V125, P3367, DOI 10.1242/jcs.097345; Keller K, 2014, MUSCLES LIGAMENTS TR, V3, P346; KNAPPEIS GG, 1968, J CELL BIOL, V38, P202, DOI 10.1083/jcb.38.1.202; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Lundvall A, 2011, J GLAUCOMA, V20, P7, DOI 10.1097/IJG.0b013e3181d1d1ef; Lynch JM, 2012, CELL, V149, P1257, DOI 10.1016/j.cell.2012.03.050; Meurs KM, 2012, HUM GENET, V131, P1319, DOI 10.1007/s00439-012-1158-2; Moharir A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074299; Momken I, 2005, J PHYSIOL-LONDON, V565, P951, DOI 10.1113/jphysiol.2005.086397; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Nuss JE, 2009, AGING-US, V1, P557, DOI 10.18632/aging.100055; Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211; Obermann WMJ, 1998, MOL BIOL CELL, V9, P829, DOI 10.1091/mbc.9.4.829; Ogata T, 1997, ANAT REC, V248, P214; Ortego J, 1997, FEBS LETT, V413, P349, DOI 10.1016/S0014-5793(97)00934-4; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; PANG IH, 1994, CURR EYE RES, V13, P51, DOI 10.3109/02713689409042398; Piasecki M, 2016, BIOGERONTOLOGY, V17, P485, DOI 10.1007/s10522-015-9627-3; Picard M, 2013, J APPL PHYSIOL, V114, P161, DOI 10.1152/japplphysiol.01096.2012; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Potthoff MJ, 2007, MOL CELL BIOL, V27, P8143, DOI 10.1128/MCB.01187-07; Randazzo D, 2017, AM J PHYSIOL-CELL PH, V312, pC16, DOI 10.1152/ajpcell.00098.2016; Samples J., 2010, GLAUCOMA BOOK PRACTI; Savinova OV, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-12; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; Shepard AR, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-5; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Vafiadaki E, 2000, GENETICS NERVOUS SYS, V12, P625; VANDEURSEN J, 1993, CELL, V74, P621, DOI 10.1016/0092-8674(93)90510-W; VANDEURSEN J, 1994, P NATL ACAD SCI USA, V91, P9091, DOI 10.1073/pnas.91.19.9091; Ventura-Clapier R, 2004, MOL CELL BIOCHEM, V256, P29, DOI 10.1023/B:MCBI.0000009857.69730.97; Weller AH, 1997, MUSCLE NERVE, V20, P72, DOI 10.1002/(SICI)1097-4598(199701)20:1<72::AID-MUS10>3.0.CO;2-3; Wiggs JL, 1998, AM J HUM GENET, V63, P1549, DOI 10.1086/302098; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zillig M, 2005, INVEST OPHTH VIS SCI, V46, P223, DOI 10.1167/iovs.04-0988; Zode GS, 2011, J CLIN INVEST, V121, P3542, DOI 10.1172/JCI58183	58	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206801	10.1371/journal.pone.0206801	http://dx.doi.org/10.1371/journal.pone.0206801			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395621	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400054
J	Ahn, KH; Lee, EH; Cho, GJ; Hong, SC; Oh, MJ; Kim, HJ				Ahn, Ki Hoon; Lee, Eun Hee; Cho, Geum Joon; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong			Anterior placenta previa in the mid-trimester of pregnancy as a risk factor for neonatal respiratory distress syndrome	PLOS ONE			English	Article							CESAREAN-SECTION; INFANTS BORN; MANAGEMENT; OUTCOMES; PRETERM; 2ND; DIAGNOSIS; LOCATION; ANEMIA; LABOR	This study investigated whether anterior placenta previa in the second trimester is associated with neonatal respiratory distress syndrome (RDS). The neonates delivered by 2067 women between 2007 and 2015 were evaluated for the presence of RDS through birth records. The location of the placenta and the presence of placenta previa during the second and third trimesters were assessed and recorded. Demographic, prenatal, and perinatal records were reviewed. Anterior placenta previa in the second and third trimesters was correlated with RDS. Infants with lower gestational ages and birth weights had higher rates of RDS. Multivariate logistic regression analysis identified a significant association between anterior placenta previa in the second trimester and neonatal RDS. Anterior placenta previa in the second trimester is associated with neonatal RDS. Obstetricians should be aware that anterior placenta previa detected during the second trimester, irrespective of whether the placenta will migrate in the third trimester, may be an independent risk factor for neonatal RDS.	[Ahn, Ki Hoon; Cho, Geum Joon; Hong, Soon-Cheol; Oh, Min-Jeong; Kim, Hai-Joong] Korea Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea; [Lee, Eun Hee] Korea Univ, Dept Pediat, Coll Med, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Ahn, KH (corresponding author), Korea Univ, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea.	akh1220@hanmail.net	Rhim, Sonny H./W-9532-2019	AHN, KI HOON/0000-0002-6314-4621				Anadkat JS, 2012, J PERINATOL, V32, P780, DOI 10.1038/jp.2011.191; Baba Y, 2014, J OBSTET GYNAECOL RE, V40, P1243, DOI 10.1111/jog.12340; Bekku S, 2009, J MATERN FETAL MED, V9, P110; Berthelot-Ricou A, 2013, J MATERN-FETAL NEO M, V26, P176, DOI 10.3109/14767058.2012.733743; Bizzarro MJ, 2004, PEDIATR CLIN N AM, V51, P1087, DOI 10.1016/j.pcl.2004.03.006; Cooley SM, 2011, J MATERN-FETAL NEO M, V24, P493, DOI 10.3109/14767058.2010.497877; Crane JMG, 1999, OBSTET GYNECOL, V93, P541, DOI 10.1016/S0029-7844(98)00480-3; Durnwald CP, 2008, J MATERN-FETAL NEO M, V21, P247, DOI 10.1080/14767050801926709; Eichelberger KY, 2011, AM J PERINAT, V28, P735, DOI 10.1055/s-0031-1280853; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; Jang DG, 2011, INT J MED SCI, V8, P554, DOI 10.7150/ijms.8.554; Kong XY, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0716-5; KURMANAVICHIUS J, 1990, EUR J OBSTET GYN R B, V35, P139, DOI 10.1016/0028-2243(90)90154-S; Lin CH, 2001, EARLY HUM DEV, V60, P215, DOI 10.1016/S0378-3782(00)00121-3; Liu J, 2010, CHINESE MED J-PEKING, V123, P2640, DOI 10.3760/cma.j.issn.0366-6999.2010.19.004; Ogueh O, 2003, INT J GYNECOL OBSTET, V83, P11, DOI 10.1016/S0020-7292(03)00211-X; Osmundson SS, 2013, J ULTRAS MED, V32, P631, DOI 10.7863/jum.2013.32.4.631; Qiu XM, 2008, OBSTET GYNECOL, V111, P365, DOI 10.1097/AOG.0b013e318162688f; Robinson AJ, 2012, AUST NZ J OBSTET GYN, V52, P156, DOI 10.1111/j.1479-828X.2012.01416.x; Schneiderman M, 2013, J MATERN-FETAL NEO M, V26, P1121, DOI 10.3109/14767058.2013.770465; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Torricelli M, 2015, PLACENTA, V36, P463, DOI 10.1016/j.placenta.2014.12.018; Tsuda H, 2014, EARLY HUM DEV, V90, P51, DOI 10.1016/j.earlhumdev.2013.10.005	23	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0207061	10.1371/journal.pone.0207061	http://dx.doi.org/10.1371/journal.pone.0207061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388184	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800076
J	Chen, SM; Kuhn, M; Prettner, K; Bloom, DE				Chen, Simiao; Kuhn, Michael; Prettner, Klaus; Bloom, David E.			The macroeconomic burden of noncommunicable diseases in the United States: Estimates and projections	PLOS ONE			English	Article							ECONOMIC BURDEN; HEALTH-CARE; DEMOGRAPHIC-CHANGE; LIFE-CYCLE; PRODUCTIVITY; RETIREMENT; OSTEOPOROSIS; DISORDERS; GROWTH; IMPACT	We develop and calibrate a dynamic production function model to assess how noncommunicable diseases (NCDs) will affect U.S. productive capacity in 2015-2050. In this framework, aggregate output is produced according to a human capital-augmented production function that accounts for the effects of projected disease prevalence. NCDs influence the economy through the following pathways: 1) when working-age individuals die of a disease, aggregate output undergoes a direct loss because physical capital can only partially substitute for the loss of human capital in the production process. 2) If working-age individuals suffer from a disease but do not die from it, then, depending on the condition's severity, they tend to be less productive, might work less, or might retire earlier. 3) Current NCD interventions such as medical treatments and prevention require substantial resources. Part of these resources could otherwise be used for productive investments in infrastructure, education, or research and development. This implies a loss of savings across the population and hampers economy-wide physical capital accumulation. Our results indicate a total loss of USD94.9 trillion (in constant 2010 USD) due to all NCDs. Mental health conditions and cardiovascular diseases impose the highest burdens, followed by cancer, diabetes, and chronic respiratory diseases. In per capita terms, the economic burden of all NCDs in 2015-2050 is USD265,000. The total NCD burden roughly corresponds to an annual tax rate of 10.8% on aggregate income.	[Chen, Simiao] Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany; [Kuhn, Michael] Vienna Inst Demog, Wittgenste Ctr, IIASA, VID OAW,WU, Vienna, Austria; [Prettner, Klaus] Univ Hohenheim, Inst Econ, Stuttgart, Germany; [Bloom, David E.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Ruprecht Karls University Heidelberg; International Institute for Applied Systems Analysis (IIASA); University Hohenheim; Harvard University; Harvard T.H. Chan School of Public Health	Chen, SM (corresponding author), Heidelberg Univ, Heidelberg Inst Global Hlth, Heidelberg, Germany.; Bloom, DE (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.	sic104@mail.harvard.edu; dbloom@hsph.harvard.edu	Chen, Simiao/O-4017-2017	Chen, Simiao/0000-0003-0555-2157; Prettner, Klaus/0000-0002-8971-8750; Kuhn, Michael/0000-0003-0424-3221; Bloom, David/0000-0003-3731-3345	National Institute on Aging, National Institutes of Health [P30AG024409, R01AG048037]; Carnegie Corporation of New York; NATIONAL INSTITUTE ON AGING [R01AG048037, P30AG024409] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Carnegie Corporation of New York; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Research reported in this paper was supported by the National Institute on Aging, National Institutes of Health, under award numbers P30AG024409 and R01AG048037. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This research was also made possible by a grant from the Carnegie Corporation of New York (https://www.carnegie.org < https://www.carnegie.org/>). The statements made and views expressed are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GF, 2003, HEALTH AFFAIR, V22, P89, DOI 10.1377/hlthaff.22.3.89; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Barro RJ, 2013, J DEV ECON, V104, P184, DOI 10.1016/j.jdeveco.2012.10.001; BENPORATH Y, 1967, J POLIT ECON, V75, P352, DOI 10.1086/259291; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; BLANCHARD OJ, 1985, J POLIT ECON, V93, P223, DOI 10.1086/261297; Bloom DE, 2007, J MONETARY ECON, V54, P92, DOI 10.1016/j.jmoneco.2006.12.004; Bloom DE, 2018, SCIENCE, V361, DOI 10.1126/science.aat9644; Bloom DE, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/rpsp.2018.18, 10.26633/RPSP.2018.18]; Bloom DE, 2014, J ECON AGEING, V4, P100, DOI 10.1016/j.jeoa.2014.08.003; Bloom DE, 2014, SCAND J ECON, V116, P838, DOI 10.1111/sjoe.12060; Bloom DE, 2003, SCAND J ECON, V105, P319, DOI 10.1111/1467-9442.t01-1-00001; BLOOM DE, 2018, OXFORD ENCYCLOPEDIA, V361, P766; Bloom DE, 2015, EC NONCOMMUNICABLE D; Bloom DE, 2017, NATL BUREAU EC RES W, DOI [10.3386/w23601, DOI 10.3386/W23601]; Bloom DE, 2018, J EC AGEING; Bloom DE, 2011, GLOBAL EC BURDEN NON; Bradley CJ, 2013, J CANCER SURVIV, V7, P227, DOI 10.1007/s11764-012-0263-5; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Cervellati M, 2013, ECONOMETRICA, V81, P2055, DOI 10.3982/ECTA11169; Chaker L, 2015, EUR J EPIDEMIOL, V30, P357, DOI 10.1007/s10654-015-0026-5; Davis MA, 2017, J AM BOARD FAM MED, V30, P407, DOI 10.3122/jabfm.2017.04.170112; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dwyer DS, 1999, J HEALTH ECON, V18, P173, DOI 10.1016/S0167-6296(98)00034-4; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Feenstra RC, 2015, AM ECON REV, V105, P3150, DOI 10.1257/aer.20130954; Florence CS, 2016, MED CARE, V54, P901, DOI 10.1097/MLR.0000000000000625; Frankovic I, 2018, ECON WPS VIENNA U TE; Garthwaite CL, 2012, AM ECON J-APPL ECON, V4, P116, DOI 10.1257/app.4.3.116; Heckman J.J., 2006, HDB EC ED, V1, P307, DOI DOI 10.1016/S1574-0692(06)01007-5; Jackle R, 2010, J HUM RESOUR, V45, P364; Korenstein D, 2012, ARCH INTERN MED, V172, P171, DOI 10.1001/archinternmed.2011.772; Krueger D, 2007, J MONETARY ECON, V54, P49, DOI 10.1016/j.jmoneco.2006.12.016; Kuhn M, 2016, J HEALTH ECON, V46, P100, DOI 10.1016/j.jhealeco.2016.01.009; Lindeboom M, 2009, J APPL ECONOMET, V24, P1024, DOI 10.1002/jae.1077; LUCAS RE, 1988, J MONETARY ECON, V22, P3, DOI 10.1016/0304-3932(88)90168-7; McGarry K, 2004, J HUM RESOUR, V39, P624, DOI 10.2307/3558990; Mincer J., 1974, SCH EXPERIENCE EARNI, V2; Montenegro C.E., 2014, 7020 WORLD BANK GROU, DOI [10.1596/1813-9450-7020, DOI 10.1596/1813-9450-7020]; Nair K, 2012, POPUL HEALTH MANAG, V15, P267, DOI 10.1089/pop.2011.0049; OECD, 2017, HLTH GLANC 2017 OECD; OECD, 2018, OECD EC SURV US PAR; Sasser AC, 2005, WOMEN HEALTH ISS, V15, P97, DOI 10.1016/j.whi.2004.11.006; Skinner J, 2015, REV ECON STAT, V97, P951, DOI 10.1162/REST_a_00535; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Squires David, 2015, Issue Brief (Commonw Fund), V15, P1; Stanciole A., 2006, ESTIMATION EC IMPACT; Suhrcke M., 2006, CHRONIC DIS EC PERSP; University of Groningen and University of California, 2017, CAP STOCK CONST NAT; World Bank, 2018, WORLD BANK DAT GROSS; World Bank, 2017, GLOB EC PROSP; World Health Organization, 2017, TOG ROAD UN HLTH COV; World Health Organization, 2017, WHO METH DAT SOURC G; World Health Organization, 2016, GLOB HLTH EST 2015 B; Zhao ZX, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-35	56	62	63	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206702	10.1371/journal.pone.0206702	http://dx.doi.org/10.1371/journal.pone.0206702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383802	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000449027600087
J	Makinde, HM; Just, TB; Cuda, CM; Bertolino, N; Procissi, D; Schwulst, SJ				Makinde, Hadijat M.; Just, Talia B.; Cuda, Carla M.; Bertolino, Nicola; Procissi, Daniele; Schwulst, Steven J.			Monocyte depletion attenuates the development of posttraumatic hydrocephalus and preserves white matter integrity after traumatic brain injury	PLOS ONE			English	Article							DIFFUSION TENSOR; MILD; REHABILITATION; DISORDERS; ABNORMALITIES; DISABILITY; SYMPTOMS; MRI	Monocytes are amongst the first cells recruited into the brain after traumatic brain injury (TBI). We have shown monocyte depletion 24 hours prior to TBI reduces brain edema, decreases neutrophil infiltration and improves behavioral outcomes. Additionally, both lesion and ventricle size correlate with poor neurologic outcome after TBI. Therefore, we aimed to determine the association between monocyte infiltration, lesion size, and ventricle volume. We hypothesized that monocyte depletion would attenuate lesion size, decrease ventricle enlargement, and preserve white matter in mice after TBI. C57BL/6 mice underwent pan monocyte depletion via intravenous injection of liposome-encapsulated clodronate. Control mice were injected with liposome-encapsulated PBS. TBI was induced via an open-head, controlled cortical impact. Mice were imaged using magnetic resonance imaging (MRI) at 1, 7, and 14 days post-injury to evaluate progression of lesion and to detect morphological changes associated with injury (3D T1-weighted MRI) including regional alterations in white matter patterns (multi-direction diffusion MRI). Lesion size and ventricle volume were measured using semi-automatic segmentation and active contour methods with the software program ITK-SNAP. Data was analyzed with the statistical software program PRISM. No significant effect of monocyte depletion on lesion size was detected using MRI following TBI (p = 0.4). However, progressive ventricle enlargement following TBI was observed to be attenuated in the monocyte-depleted cohort (5.3 +/- 0.9mm(3)) as compared to the sham-depleted cohort (13.2 +/- 3.1mm(3); p = 0.02). Global white matter integrity and regional patterns were evaluated and quantified for each mouse after extracting fractional anisotropy maps from the multi-direction diffusion-MRI data using Siemens Syngo DTI analysis package. Fractional anisotropy (FA) values were preserved in the monocyte-depleted cohort (123.0 +/- 4.4mm(3)) as compared to sham-depleted mice (94.9 +/- 4.6mm(3); p = 0.025) by 14 days post-TBI. All TBI mice exhibited FA values lower than those from a representative naive control group with intact white matter tracts and FA similar to 200 mm(3)). The MRI derived assessment of injury progression suggests that monocyte depletion at the time of injury may be a novel therapeutic strategy in the treatment of TBI. Furthermore, non-invasive longitudinal imaging allows for the evaluation of both TBI progression as well as therapeutic response over the course of injury.	[Makinde, Hadijat M.; Just, Talia B.; Schwulst, Steven J.] Northwestern Univ, Div Trauma & Crit Care, Dept Surg, Chicago, IL 60611 USA; [Cuda, Carla M.] Northwestern Univ, Dept Med, Div Rheumatol, Chicago, IL 60611 USA; [Bertolino, Nicola; Procissi, Daniele] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Procissi, Daniele] Northwestern Univ, Dept Biomed Engn, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Schwulst, SJ (corresponding author), Northwestern Univ, Div Trauma & Crit Care, Dept Surg, Chicago, IL 60611 USA.	s-schwulst@northwestern.edu		Procissi, Daniele/0000-0001-5350-0170; Schwulst, Steven/0000-0003-4248-8545; Bertolino, Nicola/0000-0002-5924-0995; Just, Talia/0000-0002-6372-7974; Makinde, Hadijat-Kubura/0000-0001-8492-4187; Cuda, Carla/0000-0002-2022-8171	National Institutes of Health/National Institute of General Medical Sciences [1K08GM117341-01]; American College of Surgeons/C. James Carrico Faculty Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM117341] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American College of Surgeons/C. James Carrico Faculty Research Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 1) National Institutes of Health/National Institute of General Medical Sciences, Grant number: 1K08GM117341-01, Granted to SJS. 2) American College of Surgeons/C. James Carrico Faculty Research Award, No grant number, Granted to SJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badea A, 2012, NEUROIMAGE, V63, P1633, DOI 10.1016/j.neuroimage.2012.07.021; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Dall'Ara E, 2016, MECH AGEING DEV, V160, P93, DOI 10.1016/j.mad.2016.08.001; Di G, 2018, WORLD NEUROSURG; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fotakopoulos G, 2016, J NEUROL SURG PART A, V77, P88, DOI 10.1055/s-0035-1558411; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Hu QX, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00337; Jin X, 2012, J SOFTWARE, V7, P6, DOI DOI 10.1371/J0URNAL.P0NE.0041892; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Makinde HM, 2017, SHOCK, V48, P276, DOI 10.1097/SHK.0000000000000859; Martin LA, 2013, JAMA PSYCHIAT, V70, P1100, DOI 10.1001/jamapsychiatry.2013.1985; Mazzini L, 2003, ARCH PHYS MED REHAB, V84, P1637, DOI 10.1053/S0003-9993(03)00314-9; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Nasi D, 2018, WORLD NEUROSURG; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Pearson WS, 2012, WEST J EMERG MED, V13, P289, DOI 10.5811/westjem.2012.3.11559; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scholz J, 2016, NEUROIMAGE, V142, P656, DOI 10.1016/j.neuroimage.2016.03.069; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Trahanas DM, 2015, SHOCK, V43, P255, DOI 10.1097/SHK.0000000000000291; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Vadivelu S, 2016, NEUROSURG FOCUS, V41, DOI 10.3171/2016.8.FOCUS16266; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Weintraub AH, 2017, ARCH PHYS MED REHAB, V98, P312, DOI 10.1016/j.apmr.2016.08.478; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1877, DOI 10.1016/j.apmr.2012.12.027; Whyte J, 2013, ARCH PHYS MED REHAB, V94, P1855, DOI 10.1016/j.apmr.2012.10.041; Wu YJL, 2017, BIRTH DEFECTS RES, V109, P758, DOI 10.1002/bdr2.1051; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	42	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0202722	10.1371/journal.pone.0202722	http://dx.doi.org/10.1371/journal.pone.0202722			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383765	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600006
J	Asnaghi, L; Whiten, DT; Key, N; Choi, JH; Mahale, A; Alkatan, H; Edward, DP; Elkhamary, SM; Al-Mesfer, S; Maktabi, A; Hurtado, CG; Leen, GY; Carcaboso, AM; Mumm, JS; Abu Safieh, L; Eberhart, CG				Asnaghi, Laura; Whiten, David T.; Key, Nolan; Choi, Joshua; Mahale, Alka; Alkatan, Hind; Edward, Deepak P.; Elkhamary, Sahar M.; Al-Mesfer, Saleh; Maktabi, Azza; Hurtado, Christopher G.; Leen, Grace Y.; Carcaboso, Angel M.; Mumm, Jeff S.; Abu Safieh, Leen; Eberhart, Charles G.			ACVR1C/SMAD2 signaling promotes invasion and growth in retinoblastoma	ONCOGENE			English	Article							TGF-BETA; TUMORIGENIC PHENOTYPE; CELL-GROWTH; ACTIVIN-A; CANCER; RECEPTOR; PROTEINS; DIFFERENTIATION; EXPRESSION; REVEALS	Retinoblastoma is the most common intraocular cancer in children. While the primary tumor can often be treated by local or systemic chemotherapy, metastatic dissemination is generally resistant to therapy and remains a leading cause of pediatric cancer death in much of the world. In order to identify new therapeutic targets in aggressive tumors, we sequenced RNA transcripts in five snap frozen retinoblastomas which invaded the optic nerve and five which did not. A three-fold increase was noted in mRNA levels of ACVR1C/ALK7, a type I receptor of the TGF-beta family, in invasive retinoblastomas, while downregulation of DACT2 and LEFTY2, negative modulators of the ACVR1C signaling, was observed in most invasive tumors. A two-to three-fold increase in ACVR1C mRNA was also found in invasive WERI Rb1 and Y79 cells as compared to non-invasive cells in vitro. Transcripts of ACVR1C receptor and its ligands (Nodal, Activin A/B, and GDF3) were expressed in six retinoblastoma lines, and evidence of downstream SMAD2 signaling was present in all these lines. Pharmacological inhibition of ACVR1C signaling using SB505124, or genetic downregulation of the receptor using shRNA potently suppressed invasion, growth, survival, and reduced the protein levels of the mesenchymal markers ZEB1 and Snail. The inhibitory effects on invasion, growth, and proliferation were recapitulated by knocking down SMAD2, but not SMAD3. Finally, in an orthotopic zebrafish model of retinoblastoma, a 55% decrease in tumor spread was noted (p = 0.0026) when larvae were treated with 3 mu M of SB505124, as compared to DMSO. Similarly, knockdown of ACVR1C in injected tumor cells using shRNA also resulted in a 54% reduction in tumor dissemination in the zebrafish eye as compared to scrambled shRNA control (p = 0.0005). Our data support a role for the ACVR1C/SMAD2 pathway in promoting invasion and growth of retinoblastoma.	[Asnaghi, Laura; Key, Nolan; Choi, Joshua; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Whiten, David T.; Edward, Deepak P.; Hurtado, Christopher G.; Leen, Grace Y.; Mumm, Jeff S.; Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Mahale, Alka; Alkatan, Hind; Edward, Deepak P.; Elkhamary, Sahar M.; Al-Mesfer, Saleh; Maktabi, Azza; Abu Safieh, Leen] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Edward, Deepak P.] Univ Illinois, Eye & Ear Infirm, Chicago, IL 60612 USA; [Elkhamary, Sahar M.] Mansoura Fac Med, Dept Diagnost Radiol, Mansoura, Egypt; [Carcaboso, Angel M.] Inst Rec St Joan de Deu, Barcelona, Spain; [Eberhart, Charles G.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Alkatan, Hind] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh, Saudi Arabia	Johns Hopkins University; Johns Hopkins University; King Khaled Eye Specialist Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Egyptian Knowledge Bank (EKB); Mansoura University; Johns Hopkins University; King Saud University	Eberhart, CG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.; Eberhart, CG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA.; Abu Safieh, L (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.; Eberhart, CG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.	leensafieh@yahoo.co.uk; ceberha@jhmi.edu	Elkhamary, Sahar M/AAR-6991-2020; ALKATAN, HIND M/AAU-3752-2021; Elkhamary, Sahar M/R-2021-2017; Mumm, Jeff S/F-3125-2013; Elkhamary, Sahar M/Z-1797-2018	Elkhamary, Sahar M/0000-0001-8694-4376; ALKATAN, HIND M/0000-0002-9968-4099; Elkhamary, Sahar M/0000-0001-8694-4376; Elkhamary, Sahar M/0000-0001-8694-4376; Mumm, Jeff/0000-0002-2575-287X; Lee, Grace/0000-0003-1999-0836; Carcaboso, Angel/0000-0002-8485-426X	King Khaled Eye Specialist Hospital (KKESH)-Wilmer Eye Institute (WEI) Collaborative Research Grant; NIH [R21CA229919]; Jenny Fund; ISCIII-FEDER [CP13/00189]; MINECO (Retos program; Cure4RB project) [RTC-2015-4319-1];  [EY001765]; NATIONAL CANCER INSTITUTE [R21CA229919] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY001765, T32EY007143] Funding Source: NIH RePORTER	King Khaled Eye Specialist Hospital (KKESH)-Wilmer Eye Institute (WEI) Collaborative Research Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jenny Fund; ISCIII-FEDER; MINECO (Retos program; Cure4RB project); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	King Khaled Eye Specialist Hospital (KKESH)-Wilmer Eye Institute (WEI) Collaborative Research Grant, NIH Grant R21CA229919, the core grant EY001765, and The Jenny Fund. AMC acknowledges funding from ISCIII-FEDER (CP13/00189) and MINECO (Retos program; Cure4RB project RTC-2015-4319-1).	Arima Y, 2012, J BIOL CHEM, V287, P7896, DOI 10.1074/jbc.M111.313759; Asnaghi L, 2016, ONCOTARGET, V7, P70028, DOI 10.18632/oncotarget.12142; Asnaghi L, 2013, INVEST OPHTH VIS SCI, V54, P295, DOI 10.1167/iovs.12-10209; Badhu B, 2005, CLIN EXP OPHTHALMOL, V33, P386, DOI 10.1111/j.1442-9071.2005.01010.x; Bashir M, 2015, NPJ BREAST CANCER, V1, DOI 10.1038/npjbcancer.2015.7; Bertacchi M, 2015, STEM CELL REP, V5, P532, DOI 10.1016/j.stemcr.2015.08.011; Bondestam J, 2001, CYTOGENET CELL GENET, V95, P157, DOI 10.1159/000059339; Busch M, 2018, ONCOL REP, V39, P160, DOI 10.3892/or.2017.6100; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Chantada GL, 2011, PEDIATR BLOOD CANCER, V56, P341, DOI 10.1002/pbc.22843; Chawla B, 2016, OPHTHALMOLOGY, V123, P1933, DOI 10.1016/j.ophtha.2016.05.034; Chen XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10351; Chung IC, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-348; Condro MC, 2016, J COMP NEUROL, V524, P3827, DOI 10.1002/cne.24035; Gong WC, 2016, ONCOTARGET, V7, P70152, DOI 10.18632/oncotarget.12161; Gray PC, 2012, FEBS LETT, V586, P1836, DOI 10.1016/j.febslet.2012.01.051; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Hamilton L, 2016, ZEBRAFISH, V13, P523, DOI 10.1089/zeb.2016.1339; Honavar Santosh G, 2005, Ophthalmol Clin North Am, V18, P65, DOI 10.1016/j.ohc.2004.09.001; Hu TT, 2017, ANTICANCER RES, V37, P3441, DOI 10.21873/anticanres.11712; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Joseph JV, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.395; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kanno C, 2009, CURR EYE RES, V34, P652, DOI 10.1080/02713680903007147; Kirsammer G, 2014, SEMIN CANCER BIOL, V29, P40, DOI 10.1016/j.semcancer.2014.07.007; Lawrence MG, 2011, PROSTATE, V71, P1198, DOI 10.1002/pros.21335; Leal-Leal Carlos A, 2006, Clin Transl Oncol, V8, P39, DOI 10.1007/s12094-006-0093-x; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Liu Y, 2017, INT J MOL MED, V40, P1172, DOI 10.3892/ijmm.2017.3102; Liu YQ, 2013, J BIOL CHEM, V288, P11572, DOI 10.1074/jbc.M112.434951; Lonardo E, 2011, CELL STEM CELL, V9, P433, DOI 10.1016/j.stem.2011.10.001; Loomans HA, 2016, AM J CANCER RES, V6, P2431; Lv FZ, 2015, INT J IMMUNOPATH PH, V28, P77, DOI 10.1177/0394632015572557; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCFALL RC, 1977, CANCER RES, V37, P1003; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Pacifici M, 2016, CYTOKINE GROWTH F R, V27, P93, DOI 10.1016/j.cytogfr.2015.12.007; Pascual-Pasto G, 2016, CANCER LETT, V380, P10, DOI 10.1016/j.canlet.2016.06.012; Peng L, 2017, ONCOTARGET, V8, P34387, DOI 10.18632/oncotarget.16166; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; REID TW, 1974, J NATL CANCER I, V53, P347, DOI 10.1093/jnci/53.2.347; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakami S, 2008, MECH DEVELOP, V125, P106, DOI 10.1016/j.mod.2007.10.001; Schmierer B, 2003, J BIOL CHEM, V278, P21197, DOI 10.1074/jbc.M212425200; Schubert FR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-157; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strizzi Luigi, 2009, Expert Rev Dermatol, V4, P67, DOI 10.1586/17469872.4.1.67; Tanaka K, 2007, ONCOGENE, V26, P6456, DOI 10.1038/sj.onc.1210459; Teng Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-453; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Villegas VM, 2013, CURR OPIN OPHTHALMOL, V24, P581, DOI 10.1097/ICU.0000000000000002; Weingart MF, 2015, ONCOTARGET, V6, P3165, DOI 10.18632/oncotarget.3078; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; White DT, 2017, P NATL ACAD SCI USA, V114, pE3719, DOI 10.1073/pnas.1617721114; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097578; Yoshinaga K, 2004, CLIN CANCER RES, V10, P5702, DOI 10.1158/1078-0432.CCR-03-0262	59	24	24	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2019	38	12					2056	2075		10.1038/s41388-018-0543-2	http://dx.doi.org/10.1038/s41388-018-0543-2			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HP6UR	30401983	Green Accepted			2022-12-26	WOS:000461822600005
J	Carter, SP; Robertson, A; Palphramand, KL; Chambers, MA; McDonald, RA; Delahay, RJ				Carter, Stephen P.; Robertson, Andrew; Palphramand, Kate L.; Chambers, Mark A.; McDonald, Robbie A.; Delahay, Richard J.			Bait uptake by wild badgers and its implications for oral vaccination against tuberculosis	PLOS ONE			English	Article							ESTIMATING POPULATION-SIZE; MELES-MELES; EUROPEAN BADGERS; ENDOBRONCHIAL CHALLENGE; PROTECTIVE IMMUNITY; MYCOBACTERIUM-BOVIS; CANDIDATE BAITS; BCG; DELIVERY; IMPACT	The deployment of baits containing vaccines or toxins has been used successfully in the management of wildlife populations, including for disease control. Optimisation of deployment strategies seeks to maximise uptake by the targeted population whilst ensuring cost-effectiveness. Tuberculosis (TB) caused by infection with Mycobacterium bovis affects a broad range of mammalian hosts across the globe, including cattle, wildlife and humans. The control of TB in cattle in the UK and Republic of Ireland is hampered by persistent infection in European badgers (Meles meles). The present study aimed to determine the best strategy for maximising uptake of an oral vaccine by wild badgers, using a surrogate novel bait deployed at 40 badger social groups. Baits contained a blood-borne biomarker (lophenoxic Acid, IPA) in order to measure consumption in badgers subsequently cage trapped at targeted setts. Evidence for the consumption of bait was found in 83% (199/240) of captured badgers. The probability that badgers had consumed at least one bait (IPA >10 mu g ml(-1)) was significantly higher following deployment in spring than in summer. Lower uptake amongst social groups where more badgers were captured, suggested competition for baits. The probability of bait consumption was significantly higher at groups where main and outlier setts were provided with baits than at those where outliers were present but not baited. Badgers captured 10-14 days post bait feeding had significantly higher levels of bait uptake compared to those caught 24-28 days later. Uptake rates did not vary significantly in relation to badger age and whether bait was placed above ground or down setts. This study suggests that high levels of bait uptake can be achieved in wild badger populations and identifies factors influencing the potential success of different deployment strategies. The implications for the development of an oral badger vaccine are discussed.	[Carter, Stephen P.; Robertson, Andrew; Palphramand, Kate L.; Delahay, Richard J.] Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Woodchester Pk, Woodchester, Glos, England; [Carter, Stephen P.; McDonald, Robbie A.] Vincent Wildlife Trust, Ledbury, Hereford, England; [Robertson, Andrew] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Chambers, Mark A.] Anim & Plant Hlth Agcy, Dept Bacteriol, Woodham Lane, New Haw, Surrey, England	Animal & Plant Health Agency UK; University of Exeter; Animal & Plant Health Agency UK	Delahay, RJ (corresponding author), Anim & Plant Hlth Agcy, Natl Wildlife Management Ctr, Woodchester Pk, Woodchester, Glos, England.	Dez.Delahay@apha.gsi.gov.uk	Delahay, Richard/GSI-4663-2022; McDonald, Robbie/AAK-2718-2020; Carter, Steve/J-1686-2014	McDonald, Robbie/0000-0002-6922-3195; Palphramand, Kate/0000-0003-0096-0629; Carter, Steve/0000-0002-9487-7377	United Kingdom Department for Environment, Food and Rural Affairs (DEFRA) [SE3246]	United Kingdom Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA))	This research was funded by the United Kingdom Department for Environment, Food and Rural Affairs (DEFRA) - project SE3246. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2014, ARXIV14065823; Blancou J, 2009, OPTIONS CONTROL DIS; Cagnacci F, 2005, APPL ANIM BEHAV SCI, V92, P159, DOI 10.1016/j.applanim.2004.11.003; Carter SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049833; Carter Stephen P., 2009, P121, DOI 10.1007/978-4-431-77134-0_7; Chambers MA, 2014, VET REC, V175, P90, DOI 10.1136/vr.102581; Chambers MA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00006; Cheeseman C. L., 1980, A handbook on biotelemetry and radio tracking, P649; Corner LAL, 2010, VACCINE, V28, P6265, DOI 10.1016/j.vaccine.2010.06.120; Corner LAL, 2008, TUBERCULOSIS, V88, P601, DOI 10.1016/j.tube.2008.03.002; de Leeuw A., 2006, ADV VERT PEST MANAG, V4, P243; de Leeuw ANS, 2004, VET J, V167, P186, DOI 10.1016/S1090-0233(03)00113-8; Defra, 2014, STRAT ACH OFF BOV TU, P80; Delahay RJ, 2000, MAMMAL REV, V30, P73, DOI 10.1046/j.1365-2907.2000.00058.x; Delahay RJ, 2003, VET J, V166, P43, DOI 10.1016/S1090-0233(03)00071-6; Donnelly CA, 2003, NATURE, V426, P834, DOI 10.1038/nature02192; Frantz AC, 2004, J APPL ECOL, V41, P985, DOI 10.1111/j.0021-8901.2004.00951.x; Garnett BT, 2002, P ROY SOC B-BIOL SCI, V269, P1487, DOI 10.1098/rspb.2002.2072; Gormley E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168851; Gowtage S, 2017, VACCINE, V35, P987, DOI 10.1016/j.vaccine.2016.12.004; Griffin JM, 2005, PREV VET MED, V67, P237, DOI 10.1016/j.prevetmed.2004.10.009; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Judge J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00378-3; Judge J, 2014, SCI REP-UK, V4, DOI 10.1038/srep03809; Lesellier S, 2011, VACCINE, V29, P3782, DOI 10.1016/j.vaccine.2011.03.028; Macdonald DW, 2002, ETHOLOGY, V108, P613, DOI 10.1046/j.1439-0310.2002.00807.x; Maki J, 2017, VET RES, V48, DOI 10.1186/s13567-017-0459-9; McDonald RA, 2014, NATURE, V511, P158, DOI 10.1038/nature13514; Neal E, 1996, BADGERS POYSER NATUR; Nugent G, 2015, NEW ZEAL VET J, V63, P28, DOI 10.1080/00480169.2014.963791; Palmer Mitchell V., 2012, Veterinary Medicine International, P236205, DOI 10.1155/2012/236205; Palphramand K, 2017, VACCINE, V35, P4402, DOI 10.1016/j.vaccine.2017.06.059; Palphramand KL, 2011, EUR J WILDLIFE RES, V57, P35, DOI 10.1007/s10344-010-0397-6; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Robertson A, 2016, PREV VET MED, V135, P95, DOI 10.1016/j.prevetmed.2016.11.007; Robertson A, 2015, EUR J WILDLIFE RES, V61, P263, DOI 10.1007/s10344-014-0896-y; Scheppers TLJ, 2007, WILDLIFE BIOL, V13, P195, DOI 10.2981/0909-6396(2007)13[195:ESGSOE]2.0.CO;2; Southey AK, 2001, J ZOOL, V253, P133, DOI 10.1017/S0952836901000127; TREWHELLA WJ, 1991, J APPL ECOL, V28, P454, DOI 10.2307/2404561; Tuyttens FAM, 1999, J MAMMAL, V80, P950, DOI 10.2307/1383265; Weber N, 2013, BEHAV ECOL SOCIOBIOL, V67, P471, DOI 10.1007/s00265-012-1467-4; Wilson GJ, 2003, J ZOOL, V259, P49, DOI 10.1017/S0952836902002947	43	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206136	10.1371/journal.pone.0206136	http://dx.doi.org/10.1371/journal.pone.0206136			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412584	Green Submitted, Green Published, gold			2022-12-26	WOS:000449772600011
J	Al-Eisa, RA; Al-Salmi, FA; Hamza, RZ; El-Shenawy, NS				Al-Eisa, Rasha A.; Al-Salmi, Fawziah A.; Hamza, Reham Z.; El-Shenawy, Nahla S.			Role of L-carnitine in protection against the cardiac oxidative stress induced by aspartame in Wistar albino rats	PLOS ONE			English	Article							VITAMIN-E; GLUTATHIONE; LIVER; DISEASE; DAMAGE; DEFICIENCY; METABOLISM; RESPONSES; PLASMA; HEART	Aspartame (ASP) has been used as an alternative to sucrose for diabetics and obese people worldwide. Co-administration of L-carnitine (LC) with ASP has a protective effect against the liver and kidney toxicity induced of ASP. The goal of the investigation was to assess the enhancement of LC effect on the cardiac toxicity caused of ASP. The rats were divided into 6 groups: control with saline, LC (10 mg/kg), ASP (75 mg/kg), ASP (150 mg/kg), LC with 75 mg/kg of ASP, and LC with 150 mg/kg ASP. The antioxidants were determined by measuring the activities of myeloperoxidase, xanthine oxidase, superoxide dismutase, catalase, and glutathione peroxidase, and by assessing the levels of lipid peroxidation, total thiols, and glutathione. There was a significant elevation in LPO, in conjunction with a significant decline in the enzymatic antioxidants superoxide dismutase, catalase, and glutathione peroxidase and the non-enzymatic antioxidants glutathione and thiols. The cardiac myofibrils were found in a disarrayed pattern in ASP treated-animals as compared to the control rats. The animals treated with ASP-HD showed more than one apoptotic cell with a large tail and a small head, and the relaxed loops of the damaged DNA were extended to form a comet-shaped structure. These effects may be due to the excessive generation of reactive oxygen species by ASP, which reduces cardiac function. Co-administration of LC with ASP improved all of the above-mentioned parameters that were disrupted of ASP alone. This study evidences a sufficient originality in showing how LC plays a positive role against cardiac toxicity of ASP.	[Al-Eisa, Rasha A.; Al-Salmi, Fawziah A.; Hamza, Reham Z.] Taif Univ, Fac Sci, Biol Dept, At Taif, Saudi Arabia; [Hamza, Reham Z.] Zagazig Univ, Fac Sci, Zool Dept, Zagazig, Egypt; [El-Shenawy, Nahla S.] Suez Canal Univ, Fac Sci, Zool Dept, Ismailia, Egypt	Taif University; Egyptian Knowledge Bank (EKB); Zagazig University; Egyptian Knowledge Bank (EKB); Suez Canal University	Hamza, RZ (corresponding author), Taif Univ, Fac Sci, Biol Dept, At Taif, Saudi Arabia.; Hamza, RZ (corresponding author), Zagazig Univ, Fac Sci, Zool Dept, Zagazig, Egypt.; El-Shenawy, NS (corresponding author), Suez Canal Univ, Fac Sci, Zool Dept, Ismailia, Egypt.	dr_reham_z@yahoo.com; nahla.el-shenawy@scuegypt.edu.eg	Hamza, Reham/N-4030-2018; El-Shenawy, Nahla S./AAS-9714-2021	Hamza, Reham/0000-0001-7083-9467; alsalmi, fawziah/0000-0002-2215-281X; , Rasha/0000-0001-6373-849X				Abhilash S, 2014, INT J CLIMATOL, V34, P98, DOI 10.1002/joc.3668; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Alkafafy ME, 2015, INT J IMMUNOPATH PH, V28, P247, DOI 10.1177/0394632015586134; ALTURA BM, 1983, SCIENCE, V221, P376, DOI 10.1126/science.6867714; Atasayar S, 2009, EXP TOXICOL PATHOL, V61, P23, DOI 10.1016/j.etp.2008.04.016; Bartels GL, 1997, EUR HEART J, V18, P84; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Burkhart CG, 2009, INT J CARDIOL, V137, P307, DOI 10.1016/j.ijcard.2009.01.028; Butchko HH, 2002, REGUL TOXICOL PHARM, V35, pS1, DOI 10.1006/rtph.2002.1542; Chaitanya KV, 2010, J PHARM RES, V3, P1330; Choudhary AK, 2016, J TAIBAH UNIV SCI, V10, P505, DOI 10.1016/j.jtusci.2015.07.006; Choudhary AK, 2015, ENDOCRINOL NUTR, V62, P114, DOI 10.1016/j.endonu.2014.11.004; El-Eisa RA, 2018, INT J PHARM; Elshazly S. A., 2012, American Journal of Biochemistry and Molecular Biology, V2, P120; Endoh D, 2002, J VET MED SCI, V64, P761, DOI 10.1292/jvms.64.761; Fatouros IG, 2010, MED SCI SPORT EXER, V42, P1809, DOI 10.1249/MSS.0b013e3181dbacab; Findikli Z., 2014, J TOXICOLOGY ENV HLT, V6, P147; Gabe M., 1968, TECHNIQUES HISTOLOGI; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Gudadhe DR., 2013, IOSR J PHARM, V3, P30, DOI [10.9790/3013-32203033, DOI 10.9790/3013-32203033]; Gudadhe JA, 2014, IET NANOBIOTECHNOL, V8, P190, DOI 10.1049/iet-nbt.2013.0010; Gulec M, 2006, MOL CELL BIOCHEM, V290, P61, DOI 10.1007/s11010-006-9165-z; HAFEMAN DG, 1974, J NUTR, V104, P580, DOI 10.1093/jn/104.5.580; Halliwell B., 2007, FREE RADICAL BIO MED, P30; Hamza R, 2017, HUM EXP TOXICOL, V36, P1212, DOI 10.1177/0960327117695634; Hamza R. Z, 2018, J BASIC CLIN PHYSL P; HU ML, 1994, METHOD ENZYMOL, V233, P380; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; Iman MM, 2011, AFR J PHARM PHARMACO, V5, P678; Iyyaswamy A, 2012, J BIOSCIENCES, V37, P679, DOI 10.1007/s12038-012-9236-0; JAIN SK, 1982, BIOCHIM BIOPHYS ACTA, V688, P11, DOI 10.1016/0005-2736(82)90572-7; Lango R, 2001, CARDIOVASC RES, V51, P21, DOI 10.1016/S0008-6363(01)00313-3; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; LITWACK G, 1953, J BIOL CHEM, V200, P303; Liu XM, 2002, CHEM RES TOXICOL, V15, P512, DOI 10.1021/tx0101649; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Magnuson BA, 2007, CRIT REV TOXICOL, V37, P629, DOI 10.1080/10408440701516184; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MOSER RH, 1994, JAMA-J AM MED ASSOC, V272, P1543; Mourad IM, 2011, INT J PHARM BIOMED S, V2, P4; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Parthasarathy NJ, 2006, J OCCUP HEALTH, V48, P20, DOI 10.1539/joh.48.20; PAULSON DJ, 1984, METABOLISM, V33, P358, DOI 10.1016/0026-0495(84)90199-9; PIEPER GM, 1987, BIOCHEM MED METAB B, V38, P111, DOI 10.1016/0885-4505(87)90068-5; Prokic MD, 2014, J BIOSCIENCES, V39, P859, DOI 10.1007/s12038-014-9487-z; Roberts HJ, 2004, TEX HEART I J, V31, P105; Shahbaz S, 2015, WORLD J CARDIOL, V7, P633, DOI 10.4330/wjc.v7.i10.633; SPAGNOLI LG, 1982, LANCET, V1, P1419; Surai P.F., 2015, EC VET SCI, V2, P66; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Upasani C. D., 2001, Indian Journal of Experimental Biology, V39, P70; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6	53	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0204913	10.1371/journal.pone.0204913	http://dx.doi.org/10.1371/journal.pone.0204913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403670	gold, Green Submitted, Green Published			2022-12-26	WOS:000449379500009
J	Cheng, PN; Chiu, HC; Chiu, YC; Chen, SC; Chen, Y				Cheng, Pin-Nan; Chiu, Hung-Chih; Chiu, Yen-Cheng; Chen, Shu-Chuan; Chen, Yi			Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; NATURAL-HISTORY; INSULIN-RESISTANCE; VIRUS-INFECTION; PROGRESSION; CIRRHOSIS; MORTALITY; FIBROTEST; GENOTYPE; OBESITY	Background and aim The role of non-invasive methods to evaluate fibrosis severity of chronic hepatitis C (CHC) subjects in community needs to be explored. This study investigated FIB-4 and transient elastography (TE) in staging liver fibrosis of CHC subjects in community. Methods A total of 905 subjects who were positive for anti-HCV antibody from five districts of Tainan City of Taiwan were invited to participate in surveillance activities for CHC. FIB-4 and TE were measured for each participant. Results A total of 502 subjects with detectable HCV RNA and valid TE were enrolled. The distribution of FIB-4 and TE values differed markedly. Both methods exhibited a strongest correlation in subjects with at age 50-60 years (r = 0.655, p <0.001). FIB-4 score increased proportionally with age (p <0.001), but TE did not (p = 0.142). The intraclass correlation efficient of both methods was 0.255 (p <0.001). Subjects with TE defined advanced fibrosis exhibited younger age, higher BMI, higher platelet count, lower FIB-4 score, higher incidence of fatty liver and splenomegaly, and higher controlled attenuation parameter value than those defined by FIB-4. By multivariate logistic regression analysis, higher ALT levels, higher incidence of fatty liver, and presence of splenomegaly were the independent factors associated with advanced fibrosis defined by TE rather than defined by FIB-4. Conclusions FIB-4 and TE defined different distribution of fibrosis stages in same HCV population. FIB-4 was deeply influenced by age whereas TE was not. TE had the advantages over than FIB-4 in strong association with splenomegaly and in detecting the role of non-alcoholic fatty liver disease in advanced fibrosis.	[Cheng, Pin-Nan; Chiu, Hung-Chih; Chiu, Yen-Cheng] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Gastroenterol & Hepatol, Tainan, Taiwan; [Chen, Shu-Chuan; Chen, Yi] Tainan City Govt, Publ Hlth Bur, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital	Cheng, PN (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Internal Med,Div Gastroenterol & Hepatol, Tainan, Taiwan.	pncheng@mail.ncku.edu.tw		Chiu, Hung-Chih/0000-0001-9538-7188	CHENG-HSING Medical Foundation of National Cheng Kung University Hospital	CHENG-HSING Medical Foundation of National Cheng Kung University Hospital	The study was financially supported by the CHENG-HSING Medical Foundation of National Cheng Kung University Hospital.	Adinolfi LE, 2001, HEPATOLOGY, V33, P1358, DOI 10.1053/jhep.2001.24432; Arena U, 2008, HEPATOLOGY, V47, P380, DOI 10.1002/hep.22007; Bloom S, 2018, J HEPATOL, V28; Bruno S, 2016, J HEPATOL, V64, P1217, DOI 10.1016/j.jhep.2016.01.034; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chen CH, 2007, J FORMOS MED ASSOC, V106, P148, DOI 10.1016/S0929-6646(09)60231-X; Cheng PN, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003193; Curry MP, 2017, ALIMENT PHARM THER, V46, P540, DOI 10.1111/apt.14204; Dienstag JL, 2011, HEPATOLOGY, V54, P396, DOI 10.1002/hep.24370; Everhart JE, 2010, HEPATOLOGY, V51, P585, DOI 10.1002/hep.23315; Gane EJ, 2017, LANCET GASTROENTEROL, V2, P805, DOI 10.1016/S2468-1253(17)30159-0; Hamaguchi M, 2007, AM J GASTROENTEROL, V102, P2708, DOI 10.1111/j.1572-0241.2007.01526.x; Karlas T, 2018, ALIMENT PHARM THER, V47, P989, DOI 10.1111/apt.14529; Negro F, 2015, GASTROENTEROLOGY, V149, P1345, DOI 10.1053/j.gastro.2015.08.035; Olson APJ, 2015, CRIT ULTRASOUND J, V7, DOI 10.1186/s13089-015-0030-8; Ortiz V, 2002, AM J GASTROENTEROL, V97, P2408, DOI 10.1111/j.1572-0241.2002.05995.x; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Sagir A, 2008, HEPATOLOGY, V47, P592, DOI 10.1002/hep.22056; Sangiovanni A, 2006, HEPATOLOGY, V43, P1303, DOI 10.1002/hep.21176; Shintani Y, 2004, GASTROENTEROLOGY, V126, P840, DOI 10.1053/j.gastro.2003.11.056; Siddiqui MS, 2019, CLIN GASTROENTEROL H, V17, P156, DOI 10.1016/j.cgh.2018.04.043; Thein HH, 2008, HEPATOLOGY, V48, P418, DOI 10.1002/hep.22375; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; Yang JF, 2010, KAOHSIUNG J MED SCI, V26, P461, DOI 10.1016/S1607-551X(10)70073-5; Younossi Z, 2013, HEPATOLOGY, V58, P1897, DOI 10.1002/hep.26437; Yu ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000690; 2018, J HEPATOL, V69, P461, DOI DOI 10.1016/J.JHEP.2018.03.026	29	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206947	10.1371/journal.pone.0206947	http://dx.doi.org/10.1371/journal.pone.0206947			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403744	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500085
J	Park, J; Kim, J				Park, Juhyeon; Kim, Jeongseob			Defining heatwave thresholds using an inductive machine learning approach	PLOS ONE			English	Article							WARNING SYSTEMS; WAVE IMPACT; MORTALITY; HEALTH; TEMPERATURE; MORBIDITY; COUNTY; CHINA	Establishing appropriate heatwave thresholds is important in reducing adverse human health consequences as it enables a more effective heatwave warning system and response plan. This paper defined such thresholds by focusing on the non-linear relationship between heatwave outcomes and meteorological variables as part of an inductive approach. Daily data on emergency department visitors who were diagnosed with heat illnesses and information on 19 meteorological variables were obtained for the years 2011 to 2016 from relevant government agencies. A Multivariate Adaptive Regression Splines (MARS) analysis was performed to explore points (referred to as "knots") where the behaviour of the variables rapidly changed. For all emergency department visitors, two thresholds (a maximum daily temperature >= 32.58 degrees C for 2 consecutive days and a heat index >= 79.64) were selected based on the dramatic rise of morbidity at these points. Nonetheless, visitors, who included children and outside workers diagnosed in the early summer season, were reported as being sensitive to heatwaves at lower thresholds. The average daytime temperature (from noon to 6 PM) was determined to represent an alternative threshold for heatwaves. The findings have implications for exploring complex heatwave-morbidity relationships and for developing appropriate intervention strategies to prevent and mitigate the health impact of heatwaves.	[Park, Juhyeon; Kim, Jeongseob] Ulsan Natl Inst Sci & Technol, Sch Urban & Environm Engn, Ulsan, South Korea	Ulsan National Institute of Science & Technology (UNIST)	Kim, J (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Urban & Environm Engn, Ulsan, South Korea.	jskim14@unist.ac.kr	Kim, Jeongseob/L-5595-2014	Kim, Jeongseob/0000-0002-9578-3348; Park, Juhyeon/0000-0002-9562-5454	UNIST (Ulsan National Institute of Science Technology) [1.180046.01]	UNIST (Ulsan National Institute of Science Technology)	This work was supported by the Basic Research Fund (1.180046.01) of UNIST (Ulsan National Institute of Science & Technology).	Abdel-Aty M, 2011, ACCIDENT ANAL PREV, V43, P461, DOI 10.1016/j.aap.2010.10.002; Abrahamson V, 2009, J PUBLIC HEALTH-UK, V31, P119, DOI 10.1093/pubmed/fdn102; Analitis A, 2014, EPIDEMIOLOGY, V25, P15, DOI 10.1097/EDE.0b013e31828ac01b; Astrom C, 2015, INT J ENV RES PUB HE, V12, P254, DOI 10.3390/ijerph120100254; Aring;strom DO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155045; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Azhar GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091831; Basu R, 2008, AM J EPIDEMIOL, V168, P632, DOI 10.1093/aje/kwn170; Chang LY, 2017, J TRANSP SAF SECUR, V9, P419, DOI 10.1080/19439962.2016.1237601; Flynn A, 2005, QJM-INT J MED, V98, P227, DOI 10.1093/qjmed/hci025; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Gronlund Carina J, 2014, Curr Epidemiol Rep, V1, P165; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hajat S, 2010, J EPIDEMIOL COMMUN H, V64, P753, DOI 10.1136/jech.2009.087999; Hansen A, 2011, HEALTH PROMOT J AUST, V22, pS17, DOI 10.1071/HE11417; Kent ST, 2014, ENVIRON HEALTH PERSP, V122, P151, DOI 10.1289/ehp.1307262; Koppe C., 2004, HEAT WAVES RISKS RES; Korea Meterological Administration, 2017, NAT CLIM DAT SERV SY; Li MM, 2015, INT J ENV RES PUB HE, V12, P5256, DOI 10.3390/ijerph120505256; Lowe D, 2011, INT J ENV RES PUB HE, V8, P4623, DOI 10.3390/ijerph8124623; Luo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055280; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; McGregor G.R., 2015, HEATWAVES HLTH GUIDA; Michelozzi P, 2006, J EPIDEMIOL COMMUN H, V60, P417, DOI 10.1136/jech.2005.040857; Ministry of Security and Public Administration, 2017, ROAD NAM ADDR INF SY; Pascal M, 2013, INT J BIOMETEOROL, V57, P21, DOI 10.1007/s00484-012-0530-1; Seoul Metropolitan Government, 2017, LOC PUBL HLTH CTR SE; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STEADMAN RG, 1979, J APPL METEOROL, V18, P861, DOI 10.1175/1520-0450(1979)018<0861:TAOSPI>2.0.CO;2; Sun XM, 2014, SCI TOTAL ENVIRON, V493, P789, DOI 10.1016/j.scitotenv.2014.06.042; Thom EC., 1959, WEATHERWISE, V12, P57, DOI [10.1080/00431672.1959.9926960, DOI 10.1080/00431672.1959.9926960]; Toloo G, 2013, INT J PUBLIC HEALTH, V58, P667, DOI 10.1007/s00038-013-0465-2; Tong SL, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003579; Tong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012155; Wang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134233; Xiang JJ, 2014, ENVIRON RES, V133, P90, DOI 10.1016/j.envres.2014.04.042; Xu ZW, 2016, ENVIRON INT, V89-90, P193, DOI 10.1016/j.envint.2016.02.007; Xu ZW, 2014, INT J BIOMETEOROL, V58, P239, DOI 10.1007/s00484-013-0655-x; Yip FY, 2008, INT J BIOMETEOROL, V52, P765, DOI 10.1007/s00484-008-0169-0; Zhang Yunquan, 2017, Glob Health Res Policy, V2, P10, DOI 10.1186/s41256-017-0030-2; Zhang YQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45093	41	7	7	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206872	10.1371/journal.pone.0206872	http://dx.doi.org/10.1371/journal.pone.0206872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403743	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500078
J	Sanuade, OA; Boatemaa, S; Kushitor, MK				Sanuade, Olutobi Adekunle; Boatemaa, Sandra; Kushitor, Mawuli Komla			Hypertension prevalence, awareness, treatment and control in Ghanaian population: Evidence from the Ghana demographic and health survey	PLOS ONE			English	Article							URBAN-POOR COMMUNITIES; BLOOD-PRESSURE; COVERAGE; DISTRICT; AFRICA; ACCRA	Hypertension is a major cause of cardiovascular disease morbidity and mortality in Ghana. This study examines the prevalence, awareness, treatment and control of hypertension among Ghanaian aged 15-49 years. This cross-sectional study retrieved data from the 2014 Ghana Demographic and Health Survey (GDHS). The sample, comprising of 13,247 respondents aged 15-49 years, was analysed using descriptive statistics, Chi-Square tests, independent sample t-tests and binary logistic regressions. The overall prevalence of hypertension was 13.0% (12.1% for males and 13.4% for females). Among respondents who had hypertension, 45.6% were aware of their hypertension status; 40.5% were treating the condition while 23.8% had their blood pressure controlled (BP <140/90 mmHg). Socio-economic and demographic factors, health insurance coverage and recent visit to health facilities played significant roles in hypertension prevalence and awareness. While region of residence and health facility visits were predictors of hypertension treatment, age and region of residence predicted hypertension control in this population. This study suggests that in order to address the increasing burden of hypertension in Ghana, there should be an expansion of the National Health Insurance Scheme and development of measures to reduce health inequities. Also, some of the determining factors such as age, gender, marital status are similar to other cultures; therefore, existing interventions from those cultures could be adapted in addressing hypertension prevalence, awareness, treatment and control in Ghana.	[Sanuade, Olutobi Adekunle] UCL, Inst Adv Studies, London, England; [Boatemaa, Sandra] Stellenbosch Univ, Ctr Complex Syst Transit, Stellenbocsh, South Africa; [Kushitor, Mawuli Komla] Univ Ghana, Reg Inst Populat Studies, Accra, Ghana	University of London; University College London; University of Ghana	Sanuade, OA (corresponding author), UCL, Inst Adv Studies, London, England.	o.sanuade@ucl.ac.uk	Kushitor, Sandra Boatemaa/CAG-8145-2022; Sanuade, Olutobi Adekunle/AAY-2526-2021	Kushitor, Sandra Boatemaa/0000-0002-0638-6261; Sanuade, Olutobi Adekunle/0000-0003-4972-1098	Wellcome Trust through the Institute of Advanced Studies, UCL [106534]; National Research Foundation through the Department of Science and Technology, Centre of Excellence in Food Security [29673]	Wellcome Trust through the Institute of Advanced Studies, UCL; National Research Foundation through the Department of Science and Technology, Centre of Excellence in Food Security	OAS is supported by Wellcome Trust [106534] through the Institute of Advanced Studies, UCL, and SB is supported by the National Research Foundation [29673] through the Department of Science and Technology, Centre of Excellence in Food Security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2012, Ghana Med J, V46, P4; Agyemang C, 2006, PUBLIC HEALTH, V120, P525, DOI 10.1016/j.puhe.2006.02.002; Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Aikins ADG, 2003, J HEALTH PSYCHOL, V8, P557, DOI 10.1177/13591053030085007; Aikins AD, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-S2-S3; Aikins AD, 2015, ETHNIC HEALTH, V20, P391, DOI 10.1080/13557858.2014.921896; Anion JT, 1984, W AFR J MED, V3, P85; Awuah RB, 2014, J HYPERTENS, V32, P1203, DOI 10.1097/HJH.0000000000000165; Awuah RB, 2016, CHRONIC NON-COMMUNICABLE DISEASES IN LOW- AND MIDDLE-INCOME COUNTRIES, P1, DOI 10.1079/9781780643328.0001; Awuah RB, 2018, ETHNICITY HLTH, P1, DOI 10.1080/13557858.2018.; Belue R, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-10; Beune EJAJ, 2006, J HUM HYPERTENS, V20, P946, DOI 10.1038/sj.jhh.1002094; Beune EJAJ, 2008, J HYPERTENS, V26, P648, DOI 10.1097/HJH.0b013e3282f4d20b; Blanchet NJ, 2012, EFFECT GHANAS NATL H, V46; Bosu W K, 2012, Ghana Med J, V46, P69; Bosu WK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-418; Buford TW, 2016, AGEING RES REV, V26, P96, DOI 10.1016/j.arr.2016.01.007; Cappuccio FP, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-13; de-Graft Aikins Ad-G, 2010, GLOBAL HLTH, V6, P1; Dedey F, 2016, FACTORS ASS WAITING; Doherty DT, 2010, BRIT J HEALTH PSYCH, V15, P213, DOI 10.1348/135910709X457423; Dzakpasu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049430; Edington GM, 1954, T ROY SOC TROP MED H, P219; Forouzanfar MH, 2015, JAMA-J AM MED ASSOC, V31, P165; Ghana Health Service, 2015, 2014 GHAN DEM HLTH S, P1; Ghana Health Service, 2010, STAND TREATM GUID; Goma Fastone M, 2011, Int Arch Med, V4, P34, DOI 10.1186/1755-7682-4-34; Goodman DM, 2017, 3 DELAY UNDERSTANDIN, P1; Hart PD, 2004, AM J MED, V117, P62, DOI 10.1016/j.amjmed.2004.04.003; Jackson J., 2011, GENDER DIFFERENCES S; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Joffres M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003423; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kleinman A., 1980, PATIENTS HEALERS CON; Kolling M, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-8; Kushitor MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194677; Kusi A, 2015, REFUSAL ENROL GHANAS, P1; Leng Y, 2015, NEUROLOGY, V84, P1072, DOI 10.1212/WNL.0000000000001371; Ministry of Health, 2010, DIET PHYS ACT GUID G; Musinguzi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062236; Nejjari C, 2013, J HYPERTENS, V31, P49, DOI 10.1097/HJH.0b013e32835a6611; Odusola AO, 2015, J HYPERTENS; Ogedegbe G, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-73; Pinto E, 2007, POSTGRAD MED J, V83, P109, DOI 10.1136/pgmj.2006.048371; Pires JE, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-90; POULTER NR, 1990, BMJ-BRIT MED J, V300, P967, DOI 10.1136/bmj.300.6730.967; Rishworth AC, 2014, THESIS; Sarfo F S, 2014, Ghana Med J, V48, P127, DOI 10.4314/gmj.v48i3.2; Sarpong N, 2010, TROP MED INT HEALTH, V15, P191, DOI 10.1111/j.1365-3156.2009.02439.x; Schwandt HM, 2010, J FAM ISSUES, V31, P1211, DOI 10.1177/0192513X10365487; Shafi ST, 2017, J EPIDEMIOL GLOB HEA, V7, P135, DOI 10.1016/j.jegh.2017.01.001; Spencer J, 2005, ETHNIC DIS, V15, P748; Steptoe A, 2008, HYPERTENSION, V52, P220, DOI 10.1161/HYPERTENSIONAHA.108.115477; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, WHODCOWHD20132; Wiredu EK, 2001, GHANA MED J, V35, P151; Yim HJ, 2012, KOREAN J FAM MED, V33, P390, DOI 10.4082/kjfm.2012.33.6.390	58	46	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205985	10.1371/journal.pone.0205985	http://dx.doi.org/10.1371/journal.pone.0205985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403686	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500042
J	Siragusa, M; Dall'Olio, S; Fredericia, PM; Jensen, M; Groesser, T				Siragusa, Mattia; Dall'Olio, Stefano; Fredericia, Pil M.; Jensen, Mikael; Groesser, Torsten			Cell colony counter called CoCoNut	PLOS ONE			English	Article							PETRI DISHES; TRANSFORM	Clonogenic assays are powerful tools for testing cell reproductive death after biological damage caused by, for example, ionizing radiation. Traditionally, the methods require a cumbersome, slow and eye-straining manual counting of viable colonies under a microscope. To speed up the counting process and minimize those issues related to the subjective decisions of the scoring personnel, we developed a semi-automated, image-based cell colony counting setup, named CoCoNut (Colony Counter developed by the Nutech department at the Technical University of Denmark). It consists in an ImageJ macro and a photographic 3D-printed light-box, conceived and demonstrated to work together for Crystal Violet-stained colonies. Careful attention was given to the image acquisition process, which allows background removal (i.e. any unwanted element in the picture) in a minimally invasive manner. This is mainly achieved by optimal lighting conditions in the light-box and dividing the image of a flask that contains viable colonies by the picture of an empty flask. In this way, CoCoNut avoids using aggressive background removal filters that usually lead to suboptimal colony count recovery. The full method was tested with V79 and HeLa cell survival samples. Results were compared to other freely available tools. CoCoNut proved able to successfully distinguish between single and merged colonies and to identify colonies bordering on flask edges. CoCoNut software calibration is fast; it requires the adjustment of a single parameter that is the smallest colony area to be counted. The employment of a single parameter reduces the risk of subjectivity, providing a robust and user-friendly tool, whose results can be easily compared over time and among different bio-laboratories. The method is inexpensive and easy to obtain. Among its advantages, we highlight the possibility of combining the macro with a perfectly reproducible 3D-printed light-box. The CoCoNut software and the 3D-printer files are provided as supporting information (S1 CoCoNut Files).	[Siragusa, Mattia; Fredericia, Pil M.; Jensen, Mikael; Groesser, Torsten] Tech Univ Denmark, Ctr Nucl Technol, Hevesy Lab, Roskilde, Denmark; [Dall'Olio, Stefano] Tech Univ Denmark, Dept Energy Convers & Storage, Roskilde, Denmark	Technical University of Denmark; Technical University of Denmark	Siragusa, M (corresponding author), Tech Univ Denmark, Ctr Nucl Technol, Hevesy Lab, Roskilde, Denmark.	masir@dtu.dk	Jensen, Mikael/I-8358-2012	Jensen, Mikael/0000-0002-9109-2187				Barber PR, 2001, PHYS MED BIOL, V46, P63, DOI 10.1088/0031-9155/46/1/305; Bernard R, 2001, PHYS MED BIOL, V46, P3061, DOI 10.1088/0031-9155/46/11/320; Bewes JM, 2008, PHYS MED BIOL, V53, P5991, DOI 10.1088/0031-9155/53/21/007; Biston MC, 2003, PHYS MED BIOL, V48, P1551, DOI 10.1088/0031-9155/48/11/305; Cai ZL, 2011, INT J RADIAT BIOL, V87, P1135, DOI 10.3109/09553002.2011.622033; Choudhry P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148469; Dahle J, 2004, CYTOM PART A, V60A, P182, DOI 10.1002/cyto.a.20038; Dobson K, 1999, CALCIFIED TISSUE INT, V65, P166, DOI 10.1007/s002239900677; Geissmann Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054072; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Hoekstra SJ, 1998, IN VITRO MOL TOXICOL, V11, P207; Khan AU, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24916-9; Marotz J, 2001, COMPUT METH PROG BIO, V66, P183, DOI 10.1016/S0169-2607(00)00128-0; MUKHERJEE DP, 1995, INT J BIOMED COMPUT, V38, P131, DOI 10.1016/0020-7101(94)01043-Z; Niyazi M, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-4; PARRY RL, 1991, BIOTECHNIQUES, V10, P772; PUCK TT, 1955, P NATL ACAD SCI USA, V41, P432, DOI 10.1073/pnas.41.7.432; PUCK TT, 1956, J EXP MED, V103, P653, DOI 10.1084/jem.103.5.653; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; THIELMANN HW, 1985, CYTOMETRY, V6, P130, DOI 10.1002/cyto.990060208; WILSON IG, 1995, APPL ENVIRON MICROB, V61, P3158, DOI 10.1128/AEM.61.8.3158-3160.1995; Wouters A, 2010, PHYS MED BIOL, V55, pN167, DOI 10.1088/0031-9155/55/7/N01	22	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205823	10.1371/journal.pone.0205823	http://dx.doi.org/10.1371/journal.pone.0205823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403680	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500026
J	Shim, H; Jang, JY; Kim, JW; Ryu, H; Jung, PY; Kim, S; Kwon, HY; Kim, KM; Chung, H; Bae, KS				Shim, Hongjin; Jang, Ji Young; Kim, Ji Wan; Ryu, Hoon; Jung, Pil Young; Kim, Seongyup; Kwon, Hye Youn; Kim, Kwang Min; Chung, Hoejeong; Bae, Keum Seok			Effectiveness and postoperative wound infection of preperitoneal pelvic packing in patients with hemodynamic instability caused by pelvic fracture	PLOS ONE			English	Article							LIFE-THREATENING HEMORRHAGE; UNSTABLE PATIENTS; TRAUMA CENTER; MANAGEMENT; MORTALITY; SURGERY; ANGIOEMBOLIZATION; ASSOCIATION; EXPERIENCE; GUIDELINE	Introduction Despite the use of a multidisciplinary treatment approach, the mortality rate of hemodynamic instability due to severe pelvic fracture remains 40-60%. Several recent studies have shown that preperitoneal pelvic packing (PPP) was useful for achieving hemostasis in these patients in the acute phase. However, few studies have examined postoperative complications. The purpose of the present study was to evaluate clinical outcomes and wound infections of PPP in these patients. Materials and methods We retrospectively reviewed the medical charts of 62 patients with hemorrhagic shock due to pelvic fracture between March 2011 and May 2017. Excluding four patients (two with other major hemorrhage sites and two who experienced cardiac arrest in the emergency room), the patients were divided into PPP (n = 30) and non-PPP (n = 28) groups according to PPP application. Clinical outcomes including early-stage mortality, transfusion amount, and surgical site infection (SSI) were compared between the two groups. Results The overall mortality rate was 48.3% and the mean Injury Severity Score (ISS) was 39 +/- 9. The 30 patients in the PPP group had a significantly lower hemorrhage-induced mortality rate than the 28 patients in the non-PPP group (16.7% vs 50%, p = 0.019), although both groups had similar patient characteristics (age, ISS, and initial serum lactate level). Independent factors associated with hemorrhage-induced mortality were PPP and the requirement of packed red blood cells for 4 h. In the PPP group, SSI occurred in 5 of 25 (20%) patients. Conclusions PPP may be considered as a hemostatic modality for hemodynamic instability due to pelvic fracture because it reduces the hemorrhage-induced mortality rate. However, wound infections after the procedure should be considered.	[Shim, Hongjin; Jang, Ji Young; Jung, Pil Young; Kim, Seongyup; Kim, Kwang Min; Bae, Keum Seok] Wonju Severance Christian Hosp, Trauma Ctr, Wonju, South Korea; [Shim, Hongjin; Jang, Ji Young; Ryu, Hoon; Jung, Pil Young; Kim, Seongyup; Kwon, Hye Youn; Kim, Kwang Min; Bae, Keum Seok] Yonsei Univ, Wonju Coll Med, Dept Surg, Wonju, South Korea; [Kim, Ji Wan] Univ Ulsan, Asan Med Ctr, Dept Orthoped Surg, Seoul, South Korea; [Chung, Hoejeong] Yonsei Univ, Wonju Coll Med, Dept Orthoped Surg, Wonju, South Korea	Yonsei University; University of Ulsan; Asan Medical Center; Yonsei University	Jang, JY (corresponding author), Wonju Severance Christian Hosp, Trauma Ctr, Wonju, South Korea.; Jang, JY (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Surg, Wonju, South Korea.	drjangjiyoung@gmail.com		Kim, Kwangmin/0000-0003-0496-1303; JUNG, PIL YOUNG/0000-0001-6460-8072; Jang, Ji Young/0000-0001-6372-4194				Berrios SI, 2017, JAMA SURG, V152, P784, DOI 10.1001/jamasurg.2017.0904; Biffl WL, 2001, ANN SURG, V233, P843, DOI 10.1097/00000658-200106000-00015; Boffard KD., 2011, MANUAL DEFINITIVE SU; Burlew CC, 2017, J TRAUMA ACUTE CARE, V82, P233, DOI 10.1097/TA.0000000000001324; Burlew CC, 2011, J AM COLL SURGEONS, V212, P628, DOI 10.1016/j.jamcollsurg.2010.12.020; Chiara O, 2016, WORLD J EMERG SURG, V11, DOI 10.1186/s13017-016-0077-2; Coccolini F, 2017, WORLD J EMERG SURG, V12, DOI 10.1186/s13017-017-0117-6; Committee on trauma American College of Surgeons', 2018, ADV TRAUM LIF SUPP A; CONOLLY WB, 1969, J TRAUM, V9, P104, DOI 10.1097/00005373-196902000-00002; Costantini TW, 2016, J TRAUMA ACUTE CARE, V80, P717, DOI 10.1097/TA.0000000000001034; Cothren CC, 2007, J TRAUMA, V62, P834, DOI 10.1097/TA.0b013e31803c7632; Giannoudis PV, 2004, INJURY, V35, P671, DOI 10.1016/j.injury.2004.03.003; Goldberg SR, 2012, J TRAUMA ACUTE CARE, V73, pS321, DOI 10.1097/TA.0b013e3182701902; HUITTINEN VM, 1973, SURGERY, V73, P454; Jang JY, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0196-5; Li QH, 2016, INJURY, V47, P395, DOI 10.1016/j.injury.2015.10.008; Osborn PM, 2009, INJURY, V40, P54, DOI 10.1016/j.injury.2008.08.038; Pape HC, 1999, CHIRURG, V70, P1287, DOI 10.1007/s001040050781; Perkins ZB, 2014, BONE JOINT J, V96B, P1090, DOI 10.1302/0301-620X.96B8.33383; Sathy AK, 2009, J BONE JOINT SURG AM, V91A, P2803, DOI 10.2106/JBJS.H.00598; Smith W, 2007, J ORTHOP TRAUMA, V21, P31, DOI 10.1097/BOT.0b013e31802ea951; Tai DKC, 2011, J TRAUMA, V71, pE79, DOI 10.1097/TA.0b013e31820cede0; Totterman A, 2007, J TRAUMA, V62, P843, DOI 10.1097/01.ta.0000221673.98117.c9	23	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206991	10.1371/journal.pone.0206991	http://dx.doi.org/10.1371/journal.pone.0206991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395596	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400072
J	Davies, IP; Haugo, RD; Robertson, JC; Levin, PS				Davies, Ian P.; Haugo, Ryan D.; Robertson, James C.; Levin, Phillip S.			The unequal vulnerability of communities of color to wildfire	PLOS ONE			English	Article							SOCIAL VULNERABILITY; CLIMATE-CHANGE; RISK; DISASTERS; FIRE; RESILIENCE	Globally, environmental disasters impact billions of people and cost trillions of dollars in damage, and their impacts are often felt most acutely by minority and poor communities. Wildfires in the U.S. have similarly outsized impacts on vulnerable communities, though the ethnic and geographic distribution of those communities may be different than for other hazards. Here, we develop a social-ecological approach for characterizing fire vulnerability and apply it to >70,000 census tracts across the United States. Our approach incorporates both the wildfire potential of a landscape and socioeconomic attributes of overlying communities. We find that over 29 million Americans live with significant potential for extreme wildfires, a majority of whom are white and socioeconomically secure. Within this segment, however, are 12 million socially vulnerable Americans for whom a wildfire event could be devastating. Additionally, wildfire vulnerability is spread unequally across race and ethnicity, with census tracts that were majority Black, Hispanic or Native American experiencing ca. 50% greater vulnerability to wildfire compared to other census tracts. Embracing a social-ecological perspective of fire-prone landscapes allows for the identification of areas that are poorly equipped to respond to wildfires.	[Davies, Ian P.; Levin, Phillip S.] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Haugo, Ryan D.] Nature Conservancy, Portland, OR USA; [Robertson, James C.; Levin, Phillip S.] Nature Conservancy, Seattle, WA USA	University of Washington; University of Washington Seattle; Nature Conservancy; Nature Conservancy	Davies, IP (corresponding author), Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA.	ipdavies@uw.edu		Davies, Ian/0000-0003-2458-7486				Adger WN, 2005, SCIENCE, V309, P1036, DOI 10.1126/science.1112122; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; [Anonymous], 2005, DISASTER SAFETY REV; Axelrod J, 2017, AM CITY COUNTY; Bowker JM, 2008, J FOREST, V106, P268; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Brodie M, 2006, AM J PUBLIC HEALTH, V96, P1402, DOI 10.2105/AJPH.2005.084475; Calkin DE, 2014, P NATL ACAD SCI USA, V111, P746, DOI 10.1073/pnas.1315088111; Cannon Terry, 1994, DISASTERS DEV ENV, P13; Collins TW, 2008, J POLIT ECOL, V15, P21, DOI 10.2458/v15i1.21686; Collins TW, 2008, PROF GEOGR, V60, P508, DOI 10.1080/00330120802211737; Collins TW, 2009, ENVIRON MANAGE, V44, P441, DOI 10.1007/s00267-009-9333-5; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; Cutter SL, 2008, P NATL ACAD SCI USA, V105, P2301, DOI 10.1073/pnas.0710375105; Cutter SL, 2008, GLOBAL ENVIRON CHANG, V18, P598, DOI 10.1016/j.gloenvcha.2008.07.013; Dillon G.K., 2015, US FOR SERV ROCKY MT, P60; Doerr SH, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0345; Donovan GH, 2007, LAND ECON, V83, P217, DOI 10.3368/le.83.2.217; Downey L, 2008, SOCIOL PERSPECT, V51, P759, DOI 10.1525/sop.2008.51.4.759; Fatemi Farin, 2017, PLoS Curr, V9, DOI 10.1371/currents.dis.526884afe308f8876dce69c545357ecd; Finney MA, 2011, STOCH ENV RES RISK A, V25, P973, DOI 10.1007/s00477-011-0462-z; Fixler K, 2018, N BAY BUSINESS J APR; Flanagan BE, 2011, J HOMEL SECUR EMERG, V8, DOI 10.2202/1547-7355.1792; Fothergill A, 2004, NAT HAZARDS, V32, P89, DOI 10.1023/B:NHAZ.0000026792.76181.d9; Fu AS, 2013, CRIT SOCIOL, V39, P833, DOI 10.1177/0896920512455936; Gerety R.M., 2015, FARM WORKERS WILDFIR; Gould KA, 2016, J POLIT ECOL, V23, P93, DOI 10.2458/v23i1.20181; Hicks CC, 2016, SCIENCE, V352, P38, DOI 10.1126/science.aad4977; Kneebone E, CONFRONTING SUBURBAN, DOI DOI 10.7864/J.CTT4CG88Q; Koenker R., 2018, QUANTREG QUANTILE RE; Logan JR, 2006, IMPACT KATRINA RACE; Loomis J., 2004, Journal of Forest Economics, V10, P149, DOI 10.1016/j.jfe.2004.08.001; McGranahan G, 2007, ENVIRON URBAN, V19, P17, DOI 10.1177/0956247807076960; Mercer DE, 2005, FOREST POLICY ECON, V7, P782, DOI 10.1016/j.forpol.2005.03.003; Moeltner K, 2013, J ENVIRON ECON MANAG, V66, P476, DOI 10.1016/j.jeem.2013.09.004; Morrow BH, 1999, DISASTERS, V23, P1, DOI 10.1111/1467-7717.00102; Muttarak R, 2014, ECOL SOC, V19, DOI 10.5751/ES-06476-190142; Nagler E., 2017, INT UNDERGRAD J SERV, V6, P10; Ojerio R, 2011, NAT HAZARDS REV, V12, P28, DOI 10.1061/(ASCE)NH.1527-6996.0000027; Samhouri JF, 2012, BIOL CONSERV, V145, P118, DOI 10.1016/j.biocon.2011.10.021; Schoennagel T, 2017, P NATL ACAD SCI USA, V114, P4582, DOI 10.1073/pnas.1617464114; Scott JH, 2013, A WILDFIRE RISK ASSE; Sharkey P, 2007, J BLACK STUD, V37, P482, DOI 10.1177/0021934706296188; Smith AMS, 2016, BIOSCIENCE, V66, P130, DOI 10.1093/biosci/biv182; Sperling J, 2012, CITYSCAPE, V14, P219; UNISDR C., 2015, HUMAN COST NATURAL D; Venn T. J., 2009, Small-scale Forestry, V8, P43, DOI 10.1007/s11842-008-9065-z; Wigtil G, 2016, INT J WILDLAND FIRE, V25, P896, DOI 10.1071/WF15109; Yonetani M., 2015, GLOBAL ESTIMATES 201	49	71	71	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0205825	10.1371/journal.pone.0205825	http://dx.doi.org/10.1371/journal.pone.0205825			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388129	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800016
J	Ramos, DD; Bustamante, MMC; Silva, FDDE; Carvalheiro, LG				Ramos, Davi de L.; Bustamante, Mercedes M. C.; da Silva E Silva, Felipe D.; Carvalheiro, Luisa G.			Crop fertilization affects pollination service provision - Common bean as a case study	PLOS ONE			English	Article							FORAGING RANGES; BIODIVERSITY; AGRICULTURE; NECTAR; INTENSIFICATION; LANDSCAPES; EXPANSION; RESPONSES; DISTANCE; NITROGEN	The demand for insect-pollinated crops is increasing. Conventional agricultural intensification heavily relies on increased input of fertilizers, which can have negative effects on local biodiversity. Such effects may be particularly accentuated in biodiversity hotspots that are naturally nutrient-poor. Ecological intensification of farming, i.e. practices that increase production through the increase of ecosystem services, emerges as an alternative to conventional intensification. For example, practices that boost abundance and diversity of crop pollinators can lead to substantial increases in cropland productivity. However, little is known about the synergisms and trade-offs between fertilizer input and such ecological intensification practices. Here we investigate interactive effects between fertilization practices and the provision of ecosystem services in a biodiversity hotspot where conventional agriculture is rapidly expanding (Brazilian savannas). We focus on a highly nitrogen-demanding crop species that benefits from pollinators (the common bean, Phaseolus vulgaris L.), for which nitrogen input greatly varies in the study region. Our findings show that positive effects of native pollinators on crop yield are most accentuated under low inputs of nitrogen (e.g. equal to or below 72kg ha(-1)). This interactive effect could be due to changes in flower visitor community composition or behaviour. Our study also suggests that landscape management practices that minimize isolation from patches of natural vegetation and maximize its cover nearby (within 500 meters) of production areas can increase pollinator and biocontrol agent abundance and richness. Overall, these results suggest that ecological intensification is a valuable alternative for common bean production in Brazil, and potentially other regions of the world. Land productivity can be enhanced if an adequate balance of chemical inputs and landscape management is achieved.	[Ramos, Davi de L.; Bustamante, Mercedes M. C.; Carvalheiro, Luisa G.] Univ Brasilia UnB, Dept Ecol, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [da Silva E Silva, Felipe D.] Univ Brasilia UnB, Ctr Desenvolvimento Sustentavel, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [da Silva E Silva, Felipe D.] Inst Fed Mato Grosso IFMT, Av Sen Filinto Muller, Cuiaba, MT, Brazil; [Carvalheiro, Luisa G.] Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil	Universidade de Brasilia; Universidade de Brasilia; Instituto Federal de Mato Grosso (IFMT); Universidade Federal de Goias	Carvalheiro, LG (corresponding author), Univ Brasilia UnB, Dept Ecol, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil.; Carvalheiro, LG (corresponding author), Univ Fed Goias, Dept Ecol, Goiania, Go, Brazil.	lgcarvalheiro@gmail.com	Bustamante, Mercedes/GQZ-8625-2022; Carvalheiro, Luisa/D-9414-2012; Bustamante, Mercedes/AAQ-7231-2020	Carvalheiro, Luisa/0000-0001-7655-979X; Bustamante, Mercedes/0000-0003-1008-452X; Silva e Silva, Felipe Deodato da/0000-0001-9445-9493; Ramos, Davi/0000-0003-4870-3533	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [BJT 300005/2015-6]; FAPDF [193.001.3112016 - EDITAL 03201]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	DLR, MMCB and LGC were funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ; grant BJT 300005/2015-6), FDSS was funded by FAPDF (Processo n 193.001.3112016 - EDITAL 03201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Bragantini C, 2005, ALGUNS ASPECTOS ARMA, P187; Brittain C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090082; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bustamante MMC, 2006, BIOGEOCHEMISTRY, V79, P209, DOI 10.1007/s10533-006-9006-x; Carvalheiro LG, 2012, J APPL ECOL, V49, P1373, DOI 10.1111/j.1365-2664.2012.02217.x; Carvalheiro LG, 2010, J APPL ECOL, V47, P810, DOI 10.1111/j.1365-2664.2010.01829.x; Ceulemans T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175160; Crane E., 1991, Acta Horticulturae (Wageningen), V288, P29; DADSON RB, 1984, FIELD CROP RES, V9, P101, DOI 10.1016/0378-4290(84)90016-9; FAO (Food and Agriculture Organization), 2010, CLIM SMART AGR POL P; Ferreira CM, 2002, EMBRAPA ARROZE FEIJA, V135, P47; Ferreira PA, 2015, LANDSCAPE ECOL, V30, P2067, DOI 10.1007/s10980-015-0231-3; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Gardener MC, 2002, OIKOS, V98, P552, DOI 10.1034/j.1600-0706.2002.980322.x; Gardener MC, 2001, OIKOS, V92, P101, DOI 10.1034/j.1600-0706.2001.920112.x; Garibaldi LA, 2016, SCIENCE, V351, P388, DOI 10.1126/science.aac7287; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Garnett T, 2013, SCIENCE, V341, P33, DOI 10.1126/science.1234485; Gathmann A, 2002, J ANIM ECOL, V71, P757, DOI 10.1046/j.1365-2656.2002.00641.x; Giannini TC, 2015, J ECON ENTOMOL, V108, P849, DOI 10.1093/jee/tov093; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Hoehn P, 2008, P ROY SOC B-BIOL SCI, V275, P2283, DOI 10.1098/rspb.2008.0405; Hoover SER, 2012, ECOL LETT, V15, P227, DOI 10.1111/j.1461-0248.2011.01729.x; Howell AD, 2017, ANN ENTOMOL SOC AM, V110, P233, DOI 10.1093/aesa/saw081; Ibarra-Perez FJ, 1999, CROP SCI, V39, P428, DOI 10.2135/cropsci1999.0011183X0039000200022x; Jauker F, 2009, LANDSCAPE ECOL, V24, P547, DOI 10.1007/s10980-009-9331-2; Kehoe L, 2017, NAT ECOL EVOL, V1, P1129, DOI 10.1038/s41559-017-0234-3; Kingha B.M.T., 2012, J AGR EXTENSION RURA, V4, P330, DOI [10.5897/JAERD11.151, DOI 10.5897/JAERD11.151]; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kremen C, 2015, J APPL ECOL, V52, P602, DOI 10.1111/1365-2664.12418; Lanz B, 2018, ECOL ECON, V144, P260, DOI 10.1016/j.ecolecon.2017.07.018; Leikam DF, 2003, ESTIMATING MANURE NU, P1; Lobato, 2004, CERRADO CORRECAO SOL, P416; Machado, 2014, BIOL POLINIZACAO, P527; MAPA Ministerio da Agricultura Pecuaria e Abastecimento, 2008, PEC AB; Marini L, 2015, AGR ECOSYST ENVIRON, V207, P61, DOI 10.1016/j.agee.2015.03.027; Masiga R., 2014, Journal of Pollination Ecology, V14, P255; Morales MN, 2007, THESIS; Mosier AR, 2004, AGR NITROGEN CYCLE A; Munoz A, 2005, OECOLOGIA, V143, P126, DOI 10.1007/s00442-004-1780-3; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nicolson SW, 2011, AFR ZOOL, V46, P197, DOI 10.3377/004.046.0201; OECD Organisation for Economic Co-operation and Development, 2015, SER HARM REG OV BIOT, V59; Oliveira PS., 2002, CERRADOS BRAZIL ECOL, P398; Ouyang Z, 2016, SCIENCE, V352, P1455, DOI 10.1126/science.aaf2295; Petanidou T, 2006, OIKOS, V115, P155, DOI 10.1111/j.2006.0030-1299.14487.x; Quintela ED, 2009, BRASILIAEMBRAPA ARRO, V142, P51; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Roubik DW, 2005, FAO AGR SERVICES B; Rusch A, 2013, AGR ECOSYST ENVIRON, V166, P118, DOI 10.1016/j.agee.2011.05.004; Saez A, 2014, J APPL ECOL, V51, P1603, DOI 10.1111/1365-2664.12325; Silva HT, 2003, CARACTERIZACAO BOT E, V156; Simon S., 2014, Organic farming, prototype for sustainable agricultures, P83; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steward PR., 2014, AGR FOOD SECURITY, V3, P1, DOI DOI 10.1186/2048-7010-3-5; Strassburg BBN, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0099; Vaissiere BE, 2011, GLOBAL ACTION POLLIN; Woodcock BA, 2016, AGR ECOSYST ENVIRON, V231, P15, DOI 10.1016/j.agee.2016.06.023	63	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0204460	10.1371/journal.pone.0204460	http://dx.doi.org/10.1371/journal.pone.0204460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388124	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800007
J	Hsu, JC; Sue, YC; Tang, BY; Lu, CY				Hsu, Jason C.; Sue, Yu-Chi; Tang, Bo-Yun; Lu, Christine Y.			Use of assisted reproductive technologies before and after the Artificial Reproduction Act in Taiwan	PLOS ONE			English	Article							ECONOMIC-IMPACT; MULTIPLE BIRTHS; FERTILITY; INFERTILITY; MANAGEMENT; SAFETY; RISK; IVF; THIAZOLIDINEDIONES; SUBFERTILITY	Background Low birth rates and infertility are growing concerns for many countries. The Artificial Reproduction Act (ARA) was implemented in 2007 to better support the use of assisted reproductive technology (ART) in Taiwan. This study aims to examine trends in the use of ART and to determine impacts of the ARA on ART use. Method This study used data from the Health Promotion Administration in Taiwan. We used auto-regression models to examine the recent trends (1998-2017) in fertility related indicators and the use of ART. An interrupted time series design and segmented linear regression models were applied to analyze the changes in number of ART treatment cycles and birth rates by ART following the ARA. Results The number of births by ART has gradually increased, with an annual growth rate of 21.55%. The rate of births by ART increased from 0.86% in 1998 to 1.44% in 2007, and to 4.33% in 2016 (annual growth rate: 41.23%). We estimated a relative increase of 78.51% (95% CI: 46.13%, 110.90%) in the number of births by ART and a relative increase of 35.67% (95% CI: 18.87%, 52.47%) in rate of births by ART 5 years following the ARA was implemented. Conclusion ART has been seen as an approach to improve fertility. Our analysis suggests that the ART use and births associated from ART use both increased in Taiwan following the implementation of ARA. This experience in Taiwan may offer important lessons for other countries that are facing low fertility challenges.	[Hsu, Jason C.] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan; [Hsu, Jason C.] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan; [Sue, Yu-Chi; Tang, Bo-Yun] Natl Cheng Kung Univ, Coll Med, Sch Med, Tainan, Taiwan; [Lu, Christine Y.] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.] Harvard Pilgr Hlth Care Inst, Boston, MA USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Harvard University; Harvard Medical School	Hsu, JC (corresponding author), Natl Cheng Kung Univ, Coll Med, Sch Pharm, Tainan, Taiwan.; Hsu, JC (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan.	jasonhsu@mail.ncku.edu.tw						Barnes A, 2014, FERTIL STERIL, V102, P424, DOI 10.1016/j.fertnstert.2014.05.001; Bongaarts J, 1998, POPUL DEV REV, V24, P271, DOI 10.2307/2807974; Bongarrts J, 2000, TRANSITIONAL FERTILI; Chambers GM, 2009, FERTIL STERIL, V91, P2281, DOI 10.1016/j.fertnstert.2009.04.029; Collins JA, 2002, HUM REPROD UPDATE, V8, P265, DOI 10.1093/humupd/8.3.265; Conklin A, 2008, POLITICS CLIN MANY F, VII, P25; Connolly MP, 2009, HUM REPROD, V24, P2796, DOI 10.1093/humrep/dep260; Cook T.D., 2002, EXPT QUASIEXPERIMENT; de Ziegler D, 2013, FERTIL STERIL, V100, P1509, DOI 10.1016/j.fertnstert.2013.10.020; Dermout S, 2010, HUM REPROD, V25, P443, DOI 10.1093/humrep/dep410; Gauthier AH, 2007, POPUL RES POLICY REV, V26, P323, DOI 10.1007/s11113-007-9033-x; Health Promotion Administration Taiwan Ministry of Health and Welfare, 2014 REP ASS REPR TE; Health_ Promotion_ Administraton, 2014, EXPL 3 STAG ART REPR; Heng BC, 2007, REPROD BIOMED ONLINE, V15, P7, DOI 10.1016/S1472-6483(10)60352-5; Hoorens S, 2007, HUM REPROD, V22, P2471, DOI 10.1093/humrep/dem181; Hsu JC, 2015, PHARMACOEPIDEM DR S, V24, P1026, DOI 10.1002/pds.3834; Hsu JC, 2015, CLIN THER, V37, P1420, DOI 10.1016/j.clinthera.2015.04.006; Hughes EG, 2001, FERTIL STERIL, V76, P431, DOI 10.1016/S0015-0282(01)01928-8; Humaidan P, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008297; Jensen MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143722; Kissin DM, 2015, FERTIL STERIL, V103, P954, DOI 10.1016/j.fertnstert.2014.12.127; Langridge AT, 2012, J EPIDEMIOL COMMUN H, V66, P296, DOI 10.1136/jech.2009.100347; Li H, 2017, J PSYCHOSOM OBST GYN, V38, P12, DOI 10.1080/0167482X.2016.1265500; Liberman RF, 2017, BIRTH DEFECTS RES, V109, P1144, DOI 10.1002/bdr2.1055; Lu CY, 2015, CLIN THER, V37, P1280, DOI 10.1016/j.clinthera.2015.03.027; Lu CY, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3596; Lu CY, 2010, MED CARE, V48, P4, DOI 10.1097/MLR.0b013e3181bd4c10; Lunenfeld B, 2004, HUM REPROD UPDATE, V10, P317, DOI 10.1093/humupd/dmh028; Mcdonald P, 2002, POPULATION, P417; McGregor J, 2007, MED LAW, V26, P117; Milazzo A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165805; Mills T. C., 1990, TIME SERIES TECHNIQU; Morgan SP, 2003, DEMOGRAPHY, V40, P589, DOI 10.2307/1515198; Nachtigall RD, 2006, FERTIL STERIL, V85, P871, DOI 10.1016/j.fertnstert.2005.08.066; Schmidt L, 2005, HUM REPROD, V20, P3248, DOI 10.1093/humrep/dei193; Semba Y, 2009, SURROGACY DONOR CONC; Sorenson C, 2006, EURO OBSERVER, V8, P7; Toftager M, 2016, HUM REPROD, V31, P1253, DOI 10.1093/humrep/dew051; United Nations, 2015, ESAPWP241 UN; Vayena E., 2002, CURRENT PRACTICES CO; Vitale Salvatore Giovanni, 2017, Oman Med J, V32, P443, DOI 10.5001/omj.2017.85; Wang JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140581; Wolf N., 2001, MISCONCEPTIONS TRUTH; Zhang F, 2009, J CLIN EPIDEMIOL, V62, P143, DOI 10.1016/j.jclinepi.2008.08.007	44	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206208	10.1371/journal.pone.0206208	http://dx.doi.org/10.1371/journal.pone.0206208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383814	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600032
J	Lenormand, M; Luque, S; Langemeyer, J; Tenerelli, P; Zulian, G; Aalders, I; Chivulescu, S; Clemente, P; Dick, J; van Dijk, J; van Eupen, M; Giuca, RC; Kopperoinen, L; Lellei-Kovacs, E; Leone, M; Lieskovsky, J; Schirpke, U; Smith, AC; Tappeiner, U; Woods, H				Lenormand, Maxime; Luque, Sandra; Langemeyer, Johannes; Tenerelli, Patrizia; Zulian, Grazia; Aalders, Inge; Chivulescu, Serban; Clemente, Pedro; Dick, Jan; van Dijk, Jiska; van Eupen, Michiel; Giuca, Relu C.; Kopperoinen, Leena; Lellei-Kovacs, Eszter; Leone, Michael; Lieskovsky, Juraj; Schirpke, Uta; Smith, Alison C.; Tappeiner, Ulrike; Woods, Helen			Multiscale socio-ecological networks in the age of information	PLOS ONE			English	Article							CULTURAL ECOSYSTEM SERVICES; SOCIAL MEDIA DATA; PATTERNS; VALUES	Interactions between people and ecological systems, through leisure or tourism activities, form a complex socio-ecological spatial network. The analysis of the benefits people derive from their interactions with nature-also referred to as cultural ecosystem services (CES)-enables a better understanding of these socio-ecological systems. In the age of information, the increasing availability of large social media databases enables a better understanding of complex socio-ecological interactions at an unprecedented spatio-temporal resolution. Within this context, we model and analyze these interactions based on information extracted from geotagged photographs embedded into a multiscale socio-ecological network. We apply this approach to 16 case study sites in Europe using a social media database (Flickr) containing more than 150,000 validated and classified photographs. After evaluating the representativeness of the network, we investigate the impact of visitors' origin on the distribution of socio-ecological interactions at different scales. First at a global scale, we develop a spatial measure of attractiveness and use this to identify four groups of sites. Then, at a local scale, we explore how the distance traveled by the users to reach a site affects the way they interact with this site in space and time. The approach developed here, integrating social media data into a network-based framework, offers a new way of visualizing and modeling interactions between humans and landscapes. Results provide valuable insights for understanding relationships between social demands for CES and the places of their realization, thus allowing for the development of more efficient conservation and planning strategies.	[Lenormand, Maxime; Luque, Sandra; Tenerelli, Patrizia] Irstea, UMR TETIS, 500 Rue JF Breton, FR-34093 Montpellier, France; [Langemeyer, Johannes] Univ Autonoma Barcelona, Inst Environm Sci & Technol, C Columnes S-N,Campus UAB, Bellaterra 08193, Spain; [Zulian, Grazia] European Commiss, Joint Res Ctr, Directorate Sustainable Resources D, Unit Land Resources D3, Ispra, Italy; [Aalders, Inge] James Hutton Inst, Craigiebuckler AB15 8QH, Aberdeen, Scotland; [Chivulescu, Serban] Natl Inst Res & Dev & Forestry, Blvd Eroilor 128, Voluntari 077191, Ilfov, Romania; [Clemente, Pedro] NOVA Univ Lisbon, Ctr Environm & Sustainabil Res CENSE, NOVA Sch Sci & Technol, Campus Caparica, P-2829516 Caparica, Portugal; [Dick, Jan; Woods, Helen] Ctr Ecol & Hydrol, Bush Estate, Penicuik EH26 0QB, Midlothian, Scotland; [van Dijk, Jiska] Norwegian Inst Nat Res NINA, Hogskoleringen 9, N-7034 Trondheim, Norway; [van Eupen, Michiel] Wageningen Univ & Res, Environm Res, POB 47, NL-6700 AA Wageningen, Netherlands; [Giuca, Relu C.] Univ Bucharest, Res Ctr Syst Ecol & Sustainabil, Splaiul Independentei 91-95, Bucharest 050095, Romania; [Kopperoinen, Leena] Finnish Environm Inst, POB 140, FI-00251 Helsinki, Finland; [Lellei-Kovacs, Eszter] MTA Ctr Ecol Res, Inst Ecol & Bot, Alkotmany U 2-4, H-2163 Vacratot, Hungary; [Leone, Michael] Res Inst Nat & Forest INBO, Havenlaan 88 Bus 73, B-1000 Brussels, Belgium; [Lieskovsky, Juraj] Slovak Acad Sci, Inst Landscape Ecol, Akad 2, Nitra 94901, Slovakia; [Schirpke, Uta] Eurac Res, Inst Alpine Environm, Viale Druso 1, I-39100 Bolzano, Italy; [Smith, Alison C.] Univ Oxford, Environm Change Inst, Dyson Perrins Bldg,South Pk Rd, Oxford OX1 3QY, England; [Tappeiner, Ulrike] Univ Innsbruck, Dept Ecol, Sternwartestr 15, A-6020 Innsbruck, Austria	AgroParisTech; INRAE; Autonomous University of Barcelona; European Commission Joint Research Centre; EC JRC ISPRA Site; James Hutton Institute; National Research & Development Institute in Forestry "Marin Dracea"; Universidade Nova de Lisboa; UK Centre for Ecology & Hydrology (UKCEH); Norwegian Institute Nature Research; Wageningen University & Research; University of Bucharest; Finnish Environment Institute; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Research Institute for Nature & Forest; Slovak Academy of Sciences; European Academy of Bozen-Bolzano; University of Oxford; University of Innsbruck	Lenormand, M (corresponding author), Irstea, UMR TETIS, 500 Rue JF Breton, FR-34093 Montpellier, France.	maxime.lenormand@irstea.fr	Langemeyer, Johannes/AAH-7736-2020; Chivulescu, Serban/AAG-6867-2021; Smith, Alison/P-3326-2019; Tappeiner, Ulrike/B-8727-2009; Luque, Sandra/AAS-3613-2020; Langemeyer, Johannes/AAY-6252-2020; Lieskovský, Juraj/M-4535-2014; Kopperoinen, Leena/AAF-9040-2020; Schirpke, Uta/AAF-5256-2020; Lellei-Kovács, Eszter/GPL-6111-2022	Langemeyer, Johannes/0000-0002-0558-8486; Chivulescu, Serban/0000-0001-7079-5812; Smith, Alison/0000-0003-2649-2202; Tappeiner, Ulrike/0000-0002-0195-7459; Lieskovský, Juraj/0000-0002-9779-8340; Kopperoinen, Leena/0000-0003-1672-6087; Schirpke, Uta/0000-0002-2075-6118; Leone, Michael/0000-0001-6976-8868; Clemente, Pedro/0000-0002-3667-2584	ALTER-Net network through the ALTER-Net High Impact Action program; FP7 OpenNESS project [308428]; French National Research Agency [ANR-17-CE03-0003]	ALTER-Net network through the ALTER-Net High Impact Action program; FP7 OpenNESS project; French National Research Agency(French National Research Agency (ANR))	This publication has been funded by the ALTER-Net network through the ALTER-Net High Impact Action program. This study was partially supported by the FP7 OpenNESS project (grant agreement 308428). ML thanks the French National Research Agency for its financial support (project NetCost, ANR-17-CE03-0003 grant).	Barbosa H, 2018, PHYS REP, V734, P1, DOI 10.1016/j.physrep.2018.01.001; Barchiesi D, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150046; Barthelemy Marc, 2011, Physics Reports, V499, P1, DOI 10.1016/j.physrep.2010.11.002; Bassolas A, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0073-5; Bojic I, 2015, LECT NOTES COMPUT SC, V9471, P194, DOI 10.1007/978-3-319-27433-1_14; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Cao YP, 2015, MULTIMED TOOLS APPL, V74, P11499, DOI 10.1007/s11042-014-2247-0; Casalegno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068437; Chan KMA, 2016, P NATL ACAD SCI USA, V113, P1462, DOI 10.1073/pnas.1525002113; Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111; Figueroa-Alfaro RW, 2017, J ENVIRON PLANN MAN, V60, P266, DOI 10.1080/09640568.2016.1151772; Frias-Martinez V, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P239, DOI 10.1109/SocialCom-PASSAT.2012.19; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Grabowicz PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029358; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Java Akshay, 2007, P JOINT 9 WEBKDD 1 S, P56, DOI 10.1145/1348549.1348556; Knights AM, 2013, ECOL APPL, V23, P755, DOI 10.1890/12-1137.1; Krishnamurthy B., 2008, PROC 1 WORKSHOP ONLI, P19, DOI DOI 10.1145/1397735.1397741; Langemeyer J, 2018, LAND USE POLICY, V77, P542, DOI 10.1016/j.landusepol.2018.05.049; Lenormand M, 2016, P 2016 SPAT ACC C 9, P9; Lenormand M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0473; Lenormand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105184; Levin N, 2017, APPL GEOGR, V79, P115, DOI 10.1016/j.apgeog.2016.12.009; Levin N, 2015, ECOL APPL, V25, P2153, DOI 10.1890/15-0113.1.sm; Pastur GM, 2016, LANDSCAPE ECOL, V31, P383, DOI 10.1007/s10980-015-0254-9; Schirpke U, 2018, ECOSYST SERV, V31, P336, DOI 10.1016/j.ecoser.2017.11.017; Schulze K, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12435; Tenerelli P, 2017, LANDSCAPE ECOL, V32, P1097, DOI 10.1007/s10980-017-0498-7; Tenerelli P, 2016, ECOL INDIC, V64, P237, DOI 10.1016/j.ecolind.2015.12.042; Tenkanen H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18007-4; Tizzoni M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003716; United Nations World Tourism Organization, 2017, UNWTO WORLD TOUR BAR; van Zanten BT, 2016, P NATL ACAD SCI USA, V113, P12974, DOI 10.1073/pnas.1614158113; Wood SA, 2013, SCI REP-UK, V3, DOI 10.1038/srep02976	35	21	21	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206672	10.1371/journal.pone.0206672	http://dx.doi.org/10.1371/journal.pone.0206672			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383800	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000449027600081
J	Alonzo, JR; Venkataraman, C; Field, MS; Stover, PJ				Alonzo, Judith R.; Venkataraman, Chantel; Field, Martha S.; Stover, Patrick J.			The mitochondrial inner membrane protein MPV17 prevents uracil accumulation in mitochondrial DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						folate; one-carbon metabolism; mitochondria; thymidine kinase 2; nucleoside; nucleotide transport; mitochondrial transport; nucleoside; nucleotide biosynthesis; mitochondrial disease; mitochondrial thymidylate synthesis; MPV17; mitochondrial DNA-depletion syndrome (MDS); deoxythymidine monophosphate (dTMP)	NOVO THYMIDYLATE BIOSYNTHESIS; ONE-CARBON METABOLISM; DEPLETION SYNDROME; MICROBIOLOGICAL ASSAY; MAMMALIAN-CELLS; FOLATE; DELETIONS; MUTATION; ENCODES; METHYLENETETRAHYDROFOLATE	Mitochondrial inner membrane protein MPV17 is a protein of unknown function that is associated with mitochondrial DNA (mtDNA)-depletion syndrome (MDS). MPV17 loss-of-function has been reported to result in tissue-specific nucleotide pool imbalances, which can occur in states of perturbed folate-mediated one-carbon metabolism (FOCM), but MPV17 has not been directly linked to FOCM. FOCM is a metabolic network that provides one-carbon units for the de novo synthesis of purine and thymidylate nucleotides (e.g. dTMP) for both nuclear DNA (nuDNA) and mtDNA replication. In this study, we investigated the impact of reduced MPV17 expression on markers of impaired FOCM in HeLa cells. Depressed MPV17 expression reduced mitochondrial folate levels by 43% and increased uracil levels, a marker of impaired dTMP synthesis, in mtDNA by 3-fold. The capacity of mitochondrial de novo and salvage pathway dTMP biosynthesis was unchanged by the reduced MPV17 expression, but the elevated levels of uracil in mtDNA suggested that other sources of mitochondrial dTMP are compromised in MPV17-deficient cells. These results indicate that MPV17 provides a third dTMP source, potentially by serving as a transporter that transfers dTMP from the cytosol to mitochondria to sustain mtDNA synthesis. We propose that MPV17 loss-of-function and related hepatocerebral MDS are linked to impaired FOCM in mitochondria by providing insufficient access to cytosolic dTMP pools and by severely reducing mitochondrial folate pools.	[Alonzo, Judith R.; Stover, Patrick J.] Cornell Univ, Grad Field Biochem Mol & Cellular Biol, Ithaca, NY 14853 USA; [Venkataraman, Chantel; Field, Martha S.; Stover, Patrick J.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stover, PJ (corresponding author), Texas A&M Univ, Coll Agr & Life Sci, Agr & Life Sci Bldg,600 John Kimbrough Blvd, College Stn, TX 77843 USA.	Patrick.Stover@ag.tamu.edu		Field, Martha/0000-0001-7547-5180	Public Health Service Grant [R37DK58144]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058144] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service Grant R37DK58144 (to P.J.S.). The authors declare that they have no conflicts of interest with the contents of this article.	AlSaman A, 2012, SAUDI J GASTROENTERO, V18, P285, DOI 10.4103/1319-3767.98439; Anderson DD, 2012, J BIOL CHEM, V287, P7051, DOI 10.1074/jbc.M111.333120; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; Antonenkov VD, 2015, J BIOL CHEM, V290, P13840, DOI 10.1074/jbc.M114.608083; Bailey LB., 2009, FOLATE HLTH DIS; Basten GP, 2006, BRIT J CANCER, V94, P1942, DOI 10.1038/sj.bjc.6603197; Bijarnia-Mahay S, 2014, INDIAN PEDIATR, V51, P666, DOI 10.1007/s13312-014-0475-z; Blakely EL, 2012, NEUROMUSCULAR DISORD, V22, P587, DOI 10.1016/j.nmd.2012.03.006; Blount BC, 1997, P NATL ACAD SCI USA, V94, P3290, DOI 10.1073/pnas.94.7.3290; Branda RF, 2002, MUTAT RES-FUND MOL M, V501, P29, DOI 10.1016/S0027-5107(02)00014-3; Casalena G, 2014, AM J PHYSIOL-RENAL, V306, pF1372, DOI 10.1152/ajprenal.00608.2013; Chou YF, 2009, EUR J NUTR, V48, P429, DOI 10.1007/s00394-009-0031-0; Crott JW, 2005, MUTAT RES-FUND MOL M, V570, P63, DOI 10.1016/j.mrfmmm.2004.09.009; DAS KC, 1989, AM J HEMATOL, V31, P11, DOI 10.1002/ajh.2830310103; Di Noia MA, 2014, J BIOL CHEM, V289, P33137, DOI 10.1074/jbc.M114.610808; Dotzlaf J, 2007, HYBRIDOMA, V26, P155, DOI 10.1089/hyb.2007.004; El-Hattab A. W., 2012, GENEREVIEWS; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Ferraro P, 2006, P NATL ACAD SCI USA, V103, P18586, DOI 10.1073/pnas.0609020103; Field MS, 2014, J BIOL CHEM, V289, P29642, DOI 10.1074/jbc.M114.599589; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Gonzalez-Vioque E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002035; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Horne DW, 1997, METHOD ENZYMOL, V281, P38; LIN BF, 1993, J BIOL CHEM, V268, P21674; Lollgen S, 2015, BIOL CHEM, V396, P13, DOI 10.1515/hsz-2014-0198; LOWE KE, 1993, J BIOL CHEM, V268, P21665; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; Molloy AM, 1997, METHOD ENZYMOL, V281, P43; Neuburger M, 1996, J BIOL CHEM, V271, P9466, DOI 10.1074/jbc.271.16.9466; Rosa ID, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005779; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Stover PJ, 2012, CANCER CELL, V22, P3, DOI 10.1016/j.ccr.2012.06.010; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; TRENT DF, 1991, BIOCHEM PHARMACOL, V42, P1015, DOI 10.1016/0006-2952(91)90283-B; Venegas V, 2011, CURR PROTOC HUM GENE, V19, P17, DOI DOI 10.1002/0471142905.HG1907S68; WEIHER H, 1990, CELL, V62, P425, DOI 10.1016/0092-8674(90)90008-3; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200; Ye YL, 2010, J NUTR BIOCHEM, V21, P793, DOI 10.1016/j.jnutbio.2009.05.005; ZWACKA RM, 1994, EMBO J, V13, P5129, DOI 10.1002/j.1460-2075.1994.tb06842.x	41	18	19	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20285	20294		10.1074/jbc.RA118.004788	http://dx.doi.org/10.1074/jbc.RA118.004788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385507	hybrid, Green Published			2022-12-26	WOS:000454685900033
J	Simon, EJ; Linstedt, AD				Simon, Emily J.; Linstedt, Adam D.			Site-specific glycosylation of Ebola virus glycoprotein by human polypeptide GalNAc-transferase 1 induces cell adhesion defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; Ebola virus; viral protein; glycoprotein; adhesion; acetylgalactosaminyltransferase; deadhesion; mucin-like domain; pathogenesis; ppGalNAc-T1	O-GLYCOSYLATION; ENVELOPE	The surface glycoprotein (GP) of Ebola virus causes many of the virus's pathogenic effects, including a dramatic loss of endothelial cell adhesion associated with widespread hemorrhaging during infection. Although the GP-mediated deadhesion depends on its extracellular mucin-like domain, it is unknown whether any, or all, of this domain's densely clustered O-glycosylation sites are required. It is also unknown whether any of the 20 distinct polypeptide GalNAc-transferases (ppGalNAc-Ts) that initiate mucin-type O-glycosylation in human cells are functionally required. Here, using HEK293 cell lines lacking specific glycosylation enzymes, we demonstrate that GP requires extended O-glycans to exert its deadhesion effect. We also identified ppGalNAc-T1 as largely required for the GP-mediated adhesion defects. Despite its profound effect on GP function, the absence of ppGalNAc-T1 only modestly reduced the O-glycan mass of GP, indicating that even small changes in the bulky glycodomain can cause loss of GP function. Indeed, protein-mapping studies identified a small segment of the mucin-like domain critical for function and revealed that mutation of five glycan acceptor sites within this segment are sufficient to abrogate GP function. Together, these results argue against a mechanism of Ebola GP-induced cell detachment that depends solely on ectodomain bulkiness and identify a single host-derived glycosylation enzyme, ppGalNAc-T1, as a potential target for therapeutic intervention against Ebola virus disease.	[Simon, Emily J.; Linstedt, Adam D.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Linstedt, AD (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.	linstedt@cmu.edu			National Institutes of Health [1R21DE026714, UO1 CA230677]; NATIONAL CANCER INSTITUTE [U01CA230677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE026714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Institutes of Health Grants 1R21DE026714 and UO1 CA230677 (to A. D. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bagdonaite I, 2016, J BIOL CHEM, V291, P12014, DOI 10.1074/jbc.M116.721746; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Beniac D, 2017, SCI REP-UK, V7, DOI 10.1038/srep46374; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Chan SY, 2000, J GEN VIROL, V81, P2155, DOI 10.1099/0022-1317-81-9-2155; Collar AL, 2017, VIROLOGY, V502, P39, DOI 10.1016/j.virol.2016.12.010; Escudero-Perez B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004509; Francica JR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001098; Francica JR, 2009, VIROLOGY, V383, P237, DOI 10.1016/j.virol.2008.10.029; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Liu F, 2017, J BIOL CHEM, V292, P21304, DOI 10.1074/jbc.M117.814202; Miwa HE, 2010, J BIOL CHEM, V285, P1208, DOI 10.1074/jbc.M109.035436; Mukhopadhyay S, 2010, MOL BIOL CELL, V21, P1282, DOI 10.1091/mbc.E09-11-0985; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Schjoldager KT, 2015, EMBO REP, V16, P1713, DOI 10.15252/embr.201540796; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Song L, 2017, ELIFE, V6, DOI 10.7554/eLife.24051; Song LN, 2014, J BIOL CHEM, V289, P30556, DOI 10.1074/jbc.M114.599563; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Steentoft C, 2011, NAT METHODS, V8, P977, DOI [10.1038/nmeth.1731, 10.1038/NMETH.1731]; Tenno M, 2007, MOL CELL BIOL, V27, P8783, DOI 10.1128/MCB.01204-07; Tian E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115861; Tian E, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1874; Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14; Van den Steen P, 1998, CRIT REV BIOCHEM MOL, V33, P151; Wang SJ, 2018, J BIOL CHEM, V293, P7408, DOI 10.1074/jbc.M117.817981; Wang YC, 2010, P NATL ACAD SCI USA, V107, P9228, DOI 10.1073/pnas.0914004107; Yang ZY, 2000, NAT MED, V6, P886, DOI 10.1038/78654	28	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19866	19873		10.1074/jbc.RA118.005375	http://dx.doi.org/10.1074/jbc.RA118.005375			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30389789	Green Published, hybrid			2022-12-26	WOS:000454294900030
J	Dayie, NTKD; Tetteh-Ocloo, G; Labi, AK; Olayemi, E; Slotved, HC; Lartey, M; Donkor, ES				Dayie, Nicholas T. K. D.; Tetteh-Ocloo, Georgina; Labi, Appiah-Korang; Olayemi, Edeghonghon; Slotved, Hans-Christian; Lartey, Margaret; Donkor, Eric S.			Pneumococcal carriage among sickle cell disease patients in Accra, Ghana: Risk factors, serotypes and antibiotic resistance	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; NASOPHARYNGEAL CARRIAGE; CONJUGATE VACCINES; HEALTHY-CHILDREN; SUSCEPTIBILITIES; COLONIZATION; EPIDEMIOLOGY; VACCINATION; DURATION; KENYA	Background Pneumococcal carriage is the precursor for development of pneumococcal disease, and is also responsible for transmission of the organism from person-to-person. Individuals with Sickle Cell Disease (SCD) are more likely to develop invasive disease with S. pneumoniae compared to their healthy counterparts and the presentation of disease in the former is usually abrupt and severe. In Africa, little is known about the pneumococcus in relation to people with SCD Sickle Cell Disease (SCD). The aim of the study was to investigate the epidemiology of pneumococcal carriage among SCD patients including the carriage prevalence, risk factors, serotypes and antibiotic resistance. Method This was a cross sectional study involving 402 SCD patients recruited from Korle Bu Teaching Hospital and Princess Marie Louis Hospital in Accra from October 2016 to March 2017. The study subjects included 202 children of the age groups: <= 5 years (94), >5-9 years (75), >= 10-13 years (33) and 200 adults of the age groups: 14-20 years (46), 21-40 years (112), 41-60 years (25), <= 61 years (17). Nasopharyngeal (NP) swabs were collected from the study participants as well as epidemiological data on demographic, household and clinical features. The NP specimens were cultured for S. pneumoniae and the isolates were sero-typed by latex agglutination. Antimicrobial susceptibility tests of the isolates were done by the disc diffusion test and E-test. Results Prevalence of S. pneumoniae carriage among children and adult SCD patients enrolled in the study were 79/202 (39.1%; 95% CI: 32.3 to 46.2) and 20/200 (10.0%; 95% CI: 6.2 to 15.0) respectively. Risk factors associated with pneumococcal carriage were age (OR = 1.137; 95% CI: 1.036-1.248; p = 0.007) and runny nose (OR = 5.371; 95% CI: 1.760-16.390; p = 0.003). Overall, twenty-six pneumococcal serotypes were isolated from the study participants and the predominant serotype was 6B (10.6%), followed by 23B (8.2%). Among the children, serotype coverage of the 13-valent Pneumococcal Conjugate Vaccine, which is currently used in Ghana was 32.4%. Prevalence of penicillin resistance among the pneumococcal isolates was 37.4% (37/99) and all the penicillin-resistant isolates exhibited intermediate penicillin resistance with the exception of one isolate that showed full resistance and was susceptible to ceftriaxone. Prevalence of resistance to the other antibiotics ranged from 2.5% (levofloxacin) to 85% (cotrimoxazole). Multidrug resistance occurred among 34.3% (34/99) of the pneumococcal isolates. Conclusion Pneumococcal carriage was four-fold higher in SCD children than adults and was characterized by predominance of non-vaccine serotypes and considerable level of multidrug resistance, though penicillin, cefotaxime and levofloxacin resistance appeared to be very low.	[Dayie, Nicholas T. K. D.; Tetteh-Ocloo, Georgina; Donkor, Eric S.] Univ Ghana, Sch Biomed & Allied Hlth Sci, Dept Med Microbiol, Accra, Ghana; [Labi, Appiah-Korang] Korle Bu Teaching Hosp, Dept Microbiol, Accra, Ghana; [Olayemi, Edeghonghon] Univ Ghana, Sch Biomed & Allied Hlth Sci, Dept Haemataol, Accra, Ghana; [Slotved, Hans-Christian] Statens Serum Inst, Dept Microbiol Surveillance & Res, Copenhagen, Denmark; [Lartey, Margaret] Univ Ghana, Sch Med & Dent, Dept Med, Accra, Ghana	University of Ghana; University of Ghana; Statens Serum Institut; University of Ghana	Donkor, ES (corresponding author), Univ Ghana, Sch Biomed & Allied Hlth Sci, Dept Med Microbiol, Accra, Ghana.	esampane-donkor@ug.edu.gh	Labi, Appiah-Korang/GWN-2604-2022; Slotved, Hans-Christian/H-7476-2019	Slotved, Hans-Christian/0000-0002-7294-4911; Dayie, Nicholas T.K.D./0000-0003-4491-6902; Olayemi, Edeghonghon/0000-0002-1646-4470; Donkor, Eric S./0000-0002-9368-0636	Office of Research, Innovation and Development of the University of Ghana [URF/9/ILG-068/2015-2016]	Office of Research, Innovation and Development of the University of Ghana	The study was funded through a grant from the Office of Research, Innovation and Development of the University of Ghana (Grant no. URF/9/ILG-068/2015-2016 to Nicholas TKD Dayie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2008, PEDIATR INFECT DIS J, V27, P59, DOI 10.1097/INF.0b013e31814da70c; Alexander Ellie, 2008, J Infect Public Health, V1, P40, DOI 10.1016/j.jiph.2008.08.005; ANGLIN DL, 1984, J PEDIATR-US, V104, P18, DOI 10.1016/S0022-3476(84)80582-X; [Anonymous], 2013, GHAN DEM PROF 2013; [Anonymous], 2012, WKLY EPIDEMIOL REC; Anthony L, 2012, INT J INFECT DIS, V16, pE753, DOI 10.1016/j.ijid.2012.05.1037; Baffoe-Bonnie B, 2000, GHANA MED J, V34, P18; Baffuor-Asare M., 2018, THESIS; Boadu I, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0241-z; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Booth C, 2010, INT J INFECT DIS, V14, pE2, DOI 10.1016/j.ijid.2009.03.010; Carter R, 2014, CELL HOST MICROBE, V15, P587, DOI 10.1016/j.chom.2014.04.005; Choe YJ, 2016, VACCINE, V34, P4771, DOI 10.1016/j.vaccine.2016.08.030; CLSI, 2016, M100 PERF STAND ANT, V26; Collins DA, 2017, PNEUMONIA, V9, DOI 10.1186/s41479-017-0038-x; Daana M, 2015, VACCINE, V33, P1021, DOI 10.1016/j.vaccine.2015.01.003; Daniels Calvin C, 2016, J Pediatr Pharmacol Ther, V21, P27, DOI 10.5863/1551-6776-21.1.27; Daw NC, 1997, PEDIATRICS, V99, DOI 10.1542/peds.99.4.e7; Dayie NTKD, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-490; Demczuk WHB, 2018, VACCINE, V36, P4701, DOI 10.1016/j.vaccine.2018.06.018; Donkor ES, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2224-0; Donkor ES, 2013, INT J GEN MED, V6, P757, DOI 10.2147/IJGM.S45842; Donkor ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053925; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Donkor ES, 2010, SCAND J INFECT DIS, V42, P254, DOI 10.3109/00365540903490000; DONKOR ES, 2014, ADV MICROBIOL, V4, P627, DOI DOI 10.4236/aim.2014.410069; Donkor ES, 2008, INTERNET J MICROBIOL, V5, P2, DOI [10.5580/16d5, DOI 10.5580/16D5]; Donkor ES, 2007, INTERNET J MICROBIOL, V4, P2, DOI DOI 10.5580/33a; Duedu KO, 2017, INT J MICROBIOL; Ekdahl K, 1997, CLIN INFECT DIS, V25, P1113, DOI 10.1086/516103; Hanage WP, 2008, FUTURE MICROBIOL, V3, P23, DOI 10.2217/17460913.3.1.23; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Kateete David P, 2012, BMC Res Notes, V5, P28, DOI 10.1186/1756-0500-5-28; Klugman KP, 2002, J ANTIMICROB CHEMOTH, V50, P1, DOI 10.1093/jac/dkf500; Korle- Bu Teaching Hospital, 2009, ANN REP KORL BU TEAC; Labi AK, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0947-3; Masala GL, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0620; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Miller ML, 2007, J INFECT DIS, V195, P581, DOI 10.1086/510626; Mills RO, 2015, INFECT DIS-NOR, V47, P326, DOI 10.3109/00365548.2014.994185; Newman Mercy J, 2011, Infect Drug Resist, V4, P215, DOI 10.2147/IDR.S21769; Oodate M, 2018, JPN J INFECT DIS, V71, P14, DOI 10.7883/yoken.JJID.2017.236; Orsi A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071140; OVERTURF GD, 1977, AM J DIS CHILD, V131, P784, DOI 10.1001/archpedi.1977.02120200066014; Paul J, 1996, J INFECTION, V32, P139, DOI 10.1016/S0163-4453(96)91374-2; Principi N, 1999, PEDIATR INFECT DIS J, V18, P517, DOI 10.1097/00006454-199906000-00008; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Schaumburg F, 2013, CLIN MICROBIOL INFEC, V19, P235, DOI 10.1111/j.1469-0691.2012.03771.x; Singleton RJ, 2007, JAMA-J AM MED ASSOC, V297, P1784, DOI 10.1001/jama.297.16.1784; Sleeman K. L, 2008, J MED MICROBIOL, V57, P185, DOI DOI 10.1099/JMM.0.47470-0; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Smith AM, 1997, MICROB DRUG RESIST, V3, P385, DOI 10.1089/mdr.1997.3.385; SMITH T, 1993, EPIDEMIOL INFECT, V111, P27, DOI 10.1017/S0950268800056648; Tetteh-Quarcoo PB, 2013, ENVIRON HEALTH INSIG, V7, P59, DOI 10.4137/EHI.S12820; Tettey EY, 2018, THESIS; Usuf E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085001; Van Bambeke F, 2007, DRUGS, V67, P2355, DOI 10.2165/00003495-200767160-00005; Wahl B, 2018, LANCET GLOB HEALTH, V6, pE744, DOI 10.1016/S2214-109X(18)30247-X; World Health Organization, GHAN WHO UNICEF EST; Zuccotti G, 2014, VACCINE, V32, P527, DOI 10.1016/j.vaccine.2013.12.003	61	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206728	10.1371/journal.pone.0206728	http://dx.doi.org/10.1371/journal.pone.0206728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408061	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300033
J	Gallo, W; Esguerra, JLS; Eliasson, L; Melander, O				Gallo, Widet; Esguerra, Jonathan Lou S.; Eliasson, Lena; Melander, Olle			miR-483-5p associates with obesity and insulin resistance and independently associates with new onset diabetes mellitus and cardiovascular disease	PLOS ONE			English	Article							CIRCULATING MICRORNAS; NONCODING RNAS; RISK; BIOMARKERS; PREDICTION; FAILURE; STROKE; CANCER; CELLS; SERUM	Our aim was to identify serum microRNAs (miRNAs) in healthy humans which associate with future onset of both diabetes mellitus and cardiovascular disease. We performed global profiling of 753 mature human miRNAs in serum of 12 pilot subjects followed by measurement of 47 consistently expressed miRNAs in fasting serum of 553 healthy subjects from the baseline exam (1991-1994) of the population based Malmo Diet and Cancer Study Cardiovascular Cohort (MDC-CC), of whom 140 developed diabetes, and 169 cardiovascular diseases during follow-up. We used multivariate logistic regression to test individual miRNAs for association with incident diabetes and cardiovascular disease as compared to control subjects (n = 259). After Bonferroni correction and adjustment for age and sex, each SD increment of log-transformed miR-483-5p was significantly associated with both incident diabetes (OR = 1.48; 95% CI 1.18-1.84, P = 0.001) and cardiovascular disease (OR = 1.40; 95% CI 1.15, 1.72, P = 0.001). In cross sectional analysis, miR-483-5p was correlated with BMI (r = 0.162, P = 0.0001), fasting insulin (r = 0.156, P = 0.0002), HDL (r = -0.099, P = 0.02) and triglycerides (r = 0.11, P = 0.01). Adjustment for these metabolic risk factors, as well as traditional risk factors attenuated the miR-483-5p association with incident diabetes (OR = 1.28 95% CI 1.00-1.64, P = 0.049) whereas its association with incident cardiovascular disease remained virtually unchanged (OR = 1.46 95% CI, 1.18-1.81, P = 0.0005). In conclusion, miR-483-5p associates with both diabetes and cardiovascular disease. The association with diabetes seems partly mediated by obesity and insulin resistance, whereas the association with incident cardiovascular disease is independent of these metabolic factors and traditional cardiovascular disease risk factors.	[Gallo, Widet; Melander, Olle] Lund Univ, Dept Clin Sci Malmo, Hypertens & Cardiovasc Dis, Malmo, Sweden; [Gallo, Widet; Esguerra, Jonathan Lou S.; Eliasson, Lena; Melander, Olle] Lund Univ, Ctr Diabet, Skane Univ Hosp, Malmo, Sweden; [Esguerra, Jonathan Lou S.; Eliasson, Lena] Lund Univ, Dept Clin Sci Malmo, Islet Cell Exocytosis, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Melander, O (corresponding author), Lund Univ, Dept Clin Sci Malmo, Hypertens & Cardiovasc Dis, Malmo, Sweden.; Melander, O (corresponding author), Lund Univ, Ctr Diabet, Skane Univ Hosp, Malmo, Sweden.	olle.melander@med.iu.se	Esguerra, Jonathan/M-2366-2014; Eliasson, Lena/E-9294-2012	Esguerra, Jonathan/0000-0001-8454-6606; Eliasson, Lena/0000-0002-6467-5029; Melander, Olle/0000-0002-2581-484X; Gallo, Widet/0000-0002-6258-9848	Swedish Foundation for Strategic Research (IRC-LUDC); Swedish Research Council (SFO-EXODIAB); Swedish Research Council [LE [2016-0124]]; Region Skane-ALF/Skane University Hospital; Albert Pahlsson Foundation; Knut and Alice Wallenberg Foundation; Goran Gustafsson Foundation; Swedish Heart- and Lung Foundation; Novo Nordisk Foundation; Swedish Diabetes Foundation [DIA2016-130]; European Union [667191]; Crafoord Foundation; Magnus Bergvalls Stiftelse; Syskonen Svenssons Foundation; Diabetes Research & Wellness Foundation	Swedish Foundation for Strategic Research (IRC-LUDC); Swedish Research Council (SFO-EXODIAB)(Swedish Research Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane-ALF/Skane University Hospital; Albert Pahlsson Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Goran Gustafsson Foundation; Swedish Heart- and Lung Foundation(Swedish Heart-Lung Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Diabetes Foundation; European Union(European Commission); Crafoord Foundation; Magnus Bergvalls Stiftelse; Syskonen Svenssons Foundation; Diabetes Research & Wellness Foundation	This work was supported by the Swedish Foundation for Strategic Research (IRC-LUDC) and Swedish Research Council (SFO-EXODIAB). The project received grants from the Swedish Research Council (OM; LE [2016-0124]); Region Skane-ALF/Skane University Hospital (OM; LE), and Albert Pahlsson Foundation (LE; JLSE). OM also received support from the Knut and Alice Wallenberg Foundation; the Goran Gustafsson Foundation; the Swedish Heart-and Lung Foundation, and the Novo Nordisk Foundation. LE was also supported by The Swedish Diabetes Foundation (DIA2016-130). JLSE received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 667191 (T2DSystems); Crafoord Foundation; Magnus Bergvalls Stiftelse and Syskonen Svenssons Foundation. LE also received support from Diabetes Research & Wellness Foundation. WG, OM, LE and JLSE contributed to study concept and design, statistical analyses, interpretation of data and drafted the manuscript. WG and JLSE performed the experiments. WG, OM, JLSE and LE made intellectual contributions to drafting and revising the manuscript and approved the final version.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Bolmeson C, 2011, BIOCHEM BIOPH RES CO, V404, P16, DOI 10.1016/j.bbrc.2010.11.024; Cederholm J, 2008, DIABETES CARE, V31, P2038, DOI 10.2337/dc08-0662; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; D'Alessandra Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080345; De Rosa S, 2011, CIRCULATION, V124, P1936, DOI 10.1161/CIRCULATIONAHA.111.037572; Eliasson L, 2014, ACTA PHYSIOL, V211, P273, DOI 10.1111/apha.12285; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Gallo A., 2012, PLOS ONE, V7; Gangwar RS, 2018, AM J HYPERTENS, V31, P150, DOI 10.1093/ajh/hpx197; Gidlof O, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-12; Guay C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0097-7; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Harling L, 2017, EUR J CARDIO-THORAC, V51, P73, DOI 10.1093/ejcts/ezw245; Jalabert A, 2016, DIABETOLOGIA, V59, P1049, DOI 10.1007/s00125-016-3882-y; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Kadakia R, 2016, HORM RES PAEDIAT, V85, P75, DOI 10.1159/000443500; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lindholm E, 2001, EUR J EPIDEMIOL, V17, P983, DOI 10.1023/A:1020036805655; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Ma N, 2011, MOL CELL ENDOCRINOL, V333, P96, DOI 10.1016/j.mce.2010.11.027; McManus DD, 2015, HEART RHYTHM, V12, P3, DOI 10.1016/j.hrthm.2014.09.050; Mendis S, 2011, 9789241564373 WHO; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ortega FJ, 2014, DIABETES CARE, V37, P1375, DOI 10.2337/dc13-1847; Pescador N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077251; Rong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073272; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; Schwartz SS, 2017, TRENDS ENDOCRIN MET, V28, P645, DOI 10.1016/j.tem.2017.05.005; Shi L, 2015, REPROD BIOMED ONLINE, V31, P565, DOI 10.1016/j.rbmo.2015.06.023; Smith JG, 2010, J AM COLL CARDIOL, V56, P1713, DOI 10.1016/j.jacc.2010.05.049; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Willeit P, 2017, DIABETES, V66, P347, DOI 10.2337/db16-0731; Zampetaki A, 2012, J AM COLL CARDIOL, V60, P290, DOI 10.1016/j.jacc.2012.03.056; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761617	41	30	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206974	10.1371/journal.pone.0206974	http://dx.doi.org/10.1371/journal.pone.0206974			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408096	gold, Green Submitted, Green Published			2022-12-26	WOS:000449512300060
J	Kibler, CE; Milligan, SL; Farris, TR; Zhu, B; Mitra, S; McBride, JW				Kibler, Clayton E.; Milligan, Sarah L.; Farris, Tierra R.; Zhu, Bing; Mitra, Shubhajit; McBride, Jere W.			Ehrlichia chaffeensis TRP47 enters the nucleus via a MYND-binding domain-dependent mechanism and predominantly binds enhancers of host genes associated with signal transduction, cytoskeletal organization, and immune response	PLOS ONE			English	Article							EXPRESSION; MOTIF; FAMILY; PHD2	Ehrlichia chaffeensis is an obligately intracellular bacterium that establishes infection in mononuclear phagocytes through largely undefined reprogramming strategies including modulation of host gene transcription. In this study, we demonstrate that the E. chaffeensis effector TRP47 enters the host cell nucleus and binds regulatory regions of host genes relevant to infection. TRP47 was observed in the nucleus of E. chaffeensis-infected host cells, and nuclear localization was dependent on a variant MYND-binding domain. An electrophoretic mobility shift assay (EMSA) demonstrated that TRP47 directly binds host DNA via its tandem repeat domain. Utilizing chromatin immunoprecipitation followed by high-throughput DNA sequencing (ChIP-seq) with E. chaffeensis-infected cells, TRP47 was found to bind at multiple sites in the human genome (n = 2,051 at p < 10(-30)). Ontology analysis identified genes involved in functions such as immune response, cytoskeletal organization, and signal transduction. TRP47-bound genes included RNA-coding genes, many of these linked to cell proliferation or apoptosis. Comparison of TRP47 binding sites with those of previously-identified E. chaffeensis nucleomodulins identified multiple genes and gene functional categories in common including intracellular transport, cell signaling, and transcriptional regulation. Further, motif analysis followed by EMSA with synthetic oligonucleotides containing discovered motifs revealed a conserved TRP47 DNA-binding motif. This study reveals that TRP47 is a nucleomodulin that enters the nucleus via a MYND-binding domain and appears to play a role in host cell reprogramming by regulation of transcription.	[Kibler, Clayton E.; Milligan, Sarah L.; Zhu, Bing; Mitra, Shubhajit; McBride, Jere W.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Farris, Tierra R.; McBride, Jere W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [McBride, Jere W.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA; [McBride, Jere W.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [McBride, Jere W.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	McBride, JW (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.; McBride, JW (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; McBride, JW (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.; McBride, JW (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA.; McBride, JW (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.	jemcbrid@utmb.edu		Kibler, Clayton/0000-0002-1900-2351	National Institute of Allergy and Infectious Diseases [AI106859]; NIH	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institute of Allergy and Infectious Diseases AI106859 (to JWM) https://grants.nih.gov/. This work was also supported by NIH grant for study design, data collection and analysis.	Ansieau S, 2002, J BIOL CHEM, V277, P4906, DOI 10.1074/jbc.M110078200; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; De S, 2014, BRIEF BIOINFORM, V15, P919, DOI 10.1093/bib/bbt053; Fan Q, 2016, PROTEIN CELL, V7, P899, DOI 10.1007/s13238-016-0316-z; Farris TR, 2016, INFECT IMMUN, V84, P3182, DOI 10.1128/IAI.00657-16; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Gelmetti V, 1998, MOL CELL BIOL, V18, P7185, DOI 10.1128/MCB.18.12.7185; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Iancu IV, 2017, J CELL MOL MED, V21, P3787, DOI 10.1111/jcmm.13288; Kay S, 2007, SCIENCE, V318, P648, DOI 10.1126/science.1144956; Klema VJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194891; Kuriakose JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024136; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Li J, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12312; Lina TT, 2016, MBIO, V7, DOI 10.1128/mBio.00672-16; Lina TT, 2016, FRONT CELL INFECT MI, V6, P1, DOI [10.3389/fcimb.2016.00001, DOI 10.3389/FCIMB.2016.00001]; Liu YZ, 2007, CANCER CELL, V11, P483, DOI 10.1016/j.ccr.2007.04.010; Luo T, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00178; Luo T, 2016, INFECT IMMUN, V84, P686, DOI 10.1128/IAI.01289-15; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; McBride JW, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001730; McBride JW, 2002, INFECT IMMUN, V70, P2700, DOI 10.1128/IAI.70.5.2700-2703.2002; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Pientka FK, 2012, J CELL SCI, V125, P5168, DOI 10.1242/jcs.109041; Poudel S, 2013, BIOCHEM BIOPH RES CO, V431, P572, DOI 10.1016/j.bbrc.2013.01.012; Song DS, 2013, J BIOL CHEM, V288, P9662, DOI 10.1074/jbc.M112.440552; Wakeel A, 2009, INFECT IMMUN, V77, P1734, DOI 10.1128/IAI.00027-09; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Watanabe M, 2012, EUR J IMMUNOL, V42, P1850, DOI 10.1002/eji.201141897; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004; Zhu B, 2011, INFECT IMMUN, V79, P4370, DOI 10.1128/IAI.05422-11; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	36	11	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0205983	10.1371/journal.pone.0205983	http://dx.doi.org/10.1371/journal.pone.0205983			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408047	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300012
J	Venugopal, V; Krishnan, S; Palanimuthu, VR; Sankarankutty, S; Kalaimani, JK; Karupiah, S; Kit, NS; Hock, TT				Venugopal, Vijayan; Krishnan, Shalini; Palanimuthu, Vasanth Raj; Sankarankutty, Subin; Kalaimani, Jayaraja Kumar; Karupiah, Sundram; Kit, Ng Siew; Hock, Tang Thean			Anti-EGFR anchored paclitaxel loaded PLGA nanoparticles for the treatment of triple negative breast cancer. In-vitro and in-vivo anticancer activities	PLOS ONE			English	Article								The aim of the present study is to analyze the viability of anti-EGFR anchored immunonano-particle (INP) bearing Paclitaxel (PTX) to specifically bind the EGFR protein on the TNBC cells. The NP was prepared by nanoprecipitation and characterized the particle size, charge, entrapment of drug and release of it. The anti-EGFR anchored and the integrity was confirmed by SDS-PAGE. Cytotoxicity and NPs cellular uptake was analyzed with MDAMB-468 type cancer cells and the EGFR expression was confirmed by PCR, qualitatively and quantitatively. The in-vivo antitumor activity of INP was determined by using athymic mice model and targeting efficiency was measured by calculating the PTX accumulation in the tumor plasma. The prepared INP with the size of 336.3 nm and the charge of -3.48 mV showed sustained drug release upto 48 h. The INP showed significant reduction of cancer cell viability of 10.6% for 48 h with 93 fold higher PTX accumulation in the tumor plasma compared with NPs. Based on these reports, we recommend that anti-EGFR anchored PTX loaded NP may have the ability to target the TNBC cells and improve the therapeutic action and subsidize the side effects of PTX for the treatment of TNBC.	[Venugopal, Vijayan; Krishnan, Shalini; Sankarankutty, Subin; Kalaimani, Jayaraja Kumar] Asian Inst Med Sci & Technol AIMST Univ, Dept Pharmaceut Technol, Fac Pharm, Kedah, Malaysia; [Palanimuthu, Vasanth Raj] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast, Antrim, North Ireland; [Palanimuthu, Vasanth Raj] China Med Univ Queens Univ Belfast Joint Coll CQC, Shenyang, Liaoning, Peoples R China; [Karupiah, Sundram] Asian Inst Med Sci & Technol AIMST Univ, Dept Pharmaceut Chem, Fac Pharm, Kedah, Malaysia; [Kit, Ng Siew; Hock, Tang Thean] Univ Sains Malaysia, Adv Med & Dent Inst, George Town, Malaysia	Queens University Belfast; Universiti Sains Malaysia	Venugopal, V (corresponding author), Asian Inst Med Sci & Technol AIMST Univ, Dept Pharmaceut Technol, Fac Pharm, Kedah, Malaysia.	vijayanv2@gmail.com	Karupiah, Sundram A/L/B-4458-2011; Ng, Siew Kit/M-6050-2015	Ng, Siew Kit/0000-0002-3861-9787; vijayan, venugopal/0000-0002-7320-7390	Ministry of Higher Education (MOHE), Malaysia under the Fundamental Research Grant Scheme (FRGS) [FRGS/1/2015/SKK09/AIMST/02/4]; AIMST University; Department of biological sciences, USM, Malaysia	Ministry of Higher Education (MOHE), Malaysia under the Fundamental Research Grant Scheme (FRGS); AIMST University; Department of biological sciences, USM, Malaysia	This work was fully supported by Ministry of Higher Education (MOHE), Malaysia under the Fundamental Research Grant Scheme (FRGS) [grant number: FRGS/1/2015/SKK09/AIMST/02/4], received by Dr. Vijayan, AIMST University, Malaysia.; Authors are acknowledging the AIMST University and also Department of biological sciences, USM, Malaysia for the support and facilities.	Awasthi N, 2013, CARCINOGENESIS, V34, P2361, DOI 10.1093/carcin/bgt227; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bilati U, 2005, EUR J PHARM SCI, V24, P67, DOI 10.1016/j.ejps.2004.09.011; Bothun Geoffrey D., 2008, Journal of Nanobiotechnology, V6, P13, DOI 10.1186/1477-3155-6-13; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen KM, 2011, BIOMACROMOLECULES, V12, P2552, DOI 10.1021/bm200374e; Chen LA, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/10/105708; Comen EA, 2011, J CLIN ONCOL, V29, P2610, DOI 10.1200/JCO.2011.36.1873; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; des Rieux A, 2006, J CONTROL RELEASE, V116, P1, DOI 10.1016/j.jconrel.2006.08.013; El-Rehim DMA, 2004, J PATHOL, V203, P661, DOI 10.1002/path.1559; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Hudis CA, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S1-01; Hurvitz S, 2016, CURR OPIN OBSTET GYN, V28, P59, DOI 10.1097/GCO.0000000000000239; Jin C, 2009, PHARM RES-DORDR, V26, P1776, DOI 10.1007/s11095-009-9889-z; Kim SK, 2012, J CONTROL RELEASE, V157, P279, DOI 10.1016/j.jconrel.2011.08.014; Kuhn DA, 2014, BEILSTEIN J NANOTECH, V5, P1625, DOI 10.3762/bjnano.5.174; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lepeltier E, 2014, ADV DRUG DELIVER REV, V71, P86, DOI 10.1016/j.addr.2013.12.009; Martin N, 1998, J CHROMATOGR B, V709, P281, DOI 10.1016/S0378-4347(98)00060-7; Nahta R, 2004, CANCER RES, V64, P2343, DOI 10.1158/0008-5472.CAN-03-3856; Nakai K, 2016, AM J CANC RES; Perri M, 2016, J BIOCH ANAL STUD, V1, DOI [10.16966/2576-5833.104, DOI 10.16966/2576-5833.104]; Pinon-Segundo E, 2006, PHARM DEV TECHNOL, V11, P493, DOI 10.1080/10837450600940824; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Sah E, 2015, J NANOMATER, DOI [10.1155/2015/127235, DOI 10.1155/2015/127235]; Singh V, 2010, INT J POLYM SCI, DOI [10.1155/2010/270273, DOI 10.1155/2010/270273]; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Xu YY, 2016, ONCOTARGET, V7, P20890, DOI 10.18632/oncotarget.7896	31	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206109	10.1371/journal.pone.0206109	http://dx.doi.org/10.1371/journal.pone.0206109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408068	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300014
J	Feng, JW; Li, L; Jin, JL; Dai, JS; Luo, P				Feng, Jianwei; Li, Li; Jin, Jianli; Dai, Junsheng; Luo, Peng			An improved geomechanical model for the prediction of fracture generation and distribution in brittle reservoirs	PLOS ONE			English	Article							PALEOTECTONIC STRESS-FIELDS; TIGHT GAS SANDSTONES; SHALE RESERVOIRS; NIUTITANG FORMATION; TECTONIC STRESS; CENGONG BLOCK; SICHUAN BASIN; SOUTH CHINA; TARIM BASIN; EVOLUTION	It is generally difficult to predict fractures of low-permeability reservoirs under high confining pressures by data statistical method and simplified strain energy density method. In order to establish a series of geomechanical models for the prediction of multi-scale fractures in brittle tight sandstones, firstly, through a series of rock mechanics experiments and CT scanning, we determined 0.85 sigma(c) as the key thresholds for mass release of elastic strain energy and bursting of micro-fractures. A correlation between fracture volume density and strain energy density under uniaxial stress state was developed based on the Theory of Geomechanics. Then using the combined Mohr-Coulomb criterion and Griffith's criterion and considering the effect of filling degree in fractures, we continued to modify and deduce the mechanical models of fracture parameters under complex stress states. Finally, all the geomechanical equations were loaded into the finite element (FE) platform to quantitatively simulate the present-day 3-D distributions of fracture density, aperture, porosity, permeability and occurrence based on paleostructure restoration of the Keshen anticline. Its predictions agreed well with in-situ core observations and formation micro-imaging (FMI) interpretations. The prediction results of permeability were basically consistent with the unobstructed flow distributions before and after the reservoir reformation.	[Feng, Jianwei; Li, Li; Dai, Junsheng] China Univ Petr East China, Sch Geosci, Qingdao, Peoples R China; [Feng, Jianwei; Li, Li; Dai, Junsheng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Mineral Resources, Qingdao, Peoples R China; [Jin, Jianli] Res Inst Petr Explorat & Dev, Beijing, Peoples R China; [Luo, Peng] Saskatchewan Res Council, Energy Div, Regina, SK, Canada	China University of Petroleum; Qingdao National Laboratory for Marine Science & Technology	Feng, JW (corresponding author), China Univ Petr East China, Sch Geosci, Qingdao, Peoples R China.; Feng, JW (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Mineral Resources, Qingdao, Peoples R China.; Luo, P (corresponding author), Saskatchewan Res Council, Energy Div, Regina, SK, Canada.	Linqu_fengjw@126.com; peng.luo@src.sk.ca		Luo, Peng/0000-0003-1592-6810	National Oil and Gas Major Project [2016ZX05047-003, 2016ZX05014002-006]; National Natural Science Foundation of China [41572124, 41628201, 51774317]; Fundamental Research Funds for the Central Universities [17CX05010, 18CX02100A]	National Oil and Gas Major Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was financially supported by the National Oil and Gas Major Project (2016ZX05047-003, 2016ZX05014002-006), the National Natural Science Foundation of China (41572124, 41628201, 51774317) and the Fundamental Research Funds for the Central Universities (17CX05010, 18CX02100A).	Allen MB, 1999, AAPG BULL, V83, P1279; Atkinson B.K., 1987, FRACTURE MECH ROCK, P27, DOI DOI 10.1016/B978-0-12-066266-1.50007-7; Bergbauer S, 2007, GEOL SOC SPEC PUBL, V292, P185, DOI 10.1144/SP292.11; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Camp W.K., 2008, UNDERSTANDING EXPLOR, V3, P137, DOI DOI 10.1306/13131054H33104; Chen B., 1998, ACTA PETROLEI SINICA, V19, P50; CHEN ZX, 1989, TRANSPORT POROUS MED, V4, P147, DOI 10.1007/BF00134995; Conti J, 2016, INT ENERGY OUTLOOK 2, DOI [10.2172/1296780, DOI 10.2172/1296780]; Dai J.S., 1999, SCI GEOL SIN, V8, P223; [戴俊生 Dai Junsheng], 2011, [地学前缘, Earth Science Frontiers], V18, P277; Deng SG, 2013, PETROL SCI, V10, P336, DOI 10.1007/s12182-013-0282-5; [丁文龙 Ding Wenlong], 2015, [地球科学进展, Advance in Earth Sciences], V30, P737; DURHAM WB, 1994, J GEOPHYS RES-SOL EA, V99, P9391, DOI 10.1029/94JB00242; Gdoutos EE, 2012, ARCH APPL MECH, V82, P1361, DOI 10.1007/s00419-012-0690-9; Ghamgosar M, 2016, ROCK MECH ROCK ENG, V49, P893, DOI 10.1007/s00603-015-0793-z; Griffith AA., 1921, PHILOS T R SOC LON A, V221, P163; Gudmundsson A, 2010, J STRUCT GEOL, V32, P1643, DOI 10.1016/j.jsg.2009.08.013; Hennings PH, 2000, AAPG BULL, V84, P830; Hicks TW, 1996, INT J ROCK MECH MIN, V33, P499, DOI 10.1016/0148-9062(96)00002-2; Hoek E, 1980, UNDERGROUND EXCAVATI, P80; Houska J., 2014, GEOFLUIDS, V9, P251; Huang FQ, 1999, SEISM GEOL, V21, P261; Huang YJ, 2015, INT J SOLIDS STRUCT, V67-68, P340, DOI 10.1016/j.ijsolstr.2015.05.002; Jia CZ, 2004, CHARACTERISTICS MESO, P229; Jing Z, 1998, NEW 3 D STOCHASTIC M, P28; Jiu K, 2013, J PETROL SCI ENG, V110, P119, DOI 10.1016/j.petrol.2013.09.002; Ju W, 2017, J PETROL SCI ENG, V156, P884, DOI 10.1016/j.petrol.2017.06.068; Ju W, 2014, TECTONOPHYSICS, V610, P182, DOI 10.1016/j.tecto.2013.11.022; Kim JS, 2015, ROCK MECH ROCK ENG, V48, P495, DOI 10.1007/s00603-014-0590-0; Kravchenko SG, 2014, ENG FRACT MECH, V119, P132, DOI 10.1016/j.engfracmech.2014.02.018; Laubach SE, 2003, AAPG BULL, V87, P561, DOI 10.1306/11060201106; Laubach SE, 2016, GEOL MAG, V153, P887, DOI 10.1017/S0016756816000157; Li ZT, FUEL; Liu JH, 2017, TECTONOPHYSICS, V712, P663, DOI 10.1016/j.tecto.2017.06.030; Lu H., 2016, CHINA J NAT GAS GEOS, V1, P61, DOI [10.1016/j.jnggs.2016.05.003, DOI 10.1016/J.JNGGS.2016.05.003]; Luo JH, 2002, INTRO MATRIX ANAL, P6; Masaferro JL, 2003, AAPG BULL, V87, P1083, DOI 10.1306/02070301102; McKinnon SD, 1998, J STRUCT GEOL, V20, P1673, DOI 10.1016/S0191-8141(98)00080-7; McLennan JA, 2009, WYOMING AAPG B, V3, P1585; Muller RD, 2015, GONDWANA RES, V28, P612, DOI 10.1016/j.gr.2014.05.008; Muller RD, 2012, AUST J EARTH SCI, V59, P13, DOI 10.1080/08120099.2011.605801; Olson JE, 2009, AAPG BULL, V93, P1535, DOI 10.1306/08110909100; Price N.J., 1966, FAULT JOINT DEV BRIT, P133; Qin J.S, 2002, J XIAN PETROLEUM I, V4, P28; Rajabi M, 2016, MAR PETROL GEOL, V77, P776, DOI 10.1016/j.marpetgeo.2016.07.021; Sanz PF, 2008, J STRUCT GEOL, V30, P1177, DOI 10.1016/j.jsg.2008.06.002; Shanley KW, 2015, AAPG BULL, V99, P1957, DOI 10.1306/03041411168; Shrivastava C, 2011, SPE MIDDLE E UNCONVE; Smart KJ, 2012, TECTONOPHYSICS, V576, P171, DOI 10.1016/j.tecto.2012.05.024; Smart KJ, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003742; Song ZZ, 2018, MAR PETROL GEOL, V92, P842, DOI 10.1016/j.marpetgeo.2017.12.018; Sun W, 2017, CONSTR BUILD MATER, V138, P69, DOI 10.1016/j.conbuildmat.2017.01.088; Tan Chengxuan, 1999, ACTA GEOSCI SIN, V20, P392; Taylor TR, 2010, AAPG BULL, V94, P1093, DOI 10.1306/04211009123; Tuckwell GW, 2003, J STRUCT GEOL, V25, P1241, DOI 10.1016/S0191-8141(02)00165-7; Wang P, 1993, PRINCIPLES STRUCTURA, P16; Wang RY, 2016, J PETROL SCI ENG, V138, P31, DOI 10.1016/j.petrol.2015.12.004; Wang S., 2003, CHIN J GEOPHYS, V46, P1114; Wu ZH, 2017, MAR PETROL GEOL, V80, P369, DOI 10.1016/j.marpetgeo.2016.12.008; Xue YC, 2014, J PETROL SCI ENG, V121, P159, DOI 10.1016/j.petrol.2014.06.033; Zeng LB, 2010, ACTA GEOL SIN-ENGL, V84, P1229, DOI 10.1111/j.1755-6724.2010.00293.x; Zeng LB, 2010, MAR PETROL GEOL, V27, P1616, DOI 10.1016/j.marpetgeo.2010.04.010; [曾庆鲁 Zeng Qinglu], 2017, [天然气地球科学, Natural Gas Geoscience], V28, P397; Zhang ZP, 2006, EARTH SCI J CHINA U, V31, P75; [赵文韬 Zhao Wentao], 2013, [大地构造与成矿学, Geotectonica et Metallogenia], V37, P603; Zhao YH, 1998, INT J ROCK MECH MIN, V35, P349, DOI 10.1016/S0148-9062(97)00340-9; [郑淳方 Zheng Chunfang], 2016, [地质通报, Geological Bulletin of China], V35, P130; [周新桂 Zhou Xingui], 2003, [地球科学进展, Advance in Earth Sciences], V18, P398; 宋惠珍, 1999, [地质力学学报, Journal of Geomechanics], V5, P76	69	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205958	10.1371/journal.pone.0205958	http://dx.doi.org/10.1371/journal.pone.0205958			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403681	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500036
J	Jingi, AM; Hamadou, B; Noubiap, JJ; Mfeukeu-Kuate, L; Boombhi, J; Nganou, CN; Ateba, NA; Ndoadoumgue, AL; Nyaga, UF; Menanga, A; Kingue, S				Jingi, Ahmadou M.; Hamadou, Ba; Noubiap, Jean Jacques; Mfeukeu-Kuate, Liliane; Boombhi, Jerome; Nganou, Chris Nadege; Ateba, Narcisse Assene; Ndoadoumgue, Aude Laetitia; Nyaga, Ulrich Flore; Menanga, Alain; Kingue, Samuel			Correlations of left ventricular systolic function indices with aortic root systolic excursion (ARSE): A cross-sectional echocardiographic study	PLOS ONE			English	Article							POINT SEPTAL SEPARATION; EMERGENCY PHYSICIANS; HEART-FAILURE; RISK-FACTORS; HYPERTENSION; PREVALENCE; DIAGNOSIS	Background Heart failure (HF), is a major public health issue globally. Echocardiography is cost-effective in the diagnosis in expert hands. This study was conducted to estimate the usefulness of Aortic Root Systolic Excursion (ARSE) as a simple and accurate measure to estimate Left Ventricular (LV) function. Methods This was a cross-sectional echocardiographic study among adults aged >= 18 years, with or without heart failure, in sinus rhythm, and with no LV out-let obstruction. We studied the correlations of ARSE with some selected indices of LV Systolic Functions. We determined optimal cut-offs of ARSE in detecting LV dysfunction. We generated a simple regression equation to best estimate LV ejection fraction according to the modified Simpson method. Results Overall 213 echocardiograms were included from 106 males (49.8%), with mean age of the participants being 52.4 (SD: 18.3) years. The rate of LV systolic dysfunction was highest with Teicholz method (17.4%) and lowest with MAPSE method (5.2%). ARSE correlated with the LV functions. This was highest for the Simpson method (r = 0.619, p<0.001), and lowest for the ITV method (r = 0.319, p<0.001). Optimal cut-offs to detect LV systolic dysfunction was approximate to 6.6 mm. For an LV ejection fraction < 55%, the sensitivity was 82.9%, and the specificity was 97.2%, with an AUROC of 91.6%.The logarithmic regression equation was best in predicting LV ejection fraction (AUC: 60.2%), followed by the power model (AUC: 56.7%), and the linear model (AUC: 53.6%). Conclusion ARSE correlated well with LV systolic function. The cut-off <= 6.5 mm suggest LV systolic dysfunction. LV Ejection Fraction was best estimated with the generic equation: LVEF (%) = 29 x In [ARSE].	[Jingi, Ahmadou M.; Hamadou, Ba; Mfeukeu-Kuate, Liliane; Boombhi, Jerome; Nganou, Chris Nadege; Ateba, Narcisse Assene; Ndoadoumgue, Aude Laetitia; Nyaga, Ulrich Flore; Menanga, Alain; Kingue, Samuel] Univ Yaounde I, Dept Med & Specialties, Fac Med & Biomed Sci, Yaounde, Cameroon; [Hamadou, Ba; Mfeukeu-Kuate, Liliane; Nganou, Chris Nadege] Yaounde Cent Hosp, Cardiol Unit, Yaounde, Cameroon; [Noubiap, Jean Jacques] Univ Cape Town, Dept Med, Cape Town, South Africa; [Noubiap, Jean Jacques] Groote Schuur Hosp, Cape Town, South Africa; [Boombhi, Jerome; Menanga, Alain; Kingue, Samuel] Yaounde Gen Hosp, Cardiol Unit, Yaounde, Cameroon	University of Yaounde I; University of Cape Town; University of Cape Town	Noubiap, JJ (corresponding author), Univ Cape Town, Dept Med, Cape Town, South Africa.; Noubiap, JJ (corresponding author), Groote Schuur Hosp, Cape Town, South Africa.	noubiapjj@yahoo.fr		Noubiap, Jean Jacques/0000-0002-7722-9757; Ndoadoumgue, Aude Laetitia/0000-0002-7456-2036				Agbor VN, 2018, INT J CARDIOL, V257, P207, DOI 10.1016/j.ijcard.2017.12.048; [Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; BURGGRAF GW, 1978, CATHETER CARDIO DIAG, V4, P29, DOI 10.1002/ccd.1810040104; Dickstein K, 2005, EUR J HEART FAIL, V7, P303, DOI 10.1016/j.ejheart.2005.01.003; Glezeva N, 2015, TROP MED INT HEALTH, V20, P581, DOI 10.1111/tmi.12461; Jingi Ahmadou M, 2015, BMC Res Notes, V8, P762, DOI 10.1186/s13104-015-1747-y; Jingi AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111812; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kimura BJ, 2013, ECHOCARDIOGR-J CARD, V30, P1126, DOI 10.1111/echo.12252; Kingue S, 2015, J CLIN HYPERTENS, V17, P819, DOI 10.1111/jch.12604; Klimczak C, 2010, ECHOCARDIOGRAPHIE CL; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Maleki M, 2012, IRAN J MED SCI, V37, P222; Secko MA, 2011, ACAD EMERG MED, V18, P1223, DOI 10.1111/j.1553-2712.2011.01196.x; Silverstein JR, 2006, AM J CARDIOL, V97, P137, DOI 10.1016/j.amjcard.2005.07.118; Unluer EE, 2012, EMERG MED J, V29, P280, DOI 10.1136/emj.2011.111229; Weekes AJ, 2012, J ULTRAS MED, V31, P1891	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206199	10.1371/journal.pone.0206199	http://dx.doi.org/10.1371/journal.pone.0206199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399146	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000010
J	Svedman, FC; Lohcharoenkal, W; Bottai, M; Brage, SE; Sonkoly, E; Hansson, J; Pivarcsi, A; Eriksson, H				Svedman, Fernanda Costa; Lohcharoenkal, Warangkana; Bottai, Matteo; Brage, Suzanne Egyhazi; Sonkoly, Eniko; Hansson, Johan; Pivarcsi, Andor; Eriksson, Hanna			Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma	PLOS ONE			English	Article							IMPROVED SURVIVAL; DOWN-REGULATION; BRAF; IDENTIFICATION; DABRAFENIB; RESISTANCE; CELLS; MULTICENTER; VEMURAFENIB; INHIBITION	Background Mitogen activated-protein kinase pathway inhibitors (MAPKis) improve treatment outcome in patients with disseminated BRAFV600 mutant cutaneous malignant melanoma (CMM) but responses are of limited duration due to emerging resistance. Although extensive research in mechanisms of resistance is being performed, predictive biomarkers for durable responses are still lacking. We used miRNA qPCR to investigate if different levels of extracellular microvesicle microRNA (EV miRNA) in matched plasma samples collected from patients with metastatic IV BRAFV600 mutated CMM before, during and after therapy with MAPKis could serve as predictive biomarkers. Materials and methods EV miRNAs were extracted from plasma samples from 28 patients collected before and during therapy, measured by quantitative PCR-array and correlated to therapy outcome. Results Increased levels of EV let-7g-5p during treatment compared to before treatment (EV let-7g-5p_delta) were associated with better disease control with MAPKis (odds ratio 8568.4, 95% CI = 4.8-1.5e+07, P = 0.000036). Elevated levels of EV miR-497-5p during therapy were associated with prolonged progression free survival (PFS) (hazard ratio = 0.27, 95% CI = 0.13-0.52, P <0.000061). Conclusions EV miRNAs let-7g-5p and miR-497-5p were identified as putative novel predictive biomarkers of MAPKi treatment benefit in metastatic CMM patients highlighting the potential relevance of assessing EV miRNA during and after treatment to unravel novel mechanisms of resistance.	[Svedman, Fernanda Costa; Brage, Suzanne Egyhazi; Hansson, Johan; Eriksson, Hanna] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Svedman, Fernanda Costa; Hansson, Johan; Eriksson, Hanna] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden; [Lohcharoenkal, Warangkana; Sonkoly, Eniko; Pivarcsi, Andor] Karolinska Inst, Dept Med, Unit Dermatol & Venerol, Stockholm, Sweden; [Bottai, Matteo] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Sonkoly, Eniko] Karolinska Univ Hosp, Unit Dermatol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Svedman, FC (corresponding author), Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden.; Svedman, FC (corresponding author), Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden.	fernanda.costa-svedman@sll.se	Eriksson, Hanna/AAJ-8980-2020	Eriksson, Hanna/0000-0001-6728-5344; Lohcharoenkal, Warangkana/0000-0001-6541-1693	the Swedish Cancer Society (Cancerfonden) [CAN 2015/694]; Swedish Research Council (Vetenskapsradet) [2015-02844, D0322301]; Swedish Skin Foundation (Hudfonden) [2558]; Cancer Research Funds of Radiumhemmet [144073]; Swedish Cancer Society (Cancerfonden) [150574]; Knut and Alice Wallenberg Foundation [Dnr KAW 2013.0093]; Stockholm County Council (ALF) [LS2015-1198]; Swedish Medical Society [SLS 6844391]; Radiumhemmet Research Funds [161052]; Swedish Cancer Society [CAN2014-424]; Swedish Society for Medical Research [160502]; KI funds [2016fobi50190]; Axel and Eva Wallstrom funds [2018-00222]	the Swedish Cancer Society (Cancerfonden); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Skin Foundation (Hudfonden); Cancer Research Funds of Radiumhemmet; Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County Council (ALF)(Stockholm County Council); Swedish Medical Society; Radiumhemmet Research Funds; Swedish Cancer Society(Swedish Cancer Society); Swedish Society for Medical Research; KI funds; Axel and Eva Wallstrom funds	This work was supported by: to AP: the Swedish Cancer Society (Cancerfonden) (grant number CAN 2015/694) https://www.cancerfonden. se/; the Swedish Research Council (Vetenskapsradet) (grant number 2015-02844 https://www.vr.se; the Swedish Skin Foundation (Hudfonden) (grant number 2558) https://www.hudfonden.se/; to JH: the Cancer Research Funds of Radiumhemmet (grant number 144073) https://www.rahfo.se/om-oss/in-english/, the Swedish Research Council (Vetenskapsradet) (grant numbers D0322301); the Swedish Cancer Society (Cancerfonden) (grant numbers 150574); the Knut and Alice Wallenberg Foundation (grant number Dnr KAW 2013.0093), https://kaw.wallenberg.org/; and the Stockholm County Council (ALF) (grant number LS2015-1198), https://forskningsstod.vmi.se/Ansokan/start.asp; to HE: Swedish Medical Society SLS 6844391, https://forskningsstod.vmi.se/Ansokan/start.asp; Radiumhemmet Research Funds 161052; The Swedish Cancer Society CAN2014-424; The Swedish Society for Medical Research 160502, https://www.ssmf.se/in-english; KI funds 2016fobi50190, https://fonder.ki.se/; Axel and Eva Wallstrom funds 2018-00222, https://ki.se/medarbetare/alex-och-eva-wallstroms-stiftelse-for-vetenskaplig-forskning-och-utbildning.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Jia SD, 2014, EXPERT REV MOL DIAGN, V14, P307, DOI 10.1586/14737159.2014.893828; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Li TD, 2018, MELANOMA RES, V28, P295, DOI 10.1097/CMR.0000000000000450; Liu SJ, 2012, AM J PATHOL, V181, P1823, DOI 10.1016/j.ajpath.2012.07.009; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Lunavat TR, 2017, P NATL ACAD SCI USA, V114, pE5930, DOI 10.1073/pnas.1705206114; Menzies AM, 2015, CANCER-AM CANCER SOC, V121, P3826, DOI 10.1002/cncr.29586; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Obenauf AC, 2015, NATURE, V520, P368, DOI 10.1038/nature14336; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Petrillo M, 2016, ANN ONCOL, V27, P625, DOI 10.1093/annonc/mdw007; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Robert C, 2015, NEW ENGL J MED, V372, P30, DOI 10.1056/NEJMoa1412690; Salendo J, 2013, RADIOTHER ONCOL, V108, P451, DOI 10.1016/j.radonc.2013.06.032; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Shao XJ, 2015, CELL PHYSIOL BIOCHEM, V36, P2051, DOI 10.1159/000430172; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Witwer KW, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20360; Xiao DY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046874; Xin Y, 2016, TUMOR BIOL, V37, P1487, DOI 10.1007/s13277-015-4599-0; Zheng DL, 2012, FEBS LETT, V586, P4165, DOI 10.1016/j.febslet.2012.10.014; Zhou YX, 2015, MELANOMA RES, V25, P119, DOI 10.1097/CMR.0000000000000140; Zhu W, 2012, MED ONCOL, V29, P384, DOI 10.1007/s12032-010-9797-4	37	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206942	10.1371/journal.pone.0206942	http://dx.doi.org/10.1371/journal.pone.0206942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399176	Green Submitted, gold, Green Published			2022-12-26	WOS:000449374000033
J	Zhuang, WJ; Wang, SL; Hao, J; Xu, MY; Chi, H; Piao, SY; Ma, JQ; Zhang, XL; Ha, SP				Zhuang, Wenjuan; Wang, Shaolin; Hao, Juan; Xu, Manyun; Chi, Hao; Piao, Shunyu; Ma, Jianqing; Zhang, Xiaolong; Ha, Shaoping			Genotype-ocular biometry correlation analysis of eight primary angle closure glaucoma susceptibility loci in a cohort from Northern China	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; EPIDEMIOLOGY	Purpose Recent genome-wide association studies (GWAS) have verified eight genetic loci that were significantly associated with primary angle-closure glaucoma (PACG). The present study investigated whether these variants are associated with the ocular biometric parameters of anterior chamber depth (ACD) and axial length (AL) in a northern Chinese population, as well as whether there were differences in the association of genetic markers in our cohort based on ethnicity. Methods A case-control association study of 500 patients and 720 controls was undertaken. All individuals were genotyped for eight single nucleotide polymorphisms (SNPs) (rs11024102 in PLEKHA7, rs3753841 in COL11A1, rs1015213 located between PCMTD1 and ST18, rs3816415 in EPDR1, rs1258267 in CHAT, rs736893 in GLIS3, rs7494379 in FERMT2, and rs3739821 mapping between DPM2 and FAM102A) using an improved multiplex ligation detection reaction (iMLDR) technique. Allelic and genotypic frequency differences were evaluated using a logistic regression model. Generalized estimation equation (GEE) analysis was conducted for association testing between genotypes and ocular biometric parameters. False discovery rate (FDR) correction for multiple comparisons was employed, and the statistical power was calculated via power and sample size calculation. Results Four of the eight SNPs, rs3753841, rs1258267, rs736893 and rs7494379, were associated with PACG (p = 0.007, 0.0016, 0.0045, 0.045, respectively), and only rs3753841, rs1258267 and rs736893 surpassed the FDR correction. For subgroup analysis, only rs1258267 could withstand multiple testing correction in the Han nationality (p = 0.00571). In the GEE tests, rs3753841, rs1258267 and rs736893 were found to be nominally associated with ACD (p = 0.023, 0.016, 0.01, respectively). However, these associations could not survive FDR correction. Conclusions The SNP rs3753841 in COL11A1, rs1258267 in CHAT and rs736893 in GLIS3 are associated with PACG in northern Chinese people, and the association of genetic markers manifests a tendency of ethnic diversity. Larger population-based studies are warranted to reveal additional PACG loci and ethnic aspects of PACG.	[Zhuang, Wenjuan; Wang, Shaolin; Xu, Manyun; Zhang, Xiaolong; Ha, Shaoping] Northwest Univ Nationalities, Peoples Hosp Ningxia Hui Autonomous Reg, Ningxia Eye Hosp, Affiliated Hosp 1, Yinchuan, Peoples R China; [Wang, Shaolin; Piao, Shunyu] Ningxia Med Univ, Clin Med Coll, Yinchuan, Peoples R China; [Hao, Juan] Taiyuan Cent Hosp, Dept Ophthalmol, Taiyuan, Shanxi, Peoples R China; [Chi, Hao] Jinan Univ, Shandong Acad Med Sci, Jinan, Shandong, Peoples R China; [Ma, Jianqing] Wuzhong Peoples Hosp, Dept Ophthalmol, Wuzhong, Peoples R China	Northwest Minzu University; Ningxia Medical University; Shanxi Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhuang, WJ (corresponding author), Northwest Univ Nationalities, Peoples Hosp Ningxia Hui Autonomous Reg, Ningxia Eye Hosp, Affiliated Hosp 1, Yinchuan, Peoples R China.	zh_wenj@163.com			National Basic Research Program of China [81460093]; Ningxia Nature Science Funding from the Department of Science and technology of Ningxia Hui Autonomous Region [NZ16194]	National Basic Research Program of China(National Basic Research Program of China); Ningxia Nature Science Funding from the Department of Science and technology of Ningxia Hui Autonomous Region	This work was supported by grants from the National Basic Research Program of China (Program #81460093 to WZ) and Ningxia Nature Science Funding (Grant- NZ16194 to WZ) from the Department of Science and technology of Ningxia Hui Autonomous Region. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSBIRK PH, 1976, ACTA OPHTHALMOL, P5; Amerasinghe N, 2011, OPHTHALMOLOGY, V118, P480, DOI 10.1016/j.ophtha.2010.06.043; Awadalla MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067903; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CONGDON N, 1992, SURV OPHTHALMOL, V36, P411, DOI 10.1016/S0039-6257(05)80022-0; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Foster PJ, 1996, ARCH OPHTHALMOL-CHIC, V114, P1235, DOI 10.1001/archopht.1996.01100140435011; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; He MG, 2008, INVEST OPHTH VIS SCI, V49, P81, DOI 10.1167/iovs.07-1052; Khor CC, 2016, NAT GENET, V48, P556, DOI 10.1038/ng.3540; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Lavanya R, 2008, ARCH OPHTHALMOL-CHIC, V126, P686, DOI 10.1001/archopht.126.5.686; LOWE R F, 1973, Transactions of the Ophthalmological Society of New Zealand, V25, P81; LOWE RF, 1972, BRIT J OPHTHALMOL, V56, P13, DOI 10.1136/bjo.56.1.13; LOWE RF, 1970, BRIT J OPHTHALMOL, V54, P161, DOI 10.1136/bjo.54.3.161; Nongpiur ME, 2018, OPHTHALMOLOGY, V125, P664, DOI 10.1016/j.ophtha.2017.11.016; Nongpiur ME, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004089; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Vithana EN, 2012, NAT GENET, V44, P1142, DOI 10.1038/ng.2390; Wang NL, 2002, CHINESE MED J-PEKING, V115, P1706; Wright C, 2016, ACTA OPHTHALMOL, V94, P217, DOI 10.1111/aos.12784; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206935	10.1371/journal.pone.0206935	http://dx.doi.org/10.1371/journal.pone.0206935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399154	gold, Green Submitted, Green Published			2022-12-26	WOS:000449374000031
J	Marshak, AR; Heck, KL; Jud, ZR				Marshak, Anthony R.; Heck, Kenneth L., Jr.; Jud, Zachary R.			Ecological interactions between Gulf of Mexico snappers (Teleostei: Lutjanidae) and invasive red lionfish (Pterois volitans)	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; HABITAT COMPLEXITY; WESTERN ATLANTIC; NATIVE GROUPER; FISH COMMUNITY; PATTERNS; IMPACTS; SHIFTS; RECRUITMENT; SELECTIVITY	Indo-Pacific red lionfish (Pterois volitans) have invaded the western Atlantic, and most recently the northern Gulf of Mexico (nGOM), at a rapid pace. Given their generalist habitat affinities and diet, and strong ecological overlap with members of the commercially valuable snapper-grouper complex, increased density and abundance of lionfish could result in significant competitive interactions with nGOM commercially important species. We experimentally investigated the intensity of behavioral interactions between lionfish and indigenous, abundant and economically important juvenile nGOM red snapper (Lutjanus campechanus), and other increasingly abundant juvenile tropical snapper species (gray snapper-L. griseus and lane snapper-L. synagris) in large outdoor mesocosms to examine snapper vulnerabilities to lionfish competition. When paired with lionfish, red snapper swimming activity (i.e., time swimming and roving around experimental tank or at structure habitat during experiments) was significantly lower than in intraspecific control trials, but gray and lane snapper swimming activities in the presence of lionfish did not significantly differ from their intraspecific controls. Additionally in paired trials, red and lane snapper swimming activities were significantly lower than those of lionfish, while no significant difference in swimming activities was observed between lionfish and gray snapper. We found that red snapper prey consumption rates in the presence of lionfish were significantly lower than in their intraspecific 3-individual control trials, but when paired together no significant differences in prey consumption rates between red snapper and lionfish were observed. When paired with lane or gray snapper, lionfish were observed having comparatively higher prey consumption than snappers, or as observed in lionfish intraspecific 1-individual controls. However, lane and gray snapper consumption rates in the presence of lionfish did not significantly differ from those in intraspecific controls. These findings suggest that competition between juvenile snappers and invasive lionfish may be variable, with lionfish exhibiting differing degrees of competitive dominance and snappers exhibiting partial competitive vulnerability and resistance to lionfish. While the degree of intensity at which these interactions may occur in nGOM reefs may differ from those observed in our findings, this study enables greater understanding of the potential ecological effects of red lionfish on native reef fishes.	[Marshak, Anthony R.; Heck, Kenneth L., Jr.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA; [Marshak, Anthony R.; Heck, Kenneth L., Jr.] Dauph Isl Sea Lab, Dauphin Isl, AL 36528 USA; [Jud, Zachary R.] Florida Int Univ, Dept Biol Sci, Marine Sci Program, North Miami, FL USA; [Marshak, Anthony R.] NOAA, ECS Fed LLC, Natl Marine Fisheries Serv, Off Sci & Technol, Silver Spring, MD 20910 USA; [Jud, Zachary R.] Florida Oceanog Soc, Stuart, FL USA	University of South Alabama; State University System of Florida; Florida International University; National Oceanic Atmospheric Admin (NOAA) - USA	Marshak, AR (corresponding author), Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA.; Marshak, AR (corresponding author), Dauph Isl Sea Lab, Dauphin Isl, AL 36528 USA.; Marshak, AR (corresponding author), NOAA, ECS Fed LLC, Natl Marine Fisheries Serv, Off Sci & Technol, Silver Spring, MD 20910 USA.	tony.marshak@noaa.gov		Marshak, Anthony/0000-0003-3405-3111	Dauphin Island Sea Lab; Richard C. Shelby Centre for Ecosystem-Based Fisheries Management	Dauphin Island Sea Lab; Richard C. Shelby Centre for Ecosystem-Based Fisheries Management	This study was supported by the Dauphin Island Sea Lab and Richard C. Shelby Centre for Ecosystem-Based Fisheries Management to authors KL Heck, Jr. and Anthony Marshak. Additionally, an institutional fellowship was awarded to Anthony Marshak while he was a graduate student at the Dauphin Island Sea Lab, through which this study was additionally supported.	Ajemian MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126354; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Albins MA, 2015, MAR ECOL PROG SER, V522, P231, DOI 10.3354/meps11159; Albins MA, 2013, BIOL INVASIONS, V15, P29, DOI 10.1007/s10530-012-0266-1; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Barbour AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019666; Benkwitt CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066995; Black AN, 2014, J EXP MAR BIOL ECOL, V460, P1, DOI 10.1016/j.jembe.2014.06.002; Byron Dorothy, 2014, Gulf of Mexico Science, V32, P75; Chagaris D, 2017, FISHERIES, V42, P421, DOI 10.1080/03632415.2017.1340273; Claydon JAB, 2012, MAR ECOL PROG SER, V448, P119, DOI 10.3354/meps09534; Cote IM, 2013, BIOL CONSERV, V164, P50, DOI 10.1016/j.biocon.2013.04.014; Cowan JH, 2011, REV FISH BIOL FISHER, V21, P187, DOI 10.1007/s11160-010-9165-7; Cowan JH, 2012, MAR COAST FISH, V4, P496, DOI 10.1080/19425120.2012.690825; Cure K, 2014, MAR ECOL PROG SER, V506, P243, DOI 10.3354/meps10789; Curtis JS, 2017, MAR ECOL PROG SER, V573, P215, DOI 10.3354/meps12164; Curtis-Quick J, 2014, P GULF CARIB FISH I, V66, P199; Dahl KA, 2016, MAR ECOL PROG SER, V558, P207, DOI 10.3354/meps11898; Dahl KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105852; Dance MA, 2011, B MAR SCI, V87, P301, DOI 10.5343/bms.2010.1040; Darling ES, 2011, BIOL INVASIONS, V13, P2045, DOI 10.1007/s10530-011-0020-0; Darnell RM, 1987, E GULF SHELF BIOATLA; Garcia-Rivas MD, 2017, MAR BIOL RES, V13, P899, DOI 10.1080/17451000.2017.1314496; Didham RK, 2005, TRENDS ECOL EVOL, V20, P470, DOI 10.1016/j.tree.2005.07.006; Duarte CM, 2015, BIOSCIENCE, V65, P130, DOI 10.1093/biosci/biu198; Elise S, 2015, MAR BIOL, V162, P319, DOI 10.1007/s00227-014-2571-y; Ellis RD, 2016, MAR ECOL PROG SER, V558, P267, DOI 10.3354/meps11808; Arias-Gonzalez JE, 2011, ENVIRON RES, V111, P917, DOI 10.1016/j.envres.2011.07.008; FESTING MFW, 1994, LAB ANIM, V28, P212, DOI 10.1258/002367794780681697; Fogg Alexander Q., 2013, Gulf and Caribbean Research, V25, P111; Franks James S., 2000, Gulf and Caribbean Research, V12, P11; Garner SB, 2017, ICES J MAR SCI, V74, P1437, DOI 10.1093/icesjms/fsx001; Gomez-Laplaza LM, 2003, LAB ANIM-UK, V37, P108, DOI 10.1258/00236770360563741; Green SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI 10.3354/meps09208; Green SJ, 2014, ECOL APPL, V24, P1311, DOI 10.1890/13-0979.1; Griffen BD, 2007, ECOLOGY, V88, P3012, DOI 10.1890/07-0172.1; Hackerott S, 2017, PEERJ, V5, DOI 10.7717/peerj.3270; Hackerott S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068259; Harrison S, 2015, FISHERIES, V40, P152, DOI 10.1080/03632415.2015.1027161; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jacquet J, 2015, BIOSCIENCE, V65, P745, DOI 10.1093/biosci/biv087; Johnston MW, 2011, MAR POLLUT BULL, V62, P1218, DOI 10.1016/j.marpolbul.2011.03.028; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Juliano S.A., 2001, DESIGN ANAL ECOLOGIC, P178, DOI DOI 10.1201/9781003059813; Karnauskas M, 2017, NOAA TECHNICAL MEMOR; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kindinger TL, 2017, BIOL INVASIONS, V19, P131, DOI 10.1007/s10530-016-1268-1; Kovalcsik R, 2006, LAB ANIMAL, V35, P49, DOI 10.1038/laban1006-49; Layman CA, 2014, MAR BIOL, V161, P2179, DOI 10.1007/s00227-014-2491-x; Lonnstedt OM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0281; Luo JG, 2009, MAR ECOL PROG SER, V380, P255, DOI 10.3354/meps07911; Marsh-Hunkin KE, 2013, MAR BIOL, V160, P1029, DOI 10.1007/s00227-012-2156-6; Marshak AR, 2017, J FISH BIOL, V91, P1139, DOI 10.1111/jfb.13406; McDonald MD, 2011, COMP BIOCHEM PHYS C, V153, P107, DOI 10.1016/j.cbpc.2010.09.006; Mercado-Silva N, 2009, RIVER RES APPL, V25, P1090, DOI 10.1002/rra.1205; Morris J.A., 2009, NOAA TECH MEMO NOS N, V99, P1; Morris JA, 2011, BIOL INVASIONS, V13, P7, DOI 10.1007/s10530-010-9786-8; Morris JA, 2009, ENVIRON BIOL FISH, V86, P389, DOI 10.1007/s10641-009-9538-8; Mudrak PA, 2012, T AM FISH SOC, V141, P487, DOI 10.1080/00028487.2012.667045; O'Farrell S, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00126.1; OGUTUOHWAYO R, 1990, ENVIRON BIOL FISH, V27, P81, DOI 10.1007/BF00001938; Ouzts AC, 2003, T AM FISH SOC, V132, P1186, DOI 10.1577/T02-085; Overli O, 1998, CAN J ZOOL, V76, P1366, DOI 10.1139/cjz-76-7-1366; Patterson WF, 2012, B MAR SCI, V88, P647, DOI 10.5343/bms.2011.1086; Raymond WW, 2015, ENVIRON BIOL FISH, V98, P57, DOI 10.1007/s10641-014-0236-9; Rilov G, 2009, BIOL INVASIONS MARIN, V204; Sax DF, 2007, TRENDS ECOL EVOL, V22, P465, DOI 10.1016/j.tree.2007.06.009; Scyphers SB, 2015, CONSERV LETT, V8, P242, DOI 10.1111/conl.12127; Selwyn J, 2014, P 66 GULF CAR FISH I, P213; Simberloff D, 2004, BIOL INVASIONS, V6, P161, DOI 10.1023/B:BINV.0000022133.49752.46; Simmons CM, 2017, CAN J FISH AQUAT SCI, DOI [10.1139/cjfas-2016-0396, DOI 10.1139/CJFAS-2016-0396]; South J, 2017, ENVIRON BIOL FISH, V100, P1155, DOI 10.1007/s10641-017-0633-y; Sumaila UR, 2011, NAT CLIM CHANGE, V1, P449, DOI 10.1038/NCLIMATE1301; Switzer TS, 2015, MAR COAST FISH, V7, DOI 10.1080/19425120.2014.987888; Tamburello N, 2015, BIOL INVASIONS, V17, P1639, DOI 10.1007/s10530-014-0822-y; Tarnecki JH, 2015, MAR COAST FISH, V7, P135, DOI 10.1080/19425120.2015.1020402; Valdivia A, 2014, PEERJ, V2, DOI 10.7717/peerj.348; Van Kessel N, 2011, CURR ZOOL, V57, P844; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Wells RJD, 2008, MAR ECOL PROG SER, V361, P213, DOI 10.3354/meps07425; Wells RJD, 2008, ICES J MAR SCI, V65, P1610, DOI 10.1093/icesjms/fsn145; Wiles GJ, 2003, CONSERV BIOL, V17, P1350, DOI 10.1046/j.1523-1739.2003.01526.x; Zambrano L, 2010, BIOL INVASIONS, V12, P3061, DOI 10.1007/s10530-010-9697-8; Zar J.H., 2010, BIOSTAT ANAL	84	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206749	10.1371/journal.pone.0206749	http://dx.doi.org/10.1371/journal.pone.0206749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383854	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600093
J	Nicholson, TL; Brunelle, BW; Bayles, DO; Alt, DP; Shore, SM				Nicholson, Tracy L.; Brunelle, Brian W.; Bayles, Darrell O.; Alt, David P.; Shore, Sarah M.			Comparative genomic and methylome analysis of non-virulent D74 and virulent Nagasaki Haemophilus parasuis isolates	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; DNA ADENINE METHYLATION; RESTRICTION ENZYMES; STRESS RESISTANCE; PHASE VARIATION; INFECTION; GROWTH; INHIBITION; STRAINS; METHYLTRANSFERASES	Haemophilus parasuis is a respiratory pathogen of swine and the etiological agent of Glassser's disease. H. parasuis isolates can exhibit different virulence capabilities ranging from lethal systemic disease to subclinical carriage. To identify genomic differences between phenotypically distinct strains, we obtained the closed whole-genome sequence annotation and genome-wide methylation patterns for the highly virulent Nagasaki strain and for the non-virulent D74 strain. Evaluation of the virulence-associated genes contained within the genomes of D74 and Nagasaki led to the discovery of a large number of toxin-antitoxin (TA) systems within both genomes. Five predicted hemolysins were identified as unique to Nagasaki and seven putative contact-dependent growth inhibition toxin proteins were identified only in strain D74. Assessment of all potential vtaA genes revealed thirteen present in the Nagasaki genome and three in the D74 genome. Subsequent evaluation of the predicted protein structure revealed that none of the D74 VtaA proteins contain a collagen triple helix repeat domain. Additionally, the predicted protein sequence for two D74 VtaA proteins is substantially longer than any predicted Nagasaki VtaA proteins. Fifteen methylation sequence motifs were identified in D74 and fourteen methylation sequence motifs were identified in Nagasaki using SMRT sequencing analysis. Only one of the methylation sequence motifs was observed in both strains indicative of the diversity between D74 and Nagasaki. Subsequent analysis also revealed diversity in the restriction-modification systems harbored by D74 and Nagasaki. The collective information reported in this study will aid in the development of vaccines and intervention strategies to decrease the prevalence and disease burden caused by H. parasuis.	[Nicholson, Tracy L.; Brunelle, Brian W.; Bayles, Darrell O.; Alt, David P.; Shore, Sarah M.] ARS, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA	United States Department of Agriculture (USDA)	Nicholson, TL (corresponding author), ARS, Natl Anim Dis Ctr, USDA, Ames, IA 50011 USA.	tracy.nicholson@ARS.USDA.GOV		Nicholson, Tracy/0000-0002-1471-0359	United States Department of Agriculture, Agriculture Research Service [5030-32000-119-00D]	United States Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding was provided by the United States Department of Agriculture, Agriculture Research Service (Project#5030-32000-119-00D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki SK, 2005, SCIENCE, V309, P1245, DOI 10.1126/science.1115109; Aoki SK, 2008, MOL MICROBIOL, V70, P323, DOI 10.1111/j.1365-2958.2008.06404.x; Aoki SK, 2010, NATURE, V468, P439, DOI 10.1038/nature09490; Aragon V, 2012, DIS SWINE, P760; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Atack JM, 2018, TRENDS MICROBIOL, V26, P715, DOI 10.1016/j.tim.2018.01.008; Atack JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8828; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BIBERSTEIN EL, 1969, J MED MICROBIOL, V2, P75, DOI 10.1099/00222615-2-1-75; Blanco I, 2004, VET MICROBIOL, V103, P21, DOI 10.1016/j.vetmic.2004.06.011; Brockmeier SL, 2004, VET MICROBIOL, V99, P75, DOI 10.1016/j.vetmic.2003.08.013; Brockmeier SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103787; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Chen LP, 2012, VET MICROBIOL, V155, P310, DOI 10.1016/j.vetmic.2011.08.020; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104; Costa-Hurtado M, 2013, VET J, V198, P571, DOI 10.1016/j.tvjl.2013.08.027; Costa-Hurtado M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-57; Darling A. E., 2010, PLOS ONE, V5; Dayao DAE, 2016, AUST VET J, V94, P227, DOI 10.1111/avj.12458; den Dunnen JT, 2000, HUM MUTAT, V15, P7; El Garch F, 2017, VET REC, V180, P591, DOI 10.1136/vr.103954; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Frandoloso R, 2012, VET MICROBIOL, V154, P347, DOI 10.1016/j.vetmic.2011.07.022; Garcia EC, 2018, CURR OPIN MICROBIOL, V42, P40, DOI 10.1016/j.mib.2017.09.011; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hayes CS, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a010025; Hayes F, 2011, CRIT REV BIOCHEM MOL, V46, P386, DOI 10.3109/10409238.2011.600437; He LQ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00212; Heithoff DM, 1999, SCIENCE, V284, P967, DOI 10.1126/science.284.5416.967; Howell KJ, 2015, J CLIN MICROBIOL, V53, P3812, DOI 10.1128/JCM.01991-15; Howell KJ, 2013, J BACTERIOL, V195, P4264, DOI 10.1128/JB.00471-13; Jia AQ, 2017, J CLIN MICROBIOL, V55, P3249, DOI [10.1128/JCM.00688-17, 10.1128/jcm.00688-17]; Johnson TJ, 2011, J BACTERIOL, V193, P3676, DOI 10.1128/JB.05177-11; Kedzierska B, 2016, MOLECULES, V21, DOI 10.3390/molecules21060790; Kehrenberg C, 2006, J ANTIMICROB CHEMOTH, V58, P13, DOI 10.1093/jac/dkl174; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lancashire JF, 2005, ANTIMICROB AGENTS CH, V49, P1927, DOI 10.1128/AAC.49.5.1927-1931.2005; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; LITTLE TWA, 1970, VET REC, V87, P399, DOI 10.1136/vr.87.14.399; Liu HS, 2016, VET IMMUNOL IMMUNOP, V180, P53, DOI 10.1016/j.vetimm.2016.09.002; Luan SL, 2013, VET MICROBIOL, V166, P558, DOI 10.1016/j.vetmic.2013.07.008; Marinus MG, 2009, FEMS MICROBIOL REV, V33, P488, DOI 10.1111/j.1574-6976.2008.00159.x; Martinez-Moliner V, 2012, MICROBIOL-SGM, V158, P2117, DOI 10.1099/mic.0.056994-0; Mazar J, 2007, TRENDS MICROBIOL, V15, P508, DOI 10.1016/j.tim.2007.10.005; Moleres J, 2015, APPL ENVIRON MICROB, V81, P3255, DOI 10.1128/AEM.03865-14; Oliveira S, 2003, CAN J VET RES, V67, P146; Olvera A, 2013, VET MICROBIOL, V164, P387, DOI 10.1016/j.vetmic.2013.02.022; Olvera A, 2011, VACCINE, V29, P2797, DOI 10.1016/j.vaccine.2011.01.105; Olvera A, 2010, VET RES, V41, DOI 10.1051/vetres/2009074; Pina S, 2009, J BACTERIOL, V191, P576, DOI 10.1128/JB.00703-08; Poole SJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002217; RILEY MGI, 1977, J AM VET MED ASSOC, V171, P649; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P418, DOI 10.1093/nar/gkg069; Ruhe ZC, 2013, TRENDS MICROBIOL, V21, P230, DOI 10.1016/j.tim.2013.02.003; Ruiz A, 2001, J CLIN MICROBIOL, V39, P1757, DOI 10.1128/JCM.39.5.1757-1762.2001; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210; Tadjine A, 2004, J CLIN MICROBIOL, V42, P839, DOI 10.1128/JCM.42.2.839-840.2004; Tommassen J, 2007, SCIENCE, V317, P903, DOI 10.1126/science.1146518; United States DoA, 2015, SWINE 2012 2; United States DoA, 2015, SWINE 2012 1; vanderWoude M, 1996, TRENDS MICROBIOL, V4, P5, DOI 10.1016/0966-842X(96)81498-3; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang XR, 2013, VET MICROBIOL, V164, P184, DOI 10.1016/j.vetmic.2013.01.037; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wen YP, 2018, GENE, V643, P107, DOI 10.1016/j.gene.2017.12.010; White M, 2010, PIG HEALTH GLASSERS; Willett JLE, 2015, J MOL BIOL, V427, P3754, DOI 10.1016/j.jmb.2015.09.010; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Zhang B, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-44; Zhang B, 2012, VET MICROBIOL, V158, P226, DOI 10.1016/j.vetmic.2012.01.023; Zhang B, 2012, MICROB PATHOGENESIS, V52, P117, DOI 10.1016/j.micpath.2011.11.002	83	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205700	10.1371/journal.pone.0205700	http://dx.doi.org/10.1371/journal.pone.0205700			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383795	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600021
J	Sahin, B; Gomis-Cebolla, J; Gunes, H; Ferre, J				Sahin, Burcu; Gomis-Cebolla, Joaquin; Gunes, Hatice; Ferre, Juan			Characterization of Bacillus thuringiensis isolates by their insecticidal activity and their production of Cry and Vip3 proteins	PLOS ONE			English	Article							SPODOPTERA-LITTORALIS; SUSCEPTIBILITY; TOXICITY; BINDING; MIDGUT; TOXINS; ENVIRONMENTS; FRUGIPERDA; SPECTRUM; STRAINS	Bacillus thuringiensis (Bt) constitutes the active ingredient of many successful bioinsecticides used in agriculture. In the present study, the genetic diversity and toxicity of Bt isolates was investigated by characterization of native isolates originating from soil, fig leaves and fruits from a Turkish collection. Among a total of 80 Bt isolates, 18 of them were found carrying a vip3 gene (in 23% of total), which were further selected. Insecticidal activity of spore/crystal mixtures and their supernatants showed that some of the Bt isolates had significantly more toxicity against some lepidopteran species than the HD1 reference strain. Five isolates were analyzed by LC-MS/MS to determine the Cry protein composition of their crystals. The results identified the Cry1Ac protein and a Cry2A-type protein in all isolates, Cry1Ea in 3 of them and Cry1Aa in one. The sequence analysis of the new vip3 genes showed that they had a high similarity to either vip3Aa, vip3Af or vip3Ag (94-100%). The vip3Aa gene of the 6A Bt isolate was cloned and sequenced. The protein was named Vip3Aa65 by the Bacillus thuringiensis Nomenclature Committee. The expressed and purified Vip3Aa65 protein was tested against five lepidopteran species and its toxicity compared to that of a reference protein (Vip3Aa16). Both proteins had similar toxicity against Grapholita molesta and Helicoverpa armigera, whereas Vip3Aa65 was less active than Vip3Aa16 against three species from the Spodoptera genus. A tetrameric structure of the Vip3Aa65 protein was detected by gel filtration chromatography. The study revealed some isolates with high insecticidal activity which can be considered promising candidates to be used in pest control.	[Sahin, Burcu; Gunes, Hatice] Mugla Sitki Kocman Univ, Fac Sci, Dept Biol, Mugla, Turkey; [Sahin, Burcu; Gomis-Cebolla, Joaquin; Ferre, Juan] Univ Valencia, Dept Genet, ERI Biotecnol & Biomed BIOTECMED, Burjassot, Spain	Mugla Sitki Kocman University; University of Valencia	Ferre, J (corresponding author), Univ Valencia, Dept Genet, ERI Biotecnol & Biomed BIOTECMED, Burjassot, Spain.	juan.ferre@uv.es	Gomis-Cebolla, Joaquin/H-2690-2018; Ferré, Juan/L-9426-2014; Gomis-Cebolla, Joaquin/GZA-8107-2022	Gomis-Cebolla, Joaquin/0000-0002-3099-1058; Ferré, Juan/0000-0001-5535-0612; 	Spanish Ministry of Economy and Competitivity [AGL2015-70584-C02-1-R, BES-2013-065848]; Generalitat Valenciana [GVPROMETEOII-2015-001]; European FEDER funds; BAP of Mugla Sitki Kocman University, Turkey [15/082]; Scientific and Technological Research Council of Turkey [2214/A]; PE I+D+i 2013-2016 - ISCIII [PT13/0001]; FEDER funds	Spanish Ministry of Economy and Competitivity(Spanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European FEDER funds(European Commission); BAP of Mugla Sitki Kocman University, Turkey; Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); PE I+D+i 2013-2016 - ISCIII; FEDER funds(European Commission)	This research was supported by the Spanish Ministry of Economy and Competitivity (AGL2015-70584-C02-1-R to JF), by grants from the Generalitat Valenciana (GVPROMETEOII-2015-001 to JF), and by European FEDER funds, and by a grant (15/082 to HG) from BAP of Mugla Sitki Kocman University, Turkey. JGC was recipient of a PhD grant from the Spanish Ministry of Economy and Competitivity (grant ref. BES-2013-065848). BS was supported 2214/A Scholarship Program of The Scientific and Technological Research Council of Turkey (Doctorate level). The proteomic analysis was performed in the proteomics facility of SCSIE University of Valencia that belongs to ProteoRed, PRB2-ISCIII, supported by grant PT13/0001 of the PE I+D+i 2013-2016, funded by ISCIII and FEDER funds.	Abdelkefi-Mesrati L, 2011, J INVERTEBR PATHOL, V107, P198, DOI 10.1016/j.jip.2011.05.014; Abdelkefi-Mesrati L, 2011, J INVERTEBR PATHOL, V106, P250, DOI 10.1016/j.jip.2010.10.002; Abdelkefi-Mesrati L, 2009, MOL BIOTECHNOL, V43, P15, DOI 10.1007/s12033-009-9178-4; Alberola TM, 1999, J INVERTEBR PATHOL, V74, P127, DOI 10.1006/jipa.1999.4871; Alper M, 2014, TURK J AGRIC FOR, V38, P898, DOI 10.3906/tar-1402-27; Apaydin O, 2005, WORLD J MICROB BIOT, V21, P285, DOI 10.1007/s11274-004-3633-y; Azzouz H, 2014, PEST MANAG SCI, V70, P1192, DOI 10.1002/ps.3661; Banyuls N, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Baranek J, 2015, J INVERTEBR PATHOL, V130, P72, DOI 10.1016/j.jip.2015.06.006; Bel Y, 2017, TOXINS, V9, DOI 10.3390/toxins9040131; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Bergamasco VB, 2013, J INVERTEBR PATHOL, V112, P152, DOI 10.1016/j.jip.2012.11.011; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chakroun M, 2016, MICROBIOL MOL BIOL R, V80, P329, DOI 10.1128/MMBR.00060-15; Chakroun M, 2014, APPL ENVIRON MICROB, V80, P6258, DOI 10.1128/AEM.01521-14; Chakroun M, 2012, J INVERTEBR PATHOL, V110, P334, DOI 10.1016/j.jip.2012.03.021; Cinar C, 2005, THESIS; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; de Rijk TC, 2013, ANAL BIOANAL CHEM, V405, P1631, DOI 10.1007/s00216-012-6591-5; Djenane Z, 2017, TOXINS, V9, DOI 10.3390/toxins9040139; Estruch JJ, 1996, P NATL ACAD SCI USA, V93, P5389, DOI 10.1073/pnas.93.11.5389; Ferrandis MD, 1999, SYST APPL MICROBIOL, V22, P179, DOI 10.1016/S0723-2020(99)80064-2; Gayen S, 2012, J PLANT BIOCHEM BIOT, V21, pS128, DOI 10.1007/s13562-012-0148-8; Gomis-Cebolla J, 2018, TOXINS, V10, DOI 10.3390/toxins10050193; Gomis-Cebolla J, 2017, J INVERTEBR PATHOL, V142, P60, DOI [10.1016/j.jip.2016.10.001, 10.1016/j.jip.2016.09.006]; GUENNELON G, 1981, AGRONOMIE, V1, P59, DOI 10.1051/agro:19810108; Hernandez-Rodriguez CS, 2009, J APPL MICROBIOL, V107, P219, DOI 10.1111/j.1365-2672.2009.04199.x; Iriarte J, 1998, SYST APPL MICROBIOL, V21, P97, DOI 10.1016/S0723-2020(98)80012-X; Lee MK, 2006, BIOCHEM BIOPH RES CO, V339, P1043, DOI 10.1016/j.bbrc.2005.11.112; Lee MK, 2003, APPL ENVIRON MICROB, V69, P4648, DOI 10.1128/AEM.69.8.4648-4657.2003; Li C, 2007, BIOCONTROL SCI TECHN, V17, P699, DOI 10.1080/09583150701527177; Lone Showkat Ahmad, 2017, Biotechnol Rep (Amst), V15, P27, DOI 10.1016/j.btre.2017.05.001; Lemes ARN, 2017, PEERJ, V5, DOI 10.7717/peerj.2866; PALMA L, 2017, TOXINS, V9, P65516; Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296; Pimentel D., 2009, INTEGRATED PEST MANA; POITOUT S, 1974, Annales de Zoologie Ecologie Animale, V6, P431; Rice WC, 1999, LETT APPL MICROBIOL, V28, P378, DOI 10.1046/j.1365-2672.1999.00536.x; de Escudero IR, 2014, J INVERTEBR PATHOL, V117, P51, DOI 10.1016/j.jip.2014.01.006; Sahin B, 2017, GAZI U J SCI, V30, P223; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchis V, 2008, AGRON SUSTAIN DEV, V28, P11, DOI 10.1051/agro:2007054; Hernandez-Rodriguez CS, 2009, J BASIC MICROB, V49, P152, DOI 10.1002/jobm.200800121; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Selvapandiyan A, 2001, APPL ENVIRON MICROB, V67, P5855, DOI 10.1128/AEM.67.12.5855-5858.2001; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; STEWART GSAB, 1981, BIOCHEM J, V198, P101, DOI 10.1042/bj1980101; Yu CG, 1997, APPL ENVIRON MICROB, V63, P532, DOI 10.1128/AEM.63.2.532-536.1997; Zack MD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11702-2	49	13	13	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206813	10.1371/journal.pone.0206813	http://dx.doi.org/10.1371/journal.pone.0206813			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383811	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600099
J	Tun, K; Shurko, JF; Ryan, L; Lee, GC				Tun, Khine; Shurko, James F.; Ryan, Laurajo; Lee, Grace C.			Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012	PLOS ONE			English	Article							ACUTE BACTERIAL SKIN; STAPHYLOCOCCUS-AUREUS EPIDEMIOLOGY; ACQUIRED METHICILLIN-RESISTANT; RISK-FACTORS; MRSA SKIN; CARE; MANAGEMENT	Objective The aim of this study was to compare the incidence of skin and soft tissue infections (SSTIs) across healthcare settings and analyze direct healthcare expenditures related to SSTIs in 2000 and 2012 in the United States. Methods We performed a retrospective, cross-sectional analysis of nationally representative data from the Medical Expenditure Panel Surveys. Population-based incidence rates were examined for all healthcare settings that include inpatient visits, emergency department visits and ambulatory visits for SSTIs. The direct costs of healthcare services utilization were reported. Population-based prescribing rates for each antimicrobial class during ambulatory visits were compared. Results A total of 2.4 million patients experienced an SSTI in 2000 compared to 3.3 million in 2012 (40% increase). From 2000 to 2012, the incidence of patients with at least one hospital visit for SSTIs increased 22%, ambulatory care visits increased 30%, and emergency department visits increased 40%. The incidence of SSTIs in children and adolescents declined 50% (from 150 to 76 per 10,000 person; RR = 0.51, 95% CI: 0.38-0.67; p<0.001) whereas SSTIs in older adults (> 65 years of age) increased almost 2-fold (from 67 to 130 per 10,000 person; RR = 1.94, 95% CI: 1.44-2.61; p<0.001). The annual incidence of SSTI in adults did not change significantly from 2000 to 2012 (from 84 to 81 per 10,000 person; RR = 0.96, 95% CI: 0.71-1.31; p = 0.41). The total estimated direct healthcare costs of SSTIs increased 3-fold from $4.8 billion in 2000 to $15.0 billion in 2012, largely driven by an 8-fold increase in ambulatory expenditures for SSTIs. Total population-based antimicrobial prescription rates for SSTIs increased 4-fold from 2000 to 2012 (from 59.5 to 250.4 per 10,000 person). Conclusions The highest healthcare utilization for SSTI treatment occurred in the ambulatory care setting and also accounted for the largest increase in overall direct expenditures from 2000 to 2012.	[Tun, Khine; Shurko, James F.; Ryan, Laurajo; Lee, Grace C.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Tun, Khine; Shurko, James F.; Ryan, Laurajo; Lee, Grace C.] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Lee, GC (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.; Lee, GC (corresponding author), UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX 78229 USA.	leeg3@uthscsa.edu						Centers for Disease Control and Prevention, 2007, OUTPATIENT MANAGEMEN; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Dryden M, 2008, SURG INFECT, V9, pS3, DOI 10.1089/sur.2008.066.supp; Ektare V, 2015, J MED ECON, V18, P1092, DOI 10.3111/13696998.2015.1078339; Esposito S, 2016, CURR OPIN INFECT DIS, V29, P109, DOI 10.1097/QCO.0000000000000239; Farley JE, 2008, J AM ACAD NURSE PRAC, V20, P85, DOI 10.1111/j.1745-7599.2007.00290.x; Frei CR, 2010, J AM BOARD FAM MED, V23, P714, DOI 10.3122/jabfm.2010.06.090270; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Itani KMF, 2011, AM J INFECT CONTROL, V39, P42, DOI 10.1016/j.ajic.2010.03.018; Labreche MJ, 2013, J AM BOARD FAM MED, V26, P508, DOI 10.3122/jabfm.2013.05.120247; Lee GC, 2017, J ANTIMICROB CHEMOTH, V72, P2461, DOI 10.1093/jac/dkx200; Lee GC, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0175-8; Levit K, 2009, HCUP FACTS FIGURES S; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Marton JP, 2008, CURR MED RES OPIN, V24, P2821, DOI [10.1185/03007990802365169, 10.1185/03007990802365169 ]; Medical Expenditure Panel Survey (MEPS), 2014, HC155 MEPS; Menzin J, 2010, AM J INFECT CONTROL, V38, P44, DOI 10.1016/j.ajic.2009.04.287; Miller LG, 2007, CLIN INFECT DIS, V44, P483, DOI 10.1086/511041; Parchman ML, 2009, J AM BOARD FAM MED, V22, P375, DOI 10.3122/jabfm.2009.04.090003; Revankar Nikhil, 2014, J Med Econ, V17, P730, DOI 10.3111/13696998.2014.941065; Sitali L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0935-7; Suaya JA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-296; Verastegui JE, 2016, EXPERT REV CLIN PHAR, V9, P1039, DOI 10.1080/17512433.2016.1195683	24	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206893	10.1371/journal.pone.0206893	http://dx.doi.org/10.1371/journal.pone.0206893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383858	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600104
J	Hu, YB; Yan, C; Mu, L; Mil, YL; Zhao, H; Hu, H; Li, XL; Tao, DD; Wu, YQ; Gong, JP; Qin, JC				Hu, Y-B; Yan, C.; Mu, L.; Mil, Y-L; Zhao, H.; Hu, H.; Li, X-L; Tao, D-D; Wu, Y-Q; Gong, J-P; Qin, J-C			Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance	ONCOGENE			English	Article							STEM-CELLS; SELF-RENEWAL; BETA-CATENIN; EXPRESSION; PROGRESSION; HETEROGENEITY; EQUILIBRIUM; ENVIRONMENT; FIBROBLASTS; POPULATION	Cancer stem cells (CSCs) are inherently resistant to chemotherapy, and CSCs in chemotherapy-failed recurrent tumors are enriched; however, the cellular origin of chemotherapy-induced CSC enrichment remains unclear. Communication with stromal fibroblasts may induce cancer cell dedifferentiation into CSCs through secreted factors. We recently demonstrated that fibroblast-derived exosomes promote chemoresistance in colorectal cancer (CRC). Here, we report that fibroblasts confer CRC chemoresistance via exosome-induced reprogramming (dedifferentiation) of bulk CRC cells to phenotypic and functional CSCs. At the molecular level, we provided evidence that the major reprogramming regulators in fibroblast-exosomes are Wnts. Exosomal Wnts were found to increase Wnt activity and drug resistance in differentiated CRC cells, and inhibiting Wnt release diminished this effect in vitro and in vivo. Together, our results indicate that exosomal Wnts derived from fibroblasts could induce the dedifferentiation of cancer cells to promote chemoresistance in CRC, and suggest that interfering with exosomal Wnt signaling may help to improve chemosensitivity and the therapeutic window.	[Hu, Y-B; Yan, C.; Mu, L.; Mil, Y-L; Zhao, H.; Hu, H.; Wu, Y-Q; Gong, J-P; Qin, J-C] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Surg, Wuhan 430030, Hubei, Peoples R China; [Hu, Y-B; Yan, C.; Mu, L.; Mil, Y-L; Zhao, H.; Hu, H.; Li, X-L; Tao, D-D; Gong, J-P; Qin, J-C] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Mol Med Ctr, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Gong, JP; Qin, JC (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Surg, Wuhan 430030, Hubei, Peoples R China.; Gong, JP; Qin, JC (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Mol Med Ctr, Wuhan 430030, Hubei, Peoples R China.	jpgong@tjh.tjmu.edu.cn; jcqin@tjh.tjmu.edu.cn		Qin, Jichao/0000-0002-2961-7624	National Nature Science Foundation of China [81272660, 81572894, 81702948]; China Postdoctoral Science Foundation [2016M602313]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank animal facility of Tongji Medical College for animal experiments. We apologize to the colleagues whose work was not cited owing to space constraint. This work was supported by National Nature Science Foundation of China (81272660, 81572894, 81702948), China Postdoctoral Science Foundation funded project (2016M602313).	Aguirre-Gamboa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074250; Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chalamalasetty RB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1381; Chen Y, 2017, ONCOGENE, V36, P4692, DOI 10.1038/onc.2017.100; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Hawinkels LJAC, 2014, ONCOGENE, V33, P97, DOI 10.1038/onc.2012.536; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Hu YB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125625; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Janda CY, 2017, NATURE, V545, P234, DOI 10.1038/nature22306; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Koch R, 2014, BLOOD, V123, P2189, DOI 10.1182/blood-2013-08-523886; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lin L, 2011, CANCER RES, V71, P7226, DOI 10.1158/0008-5472.CAN-10-4660; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Luga V, 2012, CELL, V151, P1542, DOI 10.1016/j.cell.2012.11.024; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; McAllister SS, 2014, NAT CELL BIOL, V16, P717, DOI 10.1038/ncb3015; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Mincheva-Nilsson L, 2016, CURR PROTOC IMMUNOL, V115; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Mu L, 2017, ONCOTARGET, V8, DOI DOI 10.18632/ONCOTARGET.22.392; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Saha S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13096; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tang DG, 2012, CELL RES, V22, P457, DOI 10.1038/cr.2012.13; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; TRAINER DL, 1988, INT J CANCER, V41, P287, DOI 10.1002/ijc.2910410221; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Webber J, 2010, CANCER RES, V70, P9621, DOI 10.1158/0008-5472.CAN-10-1722; Wicha MS, 2014, NAT MED, V20, P14, DOI 10.1038/nm.3434; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221; Yan C, 2016, ONCOTARGET, V7, P80700, DOI 10.18632/oncotarget.13029	53	104	111	1	40	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1951	1965		10.1038/s41388-018-0557-9	http://dx.doi.org/10.1038/s41388-018-0557-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30390075	Green Published, hybrid			2022-12-26	WOS:000461164400012
J	Abebe, TB; Gebreyohannes, EA; Tefera, YG; Bhagavathula, AS; Erku, DA; Belachew, SA; Gebresillassie, BM; Abegaz, TM				Abebe, Tamrat Befekadu; Gebreyohannes, Eyob Alemayehu; Tefera, Yonas Getaye; Bhagavathula, Akshaya Srikanth; Erku, Daniel Asfaw; Belachew, Sewunet Admasu; Gebresillassie, Begashaw Melaku; Abegaz, Tadesse Melaku			The prognosis of heart failure patients: Does sodium level play a significant role?	PLOS ONE			English	Article							PRESERVED SYSTOLIC FUNCTION; SALINE SOLUTION INFUSION; HIGH-DOSE FUROSEMIDE; SERUM SODIUM; HOSPITALIZED-PATIENTS; CLINICAL CHARACTERISTICS; VASOPRESSIN ANTAGONIST; PREDICTING MORTALITY; SEVERE HYPONATREMIA; EJECTION FRACTION	Introduction Heart failure (HF), a major cardiovascular disorder, remains a grievous clinical condition regardless of advances in medical care. Hyponatremia is classified as a serum sodium concentration of <135 mEq/L, and the prevalence, clinical impact and prognostic factor of hyponatremia in heart failure patients varies widely. The current study was conducted with the aim of assessing the prevalence of hyponatremia in patients hospitalized with a diagnosis of HF and comparing baseline clinical characteristic of HF patients based on their sodium status. Survival difference between patients with hyponatremia and normonatremia was also assessed and the clinical prognostic indicators of overall mortality in HF patients were evaluated. Method A retrospective cohort study was conducted to assess medical records of heart failure patients who were admitted to Gondar University Referral Hospital. Patients were categorized based on their sodium level status at their first admission to the internal medicine department. Each patient was assigned to either of the following groups: hyponatremia if sodium < 135 mmol/L, or normonatremia if sodium >= 135 mmol/L. Result Among 388 participants, the prevalence of hyponatremia in the study cohorts was 51.03%. Kaplan-Meier survival curves showed that there was a significant difference in survival status of HF patients among the two cohorts (Log-Rank test, P<0.0001). Hence, patients with normal sodium levels had a higher chance of survival over hyponatremic patients. Multivariate Cox regression has revealed a statistically significant association of mortality with the following variables: advanced age (AHR = 1.035 (1.012-1.058), P = 0.003), hyponatremia (AHR = 4.003 (1.778-9.009), P = 0.001), higher creatinine level (AHR = 1.929 (1.523-2.443), P =<0.0001) and, prescription of angiotensin-converting enzyme inhibitors (AHR = 0.410 (0.199-0.842), P = 0.015) and spironolactone (AHR = 0.511 (0.275-0.949), P = 0.033. Conclusion In conclusion, hyponatremia is one of the crucial factors in the clinical prognosis of heart failure patients. However, as other prognostic factors (i.e. medication, creatine level, and age) also played vital roles in overall survival, well-controlled clinical trials (complete with medication dosing, laboratory outputs and long-term prospective follow up) are required to further study the impact of hyponatremia in HF patient's prognosis in low income nations.	[Abebe, Tamrat Befekadu; Gebreyohannes, Eyob Alemayehu; Tefera, Yonas Getaye; Bhagavathula, Akshaya Srikanth; Erku, Daniel Asfaw; Belachew, Sewunet Admasu; Gebresillassie, Begashaw Melaku; Abegaz, Tadesse Melaku] Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia; [Abebe, Tamrat Befekadu] Karolinska Inst, Dept Learning Informat Management & Eth LIME, Solna, Sweden; [Bhagavathula, Akshaya Srikanth] United Arab Emirates Univ, Dept Internal Med, Al Ain, U Arab Emirates; [Erku, Daniel Asfaw] Univ Queensland, Sch Pharm, Brisbane, Qld, Australia	University of Gondar; Karolinska Institutet; United Arab Emirates University; University of Queensland	Abebe, TB (corresponding author), Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia.; Abebe, TB (corresponding author), Karolinska Inst, Dept Learning Informat Management & Eth LIME, Solna, Sweden.	Befekadutamrat@gmail.com	Gebreyohannes, Eyob/E-5608-2018; Bhagavathula, Akshaya/GQH-1302-2022; Bhagavathula, Akshaya Srikanth/G-6649-2015; Erku, Daniel/AAC-1508-2020	Gebreyohannes, Eyob/0000-0002-0075-4553; Bhagavathula, Akshaya Srikanth/0000-0002-0581-7808; Erku, Daniel/0000-0002-8878-0317; Tefera, Yonas Getaye/0000-0002-9205-9442; Admasu Belachew, Sewunet/0000-0002-1050-8188; Abebe, Tamrat Befekadu/0000-0002-9367-7592				Abebe TB, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0680-5; Abebe TB, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0418-9; Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Agbor VN, 2018, INT J CARDIOL, V257, P207, DOI 10.1016/j.ijcard.2017.12.048; Albert NM, 2013, J CARD FAIL, V19, P1, DOI 10.1016/j.cardfail.2012.11.007; Andell P, 2017, HEART, V103, P1696, DOI 10.1136/heartjnl-2016-310894; Lorido JCA, 2013, CARDIOL J, V20, P506, DOI 10.5603/CJ.2013.0136; Assadi F, 2012, J NEPHROL, V25, P473, DOI 10.5301/jn.5000060; Balling L, 2011, EUR J HEART FAIL, V13, P968, DOI 10.1093/eurjhf/hfr086; Bettari L, 2012, J CARD FAIL, V18, P74, DOI 10.1016/j.cardfail.2011.09.005; Bettari L, 2012, HEART FAIL REV, V17, P17, DOI 10.1007/s10741-010-9193-3; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Campbell TJ, 2003, MED J AUSTRALIA, V179, P98, DOI 10.5694/j.1326-5377.2003.tb05445.x; DZAU VJ, 1984, ANN INTERN MED, V100, P777, DOI 10.7326/0003-4819-100-6-777; ELISAF M, 1995, CARDIOLOGY, V86, P477, DOI 10.1159/000176926; Fall PJ, 2000, POSTGRAD MED, V107, P75, DOI 10.3810/pgm.2000.5.1.1068; Filippatos TD, 2013, WORLD J CARDIOL, V5, P317, DOI [10.4330/wjc.v5.i9.317, 10.4330/wjc.v5.i7.210]; Ghali JK, 2010, J CARD FAIL, V16, P419, DOI 10.1016/j.cardfail.2009.12.021; Gheorghiade M, 2004, JAMA-J AM MED ASSOC, V291, P1963, DOI 10.1001/jama.291.16.1963; Gheorghiade M, 2007, EUR HEART J, V28, P980, DOI 10.1093/eurheartj/ehl542; Gheorghiade M, 2007, JAMA-J AM MED ASSOC, V297, P1332, DOI 10.1001/jama.297.12.1332; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; Goh KP, 2004, AM FAM PHYSICIAN, V69, P2387; Goldsmith SR, 2013, J CARD FAIL, V19, P398, DOI 10.1016/j.cardfail.2013.04.003; Hamaguchi S, 2014, J CARDIOL, V63, P182, DOI 10.1016/j.jjcc.2013.07.012; KARP BI, 1993, MEDICINE, V72, P359, DOI 10.1097/00005792-199311000-00001; Kearney MT, 2004, HEART, V90, P1137, DOI 10.1136/hrt.2003.021733; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Konstam MA, 2007, JAMA-J AM MED ASSOC, V297, P1319, DOI 10.1001/jama.297.12.1319; Kwon TH, 2001, SEMIN NEPHROL, V21, P231, DOI 10.1053/snep.2001.21647; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Lee SE, 2012, HEART, V98, P1798, DOI 10.1136/heartjnl-2012-302334; Licata G, 2003, AM HEART J, V145, P459, DOI 10.1067/mhj.2003.166; LILLY LS, 1984, J CLIN ENDOCR METAB, V59, P924, DOI 10.1210/jcem-59-5-924; Lu DY, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002668; Macin SM, 2004, REV ESP CARDIOL, V57, P45, DOI 10.1016/S1885-5857(06)60086-8; Madan VD, 2011, CIRC-HEART FAIL, V4, P637, DOI 10.1161/CIRCHEARTFAILURE.111.961011; Mahmood SS, 2013, GLOB HEART, V8, P77, DOI 10.1016/j.gheart.2012.12.006; Misganaw A, 2017, POPUL HEALTH METR, V15, DOI 10.1186/s12963-017-0145-1; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Ojeda S, 2003, REV ESP CARDIOL, V56, P1050, DOI 10.1157/13054030; Oren RM, 2005, AM J CARDIOL, V95, p2B; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PACKER M, 1987, CIRCULATION, V75, P80; Paterna S, 2000, EUR J HEART FAIL, V2, P305, DOI 10.1016/S1388-9842(00)00094-5; Perry G, 1997, NEW ENGL J MED, V336, P525; Pfennig Camiron L, 2012, Emerg Med Pract, V14, P1; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rossi Joseph, 2007, Acute Card Care, V9, P82, DOI 10.1080/17482940701210179; Rusinaru D, 2012, EUR J HEART FAIL, V14, P1139, DOI 10.1093/eurjhf/hfs099; Schrier RW, 2013, NAT REV NEPHROL, V9, P37, DOI 10.1038/nrneph.2012.246; Shapiro DS, 2010, INTERN MED J, V40, P574, DOI 10.1111/j.1445-5994.2010.02217.x; Shlipak MG, 2004, J AM SOC NEPHROL, V15, P2195, DOI 10.1097/01.ASN.0000135121.81744.75; Sica Domenic A, 2005, Congest Heart Fail, V11, P274, DOI 10.1111/j.1527-5299.2005.04180.x; Tefera YG, 2017, VASC HEALTH RISK MAN, V13, P143, DOI 10.2147/VHRM.S131259; Thibonnier M, 1998, ADV EXP MED BIOL, V449, P251; Tyminska A, 2017, AM J CARDIOL, V119, P2021, DOI 10.1016/j.amjcard.2017.03.035; Vazquez R, 2009, EUR HEART J, V30, P1088, DOI 10.1093/eurheartj/ehp032; WHO/UNICEF/UNU, 2001, IRON DEFICIENCY ANAE	59	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207242	10.1371/journal.pone.0207242	http://dx.doi.org/10.1371/journal.pone.0207242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408132	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300093
J	Fries, GR; Khan, S; Stamatovich, S; Dyukova, E; Walss-Bass, C; Lane, SD; Schmitz, JM; Wardle, MC				Fries, Gabriel Rodrigo; Khan, Sarwar; Stamatovich, Sydney; Dyukova, Elena; Walss-Bass, Consuelo; Lane, Scott D.; Schmitz, Joy M.; Wardle, Margaret C.			Anhedonia in cocaine use disorder is associated with inflammatory gene expression	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; DEPENDENCE; ABUSE; MECHANISMS; DEPRESSION; ADDICTION; STRESS; LEPTIN; IRF-1; PATHOPHYSIOLOGY	Treatments for Cocaine Use Disorder (CUD) are variably effective, and there are no FDA-approved medications. One approach to developing new treatments for CUD may be to investigate and target poor prognostic signs. One such sign is anhedonia (i.e. a loss of pleasure or interest in non-drug rewards), which predicts worse outcomes in existing CUD treatments. Inflammation is thought to underlie anhedonia in many other disorders, but the relationship between anhedonia and inflammation has not been investigated in CUD. Therefore, we assessed peripheral genome-wide gene expression in n = 48 individuals with CUD with high (n = 24) vs. low (n = 24) levels of anhedonia, defined by a median split of self-reported anhedonia. Our hypothesis was that individuals with high anhedonia would show differential gene expression in inflammatory pathways. No individual genes were significantly different between the low and high anhedonia groups when using t-tests with a stringent false discovery rate correction (FDR-corrected p < 0.05). However, an exploratory analysis identified 166 loci where t-tests suggested group differences at a nominal p < 0.05. We used DAVID, a bioinformatics tool that provides functional interpretations of complex lists of genes, to examine representation of this gene list in known pathways. It confirmed that mechanisms related to immunity were the top significant associations with anhedonia in the sample. Further, the two top differentially expressed genes in our sample, IRF1 and GBP5, both have primary inflammation and immune functions, and were significantly negatively correlated with total scores on our self-report of anhedonia across all 48 subjects. These results suggest that prioritizing development of anti-inflammatory medications for CUD may pay dividends, particularly in combination with treatment-matching strategies using either phenotypic measures of anhedonia or biomarkers of inflammatory gene expression to individualize treatment.	[Fries, Gabriel Rodrigo; Khan, Sarwar; Stamatovich, Sydney; Dyukova, Elena; Walss-Bass, Consuelo; Lane, Scott D.; Schmitz, Joy M.; Wardle, Margaret C.] Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Wardle, MC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	Margaret.C.Wardle@uthAmc.edu	Fries, Gabriel R/P-8810-2014; Fries, Gabriel R/C-1521-2009; Walss-Bass, Consuelo/K-5702-2015	Fries, Gabriel R/0000-0002-5468-2612; Fries, Gabriel R/0000-0002-5468-2612; Wardle, Margaret/0000-0001-6071-6105; Walss-Bass, Consuelo/0000-0003-2474-5448	National Institutes of Health [K08 DA040006, P50 DA009262]; NATIONAL INSTITUTE ON DRUG ABUSE [K08DA040006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health [grant numbers K08 DA040006 to M.W., P50 DA009262 to J.S.]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2017, NAT REV RHEUMATOL, V13, P100, DOI 10.1038/nrrheum.2016.209; Armstrong MJ, 2012, CANCER LETT, V319, P56, DOI 10.1016/j.canlet.2011.12.027; Center for Behavioral Health Statistics and Quality, 2015, NSDUH SER H; Coller JK, 2012, PHARMACOL THERAPEUT, V134, P219, DOI 10.1016/j.pharmthera.2012.01.008; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2014, TRENDS NEUROSCI, V37, P39, DOI 10.1016/j.tins.2013.10.003; Degenhardt L, 2014, DRUG ALCOHOL DEPEN, V137, P36, DOI 10.1016/j.drugalcdep.2013.12.025; Felger JC, 2013, NEUROSCIENCE, V246, P199, DOI 10.1016/j.neuroscience.2013.04.060; Felger JC, 2017, NEUROPSYCHOPHARMACOL, V42, P216, DOI 10.1038/npp.2016.143; Ferguson LB, 2018, NEUROPSYCHOPHARMACOL, V43, P1257, DOI 10.1038/npp.2017.301; First MB, 1996, STRUTURED CLIN INTER; First MB, 2015, STRUTURED CLIN INTER; Fox HC, 2017, J PSYCHOPHARMACOL, V31, P883, DOI 10.1177/0269881117691455; Fox HC, 2012, HUM PSYCHOPHARM CLIN, V27, P156, DOI 10.1002/hup.1251; Frank MG, 2011, BRAIN BEHAV IMMUN, V25, pS21, DOI 10.1016/j.bbi.2011.01.005; Franken IHA, 2007, J AFFECT DISORDERS, V99, P83, DOI 10.1016/j.jad.2006.08.020; Gao J, 2010, CELL DEATH DIFFER, V17, P699, DOI 10.1038/cdd.2009.156; Garfield JBB, 2014, AUST NZ J PSYCHIAT, V48, P36, DOI 10.1177/0004867413508455; HALL SM, 1991, J CONSULT CLIN PSYCH, V59, P526, DOI 10.1037/0022-006X.59.4.526; Hatzigiakoumis Daniele Stavros, 2011, Front Psychiatry, V2, P10, DOI 10.3389/fpsyt.2011.00010; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irwin MR, 2007, J PHARMACOL EXP THER, V320, P507, DOI 10.1124/jpet.106.112797; Jonkman S, 2013, NEUROPSYCHOPHARMACOL, V38, P198, DOI 10.1038/npp.2012.120; Juszczak GR, 2018, PROG NEURO-PSYCHOPH, V82, P136, DOI 10.1016/j.pnpbp.2017.11.020; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Levandowski ML, 2016, DRUG ALCOHOL DEPEN, V167, P140, DOI 10.1016/j.drugalcdep.2016.08.010; Levandowski ML, 2014, J PSYCHIATR RES, V53, P180, DOI 10.1016/j.jpsychires.2014.02.017; Leventhal AM, 2006, J CLIN PSYCHOL, V62, P1545, DOI 10.1002/jclp.20327; Leventhal AM, 2014, J CONSULT CLIN PSYCH, V82, P122, DOI 10.1037/a0035046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubman DI, 2009, ARCH GEN PSYCHIAT, V66, P205, DOI 10.1001/archgenpsychiatry.2008.522; Mariani JJ, 2012, PSYCHIAT CLIN N AM, V35, P425, DOI 10.1016/j.psc.2012.03.012; Martinotti G, 2008, AM J DRUG ALCOHOL AB, V34, P177, DOI 10.1080/00952990701877078; Martinotti G, 2017, PSYCHONEUROENDOCRINO, V85, P35, DOI 10.1016/j.psyneuen.2017.08.004; MCLELLAN AT, 1980, J NERV MENT DIS, V168, P26, DOI 10.1097/00005053-198001000-00006; Miller AH, 2009, BIOL PSYCHIAT, V65, P732, DOI 10.1016/j.biopsych.2008.11.029; Moreira FP, 2016, DRUG ALCOHOL DEPEN, V158, P181, DOI 10.1016/j.drugalcdep.2015.11.024; Narendran R, 2014, J NEUROSCI, V34, P9945, DOI 10.1523/JNEUROSCI.0928-14.2014; Narvaez JCM, 2013, NEUROSCI LETT, V544, P80, DOI 10.1016/j.neulet.2013.03.045; Niu TH, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00271; Palmer C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-115; Pettorruso M, 2018, BRAIN STIMUL, V11, P1195, DOI 10.1016/j.brs.2018.06.001; Pianca TG, 2017, DRUG ALCOHOL DEPEN, V177, P207, DOI 10.1016/j.drugalcdep.2017.03.043; Pietri P, 2015, CURR MED CHEM, V22, P2754, DOI 10.2174/0929867322666150420104727; Ray LA, 2014, INT REV NEUROBIOL, V118, P381, DOI 10.1016/B978-0-12-801284-0.00012-9; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Sahu S, 2016, AM J PHYSIOL-CELL PH, V311, pC212, DOI 10.1152/ajpcell.00068.2016; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmitz JM, 2017, ADDICTION, V112, P1861, DOI 10.1111/add.13868; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shapiro MD, 2016, CIRC RES, V118, P732, DOI 10.1161/CIRCRESAHA.115.306471; Shenoy AR, 2012, SCIENCE, V336, P481, DOI 10.1126/science.1217141; Slavich GM, 2014, PSYCHOL BULL, V140, P774, DOI 10.1037/a0035302; SNAITH RP, 1995, BRIT J PSYCHIAT, V167, P99, DOI 10.1192/bjp.167.1.99; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Taniguchi T, 2002, ELSEVIER CURRENT TRE, V14, P111, DOI [10.1016/S0952-7915(01)00305-3, DOI 10.1016/S0952-7915(01)00305-3]; Tylee DS, 2013, AM J MED GENET B, V162, P595, DOI 10.1002/ajmg.b.32150; Wardle MC, 2017, J SUBST ABUSE TREAT, V72, P32, DOI 10.1016/j.jsat.2016.08.020; Wetherill L, 2008, ALCOHOL CLIN EXP RES, V32, P2031, DOI 10.1111/j.1530-0277.2008.00790.x; Yuferov V, 2009, NEUROPSYCHOPHARMACOL, V34, P1185, DOI 10.1038/npp.2008.187; Zhang XJ, 2015, BRIT J PHARMACOL, V172, P5457, DOI 10.1111/bph.12881; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207231	10.1371/journal.pone.0207231	http://dx.doi.org/10.1371/journal.pone.0207231			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408130	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300092
J	Khoiy, KA; Asgarian, KT; Loth, F; Amini, R				Khoiy, Keyvan Amini; Asgarian, Kourosh T.; Loth, Francis; Amini, Rouzbeh			Dilation of tricuspid valve annulus immediately after rupture of chordae tendineae in ex-vivo porcine hearts	PLOS ONE			English	Article							VENTRICULAR PRESSURE-OVERLOAD; MITRAL REGURGITATION; INTERSTITIAL-CELLS; NATIVE TISSUE; IN-VIVO; INSUFFICIENCY; LEAFLETS; REPAIR; DYSFUNCTION; RELAXATION	Purpose Chordae rupture is one of the main lesions observed in traumatic heart events that might lead to severe tricuspid valve (TV) regurgitation. TV regurgitation following chordae rupture is often well tolerated with few or no symptoms for most patients. However, early repair of the TV is of great importance, as it might prevent further exacerbation of the regurgitation due to remodeling responses. To understand how TV regurgitation develops following this acute event, we investigated the changes on TV geometry, mechanics, and function of ex-vivo porcine hearts following chordae rupture. Methods Sonomicrometry techniques were employed in an ex-vivo heart apparatus to identify how the annulus geometry alters throughout the cardiac cycle after chordae rupture, leading to the development of TV regurgitation. Results We observed that the TV annulus significantly dilated (similar to 9% in area) immediately after chordae rupture. The annulus area and circumference ranged from 11.4 +/- 2.8 to 13.3 +/- 2.9 cm(2) and from 12.5 +/- 1.5 to 13.5 +/- 1.3 cm, respectively, during the cardiac cycle for the intact heart. After chordae rupture, the annulus area and circumference were larger and ranged from 12.3 +/- 3.0 to 14.4 +/- 2.9 cm(2) and from 13.0 +/- 1.5 to 14.0 +/- 1.2 cm, respectively. Conclusions In our ex-vivo study, we showed for the first time that the TV annulus dilates immediately after chordae rupture. Consequently, secondary TV regurgitation may be developed because of such changes in the annulus geometry. In addition, the TV leaflet and the right ventricle myocardium are subjected to a different mechanical environment, potentially causing further negative remodeling responses and exacerbating the detrimental outcomes of chordae rupture.	[Khoiy, Keyvan Amini; Amini, Rouzbeh] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Asgarian, Kourosh T.] Mid Atlantic Surg Associates, Neptune, NJ USA; [Loth, Francis] Univ Akron, Dept Mech Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron; University System of Ohio; University of Akron	Amini, R (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.	ramini@uakron.edu		Amini, Rouzbeh/0000-0003-3632-6195	Firestone Research Initiative Fellowship Award; American Heart Association [16SDG27770088]	Firestone Research Initiative Fellowship Award; American Heart Association(American Heart Association)	Funding for this project was provided in part by the Firestone Research Initiative Fellowship Award (RA) and by American Heart Association grant 16SDG27770088 (RA). The funders provided support in the form of salaries for authors KAK and RA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. KTA is employed by Mid Atlantic Surgical Associates, a cardiac care provider, which did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amini R, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026105; Amini R, 2012, ANN BIOMED ENG, V40, P1455, DOI 10.1007/s10439-012-0524-5; BAIRATI A, 1981, ANAT EMBRYOL, V161, P329, DOI 10.1007/BF00301830; Basu A, 2016, CARDIOVASC ENG TECHN, V7, P270, DOI 10.1007/s13239-016-0267-9; BERGER M, 1985, J AM COLL CARDIOL, V6, P359, DOI 10.1016/S0735-1097(85)80172-8; BRANDENBURG RO, 1966, AM J CARDIOL, V18, P911, DOI 10.1016/0002-9149(66)90440-1; CARPENTIER A, 1983, J THORAC CARDIOV SUR, V86, P323; Carpentier A, 2011, CARPENTIERS RECONSTR; CROXSON MS, 1971, BRIT HEART J, V33, P750; DONTIGNY L, 1992, J TRAUMA, V33, P266, DOI 10.1097/00005373-199208000-00017; Eckert CE, 2009, ANN BIOMED ENG, V37, P1757, DOI 10.1007/s10439-009-9749-3; Fawzy H, 2011, J THORAC CARDIOV SUR, V141, P1037, DOI 10.1016/j.jtcvs.2010.05.039; FILIP DA, 1986, CIRC RES, V59, P310, DOI 10.1161/01.RES.59.3.310; Flynn BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012337; GAYET C, 1987, CHEST, V92, P429, DOI 10.1378/chest.92.3.429; Greyson C, 1997, CARDIOVASC RES, V34, P281, DOI 10.1016/S0008-6363(97)00038-2; Greyson C, 2000, AM J PHYSIOL-HEART C, V278, pH1414, DOI 10.1152/ajpheart.2000.278.5.H1414; Guertler CA, 2018, J BIOMECH, V69, P10, DOI 10.1016/j.jbiomech.2018.01.016; Haskett D, 2010, BIOMECH MODEL MECHAN, V9, P725, DOI 10.1007/s10237-010-0209-7; Hiro ME, 2004, J HEART VALVE DIS, V13, P452; Huang S, 2015, P I MECH ENG H, V229, P721, DOI 10.1177/0954411915604336; Jost CHA, 2007, CIRCULATION, V115, P277, DOI 10.1161/CIRCULATIONAHA.106.619338; Khoiy KA, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040126; Khoiy KA, 2018, J MECH BEHAV BIOMED, V78, P154, DOI 10.1016/j.jmbbm.2017.11.017; Khoiy KA, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034621; Khoiy KA, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034426; Ma WG, 2010, ANN THORAC SURG, V90, P1934, DOI 10.1016/j.athoracsur.2010.07.081; Maisano F, 1996, EUR J CARDIO-THORAC, V10, P867, DOI 10.1016/S1010-7940(96)80313-7; MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102; MOHRMAN DE, 2002, CARDIOVASCULAR PHYSL; Mulholland DL, 1996, CAN J CARDIOL, V12, P231; NAJA I, 1992, J CARDIOVASC SURG, V33, P256; NOERA G, 1991, ANN THORAC SURG, V51, P320, DOI 10.1016/0003-4975(91)90816-9; PHORNPHUTKUL C, 1973, CIRCULATION, V47, P587, DOI 10.1161/01.CIR.47.3.587; Rausch MK, 2018, ANN BIOMED ENG, V46, P443, DOI 10.1007/s10439-017-1961-y; Robitaille MC, 2011, INTERFACE FOCUS, V1, P767, DOI 10.1098/rsfs.2011.0039; Rogers JH, 2009, CIRCULATION, V119, P2718, DOI 10.1161/CIRCULATIONAHA.108.842773; Schmitto JD, 2009, EUR J CARDIO-THORAC, V35, P229, DOI 10.1016/j.ejcts.2008.09.010; SHANKAR KR, 1967, AM J CARDIOL, V20, P122, DOI 10.1016/0002-9149(67)90117-8; Solomon SB, 1999, AM J PHYSIOL-HEART C, V276, pH1994, DOI 10.1152/ajpheart.1999.276.6.H1994; Stephens EH, 2008, CIRCULATION, V118, pS243, DOI 10.1161/CIRCULATIONAHA.107.757526; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0; Vayre F, 1996, ARCH MAL COEUR VAISS, V89, P459; WALLER BF, 1986, J AM COLL CARDIOL, V7, P1063, DOI 10.1016/S0735-1097(86)80224-8; WILLEMS IEMG, 1994, LAB INVEST, V71, P127; Zareian R, 2010, LANGMUIR, V26, P9917, DOI 10.1021/la100384e	47	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206744	10.1371/journal.pone.0206744	http://dx.doi.org/10.1371/journal.pone.0206744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408050	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300035
J	Cecchini, M				Cecchini, Michele			Use of healthcare services and expenditure in the US in 2025: The effect of obesity and morbid obesity	PLOS ONE			English	Article							BODY-MASS INDEX; MEDICAL EXPENDITURES; OVERWEIGHT; IMPACT; TRENDS; COSTS	Objective This paper explores the contribution of body-mass index (BMI) categories in shaping past trends of use of healthcare services and associated expenditure in the US and projects results to 2025. Methods The study uses Medical Expenditure Panel Survey (MEPS) data for 2000-2012, reweighted on National Health and Nutrition Survey (NHANES) data for 1972-2012 and US Census Bureau data, to carry out projections for up to 2025. A combination of logistic regressions and generalized linear models was used to model use and associated expenditure for the following healthcare services: inpatient care (with/without surgery), office-based care, outpatient-care, drug prescription and home health care. Quantile regressions were used to analyse and project BMI levels. Results 20.5 million individuals will be severely obese in 2025. Normal-weight and overweight individuals have stable trends in use for many healthcare services. Conversely, use of healthcare services in patients in class II and class III obesity will increase substantially. Total healthcare expenditure increases more quickly in the obese population than in normal-weight individuals. Conclusions Class III obesity (BMI >= 40 kg/m(2)) significantly affects demand and expenditure for all healthcare services. Careful healthcare service planning and implementing effective policy actions to counteract such trends is crucial to meet future demand.	[Cecchini, Michele] Imperial Coll London, Inst Global Hlth Innovat, London, England; [Cecchini, Michele] OECD, Hlth Div, Paris, France	Imperial College London; Organisation for Economic Co-operation & Development (OECD)	Cecchini, M (corresponding author), Imperial Coll London, Inst Global Hlth Innovat, London, England.; Cecchini, M (corresponding author), OECD, Hlth Div, Paris, France.	michele.cecchini@oecd.org						AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Andreyeva T, 2004, OBES RES, V12, P1936, DOI 10.1038/oby.2004.243; Arterburn DE, 2005, INT J OBESITY, V29, P334, DOI 10.1038/sj.ijo.0802896; Bell JF, 2011, OBESITY, V19, P228, DOI 10.1038/oby.2010.104; Bertakis KD, 2005, OBES RES, V13, P372, DOI 10.1038/oby.2005.49; Bumpus K, 2015, J ACAD NUTR DIET, V115, P338, DOI 10.1016/j.jand.2014.12.022; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cawley J, 2012, J HEALTH ECON, V31, P219, DOI 10.1016/j.jhealeco.2011.10.003; CDC-Centers for Disease Control and Prevention, NHANES NAT HLTH NUTR; CDC-Centers for Disease Control and Prevention, NUTR PHYS ACT OB DAT; Cecchini M, 2015, PHARMACOECONOMICS, V33, P765, DOI 10.1007/s40273-015-0301-z; Chang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066550; CMS-Office of the Actuary of the Centers for Medicare and Medicaid Services, 2011, NAT HLTH EXP ACC MET; CMS-Office of the Actuary of the Centers for Medicare and Medicaid Services, 2015, NAT HLTH EXP DAT; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cremieux PY, 2007, PHARMACOECONOMICS, V25, P209, DOI 10.2165/00019053-200725030-00004; Decker SL, 2009, HEALTH AFFAIR, V28, P26, DOI 10.1377/hlthaff.28.1.26; Elrashidi MY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002467; Finkelstein EA, 2012, AM J PREV MED, V42, P563, DOI 10.1016/j.amepre.2011.10.026; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Goetzel RZ, 2010, J OCCUP ENVIRON MED, V52, pS52, DOI 10.1097/JOM.0b013e3181c95b84; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; James PT, 2004, COMP QUANTIFICATION; Malik VS, 2016, JAMA-J AM MED ASSOC, V316, P583, DOI 10.1001/jama.2016.8005; Martin BI, 2009, SPINE, V34, P2077, DOI 10.1097/BRS.0b013e3181b1fad1; Ogden CL, 2015, NCHS DATA BRIEF, P1, DOI DOI 10.1017/S1368980017000088; Ortman JM, 2014, AGING NATION OLDER P; Peterson MD, 2015, AM J PREV MED, V48, P426, DOI 10.1016/j.amepre.2014.11.007; Ruhm C, 2007, CURRENT FUTURE PREVA, DOI [10.3386/w13181, DOI 10.3386/W13181]; Sturm R, 2013, INT J OBESITY, V37, P889, DOI 10.1038/ijo.2012.159; Trasande L, 2009, OBESITY, V17, P1749, DOI 10.1038/oby.2009.67; USCB-US Census Bureau, POPULATION PROJECTIO; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; WHO, BMI CLASSIFICATION, DOI DOI 11/44679/INDEX.HTM; Wignall Doug, 2008, J Diabetes Sci Technol, V2, P263	36	15	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206703	10.1371/journal.pone.0206703	http://dx.doi.org/10.1371/journal.pone.0206703			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403716	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500071
J	Xin, Y; Mudiyanselage, CMK; Just, W				Xin, Ying; Mudiyanselage, Chathuri Madubhashini Karunarathna; Just, Winfried			Development of epithelial tissues: How are cleavage planes chosen?	PLOS ONE			English	Article							PROLIFERATING EPITHELIA; CELL DIVISIONS; TOPOLOGY; GEOMETRY; ORIENTATION; PACKING; MORPHOGENESIS; EMERGENCE; MECHANICS; SHAPE	The cross-section of a cell in a monolayer epithelial tissue can be modeled mathematically as a k-sided polygon. Empirically studied distributions of the proportions of k-sided cells in epithelia show remarkable similarities in a wide range of evolutionarily distant organisms. A variety of mathematical models have been proposed for explaining this phenomenon. The highly parsimonious simulation model of (Patel et al., PLoS Comput. Biol., 2009) that takes into account only the number of sides of a given cell and cell division already achieves a remarkably good fit with empirical distributions from Drosophila, Hydra, Xenopus, Cucumber, and Anagallis. Within the same modeling framework as in that paper, we introduce additional options for the choice of the endpoints of the cleavage plane that appear to be biologically more realistic. By taking the same data sets as our benchmarks, we found that combinations of some of our new options consistently gave better fits with each of these data sets than previously studied ones. Both our algorithm and simulation data are made available as research tools for future investigations.	[Xin, Ying; Mudiyanselage, Chathuri Madubhashini Karunarathna; Just, Winfried] Ohio Univ, Dept Math, Athens, OH 45701 USA; [Xin, Ying] Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA; [Just, Winfried] Ohio Univ, Quantitat Biol Inst, Athens, OH 45701 USA	University System of Ohio; Ohio University; Montana State University System; Montana State University Bozeman; University System of Ohio; Ohio University	Xin, Y (corresponding author), Ohio Univ, Dept Math, Athens, OH 45701 USA.; Xin, Y (corresponding author), Montana State Univ, Dept Math Sci, Bozeman, MT 59717 USA.	yx123812@ohio.edu		Xin, Ying/0000-0002-1856-0482				Abera MK, 2014, ANN BOT-LONDON, V114, P605, DOI 10.1093/aob/mcu078; Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Axelrod JD, 2006, CELL, V126, P643, DOI 10.1016/j.cell.2006.07.018; Buckalew R, 2015, DEV DYNAM, V244, P1014, DOI 10.1002/dvdy.24298; Carter R, 2017, DEVELOPMENT, V144, P4386, DOI 10.1242/dev.157073; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; COWAN R, 1988, J THEOR BIOL, V131, P33, DOI 10.1016/S0022-5193(88)80118-8; Dubertret B, 1998, PHYS REV E, V58, P6368, DOI 10.1103/PhysRevE.58.6368; Dubertret B, 1997, BIOPHYS J, V73, P38, DOI 10.1016/S0006-3495(97)78045-7; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-26; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Gibson WT, 2009, CURR TOP DEV BIOL, V89, P87, DOI 10.1016/S0070-2153(09)89004-2; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Gonzalez-Valverde I, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2877; KORN RW, 1973, NEW PHYTOL, V72, P1357, DOI 10.1111/j.1469-8137.1973.tb02114.x; LeGoff L, 2013, DEVELOPMENT, V140, P4051, DOI 10.1242/dev.090878; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043108; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; Reddy GV, 2004, DEVELOPMENT, V131, P4225, DOI 10.1242/dev.01261; Sahlin P, 2009, L N INST COMP SCI SO, V4, P971; Sahlin P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011750; Sanchez-Gutierrez D, 2016, EMBO J, V35, P77, DOI 10.15252/embj.201592374; Sandersius SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018081; Staple DB, 2010, EUR PHYS J E, V33, P117, DOI 10.1140/epje/i2010-10677-0; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Wyatt TPJ, 2015, P NATL ACAD SCI USA, V112, P5726, DOI 10.1073/pnas.1420585112; Xu GK, 2016, J BIOMECH, V49, P401, DOI 10.1016/j.jbiomech.2015.12.046; Xu K, 2017, PEERJ, V5, DOI 10.7717/peerj.3314	33	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205834	10.1371/journal.pone.0205834	http://dx.doi.org/10.1371/journal.pone.0205834			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403682	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500027
J	Garcia-Lopez, S; Albo-Castellanos, C; Urdinguio, RG; Canon, S; Sanchez-Cabo, F; Martinez-Serrano, A; Fraga, MF; Bernad, A				Garcia-Lopez, Silvia; Albo-Castellanos, Carmen; Urdinguio, Rocio G.; Canon, Susana; Sanchez-Cabo, Fatima; Martinez-Serrano, Alberto; Fraga, Mario F.; Bernad, Antonio			Deregulation of the imprinted DLK1-DIO3 locus ncRNAs is associated with replicative senescence of human adipose-derived stem cells	PLOS ONE			English	Article							NONCODING RNA MEG3; MESENCHYMAL STROMAL CELLS; BONE-MARROW; PROMOTES APOPTOSIS; DNA METHYLATION; CANCER-PATIENTS; EXPRESSION; BIOLOGY; CLUSTER; PATHWAY	Background Human adult adipose-derived stem cells (hADSCs) have become the most promising cell source for regenerative medicine. However the prolonged ex vivo expansion periods required to obtain the necessary therapeutic dose promotes progressive senescence, with the concomitant reduction of their therapeutic potential. Aim and scope A better understanding of the determinants of hADSC senescence is needed to improve biosafety while preserving therapeutic efficiency. Here, we investigated the association between deregulation of the imprinted DLK1-DIO3 region and replicative senescence in hADSC cultures. Methods We compared hADSC cultures at short (P-s) and prolonged (P-L) passages, both in standard and low [O-2] (21 and 3%, respectively), in relation to replicative senescence. hADSCs were evaluated for expression alterations in the DLK1-DIO3 region on chromosome 14q32, and particularly in its main miRNA cluster. Results Comparison of hADSCs cultured at P-L or P-s surprisingly showed a quite significant fraction (69%) of upregulated miRNAs in P-L cultures mapping to the imprinted 14q32 locus, the largest miRNA cluster described in the genome. In agreement, expression of the lncRNA MEG3 (Maternally Expressed 3; Meg3/Gtl2), cultured at 21 and 3% [O-2], was also significantly higher in P-L than in P-s passages. During hADSC replicative senescence the AcK16H4 activating mark was found to be significantly associated with the deregulation of the entire DLK1-DIO3 locus, with a secondary regulatory role for the methylation of DMR regions. Conclusion A direct relationship between DLK1-DIO3 deregulation and replicative senescence of hADSCs is reported, involving upregulation of a very significant fraction of its largest miRNA cluster (14q32.31), paralleled by the progressive overexpression of the lncRNA MEG3, which plays a central role in the regulation of Dlk1/Dio3 activation status in mice.	[Garcia-Lopez, Silvia; Canon, Susana; Bernad, Antonio] CSIC, CNB, Dept Immunol & Oncol, Campus Cantoblanco, Madrid, Spain; [Garcia-Lopez, Silvia; Albo-Castellanos, Carmen; Canon, Susana; Bernad, Antonio] Ctr Nacl Invest Carlos III CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain; [Urdinguio, Rocio G.; Fraga, Mario F.] UO, HUCA, Canc Epigenet Lab, Inst Oncol Asturias IUOPA, Asturias, Spain; [Urdinguio, Rocio G.; Fraga, Mario F.] UO, Nanomat & Nanotechnol Res Ctr CINN CSIC, Asturias, Spain; [Sanchez-Cabo, Fatima] Ctr Nacl Invest Cardiovasc Carlos III CNIC, Bioinformat Unit, Madrid, Spain; [Garcia-Lopez, Silvia; Martinez-Serrano, Alberto] Univ Autonoma Madrid, Mol Biol Dept UAM, Ctr Mol Biol Severo Ochoa, CSIC, Campus Cantoblanco, Madrid, Spain; [Garcia-Lopez, Silvia; Martinez-Serrano, Alberto] Univ Autonoma Madrid, Mol Neuropathol Dept, Ctr Mol Biol Severo Ochoa, CSIC, Campus Cantoblanco, Madrid, Spain; [Albo-Castellanos, Carmen] Gipuzkoako Zientzia & Teknol Pk, VIVEbioTECH, Donostia San Sebastian, Gipuzkoa, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Bernad, A (corresponding author), CSIC, CNB, Dept Immunol & Oncol, Campus Cantoblanco, Madrid, Spain.; Bernad, A (corresponding author), Ctr Nacl Invest Carlos III CNIC, Dept Cardiovasc Dev & Repair, Madrid, Spain.	abernad@cnb.csic.es	Fraga, Mario F/H-7824-2017; Martínez-Serrano, Alberto/J-8146-2014; Urdinguio, Rocio/AAA-9015-2020; Bernad, Antonio/P-8573-2017; Sanchez-Cabo, Fatima/AAC-5563-2020	Fraga, Mario F/0000-0001-8450-2603; Urdinguio, Rocio/0000-0003-2736-5758; Sanchez-Cabo, Fatima/0000-0003-1881-1664; Bernad, Antonio/0000-0003-0620-9668; Martinez Serrano, Alberto/0000-0003-3927-6699	Spanish Ministry of Economy, Industry (AEI/FEDER, UE) [SAF2015-70882-R]; Comunidad Autonoma de Madrid [S2010/BMD-2420]; Instituto Salud Carlos III (RETICS TerCel) [RD12/0019/0018, RD12/0019/0013]; European Commission [FP7-HEALTH-2009/CARE-MI]; MINECO [SAF2010-17167]; Plan Nacional de I+D+I 2013-2016/FEDER [PI15/00892]; Asturias Regional Government [GRUPIN14-052]; IUOPA (Obra Social Cajastur); Fundacion Cientifica de la AECC; Spanish Programa de Formacion del Profesorado Universitario	Spanish Ministry of Economy, Industry (AEI/FEDER, UE); Comunidad Autonoma de Madrid(Comunidad de Madrid); Instituto Salud Carlos III (RETICS TerCel)(Instituto de Salud Carlos III); European Commission(European CommissionEuropean Commission Joint Research Centre); MINECO(Spanish Government); Plan Nacional de I+D+I 2013-2016/FEDER; Asturias Regional Government(Principality of Asturias); IUOPA (Obra Social Cajastur); Fundacion Cientifica de la AECC; Spanish Programa de Formacion del Profesorado Universitario	This work was supported by grants to AB from the Spanish Ministry of Economy, Industry (SAF2015-70882-R; AEI/FEDER, UE), Comunidad Autonoma de Madrid (S2010/BMD-2420), Instituto Salud Carlos III (RETICS TerCel, RD12/0019/0018) and the European Commission (FP7-HEALTH-2009/CARE-MI). AMS was supported by grants from the MINECO (SAF2010-17167) and Instituto Salud Carlos III (RETICS TerCel, RD12/0019/0013), and MFF and RGU by grants from the Plan Nacional de I+D+I 2013-2016/FEDER (PI15/00892), the Asturias Regional Government (GRUPIN14-052), the IUOPA (Obra Social Cajastur) and the Fundacion Cientifica de la AECC. SGL held a predoctoral fellowship from the Spanish Programa de Formacion del Profesorado Universitario.	Benetatos L, 2014, CELL MOL LIFE SCI, V71, P4421, DOI 10.1007/s00018-014-1698-9; Benetatos L, 2012, CRIT REV EUKAR GENE, V22, P1; Berenstein R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1078-3; Boon RA, 2016, J AM COLL CARDIOL, V68, P2589, DOI 10.1016/j.jacc.2016.09.949; Brown WM, 2015, BRIT J SPORT MED, V49, DOI 10.1136/bjsports-2014-094073; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Sepulveda JC, 2014, STEM CELLS, V32, P1865, DOI 10.1002/stem.1654; Chandel NS, 2016, NAT CELL BIOL, V18, P823, DOI 10.1038/ncb3385; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cruz FM, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.255; Cui XR, 2017, ONCOTARGET, V8, P19049, DOI 10.18632/oncotarget.14987; Dai RJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153509; Das PP, 2015, CELL REP, V12, P1456, DOI 10.1016/j.celrep.2015.07.053; Duan WL, 2016, ONCOTARGET, V7, P78850, DOI 10.18632/oncotarget.12880; Estrada JC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.211; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; Farahzadi R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188052; Fei CM, 2014, EUR J HAEMATOL, V93, P476, DOI 10.1111/ejh.12385; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Gu L, 2017, BIOMED PHARMACOTHER, V89, P1269, DOI 10.1016/j.biopha.2017.02.041; Hackl M, 2010, AGING CELL, V9, P291, DOI 10.1111/j.1474-9726.2010.00549.x; Haque N, 2013, SCI WORLD J, DOI 10.1155/2013/632972; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hong LX, 2010, CANCER RES, V70, P8547, DOI 10.1158/0008-5472.CAN-10-1938; Huang ZL, 2017, ONCOL REP, V37, P3093, DOI 10.3892/or.2017.5568; Pino-Barrio MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118499; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kruer TL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166363; Lafferty-Whyte K, 2009, BBA-MOL BASIS DIS, V1792, P341, DOI 10.1016/j.bbadis.2009.02.003; Lahbib-Mansais Y, 2016, BMC CELL BIOL, V17, DOI 10.1186/s12860-016-0113-9; Lara E, 2009, ONCOGENE, V28, P781, DOI 10.1038/onc.2008.436; Laufer BI, 2013, DIS MODEL MECH, V6, P977, DOI 10.1242/dmm.010975; Li XY, 2017, ONCOTARGET, V8, P26573, DOI 10.18632/oncotarget.15719; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2017, MOL NEUROBIOL, V54, P8179, DOI 10.1007/s12035-016-0270-z; Luo ZJ, 2016, GENE DEV, V30, P92, DOI 10.1101/gad.270413.115; Maes OC, 2009, J CELL PHYSIOL, V221, P109, DOI 10.1002/jcp.21834; Molina-Pinelo S, 2018, ONCOTARGET, V9, P4395, DOI 10.18632/oncotarget.10611; Noer A, 2009, STEM CELLS DEV, V18, P725, DOI 10.1089/scd.2008.0189; Ogata T, 2008, EPIGENETICS-US, V3, P181, DOI 10.4161/epi.3.4.6550; Park H, 2015, DIFFERENTIATION, V90, P91, DOI 10.1016/j.diff.2015.10.010; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Peters J, 2014, NAT REV GENET, V15, P517, DOI 10.1038/nrg3766; Qian PX, 2016, CELL STEM CELL, V18, P214, DOI 10.1016/j.stem.2015.11.001; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Shi XF, 2013, CANCER LETT, V339, P159, DOI 10.1016/j.canlet.2013.06.013; Stadtfeld M, 2012, NAT GENET, V44, P398, DOI 10.1038/ng.1110; Tacutu R, 2013, NUCLEIC ACIDS RES, V41, pD1027, DOI 10.1093/nar/gks1155; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; White RR, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2061-8; Wylie AA, 2000, GENOME RES, V10, P1711, DOI 10.1101/gr.161600; Xiu YL, 2017, ONCOTARGET, V8, P31727, DOI 10.18632/oncotarget.15955; Xu XB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7008; Yang Y, 2012, FEBS LETT, V586, P3608, DOI 10.1016/j.febslet.2012.08.003; Zhang J, 2016, J CLIN LAB ANAL, V30, P1116, DOI 10.1002/jcla.21990; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	60	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206534	10.1371/journal.pone.0206534	http://dx.doi.org/10.1371/journal.pone.0206534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395586	Green Submitted, gold, Green Published			2022-12-26	WOS:000449291400032
J	Jang, TY; Yeh, ML; Huang, CI; Lin, ZY; Chen, SC; Hsieh, MH; Dai, CY; Huang, JF; Huang, CF; Chuang, WL; Yu, ML				Jang, Tyng-Yuan; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Hsieh, Meng-Hsuan; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung			Association of hyperuricemia with disease severity in chronic hepatitis C patients	PLOS ONE			English	Article							SERUM URIC-ACID; FATTY LIVER-DISEASE; BODY-MASS INDEX; VIRUS-INFECTION; CARDIOVASCULAR RISK; INSULIN-RESISTANCE; GENETIC-VARIANTS; FIBROSIS; TAIWAN; ADULTS	Background/aims Hepatitis C virus (HCV) infection is associated with extrahepatic manifestations such as metabolic abnormalities. The association between chronic hepatitis C (CHC) and uric acid levels has rarely been investigated. We aimed to evaluate the levels of serum uric acid in CHC patients. Methods Three hundred and seventy-three histologically confirmed CHC patients who were scheduled to receive antiviral therapy were consecutively enrolled, and 746 age- and sex-matched uninfected controls were included for comparison. Hyperuricemia was defined as a uric acid level > 7 mg/dL in men and > 6.0 mg/dL in women. Results Hyperuricemia was identified in 15.8% of the CHC patients. The uric acid levels did not differ between the CHC patients and the controls (5.54 +/- 1.20 mg/dL vs. 5.45 +/- 1.45 mg/dL, P = 0.3). Among the 373 CHC patients, the factors associated with hyperuricemia included body mass index (BMI) (OR/CI: 1.13/1.04-1.21, P = 0.003) and estimated glomerular filtration rate (eGFR) (OR/CI: 0.98/0.97-1.00, P = 0.02). Logistic regression analysis revealed that the factors associated with hyperuricemia in male patients included BMI (OR/CI: 1.12/1.05-1.30, P = 0.006) and advanced fibrosis (F3-4) (OR/CI: 0.27/0.09-0.83, P = 0.02), whereas the factors associated with hyperuricemia in female patients included eGFR (OR/CI: 0.97/0.95-0.99, P = 0.02) and diabetes (OR/CI: 3.03/1.11-8.25, P = 0.03). There was a significant decreasing trend of serum uric acid levels with the progression of fibrotic stages among male patients (6.21 +/- 1.03 mg/dL 5.82 +/- 1.16 mg/dL and 5.44 +/- 1.28 mg/dL in stages F0-2, F3, and F4, respectively, trend P = 0.01). Conclusions Hyperuricemia was inversely associated with liver disease severity in CHC male patients.	[Jang, Tyng-Yuan; Yeh, Ming-Lun; Huang, Ching-, I; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan; [Yeh, Ming-Lun; Lin, Zu-Yau; Chen, Shinn-Cherng; Dai, Chia-Yen; Huang, Jee-Fu; Huang, Chung-Feng; Chuang, Wan-Long; Yu, Ming-Lung] Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan; [Hsieh, Meng-Hsuan; Dai, Chia-Yen; Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Hsieh, Meng-Hsuan; Dai, Chia-Yen] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Prevent Med, Kaohsiung, Taiwan; [Yu, Ming-Lung] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Yu, Ming-Lung] Natl Chiao Tung Univ, Coll Biol Sci & Technol, Hsinchu, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Sun Yat Sen University; National Yang Ming Chiao Tung University	Huang, CF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Hepatobiliary Div, Kaohsiung, Taiwan.; Huang, CF (corresponding author), Kaohsiung Med Univ, Coll Med, Fac Internal Med, Sch Med, Kaohsiung, Taiwan.; Huang, CF (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Occupat Med, Kaohsiung, Taiwan.	fengcheerup@gmail.com	Yu, Ming-Lung/AAZ-4306-2020; Chuang, Wan-Long/ABF-7427-2021; Dai, Chia-Yen/V-6560-2019; Huang, Jee-Fu/AAX-4622-2020; Hsieh, Meng Hsuan/AAY-7973-2021	Yu, Ming-Lung/0000-0001-8145-1900; Chuang, Wan-Long/0000-0002-2376-421X; Dai, Chia-Yen/0000-0003-2296-3054; Huang, Jee-Fu/0000-0002-2752-7051; Tyng Yuan, Jang/0000-0003-2961-130X; Hsieh, Meng-Hsuen/0000-0001-9739-3901	Kaohsiung Medical University Hospital [KMUH104-4R06, KMUH105-5R05]; Kaohsiung Medical University [NSC 103-2314-B-037-055-MY3]	Kaohsiung Medical University Hospital; Kaohsiung Medical University	This study was supported by Kaohsiung Medical University Hospital (KMUH104-4R06 and KMUH105-5R05) and Kaohsiung Medical University (NSC 103-2314-B-037-055-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzali A, 2010, HEPATOLOGY, V52, P578, DOI 10.1002/hep.23717; ANTON FM, 1986, METABOLISM, V35, P343; Ballestri S, 2016, HEPATOL RES, V46, P1074, DOI 10.1111/hepr.12656; Cao W, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/4375253; Chen Stephen L, 2006, Int J Med Sci, V3, P47; Chuang SY, 2011, ASIA PAC J CLIN NUTR, V20, P301; Dai CY, 2015, J GASTROEN HEPATOL, V30, P879, DOI 10.1111/jgh.12313; DECAUX G, 1982, AM J MED, V73, P328, DOI 10.1016/0002-9343(82)90718-5; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hediger MA, 2005, PHYSIOLOGY, V20, P125, DOI 10.1152/physiol.00039.2004; Hovind P, 2009, DIABETES, V58, P1668, DOI 10.2337/db09-0014; Huang CH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004501; Huang CF, 2017, ONCOTARGET, V8, P32618, DOI 10.18632/oncotarget.15941; Huang CF, 2015, J HEPATOL, V62, P512, DOI 10.1016/j.jhep.2014.10.011; Huang JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139796; Huang JF, 2013, KAOHSIUNG J MED SCI, V29, P61, DOI 10.1016/j.kjms.2012.11.001; Huang JF, 2009, KAOHSIUNG J MED SCI, V25, P299, DOI 10.1016/S1607-551X(09)70520-0; Huang Q, 2016, BIOMED REP, V5, P188, DOI 10.3892/br.2016.698; Jaruvongvanich V, 2017, EUR J GASTROEN HEPAT, V29, P694, DOI 10.1097/MEG.0000000000000865; Kawaguchi Y, 2014, WORLD J GASTROENTERO, V20, P2888, DOI 10.3748/wjg.v20.i11.2888; Kim G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186990; Kim Tae Nyun, 2013, J Bone Metab, V20, P1, DOI 10.11005/jbm.2013.20.1.1; Krishnan E, 2012, AM J EPIDEMIOL, V176, P108, DOI 10.1093/aje/kws002; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee MS, 2005, ASIA PAC J CLIN NUTR, V14, P285; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; OKAMOTO H, 1993, J GEN VIROL, V74, P2385, DOI 10.1099/0022-1317-74-11-2385; Pellicano R, 2008, J MED VIROL, V80, P628, DOI 10.1002/jmv.21123; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Petta S, 2012, LIVER INT, V32, P1443, DOI 10.1111/j.1478-3231.2012.02842.x; Prasad Sah Om Shankar, 2015, Nephrourol Mon, V7, pe27233, DOI 10.5812/numonthly.7(3)2015.27233; PUIG JG, 1991, ARCH INTERN MED, V151, P726, DOI 10.1001/archinte.151.4.726; Qiu L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-664; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Rodrigues SL, 2012, ARQ BRAS CARDIOL, V98, P13, DOI 10.1590/S0066-782X2011005000116; SCHEUER PJ, 1991, J HEPATOL, V13, P372, DOI 10.1016/0168-8278(91)90084-O; Sinclair M, 2016, ALIMENT PHARM THER, V43, P765, DOI 10.1111/apt.13549; Song PG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22570-9; Tanaka K, 2015, ENVIRON HEALTH PREV, V20, P347, DOI 10.1007/s12199-015-0473-3; Tartof SY, 2018, CLIN J AM SOC NEPHRO, V13, P1471, DOI 10.2215/CJN.01530218; Tsai YT, 2012, ASIA PAC J CLIN NUTR, V21, P263; Uedono H, 2017, AM J PHYSIOL-RENAL, V312, pF992, DOI 10.1152/ajprenal.00645.2016; Wang HG, 2014, IRAN J PUBLIC HEALTH, V43, P1503; White DL, 2012, HEPATOLOGY, V55, P759, DOI 10.1002/hep.24618; Yoneda M, 2014, CLIN BIOCHEM, V47, P1138, DOI 10.1016/j.clinbiochem.2014.04.026; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023; Zhu YY, 2012, AM J MED, V125, P679, DOI 10.1016/j.amjmed.2011.09.033	48	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0207043	10.1371/journal.pone.0207043	http://dx.doi.org/10.1371/journal.pone.0207043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395654	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400077
J	Kasaie, P; Radford, M; Kapoor, S; Jung, Y; Novoa, BH; Dowdy, D; Shah, M				Kasaie, Parastu; Radford, Matthew; Kapoor, Sunaina; Jung, Younghee; Novoa, Beatriz Hernandez; Dowdy, David; Shah, Maunank			Economic and epidemiologic impact of guidelines for early ART initiation irrespective of CD4 count in Spain	PLOS ONE			English	Article							PLAN RECOMMENDED GUIDELINES; COST-EFFECTIVENESS ANALYSIS; ADJUSTED LIFE-YEARS; ANTIRETROVIRAL THERAPY; HIV-1 TRANSMISSION; NATURAL-HISTORY; VIRAL LOAD; INFECTION; CARE; PREVALENCE	Introduction Emerging data suggest that early antiretroviral therapy (ART) could reduce serious AIDS and non-AIDS events and deaths but could also increase costs. In January 2016, the Spanish guidelines were updated to recommend ART at any CD4 count. However, the epidemiologic and economic impacts of early ART initiation in Spain remain unclear. Methods The Johns Hopkins HIV Economic-Epidemiologic Mathematical Model (JHEEM) was utilized to estimate costs, transmissions, and outcomes in Spain over 20 years. We compared implementation of guidelines for early ART initiation to a counterfactual scenario deferring ART until CD4-counts fall below 350 cells/mm(3). We additionally studied the impact of early ART initiation in combination with improvements to HIV screening, care linkage and engagement. Results Early ART initiation (irrespective of CD4-count) is expected to avert 20,100 [95% Uncertainty Range (UR) 11,100-83,000] new HIV cases over the next two decades compared to delayed ART (28% reduction), at an incremental health system cost of (sic)1.05 billion [(sic)0.66 - (sic)1.63] billion, and an incremental cost-effectiveness ratio (ICER) of (sic)29,700 [(sic)13,700 - (sic)41,200] per QALY gained. Projected ICERs declined further over longer time horizon; e.g., an ICER of (sic)12,691 over 30 years. Furthermore, the impact of early ART initiation was potentiated by improved HIV screening among high-risk individuals, averting an estimated 41,600 [23,200-172,200] HIV infections (a 58% decline) compared to delayed ART. Conclusions Recommendations for ART initiation irrespective of CD4-counts are cost-effective and could avert > 30% of new cases in Spain. Improving HIV diagnosis can amplify this impact.	[Kasaie, Parastu; Jung, Younghee; Dowdy, David] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Radford, Matthew; Novoa, Beatriz Hernandez] ViiV Healthcare Inc, Brentford, Middx, England; [Kapoor, Sunaina; Shah, Maunank] Johns Hopkins Sch Med, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Kasaie, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.	pkasaie@jhu.edu	Kasaie, Parastu/AAD-1960-2021		Johns Hopkins University Center for AIDS Research [P30AI094189]; ViiV Healthcare Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research; ViiV Healthcare Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PK was supported by Johns Hopkins University Center for AIDS Research (P30AI094189); PK and MS were supported by a research grant from ViiV Healthcare Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MR and BH are employees of ViiV Healthcare Inc. The funders had an indirect role through the participation of two co-authors, who contributed by providing guidance on locally relevant data sources and interpretation for HIV epidemiology and costs, and assisted with the review of the manuscript and final approval. MR and BH specific roles are articulated in the 'author contributions' section.	Alkema L, 2008, SEX TRANSM INFECT, V84, pI11, DOI 10.1136/sti.2008.029991; Alkema L, 2007, ANN APPL STAT, V1, P229, DOI 10.1214/07-AOAS111; [Anonymous], 2016, GLOB AIDS UPD 2016; [Anonymous], 2017, IGUALDAD MDSSSE PLAN; [Anonymous], 2017, PANEL EXPERTOS GESID; Gullon JA, 2016, ARCH BRONCONEUMOL, V52, P583, DOI 10.1016/j.arbres.2016.05.002; Berenguer J, 2016, ENFERM INFEC MICR CL, V34, P361, DOI 10.1016/j.eimc.2015.07.012; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; Campbell CNJ, 2015, AIDS CARE, V27, P1449, DOI 10.1080/09540121.2015.1109584; CASCADE Collaboration, 2000, LANCET, V355, P1158, DOI 10.1016/S0140-6736(00)02069-9; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Control ECfDPa, 2017, STAT HIV RESP EUR UN; Corral J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0725-3; Currie S, 2009, INT J STD AIDS, V20, P265, DOI 10.1258/ijsa.2008.008268; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Del Amo J, 2016, GES C; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; European AIDS Clinical Society, 2017, EUR GUID TREATM HIV; European Centre for Disease Prevention and Control, 2016, HIV AIDS SURV EUR 20; Gourlay A, 2017, CLIN INFECT DIS, V64, P1644, DOI 10.1093/cid/cix212; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hyle EP, 2013, JAMA INTERN MED, V173, P1746, DOI 10.1001/jamainternmed.2013.9329; IMF, 2017, WORLD EC FIN SURV RE; Katz DA, 2014, SEX TRANSM DIS, V41, P2, DOI 10.1097/OLQ.0000000000000046; Lingappa JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012598; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Lyles RH, 2000, J INFECT DIS, V181, P872, DOI 10.1086/315339; Mabileau G, 2017, EFFECTIVENESS COST E; Rodriguez JM, 2011, VALUE HEALTH, V14, P458, DOI 10.1016/j.jval.2010.10.039; Marseille E, 2015, B WORLD HEALTH ORGAN, V93, P118, DOI 10.2471/BLT.14.138206; Martin-Fernandez J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-287; Mocroft A, 2012, ANTIVIR THER, V17, P1291, DOI 10.3851/IMP2407; Moreno S, 2017, ENFERM INFEC MICR CL, V35, P377, DOI [10.1016/j.eimc.2016.11.016, 10.1016/j.eimce.2016.11.002]; Moreno S, 2012, SEX TRANSM INFECT, V88, P522, DOI 10.1136/sextrans-2012-050481; Murphy EL, 2001, ANN INTERN MED, V135, P17, DOI 10.7326/0003-4819-135-1-200107030-00005; Nakagawa F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125018; National Center for Epidemiology, 2011, AR HIV SURV RISK BEH; National Center for Epidemiology/General Subdirectorate for Health Promotion and Epidemiology National Plan on AIDS, 2016, MORT HIV AIDS SPAIN; National Center for Epidemiology/General Subdirectorate for Health Promotion and Epidemiology National Plan on AIDS, 2016, EP SURV HIV AIDS SPA; Oliva J, 2014, ENFERM INFEC MICR CL, V32, P170, DOI 10.1016/j.eimc.2013.09.007; Pares-Badell O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105471; Reekie J, 2011, AIDS, V25, P2259, DOI 10.1097/QAD.0b013e32834cdb4b; Regueiro A, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009148; Rivero A, 2018, ENFERM INFEC MICR CL, V36, P268, DOI 10.1016/j.eimc.2017.04.002; Rivero A, 2017, ENFERM INFEC MICR CL, V35, P88, DOI 10.1016/j.eimc.2016.06.013; Roser M., 2017, HIV AIDS; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; Sabater E, 2016, APPL HEALTH ECON HEA, V14, P465, DOI 10.1007/s40258-016-0243-4; Sacristán J.A., 2002, Gac Sanit, V16, P334; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Services CfMM, 2017, CLIN LAB FEE SCHED 2; Shah M, 2016, LANCET HIV, V3, pE140, DOI 10.1016/S2352-3018(16)00007-2; Shah M, 2016, CLIN INFECT DIS, V62, P220, DOI 10.1093/cid/civ801; Sobrino-Vegas P, 2011, ENFERM INFEC MICR CL, V29, P645, DOI 10.1016/j.eimc.2011.06.002; Trapero-Bertran M, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0015-5; Treskova M, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003961; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2016, AIDSINFO 2016; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wolbers M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000239; Yazdanpanah Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084173; Yazdanpanah Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013132	65	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206755	10.1371/journal.pone.0206755	http://dx.doi.org/10.1371/journal.pone.0206755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395635	Green Submitted, gold, Green Published			2022-12-26	WOS:000449291400049
J	Kermagoret, C; Dupras, J				Kermagoret, Charlene; Dupras, Jerome			Coupling spatial analysis and economic valuation of ecosystem services to inform the management of an UNESCO World Biosphere Reserve	PLOS ONE			English	Article							LANDSCAPE; SCIENCE; QUEBEC; CONSERVATION; BIODIVERSITY; DEMAND; AREAS		[Kermagoret, Charlene; Dupras, Jerome] Univ Quebec Outaouais, Dept Sci Nat, Ripon, PQ, Canada	University of Quebec; University Quebec Outaouais	Dupras, J (corresponding author), Univ Quebec Outaouais, Dept Sci Nat, Ripon, PQ, Canada.	jerome.dupras@uqo.ca	Kermagoret, Charlene/Q-1327-2017	Kermagoret, Charlene/0000-0003-2402-7833	Social Sciences and Humanities Research Council of Canada [435-2017-1078]; Manicouaga-Uapishka World Biosphere Reserve	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Manicouaga-Uapishka World Biosphere Reserve	This work was supported by the Manicouaga-Uapishka World Biosphere Reserve and the Social Sciences and Humanities Research Council of Canada (Grant: 435-2017-1078). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson E, 2015, ECOSYST SERV, V12, P157, DOI 10.1016/j.ecoser.2014.08.001; [Anonymous], 2010, QUEBEC LAND COVER MA; [Anonymous], 2004, FINANCIERE AGRICOLE; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bateman IJ, 2011, ENVIRON RESOUR ECON, V48, P177, DOI 10.1007/s10640-010-9418-x; Boudreau J, 2008, REMOTE SENS ENVIRON, V112, P3876, DOI 10.1016/j.rse.2008.06.003; Braat LC, 2012, ECOSYST SERV, V1, P4, DOI 10.1016/j.ecoser.2012.07.011; Bridgewater P, 2017, P NATL ACAD SCI USA, V114, pE4318, DOI 10.1073/pnas.1702761114; Burkhard B, 2014, LANDSCAPE ONLINE, V34, P1, DOI [DOI 10.3097/LO.201434, 10.3097/lo.201434, 10.3097/LO.201434]; Carpenter S.R., 2005, ECOSYSTEMS HUMAN WEL, V2; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chan K.M.A., 2012, RETHINKING ECOSYSTEM; Chevassus-au-Louis B., 2009, APPROCHE EC BIODIVER; CONDON B, 1995, CAN J FOREST RES, V25, P319, DOI 10.1139/x95-036; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Coursolle C., 2011, EC FLUX CARB CLIM DI; Daily GC, 1997, NATURES SERVICES SOC, DOI DOI 10.12987/9780300188479-039; Deckmyn G, 2014, CANADIAN J FOREST RE, V44; Doyon M, 2015, COMPLEXE ROMAINE COM; Dupras J, 2015, CAN GEOGR-GEOGR CAN, V59, P93, DOI 10.1111/cag.12138; Dupras J, 2015, J ENVIRON POL PLAN, V17, P180, DOI 10.1080/1523908X.2014.927755; ECCC, 2016, TECHN UPD ENV CLIM C; Ecoforestry information System (Quebec) (SIEF), 2014, EC INF SYST QUEB; Ehrlich P.R., 1981, EXTINCTION; EHRLICH PR, 1983, BIOSCIENCE, V33, P248, DOI 10.2307/1309037; Francis G., 2004, ENVIRONMENT, V32, P61; Francis RA, 2010, J NAT CONSERV, V18, P89, DOI 10.1016/j.jnc.2009.04.002; Garneau M, 2016, REMOTE SENSING ENV, p60p; Gomez-Baggethun E, 2010, ECOL ECON, V69, P1209, DOI 10.1016/j.ecolecon.2009.11.007; Haines-Young R., 2018, COMMON INT CLASSIFIC; He J, 2015, WETL ECOL MANAG, V23, P707, DOI 10.1007/s11273-015-9414-6; Hoerbinger S, 2017, ECOLOGICAL ENG; Ishwaran N, 2012, ENVIRON DEV, V1, P91, DOI 10.1016/j.envdev.2011.11.001; Jacobs S, 2016, ECOL INDIC, V61, P715, DOI 10.1016/j.ecolind.2015.10.023; Jonsson BG, 2017, REFERENCE MODULE EAR; Jordano P, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002559; Kelemen E, 2014, NONMONETARY TECHNIQU; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Kumar Pushpam, 2010, EC ECOSYSTEMS BIODIV, DOI DOI 10.1017/S1355770X11000088; Langemeyer J, 2016, ENVIRON SCI POLICY, V62, P45, DOI 10.1016/j.envsci.2016.02.013; Laurans Y, 2013, J ENVIRON MANAGE, V119, P208, DOI 10.1016/j.jenvman.2013.01.008; Laurans Y, 2013, J ENVIRON MANAGE, V116, P135, DOI 10.1016/j.jenvman.2012.11.031; Levrel H, 2016, VALEURS BIODIVERSITE, P103; Loomis J, 2000, ECOL ECON, V33, P103, DOI 10.1016/S0921-8009(99)00131-7; Magnan G, 2014, HOLOCENE, V24, P1054, DOI 10.1177/0959683614540727; Marchese C, 2015, GLOB ECOL CONSERV, V3, P297, DOI 10.1016/j.gecco.2014.12.008; Marre JB, 2015, MAR POLICY, V56, P117, DOI 10.1016/j.marpol.2015.02.011; Martin DM, 2018, ECOSYST SERV, V29, P13, DOI 10.1016/j.ecoser.2017.10.022; Martinez-Alier J, 1998, ECOLOGICAL EC, V26, P77; MDDELCC, 2013, EC VALUES NATURAL WO; MEHRING M, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9071037; Messier JPL, 2007, FORM PROP UNESCO RES; Munda G., 2014, EUR J OPER RES, V158, P662; Murphy HT, 2004, OIKOS, V105, P3, DOI 10.1111/j.0030-1299.2004.12754.x; Nieto-Romero M, 2014, ENVIRON SCI POLICY, V37, P121, DOI 10.1016/j.envsci.2013.09.003; [OECD] OrgaILSation for Economic Co-operation and Development, 2006, COST BEN AN ENV, P85; Pandeya B, 2016, ECOSYST SERV, V22, P250, DOI 10.1016/j.ecoser.2016.10.015; Pascual U., 2012, EC ECOSYSTEMS BIODIV, P183; Pearce D, 1993, EC VALUES NATURAL WO; Pendleton L, 2015, MAR ECOL PROG SER, V530, P183, DOI 10.3354/meps11111; Plottu E, 2007, ECOL ECON, V61, P52, DOI 10.1016/j.ecolecon.2006.09.027; Poder TG, 2016, PLOS ONE, V11; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Rodriguez JP, 2006, ECOL SOC, V11; Schultz L, 2011, WORLD DEV, V39, P662, DOI 10.1016/j.worlddev.2010.09.014; Staes J, 2017, ECOSYST SERV, V24, P124, DOI 10.1016/j.ecoser.2017.02.020; Study of Critical Environmental Problems (SCEP), 1970, MANS IMP GLOB ENV AS; Syrbe RU, 2012, ECOL INDIC, V21, P80, DOI 10.1016/j.ecolind.2012.02.013; Turner K., 1993, SUSTAINABLE ENV EC M; UNESCO, 1998, EM ACT PLAN BETHL AR; UNESCO, 2008, MADR ACT PLAN BIOSPH; Villamagna AM, 2013, ECOL COMPLEX, V15, P114, DOI 10.1016/j.ecocom.2013.07.004; Wei HJ, 2017, ECOSYST SERV, V25, P15, DOI 10.1016/j.ecoser.2017.03.017; Xu WH, 2017, P NATL ACAD SCI USA, V114, pE4319, DOI 10.1073/pnas.1703083114; Xu WH, 2017, P NATL ACAD SCI USA, V114, P1601, DOI 10.1073/pnas.1620503114	76	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205935	10.1371/journal.pone.0205935	http://dx.doi.org/10.1371/journal.pone.0205935			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395618	Green Published, gold			2022-12-26	WOS:000449291400014
J	Ngo, TV; Gammeltoft, T; Nguyen, HTT; Meyrowitsch, DW; Rasch, V				Toan Van Ngo; Gammeltoft, Tine; Hanh Thuy Thi Nguyen; Meyrowitsch, Dan W.; Rasch, Vibeke			Antenatal depressive symptoms and adverse birth outcomes in Hanoi, Vietnam	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; COMMON MENTAL-DISORDERS; PRETERM BIRTH; MATERNAL DEPRESSION; RISK-FACTORS; PROSPECTIVE COHORT; GESTATIONAL-AGE; PREGNANCY; WEIGHT; WOMEN	Background Antenatal depression is a significant health problem in low and middle- income countries. Although the condition is associated with severe adverse consequences for the mother and newborn, it remains a neglected problem. The purpose of this study was to describe the association between antenatal depressive symptoms and preterm birth (PTB), low birth weight (LBW), and small for gestation age (SGA). Methods The study was conducted in Dong Anh District, Hanoi, Vietnam, among pregnant women of less than 24 weeks of gestation. Information on socioeconomic characteristics and reproductive history was collected at enrollment and ADS and experiences of intimate partner violence were assessed at week 32. Birth outcomes were determined at delivery. Bivariate and logistic regression analyses were applied to assess the associations between ADS and PTB, LBW, and SGA. Results ADS was significantly associated with an increased risk of PTB (crude OR = 2.4; 95%; CI: 1.01-5.4 and adjusted OR = 2.4; 95% CI: 1.1-5.2, respectively) and a significantly increased risk for giving birth to an LBW infant (crude OR = 3.1; 95% CI: 1.4-7.0 and adjusted OR = 3.5; 95% CI: 1.6-7.6, respectively). In contrast, ADS was not statistically associated with small for gestation age. Conclusion ADS is associated with an increased risk of PTB and LBW but not associated with SGA.	[Toan Van Ngo; Hanh Thuy Thi Nguyen] Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam; [Gammeltoft, Tine] Univ Copenhagen, Dept Anthropol, Copenhagen, Denmark; [Meyrowitsch, Dan W.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Rasch, Vibeke] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark; [Rasch, Vibeke] Univ Southern Denmark, Dept Clin Res, Odense, Denmark	Hanoi Medical University; University of Copenhagen; University of Copenhagen; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Ngo, TV (corresponding author), Hanoi Med Univ, Inst Prevent Med & Publ Hlth, Hanoi, Vietnam.	ngovantoan57@yahoo.com	Rasch, Vibeke/G-9393-2019	Rasch, Vibeke/0000-0001-6557-0985; Meyrowitsch, Dan/0000-0003-1108-8987; Gammeltoft, Tine Mette/0000-0002-6723-2370	Danish International Development Agency	Danish International Development Agency	This study is funded by the Danish International Development Agency. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnett B, 1999, ARCH WOMEN MENT HLTH, V2, P67, DOI DOI 10.1007/S007370050038; Benedict Weobong AHAtAea, 2014, ASS ANTENATAL DEPRES; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bindt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080711; Brittain K, 2015, RISK FACTORS ANTENAT; Chang HY, 2014, EARLY HUM DEV, V90, P15, DOI 10.1016/j.earlhumdev.2013.11.006; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd; Ecklund-Flores L, 2017, DEV PSYCHOBIOL, V59, P314, DOI 10.1002/dev.21496; Federenko IS, 2004, CNS SPECTRUMS, V9, P198, DOI 10.1017/S1092852900008993; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Goedhart G, 2010, PSYCHOSOM MED, V72, P769, DOI 10.1097/PSY.0b013e3181ee4a62; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gravett MG, 2010, BMC PREGNANCY CHILDB; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Benute GRG, 2010, CLINICS, V65, P1127, DOI 10.1590/S1807-59322010001100013; Health Do, 2006, ED DEPR SCAL TRANSL; Hendrick V, 1998, PSYCHOPHARMACOL BULL, V34, P297; Henriksen L SB, 2014, BMJ OPEN, V4, P1; Kelly RH, 2002, OBSTET GYNECOL, V100, P297, DOI 10.1016/S0029-7844(02)02014-8; Khashan AS, 2014, PSYCHOL MED, V44, P2799, DOI 10.1017/S0033291714000300; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; Liu C, 2016, BJOG-INT J OBSTET GY, V123, P1973, DOI 10.1111/1471-0528.13891; March of Dimes P Save The Children WHO, 2012, BORN TOO SOON THE GL; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; McCowan L HR, 2009, BEST PRACT RES CLIN, V23; Mochache K, 2018, ANN GEN PSYCHIATR, V17, DOI 10.1186/s12991-018-0202-6; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Neggers Y, 2006, ACTA OBSTET GYN SCAN, V85, P277, DOI 10.1080/00016340600566121; Niemi M, 2013, TROP MED INT HEALTH, V18, P687, DOI 10.1111/tmi.12101; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Smith KF, 2015, J COMMUN HEALTH, V40, P984, DOI 10.1007/s10900-015-0022-4; Staneva A, 2015, WOMEN BIRTH, V28, P179, DOI 10.1016/j.wombi.2015.02.003; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Tran TD, 2011, J AFFECT DISORDERS, V133, P281, DOI 10.1016/j.jad.2011.03.038; Tsukamoto H FH, 2007, PEDIAT INT, V49; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Weissman MM, 2004, J AFFECT DISORDERS, V78, P93, DOI 10.1016/S0165-0327(02)00301-4; WHO, 2000, OB PREV MAN GLOB EP; WHO/Europe, 2012, NONC DIS DEPR DEF; WHO U, 2004, LOW BIRTH WEIGHT COU; World Health Organization, 2005, WHO MULTICOUNTRY STU; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS; Yonkers K.A., 2009, MANAGEMENT DEPRESSIO	46	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206650	10.1371/journal.pone.0206650	http://dx.doi.org/10.1371/journal.pone.0206650			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388162	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800048
J	Rivera, MGU; Pelegrin, SC; Ruiz, CB; Andrade, BL; Lumbreras, J; Mulet, AO; Montana, AP; Serlavos, MF; Rota, JIA; Balaguer, JF; Sanchez, OD; Ferreres, LP; Bonet, AM; Valles, MJP; Valero, RMRD				Uriol Rivera, Miguel G.; Cabello Pelegrin, Sheila; Ballester Ruiz, Carmen; Lopez Andrade, Bernardo; Lumbreras, Javier; Obrador Mulet, Aina; Perez Montana, Albert; Ferreruela Serlavos, Mireia; Ayestaran Rota, Jose Ignacio; Ferrer Balaguer, Joana; Delgado Sanchez, Olga; Pallares Ferreres, Lucio; Mas Bonet, Antonio; Picado Valles, Maria Jose; de Gopegui Valero, Rosa Maria Ruiz			Impact of a multidisciplinary team for the management of thrombotic microangiopathy	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; THROMBOCYTOPENIC PURPURA; ECULIZUMAB; COMPLEMENT; CONSENSUS; CANCER; CARCINOMA; DIAGNOSIS; OUTCOMES	Background Thrombotic microangiopathy (TMA) is an important complication associated with several diseases that are rare and life-threatening. TMA is common to thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS). TTP is defined by a severe deficiency of ADAMTS13, and early treatment is associated with good prognosis. The diagnosis of HUS can be difficult due to the potential multiple etiologies, and the best treatment option in most cases is not well-established yet. The implementation of a multidisciplinary team (MDT) could decrease the time to diagnosis and treatment for HUS and may improve the outcomes of these patients. Objective To determine the impact of MDT on morbidity and mortality [death or chronic renal replacement therapy (CRRT) requirements], incidence and response time [(RT) defined as the period between hospital admission and the first day of direct therapy administration], length of stay at an intensive care unit (ICU-LOS) and total hospitalization (T-LOS) were also assessed. Methods We compared a pre-MDT implementation period (from January/2008 to May/2016) versus post-MDT period (from May/2016 to December/2016). The screening TMA diagnosis was made according the following criteria: hemolytic anemia, thrombocytopenia and acute renal damage and without ADAMTS13 deficiency. An online chat was implemented to provide instant medical information. Results Twenty-eight patients were included. The incidence changed from 2.3 cases/pre-MDT: (all cases: n = 18) to 10 cases/year post-MDT (all cases: n = 10). Two patients died in pre-MDT and post- MDT (11% versus 20%, P= 0.60). From pre-MDT, the number of patients who required CRRT by post-MDT decreased from 7 (39%) to 0, P= 0.03. Similarly, RT, ICULOS and T-LOS [median(p25-p75)] decreased from 10 (2-12) days to 0.5 (0-1.5) days, P= 0.04, from 16 (9-30) days to 10 (4-13) days, P= 0.01 and from 33 (22-53) days to 16 (1232) days, P < 0.01, respectively. Conclusion MDT implementation was associated with a greater number of patients who meet TMA criteria. A decrease in the RT and T-LOS periods were observed and associated with better outcomes in these patients.	[Uriol Rivera, Miguel G.; Cabello Pelegrin, Sheila; Obrador Mulet, Aina] Son Espases Univ Hosp, Nephrol Dept, Palma De Mallorca, Spain; [Ballester Ruiz, Carmen; Lopez Andrade, Bernardo; Perez Montana, Albert] Son Espases Univ Hosp, Hematolgy Dept, Palma De Mallorca, Spain; [Lumbreras, Javier] Son Espases Univ Hosp, Pediat Nephrol Unit, Palma De Mallorca, Spain; [Ferreruela Serlavos, Mireia; Ayestaran Rota, Jose Ignacio] Son Espases Univ Hosp, Intens Care Unit, Palma De Mallorca, Spain; [Ferrer Balaguer, Joana] Son Espases Univ Hosp, Inmmunol Dept, Palma De Mallorca, Spain; [Delgado Sanchez, Olga] Son Espases Univ Hosp, Pharm Dept, Palma De Mallorca, Spain; [Pallares Ferreres, Lucio] Son Espases Univ Hosp, Autoinmmune Dis Unit, Palma De Mallorca, Spain; [Mas Bonet, Antonio; Picado Valles, Maria Jose] Son Espases Univ Hosp, Neuroradiol Unit, Palma De Mallorca, Spain; [de Gopegui Valero, Rosa Maria Ruiz] Son Espases Univ Hosp, Dept Gynecol & Obstet, Palma De Mallorca, Spain	Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases; Hospital Universitari Son Espases	Rivera, MGU (corresponding author), Son Espases Univ Hosp, Nephrol Dept, Palma De Mallorca, Spain.	miguelg.uriol@ssib.es		Lopez-Andrade, Bernardo/0000-0002-2967-1874; Uriol Rivera, Miguel/0000-0003-1762-4226; Lumbreras Fernandez, Javier/0000-0003-1855-0724	Alexion Pharmaceuticals Inc.	Alexion Pharmaceuticals Inc.	MGUR received travel grants and honoraria from Alexion Pharmaceuticals Inc. for speaking or participation at meetings and consultancy. SCP, MCBR, JL, JIAR, received travel grants and honoraria from Alexion Pharmaceuticals Inc. for speaking or participation at meetings. BLA, MJPV, MFS received travel grants Alexion Pharmaceuticals Inc. for participation at meetings. AMB also received travel grants Alexion Pharmaceuticals Inc. for participation at meetings. There are no patents, products in development or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Al-Nouri ZL, 2015, BLOOD, V125, P616, DOI 10.1182/blood-2014-11-611335; Campistol JM, 2015, NEFROLOGIA, V35, P421, DOI 10.1016/j.nefro.2015.07.005; Cavero T, 2017, NEPHROL DIAL TRANSPL, V32, P466, DOI 10.1093/ndt/gfw453; Chinen K, 2010, PATHOL RES PRACT, V206, P682, DOI 10.1016/j.prp.2010.05.002; Coppo P, 2017, REV MED INTERNE, V38, P731, DOI 10.1016/j.revmed.2017.06.025; Coppo P, 2015, HEMATOL-AM SOC HEMAT, P637, DOI 10.1182/asheducation-2015.1.637; El-Fekih RK, 2017, NEPHROL THER, V13, P439, DOI 10.1016/j.nephro.2017.01.023; Epperla N, 2017, TRANSFUSION, V57, P2775, DOI 10.1111/trf.14263; George JN, 2014, NEW ENGL J MED, V371, P654, DOI 10.1056/NEJMra1312353; Go RS, 2016, MAYO CLIN PROC, V91, P1189, DOI 10.1016/j.mayocp.2016.05.015; Goodship THJ, 2017, KIDNEY INT, V91, P539, DOI 10.1016/j.kint.2016.10.005; Grange S, 2017, NEPHROL THER, V13, pS109, DOI 10.1016/j.nephro.2017.01.016; Greenbaum LA, 2016, KIDNEY INT, V89, P701, DOI 10.1016/j.kint.2015.11.026; Hovinga JAK, 2004, SEMIN HEMATOL, V41, P75, DOI 10.1053/j.seminhematol.2003.10.008; Keir L, 2011, PEDIATR NEPHROL, V26, P523, DOI 10.1007/s00467-010-1637-4; Kwaan HC, 2001, ACTA HAEMATOL-BASEL, V106, P52, DOI 10.1159/000046589; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Loirat C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-60; Postalcioglu M, 2017, BIOL BLOOD MARROW TR, V23, pS292, DOI 10.1016/j.bbmt.2016.12.208; Roman E, 2017, NEFROLOGIA, V37, P478, DOI 10.1016/j.nefro.2017.01.006; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Ruiz-Torres MP, 2005, THROMB HAEMOSTASIS, V93, P443, DOI 10.1160/TH04-07-0450; Scully M, 2017, J THROMB HAEMOST, V15, P312, DOI 10.1111/jth.13571; Scully M, 2016, J ONCOL PRACT, V12, P531, DOI 10.1200/JOP.2016.012708; Szilagyi A, 2013, NEPHROL DIAL TRANSPL, V28, P2237, DOI 10.1093/ndt/gft198; Takanashi J, 2014, NEUROLOGY, V82, P564, DOI 10.1212/WNL.0000000000000120; Vasko R, 2010, THER APHER DIAL, V14, P222, DOI 10.1111/j.1744-9987.2009.00710.x; Weissenborn K, 2012, NEUROLOGY, V79, P1466, DOI 10.1212/WNL.0b013e31826d5f26; Willemsen AECAB, 2011, ACTA ONCOL, V50, P462, DOI 10.3109/0284186X.2010.491088	30	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206558	10.1371/journal.pone.0206558	http://dx.doi.org/10.1371/journal.pone.0206558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388144	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800042
J	Feng, SY; Wang, XQ; Wang, QD; Fang, J; Wu, YX; Yi, L; Wei, KL				Feng, Shuyuan; Wang, Xueqin; Wang, Qiandong; Fang, Jing; Wu, Yaxue; Yi, Li; Wei, Kunlin			The uncanny valley effect in typically developing children and its absence in children with autism spectrum disorders	PLOS ONE			English	Article							MIND PERCEPTION; HUMAN REALISM; ROBOTS; PATTERNS; EYES; FACE; INDIVIDUALS; COMPETENCE; MISMATCH; PARTNERS	Robots and virtual reality are gaining popularity in the intervention of children with autism spectrum disorder (ASD). To shed light on children's attitudes towards robots and characters in virtual reality, this study aims to examine whether children with ASD show the uncanny valley effect. We varied the realism of facial appearance by morphing a cartoon face into a human face, and induced perceptual mismatch by enlarging the eyes, which has previously been shown as an effective method to induce the uncanny valley effect in adults. Children with ASD and typically developing (TD) children participated in a two-alternative forced choice task that asked them to choose one they liked more from the two images presented on the screen. We found that TD children showed the effect, i.e., the enlargement of eye size and the approaching realism reduced their preference. In contrast, children with ASD did not show the uncanny valley effect. Our findings in TD children help resolve the controversy in the literature about the existence of the uncanny valley effect among young children. Meanwhile, the absence of the uncanny valley effect in children with ASD might be attributed to their reduced sensitivity to subtle changes of face features and their limited visual experience to faces caused by diminished social motivation. Last, our findings provide practical implications for designing robots and virtual characters for the intervention of children with ASD.	[Feng, Shuyuan; Wu, Yaxue; Yi, Li; Wei, Kunlin] Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China; [Feng, Shuyuan; Wu, Yaxue; Yi, Li; Wei, Kunlin] Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China; [Wang, Xueqin] Sun Yat Sen Univ, Sch Math & Computat Sci, Dept Stat Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Xueqin] Sun Yat Sen Univ, Southern China Res Ctr Stat Sci, Guangzhou, Guangdong, Peoples R China; [Wang, Qiandong] Peking Univ, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Wang, Qiandong] Peking Univ, Acad Adv Interdisciplinary Studies, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China; [Fang, Jing] Qingdao Autism Res Inst, Qingdao, Shandong, Peoples R China	Peking University; Peking University; Sun Yat Sen University; Sun Yat Sen University; Peking University; Peking University	Yi, L; Wei, KL (corresponding author), Peking Univ, Sch Psychol & Cognit Sci, Beijing, Peoples R China.; Yi, L; Wei, KL (corresponding author), Peking Univ, Beijing Key Lab Behav & Mental Hlth, Beijing, Peoples R China.	yilipku@pku.edu.cn; wei_kunlin@126.com			National Natural Science Foundation of China [31571135, 31871116, 31371020, 31328010, 31622029, 61533001]; National High Technology Research and Development Program of China [2012AA011602]; Beijing Municipal Science & Technology Commission [Z171100000117015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission)	This work was supported by the National Natural Science Foundation of China, No. 31571135, 31871116, http://www.nsfc.gov.cn/, received by Yi L; National Natural Science Foundation of China, Nos. 31371020, 31328010, 31622029 and 61533001, http://www.nsfc.gov.cn/, received by Wei K; National High Technology Research and Development Program of China, No. 2012AA011602, http://www.htrdc.com/kjb/web/cms/www/kjb/index/, received by Wei K and the Beijing Municipal Science & Technology Commission, No. Z171100000117015, http://www.bjkw.gov.cn/, received by Yi L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Boyd LE, 2018, PROCEEDINGS OF THE 2018 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI 2018), DOI 10.1145/3173574.3173778; BRADLEY RA, 1952, BIOMETRIKA, V39, P324, DOI 10.1093/biomet/39.3-4.324; Brink KA, 2019, CHILD DEV, V90, P1202, DOI 10.1111/cdev.12999; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Chattopadhyay D, 2016, J VISION, V16, DOI 10.1167/16.11.7; Chawarska K, 2009, J AUTISM DEV DISORD, V39, P1663, DOI 10.1007/s10803-009-0803-7; Cheetham M, 2013, JOVE-J VIS EXP, DOI 10.3791/4375; Cheetham M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01219; Chevallier C, 2015, AUTISM RES, V8, P620, DOI 10.1002/aur.1479; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Constantino JN, 2002, SOCIAL RESPONSIVENES, DOI [10.1007/978-1-4419-1698-3_296, DOI 10.1007/978-1-4419-1698-3_296]; Duquette A, 2008, AUTON ROBOT, V24, P147, DOI 10.1007/s10514-007-9056-5; Gastgeb HZ, 2011, J AUTISM DEV DISORD, V41, P1609, DOI 10.1007/s10803-011-1190-4; Gastgeb HZ, 2009, AUTISM RES, V2, P279, DOI 10.1002/aur.93; Gray K, 2012, COGNITION, V125, P125, DOI 10.1016/j.cognition.2012.06.007; Hashimoto T, 2013, ACMIEEE INT CONF HUM, P133, DOI 10.1109/HRI.2013.6483537; Jentsch Ernst, 1997, ANGELAKI, P7, DOI DOI 10.1080/09697259708571910; Jones W, 2008, ARCH GEN PSYCHIAT, V65, P946, DOI 10.1001/archpsyc.65.8.946; Jones W, 2013, NATURE, V504, P427, DOI 10.1038/nature12715; Kanda T, 2004, HUM-COMPUT INTERACT, V19, P61, DOI 10.1207/s15327051hci1901&2_4; Katsyri J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00390; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Lahiri U, 2011, IEEE T NEUR SYS REH, V19, P443, DOI 10.1109/TNSRE.2011.2153874; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lao JP, 2017, BEHAV RES METHODS, V49, P559, DOI 10.3758/s13428-016-0737-x; Lewkowicz DJ, 2012, DEV PSYCHOBIOL, V54, P124, DOI 10.1002/dev.20583; Looser CE, 2010, PSYCHOL SCI, V21, P1854, DOI 10.1177/0956797610388044; MacDorman KF, 2006, INTERACT STUD, V7, P297, DOI 10.1075/is.7.3.03mac; MacDorman KF, 2017, COGNITION, V161, P132, DOI 10.1016/j.cognition.2017.01.009; MacDorman KF, 2016, COGNITION, V146, P190, DOI 10.1016/j.cognition.2015.09.019; MacDorman KF, 2009, COMPUT HUM BEHAV, V25, P695, DOI 10.1016/j.chb.2008.12.026; Mathur MB, 2016, COGNITION, V146, P22, DOI 10.1016/j.cognition.2015.09.008; Mitchell WJ, 2011, I-PERCEPTION, V2, P10, DOI 10.1068/i0415; Mori M., 1970, ENERGY, V7, P33, DOI DOI 10.1109/MRA.2012.2192811; Norbury CF, 2009, J CHILD PSYCHOL PSYC, V50, P834, DOI 10.1111/j.1469-7610.2009.02073.x; Olsen A., 2012, CISC VIS NETW IND GL; Pan ZG, 2006, COMPUT GRAPH-UK, V30, P20, DOI 10.1016/j.cag.2005.10.004; Peca A, 2014, COMPUT HUM BEHAV, V41, P268, DOI 10.1016/j.chb.2014.09.035; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Pollick F. E., 2010, SOCIAL INFORM TELECO, P69, DOI DOI 10.1007/978-3-642-12630-7_8; Ramey C., 2005, P VIEWS UNCANNY VALL, P8; Riby DM, 2008, NEUROPSYCHOLOGIA, V46, P2855, DOI 10.1016/j.neuropsychologia.2008.05.003; Riby DM, 2009, Q J EXP PSYCHOL, V62, P189, DOI 10.1080/17470210701855629; Saygin AP, 2012, SOC COGN AFFECT NEUR, V7, P413, DOI 10.1093/scan/nsr025; Scassellati B, 2012, ANNU REV BIOMED ENG, V14, P275, DOI 10.1146/annurev-bioeng-071811-150036; Schein C, 2015, INTERACT STUD, V16, P173, DOI 10.1075/is.16.2.02sch; Seyama J, 2007, PRESENCE-TELEOP VIRT, V16, P337, DOI 10.1162/pres.16.4.337; Speer LL, 2007, AUTISM, V11, P265, DOI 10.1177/1362361307076925; Tanaka JW, 2016, J AUTISM DEV DISORD, V46, P1538, DOI 10.1007/s10803-013-1976-7; Thompson JC, 2011, PERCEPTION, V40, P695, DOI 10.1068/p6900; Tung FW, 2016, INT J HUM-COMPUT INT, V32, P493, DOI 10.1080/10447318.2016.1172808; von Hofsten C, 2009, RES AUTISM SPECT DIS, V3, P556, DOI 10.1016/j.rasd.2008.12.003; Warren Z, 2015, J AUTISM DEV DISORD, V45, P3870, DOI 10.1007/s10803-014-2334-0; Wei CW, 2011, TURK ONLINE J EDUC T, V10, P11; Wolf JM, 2008, AUTISM RES, V1, P329, DOI 10.1002/aur.56; Woods S, 2006, INTERACT COMPUT, V18, P1390, DOI 10.1016/j.intcom.2006.05.001; Yi L, 2014, AUTISM RES, V7, P72, DOI 10.1002/aur.1340; Yi L, 2013, J VISION, V13, DOI 10.1167/13.10.5	61	13	13	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206343	10.1371/journal.pone.0206343	http://dx.doi.org/10.1371/journal.pone.0206343			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383848	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600041
J	Ma, XD; Wang, AH; Wang, FG; He, CM; Liu, DM; Gerstberger, P; Xing, FW				Ma, Xiao-Dong; Wang, Ai-Hua; Wang, Fa-Guo; He, Chun-Mei; Liu, Dong-Ming; Gerstberger, Pedro; Xing, Fu-Wu			A revised classification of Chinese Davalliaceae based on new evidence from molecular phylogenetics and morphological characteristics	PLOS ONE			English	Article							GENERIC CLASSIFICATION; SEQUENCES; FERNS; CHLOROPLAST; INSIGHTS	Although the phylogenetic framework of Davalliaceae is known, the classification of Chinese Davalliaceae is still controversial. In this study, a molecular phylogenetic tree of 60 accessions, including 29 species produced in China, was constructed using five plastid DNA markers-atpB, atpB-rbcL, rbcL, rbcL-accD, and accD. New data on studied specimens, field investigations, and scanning electron microscopy analysis of leaf epidermis and spores were used to reclassify Chinese Davalliaceae. The taxonomic position of Davallia canariensis was confirmed based on new evidence and a new key to sections of Chinese Davalliaceae was proposed. The taxonomically controversial genus Paradavallodes was confirmed as a polyphyletic group, and it was assigned to Davallia sect. Trogostolon and Davallia sect. Davallodes. Further, species endemic to China were delimited, 21 species were admitted to six sections of Davallia, two new combinations were proposed, two new synonyms were defined and a new key to Chinese species of Davalliaceae was presented.	[Ma, Xiao-Dong; Wang, Fa-Guo; Liu, Dong-Ming; Xing, Fu-Wu] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Ma, Xiao-Dong] Chinese Acad, Forestry Res Inst Forestry, Beijing, Peoples R China; [Wang, Ai-Hua] Guangxi Teachers Educ Univ, Minist Educ, Key Lab Environm Change & Resources Use Beibu Gul, Nanning, Guangxi, Peoples R China; [He, Chun-Mei] Guangdong Acad Forestry, Guangzhou, Guangdong, Peoples R China; [Gerstberger, Pedro] Univ Bayreuth, Dept Plant Ecol, Bayreuth, Bavaria, Germany	Chinese Academy of Sciences; South China Botanical Garden, CAS; Nanning Normal University; University of Bayreuth	Wang, FG (corresponding author), Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot, South China Bot Garden, Guangzhou, Guangdong, Peoples R China.	wangfg@scib.ac.cn	Ma, Xiao-dong/AAX-1333-2021	Ma, Xiao-dong/0000-0002-6537-7920	Youth Innovation Promotion Association of Chinese Academy of Sciences [2013229]; National Natural Science Foundation of China [30800056]; Science and Technology Planning Project of Guangdong Province [2015A020220011]	Youth Innovation Promotion Association of Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province	This work was funded by the Youth Innovation Promotion Association of Chinese Academy of Sciences (2013229), the National Natural Science Foundation of China (30800056), and Science and Technology Planning Project of Guangdong Province (2015A020220011), all to FGW.	Chen CW, 2014, BLUMEA, V59, P49, DOI 10.3767/000651914X683827; Chen CW, 2012, AM J BOT, V99, pE223, DOI 10.3732/ajb.1100498; Ching R.C., 1966, ACTA PHYTOTAX SINICA, V11, P17; Ching R-C, 1966, ACTA PHYTOTAX SINICA, V11, P11; CHING RC, 1978, ACTA PHYTOTAX SINICA, V16, P1; Ching RC, 1959, FLORA CHINA, V2, P282; Ching RC, 1940, SUNYATSENIA, V5, P201; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; Copeland E. B, 1908, PHILIPP J SCI, VC 3, P31; Copeland EB, 1908, PHILIPPINE J SCI C, V3C, P21; Copeland EB, 1947, GENERA FILICUM; COPELAND EDWIN B., 1940, PHILIPPINE JOUR SCI, V73, P345; COPELAND EDWIN BINGHAM, 1927, PHILLIPPINE JOUR SCI, V34, P239; Doyle J. J., 1987, PHYTOCHEM B, P11; Ebihara Atsushi, 2002, Acta Phytotaxonomica et Geobotanica, V53, P35; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Haufler CH, 1995, AM FERN J, V85, P361, DOI 10.2307/1547815; HOLTTUM R E, 1972, Kew Bulletin, V27, P245, DOI 10.2307/4109449; HOLTTUM RE, 1949, BIOL REV, V24, P267, DOI 10.1111/j.1469-185X.1949.tb00577.x; Holttum RE, 1955, REVISED FLORA MALAYA, V2; Kato M., 1985, J FS U TOKYO, V13, P553; Kato Masahiro, 2008, APG Acta Phytotaxonomica et Geobotanica, V59, P1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu HM, 2013, AUST SYST BOT, V26, P378, DOI 10.1071/SB13029; Ma Xiao-Dong, 2015, Plant Science Journal, V33, P438; Nooteboom H. P, 1996, ACTA PHYTOTAXONOMICA, V34, P162; NOOTEBOOM HP, 1992, BLUMEA, V37, P165; NOOTEBOOM HP, 1994, BLUMEA, V39, P151; Tsutsumi C., 2005, Fern Gazette, V17, P147; Tsutsumi C, 2008, SYST BOT, V33, P44, DOI 10.1600/036364408783887492; Tsutsumi C, 2006, BOT J LINN SOC, V151, P495, DOI 10.1111/j.1095-8339.2006.00535.x; Tsutsumi C, 2016, TAXON, V65, P1236, DOI 10.12705/656.2; Walsh BM, 2001, INT J PLANT SCI, V162, P1409, DOI 10.1086/323273; Wang FG, 2015, J SYST EVOL, V53, P72, DOI 10.1111/jse.12115; Wu CY., 1983, FLORA TIBET, V1, P281; Wu S. H, 1999, FLORA REIPUBLICAE PO, V6, P161; Xing F. W., 2013, FLORA OF CHINA, V2-3, P749	39	0	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206345	10.1371/journal.pone.0206345	http://dx.doi.org/10.1371/journal.pone.0206345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383865	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600042
J	Piwowar, M; Kocemba-Pilarczyk, KA; Piwowar, P				Piwowar, Monika; Kocemba-Pilarczyk, King A.; Piwowar, Piotr			Regularization and grouping -omics data by GCA method: A transcriptomic case	PLOS ONE			English	Article							MULTIPLE-MYELOMA; BIG DATA; EXPRESSION; PATHWAY	The paper presents the application of Grade Correspondence Analysis (GCA) and Grade Correspondence Cluster Analysis (GCCA) for ordering and grouping -omics datasets, using transcriptomic data as an example. Based on gene expression data describing 256 patients with Multiple Myeloma it was shown that the GCA method could be used to find regularities in the analyzed collections and to create characteristic gene expression profiles for individual groups of patients. GCA iteratively permutes rows and columns to maximize the tauKendall or rho-Spearman coefficients, which makes it possible to arrange rows and columns in such a way that the most similar ones remain in each other's neighbourhood. In this way, the GCA algorithm highlights regularities in the data matrix. The ranked data can then be grouped using the GCCA method, and after that aggregated in clusters, providing a representation that is easier to analyze-especially in the case of large sets of gene expression profiles. Regularization of transcriptomic data, which is presented in this manuscript, has enabled division of the data set into column clusters (representing genes) and row clusters (representing patients). Subsequently, rows were aggregated (based on medians) to visualise the gene expression profiles for patients with Multiple Myeloma in each collection. The presented analysis became the starting point for characterisation of differentiated genes and biochemical processes in which they are involved. GCA analysis may provide an alternative analytical method to support differentiation and analysis of gene expression profiles characterising individual groups of patients.	[Piwowar, Monika] Jagiellonian Univ, Dept Bioinformat & Telemed, Med Coll, Krakow, Poland; [Kocemba-Pilarczyk, King A.] Jagiellonian Univ, Chair Med Biochem, Med Coll, Krakow, Poland; [Piwowar, Piotr] AGH Univ Sci & Technol, Fac Elect Engn Automat Comp Sci & Biomed Engn, Dept Measurements & Elect, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Jagiellonian University; Collegium Medicum Jagiellonian University; AGH University of Science & Technology	Piwowar, M (corresponding author), Jagiellonian Univ, Dept Bioinformat & Telemed, Med Coll, Krakow, Poland.	mpiwowar@cm-uj.krakow.pl	Piwowar, Piotr/U-4800-2017; Kocemba, Kinga/AAE-6520-2021; kocemba, kinga/AAE-2305-2019; Piwowar, Monika Weronika/L-5452-2013	Piwowar, Piotr/0000-0003-2874-5090; kocemba, kinga/0000-0002-7119-2412; Piwowar, Monika Weronika/0000-0003-4645-8730	Jagiellonian University Medical College [K/ZDS/006364]	Jagiellonian University Medical College	The Jagiellonian University Medical College sponsored the preparation of the manuscript as part of the grant number: K/ZDS/006364 to MP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellazzi R, 2011, METHOD INFORM MED, V50, P536, DOI 10.3414/ME11-06-0002; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Binder H, 2015, DTSCH ARZTEBL INT, V112, P137, DOI 10.3238/arztebl.2015.0137; Blotta S, 2012, BLOOD, V120, P5002, DOI 10.1182/blood-2011-07-368142; Bodor A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-103; Chen LJ, 2010, BLOOD, V115, P61, DOI 10.1182/blood-2009-03-210526; Cruz-Cano R, 2014, COMPUT STAT DATA AN, V70, P88, DOI 10.1016/j.csda.2013.09.020; Ezponda T, 2014, CLIN CANCER RES, V20, P5001, DOI 10.1158/1078-0432.CCR-13-2499; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grzegorek M, 2013, ADV INTELL SYST, V226, P451, DOI 10.1007/978-3-319-00969-8_44; HALL JE, 1991, CLIN CARDIOL, V14, P6, DOI 10.1002/clc.4960141802; Hanamura I, 2006, LEUKEMIA, V20, P1288, DOI 10.1038/sj.leu.2404253; Kowalczyk T, 2000, STAT PROBABIL LETT, V46, P371, DOI 10.1016/S0167-7152(99)00125-X; Kowalczyk T., 2004, GRADE MODELS METHODS; Kryukov F, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0906-9; Mahoney MW, 2009, P NATL ACAD SCI USA, V106, P697, DOI [10.1073/pnas.0803205106, 10.1073/pnas.0803205105]; Munoz-Torres PM, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0104-6; Niewiadomska-bugaj M, 2005, KENDALL S AND GINI C, P125; Pinter M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan5616; Piwowar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128854; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Ram RS, 2017, FRONT SURG, V4, DOI 10.3389/fsurg.2017.00030; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; SZCZESNY W, 1991, J CLASSIF, V8, P201, DOI 10.1007/BF02616239; Waller T, 2015, BIODATA MIN, V8, DOI 10.1186/s13040-015-0052-6; Welcz A, 2012, MODELS METHODS GRADE; Zhan FH, 2007, BLOOD, V109, P1692, DOI 10.1182/blood-2006-07-037077; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458	29	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206608	10.1371/journal.pone.0206608	http://dx.doi.org/10.1371/journal.pone.0206608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383819	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600072
J	Matsushita, A; Sato, T; Mukai, S; Fujishita, T; Mishiro-Sato, E; Okuda, M; Aoki, M; Hasegawa, Y; Sekido, Y				Matsushita, Akihiro; Sato, Tatsuhiro; Mukai, Satomi; Fujishita, Teruaki; Mishiro-Sato, Emi; Okuda, Maho; Aoki, Masahiro; Hasegawa, Yoshinori; Sekido, Yoshitaka			TAZ activation by Hippo pathway dysregulation induces cytokine gene expression and promotes mesothelial cell transformation	ONCOGENE			English	Article							MALIGNANT PLEURAL MESOTHELIOMA; YAP; MUTATIONS; NF2; INTERLEUKIN-1-BETA; PROLIFERATION; DEGRADATION; PROTEIN; INJURY	Malignant mesothelioma (MM) constitutes a very aggressive tumor that is caused by asbestos exposure after long latency. The NF2 tumor suppressor gene is mutated in 40-50% of MM; moreover, one of its downstream signaling cascades, the Hippo signaling pathway, is also frequently inactivated in MM cells. Although the YAP transcriptional coactivator, which is regulated by the Hippo pathway, can function as a pro-oncogenic protein, the role of TAZ, a paralog of YAP, in MM cells has not yet been clarified. Here, we show that TAZ is expressed and underphosphorylated (activated) in the majority of MM cells compared to immortalized mesothelial cells. ShRNA-mediated TAZ knockdown highly suppressed cell proliferation, anchorage-independent growth, cell motility, and invasion in MM cells harboring activated TAZ. Conversely, transduction of an activated form of TAZ in immortalized mesothelial cells enhanced these in vitro phenotypes and conferred tumorigenicity in vivo. Microarray analysis determined that activated TAZ most significantly enhanced the transcription of genes related to "cytokine-cytokine receptor interaction." Among selected cytokines, we found that IL-1 signaling activation plays a major role in proliferation in TAZ-activated MM cells. Both IL1B knockdown and an IL-1 receptor antagonist significantly suppressed malignant phenotypes of immortalized mesothelial cells and MM cells with activated TAZ. Overall, these results indicate an oncogenic role for TAZ in MMs via transcriptional induction of distinct pro-oncogenic genes including cytokines. Among these, IL-1 signaling appears as one of the most important cascades, thus potentially serving as a target pathway in MM cells harboring Hippo pathway inactivation.	[Matsushita, Akihiro; Sato, Tatsuhiro; Mukai, Satomi; Okuda, Maho; Sekido, Yoshitaka] Aichi Canc Ctr Res Inst, Div Canc Biol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi, Japan; [Matsushita, Akihiro; Hasegawa, Yoshinori] Nagoya Univ, Dept Resp Med, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi, Japan; [Fujishita, Teruaki; Mishiro-Sato, Emi; Aoki, Masahiro] Aichi Canc Ctr Res Inst, Div Pathophysiol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi, Japan; [Aoki, Masahiro; Sekido, Yoshitaka] Nagoya Univ, Field Canc Pathobiol & Informat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi, Japan	Aichi Cancer Center; Nagoya University; Aichi Cancer Center; Nagoya University	Sekido, Y (corresponding author), Aichi Canc Ctr Res Inst, Div Canc Biol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi, Japan.; Sekido, Y (corresponding author), Nagoya Univ, Field Canc Pathobiol & Informat, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi, Japan.	ysekido@aichi-cc.jp	Aoki, Masahiro/A-5149-2016	Aoki, Masahiro/0000-0003-4316-9490; Mishiro-Sato, Emi/0000-0001-5528-4440; Fujishita, Teruaki/0000-0002-4397-2438; Sekido, Yoshitaka/0000-0002-2428-3848	JSPS KAKENHI [25090053, 16H04706, 17K19628]; AMED P-PRIME; AMED P-CREATE; Aichi Cancer Research Foundation; Takeda Science Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED P-PRIME; AMED P-CREATE; Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Ms. Ikue Hasegawa, Miwako Nishizawa, and Haruna Ikeda for technical assistance. We thank Dr. Hata for TAZ expression lentiviruses and Dr. Gazdar for MM cell lines. This work was supported by JSPS KAKENHI 25090053 (YS), 16H04706 (YS), and 17K19628 (YS); AMED P-PRIME and P-CREATE (YS); Aichi Cancer Research Foundation (TS); and Takeda Science Foundation (TS).	Adachi Y, 2006, INT J CANCER, V119, P1303, DOI 10.1002/ijc.22006; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; BIANCHI AB, 1995, P NATL ACAD SCI USA, V92, P10854, DOI 10.1073/pnas.92.24.10854; Bibby AC, 2016, EUR RESPIR REV, V25, P472, DOI 10.1183/16000617.0063-2016; Bueno R, 2016, NAT GENET, V48, P407, DOI 10.1038/ng.3520; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Disselhorst MMJ, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0488-7; Felley-Bosco E, 2014, TRANSL LUNG CANCER R, V3, P75, DOI 10.3978/j.issn.2218-6751.2014.02.03; Frank AL, 2014, ANN GLOB HEALTH, V80, P257, DOI 10.1016/j.aogh.2014.09.016; Fujii M, 2012, J EXP MED, V209, P479, DOI 10.1084/jem.20111653; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Huang W, 2012, J BIOL CHEM, V287, P26245, DOI 10.1074/jbc.M112.382036; Kadariya Y, 2016, CANCER PREV RES, V9, P406, DOI 10.1158/1940-6207.CAPR-15-0347; Kakiuchi T, 2016, CARCINOGENESIS, V37, P1098, DOI 10.1093/carcin/bgw084; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Menezes ME, 2014, ADV EXP MED BIOL, V818, P127, DOI 10.1007/978-1-4471-6458-6_6; Mizuno T, 2012, ONCOGENE, V31, P5117, DOI 10.1038/onc.2012.5; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Murakami H, 2011, CANCER RES, V71, P873, DOI 10.1158/0008-5472.CAN-10-2164; Nelson DB, 2017, J CLIN ONCOL, V35, P3354, DOI 10.1200/JCO.2017.73.8401; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; SEKIDO Y, 1995, CANCER RES, V55, P1227; Sekido Y, 2013, CARCINOGENESIS, V34, P1413, DOI 10.1093/carcin/bgt166; Stadlmann S, 2006, WOUND REPAIR REGEN, V14, P187, DOI 10.1111/j.1743-6109.2006.00109.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka I, 2015, ONCOGENE, V34, P73, DOI 10.1038/onc.2013.528; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tranchant R, 2017, CLIN CANCER RES, V23, P3191, DOI 10.1158/1078-0432.CCR-16-1971; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang YH, 2004, INT J ONCOL, V25, P173; Whitaker EL, 2012, CYTOKINE GROWTH F R, V23, P323, DOI 10.1016/j.cytogfr.2012.08.004; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Yap TA, 2017, NAT REV CANCER, V17, P475, DOI 10.1038/nrc.2017.42; Yokoyama T, 2008, CARCINOGENESIS, V29, P2139, DOI 10.1093/carcin/bgn200; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005	41	12	12	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1966	1978		10.1038/s41388-018-0417-7	http://dx.doi.org/10.1038/s41388-018-0417-7			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30401981				2022-12-26	WOS:000461164400013
J	Mukhtar, F; Butt, ZA				Mukhtar, Fatima; Butt, Zahid A.			Risk of adverse treatment outcomes among new pulmonary TB patients co-infected with diabetes in Pakistan: A prospective cohort study	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; ACTIVE TUBERCULOSIS; TREATMENT RESPONSE; MELLITUS; MORTALITY; TRENDS; INDIA; CHINA	Purpose The escalating burden of diabetes in countries tackling high burden of tuberculosis (TB) has adverse implications for co-infected individuals and National TB control efforts. We aimed to study whether there was a difference in treatment outcome among diabetic and non-diabetic pulmonary TB patients and identify the determinants of treatment outcome among the two groups. Materials and methods This prospective cohort study recruited new patients of pulmonary tuberculosis (PTB) aged 15 years and above who were diagnosed at and registered with Gulab Devi Chest Hospital, Lahore, Pakistan for anti-tuberculosis treatment (ATT). PTB patients were screened for diabetes using random and fasting blood glucose tests. Diabetic and non-diabetic PTB patients were followed up at second, fifth and sixth month of ATT and 6 months after ATT completion to determine treatment outcome. Multivariate logistic regression analysis was conducted to assess association between various factors and treatment outcome. Results Of 614 PTB patients, (n = 113 [18%]) were diabetic and (n = 501 [82%]) non-diabetic. Final model showed that diabetics were more likely to experience an unfavorable outcome as compared to non-diabetics (adjusted odds ratio [aOR] = 2.70, 95% Confidence Interval [CI] = 1.30 to 5.59). Other predictors of unfavorable outcome included rural residence (aOR = 1.98, 95% CI = 1.14 to 3.47), body mass index less than 18.50 (aOR = 1.89, 95% CI = 1.03 to 3.47) and being a smoker (aOR = 2.03, 95% CI = 1.04 to 3.94). Conclusion Our study shows unfavorable treatment outcome among diabetic PTB patients. Integrated models of care with screening/testing and management for diabetes and TB could improve TB treatment outcomes.	[Mukhtar, Fatima] Lahore Med & Dent Coll, Dept Community Med, Lahore, Pakistan; [Mukhtar, Fatima; Butt, Zahid A.] Hlth Serv Acad, Dept Epidemiol & Biostat, Islamabad, Pakistan; [Butt, Zahid A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Mukhtar, Fatima] Univ Hlth Sci, Dept Community Med, Lahore Med & Dent Coll, Lahore, Pakistan	Health Services Academy; University of British Columbia; University of Health Science - Pakistan	Mukhtar, F (corresponding author), Lahore Med & Dent Coll, Dept Community Med, Lahore, Pakistan.; Mukhtar, F (corresponding author), Hlth Serv Acad, Dept Epidemiol & Biostat, Islamabad, Pakistan.; Mukhtar, F (corresponding author), Univ Hlth Sci, Dept Community Med, Lahore Med & Dent Coll, Lahore, Pakistan.	fatimamukhtar@doctor.com	Butt, Zahid Ahmad/W-4292-2017	Butt, Zahid Ahmad/0000-0002-2486-4781				Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; [Anonymous], 2010, TREATM TUB GUID; [Anonymous], 2012, TUB CONTR PROGR PAK; Baghaei P, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-58; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Balasubramanian Rani, 2007, Indian J Tuberc, V54, P168; Chiang CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121698; Choi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-360; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Dooley KE, 2009, AM J TROP MED HYG, V80, P634, DOI 10.4269/ajtmh.2009.80.634; Dostalek M, 2012, CLIN PHARMACOKINET, V51, P481, DOI 10.2165/11631900-000000000-00000; El-Shabrawy M, 2017, EGYPT J CHEST DIS TU, V66, P145, DOI 10.1016/j.ejcdt.2015.11.002; Ezard Nadine, 2011, Confl Health, V5, P1, DOI 10.1186/1752-1505-5-1; Harries AD, 2010, TROP MED INT HEALTH, V15, P659, DOI 10.1111/j.1365-3156.2010.02523.x; Jabbar A., 2006, Eastern Mediterranean Health Journal, V12, P522; Jee SH, 2009, AM J EPIDEMIOL, V170, P1478, DOI 10.1093/aje/kwp308; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Khanna A, 2013, PUBLIC HEALTH ACTION, V3, pS48, DOI 10.5588/pha.13.0025; Leegaard A, 2011, DIABETES CARE, V34, P2530, DOI 10.2337/dc11-0902; Lin Y, 2012, TROP MED INT HEALTH, V17, P1302, DOI 10.1111/j.1365-3156.2012.03069.x; Magee MJ, 2011, INT J EPIDEMIOL, V40, P428, DOI 10.1093/ije/dyq268; Mi FL, 2013, TROP MED INT HEALTH, V18, P1379, DOI 10.1111/tmi.12198; Mukhtar F, 2017, J EPIDEMIOL GLOB HEA, V7, P249, DOI 10.1016/j.jegh.2017.08.003; Mukhtar F, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012970; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Ponce-De-Leon A, 2004, DIABETES CARE, V27, P1584, DOI 10.2337/diacare.27.7.1584; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Restrepo BI, 2008, AM J TROP MED HYG, V79, P541, DOI 10.4269/ajtmh.2008.79.541; Satyanarayana S, 2013, PUBLIC HEALTH ACTION, V3, pS1, DOI [10.5588/pha.13.0008, 10.5588/pha.13.0039]; Singla R, 2006, INT J TUBERC LUNG D, V10, P74; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Tatar D, 2009, JPN J INFECT DIS, V62, P423; WHO, 2016, GLOB TUB REP; WHO, 2011, COLLABORATIVE FRAMEW; Workneh MH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0115-z; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization International Union against Tuberculosis and Lung Disease, 2011, COLL FRAM CAR CONTR; Yen YF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002300; Zakariya AM, 2008, JPMI, V22, P266; Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207148	10.1371/journal.pone.0207148	http://dx.doi.org/10.1371/journal.pone.0207148			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408109	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300083
J	Nemeth, BC; Pesei, ZG; Hegyi, E; Szucs, A; Szentesi, A; Hegyi, P; Lowe, ME; Sahin-Toth, M				Nemeth, Balazs Csaba; Pesei, Zsofia Gabriella; Hegyi, Eszter; Szucs, Akos; Szentesi, Andrea; Hegyi, Peter; Lowe, Mark E.; Sahin-Toth, Miklos			The common truncation variant in pancreatic lipase related protein 2 (PNLIPRP2) is expressed poorly and does not alter risk for chronic pancreatitis	PLOS ONE			English	Article							EXOCRINE DYSFUNCTION; ACUTE RECURRENT; GENETIC RISK; CEL; MUTATIONS; DISEASE; DEFICIENCY; CHILDREN; ALLELE	A nonsense variant (p.W358X) of human pancreatic lipase related protein 2 (PNLIPRP2) is present in different ethnic populations with a high allele frequency. In cell culture experiments, the truncated protein mainly accumulates inside the cells and causes endoplasmic reticulum stress. Here, we tested the hypothesis that variant p.W358X might increase risk for chronic pancreatitis through acinar cell stress. We sequenced exon 11 of PNLIPRP2 in a cohort of 256 subjects with chronic pancreatitis (152 alcoholic and 104 non-alcoholic) and 200 controls of Hungarian origin. We observed no significant difference in the distribution of the truncation variant between patients and controls. We analyzed mRNA expression in human pancreatic cDNA samples and found the variant allele markedly reduced. We conclude that the p.W358X truncation variant of PNLIPRP2 is expressed poorly and has no significant effect on the risk of chronic pancreatitis.	[Nemeth, Balazs Csaba; Pesei, Zsofia Gabriella; Hegyi, Eszter; Sahin-Toth, Miklos] Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Boston, MA 02215 USA; [Nemeth, Balazs Csaba; Pesei, Zsofia Gabriella; Szentesi, Andrea] Univ Szeged, Dept Med 1, Szeged, Hungary; [Hegyi, Eszter; Szentesi, Andrea; Hegyi, Peter] Univ Pecs, Inst Translat Med, Pecs, Hungary; [Szucs, Akos] Semmelweis Univ, Dept Surg 1, Budapest, Hungary; [Hegyi, Peter] Univ Pecs, Dept Med 1, Pecs, Hungary; [Lowe, Mark E.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA	Boston University; Szeged University; University of Pecs; Semmelweis University; University of Pecs; Washington University (WUSTL)	Sahin-Toth, M (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Mol & Cell Biol, Ctr Exocrine Disorders, Boston, MA 02215 USA.	miklos@bu.edu		Hegyi, Eszter/0000-0002-9137-7561; Nemeth, Balazs/0000-0001-5338-7577; Sahin-Toth, Miklos/0000-0003-4513-9922; Szentesi, Andrea/0000-0003-2097-6927	NIH [R01 DK082412, R01 DK058088, R01 DK097241, R01 DK080820]; Hungarian National Research, Development and Innovation Fund [FK124632]; Hungarian Scientific Research Fund [K116634]; Momentum Grant of the Hungarian Academy of Sciences [LP2014-10/2014]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK108334, R01DK058088, R01DK097241, R01DK080820, R01DK082412] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hungarian National Research, Development and Innovation Fund; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Momentum Grant of the Hungarian Academy of Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The studies were supported by NIH grants R01 DK082412 and R01 DK058088 (to MST), R01 DK097241 and R01 DK080820 (to MEL) and the Hungarian National Research, Development and Innovation Fund grant #FK124632 (to BCN). The registry of the Hungarian Pancreatic Study Group was supported by the Hungarian Scientific Research Fund (K116634 to PH) and the Momentum Grant of the Hungarian Academy of Sciences (LP2014-10/2014 to PH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai HX, 2011, J PEDIATR GASTR NUTR, V52, P262, DOI 10.1097/MPG.0b013e3182061d75; Behar DM, 2014, J LIPID RES, V55, P307, DOI 10.1194/jlr.P041103; Cao HN, 2003, J HUM GENET, V48, P443, DOI 10.1007/s10038-003-0051-1; Conwell DL, 2017, DIGEST DIS SCI, V62, P2133, DOI 10.1007/s10620-017-4621-z; CYGLER M, 1993, PROTEIN SCI, V2, P366; Fjeld K, 2015, NAT GENET, V47, P518, DOI 10.1038/ng.3249; Giefer MJ, 2017, J PEDIATR-US, V186, P95, DOI 10.1016/j.jpeds.2017.03.063; GILLER T, 1992, J BIOL CHEM, V267, P16509; Hall TC, 2014, J EVAL CLIN PRACT, V20, P203, DOI 10.1111/jep.12117; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Kleeff J, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.60; Lowe ME, 2002, J LIPID RES, V43, P2007, DOI 10.1194/jlr.R200012-JLR200; Lowe ME, 1998, J BIOL CHEM, V273, P31215, DOI 10.1074/jbc.273.47.31215; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Sahin-Toth M, 2017, CURR OPIN GASTROEN, V33, P390, DOI 10.1097/MOG.0000000000000380; Schwarzenberg SJ, 2015, J PEDIATR-US, V166, P890, DOI 10.1016/j.jpeds.2014.11.019; Szabo A, 2015, BBA-MOL BASIS DIS, V1852, P1372, DOI 10.1016/j.bbadis.2015.04.002; Ting J, 2016, J PEDIATR GASTR NUTR, V62, P443, DOI 10.1097/MPG.0000000000001057; Weiss FU, 2018, CURR OPIN GASTROEN, V34, P322, DOI 10.1097/MOG.0000000000000461; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Xiao XJ, 2016, J BIOL CHEM, V291, P23224, DOI 10.1074/jbc.M116.734384; Xiao XJ, 2011, J BIOL CHEM, V286, P26353, DOI 10.1074/jbc.M111.249813; Yadav D, 2012, AM J GASTROENTEROL, V107, P1096, DOI 10.1038/ajg.2012.126	27	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206869	10.1371/journal.pone.0206869	http://dx.doi.org/10.1371/journal.pone.0206869			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408063	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000449512300046
J	Garrido, FJO; Piston, F; Gomez, LD; McQueen-Mason, SJ				Ostos Garrido, Francisco J.; Piston, Fernando; Gomez, Leonardo D.; McQueen-Mason, Simon J.			Biomass recalcitrance in barley, wheat and triticale straw: Correlation of biomass quality with classic agronomical traits	PLOS ONE			English	Article							AGRICULTURAL RESIDUES; NUTRITIVE-VALUE; ETHANOL; SUGAR; PRETREATMENT; CULTIVARS; DIGESTIBILITY; TECHNOLOGIES; DEGRADATION; FRACTIONS	The global production of cereal straw as an agricultural by-product presents a significant source of biomass, which could be used as feedstock for the production of second generation biofuels by fermentation. The production of sugars for fermentation is an important measure of straw quality and in its suitability for biofuel production. In this paper, we present a characterization of straw digestibility from a wide range of cereal. Our main objective is to evaluate the variability of fermentable sugars released from different species including wheat (Triticum durum L., Triticum aestivum L.), barley (Hordeum vulgare L.) and triticale (X Triticosecale Wittmack). To this end, we adapted a saccharification method (IAS Method) capable of detecting significant differences of released sugars between cultivars and species, while using separately another method that would serve as a control and with which we could contrast our results (CNAP method). ANOVA analyses revealed that barley has a higher saccharification potential than wheat and triticale and shows more variation between genotypes. Thus, populations derived from crosses among them such as Steptoe x Morex and OWB Dominant x OWB Recessive hold potential for the identification of genetic basis for saccharification-related traits. The correlation of glucose released between the two methods was moderate (R-2 = 0.57). An evaluation of the inter- and intra- specific correlation between a number of chemical and agronomical parameters and saccharification suggests that the cell wall thickness and lignin content in straw could be used in breeding programs for the improvement of the saccharification potential. Finally, the lack of correlation between grain yield and saccharification suggests that it would be possible to make a selection of genotypes for dual purpose, low recalcitrance and grain yield.	[Ostos Garrido, Francisco J.; Piston, Fernando] Spanish Council Sci Res IAS CSIC, Inst Sustainable Agr, Alameda Obispo S-N, Cordoba, Spain; [Gomez, Leonardo D.; McQueen-Mason, Simon J.] Univ York, Dept Biol, CNAP, York, N Yorkshire, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); University of York - UK	Gomez, LD; McQueen-Mason, SJ (corresponding author), Univ York, Dept Biol, CNAP, York, N Yorkshire, England.	leonardo.gomez@york.ac.uk; simon.mcqueenmason@york.ac.uk	Piston, Fernando/AAD-6975-2020; Garrido, Francisco José Ostos/AAC-4151-2021	Garrido, Francisco José Ostos/0000-0003-3528-1220; Gomez, Leonardo Dario/0000-0001-6382-9447; , Rachael Simister/0000-0002-5890-6441	Spanish Ministry of Economy and Competitiveness [AGL2011-22596]; FEDER; FPI from the Spanish Ministry of Economy and Competitiveness [BES-2012-052455];  [EEBB-I-15-10360]; BBSRC [BB/N013689/1, BB/N023269/1, BB/L001926/1] Funding Source: UKRI	Spanish Ministry of Economy and Competitiveness(Spanish Government); FEDER(European Commission); FPI from the Spanish Ministry of Economy and Competitiveness; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by AGL2011-22596 financed by the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es/) and co-financed with FEDER. FJO was supported by the funding of FPI grant BES-2012-052455 from the Spanish Ministry of Economy and Competitiveness. A short-term stay in CNAP by FJO was funded by EEBB-I-15-10360.	[Anonymous], 2008, SSF EXPT PROTOCOLS L; Arru L, 2003, THEOR APPL GENET, V106, P668, DOI 10.1007/s00122-002-1115-x; Bellucci A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01046; Brady J, 1934, J AGR SCI, V24, P209, DOI 10.1017/S0021859600006602; CAPPER BS, 1988, ANIM FEED SCI TECH, V21, P127, DOI 10.1016/0377-8401(88)90095-8; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Caruso G, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0362-9; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Chen Y, 2007, APPL BIOCHEM BIOTECH, V143, P80, DOI 10.1007/s12010-007-0030-7; Chen Y, 2007, APPL BIOCHEM BIOTECH, V142, P276, DOI 10.1007/s12010-007-0026-3; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; de Mendiburu Felipe, 2015, CRAN PACKAGE AGRICOL; Decker SR, 2009, BIOENERG RES, V2, P179, DOI 10.1007/s12155-009-9051-0; Duguid KB, 2007, BIOMASS BIOENERG, V31, P585, DOI 10.1016/j.biombioe.2007.03.002; Ercolano MR, 2015, BIOMASS BIOENERG, V72, P242, DOI 10.1016/j.biombioe.2014.10.030; Fox J, 2015, CAR COMPANION APPL R; Gomez LD, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-23; Hadley W., 2009, GGPLOT2 ELEGANT GRAP; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; IEA, 2008, 1 2 GEN BIOF TECHN O; IEA, 2011, WORLD EN OUTL; IEA, 2010, WORLD ENERGY OUTLOOK; Jensen JW, 2011, BIOMASS BIOENERG, V35, P1114, DOI 10.1016/j.biombioe.2010.11.036; Jezowski S, 1981, POLISH J THEORETICAL; KLEINHOFS A, 1993, THEOR APPL GENET, V86, P705, DOI 10.1007/BF00222660; Lindedam J, 2012, BIOMASS BIOENERG, V37, P221, DOI 10.1016/j.biombioe.2011.12.009; Lindedam J, 2014, BIOMASS BIOENERG, V66, P261, DOI 10.1016/j.biombioe.2014.03.006; Mewalal R, 2014, PLANT CELL PHYSIOL, V55, P1031, DOI 10.1093/pcp/pcu050; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Oakey H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-185; OHLDE GW, 1992, ANIM FEED SCI TECH, V36, P173, DOI 10.1016/0377-8401(92)90055-B; ORSKOV ER, 1990, ANIM PROD, V51, P155, DOI 10.1017/S0003356100005250; Orskov ER, 1988, CONSISTENCY DIFFEREN; Pauly M., 2010, JOVE-J VIS EXP, V37, P1745, DOI [10.3791/1745, DOI 10.3791/1745]; R Core Team, 2015, R R STATS PACK; Rao SC, 1989, AGRONOMY J; Saint Pierre C, 2010, FUNCT PLANT BIOL, V37, P166, DOI 10.1071/FP09174; Santoro N, 2010, BIOENERG RES, V3, P93, DOI 10.1007/s12155-009-9074-6; Studer MH, 2010, BIOTECHNOL BIOENG, V105, P231, DOI 10.1002/bit.22527; TAN ZL, 1995, ANIM FEED SCI TECH, V53, P337, DOI 10.1016/0377-8401(94)00721-K; Tandon JP, 1973, RELATIONSHIP LODGING; Tolera A, 2008, J ANIM PHYSIOL AN N, V92, P121, DOI 10.1111/j.1439-0396.2007.00717.x; Tondelli A, 2006, THEOR APPL GENET, V112, P445, DOI 10.1007/s00122-005-0144-7; Travis AJ, 1996, J AGR SCI-CAMBRIDGE, V127, P1, DOI 10.1017/S0021859600077327; Van Acker R, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-46; WHITE LM, 1981, AGRON J, V73, P117, DOI 10.2134/agronj1981.00021962007300010026x; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P1959, DOI 10.1016/j.biortech.2005.01.010; Wyman CE, 2005, BIORESOURCE TECHNOL, V96, P2026, DOI 10.1016/j.biortech.2005.01.018; Yuan TQ, 2010, CEREAL STRAW AS A RESOURCE FOR SUSTAINABLE BIOMATERIALS AND BIOFUELS: CHEMISTRY, EXTRACTIVES, LIGNINS, HEMICELLULOSES AND CELLULOSE, P1, DOI 10.1016/B978-0-444-53234-3.00001-8	50	6	7	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205880	10.1371/journal.pone.0205880	http://dx.doi.org/10.1371/journal.pone.0205880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403701	Green Accepted, Green Published, gold			2022-12-26	WOS:000449379500032
J	Wolter, T; Kleinmann, B				Wolter, Tilman; Kleinmann, Barbara			Placebo acceptability in chronic pain patients: More dependent on application mode and resulting condition than on individual factors	PLOS ONE			English	Article							OPEN-LABEL PLACEBO; DOSE REDUCTION; DECEPTION; DEPRESSION; RESPONSES; EFFICACY; ANXIETY; DASS	Introduction Placebo effects can be very effective in certain pain conditions, but their use is still highly controversial. Several studies show that patients would accept a placebo treatment under certain circumstances, particularly when they are informed prior to the treatment or when there are no effective treatment alternatives. This study examines the question, which factors influence the degree of acceptability of a hypothetical placebo application. Methods Patients filled in a questionnaire dealing with placebo applications. Moreover general data, diagnosis, duration of pain, pain ratings and anxiety/depression/stress scores, sleep disorders and opioid intake were collected from the patients' charts. 129 patients (44 men / 85 women, mean age 51.5 years, 18.0-80.9 years) entered the study. All patients had chronic pain syndromes and were treated in an universitary academic interdisciplinary pain center. Mean duration of pain was 14.7 years. Results The study did not show significant differences in placebo acceptability among patients with different pain diagnoses or accompanying psychological diagnoses or disorders. Hidden placebo application was considered much more unacceptable for the patients than the enhanced placebo or the open placebo application. An improved condition was associated with less feeling of deception, more trust and less negative mood than an unchanged or worsened condition. Conclusion Acceptance of placebo as pain therapy is much more dependent on the way of application (hidden or open) or on the resulting condition (improved, unchanged or worsened) than on factors inherent in the individual patients.	[Wolter, Tilman; Kleinmann, Barbara] Univ Hosp Freiburg, Interdisciplinary Pain Ctr, Freiburg, Germany	University of Freiburg	Wolter, T (corresponding author), Univ Hosp Freiburg, Interdisciplinary Pain Ctr, Freiburg, Germany.	tilman.wolter@uniklinik-freiburg.de						Association A. M., 2016, AMA COD MED ETH; Avins AL, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-44; Beck AT, 1997, BEHAV RES THER, V35, P1039, DOI 10.1016/S0005-7967(97)00073-9; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Blease C, 2016, BIOETHICS, V30, P407, DOI 10.1111/bioe.12245; Carvalho C, 2016, PAIN, V157, P2766, DOI 10.1097/j.pain.0000000000000700; Colloca L, 2006, PAIN, V124, P126, DOI 10.1016/j.pain.2006.04.005; Colloca L, 2010, PAIN, V151, P430, DOI 10.1016/j.pain.2010.08.007; Doering BK, 2012, TRENDS PHARMACOL SCI, V33, P165, DOI 10.1016/j.tips.2011.12.001; Enck P, 2013, NAT REV DRUG DISCOV, V12, P191, DOI 10.1038/nrd3923; Chaparro LE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004959.pub4; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fassler M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-15; Finniss DG, 2010, LANCET, V375, P686, DOI 10.1016/S0140-6736(09)61706-2; Hrobjartsson A, 2003, EVAL HEALTH PROF, V26, P153, DOI 10.1177/0163278703026002002; Kam-Hansen S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006175; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Kisaalita N, 2014, PAIN, V155, P2638, DOI 10.1016/j.pain.2014.09.029; Kisaalita NR, 2012, J PAIN, V13, P891, DOI 10.1016/j.jpain.2012.06.003; Kisaalita NR, 2011, J PAIN, V12, P920, DOI 10.1016/j.jpain.2011.02.353; LEVINE JD, 1981, PAIN, V10, P379, DOI 10.1016/0304-3959(81)90099-3; Locher C, 2017, PAIN; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Miller FG, 2005, PLOS MED, V2, P853, DOI 10.1371/journal.pmed.0020262; Miller FG, 2009, AM J BIOETHICS, V9, P39, DOI 10.1080/15265160903316263; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Muller M, 2016, EUR J PAIN, V20, P1530, DOI 10.1002/ejp.877; Nagel B, 2002, SCHMERZ, V16, P263, DOI 10.1007/s00482-002-0162-1; Nilges P, 2015, SCHMERZ, V29, P649, DOI 10.1007/s00482-015-0019-z; Nilges P, 2010, SCHMERZ, V24, P209, DOI 10.1007/s00482-010-0908-0; Sandler AD, 2008, CHILD CARE HLTH DEV, V34, P104, DOI 10.1111/j.1365-2214.2007.00797.x; Sandler AD, 2010, J DEV BEHAV PEDIATR, V31, P369, DOI 10.1097/DBP.0b013e3181e121ed; Sinke C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118363; Sullivan M, 2005, J PAIN, V6, P215, DOI 10.1016/j.jpain.2005.01.347; Vase L, 2009, PAIN, V145, P36, DOI 10.1016/j.pain.2009.04.008	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206968	10.1371/journal.pone.0206968	http://dx.doi.org/10.1371/journal.pone.0206968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399194	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000036
J	Adusei, KA; Owusu-Ofori, A				Adusei, Kwame Agyemang; Owusu-Ofori, Alex			Prevalence of Plasmodium parasitaemia in blood donors and a survey of the knowledge, attitude and practices of transfusion malaria among health workers in a hospital in Kumasi, Ghana	PLOS ONE			English	Article							TRANSMITTED MALARIA; FALCIPARUM MALARIA; TRANSMISSION; DIAGNOSIS	Malaria is one of the transfusion transmissible infections in malaria endemic countries such as Ghana. Healthy blood donors may harbour Plasmodium parasites without showing signs of malaria. Blood from such donors constitutes a risk to transfusion recipients and the recipients of this blood may go on to develop transfusion transmitted malaria (TTM). In many malaria endemic countries, blood donors are not screened for Plasmodium parasites. We investigated the prevalence of Plasmodium in blood donors in a hospital in Ghana as well as evaluate health workers knowledge, attitude and practices towards TTM. The study was carried out at the Kwadaso Seventh Day Adventist Hospital in Kumasi, Ghana from September 2016 to May 2017. Blood samples from 100 blood donors and 100 non-donors were examined for Plasmodium using microscopy and a rapid diagnostic test (RDT). In addition the blood groups of participants were determined. To obtain information concerning knowledge, attitude and practices of transfusion transmitted malaria, questionnaires were administered to 100 health workers including doctors, nurses and laboratory technicians. The prevalence rate of Plasmodium parasitaemia in blood donors by RDT and microscopy was 8% and 3% respectively, compared to non-donors who had a prevalence of 5% and 2% by RDT and microscopy respectively. Out of 100 health workers surveyed, 26% (26/100) had never heard of transfusion transmitted malaria. In an emergency situation, 41% health workers were willing to transfuse malaria positive blood but only 2%, 4% and 8% were willing to transfuse blood that was positive for HIV, Hepatitis B and Syphilis respectively. Regular training workshops may help improve the knowledge of health workers as a quarter of workers had not heard about transfusion transmitted malaria and 6.8% did not know that malaria was transmissible by transfusion.	[Adusei, Kwame Agyemang] Kwame Nkrumah Univ Sci & Technol, Med Lab Technol, Kumasi, Ghana; [Owusu-Ofori, Alex] Kwame Nkrumah Univ Sci & Technol, Dept Clin Microbiol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Adusei, KA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Med Lab Technol, Kumasi, Ghana.	kwameagadusie@gmail.com	Owusu-Ofori, Alex/AAU-9071-2020	adusei, kwame/0000-0002-8909-5178; Owusu-Ofori, Alex Kwame/0000-0002-2172-8645				Alli J. A., 2010, Research Journal of Medical Sciences, V4, P255, DOI 10.3923/rjmsci.2010.255.275; Appiah-Darkwah I., 2011, International Journal of Tropical Medicine, V6, P61; Ayensu F, 2016, DOMA INT J RES DUR, V1, P75; BRUCECHW.LJ, 1974, B WORLD HEALTH ORGAN, V50, P337; Chattopadhyay R, 2011, TRANSFUSION, V51, P630, DOI 10.1111/j.1537-2995.2010.02872.x; Cserti CM, 2007, BLOOD, V110, P2250, DOI 10.1182/blood-2007-03-077602; Diop S, 2009, TRANSFUS CLIN BIOL, V16, P454, DOI 10.1016/j.tracli.2009.02.004; Directorate Generale of Health Services (BANBACT), 2013, MOH TECHN ASS WHO SU; District Health Information System, 2016, MAL CONTR SURV B; GARFIELD MD, 1978, JAMA-J AM MED ASSOC, V240, P2285, DOI 10.1001/jama.240.21.2285; Kakkilaya BS, 2003, LAB MED, V34, P602, DOI 10.1309/J4ANKCCJ147JB2FR; Kim S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0633-3; Kitchen AD, 2006, VOX SANG, V90, P77, DOI 10.1111/j.1423-0410.2006.00733.x; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Nag Ipsita, 2012, Asian J Transfus Sci, V6, P54, DOI 10.4103/0973-6247.95059; Owusu-Ofori A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1289-3; Owusu-Ofori AK, 2010, CLIN INFECT DIS, V51, P1192, DOI 10.1086/656806; Pathirana SL, 2005, ANN TROP MED PARASIT, V99, P119, DOI 10.1179/136485905X19946; Periyavan Sundar, 2010, Asian J Transfus Sci, V4, P41, DOI 10.4103/0973-6247.59391; Ross R., 1911, PREVENTION MALARIA; Seed CR, 2005, TRANSFUS MED REV, V19, P229, DOI 10.1016/j.tmrv.2005.02.004; Strom GEA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-417; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x; Tela I, 2015, R A J APPL RES, V1, P255, DOI [DOI 10.18535/RAJAR/V18531I18537.18504, 10.18535/rajar/v18531i18537.18504]; Thongdee P, 2014, KOREAN J PARASITOL, V52, P377, DOI [10.3347/kjp.2014.52.4.377, 10.3347/kjp.2014.52.4.377.]; Ukaga CN, 2011, NIGERIAN J PARASITOL, V32, P175; Vareil MO, 2011, EMERG INFECT DIS, V17, P248, DOI 10.3201/eid1702.100595; Warhurst D, 1996, J CLIN PATHOL, P49; WHO, PREQ DIAGN PROGR PUB; WHO, 2009, GLOB MAL PROGR PREGN; WHO, 2009, BLOOD TRANSF SAF TES; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2016, MAL PAR COUNT MAL MI	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206303	10.1371/journal.pone.0206303	http://dx.doi.org/10.1371/journal.pone.0206303			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395615	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400019
J	Ozasa, M; Ichikawa, H; Sato, S; Tanaka, T; Johkoh, T; Kataoka, K; Yamano, Y; Kondoh, Y; Nakamura, H; Kawakami, A; Bychkov, A; Taniguchi, H; Fukuoka, J				Ozasa, Mutsumi; Ichikawa, Hiromi; Sato, Shuntaro; Tanaka, Tomonori; Johkoh, Takeshi; Kataoka, Kensuke; Yamano, Yasuhiko; Kondoh, Yasuhiro; Nakamura, Hideki; Kawakami, Atsushi; Bychkov, Andrey; Taniguchi, Hiroyuki; Fukuoka, Junya			Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias	PLOS ONE			English	Article							COLLAGEN VASCULAR-DISEASE; AUTOIMMUNE FEATURES; LUNG-DISEASE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; PULMONARY-FIBROSIS; AMERICAN-COLLEGE; DIAGNOSIS	Objectives Idiopathic interstitial pneumonia (IIP) and connective tissue disease -associated interstitial pneumonia (CTD-IP) are the two most common types of interstitial pneumonia. IIP and CTD-IP share common histological features, yet their clinical management is different. Separation of the two conditions based solely on histology can be challenging, and there are no established criteria. Materials and methods We selected 105 consecutive cases of IIP (79 usual interstitial pneumonia and 26 non-specific interstitial pneumonia) and 49 cases of CTD-IP for derivation and 32 cases of IIP and 10 cases of CTD-IP for validation. Fourteen histological parameters were evaluated independently by two pathologists for derivation group and graded into 0 to 3. The association between the score for each marker and a diagnosis of CTD was investigated using Fisher's exact test and stepwise logistic regression analysis. A formula for calculating the probability of IIP and CTD-IP was constructed by the markers identified in the regression test with coefficients for each finding. The formula was confirmed using validation case group. Results Stepwise logistic regression analysis showed that plasmacytosis, lymphoid follicle with germinal center, and airspace fibrin were suggestive of CTD-IP and that fibroblastic foci, smooth muscle hyperplasia, cellular IP, dense perivascular collagen, and fat metaplasia were suggestive of IIP. The formula used to calculate the probabilities based on estimated values for each finding was created, and user-friendly web based app was composed at www.ctdip.com. On the validation study, 30 out of 32 IIP and eight out of 10 CTD-IPs were distinguished correctly by the app (Specificity: 93%, Sensitivity: 80%). Conclusions We identified histological markers and derived a practical formula and user-friendly app to distinguish CTD-IPs from IIP.	[Ozasa, Mutsumi; Ichikawa, Hiromi; Tanaka, Tomonori; Fukuoka, Junya] Nagasaki Univ Hosp, NEDCP, Nagasaki, Japan; [Sato, Shuntaro] Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan; [Johkoh, Takeshi] Mutual Aid Assoc Publ Sch Teachers, Dept Radiol, Kinki Cent Hosp, Itami, Hyogo, Japan; [Kataoka, Kensuke; Yamano, Yasuhiko; Kondoh, Yasuhiro; Taniguchi, Hiroyuki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi, Japan; [Nakamura, Hideki; Kawakami, Atsushi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Immunol & Rheumatol, Unit Translat Med, Nagasaki, Japan; [Bychkov, Andrey; Fukuoka, Junya] Kameda Med Ctr, Dept Pathol, Kamogawa, Japan	Nagasaki University; Nagasaki University; Tosei General Hospital; Nagasaki University	Fukuoka, J (corresponding author), Nagasaki Univ Hosp, NEDCP, Nagasaki, Japan.; Fukuoka, J (corresponding author), Kameda Med Ctr, Dept Pathol, Kamogawa, Japan.	fukuokaj@nagasaki-u.ac.jp	Tanaka, Tomonori/AAH-6168-2020; Sato, Shuntaro/AAN-8048-2020; Bychkov, Andrey/N-1884-2019; Fukuoka, Junya/AAT-2924-2021; Kondo, Yasuhiro/AAP-3658-2020	Sato, Shuntaro/0000-0002-6055-3649; Bychkov, Andrey/0000-0002-4203-5696; 	Diffuse Lung Disease Research Group from the Ministry of Health, Labour and Welfare [16ek0109064h0003]; Japan Agency for Medical Research and Development	Diffuse Lung Disease Research Group from the Ministry of Health, Labour and Welfare; Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Diffuse Lung Disease Research Group from the Ministry of Health, Labour and Welfare (https://research-er.jp/projects/view/918516), grant No: 16ek0109064h0003. This study was funded by Japan Agency for Medical Research and Development (to JF). No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegunsoye A, 2017, ARCH PATHOL LAB MED, V141, P960, DOI 10.5858/arpa.2016-0427-OA; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Castelino FV, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3097; Cipriani NA, 2012, ARCH PATHOL LAB MED, V136, P1253, DOI 10.5858/arpa.2012-0102-OA; Fischer A, 2015, EUR RESPIR J, V46, P976, DOI 10.1183/13993003.00150-2015; Fischer A, 2010, CHEST, V138, P251, DOI 10.1378/chest.10-0194; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Fujibayashi Takashi, 2004, Mod Rheumatol, V14, P425, DOI 10.3109/s10165-004-0338-x; Fukuoka J, 2005, PRACTICAL PULMONARY, P181; Kasukawa R., 1987, PRELIMINARY DIAGNOST; Kim HC, 2015, CHEST, V147, P165, DOI 10.1378/chest.14-0272; KingJr TE, 2002, NONNEOPLASTIC DISORD; Kono M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094775; Leslie KO, 2007, SEMIN RESP CRIT CARE, V28, P369, DOI 10.1055/s-2007-985609; Lynch DA, 2018, LANCET RESP MED, V6, P138, DOI 10.1016/S2213-2600(17)30433-2; Oldham JM, 2016, EUR RESPIR J, V47, P1767, DOI 10.1183/13993003.01565-2015; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Song JW, 2009, CHEST, V136, P23, DOI 10.1378/chest.08-2572; Su R, 2011, J RHEUMATOL, V38, P693, DOI 10.3899/jrheum.100675; Suda T, 2010, RESP MED, V104, P1527, DOI 10.1016/j.rmed.2010.04.022; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vij R, 2013, CHEST, V143, P814, DOI 10.1378/chest.12-0741; Walsh SLF, 2016, LANCET RESP MED, V4, P557, DOI 10.1016/S2213-2600(16)30033-9	25	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206186	10.1371/journal.pone.0206186	http://dx.doi.org/10.1371/journal.pone.0206186			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395623	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400017
J	Pickle, NT; Wilken, JM; Fey, NP; Silverman, AK				Pickle, Nathaniel T.; Wilken, Jason M.; Fey, Nicholas P.; Silverman, Anne K.			A comparison of stability metrics based on inverted pendulum models for assessment of ramp walking	PLOS ONE			English	Article							BODY ANGULAR-MOMENTUM; DYNAMIC STABILITY; SLOPED WALKING; GAIT; LOCOMOTION; BALANCE; ADULTS; COST	Maintaining balance on ramps is important for mobility. However, balance is commonly assessed using inverted pendulum-based metrics (e.g., margin of stability), which may not be appropriate for assessment of human walking on non-level surfaces. To investigate this, we analyzed stability on ramps using four different inverted pendulum models: extrapolated center of mass (XCOM), foot placement estimate (FPE), foot placement estimate neglecting angular momentum (FPENOH), and capture point (CAP). We analyzed experimental data from 10 able-bodied individuals walking on a ramp at 0 degrees, +/- 5 degrees, and +/- 10 degrees. Contrary to our hypothesis that the magnitude of differences between metrics would be greatest at +/- 10 degrees, we observed the greatest magnitude of differences between metrics at 0 degrees. In general, the stability metrics were bounded by FPE and CAP at each slope, consistent with prior studies of level walking. Our results also suggest that clinical providers and researchers should be aware that assessments that neglect angular momentum (e.g., margin of stability, XCOM) may underestimate stability in the sagittal-plane in comparison to analyses which incorporate angular momentum (e.g., FPE). Except for FPENOH-CAP (r = 0.82), differences between metrics were only moderately correlated (vertical bar r vertical bar <= 0.65) with violations of leg length assumptions in the underlying inverted pendulum models. The differences in FPENOH relative to FPE and CAP were strongly correlated with body center of mass vertical velocity (max vertical bar r vertical bar = 0.92), suggesting that model representations of center of mass motion influence stability metrics. However, there was not a clear overall relationship between model inputs and differences in stability metrics. Future sensitivity analyses may provide additional insight into model characteristics that influence stability metrics.	[Pickle, Nathaniel T.; Fey, Nicholas P.] Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA; [Pickle, Nathaniel T.; Silverman, Anne K.] Colorado Sch Mines, Dept Mech Engn, Golden, CO 80401 USA; [Wilken, Jason M.] Brooke Army Med Ctr, Dept Rehabil Med, San Antonio, TX USA; [Fey, Nicholas P.] Univ Texas Dallas, Dept Mech Engn, Richardson, TX 75083 USA; [Fey, Nicholas P.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Med & Rehabil, Dallas, TX 75390 USA; [Wilken, Jason M.] Univ Iowa, Dept Phys Therapy & Rehabil Sci, Iowa City, IA USA	University of Texas System; University of Texas Dallas; Colorado School of Mines; San Antonio Military Medical Center; United States Department of Defense; United States Army; University of Texas System; University of Texas Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa	Pickle, NT (corresponding author), Univ Texas Dallas, Dept Bioengn, Richardson, TX 75083 USA.; Pickle, NT (corresponding author), Colorado Sch Mines, Dept Mech Engn, Golden, CO 80401 USA.	Nathaniel.pickle@utdallas.edu	Silverman, Anne K/M-2727-2016; Wilken, Jason/ABA-3309-2021	Silverman, Anne K/0000-0002-2228-4548; Wilken, Jason/0000-0002-5556-7667; Pickle, Nathaniel/0000-0001-5676-7989	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development Award [R03HD075946]; United States Department of Defense [W81K00-09-P-1129]	National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development Award; United States Department of Defense(United States Department of Defense)	This work was supported by the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development Award No. R03HD075946 (AKS) and United States Department of Defense award No. W81K00-09-P-1129 (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierbaum S, 2011, J BIOMECH, V44, P1921, DOI 10.1016/j.jbiomech.2011.04.027; Bosse I, 2012, HUM MOVEMENT SCI, V31, P1560, DOI 10.1016/j.humov.2012.05.003; Collins TD, 2009, GAIT POSTURE, V30, P173, DOI 10.1016/j.gaitpost.2009.04.004; Curtze C, 2011, GAIT POSTURE, V33, P292, DOI 10.1016/j.gaitpost.2010.11.023; DEMPSTER P, 1995, MED SCI SPORT EXER, V27, P1692; Essun H., 1993, EUR J PHYS, V14, P201, DOI DOI 10.1088/0143-0807/14/5/002; Goswami A, 1997, AUTON ROBOT, P1; Hak L, 2013, ARCH PHYS MED REHAB, V94, P2186, DOI 10.1016/j.apmr.2013.07.020; Herr H, 2008, J EXP BIOL, V211, P467, DOI 10.1242/jeb.008573; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Jeffers JR, 2015, J BIOMECH, V48, P2919, DOI 10.1016/j.jbiomech.2015.04.023; Kajita S, 2001, IROS 2001: PROCEEDINGS OF THE 2001 IEEE/RJS INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P239, DOI 10.1109/IROS.2001.973365; KAJITA S, 1992, IEEE T ROBOTIC AUTOM, V8, P431, DOI 10.1109/70.149940; Karamanidis K, 2008, J ELECTROMYOGR KINES, V18, P980, DOI 10.1016/j.jelekin.2007.04.003; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; KUSTER M, 1995, CLIN BIOMECH, V10, P79, DOI 10.1016/0268-0033(95)92043-L; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; Millard M, 2012, J COMPUT NONLIN DYN, V7, DOI 10.1115/1.4005462; Millard M, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.4000193; Ortega JD, 2005, J APPL PHYSIOL, V99, P2099, DOI 10.1152/japplphysiol.00103.2005; Pickle NT, 2016, J BIOMECH, V49, P3244, DOI 10.1016/j.jbiomech.2016.08.004; Pickle NT, 2016, J BIOMECH, V49, P3397, DOI 10.1016/j.jbiomech.2016.09.010; Pratt J, 2006, IEEE-RAS INT C HUMAN, P200, DOI 10.1109/ichr.2006.321385; Rabago CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166815; Ramos OE, 2015, IEEE-RAS INT C HUMAN, P851, DOI 10.1109/HUMANOIDS.2015.7363461; Ruina A, 2005, J THEOR BIOL, V237, P170, DOI 10.1016/j.jtbi.2005.04.004; Silverman AK, 2012, J BIOMECH, V45, P965, DOI 10.1016/j.jbiomech.2012.01.012; Vistamehr A, 2016, J BIOMECH, V49, P396, DOI 10.1016/j.jbiomech.2015.12.047; Wight DL, 2008, J COMPUT NONLIN DYN, V3, DOI 10.1115/1.2815334; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206875	10.1371/journal.pone.0206875	http://dx.doi.org/10.1371/journal.pone.0206875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395597	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400063
J	Horacio, AN; Silva-Costa, C; Lopes, E; Ramirez, M; Melo-Cristino, J				Horacio, Andreia N.; Silva-Costa, Catarina; Lopes, Elisia; Ramirez, Mario; Melo-Cristino, Jose		Portuguese Grp Study Streptococcal	Conjugate vaccine serotypes persist as major causes of non-invasive pneumococcal pneumonia in Portugal despite declines in serotypes 3 and 19A (2012-2015)	PLOS ONE			English	Article							OBSERVATIONAL COHORT; DISEASE; IMPACT; CHILDREN; 7-VALENT; ADULTS; INFECTIONS; MORTALITY; CARRIAGE; ENGLAND	Non-invasive pneumococcal pneumonia (NIPP) is a frequent cause of morbidity and mortality worldwide. The 13-valent pneumococcal conjugate vaccine (PCV13) was included in the national immunization program of children living in Portugal in 2015. Until then, PCV7 (since late 2001) and PCV13 (since early 2010) were given through the private market. We determined the serotype distribution and antimicrobial susceptibility of isolates causing adult NIPP in 2012-2015 and compared the results with previously published data (2007-2011). There were 50 serotypes among the 1435 isolates. The most common were serotypes: 3 (14%), 11A (8%), 19F (6%), 23A (5%), 6C (5%), 19A (4%), 23B (4%), 9N (4%) and non-typable isolates (4%). When considering data since the availability of PCV13 for children in the private market, the proportion of PCV13 serotypes declined from 44.0% in 2010 to 29.7% in 2015 (p < 0.001), mainly due to early decreases in the proportions of serotypes 3 and 19A. In contrast, during the same period, PCV7 serotypes (11.9% in 2012-2015) and the serotypes exclusive of the 23-valent polysaccharide vaccine (26.0% in 2012-2015), remained relatively stable, while non-vaccine types increased from 27.0% in 2010 to 41.9% in 2015 (p<0.001). According to the Clinical and Laboratory Standards Institute (CLSI) breakpoints, penicillin non-susceptible and erythromycin resistant isolates accounted for 1% and 21.7%, respectively, of the isolates recovered in 2012-2015, with no significant changes seen since 2007. Comparison of NIPP serotypes with contemporary invasive disease serotypes identified associations of 19 serotypes with either disease presentation. The introduction of PCV13 in the national immunization program for children from 2015 onwards may lead to reductions in the proportion of NIPP due to vaccine serotypes but continued NIPP surveillance is essential due to a different serotype distribution from invasive disease.	[Horacio, Andreia N.; Silva-Costa, Catarina; Lopes, Elisia; Ramirez, Mario; Melo-Cristino, Jose] Univ Lisbon, Fac Med, Inst Microbiol, Inst Med Mol, Lisbon, Portugal	Universidade de Lisboa	Ramirez, M (corresponding author), Univ Lisbon, Fac Med, Inst Microbiol, Inst Med Mol, Lisbon, Portugal.	ramirez@fm.ul.pt	Silva-Costa, Catarina/J-8167-2013; Melo-Cristino, Jose A G/H-3726-2013; Ramirez, Mario/B-4993-2008	Silva-Costa, Catarina/0000-0001-9681-0574; Melo-Cristino, Jose A G/0000-0001-8643-1722; Ramirez, Mario/0000-0002-4084-6233	Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/81205/2011, PTDC/DTP-EPI/1555/2014]; FEDER, through POR Lisboa - 2020 Programa Operacional Regional de Lisboa, PORTUGAL 2020 [LISBOA-01-0145-FEDER-007391]; Fundacao para a Ciencia e a Tecnologia; Pfizer	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); FEDER, through POR Lisboa - 2020 Programa Operacional Regional de Lisboa, PORTUGAL 2020; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Pfizer(Pfizer)	ANH was supported by a grant from Fundacao para a Ciencia e Tecnologia, Portugal SFRH/BD/81205/2011. This work was partly supported by Fundacao para a Ciencia e a Tecnologia, Portugal (PTDC/DTP-EPI/1555/2014), LISBOA-01-0145-FEDER-007391, project cofunded by FEDER, through POR Lisboa - 2020 Programa Operacional Regional de Lisboa, PORTUGAL 2020 and Fundacao para a Ciencia e a Tecnologia, and an unrestricted Investigator initiated project from Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar SI, 2008, CLIN MICROBIOL INFEC, V14, P835, DOI 10.1111/j.1469-0691.2008.02031.x; Aguiar SI, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.12.20750; Benfield T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072743; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Clinical and Laboratory Standards Institute, 2007, PERF STAND ANT SUSC; Clinical and Laboratory Standards Institute, 2015, PERF STAND ANT SUSC; Costa Rui P., 2016, Rev Port Med Geral Fam, V32, P70; Direccao Geral de Saude, 2015, 112015 GER SAUD; Fedson DS, 2011, EXPERT REV VACCINES, V10, P1143, DOI [10.1586/ERV.11.99, 10.1586/erv.11.99]; Froes F, 2014, REV PORT PNEUMOL, V20, P111, DOI 10.1016/j.rppneu.2014.02.001; Georgalis L, 2017, EUR J CLIN MICROBIOL, V36, P575, DOI 10.1007/s10096-016-2834-2; Harboe ZB, 2014, CLIN INFECT DIS, V59, P1066, DOI 10.1093/cid/ciu524; Horacio AN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01616; Horacio AN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153602; Horacio AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103092; Horacio AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073704; Horacio AN, 2012, VACCINE, V30, P218, DOI 10.1016/j.vaccine.2011.11.022; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Mendes RE, 2015, ANTIMICROB AGENTS CH, V59, P5595, DOI 10.1128/AAC.00182-15; Moore MR, 2015, LANCET INFECT DIS, V15, P301, DOI 10.1016/S1473-3099(14)71081-3; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Pletz MW, 2016, VACCINE, V34, P2342, DOI 10.1016/j.vaccine.2016.03.052; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Rodrigues F, 2013, CLIN INFECT DIS, V57, P473, DOI 10.1093/cid/cit233; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Silva-Costa C, 2018, EMERG INFECT DIS; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Sousa M., 2009, REV PORT CLIN GERAL, V25, P531, DOI [10.32385/rpmgf.v25i5.10666, DOI 10.32385/RPMGF.V25I5.10666]; Steens A, 2013, VACCINE, V31, P6232, DOI 10.1016/j.vaccine.2013.10.032; Valente C, 2016, VACCINE, V34, P4072, DOI 10.1016/j.vaccine.2016.06.017; van Werkhoven CH, 2016, VACCINE, V34, P3275, DOI 10.1016/j.vaccine.2016.05.002; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206912	10.1371/journal.pone.0206912	http://dx.doi.org/10.1371/journal.pone.0206912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388168	Green Submitted, Green Published			2022-12-26	WOS:000449289800069
J	Li, SJ; Vodicka, E; Peterson, A; Stergachis, A				Li, Shang-Ju; Vodicka, Elisabeth; Peterson, Anne; Stergachis, Andy			Translating medicines to patients: A novel methodology for quantifying the global medical supplies and donations program	PLOS ONE			English	Article							DRUG DONATIONS; HOSPITALS	Background International medical donation programs can help alleviate the burden of illness and serve as a safety net for the global health care system. However, to our knowledge no studies have assessed the number of individuals served through medical donation programs. As such, this study aimed to evaluate the impact of the Americares Foundation's (Americares) medical donation program in terms of the number of patients served. Methods We conducted an outcome evaluation study in 34 health facilities in 10 countries that receive medical donations from Americares. Medical records were randomly sampled at each participating facility and evaluated for types of medications and number of courses of prescribed treatments. Facility level data and donation inventory data were also collected. We developed an algorithm for converting quantities of donated medicines into the number of individuals served at the facility level. These estimates were then extrapolated to the country and region levels to assess the total impact of medications donated in 2015. Probabilistic sensitivity analysis was conducted to derive 95% credible ranges for projected estimates and to assess model uncertainty. Results Records of 3,205 unique patients were reviewed, encompassing 10,449 medical visits. The average number of medications and courses of treatments prescribed per visit were 2.63 and 2.68, respectively. The average medication destruction rate ranged from 0% to 24% at facilities, with a cross-country average of 7%. For the 10 countries included in the study, we project that 700,377 unique individuals were served through the program (95% credible range: 518,401-905,982). Scaled across all regions receiving Americares donations, we project that the program supported an estimated 5.1 million beneficiaries, including 484,188 chronic care and 4.65 million acute care patients. Conclusions This study provides a novel methodology for medical donation programs seeking to estimate one of their key outcomes-patients served-and global reach. Rigorous assessments of program outcomes can provide important insights into the value of medical donation initiatives.	[Li, Shang-Ju; Peterson, Anne] Americares Fdn Inc, Stamford, CT 06906 USA; [Vodicka, Elisabeth; Stergachis, Andy] Univ Washington, Sch Pharm, Seattle, WA 98195 USA; [Stergachis, Andy] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Li, SJ (corresponding author), Americares Fdn Inc, Stamford, CT 06906 USA.	sjli@americares.org		Li, Shang Ju/0000-0003-3225-6580	Johnson & Johnson Evaluation Capacity Building Funds; Americares Monitoring and Evaluation internal budget	Johnson & Johnson Evaluation Capacity Building Funds; Americares Monitoring and Evaluation internal budget	This study was 50% funded through Johnson & Johnson Evaluation Capacity Building Funds. The rest was funded through the Americares Monitoring and Evaluation internal budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2010, ANN PHARMACOTHER, V44, P1986, DOI 10.1345/aph.1P423; [Anonymous], 2015, NON TRADITIONAL REF; Autier P, 2013, DRUG DONATIONS POSTE; Bellhouse R, ENCY BIOSTATISTICS; Bero L, 2010, B WORLD HEALTH ORGAN, V88, P922, DOI 10.2471/BLT.10.079764; Boatin B, 2008, ANN TROP MED PARASIT, V102, P13, DOI 10.1179/136485908X337427; Dong LF, 2011, FAM PRACT, V28, P63, DOI 10.1093/fampra/cmq077; Embrey M., 2012, MDS 3 MANAGING ACCES; Gustavsen KM, 2009, ANN TROP MED PARASIT, V103, pS11, DOI 10.1179/000349809X12502035776478; Herrera AR, 2006, REFORMA SALUD COSTA; Hogerzeil H, 1993, LANCET, V342, P771; Jenny AM, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0210-8; Karimi A, 2014, J RES PHARM PRACT, V3, P39, DOI 10.4103/2279-042X.137058; Kasabi GS, 2015, INDIAN J MED RES, V142, P216, DOI 10.4103/0971-5916.164261; Ladner J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-470; Mahmood A, 2016, SAUDI PHARM J, V24, P189, DOI 10.1016/j.jsps.2015.03.003; Mariacher GG, 2008, INT J HEALTH PLAN M, V23, P313, DOI 10.1002/hpm.901; Odusanya OO, 2004, J COMMUNITY MED PRIM, V16, P21; Organization WH, 1993, NON TRADITIONAL REF; Sharif SI, 2008, LIBYAN J MED, V3, P10, DOI 10.4176/070928; Tekinturhan E, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-304; Wertheimer Albert I, 2004, J Int Assoc Physicians AIDS Care (Chic), V3, P74, DOI 10.1177/154510970400300302; World Health Organization, 2004, NON TRADITIONAL REF; World Health Organization, 2011, PHIL HLTH SYST REV; World Health Organization, 2011, GUID MED DON REV 201	25	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206790	10.1371/journal.pone.0206790	http://dx.doi.org/10.1371/journal.pone.0206790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388156	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800058
J	Kumarathasan, P; Williams, G; Bielecki, A; Blais, E; Hemmings, DG; Smith, G; von Dadelszen, P; Fisher, M; Arbuckle, TE; Fraser, WD; Vincent, R				Kumarathasan, Premkumari; Williams, Gabriela; Bielecki, Agnieszka; Blais, Erica; Hemmings, Denise G.; Smith, Graeme; von Dadelszen, Peter; Fisher, Mandy; Arbuckle, Tye E.; Fraser, William D.; Vincent, Renaud			Characterization of maternal plasma biomarkers associated with delivery of small and large for gestational age infants in the MIREC study cohort	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PREGNANCY-INDUCED HYPERTENSION; HIGH BIRTH-WEIGHT; MATRIX METALLOPROTEINASES; TYROSINE KINASE-1; OUTCOMES; IMPACT; PREECLAMPSIA; NUTRITION; WOMEN	Objective Neonatal morbidity and mortality can be influenced by maternal health status. Information on maternal and fetal biomarkers of adverse health outcomes is limited. This work aims at identifying maternal biomarkers associated with low and high birth weight for gestational age groups. Design and settings Population-based prospective cohort study of the potential adverse health effects of exposure to environmental contaminants on pregnancy and infant health. Methods Third trimester maternal plasma samples (n = 1588) from a pregnancy cohort (Maternal-Infant Research on Environmental Chemicals Study, MIREC) were analyzed for changes in a target spectrum of biomarkers of vascular health (e.g., matrix metalloproteinases MMPs, vascular endothelial cell growth factor VEGF), inflammation (e.g. cellular adhesion molecules CAMs, cytokines, chemokines) by affinity-based multiplex protein array analyses. Multivariate logistic regression analyses were done to examine associations between target plasma biomarkers, maternal-infant characteristics, and birth weight outcomes assessed as small for gestational age (SGA) <= 10th percentile and large for gestational age (LGA) >= 90th percentile groups. Results and outcomes Our results revealed that maternal plasma biomarkers monocyte chemoattractant protein-1 MCP-1 (p<0.05, +ve) and VEGF (p<0.05, -ve) along with parity = 1 (p<0.01, -ve) and gestational hypertension (p<0.05, +ve) were associated with SGA births. Meanwhile, LGA was associated with maternal plasma VEGF (p<0.05, +ve) and MMP-9 (p<0.05, -ve) and gestational hypertension (p<0.01, +ve), pre-pregnancy body mass index (p<0.01, +ve), parity (p<0.05, +ve) and education (p<0.05, -ve). Conclusions Third trimester maternal plasma biomarkers in combination with maternal health and socioeconomic characteristics can be useful in predicting SGA and LGA outcomes. Maternal vascular health and inflammatory status may contribute to both SGA and LGA births through distinct molecular mechanisms.	[Kumarathasan, Premkumari; Williams, Gabriela; Bielecki, Agnieszka; Blais, Erica; Fisher, Mandy; Arbuckle, Tye E.; Vincent, Renaud] Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada; [Kumarathasan, Premkumari] Univ Ottawa, Fac Hlth Sci, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Hemmings, Denise G.] Univ Alberta, Obstet & Gynecol, Edmonton, AB, Canada; [Smith, Graeme] Queens Univ, Obstet & Gynecol, Kingston, ON, Canada; [von Dadelszen, Peter] Kings Coll London, Obstet & Gynecol, London, England; [Fraser, William D.] Ctr Hosp Univ Sherbrooke, Sherbrooke, PQ, Canada; [Vincent, Renaud] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	Health Canada; University of Ottawa; University of Alberta; Queens University - Canada; University of London; King's College London; University of Sherbrooke; University of Ottawa	Kumarathasan, P (corresponding author), Hlth Canada, Hlth Environm & Consumer Safety Branch, Environm Hlth Sci & Res Bur, Ottawa, ON, Canada.; Kumarathasan, P (corresponding author), Univ Ottawa, Fac Hlth Sci, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada.	premkumari.kumarathasan@hc-sc.gc.ca	von Dadelszen, Peter/AAP-7480-2021; Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; von Dadelszen, Peter/0000-0003-4136-3070	Canadian Federal Government Funding (Chemicals Management Plan) at Health Canada; Canadian Federal Government Funding (Clean Air Regulatory Agenda) at Health Canada; Chemicals Management Plan of Health Canada; Canadian Institutes for Health Research [MOP - 81285]; Ontario Ministry of the Environment; Biostatistics Unit at Health Canada; Chemicals Management Plan; Clean Air Regulatory Agenda at Health Canada	Canadian Federal Government Funding (Chemicals Management Plan) at Health Canada; Canadian Federal Government Funding (Clean Air Regulatory Agenda) at Health Canada; Chemicals Management Plan of Health Canada; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of the Environment; Biostatistics Unit at Health Canada; Chemicals Management Plan; Clean Air Regulatory Agenda at Health Canada	This work was supported by the Canadian Federal Government Funding (Chemicals Management Plan and the Clean Air Regulatory Agenda) at Health Canada. The MIREC Research Platform is supported by the Chemicals Management Plan of Health Canada, the Canadian Institutes for Health Research (grant #MOP - 81285) and the Ontario Ministry of the Environment.; The authors would like to thank the Biostatistics Unit at Health Canada and Harun Kalayci for their support in this study. This work was supported by the Chemicals Management Plan and the Clean Air Regulatory Agenda at Health Canada. The MIREC Research Platform is supported by the Chemicals Management Plan of Health Canada, the Canadian Institutes for Health Research (grant #MOP-81285), and the Ontario Ministry of the Environment. We also acknowledge the valuable contribution of the MIREC participants and the MIREC Study group, especially the site investigators: Peter von Dadelszen, Denise Hemmings, Jingwei Wang, Michael Helewa, Shayne Taback, Mathew Sermer, Warren Foster, Greg Ross, Paul Fredette, Graeme Smith, Mark Walker, Roberta Shear and Linda Dodds.	Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Alsuwaida A, 2011, J MATERN-FETAL NEO M, V24, P1432, DOI 10.3109/14767058.2011.575483; ANDREWS KW, 1994, AM J IND MED, V26, P13, DOI 10.1002/ajim.4700260103; Arbuckle TE, 2013, PAEDIATR PERINAT EP, V27, P415, DOI 10.1111/ppe.12061; Arslan M, 2004, INT J GYNECOL OBSTET, V84, P120, DOI 10.1016/S0020-7292(03)00332-1; Au F, 2016, CHEMOSPHERE, V159, P506, DOI 10.1016/j.chemosphere.2016.06.011; Benton SJ, 2016, PLACENTA, V42, P1, DOI 10.1016/j.placenta.2016.03.010; Benton SJ, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.09.019; Boyd DR, 2008, ENVIRON RES, V106, P240, DOI 10.1016/j.envres.2007.08.009; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Conde-Agudelo A, 2011, BJOG-INT J OBSTET GY, V118, P1042, DOI 10.1111/j.1471-0528.2011.02923.x; Das UG, 2004, PEDIATR CLIN N AM, V51, P639, DOI 10.1016/j.pcl.2004.01.004; El-Mousawi M, 2003, J BIOL CHEM, V278, P46681, DOI 10.1074/jbc.M308681200; Esplin MS, 2005, PLACENTA, V26, P661, DOI 10.1016/j.placenta.2004.09.012; Gelson E, 2010, EXPERT REV OBSTET GY, V5, P605; Godfrey K, 1996, BRIT MED J, V312, P410, DOI 10.1136/bmj.312.7028.410; Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022; Heinze G, 2006, STAT MED, V25, P4216, DOI 10.1002/sim.2687; Howe LD, 2012, INT J EPIDEMIOL, V41, P722, DOI 10.1093/ije/dys025; Hulboy DL, 1997, MOL HUM REPROD, V3, P27, DOI 10.1093/molehr/3.1.27; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; King JC, 2003, J NUTR, V133, p1732S, DOI 10.1093/jn/133.5.1732S; Kodama Y, 2006, J AM COLL CARDIOL, V48, P43, DOI 10.1016/j.jacc.2006.03.035; KOZUKI N, 2013, BMC PUBLIC HEALTH S3, V13; Kramer MS, 2010, CYTOKINE, V49, P10, DOI 10.1016/j.cyto.2009.08.014; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Krause BJ, 2011, PLACENTA, V32, P797, DOI 10.1016/j.placenta.2011.06.025; Kumarathasan P, 2014, J PROTEOMICS, V100, P136, DOI 10.1016/j.jprot.2013.12.003; Kumarathasan P, 2001, ANAL BIOCHEM, V299, P37, DOI 10.1006/abio.2001.5362; Kumarathasan P, 2016, BIOMARKERS, V21, P257, DOI 10.3109/1354750X.2015.1134663; Lawlor DA, 2012, EUR HEART J, V33, P335, DOI 10.1093/eurheartj/ehr300; Martinez-Varea A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/210241; Mathews F, 1999, BRIT MED J, V319, P339, DOI 10.1136/bmj.319.7206.339; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mohammadbeigi A, 2013, ANN MED HEALTH SCI R, V3, P546, DOI 10.4103/2141-9248.122098; Moustafa AA, 2015, DIET AND EXERCISE IN COGNITIVE FUNCTION AND NEUROLOGICAL DISEASES, P73; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Muti M, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0110-5; Myers JE, 2005, HYPERTENS PREGNANCY, V24, P103, DOI 10.1081/PRG-200059836; Ng SK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-460; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Perera FP, 2007, ENVIRON HEALTH PERSP, V115, P1497, DOI 10.1289/ehp.10144; Polliotti BM, 2003, OBSTET GYNECOL, V101, P1266, DOI 10.1016/S0029-7844(03)00338-7; Rahman A, 2016, SCI TOTAL ENVIRON, V569, P1022, DOI 10.1016/j.scitotenv.2016.06.134; Reuvekamp A, 1999, BRIT J OBSTET GYNAEC, V106, P1019, DOI 10.1111/j.1471-0528.1999.tb08107.x; ROBERTS JM, 1993, LANCET, V341, P1447, DOI 10.1016/0140-6736(93)90889-O; Ross JA, 2006, CANCER EPIDEM BIOMAR, V15, P1, DOI 10.1158/1055-9965.EPI-05-0923; Senger DR, 1996, AM J PATHOL, V149, P293; Smith CJ, 2015, DIABETES METAB SYNDR, V8, P295, DOI 10.2147/DMSO.S61296; Stieb DM, 2012, ENVIRON RES, V117, P100, DOI 10.1016/j.envres.2012.05.007; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Suuronen EJ, 2010, J THORAC CARDIOV SUR, V139, P209, DOI 10.1016/j.jtcvs.2009.04.055; Ugwuja EI, 2011, J HEALTH POPUL NUTR, V29, P156; Vahter M, 2002, ENVIRON RES, V88, P145, DOI 10.1006/enrs.2002.4338; Valdes G, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-79; Veas CJ, 2011, J MATERN-FETAL NEO M, V24, P1371, DOI 10.3109/14767058.2011.556204; Verma A, 2012, J CLIN DIAGN RES, V6, P1531, DOI 10.7860/JCDR/2012/4508.2551; Wang LF, 2015, EXP THER MED, V10, P1229, DOI 10.3892/etm.2015.2635; Wigle DT, 2008, J TOXICOL ENV HEAL B, V11, P373, DOI 10.1080/10937400801921320; World Health Organization (WHO), 2012, WORLD HLTH STAT 2012; Xiong X, 1999, AM J OBSTET GYNECOL, V180, P207, DOI 10.1016/S0002-9378(99)70176-6; Xiong X, 2002, AM J EPIDEMIOL, V155, P203, DOI 10.1093/aje/155.3.203; Xiong X, 2000, AM J OBSTET GYNECOL, V183, P148, DOI 10.1067/mob.2000.105735	64	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0204863	10.1371/journal.pone.0204863	http://dx.doi.org/10.1371/journal.pone.0204863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383759	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600013
J	Kusonmano, K; Halle, MK; Wik, E; Hoivik, EA; Krakstad, C; Mauland, KK; Tangen, IL; Berg, A; Werner, HMJ; Trovik, J; Oyan, AM; Kalland, KH; Jonassen, I; Salvesen, HB; Petersen, K				Kusonmano, Kanthida; Halle, Mari K.; Wik, Elisabeth; Hoivik, Erling A.; Krakstad, Camilla; Mauland, Karen K.; Tangen, Ingvild L.; Berg, Anna; Werner, Henrica M. J.; Trovik, Jone; Oyan, Anne M.; Kalland, Karl-Henning; Jonassen, Inge; Salvesen, Helga B.; Petersen, Kjell			Identification of highly connected and differentially expressed gene subnetworks in metastasizing endometrial cancer	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; NETWORK ANALYSIS; CARCINOMA; TRANSCRIPTION; PACKAGE; MARKERS; PROTEIN	We have identified nine highly connected and differentially expressed gene subnetworks between aggressive primary tumors and metastatic lesions in endometrial carcinomas. We implemented a novel pipeline combining gene set and network approaches, which here allows integration of protein-protein interactions and gene expression data. The resulting subnetworks are significantly associated with disease progression across tumor stages from complex atypical hyperplasia, primary tumors to metastatic lesions. The nine subnetworks include genes related to metastasizing features such as epithelial-mesenchymal transition (EMT), hypoxia and cell proliferation. TCF4 and TWIST2 were found as central genes in the subnetwork related to EMT. Two of the identified subnetworks display statistically significant association to patient survival, which were further supported by an independent validation in the data from The Cancer Genome Atlas data collection. The first subnetwork contains genes related to cell proliferation and cell cycle, while the second contains genes involved in hypoxia such as HIF1A and EGLN3. Our findings provide a promising context to elucidate the biological mechanisms of metastasis, suggest potential prognostic markers and further identify therapeutic targets. The pipeline R source code is freely available, including permutation tests to assess statistical significance of the identified subnetworks.	[Kusonmano, Kanthida; Jonassen, Inge; Petersen, Kjell] Univ Bergen, Dept Informat, Computat Biol Unit, Bergen, Norway; [Kusonmano, Kanthida; Halle, Mari K.; Hoivik, Erling A.; Krakstad, Camilla; Mauland, Karen K.; Tangen, Ingvild L.; Berg, Anna; Werner, Henrica M. J.; Trovik, Jone; Salvesen, Helga B.] Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway; [Kusonmano, Kanthida] King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Halle, Mari K.; Hoivik, Erling A.; Krakstad, Camilla; Mauland, Karen K.; Tangen, Ingvild L.; Berg, Anna; Werner, Henrica M. J.; Trovik, Jone; Oyan, Anne M.; Kalland, Karl-Henning; Salvesen, Helga B.] Univ Bergen, Ctr Canc Biomarkers, Dept Clin Sci, Bergen, Norway; [Wik, Elisabeth] Univ Bergen, Ctr Canc Biomarkers, Dept Clin Med, Bergen, Norway; [Wik, Elisabeth] Haukeland Hosp, Gade Inst, Dept Pathol, Bergen, Norway; [Oyan, Anne M.; Kalland, Karl-Henning] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Jonassen, Inge] Univ Bergen, Ctr Canc Biomarkers, Dept Informat, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; King Mongkuts University of Technology Thonburi; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Kusonmano, K (corresponding author), Univ Bergen, Dept Informat, Computat Biol Unit, Bergen, Norway.; Kusonmano, K (corresponding author), Haukeland Hosp, Dept Obstet & Gynecol, Bergen, Norway.; Kusonmano, K (corresponding author), King Mongkuts Univ Technol Thonburi, Sch Bioresources & Technol, Bioinformat & Syst Biol Program, Bangkok, Thailand.	kanthida.kus@mail.kmutt.ac.th	Wik, E./AAA-9105-2020; Werner, henrica/ABG-1235-2021; Krakstad, Camilla/AAB-5138-2020; Jonassen, Inge/AAC-7035-2020; Kalland, Karl-Henning/B-9445-2017; Kusonmano, Kanthida/AAQ-2802-2020; Halle, Mari K/AAT-4856-2020	Werner, henrica/0000-0001-5186-8369; Krakstad, Camilla/0000-0002-0174-8139; Kalland, Karl-Henning/0000-0003-4486-2334; Halle, Mari K/0000-0002-2660-8271; Kusonmano, Kanthida/0000-0002-6532-9144	Research Council of Norway; Norwegian Cancer Society; Helse-Vest; University of Bergen; Bergen Research Foundation	Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Helse-Vest; University of Bergen; Bergen Research Foundation	This study was conducted with the support from the Research Council of Norway, the Norwegian Cancer Society, Helse-Vest, the University of Bergen and the Bergen Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz N, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0099-x; Nieto MA, 2013, SCIENCE, V342, P708, DOI 10.1126/science.1234850; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0375; Bidus MA, 2006, CLIN CANCER RES, V12, P83, DOI 10.1158/1078-0432.CCR-05-0835; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Costa-Silva J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190152; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Fang XC, 2013, CANCER TREAT REV, V39, P77, DOI 10.1016/j.ctrv.2012.06.001; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Glickman ME, 2014, J CLIN EPIDEMIOL, V67, P850, DOI 10.1016/j.jclinepi.2014.03.012; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kong B, 2014, J CLIN NEUROSCI, V21, P316, DOI 10.1016/j.jocn.2013.06.026; Kriegl L, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-123; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liberzon A, 2014, METHODS MOL BIOL, V1150, P153, DOI 10.1007/978-1-4939-0512-6_9; Linderman GC, 2012, NUCLEIC ACIDS RES, V40, pW152, DOI 10.1093/nar/gks526; LIU Y, 2012, BMC SYST BIOL, V6; Mao YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078200; Markowetz F, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000655; Oza AM, 2011, J CLIN ONCOL, V29, P3278, DOI 10.1200/JCO.2010.34.1578; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Pan YB, 2017, ONCOTARGET, V8, P114613, DOI 10.18632/oncotarget.23061; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Requejo-Aguilar R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5514; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Samur MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056228; Serin EAR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00444; Song S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-502; Stefansson IM, 2004, HISTOPATHOLOGY, V44, P472, DOI 10.1111/j.1365-2559.2004.01882.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka T, 2014, J CANCER RES CLIN, V140, P503, DOI 10.1007/s00432-014-1593-7; Trovik J, 2011, CLIN CANCER RES, V17, P3368, DOI 10.1158/1078-0432.CCR-10-2412; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulitsky I, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-8; Wang J, 2017, NUCLEIC ACIDS RES, V45, pW130, DOI 10.1093/nar/gkx356; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028; Wik E, 2014, GYNECOL ONCOL, V134, P599, DOI 10.1016/j.ygyno.2014.06.026; Wu MC, 2009, STAT METHODS MED RES, V18, P577, DOI 10.1177/0962280209351925; Yuan BB, 2006, CLIN CANCER RES, V12, P405, DOI 10.1158/1078-0432.CCR-05-0903; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhou T, 2007, CELL CYCLE, V6, P972, DOI 10.4161/cc.6.8.4106	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206665	10.1371/journal.pone.0206665	http://dx.doi.org/10.1371/journal.pone.0206665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383835	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600080
J	Patino-Ruiz, M; Dwivedi, M; Calinescu, O; Karabel, M; Padan, E; Fendler, K				Patino-Ruiz, Miyer; Dwivedi, Manish; Calinescu, Octavian; Karabel, Mehmet; Padan, Etana; Fendler, Klaus			Replacement of Lys-300 with a glutamine in the NhaA Na+/H+ antiporter of Escherichia coli yields a functional electrogenic transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane transport; sodium-proton exchange; electrophysiology; fluorescence; site-directed mutagenesis	CATION-BINDING; ALKALINE PH; MECHANISM; EXCHANGER; TRANSLOCATION; STABILITY; RESIDUES; PROTEIN; GENE	Much of the research on Na+/H+ exchange has been done in prokaryotic models, mainly on the NhaA Na+/H+-exchanger from Escherichia coli (EcNhaA). Two conserved aspartate residues, Asp-163 and Asp-164, are essential for transport and are candidates for possible binding sites for the two H+ that are exchanged for one Na+ to make the overall transport process electrogenic. More recently, a proposed mechanism of transport for EcNhaA has suggested direct binding of one of the transported H+ to the conserved Lys-300 residue, a salt bridge partner of Asp-163. This contention is supported by a study reporting that substitution of the equivalent residue, Lys-305, of a related Na+/H+ antiporter, NapA from Thermus thermophilus, renders the transporter electroneutral. In this work, we sought to establish whether the Lys-300 residue and its partner Asp-163 are essential for the electrogenicity of EcNhaA. To that end, we replaced Lys-300 with Gln, either alone or together with the simultaneous substitution of Asp-163 with Asn, and characterized these transporter variants in electrophysiological experiments combined with H+ transport measurements and stability analysis. We found that K300Q EcNhaA can still support electrogenic Na+/H+ antiport in EcNhaA, but has reduced thermal stability. A parallel electrophysiological investigation of the K305Q variant of TtNapA revealed that it is also electrogenic. Furthermore, replacement of both salt bridge partners in the ion-binding site of EcNhaA produced an electrogenic variant (D163N/K300Q). Our findings indicate that alternative mechanisms sustain EcNhaA activity in the absence of canonical ion-binding residues and that the conserved lysines confer structural stability.	[Patino-Ruiz, Miyer; Calinescu, Octavian; Karabel, Mehmet; Fendler, Klaus] Max Planck Inst Biophys, D-60438 Frankfurt, Germany; [Dwivedi, Manish; Padan, Etana] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Calinescu, Octavian] Carol Davila Univ Med & Pharm, Dept Biophys, Bucharest 050474, Romania	Max Planck Society; Hebrew University of Jerusalem; Carol Davila University of Medicine & Pharmacy	Fendler, K (corresponding author), Max Planck Inst Biophys, Dept Biol Chem, Max von Laue Str 3, D-60438 Frankfurt, Germany.	fendler@biophys.mpg.de	Calinescu, Octavian/P-4278-2014; DWIVEDI, MANISH/AAI-8940-2021	Calinescu, Octavian/0000-0001-8003-0442; DWIVEDI, MANISH/0000-0001-5217-9039; Fendler, Klaus/0000-0002-5699-7060; Patino-Ruiz, Miyer Fabian/0000-0003-0607-4281	DIP (DFG, German-Israeli Project Cooperation Grant) [LA3655/1-1]; PBC, Council for Higher Education; Hebrew University; Ministry of Research and Innovation, CNCS-UEFISCDI within PNCDI III [PN-III-P1-1.1-PD-2016-0802]; Israel Science Foundation [284/12, 939/14]	DIP (DFG, German-Israeli Project Cooperation Grant); PBC, Council for Higher Education; Hebrew University; Ministry of Research and Innovation, CNCS-UEFISCDI within PNCDI III; Israel Science Foundation(Israel Science Foundation)	Supported by DIP (DFG, German-Israeli Project Cooperation Grant LA3655/1-1).; Supported by the PBC, Council for Higher Education, and the Hebrew University Program for Fellowships for Outstanding Postdoctoral Fellows from China and India (2015). Present address: Amity Institute of Biotechnology, Amity University Uttar Pradesh Malhaur, Lucknow-226028, India.; Supported by Ministry of Research and Innovation, CNCS-UEFISCDI, Project No. PN-III-P1-1.1-PD-2016-0802, within PNCDI III.; Supported by Israel Science Foundation Grants 284/12 and 939/14.	Alkoby D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093200; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Calinescu O, 2017, J BIOL CHEM, V292, P7932, DOI 10.1074/jbc.M117.778175; Calinescu O, 2015, BIOL CHEM, V396, P1091, DOI 10.1515/hsz-2014-0278; Calinescu O, 2014, FEBS LETT, V588, P3111, DOI 10.1016/j.febslet.2014.05.066; Coincon M, 2016, NAT STRUCT MOL BIOL, V23, P248, DOI 10.1038/nsmb.3164; Dwivedi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep23339; Furrer EM, 2007, FEBS LETT, V581, P572, DOI 10.1016/j.febslet.2006.12.059; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Harms MJ, 2011, P NATL ACAD SCI USA, V108, P18954, DOI 10.1073/pnas.1104808108; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; INOUE H, 1995, FEBS LETT, V363, P264, DOI 10.1016/0014-5793(95)00331-3; Kozachkov L, 2007, BIOCHEMISTRY-US, V46, P2419, DOI 10.1021/bi602393s; Lee C, 2014, J GEN PHYSIOL, V144, P529, DOI 10.1085/jgp.201411219; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Lentes CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101575; Maes M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.391128; Mager T, 2011, J BIOL CHEM, V286, P23570, DOI 10.1074/jbc.M111.230235; Olkhova E, 2009, PROTEINS, V76, P548, DOI 10.1002/prot.22368; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; Padan E, 2005, BBA-BIOMEMBRANES, V1717, P67, DOI 10.1016/j.bbamem.2005.09.010; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; PINNER E, 1993, J BIOL CHEM, V268, P1729; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Rimon A, 2007, J BIOL CHEM, V282, P26810, DOI 10.1074/jbc.M704469200; Rimon A, 2018, J MOL BIOL, V430, P867, DOI 10.1016/j.jmb.2018.01.014; ROSEN BP, 1986, METHOD ENZYMOL, V125, P328; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; Schulz P, 2008, METHODS, V46, P97, DOI 10.1016/j.ymeth.2008.07.002; TAGLICHT D, 1991, J BIOL CHEM, V266, P11289; TAGLICHT D, 1993, J BIOL CHEM, V268, P5382; Uzdavinys P, 2017, P NATL ACAD SCI USA, V114, pE1101, DOI 10.1073/pnas.1614521114; Venturi M, 2003, MEMBRANE PROTEIN PUR, P179; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Weichel M, 2008, BIOPROCESS INT, P42; Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009	38	12	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					246	256		10.1074/jbc.RA118.004903	http://dx.doi.org/10.1074/jbc.RA118.004903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409911	hybrid, Green Published			2022-12-26	WOS:000455105500027
J	Womack, JA; Novick, G; Fried, T				Womack, Julie A.; Novick, Gina; Fried, Terri			The beginning of the end: A qualitative study of falls among HIV plus individuals	PLOS ONE			English	Article							RISK-FACTORS; OLDER; EXPERIENCE; HEALTH; WOMEN	Falls are an important concern for individuals living with HIV (HIV+). The purpose of this study was to understand perceptions of HIV+ individuals who had fallen regarding what caused their falls, prevention strategies that they used, and the impact of falls on their lives. Qualitative Description was the approach best suited to our study. We conducted in-depth interviews with 21 HIV+ individuals aged 47 to 71 years who had fallen within the past two years and who received care in a primary care/HIV clinic. Participants identified causes of falls as intrinsic (HIV, opportunistic infections, antiretroviral therapy, substance use, polypharmacy) or extrinsic (icy sidewalks, wet floors). Among those who felt that their falls could be prevented, prevention strategies included physical therapy and avoiding extrinsic fall risk factors. Some participants, however, felt that their falls could not be prevented. While some participants responded adaptively to falls, for many, the experience of falling was connected with deep feelings of loss and suffering. For these individuals, falls were understood to be "the beginning of the end" and a source of social isolation, changing family roles, diminished sense of self, and stigma.	[Womack, Julie A.; Fried, Terri] VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [Womack, Julie A.; Novick, Gina] Yale Sch Nursing, West Haven, CT 06516 USA; [Fried, Terri] Yale Sch Med, Div Geriatr, Dept Internal Med, New Haven, CT USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Womack, JA (corresponding author), VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.; Womack, JA (corresponding author), Yale Sch Nursing, West Haven, CT 06516 USA.	Julie.womack@yale.edu			NINR [K01NR013437]; NCRR [UL1RR024139]; NCATS [UL1RR024139]	NINR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded in part by K01NR013437 (NINR), and UL1RR024139 (NCRR and NCATS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2014, COMPREHENSIVE PSYCHO; BALLINGER C, 2000, BRIT J OCCUPATIONAL, V63, P573, DOI DOI 10.1177/030802260006301203; Bunn F, 2008, AGEING SOC, V28, P449, DOI 10.1017/S0144686X07006861; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Bury M, 1988, LIVING CHRONIC ILLNE; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Emden C, 1999, Int J Nurs Pract, V5, P2; Erlandson KM, 2016, HIV MED, V17, P740, DOI 10.1111/hiv.12378; Erlandson KM, 2012, JAIDS-J ACQ IMM DEF, V61, P484, DOI 10.1097/QAI.0b013e3182716e38; Faes MC, 2010, AGING MENT HEALTH, V14, P834, DOI 10.1080/13607861003781825; Fletcher PC, 2002, J GERONTOL A-BIOL, V57, pM504, DOI 10.1093/gerona/57.8.M504; Glaser B.G., 1968, DISCOV GROUNDED THEO; Hendrich AL, 2003, APPL NURS RES, V16, P9, DOI 10.1053/apnr.2003.YAPNR2; JOHNSON JL, 1990, HEART LUNG, V19, P126; Kim TW, 2018, AIDS CARE, V30, P150, DOI 10.1080/09540121.2017.1384532; Kleinman A., 1988, ILLNESS NARRATIVES; Kong KSW, 2002, J ADV NURS, V37, P234, DOI 10.1046/j.1365-2648.2002.02094.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40, DOI 10.1111/j.1532-5415.1999.tb01899.x; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; McWilliam CL, 1996, ADV NURS SCI, V18, P1; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Novick G, 2008, RES NURS HEALTH, V31, P391, DOI 10.1002/nur.20259; Novick G, 2011, QUAL HEALTH RES, V21, P97, DOI 10.1177/1049732310378655; Patton, 2014, QUALITATIVE RES EVAL; RODGERS BL, 1993, RES NURS HEALTH, V16, P219, DOI 10.1002/nur.4770160309; Roe B, 2008, J ADV NURS, V63, P586, DOI 10.1111/j.1365-2648.2008.04735.x; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P179, DOI 10.1002/nur.4770180211; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Sandelowski M, 2015, NURS INQ, V22, P86, DOI 10.1111/nin.12080; Sandelowski M, 2010, RES NURS HEALTH, V33, P77, DOI 10.1002/nur.20362; Sharma A, 2016, ANTIVIR THER, V21, P697, DOI 10.3851/IMP3070; Simpson Janet M, 2003, Br J Community Nurs, V8, P154; Strauss AL, 1984, ILLNESS CHRONIC QUAL; Strauss AL., 1975, CHRONIC ILLNESS QUAL; Sullivan-Bolyai S, 2005, NURS OUTLOOK, V53, P127, DOI 10.1016/j.outlook.2005.03.005; Tassiopoulos K, 2017, AIDS, V31, P2287, DOI [10.1097/QAD.0000000000001613, 10.1097/qad.0000000000001613]; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; Tischler L, 2005, PHYS OCCUP THER GERI, V23, P37, DOI 10.1300/J148v23n04_03; Womack JA, 2018, LONGITUDINAL ASS CD4; Womack JA, 2017, INT WORKSH HIV HEP O	43	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207006	10.1371/journal.pone.0207006	http://dx.doi.org/10.1371/journal.pone.0207006			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408088	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300063
J	Cui, JT; Yan, WJ; Xie, HJ; Xu, SX; Wang, QF; Zhang, WH; Ni, AP				Cui, Jingtao; Yan, Wenjuan; Xie, Hongjie; Xu, Shaoxia; Wang, Qiaofeng; Zhang, Weihong; Ni, Anping			A retrospective seroepidemiologic survey of Chlamydia pneumoniae infection in patients in Beijing between 2008 and 2017	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; CHLAMYDOPHILA-PNEUMONIAE; TRACHOMATIS; PREVALENCE; ANTIBODIES; TWAR; POPULATION; PREVENTION; ETIOLOGY; MAINLAND	Background Chlamydia pneumoniae (C. pneumoniae) is an obligate intracellular bacterium and a human pathogen that causes respiratory infectious diseases. More than 50% of the adult population worldwide was once infected with C. pneumoniae, but investigations into this topic are insufficient in mainland China. Methods Anti-C. pneumoniae IgG and IgM antibodies were detected using micro-immunofluorescence test in serum samples of patients visiting Peking Union Medical College Hospital between 2008 and 2017 for routine medical purposes, and the aim of this retrospective study was to analyze the test results. Results Among 12,050 serum specimens tested for anti-C. pneumoniae IgG and IgM antibodies, the overall prevalence of anti-C. pneumoniae IgG antibodies was 86.6%, 87.2% for men and 86.0% for women. Adult men (>20 years) were found to have a significantly higher prevalence of antiC. pneumoniae IgG than women (chi(2) = 30.32, P = 0.000). 3 to 5 years old patients were observed to have the lowest prevalence of anti-C. pneumoniae IgG, 42.8%, then increased with age, reaching the highest level of 98.6% in patients over 70 years of age. In the 10,434 specimens with C. pneumoniae IgG antibodies, the total geometric mean titer (GMT) for C. pneumoniae IgG was 45.71. Although GMTs were found to be significantly higher among all men than among all women (t = 5.916, P = 0.000), sex difference actually began in patients over 40 years of age and increased in the elderly. In the total 12,050 specimens, 1.2% had anti-C. pneumoniae IgM, 3.3% had anti-C. pneumoniae IgG with titers equal to or greater than 1:512; 0.39% had >= 4-fold increasing titers of antibodies in acute and convalescent phase paired samples, and 4.4% were finally confirmed to have acute antibodies against C. pneumoniae. 6 to 10 years old patients were found to have the highest rate of both IgM antibodies (3.9%) and acute antibodies A (6.2%) against C. pneumoniae. Acute antibodies against C. pneumoniae were found to be more frequent in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD, 14.0%, chi(2 )= 20.43, P = 0.000), patients with pneumonia (7.8%, chi(2)= 51.87, P = 0.000) and patients with acute respiratory tract infection (12.3%, chi(2) = 60.91, P = 0.000) than among all patients (4.4%). Both anti-C. pneumoniae IgG and IgM antibodies should be tested for acute antibodies against C. pneumoniae as testing for either alone will underestimate by a maximum of two-thirds the incidence of acute antibodies against C. pneumoniae. Conclusions More than 86% of Chinese patients on an average were once infected with C. pneumoniae. Adult men had both a higher prevalence and higher levels of antibodies than women. 6 to10 year old patients were found to have the most frequent acute infection of C. pneumoniae. C. pneumoniae is associated with AECOPD, pneumonia and acute respiratory tract infection. Anti-C. pneumoniae IgG and IgM should be tested simultaneously to avoid underestimation of acute antibodies against C. pneumoniae.	[Ni, Anping] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ni, AP (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Labs, Beijing, Peoples R China.	niap@pumch.cn						Blasi F, 2002, THORAX, V57, P672, DOI 10.1136/thorax.57.8.672; Cannon CP, 2005, NEW ENGL J MED, V352, P1646, DOI 10.1056/NEJMoa043528; Cao JC, 2017, ONCOTARGET, V8, P55435, DOI 10.18632/oncotarget.19314; Chen KP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1422-1; Choi TY, 1998, J CLIN MICROBIOL, V36, P3426, DOI 10.1128/JCM.36.11.3426-3428.1998; Choroszy-Krol I, 2014, ADV CLIN EXP MED, V23, P123, DOI 10.17219/acem/37035; Del Valle-Mendoza Juana, 2017, BMC Res Notes, V10, P688, DOI 10.1186/s13104-017-3000-3; del Valle-Mendoza J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170787; Dowell SF, 2001, CLIN INFECT DIS, V33, P492, DOI 10.1086/322632; Grayston JT, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftu015; Grayston JT, 2005, NEW ENGL J MED, V352, P1637, DOI 10.1056/NEJMoa043526; GRAYSTON JT, 1990, J INFECT DIS, V161, P618, DOI 10.1093/infdis/161.4.618; Hao OM, 2018, J MED VIROL, V90, P421, DOI 10.1002/jmv.24963; Hsu MC, 2007, MICROBIOL IMMUNOL, V51, P539, DOI 10.1111/j.1348-0421.2007.tb03942.x; KANAMOTO Y, 1991, J CLIN MICROBIOL, V29, P816, DOI 10.1128/JCM.29.4.816-818.1991; Koivisto AL, 1999, SCAND J INFECT DIS, V31, P135, DOI 10.1080/003655499750006164; Kumar S, 2016, INDIAN J PATHOL MICR, V59, P499, DOI 10.4103/0377-4929.191803; KUO CC, 1993, ARTERIOSCLER THROMB, V13, P1501, DOI 10.1161/01.ATV.13.10.1501; KUO CC, 1995, CLIN MICROBIOL REV, V8, P451, DOI 10.1128/CMR.8.4.451; Lim WS, 2001, THORAX, V56, P296, DOI 10.1136/thorax.56.4.296; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119170; Liu YN, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-31; Messous S, 2017, MED MALADIES INFECT, V47, P158, DOI 10.1016/j.medmal.2016.12.002; Miyashita N, 2002, J CLIN PATHOL, V55, P115, DOI 10.1136/jcp.55.2.115; Muro S, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003371; Ni AP, 1996, SCAND J INFECT DIS, V28, P553, DOI 10.3109/00365549609037959; Ning GJ, 2017, HUM VACC IMMUNOTHER, V13, P2742, DOI 10.1080/21645515.2017.1371381; O'Neill C, 1999, EPIDEMIOL INFECT, V122, P111, DOI 10.1017/S0950268898001757; Principi Nicola, 2001, Clinical Infectious Diseases, V32, P1281, DOI 10.1086/319981; Raeven VM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1641-9; Sachse K, 2015, SYST APPL MICROBIOL, V38, P99, DOI 10.1016/j.syapm.2014.12.004; SALARI SH, 1981, J GEN MICROBIOL, V123, P197; WANG JH, 1993, SCAND J INFECT DIS, V25, P565, DOI 10.3109/00365549309008544; Wang SP, 2000, J INFECT DIS, V181, pS421, DOI 10.1086/315622; WANG SP, 1979, J CLIN MICROBIOL, V10, P259, DOI 10.1128/JCM.10.2.259-261.1979; Wang SP, 1990, CHLAMYDIAL INFECT, P402; Yazouli LE, 2018, J INFECT PUBLIC HEAL, V11, P246, DOI 10.1016/j.jiph.2017.07.029	37	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206995	10.1371/journal.pone.0206995	http://dx.doi.org/10.1371/journal.pone.0206995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403740	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500088
J	Savage, RD; Rosella, LC; Crowcroft, NS; Horn, M; Khan, K; Varia, M				Savage, Rachel D.; Rosella, Laura C.; Crowcroft, Natasha S.; Horn, Maureen; Khan, Kamran; Varia, Monali			Accuracy of health administrative data to identify cases of reportable travel or migration-related infectious diseases in Ontario, Canada	PLOS ONE			English	Article							SURVEILLANCE	An ongoing challenge of estimating the burden of infectious diseases known to disproportionately affect migrants (e.g. malaria, enteric fever) is that many health information systems, including reportable disease surveillance systems, do not systematically collect data on migrant status and related factors. We explored whether health administrative data linked to immigration records offered a viable alternative for accurately identifying cases of hepatitis A, malaria and enteric fever in Ontario, Canada. Using linked health care databases generated by Ontario's universal health care program, we constructed a cohort of medically-attended individuals with presumed hepatitis A, malaria or enteric fever in Peel region using diagnostic codes. Immigrant status was ascertained using linked immigration data. The sensitivity and positive predictive value (PPV) of diagnostic codes was evaluated through probabilistic linkage of the cohort to Ontario's reportable disease surveillance system (iPHIS) as the reference standard. Linkage was successful in 90.0% (289/321) of iPHIS cases. While sensitivity was high for hepatitis A and enteric fever (85.8% and 83.7%) and moderate for malaria (69.0%), PPV was poor for all diseases (0.3-41.3%). The accuracy of diagnostic codes did not vary by immigrant status. A dated coding system for outpatient physician claims and exclusion of new immigrants not yet eligible for health care were key challenges to using health administrative data to identify cases. Despite this, we show that linkages of health administrative and immigration records with reportable disease surveillance data are feasible and have the potential to bridge important gaps in estimating burden using either data source independently.	[Savage, Rachel D.; Rosella, Laura C.; Crowcroft, Natasha S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Savage, Rachel D.; Rosella, Laura C.] ICES, Toronto, ON, Canada; [Rosella, Laura C.; Crowcroft, Natasha S.] Publ Hlth Ontario, Toronto, ON, Canada; [Crowcroft, Natasha S.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Horn, Maureen; Varia, Monali] Peel Publ Hlth, Mississauga, ON, Canada; [Khan, Kamran] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Khan, Kamran] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada; [Savage, Rachel D.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Savage, RD (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Savage, RD (corresponding author), ICES, Toronto, ON, Canada.; Savage, RD (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	rachel.savage@mail.utoronto.ca			Canadian Institutes of Health Research [FRN 128757]; Ontario Ministry of Health and Long-Term Care (MOHLTC); Peel Public Health (PPH); ICES; Public Health Ontario (PHO)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Peel Public Health (PPH); ICES(University of Toronto); Public Health Ontario (PHO)	This work was supported by a doctoral research award from the Canadian Institutes of Health Research [FRN 128757] to RDS and by Peel Public Health (PPH), as well as ICES and Public Health Ontario (PHO), which are funded by annual grants from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. Parts of this material are based on data and/or information compiled and provided by CIHI. No endorsement by PPH, ICES, PHO, the Ontario MOHLTC or CIHI is intended or should be inferred.	[Anonymous], DAD ABSTR MAN 2015 2; Baer A, 2014, TRAVEL MED INFECT DI, V12, P525, DOI 10.1016/j.tmaid.2014.05.005; Boggild A, 2014, CANADIAN RECOMMENDAT; Cassini A, 2018, EUROSURVEILLANCE, V23, P15, DOI 10.2807/1560-7917.ES.2018.23.16.17-00454; Chiu M, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0375-3; Committee to Advise on Tropical Medicine and Travel, 2008, CCDR, V34; Committee to Advise on Tropical Medicine and Travel, 2015, STAT INT TRAV WHO IN; Crowcroft NS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195984; European Centre for Disease Prevention and Control, TECHN REP ASS BURD K; Fathima S, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2321-1; Friedman S M, 2006, Can Commun Dis Rep, V32, P187; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Goel R, 2012, CAN MED ASSOC J, V184, pE103, DOI 10.1503/cmaj.111095; Greenaway C, 2014, CCDR, V40; Harling R, 2004, J INFECTION, V48, P139, DOI 10.1016/S0163-4453(03)00080-X; Horn M, 2013, ENCOURAGING TRAVELLE; Iron K, 2008, LIVING DYING ONTARIO; Kalich A, 2016, J IMMIGR MINOR HEALT, V18, P697, DOI 10.1007/s10903-015-0237-6; Kwong JC, 2010, ONTARIO BURDEN INFEC; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; National Health Service England, 2017, WHICH TRAV VAC FREE; Nicholls SG, 2017, CAN MED ASSOC J, V189, pE1054, DOI 10.1503/cmaj.170807; Ontario Ministry of Health and Long-Term Care, 1998, OHIP B; Ontario Ministry of Health and Long-Term Care, ONT HLTH INS PROGR M; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Region of Peel, 2013, 2011 NAT HOUS SURV B; Savage RD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1636-6; Sickbert-Bennett EE, 2011, EMERG INFECT DIS, V17, P23, DOI 10.3201/eid1701.100660; Sickbert-Bennett EE, 2010, AM J EPIDEMIOL, V172, P1299, DOI 10.1093/aje/kwq285; Szklo M., 2007, EPIDEMIOLOGY BASICS; Tang Karen L, 2017, CMAJ Open, V5, pE617, DOI 10.9778/cmajo.20170036; World Health Organisation, 2012, INT TRAV HLTH SPEC G; World Health Organization, 2003, CLIMATE CHANGE HUMAN; Yu O, 2011, EPIDEMIOL INFECT, V139, P1296, DOI 10.1017/S0950268810002529	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207030	10.1371/journal.pone.0207030	http://dx.doi.org/10.1371/journal.pone.0207030			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403758	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500096
J	Awidi, M; Bawaneh, H; Zureigat, H; AlHusban, M; Awidi, A				Awidi, Muhammad; Bawaneh, Hisham; Zureigat, Hadil; AlHusban, Muna; Awidi, Abdalla			Contributing factors to iron deficiency anemia in women in Jordan: A single-center cross- sectional study	PLOS ONE			English	Article								Objectives This study aimed to understand the impact of iron deficiency anemia in female users of a hematology service in a developing country. Design Retrospective cross-sectional study of adult and adolescent women with iron deficiency anemia who presented to a hospital department of hematology. Setting A tertiary university hospital inpatient and outpatient hematology service. Participants All female patients who were >13 years of age with confirmed iron deficiency anemia and received hospital hematology services. Results A total of 208 patients were enrolled and analyzed in the registry. The mean age of the patients was 41.4 years (range, 14-82). A total of 195 patients had anemia that was moderate or severe according to the World Health Organization anemia classification with 13 patients having mild anemia. A total of 108 patients had comorbidities, which were primarily endocrine and cardiovascular. Iron deficiency anemia was associated with very heavy (n = 56, 30%) or heavy menses (n = 84, 45%) in 140 patients and was associated with poor (<200 g/week of red meat) (n = 101, 54%) or very poor (vegan, strict vegetarian) nutrition (n = 34, 18%) in 135 patients. A total of 101 patients had a previous pregnancy history with a mean of six previous pregnancies (range, 1-11 pregnancy episodes per patient). Blood film was performed on all patients; only four had a picture consistent with thalassemia minor. Conclusion Iron deficiency anemia is caused by multiple factors. Heavy menses and low consumption of red meat were found to be associated with the severity of anemia. Our findings may be useful for healthcare planners and policy makers in increasing efforts to reduce the prevalence and severity of iron deficiency anemia among women in Jordan.	[Awidi, Muhammad; Awidi, Abdalla] Univ Jordan, Cell Therapy Ctr, Amman, Jordan; [Bawaneh, Hisham; Awidi, Abdalla] Univ Jordan, Univ Jordan Hosp, Amman, Jordan; [Zureigat, Hadil; AlHusban, Muna; Awidi, Abdalla] Univ Jordan, Fac Med, Amman, Jordan	University of Jordan; University of Jordan; University of Jordan	Awidi, M (corresponding author), Univ Jordan, Cell Therapy Ctr, Amman, Jordan.	muhammadawidi@gmail.com	Awidi, Muhammad/F-7622-2018	Awidi, Muhammad/0000-0002-4205-8417; awidi, abdalla/0000-0002-4884-948X				Al-Shaikh GK, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1508-0; Bach V, 2014, CLIN INTERV AGING, V9, P1187, DOI 10.2147/CIA.S61125; Bank TW, 2017, JORD COUNTR RECL SEC; Berger Jacques, 2002, Sante, V12, P22; Caira C, 2013, FUTUR CARDIOL, V9, P437, DOI [10.2217/fca.13.12, 10.2217/FCA.13.12]; Derbyshire E, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070768; HIGHAM JM, 1990, BRIT J OBSTET GYNAEC, V97, P734, DOI 10.1111/j.1471-0528.1990.tb16249.x; Hug BL, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13847; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Lopez A, 2016, LANCET, V387, P907, DOI 10.1016/S0140-6736(15)60865-0; Powell N, 2008, EUR J GASTROEN HEPAT, V20, P1094, DOI 10.1097/MEG.0b013e328304d621; Schuepbach Reto A, 2011, Int J Biomed Sci, V7, P150; Serdula MK, 2014, EUR J CLIN NUTR, V68, P1124, DOI 10.1038/ejcn.2014.100; Simonsen SME, 2005, OBSTET GYNECOL, V106, P454, DOI 10.1097/01.AOG.0000175839.46609.8e; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2001, IR DEF AN ASS PREV C; World Health Organization Centers for Disease Control and Prevention, 2007, ASS IR STAT POP	18	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205868	10.1371/journal.pone.0205868	http://dx.doi.org/10.1371/journal.pone.0205868			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395644	gold, Green Submitted, Green Published			2022-12-26	WOS:000449291400013
J	Brito, SA; Barbosa, IS; de Almeida, CLF; de Medeiros, JW; Neto, JCS; Rolim, LA; da Silva, TG; Ximenes, RM; de Menezes, IRA; Caldas, GFR; Wanderley, AG				Brito, Samara A.; Barbosa, Isabela S.; de Almeida, Cynthia L. F.; de Medeiros, Jonathan W.; Silva Neto, Jacinto C.; Rolim, Larissa A.; da Silva, Teresinha G.; Ximenes, Rafael M.; de Menezes, Irwin R. A.; Caldas, Germana F. R.; Wanderley, Almir G.			Evaluation of gastroprotective and ulcer healing activities of yellow mombin juice from Spondias mombin L.	PLOS ONE			English	Article							GASTRIC-ULCER; RATS; INDOMETHACIN; MECHANISM; STOMACH; LESIONS; CANCER	Spondias mombin L. (yellow mombin) is a tree with a nutritional fruit that is commonly consumed in the North and Northeast of Brazil, as the juice of its pulp is rich in antioxidant compounds. This study aimed to investigate the gastroprotective and ulcer healing activities of yellow mombin juice (YMJ) in Wistar rats, and to elucidate the possible involved mechanisms. Phytochemical characterization of the lyophilized fruit juice was performed by high-performance liquid chromatography (HPLC). The gastroprotective activity of YMJ was investigated in ethanol (25, 50, and 100% YMJ) and indomethacin (100% YMJ) models of acute gastric ulcer in rats. Then, the effect of YMJ on mucus production and gastric secretions, and the involvement of non-protein sulfhydryl groups and prostaglandins in the gastroprotective process were examined. Moreover, the ulcer healing effect of YMJ was investigated in a model of acetic acid-induced chronic ulcer through histological and immunohistochemical analyses. HPLC results identified the presence of epicatechin (7.1 +/- 1.6 mu g/mL) and quercetin (17.3 +/- 2.5 mu g/mL) in YMJ. Ethanol-induced gastric lesions were inhibited by YMJ (25, 50, and 100%) by 42.42, 45.09, and 98.21% respectively, and indomethacin-induced lesions were inhibited by YMJ (100%) by 58.96%, compared to control group. Moreover, YMJ reduced gastric content and total acidy by 57.35 and 71.97%, respectively, compared to the control group. Treatment with YMJ also promoted healing of chronic ulcer, regeneration of the gastric mucosa, and restoration of mucus levels in glandular cells, as confirmed by histological analysis. It also increased cellular proliferation, as demonstrated by high reactivity to Ki-67 and bromodeoxyuridine. In conclusion, YMJ was found to possess gastroprotective and ulcer healing activities that are correlated to its antisecretory action. These results support the commercial exploration of YMJ as a functional food.	[Brito, Samara A.; de Almeida, Cynthia L. F.; da Silva, Teresinha G.; Ximenes, Rafael M.; Wanderley, Almir G.] Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil; [Brito, Samara A.] Coll Santa Maria, Cajazeiras, Paraiba, Brazil; [Barbosa, Isabela S.; Wanderley, Almir G.] Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil; [de Almeida, Cynthia L. F.] Univ Fed Vale Sao Francisco, Coll Nursing, Petrolina, PE, Brazil; [de Medeiros, Jonathan W.] Univ Estadual Pernambuco, Dept Cellular & Appl Mol Biol, Recife, PE, Brazil; [Silva Neto, Jacinto C.] Univ Fed Pernambuco, Dept Histol & Embryol, Recife, PE, Brazil; [Rolim, Larissa A.] Univ Fed Vale Sao Francisco, Analyt Ctr Drugs Med & Food, Petrolina, PE, Brazil; [da Silva, Teresinha G.; Ximenes, Rafael M.] Univ Fed, Dept Antibiot, Recife, PE, Brazil; [de Menezes, Irwin R. A.] Univ Reg Cariri, Dept Biol Chem, Crato, Ceara, Brazil; [Caldas, Germana F. R.] Ctr Univ Doutor Leao Sampaio, Juazeiro Do Norte, Ceara, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal do Vale do Sao Francisco; Universidade Federal de Pernambuco; Universidade Federal de Pernambuco; Universidade Federal do Vale do Sao Francisco; Universidade Regional do Cariri	Wanderley, AG (corresponding author), Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil.; Wanderley, AG (corresponding author), Univ Fed Pernambuco, Dept Physiol & Pharmacol, Recife, PE, Brazil.	almir.wanderley@ufpe.br	WANDERLEY, ALMIR GONÇALVES/T-3087-2019; de Menezes, Irwin Rose Alencar/A-6777-2012; Silva Neto, Jacinto da Costa/R-5602-2017; Ximenes, Rafael/AAG-9874-2021; Ximenes, Rafael M/J-3247-2012; Gonçalves-Silva, TERESINHA/ABE-4945-2021; Rolim, Larissa A/E-6942-2014	WANDERLEY, ALMIR GONÇALVES/0000-0001-5193-1153; de Menezes, Irwin Rose Alencar/0000-0003-1065-9581; Silva Neto, Jacinto da Costa/0000-0003-4418-801X; Ximenes, Rafael/0000-0002-2011-2865; Ximenes, Rafael M/0000-0002-2011-2865; Rolim, Larissa A/0000-0002-2403-1026	Coordination for the Improvement of Higher Level Personnel, Brazil (CAPES, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Coordination for the Improvement of Higher Level Personnel, Brazil (CAPES, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	This work was funded by Coordination for the Improvement of Higher Level Personnel, Brazil (CAPES, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) that granted a doctoral scholarship to SAB. http://www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Suarez JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025878; Anantharaju PG, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0217-2; Brito SA, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1731459; Cabral B, 2016, REV BRAS FARMACOGN, V26, P304, DOI 10.1016/j.bjp.2016.02.002; Calam J, 2001, BRIT MED J, V323, P980, DOI 10.1136/bmj.323.7319.980; Chandranath SI, 2002, CLIN EXP PHARMACOL P, V29, P173, DOI 10.1046/j.1440-1681.2002.03626.x; DJAHANGUIRI B, 1969, SCAND J GASTROENTERO, V4, P265; DOLBEARE F, 1995, HISTOCHEM J, V27, P339; Hajrezaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051537; Hu XT, 2015, EUR J PHARMACOL, V754, P133, DOI 10.1016/j.ejphar.2015.02.007; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Kaplan KA, 2012, J FOOD SCI, V77, pH224, DOI 10.1111/j.1750-3841.2012.02920.x; Kato S, 2002, JPN J PHARMACOL, V89, P1, DOI 10.1254/jjp.89.1; Kolgazi M, 2017, J PHYSIOL PHARMACOL, V68, P765; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Lu Y, 2008, FREE RADICAL BIO MED, V44, P723, DOI 10.1016/j.freeradbiomed.2007.11.004; Magierowski M, 2018, BIOCHEM PHARMACOL, V149, P131, DOI 10.1016/j.bcp.2017.11.020; Matsuda H, 1999, LIFE SCI, V65, pPL27, DOI 10.1016/S0024-3205(99)00241-6; Mitchell JD, 2015, PHYTOKEYS, V55, P1, DOI 10.3897/phytokeys.55.8489; MORIMOTO Y, 1991, JPN J PHARMACOL, V57, P495, DOI 10.1254/jjp.57.495; MURAKAMI S, 1992, J PHARM PHARMACOL, V44, P926, DOI 10.1111/j.2042-7158.1992.tb03238.x; Murakami S., 1991, J ENZYM INHIB, V5, P293, DOI DOI 10.3109/14756369109069071; Nakao K, 2014, J FORENSIC LEG MED, V22, P99, DOI 10.1016/j.jflm.2013.12.016; Okabe S, 2005, BIOL PHARM BULL, V28, P1321, DOI 10.1248/bpb.28.1321; RAFATULLAH S, 1990, J ETHNOPHARMACOL, V29, P25, DOI 10.1016/0378-8741(90)90094-A; Caldas GFR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134558; Rozza A L, 2012, Evid Based Complement Alternat Med, V2012, P708156, DOI 10.1155/2012/708156; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHAY H, 1945, GASTROENTEROLOGY, V5, P43; Singh DP, 2017, EXP TOXICOL PATHOL, V69, P17, DOI 10.1016/j.etp.2016.10.004; Souza Francisco Xavier de, 2006, Rev. Bras. Frutic., V28, P414, DOI 10.1590/S0100-29452006000300017; Taha MME, 2012, J ETHNOPHARMACOL, V141, P273, DOI 10.1016/j.jep.2012.02.030; TAKAGI K, 1969, JPN J PHARMACOL, V19, P418, DOI 10.1254/jjp.19.418; Testerman TL, 2014, WORLD J GASTROENTERO, V20, P12781, DOI 10.3748/wjg.v20.i36.12781; Tiburski JH, 2011, FOOD RES INT, V44, P2326, DOI 10.1016/j.foodres.2011.03.037; Wallace JL, 2008, PHYSIOL REV, V88, P1547, DOI 10.1152/physrev.00004.2008; Wang L, 2017, J NAT MED-TOKYO, V71, P257, DOI 10.1007/s11418-016-1057-2; Yandrapu Harathi, 2015, Curr Gastroenterol Rep, V17, P24, DOI 10.1007/s11894-015-0452-2; Zakaria ZA, 2016, BMC COMPLEM ALTERN M, V16, P2	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0201561	10.1371/journal.pone.0201561	http://dx.doi.org/10.1371/journal.pone.0201561			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395566	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400003
J	Li, YP; Yang, Y; Yi, JT; Ho, JH; Shi, JY; Goh, SH; Lee, FH				Li, Yu Ping; Yang, Yu; Yi, Jiang Tao; Ho, Jia Hui; Shi, Jian Yong; Goh, Siang Huat; Lee, Fook Hou			Causes of post-installation penetration of jack-up spudcan foundations in clays	PLOS ONE			English	Article								This paper examines possible causes of additional spudcan settlement after preloading using both centrifuge model tests and small strain finite element analysis, in which spudcan settlement due to cavity collapse, consolidation settlement and settlement due to cyclic loading are incorporated. Back-analyses of seven jack-up rigs in the Gulf of Mexico show that even complete cavity collapse could only explain part of the measured additional settlements in the majority of the cases. Small strain finite element analyses also show that spudcan consolidation settlement is likely to account for even less of the additional settlement than cavity collapse in the sites considered. On the other hand, centrifuge model tests show that large amplitude cyclic rocking has a very significant effect on spudcan settlement, even if half of the preload has been removed. However, this effect cannot be explained by the exceedance of the yield envelope since the loading combination had not exceeded the yield envelope. One possible explanation is the stiffness and strength degradation of the soil under cyclic loading. In view of this, a conservative approach is recommended in instances where large amplitude cyclic rocking, such as that arising from storm loading, is expected shortly after preloading. The presence of lattice legs is found to reduce the spudcan settlement during large amplitude cyclic rocking.	[Li, Yu Ping; Shi, Jian Yong] Hohai Univ, Geotech Engn Res Inst, Minist Educ Geomech & Embankment Engn, Key Lab, Nanjing, Jiangsu, Peoples R China; [Yang, Yu; Goh, Siang Huat; Lee, Fook Hou] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore, Singapore; [Yi, Jiang Tao] Chongqing Univ, Minist Educ, Sch Civil Engn, Key Lab New Technol Construct Cities Mt Area, Chongqing, Peoples R China; [Ho, Jia Hui] Singapore Inst Technol, Engn Cluster, Singapore, Singapore	Hohai University; National University of Singapore; Chongqing University; Singapore Institute of Technology	Yi, JT (corresponding author), Chongqing Univ, Minist Educ, Sch Civil Engn, Key Lab New Technol Construct Cities Mt Area, Chongqing, Peoples R China.	yijt@foxmail.com	Lee, Fook Hou/Q-5696-2019		National Natural Science Foundation of China [41702290, 41530637, 51509025, 51778091]; Agency for Science Technology and Research; Maritime and Port Authority of Singapore [0821350042]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agency for Science Technology and Research(Agency for Science Technology & Research (A*STAR)); Maritime and Port Authority of Singapore	This work was supported by The National Natural Science Foundation of China (41702290, 41530637, 51509025, and 51778091) http://www.nsfc.gov.cn/, the Agency for Science Technology and Research and the Maritime and Port Authority of Singapore (No: 0821350042), https://www.mpa.gov.sg/web/portal/home.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BSI STAND PUBL; Bienen B, 2013, J GEOTECH GEOENVIRON, V139, P2048, DOI 10.1061/(ASCE)GT.1943-5606.0000943; Brennan R, 2006, P OFFSH TECHN C HOUS; Finnie I.M., 1994, P 7 INT C BEH OFFSH, P217; Hansen JB, 1970, REVISED EXTENDED FOR, P5; Ho JH, 2014, THESIS; Hodder MS, 2010, INT J GEOMECH, V10, P117, DOI 10.1061/(ASCE)GM.1943-5622.0000041; Hossain MS, 2005, GEOTECHNIQUE, V55, P679, DOI 10.1680/geot.2005.55.9.679; Hossain MS, 2009, INT J GEOMECH, V9, P122, DOI DOI 10.1061/(ASCE)1532-3641(2009)9:3(122); Hossain MS, 2009, J GEOTECH GEOENVIRON, V135, P1264, DOI 10.1061/(ASCE)GT.1943-5606.0000054; Houlsby GT, 2003, GEOTECHNIQUE, V53, P513, DOI 10.1680/geot.53.5.513.37507; Ishihara K., 1975, SOILS FOUND, V15, P29, DOI [10.3208/sandf1972.15.29, DOI 10.3208/SANDF1972.15.29]; Li YP, 2017, GEOTECHNIQUE, V67, P1, DOI 10.1680/jgeot.15.P.014; Li YP, 2017, 15 INT C INT ASS COM; Menzies D., 2008, P OFFSH TECHN C; Skempton A.W., 1951, BEARING CAPACITY CLA, P50, DOI DOI 10.1680/SPOSM.02050.0008; SNAME, 2008, SOC NAV ARCH MAR ENG; Templeton JS, 2009, P 12 INT C JACK UP P; Wang D, 2016, GEOTECHNIQUE, V66, P947, DOI 10.1680/jgeot.15.P.048; Wood DV, 1994, SOIL BEHAV CRITICAL; WROTH CP, 1984, GEOTECHNIQUE, V34, P449, DOI 10.1680/geot.1984.34.4.449; Yang Y., 2014, THESIS; Yang Y, 2014, COMM COM INF SC, V484, P545; Yi JT, 2014, COMPUT GEOTECH, V56, P133, DOI 10.1016/j.compgeo.2013.11.007	24	3	3	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206626	10.1371/journal.pone.0206626	http://dx.doi.org/10.1371/journal.pone.0206626			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395581	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400037
J	Liu, Y; Moura, ECCM; Dorr, JM; Scheidelaar, S; Heger, M; Egmond, MR; Killian, JA; Mohammadi, T; Breukink, E				Liu, Yao; Moura, Elisabete C. C. M.; Dorr, Jonas M.; Scheidelaar, Stefan; Heger, Michel; Egmond, Maarten R.; Killian, J. Antoinette; Mohammadi, Tamimount; Breukink, Eefjan			Bacillus subtilis MraY in detergent-free system of nanodiscs wrapped by styrene-maleic acid copolymers	PLOS ONE			English	Article							MEMBRANE-PROTEINS; FUNCTIONAL RECONSTITUTION; HIGH-THROUGHPUT; PURIFICATION; FLUORESCENCE; STEP; BIOSYNTHESIS; INHIBITORS; ASSAY; SLYD	As an integral membrane protein, purification and characterization of phospho-N-acetylmuramyl- pentapeptide translocase MraY have proven difficult. Low yield and concerns of retaining stability and activity after detergent solubilization have hampered the structure-function analysis. The recently developed detergent-free styrene-maleic acid (SMA) copolymer system offers an alternative approach that may overcome these disadvantages. In this study, we used the detergent free system to purify MraY from Bacillus subtilis. This allowed efficient extraction of MraY that was heterologously produced in Escherichia coli membranes into SMA-wrapped nanodiscs. The purified MraY embedded in these nanodiscs (SMA-MraY) was comparable to the micellar MraY extracted with a conventional detergent (DDM) with regard to the yield and the purity of the recombinant protein but required significantly less time. The predominantly alpha-helical secondary structure of the protein in SMA-wrapped nanodiscs was also more stable against heat denaturation compared to the micellar protein. Thus, this detergent-free system is amenable to extract MraY efficiently and effectively while maintaining the biophysical properties of the protein. However, the apparent activity of the SMA-MraY was reduced compared to that of the detergent-solubilized protein. The present data indicates that this is caused by a lower accessibility of the enzyme in SMA-wrapped nanodiscs towards its polyisoprenoid substrate.	[Liu, Yao; Moura, Elisabete C. C. M.; Dorr, Jonas M.; Scheidelaar, Stefan; Heger, Michel; Egmond, Maarten R.; Killian, J. Antoinette; Mohammadi, Tamimount; Breukink, Eefjan] Univ Utrecht, Inst Biomembranes, Dept Membrane Biochem & Biophys, Utrecht, Netherlands; [Heger, Michel] Univ Amsterdam, Acad Med Ctr, Dept Expt Surg, Amsterdam, Netherlands; [Moura, Elisabete C. C. M.] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Scheidelaar, Stefan] Polyscope BV, Sittard, Netherlands	Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; University of Milan	Breukink, E (corresponding author), Univ Utrecht, Inst Biomembranes, Dept Membrane Biochem & Biophys, Utrecht, Netherlands.	E.J.Breukink@uu.nl	Killian, J. Antoinette/I-3001-2016; Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; Heger, Michal/0000-0002-0630-4465; Moura, Elisabete/0000-0002-3624-4731	ZonMW from the Netherlands Organization for Scientific Research (NWO) [205.100.008]; seventh Framework Program of the European Union (Marie Curie Initial Training Network "ManiFold" [317371]; Foundation for Fundamental Research on Matter of NWO	ZonMW from the Netherlands Organization for Scientific Research (NWO); seventh Framework Program of the European Union (Marie Curie Initial Training Network "ManiFold"; Foundation for Fundamental Research on Matter of NWO	EB received ZonMW (https://www.zonmw.nl/nl/) grant (No. 205.100.008) from the Netherlands Organization for Scientific Research (NWO). JMD is supported by the seventh Framework Program of the European Union (Marie Curie Initial Training Network "ManiFold", http://www.manifold-idp.nl/Grant No. 317371). SS is supported by the Foundation for Fundamental Research on Matter (https://www.universitypositions.eu/university/foundation-for-fundamental-research-on-matter-fom) of NWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dabbagh B, 2016, BIOCHIMIE, V127, P249, DOI 10.1016/j.biochi.2016.06.005; Arenas RC, 2017, SCI REP-UK, V7, DOI 10.1038/srep45875; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; Bouhss A, 2008, FEMS MICROBIOL REV, V32, P208, DOI 10.1111/j.1574-6976.2007.00089.x; Boyle DS, 1998, J BACTERIOL, V180, P6429; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; CHEN RF, 1967, ARCH BIOCHEM BIOPHYS, V120, P609, DOI 10.1016/0003-9861(67)90526-7; Chung BC, 2016, NATURE, V533, P557, DOI 10.1038/nature17636; Chung BC, 2013, SCIENCE, V341, P1012, DOI 10.1126/science.1236501; Dominguez-Gil T, 2016, DRUG RESIST UPDATE, V28, P91, DOI 10.1016/j.drup.2016.07.002; Dorr JM, 2016, EUR BIOPHYS J BIOPHY, V45, P3, DOI 10.1007/s00249-015-1093-y; Dorr JM, 2014, P NATL ACAD SCI USA, V111, P18607, DOI 10.1073/pnas.1416205112; Fer MJ, 2015, ORG BIOMOL CHEM, V13, P7193, DOI 10.1039/c5ob00707k; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; GRZYBEK H, 1973, MIKROSKOPIE, V28, P292; Gulati S, 2014, BIOCHEM J, V461, P269, DOI 10.1042/BJ20131477; Hachmann JP, 2005, ANAL BIOCHEM, V342, P237, DOI 10.1016/j.ab.2005.04.015; Henrich E, J BIOL CHEM; Henrich E, 2017, ELIFE, V6, DOI 10.7554/eLife.20954; Henrich E, 2015, METHOD ENZYMOL, V556, P351, DOI 10.1016/bs.mie.2014.12.016; Jamshad M, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140171; Kaufmann T, 2012, J MATER CHEM, V22, P6190, DOI 10.1039/c2jm16807c; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knowles TJ, 2009, J AM CHEM SOC, V131, P7484, DOI 10.1021/ja810046q; KOHLRAUSCH U, 1991, FEMS MICROBIOL LETT, V78, P253; Leach MR, 2007, J BIOL CHEM, V282, P16177, DOI 10.1074/jbc.M610834200; Lee SC, 2016, NAT PROTOC, V11, P1149, DOI 10.1038/nprot.2016.070; Liu Y, 2016, J BIOL CHEM; Liu Y, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5030028; Long AR, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-41; Maurye P, 2014, J BIOSCI BIOENG, V117, P769, DOI 10.1016/j.jbiosc.2013.11.007; Mihalyi A, 2014, BIOORGAN MED CHEM, V22, P4566, DOI 10.1016/j.bmc.2014.07.035; Morrison KA, 2016, BIOCHEM J, V473, P4349, DOI 10.1042/BCJ20160723; Parsy CB, 2007, J CHROMATOGR B, V853, P314, DOI 10.1016/j.jchromb.2007.03.046; Postis V, 2015, BBA-BIOMEMBRANES, V1848, P496, DOI 10.1016/j.bbamem.2014.10.018; Rehan S, 2017, BBA-BIOMEMBRANES, V1859, P1059, DOI 10.1016/j.bbamem.2017.02.017; Shapiro AB, 2012, J BIOMOL SCREEN, V17, P662, DOI 10.1177/1087057112436885; Stachyra T, 2004, ANTIMICROB AGENTS CH, V48, P897, DOI 10.1128/AAC.48.3.897-902.2004; Swainsbury DJK, 2014, ANGEW CHEM INT EDIT, V53, P11803, DOI 10.1002/anie.201406412; van Dongen SFM, 2009, BIOCONJUGATE CHEM, V20, P20, DOI 10.1021/bc8004304; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; WEPPNER WA, 1979, BIOCHIM BIOPHYS ACTA, V552, P418, DOI 10.1016/0005-2736(79)90186-X; Zawadzke LE, 2003, ANAL BIOCHEM, V314, P243, DOI 10.1016/S0003-2697(02)00622-X; Zhang JW, 2005, J BIOL CHEM, V280, P4360, DOI 10.1074/jbc.M411799200	44	8	9	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206692	10.1371/journal.pone.0206692	http://dx.doi.org/10.1371/journal.pone.0206692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395652	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400042
J	Backer, R; Ghidotti, M; Schwinghamer, T; Saeed, W; Grenier, C; Dion-Laplante, C; Fabbri, D; Dutilleul, P; Seguin, P; Smith, DL				Backer, Rachel; Ghidotti, Michele; Schwinghamer, Timothy; Saeed, Werda; Grenier, Claudia; Dion-Laplante, Carl; Fabbri, Daniele; Dutilleul, Pierre; Seguin, Philippe; Smith, Donald L.			Getting to the root of the matter: Water-soluble and volatile components in thermally-treated biosolids and biochar differentially regulate maize (Zea mays) seedling growth	PLOS ONE			English	Article							ORGANIC-COMPOUNDS; PLANT-GROWTH; SOIL; PYROLYSIS; GERMINATION; BIOMASS; QUALITY; IMPACT	The use of thermally treated biomass, including biochar, as soil amendments can improve soil fertility by providing nutrients, stable C and improving soil water-holding capacity. However, if the degree of carbonization is low, these soil amendments can lower crop productivity as a result of high salinity or organic compounds. The overall effect of these soil amendments is mediated by complex relationships between production conditions, soil properties and environmental conditions. This study aimed to 1) characterize the physiochemical properties and organic compounds released by three soil amendments (softwood biochar or pyrogenic carbonaceous biosolids), 2) determine the effects of these amendments on maize (Zea mays) seedling productivity, and 3) relate properties of these amendments to effects on maize seedling productivity under controlled environment conditions. Physicochemical properties and mobile organic compounds (water-soluble and volatile organic compounds were determined. The amendments were tested in maize germination and greenhouse experiments. Chemical fingerprinting of volatile and water-soluble compounds revealed over 100 mobile organic species. Increasing treatment temperature from 270 to 320 degrees C reduces phytotoxicity of pyrogenic carbonaceous biosolids soil amendments. Water-soluble components of pyrogenic carbonaceous biosolids produced at 270 degrees C (inorganic N, Na and/or organic compounds) were associated with reduced maize seedling productivity. Volatile components of pyrogenic carbonaceous biosolids produced at 320 degrees C were associated with improved maize seedling productivity; nitrogen uptake was increased in spite of smaller root systems as a result of increased mineralization of soil or amendment N and/or uptake of organic N compounds. These results suggest that pyrogenic carbonaceous biosolids have potential benefits to provide plant nutrients when the amount of organic and inorganic species are limited during early growth stages, under greenhouse conditions. Future studies should examine these effects under field conditions to confirm whether controlled environment results translate into effects on yield.	[Backer, Rachel; Schwinghamer, Timothy; Saeed, Werda; Grenier, Claudia; Dion-Laplante, Carl; Dutilleul, Pierre; Seguin, Philippe; Smith, Donald L.] McGill Univ, Dept Plant Sci, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada; [Ghidotti, Michele; Fabbri, Daniele] Univ Bologna, CIRI EA, Dept Chem Giacomo Ciamician, Ravenna Campus, Ravenna, Italy; [Ghidotti, Michele; Fabbri, Daniele] Univ Bologna, CIRSA, Dept Chem Giacomo Ciamician, Ravenna Campus, Ravenna, Italy	McGill University; University of Bologna; University of Bologna	Backer, R (corresponding author), McGill Univ, Dept Plant Sci, Macdonald Campus, Ste Anne De Bellevue, PQ, Canada.	rachel.backer@mail.mcgill.ca		Seguin, Philippe/0000-0001-7737-7621; backer, rachel/0000-0002-5631-9833; Schwinghamer, Timothy/0000-0001-7727-7284	Natural Sciences and Engineering Research Council of Canada [438683]; Biofuelnet, a Network Centres of Excellence	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Biofuelnet, a Network Centres of Excellence	This project was funded by the Natural Sciences and Engineering Research Council of Canada by award titled "Biochar: biofuels help themselves". Details are available here: http://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng. asp?id= 438683. Funding was also provided by Biofuelnet, a Network Centres of Excellence. Details are available here: http://www.nce-rce.gc.ca/NetworksCentres-CentresReseaux/NCE-RCE/BioFuelNet_eng.asp.	Abiven S, 2015, PLANT SOIL, V395, P45, DOI 10.1007/s11104-015-2533-2; Ameloot N, 2015, GCB BIOENERGY, V7, P135, DOI 10.1111/gcbb.12119; Backer RGM, 2016, J PLANT NUTR SOIL SC, V179, P399, DOI 10.1002/jpln.201500520; Backer RG, 2017, PLANT SOIL, P1; Benavente I, 2018, SCI TOTAL ENVIRON, V634, P1308, DOI 10.1016/j.scitotenv.2018.04.120; Bruun EW, 2014, SOIL USE MANAGE, V30, P109, DOI 10.1111/sum.12102; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Buss W, 2016, SCI TOTAL ENVIRON, V569, P496, DOI 10.1016/j.scitotenv.2016.06.129; Buss W, 2014, J ENVIRON MANAGE, V137, P111, DOI 10.1016/j.jenvman.2014.01.045; Chan KY, 2008, AUST J SOIL RES, V46, P437, DOI 10.1071/SR08036; Chen WH, 2015, RENEW SUST ENERG REV, V44, P847, DOI 10.1016/j.rser.2014.12.039; de la Rosa JM, 2011, SOIL BIOL BIOCHEM, V43, P2368, DOI 10.1016/j.soilbio.2011.08.008; Deenik JL, 2010, SOIL SCI SOC AM J, V74, P1259, DOI 10.2136/sssaj2009.0115; Dutta T, 2017, GCB BIOENERGY, V9, P990, DOI 10.1111/gcbb.12363; EBC (European Biochar Certificate), 2018, GUID SUST PROD BIOCH; Enders A, 2012, BIORESOURCE TECHNOL, V114, P644, DOI 10.1016/j.biortech.2012.03.022; Environment and Climate Change Canada, 2018, CLIMATE NORMALS 1981; Gasco G, 2016, BIOL AGRIC HORTIC, V32, P237, DOI 10.1080/01448765.2016.1166348; Gasco G, 2018, ENVIRON SCI POLLUT R, V25, P26461, DOI 10.1007/s11356-018-2703-x; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Ghidotti M, 2017, ENVIRON SCI TECHNOL, V51, P6580, DOI 10.1021/acs.est.7b00520; Ghidotti M, 2017, ACS SUSTAIN CHEM ENG, V5, P510, DOI 10.1021/acssuschemeng.6b01869; Graber ER, 2010, PLANT SOIL, V337, P481, DOI 10.1007/s11104-010-0544-6; Gul S, 2016, SOIL BIOL BIOCHEM, V103, P1, DOI 10.1016/j.soilbio.2016.08.001; Kochanek J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161234; Maynard D., 1993, SOIL SAMPL METHODS A, V1; Ogura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep28011; Rajkovich S, 2012, BIOL FERT SOILS, V48, P271, DOI 10.1007/s00374-011-0624-7; Ramirez WA, 2008, ECOTOXICOLOGY, V17, P834, DOI 10.1007/s10646-008-0246-5; Rombola AG, 2015, J AGR FOOD CHEM, V63, P6660, DOI 10.1021/acs.jafc.5b01540; Scharenbroch BC, 2013, J ENVIRON QUAL, V42, P1372, DOI 10.2134/jeq2013.04.0124; Schwinghamer T, 2017, AGRON J, V109, P870, DOI 10.2134/agronj2016.08.0473; Gonzaga MIS, 2017, SOIL TILL RES, V165, P59, DOI 10.1016/j.still.2016.07.009; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Spokas KA, 2011, CHEMOSPHERE, V85, P869, DOI 10.1016/j.chemosphere.2011.06.108; Sun JL, 2017, SCI TOTAL ENVIRON, V576, P858, DOI 10.1016/j.scitotenv.2016.10.095; Thivierge MN, 2016, AGRON J, V108, P459, DOI 10.2134/agronj2015.0291; Tran T.S., 1993, SOIL SAMPL METHODS A, V43, P49; Trifonova R, 2009, MICROB ECOL, V58, P632, DOI 10.1007/s00248-009-9518-8; Vaughn SF, 2015, IND CROP PROD, V66, P44, DOI 10.1016/j.indcrop.2014.12.026; Wang T, 2012, ORG GEOCHEM, V51, P45, DOI 10.1016/j.orggeochem.2012.07.009; Xu N, 2016, EUR J SOIL BIOL, V74, P1, DOI 10.1016/j.ejsobi.2016.02.004; Yang HP, 2007, FUEL, V86, P1781, DOI 10.1016/j.fuel.2006.12.013; Yuan HR, 2015, J ANAL APPL PYROL, V112, P284, DOI 10.1016/j.jaap.2015.01.010; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	45	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206924	10.1371/journal.pone.0206924	http://dx.doi.org/10.1371/journal.pone.0206924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388186	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800072
J	Studencan, M; Alusik, D; Plachy, L; Bajerovska, L; Ilavsky, M; Karas, J; Kilianova, A; Sykora, J; Hosa, V; Kmec, J; Slanina, M; Boguska, D				Studencan, Martin; Alusik, Daniel; Plachy, Lukas; Bajerovska, Lubica; Ilavsky, Michel; Karas, Jozef; Kilianova, Adriana; Sykora, Juraj; Hosa, Vladimir; Kmec, Jan; Slanina, Miroslav; Boguska, Daniela			Significant benefits of new communication technology for time delay management in STEMI patients	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION	Background In the acute phase of STEMI, the length of the total ischemic interval is the principal factor affecting both short- and long-term mortality. The length of the interval remains a global problem, and in EU countries these figures vary between 160 and 325 min. Methods and results The aim of our research was to assess the benefit of the systematic implementation of the new smartphone-based communication technology "STEMI" enabling immediate ECG picture and voice consultation between an EMS crew in the field and a cardiologist in the PCI-center. The transfer of ECG was associated with 92% technical success. 5 Monthly data from 2016 were compared from the reference2 monthly data set in 2015 when the data in the same area was collected in the SLOVAKS registry. The 5-months data from 2016 were compared to the reference group from 2015, when similar 2-months data in the same area in SLOVAKS registry was collected but communication technology "STEMI" technology was not used. In the monitored period in 2016 we recorded a significant decrease in unwanted secondary STEMI transportations (34.32% vs. 12.9%, p<0.001) and a significant reduction in the total ischemic interval (241 min vs. 181 min, p = 0.03). There was no significant decrease in the subinterval of "admission-pPCI" (28min vs. 23 min, p = 0.144). Conclusion The systematic use of smartphone-based communication technology "STEMI" enabling remote ECG picture consultation between an EMS crew and a cardiologist in PCI-center had a positive impact on the quality of care for patients with acute STEMI and brought clinical practice closer to the current ESC Guidelines. It significantly decreased the ratio of unwanted secondary transportations and led to a significant reduction in the total ischemic interval.	[Studencan, Martin; Alusik, Daniel; Plachy, Lukas; Kmec, Jan; Slanina, Miroslav] JA Reiman & Presov Univ, Cardioctr, Cardiol Clin, Teaching Hosp,Fac Hlth Care, Presov, Slovakia; [Bajerovska, Lubica; Sykora, Juraj] EMS Kosice, Kosice, Slovakia; [Ilavsky, Michel; Karas, Jozef; Kilianova, Adriana; Hosa, Vladimir] EMS Falck, Kosice, Slovakia; [Boguska, Daniela] Presov Univ, Fac Hlth Care, Presov, Slovakia	University of Presov	Studencan, M (corresponding author), JA Reiman & Presov Univ, Cardioctr, Cardiol Clin, Teaching Hosp,Fac Hlth Care, Presov, Slovakia.	mstudencan@gmail.com	Plachy, Lukas/AAX-1416-2021; Kmec, Ján/ABE-4250-2021	Plachy, Lukas/0000-0002-6785-396X; Kmec, Ján/0000-0002-3036-891X; Studencan, Martin/0000-0002-1678-3420				Al Mawiri A, 2016, AM J INTERNAL MED, V4, P75; Denktas AE, 2011, JACC-CARDIOVASC INTE, V4, P599, DOI 10.1016/j.jcin.2011.02.012; Ibanez B, 2017, EUR HEART J; Kamenski G, 2007, CARDIOLOGY, V16, P141; Kawecki D, 2017, JACC-CARDIOVASC INTE, V10, P438, DOI 10.1016/j.jcin.2016.11.028; Le May MR, 2005, J AM COLL CARDIOL, V46, P417, DOI 10.1016/j.jacc.2005.04.042; O'Gara PT, 2013, CATHETER CARDIO INTE, V82, pE1, DOI 10.1002/ccd.24776; Sillesen M, 2008, J ELECTROCARDIOL, V41, P49, DOI 10.1016/j.jelectrocard.2007.08.058; Sorensen JT, 2011, EUR HEART J, V32, P430, DOI 10.1093/eurheartj/ehq437; Studencan M, 2017, CARDIOLOGY LETT, V26, P125; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492	12	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0205832	10.1371/journal.pone.0205832	http://dx.doi.org/10.1371/journal.pone.0205832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388116	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800017
J	Zhang, CY; Wang, HM; Liu, XM; Hu, YP; Ding, L; Zhang, X; Sun, QL; Li, YL				Zhang, Caiyan; Wang, Huimin; Liu, Xiaomin; Hu, Yanping; Ding, Lei; Zhang, Xing; Sun, Qiangling; Li, Yanli			Oncogenic microRNA-411 promotes lung carcinogenesis by directly targeting suppressor genes SPRY4 and TXNIP	ONCOGENE			English	Article							PROSTATE-CANCER CELLS; DOWN-REGULATION; STEM-CELLS; SPROUTY4; PROLIFERATION; MIGRATION; INVASION; PATHWAY; CONTRIBUTES; METHYLATION	Lung cancer is one of the most common malignant diseases globally, composed of non-small cell lung cancer (NSCLC, 85%) and small cell lung cancer (SCLC, 15%). MicroRNAs (miRNAs) are single-stranded noncoding RNAs having important roles in lung cancer development. miR-411-5p/3p were reported to be increased significantly in human NSCLC tissues and cell lines. Moreover, miR-411-5p/3p overexpression could accelerate cell proliferation and migration, and impede cell apoptosis in NSCLC cell lines. Mechanically, SPRY4 is confirmed a direct target of miR-411-5p/3p. Furthermore, our findings showed that miR-411-5p/3p promoted lung tumor growth in vivo, decreased SPRY4 expression dramatically, and induced EGFR, AKT signaling activation, as well as epithelial-mesenchymal transition (EMT) simultaneously in tumor tissues. In addition, we showed that miR-411-5p also targeted tumor suppressor TXNIP, involved in regulating positively cell cycle progress in SPC-A1 cells rather than in H1299. Whether cell specificity of low TXNIP mRNA level in H1299 is responsible for the different response to cell cycle between H1299 and SPC-A1 would need further explorations. Collectively, these results suggest that miR-411-5p/3p are required for NSCLC development by suppressing SPRY4 and TXNIP; thus, the miR-411-SPRY4-AKT axis might act as a promising target for lung cancer therapy clinically.	[Zhang, Caiyan; Wang, Huimin; Hu, Yanping; Ding, Lei; Li, Yanli] Shanghai Univ, Sch Life Sci, Lab Noncoding RNA & Canc, Shanghai 200444, Peoples R China; [Liu, Xiaomin; Zhang, Xing] Shanghai Univ, Sch Environm Sci & Engn, Shanghai 200444, Peoples R China; [Hu, Yanping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China; [Sun, Qiangling] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Cent Lab, Shanghai 200030, Peoples R China	Shanghai University; Shanghai University; China Pharmaceutical University; Shanghai Jiao Tong University	Li, YL (corresponding author), Shanghai Univ, Sch Life Sci, Lab Noncoding RNA & Canc, Shanghai 200444, Peoples R China.	liyanli@shu.edu.cn	li, yanli/AAT-2012-2021; wang, hui/GRS-4730-2022; wang, huimin/HDM-8421-2022	li, yanli/0000-0002-2936-0339; DING, LEI/0000-0001-9556-9635; Zhang, Xing/0000-0003-4680-5085	NNSFC (National Natural Science Foundation of China) [91543123]	NNSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC))	This work is supported by NNSFC (National Natural Science Foundation of China, Training Program of the Major Research Plan) No. 91543123	Baranwal S, 2010, INT J CANCER, V126, P1283, DOI 10.1002/ijc.25014; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Carter CA, 2016, CASE REP ONCOL, V9, P62, DOI 10.1159/000443725; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Chen MW, 2017, CANCER RES, V77, P1955, DOI 10.1158/0008-5472.CAN-16-1115; Cherni I, 2011, FUTURE ONCOL, V7, P1045, DOI [10.2217/fon.11.74, 10.2217/FON.11.74]; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Guo LF, 2016, MOL MED REP, V14, P2975, DOI 10.3892/mmr.2016.5645; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jiang L, 2016, INFLAMM RES, V65, P905, DOI 10.1007/s00011-016-0973-7; Jing HY, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0292-7; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Leeksma OC, 2002, EUR J BIOCHEM, V269, P2546, DOI 10.1046/j.1432-1033.2002.02921.x; Li YL, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.50; Li Yan, 2015, Asian Pac J Cancer Prev, V16, P2953; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Nadal E, 2014, CLIN CANCER RES, V20, P3107, DOI 10.1158/1078-0432.CCR-13-3348; Nie WW, 2015, ONCOTARGET, V6, P3003, DOI 10.18632/oncotarget.3096; Peter ME, 2010, CELL STEM CELL, V6, P4, DOI 10.1016/j.stem.2009.12.006; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Sasaki A, 2003, NAT CELL BIOL, V5, P427, DOI 10.1038/ncb978; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; So WK, 2016, TUMOR BIOL, V37, P9197, DOI 10.1007/s13277-016-4790-y; Spangle JM, 2016, CELL REP, V15, P2692, DOI 10.1016/j.celrep.2016.05.046; Sun M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.225; Tennis MA, 2010, MOL CANCER RES, V8, P833, DOI 10.1158/1541-7786.MCR-09-0400; van Schooneveld E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3127; Vanas V, 2014, TUMOR BIOL, V35, P4447, DOI 10.1007/s13277-013-1587-0; Wang GD, 2015, AM J TRANSL RES, V7, P2000; Wang JH, 2006, PROSTATE, V66, P613, DOI 10.1002/pros.20353; Wang P, 2017, ONCOTARGET, V8, P57012, DOI 10.18632/oncotarget.18505; Wei M, 2017, ONCOTARGET, V8, P5323, DOI 10.18632/oncotarget.14142; Wu JY, 2017, CANCER LETT, V400, P18, DOI 10.1016/j.canlet.2017.04.021; Xia KK, 2015, BIOMED PHARMACOTHER, V70, P158, DOI 10.1016/j.biopha.2015.01.001; Yamamoto K, 2014, ONCOL REP, V32, P2365, DOI 10.3892/or.2014.3481; Zhang YD, 2016, BIOCHEM BIOPH RES CO, V476, P607, DOI 10.1016/j.bbrc.2016.06.006; Zhao ZJ, 2016, TUMOR BIOL, V37, P5551, DOI 10.1007/s13277-015-4425-8	44	51	51	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1892	1904		10.1038/s41388-018-0534-3	http://dx.doi.org/10.1038/s41388-018-0534-3			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30390072	Green Published, hybrid			2022-12-26	WOS:000461164400008
J	Gallo, GL; Valko, A; Aramburu, SI; Etchegaray, E; Volker, C; Parodi, AJ; D'Alessio, C				Gallo, Giovanna L.; Valko, Ayelen; Aramburu, Sofia I.; Etchegaray, Emiliana; Voelker, Christof; Parodi, Armando J.; D'Alessio, Cecilia			Abrogation of glucosidase I-mediated glycoprotein deglucosylation results in a sick phenotype in fission yeasts: Model for the human MOGS-CDG disorder	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum (ER); N-linked glycosylation; Schizosaccharomyces pombe; yeast; glycoprotein; CDG-IIb; congenital disorders of glycosylation; glucosidase I; glycan; MOGS-CDG	SCHIZOSACCHAROMYCES-POMBE; UDP-GLC; OLIGOSACCHARYLTRANSFERASE COMPLEX; ENDOPLASMIC-RETICULUM; N-GLYCOSYLATION; PROTEIN; GLUCOSYLTRANSFERASE; OLIGOSACCHARIDE; BIOSYNTHESIS; DEGRADATION	Glucosidase I (GI) removes the outermost glucose from protein-linked Glc(3)Man(9)GlcNAc(2) (G3M9) in the endoplasmic reticulum (ER). Individuals with congenital disorders of glycosylation MOGS-CDG bear mutations in the GI-encoding gene (gls1). Although GI absence has been reported to produce lethality in Schizosaccharomyces pombe yeasts, here we obtained two viable gls1 mutants, one with a very sick but not lethal phenotype (gls1-S) and the other with a healthier one (gls1-H). The sick strain displayed only G3M9 as an ER protein-linked oligosaccharide, whereas the healthier strain had both G3M9 and Man(9)GlcNAc(2). The lipid-linked oligosaccharide patterns of the two strains revealed that the most abundantly formed glycans were G3M9 in gls1-S and Glc(2)Man(9)GlcNAc(2) in gls1-H, suggesting reduced Alg10p glucosyltransferase activity in the gls1-H strain. A mutation in the alg10(+) gene was indeed observed in this strain. Our results indicated that abrogated G3M9 deglucosylation was responsible for the severe defects observed in gls1-S cells. Further studies disclosed that the defects could not be ascribed to disruption of glycoprotein entrance into calnexin-folding cycles, inhibition of the oligosaccharyltransferase by transfer reaction products, or reduced proteasomal degradation of misfolded glycoproteins. Lack of triglucosylated glycoprotein deglucosylation neither significantly prevented glycan elongation in the Golgi nor modified the overall cell wall monosaccharide composition. Nevertheless, it resulted in a distorted cell wall and in the absence of underlying ER membranes. Furthermore, Golgi expression of human endomannosidase partially restored normal growth in gls1-S cells. We propose that accumulation of G3M9-bearing glycoproteins is toxic and at least partially responsible for defects observed in MOGS-CDG.	[Gallo, Giovanna L.; Valko, Ayelen; Aramburu, Sofia I.; Etchegaray, Emiliana; Parodi, Armando J.; D'Alessio, Cecilia] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir IIBBA, C1405BWE, Buenos Aires, DF, Argentina; [Voelker, Christof] Univ Bonn, Fac Med, Inst Biochem & Mol Biol, D-53115 Bonn, Germany; [D'Alessio, Cecilia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, C1428EGA, Buenos Aires, DF, Argentina; [Parodi, Armando J.; D'Alessio, Cecilia] Natl Res Council CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Bonn; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	D'Alessio, C (corresponding author), Fdn Inst Leloir, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	cdalessio@leloir.org.ar	Gallo, Giovanna/GXH-4399-2022; Gallo, Giovanna/GXF-5113-2022	Gallo, Giovanna/0000-0002-1102-7108; D'Alessio, Cecilia/0000-0001-7371-5080; Valko, Ayelen/0000-0002-1296-0178	National Research Council (CONIC ET, Argentina) [PIP-11220150100759]	National Research Council (CONIC ET, Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported in part by the National Research Council (CONIC ET, Argentina) Grant PIP-11220150100759. The authors declare that they have no conflicts of interest with the contents of this article.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Alfa C., 1993, EXPT FISSION YEAST L; Bredeston LM, 2017, GLYCOBIOLOGY, V27, P64, DOI 10.1093/glycob/cww092; Burda P, 1998, GLYCOBIOLOGY, V8, P455, DOI 10.1093/glycob/8.5.455; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caramelo JJ, 2003, P NATL ACAD SCI USA, V100, P86, DOI 10.1073/pnas.262661199; Chavan M, 2003, P NATL ACAD SCI USA, V100, P15381, DOI 10.1073/pnas.2536561100; Chino A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009652; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2003, J BIOL CHEM, V278, P22379, DOI 10.1074/jbc.M300892200; D'Alessio C, 2010, SEMIN CELL DEV BIOL, V21, P491, DOI 10.1016/j.semcdb.2009.12.014; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez F, 1996, EMBO J, V15, P705, DOI 10.1002/j.1460-2075.1996.tb00406.x; FERNANDEZ FS, 1994, J BIOL CHEM, V269, P30701; Freeze HH, 2015, ESSENTIALS GLYCOBIOL, P569; Hagan I. M., 2016, FISSION YEAST LAB MA; Hardt B, 2005, BIOCHIMIE, V87, P169, DOI 10.1016/j.biochi.2004.11.004; Herscovics A, 1999, BBA-GEN SUBJECTS, V1426, P275, DOI 10.1016/S0304-4165(98)00129-9; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Hossain TJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151891; Katoh T, 2013, GLYCOBIOLOGY, V23, P1142, DOI 10.1093/glycob/cwt051; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; McDowall MD, 2015, NUCLEIC ACIDS RES, V43, pD656, DOI 10.1093/nar/gku1040; Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nunez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121059; Osumi M, 2012, J ELECTRON MICROSC, V61, P343, DOI 10.1093/jmicro/dfs082; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; Piel M, 2009, CURR BIOL, V19, pR823, DOI 10.1016/j.cub.2009.08.012; R Core Team, 2021, R LANGUAGE ENV STAT; Roux AE, 2006, AGING CELL, V5, P345, DOI 10.1111/j.1474-9726.2006.00225.x; Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846; Sambrook J., 2001, MOL CLONING LAB MANU; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Soussillane P, 2009, GLYCOCONJUGATE J, V26, P597, DOI 10.1007/s10719-008-9201-1; Stigliano ID, 2011, MOL BIOL CELL, V22, P1810, DOI 10.1091/mbc.E11-01-0019; Stigliano ID, 2009, MOL BIOL CELL, V20, P3974, DOI 10.1091/mbc.E09-04-0316; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Volker C, 2002, GLYCOBIOLOGY, V12, P473, DOI 10.1093/glycob/cwf050; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Wood V, 2012, NUCLEIC ACIDS RES, V40, pD695, DOI 10.1093/nar/gkr853	49	4	4	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					19957	19973		10.1074/jbc.RA118.004844	http://dx.doi.org/10.1074/jbc.RA118.004844			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389790	Green Published, hybrid			2022-12-26	WOS:000454685900002
J	Johansson, H; Ellstrom, P; Artursson, K; Berg, C; Bonnedahl, J; Hansson, I; Hernandez, J; Lopez-Martin, J; Medina-Vogel, G; Moreno, L; Olsen, B; Engvall, EO; Skarin, H; Troell, K; Waldenstrom, J; Agren, J; Gonzalez-Acuna, D				Johansson, Hakan; Ellstrom, Patrik; Artursson, Karin; Berg, Charlotte; Bonnedahl, Jonas; Hansson, Ingrid; Hernandez, Jorge; Lopez-Martin, Juana; Medina-Vogel, Gonzalo; Moreno, Lucile; Olsen, Bjorn; Engvall, Eva Olsson; Skarin, Hanna; Troell, Karin; Waldenstrom, Jonas; Agren, Joakim; Gonzalez-Acuna, Daniel			Characterization of Campylobacter spp. isolated from wild birds in the Antarctic and Sub-Antarctic	PLOS ONE			English	Article							SEQUENCE TYPING SYSTEM; INFECTIOUS-DISEASES; SP NOV.; C-LARI; JEJUNI; PENGUINS; UPSALIENSIS; SALMONELLA; COLI; EPIDEMIOLOGY	A lack of knowledge of naturally occurring pathogens is limiting our ability to use the Antarctic to study the impact human-mediated introduction of infectious microorganisms have on this relatively uncontaminated environment. As no large-scale coordinated effort to remedy this lack of knowledge has taken place, we rely on smaller targeted efforts to both study present microorganisms and monitor the environment for introductions. In one such effort, we isolated Campylobacter species from fecal samples collected from wild birds in the Antarctic Peninsula and the sub-Antarctic island of South Georgia. Indeed, in South Georgia, we found Campylobacter lari and the closely related Campylobacter peloridis, but also distantly related human-associated multilocus sequence types of Campylobacter jejuni. In contrast, in the Antarctic Peninsula, we found C. tart and two closely related species, Campylobacter subantarcticus and Campylobacter volucris, but no signs of human introduction. In fact, our finding of human-associated sequence types of C. jejuni in South Georgia, but not in the Antarctic Peninsula, suggests that efforts to limit the spread of infectious microorganisms to the Antarctic have so far been successful in preventing the introduction of C. jejuni. However, we do not know how it came to South Georgia and whether the same mode of introduction could spread it from there to the Antarctic Peninsula.	[Johansson, Hakan; Bonnedahl, Jonas; Waldenstrom, Jonas] Linnaeus Univ, Ctr Ecol & Evolut Microbial Model Syst, Kalmar, Sweden; [Ellstrom, Patrik; Hernandez, Jorge; Olsen, Bjorn] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Ellstrom, Patrik; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Artursson, Karin; Engvall, Eva Olsson; Skarin, Hanna; Troell, Karin; Agren, Joakim] Natl Vet Inst, Uppsala, Sweden; [Berg, Charlotte] Swedish Univ Agr Sci, Dept Anim Environm & Hlth, Skara, Sweden; [Bonnedahl, Jonas] Kalmar Cty Hosp, Dept Infect Dis, Kalmar, Sweden; [Hansson, Ingrid] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Hernandez, Jorge] Kalmar Cty Hosp, Lab Microbiol, Kalmar, Sweden; [Lopez-Martin, Juana] Univ Concepcion, Fac Ciencias & Vet, Dept Patol & Med Prevent, Chillan, Chile; [Medina-Vogel, Gonzalo] Univ Andres Bello, Ctr Invest Sustentabilidad, Santiago, Chile; [Moreno, Lucile] Univ Concepcion, Fac Ciencias Nat & Oceanograf, Concepcion, Chile; [Gonzalez-Acuna, Daniel] Univ Concepcion, Fac Ciencias Vet, Chillan, Chile	Linnaeus University; Uppsala University; Uppsala University; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Universidad de Concepcion; Universidad Andres Bello; Universidad de Concepcion; Universidad de Concepcion	Gonzalez-Acuna, D (corresponding author), Univ Concepcion, Fac Ciencias Vet, Chillan, Chile.	danigonz@udec.cl	Bonnedahl, Jonas/GZG-8435-2022; Berg, Charlotte/G-5760-2012	Berg, Charlotte/0000-0001-5671-5273; Moreno, Lucila/0000-0003-3159-4916	Chilean Antarctic Institute (INACH) [T-12-13]; Swedish Research Council Formas [2014-829]; Wellcome Trust	Chilean Antarctic Institute (INACH); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was funded by the Chilean Antarctic Institute (INACH number T-12-13) and the Swedish Research Council Formas (2014-829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Chilean Antarctic Institute (INACH number T-12-13) and the Swedish Research Council Formas (2014-829). The study made use of the Campylobacter Multi Locus Sequence Typing website (https://pubmlst.org/campylobacter/) sited at the University of Oxford [33], the development of which was funded by the Wellcome Trust.	[Anonymous], 1964, 3 ANT TREAT CONS M; Bonnedahl J, 2005, AMBIO, V34, P430, DOI 10.1639/0044-7447(2005)034[0430:ISOHBP]2.0.CO;2; Broman T, 2000, APPL ENVIRON MICROB, V66, P449, DOI 10.1128/AEM.66.1.449-452.2000; CAWTHRAW S, 1994, AVIAN DIS, V38, P341, DOI 10.2307/1591960; Colles FM, 2009, ENVIRON MICROBIOL, V11, P258, DOI 10.1111/j.1462-2920.2008.01773.x; Colles FM, 2003, APPL ENVIRON MICROB, V69, P7409, DOI 10.1128/AEM.69.12.7409-7413.2003; Convey Peter, 2012, BIODIVERSITY-OTTAWA, V13, P234, DOI 10.1080/14888386.2012.703551; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Debruyne L, 2010, INT J SYST EVOL MICR, V60, P1870, DOI 10.1099/ijs.0.013748-0; Debruyne L, 2010, INT J SYST EVOL MICR, V60, P815, DOI 10.1099/ijs.0.011056-0; Debruyne L, 2009, INT J SYST EVOL MICR, V59, P1126, DOI 10.1099/ijs.0.000851-0; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; EFSA, 2016, EFSA J, V14; French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08; Garcia-Pena FJ, 2017, ECOHEALTH, V14, P78, DOI 10.1007/s10393-016-1203-z; Garcia-Pena FJ, 2010, APPL ENVIRON MICROB, V76, P6013, DOI 10.1128/AEM.00316-10; Gonzalez-Acuna D, 2013, POLAR BIOL, V36, P1749, DOI 10.1007/s00300-013-1394-5; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Government of South Georgia and the South Sandwich Islands, 2016, BIOD ACT PLAN S GEOR; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Griekspoor P, 2009, EMERG INFECT DIS, V15, P847, DOI 10.3201/eid1505.081160; Grimaldi WW, 2015, POLAR BIOL, V38, P591, DOI 10.1007/s00300-014-1632-5; Humphrey S, 2014, MBIO, V5, DOI 10.1128/mBio.01364-14; Hurt AC, 2016, J VIROL, V90, P9674, DOI 10.1128/JVI.01404-16; International Association of Antarctica Tour Operators (IAATO), 2016, 2015 2016 NUMB TOUR; Iveson JB, 2009, EPIDEMIOL INFECT, V137, P858, DOI 10.1017/S0950268808001222; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kerry K.R., 2009, P1; Leotta Gerardo, 2006, Polish Polar Research, V27, P303; Mandrell RE, 2005, APPL ENVIRON MICROB, V71, P6292, DOI 10.1128/AEM.71.10.6292-6307.2005; Manning G, 2003, APPL ENVIRON MICROB, V69, P6370, DOI 10.1128/AEM.69.11.6370-6379.2003; Miller WG, 2014, LETT APPL MICROBIOL, V58, P582, DOI 10.1111/lam.12228; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Nachamkin I., 1995, CAMPYLOBACTER ARCOBA, P113; Olsen B, 1996, LANCET, V348, P1319, DOI 10.1016/S0140-6736(05)65807-2; Palmgren H, 2000, EPIDEMIOL INFECT, V125, P257, DOI 10.1017/S0950268899004586; Platts-Mills JA, 2014, CURR OPIN INFECT DIS, V27, P444, DOI 10.1097/QCO.0000000000000091; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; S.C.A.R. Annex to S.C.A.R, 1959, POLAR REC, V9, P596; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tompkins DM, 1999, PARASITOL TODAY, V15, P311, DOI 10.1016/S0169-4758(99)01484-2; Tonnessen JN., 1982, HIST MODERN WHALING; Waldenstrom J, 2014, ECOLOGY HOST ASS CAM, P265; Waldenstrom J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009082; Walton D, 2012, ANTARCT SCI, V24, P321, DOI 10.1017/S0954102012000594; Wang GH, 2002, J CLIN MICROBIOL, V40, P4744, DOI 10.1128/JCM.40.12.4744-4747.2002; Woehler Eric J., 2014, HUMAN IMPACTS ANTARC, P27; WOODS R, 2009, DIS ANTARCTIC SEABIR	53	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206502	10.1371/journal.pone.0206502	http://dx.doi.org/10.1371/journal.pone.0206502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412585	Green Published, gold, Green Submitted			2022-12-26	WOS:000449772600017
J	Schlesinger, MD; Feinberg, JA; Nazdrowicz, NH; Kleopfer, JD; Beane, JC; Bunnell, JF; Burger, J; Corey, E; Gipe, K; Jaycox, JW; Kiviat, E; Kubel, J; Quinn, DP; Raithel, C; Scott, PA; Wenner, SM; White, EL; Zarate, B; Shaffer, HB				Schlesinger, Matthew D.; Feinberg, Jeremy A.; Nazdrowicz, Nathan H.; Kleopfer, J. D.; Beane, Jeffrey C.; Bunnell, John F.; Burger, Joanna; Corey, Edward; Gipe, Kathy; Jaycox, Jesse W.; Kiviat, Erik; Kubel, Jacob; Quinn, Dennis P.; Raithel, Christopher; Scott, Peter A.; Wenner, Sarah M.; White, Erin L.; Zarate, Brian; Shaffer, H. Bradley			Follow-up ecological studies for cryptic species discoveries: Decrypting the leopard frogs of the eastern U.S	PLOS ONE			English	Article							RANA-PIPIENS COMPLEX; BATRACHOCHYTRIUM-DENDROBATIDIS; HAPLOTYPE RECONSTRUCTION; EXTINCTION RISK; POPULATION; DIVERSITY; BIODIVERSITY; SYSTEMATICS; CLIMATE; EVOLUTIONARY	Cryptic species are a challenge for systematics, but their elucidation also may leave critical information gaps about the distribution, conservation status, and behavior of affected species. We use the leopard frogs of the eastern U.S. as a case study of this issue. We refined the known range of the recently described Rana kauffeldi, the Atlantic Coast Leopard Frog, relative to the region's two other leopard frog species, conducted assessments of conservation status, and improved methods for separating the three species using morphological field characters. We conducted over 2,000 call and visual surveys and took photographs of and tissue samples from hundreds of frogs. Genetic analysis supported a three-species taxonomy and provided determinations for 220 individual photographed frogs. Rana kauffeldi was confirmed in eight U.S. states, from North Carolina to southern Connecticut, hewing closely to the Atlantic Coastal Plain. It can be reliably differentiated in life from R. pipiens, and from R. sphenocephala 90% of the time, based on such characters as the femoral reticulum patterning, dorsal spot size and number, and presence of a snout spot. However, the only diagnostic character separating R. kauffeldi from R. sphenocephala remains the breeding call described in 2014. Based on our field study, museum specimens, and prior survey data, we suggest that R. kauffeldi has declined substantially in the northern part of its range, but is more secure in the core of its range. We also report, for the first time, apparent extirpations of R. pipiens from the southeastern portion of its range, previously overlooked because of confusion with R. kauffeldi. We conclude with a generalized ecological research agenda for cryptic species. For R. kauffeldi, needs include descriptions of earlier life stages, studies of niche partitioning with sympatric congeners and the potential for hybridization, and identification of conservation actions to prevent further declines.	[Schlesinger, Matthew D.; White, Erin L.] SUNY Albany, Coll Environm Sci & Forestry, New York Nat Heritage Program, Albany, NY 12222 USA; [Feinberg, Jeremy A.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Feinberg, Jeremy A.] Smithsonian Inst, Natl Museum Natl Hist & Conservat Biol Inst, Washington, DC 20560 USA; [Nazdrowicz, Nathan H.] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE USA; [Kleopfer, J. D.] Virginia Dept Game & Inland Fisheries, Charles City, VA USA; [Beane, Jeffrey C.] North Carolina Museum Nat Sci, Raleigh, NC USA; [Bunnell, John F.] New Jersey Pinelands Commiss, New Lisbon, NJ USA; [Burger, Joanna] Rutgers State Univ, Div Life Sci, Piscataway, NJ USA; [Corey, Edward] North Carolina Div Pk & Recreat, Raleigh, NC USA; [Gipe, Kathy] Penn Fish & Boat Commiss, Nat Divers Sect, Bellefonte, PA USA; [Jaycox, Jesse W.] New York State Off Pk Recreat & Hist Preservat, Staatsburg, NY USA; [Kiviat, Erik] Hudsonia Ltd, Annandale On Hudson, NY USA; [Kubel, Jacob] Nat Heritage & Endangered Species Program, Massachusetts Div Fisheries & Wildlife, Westborough, MA USA; [Quinn, Dennis P.] CTHerpConsultant LLC, Southington, CT USA; [Raithel, Christopher] Rhode Isl Dept Environm Management, Div Fish & Wildlife, Providence, RI USA; [Scott, Peter A.; Wenner, Sarah M.; Shaffer, H. Bradley] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Zarate, Brian] New Jersey Div Fish & Wildlife, Endangered & Nongame Species Program, Clinton, NY USA; [Shaffer, H. Bradley] Univ Calif Los Angeles, UCLA La Kretz Ctr Calif Conservat Sci, Inst Environm & Sustainabil, Los Angeles, CA USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) College of Environmental Science & Forestry; Rutgers State University New Brunswick; Smithsonian Institution; University of Delaware; Rutgers State University New Brunswick; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Schlesinger, MD (corresponding author), SUNY Albany, Coll Environm Sci & Forestry, New York Nat Heritage Program, Albany, NY 12222 USA.	mdschles@esf.edu	Scott, Peter/GYA-5335-2022		Northeast Association of Fish and Wildlife Agencies as Regional Conservation Needs grant [2013-03]; Hudson River Foundation; NSF [DEB 1239961]	Northeast Association of Fish and Wildlife Agencies as Regional Conservation Needs grant; Hudson River Foundation; NSF(National Science Foundation (NSF))	This study was funded by the Northeast Association of Fish and Wildlife Agencies as Regional Conservation Needs grant 2013-03, administered by the Wildlife Management Institute, with matching funds and in-kind from the authors' institutions. J. Feinberg, J. Burger, and E. Kiviat were also supported by grants from the Hudson River Foundation, and B. Shaffer and S. Wenner by the NSF (DEB 1239961). The funders provided support in the form of salaries for authors [MDS, JAF, NHN, JB, EK, SMW, HBS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. EK and DPQ are affiliated with Hudsonia, Ltd. and CTHerpConsultant, LLC, respectively. The commercial affiliations of these two authors did not play any role in the study.	Altig R., 2015, HDB LARVAL AMPHIBIAN; Amburgey SM, 2018, GLOBAL CHANGE BIOL, V24, P439, DOI 10.1111/gcb.13817; Andrews KR, 2016, NAT REV GENET, V17, P81, DOI 10.1038/nrg.2015.28; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; Bailey R.G., 1998, ECOREGIONS ECOSYSTEM; Balmford A, 1999, NATURE, V398, P204, DOI 10.1038/18339; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown RM, 2015, HERPETOLOGICA, V71, P223, DOI 10.1655/Herpetologica-D-14-00075; Chatfield MWH, 2013, ECOHEALTH, V10, P90, DOI 10.1007/s10393-013-0833-7; CLARKSON RW, 1989, SOUTHWEST NAT, V34, P531, DOI 10.2307/3671513; Clulow S, 2016, ZOOTAXA, V4184, P285, DOI 10.11646/zootaxa.4184.2.3; Conant R., 1991, FIELD GUIDE REPTILES; Cooper N, 2008, GLOBAL ECOL BIOGEOGR, V17, P211, DOI 10.1111/j.1466-8238.2007.00355.x; Corser JD, 2012, J GREAT LAKES RES, V38, P806, DOI 10.1016/j.jglr.2012.09.005; Cosentino BJ, 2014, BIOL CONSERV, V180, P31, DOI 10.1016/j.biocon.2014.09.027; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Egea-Serrano A, 2012, ECOL EVOL, V2, P1382, DOI 10.1002/ece3.249; ESRI, 2011, ARCGIS DESKT REL 10; Esselstyn JA, 2014, J MAMMAL, V95, P216, DOI 10.1644/13-MAMM-A-215; Faber-Langendoen D, 2012, NATURESERVE CONSERVA, P44; Falush D, 2003, GENETICS, V164, P1567; Feinberg JA, RAPID ASSESSMENT POS; Feinberg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108213; Fenneman N. M., 1946, PHYS DIVISIONS US; Fenneman N.M., 1938, PHYSIOGRAPHY E US; Florida R, 2008, CAMB J REG ECON SOC, V1, P459, DOI 10.1093/cjres/rsn018; Forti LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169911; Franklin I.R., 1980, CONSERVATION BIOL EV; FROST JS, 1976, COPEIA, P332; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gehara M, 2013, CONSERV GENET, V14, P973, DOI 10.1007/s10592-013-0488-5; Highton R, 2014, MOL PHYLOGENET EVOL, V71, P127, DOI 10.1016/j.ympev.2013.11.002; HILLIS DM, 1988, ANNU REV ECOL SYST, V19, P39; Hopkinson CS, 2008, FRONT ECOL ENVIRON, V6, P255, DOI 10.1890/070153; Howard TG, 2013, ANN NY ACAD SCI, V1298, P103, DOI 10.1111/nyas.12172; Howlader MSA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149597; IUCN, 2013, IUCN RED LIST THREAT; JOHNSON C, 1966, TEX J SCI, V18, P361; Jones MR, 2016, MOL ECOL, V25, P185, DOI 10.1111/mec.13304; Jones T, 2005, SCIENCE, V308, P1161, DOI 10.1126/science.1109191; Kauffeld C. F., 1937, Herpetologica Chicago, V1, P84; Kauffeld CF, 1936, HERPETOLOGICA, V1, P11; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kiviat E., 2011, URBAN HABITATS, V6; KLEMENS M W, 1987, Northeastern Environmental Science, V6, P99; Klemens MW, 1993, AMPHIBIANS REPTILES; Lambert MR, 2015, P NATL ACAD SCI USA, V112, P11881, DOI 10.1073/pnas.1501065112; Lannoo M, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P1; Lemmon EM, 2008, ZOOTAXA, P1; Lemmon EM, 2007, MOL PHYLOGENET EVOL, V44, P1068, DOI 10.1016/j.ympev.2007.04.010; Lindenmayer DB, 2007, OIKOS, V116, P1220, DOI 10.1111/j.2007.0030-1299.15683.x; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Marsh DM, 2017, DIVERS DISTRIB, V23, P158, DOI 10.1111/ddi.12516; Moore JA, 1944, B AM MUS NAT HIST, V82, P346; NatureServe, 2015, NATURESERVE CONS STA; Newman CE, 2012, MOL PHYLOGENET EVOL, V63, P445, DOI 10.1016/j.ympev.2012.01.021; Niemiller ML, 2013, BIODIVERS CONSERV, V22, P1799, DOI 10.1007/s10531-013-0514-4; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Noss R, 2016, ANNOUNCING WORLDS 36; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Pace AE, 1974, SYSTEMATIC BIOL STUD, P140; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Parris MJ, 2001, EVOL ECOL RES, V3, P91; Pauly GB, 2007, MOL ECOL, V16, P415, DOI 10.1111/j.1365-294X.2006.03149.x; de Leon GPP, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0371; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Platz J.E., 1972, Copeia, V1972, P232, DOI 10.2307/1442482; PLATZ JE, 1979, COPEIA, P383; PLATZ JE, 1984, COPEIA, P940; PLATZ JE, 1993, J HERPETOL, V27, P154, DOI 10.2307/1564931; Pope SE, 2000, ECOLOGY, V81, P2498; PORTER K. R., 1941, BIOL BULL, V80, P238, DOI 10.2307/1537601; Pritchard JK, 2000, GENETICS, V155, P945; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; R Core Team, 2021, R LANGUAGE ENV STAT; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Richter SC, 2005, AMPHIBIAN DECLINES C; Rodriguez A, 2017, ZOOTAXA, V4221, P501, DOI 10.11646/zootaxa.4221.5.1; Rorabaugh JC, 2005, AMPHIBIAN DECLINES C; SAVAGE JM, 1995, BIOSCIENCE, V45, P673, DOI 10.2307/1312672; Scavia D, 2002, ESTUARIES, V25, P149, DOI 10.1007/BF02691304; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Searcy CA, 2013, BIOL CONSERV, V158, P80, DOI 10.1016/j.biocon.2012.08.033; Seburn David C., 2014, Canadian Field-Naturalist, V128, P151; Semlitsch RD, 2003, CONSERV BIOL, V17, P1219, DOI 10.1046/j.1523-1739.2003.02177.x; Shannon G, 2016, BIOL REV, V91, P982, DOI 10.1111/brv.12207; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Taylor B, 2005, ENVIRON HEALTH PERSP, V113, P1497, DOI 10.1289/ehp.7585; The Mid-Atlantic Center for Herpetology and Conservation, 2016, PENNS AMPH REPT SURV; The Nature Conservancy, 2001, MID COAST PLAIN EC P; Tomaino A., 2012, NATURESERVE CONSERVA; TRACY CR, 1994, ECOL APPL, V4, P205; Trillo PA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174743; Trontelj P, 2009, SYST BIODIVERS, V7, P1, DOI 10.1017/S1477200008002909; United States Fish and Wildlife Service, 2009, FED REGISTER, V74, P6699; USGS and USDA. Federal standards and procedures for the National Watershed Boundary Dataset (WBD), 2013, US GEOL SURV TECHN M; Venchi A, 2015, ZOOTAXA, V3990, P272, DOI 10.11646/zootaxa.3990.2.7; Voordouw Maarten J., 2010, BMC Ecology, V10, P6, DOI 10.1186/1472-6785-10-6; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017; WHEELER QD, 1995, BIODIVERS CONSERV, V4, P476, DOI 10.1007/BF00056338; White AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063088; Yuan ZY, 2016, SYST BIOL, V65, P824, DOI 10.1093/sysbio/syw055	107	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0205805	10.1371/journal.pone.0205805	http://dx.doi.org/10.1371/journal.pone.0205805			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412587	gold, Green Published, Green Submitted			2022-12-26	WOS:000449772600009
J	Vaghchhipawala, Z; Radke, S; Nagy, E; Russell, ML; Johnson, S; Gelvin, SB; Gilbertson, LA; Ye, XD				Vaghchhipawala, Zarir; Radke, Sharon; Nagy, Ervin; Russell, Mary L.; Johnson, Susan; Gelvin, Stanton B.; Gilbertson, Larry A.; Ye, Xudong			RepB C-terminus mutation of a pRi-repABC binary vector affects plasmid copy number in Agrobacterium and transgene copy number in plants	PLOS ONE			English	Article							T-DNA; PARTICLE BOMBARDMENT; ANTISENSE RNA; REPLICATION; GENERATION; SEQUENCES; ELEMENTS; PROTEIN; REGION; PARS	A native repABC replication origin from pRiA4b was previously reported as a single copy plasmid in Agrobacterium tumefaciens and can improve the production of transgenic plants with a single copy insertion of transgenes when it is used in binary vectors for Agrobacterium-mediated transformation. A high copy pRi-repABC variant plasmid, pTF::Ri, which does not improve the frequency of single copy transgenic plants, has been reported in the literature. Sequencing the high copy pTF::Ri repABC operon revealed the presence of two mutations: one silent mutation and one missense mutation that changes a tyrosine to a histidine (Y299H) in a highly conserved area of the C-terminus of the RepB protein (RepB(Y299H)). Reproducing these mutations in the wild-type pRi-repABC binary vector showed that Agrobacterium cells with the RepB(Y299H) mutation grow faster on both solidified and in liquid medium, and have higher plasmid copy number as determined by ddPCR. In order to investigate the impact of the RepB(Y299H) mutation on transformation and quality plant production, the RepB(Y299H) mutated pRi-repABC binary vector was compared with the original wild-type pRi-repABC binary vector and a multi-copy oriV binary vector in canola transformation. Molecular analyses of the canola transgenic plants demonstrated that the multi-copy pRi-repABC with the RepB(Y299H) mutation provides no advantage in generating high frequency single copy, backbone-free transgenic plants in comparison with the single copy wild-type pRi-repABC binary vector.	[Vaghchhipawala, Zarir; Nagy, Ervin; Johnson, Susan; Gilbertson, Larry A.; Ye, Xudong] Monsanto Co, St Louis, MO 63167 USA; [Radke, Sharon; Russell, Mary L.] Monsanto Co, Woodland Campus, Woodland, CA USA; [Johnson, Susan; Gelvin, Stanton B.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Vaghchhipawala, Zarir] KWS Gateway Res Ctr, St Louis, MO USA	Monsanto; Monsanto; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ye, XD (corresponding author), Monsanto Co, St Louis, MO 63167 USA.	xudong.ye@monsanto.com		Ye, Xudong/0000-0001-5104-6947; Nagy, Ervin/0000-0002-7218-6313	Monsanto Company	Monsanto Company	This work was solely funded by Monsanto Company in the form of salaries for all authors except for Purdue collaborators who provided the original pTF:: Ri and advices, and the supplies for all experiments. The funder did not have any additional role in the experiment design, data collection and analyses, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Anand A, 2008, PLANT PHYSIOL, V146, P703, DOI 10.1104/pp.107.111302; Bouet JY, 1999, EMBO J, V18, P1415, DOI 10.1093/emboj/18.5.1415; Cevallos MA, 2008, PLASMID, V60, P19, DOI 10.1016/j.plasmid.2008.03.001; Chai YR, 2005, MOL MICROBIOL, V58, P1114, DOI 10.1111/j.1365-2958.2005.04886.x; Chai YR, 2005, MOL MICROBIOL, V56, P1574, DOI 10.1111/j.1365-2958.2005.04636.x; De Buck S, 2007, PLANT PHYSIOL, V145, P1171, DOI 10.1104/pp.107.104067; Estrella MJ, 2009, APPL ENVIRON MICROB, V75, P1088, DOI 10.1128/AEM.02405-08; Fu XD, 2000, TRANSGENIC RES, V9, P11, DOI 10.1023/A:1008993730505; GALLIE DR, 1985, J BACTERIOL, V161, P1034, DOI 10.1128/JB.161.3.1034-1041.1985; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jackson MA, 2013, TRANSGENIC RES, V22, P143, DOI 10.1007/s11248-012-9639-6; Jahn M, 2014, ANAL CHEM, V86, P5969, DOI 10.1021/ac501118v; Jiang Yiming, 2014, Recent Pat Food Nutr Agric, V6, P3, DOI 10.2174/2212798406666141024104637; JOUANIN L, 1985, MOL GEN GENET, V201, P370, DOI 10.1007/BF00331325; Koper P, 2016, MOL MICROBIOL, V102, P446, DOI 10.1111/mmi.13472; Lowe BA, 2009, TRANSGENIC RES, V18, P831, DOI 10.1007/s11248-009-9265-0; MATZKE AJM, 1994, MOL GEN GENET, V244, P219, DOI 10.1007/BF00285449; Milian AS, 2015, ANTIMICROB AGENTS CH, V59, P3335, DOI 10.1128/AAC.00235-15; NISHIGUCHI R, 1987, MOL GEN GENET, V206, P1, DOI 10.1007/BF00326529; Oltmanns H, 2010, PLANT PHYSIOL, V152, P1158, DOI 10.1104/pp.109.148585; Pappas KM, 2003, MOL MICROBIOL, V48, P1059, DOI 10.1046/j.1365-2958.2003.03488.x; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pinto UM, 2012, NAT REV MICROBIOL, V10, P755, DOI 10.1038/nrmicro2882; Plotka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169846; Prakash NS, 2009, PLANT CELL REP, V28, P1655, DOI 10.1007/s00299-009-0765-4; Ramirez-Romero MA, 2000, J BACTERIOL, V182, P3117, DOI 10.1128/JB.182.11.3117-3124.2000; Tinland B, 1998, TRENDS PLANT SCI, V3, P125, DOI 10.1016/S1360-1385(98)01217-5; Travella S, 2005, PLANT CELL REP, V23, P780, DOI 10.1007/s00299-004-0892-x; Venkova-Canova T, 2004, MOL MICROBIOL, V54, P1431, DOI 10.1111/j.1365-2958.2004.04366.x; WILLIAMS DR, 1992, J GEN MICROBIOL, V138, P1; Ye X, Chimeric promoter molecules for gene expression in prokaryotes, Patent No. [US8501928B2, 8501928]; Ye XD, 2011, TRANSGENIC RES, V20, P773, DOI 10.1007/s11248-010-9458-6	33	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0200972	10.1371/journal.pone.0200972	http://dx.doi.org/10.1371/journal.pone.0200972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412579	Green Published, Green Submitted, gold			2022-12-26	WOS:000449772600003
J	Wen, NN; Yu, MF; Liu, J; Cai, CL; Liu, QH; Shen, JH				Wen, Nana; Yu, Meng-Fei; Liu, Jing; Cai, Congli; Liu, Qing-Hua; Shen, Jinhua			Deficiency of MTMR14 impairs male fertility in Mus musculus	PLOS ONE			English	Article							ION CHANNELS; MOUSE SPERM; CALCIUM-CHANNELS; SPERMATOZOA; CA2+; AUTOPHAGY; PHOSPHATASE; INFERTILITY; MIP/MTMR14; MICE	Calcium signalling is critical for successful fertilization. In spermatozoa, capacitation, hyper-activation of motility and acrosome reactions are all mediated by increases in intracellular Ca2+. Our previous reports have shown that deficiency of MTMR14, a novel phosphoinositide phosphatase, induces a muscle disorder by disrupting Ca2+ homeostasis. Recently, we found that MTMR14 is also expressed in the testes; however, whether deficiency of MTMR14 in the testes also alters the Ca2+ concentration and impairs male fertility remains entirely unknown. In the present study, we found that MTMR14 is also expressed in the testes and mature sperm cells, suggesting that deficiency of MTMR14 might have some effect on male fertility. Both in vivo fertility and in vitro fertilization tests were then performed, and we found that MTMR14(-/-) male mice showed decreased fertility. A series of experiments were then arranged to test the testis and sperm parameters; we found that MTMR14 deficiency caused small size of the testes, small numbers of both total and immotile sperm, expanded membrane of sperm tail, a decreased proportion of acrosome reaction, and in contrast, an increased proportion of abnormal sperm and augmented apoptosis, etc. Further study also found that the muscle force of the vas deferens decreased significantly in KO mice. Intracellular calcium homeostasis in the testes and epididymis was impaired by MTMR14 deletion; moreover, the relative mRNA expression levels of Itpr1, Itpr2, and Ryr3 were dramatically decreased in MTMR14 KO mice. Thus, MTMR14 deletion impairs male fertility by causing decreased muscle force of the vas deferens and intracellular calcium imbalance.	[Wen, Nana; Yu, Meng-Fei; Liu, Jing; Liu, Qing-Hua; Shen, Jinhua] South Cent Univ Nationalities, Coll Life Sci, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Hubei, Peoples R China; [Cai, Congli] Wuhan Youzhiyou Biopharmaceut Co Ltd, Biolake, Wuhan, Hubei, Peoples R China	South Central Minzu University	Shen, JH (corresponding author), South Cent Univ Nationalities, Coll Life Sci, Hubei Prov Key Lab Protect & Applicat Special Pla, Wuhan, Hubei, Peoples R China.	2011084@mail.scuec.edu.cn			National Natural Science Foundation of China [31771274]; 'Fundamental Research Funds for the Central Universities', South-Central University for Nationalities [CZY18020]; Wuhan Youzhiyou Biopharmaceutical Co., Ltd	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 'Fundamental Research Funds for the Central Universities', South-Central University for Nationalities; Wuhan Youzhiyou Biopharmaceutical Co., Ltd	Wuhan Youzhiyou Biopharmaceutical Co., Ltd, only provided support in the form of salary for the author [CC], but did not have any additional role in the whole project. This project was supported by the National Natural Science Foundation of China (Grant No: 31771274 to Jinhua Shen), and also supported by 'the Fundamental Research Funds for the Central Universities', South-Central University for Nationalities (Grant No: CZY18020 to Jinhua Shen). The funder provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amoasii L, 2012, CURR TOP MICROBIOL, V362, P209, DOI 10.1007/978-94-007-5025-8_10; Beltran C, 2016, ADV ANAT EMBRYOL CEL, V220, P35, DOI 10.1007/978-3-319-30567-7_3; Chung JJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1153; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Dowling JJ, 2010, HUM MOL GENET, V19, P2668, DOI 10.1093/hmg/ddq153; Evans JP, 2002, NAT CELL BIOL, V4, pS57, DOI 10.1038/ncb-nm-fertilityS57; Gibbs EM, 2010, AUTOPHAGY, V6, P819, DOI 10.4161/auto.6.6.12624; Hildebrand MS, 2010, EUR J HUM GENET, V18, P1178, DOI 10.1038/ejhg.2010.108; Hnia Karim, 2012, Adv Biol Regul, V52, P98; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Holt JDS, 2005, J PHARMACOL EXP THER, V315, P601, DOI 10.1124/jpet.105.090498; Jin JL, 2005, BIOL REPROD, V73, P1235, DOI 10.1095/biolreprod.105.045468; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Liu J, 2014, MOL CELL BIOCHEM, V392, P31, DOI 10.1007/s11010-014-2015-5; Meyer D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032354; Navarro B, 2011, P NATL ACAD SCI USA, V108, P14342, DOI 10.1073/pnas.1111695108; Powers SK, 2010, AGING-US, V2, P538, DOI 10.18632/aging.100193; Print CG, 2000, BIOESSAYS, V22, P423, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;423::AID-BIES4&gt;3.0.CO;2-0; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Robles M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169295; Romero-Suarez S, 2010, AGING-US, V2, P504, DOI 10.18632/aging.100190; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Shen JH, 2009, NAT CELL BIOL, V11, P769, DOI 10.1038/ncb1884; Shukla KK, 2012, J ANDROL, V33, P777, DOI 10.2164/jandrol.111.015552; Tanyeri MH, 2017, INT UROL NEPHROL, V49, P1561, DOI 10.1007/s11255-017-1640-9; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; Wennemuth G, 2000, J BIOL CHEM, V275, P21210, DOI 10.1074/jbc.M002068200; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Xia JS, 2007, BIOL REPROD, V77, P551, DOI 10.1095/biolreprod.107.061358; Yang KF, 2012, MOL CELL BIOL, V32, P216, DOI 10.1128/MCB.06158-11; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zhang MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041412; Zhao LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186727	38	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206224	10.1371/journal.pone.0206224	http://dx.doi.org/10.1371/journal.pone.0206224			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412589	gold, Green Submitted, Green Published			2022-12-26	WOS:000449772600013
J	Jeong, A; Min, JH; Kang, YK; Kim, J; Choi, M; Seok, JM; Kim, BJ				Jeong, Ansuk; Min, Ju-Hong; Kang, Yu Kyoung; Kim, Juhyeon; Choi, Misong; Seok, Jin Myoung; Kim, Byung Joon			Factors associated with quality of life of people with Myasthenia Gravis	PLOS ONE			English	Article							CHRONIC ILLNESS; SOCIAL SUPPORT; HEALTH; CANCER; COMMUNICATION; ANXIETY	Purpose As most of patients with Myasthenia Gravis have limitations in their physical functioning, many experience changes in psychological states and often have depression. The objective of the current study was to examine the roles of communication with medical professionals, patients' loneliness, and patients' depression, in relation to their effects on the patients' quality of life. Methods For 120 patients with MG of 18 years and older, demographic variables, along with communication with medical professionals, loneliness, depression, and quality of life were measured. Results As a result, people suffering from MG experienced lower quality of life when their career has changed due to the illness. At the same time, depression was a significant predictor of their quality of life, both in physical and mental domains. Conclusions The implications for clinical settings and the suggestions for future research are discussed.	[Jeong, Ansuk; Kang, Yu Kyoung] Univ Utah Asia Campus, Dept Psychol, Incheon, South Korea; [Min, Ju-Hong; Kim, Juhyeon; Kim, Byung Joon] Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Choi, Misong] Yeouido St Marys Hosp, Dept Neurol, Seoul, South Korea; [Seok, Jin Myoung] Soonchunhyang Univ, Cheonan Hosp, Dept Neurol, Cheonan, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Soonchunhyang University	Min, JH; Kim, BJ (corresponding author), Sungkyunkwan Univ, Coll Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	juhongm@gmail.com; bjkim@skku.edu		Min, Ju-Hong/0000-0002-7338-9067	National Research Foundation of Korea [2017R1C1B5076469]	National Research Foundation of Korea(National Research Foundation of Korea)	This research was supported by the National Research Foundation of Korea (2017R1C1B5076469 to AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio L, 2015, J CLIN NURS, V24, P2357, DOI 10.1111/jocn.12827; Ariatti A, 2014, INT J NEUROSCI, V124, P427, DOI 10.3109/00207454.2013.853664; Barnett C, 2013, J NEUROL NEUROSUR PS, V84, P94, DOI 10.1136/jnnp-2011-301449; Basta IZ, 2012, NEUROL SCI, V33, P1375, DOI 10.1007/s10072-012-1170-2; Boldingh MI, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0298-1; Burns TM, 2010, NEUROLOGY, V74, P1434, DOI 10.1212/WNL.0b013e3181dc1b1e; Burns TM, 2008, MUSCLE NERVE, V38, P1553, DOI 10.1002/mus.21185; Chen YT, 2013, J NEUROSCI NURS, V45, pE3, DOI 10.1097/JNN.0b013e31828291a6; Cioncoloni D, 2016, NEUROL SCI, V37, P717, DOI 10.1007/s10072-016-2556-3; Goffman E, 1955, PSYCHIATR, V18, P213, DOI 10.1080/00332747.1955.11023008; Hoffmann S, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.538; Jeong A, 2016, PSYCHO-ONCOLOGY, V25, P1301, DOI 10.1002/pon.4060; Jeong A, 2016, PSYCHO-ONCOLOGY, V25, P84, DOI 10.1002/pon.3878; Koopman Wilma J, 2016, Can J Neurosci Nurs, V38, P56; Lam WWT, 2005, QUAL LIFE RES, V14, P1187, DOI 10.1007/s11136-004-2391-5; Lee HL, 2017, MUSCLE NERVE; Leonardi M, 2010, J NEUROL, V257, P98, DOI 10.1007/s00415-009-5279-z; Muppidi S, 2011, MUSCLE NERVE, V44, P727, DOI 10.1002/mus.22140; Raggi A, 2010, NEUROL SCI, V31, P231, DOI 10.1007/s10072-009-0194-8; Raggi A, 2010, NEUROL SCI, V31, P41, DOI 10.1007/s10072-009-0167-y; Richards HS, 2014, ORBIT, V33, P263, DOI 10.3109/01676830.2014.904375; Russell DW, 1996, J PERS ASSESS, V66, P20, DOI 10.1207/s15327752jpa6601_2; Sanders DB, 2016, NEUROLOGY, V87, P419, DOI 10.1212/WNL.0000000000002790; Stankovic M, 2018, ACTA NEUROL BELG, V118, P423, DOI 10.1007/s13760-018-0915-y; Stark DPH, 2000, BRIT J CANCER, V83, P1261, DOI 10.1054/bjoc.2000.1405; Sussman Jon, 2015, Pract Neurol, V15, P199, DOI 10.1136/practneurol-2015-001126; Turvey CL, 2009, AM J GERIAT PSYCHIAT, V17, P632, DOI 10.1097/JGP.0b013e31819c498c; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Utsugisawa K, 2014, MUSCLE NERVE, V50, P493, DOI 10.1002/mus.24213; Walklet Elaine, 2016, J Neuromuscul Dis, V3, P347; Wolf M H, 1978, J Behav Med, V1, P391, DOI 10.1007/BF00846695; Yang YX, 2016, INT J NEUROSCI, V126, P455, DOI 10.3109/00207454.2015.1038712	32	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206754	10.1371/journal.pone.0206754	http://dx.doi.org/10.1371/journal.pone.0206754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408057	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300037
J	Lippman, SA; Gilmore, HJ; Lane, T; Radebe, O; Chen, YH; Mlotshwa, N; Maleke, K; Manyuchi, AE; McIntyre, J				Lippman, Sheri A.; Gilmore, Hailey J.; Lane, Tim; Radebe, Oscar; Chen, Yea-Hung; Mlotshwa, Nkuli; Maleke, Kabelo; Manyuchi, Albert E.; McIntyre, James			Ability to use oral fluid and fingerstick HIV self-testing (HIVST) among South African MSM	PLOS ONE			English	Article							WHOLE-BLOOD; MEN; CARE; SEX; ACCURACY; ACCEPTABILITY; PERCEPTIONS; POPULATION; ENGAGEMENT; COMMUNITY	Background HIV self-testing (HIVST) may increase HIV testing uptake, facilitating earlier treatment for key populations like MSM who experience barriers accessing clinic-based HIV testing. HIVST usability among African MSM has not been explored. Methods We assessed usability of oral fluid (OF) and fingerstick (FS; blood) HIVST kits during three phases among MSM with differing degrees of HIVST familiarity in Mpumalanga, South Africa. In 2015, 24 HIVST-naive MSM conducted counselor-observed OF and FS HIVST after brief demonstration. In 2016 and 2017, 45 and 64 MSM with experience using HIVST in a pilot study chose one HIVST to conduct with a counselor-observer present. In addition to written, the latter group had access to video instructions. We assessed frequency of user errors and reported test use ease, changes in error frequency by phase, and covariates associated with correct usage using log-Poisson and Gaussian generalized estimating equations. Results Among OF users (n = 57), 15-30% committed errors in each phase; however, observers consistently rated participants as able to test alone. Among FS users (n = 100), observers noted frequent errors, most commonly related to blood collection and delivery. We found suggestive evidence (not reaching statistical significance) that user errors decreased, with 37.5%, to 28.1%, and 18.2% committing errors in phases I, II, and III, respectively (p-value: 0.08), however observer concerns remained constant. Ease and confidence using HIVST increased with HIV testing experience. Participants using three HIVST were more likely (RR: 1.92, 95% CI: 1.32, 2.80) to report ease compared to those without prior HIVST experience. Never testers (RR: 0.66, 95% CI: 0.44-0.99) reported less ease performing HIVST compared to participants testing in the past six months. Conclusions MSM were able to perform the OF test. Fingerstick test performance was less consistent; however preference for fingerstick was strong and performance may improve with exposure and instructional resources. Continued efforts to provide accessible instructions are paramount.	[Lippman, Sheri A.; Gilmore, Hailey J.; Lane, Tim] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA; [Radebe, Oscar; Mlotshwa, Nkuli; Maleke, Kabelo; Manyuchi, Albert E.; McIntyre, James] Anova Hlth Inst, Johannesburg, South Africa; [Chen, Yea-Hung] San Francisco Dept Publ Hlth, Ctr Publ Hlth Res, San Francisco, CA USA; [McIntyre, James] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa	University of California System; University of California San Francisco; San Francisco Department of Public Health; University of Cape Town	Lippman, SA (corresponding author), Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA.	sheri.lippman@ucsf.edu	McIntyre, James/V-7115-2019	Lippman, Sheri/0000-0003-3152-9372	National Institutes of Health [R21MH103038]; President's Emergency Plan for AIDS Relief through the US Department of Health and Human Services; Centers for Disease Control and Prevention South Africa Country Office [U2GGH000251]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062246, R21MH103038] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); President's Emergency Plan for AIDS Relief through the US Department of Health and Human Services; Centers for Disease Control and Prevention South Africa Country Office; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by a grant from the National Institutes of Health (www.nih.gov; R21MH103038 to SAL) and in part by the President's Emergency Plan for AIDS Relief through the US Department of Health and Human Services and the Centers for Disease Control and Prevention South Africa Country Office under the terms of a Cooperative Agreement (www.cdc.gov; U2GHH000251 to TEL). HIV self-testing kits were donated by Atomo Diagnostics and OraSure Technologies, Inc. The funders and test kit donors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiimwe S, 2014, AIDS BEHAV, V18, P2477, DOI 10.1007/s10461-014-0765-4; Atomo Diagnostics Pty Ltd, 2014, TECHN INF PACK ATOMO; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Carballo-Dieguez A, 2012, AIDS BEHAV, V16, P1753, DOI 10.1007/s10461-012-0274-2; Choko AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158107; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; de la Fuente L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046555; Department of Health Republic of South Africa, 2018, NAT HIV SELF SCREEN; DiCarlo AL, 2014, CULT HEALTH SEX, V16, P867, DOI 10.1080/13691058.2014.913812; Estem KS, 2016, CURR HIV-AIDS REP, V13, P107, DOI 10.1007/s11904-016-0307-y; Figueroa C, 2018, LANCET HIV, V5, pE277, DOI 10.1016/S2352-3018(18)30044-4; Frasca T, 2014, AIDS BEHAV, V18, P950, DOI 10.1007/s10461-013-0630-x; Gresenguet Gerard, 2017, Open AIDS J, V11, P101, DOI 10.2174/1874613601711010101; Heckathorn D., 2002, SOCPROBL, V49; HIVST.org, 2018, HIV SELF TEST RES PO; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; Katz D, 2015, SELF TESTING INCREAS; Kurth AE, 2016, AIDS BEHAV, V20, P870, DOI 10.1007/s10461-015-1213-9; Lane T, 2008, SEX TRANSM INFECT, V84, P430, DOI 10.1136/sti.2008.031567; Lane T, 2016, JAIDS-J ACQ IMM DEF, V73, P609, DOI 10.1097/QAI.0000000000001162; Lane T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111063; Lippman SA, 2018, JAIDS-J ACQ IMM DEF, V77, P279, DOI [10.1097/QAI.0000000000001601, 10.1097/qai.0000000000001601]; Maughan-Brown B, 2017, J INT AIDS SOC, V20, P18; Mooney AC, 2017, AIDS EDUC PREV, V29, P274, DOI 10.1521/aeap.2017.29.3.274; National Department of Health, 2012, NAT ANT SENT HIV SYP; Pai NP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079772; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Peck RB, 2014, AIDS BEHAV, V18, pS422, DOI 10.1007/s10461-014-0818-8; Perez GM, 2016, TROP MED INT HEALTH, V21, P759, DOI 10.1111/tmi.12703; Rispel LC, 2011, J PUBLIC HEALTH POL, V32, pS137, DOI 10.1057/jphp.2011.29; Sharma M, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002262; Shisana O, 2014, S AFRICAN NATL HIV P; Skovdal M, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-13; South Africa Demographic and Health Survey, 2017, S AFR DEM HLTH SURV; South African National AIDS Council, 2011, HCT ART EXP RES; Stekler JD, 2013, J CLIN VIROL, V58, pE119, DOI 10.1016/j.jcv.2013.09.018; Stevens DR, 2018, AIDS BEHAV, V22, P497, DOI 10.1007/s10461-017-1707-8; Treves-Kagan S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2753-2; UNAIDS, 2010, GLOB REP UNAIDS REP; US Food and Drug Administration (USFDA), 2012, ORAQUICK IN HOM HIV; Volk JE, 2016, INT J STD AIDS, V27, P531, DOI 10.1177/0956462415586676; Woods WJ, 2016, AIDS CARE, V28, P111, DOI 10.1080/09540121.2016.1146399; World Health Organization, 2016, GUIDELINES ON HIV TE; Zhong F, 2017, HIV MED, V18, P376, DOI 10.1111/hiv.12437	45	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206849	10.1371/journal.pone.0206849	http://dx.doi.org/10.1371/journal.pone.0206849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408055	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300042
J	Racioppi, A; Sheinbaum, T; Gross, GM; Ballespi, S; Kwapil, TR; Barrantes-Vidal, N				Racioppi, Anna; Sheinbaum, Tamara; Gross, Georgina M.; Ballespi, Sergi; Kwapil, Thomas R.; Barrantes-Vidal, Neus			Prediction of prodromal symptoms and schizophrenia-spectrum personality disorder traits by positive and negative schizotypy: A 3-year prospective study	PLOS ONE			English	Article							ULTRA-HIGH-RISK; SOCIAL ANHEDONIA; PSYCHOMETRIC SCHIZOTYPY; PSYCHOSIS; AVOIDANT; SCALES; ANXIETY; PSYCHOPATHOLOGY; TEMPERAMENT; RELIABILITY	The present study extends previous cross-sectional findings by examining the predictive validity of positive and negative schizotypy in a young adult sample at a three-year follow-up. Schizotypy and schizophrenia share a comparable multidimensional structure with positive and negative dimensions being the most strongly supported factors. Previous cross-sectional and longitudinal studies employing the psychometric high-risk strategy indicated that schizotypy is a useful method for identifying risk and resilience factors for the development of schizophrenia-spectrum psychopathology. In the present study, 103 participants (77% of 134 candidate participants) were reassessed at a three-year follow-up. As hypothesized, positive schizotypy predicted psychotic-like symptoms, depression, low self-esteem, and general psychopathology. Negative schizotypy predicted emotional disturbances, schizoid personality traits, and mental health treatment during the past year. As expected, both schizotypy dimensions predicted schizotypal, paranoid, and avoidant personality traits, and impaired functioning. These longitudinal findings provide additional evidence supporting the multidimensional model of schizotypy as a valid framework for studying etiological mechanisms and trajectories of psychosis.	[Racioppi, Anna; Ballespi, Sergi; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Spain; [Sheinbaum, Tamara] Univ Southern Calif, Dept Psychol, Los Angeles, CA USA; [Gross, Georgina M.] VA Connecticut Healthcare Syst, West Haven, CT USA; [Gross, Georgina M.] Yale Sch Med, New Haven, CT USA; [Kwapil, Thomas R.] Univ Illinois, Dept Psychol, Champaign, IL USA; [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanitaria, Barcelona, Spain; [Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Barcelona, Spain	Autonomous University of Barcelona; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; University of Illinois System; University of Illinois Urbana-Champaign; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Barrantes-Vidal, N (corresponding author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, Barcelona, Spain.; Barrantes-Vidal, N (corresponding author), St Pere Claver Fundacio Sanitaria, Barcelona, Spain.; Barrantes-Vidal, N (corresponding author), Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Barcelona, Spain.	neus.barrantes@uab.cat	Barrantes-Vidal, Neus/A-9578-2013; Sheinbaum, Tamara/A-8008-2016; Racioppi, Anna/ABC-8658-2020	Barrantes-Vidal, Neus/0000-0002-8671-1238; Sheinbaum, Tamara/0000-0002-2268-7697; Racioppi, Anna/0000-0002-5575-2811	Spanish Ministerio de Economia y Competitividad [BOE-A-2015-6508, PSI2017-87512-C2-01]; Comissionat per a Universitats i Recerca of Generalitat de Catalunya [2017SGR1612]; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award; Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain; European Social Found (ESF)	Spanish Ministerio de Economia y Competitividad(Spanish Government); Comissionat per a Universitats i Recerca of Generalitat de Catalunya; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award(ICREA); Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain; European Social Found (ESF)(European Social Fund (ESF))	Authors are supported by the Spanish Ministerio de Economia y Competitividad (PSI2017-87512-C2-01) and the Comissionat per a Universitats i Recerca of Generalitat de Catalunya (2017SGR1612). N. Barrantes-Vidal is supported by Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Award and Centro de Investigacion Biomedica en Red de Salud Mental (CIBERSAM), Instituto de Salud Carlos III, Barcelona, Spain. A. Racioppi is supported by the Spanish Ministerio de Economia y Competitividad (BOE-A-2015-6508) and by the European Social Found (ESF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDINGTON D, 1992, SCHIZOPHR RES, V6, P201, DOI 10.1016/0920-9964(92)90003-N; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrantes-Vidal N, 2003, SCHIZOPHR RES, V61, P293, DOI 10.1016/S0920-9964(02)00321-3; Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191; Barrantes-Vidal N, 2013, J ABNORM PSYCHOL, V122, P1077, DOI 10.1037/a0034793; Barrantes-Vidal N, 2013, SCHIZOPHR RES, V145, P50, DOI 10.1016/j.schres.2013.01.007; Barrantes-Vidal N, 2010, SCHIZOPHR RES, V122, P219, DOI 10.1016/j.schres.2010.01.006; Barrantes-Vidal N, 2009, SCHIZOPHR RES, V115, P303, DOI 10.1016/j.schres.2009.09.021; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Blanchard JJ, 2011, SCHIZOPHRENIA BULL, V37, P587, DOI 10.1093/schbul/sbp107; Bolinskey PK, 2015, PSYCHIAT RES, V225, P335, DOI 10.1016/j.psychres.2014.12.015; Brown LH, 2008, J SOC CLIN PSYCHOL, V27, P127, DOI 10.1521/jscp.2008.27.2.127; Brown LH, 2007, PSYCHOL SCI, V18, P778, DOI 10.1111/j.1467-9280.2007.01978.x; Chapman L. J., 1983, INFREQUENCY SC UNPUB; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; CHAPMAN LJ, 1994, J ABNORM PSYCHOL, V103, P171, DOI 10.1037/0021-843X.103.2.171; Chun CA, 2017, PERSONAL DISORD, V8, P64, DOI 10.1037/per0000141; Claridge G., 1995, SCHIZOTYPAL PERSONAL, P192, DOI DOI 10.1017/CBO9780511759031.010; Claridge G.E., 1997, SCHIZOTYPY IMPLICATI, DOI 10.1093/med:psych/9780198523536.001.0001; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; De Loore E, 2011, SCHIZOPHR RES, V127, P252, DOI 10.1016/j.schres.2011.01.015; Debbane M, 2015, SCHIZOPHRENIA BULL, V41, pS386, DOI 10.1093/schbul/sbu175; Debbane M, 2015, SCHIZOPHRENIA BULL, V41, pS396, DOI 10.1093/schbul/sbu176; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; Eckblad M.L., 1982, REVISED SOCIAL UNPUB; First M. B., 1997, STRUCTURED CLIN INTE; Fogelson DL, 2007, SCHIZOPHR RES, V91, P192, DOI 10.1016/j.schres.2006.12.023; Fogelson DL, 1999, PSYCHIAT RES, V87, P137, DOI 10.1016/S0165-1781(99)00086-4; Fonseca-Pedrero E, 2018, PSYCHOL MED, V48, P451, DOI 10.1017/S0033291717001829; Fresan A, 2015, J PSYCHIATR RES, V61, P168, DOI 10.1016/j.jpsychires.2014.12.013; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gooding DC, 2005, J ABNORM PSYCHOL, V114, P170, DOI 10.1037/0021-843X.114.1.170; Gooding DC, 2007, SCHIZOPHR RES, V94, P373, DOI 10.1016/j.schres.2007.04.018; Grilo CM, 2004, J CONSULT CLIN PSYCH, V72, P767, DOI 10.1037/0022-006X.72.5.767; Hanssen M, 2005, BRIT J CLIN PSYCHOL, V44, P181, DOI 10.1348/014466505X29611; Horton LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096269; Johnson JG, 2000, ACTA PSYCHIAT SCAND, V102, P265, DOI 10.1034/j.1600-0447.2000.102004265.x; Keshavan MS, 2005, AM J PSYCHIAT, V162, P102, DOI 10.1176/appi.ajp.162.1.102; Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827; Kwapil TR, 2008, SCHIZOPHRENIA BULL, V34, P444, DOI 10.1093/schbul/sbm098; Kwapil TR, 2018, SCHIZOPHR RES, V193, P209, DOI 10.1016/j.schres.2017.07.001; Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186; Kwapil TR, 2013, J ABNORM PSYCHOL, V122, P807, DOI 10.1037/a0033759; Kwapil TR, 2012, J PSYCHOPATHOL BEHAV, V34, P145, DOI 10.1007/s10862-011-9258-1; Kwapil TR, 1998, J ABNORM PSYCHOL, V107, P558, DOI 10.1037/0021-843X.107.4.558; Kwapil TR, NEGATIVE SYMPT UNPUB; Lee SY, 2011, J NERV MENT DIS, V199, P106, DOI 10.1097/NMD.0b013e3182083b96; Lenzenweger MF, 2015, SCHIZOPHRENIA BULL, V41, pS483, DOI 10.1093/schbul/sbu184; Lenzenweger MF, 2010, DEV PSYCHOPATHOL, V22, P867, DOI 10.1017/S0954579410000519; Lenzenweger MF, 2009, DEV PSYCHOPATHOL, V21, P1211, DOI 10.1017/S0954579409990125; Lewandowski KE, 2006, SCHIZOPHR RES, V83, P225, DOI 10.1016/j.schres.2005.11.024; Miettunen J, 2011, J NERV MENT DIS, V199, P230, DOI 10.1097/NMD.0b013e3182125d2c; Miller TJ, 2003, SCHIZOPHRENIA BULL, V29, P703, DOI 10.1093/oxfordjournals.schbul.a007040; RAINE A, 1991, SCHIZOPHRENIA BULL, V17, P555, DOI 10.1093/schbul/17.4.555; Roberts BW, 2000, PSYCHOL BULL, V126, P3, DOI 10.1037/0033-2909.126.1.3; Ros-Morente A, 2010, ACTAS ESP PSIQUIATRI, V38, P33; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Shea MT, 2002, AM J PSYCHIAT, V159, P2036, DOI 10.1176/appi.ajp.159.12.2036; Solano JJR, 2000, SCHIZOPHR RES, V44, P137, DOI 10.1016/S0920-9964(99)00203-0; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; van Rossum I, 2011, SCHIZOPHRENIA BULL, V37, P561, DOI 10.1093/schbul/sbp101; VOLLEMA MG, 1995, SCHIZOPHRENIA BULL, V21, P19, DOI 10.1093/schbul/21.1.19; Werbeloff N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119852; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x	66	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207150	10.1371/journal.pone.0207150	http://dx.doi.org/10.1371/journal.pone.0207150			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408119	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300085
J	Sullivan, CD; Slade, EM; Bai, M; Shi, K; Riordan, P				Sullivan, Casey D.; Slade, Eleanor M.; Bai, Ming; Shi, Kun; Riordan, Philip			Evidence of forest restoration success and the conservation value of community-owned forests in Southwest China using dung beetles as indicators	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; BIODIVERSITY CONSERVATION; LAND-USE; ECOSYSTEM SERVICES; COST-EFFECTIVENESS; MAPUTALAND-CENTER; SOUTHEAST-ASIA; DIVERSITY; FRAGMENTATION; COLEOPTERA	Protection of the world's remaining forests and biodiversity is a matter of global concern. Yunnan, China is home to China's only mainland tropical rainforests, and 20% of China's total biodiversity. Despite restoration measures and establishment of new protected areas, this region is still experiencing biodiversity loss due to inadequate management and monitoring. We evaluate restoration success of China's tropical forests in Xishuangbanna National Nature Reserve (XSBN-NNR), Yunnan, China using dung beetles as an indicator taxon. We sampled across a land-use gradient of human alteration: protected forest, restored forest, community owned forest, and rubber plantation. We collected 3,748 dung beetles from 21 species over a 3 month period. Multivariate analyses revealed unique assemblages in each land-use category, but with restored forest most similar to protected areas, suggesting restoration success in this region. Community forests were more diverse than plantations, suggesting that community forests may be a valuable and practical conservation tool in this region. Most species were generalists, although some had dietary and habitat preferences. Furthermore, dietary niche breadths were, on average, higher in disturbed areas, suggesting that disturbance may result in dietary changes. We show that restoration of tropical forests appears to be successful for a key ecological and biological indicator group-dung beetles. Furthermore, community-owned forests appear to be valuable and practical method of maintaining ecosystem health and biodiversity in the region. Future management in this region would likely benefit from encouragement to maintain community-owned forests, economic incentives for restoring farmland to forest, and increased environmental monitoring across the land-use gradient.	[Sullivan, Casey D.; Shi, Kun; Riordan, Philip] Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing, Peoples R China; [Slade, Eleanor M.] Univ Lancaster, Lancaster Environm Ctr, Lancaster, England; [Slade, Eleanor M.] Univ Oxford, Dept Zool, Oxford, England; [Bai, Ming] Chinese Acad Sci, Key Lab Zool Systemat & Evolut, Inst Zool, Beijing, Peoples R China; [Shi, Kun] Ecobridge Continental, Huizhi Tower, Beijing, Peoples R China; [Riordan, Philip] Marwell Wildlife, Thompsons Lane, Winchester, Hants, England	Beijing Forestry University; Lancaster University; University of Oxford; Chinese Academy of Sciences; Institute of Zoology, CAS	Shi, K (corresponding author), Beijing Forestry Univ, Wildlife Inst, Sch Nat Conservat, Beijing, Peoples R China.; Shi, K (corresponding author), Ecobridge Continental, Huizhi Tower, Beijing, Peoples R China.	kunshi@bjfu.edu.cn	Slade, Eleanor M/O-3874-2014; Riordan, Philip/AAY-6420-2020	Slade, Eleanor M/0000-0002-6108-1196; Riordan, Philip/0000-0001-6285-8596; Shi, Kun/0000-0002-3731-8421	Second National Survey of Terrestrial Wildlife in China; State Forestry Administration of China; National Natural Science Foundation of China [31672345]; Research Equipment Development Project of Chinese Academy of Sciences [YZ201509]	Second National Survey of Terrestrial Wildlife in China; State Forestry Administration of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Equipment Development Project of Chinese Academy of Sciences	This research was supported in part by the Second National Survey of Terrestrial Wildlife in China, State Forestry Administration of China, the National Natural Science Foundation of China (No. 31672345) (KS), Research Equipment Development Project of Chinese Academy of Sciences (YZ201509) (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the field team, and our guides and their families, the Wang family and the Chen family. We would also like to thank our field technicians, Wu Ziyou and Che Xingjin, and to acknowledge the staff in the Mengyang subunit of the Xishuangbanna National Nature Reserve. Finally, we thank several anonymous reviewers for suggestions made on previous versions of this manuscript. This research was supported in part by the Second National Survey of Terrestrial Wildlife in China, State Forestry Administration of China, the National Natural Science Foundation of China (No. 31672345), and Research Equipment Development Project of Chinese Academy of Sciences (YZ201509).	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Adhikari B, 2007, FOREST POLICY ECON, V9, P464, DOI 10.1016/j.forpol.2005.11.002; Aguilar-Amuchastegui N, 2007, FOREST ECOL MANAG, V253, P56, DOI 10.1016/j.foreco.2007.07.004; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bicknell JE, 2014, ECOL INDIC, V43, P154, DOI 10.1016/j.ecolind.2014.02.030; Birch JC, 2014, ECOSYST SERV, V8, P118, DOI 10.1016/j.ecoser.2014.03.005; Boonrotpong Singtoe, 2004, ScienceAsia, V30, P59, DOI 10.2306/scienceasia1513-1874.2004.30.059; Botes A, 2006, BIOL CONSERV, V130, P573, DOI 10.1016/j.biocon.2006.01.020; Cao C, 2016, P ISCSLP 2016, P1; Cao M, 2006, BIOTROPICA, V38, P306, DOI 10.1111/j.1744-7429.2006.00146.x; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; CHAPMAN EC, 1991, GEOGR J, V157, P36, DOI 10.2307/635142; Chazdon RL, 2003, PERSPECT PLANT ECOL, V6, P51, DOI 10.1078/1433-8319-00042; Chen HP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152324; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Crawley M.J., 2007, R BOOK; Crouzeilles R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11666; Davis AJ, 2000, GLOBAL ECOL BIOGEOGR, V9, P281, DOI 10.1046/j.1365-2699.2000.00189.x; Davis AJ, 2000, COLEOPTS BULL, V54, P221, DOI 10.1649/0010-065X(2000)054[0221:SRODFB]2.0.CO;2; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Derhe MA, 2016, J APPL ECOL, V53, P1714, DOI 10.1111/1365-2664.12728; Distefano E, 2005, CONFLICT, V7, P1; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Edwards DP, 2012, ECOL APPL, V22, P561, DOI 10.1890/11-1362.1; Edwards DP, 2011, P ROY SOC B-BIOL SCI, V278, P82, DOI 10.1098/rspb.2010.1062; Edwards FA, 2014, ANIM CONSERV, V17, P163, DOI 10.1111/acv.12074; Filgueiras BKC, 2015, ECOL INDIC, V55, P65, DOI 10.1016/j.ecolind.2015.02.032; Filgueiras BKC, 2011, BIOL CONSERV, V144, P362, DOI 10.1016/j.biocon.2010.09.013; Gao T, 2015, ECOL INDIC, V57, P420, DOI 10.1016/j.ecolind.2015.05.028; Gardner TA, 2008, J APPL ECOL, V45, P883, DOI 10.1111/j.1365-2664.2008.01454.x; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gray CL, 2016, BIOL CONSERV, V194, P176, DOI 10.1016/j.biocon.2015.12.017; Gray CL, 2014, DO RIPARIAN RESERVES; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Heino J, 2005, ECOGRAPHY, V28, P345, DOI 10.1111/j.0906-7590.2005.04151.x; Heinonen J, 2009, BIODIVERSITY ECOTOUR, DOI [10.1080/17538947.2013.786146, DOI 10.1080/17538947.2013.786146]; Horgan FG, 2005, FOREST ECOL MANAG, V216, P117, DOI 10.1016/j.foreco.2005.05.049; Hosaka T, 2014, BIOTROPICA, V46, P720, DOI 10.1111/btp.12158; Hseih TC, 2016, INEXT INTERPOLATION; Huang C, 2004, THEORY PRACTICE VOLU; Hughes AC, 2017, BIOL CONSERV, V209, P395, DOI 10.1016/j.biocon.2017.03.007; Kudavidanage EP, 2012, RAFFLES B ZOOL, P141; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Li HM, 2009, BIODIVERS CONSERV, V18, P3421, DOI 10.1007/s10531-009-9651-1; McGeoch MA, 2002, J APPL ECOL, V39, P661, DOI 10.1046/j.1365-2664.2002.00743.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nichols E, 2009, OIKOS, V118, P481, DOI 10.1111/j.1600-0706.2009.17268.x; Nichols Elizabeth S., 2011, P267; Novais SMA, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew069; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pagdee A, 2006, ASIA PACIFIC J SCI T, V11, P25; Panfil SN, 2016, CONSERV LETT, V9, P143, DOI 10.1111/conl.12188; Paoletti MG, 1996, CRIT REV PLANT SCI, V15, P21, DOI 10.1080/713608126; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Poffenberger M, 2006, INT J ENVIRON SUSTAI, V5, P57, DOI 10.1504/IJESD.2006.008683; Pu YingShan, 2001, Journal of Forestry Research, V12, P25, DOI 10.1007/BF02856795; Qiu J, 2009, NATURE, V457, P246, DOI 10.1038/457246a; R Core Team, 2021, R LANGUAGE ENV STAT; Ravindranath NH, 2006, INT J ENVIRON SUSTAI, V5, P1, DOI 10.1504/IJESD.2006.008678; Reid W, 2005, EC HUM WELL BEING SY, P1; Roberts D.W., 2016, LABDSV ORDINATION MU; Rodrigues RR, 2009, BIOL CONSERV, V142, P1242, DOI 10.1016/j.biocon.2008.12.008; Rodrigues RR, 2011, FOREST ECOL MANAG, V261, P1605, DOI 10.1016/j.foreco.2010.07.005; Schulze CH, 2004, ECOL APPL, V14, P1321, DOI 10.1890/02-5409; Senf C, 2013, REMOTE SENS-BASEL, V5, P2795, DOI 10.3390/rs5062795; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Shahabuddin, 2005, BIODIVERS CONSERV, V14, P863, DOI 10.1007/s10531-004-0654-7; Silverstone PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125527; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Sreedhar RV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123580; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Uchida E, 2005, LAND ECON, V81, P247, DOI 10.3368/le.81.2.247; Van Rensburg BJ, 1999, BIOL CONSERV, V88, P145, DOI 10.1016/S0006-3207(98)00109-8; Velho N, 2015, ANIM CONSERV, P1; Venables WN, 2002, MODERN APPPLIED STAT; Vinod K.V., 2007, Journal of Insect Science (Tucson), V7, P1, DOI 10.1673/031.007.5601; Wells K, 2007, J BIOGEOGR; Wheeler CE, 2016, FOREST ECOL MANAG, V373, P44, DOI 10.1016/j.foreco.2016.04.025; Williams YM, 2006, NICHE BREADTH GEOGRA, P532, DOI [10.1098/rsbl.2006.0541, DOI 10.1098/RSBL.2006.0541]; Xu HG, 2008, BIOSCIENCE, V58, P632, DOI 10.1641/B580710; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; Yang YM, 2004, BIODIVERS CONSERV, V13, P813, DOI 10.1023/B:BIOC.0000011728.46362.3c; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhang MG, 2012, BIOL CONSERV, V153, P257, DOI 10.1016/j.biocon.2012.04.023; Zhu H, 2004, BIODIVERS CONSERV, V13, P1355, DOI 10.1023/B:BIOC.0000019397.98407.c3; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833	91	5	6	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0204764	10.1371/journal.pone.0204764	http://dx.doi.org/10.1371/journal.pone.0204764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408034	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300007
J	O'Brien, DM; Boisseau, RP				O'Brien, Devin M.; Boisseau, Romain P.			Overcoming mechanical adversity in extreme hindleg weapons	PLOS ONE			English	Article							SEXUAL-SELECTION; SLENDER CRAYFISH; HANDICAP PRINCIPLE; POSITIVE ALLOMETRY; SOCIAL COMPETITION; DISHONEST SIGNALS; MATE PREFERENCES; METABOLIC COST; FEMALE CHOICE; FIDDLER-CRAB	The size of sexually selected weapons and their performance in battle are both critical to reproductive success, yet these traits are often in opposition. Bigger weapons make better signals. However, due to the mechanical properties of weapons as lever systems, increases in size may inhibit other metrics of performance as different components of the weapon grow out of proportion with one another. Here, using direct force measurements, we investigated the relationship between weapon size and weapon force production in two hindleg weapon systems, frog-legged beetles (Sagra femorata) and leaf-footed cactus bugs (Narnia femorata), to test for performance tradeoffs associated with increased weapon size. In male frog-legged beetles, relative force production decreased as weapon size increased. Yet, absolute force production was maintained across weapon sizes. Surprisingly, mechanical advantage was constant across weapon sizes and large weaponed males had disproportionately large leg muscles. In male leaf-footed cactus bugs, on the other hand, there was no relationship between weapon size and force production, likely reflecting the importance of their hindlegs as signals rather than force-producing structures of male-male competition. Overall, our results suggest that when weapon force production is important for reproductive success, large weaponed animals may overcome mechanical challenges by maintaining proportional lever components and investing in (potentially costly) compensatory mechanisms.	[O'Brien, Devin M.; Boisseau, Romain P.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	University of Montana System; University of Montana	O'Brien, DM (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	dmobrien@colby.edu		Boisseau, Romain/0000-0003-4317-1064				Addesso KM, 2014, BEHAVIOUR, V151, P479, DOI 10.1163/1568539X-00003137; Adolph SC, 2008, J EXP BIOL, V211, P1336, DOI 10.1242/jeb.011296; Allen BJ, 2007, FUNCT ECOL, V21, P154, DOI 10.1111/j.1365-2435.2006.01219.x; BARRETTE C, 1990, BEHAV ECOL SOCIOBIOL, V26, P383; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beltman JGM, 2004, ACTA PHYSIOL SCAND, V182, P179, DOI 10.1111/j.1365-201X.2004.01338.x; Biernaskie JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0876; Bonduriansky R, 2005, EVOLUTION, V59, P138, DOI 10.1111/j.0014-3820.2005.tb00901.x; Bonduriansky R, 2003, EVOLUTION, V57, P2450, DOI 10.1111/j.0014-3820.2003.tb01490.x; BURKHARDT D, 1987, ENTOMOL GEN, V12, P221; BURKHARDT D, 1988, J COMP PHYSIOL A, V162, P649, DOI 10.1007/BF01342640; Burrows M, 2002, J EXP BIOL, V205, P1519; Bywater CL, 2008, FUNCT ECOL, V22, P311, DOI 10.1111/j.1365-2435.2008.01379.x; Bywater CL, 2014, J EXP BIOL, V217, P2848, DOI 10.1242/jeb.099390; CASEY TM, 1981, J EXP BIOL, V91, P117; Cirino LA, 2017, INSECTS, V8, DOI 10.3390/insects8010013; Claverie T, 2007, P R SOC B, V274, P3033, DOI 10.1098/rspb.2007.1223; Claverie T, 2011, EVOLUTION, V65, P443, DOI 10.1111/j.1558-5646.2010.01133.x; CLUTTONBROCK TH, 1979, ANIM BEHAV, V27, P211, DOI 10.1016/0003-3472(79)90141-6; CONNER J, 1988, EVOLUTION, V42, P736, DOI 10.1111/j.1558-5646.1988.tb02492.x; CRESPI BJ, 1986, ECOL ENTOMOL, V11, P119, DOI 10.1111/j.1365-2311.1986.tb00286.x; Dauncey MJ, 1996, P NUTR SOC, V55, P543, DOI 10.1079/PNS19960047; Dennenmoser S, 2013, EVOLUTION, V67, P1181, DOI 10.1111/evo.12018; DICKINSON MH, 1995, SCIENCE, V268, P87, DOI 10.1126/science.7701346; Eberhard W.G., 1979, P231; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Eshel I, 2000, EVOL ECOL RES, V2, P509; Ezenwa VO, 2008, ANIM BEHAV, V75, P2013, DOI 10.1016/j.anbehav.2007.12.013; Fisher RA, GENETICAL THEORY NAT; Fromhage L, 2014, EVOLUTION, V68, P1332, DOI 10.1111/evo.12349; Goyens J, 2016, J EXP BIOL, V219, P2955, DOI 10.1242/jeb.141614; Goyens J, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0222; Goyens J, 2014, J EXP BIOL, V217, P1065, DOI 10.1242/jeb.091744; GREEN AJ, 1992, ANIM BEHAV, V43, P170, DOI 10.1016/S0003-3472(05)80086-7; Greenwood PL, 2000, J ANIM SCI, V78, P50; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; Holwell GI, 2010, BEHAV ECOL SOCIOBIOL, V64, P617, DOI 10.1007/s00265-009-0879-2; Hongo Y, 2007, BEHAV ECOL SOCIOBIOL, V62, P245, DOI 10.1007/s00265-007-0459-2; Hortobagyi T, 2011, J GERONTOL A-BIOL, V66, P541, DOI 10.1093/gerona/glr008; Husak JF, 2006, COPEIA, P301, DOI 10.1643/0045-8511(2006)6[301:BPPDIM]2.0.CO;2; Husak JF, 2011, BEHAVIOUR, V148, P1, DOI 10.1163/000579510X541265; Huyghe K, 2005, FUNCT ECOL, V19, P800, DOI 10.1111/j.1365-2435.2005.01038.x; IWASA Y, 1991, EVOLUTION, V45, P1431, DOI [10.1111/j.1558-5646.1991.tb02646.x, 10.2307/2409890]; Iwasa Y, 1999, J THEOR BIOL, V200, P97, DOI 10.1006/jtbi.1999.0979; JOHNSTONE RA, 1995, BIOL REV, V70, P1, DOI 10.1111/j.1469-185X.1995.tb01439.x; JONES AR, 1980, MAR BEHAV PHYSIOL, V7, P47, DOI 10.1080/10236248009386970; Joseph PN, 2016, ECOL EVOL, V6, P4792, DOI 10.1002/ece3.2246; JOUBERT D. M., 1956, Journal of Agricultural Science, V47, P59, DOI 10.1017/S0021859600039794; Katsuki M, ENTOMOL SCI; Kawano K, 1997, ANN ENTOMOL SOC AM, V90, P453, DOI 10.1093/aesa/90.4.453; Kilmer JT, 2017, J EVOLUTION BIOL, V30, P4, DOI 10.1111/jeb.12986; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kruuk LEB, 2002, EVOLUTION, V56, P1683, DOI 10.1111/j.0014-3820.2002.tb01480.x; Lailvaux SP, 2005, FUNCT ECOL, V19, P632, DOI 10.1111/j.1365-2435.2005.01024.x; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; Lappin AK, 2005, AM NAT, V166, P426, DOI 10.1086/432564; Levinton JS, 2005, FUNCT ECOL, V19, P159, DOI 10.1111/j.0269-8463.2005.00968.x; McCullough EL, 2016, TRENDS ECOL EVOL; McCullough EL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0696; McHenry MJ, 2011, BIOL LETTERS, V7, P384, DOI 10.1098/rsbl.2010.1029; Miller CW, 2016, J EVOLUTION BIOL, V29, P2266, DOI 10.1111/jeb.12954; Mills MR, 2016, J EXP ZOOL PART A, V325, P3, DOI 10.1002/jez.1961; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Moczek AP, 2004, AM NAT, V163, P184, DOI 10.1086/381741; Nolen ZJ, 2017, BEHAV PROCESS, V138, P1, DOI 10.1016/j.beproc.2017.01.020; O'Brien DM, 2017, EVOLUTION, V71, P2584, DOI 10.1111/evo.13336; Painting CJ, 2014, BEHAV ECOL, V25, P1223, DOI 10.1093/beheco/aru119; Panhuis TM, 1999, BEHAV ECOL SOCIOBIOL, V46, P221, DOI 10.1007/s002650050613; PARKER GA, 1981, ANIM BEHAV, V29, P221, DOI 10.1016/S0003-3472(81)80170-4; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Paul J, 1999, J EXP BIOL, V202, P797; PETRIE M, 1988, ANIM BEHAV, V36, P1174, DOI 10.1016/S0003-3472(88)80076-9; POMIANKOWSKI A, 1987, PROC R SOC SER B-BIO, V231, P123, DOI 10.1098/rspb.1987.0038; Procter DS, 2012, J EVOLUTION BIOL, V25, P803, DOI 10.1111/j.1420-9101.2012.02485.x; Sasson DA, 2016, ECOL EVOL; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; SMITH JM, 1976, AM SCI, V64, P41; SMITH JM, 1976, J THEOR BIOL, V57, P239, DOI 10.1016/S0022-5193(76)80016-1; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Sneddon LU, 1997, BEHAV ECOL SOCIOBIOL, V41, P237, DOI 10.1007/s002650050384; Sutton GP, 2011, J EXP BIOL, V214, P836, DOI 10.1242/jeb.052399; TANAKA Y, 1980, J EXP BIOL, V88, P1; TOPINSKI P, 1975, Acta Theriologica, V20, P267; Vanpe C, 2010, OIKOS, V119, P1484, DOI 10.1111/j.1600-0706.2010.18312.x; Walter GM, 2011, J EXP BIOL, V214, P3294, DOI 10.1242/jeb.056754; Waltzek TB, 2003, J MORPHOL, V257, P96, DOI 10.1002/jmor.10111; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; WILKINSON GS, 1994, P ROY SOC B-BIOL SCI, V255, P1, DOI 10.1098/rspb.1994.0001; Willisch CS, 2015, EVOL BIOL, V42, P1, DOI 10.1007/s11692-014-9294-3; Wilson RS, 2007, AM NAT, V170, P284, DOI 10.1086/519399; Wilson RS, 2009, J EXP BIOL, V212, P853, DOI 10.1242/jeb.024547; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3; ZEH DW, 1988, AM NAT, V132, P454, DOI 10.1086/284863; ZEH DW, 1987, EVOLUTION, V41, P1072, DOI 10.1111/j.1558-5646.1987.tb05877.x; 2013, ANIMAL CONTESTS, P1	99	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206997	10.1371/journal.pone.0206997	http://dx.doi.org/10.1371/journal.pone.0206997			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403752	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500089
J	Ranawade, A; Mallick, A; Gupta, BP				Ranawade, Ayush; Mallick, Avijit; Gupta, Bhagwati P.			PRY-1/Axin signaling regulates lipid metabolism in Caenorhabditis elegans	PLOS ONE			English	Article							PATHWAY TARGET GENES; WNT PATHWAY; BETA-CATENIN; LIFE-SPAN; AXIN; IDENTIFICATION; ACTIVATION; EXPRESSION; ADIPOSITY; LONGEVITY	The nematode Caenorhabditis elegans constitutes a leading animal model to study how signaling pathway components function in conserved biological processes. Here, we describe the role of an Axin family member, PRY-1, in lipid metabolism. Axins are scaffolding proteins that play crucial roles in signal transduction pathways by physically interacting with multiple factors and coordinating the assembly of protein complexes. Genome-wide transcriptome profiling of a pry-1 mutant revealed differentially regulated genes that are associated with lipid metabolism such as vitellogenins (yolk lipoproteins), fatty acid desaturases, lipases, and fatty acid transporters. Consistent with these categorizations, we found that pry-1 is crucial for the maintenance of lipid levels. Knockdowns of vitgenes in a pry-1 mutant background restored lipid levels, suggesting that vitellogenins contribute to PRY-1 function in lipid metabolic processes. Additionally, lowered expression of desaturases and lipidomic analysis provided evidence that fatty acid synthesis is reduced in pry-1 mutants. Accordingly, an exogenous supply of oleic acid restored depleted lipids in somatic tissues of worms. Overall, our findings demonstrate that PRY-1/Axin signaling is essential for lipid metabolism and involves the regulation of yolk proteins.	[Ranawade, Ayush; Mallick, Avijit; Gupta, Bhagwati P.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Ranawade, Ayush] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	McMaster University; Harvard University	Gupta, BP (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	guptab@mcmaster.ca	Gupta, Bhagwati P/A-2818-2008; RANAWADE, AYUSH/J-9243-2019	Gupta, Bhagwati P/0000-0001-8572-7054; RANAWADE, AYUSH/0000-0002-4395-2293; Mallick, Avijit/0000-0002-9423-7134	Natural Sciences and Engineering Research Council of Canada; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Discovery grant from the Natural Sciences and Engineering Research Council of Canada to Bhagwati Gupta (http://www.nserc-crsng.gc.ca).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrit FRG, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005788; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Angeles-Albores D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1229-9; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Chen Y, 2013, IUBMB LIFE, V65, P685, DOI 10.1002/iub.1184; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Garg A, 2009, BBA-MOL CELL BIOL L, V1791, P507, DOI 10.1016/j.bbalip.2008.12.014; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; Gorrepati L, 2015, G3-GENES GENOM GENET, V5, P1551, DOI 10.1534/g3.115.017715; Goudeau J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000599; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; Hillier LW, 2009, GENOME RES, V19, P657, DOI 10.1101/gr.088112.108; Hou NS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00143; Jackson BM, 2014, G3-GENES GENOM GENET, V4, P733, DOI 10.1534/g3.113.009522; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Korswagen H.C., 2013, WNT SIGNALING C ELEG; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lemieux GA, 2016, TRENDS ENDOCRIN MET, V27, P586, DOI 10.1016/j.tem.2016.05.004; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lynn DA, 2015, P NATL ACAD SCI USA, V112, P15378, DOI 10.1073/pnas.1514012112; Maloof JN, 1999, DEVELOPMENT, V126, P37; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Na H, 2015, BBA-MOL CELL RES, V1853, P2481, DOI 10.1016/j.bbamcr.2015.05.020; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Nomura T, 2010, GENES NUTR, V5, P17, DOI 10.1007/s12263-009-0157-y; Ranawade AV, 2013, G3-GENES GENOM GENET, V3, P1363, DOI 10.1534/g3.113.006999; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Seah NE, 2016, AUTOPHAGY, V12, P261, DOI 10.1080/15548627.2015.1127464; Smolenaars MMW, 2007, J LIPID RES, V48, P489, DOI 10.1194/jlr.R600028-JLR200; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Steinbaugh MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07836; van der Bent ML, 2014, SCI REP-UK, V4, DOI 10.1038/srep04926; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Van Rompay L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16381; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Xu M, 2011, J BIOL CHEM, V286, P28111, DOI 10.1074/jbc.M111.227165; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Yang H, 2009, J LEUKOCYTE BIOL, V85, P928, DOI 10.1189/jlb.1008621; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang YL, 2013, CELL METAB, V18, P546, DOI 10.1016/j.cmet.2013.09.005; Zugasti O, 2005, GENOME RES, V15, P1402, DOI 10.1101/gr.3935405	56	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206540	10.1371/journal.pone.0206540	http://dx.doi.org/10.1371/journal.pone.0206540			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403720	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500067
J	Vieten, C; Wahbeh, H; Cahn, BR; MacLean, K; Estrada, M; Mills, P; Murphy, M; Shapiro, S; Radin, D; Josipovic, Z; Presti, DE; Sapiro, M; Bays, JC; Russell, P; Vago, D; Travis, F; Walsh, R; Delorme, A				Vieten, Cassandra; Wahbeh, Helene; Cahn, B. Rael; MacLean, Katherine; Estrada, Mica; Mills, Paul; Murphy, Michael; Shapiro, Shauna; Radin, Dean; Josipovic, Zoran; Presti, David E.; Sapiro, Michael; Bays, Jan Chozen; Russell, Peter; Vago, David; Travis, Fred; Walsh, Roger; Delorme, Arnaud			Future directions in meditation research: Recommendations for expanding the field of contemplative science	PLOS ONE			English	Article							MYSTICAL EXPERIENCE QUESTIONNAIRE; ORIENTED RECOVERY ENHANCEMENT; MINDFULNESS MEDITATION; TRANSCENDENTAL-MEDITATION; CHRONIC PAIN; PSYCHOLOGICAL STRESS; BRAIN; METAANALYSIS; AWARENESS; MECHANISMS	The science of meditation has grown tremendously in the last two decades. Most studies have focused on evaluating the clinical effectiveness of mindfulness-based interventions, neural and other physiological correlates of meditation, and individual cognitive and emotional aspects of meditation. Far less research has been conducted on more challenging domains to measure, such as group and relational, transpersonal and mystical, and difficult aspects of meditation; anomalous or extraordinary phenomena related to meditation; and post-conventional stages of development associated with meditation. However, these components of meditation may be crucial to people's psychological and spiritual development, could represent important mediators and/or mechanisms by which meditation confers benefits, and could themselves be important outcomes of meditation practices. In addition, since large numbers of novices are being introduced to meditation, it is helpful to investigate experiences they may encounter that are not well understood. Over the last four years, a task force of meditation researchers and teachers met regularly to develop recommendations for expanding the current meditation research field to include these important yet often neglected topics. These meetings led to a cross-sectional online survey to investigate the prevalence of a wide range of experiences in 1120 meditators. Results show that the majority of respondents report having had many of these anomalous and extraordinary experiences. While some of the topics are potentially controversial, they can be subjected to rigorous scientific investigation. These arenas represent largely uncharted scientific terrain and provide excellent opportunities for both new and experienced researchers. We provide suggestions for future directions, with accompanying online materials to encourage such research.	[Vieten, Cassandra; Wahbeh, Helene; Radin, Dean; Sapiro, Michael; Russell, Peter; Delorme, Arnaud] Inst Noet Sci, Res Dept, Petaluma, CA 94952 USA; [Wahbeh, Helene] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA; [Cahn, B. Rael] Univ Southern Calif, Dept Psychiat, Los Angeles, CA USA; [MacLean, Katherine] Ctr Optimal Living, New York, NY USA; [Estrada, Mica] Univ Calif San Francisco, Sch Nursing, Inst Hlth & Aging, San Francisco, CA 94143 USA; [Mills, Paul; Delorme, Arnaud] Univ Calif San Diego, Dept Family Med & Publ Hlth, San Diego, CA 92103 USA; [Murphy, Michael] Esalen Inst, Ctr Theory & Res, Big Sur, CA USA; [Shapiro, Shauna] Santa Clara Univ, Dept Counseling Psychol, Santa Clara, CA 95053 USA; [Josipovic, Zoran] NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA; [Josipovic, Zoran] Nondual Inst, New York, NY USA; [Presti, David E.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bays, Jan Chozen] Randall Childrens Hosp, Portland, OR USA; [Vago, David] Vanderbilt Univ, Med Ctr, Osher Ctr Integrat Med, Nashville, TN USA; [Travis, Fred] Maharishi Univ Management, Ctr Brain Consciousness & Cognit, Fairfield, IA USA; [Walsh, Roger] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA	Oregon Health & Science University; University of Southern California; University of California System; University of California San Francisco; University of California System; University of California San Diego; Santa Clara University; New York University; University of California System; University of California Berkeley; Vanderbilt University; University of California System; University of California Irvine	Vieten, C (corresponding author), Inst Noet Sci, Res Dept, Petaluma, CA 94952 USA.	cvieten@noetic.org	Vago, David R/P-5264-2014; Vago, David/I-4341-2019	Vago, David R/0000-0002-6269-9027; Vago, David/0000-0002-6269-9027; Vieten, Cassandra/0000-0003-3081-5174; Josipovic, Zoran/0000-0003-0262-4370; Delorme, Arnaud/0000-0002-0799-3557	Mental Insight Foundation; Social Relations of Knowledge Institute	Mental Insight Foundation; Social Relations of Knowledge Institute	We appreciate the support of the Mental Insight Foundation (https://projects.propublica.org/nonprofits/organizations/943256579) and the Social Relations of Knowledge Institute (http://www.nonprofitfacts.com/CA/Social-Relations-Of-Knowledge-Institute.html) for their financial support of this project. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aldwin C. M., 2015, APA HDB PSYCHOL APA, V1, P331, DOI 10.1037/14458-014; Augustinova M, 2012, J EXP SOC PSYCHOL, V48, P1213, DOI 10.1016/j.jesp.2012.04.014; Aurobindo S, 1963, FUTURE EVOLUTION MAN; Bair P, 2010, LIVING HEART LIVING; Barnes PM, 2008, NATL HLTH STAT REPOR, V12, P1, DOI DOI 10.1037/E623942009-001; Barrett FS, 2015, J PSYCHOPHARMACOL, V29, P1182, DOI 10.1177/0269881115609019; BENSON H, 1982, NATURE, V295, P234, DOI 10.1038/295234a0; Berkovich-Ohana A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00912; Berman AE, 2015, CONSCIOUS COGN, V31, P1, DOI 10.1016/j.concog.2014.10.002; BLACK DS, 2016, ANN NY ACAD SCI, V1373, P13, DOI DOI 10.1111/NYAS.12998; Boccia M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/419808; BOND CF, 1983, PSYCHOL BULL, V94, P265, DOI 10.1037/0033-2909.94.2.265; Bormann JE, 2012, INT J BEHAV MED, V19, P496, DOI 10.1007/s12529-011-9186-1; Bornemann B, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01504; Bowen S, 2014, JAMA PSYCHIAT, V71, P547, DOI 10.1001/jamapsychiatry.2013.4546; Braboszcz C, 2011, NEUROIMAGE, V54, P3040, DOI 10.1016/j.neuroimage.2010.10.008; Braud W., 2010, PATANJALI YOGA SUTRA, P241; Brewer JA, 2013, PSYCHOL ADDICT BEHAV, V27, P366, DOI 10.1037/a0028490; Cahn BR, 2013, SOC COGN AFFECT NEUR, V8, P100, DOI 10.1093/scan/nss060; Carter OL, 2005, CURR BIOL, V15, pR412, DOI 10.1016/j.cub.2005.05.043; CASTILLO RJ, 1990, PSYCHIATRY, V53, P158; Chebat JC, 2003, J BUS RES, V56, P529, DOI 10.1016/S0148-2963(01)00247-8; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 2004, FEELING GOOD SCI WEL; Condon P, 2013, PSYCHOL SCI, V24, P2125, DOI 10.1177/0956797613485603; Cook-Greuter S, 1999, POSTAUTONOMOUS EGO D; Cooney JW, 2003, TRENDS COGN SCI, V7, P161, DOI 10.1016/S1364-6613(03)00058-5; Csikszentmihalyi M, 2014, APPL FLOW HUMAN DEV, P99; Curiati JA, 2005, J ALTERN COMPLEM MED, V11, P465, DOI 10.1089/acm.2005.11.465; Dahl CJ, 2015, TRENDS COGN SCI, V19, P515, DOI 10.1016/j.tics.2015.07.001; Daubenmier J, 2013, PSYCHOPHYSIOLOGY, V50, P777, DOI 10.1111/psyp.12057; Demick J, 2012, HDB ADULT DEV; Deng W, 2016, PSYCHONEUROENDOCRINO, V64, P150, DOI 10.1016/j.psyneuen.2015.11.017; Dura-Vila G, 2009, MENT HEALTH RELIG CU, V12, P543, DOI 10.1080/13674670902858800; Farb N, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00763; Felver JC, 2016, MINDFULNESS, V7, P34, DOI 10.1007/s12671-015-0389-4; Feuerstein G, 2002, YOGA TRADITION ITS H; FISCHER R, 1971, SCIENCE, V174, P897, DOI 10.1126/science.174.4012.897; Fox KCR, 2016, NEUROSCI BIOBEHAV R, V65, P208, DOI 10.1016/j.neubiorev.2016.03.021; Fox KCR, 2014, NEUROSCI BIOBEHAV R, V43, P48, DOI 10.1016/j.neubiorev.2014.03.016; FRENCH AP, 1975, J NERV MENT DIS, V161, P55, DOI 10.1097/00005053-197507000-00007; Fresco DM, 2007, BEHAV THER, V38, P234, DOI 10.1016/j.beth.2006.08.003; Gard T, 2014, ANN NY ACAD SCI, V1307, P89, DOI 10.1111/nyas.12348; Garland EL, 2014, J CONSULT CLIN PSYCH, V82, P448, DOI 10.1037/a0035798; Garland EL, 2013, PSYCHOTHER PSYCHOSOM, V82, P311, DOI 10.1159/000348868; Gittelsohn J, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110015; Goleman D, 1971, J TRANSPERS PSYCHOL, V3, P1; Goleman D, 1988, THE MEDITATION MIND; Gotink RA, 2016, BRAIN COGNITION, V108, P32, DOI 10.1016/j.bandc.2016.07.001; Goyal M, 2014, JAMA INTERN MED, V174, P357, DOI 10.1001/jamainternmed.2013.13018; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; Grof S, 2012, J TRANSPERSONAL PSYC, V44, P137, DOI DOI 10.1002/9781118591277.CH5; Guerin B, 2010, SOCIAL FACILITATION; Gutchess A, 2014, SCIENCE, V346, P579, DOI 10.1126/science.1254604; Guzman G, 2008, ECON BOT, V62, P404, DOI 10.1007/s12231-008-9033-8; Hackett C, 2014, YB INT RELIG DEMOGRA, P131; Hackett Conrad, 2012, GLOBAL RELIG LANDSCA; Hasenkamp W, 2012, NEUROIMAGE, V59, P750, DOI 10.1016/j.neuroimage.2011.07.008; Heeter C., 1992, PRESENCE, V1, P262, DOI DOI 10.1162/PRES.1992.1.2.262; Holzel BK, 2011, PSYCHIAT RES-NEUROIM, V191, P36, DOI 10.1016/j.pscychresns.2010.08.006; Hood R.W., 2005, HDB PSYCHOL RELIG SP, P348; Hood R. W., 2018, PSYCHOL RELIG EMPIRI; Hutcherson CA, 2008, EMOTION, V8, P720, DOI 10.1037/a0013237; Jain Shamini, 2015, Glob Adv Health Med, V4, P58, DOI 10.7453/gahmj.2015.034.suppl; James William, 1902, VARIETIES RELIG EXPE; Jaseja H, 2010, EPILEPSY BEHAV, V17, P124, DOI 10.1016/j.yebeh.2009.10.022; Josipovic Z, 2016, ANN NY ACAD SCI, V1373, P65, DOI 10.1111/nyas.13078; Josipovic Z, 2014, ANN NY ACAD SCI, V1307, P9, DOI 10.1111/nyas.12261; Josipovic Z, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00538; Josipovic Z, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00183; Jung C, 1943, PSYCHOL E MEDITATION; Jung C.G., 1963, MEMORIES DREAMS REFL; Kabat-Zinn J., 1986, CLIN J PAIN, V2, P159, DOI DOI 10.1097/00002508-198602030-00004; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Katterman SN, 2014, EAT BEHAV, V15, P197, DOI 10.1016/j.eatbeh.2014.01.005; Kegan R., 1995, OUR HEADS MENTAL DEM; Kelly EdwardF., 2015, PHYS RECONCILIATION, P315; Kelly EF, 2007, IRREDUCIBLE MIND PSY; Kemeny ME, 2012, EMOTION, V12, P338, DOI 10.1037/a0026118; Kerr CE, 2011, BRAIN RES BULL, V85, P96, DOI 10.1016/j.brainresbull.2011.03.026; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Khalsa SS, 2008, PSYCHOPHYSIOLOGY, V45, P671, DOI 10.1111/j.1469-8986.2008.00666.x; Khoury B, 2013, CLIN PSYCHOL REV, V33, P763, DOI 10.1016/j.cpr.2013.05.005; Killen M., 2005, HDB MORAL DEV; Kohlberg L, 2010, MORAL PSYCHOL HIST C, P40; Kozhevnikov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058244; Kuijpers HJH, 2007, PSYCHOPATHOLOGY, V40, P461, DOI 10.1159/000108125; Kuyken W, 2016, JAMA PSYCHIAT, V73, P565, DOI 10.1001/jamapsychiatry.2016.0076; Lansky EP, 2006, EPILEPSY BEHAV, V9, P394, DOI 10.1016/j.yebeh.2006.04.019; Last N, 2017, J ALZHEIMERS DIS, V56, P275, DOI 10.3233/JAD-160899; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Lebuda I, 2016, PERS INDIV DIFFER, V93, P22, DOI 10.1016/j.paid.2015.09.040; Levin J, 2005, EXPLORE-NY, V1, P89, DOI 10.1016/j.explore.2004.12.002; Lim D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118221; Lindahl JR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176239; Lindahl JR, 2014, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00973; Lutz A, 2015, AM PSYCHOL, V70, P632, DOI 10.1037/a0039585; MacLean KA, 2012, J SCI STUD RELIG, V51, P721, DOI 10.1111/j.1468-5906.2012.01685.x; MacLean KA, 2010, PSYCHOL SCI, V21, P829, DOI 10.1177/0956797610371339; Mantzios M, 2014, APPL PSYCHOL-HLTH WE, V6, P173, DOI 10.1111/aphw.12023; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Maslow A.H., 1970, RELIG VALUES PEAK EX; Maslow A.H., 1968, PSYCHOL BEING, V(2nd); Melloni M, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-47; Metzner R, 1998, J PSYCHOACTIVE DRUGS, V30, P333; Miller WR, 2004, J CLIN PSYCHOL, V60, P453, DOI 10.1002/jclp.20000; Murphy Michael, 1992, FUTURE BODY EXPLORAT; Norbu CN, 2013, RELIGIONS, V4, P412, DOI 10.3390/rel4030412; O'Connor M, 2002, COUNS VALUES, V46, P137, DOI DOI 10.1002/j.2161-007X.2002.tb00284.x; Otis L. S., 1984, MEDITATION CLASSIC C, P201; Radin D.I., 2007, J SCI EXPLORATION, V21, P295; Radin Dean, 2015, Glob Adv Health Med, V4, P67, DOI 10.7453/gahmj.2015.012.suppl; Radin D, 2015, EXPLORE-NY, V11, P82, DOI 10.1016/j.explore.2014.12.011; Radin D, 2012, PHYS ESSAYS, V25, P157, DOI 10.4006/0836-1398-25.2.157; Radin Dean.., 2013, SUPERNORMAL SCI YOGA; Radin DI, 2011, EXPLORE-NY, V7, P286, DOI 10.1016/j.explore.2011.06.004; Rangdrol T, 1994, FLIGHT GARUDA; Ricard Matthieu, 2012, WOLF SING SESS INT S; Rocha T, 2014, ATLANTIC, V25; Roney-Dougal S. M., 2008, J SCI EXPLOR, V22, P161; Roney-Dougal SM, 2013, J SOC PSYCHICAL RES, V77, P72; Roney-Dougal SM, 2011, J SCI EXPLORATION, V25; Rosenberg EL, 2015, EMOTION, V15, P775, DOI 10.1037/emo0000080; Saatcioglu F, 2013, ASIAN J PSYCHIATR, V6, P74, DOI 10.1016/j.ajp.2012.10.002; Sanada K, 2016, FRONT PHYSIOL, V7, DOI 10.3359/fphys.2016.00/171; Sauer S., 2010, ASSESSING MINDFULNES, P25; Saunders SM, 2010, PROF PSYCHOL-RES PR, V41, P355, DOI 10.1037/a0020953; Schlitz M, 2008, LIVING DEEPLY ART SC; Schultes Richard Evans, 1995, ETHNOBOTANY EVOLUTIO; Scotton BW, 2008, TXB TRANSPERSONAL PS; Segal Z.V., 2004, MINDFULNESS BASED CO; Shankar SSR, 2014, PATANJALI YOGA SUTRA; Shapiro DH, 1992, INT J PSYCHOSOMATICS; Shapiro SL, 2015, EDUC PSYCHOL REV, V27, P1, DOI 10.1007/s10648-014-9265-3; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Shapiro SL, 2017, MINDFULNESS SELF CAR; Sherrill HN, 2017, PSYCHIAT RES; Soldat AS, 1997, SOC COGNITION, V15, P55, DOI 10.1521/soco.1997.15.1.55; Stace W. T., 1960, MYSTICISM PHILOS; Sze JA, 2010, EMOTION, V10, P803, DOI 10.1037/a0020146; Tang YY, 2015, NAT REV NEUROSCI, V16, P213, DOI 10.1038/nrn3916; Tart C. T., 1972, ALTERED STATES CONSC; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; Teixeira M Elizabeth, 2008, Holist Nurs Pract, V22, P225, DOI 10.1097/01.HNP.0000326006.65310.a7; Tiller WA, 2007, J ALTERN COMPLEM MED, V13, P133, DOI 10.1089/acm.2006.6143; Tomasino B, 2014, BRAIN COGNITION, V90, P32, DOI 10.1016/j.bandc.2014.03.013; Tran Ulrich S, 2014, PLoS One, V9, pe110192, DOI 10.1371/journal.pone.0110192; Travis F, 2002, BIOL PSYCHOL, V61, P293, DOI 10.1016/S0301-0511(02)00048-0; Travis F, 1999, CONSCIOUS COGN, V8, P302, DOI 10.1006/ccog.1999.0403; Travis F, 2000, INT J NEUROSCI, V100, P77, DOI 10.3109/00207450008999678; Travis F, 2014, ANN NY ACAD SCI, V1307, P1, DOI 10.1111/nyas.12316; Vago DR, 2016, ANN NY ACAD SCI, V1373, P96, DOI 10.1111/nyas.13171; Vago DR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00296; Vaillant G. E., 2008, AGING WELL SURPRISIN; Vaillant GE, 2015, POSITIVE PSYCHOL PRA, P595; Vedanta S., 2015, VEDANTA PHILOS 8 LEC; Vieten C, 2008, MEANING LIFE 21 CENT, P265; Vieten C, 2006, ZYGON, V41, P915; Vimalaramsi U., 1997, ANAPANASATI SUTTA PR; Wachholtz AB, 2005, J BEHAV MED, V28, P369, DOI 10.1007/s10865-005-9008-5; Walsh R, 2006, AM PSYCHOL, V61, P227, DOI 10.1037/0003-066X.61.3.227; Walsh R., 2014, WORLDS GREAT WISDOM; Walsh R, 1979, AM J PSYCHIAT; Walsh RE., 1993, PATHS EGO TRANSPERSO; Walsh R, 2015, REV GEN PSYCHOL, V19, P278, DOI 10.1037/gpr0000045; Walton Kenneth G, 2004, Cardiol Rev, V12, P262, DOI 10.1097/01.crd.0000113021.96119.78; Watts AW., 1957, SUPREME IDENTITY ESS; Wilber Ken., 2000, INTEGRAL PSYCHOL CON; WILBER Ken, 1993, SPECTRUM CONSCIOUSNE; Wu SD, 2008, BIOMED RES-TOKYO, V29, P245, DOI 10.2220/biomedres.29.245; YAMANE D, 1994, SOCIOL RELIG, V55, P1, DOI 10.2307/3712173; Young S, 2011, S YOUNG; Zeidan F, 2012, NEUROSCI LETT, V520, P165, DOI 10.1016/j.neulet.2012.03.082; Zeidan F, 2016, ANN NY ACAD SCI, V1373, P114, DOI 10.1111/nyas.13153; Zeidan F, 2010, J PAIN, V11, P199, DOI 10.1016/j.jpain.2009.07.015; Zeng X, 2015, FRONT PSYCHOL, P6	178	49	49	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205740	10.1371/journal.pone.0205740	http://dx.doi.org/10.1371/journal.pone.0205740			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403693	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500021
J	Hirosawa, T; Ishida, M; Ishii, K; Kanehara, K; Kudo, K; Ohnuma, S; Kamei, T; Motoi, F; Naitoh, T; Selaru, FM; Unno, M				Hirosawa, Takashi; Ishida, Masaharu; Ishii, Kentaro; Kanehara, Keigo; Kudo, Katsuyoshi; Ohnuma, Shinobu; Kamei, Takashi; Motoi, Fuyuhiko; Naitoh, Takeshi; Selaru, Florin M.; Unno, Michiaki			Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer	PLOS ONE			English	Article							BRCA1-ASSOCIATED PROTEIN-1; MALIGNANT MESOTHELIOMA; PROTEASOME INHIBITORS; UVEAL MELANOMA; CARCINOMA; BORTEZOMIB; DNA; CHOLANGIOCARCINOMAS; ESTABLISHMENT; PREDISPOSE	Background BRCA-1 associated protein (BAP1) is a de-ubiquitinating enzyme that regulates gene expression. Recently, the BAP1 mutation and its involvement in cancer survival have been reported in a range of tumor types, including uveal melanoma, mesothelioma, renal cancers, and biliary tract cancers. However, the frequency of BAP1 mutation and down-regulation varies among tumor types, and little is known about the function of BAP1 silencing in cancer cells. Gallbladder carcinoma (GBC) is a type of biliary tract cancer with a poor prognosis. Few mutational studies have investigated the role of BAP1 in GBC, and no functional study in vitro-, or clinical studies about cancer survival have been done. Methods GBC cells were studied by following the small interfering RNA mediated silencing of BAP1 with regard to proliferation, migration, invasion, and drug sensitivity. We carried out genomic, epigenomic and immunohistochemical analyses to detect somatic BAP1 alterations in 47 GBC patients undergoing surgical resection. Results BAP1 depletion resulted in increased migration and invasion, but not proliferation, and also resulted in decreased sensitivity to bortezomib, a proteasome inhibitor. Suppressed expression of BAP1 occurred in 22 GBC cases (46.8%) and showed a strong trend toward a worse median survival time of 13.3 months (95% CI, 17.6-62.6) (p = 0.0034). Sanger sequencing revealed a loss-of-function mutation of BAP1 in 11 out of these 22 GBC cases (50%) with low BAP1 expression, whereas 2 out of 25 GBC cases (8%) were detected in cases with high BAP1 expression. Partial changes in methylation were observed in 6 out of 47 cases, but methylation did not show a strong relationship to BAP1 expression or to the prognosis. Conclusion Our findings showed that genetic mutations are involved in BAP1 down-regulation, leading to promotion of the invasive character of cancer cells and poor prognosis in GBC.	[Hirosawa, Takashi; Ishida, Masaharu; Ishii, Kentaro; Kanehara, Keigo; Kudo, Katsuyoshi; Ohnuma, Shinobu; Kamei, Takashi; Motoi, Fuyuhiko; Naitoh, Takeshi; Unno, Michiaki] Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi, Japan; [Selaru, Florin M.] Johns Hopkins Univ, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD USA	Tohoku University; Johns Hopkins University	Ishida, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Surg, Sendai, Miyagi, Japan.	mishida@surg.med.tohoku.ac.jp	Naitoh, Takeshi/K-1693-2014; Unno, Michiaki/AAX-5246-2020	Naitoh, Takeshi/0000-0003-4169-6334; Unno, Michiaki/0000-0002-2145-6416; Ohnuma, Shinobu/0000-0002-0205-8957; Selaru, Florin/0000-0001-7990-8238	KAKENHI [JP16K19912]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI Grant Numbers JP16K19912.	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Benedetti R, 2015, ANTIOXID REDOX SIGN, V23, P99, DOI 10.1089/ars.2013.5776; Bridgewater John A, 2016, Am Soc Clin Oncol Educ Book, V35, pe194, DOI 10.14694/EDBK_160831; Carbone M, 2013, NAT REV CANCER, V13, P153, DOI 10.1038/nrc3459; Carbone M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-179; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Cigognetti M, 2015, MODERN PATHOL, V28, P1043, DOI 10.1038/modpathol.2015.65; Coupier I, 2005, FAM CANCER, V4, P273, DOI 10.1007/s10689-005-2833-4; de Araujo ESS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376423; Den Linger CS, 2014, CLIN COLORECTAL CANC, V13, P81, DOI 10.1016/j.clcc.2013.12.005; DNA methylation patterns and epigenetic memory, 2002, GENE DEV, V16, P6, DOI [10.1101/gad.947102, DOI 10.1101/GAD.947102]; Do HD, 2013, CLIN CHEM, V59, P1376, DOI 10.1373/clinchem.2012.202390; Dou QP, 2014, CURR CANCER DRUG TAR, V14, P517, DOI 10.2174/1568009614666140804154511; Ghoshal K, 2007, DRUG TODAY, V43, P395, DOI 10.1358/dot.2007.43.6.1062666; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hui B, 2012, CANCER-AM CANCER SOC, V118, P5560, DOI 10.1002/cncr.27586; Ibragimova I, 2013, EPIGENETICS-US, V8, P486, DOI 10.4161/epi.24552; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; KOYAMA S, 1980, GANN, V71, P574; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Nasu M, 2015, J THORAC ONCOL, V10, P565, DOI 10.1097/JTO.0000000000000471; Nishikawa H, 2009, CANCER RES, V69, P111, DOI 10.1158/0008-5472.CAN-08-3355; Onken MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115472; Pilarski R, 2014, GENE CHROMOSOME CANC, V53, P177, DOI 10.1002/gcc.22129; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Rasband W., 2006, IMAGEJ; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Simbolo M, 2014, ONCOTARGET, V5, P2839, DOI 10.18632/oncotarget.1943; Sobin L, 2009, TNM CLASSIFICATION M; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togo Y, 2016, INT J ONCOL, V48, P1571, DOI 10.3892/ijo.2016.3395; van de Nes JAP, 2016, AM J SURG PATHOL, V40, P796, DOI 10.1097/PAS.0000000000000645; Yamada N, 1997, INT J ONCOL, V10, P1251	37	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206643	10.1371/journal.pone.0206643	http://dx.doi.org/10.1371/journal.pone.0206643			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395583	gold, Green Submitted, Green Published			2022-12-26	WOS:000449291400038
J	Legesse, M; Medhin, G; Bayissa, M; Mamo, G				Legesse, Mengistu; Medhin, Girmay; Bayissa, Mekonnen; Mamo, Gezahegne			Knowledge and perception of pastoral community members about brucellosis as a cause of abortion in animals and its zoonotic importance in Amibara district, Afar Region, Ethiopia	PLOS ONE			English	Article							MELITENSIS; LIVESTOCK; HEALTH; GOATS; SHEEP	Sero-epidemiological studies of brucellosis in the Afar Region showed that the disease is prevalent in livestock. However, there is little information regarding the pastoral community members' awareness about brucellosis as a cause of abortion in animals and its zoonotic importance. In this study, we assessed knowledge and perception of pastoral community members about brucellosis as a cause of abortion in animals and its zoonotic importance in Amibara district, Afar Region, Ethiopia. Between October and December 2016, a total of 475 study participants (age range 18-80 years, mean age 35.9 years) were interviewed about abortion in their animals, its causes, and diseases that can be transmitted to humans through consumption of raw milk. Almost all (97.7%) of the study participants reported that abortion in animals, especially in goats, is a major problem in the area, and they mentioned that disease (44.6%), drought (58.4%) and fly bites (29.5%) as the main causes of abortion. The study participantsalso thought that malaria (42.9%) and bovine tuberculosis (19.3%) can be transmitted to humans through consuming raw milk. Five respondents (4.2%) mentioned brucellosis (locally known as "hahayita") as a disease that can be transmitted through frequent consumption of raw milk. The majority (91.9%) mentioned malaria as a cause of febrile illness in humans and 16 (4.4%) participants mentioned brucellosis as a cause of febrile illness. Some participants also mentioned brucellosis as a cause of joint swelling (hygroma) in cattle. In conclusion, the pastoral community members in the present study area lack clear understanding about brucellosis as one of the diseases that cause abortion in their animals and its zoonotic importance. There is a need to create awareness about the zoonotic and animal health importance of brucellosis through various means such as community health extension/veterinary workers and community leaders.	[Legesse, Mengistu; Medhin, Girmay] Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Bayissa, Mekonnen] Amibara Dist Pastoral Off, Melka Were, Afar Region, Ethiopia; [Mamo, Gezahegne] Addis Ababa Univ, Coll Vet Med & Agr, Bishoftu, Ethiopia	Addis Ababa University; Addis Ababa University	Legesse, M (corresponding author), Addis Ababa Univ, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia.	mengistu.legessed@aau.edu.et	Kassa, Gezahegne Mamo/AAN-2144-2020	Kassa, Gezahegne Mamo/0000-0002-4200-884X; Medhin, Girmay/0000-0003-2146-4261	Institute of Tropical Medicine (ITM-Belgium)	Institute of Tropical Medicine (ITM-Belgium)	The study was financially supported by the the Institute of Tropical Medicine (ITM-Belgium). The funding agency had no any role in conducting the study or in preparing the manuscript.	Ashenafi F, 2007, REV SCI TECH OIE, V26, P731, DOI 10.20506/rst.26.3.1781; Babiuk S, 2008, TRANSBOUND EMERG DIS, V55, P263, DOI 10.1111/j.1865-1682.2008.01043.x; Bamaiyi PH, 2012, TROP BIOMED, V29, P513; Bekele WA, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-89; Buhari H.U., 2015, J ANIMAL HLTH PRODUC, V3, P28, DOI DOI 10.14737/J0URNAL.JAHP/2015/3.2.28.34; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; Desta A.H, 2015, EUR J PREV MED, V3, P141; Donev D, 2010, BIOLOG MED SCIE, V1, P33; Ducrotoy MJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003008; Elshamy M, 2008, J INFECT DEV COUNTR, V2, P230, DOI 10.3855/jidc.268; Genene Regassa, 2009, International Journal of Tropical Medicine, V4, P59; Getachew Gari, 2015, Ethiopian Veterinary Journal, V19, P83; Grimes JET, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0004515, 10.1371/journal.pntd.0005236]; Gumi Balako, 2013, J Vet Sci Med Diagn, V2, DOI 10.4172/2325-9590.1000109; Herrera E, 2011, TROP ANIM HLTH PROD, V43, P69, DOI [10.1007/s11250-010-9655-6, DOI 10.1007/S11250-010-9655-6]; Hertz JT, 2013, TROP MED INT HEALTH, V18, P1406, DOI 10.1111/tmi.12191; James AD, 2002, REV SCI TECH OIE, V21, P637, DOI 10.20506/rst.21.3.1356; Kansiime C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-242; Khan MY, 2001, CLIN INFECT DIS, V32, P1172, DOI 10.1086/319758; Kothalawala KACHA, 2018, TROP ANIM HEALTH PRO, V50, P983, DOI 10.1007/s11250-018-1521-y; Legesse M, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-187; Lindahl E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117318; Liu Q, 2014, INT J INFECT DIS, V25, P65, DOI 10.1016/j.ijid.2014.04.003; Mirzaie K., 2015, Journal of Advanced Veterinary and Animal Research, V2, P373, DOI 10.5455/javar.2015.b117; Musallam II, 2015, AM J TROP MED HYG, V93, P1148, DOI 10.4269/ajtmh.15-0294; Njeru J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2929-9; Obonyo M., 2015, INT J INNOVATIVE RES, V4, P375; Philimon Teshome, 2016, International Journal of Livestock Production, V7, P55, DOI 10.5897/IJLP2015.0262; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Ranjan R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167163; Reda K.T., 2011, INT J SOCIOLOGY ANTH, V3, P423; Samadi A, 2010, VET MED INT, DOI [10.4061/2010_458-_695, DOI 10.4061/2010_458-_695]; Shakerian A, 2016, TROP J PHARM RES, V15, P913, DOI 10.4314/tjpr.v15i5.3; Tadeg W. M., 2015, Journal of Veterinary Medicine and Animal Health, V7, P111; Tschopp R, 2015, PREV VET MED, V120, P187, DOI 10.1016/j.prevetmed.2015.03.004; Vilchez G, 2015, INT J INFECT DIS, V38, P95, DOI 10.1016/j.ijid.2015.06.027; WHO, 2006, ROUT POV ALL JOINT W	37	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206457	10.1371/journal.pone.0206457	http://dx.doi.org/10.1371/journal.pone.0206457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395605	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400024
J	Lin, XH; Huang, KH; Chuang, WH; Luo, JC; Lin, CC; Ting, PH; Young, SH; Fang, WL; Hou, MC; Lee, FY				Lin, Xi-Hsuan; Huang, Kuo-Hung; Chuang, Wei-Hung; Luo, Jiing-Chyuan; Lin, Chung-Chi; Ting, Po-Hsiang; Young, Shih-Hao; Fang, Wen-Liang; Hou, Ming-Chih; Lee, Fa-Yauh			The long term effect of metabolic profile and microbiota status in early gastric cancer patients after subtotal gastrectomy	PLOS ONE			English	Article							ROUX-EN-Y; TYPE-2 DIABETES-MELLITUS; HUMAN GUT MICROBIOME; BARIATRIC SURGERY; SLEEVE GASTRECTOMY; WEIGHT-LOSS; BYPASS; OBESITY; REMISSION; IMPROVEMENT	Long term effects of subtotal gastrectomy on gut microbiota modifications with subsequent metabolic profiles are limited. We aimed to investigate and compare long-term effects of metabolic profiles and microbiota status in early gastric cancer patients post curative subtotal gastrectomy to the controls. In this cross-sectional study, we analyzed type II diabetes mellitus and metabolic syndrome occurrence in two groups: 111 patients after curative subtotal gastrectomy with Billroth II (BII) anastomosis and Roux-en-Y gastrojejuno (RYGJ) anastomosis and 344 age-sex matched controls. Fecal samples from those with BII, RYGJ, and controls were analyzed by next-generation sequencing method. Metabolic syndrome and type II diabetes mellitus occurrences were significantly lower in patients after subtotal gastrectomy with RYGJ than in controls over the long term (> 8 years) follow-up (P < 0.05). The richness and diversity of gut microbiota significantly increased after subtotal gastrectomy with RYGJ (P < 0.05). Compared with the control group, the principal component analysis revealed significant differences in bacterial genera abundance after subtotal gastrectomy with BII and RYGJ (P < 0.001). Genera of Oscillospira, Prevotella, Coprococcus, Veillonella, Clostridium, Desulfovibrio, Anaerosinus, Slackia, Oxalobacter, Victivallis, Butyrivibrio, Sporobacter, and Campylobacter shared more abundant roles both in the RYGJ group and BII groups. Early gastric cancer patients after subtotal gastrectomy with RYGJ had a lower occurrence of metabolic syndrome and type II diabetes mellitus than the controls during long term follow-up. In parallel with the metabolic improvements, gut microbial richness and diversity also significantly increased after subtotal gastrectomy with RYGJ.	[Lin, Xi-Hsuan; Chuang, Wei-Hung; Luo, Jiing-Chyuan; Lin, Chung-Chi; Ting, Po-Hsiang; Young, Shih-Hao; Hou, Ming-Chih; Lee, Fa-Yauh] Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan; [Lin, Xi-Hsuan; Luo, Jiing-Chyuan; Ting, Po-Hsiang; Young, Shih-Hao; Hou, Ming-Chih; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan; [Huang, Kuo-Hung; Fang, Wen-Liang] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei, Taiwan; [Huang, Kuo-Hung; Fang, Wen-Liang] Taipei Vet Gen Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan; [Chuang, Wei-Hung] Natl Yang Ming Univ, Inst Biomed Informat, Taipei, Taiwan; [Lin, Chung-Chi] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Luo, JC (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Med, Taipei, Taiwan.; Luo, JC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, Taipei, Taiwan.	jcluo@vghtpe.gov.tw			Taipei Veterans General Hospital [V106C-040, V105C-037, VN 106-09]; Ministry of Science and Technology of Taiwan [MOST 104-2314-B-010-010-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded in part by the grants from Taipei Veterans General Hospital (V106C-040, V105C-037 and VN 106-09) and Ministry of Science and Technology of Taiwan (MOST 104-2314-B-010-010-MY3) to JCL. But these grants did not involve in the conduct of the research, study design, data collection, analysis and interpretation of data, writing the manuscript, and in the decision to submit the article for publication.	Ahn SM, 2010, ANN NY ACAD SCI, V1212, pE37, DOI 10.1111/j.1749-6632.2011.05984.x; Bose M, 2009, OBES SURG, V19, P217, DOI 10.1007/s11695-008-9696-3; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008; Cantiello F, 2015, INT J UROL, V22, P22, DOI 10.1111/iju.12644; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clemente-Postigo M, 2015, SURG OBES RELAT DIS, V11, P933, DOI 10.1016/j.soard.2014.11.030; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Furet JP, 2010, DIABETES, V59, P3049, DOI 10.2337/db10-0253; Graessler J, 2013, PHARMACOGENOMICS J, V13, P514, DOI 10.1038/tpj.2012.43; Hamoui N, 2008, SURG OBES RELAT DIS, V4, P404, DOI 10.1016/j.soard.2007.08.020; Huang KW, 2013, COLORECTAL DIS, V15, P830, DOI 10.1111/codi.12172; Japanese Gastric Cancer Association, 1998, GASTRIC CANCER, V1, P10, DOI [DOI 10.1007/PL00011681, DOI 10.1007/S101209800016]]; Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kang KC, 2012, J KOREAN SURG SOC, V82, P347, DOI 10.4174/jkss.2012.82.6.347; Kim EH, 2014, CLIN RES HEPATOL GAS, V38, P372, DOI 10.1016/j.clinre.2013.11.009; Kong LC, 2013, AM J CLIN NUTR, V98, P16, DOI 10.3945/ajcn.113.058743; Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001; Kwon Y, 2014, SURG OBES RELAT DIS, V10, P235, DOI 10.1016/j.soard.2013.09.013; Lanzarini E, 2010, WORLD J SURG, V34, P2098, DOI 10.1007/s00268-010-0640-z; Lee WJ, 2011, ARCH SURG-CHICAGO, V146, P143, DOI 10.1001/archsurg.2010.326; Lee WJ, 2005, ANN SURG, V242, P20, DOI 10.1097/01.sla.0000167762.46568.98; Lee W, 2012, OBES SURG, V22, P1238, DOI 10.1007/s11695-011-0580-1; Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708; Lin XH, 2017, J CHIN MED ASSOC, V80, P3, DOI 10.1016/j.jcma.2016.09.002; Long SL, 2017, MOL ASPECTS MED, V56, P54, DOI 10.1016/j.mam.2017.06.002; Mashima I, 2015, J BACTERIOL, DOI [10.1016/j.soard.2014.11.030, DOI 10.1016/J.SOARD.2014.11.030]; Murphy R, 2017, OBES SURG, V27, P917, DOI 10.1007/s11695-016-2399-2; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Palleja A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0312-1; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P37; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Thaler JP, 2009, ENDOCRINOLOGY, V150, P2518, DOI 10.1210/en.2009-0367; Thirlby RC, 2006, J GASTROINTEST SURG, V10, P270, DOI 10.1016/j.gassur.2005.06.012; Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009; Tseng CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20701; Yang JT, 2010, J SURG RES, V164, pE67, DOI 10.1016/j.jss.2010.07.004; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	43	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206930	10.1371/journal.pone.0206930	http://dx.doi.org/10.1371/journal.pone.0206930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395589	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400066
J	Potez, M; Trappetti, V; Bouchet, A; Fernandez-Palomo, C; Guc, E; Kilarski, WW; Hlushchuk, R; Laissue, J; Djonov, V				Potez, Marine; Trappetti, Verdiana; Bouchet, Audrey; Fernandez-Palomo, Cristian; Guc, Esra; Kilarski, Witold W.; Hlushchuk, Ruslan; Laissue, Jean; Djonov, Valentin			Characterization of a B16-F10 melanoma model locally implanted into the ear pinnae of C57BL/6 mice	PLOS ONE			English	Article							CUTANEOUS MELANOMA; TUMOR ANGIOGENESIS; MOUSE MELANOMA; DUAL ROLE; GROWTH; CELLS; LYMPHANGIOGENESIS; MACROPHAGES; THERAPY; VARIANT	The common experimental use of B16-F10 melanoma cells focuses on exploring their metastatic potential following intravenous injection into mice. In this study, B16-F10 cells are used to develop a primary tumor model by implanting them directly into the ears of C57BL/6J mice. The model represents a reproducible and easily traceable tool for local tumor growth and for making additional in vivo observations, due to the localization of the tumors. This model is relatively simple and involves (i) surgical opening of the ear skin, (ii) removal of a square-piece of cartilage followed by (iii) the implantation of tumor cells with fibrin gel. The remodeling of the fibrin gel within the cartilage chamber, accompanying tumor proliferation, results in the formation of blood vessels, lymphatics and tissue matrix that can be readily distinguished from the pre-existing skin structures. Moreover, this method avoids the injection-enforced artificial spread of cells into the pre-existing lymphatic vessels. The tumors have a highly reproducible exponential growth pattern with a tumor doubling time of around 1.8 days, reaching an average volume of 85mm(3) 16 days after implantation. The melanomas are densely cellular with proliferative indices of between 60 and 80%. The induced angiogenesis and lymphangiogenesis resulted in the development of well-vascularized tumors. Different populations of immunologically active cells were also present in the tumor; the population of macrophages decreases with time while the population of T cells remained quasi constant. The B16-F10 tumors in the ear frequently metastasized to the cervical lymph nodes, reaching an incidence of 75% by day 16. This newly introduced B16-F10 melanoma model in the ear is a powerful tool that provides a new opportunity to study the local tumor growth and metastasis, the associated angiogenesis, lymphangiogenesis and tumor immune responses. It could potentially be used to test different treatment strategies.	[Potez, Marine; Trappetti, Verdiana; Bouchet, Audrey; Fernandez-Palomo, Cristian; Hlushchuk, Ruslan; Laissue, Jean; Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [Guc, Esra; Kilarski, Witold W.] Ecole Polytech Fed Lausanne, Inst Bioengn, Lausanne, Switzerland; [Guc, Esra; Kilarski, Witold W.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res, Lausanne, Switzerland; [Guc, Esra] Univ Edinburgh, Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Kilarski, Witold W.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA	University of Bern; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Edinburgh; University of Chicago	Djonov, V (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.	valentin.djonov@ana.unibe.ch	Fernandez-Palomo, Cristian/J-8943-2019; Kilarski, Witold W./G-8673-2012; Kilarski, Witold/AAA-1843-2019; Audrey, Bouchet/AAR-5929-2021; Hlushchuk, Ruslan/AAE-7872-2022	Fernandez-Palomo, Cristian/0000-0002-5095-262X; Kilarski, Witold W./0000-0003-0734-4749; Audrey, Bouchet/0000-0001-7228-8830; Djonov, Valentin/0000-0002-5062-1169; Potez, Marine/0000-0001-9083-564X; Hlushchuk, Ruslan/0000-0002-6722-8996	Swiss National Foundation [31003A_176038/1]; Swiss Cancer League Grant [KFS-4281-08-2017]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Swiss Cancer League Grant	The Swiss National Foundation Grant 31003A_176038/1 and the Swiss Cancer League Grant KFS-4281-08-2017 to VD supported the present work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; BERKELHAMMER J, 1982, CANCER RES, V42, P3157; Bobek V, 2010, ANTICANCER RES, V30, P4799; Bouchet A, 2014, TUMOR BIOL, V35, P6221, DOI 10.1007/s13277-014-1783-6; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chan Keefe T, 2013, Intravital, V2, DOI 10.4161/intv.25805; Cloudman AM, 1941, SCIENCE, V93, P380, DOI 10.1126/science.93.2416.380; Damsky WE, 2010, PIGM CELL MELANOMA R, V23, P853, DOI 10.1111/j.1755-148X.2010.00777.x; Danciu C, 2015, INT J EXP PATHOL, V96, P73, DOI 10.1111/iep.12114; Deng WT, 2017, ANALYST, V142, P2945, DOI 10.1039/c7an00623c; Fairchild ET, 2011, CANCER DRUG DISCOV D, P259, DOI 10.1007/978-1-60761-968-0_11; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Frydrychowicz M, 2017, SCAND J IMMUNOL, V86, P436, DOI 10.1111/sji.12615; Fukumura D, 2007, J CELL BIOCHEM, V101, P937, DOI 10.1002/jcb.21187; Garbe C, 2010, EUR J CANCER, V46, P270, DOI 10.1016/j.ejca.2009.10.032; Giavazzi R, 2014, METHODS MOL BIOL, V1070, P131, DOI 10.1007/978-1-4614-8244-4_10; GIOVANELLA BC, 1978, CANCER, V42, P2269, DOI 10.1002/1097-0142(197811)42:5<2269::AID-CNCR2820420527>3.0.CO;2-F; Guc E, 2017, BIOMATERIALS, V131, P160, DOI 10.1016/j.biomaterials.2017.03.033; Guc E, 2014, JOVE-J VIS EXP, DOI 10.3791/51388; Hacker E, 2006, CANCER RES, V66, P2946, DOI 10.1158/0008-5472.CAN-05-3196; Harding HE, 1930, J PATHOL BACTERIOL, V33, P417, DOI 10.1002/path.1700330219; HART IR, 1979, AM J PATHOL, V97, P587; Hillen F, 2007, CANCER METAST REV, V26, P489, DOI 10.1007/s10555-007-9094-7; Hlushchuk R, 2017, AM J PHYSIOL, DOI [10.1152/ajprenal.00099, DOI 10.1152/AJPRENAL.00099]; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; JAIN RK, 1988, CANCER RES, V48, P2641; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Lamagna C, 2006, J LEUKOCYTE BIOL, V80, P705, DOI 10.1189/jlb.1105656; Larue L, 2007, PIGM CELL RES, V20, P485, DOI 10.1111/j.1600-0749.2007.00411.x; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martens A, 2016, CLIN CANCER RES, V22, P4848, DOI 10.1158/1078-0432.CCR-16-0249; Massi D, 2006, J CLIN PATHOL, V59, P166, DOI 10.1136/jcp.2005.028431; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Refaeli Y, 2009, EMBO REP, V10, P965, DOI 10.1038/embor.2009.184; SCHATTEN WE, 1958, CANCER, V11, P455, DOI 10.1002/1097-0142(195805/06)11:3<455::AID-CNCR2820110303>3.0.CO;2-3; Shen HW, 2015, APPL IMMUNOHISTO M M, V23, P303, DOI 10.1097/PAI.0000000000000075; Takeshima T, 2010, CANCER RES, V70, P2697, DOI 10.1158/0008-5472.CAN-09-2982; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Ziyad Safiyyah, 2011, Genes Cancer, V2, P1085, DOI 10.1177/1947601911432334	39	20	20	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206693	10.1371/journal.pone.0206693	http://dx.doi.org/10.1371/journal.pone.0206693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395629	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400043
J	Abris, GP; Provido, SMP; Hong, S; Yu, SH; Lee, CB; Lee, JE				Abris, Grace P.; Provido, Sherlyn Mae P.; Hong, Sangmo; Yu, Sung Hoon; Lee, Chang Beom; Lee, Jung Eun			Association between dietary diversity and obesity in the Filipino Women's Diet and Health Study (FiLWHEL): A cross-sectional study	PLOS ONE			English	Article							IMMIGRANT WOMEN; ENERGY INTAKE; RISK; SCORE; ADEQUACY; VARIETY; INDICATORS; AMERICANS	Background Dietary diversity-eating a more varied diet, may be one of the important components of a healthy diet. We aimed to examine whether dietary diversity score was associated with lower prevalence of obesity. Methods This is a cross-sectional study of 402 married immigrant participants enrolled in the Filipino Women's diet and health study (FiLWHEL). Dietary information was obtained using the 24-hour recall method. Anthropometric measurements including height, weight, and waist circumference were directly measured. Dietary diversity score was calculated by summing up the reported number of food groups and additional scores for diversity within food groups were derived. We defined general obesity as body mass index (BMI) of >= 25 kg/m(2) and abdominal obesity as waist circumference of >= 80 cm. We calculated odds ratios and 95% confidence intervals using the multivariable logistic regression accounting for several potential confounders. Results Dietary diversity score was inversely associated with abdominal and general obesity; odds ratios (95% confidence intervals) were 0.49 (0.30-0.82) (p for trend = 0.009) for abdominal obesity and 0.47 (0.28-0.81) (p for trend = 0.008) for general obesity when we compared the third tertile of diversity scores with the first tertile. In the analyses of diversity within food groups, greater diversity in other vegetables was associated with 49% or 50% lower prevalence of abdominal or general obesity, respectively. Furthermore, poultry diversity score was associated with 56% lower prevalence of general obesity. Conclusion Our study suggests the evidence that high dietary diversity appears to be related to low prevalence of obesity.	[Abris, Grace P.; Provido, Sherlyn Mae P.] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Hong, Sangmo] Hallym Univ, Dept Internal Med, Div Endocrinol & Metab, Dongtan Sacred Heart Hosp, Gyeonggi, South Korea; [Yu, Sung Hoon; Lee, Chang Beom] Hallym Univ, Coll Med, Div Endocrinol & Metab, Dept Internal Med,Hanyang Univ Gun Hosp, Gyeonggi, South Korea; [Lee, Jung Eun] Seoul Natl Univ, Dept Food & Nutr, Coll Human Ecol, Res Inst Human Ecol, Seoul, South Korea	Sookmyung Women's University; Hallym University; Hallym University; Seoul National University (SNU)	Lee, JE (corresponding author), Seoul Natl Univ, Dept Food & Nutr, Coll Human Ecol, Res Inst Human Ecol, Seoul, South Korea.	jungelee@snu.ac.kr	Lee, Jung Eun/AAC-5634-2020; Hong, Sangmo/ABF-6388-2021; Hong, Sangmo/C-9515-2018	Lee, Jung Eun/0000-0003-1141-878X; Hong, Sangmo/0000-0002-8535-0565; 	Hanmi Pharmaceutical Co., Ltd [201300000001270]; Chong Kun Dang Pharm. Seoul, Korea [201600000000225]	Hanmi Pharmaceutical Co., Ltd; Chong Kun Dang Pharm. Seoul, Korea	Our study was supported by Hanmi Pharmaceutical Co., Ltd, (No. 201300000001270) and Chong Kun Dang Pharm. Seoul, Korea, (No. 201600000000225). The funding was awarded to CBL. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abris GP, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5233-z; Abris GP, 2017, NUTR RES PRACT, V11, P70, DOI 10.4162/nrp.2017.11.1.70; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Azadbakht L, 2006, PUBLIC HEALTH NUTR, V9, P728, DOI 10.1079/PHN2005887; Azadbakht L, 2011, PUBLIC HEALTH NUTR, V14, P62, DOI 10.1017/S1368980010000522; Barnes Patricia M, 2008, Adv Data, P1; Conklin AI, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002085; Crowley VEE, 2002, NAT REV DRUG DISCOV, V1, P276, DOI 10.1038/nrd770; Fernandez E, 2000, PREV MED, V31, P11, DOI 10.1006/pmed.2000.0667; Fernandez E, 1996, CANCER EPIDEM BIOMAR, V5, P433; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; [FNRI] Food and Nutrition Research Institute, 2010, 7 NAT NUTR SURV 2008; Food and Nutrition Research Institute (FNRI), 1997, PHIL FOOD COMP TABL; Foote JA, 2004, J NUTR, V134, P1779; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Garavello W, 2008, EUR J NUTR, V47, P280, DOI 10.1007/s00394-008-0722-y; Ghadirian P, 2009, BREAST CANCER RES TR, V117, P417, DOI 10.1007/s10549-008-0292-y; Gholizadeh F, 2018, PRIM CARE DIABETES, V12, P338, DOI 10.1016/j.pcd.2018.03.003; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; Hoddinott J, DIETARY DIVERSITY FO; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Jayawardena R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-314; Jessri M, 2016, AM J CLIN NUTR, V104, P1378, DOI 10.3945/ajcn.116.132647; Kant AK, 2005, J AM COLL NUTR, V24, P294, DOI 10.1080/07315724.2005.10719477; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; LaVecchia C, 1997, INT J CANCER, V72, P255, DOI 10.1002/(SICI)1097-0215(19970717)72:2&lt;255::AID-IJC9&gt;3.0.CO;2-Q; Lucenteforte E, 2008, INT J CANCER, V123, P2397, DOI 10.1002/ijc.23761; Ministry of Health & Welfare The Korean Nutrition Society, 2015, DIETARY REFERENCE IN; Narayan KMV, 2010, J AM COLL CARDIOL, V55, P966, DOI 10.1016/j.jacc.2009.07.075; National Academy of Agricultural Science, 2011, STAND FOOD COMP TABL STAND FOOD COMP TABL; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ponce X, 2006, J NUTR, V136, P2921, DOI 10.1093/jn/136.11.2921; Salehi-Abargouei A, 2016, EUR J CLIN NUTR, V70, P1, DOI 10.1038/ejcn.2015.118; SAS Institute Inc, 2017, BAS SAS 9 4 PROC GUI; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; The Korean Nutrition Society, 2011, NUTR ASS PROGR CAN P; Vadiveloo MK, 2015, AM J PREV MED, V49, P974, DOI 10.1016/j.amepre.2015.06.014; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Yang SJ, 2012, ASIA-PAC J PUBLIC HE, V24, P620, DOI 10.1177/1010539511406710; Zhang Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172406	42	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206490	10.1371/journal.pone.0206490	http://dx.doi.org/10.1371/journal.pone.0206490			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383830	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600054
J	Subbaramaiah, K; Iyengar, NM; Morrow, M; Elemento, O; Zhou, XK; Dannenberg, AJ				Subbaramaiah, Kotha; Iyengar, Neil M.; Morrow, Monica; Elemento, Olivier; Zhou, Xi Kathy; Dannenberg, Andrew J.			Prostaglandin E-2 down-regulates sirtuin 1 (SIRT1), leading to elevated levels of aromatase, providing insights into the obesity-breast cancer connection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						estrogen; obesity; adipose tissue; prostaglandin; sirtuin; hypoxia-inducible factor (HIF); aromatase	ADIPOSE-TISSUE; STROMAL CELLS; EXPRESSION; INFLAMMATION; HYPOXIA; ASSOCIATION; TRANSCRIPTS; WOMEN; OCCUR; RISK	Obesity increases the risk of hormone receptor-positive breast cancer in postmenopausal women. Levels of aromatase, the rate-limiting enzyme in estrogen biosynthesis, are increased in the breast tissue of obese women. Both prostaglandin E-2 (PGE(2)) and hypoxia-inducible factor 1 (HIF-1) contribute to the induction of aromatase in adipose stromal cells (ASCs). Sirtuin 1 (SIRT1) binds, deacetylates, and thereby inactivates HIF-1. Here, we sought to determine whether SIRT1 also plays a role in regulating aromatase expression. We demonstrate that reduced SIRT1 levels are associated with elevated levels of acetyl-HIF-1, HIF-1, and aromatase in breast tissue of obese compared with lean women. To determine whether these changes were functionally linked, ASCs were utilized. In ASCs, treatment with PGE(2), which is increased in obese individuals, down-regulated SIRT1 levels, leading to elevated acetyl-HIF-1 and HIF-1 levels and enhanced aromatase gene transcription. Chemical SIRT1 activators (SIRT1720 and resveratrol) suppressed the PGE(2)-mediated induction of acetyl-HIF-1, HIF-1, and aromatase. Silencing of p300/CBP-associated factor (PCAF), which acetylates HIF-1, blocked PGE(2)-mediated increases in acetyl-HIF-1, HIF-1, and aromatase. SIRT1 overexpression or PCAF silencing inhibited the interaction between HIF-1 and p300, a coactivator of aromatase expression, and suppressed p300 binding to the aromatase promoter. PGE(2) acted via prostaglandin E2 receptor 2 (EP2) and EP4 to induce activating transcription factor 3 (ATF3), a repressive transcription factor, which bound to a CREB site within the SIRT1 promoter and reduced SIRT1 levels. These findings suggest that reduced SIRT1-mediated deacetylation of HIF-1 contributes to the elevated levels of aromatase in breast tissues of obese women.	[Subbaramaiah, Kotha; Dannenberg, Andrew J.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Elemento, Olivier] Weill Cornell Med Coll, Caryl & Israel Englander Inst Precis Med, New York, NY 10065 USA; [Zhou, Xi Kathy] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10065 USA; [Iyengar, Neil M.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Subbaramaiah, K; Dannenberg, AJ (corresponding author), Weill Cornell Med Coll, 525 E 68th St,Rm E-803, New York, NY 10065 USA.	ksubba@med.cornell.edu; ajdannen@med.cornell.edu			National Institutes of Health [R01CA215797, U54 CA210184]; Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA215797, U54CA210184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Botwinick-Wolfensohn Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or part, by National Institutes of Health Grants R01CA215797 and U54 CA210184, the Breast Cancer Research Foundation, and the Botwinick-Wolfensohn Foundation (in memory of Mr. and Mrs. Benjamin Botwinick). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BULUN SE, 1993, J CLIN ENDOCR METAB, V77, P1622, DOI 10.1210/jc.77.6.1622; Bulun SE, 1996, J CLIN ENDOCR METAB, V81, P1273, DOI 10.1210/jc.81.3.1273; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Carter JM, 2018, CANCER PREV RES, V11, P113, DOI 10.1158/1940-6207.CAPR-17-0245; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Elangovan S, 2011, CANCER RES, V71, P6654, DOI 10.1158/0008-5472.CAN-11-1446; Ewertz M, 2011, J CLIN ONCOL, V29, P25, DOI 10.1200/JCO.2010.29.7614; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gillum MP, 2011, TRENDS MOL MED, V17, P8, DOI 10.1016/j.molmed.2010.09.005; Herbert BS, 2010, ONCOTARGET, V1, P405; Holloway KR, 2013, MOL ENDOCRINOL, V27, P480, DOI 10.1210/me.2012-1347; Hui XY, 2017, EMBO REP, V18, P645, DOI 10.15252/embr.201643184; Iyengar NM, 2016, CLIN CANCER RES, V22, P2283, DOI 10.1158/1078-0432.CCR-15-2239; Iyengar NM, 2015, ANNU REV MED, V66, P297, DOI 10.1146/annurev-med-050913-022228; Koivisto E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105168; Kurylowicz A, 2016, INT J OBESITY, V40, P1635, DOI 10.1038/ijo.2016.131; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Morris PG, 2013, CANCER PREV RES, V6, P428, DOI 10.1158/1940-6207.CAPR-12-0431; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; Pedersen SB, 2008, INT J OBESITY, V32, P1250, DOI 10.1038/ijo.2008.78; Protani M, 2010, BREAST CANCER RES TR, V123, P627, DOI 10.1007/s10549-010-0990-0; Rahman S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-11; Rey S, 2010, CARDIOVASC RES, V86, P236, DOI 10.1093/cvr/cvq045; Rohan TE, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/754815; Samarajeewa NU, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3410; Sasano H, 2003, J STEROID BIOCHEM, V86, P239, DOI 10.1016/S0960-0760(03)00363-7; SHAY JW, 1995, MOL CELL BIOL, V15, P425, DOI 10.1128/MCB.15.1.425; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Song YS, 2013, DIABETES RES CLIN PR, V101, P341, DOI 10.1016/j.diabres.2013.07.002; Sparano JA, 2015, J CLIN ONCOL, V33, P2353, DOI 10.1200/JCO.2015.60.9271; Subbaramaiah K, 2008, J BIOL CHEM, V283, P3433, DOI 10.1074/jbc.M705409200; Subbaramaiah K, 2016, J BIOL CHEM, V291, P16011, DOI 10.1074/jbc.M115.698902; Subbaramaiah K, 2012, CANCER DISCOV, V2, P356, DOI 10.1158/2159-8290.CD-11-0241; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Thompson MR, 2009, J MOL MED, V87, P1053, DOI 10.1007/s00109-009-0520-x; TrenthamDietz A, 1997, AM J EPIDEMIOL, V145, P1011, DOI 10.1093/oxfordjournals.aje.a009057; Zahid H, 2018, INT J OBESITY, V42, P711, DOI 10.1038/ijo.2017.273	44	14	16	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					361	371		10.1074/jbc.RA118.005866	http://dx.doi.org/10.1074/jbc.RA118.005866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409902	hybrid, Green Published			2022-12-26	WOS:000455105500037
J	Hauser, A; Hofmann, A; Meixenberger, K; Altmann, B; Hanke, K; Bremer, V; Bartmeyer, B; Bannert, N				Hauser, Andrea; Hofmann, Alexandra; Meixenberger, Karolin; Altmann, Britta; Hanke, Kirsten; Bremer, Viviane; Bartmeyer, Barbara; Bannert, Norbert			Increasing proportions of HIV-1 non-B subtypes and of NNRTI resistance between 2013 and 2016 in Germany: Results from the national molecular surveillance of new HIV-diagnoses	PLOS ONE			English	Article							TRANSMITTED DRUG-RESISTANCE; TRANSMISSION; INDIVIDUALS; PREVALENCE; INFECTION; DYNAMICS; TRENDS; DRIVEN; SWITCH	Background Molecular surveillance of newly diagnosed HIV-infections is important for tracking trends in circulating HIV-variants, including those with transmitted drug resistances (TDR) to sustain ART efficacy. Methods Dried serum spots (DSS) are received together with the statutory notification of a new diagnosis. 'Recent infections' (<155 days) classified by a 'recent infection test algorithm' (BED-CEIA and clinical data) are genotyped in HIV-protease (PR), reverse transcriptase (RT) and integrase (INT) to determine the HIV-1 subtype, to calculate prevalence and trends of TDR, to predict baseline susceptibility and to identify potential transmission clusters for resistant variants. Results Between January 2013 and December 2016, 1,885 recent infections were analysed regarding the PR/RT genomic region, with 43.5% of these also being subjected to the analysis of INT. The proportion of HIV-1 non-B viruses (31.3%; 591/1,885) increased from 21.6% to 36.0%, particularly the subtypes A (5.0% to 8.3%) and C (3.2% to 7.7%; all p(trends) < 0.01). The subtype A increment is mainly due to transmissions within men who have sex with men (MSM) while subtype C transmissions are associated with heterosexuals and people who inject drugs. The prevalence of TDR was stable at 11.0% (208/1,885) over the study period. Resistances to nucleotide RT inhibitors (NRTI) and PR inhibitors (PI) were 4.5% and 3.2%, respectively, without identifiable trends. In contrast, resistances to non-NRTIs (NNRTI, 4.7%) doubled between 2014 and 2016 from 3.2% to 6.4% (p(trend) = 0.02) mainly due to the K103N mutation (from 1.7% to 4.1%; p(trend) = 0.03) predominantly detected in recently infected German MSM not linked to transmission clusters. Transmitted INSTI mutations were present in only one case (T66I) and resistance to dolutegravir was not identified at all. Reduced susceptibility to recommended first-line therapies was low with 1.0% for PIs, 1.3% for NRTIs and 0.7% for INSTIs, but high for the NNRTIs efavirence (4.9%) and rilpivirine (6.0%) due to the K103N mutation and the polymorphic mutation E138A. These trends in therapy-naive individuals impact current first-line regimens and require awareness and vigilant surveillance.	[Hauser, Andrea; Meixenberger, Karolin; Altmann, Britta; Hanke, Kirsten; Bannert, Norbert] Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany; [Hauser, Andrea; Bannert, Norbert] Charite Univ Med Berlin, Inst Med Virol, Berlin, Germany; [Hofmann, Alexandra; Bremer, Viviane; Bartmeyer, Barbara] Robert Koch Inst, Div HIV AIDS STI & Blood Borne Infect, Berlin, Germany; [Hofmann, Alexandra] Charite Univ Med Berlin, Berlin, Germany	Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hauser, A (corresponding author), Robert Koch Inst, Div HIV & Other Retroviruses, Berlin, Germany.; Hauser, A (corresponding author), Charite Univ Med Berlin, Inst Med Virol, Berlin, Germany.	hausera@rki.de		Hofmann, Alexandra/0000-0002-9915-3482	German Federal Ministry of Health [FKZ 2513AUK375]	German Federal Ministry of Health	The study was funded by the German Federal Ministry of Health, Grant number: FKZ 2513AUK375. (NB, VB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank all participating laboratories for sending us dried filter spots for the laboratory analysis and the continuous exchange of ideas and suggestions. All participating laboratories are listed at www.rki.de. (http://www.rki.de/DE/Content/InfAZ/H/HIVAIDS/Studien/InzSurv_HIV/beteiligte_Labore.html). We also thank our technicians and the sequencing facility of the RKI. Many thanks to Stephen Norley and Michelle Jaschke for proofreading the manuscript. The study was funded by the German Federal Ministry of Health, Grant number: FKZ: 2513AUK375.	Beloukas A, 2016, INFECT GENET EVOL, V46, P180, DOI 10.1016/j.meegid.2016.06.033; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Brenner BG, 2016, J ANTIMICROB CHEMOTH, V71, P1948, DOI 10.1093/jac/dkw071; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Clinical EA EACS S, 2014, EACS TREATM GUID UPD; Costagliola D, 2012, LANCET INFECT DIS, V12, P119, DOI 10.1016/S1473-3099(11)70248-1; Deutsche AIDS-Gesellschaft (DAIG) O sterreichische AIDS-Gesellschaft (OAIG) Deutsche Gesellschaft fur Innere Medizin (DGIM) Deutsche STI-Gesellschaft (DSTIG) Deutsche Gesellschaft fur Infektiologie (DGI) Gesellschaft fur Virologie (GfV), 2015, DTSCH OST LEITL ANT, P50; Drescher SM, 2014, CLIN INFECT DIS, V58, P285, DOI 10.1093/cid/cit694; ECDC ECfDPaC, 2017, HIV AIDS SURV EUR 20; Esbjornsson J, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew010; European AIDS Clinical Society (EACS), 2017, EUR GUID TREATM HIV; Fabeni L, 2017, J ANTIMICROB CHEMOTH, V72, P2837, DOI 10.1093/jac/dkx231; Frange P, 2015, J ANTIMICROB CHEMOTH, V70, P2084, DOI 10.1093/jac/dkv049; Gupta RK, 2018, LANCET INFECT DIS, V18, P346, DOI [10.1016/s1473-3099(17)30702-8, 10.1016/S1473-3099(17)30702-8]; Hauser A, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.2.30436; Hauser A, 2018, J VIROL METHODS, V259, P32, DOI 10.1016/j.jviromet.2018.05.013; Hemelaar J, 2006, AIDS, V20, pW13, DOI 10.1097/01.aids.0000247564.73009.bc; Hill A, 2015, AIDS, V29, P2523, DOI 10.1097/QAD.0000000000000864; Hofmann A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2585-4; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Institute RK, 2016, KLIN ASP HIV VERS CL, P28, DOI [10.17886/EpiBull-2016-045, DOI 10.17886/EPIBULL-2016-045]; Keating P, 2017, EUROSURVEILLANCE, V22, P33, DOI 10.2807/1560-7917.ES.2017.22.49.17-00269; Knyphausen FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095956; Little SJ, 2008, J VIROL, V82, P5510, DOI 10.1128/JVI.02579-07; Liu TF, 2006, CLIN INFECT DIS, V42, P1608, DOI 10.1086/503914; Machnowska P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178297; Mbisa JL, 2015, CLIN INFECT DIS, V61, P829, DOI 10.1093/cid/civ393; Meixenberger K, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0887-1; Neogi U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099390; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Panichsillapakit T, 2016, JAIDS-J ACQ IMM DEF, V71, P228, DOI 10.1097/QAI.0000000000000831; Paraskevis D, 2017, INFECT GENET EVOL, V54, P183, DOI [10., 10.1016/j.meegid.2017.07.003]; Paraskevis D, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110322; Parczewski M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172473; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Ragonnet-Cronin M, 2016, J INFECT DIS, V213, P1410, DOI 10.1093/infdis/jiv758; Ragonnet-Cronin M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-317; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Sayan M, 2016, HIV CLIN TRIALS, V17, P109, DOI 10.1080/15284336.2016.1153303; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Tostevin A, 2017, HIV MED, V18, P204, DOI 10.1111/hiv.12414; WHO, 2010, WHO HIV DRUG RES LAB; Wittkop L, 2011, LANCET INFECT DIS, V11, P363, DOI 10.1016/S1473-3099(11)70032-9; World Health Organization, 2010, UN ACC SCAL PRIOR HI; Yang WL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004722; Yerly S, 1998, J VIROL, V72, P3520, DOI 10.1128/JVI.72.5.3520-3523.1998; Yousef KP, 2016, JAIDS-J ACQ IMM DEF, V73, P356, DOI 10.1097/QAI.0000000000001122	47	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206234	10.1371/journal.pone.0206234	http://dx.doi.org/10.1371/journal.pone.0206234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408827	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300015
J	Adamson, SXF; Wang, RX; Wu, WZ; Cooper, B; Shannahan, J				Adamson, Sherleen Xue-Fu; Wang, Ruoxing; Wu, Wenzhuo; Cooper, Bruce; Shannahan, Jonathan			Metabolomic insights of macrophage responses to graphene nanoplatelets: Role of scavenger receptor CD36	PLOS ONE			English	Article							B TYPE-I; OXIDATIVE STRESS; SILVER NANOPARTICLES; DENSITY-LIPOPROTEIN; FIBROBLAST CELLS; PROTEIN CORONA; STEM-CELLS; MTT ASSAYS; OXIDE; TOXICITY	Graphene nanoplatelets (GNPs) are novel two-dimensional engineered nanomaterials consisting of planar stacks of graphene. Although human exposures are increasing, our knowledge is lacking regarding immune-specific responses to GNPs and mechanisms of interactions. Our current study utilizes a metabolite profiling approach to evaluate macrophage responses to GNPs. Furthermore, we assessed the role of the scavenger receptor CD36 in mediating these GNP-induced responses. GNPs were purchased with dimensions of 2 mu m x 2 mu m x 12 nm. Macrophages were exposed to GNPs at different concentrations of 0, 25, 50, or 100 mu g/ml for 1, 3, or 6 h. Following exposure, no cytotoxicity was observed, while GNPs readily associated with macrophages in a concentration-dependent manner. After the 1 h-pretreatment of either a CD36 competitive ligand sulfo-N-succinimidyl oleate (SSO) or a CD36 specific antibody, the cellular association of GNPs by macrophages was significantly reduced. GNP exposure was determined to alter mitochondrial membrane potential while the pretreatment with a CD36 antibody inhibited these changes. In a separate exposure, macrophages were exposed to GNPs at concentrations of 0, 50, or 100 mu g/ ml for 1 or 3h or 100 mu M SSO (a CD36 specific ligand) for 1 h and collected for metabolite profiling. Principal component analysis of identified compounds determined differential grouping based on exposure conditions. The number of compounds changed following exposure was determined to be both concentration- and time-dependent. Identified metabolites were determined to relate to several metabolism pathways such as glutathione metabolism, Pantothenate and CoA biosynthesis, Sphingolipid metabolism, Purine metabolism, arachidonic acid metabolism and others. Lastly, a number of metabolites were found in common between cells exposed to the CD36 receptor ligand, SSO, and GNPs suggesting both CD36-dependent and independent responses to GNP exposure. Together our data demonstrates GNP-macrophage interactions, the role of CD36 in the cellular response, and metabolic pathways disrupted due to exposure.	[Adamson, Sherleen Xue-Fu; Shannahan, Jonathan] Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA; [Wang, Ruoxing; Wu, Wenzhuo] Purdue Univ, Sch Ind Engn, W Lafayette, IN 47907 USA; [Cooper, Bruce] Purdue Univ, Bindley Biosci Ctr, Metabolite Profiling Facil, Discovery Pk, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Shannahan, J (corresponding author), Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA.	jshannah@purdue.edu	Wu, Wenzhuo/G-1334-2010; Wang, Ruoxing/AAR-8021-2021	Wu, Wenzhuo/0000-0003-0362-6650; Shannahan, Jonathan H/0000-0002-1065-7810	National Institute of Environmental Health Sciences [R00 ES 024392]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES024392] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences R00 ES 024392 to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson SXF, 2018, TOXICOL IN VITRO, V51, P40, DOI 10.1016/j.tiv.2018.05.003; Akhavan O, 2012, BIOMATERIALS, V33, P8017, DOI 10.1016/j.biomaterials.2012.07.040; [Anonymous], 2015, DISORDERS PURINE MET; [Anonymous], 2017, DISORDERS PURINE PYR; [Anonymous], 2014, PURINE PYRIMIDINE ME; Aw TY, 2003, NEWS PHYSIOL SCI, V18, P201, DOI 10.1152/nips.01448.2003; Banki K, 1999, J IMMUNOL, V162, P1466; Baracca A, 2003, BBA-BIOENERGETICS, V1606, P137, DOI 10.1016/S0005-2728(03)00110-5; Bo Y, 2014, TOXICOL MECH METHOD, V24, P461, DOI 10.3109/15376516.2014.939321; Boyles MSP, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0160-6; Brownson DAC, 2010, ANALYST, V135, P2768, DOI 10.1039/c0an00590h; Cai JY, 2003, FREE RADICAL BIO MED, V34, P928, DOI 10.1016/S0891-5849(03)00023-6; CAMERON JS, 1993, PEDIATR NEPHROL, V7, P105, DOI 10.1007/BF00861588; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Carrola J, 2016, NANOTOXICOLOGY, V10, P1105, DOI 10.1080/17435390.2016.1177744; Chaurasia B, 2018, TRENDS ENDOCRIN MET, V29, P66, DOI 10.1016/j.tem.2017.09.005; Chawla Jasvinder, 2014, Handb Clin Neurol, V120, P891, DOI 10.1016/B978-0-7020-4087-0.00059-0; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P892, DOI 10.1101/pdb.prot5640; Chen QM, 2018, LAND USE POLICY, V76, P1, DOI 10.1016/j.landusepol.2018.04.018; Chng ELK, 2014, NANOSCALE, V6, P10792, DOI 10.1039/c4nr03608e; Cho S, 2005, J NEUROSCI, V25, P2504, DOI 10.1523/JNEUROSCI.0035-05.2005; Choi W, 2010, CRIT REV SOLID STATE, V35, P52, DOI 10.1080/10408430903505036; Chowdhury SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02584; de Villiers M, 2015, NAT CHEM BIOL, V11, P757, DOI 10.1038/nchembio.1912; Ema M, 2017, REGUL TOXICOL PHARM, V85, P7, DOI 10.1016/j.yrtph.2017.01.011; EMAUS RK, 1986, BIOCHIM BIOPHYS ACTA, V850, P436, DOI 10.1016/0005-2728(86)90112-X; Ferrari AC, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.187401; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Fisichella M, 2009, TOXICOL IN VITRO, V23, P697, DOI 10.1016/j.tiv.2009.02.007; Frohlich E, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0320-3; Gioria S, 2016, NANOTOXICOLOGY, V10, P736, DOI 10.3109/17435390.2015.1121412; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Gout I, 2018, BIOCHEM SOC T, V46, P721, DOI 10.1042/BST20170506; Guo L, 2011, J LIPID RES, V52, P2272, DOI 10.1194/jlr.M019091; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hernandez-Corbacho MJ, 2017, BBA-MOL CELL BIOL L, V1862, P56, DOI 10.1016/j.bbalip.2016.09.019; Holder AL, 2012, CHEM RES TOXICOL, V25, P1885, DOI 10.1021/tx3001708; Hu X, 2015, ENVIRON SCI TECHNOL, V49, P10710, DOI 10.1021/acs.est.5b02211; Iqbal J, 2017, TRENDS ENDOCRIN MET, V28, P506, DOI 10.1016/j.tem.2017.03.005; Jones E, 2017, CELL MOL LIFE SCI, V74, P1347, DOI 10.1007/s00018-016-2421-9; Kahlert S, 2008, J NEUROSCI METH, V171, P87, DOI 10.1016/j.jneumeth.2008.02.015; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kennedy DO, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020068; Kumar S, 2012, PARASITE IMMUNOL, V34, P372, DOI 10.1111/j.1365-3024.2012.01367.x; Lagasse HAD, 2016, J LEUKOCYTE BIOL, V99, P659, DOI 10.1189/jlb.4HI0315-130RRR; Lalwani G, 2016, ADV DRUG DELIVER REV, V105, P109, DOI 10.1016/j.addr.2016.04.028; Lammel T, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-27; Leonardi Roberta, 2007, EcoSal Plus, V2, DOI 10.1128/ecosalplus.3.6.3.4; Li W, 2010, J CLIN INVEST, V120, P3996, DOI 10.1172/JCI42823; Li Y, 2012, BIOMATERIALS, V33, P402, DOI 10.1016/j.biomaterials.2011.09.091; Liani R, 2012, FREE RADICAL BIO MED, V52, P1318, DOI 10.1016/j.freeradbiomed.2012.02.012; Liu JH, 2012, NANOMEDICINE-UK, V7, P1801, DOI [10.2217/nnm.12.60, 10.2217/NNM.12.60]; Liu WM, 2009, CANCER CHEMOTH PHARM, V64, P861, DOI 10.1007/s00280-009-1047-0; Liu YB, 1998, P NATL ACAD SCI USA, V95, P13266, DOI 10.1073/pnas.95.22.13266; Lv MY, 2015, BIOANALYSIS, V7, P1527, DOI 10.4155/bio.15.83; Ma YF, 2014, NANOMEDICINE-UK, V9, P1565, DOI [10.2217/NNM.14.68, 10.2217/nnm.14.68]; Mao L, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0120-1; Matsunaga T, 2003, BIOCHEM BIOPH RES CO, V303, P313, DOI 10.1016/S0006-291X(03)00308-5; Molino S, 2017, IMMUNOTHERAPY-UK, V9, P1185, DOI 10.2217/imt-2017-0089; Murgia A, 2016, TOXICOL MECH METHOD, V26, P611, DOI 10.1080/15376516.2016.1220654; Nakayama M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00103; Nanda SS, 2015, INT J NANOMED, V10, P549, DOI 10.2147/IJN.S75768; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Ou LL, 2016, PART FIBRE TOXICOL, V13, DOI 10.1186/s12989-016-0168-y; Park EJ, 2017, J APPL TOXICOL, V37, P296, DOI 10.1002/jat.3361; Park EJ, 2015, ARCH TOXICOL, V89, P1557, DOI 10.1007/s00204-014-1303-x; Park YM, 2012, MOL BIOL CELL, V23, P3057, DOI 10.1091/mbc.E11-12-1051; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patwardhan GA, 2016, J BIOENERG BIOMEMBR, V48, P153, DOI 10.1007/s10863-015-9602-3; Pelin M, 2018, NANOSCALE, V10, P15894, DOI 10.1039/c8nr04950e; Qiao Y, 2014, NANOMATERIALS-BASEL, V4, P522, DOI 10.3390/nano4020522; Revel M, 2017, AQUAT TOXICOL, V193, P72, DOI 10.1016/j.aquatox.2017.10.005; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Schinwald A, 2012, ACS NANO, V6, P736, DOI 10.1021/nn204229f; Sen CK, 2000, CURR TOP CELL REGUL, V36, P1; Shannahan JH, 2015, INT J NANOMED, V10, P6509, DOI 10.2147/IJN.S92570; Shannahan JH, 2015, TOXICOL SCI, V143, P136, DOI 10.1093/toxsci/kfu217; Shin TH, 2018, BMB REP, V51, P14, DOI 10.5483/BMBRep.2018.51.1.237; Sibon OCM, 2016, NAT REV MOL CELL BIO, V17, P605, DOI 10.1038/nrm.2016.110; Sies H, 1999, FREE RADICAL BIO MED, V27, P916, DOI 10.1016/S0891-5849(99)00177-X; Silverstein Roy L, 2010, Trans Am Clin Climatol Assoc, V121, P206; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sims JT, 2009, CANCER CHEMOTH PHARM, V64, P629, DOI 10.1007/s00280-009-1004-y; Singh RP, 2012, TOXICOL LETT, V213, P249, DOI 10.1016/j.toxlet.2012.07.009; Spinazze A, 2019, INT J HYG ENVIR HEAL, V222, P76, DOI 10.1016/j.ijheh.2018.08.011; Stepanenko AA, 2015, GENE, V574, P193, DOI 10.1016/j.gene.2015.08.009; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stockert JC, 2018, ACTA HISTOCHEM, V120, P159, DOI 10.1016/j.acthis.2018.02.005; Sun YY, 2011, FUND CLIN PHARMACOL, V25, P572, DOI 10.1111/j.1472-8206.2010.00885.x; Thakur SA, 2008, J IMMUNOTOXICOL, V5, P151, DOI 10.1080/15476910802085863; Tirodkar T. S., 2012, Experimental Oncology, V34, P231; Townsend DM, 2003, BIOMED PHARMACOTHER, V57, P145, DOI 10.1016/S0753-3322(03)00043-X; Tsugita M, 2017, CELL REP, V18, P1298, DOI 10.1016/j.celrep.2017.01.004; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Van Gennip AH, 2000, ADV EXP MED BIOL, V486, P233; Wang AX, 2013, J APPL TOXICOL, V33, P1156, DOI 10.1002/jat.2877; Ward MW, 2000, J NEUROSCI, V20, P7208; Yan LY, 2013, FUTURE MED CHEM, V5, P1953, DOI [10.4155/fmc.13.148, 10.4155/FMC.13.148]; Yates M, 2011, HUM REPROD, V26, P1910, DOI 10.1093/humrep/der124; Young MM, 2013, J LIPID RES, V54, P5, DOI 10.1194/jlr.R031278; Zamiri G., 2016, Materials Research Innovations, V20, P365, DOI 10.1179/1433075X15Y.0000000044; Zani IA, 2015, CELLS-BASEL, V4, P178, DOI 10.3390/cells4020178; Zhang WD, 2015, TOXICOL LETT, V237, P61, DOI 10.1016/j.toxlet.2015.05.021; Zhang WD, 2012, ADV MATER, V24, P5391, DOI 10.1002/adma.201202678; Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	108	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207042	10.1371/journal.pone.0207042	http://dx.doi.org/10.1371/journal.pone.0207042			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403754	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500098
J	Gohari, IM; Brefo-Mensah, EK; Palmer, M; Boerlin, P; Prescott, JF				Gohari, Iman Mehdizadeh; Brefo-Mensah, Eric K.; Palmer, Michael; Boerlin, Patrick; Prescott, John F.			Sialic acid facilitates binding and cytotoxic activity of the pore-forming Clostridium perfringens NetF toxin to host cells	PLOS ONE			English	Article							STAPHYLOCOCCAL ALPHA-HEMOLYSIN; TRANSMEMBRANE PORE; CHOLERA TOXIN; AUREUS; NEUTRALIZATION; ERYTHROCYTES; GANGLIOSIDES; RECOGNITION; ENTEROTOXIN; LEUKOCIDIN	NetF-producing type A Clostridium perfringens is an important cause of canine and foal necrotizing enteritis. NetF, related to the beta-sheet pore-forming Leukocidin/Hemolysin superfamily, is considered a major virulence factor for this disease. The main purpose of this work is to demonstrate the pore-forming activity of NetF and characterize the chemical nature of its binding site. Electron microscopy using recombinant NetF (rNetF) confirmed that NetF is able to oligomerize and form large pores in equine ovarian (EO) cell membranes and sheep red blood cells. These oligomeric pores appear to be about 4-6 nm in diameter, and the number of oligomer subunits to vary from 6 to 9. Sodium periodate treatment rendered EO cells non-susceptible to NetF, suggesting that NetF binding requires cell surface carbohydrates. NetF cytotoxicity was also inhibited by a lectin that binds sialic acid, by sialidase, and by free sialic acid in excess, all of which clearly implicate sialic acid-containing membrane carbohydrates in NetF binding and/or toxicity for EO cells. Binding of NetF to sheep red blood cells was not inhibited by the gangliosides GM1, GM2 and GM3, nor did the latter promote membrane permeabilization in liposomes, suggesting that they do not constitute the cellular receptors. In contrast, treatment of EO cells with different proteases reduced their susceptibility to NetF, suggesting that the NetF receptor is a sialic acid-containing glycoprotein.	[Gohari, Iman Mehdizadeh; Boerlin, Patrick; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Brefo-Mensah, Eric K.; Palmer, Michael] Univ Waterloo, Dept Chem, Waterloo, ON, Canada; [Gohari, Iman Mehdizadeh] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA	University of Guelph; University of Waterloo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gohari, IM (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.; Gohari, IM (corresponding author), Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15260 USA.	imehdiza@pitt.edu		Brefo-Mensah, Eric K./0000-0002-9747-0185	Natural Sciences and Engineering Research Council of Canada; Ontario Veterinary College (OVC) fellowship; NSERC Discovery Grant [400560]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Veterinary College (OVC) fellowship; NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	JFP received funding from Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp) for this work. The NSERC Discovery Grant number is 400560. IMG received Ontario Veterinary College (OVC) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CRITCHLEY DR, 1986, J NEUROCHEM, V47, P213; Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Das SK, 2007, CHEMBIOCHEM, V8, P994, DOI 10.1002/cbic.200600474; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Ferguson MR, 1997, INFECT IMMUN, V65, P4299, DOI 10.1128/IAI.65.10.4299-4308.1997; Finegold SM, 2002, ANAEROBE, V8, P283, DOI 10.1006/anae.2002.0436; FUSSLE R, 1981, J CELL BIOL, V91, P83, DOI 10.1083/jcb.91.1.83; Geny B, 2006, BIOL CELL, V98, P667, DOI 10.1042/BC20050082; GLASER AL, 1995, J GEN VIROL, V76, P2223, DOI 10.1099/0022-1317-76-9-2223; Gohari IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122684; Gonzalez MR, 2008, CELL MOL LIFE SCI, V65, P493, DOI 10.1007/s00018-007-7434-y; HOLMGREN J, 1975, P NATL ACAD SCI USA, V72, P2520, DOI 10.1073/pnas.72.7.2520; Huyet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066673; JOLIVETREYNAUD C, 1988, ARCH BIOCHEM BIOPHYS, V262, P59, DOI 10.1016/0003-9861(88)90168-3; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Knapp O, 2010, OPEN TOXINOL J, V3, P53, DOI DOI 10.2174/1875414701003020053; Manich M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003764; Miles G, 2002, PROTEIN SCI, V11, P894, DOI 10.1110/ps.4360102; NELSON GJ, 1967, J LIPID RES, V8, P374; Popoff MR, 2014, ANAEROBE, V30, P220, DOI 10.1016/j.anaerobe.2014.05.014; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Rood JI, 1998, ANNU REV MICROBIOL, V52, P333, DOI 10.1146/annurev.micro.52.1.333; Rouha H, 2015, MABS-AUSTIN, V7, P243, DOI 10.4161/19420862.2014.985132; SAITO M, 1979, J BIOL CHEM, V254, P7845; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; SCHENGRUND CL, 1989, J BIOL CHEM, V264, P13233; SCHERRER R, 1971, J BACTERIOL, V107, P718, DOI 10.1128/JB.107.3.718-735.1971; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seike S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147957; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Shatursky O, 2000, INFECT IMMUN, V68, P5546, DOI 10.1128/IAI.68.10.5546-5551.2000; Sher D, 2005, J BIOL CHEM, V280, P22847, DOI 10.1074/jbc.M503242200; Sim SL, 2012, J BIOTECHNOL, V157, P315, DOI 10.1016/j.jbiotec.2011.09.028; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Sugawara N, 1999, BIOSCI BIOTECH BIOCH, V63, P884, DOI 10.1271/bbb.63.884; Valeva A, 2006, J BIOL CHEM, V281, P26014, DOI 10.1074/jbc.M601960200; Vandenesch F., 2012, FRONT CELL INFECT MI, V16, P2; VANHEYNINGEN W, 1961, J GEN MICROBIOL, V24, P107, DOI 10.1099/00221287-24-1-107; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13	43	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206815	10.1371/journal.pone.0206815	http://dx.doi.org/10.1371/journal.pone.0206815			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403719	Green Submitted, gold, Green Published			2022-12-26	WOS:000449379500076
J	Lotfan, M; Choudhary, S; Yadav, ML; Kumar, S; Singh, S; Bathla, S; Rawat, P; Kaushik, JK; Mohanty, AK				Lotfan, Masoud; Choudhary, Suman; Yadav, Munna Lal; Kumar, Sudarshan; Singh, Surender; Bathla, Shveta; Rawat, Preeti; Kaushik, Jai K.; Mohanty, Ashok K.			Primary structures of different isoforms of buffalo pregnancy-associated glycoproteins (BuPAGs) during early pregnancy and elucidation of the 3-dimensional structure of the most abundant isoform BuPAG 7	PLOS ONE			English	Article							PROTEIN-B PSPB; GONADOTROPIN RECEPTORS; ASPARTIC PROTEINASES; EXPRESSION ANALYSIS; CRYSTAL-STRUCTURES; PORCINE PEPSIN; BOVINE; FAMILY; PROGESTERONE; SECRETION	Pregnancy-associated glycoproteins (PAGs) are expressed during pregnancy by the trophoectodermal cells of fetus. Presence of PAGs in dam's circulation has been widely used in pregnancy diagnosis. The present study reports the identification and characterization of different PAG isoforms in buffalo during early stages of pregnancy. The PAG mRNAs isolated from fetal cotyledons (Pregnancy stages: 45, 75 and 90 days) were successfully cloned in pJET1.2 vector and transformed in E. coli. A total of 360 random clones were sequenced and correlated with their stages of expression. A total of 12 isoforms namely, BuPAG 1, 2, 4, 6, 7, 8, 9, 13, 15, 16, 18 and one new isoform were identified. BuPAG 7 was found as the most abundant isoform in all three stages followed by BuPAG 18. Further, a large number of variants were found for most of these isoforms. Phylogenetic relationship of identified BuPAGs showed that BuPAG 2 belonged to an ancient group while other members clustered with modern group. Three-dimensional (3D) structure of BuPAG 7 was determined by homology modeling and molecular dynamic (MD) simulations which displayed a typical fold represented by other aspartic proteinase (AP) family members. Molecular docking of Pepstatin inhibitor with BuPAG 7 revealed to interact through various hydrogen bonding and hydrophobic interactions. Various amino acid substitutions were observed in peptide-binding cleft of BuPAG 7. Superimposition of BuPAG 7 with homologous structures revealed the presence of a 35-41 amino acid long insertion (alpha helix connected by two loops) near the N- terminus which seems to be a unique feature of BuPAG 7 in AP family. This is the first report on identification and sequence characterization of PAG isoforms in buffalo with unique finding that these isoforms represent many transcript variants. We also report 3D structure of the most abundant isoform BuPAG 7 for the first time.	[Lotfan, Masoud; Choudhary, Suman; Yadav, Munna Lal; Kumar, Sudarshan; Singh, Surender; Bathla, Shveta; Rawat, Preeti; Kaushik, Jai K.; Mohanty, Ashok K.] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Mohanty, AK (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, Haryana, India.	ashokmohanty1@gmail.com	Choudhary, Suman/AAO-2410-2020		National Fund for Basic, Strategic & Frontier Application Research in Agriculture (NFBSFARA); Indian council of Agricultural research	National Fund for Basic, Strategic & Frontier Application Research in Agriculture (NFBSFARA); Indian council of Agricultural research(Indian Council of Agricultural Research (ICAR))	The authors sincerely thank National Fund for Basic, Strategic & Frontier Application Research in Agriculture (NFBSFARA) and Indian council of Agricultural research for their funding support.	Andonissamy J, 2012, ISRN MOL BIOL, V2012; Andreeva NS, 2001, PROTEIN SCI, V10, P2439, DOI 10.1110/ps.ps.25801; [Anonymous], [No title captured]; Barbato O, 2008, RES VET SCI, V85, P457, DOI 10.1016/j.rvsc.2008.01.004; Brandt GA, 2007, MOL REPROD DEV, V74, P1355, DOI 10.1002/mrd.20669; Bridges PJ, 1999, PROSTAG OTH LIPID M, V58, P113, DOI 10.1016/S0090-6980(99)00045-3; Carpenter BB, 2008, DETERMINING PREGNA B, VB-1077; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; Dosogne H, 1999, VET IMMUNOL IMMUNOP, V67, P47, DOI 10.1016/S0165-2427(98)00215-3; Dosogne H, 2000, ADV EXP MED BIOL, V480, P295; Dunn BM, 2002, CHEM REV, V102, P4431, DOI 10.1021/cr010167q; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganguly B, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-13; Garbayo JM, 2000, MOL REPROD DEV, V57, P311, DOI 10.1002/1098-2795(200012)57:4&lt;311::AID-MRD2&gt;3.0.CO;2-F; Garbayo JM, 1998, BIOL REPROD, V58, P109, DOI 10.1095/biolreprod58.1.109; Garbayo JM, 1999, BIOL REPROD, V60, P246; Garbayo JM, 2008, ANIM REPROD SCI, V103, P120, DOI 10.1016/j.anireprosci.2006.12.002; Green JA, 2005, THERIOGENOLOGY, V63, P1481, DOI 10.1016/j.theriogenology.2004.07.011; Green JA, 2000, BIOL REPROD, V62, P1624, DOI 10.1095/biolreprod62.6.1624; Green JA, 1998, REV REPROD, V3, P62; Guruprasad K, 1996, PROTEIN ENG, V9, P849, DOI 10.1093/protein/9.10.849; Haig D, 1996, AM J REPROD IMMUNOL, V35, P226; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hughes AL, 2000, P NATL ACAD SCI USA, V97, P3319, DOI 10.1073/pnas.050002797; Hughes AL, 2003, MOL BIOL EVOL, V20, P1940, DOI 10.1093/molbev/msg217; Kiewisz J, 2008, GEN COMP ENDOCR, V155, P164, DOI 10.1016/j.ygcen.2007.04.011; Klisch K, 2005, MOL REPROD DEV, V71, P453, DOI 10.1002/mrd.20296; Koshi K, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-41; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Le SQ, 1993, MOL BIOL EVOL, V18, P691; Lotfan M, 2018, GENE, V654, P127, DOI 10.1016/j.gene.2018.02.038; Panasiewicz G, 2007, ANIM REPROD SCI, V99, P285, DOI 10.1016/j.anireprosci.2006.05.009; Patel OV, 2004, MOL REPROD DEV, V67, P257, DOI 10.1002/mrd.20017; Perenyi ZS, 2002, REPROD DOMEST ANIM, V37, P100, DOI 10.1046/j.1439-0531.2002.00341.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rangasamy S, 2015, INDIAN J ANIM REPROD, V36; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; RICH DH, 1985, BIOCHEMISTRY-US, V24, P3165, DOI 10.1021/bi00334a014; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Sousa NM, 2002, REPROD NUTR DEV, V42, P227, DOI 10.1051/rnd:2002021; Szafranska B, 2007, ANIM REPROD SCI, V99, P269, DOI 10.1016/j.anireprosci.2006.05.012; SZAFRANSKA B, 1995, BIOL REPROD, V53, P21, DOI 10.1095/biolreprod53.1.21; Szafranska B, 2002, ANIM REPROD SCI, V72, P95, DOI 10.1016/S0378-4320(02)00066-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TANG J, 1995, PROTEIN PEPTIDE LETT, V2, P257; Telugu BPVL, 2010, BIOL CHEM, V391, P259, DOI [10.1515/BC.2010.016, 10.1515/bc.2010.016]; Telugu BPVL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-185; Thompson IM, 2012, J DAIRY SCI, V95, P5645, DOI 10.3168/jds.2011-5113; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Ushizawa K, 2005, BIOCHEM BIOPH RES CO, V326, P435, DOI 10.1016/j.bbrc.2004.11.045; Vawter GA, 2004, BIOL REPROD, P153; Weems YS, 1999, PROSTAG OTH LIPID M, V58, P139, DOI 10.1016/S0090-6980(99)00034-9; Weems YS, 2001, PROSTAG OTH LIPID M, V66, P77, DOI 10.1016/S0090-6980(01)00144-7; Weems YS, 1998, PROSTAG OTH LIPID M, V55, P27, DOI 10.1016/S0090-6980(98)00003-3; Wooding FBP, 2005, PLACENTA, V26, P807, DOI 10.1016/j.placenta.2004.10.014; WOODING FBP, 1983, PLACENTA, V4, P527; Xie S, 1997, P NATL ACAD SCI USA, V94, P12809, DOI 10.1073/pnas.94.24.12809; Xie SC, 1997, BIOL REPROD, V57, P1384, DOI 10.1095/biolreprod57.6.1384; XIE SC, 1994, BIOL REPROD, V51, P1145, DOI 10.1095/biolreprod51.6.1145; XIE SC, 1991, P NATL ACAD SCI USA, V88, P10247, DOI 10.1073/pnas.88.22.10247; ZOLI AP, 1992, BIOL REPROD, V46, P623, DOI 10.1095/biolreprod46.4.623; ZOLI AP, 1992, BIOL REPROD, V46, P83, DOI 10.1095/biolreprod46.1.83	65	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206143	10.1371/journal.pone.0206143	http://dx.doi.org/10.1371/journal.pone.0206143			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403702	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500055
J	Smitz, N; Jouvenet, O; Ligate, FA; Crosmary, WG; Ikanda, D; Chardonnet, P; Fusari, A; Meganck, K; Gillet, F; Melletti, M; Michaux, JR				Smitz, Nathalie; Jouvenet, Olivia; Ligate, Fredrick Ambwene; Crosmary, William-George; Ikanda, Dennis; Chardonnet, Philippe; Fusari, Alessandro; Meganck, Kenny; Gillet, Francois; Melletti, Mario; Michaux, Johan R.			A genome-wide data assessment of the African lion (Panthera leo) population genetic structure and diversity in Tanzania	PLOS ONE			English	Article							SELOUS-GAME-RESERVE; SPACE USE; SOFTWARE; CONSERVATION; INFERENCE; MICROSATELLITES; ASSOCIATION; MANAGEMENT; EVOLUTION; LIVESTOCK	The African lion (Panthera leo), listed as a vulnerable species on the IUCN Red List of Threatened Species (Appendix II of CITES), is mainly impacted by indiscriminate killing and prey base depletion. Additionally, habitat loss by land degradation and conversion has led to the isolation of some subpopulations, potentially decreasing gene flow and increasing inbreeding depression risks. Genetic drift resulting from weakened connectivity between strongholds can affect the genetic health of the species. In the present study, we investigated the evolutionary history of the species at different spatiotemporal scales. Therefore, the mitochondrial cytochrome b gene (N = 128), 11 microsatellites (N = 103) and 9,103 SNPs (N = 66) were investigated in the present study, including a large sampling from Tanzania, which hosts the largest lion population among all African lion range countries. Our results add support that the species is structured into two lineages at the continental scale (West-Central vs East-Southern), underlining the importance of reviewing the taxonomic status of the African lion. Moreover, SNPs led to the identification of three lion clusters in Tanzania, whose geographical distributions are in the northern, southern and western regions. Furthermore, Tanzanian lion populations were shown to display good levels of genetic diversity with limited signs of inbreeding. However, their population sizes seem to have gradually decreased in recent decades. The highlighted Tanzanian African lion population genetic differentiation appears to have resulted from the combined effects of anthropogenic pressure and environmental/climatic factors, as further discussed.	[Smitz, Nathalie] Royal Museum Cent Africa, Barcoding Organisms & Tissues Policy Concern BopC, JEMU, Tervuren, Belgium; [Smitz, Nathalie; Jouvenet, Olivia; Gillet, Francois; Michaux, Johan R.] Univ Liege, Conservat Genet, Dept Life Sci, Liege, Belgium; [Ligate, Fredrick Ambwene] Minist Nat Resources & Tourism, Wildlife Div, Dar Es Salaam, Tanzania; [Crosmary, William-George; Chardonnet, Philippe; Fusari, Alessandro] Fondat Int Gest Faune IGF, Paris, France; [Ikanda, Dennis] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Meganck, Kenny] Royal Museum Cent Africa, Barcoding Organisms & Tissues Policy Concern BopC, Tervuren, Belgium; [Melletti, Mario] IUCN SSC ASG, African Buffalo Initiat Grp AfBIG, Rome, Italy; [Michaux, Johan R.] Ctr Cooperat Int Rech Agron Dev CIRAD, UPR AGIRS, Campus Int Baillarguet, Montpellier, France	Royal Museum for Central Africa; University of Liege; Royal Museum for Central Africa; CIRAD	Michaux, JR (corresponding author), Univ Liege, Conservat Genet, Dept Life Sci, Liege, Belgium.; Michaux, JR (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, UPR AGIRS, Campus Int Baillarguet, Montpellier, France.	johan.michaux@uliege.be	Melletti, Mario/AAF-5043-2020	Melletti, Mario/0000-0003-3453-9699; Meganck, Kenny/0000-0002-0270-5560; Smitz, Nathalie/0000-0001-5155-0801	Belgian Fond National pour la Recherche Scientifique (FRS-FNRS) [A5/5-MCF/BIC-11561]; Belgian Federal Science Policy Office (BELSPO); IGF	Belgian Fond National pour la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Federal Science Policy Office (BELSPO)(Belgian Federal Science Policy Office); IGF	This study was supported by research grants from the Belgian Fond National pour la Recherche Scientifique (FRS-FNRS) provided to J. R. Michaux (A5/5-MCF/BIC-11561) and from IGF to Philippe Chardonnet. The Barcoding of Organisms and tissues of Policy Concern project (BopCo) and the Joint Experimental Molecular Unit (JEMU) are financed by the Belgian Federal Science Policy Office (BELSPO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082541; Andrews S., 2007, ENCY MEASUREMENT STA, P103; Anonymous, 2004, Cat News, V41, P35; [Anonymous], 1990, URSUS; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Bauer H, 2005, AFR J ECOL, V43, P208, DOI 10.1111/j.1365-2028.2005.00570.x; Bauer H., 2022, PANTHERA LEO, DOI [10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T15951A107265605.EN]; Bauer H, 2015, P NATL ACAD SCI USA, V112, P14894, DOI 10.1073/pnas.1500664112; Beal T., 2015, COUNTRY PROFILES TAN; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertola LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137975; Bjorklund M, 2003, CONSERV GENET, V4, P515, DOI 10.1023/A:1024737317695; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Chardonnet P., 2002, CONSERVATION AFRICAN; Chardonnet P, 2010, WILDL MANAG WORK PAP, V13; Cornuet JM, 1996, GENETICS, V144, P2001; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Estes R.D., 2013, MAMMALS AFRICA, VIV, P556; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HANBY JP, 1987, ANIM BEHAV, V35, P161, DOI 10.1016/S0003-3472(87)80221-X; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; Henschel Philipp, 2010, Cat News, V52, P34; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; IUCN Ssc Cat Specialist Group, 2006, REG CONS STRAT LION; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kingdon J., 2015, KINGDON FIELD GUIDE, V2; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehmann MB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003998; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Liu NJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S26; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Loveridge AJ, 2009, ECOGRAPHY, V32, P953, DOI 10.1111/j.1600-0587.2009.05745.x; McArthur RH, 1967, THEORY ISLAND BIOGEO; Menotti-Raymond M, 1999, GENOMICS, V57, P9, DOI 10.1006/geno.1999.5743; Mesochina P, 2010, CONSERVATION STATUS; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; Miller SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144605; Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Nowell K, 1996, IUCN LIB SYST, V382; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; PACKER C, 1991, NATURE, V351, P562, DOI 10.1038/351562a0; Patterson BD, 2006, J MAMMAL, V87, P193, DOI 10.1644/05-MAMM-A-226R2.1; Patterson BD, 2007, EVOL BIOL, V34, P55, DOI 10.1007/s11692-007-9003-6; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pitra C, 2002, MOL ECOL, V11, P1197, DOI 10.1046/j.1365-294X.2002.01516.x; Ploner A., 2014, HEATPLUS HEATMAPS RO; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rychlik Wojciech, 2007, V402, P35; Schaller G. B., 1972, SERENGETI LION STUDY; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Smitz N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056235; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Spong G, 2002, BEHAV ECOL SOCIOBIOL, V52, P303, DOI 10.1007/s00265-002-0515-x; STANDER P E, 1991, Madoqua, V18, P1; Stein B, 1999, GENETIC VARIATION DE; Tambling CJ, 2013, S AFR J WILDL RES, V43, P1, DOI 10.3957/056.043.0116; Tensen L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190369; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; West PM, 2002, SCIENCE, V297, P1339, DOI 10.1126/science.1073257; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Williams VL, 2015, NATURE, V523, P290, DOI 10.1038/523290a; Woodroffe R, 2000, ANIM CONSERV, V3, P165, DOI 10.1111/j.1469-1795.2000.tb00241.x; Woodroffe R, 2005, ANIM CONSERV, V8, P91, DOI 10.1017/S1367943004001829	90	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205395	10.1371/journal.pone.0205395	http://dx.doi.org/10.1371/journal.pone.0205395			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403704	Green Published, gold			2022-12-26	WOS:000449379500015
J	Jacobson, D; Glazer, E; Mason, R; Duplessis, D; Blom, K; Du Mont, J; Jassal, N; Einstein, G				Jacobson, Danielle; Glazer, Emily; Mason, Robin; Duplessis, Deanna; Blom, Kimberly; Du Mont, Janice; Jassal, Navmeet; Einstein, Gillian			The lived experience of female genital cutting (FGC) in Somali-Canadian women's daily lives	PLOS ONE			English	Article							REFUGEE COMMUNITY; MATERNITY CARE; AFRICAN WOMEN; HEALTH-CARE; PAIN; MUTILATION; CIRCUMCISION; PERCEPTIONS; SWEDEN; PHENOMENOLOGY	Many of the Somali women who have immigrated to other countries, including Canada, have experienced Female Genital Circumcision/ Mutilation/ Cutting (FGC). While there is literature on the medical aspects of FGC, we were interested in understanding the daily life experiences and bodily sensations of Somali-Canadian women in the context of FGC. Fourteen women living in the Greater Toronto Area were interviewed. Interview data were analyzed using a phenomenological approach. We found that the memory of the ceremonial cutting was vivid but was frequently described with acceptance and resignation-as something that just is; that was normal given the particular context, familial and cultural, and their young age. Most of the women recounted experiencing pain and discomfort throughout their adult lives but were intent on not noticing or giving the pain any power; they considered themselves healthy. The following themes emerged from our interviews: Every Body Had It. Discussing FGC, I'm Normal Aren't I?, and Feeling in My Body-all themes that work at normalizing their bodies in a society that they know views them as different. They dealt with both pain and pleasure in the context of their busy lives suggesting resilience in spite of the day-to-day difficulties of daily life.	[Jacobson, Danielle; Mason, Robin; Duplessis, Deanna; Du Mont, Janice; Einstein, Gillian] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Glazer, Emily; Einstein, Gillian] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Mason, Robin; Du Mont, Janice; Einstein, Gillian] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Blom, Kimberly; Jassal, Navmeet; Einstein, Gillian] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Blom, Kimberly] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto	Jacobson, D (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dani.jacobson@mail.utoronto.ca		Einstein, Gillian/0000-0002-0770-5471	Canadian Institutes of Health Research [RN86248 - 221534]; Institute of Gender and Health; Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institute of Gender and Health; Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging	This work was supported by a grant (RN86248 - 221534) from the Canadian Institutes of Health Research, Institute of Gender and Health (http://www.cihr-irsc.gc.ca/e/8673.html) and by the Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging to GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abathun AD, 2016, INT J WOMENS HEALTH, V8, P557, DOI 10.2147/IJWH.S112226; Abdalla RD, 2006, PA STUD HUM RIGHTS, P187; Abdulle M. H., 2000, THESIS; Ahmadu F., 2000, FEMALE CIRCUMCISION, P283; Alo OA, 2011, J WOMENS HEALTH, V20, P1655, DOI 10.1089/jwh.2010.2610; Ameresekere M, 2011, INT J GYNECOL OBSTET, V115, P227, DOI 10.1016/j.ijgo.2011.07.019; Andro A, 2014, SOC SCI MED, V106, P177, DOI 10.1016/j.socscimed.2014.02.003; Armour M., 2009, QUAL SOC WORK, V8, P101, DOI [10.1177/1473325008100424, DOI 10.1177/1473325008100424]; BATES MS, 1987, SOC SCI MED, V24, P47, DOI 10.1016/0277-9536(87)90138-9; Belihu FB, 2017, WOMEN BIRTH, V30, P282, DOI 10.1016/j.wombi.2016.11.008; Berg RC, 2012, SEX RES SOC POLICY, V9, P41, DOI 10.1007/s13178-011-0048-z; Berggren V, 2006, J TRANSCULT NURS, V17, P50, DOI 10.1177/1043659605281981; Berggren V, 2006, Afr J Reprod Health, V10, P24; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Berns-McGown R., 1999, MUSLIMS DIASPORA SOM; Boddy J, 2016, HAU-J ETHNOGR THEORY, V6, P41, DOI 10.14318/hau6.2.008; Bonham VL, 2001, J LAW MED ETHICS, V29, P52, DOI 10.1111/j.1748-720X.2001.tb00039.x; Carnes D, 2007, RHEUMATOLOGY, V46, P1168, DOI 10.1093/rheumatology/kem118; Cohen MZ, 2000, HERMENEUTIC PHENOMEN; Connor JJ, 2016, J SEX RES, V53, P346, DOI 10.1080/00224499.2015.1008966; Einstein G, 2008, PERSPECT BIOL MED, V51, P84, DOI 10.1353/pbm.2008.0012; Einstein G, 2012, NEW DIR PHILOS COGN, P145; Essen B, 2004, ACTA OBSTET GYN SCAN, V83, P611, DOI 10.1111/j.0001-6349.2004.00590.x; Fangen K, 2006, J REFUG STUD, V19, P96; Finnstrom B, 2006, J ADV NURS, V54, P418, DOI 10.1111/j.1365-2648.2006.03838.x; Gele AA, 2012, INT J WOMENS HEALTH, V4, P7, DOI 10.2147/IJWH.S27577; Glenn P, 2010, J PRAGMATICS, V42, P1485, DOI 10.1016/j.pragma.2010.01.009; Green CR, 2003, PAIN MED, V4, P277, DOI 10.1046/j.1526-4637.2003.03034.x; Hysing EB, 2017, SCAND J PAIN, V17, P178, DOI 10.1016/j.sjpain.2017.09.008; International Association for the Study of Pain (IASP), 2014, IASP TAX; International Association for the Study of Pain IASP, 2007, GLOB YEAR PAIN WOM R; Isman E, 2013, SEX REPROD HEALTHC, V4, P93, DOI 10.1016/j.srhc.2013.04.004; Jacoby SD, 2015, J MIDWIFERY WOM HEAL, V60, P593, DOI 10.1111/jmwh.12332; Ruiz IJ, 2017, HEALTH CARE WOMEN IN, V38, P478, DOI 10.1080/07399332.2017.1289211; Johansen R. E., 2006, THESIS; Johansen REB, 2017, CULT HEALTH SEX, V19, P528, DOI 10.1080/13691058.2016.1239838; Johansen REB, 2002, MED ANTHROPOL Q, V16, P312, DOI 10.1525/maq.2002.16.3.312; Johnsdotter S, 2009, FGM LEGISLATION IMPL; Johnsdotter S, 2005, INT NETWORK ANALYZE; Johnsdotter S, 2016, BEST PRACT RES CL OB, V32, P15, DOI 10.1016/j.bpobgyn.2015.10.012; Johnson CE, 2009, AM J PREV MED, V37, pS230, DOI 10.1016/j.amepre.2009.09.036; Johnson EB, 2005, AM J OBSTET GYNECOL, V193, P475, DOI 10.1016/j.ajog.2004.12.003; Johnson-Agbakwu CE, 2014, ETHNIC HEALTH, V19, P440, DOI 10.1080/13557858.2013.828829; Kaplan-Marcusan A, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-11; Khaja K., 2004, THESIS; Koukoui S, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0309-2; Kumar R, 2012, CURR CARDIOVASC RISK, V6, P229, DOI 10.1007/s12170-012-0233-5; Leval Amy, 2004, Health Care Women Int, V25, P743, DOI 10.1080/07399330490475593; Liberatore G, 2016, BILD INT J SOMALI ST, V16, P49; Magnusson JE, 2011, NZ MED J, V124, P1; Manderson L, 2004, INT FEM J POLIT, V6, P285, DOI DOI 10.1080/1461674042000211272; McLean Athena, 2007, SHADOW SIDE FIELDWOR; Mechlin MB, 2005, PSYCHOSOM MED, V67, P948, DOI 10.1097/01.psy.0000188466.14546.68; Mercadante S, 2007, NAT CLIN PRACT ONCOL, V4, P138, DOI 10.1038/ncponc0745; Merleau-Ponty M., 1962, PHENOMENOLOGY PERCEP; Mertens D. M., 2012, QUALITATIVE RES INTR, P19; Mpinga EK, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31489; Nour NM, 2015, SEMIN REPROD MED, V33, P41, DOI 10.1055/s-0034-1395278; Oguntoye S, 2009, WORLD ACAD SCI ENG T, V30, P1015; Okonofua FE, 2002, BJOG-INT J OBSTET GY, V109, P1089, DOI 10.1111/j.1471-0528.2002.01550.x; Ontario Council of Agencies Serving Immigrants OCASI, 2016, GETT RES MIGR OPP GO; Poland B., 1998, QUAL RES, V4, P293, DOI DOI 10.1177/107780049800400209; Purchase TCD, 2013, ACTA OBSTET GYN SCAN, V92, P858, DOI 10.1111/aogs.12144; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Robinson R, 2014, INT J SOCIAL WORK HU, V2, P51; Rushwan H, 2013, AFR J UROL, V19, P130, DOI 10.1016/j.afju.2013.03.002; Sadala MLA, 2002, J ADV NURS, V37, P282, DOI 10.1046/j.1365-2648.2002.02071.x; Schneider H., 1998, WASHINGTON POST; Sheikh H, 2009, SOMALIAS MISSING MIL; Surico D, 2015, J OBSTET GYNAECOL, V35, P393, DOI 10.3109/01443615.2014.960826; Taher M, 2017, UNDERSTANDING FEMALE; Talle A., 2008, FINNISH J ETHNICITY, V3, P64; Talle Aud, 1993, CARVED FLESH CAST SE, P83; Terry Louise, 2013, Nurs Stand, V28, P41, DOI 10.7748/ns2013.09.28.1.41.e7750; Tiilikainen M, 2003, SOC COMPASS, V50, P59, DOI 10.1177/0037768603050001964; Tiilikainen M., 2001, VARIATIONS THEME SOM, P309; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF Somalia, 2004, ER FEM GEN MUT SOM; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Varol N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2373-2; Vissandjee B, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-13; Warner-Garcia S, 2014, PRAGMATICS, V24, P157, DOI 10.1075/prag.24.1.07war; Widmark C, 2002, MIDWIFERY, V18, P113, DOI 10.1054/midw.2002.0307; Williams L, 1997, J MARRIAGE FAM, V59, P966, DOI 10.2307/353796; Winter B., 2016, WILEY BLACKWELL ENCY, V0, P1, DOI [10.1002/9781118663219.wbegss695, DOI 10.1002/9781118663219.WBEGSS695]; Wojnar DM, 2007, J HOLIST NURS, V25, P172, DOI 10.1177/0898010106295172; World Health Organization, 2008, EL FEM GEN MUT INT S; World Health Organization Department of Reproductive Health and Research, 2018, CAR GIRLS WOM LIV FE; Wuest S, 2009, BJOG-INT J OBSTET GY, V116, P1204, DOI 10.1111/j.1471-0528.2009.02215.x; Zurynski Y, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0070-y	90	25	25	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206886	10.1371/journal.pone.0206886	http://dx.doi.org/10.1371/journal.pone.0206886			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399181	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000028
J	Muller, S; Versini, A; Sindikubwabo, F; Belthier, G; Niyomchon, S; Pannequin, J; Grimaud, L; Caneque, T; Rodriguez, R				Mueller, Sebastian; Versini, Antoine; Sindikubwabo, Fabien; Belthier, Guillaume; Niyomchon, Supaporn; Pannequin, Julie; Grimaud, Laurence; Caneque, Tatiana; Rodriguez, Raphael			Metformin reveals a mitochondrial copper addiction of mesenchymal cancer cells	PLOS ONE			English	Article							STEM-CELLS; CHEMISTRY; MODE; IRON; MASS	The clinically approved drug metformin has been shown to selectively kill persister cancer cells through mechanisms that are not fully understood. To provide further mechanistic insights, we developed a drug surrogate that phenocopies metformin and can be labeled in situ by means of click chemistry. Firstly, we found this molecule to be more potent than metformin in several cancer cell models. Secondly, this technology enabled us to provide visual evidence of mitochondrial targeting with this class of drugs. A combination of fluorescence microscopy and cyclic voltammetry indicated that metformin targets mitochondrial copper, inducing the production of reactive oxygen species in this organelle, mitochondrial dysfunction and apoptosis. Importantly, this study revealed that mitochondrial copper is required for the maintenance of a mesenchymal state of human cancer cells, and that metformin can block the epithelial-to-mesenchymal transition, a biological process that normally accounts for the genesis of persister cancer cells, through direct copper targeting.	[Mueller, Sebastian; Versini, Antoine; Sindikubwabo, Fabien; Niyomchon, Supaporn; Caneque, Tatiana; Rodriguez, Raphael] PSL Res Univ, Labellisee Ligue Canc, Chem Biol Canc Team, CNRS UMR3666,INSERM U1143,Inst Curie, Paris, France; [Belthier, Guillaume; Pannequin, Julie] Univ Montpellier, CNRS INSERM, IGF, Montpellier, France; [Grimaud, Laurence] UPMC Univ Paris 06, Sorbonne Univ, PSL Res Univ, CNRS UMR8640,Ecole Normale Super, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite	Caneque, T; Rodriguez, R (corresponding author), PSL Res Univ, Labellisee Ligue Canc, Chem Biol Canc Team, CNRS UMR3666,INSERM U1143,Inst Curie, Paris, France.	tatiana.caneque-cobo@curie.fr; raphael.rodriguez@curie.fr		Versini, Antoine/0000-0001-9799-2701; Muller, Sebastian/0000-0002-3423-5364; Rodriguez, Raphael/0000-0001-7668-446X; SINDIKUBWABO, Ph.D., Fabien/0000-0002-9381-6302; Grimaud, Laurence/0000-0003-3904-1822; pannequin, julie/0000-0002-9956-373X; Caneque, Tatiana/0000-0002-1110-0643	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [647973]; Emergence Ville de Paris; Ligue Contre le Cancer (Equipe Labellisee); IPGP multidisciplinary program PARI; Paris-IdF region SESAME [12015908]	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); Emergence Ville de Paris; Ligue Contre le Cancer (Equipe Labellisee); IPGP multidisciplinary program PARI; Paris-IdF region SESAME	Results incorporated in this article have received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No [647973]), Emergence Ville de Paris, and Ligue Contre le Cancer (Equipe Labellisee). We thank the ICP-MS platform at the Institut de Physique du Globe de Paris, which is supported by IPGP multidisciplinary program PARI, and by Paris-IdF region SESAME Grant no. 12015908.	ANDRZEJEWSKI S, 2014, CANCER METAB S1, V2; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bridges HR, 2014, BIOCHEM J, V462, P475, DOI 10.1042/BJ20140620; Caneque T, 2018, NAT REV CHEM, V2, P202, DOI 10.1038/s41570-018-0030-x; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Dodani SC, 2011, J AM CHEM SOC, V133, P8606, DOI 10.1021/ja2004158; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Farnie G, 2015, ONCOTARGET, V6, P30472, DOI 10.18632/oncotarget.5401; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grillet F, 2017, GUT, V66, P1802, DOI 10.1136/gutjnl-2016-311447; Hirsch HA, 2009, CANCER RES, V69, P7507, DOI 10.1158/0008-5472.CAN-09-2994; Janzer A, 2014, P NATL ACAD SCI USA, V111, P10574, DOI 10.1073/pnas.1409844111; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X; Lamb R, 2015, ONCOTARGET, V6, P30453, DOI 10.18632/oncotarget.5852; Laws K, 2018, ANGEW CHEM INT EDIT, V57, P287, DOI 10.1002/anie.201710910; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Logie L, 2012, DIABETES, V61, P1423, DOI 10.2337/db11-0961; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Muller S, 2017, ISR J CHEM, V57, P239, DOI 10.1002/ijch.201600109; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256; Petrat F, 2002, BIOCHEM J, V362, P137, DOI 10.1042/0264-6021:3620137; Repiscak P, 2014, BIOCHEMISTRY-US, V53, P787, DOI 10.1021/bi401444n; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Skrott Z, 2017, NATURE, V552, P194, DOI 10.1038/nature25016; Sletten EM, 2009, ANGEW CHEM INT EDIT, V48, P6974, DOI 10.1002/anie.200900942; Tornoe CW, 2002, J ORG CHEM, V67, P3057, DOI 10.1021/jo011148j; Mai TT, 2017, NAT CHEM, V9, P1025, DOI [10.1038/NCHEM.2778, 10.1038/nchem.2778]; Wang HH, 2010, NEW J CHEM, V34, P1239, DOI 10.1039/c0nj00168f; Weinberg SE, 2015, NAT CHEM BIOL, V11, P9, DOI 10.1038/nchembio.1712; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhu M, 2004, ACTA CRYSTALLOGR E, V58, pm217	36	15	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206764	10.1371/journal.pone.0206764	http://dx.doi.org/10.1371/journal.pone.0206764			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399175	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000020
J	Rawal, LB; Kanda, K; Mahumud, RA; Joshi, D; Mehata, S; Shrestha, N; Poudel, P; Karki, S; Renzaho, A				Rawal, Lal B.; Kanda, Kie; Mahumud, Rashidul Alam; Joshi, Deepak; Mehata, Suresh; Shrestha, Nipun; Poudel, Prakash; Karki, Surendra; Renzaho, Andre			Prevalence of underweight, overweight and obesity and their associated risk factors in Nepalese adults: Data from a Nationwide Survey, 2016	PLOS ONE			English	Article							NONCOMMUNICABLE DISEASES; INDIA; URBAN; MORTALITY; INDEX	Introduction Over the past few decades, the total population of Nepal has increased substantially with rapid urbanization, changing lifestyle and disease patterns. There is anecdotal evidence that non-communicable diseases (NCDs) and associated risk factors are becoming key public health challenges. Using nationally representative survey data, we estimated the prevalence of underweight, overweight and obesity among Nepalese adults and explored socio-demographic factors associated with these conditions. Materials and methods We used the Nepal Demographic Health Survey 2016 data. Sample selection was based on stratified two-stage cluster sampling in rural areas and three stages in urban areas. Weight and height were measured in all adult women and men. Body mass index (BMI) was calculated using Asian specific BMI cut-points. Results A total of 13,542 adults aged 18 years and above (women 58.19%) had their weight and height measured. The mean (+/- SD) age was 40.63 +/- 16.82 years (men 42.75 +/- 17.27, women 39.15 +/- 16.34); 41.13% had no formal education and 60.97% lived in urban areas. Overall, 17.27% (95% CI: 16.64-17.91) were underweight; 31.16% (95% CI: 30.38-31.94) overweight/obese. The prevalence of both underweight (women 18.30% and men 15.83%, p<0.001) and overweight/obesity (women 32.87% and men 28.77%, p<0.001) was higher among women. The older adults (>= 65 years) (aOR: 2.40, 95% CI: 1.92-2.99, p<0.001) and the adults of poorest wealth quintile (aOR: 2.05, 95% CI: 1.62-2.59, p<0.001) were more likely to be underweight. The younger age adults (36-45 years) (aOR: 3.05, 95% CI: 2.61-3.57, p<0.001) and women (aOR: 1.53, 95% CI 1.39-1.68, p<0.001) were more likely to be overweight or obese. Also, all adults were twice likely to overweight/obese (p<0.001). No significant difference was observed for overweight/obesity by ecological regions and place of residence (urban vs. rural). Conclusion These findings confirm co-existence of double burden of underweight and overweight/obesity among Nepalese adults. These conditions are associated with increased risk of developing NCDs. Therefore, effective public health intervention approaches emphasizing improved primary health care systems for NCDs prevention and care and using multi-sectoral approach, is essential.	[Rawal, Lal B.; Poudel, Prakash; Renzaho, Andre] Western Sydney Univ, Sydney, NSW, Australia; [Kanda, Kie] JICA, Accra, Ghana; [Mahumud, Rashidul Alam] Univ Southern Queensland, Toowoomba, Qld, Australia; [Joshi, Deepak] Save Children, Kathmandu, Nepal; [Mehata, Suresh] Ipas Nepal, Kathmandu, Nepal; [Shrestha, Nipun] Victoria Univ, Melbourne, Vic, Australia; [Karki, Surendra] Australian Red Cross Blood Serv, Sydney, NSW, Australia	Western Sydney University; University of Southern Queensland; Save the Children; Victoria University; Australian Red Cross Blood Service	Rawal, LB (corresponding author), Western Sydney Univ, Sydney, NSW, Australia.	L.rawal@westernsydney.edu.au	Poudel, Prakash/ABB-6007-2021; Mahumud, Rashidul Alam/O-2477-2018; Shrestha, Nipun/ABC-6127-2021; Renzaho, Andre M.N./AAH-7679-2021	Mahumud, Rashidul Alam/0000-0001-9788-1868; Shrestha, Nipun/0000-0003-3542-8130; RENZAHO, ANDRE/0000-0002-6844-0833; Karki, Surendra/0000-0003-1561-4171; Rawal, Lal/0000-0003-1106-0108; Joshi, Deepak/0000-0001-8539-7411; Poudel, Prakash/0000-0001-9848-3749; Kanda, Kie/0000-0002-7110-2149				Adler AI, 1999, AM HEART J, V138, pS353; Aryal KK, 2014, NONCOMMUNICABLE DIS; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Bhandari GP, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-23; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177395; CBS, 2014, POPULATION MONOGRAPH; Central Bureau of Statistics of Nepal, 2014, NAT POP HOUS CENS 20; Deepa M, 2009, EUR J CLIN NUTR, V63, P259, DOI 10.1038/sj.ejcn.1602920; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Evenepoel H, 2020, OPERATIONAL PLAN EHU; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Garg C, 2010, OBES REV, V11, P105, DOI 10.1111/j.1467-789X.2009.00666.x; Ge KY, 2001, BIOMED ENVIRON SCI, V14, P53; Hong SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194454; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hossain MG, 2013, SINGAP MED J, V54, P516; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Janjua NZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122314; Jose R, 2014, PREVALENCE OBESITY O; Kamal SMM, 2015, J HEALTH POPUL NUTR, V33, P92; Katulanda P, 2010, OBES REV, V11, P751, DOI 10.1111/j.1467-789X.2010.00746.x; Kolenikov S, 2009, REV INCOME WEALTH, V55, P128, DOI 10.1111/j.1475-4991.2008.00309.x; Letamo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102675; Little Matthew, 2016, BMC Obes, V3, P12, DOI 10.1186/s40608-016-0091-7; Low WY, 2015, INT J OCCUP MED ENV, V28, P20, DOI 10.2478/s13382-014-0326-0; Mendelson R, 1990, J CANADIAN DIETETIC, V52, P229; Ministry of Health Department of Health Services, 2016, ANN HLTH REP 2072 73; Ministry of Health GoN, 2014, MULT ACT PLAN PREV C; Mirelman AJ, 2016, HEALTH POLICY PLANN, V31, P785, DOI 10.1093/heapol/czv134; Mishra SR, 2016, LANCET DIABETES ENDO, V4, P979, DOI 10.1016/S2213-8587(16)30331-X; Mishra SR, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0129-5; MISHRA SR, 2015, GLOBALIZATION HEALTH, V11; MOH Nepal New Era ICF, 2017, NEP DEM HLTH SURV 20; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; Nagai M, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000940; NANDI C, 1992, PUBLIC HEALTH REP, V107, P658; Neupane D, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000074; Pradeepa R, 2015, INDIAN J MED RES, V142, P139, DOI 10.4103/0971-5916.164234; Rawal LB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184967; Rawal LB, 2012, INT J BEHAV MED, V19, P121, DOI 10.1007/s12529-011-9162-9; ROTH GA, 2017, J AM COLL CARDIOL, V70, P1, DOI [DOI 10.1016/J.JACC.2017.04.052, DOI 10.1016/j.jacc.2017.04.052]; United Nations, 2017, SUSTAINABLE DEV GOAL; Weitoft GR, 2008, SCAND J PUBLIC HEALT, V36, P169, DOI 10.1177/1403494807085080; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; World Health Organization, 2011, CONSERVATION TROPICA; World Health Organization, 1995, WHO TECHN REP SER; World Health Organization, 2014, NONC DIS COUNTR PROF; ZAMAN MM, 2015, BMC PUBLIC HEALTH, V15	50	38	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0205912	10.1371/journal.pone.0205912	http://dx.doi.org/10.1371/journal.pone.0205912			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399189	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000449374000004
J	Fukunaga, T; Fujita, Y; Kishima, H; Yamashita, T				Fukunaga, Takanori; Fujita, Yuki; Kishima, Haruhiko; Yamashita, Toshihide			Methylation dependent down-regulation of G0S2 leads to suppression of invasion and improved prognosis of IDH1-mutant glioma	PLOS ONE			English	Article							G0/G1 SWITCH GENE; IDH1 MUTATIONS; GLIOBLASTOMA; CHEMOTHERAPY; RADIOTHERAPY; TEMOZOLOMIDE; PATHWAYS; REVEALS; PROTEIN	Isocitrate dehydrogenase (IDH) mutations are a prognostic factor in diffuse glioma. However, the mechanism by which these mutations improve prognosis are not clear. In a subset of IDH-mutant glioma, remodeling of the methylome results in the glioma-CpG island methylator phenotype (G-CIMP) and transcriptional reorganization. In this study, we focus on G0/G1 switch 2 (G0S2), which is highly downregulated in G-CIMP glioma. We found that G0S2 expression tended to increase as the WHO grade increased, and G0S2 knockdown inhibited glioma invasion. Additionally, we revealed that the overexpression of the DNA demethylase Ten-eleven translocation 2 (TET2) in IDH1-plasmid transfected glioblastoma multiforme (GBM) cells restored G0S2 expression. These results indicate that G0S2 is epigenetically silenced in /DH/-mutant glioma. In addition, the stereotactic delivery of glioma cells with decreased G0S2 expression in the mouse brain resulted in prolonged survival. The Cancer Genome Atlas (TCGA) analysis also indicated that survival is longer in the lower G0S2 expression group than in the higher G0S2 expression group. Moreover, G0S2 expression was higher in recurrent tumor specimens than at the initial diagnosis in the same patient. These results provide one explanation for the improved survival in IDH1-mutant glioma as well as a new epigenetic target for glioma treatment.	[Fukunaga, Takanori; Kishima, Haruhiko] Osaka Univ, Grad Sch Med, Dept Neurosurg, 2-2 Yamadaoka, Suita, Osaka, Japan; [Fukunaga, Takanori; Fujita, Yuki; Yamashita, Toshihide] Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka, Japan; [Fujita, Yuki; Yamashita, Toshihide] Osaka Univ, Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka, Japan; [Yamashita, Toshihide] Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University; Osaka University	Yamashita, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Neurosci, 2-2 Yamadaoka, Suita, Osaka, Japan.; Yamashita, T (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, 3-1 Yamadaoka, Suita, Osaka, Japan.; Yamashita, T (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, 1-3 Yamadaoka, Suita, Osaka, Japan.	yamashita@molneu.med.osaka-u.ac.jp		Yamashita, Toshihide/0000-0003-4559-7018	Japan Society for the Promotion of Science [17H06178, JP17K16644]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research (S) from the Japan Society for the Promotion of Science (17H06178) to T.Y., and Grant Number JP17K16644 to T.F., http://www.jsps.go.jp/english/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson C, 2009, EXPERT OPIN INV DRUG, V18, P1061, DOI 10.1517/13543780903052764; Balss J, 2008, ACTA NEUROPATHOL, V116, P597, DOI 10.1007/s00401-008-0455-2; Bezecny P, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0985-5; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Borthakur G, 2010, LEUKEMIA LYMPHOMA, V51, P73, DOI 10.3109/10428190903318329; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Cheishvili D, 2015, ONCOTARGET, V6, P33253, DOI 10.18632/oncotarget.5291; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Eckel-Passow JE, 2015, NEW ENGL J MED, V372, P2499, DOI 10.1056/NEJMoa1407279; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Frezza C, 2010, CANCER CELL, V17, P7, DOI 10.1016/j.ccr.2009.12.031; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galanis E, 2017, NEUROONCOLOGY; Gorovets D, 2012, CLIN CANCER RES, V18, P2490, DOI 10.1158/1078-0432.CCR-11-2977; Guan XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091216; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kim BA, 2017, CANCER GENOM PROTEOM, V14, P53, DOI 10.21873/cgp.20018; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Mercurio C, 2010, PHARMACOL RES, V62, P18, DOI 10.1016/j.phrs.2010.02.010; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Prados MD, 2015, NEURO-ONCOLOGY, V17, P1051, DOI 10.1093/neuonc/nov031; Reuss DE, 2015, ACTA NEUROPATHOL, V130, P407, DOI 10.1007/s00401-015-1454-8; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; RUSSELL L, 1991, DNA CELL BIOL, V10, P581, DOI 10.1089/dna.1991.10.581; Santos FPS, 2010, EXPERT REV ANTICANC, V10, P9, DOI [10.1586/ERA.09.164, 10.1586/era.09.164]; Soroceanu L, 1999, J NEUROSCI, V19, P5942, DOI 10.1523/JNEUROSCI.19-14-05942.1999; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Wang JB, 2014, ASIAN PAC J CANCER P, V15, P427, DOI 10.7314/APJCP.2014.15.1.427; Welch C, 2009, CANCER RES, V69, P6782, DOI 10.1158/0008-5472.CAN-09-0128; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67	42	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206552	10.1371/journal.pone.0206552	http://dx.doi.org/10.1371/journal.pone.0206552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388142	Green Submitted, gold, Green Published			2022-12-26	WOS:000449289800041
J	Alkie, TN; Yitbarek, A; Taha-Abdelaziz, K; Astill, J; Sharif, S				Alkie, Tamiru Negash; Yitbarek, Alexander; Taha-Abdelaziz, Khaled; Astill, Jake; Sharif, Shayan			Characterization of immunogenicity of avian influenza antigens encapsulated in PLGA nanoparticles following mucosal and subcutaneous delivery in chickens	PLOS ONE			English	Article							SYSTEMIC IMMUNE-RESPONSES; VIRUS-VACCINE; CPG OLIGONUCLEOTIDES; TARGETED DELIVERY; GENE-EXPRESSION; CELLS; PROTECTS; H5N1; IMMUNOMODULATION; RECONSTITUTION	Mucosal vaccine delivery systems have paramount importance for the induction of mucosal antibody responses. Two studies were conducted to evaluate immunogenicity of inactivated AIV antigens encapsulated in poly(D, L-lactide-co-glycolide) (PLGA) nanoparticles (NPs). In the first study, seven groups of specific pathogen free (SPF) layer-type chickens were immunized subcutaneously at 7-days of age with different vaccine formulations followed by booster vaccinations two weeks later. Immune responses were profiled by measuring antibody (Ab) responses in sera and lachrymal secretions of vaccinated chickens. The results indicated that inactivated AIV and CpG ODN co-encapsulated in PLGA NPs (2x NanoAI + CpG) produced higher amounts of hemagglutination inhibiting antibodies compared to a group vaccinated with non-adjuvanted AIV encapsulated in PLGA NPs (NanoAI). The tested adjuvanted NPs-based vaccine (2x NanoAI+CpG) resulted in higher IgG responses in the sera and lachrymal secretions at weeks 3, 4 and 5 post-vaccination when immunized subcutaneously. The incorporation of CpG ODN led to an increase in Ab-mediated responses and was found useful to be included both in the prime and booster vaccinations. In the second study, the ability of chitosan and mannan coated PLGA NPs that encapsulated AIV and CpG ODN was evaluated for inducing antibody responses when delivered via nasal and ocular routes in one-week-old SPF layer-type chickens. These PLGA NPs-based and surface modified formulations induced robust AIV-specific antibody responses in sera and lachrymal secretions. Chitosan coated PLGA NPs resulted in the production of large quantities of lachrymal IgA and IgG compared to mannan coated NPs, which also induced detectable amounts of IgA in addition to the induction of IgG in lachrymal secretions. In both mucosal and subcutaneous vaccination approaches, although NPs delivery enhanced Ab-mediated immunity, one booster vaccination was required to generate significant amount of Abs. These results highlight the potential of NPs-based AIV antigens for promoting the induction of both systemic and mucosal immune responses against respiratory pathogens.	[Alkie, Tamiru Negash; Yitbarek, Alexander; Taha-Abdelaziz, Khaled; Astill, Jake; Sharif, Shayan] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Alkie, Tamiru Negash] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada; [Taha-Abdelaziz, Khaled] Beni Suef Univ, Fac Vet Med, Pathol Dept, Bani Suwayf, Egypt	University of Guelph; Wilfrid Laurier University; Egyptian Knowledge Bank (EKB); Beni Suef University	Sharif, S (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada.	shayan@uoguelph.ca		Yitbarek, Alexander/0000-0002-3500-0305	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Canadian Poultry Research Council (CPRC); Agriculture and Agri-Food Canada; University of Guelph's Food from Thought initiative; Canada First Research Excellence Fund	Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA); Canadian Poultry Research Council (CPRC); Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); University of Guelph's Food from Thought initiative; Canada First Research Excellence Fund	This work was supported by the Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA), the Canadian Poultry Research Council (CPRC) and Agriculture and Agri-Food Canada. This research is supported in part by the University of Guelph's Food from Thought initiative, thanks to funding from the Canada First Research Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkie TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169154; Azizi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001147; Balic A, 2016, 14 AV IMM RES GROUP; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brownlie R, 2009, MOL IMMUNOL, V46, P3163, DOI 10.1016/j.molimm.2009.06.002; Calderon-Nieva D, 2017, DRUG DELIV TRANSL RE, V7, P558, DOI 10.1007/s13346-017-0400-9; Chadwick S, 2010, ADV DRUG DELIVER REV, V62, P394, DOI 10.1016/j.addr.2009.11.012; Costa TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015987; de Geus ED, 2015, AVIAN PATHOL, V44, P222, DOI 10.1080/03079457.2015.1026797; de Geus ED, 2013, DEV COMP IMMUNOL, V41, P341, DOI 10.1016/j.dci.2013.03.008; de Geus ED, 2012, J IMMUNOL, V188, P4516, DOI 10.4049/jimmunol.1200092; de Geus ED, 2011, VET IMMUNOL IMMUNOP, V143, P143, DOI 10.1016/j.vetimm.2011.05.023; de Jonge J, 2007, BIOCHEM J, V405, P41, DOI 10.1042/BJ20061756; Dhakal S, 2017, J CONTROL RELEASE, V247, P194, DOI 10.1016/j.jconrel.2016.12.039; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Eyles JE, 2001, VACCINE, V19, P4732, DOI 10.1016/S0264-410X(01)00220-1; Franca MS, 2014, CURR TOP MICROBIOL, V385, P221, DOI 10.1007/82_2014_385; Garg Neeraj K, 2010, Recent Pat Drug Deliv Formul, V4, P114; Ghotbi Z, 2011, J DRUG TARGET, V19, P281, DOI 10.3109/1061186X.2010.499463; Gizurarson S, 2015, BIOL PHARM BULL, V38, P497, DOI 10.1248/bpb.b14-00398; Gonzales JL, 2012, PREV VET MED, V107, P253, DOI 10.1016/j.prevetmed.2012.06.010; Gupta NK, 2011, VACCINE, V29, P9026, DOI 10.1016/j.vaccine.2011.09.033; Gupta SK, 2014, EXPERT REV VACCINES, V13, P909, DOI 10.1586/14760584.2014.920236; Gutjahr A, 2016, TRENDS IMMUNOL, V37, P716, DOI 10.1016/j.it.2016.08.005; Hasegawa H, 2007, EXPERT REV VACCINES, V6, P193, DOI 10.1586/14760584.6.2.193; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hikono H, 2013, VET IMMUNOL IMMUNOP, V151, P83, DOI 10.1016/j.vetimm.2012.10.005; Jain S, 2006, J LIPOSOME RES, V16, P331, DOI 10.1080/08982100600992302; Kammona O, 2017, NANOMEDICINE-UK, V12, P1057, DOI 10.2217/nnm-2017-0015; Kang HH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058417, 10.1371/journal.pone.0084097]; Kang ML, 2009, BIOTECHNOL ADV, V27, P857, DOI 10.1016/j.biotechadv.2009.06.007; Kapczynski DR, 2016, VACCINE, V34, P1575, DOI 10.1016/j.vaccine.2016.02.011; Kim S-H, 2014, EXP MOL MED, P46165; Klinman DM, 2010, VACCINE, V28, P1919, DOI 10.1016/j.vaccine.2009.10.094; Kunisawa J, 2005, CURR MOL MED, V5, P557, DOI 10.2174/1566524054863924; KuoLee R, 2008, EXPERT OPIN DRUG DEL, V5, P693, DOI 10.1517/17425247.5.6.693 ; Lee SY, 2016, J COLLOID INTERF SCI, V480, P102, DOI 10.1016/j.jcis.2016.07.006; Lemoine D, 1999, J BIOMAT SCI-POLYM E, V10, P805, DOI 10.1163/156856299X00892; Liu LL, 2018, VACCINE, V36, P729, DOI 10.1016/j.vaccine.2017.12.027; Lo CT, 2010, BIOMATERIALS, V31, P3631, DOI 10.1016/j.biomaterials.2010.01.048; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; Ma TT, 2014, INT J PHARMACEUT, V473, P296, DOI 10.1016/j.ijpharm.2014.06.052; Mallick AI, 2011, VACCINE, V29, P1657, DOI 10.1016/j.vaccine.2010.12.046; Mangal S, 2011, VACCINE, V29, P4953, DOI 10.1016/j.vaccine.2011.04.112; METSIKKO K, 1986, EMBO J, V5, P3429, DOI 10.1002/j.1460-2075.1986.tb04665.x; Mohamed S.H., 2017, BIOLOGICALS, V51, P1045; Noda T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2011.00269; Pawar D, 2013, EUR J PHARM BIOPHARM, V85, P550, DOI 10.1016/j.ejpb.2013.06.017; Pawar D, 2010, AAPS J, V12, P130, DOI 10.1208/s12248-009-9169-1; Pawar SD, 2015, J VIROL METHODS, V222, P28, DOI 10.1016/j.jviromet.2015.05.004; Peeters B, 2014, VACCINE, V32, P6445, DOI 10.1016/j.vaccine.2014.09.048; Pizzolla A, 2017, J LEUKOCYTE BIOL, V101, P851, DOI 10.1189/jlb.4MR0716-290R; Qin T, 2015, J VIROL, V89, P5904, DOI 10.1128/JVI.00296-15; Rose MA, 2012, EXPERT REV VACCINES, V11, P595, DOI [10.1586/erv.12.31, 10.1586/ERV.12.31]; Shima H, 2014, INT IMMUNOL, V26, P619, DOI 10.1093/intimm/dxu061; Sinani G, 2017, INT J PHARMACEUT, V529, P1, DOI 10.1016/j.ijpharm.2017.06.053; Singh D, 2015, MOL IMMUNOL, V68, P272, DOI 10.1016/j.molimm.2015.09.011; Singh SM, 2016, VACCINE, V34, P4807, DOI 10.1016/j.vaccine.2016.08.009; Singh SM, 2016, VIRAL IMMUNOL, V29, P269, DOI 10.1089/vim.2015.0144; Singh SM, 2015, VACCINE, V33, P3947, DOI 10.1016/j.vaccine.2015.06.043; Sonaje K, 2012, MOL PHARMACEUT, V9, P1271, DOI 10.1021/mp200572t; Song L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00326; St Paul M, 2014, VIRAL IMMUNOL, V27, P167, DOI 10.1089/vim.2013.0124; STEGMANN T, 1987, EMBO J, V6, P2651, DOI 10.1002/j.1460-2075.1987.tb02556.x; Suarez DL, 2017, VET MICROBIOL, V206, P144, DOI 10.1016/j.vetmic.2016.11.025; Swayne DE, 2012, AVIAN DIS, V56, P818, DOI 10.1637/10183-041012-Review.1; Taha-Abdelaziz K, 2017, VET MICROBIOL, V212, P67, DOI 10.1016/j.vetmic.2017.11.010; Takeuchi T, 1998, J ANAT, V193, P233, DOI 10.1046/j.1469-7580.1998.19320233.x; Tan ZL, 2017, EUR J PHARM BIOPHARM, V111, P33, DOI 10.1016/j.ejpb.2016.11.007; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; Vyas SP, 2007, EXPERT REV VACCINES, V6, P401, DOI 10.1586/14760584.6.3.401; Wattrang E, 2009, VET IMMUNOL IMMUNOP, V131, P218, DOI 10.1016/j.vetimm.2009.04.013; Wu ZG, 2010, IMMUNOLOGY, V129, P133, DOI 10.1111/j.1365-2567.2009.03129.x; Yin Y, 2015, MUCOSAL IMMUNOL, V8, P799, DOI 10.1038/mi.2014.110; Zhang JX, 2017, NANOSCALE, V9, P3269, DOI 10.1039/c7nr00532f; Zhao K, 2014, INT J NANOMED, V9, P4609, DOI 10.2147/IJN.S70633; Zheng M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28729	79	26	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206324	10.1371/journal.pone.0206324	http://dx.doi.org/10.1371/journal.pone.0206324			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383798	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600039
J	Datta, S; Mercer, CH; Keeling, MJ				Datta, Samik; Mercer, Catherine H.; Keeling, Matt J.			Capturing sexual contact patterns in modelling the spread of sexually transmitted infections: Evidence using Natsal-3	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; NATIONAL SURVEYS; SOCIAL NETWORKS; HIV-INFECTION; RISK-FACTORS; YOUNG-WOMEN; LIFE-STYLES; PREVALENCE; TRANSMISSION; PARTNERSHIPS	Background Understanding the spread of sexually transmitted infections (STIs) in a population is of great importance to the planning and delivery of health services globally. The worldwide rise of HIV since the 1980's, and the recent increase in common STIs (including HPV and Chlamydia) in many countries, means that there is an urgent need to understand transmission dynamics in order to better predict the spread of such infections in the population. Unlike many other infections which can be captured by assumptions of random mixing, STI transmission is intimately linked to the number and pattern of sexual contacts. In fact, it is the huge variation in the number of new sexual partners that gives rise to the extremes of risk within populations which need to be captured in predictive models of STI transmission. Such models are vital in providing the necessary scientific evidence to determine whether a range of controls (from education to screening to vaccination) are cost-effective. Method and results We use probability sample survey data from Britain's third National Survey of Sexual Attitudes and Lifestyles (Natsal-3) to determine robust distributions for the rate of new partnerships that involve condomless sex and can therefore facilitate the spread of STIs. Different distributions are defined depending on four individual-level characteristics: age, sex, sexual orientation, and previous sexual experience. As individual behaviour patterns can change (e.g. by remaining in a monogamous relationship for a long period) we allow risk-percentiles to be randomly redrawn, to capture longer term behaviour as measured by Natsal-3. We demonstrate how this model formulation interacts with the transmission of infection by constructing an individual-based SIS-P (Susceptible-Infected-Susceptible-Protected) transmission model for the spread of a generic STI, and observing overall population demo-graphics when varying the transmission probability within a partnership, recovery rate and the level of population protection (e.g. from vaccination where applicable).	[Datta, Samik; Keeling, Matt J.] Univ Warwick, Warwick Math Inst, SBIDER, Zeeman Inst, Coventry CV4 8UW, W Midlands, England; [Datta, Samik; Keeling, Matt J.] Univ Warwick, Sch Life Sci, Coventry CV4 8UW, W Midlands, England; [Datta, Samik] Natl Inst Water & Atmospher Res, Wellington 6021, New Zealand; [Mercer, Catherine H.] UCL, Inst Global Hlth, UCL Ctr Populat Res Sexual Hlth & HIV, London WC1E 6JB, England	University of Warwick; University of Warwick; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of London; University College London	Datta, S (corresponding author), Univ Warwick, Warwick Math Inst, SBIDER, Zeeman Inst, Coventry CV4 8UW, W Midlands, England.; Datta, S (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 8UW, W Midlands, England.; Datta, S (corresponding author), Natl Inst Water & Atmospher Res, Wellington 6021, New Zealand.	samik.datta@niwa.co.nz	Datta, Samik/P-2452-2019; Keeling, Matt J/J-9280-2012	Datta, Samik/0000-0003-2198-7900; Keeling, Matt J/0000-0003-4639-4765; Mercer, Catherine/0000-0002-4220-5034	UK Department of Health [027/0089]; Medical Research Council [G0701757]; Wellcome Trust [084840]; Economic and Social Research Council; Department of Health; MRC [G0701757] Funding Source: UKRI	UK Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the UK Department of Health [grant number 027/0089]. Natsal-3 (http://www.natsal.ac.uk/natsal-3.aspx) is a collaboration between University College London, London School of Hygiene and Tropical Medicine, National Centre for Social Research, Public Health England, and the University of Manchester. The study was supported by grants from the Medical Research Council [G0701757]; and the Wellcome Trust [084840]; with contributions from the Economic and Social Research Council and Department of Health. The funders of Natsal-3 were responsible for funding of primary data collection. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2005, J INFECT DIS, V191, pS115, DOI 10.1086/425280; ANDERSON R M, 1991; Baguelin M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001527; Barnabas RV, 2006, PLOS MED, V3, P624, DOI 10.1371/journal.pmed.0030138; Bogaards JA, 2010, AM J EPIDEMIOL, V171, P817, DOI 10.1093/aje/kwp466; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; Danon L, 2012, J R SOC INTERFACE, V9, P2826, DOI 10.1098/rsif.2012.0357; Datta S, MODELLING TRANSMISSI; De Cao E, 2014, BIOSTATISTICS, V15, P470, DOI 10.1093/biostatistics/kxu008; DESIDERATO LL, 1995, J YOUTH ADOLESCENCE, V24, P55, DOI 10.1007/BF01537560; Drolet M, 2013, CANCER EPIDEM BIOMAR, V22, P641, DOI 10.1158/1055-9965.EPI-12-1173; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Erens B, 2013, SEX TRANSM INFECT; Erens B, 2013, TECHNICAL REPORT; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P211, DOI 10.2105/AJPH.92.2.211; Freeman EE, 2007, SEX TRANSM INFECT, V83, pI17, DOI 10.1136/sti.2006.023549; Garnett G, 2000, MATH POPUL STUD, V8, P251, DOI DOI 10.1080/08898480009525485; Garnett GP, 2008, SEX TRANSM INFECT, V84, pII4, DOI 10.1136/sti.2008.029850; GARNETT GP, 1992, IMA J MATH APPL MED, V9, P127; Garnett GP, 1997, AIDS, V11, P681, DOI 10.1097/00002030-199705000-00017; Ghani AC, 1997, SEX TRANSM DIS, V24, P45, DOI 10.1097/00007435-199701000-00009; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Haavio-Mannila E., 2001, TRENDS SEXUAL LIFE M; Hahne S, 2004, J CLIN VIROL, V29, P211, DOI 10.1016/j.jcv.2003.09.016; House T, 2009, EPIDEMIOL INFECT, V137, P654, DOI 10.1017/S0950268808001416; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Johnson AM, 2001, LANCET, V358, P1835, DOI 10.1016/S0140-6736(01)06883-0; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; King EM, 2015, BRIT J CANCER, V112, P1585, DOI 10.1038/bjc.2015.90; KLOVDAHL AS, 1994, SOC SCI MED, V38, P79, DOI 10.1016/0277-9536(94)90302-6; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Kretzschmar M, 1998, MATH BIOSCI, V148, P83, DOI 10.1016/S0025-5564(97)10008-6; Leng T, 2018, EPIDEMICS-NETH, V25, P35, DOI 10.1016/j.epidem.2018.05.003; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; MAY RM, 1987, NATURE, V326, P137, DOI 10.1038/326137a0; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Mercer CH, 2013, AM J EPIDEMIOL, V178, P249, DOI 10.1093/aje/kws467; Mercer CH, 2009, INT J EPIDEMIOL, V38, P206, DOI 10.1093/ije/dyn216; Mollers M, 2013, VACCINE, V31, P394, DOI 10.1016/j.vaccine.2012.10.087; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, 2016, POP EST UK ENGL WAL; Orroth KK, 2007, SEX TRANSM INFECT, V83, pI5, DOI 10.1136/sti.2006.023531; Owusu-Edusei K, 2013, SEX TRANSM DIS, V40, P197, DOI 10.1097/OLQ.0b013e318285c6d2; Pellis L, 2009, J R SOC INTERFACE, V6, P979, DOI 10.1098/rsif.2008.0493; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Public Health England, 2016, HLTH PROTECTION REPO, V10; Public Health England, 2016, HLTH PROTECTION REPO, V11; Punyacharoensin N, 2015, AIDS, V29, P339, DOI 10.1097/QAD.0000000000000525; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Ribassin-Majed L, 2013, MATHEMATICAL MEDICIN; Sacks RJ, 2014, SEX TRANSM INFECT, V90, P315, DOI 10.1136/sextrans-2013-051179; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Senn TE, 2009, SEX TRANSM INFECT, V85, P343, DOI 10.1136/sti.2009.035758; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; Taira AV, 2004, EMERG INFECT DIS, V10, P1915, DOI 10.3201/eid1011.040222; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; WHO, 2012, GLOB INC PREV SEL CU	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206501	10.1371/journal.pone.0206501	http://dx.doi.org/10.1371/journal.pone.0206501			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383793	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600055
J	Roder, K; Kabakov, A; Moshal, KS; Murphy, KR; Xie, A; Dudley, S; Turan, NN; Lu, YC; MacRae, CA; Koren, G				Roder, Karim; Kabakov, Anatoli; Moshal, Karni S.; Murphy, Kevin R.; Xie, An; Dudley, Samuel; Turan, Niluefer N.; Lu, Yichun; MacRae, Calum A.; Koren, Gideon			Trafficking of the human ether-a-go-go-related gene (hERG) potassium channel is regulated by the ubiquitin ligase rififylin (RFFL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hERG; ubiquitin ligase; ubiquitin; single-nucleotide polymorphism (SNP); trafficking; endoplasmic-reticulum-associated protein degradation (ERAD); protein degradation; ubiquitylation (ubiquitination); action potential duration; heart disease; QT interval; RFFL; ventricular arrhythmia	QT INTERVAL DURATION; QUALITY-CONTROL; RING FINGER; COMMON VARIANTS; ENCODE PROJECT; DEGRADATION; PROTEINS; ASSOCIATION; EXPRESSION; DEATH	The QT interval is an important diagnostic feature on surface electrocardiograms because it reflects the duration of the ventricular action potential. A previous genome-wide association study has reported a significant linkage between a single-nucleotide polymorphism approximate to 11.7 kb downstream of the gene encoding the RING finger ubiquitin ligase rififylin (RFFL) and variability in the QT interval. This, along with results in animal studies, suggests that RFFL may have effects on cardiac repolarization. Here, we sought to determine the role of RFFL in cardiac electrophysiology. Adult rabbit cardiomyocytes with adenovirus-expressed RFFL exhibited reduced rapid delayed rectifier current (I-Kr). Neonatal rabbit cardiomyocytes transduced with RFFL-expressing adenovirus exhibited reduced total expression of the potassium channel ether-a-go-go-related gene (rbERG). Using transfections of 293A cells and Western blotting experiments, we observed that RFFL and the core-glycosylated form of the human ether-a-go-go-related gene (hERG) potassium channel interact. Furthermore, RFFL overexpression led to increased polyubiquitination and proteasomal degradation of hERG protein and to an almost complete disappearance of I-Kr, which depended on the intact RING domain of RFFL. Blocking the ER-associated degradation (ERAD) pathway with a dominant-negative form of the ERAD core component, valosin-containing protein (VCP), in 293A cells partially abolished RFFL-mediated hERG degradation. We further substantiated the link between RFFL and ERAD by showing an interaction between RFFL and VCP in vitro. We conclude that RFFL is an important regulator of voltage-gated hERG potassium channel activity and therefore cardiac repolarization and that this ubiquitination-mediated regulation requires parts of the ERAD pathway.	[Roder, Karim; Kabakov, Anatoli; Moshal, Karni S.; Murphy, Kevin R.; Turan, Niluefer N.; Lu, Yichun; Koren, Gideon] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Cardiol,Cardiovasc Res Ctr, Providence, RI 02903 USA; [Xie, An; Dudley, Samuel] Univ Minnesota, Dept Med, Cardiovasc Div, Box 736 UMHC, Minneapolis, MN 55455 USA; [MacRae, Calum A.] Harvard Med Sch, Cardiovasc Div, Brigham & Womens Hosp, Boston, MA 02115 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Koren, G (corresponding author), Brown Univ, Warren Alpert Med Sch, Rhode Isl Hosp, 1 Hoppin St, Providence, RI 02903 USA.	gideon_koren@brown.edu	Dudley, Samuel C/A-7085-2009; Dudley, Samuel/AAR-7950-2021; Koren, Gideon/AAG-7726-2019	Dudley, Samuel/0000-0001-5843-5961; Koren, Gideon/0000-0002-9234-0875; Murphy, Kevin/0000-0003-2791-5801	Common Fund of the Office of the Director of the National Institutes of Health; NCI; National Human Genome Research Institute (NHGRI); NHLBI; NIDA; NIMH; NINDS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134706, R01HL110791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG041688] Funding Source: NIH RePORTER	Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are indebted to Drs. Wafik S. El-Deiry (Fox Chase Cancer Center, Department of Hematology/Oncology, Philadelphia, PA) for the RFFL plasmid, Ted Dawson (Johns Hopkins University, Institute for Cell Engineering, Baltimore, MD) for the ubiquitin plasmid, and Nico Dantuma (Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden) for the VCP expression plasmids. The data used for the analyses described in this article were obtained (on 10/2/2017) from the GTEx Portal (https://www.gtexportal.org/home/).<SUP>4</SUP> The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health, and the NCI, National Human Genome Research Institute (NHGRI), NHLBI, NIDA, NIMH, and NINDS.	Akylbekova EL, 2009, CIRC-ARRHYTHMIA ELEC, V2, P427, DOI 10.1161/CIRCEP.109.858894; Apaja PM, 2013, MOL BIOL CELL, V24, P3787, DOI 10.1091/mbc.E13-07-0417; Araki K, 2003, J NEUROCHEM, V86, P749, DOI 10.1046/j.1471-4159.2003.01875.x; Araki Kazutaka, 2012, Cold Spring Harb Perspect Biol, V4, pa015438, DOI 10.1101/cshperspect.a015438; Arking DE, 2014, NAT GENET, V46, P826, DOI 10.1038/ng.3014; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Cheng JH, 2004, ACTA PHARMACOL SIN, V25, P137; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Ciechanover A, 2006, EXP BIOL MED, V231, P1197; Coumailleau F, 2004, MOL BIOL CELL, V15, P4444, DOI 10.1091/mbc.E04-04-0274; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Farnham PJ, 2012, J BIOL CHEM, V287, P30885, DOI 10.1074/jbc.R112.365940; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Foo B, 2016, J PHYSIOL-LONDON, V594, P2469, DOI 10.1113/JP270531; Fry WHD, 2011, MOL CELL BIOL, V31, P3009, DOI 10.1128/MCB.05105-11; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Gopalakrishnan K, 2011, HYPERTENSION, V57, P764, DOI 10.1161/HYPERTENSIONAHA.110.165803; Guo J, 2012, J BIOL CHEM, V287, P33132, DOI 10.1074/jbc.M112.389643; Hantouche C, 2017, J BIOL CHEM, V292, P2287, DOI 10.1074/jbc.M116.752618; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Hong Y, 2001, CLIN GENET, V59, P171, DOI 10.1034/j.1399-0004.2001.590305.x; Iwai C, 2013, CARDIOVASC RES, V100, P520, DOI 10.1093/cvr/cvt200; Kang YD, 2015, BIOCHEM J, V472, P71, DOI 10.1042/BJ20141282; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Li Matthew, 2017, P T, V42, P473; Liao W, 2008, CURR BIOL, V18, P641, DOI 10.1016/j.cub.2008.04.017; Liu F, 2016, P NATL ACAD SCI USA, V113, P4859, DOI 10.1073/pnas.1521577113; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Marjamaa A, 2009, J INTERN MED, V265, P448, DOI 10.1111/j.1365-2796.2008.02026.x; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Mitchell GF, 1998, AM J PHYSIOL-HEART C, V274, pH747, DOI 10.1152/ajpheart.1998.274.3.H747; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Newton-Cheh C, 2005, HEART RHYTHM, V2, P277, DOI 10.1016/j.hrthm.2004.11.009; Newton-Cheh C, 2009, NAT GENET, V41, P399, DOI 10.1038/ng.364; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Okiyoneda T, 2018, DEV CELL, V44, P694, DOI 10.1016/j.devcel.2018.02.001; Organ-Darling LE, 2013, AM J PHYSIOL-HEART C, V304, pH589, DOI 10.1152/ajpheart.00385.2012; Pfeufer A, 2009, NAT GENET, V41, P407, DOI 10.1038/ng.362; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Ren XQ, 2010, AM J PHYSIOL-HEART C, V299, pH1525, DOI 10.1152/ajpheart.00479.2009; Roder K, 2014, J BIOL CHEM, V289, P33730, DOI 10.1074/jbc.M114.592295; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SEED WA, 1987, BRIT HEART J, V57, P32; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Thomas DJ, 2007, NUCLEIC ACIDS RES, V35, pD663, DOI 10.1093/nar/gkl1017; TOMASELLI GF, 1994, CIRCULATION, V90, P2534, DOI 10.1161/01.CIR.90.5.2534; Tsubuki S, 1996, J BIOCHEM-TOKYO, V119, P572, DOI 10.1093/oxfordjournals.jbchem.a021280; van Noord C, 2010, BRIT J CLIN PHARMACO, V70, P16, DOI 10.1111/j.1365-2125.2010.03660.x; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yang W, 2008, CELL CYCLE, V7, P670, DOI 10.4161/cc.7.5.5701; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	55	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					351	360		10.1074/jbc.RA118.003852	http://dx.doi.org/10.1074/jbc.RA118.003852			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30401747	hybrid, Green Published			2022-12-26	WOS:000455105500036
J	Cattin, ME; Deeke, SA; Dick, SA; Verret-Borsos, ZJA; Tennakoon, G; Gupta, R; Mak, E; Roeske, CL; Weldrick, JJ; Megeney, LA; Burgon, PG				Cattin, Marie-Elodie; Deeke, Shelley A.; Dick, Sarah A.; Verret-Borsos, Zachary J. A.; Tennakoon, Gayashan; Gupta, Rishi; Mak, Esther; Roeske, Cassandra L.; Weldrick, Jonathan J.; Megeney, Lynn A.; Burgon, Patrick G.			Expression of murine muscle-enriched A-type lamin-interacting protein (MLIP) is regulated by tissue-specific alternative transcription start sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; brain; heart; gene expression; intracellular trafficking; protein-protein interaction; skeletal muscle; cellular localization; MLIP; transcriptional start site; muscle-enriched lamin-interacting protein; transcriptional regulation; splice variant; tissue-specific expression; protein isoform	IDENTIFICATION; CIP	Muscle-enriched lamin-interacting protein (Mlip) is an alternatively spliced gene whose splicing specificity is dictated by tissue type. MLIP is most abundantly expressed in brain, cardiac, and skeletal muscle. In the present study, we systematically mapped the transcriptional start and stop sites of murine Mlip. Rapid amplification of cDNA ends (RACE) of Mlip transcripts from the brain, heart, and skeletal muscle revealed two transcriptional start sites (TSSs), exon 1a and exon 1b, and only one transcriptional termination site. RT-PCR analysis of the usage of the two identified TSSs revealed that the heart utilizes only exon 1a for MLIP expression, whereas the brain exclusively uses exon 1b TSS. Loss of Mlip exon 1a in mice resulted in a 7-fold increase in the prevalence of centralized nuclei in muscle fibers with the Mlip exon1a-deficient satellite cells on single fibers exhibiting a significant delay in commitment to a MYOD-positive phenotype. Furthermore, we demonstrate that the A-type lamin-binding domain in MLIP is encoded in exon 1a, indicating that MLIP isoforms generated with exon 1b TSS lack the A-type lamin-binding domain. Collectively these findings suggest that Mlip tissue-specific expression and alternative splicing play a critical role in determining MLIP's functions in mice.	[Cattin, Marie-Elodie; Deeke, Shelley A.; Verret-Borsos, Zachary J. A.; Tennakoon, Gayashan; Gupta, Rishi; Mak, Esther; Roeske, Cassandra L.; Weldrick, Jonathan J.; Burgon, Patrick G.] Univ Ottawa, Heart Inst, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada; [Dick, Sarah A.; Megeney, Lynn A.] Ottawa Hosp, Sprott Ctr Stem Cell Res, Regenerat Med Program, Res Inst, Ottawa, ON K1H 8L6, Canada; [Deeke, Shelley A.; Dick, Sarah A.; Weldrick, Jonathan J.; Megeney, Lynn A.; Burgon, Patrick G.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON K1N 6N5, Canada; [Megeney, Lynn A.; Burgon, Patrick G.] Univ Ottawa, Fac Med, Dept Med, Ottawa, ON K1N 6N5, Canada; [Cattin, Marie-Elodie] Servier Res Inst, 125 Chemin Ronde, F-78290 Croissy Sur Seine, France	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Servier; Institut de Recherches Internationales Servier	Burgon, PG (corresponding author), Univ Ottawa, Heart Inst, 40 Ruskin St, Ottawa, ON K1Y 4W7, Canada.	patrick.burgon@icloud.com	Burgon, Patrick/ABB-1027-2021	Megeney, Lynn/0000-0002-6824-8569; Dick, Sarah A/0000-0003-0683-2900	Canadian Institutes of Health Research; Ontario Graduate Scholarship in Science and Technology fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship in Science and Technology fellowship	This work was supported by the Canadian Institutes of Health Research (to P.G.B. & L.A.M.) and an Ontario Graduate Scholarship in Science and Technology fellowship (to J.J.W.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmady E, 2011, J BIOL CHEM, V286, P19702, DOI 10.1074/jbc.M110.165548; Cattin ME, 2015, J BIOL CHEM, V290, P26699, DOI 10.1074/jbc.M115.678433; de Hoon M, 2008, BIOTECHNIQUES, V44, P627, DOI 10.2144/000112802; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Esslinger U, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172995; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hestand MS, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq602; Huang ZP, 2015, J CLIN INVEST, V125, P4122, DOI 10.1172/JCI82423; Huang ZP, 2012, CIRC RES, V110, P818, DOI 10.1161/CIRCRESAHA.111.259663; Kelemen O, 2013, GENE, V514, P1, DOI 10.1016/j.gene.2012.07.083; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Wakamatsu A, 2009, DNA RES, V16, P371, DOI 10.1093/dnares/dsp022	15	7	7	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19761	19770		10.1074/jbc.RA118.003758	http://dx.doi.org/10.1074/jbc.RA118.003758			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30389785	Green Published, hybrid			2022-12-26	WOS:000454294900021
J	Huang, JL; Liu, PP; Wang, G				Huang, Jinliang; Liu, Peipei; Wang, Geng			Regulation of mitochondrion-associated cytosolic ribosomes by mammalian mitochondrial ribonuclease T2 (RNASET2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial metabolism; RNA turnover; RNA transport; enzyme; cytosolic ribosome; mitochondrial RNA import; mtRNA degradation; ribosomal RNA degradation; synchronized translation	PROTEIN-SYNTHESIS; MESSENGER-RNAS; IMPORT; TRANSLATION; T2; LOCALIZATION; COMPONENT; SEQUENCE; VICINITY; COMPLEX	Mitochondrial proteins are encoded in both mitochondrial and nuclear genomes. The expression levels of these two pools of mitochondrial genes are co-regulated and synchronized. Import and assembly of the nucleus-encoded oxidative phosphorylation (OXPHOS) subunits affect protein synthesis in the mitochondrial matrix by engaging the mitochondrial ribosomes. How the ribosomes at the outside of mitochondria are regulated by mitochondria, however, remains mostly unexplored. Here, using an array of biochemical assays and genetic knockdown and overexpression in HEK293 or mouse cells, we show that cytosolic rRNAs that are associated with the mitochondrial outer membrane have very different decay patterns from those of both endoplasmic reticulum-associated and -nonassociated cytosolic rRNAs. Mitochondrial intermembrane space RNase T2 (RNASET2), which has been previously shown to degrade mitochondrial RNAs, is also responsible for selective degradation of the cytosolic rRNAs on the outer membrane. We noted that the degradation activity also has a positive effect on nuclear transcription of rRNAs, suggesting a compensatory feedback mechanism, and affects protein translations in and out of mitochondria. These findings establish a mechanism for the co-regulation of gene expression programs inside and outside of mitochondria in mammalian cells.	[Huang, Jinliang; Liu, Peipei; Wang, Geng] Tsinghua Univ, Sch Life Sci, Cell Biol & Dev Ctr, Minist Educ,Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Wang, G (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	wangeng@biomed.tsinghua.edu.cn		Huang, Jinliang/0000-0002-8729-7817	Priority Research Program of the Ministry of Science and Technology of China [2017YFA0504600]; National Natural Science Foundation of the People's Republic of China [31371439, 91649103]; Ministry of Education of the People's Republic of China 1000 Talents Youth Program	Priority Research Program of the Ministry of Science and Technology of China; National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China 1000 Talents Youth Program	This work was supported by Grant 2017YFA0504600 from the Priority Research Program of the Ministry of Science and Technology of China, by Grants 31371439 and 91649103 from the National Natural Science Foundation of the People's Republic of China, and by funds from the Ministry of Education of the People's Republic of China 1000 Talents Youth Program. The authors declare that they have no conflicts of interest with the contents of this article.	Acquati F, 2011, P NATL ACAD SCI USA, V108, P1104, DOI 10.1073/pnas.1013746108; Amunts A, 2015, SCIENCE, V348, P95, DOI 10.1126/science.aaa1193; Andersen KL, 2012, MOL BIOL CELL, V23, P36, DOI 10.1091/mbc.E11-08-0689; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Besse F, 2008, NAT REV MOL CELL BIO, V9, P971, DOI 10.1038/nrm2548; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Bruni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064670; Campomenosi P, 2006, ARCH BIOCHEM BIOPHYS, V449, P17, DOI 10.1016/j.abb.2006.02.022; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; CHANG DD, 1989, CELL, V56, P131, DOI 10.1016/0092-8674(89)90991-4; Cheng Y, 2018, CELL REP, V24, P2589, DOI 10.1016/j.celrep.2018.08.003; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Crowley KS, 1998, J BIOL CHEM, V273, P17278, DOI 10.1074/jbc.273.27.17278; Dennerlein S, 2017, TRENDS CELL BIOL, V27, P712, DOI 10.1016/j.tcb.2017.05.004; Duchene AM, 2009, CURR GENET, V55, P1, DOI 10.1007/s00294-008-0223-9; Gehrke S, 2015, CELL METAB, V21, P95, DOI 10.1016/j.cmet.2014.12.007; Greber BJ, 2015, SCIENCE, V348, P303, DOI 10.1126/science.aaa3872; Haud N, 2011, P NATL ACAD SCI USA, V108, P1099, DOI 10.1073/pnas.1009811107; Hillwig MS, 2011, P NATL ACAD SCI USA, V108, P1093, DOI 10.1073/pnas.1009809108; Holt CE, 2009, SCIENCE, V326, P1212, DOI 10.1126/science.1176488; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Levy S, 2016, NUCLEIC ACIDS RES, V44, P1813, DOI 10.1093/nar/gkw050; Liu PP, 2017, PROTEIN CELL, V8, P735, DOI 10.1007/s13238-017-0448-9; Margeot A, 2005, GENE, V354, P64, DOI 10.1016/j.gene.2005.04.022; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Mick DU, 2012, CELL, V151, P1528, DOI 10.1016/j.cell.2012.11.053; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Mukhopadhyay A, 2004, BIOCHEM J, V382, P385, DOI 10.1042/BJ20040065; Nierhaus KH, 2014, J BACTERIOL, V196, P3817, DOI 10.1128/JB.02297-14; Noh JH, 2016, GENE DEV, V30, P1224, DOI 10.1101/gad.276022.115; Reid DW, 2014, CELL, V158, P1362, DOI 10.1016/j.cell.2014.08.012; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Salinas T, 2006, P NATL ACAD SCI USA, V103, P18362, DOI 10.1073/pnas.0606449103; Sanchez CG, 2016, CELL STEM CELL, V18, P276, DOI 10.1016/j.stem.2015.11.004; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Sylvestre J, 2003, MOL BIOL CELL, V14, P3848, DOI 10.1091/mbc.E03-02-0074; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384; Zhang XR, 2014, CELL, V158, P607, DOI 10.1016/j.cell.2014.05.047	43	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19633	19644		10.1074/jbc.RA118.005433	http://dx.doi.org/10.1074/jbc.RA118.005433			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385512	Green Published, hybrid			2022-12-26	WOS:000454294900012
J	Tsuji, A; Yuasa, K; Asada, C				Tsuji, Akihiko; Yuasa, Keizo; Asada, Chikako			Cellulose-binding activity of a 21-kDa endo-beta-1,4-glucanase lacking cellulose-binding domain and its synergy with other cellulases in the digestive fluid of Aplysia kurodai	PLOS ONE			English	Article							MOLECULE IMAGING ANALYSIS; TRICHODERMA-REESEI; CRYSTALLINE CELLULOSE; POSTIA-PLACENTA; BOUND FORMS; BROWN-ROT; ENDOGLUCANASE; SEQUENCE; CLONING; FUNGUS	Endo-beta-1,4-glucanase AkEG21 belonging to glycosyl hydrolase family 45 (GHF45) is the most abundant cellulase in the digestive fluid of sea hare (Aplysia kurodai). The specific activity of this 21-kDa enzyme is considerably lower than those of other endo beta-1,4-glucanases in the digestive fluid of A. kurodai, therefore its role in whole cellulose hydrolysis by sea hare is still uncertain. Although AkEG21 has a catalytic domain without a cellulose binding domain, it demonstrated stable binding to cellulose fibers, similar to that of fungal cello-biohydrolase (CBH) 1 and CBH 2, which is strongly inhibited by cellohexaose, suggesting the involvement of the catalytic site in cellulose binding. Cellulose-bound AkEG21 hydrolyzed cellulose to cellobiose, cellotriose and cellotetraose, but could not digest an external substrate, azo-carboxymethyl cellulose. Cellulose hydrolysis was considerably stimulated by the synergistic action of cellulose-bound AkEG21 and AkEG45, another beta-1,4-endoglucanase present in the digestive fluid of sea hare; however no synergy in carboxymethylcellulose hydrolysis was observed. When AkEG21 was removed from the digestive fluid by immunoprecipitation, the cellulose hydrolyzing activity of the fluid was significantly reduced, indicating a critical role of AkEG21 in cellulose hydrolysis by A. kurodai. These findings suggest that AkEG21 is a processive endoglucanase functionally equivalent to the CBH, which provides a CBH-independent mechanism for the mollusk to digest seaweed cellulose to glucose.	[Tsuji, Akihiko; Yuasa, Keizo] Tokushima Univ, Grad Sch Biosci & Bioind, Dept Biomol Funct & Technol, Tokushima, Japan; [Asada, Chikako] Tokushima Univ, Grad Sch Biosci & Bioind, Dept Bioresource Chem & Technol, Tokushima, Japan	Tokushima University; Tokushima University	Tsuji, A (corresponding author), Tokushima Univ, Grad Sch Biosci & Bioind, Dept Biomol Funct & Technol, Tokushima, Japan.	tsuji.akihiko@tokushima-u.ac.jp			Japan Society for the Promotion of Science [26450284]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Scientific Research from the Japan Society for the Promotion of Science (jsps.go.jp) to AT (No: 26450284).	Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; BELDMAN G, 1985, EUR J BIOCHEM, V146, P301, DOI 10.1111/j.1432-1033.1985.tb08653.x; Bischof RH, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0507-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cohen R, 2005, APPL ENVIRON MICROB, V71, P2412, DOI 10.1128/AEM.71.5.2412-2417.2005; Davies GJ, 1995, BIOCHEMISTRY-US, V34, P16210, DOI 10.1021/bi00049a037; Druzhinina IS, 2017, MICROB BIOTECHNOL, V10, P1485, DOI 10.1111/1751-7915.12726; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gao J, 2017, ENZYME MICROB TECH, V99, P32, DOI 10.1016/j.enzmictec.2017.01.005; Georgelis N, 2015, APPL MICROBIOL BIOT, V99, P3807, DOI 10.1007/s00253-015-6534-0; Guo R, 2008, J COMP PHYSIOL B, V178, P209, DOI 10.1007/s00360-007-0214-z; Hilden L, 2004, BIOTECHNOL LETT, V26, P1683, DOI 10.1007/s10529-004-4579-8; Hirvonen M, 2003, J MOL BIOL, V329, P403, DOI 10.1016/S0022-2836(03)00467-4; Hodge JE, 1991, METHODS CARBOHYDRATE, P380; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; Jeoh T, 2017, BIOTECHNOL BIOENG, V114, P1369, DOI 10.1002/bit.26277; Kawai S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020145; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nelson N, 1944, J BIOL CHEM, V153, P375; Pauchet Y, 2014, INSECT BIOCHEM MOLEC, V49, P1, DOI 10.1016/j.ibmb.2014.03.004; PENTTILA M, 1986, GENE, V45, P253, DOI 10.1016/0378-1119(86)90023-5; Rahman MM, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00060; Ryu JS, 2011, APPL ENVIRON MICROB, V77, P7933, DOI 10.1128/AEM.05496-11; Sabbadin F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03142-x; Sakamoto K, 2009, COMP BIOCHEM PHYS B, V152, P390, DOI 10.1016/j.cbpb.2009.01.010; SALOHEIMO A, 1994, MOL MICROBIOL, V13, P219, DOI 10.1111/j.1365-2958.1994.tb00417.x; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sasaki C, 2012, CARBOHYD POLYM, V89, P298, DOI 10.1016/j.carbpol.2012.02.040; SHEPPARD PO, 1994, GENE, V150, P163, DOI 10.1016/0378-1119(94)90878-8; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Soleymani Mohsen, 2017, Bioengineering-Basel, V4, P92, DOI 10.3390/bioengineering4040092; Strakowska J, 2014, J BASIC MICROB, V54, pS2, DOI 10.1002/jobm.201300821; SVENNERHOLM L, 1956, J NEUROCHEM, V1, P42, DOI 10.1111/j.1471-4159.1956.tb12053.x; TEERI TT, 1987, GENE, V51, P43, DOI 10.1016/0378-1119(87)90472-0; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Tsuji A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170669; Tsuji A, 2014, FEBS OPEN BIO, V4, P560, DOI 10.1016/j.fob.2014.06.002; Tsuji A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065418; Tsuji A, 2012, COMP BIOCHEM PHYS B, V163, P324, DOI 10.1016/j.cbpb.2012.08.005; Valencia A, 2013, GENE, V513, P260, DOI 10.1016/j.gene.2012.10.046; Vinzant TB, 2001, APPL BIOCHEM BIOTECH, V91-3, P99, DOI 10.1385/ABAB:91-93:1-9:99; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Xu BZ, 2001, EUR J BIOCHEM, V268, P3718, DOI 10.1046/j.1432-1327.2001.02280.x; Yennawar NH, 2006, P NATL ACAD SCI USA, V103, P14664, DOI 10.1073/pnas.0605979103; Zhang G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7625; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zheng F, 2013, APPL ENVIRON MICROB, V79, P989, DOI 10.1128/AEM.02725-12	50	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0205915	10.1371/journal.pone.0205915	http://dx.doi.org/10.1371/journal.pone.0205915			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412581	Green Published, Green Submitted, gold			2022-12-26	WOS:000449772600010
J	Esmaili, N; Piccardi, M; Kruger, B; Girosi, F				Esmaili, Nazanin; Piccardi, Massimo; Kruger, Bernie; Girosi, Federico			Analysis of healthcare service utilization after transport-related injuries by a mixture of hidden Markov models	PLOS ONE			English	Article							SEQUENCES; COST	Background Transport injuries commonly result in significant disease burden, leading to physical disability, mental health deterioration and reduced quality of life. Analyzing the patterns of healthcare service utilization after transport injuries can provide an insight into the health of the affected parties, allow improved health system resource planning, and provide a baseline against which any future system-level interventions can be evaluated. Therefore, this research aims to use time series of service utilization provided by a compensation agency to identify groups of claimants with similar utilization patterns, describe such patterns, and characterize the groups in terms of demographic, accident type and injury type. Methods To achieve this aim, we have proposed an analytical framework that utilizes latent variables to describe the utilization patterns over time and group the claimants into clusters based on their service utilization time series. To perform the clustering without dismissing the temporal dimension of the time series, we have used a well-established statistical approach known as the mixture of hidden Markov models (MHMM). Ensuing the clustering, we have applied multinomial logistic regression to provide a description of the clusters against demographic, injury and accident covariates. Results We have tested our model with data on psychology service utilization from one of the main compensation agencies for transport accidents in Australia, and found that three clear clusters of service utilization can be evinced from the data. These three clusters correspond to claimants who have tended to use the services 1) only briefly after the accident; 2) for an intermediate period of time and in moderate amounts; and 3) for a sustained period of time, and intensely. The size of these clusters is approximately 67%, 27% and 6% of the number of claimants, respectively. The multinomial logistic regression analysis has showed that claimants who were 30 to 60-year-old at the time of accident, were witnesses, and who suffered a soft tissue injury were more likely to be part of the intermediate cluster than the majority cluster. Conversely, claimants who suffered more severe injuries such as a brain head injury or anon-limb fracture injury and who started their service utilization later were more likely to be part of the sustained cluster. Conclusion This research has showed that clustering of service utilization time series is an effective approach for identifying the main user groups and utilization patterns of a healthcare service. In addition, using logistic regression to describe the clusters in terms of demographic, injury and accident covariates has helped identify the salient attributes of the claimants in each cluster. This finding is very important for the compensation agency and potentially other authorities as it provides a baseline to improve need understanding, resource planning and service provision.	[Esmaili, Nazanin; Piccardi, Massimo] Univ Technol Sydney, Fac Engn & IT, Ultimo, NSW, Australia; [Esmaili, Nazanin; Girosi, Federico] Capital Markets Cooperat Res Ctr, Sydney, NSW, Australia; [Kruger, Bernie] Transport Accid Commiss, Geelong, Vic, Australia; [Girosi, Federico] Western Sydney Univ, Translat Hlth Res Inst, Penrith, NSW, Australia	University of Technology Sydney; Western Sydney University	Esmaili, N (corresponding author), Univ Technol Sydney, Fac Engn & IT, Ultimo, NSW, Australia.; Esmaili, N (corresponding author), Capital Markets Cooperat Res Ctr, Sydney, NSW, Australia.	nazanin.esmaili@uts.edu.au	Esmaili, Nazanin/M-9458-2019	Girosi, Federico/0000-0003-3937-2285; Piccardi, Massimo/0000-0001-9250-6604; Esmaili, Nazanin/0000-0002-0605-4996	Capital Markets Cooperative Research Centre (CMCRC) Limited; Transport Accident Commission (TAC)	Capital Markets Cooperative Research Centre (CMCRC) Limited; Transport Accident Commission (TAC)	This research is funded by the Capital Markets Cooperative Research Centre (CMCRC) Limited with the following URL: https://www.cmcrc.com/, and Transport Accident Commission (TAC) with the following URL: https://www.tac.vic.gov.au/. The recipients of the award are Nazanin Esmaili, Massimo Piccardi and Federico Girosi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bargi A, 2018, IEEE T NEUR NET LEAR, V29, P3953, DOI 10.1109/TNNLS.2017.2742058; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Brijnath B, 2014, J OCCUP REHABIL, V24, P766, DOI 10.1007/s10926-014-9506-9; Brussoni M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191384; Elbers NA, 2013, ACCIDENT ANAL PREV, V53, P121, DOI 10.1016/j.aap.2013.01.007; Elzinga CH, 2015, SOCIOL METHOD RES, V44, P3, DOI 10.1177/0049124114540707; Fenton JJ, 2010, ANN FAM MED, V8, P397, DOI 10.1370/afm.1133; Gales M, 2007, FOUND TRENDS SIGNAL, V1, P195, DOI 10.1561/2000000004; Gao BX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066780; Gauthier JA, 2009, SOCIOL METHOD RES, V38, P197, DOI 10.1177/0049124109342065; Guilcher S, 2013, REHABIL PSYCHOL, V58, P158; Harris IA, 2009, MED J AUSTRALIA, V190, P619, DOI 10.5694/j.1326-5377.2009.tb02589.x; Harrison T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160645; Hassan R, 2005, 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, P192; Henley G., 2018, TRENDS INJURY DEATHS; Ioannou LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178894; Kaufman L., 2009, FINDING GROUPS DATA, V344; Lesnard L, 2010, SOCIOL METHOD RES, V38, P389, DOI 10.1177/0049124110362526; Litchfield F., 2016, COST ROAD CRASHES AU; McVicar D, 2002, J ROY STAT SOC A STA, V165, P317, DOI 10.1111/1467-985X.00641; Montgomery D. C., 2015, INTRO TIME SERIES AN; Munch K, 2006, BMC BIOINFORMATICS, V7, P1; Prang KH, 2012, BRAIN INJURY, V26, P1611, DOI 10.3109/02699052.2012.698790; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Reynolds A.P., 2006, J MATH MODEL ALGORIT, V5, P475, DOI [DOI 10.1007/S10852-005-9022-1, 10.1007/s10852-005-9022-1]; Ruseckaite R, 2012, INJURY, V43, P1600, DOI 10.1016/j.injury.2011.03.011; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Serrano AG, 2006, CHEM PHYS LIPIDS, V141, P105, DOI 10.1016/j.chemphyslip.2006.02.017; Skalamera J, 2016, PREV MED, V84, P83, DOI 10.1016/j.ypmed.2015.12.011; Smyth P, 1997, ADV NEUR IN, V9, P648; State Government of Victoria, 2016, 2015 VICT ROAD TRAUM; Staton C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144971; Transport Accident Commission, 2017, TRANSP ACC REG 2017; Transport Accident Commission, 2017, TAC ANN REP; Ullrich PM, 2013, REHABIL PSYCHOL, V58, P158, DOI 10.1037/a0032047; WHO.a, 2018, ROAD TRAFF INJ; Zhou GD, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P473	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206274	10.1371/journal.pone.0206274	http://dx.doi.org/10.1371/journal.pone.0206274			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408046	Green Published, gold			2022-12-26	WOS:000449512300017
J	Ko, DK; Nadakuduti, SS; Douches, DS; Buell, CR				Ko, Dae Kwan; Nadakuduti, Satya Swathi; Douches, David S.; Buell, C. Robin			Transcriptome profiling of transgenic potato plants provides insights into variability caused by plant transformation	PLOS ONE			English	Article							AGROBACTERIUM T-DNA; SOMACLONAL VARIATION; COPY NUMBER; ARABIDOPSIS; GENE; INTEGRATION; GENOME; SITES; BIOSYNTHESIS; METHYLATION	Crop genetic engineering involves transformation in which transgenic plants are regenerated through tissue culture manipulations that can elicit somaclonal variation due to mutations, translocations, and/or epigenetic alterations. Here, we report on alterations in the transcriptome in a panel of transgenic potato plants engineered to be herbicide resistant. Using an inbred diploid potato clone (DMRH S5 28-5), ten single-insert transgenic lines derived from independent Agrobacterium-mediated transformation events were selected for herbicide resistance using an allelic variant of acetolactate synthase (mALS1). Expression abundances of the single-copy mALS1 transgene varied in individual transgenic lines was correlated with the level of phenotypic herbicide resistance, suggesting the importance of transgene expression in transgenic performance. Using RNA-sequencing, differentially expressed genes were identified with the proportion of genes up-regulated significantly higher than down-regulated genes in the panel, suggesting a differential impact of the plant transformation on gene expression activation compared to repression. Not only were transcription factors among the differentially expressed genes but specific transcription factor binding sites were also enriched in promoter regions of differentially expressed genes in transgenic lines, linking transcriptomic variation with specific transcription factor activity. Collectively, these results provide an improved understanding of transcriptomic variability caused by plant transformation.	[Ko, Dae Kwan; Buell, C. Robin] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Nadakuduti, Satya Swathi; Douches, David S.] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Douches, David S.; Buell, C. Robin] MSU AgBioRes, E Lansing, MI 48824 USA; [Buell, C. Robin] Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Buell, CR (corresponding author), Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA.; Buell, CR (corresponding author), MSU AgBioRes, E Lansing, MI 48824 USA.; Buell, CR (corresponding author), Michigan State Univ, Plant Resilience Inst, E Lansing, MI 48824 USA.	buell@msu.edu	Nadakuduti, Satya Swathi/AAB-1167-2021	Nadakuduti, Satya Swathi/0000-0002-0831-3760; Buell, C Robin/0000-0002-6727-4677; Ko, Dae Kwan/0000-0002-9720-5138	United States Department of Agriculture Biotechnology Risk Assessment Program [2013-33522-21090]	United States Department of Agriculture Biotechnology Risk Assessment Program	Funds for this research were provided by the United States Department of Agriculture Biotechnology Risk Assessment Program awarded to DSD and CRB (2013-33522-21090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Funds for this research were provided by the United States Department of Agriculture Biotechnology Risk Assessment Program awarded to DSD and CRB (2013-33522-21090). We thank Research Technology Support Facility (RTSF) Genomics Core at Michigan State University for sequencing.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barrell PJ, 2013, PLANT BIOTECHNOL J, V11, P907, DOI 10.1111/pbi.12099; Birch PRJ, 2012, FOOD SECUR, V4, P477, DOI 10.1007/s12571-012-0220-1; Butler NM, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01045; Chezem WR, 2017, PLANT CELL, V29, P1907, DOI 10.1105/tpc.16.00954; Douches DS, 1998, HORTSCIENCE, V33, P1053, DOI 10.21273/HORTSCI.33.6.1053; Doyle J. J., 1987, PHYTOCHEM B, P11; Duggleby RG, 2008, PLANT PHYSIOL BIOCH, V46, P309, DOI 10.1016/j.plaphy.2007.12.004; Filipecki M, 2006, J APPL GENET, V47, P277, DOI 10.1007/BF03194637; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gelvin SB, 2017, ANNU REV GENET, V51, P195, DOI 10.1146/annurev-genet-120215-035320; Gertz JM, 1999, 1999 BRIGHTON CONFERENCE: WEEDS, VOLS 1-3, P835; Gray JA, 2017, PLANT PHYSIOL, V173, P2308, DOI 10.1104/pp.17.00109; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Halterman D, 2016, AM J POTATO RES, V93, P1, DOI 10.1007/s12230-015-9485-1; Hardigan MA, 2016, PLANT CELL, V28, P388, DOI 10.1105/tpc.15.00538; Haslberger AG, 2003, NAT BIOTECHNOL, V21, P739, DOI 10.1038/nbt0703-739; Hirsch CD, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.12.0042; HOBBS SLA, 1990, PLANT MOL BIOL, V15, P851, DOI 10.1007/BF00039425; Ichikawa T, 2003, PLANT J, V36, P421, DOI 10.1046/j.1365-313X.2003.01876.x; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Kaeppler SM, 2000, PLANT MOL BIOL, V43, P179, DOI 10.1023/A:1006423110134; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SI, 2007, PLANT J, V51, P779, DOI 10.1111/j.1365-313X.2007.03183.x; Kim SR, 2003, PLANT MOL BIOL, V52, P761, DOI 10.1023/A:1025093101021; Kuiper HA, 2001, PLANT J, V27, P503, DOI 10.1046/j.1365-313X.2001.01119.x; Kumar S, 2002, PLANT J, V31, P543, DOI 10.1046/j.1365-313X.2002.01368.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LARKIN PJ, 1981, THEOR APPL GENET, V60, P197, DOI 10.1007/BF02342540; Lemaux PG, 2008, ANNU REV PLANT BIOL, V59, P771, DOI 10.1146/annurev.arplant.58.032806.103840; Li B, 2015, PLANT CELL, V27, P839, DOI 10.1105/tpc.114.134809; Liu WX, 2013, MOL PLANT, V6, P1487, DOI 10.1093/mp/sst031; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCarthy RL, 2009, PLANT CELL PHYSIOL, V50, P1950, DOI 10.1093/pcp/pcp139; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Peterson BA, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0003; Pogorelko GV, 2008, J GENET, V87, P133, DOI 10.1007/s12041-008-0020-8; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; RAY TB, 1984, PLANT PHYSIOL, V75, P827, DOI 10.1104/pp.75.3.827; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Stroud H, 2013, ELIFE, V2, DOI 10.7554/eLife.00354; Sun N, 2016, P NATL ACAD SCI USA, V113, P6071, DOI 10.1073/pnas.1604782113; Tester M, 2010, SCIENCE, V327, P818, DOI 10.1126/science.1183700; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van Os H, 2006, GENETICS, V173, P1075, DOI 10.1534/genetics.106.055871; Waltz E, 2015, NAT BIOTECHNOL, V33, P12, DOI 10.1038/nbt0115-12; Wilson A, 2004, TECHNICAL REPORT; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wu CY, 2008, P NATL ACAD SCI USA, V105, P12915, DOI 10.1073/pnas.0806019105; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yu Q, 2014, PEST MANAG SCI, V70, P1340, DOI 10.1002/ps.3710; Yu WC, 2016, PLANT BIOTECHNOL J, V14, P1175, DOI 10.1111/pbi.12466	60	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206055	10.1371/journal.pone.0206055	http://dx.doi.org/10.1371/journal.pone.0206055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408049	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300013
J	Marfil-Garza, BA; Belaunzaran-Zamudio, PF; Gulias-Herrero, A; Zuniga, AC; Caro-Vega, Y; Kershenobich-Stalnikowitz, D; Sifuentes-Osornio, J				Marfil-Garza, Braulio A.; Belaunzaran-Zamudio, Pablo F.; Gulias-Herrero, Alfonso; Camiro Zuniga, Antonio; Caro-Vega, Yanink; Kershenobich-Stalnikowitz, David; Sifuentes-Osornio, Jose			Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico	PLOS ONE			English	Article							MORTALITY; SURGERY; COMPLICATIONS	Background Hospital length-of-Stay has been traditionally used as a surrogate to evaluate healthcare efficiency, as well as hospital resource utilization. Prolonged Length-of-stay (PLOS) is associated with increased mortality and other poor outcomes. Additionally, these patients represent a significant economic problem on public health systems and their families. We sought to describe and compare characteristics of patients with Normal hospital Length-of-Stay (NLOS) and PLOS to identify sociodemographic and disease-specific factors associated with PLOS in a tertiary care institution that attends adults with complicated diseases from all over Mexico. Materials and methods We conducted a retrospective analysis of hospital discharges from January 2000-December 2017 using institutional databases of medical records. We compared NLOS and PLOS using descriptive and inferential statistics. PLOS were defined as those above the 95th percentile of length of hospitalization. Results We analyzed 85,904 hospitalizations (1,069,875 bed-days), of which 4,427 (5.1%) were PLOS (247,428 bed-days, 23.1% of total bed-days). Hematological neoplasms were the most common discharge diagnosis and surgery of the small bowel was the most common type of surgery. Younger age, male gender, a lower physician-to-patient ratio, emergency and weekend admissions, surgery, the number of comorbidities, residence outside Mexico City and lower socioeconomic status were associated with PLOS. Bone marrow transplant (OR 18.39 [95% CI 12.50-27.05, p<0.001), complex infectious diseases such as systemic mycoses and parasitoses (OR 4.65 [95% CI 3.40-6.63, p<0.001), and complex abdominal diseases such as intestinal fistula (OR 2.57 [95% CI 1.98-3.32) had the greatest risk for PLOS. Risk of mortality in patients with PLOS increased more than threefold (3.7% vs 13.3%, p<0.001). Conclusions We report some key sociodemographic and disease-specific differences in patients with PLOS. These could serve to develop a specific model of directed hospital healthcare for patients identified as in risk of PLOS.	[Marfil-Garza, Braulio A.; Gulias-Herrero, Alfonso; Kershenobich-Stalnikowitz, David; Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Belaunzaran-Zamudio, Pablo F.; Camiro Zuniga, Antonio; Caro-Vega, Yanink; Sifuentes-Osornio, Jose] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Sifuentes-Osornio, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico.; Sifuentes-Osornio, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico.	jose.sifuenteso@incmnsz.mx	Marfil-Garza, Braulio A/AAQ-4959-2020; Belaunzaran-Zamudio, Pablo F./T-4218-2019; camiro, antonio/AGW-3423-2022; Belaunzarán-Zamudio, Pablo Francisco/T-4085-2019	Marfil-Garza, Braulio A/0000-0002-7224-2127; Belaunzaran-Zamudio, Pablo F./0000-0003-4775-4734; camiro, antonio/0000-0003-0957-9509; Sifuentes-Osornio, Jose/0000-0001-9584-1360				Baek H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195901; Bentes ME, 1993, EVALUATION EXPERIENC, P173; Butterworth J, 2000, ANESTHESIOLOGY, V92, P414, DOI 10.1097/00000542-200002000-00023; Chaudhury H, 2005, ENVIRON BEHAV, V37, P760, DOI 10.1177/0013916504272658; Collins TC, 1999, ANN SURG, V230, P251, DOI 10.1097/00000658-199908000-00016; Cyganska M, 2016, PROC ECON FINANC, V39, P251, DOI 10.1016/S2212-5671(16)30320-3; Donze JD, 2016, JAMA INTERN MED, V176, P496, DOI 10.1001/jamainternmed.2015.8462; Fischer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112282; Freitas A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-265; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Kastor A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196106; Kelly M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-77; Krell RW, 2014, JAMA SURG, V149, P815, DOI 10.1001/jamasurg.2014.629; Kripalani S, 2014, ANNU REV MED, V65, P471, DOI 10.1146/annurev-med-022613-090415; Kuwabara Kazuaki, 2008, Environmental Health and Preventive Medicine, V13, P130, DOI 10.1007/s12199-007-0022-9; Marshall Adele, 2005, Health Care Manag Sci, V8, P213, DOI 10.1007/s10729-005-2012-z; McIntyre D, 2006, SOC SCI MED, V62, P858, DOI 10.1016/j.socscimed.2005.07.001; Ono T, 2010, PSYCHOGERIATRICS, V10, P153, DOI 10.1111/j.1479-8301.2010.00328.x; Pirson Magali, 2006, Eur J Health Econ, V7, P55, DOI 10.1007/s10198-005-0331-0; Puentes-Rosas E, 2011, SALUD PUBLICA MEXICO, V53, pS480; Ruiz M, 2015, BMJ QUAL SAF, V24, P492, DOI 10.1136/bmjqs-2014-003467; Stausberg J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143365; WHO, GLOB HLTH EXP DAT; Williams TA, 2010, BRIT J ANAESTH, V104, P459, DOI 10.1093/bja/aeq025	25	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207203	10.1371/journal.pone.0207203	http://dx.doi.org/10.1371/journal.pone.0207203			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408118	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300090
J	Wong, JY; Chan, KYK; Chan, BKK				Wong, J. Y.; Chan, K. Y. Karen; Chan, Benny K. K.			Phylogenetic, ecological and biomechanical constraints on larval form: A comparative morphological analysis of barnacle nauplii	PLOS ONE			English	Article							R PACKAGE; SHAPE; EVOLUTION; CIRRIPEDIA; MORPHOMETRICS; DIVERSITY; CRUSTACEA; PATTERNS; SIGNAL; TEMPO	Barnacle naupliar larvae are differentiated from other zooplankton by their unique pair of frontal lateral horns, frontal filaments, and a pear-shaped cephalic shield. Their morphology impose constraints on their ecological functions and reflect their evolutionary history. To explore the potential functional basis underlying the similarities and differences in barnacle larval form, we conducted a meta-analysis on the shape of the barnacle nauplii's cephalic shield and examined its relation to larval size, trophic mode, pelagic larval duration and habitat. Nauplii cephalic shield morphology of 102 species were quantified with normalized elliptic Fourier analysis. Most of the species were distributed around the center of the morphospace but a few extreme groups occupied the periphery: nauplii that were large and lecithotrophic. Subsequent principal component regression analyses showed that larval size was a good predictor of the first shape variations axis (aspect ratio). After allometry adjustment, nauplii from different trophic modes differentiated along the second axis of the major shape variations (relative frontal horn length). Habitat was a poor predictor of variations in naupliar body form, but it could be used to differentiate extreme morphology groups from other nauplii. Our result suggests that size-related biomechanical or developmental constraints and feeding requirements are important in shaping the evolution of the naupliar body form. Within the limitations of these functional constraints, habitat drives the divergence of extreme morphology groups from the majority of species. Our comparative morphometrics analysis demonstrated how variations in larval body form can be quantitatively linked to the functional needs that constrain or drive their diversity, and inform further empirical experiments on larval functional morphology.	[Wong, J. Y.] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan; [Wong, J. Y.] Acad Sinica, Biodivers Program, Taiwan Int Grad Program, Taipei, Taiwan; [Wong, J. Y.; Chan, Benny K. K.] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Chan, K. Y. Karen] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, K. Y. Karen] Swarthmore Coll, Dept Biol, Swarthmore, PA 19081 USA	National Taiwan Normal University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Hong Kong University of Science & Technology; Swarthmore College	Chan, BKK (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan.	chankk@gate.sinica.edu.tw	Wong, Jin Yung/AHH-9789-2022	Wong, Jin Yung/0000-0002-8705-0283; Chan, Kit Yu Karen/0000-0002-7775-4383	Ministry of Science and Technology, Taiwan [106-2923-B-001-002-MY3]; Academia Sinica [AS-IA-105-L03]; Croucher Foundation; TIGP PhD Fellowship	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); Croucher Foundation; TIGP PhD Fellowship	Funding of this project is provided by Ministry of Science and Technology, Taiwan (106-2923-B-001-002-MY3; https://www.most.gov.tw/? l= en) and Academia Sinica (Senior Investigator Award; AS-IA-105-L03) to BC, and by the Croucher Foundation to KC (https://croucher.org.hk/).JW is supported by TIGP PhD Fellowship (http://tigp.sinica.edu.tw/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2014, SYST BIOL, V63, P685, DOI 10.1093/sysbio/syu030; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Bright JA, 2016, P NATL ACAD SCI USA, V113, P5352, DOI 10.1073/pnas.1602683113; Cardini A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3458; Chan BKK, 2008, J ZOOL, V275, P294, DOI 10.1111/j.1469-7998.2008.00441.x; Chan KYK, 2012, INTEGR COMP BIOL, V52, P458, DOI 10.1093/icb/ics092; Claude J, 2008, MORPHOMETRICS R; Claverie T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112732; Clay TW, 2011, MAR ECOL PROG SER, V423, P185, DOI 10.3354/meps08978; Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; EMLET RB, 1985, SCIENCE, V228, P1016, DOI 10.1126/science.228.4702.1016; EMLET RB, 1994, AM ZOOL, V34, P570; Fritz JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4700; Gignac PM, 2016, INTEGR COMP BIOL, V56, P369, DOI 10.1093/icb/icw080; Hoeg JT, 2006, INVERTEBR REPROD DEV, V49, P125, DOI 10.1080/07924259.2006.9652204; Hoeg JT, 2014, ATLAS OF CRUSTACEAN LARVAE, P104; Huang S, 2015, EVOLUTION, V69, P735, DOI 10.1111/evo.12608; Katz HR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150841; Klingenberg CP, 2008, EVOL BIOL, V35, P186, DOI 10.1007/s11692-008-9029-4; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Lai JCY, 2011, ZOOL ANZ, V250, P407, DOI 10.1016/j.jcz.2011.07.002; Laubach T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-110; Lee C, 2000, J MAR BIOL ASSOC UK, V80, P457, DOI 10.1017/S0025315400002150; Marchinko KB, 2003, ZOOLOGY, V106, P127, DOI 10.1078/0944-2006-00107; McCane B, 2013, SYST BIOL, V62, P134, DOI 10.1093/sysbio/sys080; McEdward LR, 1997, BIOL J LINN SOC, V60, P381; MILLER KM, 1994, J CRUSTACEAN BIOL, V14, P579, DOI 10.2307/1549003; Moyse J., 1987, Crustacean Issues, V5, P329; MOYSE J, 1984, ZOOL J LINN SOC-LOND, V80, P323, DOI 10.1111/j.1096-3642.1984.tb01981.x; Olesen J., FUNCTIONAL MORPHOLOG; Perez-Losada M, 2004, SYST BIOL, V53, P244, DOI 10.1080/10635150490423458; Perez-Losada M, 2008, MOL PHYLOGENET EVOL, V46, P328, DOI 10.1016/j.ympev.2007.10.004; Pernet B, 2003, BIOL BULL-US, V205, P295, DOI 10.2307/1543293; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Price SA, 2015, CORAL REEFS, V34, P997, DOI 10.1007/s00338-015-1326-7; Renaud S, 2013, HYSTRIX, V24, P85, DOI 10.4404/hystrix-24.1-6296; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Roelants K, 2011, P NATL ACAD SCI USA, V108, P8731, DOI 10.1073/pnas.1100633108; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Ross PM, 2003, J CRUSTACEAN BIOL, V23, P328, DOI 10.1651/0278-0372(2003)023[0328:AKFTIO]2.0.CO;2; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soons J, 2015, PLOS ONE, V10, P1, DOI [10.1111/evo.12729, DOI 10.1111/EVO.12729]; Stayton CT, 2015, EVOLUTION, V69, P2140, DOI 10.1111/evo.12729; TRAGER GC, 1990, MAR BIOL, V105, P117, DOI 10.1007/BF01344277; Walker G, 2004, J MAR BIOL ASSOC UK, V84, P737, DOI 10.1017/S002531540400983Xh; WALKER G, 1973, J MAR BIOL ASSOC UK, V53, P455, DOI 10.1017/S0025315400022396	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206973	10.1371/journal.pone.0206973	http://dx.doi.org/10.1371/journal.pone.0206973			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408826	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300059
J	Saadeldin, MK; Elshaer, SS; Emara, IA; Maged, M; Abdel-Aziz, AK				Saadeldin, Mona Kamal; Elshaer, Shereen Saeid; Emara, Ibrahim Ali; Maged, Mohamad; Abdel-Aziz, Amal Kamal			Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; CARDIOVASCULAR-DISEASE; CIRCULATING IRISIN; HOMEOSTASIS MODEL; MYOKINE IRISIN; BONE-FORMATION; FAT MASS; MELLITUS; ASSOCIATION; WNT	Diabetes mellitus represents a major independent risk factor for developing fatal cardiovascular diseases (CVDs) presumably through accelerating atherosclerosis; the underlying cause of most CVDs. Notably, this relative risk is reported to be higher in women than men. Endeavors directed towards identifying novel reliable predictive biomarkers are immensely thereby urged to improve the long-term outcome in these diabetic female patients. Sclerostin (SOST) is a Wnt signaling antagonist whereas irisin is a muscle-derived factor released after exercising which enhances browning of white adipose tissue. Emerging lines of evidence hint at potential crosstalk between them and CVDs. The present study aimed to assess the serum levels of SOST and irisin in Egyptian type 2 diabetic (T2DM) female patients with and without atherosclerosis and explore the possible relationship between both markers and other studied parameters among the studied cohorts. In this case-control study, 69 female subjects were enrolled; 39 type 2 diabetes patients with atherosclerosis (T2DM+ATHR), 22 type 2 diabetes patients without atherosclerosis (T2DM-ATHR) and 8 healthy controls. Their serum levels of SOST and irisin were assessed using ELISA. Significant increase in SOST levels were found in T2DM+ATHR compared to T2DM-ATHR and control (259.9 +/- 17.98 vs. 165.8 +/- 13.12 and 142.0 +/- 13.31 pg/mL respectively, P<0.001). Conversely, irisin levels were significantly lower in T2DM+ATHR (P<0.001) and T2DM-ATHR (P<0.01) compared to the control group (32.91 +/- 2.545 and 58.55 +/- 13.19 vs. 473.6 +/- 112.7 pg/mL). Interestingly, significant correlations between the levels of SOST and both irisin and fasting blood glucose were noticed in T2DM+ATHR group (r = 0.3754 and 0.3381 respectively, P<0.05). In conclusion, to the best of our knowledge, this study is the first to demonstrate the correlation between SOST and irisin levels in atherosclerotic T2DM female patients implying their potential implication in diabetic cardiovascular pathophysiology and supporting their use as reliable diagnostic/prognostic biomarkers for monitoring and preventing CVDs progression of T2DM female patients.	[Saadeldin, Mona Kamal; Elshaer, Shereen Saeid] Al Azhar Univ, Fac Pharm Girls, Dept Biochem, Cairo, Egypt; [Saadeldin, Mona Kamal; Emara, Ibrahim Ali] NIDE, Dept Biochem, Cairo, Egypt; [Saadeldin, Mona Kamal; Maged, Mohamad] October Univ Modern Sci & Arts, Fac Biotechnol, Cairo, Egypt; [Abdel-Aziz, Amal Kamal] Ain Shams Univ, Fac Pharm, Dept Pharmacol & Toxicol, Cairo, Egypt; [Abdel-Aziz, Amal Kamal] European Inst Oncol, Dept Expt Oncol, Milan, Italy	Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); National Institute of Diabetes & Endocrinology; Egyptian Knowledge Bank (EKB); Modern Sciences & Arts University (MSA); Egyptian Knowledge Bank (EKB); Ain Shams University; IRCCS European Institute of Oncology (IEO)	Saadeldin, MK; Elshaer, SS (corresponding author), Al Azhar Univ, Fac Pharm Girls, Dept Biochem, Cairo, Egypt.; Saadeldin, MK (corresponding author), NIDE, Dept Biochem, Cairo, Egypt.; Saadeldin, MK (corresponding author), October Univ Modern Sci & Arts, Fac Biotechnol, Cairo, Egypt.	m.kamal@aucegypt.edu; dr.shereen.elshaer@gmail.com	Maged, Mohamed/AAY-9724-2021; Abdel-Aziz, Amal Kamal/AAA-1360-2021; Abdel-Aziz, Amal Kamal/AAB-9050-2019; Saadeldin, Mona Kamal/W-1872-2019; EMARA, IBRAHIM/F-7800-2019; Maged, Mohamad/AAE-4190-2021	Abdel-Aziz, Amal Kamal/0000-0003-1709-1183; Saadeldin, Mona Kamal/0000-0002-2072-0975; EMARA, IBRAHIM/0000-0001-8316-1181; Maged, Mohamad/0000-0001-6967-9793				Amrein K, 2012, J CLIN ENDOCR METAB, V97, P148, DOI 10.1210/jc.2011-2152; Arasu A, 2012, J CLIN ENDOCR METAB, V97, P2027, DOI 10.1210/jc.2011-3419; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bonora E, 1997, DIABETES CARE, V20, P627, DOI 10.2337/diacare.20.4.627; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; BRAY GA, 1988, WESTERN J MED, V149, P429; Catalano A, 2014, EUR J ENDOCRINOL, V171, P293, DOI 10.1530/EJE-14-0106; Christodoulides C, 2009, TRENDS ENDOCRIN MET, V20, P16, DOI 10.1016/j.tem.2008.09.002; Colaianni G, 2016, CURR OSTEOPOROS REP, V14, P132, DOI 10.1007/s11914-016-0313-4; Colaianni G, 2015, P NATL ACAD SCI USA, V112, P12157, DOI 10.1073/pnas.1516622112; Couffinhal T, 2006, CIRC RES, V99, P1287, DOI 10.1161/01.RES.0000253139.82251.31; Didangelos A, 2010, MOL CELL PROTEOMICS, V9, P2048, DOI 10.1074/mcp.M110.001693; Garcia-Martin A, 2012, J CLIN ENDOCR METAB, V97, P234, DOI 10.1210/jc.2011-2186; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Ismail IS, 2001, DIABETIC MED, V18, P501, DOI 10.1046/j.1464-5491.2001.00494.x; Jacobs MJ, 2005, DIABETES RES CLIN PR, V70, P263, DOI 10.1016/j.diabres.2005.03.032; KANE SP, POST; Klangjareonchai T, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/261545; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Liu JJ, 2013, J DIABETES COMPLICAT, V27, P365, DOI 10.1016/j.jdiacomp.2013.03.002; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Morales-Santana S, 2013, DIABETES CARE, V36, P1667, DOI 10.2337/dc12-1691; Norhammar A, 2013, DIABETOLOGIA, V56, P1, DOI 10.1007/s00125-012-2694-y; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Novo-Rodriguez C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199504; Panati K, 2016, EUR REV MED PHARMACO, V20, P689; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Rambhade SK, 2011, SYST REV PHARM, V2, P8, DOI DOI 10.4103/0975-8453.83433; Rao M. U., 2010, International Journal of PharmTech Research, V2, P1883; Shao JS, 2005, J CLIN INVEST, V115, P1210, DOI 10.1172/JCI200524140; Sheng ZF, 2012, CLIN ENDOCRINOL, V76, P797, DOI 10.1111/j.1365-2265.2011.04315.x; Shoukry A, 2016, IUBMB LIFE, V68, P544, DOI 10.1002/iub.1511; Spiegelman BM, 2013, DIABETES, V62, P1774, DOI 10.2337/db12-1665; Szulc P, 2013, J BONE MINER RES, V28, P1760, DOI 10.1002/jbmr.1888; Thorson S, 2013, J BONE MINER RES, V28, P2008, DOI 10.1002/jbmr.1929; Tsaousi A, 2011, CIRC RES, V108, P427, DOI 10.1161/CIRCRESAHA.110.233999; Urano T, 2012, J CLIN ENDOCR METAB, V97, pE1473, DOI 10.1210/jc.2012-1218; Vijayaraghavan K, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-144; Wang XH, 2002, CIRC RES, V90, P340, DOI 10.1161/hh0302.104466; Xiang L, 2014, ATHEROSCLEROSIS, V235, P328, DOI 10.1016/j.atherosclerosis.2014.04.036; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773; Yu OHY, 2017, CLIN ENDOCRINOL, V86, P520, DOI 10.1111/cen.13300; Zhang M, 2014, EUR REV MED PHARMACO, V18, P1567; Zhang YZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158038; Zheng Y, 2018, NAT REV ENDOCRINOL, V14, P88, DOI 10.1038/nrendo.2017.151; Zhou XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep29669; Zhu DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018291	48	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206761	10.1371/journal.pone.0206761	http://dx.doi.org/10.1371/journal.pone.0206761			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403705	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500073
J	Dysthe, JC; Franklin, TW; McKelvey, KS; Young, MK; Schwart, MK				Dysthe, Joseph C.; Franklin, Thomas W.; McKelvey, Kevin S.; Young, Michael K.; Schwart, Michael K.			An improved environmental DNA assay for bull trout (Salvelinus confluentus) based on the ribosomal internal transcribed spacer I	PLOS ONE			English	Article							NUCLEAR; CHAR; SPECIFICITY; MARKER	The majority of environmental DNA (eDNA) assays for vertebrate species are based on commonly analyzed regions of the mitochondrial genome. However, the high degree of mitochondrial similarity between two species of charr (Salvelinus spp.), southern Dolly Varden (S. malma lordil) and bull trout (Salvelinus confluentus), precludes the development of a mitochondrial eDNA assay to distinguish them. Presented here is an eDNA assay to detect bull trout based on the first ribosomal internal transcribed spacer (ITSI), a nuclear marker. This assay successfully detects bull trout and avoids detecting Dolly Varden as well as brook trout (S. fontinalis), Arctic char (S. alpinus), and lake trout (S. namaycush). In addition, this assay was compared with an extensively used mitochondrial bull trout assay and it was found that the ITSI-based assay produced higher detectability. Our results suggest this assay should out-perform the published mtDNA assay across the range of bull trout, while the added specificity allows reliable bull trout detection in areas where bull trout co-occur with other charr such as Dolly Varden. While clearly a superior assay in this instance, basing assays on ITSI is not without problems. For vertebrates, there are fewer ITSI sequences available than commonly sequenced regions of the mitochondrial genome. Thus, the initial in silico screening of candidate assays must be preceded by much more extensive sampling and sequencing of sympatric or closely related taxa. Further, all copies of the internal transcribed spacers within an individual may not be identical, which can lead to complications. Lastly, the copy number for ITSI varies widely across taxa; the greater detectability associated with this assay cannot be assumed for other species.	[Dysthe, Joseph C.; Franklin, Thomas W.; McKelvey, Kevin S.; Young, Michael K.; Schwart, Michael K.] US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59808 USA	United States Department of Agriculture (USDA); United States Forest Service	Dysthe, JC (corresponding author), US Forest Serv, Natl Genom Ctr Wildlife & Fish Conservat, Rocky Mt Res Stn, Missoula, MT 59808 USA.	jdysthe@fs.fed.us		Dysthe, Joseph/0000-0002-6790-7841; Franklin, Thomas/0000-0003-1658-4664				[Anonymous], 2021, LANG ENV STAT COMP; Batovska J, 2017, G3-GENES GENOM GENET, V7, P19, DOI 10.1534/g3.116.036145; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Bylemans J, 2018, ENVIRON SCI TECHNOL, V52, P6408, DOI 10.1021/acs.est.8b01071; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Carim KJ, 2016, CONSERV GENET RESOUR, V8, P197, DOI 10.1007/s12686-016-0531-1; Carim KJ, 2016, RMRSGRR355 USDA FOR; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; COSEWIC (Committee on the Status of Endangered Wildlife in Canada), 2012, COSEWIC ASS STAT REP; Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x; Isaak D, 2009, RMRSGTR224 USDA FOR, P224; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; McKelvey KS, 2016, J FISH BIOL, V88, P1215, DOI 10.1111/jfb.12863; Minamoto T, 2017, MOL ECOL RESOUR, V17, P324, DOI 10.1111/1755-0998.12586; Piggott MP, 2016, ECOL EVOL, V6, P2739, DOI 10.1002/ece3.2083; Pleyte KA, 1992, MOL PHYLOGENET EVOL, V1, P223, DOI 10.1016/1055-7903(92)90019-D; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Redenbach Z, 2002, EVOLUTION, V56, P1021, DOI 10.1111/j.0014-3820.2002.tb01413.x; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Song JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043971; Taylor EB, 2001, CAN J FISH AQUAT SCI, V58, P406, DOI 10.1139/cjfas-58-2-406; US Fish and Wildlife Service, 2015, REC PLAN COT US POP; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Wilcox TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142008; Wilcox TM, 2014, CONSERV GENET RESOUR, V6, P283, DOI 10.1007/s12686-013-0113-4; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Wright ES, 2014, ENVIRON MICROBIOL, V16, P1354, DOI 10.1111/1462-2920.12259; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Young MK, 2017, SPECIES OCCURRENCE D, DOI [10.2737/RDS-2017-0038, DOI 10.2737/RDS-2017-0038]	30	13	13	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206851	10.1371/journal.pone.0206851	http://dx.doi.org/10.1371/journal.pone.0206851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399172	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000026
J	Ahmad, NS; Hairi, NN; Said, MA; Kamaruzzaman, SB; Choo, WY; Hairi, F; Othman, S; Ismail, N; Peramalah, D; Kandiben, S; Ali, ZM; Ahmad, SN; Razak, IA; Bulgiba, A				Ahmad, Nur Sakinah; Hairi, Noran Naqiah; Said, Mas Ayu; Kamaruzzaman, Shahrul Bahyah; Choo, Wan Yuen; Hairi, Farizah; Othman, Sajaratulnisah; Ismail, Norliana; Peramalah, Devi; Kandiben, Shathanapriya; Ali, Zainudin Mohd; Ahmad, Sharifah Nor; Razak, Inayah Abdul; Bulgiba, Awang			Prevalence, transitions and factors predicting transition between frailty states among rural community-dwelling older adults in Malaysia	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; OSTEOPOROTIC FRACTURES; ELDERLY-PEOPLE; CONCORD HEALTH; MEN PROJECT; DISABILITY; METAANALYSIS; MORTALITY; WOMEN; RISK	Objectives This study aims to describe the prevalence and transitions of frailty among rural-community dwelling older adults in Malaysia and to analyse factors associated with different states of frailty transition. Frailty was conceptualized using modified Fried phenotype from the Cardiovascular Health Study. Design This is a prospective longitudinal study with 12-months follow up among older adults in Malaysia. Setting Kuala Pilah, a district in Negeri Sembilan, which is one of the fourteen states in Malaysia. Participants 2,324 community-dwelling older Malaysians aged 60 years and older. Results The overall prevalence of frailty in this study was 9.4% (95% CI 7.8-11.2). The prevalence increased at least three-fold with every 10 years of age. This increase was seen higher in women compared to men. Being frail was significantly associated with older age, women, and respondents with a higher number of chronic diseases, poor cognitive function and low socioeconomic status (p<0.05). During the 12-months follow-up, our study showed that the transition towards greater frailty states were more likely (22.9%) than transition toward lesser frailty states (19.9%) while majority (57.2%) remained unchanged. Multivariate logistic regression analysis showed that presence of low physical activity increased the likelihood of worsening transition towards greater frailty states by three times (OR 2.9, 95% CI 2.2-3.7) and lowered the likelihood of transition towards lesser frailty states (OR 0.3, 95% CI 0.2-0.4). Conclusion Frailty is reported among one in every eleven older adults in this study. The prevalence increased across age groups and was higher among women than men. Frailty possesses a dynamic status due to its potential reversibility. This reversibility makes it a cornerstone to delay frailty progression. Our study noted that physical activity conferred the greatest benefit as a modifiable factor in frailty prevention.	[Ahmad, Nur Sakinah; Hairi, Noran Naqiah; Said, Mas Ayu; Choo, Wan Yuen; Hairi, Farizah; Peramalah, Devi; Kandiben, Shathanapriya; Bulgiba, Awang] Univ Malaya, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Kamaruzzaman, Shahrul Bahyah] Univ Malaya, Fac Med, Dept Med, Div Geriatr, Kuala Lumpur, Malaysia; [Othman, Sajaratulnisah] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Ismail, Norliana] Minist Hlth Malaysia, Tobacco Control Unit, Putrajaya, Malaysia; [Ali, Zainudin Mohd; Ahmad, Sharifah Nor; Razak, Inayah Abdul] Negeri Sembilan State Hlth Dept JKNNS, Negeri Sembilan, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Kementerian Kesihatan Malaysia	Hairi, NN (corresponding author), Univ Malaya, Ctr Epidemiol & Evidence Based Practice, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	noran@um.edu.my	AMMIKAPATHI, SHATHANAPRIYA/J-2775-2015; Kamaruzzaman, Shahrul Bahyah/Q-3189-2019; Kamaruzzaman, Shahrul Bahyah/B-9728-2010; Bulgiba, Awang/B-8271-2010; devi@ummc.edu.my, devi@ummc.edu.my/GYU-6462-2022; Hairi, Farizah MOHD/B-8497-2010; OTHMAN, SAJARATULNISAH/B-9673-2010; HAIRI, NORAN/B-9339-2010; Ayu, Mas/AAK-6870-2020; Choo, Wan Yuen/ABH-3055-2021; CHOO, WAN YUEN/B-8399-2010	Bulgiba, Awang/0000-0002-5313-0445; Hairi, Farizah MOHD/0000-0002-2582-3121; HAIRI, NORAN/0000-0002-2692-9016; Ayu, Mas/0000-0002-1341-4582; Choo, Wan Yuen/0000-0002-2644-6073; Priya, Shathana/0000-0002-7567-227X	Ministry of Higher Education High Impact Research STeMM grant [E000010-20001]; University of Malaya Grant Challenge (PEACE) [GC001A-14HTM]	Ministry of Higher Education High Impact Research STeMM grant; University of Malaya Grant Challenge (PEACE)	This study was supported primarily by the following grants: Ministry of Higher Education High Impact Research STeMM grant (E000010-20001), and the University of Malaya Grant Challenge (PEACE) (GC001A-14HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002232; [Anonymous], 2004, GERONTOLOGIE SOC, V27, P15, DOI [10.3917/gs.109.0015., DOI 10.3917/GS.109.0015]; Badrasawi M, 2017, INT J GERONTOL, V11, P154, DOI 10.1016/j.ijge.2016.07.006; Bambra C., 2009, J EPIDEMIOLOGY COMMU; Bentur N, 2016, ISR MED ASSOC J, V18, P449; Blodgett J, 2014, REV CLIN GERONTOL, V24, P239, DOI 10.1017/S0959259814000124; Blyth FM, 2008, PAIN, V140, P224, DOI 10.1016/j.pain.2008.08.011; Borrat-Besson C, 2013, Active Ageing and Solidarity between Generations in Europe: First Results from SHARE After the Economic Crisis, P175; Bortz WM, 2002, J GERONTOL A-BIOL, V57, pM283, DOI 10.1093/gerona/57.5.M283; Bouillon K., 2013, FRAILTY OLDER AGE WH; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; Castell MV, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-86; Cawthon PM, 2007, J AM GERIATR SOC, V55, P1216, DOI 10.1111/j.1532-5415.2007.01259.x; Cesari M, 2014, FRONT AGING NEUROSCI, V6, DOI [10.1016/j.jamda.2015.02.003, DOI 10.1016/J.JAMDA.2015.02.003]; Chang SF, 2015, INT J NURS STUD, V52, P1362, DOI 10.1016/j.ijnurstu.2015.04.005; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Daniels R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-278; de Vries NM, 2012, AGEING RES REV, V11, P136, DOI 10.1016/j.arr.2011.11.002; del Pozo-Cruz B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183911; Ensrud KE, 2007, J GERONTOL A-BIOL, V62, P744, DOI 10.1093/gerona/62.7.744; Espinoza SE, 2012, J AM GERIATR SOC, V60, P652, DOI 10.1111/j.1532-5415.2011.03882.x; Fedarko NS, 2011, CLIN GERIATR MED, V27, P27, DOI 10.1016/j.cger.2010.08.006; Da Mata FAF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160019; Franse CB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187946; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2006, ARCH INTERN MED, V166, P418, DOI 10.1001/.418; Gobbens RJJ, 2010, J NUTR HEALTH AGING, V14, P175, DOI 10.1007/s12603-010-0045-6; Harttgen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075847; Hirani V, 2015, J AM MED DIR ASSOC, V16, P614, DOI 10.1016/j.jamda.2015.02.014; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Institute for Public Health (IPH) MoH Malaysia, 2015, NAT HLTH MORB SURV 2; Johansen KL, 2014, AM J KIDNEY DIS, V64, P600, DOI 10.1053/j.ajkd.2014.03.016; Kelly S, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0508-2; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Kojima G, 2017, J EPIDEMIOL, V27, P347, DOI 10.1016/j.je.2016.09.008; Marchiori GF, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.1417.2905; McCaul KA, 2015, J AM MED DIR ASSOC, V16, DOI 10.1016/j.jamda.2015.02.003; McDonough P, 2001, SOC SCI MED, V52, P547, DOI 10.1016/S0277-9536(00)00159-3; Ministry of Health M, 2008, NAT HLTH POL OLD PER; Ministry of Health M, 2009, CLIN PRACT GUID MAN; Morley J., 2002, SOMETHING FRAILTY, P698; Morley JE, 2013, J AM MED DIR ASSOC, V14, P392, DOI 10.1016/j.jamda.2013.03.022; Oksuzyan A, 2010, GENDER GAP HLTH EXPE; Pachana NA, 2008, AGE AGEING, V37, P666, DOI 10.1093/ageing/afn205; Pollack LR, 2017, J AM GERIATR SOC, V65, P2473, DOI 10.1111/jgs.15003; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rogers NT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170878; Roppolo M, 2015, CLIN INTERV AGING, V10, DOI 10.2147/CIA.S92328; Sathasivam J, 2015, ASIA-PAC J PUBLIC HE, V27, p52S, DOI 10.1177/1010539515583332; Singh MAF, 2002, J GERONTOL A-BIOL, V57, pM262, DOI 10.1093/gerona/57.5.M262; Song J, 2015, AM J PUBLIC HEALTH, V105, P1439, DOI 10.2105/AJPH.2014.302540; Soytas MA, 2014, REPORTED HLTH STATUS; Syddall H, 2010, AGE AGEING, V39, P197, DOI 10.1093/ageing/afp204; Theou O, 2011, J AGING RES J AGING RES, V2011; Topinkova E, 2008, ANN NUTR METAB, V52, P6, DOI 10.1159/000115340; Travison TG, 2011, J CLIN ENDOCR METAB, V96, P2464, DOI 10.1210/jc.2011-0143; Vogel T, 2009, INT J CLIN PRACT, V63, P303, DOI 10.1111/j.1742-1241.2008.01957.x; World Health Organisation W, 2015, AG HLTH FACTS SHEET; Xue QL, 2011, CLIN GERIATR MED, V27, P1, DOI 10.1016/j.cger.2010.08.009; Yu R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101096; Yunus RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180222	63	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206445	10.1371/journal.pone.0206445	http://dx.doi.org/10.1371/journal.pone.0206445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395649	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400023
J	Chen, HM; Lee, LC; Hui, KY; Tsai, WJ; Huang, C; Tsay, HJ; Liu, HK				Chen, Han-Min; Lee, Lin-Chien; Hui, Kuang-Yu; Tsai, Wei-Jern; Huang, Cheng; Tsay, Hui-Jen; Liu, Hui-Kang			The application of post-translational modification oriented serum proteomics to assess experimental diabetes with complications	PLOS ONE			English	Article							C-REACTIVE PROTEIN; D-BINDING PROTEIN; APOLIPOPROTEIN-H; INSULIN-RESISTANCE; METABOLIC DISEASE; PLASMA-PROTEINS; FETUIN-B; MICE; MELLITUS; HUMANS	Proteome analysis of serum from type 2 diabetics with complications may lead to the discovery of diagnostic or prognostic biomarkers. To circumvent the principal barrier of serum proteomics, our investigation aimed to evaluate whether a study of post-translational modification enriched serum proteins could be valuable for the discovery of biomarkers or metabolic pathways related to type 2 diabetes pathogenesis. Type 2 diabetes was induced from high-fat diet fed Sprague Dawley rats with streptozotocin injection. Once diabetic status was confirmed, serum samples from either fasted healthy or diabetic rats were pooled and profiled by two-dimensional difference gel electrophoresis or comparative 2D electrophoresis after protein enrichments using immobilized metal ion, concanavalin A, and lentil affinity chromatography, respectively. Differential expressed proteins were identified and the associated networks were established by an Ingenuity Pathway Analysis. As a result, induced rats became severe diabetic and accompanied by hyperlipidemia, fatty liver, and glomerular hypertrophy. There were 3 total, 14 phosphorylated and 23 glycosylated protein targets differentially expressed. Proteins could be linked to HNF4A, HNF1A, and NF kappa B transcriptional factors and antigen presentation, humoral immune response, and inflammatory response pathways. Predicted organ toxicity in kidney, heart, and liver matched with our histopathological results. In conclusion, post-translational modification based serum protein enrichment could be a valuable approach to enhance the resolution of serum proteomics without depleting potentially valuable abundant proteins. Our results also indicated the potential association of the hepatic secretome and hepatocyte nuclear factors in the pathogenesis of type 2 diabetes and its complications.	[Chen, Han-Min] Fu Jen Catholic Univ, Dept Life Sci, New Taipei, Taiwan; [Lee, Lin-Chien] Cheng Hsin Gen Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Hui, Kuang-Yu] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Tsai, Wei-Jern] Minist Hlth & Welf, Div Chinese Med Literature & Informat, Natl Res Inst Chinese Med, Taipei, Taiwan; [Huang, Cheng] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei, Taiwan; [Huang, Cheng] Univ Taipei, Dept Earth & Life Sci, Taipei, Taiwan; [Tsay, Hui-Jen] Natl Yang Ming Univ, Brain Res Ctr, Sch Life Sci, Inst Neurosci, Taipei, Taiwan; [Liu, Hui-Kang] Minist Hlth & Welf, Div Basic Chinese Med, Natl Res Inst Chinese Med, Taipei, Taiwan; [Liu, Hui-Kang] Taipei Med Univ, PhD Program Clin Drug Dev Chinese Herbal Med, Taipei, Taiwan	Fu Jen Catholic University; Cheng Hsin General Hospital; National Defense Medical Center; National Research Institute of Chinese Medicine; National Yang Ming Chiao Tung University; University of Taipei; National Yang Ming Chiao Tung University; National Research Institute of Chinese Medicine; Taipei Medical University	Tsay, HJ (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Sch Life Sci, Inst Neurosci, Taipei, Taiwan.; Liu, HK (corresponding author), Minist Hlth & Welf, Div Basic Chinese Med, Natl Res Inst Chinese Med, Taipei, Taiwan.; Liu, HK (corresponding author), Taipei Med Univ, PhD Program Clin Drug Dev Chinese Herbal Med, Taipei, Taiwan.	hjtsay@ym.edu.tw; hk.liu@nricm.edu.tw		Liu, Hui-Kang/0000-0002-5297-6836	National Research Institute of Chinese Medicine, Ministry of Health and Welfare [NRICM98-DHM-04, NRICM102-DBCM05-F1]; Cheng Hsin General Hospital Foundation [CHGH106-24, CHGH107-23]	National Research Institute of Chinese Medicine, Ministry of Health and Welfare; Cheng Hsin General Hospital Foundation	This research was funded by the National Research Institute of Chinese Medicine, Ministry of Health and Welfare (NRICM98-DHM-04 to HKL and NRICM102-DBCM05-F1 to HKL), and the Cheng Hsin General Hospital Foundation (CHGH106-24 to HKL and CHGH107-23 to LCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Bhat S, 2017, EXPERT REV PROTEOMIC, V14, P677, DOI 10.1080/14789450.2017.1352473; Boucher BJ, 2011, CURR DRUG TARGETS, V12, P61; Campenhout AV, 2003, FREE RADICAL RES, V37, P1069, DOI 10.1080/10715760310001600390; Cassader M, 1997, METABOLISM, V46, P522, DOI 10.1016/S0026-0495(97)90188-8; Chen HM, 2011, CLIN BIOCHEM, V44, P377, DOI 10.1016/j.clinbiochem.2011.01.002; Chen HY, 2016, INT J FOOD SCI NUTR, V67, P400, DOI 10.3109/09637486.2016.1166187; Denecke B, 2003, BIOCHEM J, V376, P135, DOI 10.1042/BJ20030676; Di Girolamo F, 2012, BIOMARK MED, V6, P759, DOI [10.2217/bmm.12.92, 10.2217/BMM.12.92]; Doyonnas R, 2001, J EXP MED, V194, P13, DOI 10.1084/jem.194.1.13; Frolov A, 2014, ANAL BIOANAL CHEM, V406, P5755, DOI 10.1007/s00216-014-8018-y; Fujii H, 2010, AM J NEPHROL, V31, P342, DOI 10.1159/000297290; Hattersley AT, 2017, DIABETOLOGIA, V60, P769, DOI 10.1007/s00125-017-4226-2; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; Hunter SJ, 2003, DIABETES, V52, P492, DOI 10.2337/diabetes.52.2.492; Itoh N, 2007, AM J PHYSIOL-ENDOC M, V293, pE1069, DOI 10.1152/ajpendo.00182.2007; JAHNENDECHENT W, 1994, EUR J BIOCHEM, V226, P59, DOI 10.1111/j.1432-1033.1994.tb20026.x; Juan YC, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/349807; Karp NA, 2009, PROTEOMICS, V9, P388, DOI 10.1002/pmic.200800485; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; Kumar V, 2014, ROBBINS COTRAN PATHO; LAPSLEY M, 1993, J CLIN PATHOL, V46, P465, DOI 10.1136/jcp.46.5.465; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Lin CY, 2009, PROTEOMICS, V9, P696, DOI 10.1002/pmic.200700470; Loukovaara M, 2005, DIABETIC MED, V22, P434, DOI 10.1111/j.1464-5491.2005.01430.x; Macedo Maria F., 2008, Inflammation & Allergy Drug Targets, V7, P41, DOI 10.2174/187152808784165162; Martovetsky G, 2013, MOL PHARMACOL, V84, P808, DOI 10.1124/mol.113.088229; Matsumura T, 2006, BIOCHEM BIOPH RES CO, V351, P965, DOI 10.1016/j.bbrc.2006.10.137; MCMILLAN DE, 1972, DIABETES, V21, P863, DOI 10.2337/diab.21.8.863; Meex RC, 2015, CELL METAB, V22, P1078, DOI 10.1016/j.cmet.2015.09.023; Mody N, 2008, AM J PHYSIOL-ENDOC M, V294, pE785, DOI 10.1152/ajpendo.00521.2007; Pearson ER, 2018, CURR OPIN GENET DEV, V50, P68, DOI 10.1016/j.gde.2018.02.005; Perin PC, 2000, NUTR METAB CARDIOVAS, V10, P311; Rahbar S, 2005, ANN NY ACAD SCI, V1043, P9, DOI 10.1196/annals.1333.002; Refai E, 2005, P NATL ACAD SCI USA, V102, P17020, DOI 10.1073/pnas.0503219102; Resjo S, 2008, PROTEOM CLIN APPL, V2, P654, DOI 10.1002/prca.200780030; Riaz S, 2010, J PHARMACEUT BIOMED, V51, P1103, DOI 10.1016/j.jpba.2009.11.016; Rodriguez W, 2005, ARTHRITIS RHEUM-US, V52, P642, DOI 10.1002/art.20846; Rodriguez W, 2007, J IMMUNOL, V178, P530, DOI 10.4049/jimmunol.178.1.530; SEYERHANSEN K, 1983, KIDNEY INT, V23, P643, DOI 10.1038/ki.1983.71; Song YH, 1998, J BIOL CHEM, V273, P28408, DOI 10.1074/jbc.273.43.28408; SRINIVAS PR, 1993, MOL ENDOCRINOL, V7, P1445, DOI 10.1210/me.7.11.1445; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stefan N, 2013, NAT MED, V19, P394, DOI 10.1038/nm.3116; Stefan N, 2013, NAT REV ENDOCRINOL, V9, P144, DOI 10.1038/nrendo.2012.258; Thrailkill KM, 2011, J CLIN ENDOCR METAB, V96, P142, DOI 10.1210/jc.2010-0980; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Wang F, 2015, KIDNEY INT, V88, P796, DOI 10.1038/ki.2015.176; Zhang B, 2007, DIABETES, V56, P1316, DOI 10.2337/db06-1273; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zoldos V, 2012, EPIGENETICS-US, V7, P164, DOI 10.4161/epi.7.2.18918	54	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206509	10.1371/journal.pone.0206509	http://dx.doi.org/10.1371/journal.pone.0206509			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395577	Green Submitted, gold, Green Published			2022-12-26	WOS:000449291400028
J	Manna, S; Dunne, EM; Ortika, BD; Pell, CL; Kama, M; Russell, FM; Mungun, T; Mulholland, EK; Hinds, J; Satzke, C				Manna, Sam; Dunne, Eileen M.; Ortika, Belinda D.; Pell, Casey L.; Kama, Mike; Russell, Fiona M.; Mungun, Tuya; Mulholland, E. Kim; Hinds, Jason; Satzke, Catherine			Discovery of a Streptococcus pneumoniae serotype 33F capsular polysaccharide locus that lacks wcjE and contains a wcyO pseudogene	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; DISEASE; ORGANIZATION; REPLACEMENT; 11A	As part of large on-going vaccine impact studies in Fiji and Mongolia, we identified 25/2750 (0.9%) of nasopharyngeal swabs by microarray that were positive for Streptococcus pneumoniae contained pneumococci with a divergent 33F capsular polysaccharide locus (designated '33F-1'). We investigated the 33F-1 capsular polysaccharide locus to better understand the genetic variation and its potential impact on serotyping results. Whole genome sequencing was conducted on ten 33F-1 pneumococcal isolates. Initially, sequence reads were used for molecular serotyping by PneumoCaT. Phenotypic typing of 33F-1 isolates was then performed using the Quellung reaction and latex agglutination. Genome assemblies were used in phylogenetic analyses of each gene in the capsular locus to investigate genetic divergence. All ten pneumococcal isolates with the 33F-1 cps locus typed as 33F by Quellung and latex agglutination. Unlike the reference 33F capsule locus sequence, DNA microarray and PneumoCaT analyses found that 33F-1 pneumococci lack the wcjE gene, and instead contain wcyO with a frameshift mutation. Phylogenetic analyses found the wzg, wzh, wzd, wze, wchA, wciG and glf genes in the 33F-1 cps locus had higher DNA sequence similarity to homologues from other serotypes than to the 33F reference sequence. We have discovered a novel genetic variant of serotype 33F, which lacks wcjE and contains a wcyO pseudogene. This finding adds to the understanding of molecular epidemiology of pneumococcal serotype diversity, which is poorly understood in low and middle-income countries.	[Manna, Sam; Dunne, Eileen M.; Ortika, Belinda D.; Pell, Casey L.; Mulholland, E. Kim; Satzke, Catherine] Royal Childrens Hosp, Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia; [Dunne, Eileen M.; Russell, Fiona M.; Mulholland, E. Kim; Satzke, Catherine] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Kama, Mike] Minist Hlth & Med Serv, Suva, Fiji; [Russell, Fiona M.] Royal Childrens Hosp, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Mungun, Tuya] Minist Hlth, Natl Ctr Communicable Dis, Ulaanbaatar, Mongolia; [Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Hinds, Jason] St Georges Univ London, Inst Infect & Immun, London, England; [Hinds, Jason] London Biosci Innovat Ctr, BUGS Biosci, London, England; [Satzke, Catherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; Ministry of Health Mongolia; National Center for Communicable Diseases of Mongolia; University of London; London School of Hygiene & Tropical Medicine; St Georges University London; University of London; University of London Royal Veterinary College; University of Melbourne	Manna, S (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia.	sam.manna@mcri.edu.au	Manna, Sam/P-2131-2017; Dunne, Eileen M/M-3203-2019; Satzke, Catherine/D-6501-2013	Manna, Sam/0000-0002-7694-9605; Dunne, Eileen M/0000-0001-5542-0780; Hinds, Jason/0000-0002-2739-1908; Satzke, Catherine/0000-0003-3164-8849	Bill & Melinda Gates Foundation [OPP1126272, OPP1084341]; Gavi, the Vaccine Alliance; Department of Foreign Affairs and Trade of the Australian Government; Fiji Health Sector Support Program; NHMRC Career Development Fellowship; veski Inspiring Women Fellowship; Pfizer; Victorian Government's Operational Infrastructure Support Program	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Gavi, the Vaccine Alliance; Department of Foreign Affairs and Trade of the Australian Government(Australian Government); Fiji Health Sector Support Program; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); veski Inspiring Women Fellowship; Pfizer(Pfizer); Victorian Government's Operational Infrastructure Support Program	This study was supported by the Bill & Melinda Gates Foundation (OPP1126272 and OPP1084341); Gavi, the Vaccine Alliance; and the Department of Foreign Affairs and Trade of the Australian Government and Fiji Health Sector Support Program (FHSSP). CS holds a NHMRC Career Development Fellowship and a veski Inspiring Women Fellowship. SM received a Robert Austrian Research Award in Pneumococcal Vaccinology funded by Pfizer. This work was also supported by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsells E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177113; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Brady AM, 2014, J INFECT DIS, V210, P1155, DOI 10.1093/infdis/jiu195; Bush CA, CHEM STRUCTURES STRE, DOI [10.1128/JB.01731-14, DOI 10.1128/JB.01731-14]; Calix JJ, 2014, J CLIN MICROBIOL, V52, P758, DOI 10.1128/JCM.02695-13; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Geno KA, 2017, J CLIN MICROBIOL, V55, P2775, DOI 10.1128/JCM.00822-17; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; Habib M, 2014, JOVE-J VIS EXP, DOI 10.3791/51208; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Kapatai G, 2016, PEERJ, V4, DOI 10.7717/peerj.2477; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LEVINSON G, 1987, MOL BIOL EVOL, V4, P203; Manna S, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.06.031; Mavroidi A, 2007, J BACTERIOL, V189, P7841, DOI 10.1128/JB.00836-07; McFetridge R, 2015, VACCINE, V33, P2793, DOI 10.1016/j.vaccine.2015.04.025; Mulholland K, 2012, LANCET, V379, P1387, DOI 10.1016/S0140-6736(12)60588-1; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ortika Belinda D, 2013, BMC Res Notes, V6, P49, DOI 10.1186/1756-0500-6-49; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Porter BD, 2014, JOVE-J VIS EXP, DOI 10.3791/51747; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Satzke C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001903; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Sorensen UBS, 2016, MBIO, V7, DOI 10.1128/mBio.01844-16; Spencer BL, 2017, INFECT IMMUN, V85, DOI 10.1128/IAI.00132-17; van Tonder AJ, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000090; Weinberger DM, 2011, LANCET, V378, P1962, DOI 10.1016/S0140-6736(10)62225-8	30	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206622	10.1371/journal.pone.0206622	http://dx.doi.org/10.1371/journal.pone.0206622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395578	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000449291400036
J	Lehmann, S; Linder, N; Retschlag, U; Schaudinn, A; Stange, R; Garnov, N; Dietrich, A; Oberbach, A; Kahn, T; Busse, H				Lehmann, Stefanie; Linder, Nicolas; Retschlag, Ulf; Schaudinn, Alexander; Stange, Roland; Garnov, Nikita; Dietrich, Arne; Oberbach, Andreas; Kahn, Thomas; Busse, Harald			MRI assessment of changes in adipose tissue parameters after bariatric surgery	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; Y GASTRIC BYPASS; BODY-COMPOSITION; RELAXATION-TIMES; IN-VIVO; 3.0 T; QUANTIFICATION; BROWN; SENSITIVITY; WOMEN	Bariatric surgery and other therapeutic options for obese patients are often evaluated by the loss of weight, reduction of comorbidities or improved quality of life. However, little is currently known about potential therapy-related changes in the adipose tissue of obese patients. The aim of this study was therefore to quantify fat fraction (FF) and T1 relaxation time by magnetic resonance imaging (MRI) after Roux-en-Y gastric bypass surgery and compare the resulting values with the preoperative ones. Corresponding MRI data were available from 23 patients (16 females and 7 males) that had undergone MRI before (M0) and one month after (M1) bariatric surgery. Patients were 22-59 years old (mean age 44.3 years) and their BMI ranged from 35.7-54.6 kg/m(2) (mean BMI 44.6 kg/m(2)) at M0. Total visceral AT volumes (VVAT-T, in L) were measured by semi-automatic segmentation of axial MRI images acquired between diaphragm and femoral heads. MRI FF and T1 relaxation times were measured in well-defined regions of visceral (VAT) and subcutaneous (SAT) adipose tissue using two custom-made analysis tools. Average BMI values were 45.4 kg/m(2) at time point M0 and 42.4 kg/m(2) at M1. Corresponding VVAT-T values were 5.94 L and 5.33 L. Intraindividual differences in both BMI and VVAT-T were highly significant (p<0.001). Average relaxation times T1 VAT were 303.7 ms at M0 and 316.9 ms at M1 (p<0.001). Corresponding T1(SAT) times were 283.2 ms and 280.7 ms (p = 0.137). Similarly, FFVAT differences (M0: 85.7%, M1: 83.4%) were significant (p <0.01) whereas FFSAT differences (M0: 86.1, M1: 85.9%) were not significant (p = 0.517). In conclusion, bariatric surgery is apparently not only related to a significant reduction in common parameters of adipose tissue distribution, here BMI and total visceral fat volume, but also significant changes in T1 relaxation time and fat fraction of visceral adipose tissue. Such quantitative MRI measures may potentially serve as independent biomarkers for longitudinal and cross-sectional measurements in obese patients.	[Lehmann, Stefanie; Linder, Nicolas; Retschlag, Ulf; Stange, Roland; Garnov, Nikita; Dietrich, Arne] Univ Leipzig, Med Ctr, Integrated Res & Treatment Ctr IFB Adipos Dis, Leipzig, Germany; [Lehmann, Stefanie; Oberbach, Andreas] Fraunhofer Inst Cell Therapy & Immunol, Dept Diagnost, Leipzig, Germany; [Linder, Nicolas; Schaudinn, Alexander; Stange, Roland; Garnov, Nikita; Kahn, Thomas; Busse, Harald] Leipzig Univ Hosp, Dept Diagnost & Intervent Radiol, Leipzig, Germany; [Dietrich, Arne] Leipzig Univ Hosp, Dept Visceral Transplantat Thorac & Vasc Surg, Sect Bariatr Surg, Leipzig, Germany; [Oberbach, Andreas] Ludwig Maximilians Univ Munchen, Dept Cardiac Surg, Munich, Germany	Leipzig University; Fraunhofer Gesellschaft; Leipzig University; Leipzig University; University of Munich	Busse, H (corresponding author), Leipzig Univ Hosp, Dept Diagnost & Intervent Radiol, Leipzig, Germany.	harald.busse@medizin.uni-leipzig.de			Federal Ministry of Education and Research (BMBF), Germany [1EO1001]	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	Grant support by the Federal Ministry of Education and Research (BMBF), Germany (#1EO1001) is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvehus M, 2012, CLIN ENDOCRINOL, V77, P684, DOI 10.1111/j.1365-2265.2011.04322.x; Alves MG, 2017, BBA CLIN, V8, P1, DOI 10.1016/j.bbacli.2017.05.001; Andersson DP, 2014, DIABETES CARE, V37, P1831, DOI 10.2337/dc13-2395; Bluher M, 2015, INTERNIST, V56, P143, DOI 10.1007/s00108-014-3534-6; Bluhre M, 2009, EXP CLIN ENDOCR DIAB, V117, P241, DOI 10.1055/s-0029-1192044; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Gaborit B, 2012, J AM COLL CARDIOL, V60, P1381, DOI 10.1016/j.jacc.2012.06.016; Garnov N, 2014, NMR BIOMED, V27, P1123, DOI 10.1002/nbm.3166; Hamilton G, 2011, J MAGN RESON IMAGING, V34, P468, DOI 10.1002/jmri.22623; Heath ML, 2009, METABOLISM, V58, P753, DOI 10.1016/j.metabol.2008.05.021; Hu HCH, 2013, J MAGN RESON IMAGING, V38, P885, DOI 10.1002/jmri.24053; Hu HH, 2013, AM J ROENTGENOL, V200, P177, DOI 10.2214/AJR.12.8996; Kang BK, 2012, INVEST RADIOL, V47, P368, DOI 10.1097/RLI.0b013e31824baff3; Leporq B, 2014, NMR BIOMED, V27, P1211, DOI 10.1002/nbm.3175; Lundbom J, 2013, INT J OBESITY, V37, P620, DOI 10.1038/ijo.2012.72; Lundbom J, 2010, NMR BIOMED, V23, P466, DOI 10.1002/nbm.1483; Maghrabi AH, 2015, OBESITY, V23, P2344, DOI 10.1002/oby.21150; Olbers T, 2006, ANN SURG, V244, P715, DOI 10.1097/01.sla.0000218085.25902.f8; Otto M, 2016, OBES SURG, V26, P479, DOI 10.1007/s11695-015-1792-6; Otto M, 2015, OBES SURG, V25, P302, DOI 10.1007/s11695-014-1382-z; Peterson P, 2013, MAGN RESON MED, V69, P688, DOI 10.1002/mrm.24297; Poitou C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125718; Schaudinn A, 2015, NMR BIOMED, V28, P583, DOI 10.1002/nbm.3286; Schauer PR, 2014, NEW ENGL J MED, V370, P2002, DOI [10.1056/NEJMoa1401329, 10.1056/NEJMc1407393]; Sovik TT, 2011, ANN INTERN MED, V155, P281, DOI 10.7326/0003-4819-155-5-201109060-00005; Thormer G, 2013, J MAGN RESON IMAGING, V37, P1144, DOI 10.1002/jmri.23890; Toro-Ramos T, 2015, OBESITY, V23, P62, DOI 10.1002/oby.20932; Wang XK, 2016, MAGN RESON MED, V75, P845, DOI 10.1002/mrm.25681	28	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206735	10.1371/journal.pone.0206735	http://dx.doi.org/10.1371/journal.pone.0206735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388152	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800054
J	Hayashi, N; Furue, Y; Kai, D; Yamada, N; Yamamoto, H; Nakano, T; Oda, M				Hayashi, Naoki; Furue, Yui; Kai, Daichi; Yamada, Noriteru; Yamamoto, Hirofumi; Nakano, Takashi; Oda, Masataka			Sulfated vizantin suppresses mucin layer penetration dependent on the flagella motility of Pseudomonas aeruginosa PAO1	PLOS ONE			English	Article							INFECTIONS; PATHOGENESIS; GENES	Pseudomonas aeruginosa is an opportunistic pathogen that causes severe infections, such as pneumonia and bacteremia. Several studies demonstrated that flagellar motility is an important virulence factor for P. aeruginosa infection. In this study, we determined whether sulfated vizantin affects P. aeruginosa flagellar motility in the absence of direct antimicrobial activity. We found that 100 mu M sulfated vizantin suppressed P. aeruginosa PAO1 from penetrating through an artificial mucin layer by affecting flagellar motility, although it did not influence growth nor bacterial protease activity. To further clarify the mechanism in which sulfated vizantin suppresses the flagellar motility of P. aeruginosa PAO1, we examined the effects of sulfated vizantin on the composition of the flagellar filament and mRNA expression of several flagella-related genes, finding that sulfated vizantin did not influence the composition of the flagellar complex (fliC, motA, and motB) in P. aeruginosa PAO1, but significantly decreased mRNA expression of the chemotaxis-related genes cheR1, cheW, and cheZ. These results indicated that sulfated vizantin is an effective inhibitor of flagellar motility in P. aeruginosa.	[Hayashi, Naoki; Furue, Yui; Kai, Daichi; Yamada, Noriteru; Oda, Masataka] Kyoto Pharmaceut Univ, Dept Microbiol & Infect Control Sci, Kyoto, Japan; [Yamamoto, Hirofumi] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Chem & Funct Mol, Tokushima, Japan; [Nakano, Takashi] Osaka Med Coll, Dept Microbiol & Infect Control, Osaka, Japan	Kyoto Pharmaceutical University; Tokushima Bunri University; Osaka Medical College	Oda, M (corresponding author), Kyoto Pharmaceut Univ, Dept Microbiol & Infect Control Sci, Kyoto, Japan.	moda@mb.kyoto.phu.ac.jp	Oda, Masataka/ABG-6047-2020		Japan society for the promotion of science (JSPS) KAKENHI [18H02657, 15H05017, 16K19129, 26860295]; Ministry of Education, Culture, Sports, Science and Technology (MEXT); Takeda Science Foundation; Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research	Japan society for the promotion of science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research	This research was funded by the Japan society for the promotion of science (JSPS) KAKENHI Grant Numbers 18H02657 and 15H05017 suppported to MO, https://www.jsps.go.jp/english/index.html; JSPS KAKENHI Grant Numbers 16K19129 and 26860295 supported to NH, https://www.jsps.go.jp/english/index.html; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Supported Program for the Strategic Research Foundation at Private Universities, Japan, 2013-2017 supported to MO, http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm; Takeda Science Foundation supported to MO, http://www.takeda-sci.or.jp/business/abroad_e.html; and Kyoto Pharmaceutical University Fund for the Promotion of Scientific Research supported to NH, https://www.kyoto-phu.ac.jp/english/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Bjarnsholt T, 2007, ANAL BIOANAL CHEM, V387, P409, DOI 10.1007/s00216-006-0774-x; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Bren A, 2000, J BACTERIOL, V182, P6865, DOI 10.1128/JB.182.24.6865-6873.2000; Campodonico VL, 2010, INFECT IMMUN, V78, P746, DOI 10.1128/IAI.00806-09; Croft L, 2000, MICROBIOL-SGM, V146, P2351, DOI 10.1099/00221287-146-10-2351; Doring G, 2007, P NATL ACAD SCI USA, V104, P11020, DOI 10.1073/pnas.0702403104; Doyle TB, 2004, J BACTERIOL, V186, P6341, DOI 10.1128/JB.186.19.6341-6350.2004; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Ferrandez A, 2002, J BACTERIOL, V184, P4374, DOI 10.1128/JB.184.16.4374-4383.2002; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Hatano Kazuo, 1996, J Infect Chemother, V2, P240, DOI 10.1007/BF02355121; Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0; Hayashi N, 2017, FRONT CELL INFECT MI, V7, DOI [10.3389/fcimb.7017.00/115, 10.3389/fcimb.2017.00415]; Hayashi N, 2013, J INFECT CHEMOTHER, V19, P305, DOI 10.1007/s10156-013-0554-4; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Klockgether Jens, 2017, F1000Res, V6, P1261, DOI 10.12688/f1000research.10506.1; LEIFSON E, 1951, J BACTERIOL, V62, P377, DOI 10.1128/JB.62.4.377-389.1951; Liu YY, 2016, LANCET INFECT DIS, V16, P161, DOI 10.1016/S1473-3099(15)00424-7; Manfredi R, 2000, EUR J EPIDEMIOL, V16, P111, DOI 10.1023/A:1007626410724; Markou P, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00115; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Nilsson E, 2007, J CHROMATOGR B, V856, P75, DOI 10.1016/j.jchromb.2007.05.029; O'Driscoll NH, 2018, ARCH MICROBIOL, V200, P793, DOI 10.1007/s00203-018-1485-3; Oda M, 2018, MICROBIOL IMMUNOL, V62, P310, DOI 10.1111/1348-0421.12589; Oda M, 2014, J IMMUNOL, V193, P4507, DOI 10.4049/jimmunol.1401796; Okumura R, 2016, NATURE, V532, P117, DOI 10.1038/nature17406; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Sabharwal N, 2016, INT J MED MICROBIOL, V306, P29, DOI 10.1016/j.ijmm.2015.11.002; Sampedro I, 2015, FEMS MICROBIOL REV, V39, P17, DOI 10.1111/1574-6976.12081; Sana TG, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00061; Schmidt J, 2011, PLOS ONE, V6; Shikata M, 2016, J INFECT CHEMOTHER, V22, P216, DOI 10.1016/j.jiac.2015.12.012; Stefani S, 2017, INT J MED MICROBIOL, V307, P353, DOI 10.1016/j.ijmm.2017.07.004; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Veesenmeyer JL, 2009, CRIT CARE MED, V37, P1777, DOI 10.1097/CCM.0b013e31819ff137; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Yamamoto H, 2016, CHEM PHARM BULL, V64, P246, DOI 10.1248/cpb.c15-00828; Yamamoto H, 2013, J MED CHEM, V56, P381, DOI 10.1021/jm3016443	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206696	10.1371/journal.pone.0206696	http://dx.doi.org/10.1371/journal.pone.0206696			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383847	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600085
J	Wang, LH; Zhang, ZY; Yu, XD; Huang, X; Liu, Z; Chai, YH; Yang, L; Wang, Q; Li, M; Zhao, J; Hou, J; Li, F				Wang, Lianghai; Zhang, Zhiyu; Yu, Xiaodan; Huang, Xuan; Liu, Zheng; Chai, Yuhang; Yang, Lei; Wang, Qian; Li, Man; Zhao, Jin; Hou, Jun; Li, Feng			Unbalanced YAP-SOX9 circuit drives stemness and malignant progression in esophageal squamous cell carcinoma	ONCOGENE			English	Article							YAP; SOX9; TAZ; EXPRESSION; PATHWAY; SUPPRESSES; PROLIFERATION; ACTIVATION; LANDSCAPE; ONCOGENE	Yes-associated protein (YAP) has been identified as a key regulator of tissue homeostasis. However, the precise role and regulatory mechanism of YAP in esophageal squamous cell carcinoma (ESCC) remains unclear. Here we report that the genetic or pharmacological inhibition of YAP repressed cancer stem cell (CSC)-like properties, including tumorsphere-forming potential, cell motility, and chemoresistance in vitro, and was sufficient to attenuate tumor growth and CSC marker expression in ESCC xenografts. Mechanistically, YAP transcriptionally activated its downstream target SOX9 via TEAD1-mediated binding. We also observed a positive correlation between YAP signaling and SOX9 expression in two independent clinical cohorts. Intriguingly, YAP-targeting microRNAs, including miR-506-3p, which were induced by SOX9, post-transcriptionally repressed YAP expression, contributing to a negative feedback mechanism. Dual inhibition of YAP and SOX9 robustly suppressed malignant phenotypes. Notably, ESCC samples from The Cancer Genome Atlas (TCGA) dataset had frequent (44%) instances of YAP gene amplification and genetic inactivation of Hippo pathway regulators. Nuclear YAP expression was elevated in 197 ESCC tissues from a Chinese cohort. Together, our findings provide evidence that genetic hyperactivation of YAP unbalances the YAP-SOX9 feedback loop and confers CSC-like features in ESCC, suggesting that this YAP-SOX9 circuit represents a potential therapeutic target.	[Wang, Lianghai; Zhang, Zhiyu; Yu, Xiaodan; Chai, Yuhang; Wang, Qian; Li, Man; Zhao, Jin; Hou, Jun; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol Immunol, Shihezi, Xinjiang, Peoples R China; [Wang, Lianghai; Zhang, Zhiyu; Yu, Xiaodan; Chai, Yuhang; Wang, Qian; Li, Man; Zhao, Jin; Hou, Jun; Li, Feng] Shihezi Univ, Sch Med, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Zhang, Zhiyu; Huang, Xuan; Liu, Zheng; Yang, Lei; Li, Feng] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China; [Zhang, Zhiyu; Huang, Xuan; Liu, Zheng; Yang, Lei; Li, Feng] Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China; [Wang, Lianghai] Cornell Univ, Dept Biomed Sci, Ithaca, NY USA; [Yu, Xiaodan] Shihezi Univ, Affiliated Hosp 1, Dept Stomatol, Sch Med, Shihezi, Peoples R China	Shihezi University; Shihezi University; Capital Medical University; Capital Medical University; Cornell University; Shihezi University	Hou, J; Li, F (corresponding author), Shihezi Univ, Sch Med, Dept Pathol Immunol, Shihezi, Xinjiang, Peoples R China.; Hou, J; Li, F (corresponding author), Shihezi Univ, Sch Med, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.; Li, F (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China.; Li, F (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Med Res Ctr, Beijing, Peoples R China.	houjun229@163.com; lifeng7855@126.com	YANG, LEI/GQH-4271-2022	Wang, Lianghai/0000-0003-3128-7780	National Natural Science Foundation of China [81460416, 81560399, 81602810]; Ministry of Science and Technology of China [2012AA02A503]; State Scholarship Foundation of China [201608650002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Scholarship Foundation of China	This work was supported by the National Natural Science Foundation of China (No. 81460416, 81560399, 81602810), the Ministry of Science and Technology of China (2012AA02A503), and the State Scholarship Foundation of China (201608650002).	Ciamporcero E, 2016, ONCOGENE, V35, P1541, DOI 10.1038/onc.2015.219; Deng J, 2015, TUMOR BIOL, V36, P6823, DOI 10.1007/s13277-015-3364-8; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galuppini F, 2017, VIRCHOWS ARCH, V471, P651, DOI 10.1007/s00428-017-2227-7; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hayashi H, 2015, CANCER RES, V75, P4985, DOI 10.1158/0008-5472.CAN-15-0291; He C, 2015, ONCOGENE, V34, P6040, DOI 10.1038/onc.2015.52; Hu N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1919-0; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Jiang YQ, 2010, ANN THORAC SURG, V90, P908, DOI 10.1016/j.athoracsur.2010.05.060; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Liu CG, 2016, HEPATOLOGY, V64, P117, DOI 10.1002/hep.28509; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Muramatsu T, 2011, CARCINOGENESIS, V32, P389, DOI 10.1093/carcin/bgq254; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sawada G, 2016, GASTROENTEROLOGY, V150, P1171, DOI 10.1053/j.gastro.2016.01.035; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shi ZC, 2015, NUCLEIC ACIDS RES, V43, P6257, DOI 10.1093/nar/gkv568; Slemmons KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140781; Song SM, 2014, CANCER RES, V74, P4170, DOI 10.1158/0008-5472.CAN-13-3569; Song YM, 2014, NATURE, V509, P91, DOI 10.1038/nature13176; Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936; Stein C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005465; Tanaka K, 2017, CANCER LETT, V385, P215, DOI 10.1016/j.canlet.2016.10.020; Varelas X, 2014, DEVELOPMENT, V141, P1614, DOI 10.1242/dev.102376; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Wang LH, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0658-2; Wang LH, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0065-x; Xu J, 2018, J CELL BIOCHEM, V119, P2492, DOI 10.1002/jcb.26343; Yeo MK, 2012, ANTICANCER RES, V32, P3835; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang SK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1096-1	41	57	57	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 21	2019	38	12					2042	2055		10.1038/s41388-018-0476-9	http://dx.doi.org/10.1038/s41388-018-0476-9			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HP6UR	30401982	Green Published, hybrid			2022-12-26	WOS:000461822600004
J	Wei, CY; Zhu, MX; Lu, NH; Peng, R; Yang, X; Zhang, PF; Wang, L; Gu, JY				Wei, Chuan-Yuan; Zhu, Meng-Xuan; Lu, Nan-Hang; Peng, Rui; Yang, Xuan; Zhang, Peng-Fei; Wang, Lu; Gu, Jian-Ying			Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma	ONCOGENE			English	Article							INTEGRATIVE ANALYSIS; AKT; IDENTIFICATION; FACILITATORS; SUPERFAMILY; PROGRESSION; PATHWAYS; PROTEINS; CANCER	Although recent therapeutic advances based on our understanding of molecular phenomena have prolonged the survival of melanoma patients, the prognosis of melanoma remains dismal and further understanding of the underlying mechanism of melanoma progression is needed. In this study, differential expression analyses revealed that many genes, including AKT1 and CDK2, play important roles in melanoma. Functional analyses of differentially expressed genes (DEGs), obtained from the GEO (Gene Expression Omnibus) database, indicated that high proliferative and metastatic abilities are the main characteristics of melanoma and that the PI3K and MAPK pathways play essential roles in melanoma progression. Among these DEGs, major facilitator superfamily domain-containing 12 (MFSD12) was found to have significantly and specifically upregulated expression in melanoma, and elevated MFSD12 level promoted cell proliferation by promoting cell cycle progression. Mechanistically, MFSD12 upregulation was found to activate PI3K signaling, and a PI3K inhibitor reversed the increase in cell proliferation endowed by MFSD12 upregulation. Clinically, high MFSD12 expression was positively associated with shorter overall survival (OS) and disease-free survival (DFS) in melanoma patients, and MFSD12 was an independent prognostic factor for OS and DFS in melanoma patients. Therapeutically, in vivo assays further confirmed that MFSD12 interference inhibited tumor growth and lung metastasis in melanoma. In conclusion, elevated MFSD12 expression promotes melanoma cell proliferation, and MFSD12 is a valuable prognostic biomarker and promising therapeutic target in melanoma.	[Wei, Chuan-Yuan; Lu, Nan-Hang; Wang, Lu; Gu, Jian-Ying] Fudan Univ, Zhongshan Hosp, Dept Plast Surg, Shanghai 200032, Peoples R China; [Wei, Chuan-Yuan; Zhu, Meng-Xuan; Peng, Rui; Yang, Xuan; Zhang, Peng-Fei] Fudan Univ, Minist Educ, Key Lab Carcinogenesis & Canc Invas, Liver Canc Inst,Zhongshan Hosp, Shanghai 200032, Peoples R China	Fudan University; Fudan University	Gu, JY (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Plast Surg, Shanghai 200032, Peoples R China.	zhongshanhospital@163.com			Scientific Research Fund of Zhongshan Hospital, Fudan University [2016ZSFZ62]; National Natural Science Foundation of China [G2016-023]; Science and Technology Committee of Shanghai [14DZ1940304]	Scientific Research Fund of Zhongshan Hospital, Fudan University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Committee of Shanghai(Shanghai Science & Technology Committee)	This study was funded by the Scientific Research Fund of Zhongshan Hospital, Fudan University (2016ZSFZ62), the National Natural Science Foundation of China (G2016-023), and the Science and Technology Committee of Shanghai (14DZ1940304).	Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Augustin R, 2010, IUBMB LIFE, V62, P315, DOI 10.1002/iub.315; Berger M, 2018, GIORN ITAL DERMAT V, V153, P349, DOI 10.23736/S0392-0488.18.05970-9; Bi DB, 2015, COMPUT BIOL CHEM, V56, P71, DOI 10.1016/j.compbiolchem.2015.04.001; Cai JB, 2015, HEPATOLOGY, V61, P1603, DOI 10.1002/hep.27682; Chen YL, 2017, INT J ONCOL, V51, P1280, DOI 10.3892/ijo.2017.4092; Crawford NG, 2017, SCIENCE, V358, P1; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096860; Kanda M, 2016, ONCOTARGET, V7, P13667, DOI 10.18632/oncotarget.7269; Kang Q, 2017, J CLIN PATHOL, V70, P677, DOI 10.1136/jclinpath-2016-204251; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Khunlertgit N, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1224-1; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Namiki T, 2015, CANCER RES, V75, P2708, DOI 10.1158/0008-5472.CAN-13-3209; Park J, 2017, CANCER IMMUNOL RES, V5, P618, DOI 10.1158/2326-6066.CIR-17-0051; Peng JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep46577; Peng R, 2018, CANCER MED-US, V7, P796, DOI 10.1002/cam4.1313; Rajabi Parvin, 2017, Adv Biomed Res, V6, P14, DOI 10.4103/2277-9175.200789; Rebelo TM, 2018, EXP CELL RES, V368, P1, DOI 10.1016/j.yexcr.2018.04.003; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Shi GM, 2008, J CANCER RES CLIN, V134, P1155, DOI 10.1007/s00432-008-0407-1; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Spinola M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-62; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tazzari PL, 2004, BRIT J HAEMATOL, V126, P675, DOI 10.1111/j.1365-2141.2004.05121.x; Wang L, 2016, ONCOTARGET, V7, P3791, DOI 10.18632/oncotarget.6302; Wang SC, 2014, TRENDS PHARMACOL SCI, V35, P178, DOI 10.1016/j.tips.2014.02.004; Wei CY, 2018, ONCOL REP, V39, P2553, DOI 10.3892/or.2018.6356; Xing ZH, 2016, BBA-GEN SUBJECTS, V1860, P2725, DOI 10.1016/j.bbagen.2016.01.012; Xu ZZ, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0840-y	38	29	30	4	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1876	1891		10.1038/s41388-018-0531-6	http://dx.doi.org/10.1038/s41388-018-0531-6			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30385854	Green Published, hybrid			2022-12-26	WOS:000461164400007
J	Igarashi, M; Watanabe, K; Tsuduki, T; Kimura, I; Kubota, N				Igarashi, Miki; Watanabe, Kazuhide; Tsuduki, Tsuyoshi; Kimura, Ikuo; Kubota, Naoto			NAPE-PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells	FASEB JOURNAL			English	Article						NAPE-PLD; Caco-2; fatty acid ethanolamide	N-ACYL-PHOSPHATIDYLETHANOLAMINE; HYDROLYZING ACID AMIDASE; GENE-EXPRESSION; FOOD-INTAKE; MOLECULAR CHARACTERIZATION; ANANDAMIDE; CACO-2; ACYLETHANOLAMINES; BIOSYNTHESIS; MECHANISMS	Oleoylethanolamide (OEA), a fatty acid ethanolamide (FAE), is a lipid mediator that controls food intake and lipid metabolism. Accumulating data imply the importance of intestinal OEA in controlling satiety in addition to gastrointestinal peptide hormones. Although the biochemical pathway of FAE production has been illustrated, the enzymes responsible for the cleavage of OEA from its precursor N-acyl-phosphatidylethanolamine (NAPE) must be identified among reported candidates in the gut. In this study, we assessed the involvement of NAPE-specific phospholipase D (NAPE-PLD), which can directly release FAEs from NAPE, in intestinal OEA synthesis and lipid metabolism. Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPER-associated protein 9 (Cas9)-mediated deletion of the NAPE-PLD gene in intestinal epithelial-like Caco-2 cells reduced OEA levels, regardless of their differentiation states. Transcriptome analysis revealed that deletion of NAPE-PLD activates a transcriptional program for nutrient transportation, including lipids and lipoproteins, and inactivates cell-cycle or mitosis-related genes in Caco-2 cells. In addition, the basolateral secretion of lipoproteins was increased in NAPE-PLD-deleted cells although lipoprotein size was not affected. By contrast, cellular lipid levels were reduced in NAPE-PLD-deleted cells. Overall, these results indicate that NAPE-PLD plays important roles in OEA synthesis and fat absorption by regulating lipoprotein production in the intestinal epithelial cells.Igarashi, M., Watanabe, K., Tsuduki, T., Kimura, I., Kubota, N. NAPE-PLD controls OEA synthesis and fat absorption by regulating lipoprotein synthesis in an in vitro model of intestinal epithelial cells.	[Igarashi, Miki; Kimura, Ikuo] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, 3-5-8 Saiwai, Fuchu, Tokyo 1838509, Japan; [Igarashi, Miki; Watanabe, Kazuhide; Kubota, Naoto] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr Sci, Dept Biosci & Biotechnol Future Bioind, Sendai, Miyagi, Japan; [Kubota, Naoto] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo, Japan; [Kubota, Naoto] Univ Tokyo, Dept Clin Nutr Therapy, Tokyo, Japan; [Kubota, Naoto] Natl Inst Hlth & Nutr, Dept Clin Nutr, Tokyo, Japan; [Igarashi, Miki] Tokyo Univ Agr & Technol, Tokyo, Japan	Tokyo University of Agriculture & Technology; RIKEN; Tohoku University; University of Tokyo; University of Tokyo; National Institute of Health & Nutrition - Japan; Tokyo University of Agriculture & Technology	Igarashi, M (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Appl Biol Sci, 3-5-8 Saiwai, Fuchu, Tokyo 1838509, Japan.	mikiigarashi@go.tuat.ac.jp	Watanabe, Kazuhide/C-9667-2017; Tsuduki, Tsuyoshi/T-2697-2019; Kimura, Ikuo/B-4193-2015	Watanabe, Kazuhide/0000-0002-5331-0593; Tsuduki, Tsuyoshi/0000-0001-7810-0528; 	Japan Society for the Promotion of Science [17K07809]; Kao Research Council for the Study of Healthcare Science; Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kao Research Council for the Study of Healthcare Science; Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution	The authors thank Dr. Tatsuya Sugawara (Kyoto University, Kyoto, Japan) for help in drafting the manuscript. The authors also thank Ms. Kumiko Tachikawa (Tokyo University of Agriculture and Technology, Tokyo, Japan) for excellent technical assistance. This research was supported by Grants-in-Aid for Scientific Research (KAKENHI), the Japan Society for the Promotion of Science 17K07809 (to M.I.), the Kao Research Council for the Study of Healthcare Science (2016) (to M.I.), and the Project of the National Agriculture and Food Research Organization (NARO) Bio-oriented Technology Research Advancement Institution (advanced integration research for agriculture and interdisciplinary fields) (to M.I. and T.T.). The authors declare no conflicts of interest.	Boger DL, 2000, BIOORG MED CHEM LETT, V10, P2613, DOI 10.1016/S0960-894X(00)00528-X; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fu J, 2008, AM J PHYSIOL-REG I, V295, pR45, DOI 10.1152/ajpregu.00126.2008; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Gaetani S, 2003, NEUROPSYCHOPHARMACOL, V28, P1311, DOI 10.1038/sj.npp.1300166; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; Grimaldi C, 2006, EXP CELL RES, V312, P363, DOI 10.1016/j.yexcr.2005.10.024; Guijarro A, 2010, PHARMACOL RES, V61, P27, DOI 10.1016/j.phrs.2009.09.003; Hasegawa A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-144; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Igarashi M, 2004, J NUTR SCI VITAMINOL, V50, P121, DOI 10.3177/jnsv.50.121; Igarashi M, 2015, BBA-MOL CELL BIOL L, V1851, P1218, DOI 10.1016/j.bbalip.2015.05.006; Inoue M, 2017, J BIOCHEM, V162, P449, DOI 10.1093/jb/mvx054; Joseph J, 2004, CANCER IMMUNOL IMMUN, V53, P723, DOI 10.1007/s00262-004-0509-9; Karwad MA, 2017, FASEB J, V31, P3267, DOI 10.1096/fj.201601346R; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Leung D, 2006, BIOCHEMISTRY-US, V45, P4720, DOI 10.1021/bi060163l; LEVY E, 1995, FASEB J, V9, P626, DOI 10.1096/fasebj.9.8.7768354; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Linsalata M, 2010, ANTICANCER RES, V30, P2583; Liu J, 2008, NEUROPHARMACOLOGY, V54, P1, DOI 10.1016/j.neuropharm.2007.05.020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord CC, 2013, BBA-MOL CELL BIOL L, V1831, P792, DOI 10.1016/j.bbalip.2013.01.002; MAKRIDES M, 1994, AM J CLIN NUTR, V60, P189, DOI 10.1093/ajcn/60.2.189; Movsesyan VA, 2004, CELL DEATH DIFFER, V11, P1121, DOI 10.1038/sj.cdd.4401442; Nauli AM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12018; Nielsen MJ, 2004, J LIPID RES, V45, P1027, DOI 10.1194/jlr.C300008-JLR200; Ogura Y, 2016, NAT CHEM BIOL, V12, P669, DOI 10.1038/nchembio.2127; Okazaki M, 2016, J OLEO SCI, V65, P265, DOI 10.5650/jos.ess16020; Oveisi F, 2004, PHARMACOL RES, V49, P461, DOI 10.1016/j.phrs.2003.12.006; PINTO M, 1983, BIOL CELL, V47, P323; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Proulx K, 2005, AM J PHYSIOL-REG I, V289, pR729, DOI 10.1152/ajpregu.00029.2005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Simon GM, 2010, MOL BIOSYST, V6, P1411, DOI 10.1039/c000237b; Stanley S, 2005, PHYSIOL REV, V85, P1131, DOI 10.1152/physrev.00015.2004; Suzuki R, 1998, LIFE SCI, V62, P861, DOI 10.1016/S0024-3205(98)00003-4; Tai T, 2012, ACS CHEM NEUROSCI, V3, P379, DOI 10.1021/cn300007s; Tsuboi K, 2005, J BIOL CHEM, V280, P11082, DOI 10.1074/jbc.M413473200; Tsuboi K, 2011, BBA-MOL CELL BIOL L, V1811, P565, DOI 10.1016/j.bbalip.2011.07.009; Ueda N, 2013, FEBS J, V280, P1874, DOI 10.1111/febs.12152; Usui S, 2002, J LIPID RES, V43, P805; VANBEERS EH, 1995, BIOCHEM J, V308, P769, DOI 10.1042/bj3080769	47	5	5	1	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3167	3179		10.1096/fj.201801408R	http://dx.doi.org/10.1096/fj.201801408R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30399323	Bronze			2022-12-26	WOS:000459794800008
J	Li, WW; Wang, WH; Liu, L; Qu, RZ; Chen, XM; Qiu, C; Li, JY; Hayball, J; Liu, L; Chen, JY; Wang, X; Pan, X; Zhao, YP				Li, Weiwei; Wang, Wenhan; Liu, Long; Qu, Ruize; Chen, Xiaomin; Qiu, Cheng; Li, Jiayi; Hayball, John; Liu, Liang; Chen, Jianying; Wang, Xia; Pan, Xin; Zhao, Yunpeng			GDF11 antagonizes TNF--induced inflammation and protects against the development of inflammatory arthritis in mice	FASEB JOURNAL			English	Article						rheumatoid arthritis; NF-B signaling pathway; synovitis; growth differentiation factor 11	DIFFERENTIATION FACTOR 11; NF-KAPPA-B; GENE; ANTIBODY; ALPHA; CELLS; AGE; OSTEOARTHRITIS; INTEGRATION; INHIBITORS	Growth differentiation factor 11 (GDF11), a key member of the TGF- superfamily, plays critical roles in various medical conditions. Recently, GDF11 was found to suppress the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B) signaling pathway and protect against inflammation. This study aimed to investigate the role of GDF11 in the development of rheumatoid arthritis (RA). We demonstrated that GDF11 treatment antagonized TNF--induced inflammation in macrophages. Moreover, GDF11 inhibited the development of arthritis in the collagen-induced arthritis and collagen antibody-induced arthritis models. Local gene transfer of GDF11 via adeno-associated virus exerted therapeutic effects, while local knockdown of GDF11 exaggerated inflammation in our collagen-induced arthritis model, as detected by expression levels of inflammatory biomarkers and the destruction of joint structures. Additionally, the results from both in vitro experiments and luciferase reporter gene mouse experiments implied that the NF-B pathway might play a critical role in the therapeutic effect of GDF11 in RA. This study presents GDF11 as a potential target for the treatment of inflammatory arthritis, including RA.Li, W., Wang, W., Liu, L., Qu, R., Chen, X., Qiu, C., Li, J., Hayball, J., Liu, L., Chen, J., Wang, X., Pan, X., Zhao, Y. GDF11 antagonizes TNF--induced inflammation and protects against the development of inflammatory arthritis in mice.	[Li, Weiwei; Liu, Long] Shandong Univ, Qilu Hosp, Dept Pathol, Jinan, Shandong, Peoples R China; [Wang, Wenhan; Wang, Xia; Pan, Xin; Zhao, Yunpeng] Shandong Univ, Qilu Hosp, Dept Orthoped, 107 West Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China; [Wang, Wenhan; Qu, Ruize; Chen, Xiaomin; Qiu, Cheng; Li, Jiayi] Shandong Univ, Med Sch, Jinan, Shandong, Peoples R China; [Hayball, John; Liu, Liang] Univ South Australia, Hanson Inst, Sch Pharm & Med Sci, Expt Therapeut Lab, Adelaide, SA, Australia; [Hayball, John; Liu, Liang] Univ South Australia, Sansom Inst Hlth Res, Adelaide, SA, Australia; [Hayball, John; Liu, Liang] Univ Adelaide, Robinson Res Inst, Adelaide, SA, Australia; [Hayball, John; Liu, Liang] Univ Adelaide, Adelaide Med Sch, Adelaide, SA, Australia; [Chen, Jianying] Inst Biopharmaceut Shandong Prov, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Hanson Institute; University of South Australia; University of South Australia; Robinson Research Institute; University of Adelaide; University of Adelaide	Pan, X; Zhao, YP (corresponding author), Shandong Univ, Qilu Hosp, Dept Orthoped, 107 West Wenhuaxi Rd, Jinan 250012, Shandong, Peoples R China.	xinpanqlyy@126.com; miraculously2008@163.com	chen, xia/GYR-3948-2022; chen, xi/GXH-3653-2022; chen, xia/GXM-5435-2022		Key Research and Development Projects of Shandong Province [2015GSF118115]; Natural Science Foundation of Shandong Province [BS2014YY048, ZR2016HM53, BS2015SW028]; Major Project of Science and Technology of Shandong Province [2015ZDJS04001]; National Natural Science Foundation of China [81501880, 81602761]	Key Research and Development Projects of Shandong Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Major Project of Science and Technology of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank C. Liu and S. Liu for their scientific input and advice. The authors thank H. Zhao, H. Li, and S. Wang for providing secretarial assistance and technical support. This work was supported in part by the Key Research and Development Projects of Shandong Province (2015GSF118115), the Natural Science Foundation of Shandong Province (BS2014YY048, ZR2016HM53, and BS2015SW028), the Major Project of Science and Technology of Shandong Province (2015ZDJS04001), and the National Natural Science Foundation of China (81501880 and 81602761). The authors declare no conflicts of interest.	Batra R, 2017, CELL, V170, P899, DOI 10.1016/j.cell.2017.07.010; Boutet MA, 2017, ANN RHEUM DIS, V76, P1300, DOI 10.1136/annrheumdis-2016-210630; DEGRAEFFMEEDER ER, 1991, LANCET, V337, P1368, DOI 10.1016/0140-6736(91)93057-G; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; El-Shami K, 2015, CA-CANCER J CLIN, V65, P427, DOI 10.3322/caac.21286; Fadini GP, 2015, DIABETES CARE, V38, pE118, DOI 10.2337/dc15-0868; Gamer LW, 2001, DEV BIOL, V229, P407, DOI 10.1006/dbio.2000.9981; Harmon EB, 2004, DEVELOPMENT, V131, P6163, DOI 10.1242/dev.01535; Jin C. H., MOLECULES, V22; Jin XN, 2016, ACTA PHARMACOL SIN, V37, P674, DOI 10.1038/aps.2016.7; Kafer R, 2017, MOL IMMUNOL, V87, P207, DOI 10.1016/j.molimm.2017.05.003; Kaiser J, 2015, SCIENCE, V348, P849, DOI 10.1126/science.348.6237.849; Kamerkar S, 2017, NATURE, V546, P498, DOI 10.1038/nature22341; Kim DH, 2015, ARTHRITIS RHEUMATOL, V67, P3058, DOI 10.1002/art.39284; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Li WW, 2015, FEBS J, V282, P2317, DOI 10.1111/febs.13278; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Matmati M, 2011, NAT GENET, V43, P908, DOI 10.1038/ng.874; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Mei W, 2016, MOL THER, V24, P1926, DOI 10.1038/mt.2016.160; Mizoguchi F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02892-y; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Ohmi Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11205; Pawlowska J, 2011, CLIN EXP IMMUNOL, V163, P157, DOI 10.1111/j.1365-2249.2010.04294.x; Poggioli T, 2016, CIRC RES, V118, P29, DOI 10.1161/CIRCRESAHA.115.307521; Roark Anne C, 1977, Chron High Educ, V15, P7; Robbins D, 2011, METHODS MOL BIOL, V716, P169, DOI 10.1007/978-1-61779-012-6_10; Scudellari M, 2015, NATURE, V517, P426, DOI 10.1038/517426a; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Smolen JS, 2016, LANCET, V388, P2023, DOI 10.1016/S0140-6736(16)30173-8; Smolen JS, 2009, LANCET, V374, P210, DOI 10.1016/S0140-6736(09)60506-7; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Suzuki T, 2018, THER CLIN RISK MANAG, V14, P453, DOI 10.2147/TCRM.S156350; Szumska D, 2008, GENE DEV, V22, P1465, DOI 10.1101/gad.479408; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tao YX, 2017, RHEUMATOLOGY, V56, P1804, DOI 10.1093/rheumatology/kex233; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang QH, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8134321; Wang WH, 2016, INFLAMMATION, V39, P1624, DOI 10.1007/s10753-016-0396-1; Widdifield J, 2015, ARTHRIT CARE RES, V67, P1047, DOI 10.1002/acr.22553; Zhang Weidong, 2004, Genet Vaccines Ther, V2, P8, DOI 10.1186/1479-0556-2-8; Zhang Y, 2016, BIOTECHNOL LETT, V38, P1423, DOI 10.1007/s10529-016-2139-7; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	47	18	18	2	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3317	3329		10.1096/fj.201801375RR	http://dx.doi.org/10.1096/fj.201801375RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30407878				2022-12-26	WOS:000459794800020
J	Chen, YY; Fang, WH; Wang, CC; Kao, TW; Chang, YW; Wu, CJ; Zhou, YC; Sun, YS; Chen, WL				Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang			Body fat has stronger associations with bone mass density than body mass index in metabolically healthy obesity	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; MINERAL DENSITY; SARCOPENIC OBESITY; OSTEOPOROSIS; PREVALENCE; MECHANISMS; FRACTURES; SOCIETY	Objective The effect of obesity-induced metabolic abnormalities on bone mineral density (BMD) and osteoporosis are well established. However, the association between metabolically healthy obesity (MHO) and BMD remains unclear. Our aim was to investigate whether different obesity phenotypes in MHO were associated with BMD in a cross-sectional study. Methods All eligible adults receiving a health examination at the Tri-Service General Hospital from 2010 to 2016 were included. They were categorized based on body mass index (BMI) or percentage body fat (PBF). The associations between BMI or PBF and BMD were analyzed by adjusting for pertinent covariables. Results Males with normal weight and overweight and females with underweight and normal weight were associated with reduced BMD (beta = 0.221, 95% CI = -0.354, -0.088; beta = -0.155, 95% CI = -0.286, -0.023) (beta = -0.736, 95% CI = -1.043, 0.429; beta = -0.340, 95% CI = -0.567, -0.112), respectively. Females in Q1 had close to significant associations with reduced BMD (beta = -0.253, 95% CI = -0.465, -0.041). Normal weight, overweight, Q2, and Q3 had stronger prediction of low BMD with ORs of 0.402 (95% CI = 0.204-0.791), 0.539 (95% CI = 0.321-0.905), 0.694 (95% CI = 0.490-0.982), and 0.466 (95% CI = 0.342-0.636), respectively. The relationship remained significant in male population that PBF was associated with reduced BMD with ORs of 0.435 (95% CI = 0.203, 0.935), 0.494 (95% CI = 0.247, 0.991), 0.268 (95% CI = 0.120, 0.597) in Q1, Q2, Q3 respectively. Conclusion Increased PBF had a significant association with low BMD in the MHO population. Obesity defined by PBF might be a useful indicator for low BMD. The association between body fat and bone health deserves further investigation regarding the potential pathophysiological mechanisms.	[Chen, Yuan-Yuei] Triserv Gen Hosp, Songshan Branch, Dept Internal Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Dept Community Med, Div Family Med, Taoyuan, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Taiwan University	Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.	weiliang0508@gmail.com	Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518				Bhupathiraju SN, 2011, AM J CLIN NUTR, V94, P1063, DOI 10.3945/ajcn.111.016030; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Cao JJ, 2011, J ORTHOP SURG RES, V6, DOI 10.1186/1749-799X-6-30; Cao JJ, 2010, ANN NY ACAD SCI, V1192, P292, DOI 10.1111/j.1749-6632.2009.05252.x; Casale M, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080470; Castro Jonathan P, 2005, Nutr Metab (Lond), V2, P9, DOI 10.1186/1743-7075-2-9; Chain A, 2017, NUTRITION, V33, P14, DOI 10.1016/j.nut.2016.08.001; Chung JH, 2016, ANN NUTR METAB, V68, P77, DOI 10.1159/000442004; Coppini LZ, 2005, CURR OPIN CLIN NUTR, V8, P329, DOI 10.1097/01.mco.0000165013.54696.64; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Janicka A, 2007, J CLIN ENDOCR METAB, V92, P143, DOI 10.1210/jc.2006-0794; Jeon YK, 2011, ENDOCR J, V58, P87, DOI 10.1507/endocrj.K10E-297; Kaji H, 2013, CURR OPIN CLIN NUTR, V16, P272, DOI 10.1097/MCO.0b013e32835fe6a5; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kim KC, 2010, YONSEI MED J, V51, P857, DOI 10.3349/ymj.2010.51.6.857; Kushner RF, 1996, AM J CLIN NUTR, V64, P423, DOI 10.1093/ajcn/64.3.423S; Lee K, 2009, ASIA PAC J CLIN NUTR, V18, P280; Muka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129116; National Department of Health, 2007, DEF MET SYNDR AD; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Phillips CM, 2017, ANN NY ACAD SCI, V1391, P85, DOI 10.1111/nyas.13230; Riggs BL, 2000, J CLIN INVEST, V106, P1203, DOI 10.1172/JCI11468; Riis BJ, 1996, BONE, V19, P9, DOI 10.1016/8756-3282(96)00102-0; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Salamat MR, 2016, ENDOCRINOL METAB, V31, P547, DOI 10.3803/EnM.2016.31.4.547; Schousboe JT, 2013, J CLIN DENSITOM, V16, P455, DOI 10.1016/j.jocd.2013.08.004; Scott D, 2016, CALCIFIED TISSUE INT, V99, P30, DOI 10.1007/s00223-016-0123-9; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Slinde F, 2001, AM J CLIN NUTR, V74, P474; Stefan N, 2013, LANCET DIABETES ENDO, V1, P152, DOI 10.1016/S2213-8587(13)70062-7; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Varenna M, 2013, CALCIFIED TISSUE INT, V93, P86, DOI 10.1007/s00223-013-9731-9; Villareal DT, 2005, AM J CLIN NUTR, V82, P923, DOI 10.1093/ajcn/82.5.923; Wang L, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/378632; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h; Yuksel O, 2001, J BONE MINER METAB, V19, P257, DOI 10.1007/s007740170029; Zhao LJ, 2007, J CLIN ENDOCR METAB, V92, P1640, DOI 10.1210/jc.2006-0572	38	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206812	10.1371/journal.pone.0206812	http://dx.doi.org/10.1371/journal.pone.0206812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408060	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300040
J	Szabo, ER; Brand, M; Hans, S; Hideghety, K; Karsch, L; Lessmann, E; Pawelke, J; Schurer, M; Beyreuther, E				Szabo, Emilia Rita; Brand, Michael; Hans, Stefan; Hideghety, Katalin; Karsch, Leonhard; Lessmann, Elisabeth; Pawelke, Joerg; Schuerer, Michael; Beyreuther, Elke			Radiobiological effects and proton RBE determined by wildtype zebrafish embryos	PLOS ONE			English	Article							RELATIVE BIOLOGICAL EFFECTIVENESS; RADIATION; BEAM; VERIFICATION; IRRADIATION; DAMAGE; MODEL	The increasing use of proton radiotherapy during the last decade and the rising number of long-term survivors has given rise to a vital discussion on potential effects on normal tissue. So far, deviations from clinically applied generic RBE (relative biological effectiveness) of 1.1 were only obtained by in vitro studies, whereas indications from in vivo trials and clinical studies are rare. In the present work, wildtype zebrafish embryos (Danio rerio) were used to characterize the effects of plateau and mid-SOBP (spread-out Bragg peak) proton radiation relative to that induced by clinical MV photon beam reference. Based on embryonic survival data, RBE values of 1.13 +/- 0.08 and of 1.20 +/- 0.04 were determined four days after irradiations with 20 Gy plateau and SOBP protons relative to 6 MV photon beams. These RBE values were confirmed by relating the rates of embryos with morphological abnormalities for the respective radiation qualities and doses. Besides survival, the rate of spine bending, as one type of developmental abnormality, and of pericardial edema, as an example for acute radiation effects, were assessed. The results revealed that independent on radiation quality both rates increased with time approaching almost 100% at the 4th day post irradiation with doses higher than 15 Gy. To sum up, the applicability of the zebrafish embryo as a robust and simple alternative model for in vivo characterization of radiobiological effects in normal tissue was validated and the obtained RBE values are comparable to previous finding in animal trials.	[Szabo, Emilia Rita; Hideghety, Katalin] ELI HU Nonprofit Ltd, Attosecond Light Pulse Source, Szeged, Hungary; [Brand, Michael; Hans, Stefan] Tech Univ Dresden, CMCB, DFG Ctr Regenerat Therapies Dresden CRTD, Dresden, Germany; [Karsch, Leonhard; Pawelke, Joerg; Beyreuther, Elke] Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany; [Karsch, Leonhard; Lessmann, Elisabeth; Pawelke, Joerg; Schuerer, Michael; Beyreuther, Elke] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany; [Karsch, Leonhard; Lessmann, Elisabeth; Pawelke, Joerg; Schuerer, Michael; Beyreuther, Elke] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Schuerer, Michael] Partner Site Dresden, Natl Ctr Tumor Dis NCT, Dresden, Germany	ELI-HU Research & Development Non-Profit; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Beyreuther, E (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Dresden, Germany.; Beyreuther, E (corresponding author), Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany.; Beyreuther, E (corresponding author), Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany.	E.Boyreuther@hzdr.de	Brand, Michael/A-5509-2010	Brand, Michael/0000-0001-5711-6512; Beyreuther, Elke/0000-0002-0582-1444	European Union [654148, GINOP-2.3.6-15-2015-00001]; European Regional Development Fund; European Union (ERC Advanced Grant Zf-BrainReg)	European Union(European Commission); European Regional Development Fund(European Commission); European Union (ERC Advanced Grant Zf-BrainReg)	The ELI-ALPS project (GINOP-2.3.6-15-2015-00001) is supported by the European Union and co-financed by the European Regional Development Fund. Moreover, the project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no 654148 Laserlab-Europe. Michael Brand and Stefan Hans are supported by the European Union (ERC Advanced Grant Zf-BrainReg).	Barriuso J, 2015, CLIN CANCER RES, V21, P969, DOI 10.1158/1078-0432.CCR-14-2921; Berger M. J., 1999, ESTAR PSTAR ASTAR CO; Beyreuther E, 2018, INT J PART THER, V5, P172, DOI 10.14338/IJPT-18-00008.1; Brand M, 2002, KEEPING RAISING ZEBR, P7; Brannen KC, 2010, BIRTH DEFECTS RES B, V89, P66, DOI 10.1002/bdrb.20223; Chaudhary P, 2014, INT J RADIAT ONCOL, V90, P27, DOI 10.1016/j.ijrobp.2014.05.010; Freeman JL, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00268; Gould S. J., 1977, ONTOGENY PHYLOGENY; Gueulette J, 1997, RADIOTHER ONCOL, V42, P303, DOI 10.1016/S0167-8140(97)01919-1; Helmbrecht S, 2016, J INSTRUM, V11, DOI 10.1088/1748-0221/11/11/T11001; Hu M, 2016, RADIAT ENVIRON BIOPH, V55, P441, DOI 10.1007/s00411-016-0663-4; ICRU, 2007, J ICRU, V7; Ilicic K, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0954-9; Jang GH, 2008, ARCH PHARM RES, V31, P779, DOI 10.1007/s12272-001-1226-1; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar MKP, 2017, ECOTOX ENVIRON SAFE, V142, P95, DOI 10.1016/j.ecoenv.2017.03.054; Li XM, 2018, CHEMOSPHERE, V200, P302, DOI 10.1016/j.chemosphere.2018.02.141; Luhr A, 2018, RADIOTHER ONCOL, V128, P56, DOI 10.1016/j.radonc.2018.05.018; McAleer MF, 2005, INT J RADIAT ONCOL, V61, P10, DOI 10.1016/j.ijrobp.2004.09.046; Muller J, 2017, ACTA ONCOL, V56, P1399, DOI 10.1080/0284186X.2017.1352102; Paganetti H, 2014, PHYS MED BIOL, V59, pR419, DOI 10.1088/0031-9155/59/22/R419; Peeler CR, 2016, RADIOTHER ONCOL, V121, P395, DOI 10.1016/j.radonc.2016.11.001; Pei DS, 2013, MUTAT RES-FUND MOL M, V743, P151, DOI 10.1016/j.mrfmmm.2012.10.003; Richter C, 2016, RADIOTHER ONCOL, V118, P232, DOI 10.1016/j.radonc.2016.01.004; Saager M, 2017, RADIOTHER ONCOL, V123, pS273, DOI 10.1016/S0167-8140(17)30957-X; Saager M, 2018, RADIOTHER ONCOL, V128, P115, DOI 10.1016/j.radonc.2018.03.002; Sayed AEH, 2016, J PHOTOCH PHOTOBIO B, V164, P132, DOI 10.1016/j.jphotobiol.2016.09.023; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Sorensen BS, 2017, ACTA ONCOL, V56, P1387, DOI 10.1080/0284186X.2017.1351621; Stern HM, 2003, NAT REV CANCER, V3, P533, DOI 10.1038/nrc1126; Szabo ER, 2016, ZEBRAFISH, V13, P481, DOI 10.1089/zeb.2016.1269; Szabo ER, 2018, INT J RADIAT BIOL, V17, P1; URANO M, 1984, INT J RADIAT ONCOL, V10, P509, DOI 10.1016/0360-3016(84)90031-2; Uzawa A, 2007, J RADIAT RES, V48, pA75, DOI 10.1269/jrr.48.A75; Zeil K, 2009, NUCL INSTRUM METH B, V267, P2403, DOI 10.1016/j.nimb.2009.04.015	35	13	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206879	10.1371/journal.pone.0206879	http://dx.doi.org/10.1371/journal.pone.0206879			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408095	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300049
J	Wu, HX; Chen, XM; Chen, H; Lu, Q; Yang, ZX; Ren, WB; Liu, J; Shao, SX; Wang, C; King-Jones, K; Chen, MS				Wu, Hai-Xia; Chen, Xiaoming; Chen, Hang; Lu, Qin; Yang, Zixiang; Ren, Weibin; Liu, Juan; Shao, Shuxia; Wang, Chao; King-Jones, Kirst; Chen, Ming-Shun			Variation and diversification of the microbiome of Schlechtendalia chinensis on two alternate host plants	PLOS ONE			English	Article							EVOLUTIONARY RELATIONSHIPS; FACULTATIVE SYMBIONTS; GUT BACTERIA; APHIDS; SEQUENCES; DIVERSITY; INSECTS	Schlechtendalia chinensis, a gall-inducing aphid, has two host plants in its life cycle. Its wintering host is a moss (typically Plagiomnium maximoviczii) and its main host is Rhus chinensis (Sumac), on which it forms galls during the summer. This study investigated bacteria associated with S. chinensis living on the two different host plants by sequencing 16S rRNAs. A total of 183 Operational Taxonomic Units (OTUs) from 50 genera were identified from aphids living on moss, whereas 182 OTUs from 49 genera were found from aphids living in Sumac galls. The most abundant bacterial genus among identified OTUs from aphids feeding on both hosts was Buchnera. Despite similar numbers of OTUs, the composition of bacterial taxa showed significant differences between aphids living on moss and those living on R. chinensis. Specifically, there were 12 OTUs from 5 genera (family) unique to aphids living on moss, and 11 OTUs from 4 genera (family) unique to aphids feeding in galls on R. chinensis. Principal Coordinate Analysis (PCoA) also revealed that bacteria from moss-residing aphids clustered differently from aphids collected from galls. Our results provide a foundation for future analyses on the roles of symbiotic bacteria in plant-aphid interactions in general, and how gall-specific symbionts differ in this respect.	[Wu, Hai-Xia; Chen, Xiaoming; Chen, Hang; Lu, Qin; Yang, Zixiang; Ren, Weibin; Liu, Juan; Shao, Shuxia; Wang, Chao] Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Yunnan, Peoples R China; [Wu, Hai-Xia; Chen, Xiaoming; Chen, Hang; Lu, Qin; Yang, Zixiang; Ren, Weibin; Liu, Juan; Shao, Shuxia; Wang, Chao] State Forestry Adm, Key Lab Cultivating & Utilizat Resources Insects, Kunming, Yunnan, Peoples R China; [Wang, Chao] Southwest Forestry Univ, Kunming, Yunnan, Peoples R China; [King-Jones, Kirst] Univ Alberta, Dept Biol Sci, Biol Sci Bldg, Edmonton, AB, Canada; [Chen, Ming-Shun] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF; Southwest Forestry University - China; University of Alberta; Kansas State University	Chen, XM (corresponding author), Chinese Acad Forestry, Res Inst Resource Insects, Kunming, Yunnan, Peoples R China.; Chen, XM (corresponding author), State Forestry Adm, Key Lab Cultivating & Utilizat Resources Insects, Kunming, Yunnan, Peoples R China.	Cafcxm@139.com	Chen, Hang/AAE-2955-2020	King-Jones, Kirst/0000-0002-9089-8015; Wu, Haixia/0000-0002-7169-6717	Grant for Essential Scientific Research of National Non-profit Institute [CAFYBB2014ZD005, CAFYBB2014QB019]; National Natural Science Foundation of China [U1402263, 31772542, 31300019]	Grant for Essential Scientific Research of National Non-profit Institute; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is funded by the Grant for Essential Scientific Research of National Non-profit Institute (No. CAFYBB2014ZD005; CAFYBB2014QB019); and the National Natural Science Foundation of China (Grant No. U1402263; 31772542; 31300019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is funded by the Grant for Essential Scientific Research of National Non-profit Institute (No. CAFYBB2014ZD005; CAFYBB2014QB019); and the National Natural Science Foundation of China (Grant No. U1402263; 31772542; 31300019).	Ateyyat M. A., 2008, Journal of Entomology, V5, P167; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Bansal R, 2014, ENV MICROBIOL REP, V6, P57, DOI 10.1111/1758-2229.12108; Bansal R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023170; BAUMANN P, 1995, APPL ENVIRON MICROB, V61, P1; BAUMANN P, 1995, ANNU REV MICROBIOL, V49, P55, DOI 10.1146/annurev.mi.49.100195.000415; Behar A, 2008, MOL ECOL, V17, P1375, DOI 10.1111/j.1365-294X.2008.03674.x; Blackburn MB, 2008, BIOL CONTROL, V46, P434, DOI 10.1016/j.biocontrol.2008.05.005; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chevalier S, 2017, FEMS MICROBIOL REV, V41, P698, DOI 10.1093/femsre/fux020; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dillon RJ, 2005, ECOL LETT, V8, P1291, DOI 10.1111/j.1461-0248.2005.00828.x; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2013, J CHEM ECOL, V39, P952, DOI 10.1007/s10886-013-0308-x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Fellous S, 2011, NAT REV GENET, V12, P663, DOI 10.1038/nrg3028-c1; Feng W, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.13501; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Hansen AK, 2014, MOL ECOL, V23, P1473, DOI 10.1111/mec.12421; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Leonardo TE, 2003, P ROY SOC B-BIOL SCI, V270, pS209, DOI 10.1098/rsbl.2003.0064; Liu P, 2014, ANN ENTOMOL SOC AM, V107, P242, DOI 10.1603/AN13118; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045161; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; MORAN N, 1994, TRENDS ECOL EVOL, V9, P15, DOI 10.1016/0169-5347(94)90226-7; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Nicol GW, 2006, TRENDS MICROBIOL, V14, P207, DOI 10.1016/j.tim.2006.03.004; Oliver KM, 2010, ANNU REV ENTOMOL, V55, P247, DOI 10.1146/annurev-ento-112408-085305; Renoz F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122099; Russell CW, 2013, APPL ENVIRON MICROB, V79, P6117, DOI 10.1128/AEM.01543-13; Shao SX, 2013, J ECON ENTOMOL, V106, P1628, DOI 10.1603/EC13114; Shigenobu S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1952; Shigenobu S, 2011, CELL MOL LIFE SCI, V68, P1297, DOI 10.1007/s00018-011-0645-2; Stroyan HG, 1997, MCGRAW HILL ENCY SCI; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Xia WW, 2011, ISME J, V5, P1226, DOI 10.1038/ismej.2011.5; Yang ZX, 2010, ENTOMOL SCI, V13, P351, DOI 10.1111/j.1479-8298.2010.00391.x; Yang ZX, 2009, ZOOTAXA, P48, DOI 10.11646/zootaxa.2204.1.4; Zytynska SE, 2016, ECOL ENTOMOL, V41, P13, DOI 10.1111/een.12281	41	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0200049	10.1371/journal.pone.0200049	http://dx.doi.org/10.1371/journal.pone.0200049			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408037	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300003
J	de Luis, M; Bartolome, C; Cardo, OG; Labarga, JMM; Alvarez-Jimenez, J				de Luis, Miguel; Bartolome, Carmen; Garcia Cardo, Oscar; Martinez Labarga, Juan Manuel; Alvarez-Jimenez, Julio			Sympatric and allopatric niche shift of endemic Gypsophila (Caryophyllaceae) taxa in the Iberian Peninsula	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; GENETIC DIVERSITY; CONSERVATISM; EVOLUTION; ECOLOGY; ROOTS	Several species of the Gypsophila genus are endemic to the Iberian Peninsula, including gypsophytes of particular ecological, evolutionary and biochemical interest, and taxa that have undergone both sympatric and allopatric genetic differentiation. The niche shift among these taxa has been assessed using ecological niche modelling and ordination techniques, adopting a niche overlap approach to compare the similarity and equivalency of the ecological niches. We used the Maximum Entropy method to study the potential distribution of these taxa in different eras: the Last Glacial Maximum (LGM), the Mid Holocene and the current conditions. We present evidence of niche shift during the speciation of G. bermejoi, with a strong niche overlap between the parental taxa (G. struthium subsp. struthium and G. tomentosa), yet both overlap much more weakly with the hybrid species. This phenomenon may be explained by genetic and epigenetic interactions, and it has been described in other species. We also studied the sister subspecies G. struthium subsp. struthium and G. struthium subsp. hispanica, with mostly allopatric distributions and with the Iberian System mountain range acting as a geographical barrier. The Iberian System and other mountain ranges may have favored differences in the climatic conditions on either side of the mountain range, which is consistent with an incipient process of bioclimatic ecological speciation. These results seem to indicate that niche shift can occur over very different timespans. In the case of G. bermejoi, speciation may have produced significant niche shifting in one or two generations due to its alloploid nature. By contrast, G. struthium subsp. struthium and G. struthium subsp. hispanica seem to have undergone a more gradual process of allopatric genetic differentiation driven by bioclimatic factors. Both these processes are relatively recent and they will have been strongly influenced by the climate change at the end of LGM.	[de Luis, Miguel; Bartolome, Carmen; Alvarez-Jimenez, Julio] Univ Alcala, Dept Ciencias Vida, Fac Ciencias, Alcala De Henares, Madrid, Spain; [Garcia Cardo, Oscar] Empresa Publ Gest & Ambiental Castilla La Mancha, Cuenca, Spain; [Martinez Labarga, Juan Manuel] Univ Politecn Madrid, Dept Sistemas Recursos Nat, ETSI Montes Forestal & Medio Nat, Madrid, Spain	Universidad de Alcala; Universidad Politecnica de Madrid	Bartolome, C (corresponding author), Univ Alcala, Dept Ciencias Vida, Fac Ciencias, Alcala De Henares, Madrid, Spain.	carmen.bartolome@uah.es	Labarga, Juan Manuel Martinez/J-1611-2019	Labarga, Juan Manuel Martinez/0000-0003-1565-7454; Bartolome Esteban, Carmen/0000-0003-3204-7797; de Luis, Miguel/0000-0002-5591-5721				Acebes B, 1998, J NAT PROD, V61, P1557, DOI 10.1021/np9705221; Acebes B, 1998, PHYTOCHEMISTRY, V49, P2077, DOI 10.1016/S0031-9422(98)00404-X; Aguirre-Gutierrez J, 2015, DIVERS DISTRIB, V21, P245, DOI 10.1111/ddi.12268; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2014, EVOLUTIONARY BIOL GE, DOI DOI 10.1007/978-3-319-07623-2_5; Barkoudah YI, 1962, REVISION GYPSOPHILA, V9, P1, DOI [10.1111/j.1438-8677.1962.tb00012.x, DOI 10.1111/J.1438-8677.1962.TB00012.X]; BOCQUET G, 1978, Candollea, V33, P269; Boscaiu M, 2010, B U AGR SCI VET MED, V67, P1843, DOI DOI 10.15835/BUASVMCN-H0RT:4903; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x; Bueno ML, 2017, ECOGRAPHY, V40, P403, DOI 10.1111/ecog.01860; Capel Molina JJ, 1978, PARALELO, V37, P5; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Costa-Tenorio M, 1998, LOS BOSQUES IBERICOS; de Luis M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190536; EHRLICH PR, 1969, SCIENCE, V165, P1228, DOI 10.1126/science.165.3899.1228; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Escudero A, 2015, BIOL REV, V90, P1, DOI 10.1111/brv.12092; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Fernandez-Lopez J., 2017, NICEOVERPLOT NUMBER; Ferrandis P., 2005, INVEST AGRAR-SIST R, V14, P195; Frajman B, 2009, SYST BIOL, V58, P328, DOI 10.1093/sysbio/syp030; Francisco Mota Juan, 2009, Anales de Biologia, V31, P71; Garcia de Pedraza L, 1972, FENOMENOS ESTANCAMIE; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Glennon KL, 2014, ECOL LETT, V17, P574, DOI 10.1111/ele.12259; Guisan A, 2014, TRENDS ECOL EVOL, V29, P260, DOI 10.1016/j.tree.2014.02.009; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HSU KJ, 1977, NATURE, V267, P399, DOI 10.1038/267399a0; Hu JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23521; Martinez-Nieto MI, 2013, BOT J LINN SOC, V173, P654, DOI 10.1111/boj.12105; Kaky E, 2016, J ARID ENVIRON, V135, P140, DOI 10.1016/j.jaridenv.2016.09.001; Korkmaz M, 2015, GENET MOL RES, V14, P8829, DOI 10.4238/2015.August.3.6; Liu B, 2003, MOL PHYLOGENET EVOL, V29, P365, DOI 10.1016/S1055-7903(03)00213-6; Lopez G., 1984, AN JARDIN BOT MADRID, V41, P35; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Martinez-Labarga JM, 2014, THESIS; McCormack JE, 2011, EVOLUTION, V65, P184, DOI 10.1111/j.1558-5646.2010.01097.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Mota J.F., 2011, DIVERSIDAD VEGETAL Y; Mota JF, 2016, LAZAROA, V37, P7, DOI 10.5209/LAZA.54044; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramstein G, 1997, NATURE, V386, P788, DOI 10.1038/386788a0; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rieseberg LH, 2007, SCIENCE, V317, P910, DOI 10.1126/science.1137729; Royzar C, 2016, FOREST ECOL MANAG, V369, P20, DOI 10.1016/j.foreco.2016.03.030; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SCHOENER TW, 1970, ECOLOGY, V51, P408, DOI 10.2307/1935376; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Thompson KA, 2014, AM J BOT, V101, P1868, DOI 10.3732/ajb.1400184; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Willis KJ, 2004, PHILOS T R SOC B, V359, P159, DOI 10.1098/rstb.2003.1387	59	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206043	10.1371/journal.pone.0206043	http://dx.doi.org/10.1371/journal.pone.0206043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403709	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500046
J	Resibois, M; Rotge, JY; Delaveau, P; Kuppens, P; Van Mechelen, I; Fossati, P; Verduyn, P				Resibois, Maxime; Rotge, Jean-Yves; Delaveau, Pauline; Kuppens, Peter; Van Mechelen, Iven; Fossati, Philippe; Verduyn, Philippe			The impact of self-distancing on emotion explosiveness and accumulation: An fMRI study	PLOS ONE			English	Article							INTENSITY PROFILES; NEURAL BASES; BRAIN; METAANALYSIS; EXPERIENCES; RUMINATION; TALAIRACH; ANGER; MNI; DETERMINANTS	Emotions unfold over time with episodes differing in explosiveness (i.e., profiles having a steep vs. a gentle start) and accumulation (i.e., profiles increasing over time vs. going back to baseline). In the present fMRI study, we wanted to replicate and extend previous findings on the psychological and neural mechanisms underlying emotion explosiveness and accumulation. Specifically, we aimed to: (a) replicate the finding that different neural mechanisms are associated with emotion explosiveness and accumulation, (b) replicate the finding that adopting a self-distanced (vs. self-immersed) perspective decreases emotion explosiveness and accumulation at the level of self-report, and (c) examine whether adopting a self-distanced (vs. self-immersed) perspective similarly modulates activity in the brain regions associated with emotion explosiveness and accumulation. Participants in an fMRI scanner were asked to adopt a self-immersed or self-distanced perspective while reading and thinking about negative social feedback, and to report on felt changes in negative affect during that period using an emotion intensity profile tracking approach. We replicated previous findings showing that emotion explosiveness and accumulation were related to activity in regions involved in self-referential processing (such as the medial prefrontal cortex) and sustained visceral arousal (such as the posterior insula), respectively. The finding that adopting a self-distanced (vs. self-immersed) perspective lowers emotion explosiveness and accumulation was also replicated at a self-report level. However, perspective taking did not impact activity in the neural correlates of emotion explosiveness and accumulation.	[Resibois, Maxime; Kuppens, Peter; Van Mechelen, Iven; Verduyn, Philippe] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Rotge, Jean-Yves; Delaveau, Pauline; Fossati, Philippe] UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225,Social & Affect Neurosci SAN Lab &, UMR S 1127,Sorbonne Univ,Inst Cerveau & Moelle,IC, Paris, France; [Rotge, Jean-Yves; Fossati, Philippe] Hop La Pitie Salpetriere, AP HP, Dept Psychiat, Paris, France; [Fossati, Philippe] UPMC Univ Paris 06, Ctr NeuroImagerie Rech CENIR, ICM, INSERM,CNRS Hop Pitie Salpetriere,Sorbonne Univ, Paris, France; [Verduyn, Philippe] Maastricht Univ, Fac Psychol & Neurosci, Maastricht, Netherlands	KU Leuven; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Maastricht University	Resibois, M (corresponding author), Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium.	maxime.resibois@kuleuven.be	kuppens, peter/DHG-5268-2022	Rotge, Jean-Yves/0000-0002-4306-4878; kuppens, peter/0000-0002-2363-2356; Verduyn, Philippe/0000-0001-8266-2216	Research Fund of KU Leuven [GOA/15/003]; Interuniversity Attraction Poles programme - Belgian government [IAP/P7/06]; French National Research Agency (Agence Nationale pour la Recherche) de la Recherche [ANR SAMENTA2012]	Research Fund of KU Leuven; Interuniversity Attraction Poles programme - Belgian government; French National Research Agency (Agence Nationale pour la Recherche) de la Recherche	The research leading to the results reported in this paper was supported in part by the Research Fund of KU Leuven (GOA/15/003) and by the Interuniversity Attraction Poles programme financed by the Belgian government (IAP/P7/06) to Peter Kuppens. Philippe Verduyn is supported as a postdoctoral fellow of the Research Foundation -Flanders (FWO). Philippe Fossati is supported by the French National Research Agency (Agence Nationale pour la Recherche) de la Recherche (ANR SAMENTA2012 [Sante Mentale et Addictions, projet SENSO]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[American Psychiatric Association American Psychiatric Association], 2000, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.B00KS.9780890425596.744053]; Amft M, 2015, BRAIN STRUCT FUNCT, V220, P1031, DOI 10.1007/s00429-013-0698-0; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Ayduk O, 2008, PSYCHOL SCI, V19, P229, DOI 10.1111/j.1467-9280.2008.02073.x; Ayduk O, 2010, J PERS SOC PSYCHOL, V98, P809, DOI 10.1037/a0019205; Bernstein A, 2015, PERSPECT PSYCHOL SCI, V10, P599, DOI 10.1177/1745691615594577; Bishop SJ, 2004, J NEUROSCI, V24, P10364, DOI 10.1523/JNEUROSCI.2550-04.2004; Brans K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092410; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037/0022-3514.75.1.219; Chang LJ, 2013, CEREB CORTEX, V23, P739, DOI 10.1093/cercor/bhs065; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Denny BT, 2014, EMOTION, V14, P425, DOI 10.1037/a0035276; Eisenberger NI, 2015, ANNU REV PSYCHOL, V66, P601, DOI 10.1146/annurev-psych-010213-115146; Eisenberger NI, 2012, NAT REV NEUROSCI, V13, P421, DOI 10.1038/nrn3231; Eisenberger NI, 2011, J COGNITIVE NEUROSCI, V23, P3448, DOI 10.1162/jocn_a_00027; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Frijda N. H., 2007, LAWS EMOTION; Frijda N.H., 1986, EMOTIONS; Goldin PR, 2005, NEUROIMAGE, V27, P26, DOI 10.1016/j.neuroimage.2005.03.018; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Heylen J, 2016, PSYCHOMETRIKA, V81, P411, DOI 10.1007/s11336-014-9433-x; Heylen J, 2015, COGNITION EMOTION, V29, P168, DOI 10.1080/02699931.2014.896783; Kohn N, 2014, NEUROIMAGE, V87, P345, DOI 10.1016/j.neuroimage.2013.11.001; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Kross E, 2005, PSYCHOL SCI, V16, P709, DOI 10.1111/j.1467-9280.2005.01600.x; Kross E, 2017, ADV EXP SOC PSYCHOL, V55, P81, DOI 10.1016/bs.aesp.2016.10.002; Kross E, 2008, PERS SOC PSYCHOL B, V34, P924, DOI 10.1177/0146167208315938; Kross E, 2012, J ABNORM PSYCHOL, V121, P559, DOI 10.1037/a0028808; Kross E, 2011, P NATL ACAD SCI USA, V108, P6270, DOI 10.1073/pnas.1102693108; Kross E, 2009, BIOL PSYCHIAT, V65, P361, DOI 10.1016/j.biopsych.2008.10.019; Kuppens P, 2015, PSYCHOL INQ, V26, P72, DOI 10.1080/1047840X.2015.960505; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Messina I, 2016, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01909, 10.3389/fpsyg.2015.00956]; Morawetz C, 2017, NEUROSCI BIOBEHAV R, V72, P111, DOI 10.1016/j.neubiorev.2016.11.014; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Papageorgiou C, 2001, COGN BEHAV PRACT, V8, P160, DOI 10.1016/S1077-7229(01)80021-3; Parkinson B, 1996, BRIT J PSYCHOL, V87, P663, DOI 10.1111/j.2044-8295.1996.tb02615.x; Penner LA, 2016, CLIN PSYCHOL SCI, V4, P629, DOI 10.1177/2167702615602864; Pinheiro J., 2017, LINEAR NONLINEAR MIX, DOI DOI 10.1186/1742-9994-4-11; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Ray RD, 2008, J PERS SOC PSYCHOL, V94, P133, DOI 10.1037/0022-3514.94.1.133; Resibois M, 2018, COGNITION EMOTION, V32, P259, DOI 10.1080/02699931.2017.1298993; Resibois M, 2018, PERS INDIV DIFFER, V123, P119, DOI 10.1016/j.paid.2017.11.018; Resibois M, 2017, SOC COGN AFFECT NEUR, V12, P1261, DOI 10.1093/scan/nsx051; Robinson J A, 1993, Memory, V1, P169; Satpute AB, 2013, BIOL PSYCHIAT, V73, P631, DOI 10.1016/j.biopsych.2012.10.001; SONNEMANS J, 1994, COGNITION EMOTION, V8, P329, DOI 10.1080/02699939408408945; SONNEMANS J, 1995, COGNITION EMOTION, V9, P483, DOI 10.1080/02699939508408977; Tops M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00429; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Verduyn P, 2012, EMOTION, V12, P1248, DOI 10.1037/a0028289; Verduyn P, 2012, COGNITION EMOTION, V26, P1486, DOI 10.1080/02699931.2012.662152; Verduyn P, 2012, PERS INDIV DIFFER, V52, P664, DOI 10.1016/j.paid.2011.12.017; Verduyn P, 2009, COGNITION EMOTION, V23, P1427, DOI 10.1080/02699930902949031; Wager TD, 2009, NEUROIMAGE, V47, P821, DOI 10.1016/j.neuroimage.2009.05.043; Waugh CE, 2015, EMOT REV, V7, P323, DOI 10.1177/1754073915590615; Waugh CE, 2012, BEHAV BRAIN SCI, V35, P170, DOI 10.1017/S0140525X11001646; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058	71	4	4	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206889	10.1371/journal.pone.0206889	http://dx.doi.org/10.1371/journal.pone.0206889			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399153	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000029
J	Guo, Q; Liu, XJ; Ao, XF; Qin, JJ; Wu, XP; Ouyang, S				Guo, Qin; Liu, Xiongjun; Ao, Xuefu; Qin, Jiajun; Wu, Xiaoping; Ouyang, Shan			Fish diversity in the middle and lower reaches of the Ganjiang River of China: Threats and conservation	PLOS ONE			English	Article							FRESH-WATER; HABITAT SELECTION; BIODIVERSITY; ASSEMBLAGES; INTEGRITY; STREAM; RISK; DAM	The Ganjiang River has abundant fish resources, which plays a significant role in maintaining and replenishing the fish resources in Poyang Lake and the Yangtze River, and contains important habitat for migratory fish. However, fish diversity has rapidly declined in the Ganjiang River, especially migratory fish. In this study, 107 fish species (including 43 Chinese endemic species) were found in the middle and lower reaches of the Ganjiang River. However, only 91 fish species were found in the main channel of the Ganjiang River, which was lower than the 108 fish species historically found there. According to the Chinese Red List, 85 Least Concern, two Critically Endangered, three Vulnerable, one Near Threatened and 16 Data Deficient fish species were found in the Ganjiang River. In addition, the species number, diversity and CPUE in the channel were all greater than in the reservoir. The Bray-Curtis resemblance matrix and non-metric multidimensional scaling (NMDS) showed that the habitats of the Ganjiang River were divided into three areas. The analysis of RDA showed that turbidity, dissolved oxygen and water depth significantly affected fish distributions and assemblage composition. These results indicated that dam construction and other human activities have seriously destroyed the fish habitat and led to the decline in fish diversity. Therefore, the conservation of fish has become urgent in the Ganjiang River, and an integrated management plan should be developed and effectively implemented.	[Guo, Qin; Ao, Xuefu; Qin, Jiajun; Wu, Xiaoping; Ouyang, Shan] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China; [Liu, Xiongjun; Wu, Xiaoping] Nanchang Univ, Minist Educ, Poyang Lake Key Lab Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China; [Liu, Xiongjun; Wu, Xiaoping] Nanchang Univ, Sch Resource Environm & Chem Engn, Nanchang, Jiangxi, Peoples R China; [Wu, Xiaoping] Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University; Nanchang University	Wu, XP; Ouyang, S (corresponding author), Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China.; Wu, XP (corresponding author), Nanchang Univ, Minist Educ, Poyang Lake Key Lab Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China.; Wu, XP (corresponding author), Nanchang Univ, Sch Resource Environm & Chem Engn, Nanchang, Jiangxi, Peoples R China.; Wu, XP (corresponding author), Nanchang Univ, Inst Life Sci, Ctr Watershed Ecol, Nanchang, Jiangxi, Peoples R China.	xpwu@ncu.edu.cn; ouys1963@qq.com			foundation project of the National Ministry of Science and Technology of China [2013FY111500]; Ministry of Science and Technology of the People's Republic of China [2005DKA21402]; Leading talent training plan of the GanPo Outstanding Talents 555 Project [18000041]	foundation project of the National Ministry of Science and Technology of China; Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Leading talent training plan of the GanPo Outstanding Talents 555 Project	This work is supported by grants from the foundation project of the National Ministry of Science and Technology of China (2013FY111500), the Ministry of Science and Technology of the People's Republic of China (Grant No. 2005DKA21402), and the Leading talent training plan of the GanPo Outstanding Talents 555 Project (18000041). The authors report no conflict of interest. The authors alone are responsible for the content and writing of this article.; This work is supported by grants from the Leading talent training plan of the GanPo Outstanding Talents 555 Project (18000041), the Ministry of Science and Technology of the People's Republic of China (Grant No. 2005DKA21402) and the foundation project of the National Ministry of Science and Technology of China (2013FY111500). The authors report no conflict of interest. The authors alone are responsible for the content and writing of this article.	Abell R, 2008, BIOSCIENCE, V58, P403, DOI 10.1641/B580507; Agostinho Angelo Antonio, 2003, P19; Aksnes DL, 2004, LIMNOL OCEANOGR, V49, P233, DOI 10.4319/lo.2004.49.1.0233; ALLAN JD, 1993, BIOSCIENCE, V43, P32, DOI 10.2307/1312104; [Anonymous], 2007, JIANGXI FISH SCI TEC; Arthington AH, 2016, AQUAT CONSERV, V26, P838, DOI 10.1002/aqc.2712; Chen Y.Y., 1998, FAUNA SINICA OSTEICH, VII; Chu X.L., 1999, FAUNA SINICA OSTEICH, DOI DOI 10.1007/s11033-010-0107-1; Clarke K.R., 1994, CHANGE MARINE COMMUN, V2, P117; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Dudgeon D, 2000, ANNU REV ECOL SYST, V31, P239, DOI 10.1146/annurev.ecolsys.31.1.239; Duncan JR, 2001, BIOL CONSERV, V102, P97, DOI 10.1016/S0006-3207(01)00077-5; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Fu CZ, 2003, BIODIVERS CONSERV, V12, P1649, DOI 10.1023/A:1023697714517; Guo S., 2012, FISH COMMUNITY STRUC; Guo Zhizi, 1995, Journal of Nanchang University (Natural Science), V19, P222; HARVEY BC, 1991, OECOLOGIA, V87, P336, DOI 10.1007/BF00634588; He MC, 1998, WATER RES, V32, P510, DOI 10.1016/S0043-1354(97)00229-7; Hsieh K. H., 2020, INEXT INTERPOLATION; Hu ML, 2010, J NANCHANG U NAT SCI, V34, P90; Huang LL, 2013, ENVIRON BIOL FISH, V96, P1229, DOI 10.1007/s10641-011-9806-2; Institute of Hydrobiology Chinese Academy of Sciences, 1976, YANGTZ RIV FISH; Jiang Zhigang, 2016, Biodiversity Science, V24, P500, DOI 10.17520/biods.2016076; Kang B, 2013, AMBIO, V42, P877, DOI 10.1007/s13280-013-0422-6; Kang B, 2009, REV FISH BIOL FISHER, V19, P465, DOI 10.1007/s11160-009-9114-5; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Larinier M, 2000, DAMS FISH MIGRATION; Leidy Robert A., 1998, P187; Liu J., 1992, RESOUR ENV YANGTZE V, V1, P17, DOI DOI 10.1093/BIOSCI/BIX110; Liu Shao-ping, 2002, Acta Hydrobiologica Sinica, V26, P679; Liu XJ, 2018, LAKE RESERV MANAGE, V34, P42, DOI 10.1080/10402381.2017.1373716; Magoulick DD, 2004, HYDROBIOLOGIA, V527, P209, DOI 10.1023/B:HYDR.0000043302.32382.59; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Magurran AE, 2009, SCIENCE, V325, P1215, DOI 10.1126/science.1177215; Marchetti MP, 2001, ECOL APPL, V11, P530, DOI 10.2307/3060907; MATTHEWS WJ, 1979, COPEIA, P70; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Nogueira C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011390; Oberdorff T, 2002, FRESHWATER BIOL, V47, P1720, DOI 10.1046/j.1365-2427.2002.00884.x; Olden JD, 2006, GLOBAL ECOL BIOGEOGR, V15, P113, DOI 10.1111/j.1466-822x.2006.00214.x; Peet R.K., 1974, Annual Rev Ecol Syst, V5, P285, DOI 10.1146/annurev.es.05.110174.001441; Petts GE, 2000, HYDROBIOLOGIA, V422, P15, DOI 10.1023/A:1017062032685; Pinkas L., 1971, CALIF DEP FISH GAME, V152, P1, DOI DOI 10.1201/B18714-2; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Puth LM, 2001, CONSERV BIOL, V15, P21, DOI 10.1046/j.1523-1739.2001.99554.x; R Core Team, 2021, R LANGUAGE ENV STAT; Richter BD, 1997, CONSERV BIOL, V11, P1081, DOI 10.1046/j.1523-1739.1997.96236.x; Rosenfield JA, 2002, GLOBAL ECOL BIOGEOGR, V11, P323, DOI 10.1046/j.1466-822X.2002.00287.x; Sa-Oliveira JC, 2015, FRESHWATER BIOL, V60, P2037, DOI 10.1111/fwb.12628; [苏念 Su Nian], 2012, [华中农业大学学报, Journal of Huazhong Agricultural University], V31, P756; Tang WQ, 1993, RESERV FISH, V65, P18; TERBRAAK CJF, 1995, AQUAT SCI, V57, P255, DOI 10.1007/BF00877430; Tian JL, 1989, FRESHW FISH, V19, P33; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; van Zalinge N, 2001, CAMBODIA FISHERIES T, VIII; Wang HJ, 2004, J WATER RESOUR ARCHI, V2, P19; Wei QW, 1997, ENVIRON BIOL FISH, V48, P241, DOI 10.1023/A:1007395612241; Wozney KM, 2011, ENVIRON BIOL FISH, V90, P183, DOI 10.1007/s10641-010-9730-x; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312; Xie P, 2003, SCIENCE, V302, P1149; Yan YZ, 2011, ECOL FRESHW FISH, V20, P199, DOI 10.1111/j.1600-0633.2010.00478.x; Yu Z., 2006, CHIN FISH EC, V5, P43; Yue P.Q, 2000, FAUNA SINICA OSTEICH; ZHANG JM, 2010, J HYDROECOLOGY, V3, P34; ZHANG ZL, 2008, JIANGXI HYDRAULIC SC, V34, P7; Zhong YX, 2005, JIANGXI FISHERY SCI, V101, P15; Zou SZ, 2011, EFFECTS LARGE HYDRAU	68	12	17	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0205116	10.1371/journal.pone.0205116	http://dx.doi.org/10.1371/journal.pone.0205116			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388121	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800011
J	Thabet, SG; Moursi, YS; Karam, MA; Graner, A; Alqudah, AM				Thabet, Samar G.; Moursi, Yasser S.; Karam, Mohamed A.; Graner, Andreas; Alqudah, Ahmad M.			Genetic basis of drought tolerance during seed germination in barley	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; NATURAL VARIATION; ARABIDOPSIS-THALIANA; TERMINAL DROUGHT; STRESS; GROWTH; YIELD; OVEREXPRESSION; ESTABLISHMENT; ASSOCIATIONS	Drought is one of the harshest abiotic stresses hindering seed germination, plant growth, and crop productivity. A high rate and uniformity of germination under stressful conditions are vital for crop establishment and growth; thus, for productivity. A better understanding of the genetic architecture of seed germination under drought stress is a prerequisite for further increasing yield potential. Barley is considered one of the most abiotic stresses-tolerant cereals. Elucidating the drought tolerance of barley during seed germination would indeed pave the way towards improving the performance of all cereals. However, we still know relatively little about the genetic control of drought tolerance during the seed germination phase. In our study, 218 worldwide spring barley accessions were subjected to PEG-induced drought during seed germination. Induced drought stress "20% PEG" significantly reduced the seed germination parameters and seedling related traits. A genome-wide association scan (GWAS) was used to identify genomic regions associated with our trait of interest. In total, 338 single nucleotide polymorphisms (SNPs) were found to be associated with several traits distributed across seven barley chromosomes, of which 26 genomic regions were associated with candidate genes. The current study found some of the quantitative trait loci (QTL) that have previously been reported to be linked to seed germination-related traits under drought conditions, as well as some new associations. Noteworthy, the identified QTL colocalized with a number of genes (within interval +/- 0.5 Mbp) that are exclusively distributed on chromosomes 1 H, 2H, and 5H. The annotation of these genes in barley shows their roles in drought tolerance through encoding different transcription factors. The function of the identified genes during seed germination was also confirmed by the annotation of their counterparts in Arabidopsis. The current analyses show the power of the GWAS both for identifying putative candidate genes and for improving plant adaptive traits in barley.	[Thabet, Samar G.; Moursi, Yasser S.; Karam, Mohamed A.] Univ Fayoum, Fac Sci, Dept Bot, Al Fayyum, Egypt; [Graner, Andreas] Leibniz Inst Plant Genet & Crop Plant Res, Res Grp Genome Divers, OT, Gatersleben, Germany; [Alqudah, Ahmad M.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Res Grp Resources Genet & Reprod, OT, Gatersleben, Germany	Egyptian Knowledge Bank (EKB); Fayoum University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Moursi, YS (corresponding author), Univ Fayoum, Fac Sci, Dept Bot, Al Fayyum, Egypt.; Alqudah, AM (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Genebank, Res Grp Resources Genet & Reprod, OT, Gatersleben, Germany.	ysm01@fayoum.edu.eg; alqudah@ipk-gatersleben.de	Karam, Mohamed/ABD-5191-2021; Gamal, Samar/CAE-9760-2022; Alqudah, Ahmad M./I-7062-2012	Alqudah, Ahmad M./0000-0002-0436-9724; Karam, Mohamed Anwar/0000-0001-8131-6194; Graner, Andreas/0000-0003-3246-6393; Moursi, Yasser/0000-0002-4036-0436				Aggarwal Sipla, 2015, Plants-Basel, V4, P298, DOI 10.3390/plants4020298; Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Alqudah AM, 2018, THEOR APPL GENET, V131, P873, DOI 10.1007/s00122-018-3053-2; Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; Alqudah AM, 2016, FRONT GENET, V7, P1, DOI [10.3389/fgene.2016.00001, DOI 10.3389/FGENE.2016.00001]; Ansari O., 2012, Journal of Stress Physiology & Biochemistry, V8, P253; Chloupek O, 2010, PLANT BREEDING, V129, P630, DOI 10.1111/j.1439-0523.2010.01801.x; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Cho SK, 2006, PLANT PHYSIOL, V142, P1664, DOI 10.1104/pp.106.087965; Comadran J, 2012, NAT GENET, V44, P1388, DOI 10.1038/ng.2447; Demarsy E, 2012, J EXP BOT, V63, P925, DOI 10.1093/jxb/err322; Demarsy E, 2006, PLANT PHYSIOL, V142, P993, DOI 10.1104/pp.106.085043; FAO, 2015, FAO STATISTICAL POCK; Forster BP, 2004, ANN APPL BIOL, V144, P157, DOI 10.1111/j.1744-7348.2004.tb00329.x; Friedel S, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00294; Grando S, 1995, EUPHYTICA, V86, P73, DOI 10.1007/BF00035941; Hetz W, 1996, PLANT J, V10, P845, DOI 10.1046/j.1365-313X.1996.10050845.x; Hossain MR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00567; Huang YC, 2012, RICE, V5, DOI 10.1186/1939-8433-5-33; Jiang WB, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-96; Kalladan R, 2013, MOL BREEDING, V32, P71, DOI 10.1007/s11032-013-9853-9; Kaur H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00713; Khokhar M. I., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P287; Kim SJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00028; KJAER B, 1991, PLANT BREEDING, V106, P261, DOI 10.1111/j.1439-0523.1991.tb00511.x; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Lee SJ, 2015, PLANT CELL PHYSIOL, V56, P84, DOI 10.1093/pcp/pcu148; Lobato A. K. S., 2008, Agricultural Journal, V3, P220; Lu B, 2007, J EXP BOT, V58, P2565, DOI 10.1093/jxb/erm107; Mansour E, 2014, MOL BREEDING, V33, P249, DOI 10.1007/s11032-013-9946-5; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Mascher M, 2013, PLANT J, V76, P718, DOI 10.1111/tpj.12319; Mathews K, GENSTAT QTL ANAL GUI; Mehravaran L., 2014, International Journal of Biosciences (IJB), V5, P248; Mikolajczak K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155938; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Ogrodowicz P, 2017, J APPL GENET, V58, P49, DOI 10.1007/s13353-016-0363-4; Partheeban C., 2017, INT J CURR MICROBIOL, V6, P1095, DOI DOI 10.20546/IJCMAS.2017.605.119; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Prabu G, 2011, PLANT MOL BIOL REP, V29, P291, DOI 10.1007/s11105-010-0230-0; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Reddy PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089125; Rollins JA, 2013, THEOR APPL GENET, V126, P2803, DOI 10.1007/s00122-013-2173-y; Samarah NH, 2009, J AGRON CROP SCI, V195, P427, DOI 10.1111/j.1439-037X.2009.00387.x; Samarah N, 2011, ARCH AGRON SOIL SCI, V57, P27, DOI 10.1080/03650340903191663; Sayed MAE-AAE-H, 2011, THESIS, P165; Shao HB, 2008, CR BIOL, V331, P587, DOI 10.1016/j.crvi.2008.03.012; Sharma M, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01218; Singh A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39266; Soda N, 2013, FUNCT INTEGR GENOMIC, V13, P351, DOI 10.1007/s10142-013-0328-1; Storey J. D., 2003, STAT SIGNIFICANCE GE, V2003; Tai WCS, 2001, FEBS LETT, V500, P177, DOI 10.1016/S0014-5793(01)02599-6; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Teulat B, 1997, NEW PHYTOL, V137, P99, DOI 10.1046/j.1469-8137.1997.00815.x; Turoczy Z, 2011, PLANT MOL BIOL, V75, P399, DOI 10.1007/s11103-011-9735-7; Tuteja N, 2008, PLANT SIGNAL BEHAV, V3, P525, DOI 10.4161/psb.3.8.6186; Varshney RK, 2012, FIELD CROP RES, V126, P171, DOI 10.1016/j.fcr.2011.10.008; Verslues PE, 2011, CURR OPIN PLANT BIOL, V14, P240, DOI 10.1016/j.pbi.2011.04.006; Wang R, 2011, COMMON UNIQUE ELEMEN; Wang XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101706; Witcombe JR, 2008, PHILOS T R SOC B, V363, P703, DOI 10.1098/rstb.2007.2179; Xuan JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075705; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yao X, 2012, J EXP BOT, V63, P2579, DOI 10.1093/jxb/err433; Yigit N, DETERMINATION EFFECT	65	38	41	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206682	10.1371/journal.pone.0206682	http://dx.doi.org/10.1371/journal.pone.0206682			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388157	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800052
J	Adeh, EH; Selker, JS; Higgins, CW				Adeh, Elnaz Hassanpour; Selker, John S.; Higgins, Chad W.			Remarkable agrivoltaic influence on soil moisture, micrometeorology and water-use efficiency	PLOS ONE			English	Article							PHOTOVOLTAIC PANELS; SOLAR; ENERGY	Power demands are set to increase by two-fold within the current century and a high fraction of that demand should be met by carbon free sources. Among the renewable energies, solar energy is among the fastest growing; therefore, a comprehensive and accurate design methodology for solar systems and how they interact with the local environment is vital. This paper addresses the environmental effects of solar panels on an unirrigated pasture that often experiences water stress. Changes to the microclimatology, soil moisture, water usage, and biomass productivity due to the presence of solar panels were quantified. The goal of this study was to show that the impacts of these factors should be considered in designing the solar farms to take advantage of potential net gains in agricultural and power production. Microclimatological stations were placed in the Rabbit Hills agrivoltaic solar arrays, located in Oregon State campus, two years after the solar array was installed. Soil moisture was quantified using neutron probe readings. Significant differences in mean air temperature, relative humidity, wind speed, wind direction, and soil moisture were observed. Areas under PV solar panels maintained higher soil moisture throughout the period of observation. A significant increase in late season biomass was also observed for areas under the PV panels (90% more biomass), and areas under PV panels were significantly more water efficient (328% more efficient).	[Adeh, Elnaz Hassanpour; Selker, John S.; Higgins, Chad W.] Oregon State Univ, Dept Biol & Ecol Engn, Corvallis, OR 97331 USA	Oregon State University	Adeh, EH (corresponding author), Oregon State Univ, Dept Biol & Ecol Engn, Corvallis, OR 97331 USA.	hassanpe@oregonstate.edu			National Institute of Food and Agriculture, U.S. Department of Agriculture [OREZ-FERM-852-E]; National Science Foundation [EAR - 1740082]	National Institute of Food and Agriculture, U.S. Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number OREZ-FERM-852-E, and by National Science Foundation award number EAR - 1740082. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeh E. H., 2017, REMARKABLE SOLAR PAN; APPELBAUM J, 1979, SOL ENERGY, V23, P497, DOI 10.1016/0038-092X(79)90073-2; Armstrong A, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074016; Barron-Gafford GA, 2016, SCI REP-UK, V6, DOI 10.1038/srep35070; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; De Bruijn SL, 2006, BIOL CONTROL, V36, P305, DOI 10.1016/j.biocontrol.2005.10.007; Dinesh H, 2016, RENEW SUST ENERG REV, V54, P299, DOI 10.1016/j.rser.2015.10.024; Dupraz C, 2011, RENEW ENERG, V36, P2725, DOI 10.1016/j.renene.2011.03.005; Dupraz C, 2011, MIX NOT MIX EVIDENCE; Hu AX, 2016, NAT CLIM CHANGE, V6, P290, DOI [10.1038/nclimate2843, 10.1038/NCLIMATE2843]; Kadowaki M, 2012, BIOSYST ENG, V111, P290, DOI 10.1016/j.biosystemseng.2011.12.006; Lewis NS, 2006, P NATL ACAD SCI USA, V103, P15729, DOI 10.1073/pnas.0603395103; Marrou H, 2013, EUR J AGRON, V50, P38, DOI 10.1016/j.eja.2013.05.004; Marrou H, 2013, EUR J AGRON, V44, P54, DOI 10.1016/j.eja.2012.08.003; Millstein D, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034001; Murphy M. J, 1976, GRASS VARIETIES CENT; Nonhebel S, 2005, RENEW SUST ENERG REV, V9, P191, DOI 10.1016/j.rser.2004.02.003; PARKES ME, 1979, J AGR ENG RES, V24, P87, DOI 10.1016/0021-8634(79)90063-5; Pavageau M, 1999, ATMOS ENVIRON, V33, P3961, DOI 10.1016/S1352-2310(99)00138-7; Ravi S, 2014, ENVIRON SCI TECHNOL, V48, P3021, DOI 10.1021/es404950n; Rodman LC, 2006, ENERG POLICY, V34, P2137, DOI 10.1016/j.enpol.2005.03.004; Rogner H. H., 2012, GLOBAL ENERGY ASSESS, P423, DOI DOI 10.13140/RG.2.1.3049.8724; Scherba A, 2011, BUILD ENVIRON, V46, P2542, DOI 10.1016/j.buildenv.2011.06.012; Seidlova L, 2009, PLANT ECOL, V200, P303, DOI 10.1007/s11258-008-9454-6; Trancik JE, 2014, NATURE, V507, P300, DOI 10.1038/507300a	25	74	76	20	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0203256	10.1371/journal.pone.0203256	http://dx.doi.org/10.1371/journal.pone.0203256			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383761	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600008
J	Rodriguez-Abello, DC; Navarro-Alberto, JA; Ramirez-Aviles, L; Zamora-Bustillos, R				Carolina Rodriguez-Abello, Diana; Augusto Navarro-Alberto, Jorge; Ramirez-Aviles, Luis; Zamora-Bustillos, Roberto			The effect of sowing time on the growth of chia (Salvia hispanica L.): What do nonlinear mixed models tell us about it?	PLOS ONE			English	Article							SENESCENCE; REGRESSION; DESCRIBE; PACKAGE; DEATH	Chia (Salvia hispanica L.) is an annual short-day plant whose growth has not been studied extensively in low-altitudes and at temperatures outside of its optimal range. The objective of this study was to describe the growth dynamics of a chia crop from an experimental plantation in south-east Mexico, on three different sowing dates. The chia grew at temperatures (18-37 degrees C) and an altitude (9 m a.s.l.) outside of the recommended conditions (20-30 degrees C, 500-1000 m a.s.l.). Three individual-plant responses were measured weekly, before seed harvest: height, number of leaves and number of inflorescences. Three theoretical nonlinear growth models were fitted to the data, a different model for each response. Mixed-effect model parameters were estimated by maximum likelihood, and the goodness of fit for each model was evaluated using two criteria: Modeling Efficiency and Root Mean Square Error. Chia seed yield was also measured in each treatment. Estimated parameters for plant height confirmed that medium sowing time (MST) and late sowing time (LST) plants had smaller heights than the early sowing time (EST) plants. Moreover, at the end of their life cycle, EST plants had a greater number of leaves and inflorescences, and higher seed yield. All of these differences were associated to the extended time of vegetative growth of EST plants favored by optimal photoperiod and temperature. Growth dynamics of chia during its ontogenic phases was explored, in more detail, with relative growth parameters derived from fitted models: a decrease in photoperiod influences the beginning of the reproductive phase, with the consequent reduction in speed of vegetative growth. In addition, nonlinear mixed-effects models can be useful in understanding the relation between growth parameters, plant maturity, and the suitable time for chia seed harvest. Our results suggest chia crops are adaptable to non-conventional environmental conditions.	[Carolina Rodriguez-Abello, Diana; Ramirez-Aviles, Luis] Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Dept Prod & Anim Agroecosistemas Trop, Merida, Yucatan, Mexico; [Augusto Navarro-Alberto, Jorge] Univ Autonoma Yucatan, Campus Ciencias Biol & Agr, Dept Ecol Trop, Merida, Yucatan, Mexico; [Zamora-Bustillos, Roberto] Inst Tecnol Conkal, Div Estudios Posgrad & Invest, Conkal, Yucatan, Mexico	Universidad Autonoma de Yucatan; Universidad Autonoma de Yucatan	Ramirez-Aviles, L (corresponding author), Univ Autonoma Yucatan, Fac Med Vet & Zootecnia, Dept Prod & Anim Agroecosistemas Trop, Merida, Yucatan, Mexico.	luis.ramirez@correo.uady.mx	Alberto, Jorge A. Navarro/A-5086-2016; ZAMORA, ROBERTO/HCH-8022-2022; Alberto, Jorge Navarro/AAG-9078-2019					Aguilar F, 2010, THESIS; Ali NM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/171956; [Anonymous], 1992, PLANT PHYSIOL; Arriagada C, 2014, THESIS; Avanza MM, 2008, SPAN J AGRIC RES, V6, P577, DOI 10.5424/sjar/2008064-352; Ayerza (h.) Ricardo, 2014, Rev. ind. agric. Tucumán, V91, P33; AYERZA R, 1995, J AM OIL CHEM SOC, V72, P1079, DOI 10.1007/BF02660727; AYERZA R, 2005, REDISCOVERING FORGOT; Ayerza R, 2009, IND CROP PROD, V30, P321, DOI 10.1016/j.indcrop.2009.03.009; Baginsky C, 2016, CHIL J AGR RES, V76, P255, DOI 10.4067/S0718-58392016000300001; Baty F, 2015, J STAT SOFTW, V66, P1; Busilacchi Héctor, 2013, cultrop, V34, P55; Cahill Joseph P., 2005, Journal of Ethnobiology, V25, P155, DOI 10.2993/0278-0771(2005)25[155:HSADOC]2.0.CO;2; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Faber NKM, 1999, CHEMOMETR INTELL LAB, V49, P79, DOI 10.1016/S0169-7439(99)00027-1; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Gregersen PL, 2013, PLANT MOL BIOL, V82, P603, DOI 10.1007/s11103-013-0013-8; Guiboileau A, 2010, CR BIOL, V333, P382, DOI 10.1016/j.crvi.2010.01.016; Gomez JAH, 2008, REV FITOTEC MEX, V31, P105; INEGI, 2009, PRONT INF GEOGR MUN; Jamboonsri W, 2012, GENET RESOUR CROP EV, V59, P171, DOI 10.1007/s10722-011-9673-x; Karadavut U., 2008, J AGR ENV SCI, V3, P888; Kebreab E, 2007, J ANIM SCI, V85, P2498, DOI 10.2527/jas.2006-738; Masclaux C, 2000, PLANTA, V211, P510, DOI 10.1007/s004250000310; NELDER JA, 1961, BIOMETRICS, V17, P89, DOI 10.2307/2527498; Oswald SA, 2012, METHODS ECOL EVOL, V3, P1073, DOI 10.1111/j.2041-210X.2012.00231.x; Paine CET, 2012, METHODS ECOL EVOL, V3, P245, DOI 10.1111/j.2041-210X.2011.00155.x; PEROTTO D, 1992, CAN J ANIM SCI, V72, P773, DOI 10.4141/cjas92-089; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Core Team, 2018, R LANG ENV STAT COMP; Ramirez JG, 2012, REV FAC ING QUIMICA, V52, P32; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Ritz C, 2008, USE R, P1; Small Ernest, 2011, Biodiversity (Ottawa), V12, P49, DOI 10.1080/14888386.2011.575104; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; Tornoe CW, 2004, COMPUT METH PROG BIO, V76, P31, DOI 10.1016/j.cmpb.2004.01.001; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Werker AR, 1997, ANN BOT-LONDON, V79, P657, DOI 10.1006/anbo.1997.0387; Yang JM, 2014, AGR SYST, V127, P81, DOI 10.1016/j.agsy.2014.01.008; Yin XY, 2003, ANN BOT-LONDON, V91, P361, DOI 10.1093/aob/mcg029	40	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206582	10.1371/journal.pone.0206582	http://dx.doi.org/10.1371/journal.pone.0206582			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383782	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600067
J	Phillips, S; Robbins, A; Loader, J; Hanger, J; Booth, R; Jelocnik, M; Polkinghorne, A; Timms, P				Phillips, Samuel; Robbins, Amy; Loader, Joanne; Hanger, Jonathan; Booth, Rosemary; Jelocnik, Martina; Polkinghorne, Adam; Timms, Peter			Chlamydia pecorum gastrointestinal tract infection associations with urogenital tract infections in the koala (Phascolarctos cinereus)	PLOS ONE			English	Article							TRACHOMATIS PLASMID; PREVALENCE; CATTLE; IDENTIFICATION; EPIDEMIOLOGY; RETROVIRUS; ORGANISMS; GENOTYPES; PSITTACI; STRAINS	Background Chlamydia infects multiple sites within hosts, including the gastrointestinal tract (GIT). In certain hosts, gastrointestinal infection is linked to treatment avoidance and self-infection at disease susceptible sites. GIT C. pecorum has been detected in livestock and koalas, however GIT prevalence rates within the koala are yet to be established. Methods Paired conjunctival, urogenital and rectal samples from 33 koalas were screened for C. pecorum and C. pecorum plasmid using 16S rRNA and CDS5-specific quantitative PCR assays, respectively. Amplicon sequencing of 359 bp ompA fragment was used to identify site-specific genotypes. Results The overall C. pecorum prevalence collectively (healthy and clinically diseased koalas) was 51.5%, 57.6% and 42.4% in urogenital, conjunctival and gastrointestinal sites, respectively. Concurrent urogenital and rectal Chlamydia was identified in 14 koalas, with no cases of GIT only Chlamydia shedding. The ompA genotype G dominated the GIT positive samples, and genotypes A and E' were dominant in urogenital tract (UGT) positive samples. Increases in C. pecorum plasmid per C. pecorum load (detected by PCR) showed clustering in the clinically diseased koala group (as assessed by scatter plot analysis). There was also a low correlation between plasmid positivity and C. pecorum infected animals at any site, with a prevalence of 47% UGT, 36% rectum and 40% faecal pellet. Conclusions GIT C. pecorum PCR positivity suggests that koala GIT C. pecorum infections are common and occur regularly in animals with concurrent genital tract infections. GIT dominant genotypes were identified and do not appear to be related to plasmid positivity. Preliminary results indicated a possible association between C. pecorum plasmid load and clinical UGT disease.	[Phillips, Samuel; Robbins, Amy; Timms, Peter] Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia; [Robbins, Amy; Loader, Joanne; Hanger, Jonathan] Endeavour Vet Ecol Pty Ltd, Toorbul, Australia; [Booth, Rosemary] Australia Zoo Wildlife Hosp, Beerwah, Australia; [Jelocnik, Martina; Polkinghorne, Adam] Univ Sunshine Coast, Anim Res Ctr, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast	Phillips, S (corresponding author), Univ Sunshine Coast, Genecol Res Ctr, Fac Sci Hlth Educ & Engn, Sunshine Coast, Qld, Australia.	Samuel.phillips@research.usc.edu.au		Polkinghorne, Adam/0000-0002-6567-2962; Robbins, Amy/0000-0001-9231-0636; Phillips, Samuel/0000-0002-2549-8111; Jelocnik, Martina/0000-0003-1340-2562; Timms, Peter/0000-0002-1682-0025	Australian Research Council (ARC); Queensland Government (Department of Transport and Main Roads); EVE; Moreton Bay Rail Link project team	Australian Research Council (ARC)(Australian Research Council); Queensland Government (Department of Transport and Main Roads); EVE; Moreton Bay Rail Link project team	This project was financially supported by Australian Research Council (ARC, Linkage Scheme) to PT and AP. This project was significantly supported by the Queensland Government (Department of Transport and Main Roads) and specifically the Moreton Bay Rail Link project team. JH, JL and AR were employed by Endeavour Veterinary Ecology (EVE). EVE provided support in the form of salaries for JH, JL and AR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Australian Research Council also did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Alfano N, 2015, SCI REP-UK, V5, DOI 10.1038/srep10189; Barker CJ, 2013, VET MICROBIOL, V167, P554, DOI 10.1016/j.vetmic.2013.08.025; Bodley K., 2008, MED AUSTR MAMMALS; Burach F, 2014, VET MICROBIOL, V172, P230, DOI 10.1016/j.vetmic.2014.04.022; Burnard D, 2016, VET MICROBIOL, V196, P78, DOI 10.1016/j.vetmic.2016.10.018; Carlson JH, 2008, INFECT IMMUN, V76, P2273, DOI 10.1128/IAI.00102-08; de Villiers D., 2015, ROLE URBAN KOALAS MA; Devereaux LN, 2003, SYST APPL MICROBIOL, V26, P245, DOI 10.1078/072320203322346092; Ferreira R, 2013, MICROBIOL RES, V168, P333, DOI 10.1016/j.micres.2013.02.001; GARLAND SM, 1995, MED J AUSTRALIA, V162, P363, DOI 10.5694/j.1326-5377.1995.tb139939.x; Gedye KR, 2018, NEW ZEAL VET J, V66, P162, DOI 10.1080/00480169.2018.1439779; Guo WN, 2016, SCI REP-UK, V6, DOI 10.1038/srep19638; Jackson M, 1997, SYST APPL MICROBIOL, V20, P187, DOI 10.1016/S0723-2020(97)80065-3; Jeffrey BM, 2010, INFECT IMMUN, V78, P2544, DOI 10.1128/IAI.01324-09; Jelocnik M, 2017, PEERJ, V5, DOI 10.7717/peerj.3799; Jelocnik M, 2016, PEERJ, V4, DOI 10.7717/peerj.1661; Jelocnik M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2053-8; Jelocnik M, 2014, VET MICROBIOL, V174, P214, DOI 10.1016/j.vetmic.2014.08.018; Jelocnik M, 2013, J CLIN MICROBIOL, V51, P2625, DOI 10.1128/JCM.00992-13; Kollipara A, 2013, VET MICROBIOL, V167, P513, DOI 10.1016/j.vetmic.2013.08.009; Korenromp EL, 2002, INT J STD AIDS, V13, P91, DOI 10.1258/0956462021924712; Lawrence A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31466; Legione AR, 2016, J MED MICROBIOL, V65, P420, DOI 10.1099/jmm.0.000241; Li J, 2016, VET MICROBIOL, V193, P93, DOI 10.1016/j.vetmic.2016.08.008; Li L, 2017, EPIDEMIOL INFECT, V145, P2701, DOI 10.1017/S0950268817001650; Ljubin-Sternak S, 2014, J PATHOG, V2014, DOI 10.1155/2014/183167; Marsh J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-77; Menon S, 2015, CLIN MICROBIOL REV, V28, P969, DOI 10.1128/CMR.00035-15; Nyari S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190114; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Rank RG, 2014, INFECT IMMUN, V82, P1362, DOI 10.1128/IAI.01244-13; Reinhold P, 2008, VET J, V175, P202, DOI 10.1016/j.tvjl.2007.01.004; Reinhold P, 2011, VET J, V189, P257, DOI 10.1016/j.tvjl.2010.09.003; Rhodes JR, 2011, BIOL CONSERV, V144, P1081, DOI 10.1016/j.biocon.2010.12.027; Shao LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177691; Shojima T, 2013, J VIROL, V87, P9943, DOI 10.1128/JVI.01385-13; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Taylor KA, 2018, ZOONOSES PUBLIC HLTH, V65, P218, DOI 10.1111/zph.12391; Taylor-Brown A., 2017, New Microbes and New Infections, V18, P28, DOI 10.1016/j.nmni.2017.04.004; Walker E, 2016, BMC VET RES, V12, DOI 10.1186/s12917-016-0832-3; Wedrowicz F, 2016, CONSERV GENET RESOUR, V8, P511, DOI 10.1007/s12686-016-0574-3; Yang RC, 2014, VET J, V201, P322, DOI 10.1016/j.tvjl.2014.05.037; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052	44	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206471	10.1371/journal.pone.0206471	http://dx.doi.org/10.1371/journal.pone.0206471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383822	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600053
J	Xu, ZL; Chang, YP; Li, L; Luo, QH; Xu, ZY; Li, XF; Qiao, XW; Xu, XY; Song, XN; Wang, Y; Cao, YE				Xu, Zhonglin; Chang, Yapeng; Li, Lu; Luo, Qinghui; Xu, Zeyuan; Li, Xiaofei; Qiao, Xuewei; Xu, Xinyi; Song, Xinni; Wang, Yao; Cao, Yue'e			Climatic and topographic variables control soil nitrogen, phosphorus, and nitrogen: Phosphorus ratios in a Picea schrenkiana forest of the Tianshan Mountains	PLOS ONE			English	Article							N-P STOICHIOMETRY; ECOLOGICAL STOICHIOMETRY; BIOGEOCHEMICAL CONSEQUENCES; ALTITUDINAL GRADIENTS; NUTRIENT LIMITATION; CNP STOICHIOMETRY; ENZYME-ACTIVITY; LOESS PLATEAU; PLANT-GROWTH; LAND-USE	Knowledge about soil nitrogen (N) and phosphorus (P) concentrations, stocks, and stoichiometric ratios is crucial for understanding the biogeochemical cycles and ecosystem function in arid mountainous forests. However, the corresponding information is scarce, particularly in arid mountainous forests. To fill this gap, we investigated the depth and elevational patterns of the soil N and P concentrations and the N: P ratios in a Picea schrenkiana forest using data from soil profiles collected during 2012-2017. Our results showed that the soil N and P concentrations and the N: P ratios varied from 0.15 g kg(-1) to 0.56 g kg(-1) (average of 0.31 g kg(-1)), from 0.09 g kg(-1) to 0.16 g kg(-1) (average of 0.12 g kg(-1)), and from 2.42 g kg(-1) to 4.36 g kg(-1) (average of 3.42 g kg(-1)), respectively; additionally, values significantly and linearly decreased with soil depth. We did not observe a significant variation in the soil N and P concentrations and the N: P ratios with the elevational gradient. In contrast, our results revealed that the mean annual temperature and mean annual precipitation exhibited a more significant influence on the soil N and P concentrations and the N: P ratios than did elevation. This finding indicated that climatic variables might have a more direct impact on soil nutrient status than elevation. The observed relationship among the soil N and P concentrations and the N: P ratios demonstrated that the soil N was closely coupled with the soil P in the P. schrenkiana forest.	[Xu, Zhonglin; Chang, Yapeng; Li, Lu; Luo, Qinghui; Xu, Zeyuan; Li, Xiaofei; Qiao, Xuewei; Xu, Xinyi; Song, Xinni; Cao, Yue'e] Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Xinjiang, Peoples R China; [Xu, Zhonglin] Xinjiang Univ, Key Lab Oasis Ecol, Minist Educ, Urumqi, Xinjiang, Peoples R China; [Wang, Yao] CMA, Inst Desert Meteorol, Urumqi, Xinjiang, Peoples R China	Xinjiang University; Xinjiang University; China Meteorological Administration	Xu, ZL (corresponding author), Xinjiang Univ, Coll Resource & Environm Sci, Urumqi, Xinjiang, Peoples R China.; Xu, ZL (corresponding author), Xinjiang Univ, Key Lab Oasis Ecol, Minist Educ, Urumqi, Xinjiang, Peoples R China.; Wang, Y (corresponding author), CMA, Inst Desert Meteorol, Urumqi, Xinjiang, Peoples R China.	galinwa@gmail.com; wangy09@lzu.edu.cn	Xu, Zhonglin/GQH-1906-2022; Li, xiaofei/GXF-7187-2022		National Science Foundation of China [31500398, 41361098]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this study was provided by the National Science Foundation of China (Nos. 31500398, 41361098). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2008, ANNU REV ECOL EVOL S, V39, P153, DOI 10.1146/annurev.ecolsys.39.110707.173515; Agren GI, 2012, NEW PHYTOL, V194, P953, DOI 10.1111/j.1469-8137.2012.04116.x; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; ATTIWILL PM, 1993, NEW PHYTOL, V124, P561, DOI 10.1111/j.1469-8137.1993.tb03847.x; Bauters M, 2017, BIOGEOSCIENCES, V14, P5313, DOI 10.5194/bg-14-5313-2017; Bing HJ, 2016, J SOIL SEDIMENT, V16, P405, DOI 10.1007/s11368-015-1200-9; Bonito GM, 2003, FOREST ECOL MANAG, V176, P563, DOI 10.1016/S0378-1127(02)00234-7; Boot CM, 2016, SOIL BIOL BIOCHEM, V92, P211, DOI 10.1016/j.soilbio.2015.10.002; BREMNER J M, 1972, Communications in Soil Science and Plant Analysis, V3, P159, DOI 10.1080/00103627209366361; Cao Y, 2017, TREES-STRUCT FUNCT, V31, P1559, DOI 10.1007/s00468-017-1569-8; Chen LY, 2016, J GEOPHYS RES-BIOGEO, V121, P2410, DOI 10.1002/2016JG003352; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cui Gao-Yang, 2015, Chinese Journal of Plant Ecology, V39, P1146, DOI 10.17521/cjpe.2015.0111; Cui W, 1996, SOILS IN XINJIANG; [戴丽 Dai Li], 2016, [干旱区研究, Arid Zone Research], V33, P780; Daufresne T, 2001, ECOL LETT, V4, P196, DOI 10.1046/j.1461-0248.2001.00210.x; De la Cruz M, 2017, BIORXIV, DOI [10.1101/147942, DOI 10.1101/147942]; Delgado-Baquerizo M, 2017, ENVIRON MICROBIOL, V19, P1176, DOI 10.1111/1462-2920.13642; Ding JZ, 2016, GLOBAL BIOGEOCHEM CY, V30, P1310, DOI 10.1002/2015GB005333; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Falkengren-Grerup U, 2006, FOREST ECOL MANAG, V225, P74, DOI 10.1016/j.foreco.2005.12.027; Fan HB, 2015, PLANT SOIL, V392, P127, DOI 10.1007/s11104-015-2444-2; Fekedulegn D, 2003, FOREST ECOL MANAG, V177, P409, DOI 10.1016/S0378-1127(02)00446-2; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fuhrer E, 2000, FOREST ECOL MANAG, V132, P29, DOI 10.1016/S0378-1127(00)00377-7; Golay MG, 2016, APPL VEG SCI, V19, P689, DOI 10.1111/avsc.12253; Hattenschwiler S, 2010, J ECOL, V98, P754, DOI 10.1111/j.1365-2745.2010.01671.x; Han WX, 2005, NEW PHYTOL, V168, P377, DOI 10.1111/j.1469-8137.2005.01530.x; Hanson PJ, 2001, TREE PHYSIOL, V21, P345, DOI 10.1093/treephys/21.6.345; Harpole WS, 2011, ECOL LETT, V14, P852, DOI 10.1111/j.1461-0248.2011.01651.x; Harris GP, 2001, MAR FRESHWATER RES, V52, P139, DOI 10.1071/MF00031; He XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24261; Hume A, 2016, FOREST ECOL MANAG, V369, P1, DOI 10.1016/j.foreco.2016.03.033; HUNTINGTON TG, 1988, SOIL SCI SOC AM J, V52, P1162, DOI 10.2136/sssaj1988.03615995005200040049x; Jiang PP, 2017, FORESTS, V8, DOI 10.3390/f8080281; Jiao F, 2013, ECOL ENG, V58, P249, DOI 10.1016/j.ecoleng.2013.06.036; Jobbagy EG, 2004, ECOLOGY, V85, P2380, DOI 10.1890/03-0245; Jobbagy EG, 2001, BIOGEOCHEMISTRY, V53, P51, DOI 10.1023/A:1010760720215; Johnson BG, 2016, OECOLOGIA, V182, P299, DOI 10.1007/s00442-016-3655-9; Keith H, 1997, PLANT SOIL, V190, P127, DOI 10.1023/A:1004279300622; Kitayama K, 2002, J ECOL, V90, P37, DOI 10.1046/j.0022-0477.2001.00634.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; Li L, 2016, CAN J SOIL SCI, V96, P461, DOI 10.1139/cjss-2015-0122; Li P, 2014, GLOBAL ECOL BIOGEOGR, V23, P979, DOI 10.1111/geb.12190; Liu Xing-Zhao, 2010, Chinese Journal of Plant Ecology, V34, P64, DOI 10.3773/j.issn.1005-264x.2010.01.010; Liu XZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088070; Liu ZP, 2013, GEODERMA, V197, P67, DOI 10.1016/j.geoderma.2012.12.011; McGroddy ME, 2004, ECOLOGY, V85, P2390, DOI 10.1890/03-0351; Meng C, 2013, J NE FORESTRY U; Meyer M, 2013, LITHOS, V177, P207, DOI 10.1016/j.lithos.2013.06.015; Midgley MG, 2016, ECOLOGY, V97, P3369, DOI 10.1002/ecy.1595; Muller M, 2017, GEODERMA, V291, P21, DOI 10.1016/j.geoderma.2016.12.015; Mukai M, 2016, ECOL RES, V31, P719, DOI 10.1007/s11284-016-1381-8; Niklas KJ, 2005, ECOL LETT, V8, P636, DOI 10.1111/j.1461-0248.2005.00759.x; Nottingham AT, 2015, SOIL BIOL BIOCHEM, V80, P26, DOI 10.1016/j.soilbio.2014.09.012; Osborne BB, 2017, ECOSYSTEMS, V20, P1089, DOI 10.1007/s10021-016-0095-7; PASTOR J, 1986, BIOGEOCHEMISTRY, V2, P3, DOI 10.1007/BF02186962; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Sardans J, 2013, FOREST ECOL MANAG, V262, P2024; Sardans J, 2016, FUNCT ECOL, V30, P676, DOI 10.1111/1365-2435.12541; Schmidt SK, 2016, ECOSYSTEMS, V19, P1164, DOI 10.1007/s10021-016-9992-z; SHERMAN M. S., 1942, Industrial and Engineering Chemistry. Analytical edition, V14, P182, DOI 10.1021/i560102a037; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; SRIVASTAVA SC, 1991, SOIL BIOL BIOCHEM, V23, P117, DOI 10.1016/0038-0717(91)90122-Z; Sterner RW, ECOLOGICAL STOICHIOM, P225; Su HX, 2007, FOREST ECOL MANAG, V246, P273, DOI 10.1016/j.foreco.2007.04.010; Sun H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077090; Thorne JH, 2018, CLIMATIC CHANGE, V148, P387, DOI 10.1007/s10584-017-2010-4; Tian HQ, 2010, BIOGEOCHEMISTRY, V98, P139, DOI 10.1007/s10533-009-9382-0; Ushio M, 2015, FUNCT ECOL, V29, P1235, DOI 10.1111/1365-2435.12424; van Huysen TL, 2016, PLANT SOIL, V406, P1, DOI 10.1007/s11104-016-2857-6; Vincent AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092942; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wang F, 2008, VARIATIONS SOIL MICR; Wang K, 2013, APPL GEOGR, V42, P73, DOI 10.1016/j.apgeog.2013.04.002; Wang T, 2005, TREES-STRUCT FUNCT, V19, P735, DOI 10.1007/s00468-005-0003-9; Wang W, 2012, ANHUI AGR SCI B, V18, P95; Wang YQ, 2009, GEODERMA, V150, P141, DOI 10.1016/j.geoderma.2009.01.021; [谢锦 Xie Jin], 2016, [生态学报, Acta Ecologica Sinica], V36, P4363; Xu SJ, 2015, BIOCHEM SYST ECOL, V62, P58, DOI 10.1016/j.bse.2015.07.037; Xu ZW, 2017, SOIL BIOL BIOCHEM, V104, P152, DOI 10.1016/j.soilbio.2016.10.020; Yang Hui, 2015, Journal of Southern Agriculture, V46, P777; Yang K, 2015, ANN FOREST SCI, V72, P435, DOI 10.1007/s13595-014-0444-7; Yang Q, 2015, DISTRIBUTION CHARACT, P14; Yang Y.H., 2010, BIOGEOSCI DISCUSS, V7, P1, DOI [10.5194/bgd-7-1-2010, DOI 10.5194/BGD-7-1-2010]; Yu H, 2017, POLYMERS-BASEL, V9, DOI [10.3390/polym9090438, 10.13064/KSSS.2017.9.3.001]; [张广帅 Zhang Guangshuai], 2016, [生态学报, Acta Ecologica Sinica], V36, P675; [张继平 Zhang Jiping], 2014, [土壤, Soils], V46, P262; Zhao WeiJun, 2016, Acta Pedologica Sinica, V53, P477; Zhao X, 2015, LAND DEGRAD DEV, V26, P54, DOI 10.1002/ldr.2199; Zhou J, 2016, CATENA, V142, P102, DOI 10.1016/j.catena.2016.03.004; [朱秋莲 Zhu Qiulian], 2013, [生态学报, Acta Ecologica Sinica], V33, P4674; Zinke PJ, 2000, FOREST ECOL MANAG, V138, P159, DOI 10.1016/S0378-1127(00)00394-7	94	6	8	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0204130	10.1371/journal.pone.0204130	http://dx.doi.org/10.1371/journal.pone.0204130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383817	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600009
J	Tamberg, T; Hong, Z; De Schepper, D; Skovbjerg, S; Dupont, DM; Vitved, L; Schar, CR; Skjoedt, K; Vogel, LK; Jensen, JK				Tamberg, Trine; Hong, Zebin; De Schepper, Daphne; Skovbjerg, Signe; Dupont, Daniel M.; Vitved, Lars; Schar, Christine R.; Skjoedt, Karsten; Vogel, Lotte K.; Jensen, Jan K.			Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epitope mapping; cancer therapy; enzyme kinetics; enzyme inhibitor; surface plasmon resonance (SPR); serine protease; matriptase; multi-domain protein; TTSP; zymogen	HEPATOCYTE GROWTH-FACTOR; FACTOR ACTIVATOR INHIBITOR-1; EPITHELIAL DEVELOPMENT; PLASMINOGEN-ACTIVATOR; PROTEASE MATRIPTASE; CRYSTAL-STRUCTURE; POTENT; CLEAVAGE; SURVIVAL; COMPLEX	Matriptase is a member of the type-II transmembrane serine protease (TTSP) family and plays a crucial role in the development and maintenance of epithelial tissues. As all chymotrypsin-like serine proteases, matriptase is synthesized as a zymogen (proform), requiring a cleavage event for full activity. Recent studies suggest that the zymogen of matriptase possesses enough catalytic activity to not only facilitate autoactivation, but also carry out its in vivo functions, which include activating several proteolytic and signaling cascades. Inhibition of zymogen matriptase may therefore be a highly effective approach for limiting matriptase activity. To this end, here we sought to characterize the catalytic activity of human zymogen matriptase and to develop mAb inhibitors against this enzyme form. Using a mutated variant of matriptase in which the serine protease domain is locked in the zymogen conformation, we confirmed that the zymogen form of human matriptase has catalytic activity. Moreover, the crystal structure of the catalytic domain of zymogen matriptase was solved to 2.5 angstrom resolution to characterize specific antibody-based matriptase inhibitors and to further structure-based studies. Finally, we describe the first antibody-based competitive inhibitors that target both the zymogen and activated forms of matriptase. We propose that these antibodies provide a more efficient way to regulate matriptase activity by targeting the protease both before and after its activation and may be of value for both research and preclinical applications.	[Tamberg, Trine; Hong, Zebin; De Schepper, Daphne; Dupont, Daniel M.; Schar, Christine R.; Jensen, Jan K.] Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark; [Vitved, Lars; Skjoedt, Karsten] Univ Southern Denmark, Dept Canc & Inflammat, DK-5230 Odense, Denmark; [Skovbjerg, Signe; Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, DK-1165 Copenhagen, Denmark	Aarhus University; University of Southern Denmark; University of Copenhagen	Jensen, JK (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Danish Chinese Ctr Proteases & Canc, Gustav Wieds Vej 10C, DK-8000 Aarhus, Denmark.	jkj@mbg.au.dk	Dupont, Daniel M./H-7556-2019	Vogel, Lotte K./0000-0001-9920-0982; Skovbjerg, Signe/0000-0002-7228-9398; Dupont, Daniel Miotto/0000-0003-1378-1670; Skjodt, Karsten/0000-0002-9161-8185	Danish Cancer Society; Danish Cancer Research Foundation	Danish Cancer Society(Danish Cancer Society); Danish Cancer Research Foundation	This work was supported by the Danish Cancer Society and the Danish Cancer Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Berg JM, 2012, BIOCHEMISTRY; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Colombo E, 2012, ACS MED CHEM LETT, V3, P530, DOI 10.1021/ml3000534; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Farady CJ, 2010, CHEMBIOCHEM, V11, P2341, DOI 10.1002/cbic.201000442; Friis S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0384-4; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Gray K, 2014, THROMB HAEMOSTASIS, V112, P402, DOI 10.1160/TH13-11-0895; Hong ZB, 2016, J BIOL CHEM, V291, P14340, DOI 10.1074/jbc.M115.707240; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kataoka H, 2018, PATHOL INT, V68, P145, DOI 10.1111/pin.12647; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; MADISON EL, 1993, SCIENCE, V262, P419, DOI 10.1126/science.8211162; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Nonboe AW, 2017, TRAFFIC, V18, P378, DOI 10.1111/tra.12482; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Pozzi N, 2013, J BIOL CHEM, V288, P11601, DOI 10.1074/jbc.M113.451542; READING CL, 1982, J IMMUNOL METHODS, V53, P261, DOI 10.1016/0022-1759(82)90175-2; Sales KU, 2015, ONCOGENE, V34, P4664, DOI 10.1038/onc.2014.391; Sales KU, 2015, ONCOGENE, V34, P288, DOI 10.1038/onc.2013.563; Schneider EL, 2012, J MOL BIOL, V415, P699, DOI 10.1016/j.jmb.2011.11.036; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Szabo R, 2008, J BIOL CHEM, V283, P29495, DOI 10.1074/jbc.M801970200; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Tanabe LM, 2017, FEBS J, V284, P1421, DOI 10.1111/febs.13971; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wu CJ, 2017, J CLIN INVEST, V127, P623, DOI 10.1172/JCI88428; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s; Zhao BY, 2013, J BIOL CHEM, V288, P11155, DOI 10.1074/jbc.M113.454611	39	8	8	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					314	326		10.1074/jbc.RA118.004126	http://dx.doi.org/10.1074/jbc.RA118.004126			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409910	Green Published, hybrid			2022-12-26	WOS:000455105500033
J	Trease, AJ; Li, HJ; Spagnol, G; Zheng, L; Stauch, KL; Sorgen, PL				Trease, Andrew J.; Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.			Regulation of Connexin32 by ephrin receptors and T-cell protein-tyrosine phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gap junction; protein phosphorylation; intrinsically disordered protein; nuclear magnetic resonance (NMR); connexin; TC-PTP; EphB1; EphA1; intercellular communication; tyrosine kinase; ephrin	GAP-JUNCTION PROTEIN; MICE DEFICIENT; PHOSPHORYLATION; KINASE; SECRETION; CX43; COMMUNICATION; PERMEABILITY; CONDUCTANCE; EXPRESSION	Gap junctions are intercellular conduits that permit the passage of ions, small metabolites, and signaling molecules between cells. Connexin32 (Cx32) is a major gap junction protein in the liver and brain. Phosphorylation is integral to regulating connexin assembly, degradation, and electrical and metabolic coupling, as well as to interactions with molecular partners. Cx32 contains two intracellular tyrosine residues, and tyrosine phosphorylation of Cx32 has been detected after activation of the epidermal growth factor receptor; however, the specific tyrosine residue and the functional implication of this phosphorylation remain unknown. To address the limited available information on Cx32 regulation by tyrosine kinases, here we used the Cx32 C-terminal (CT) domain in an in vitro kinase-screening assay, which identified ephrin (Eph) receptor family members as tyrosine kinases that phosphorylate Cx32. We found that EphB1 and EphA1 phosphorylate the Cx32CT domain residue Tyr(243). Unlike for Cx43, the tyrosine phosphorylation of the Cx32CT increased gap junction intercellular communication. We also demonstrated that T-cell protein-tyrosine phosphatase dephosphorylates pTyr(243). The data presented above along with additional examples throughout the literature of gap junction regulation by kinases, indicate that one cannot extrapolate the effect of a kinase on one connexin to another.	[Trease, Andrew J.; Li, Hanjun; Spagnol, Gaelle; Zheng, Li; Stauch, Kelly L.; Sorgen, Paul L.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Li, Hanjun] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Sorgen, PL (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	psorgen@unmc.edu		Spagnol, Gaelle/0000-0002-3201-4840; Trease, Andrew/0000-0003-4912-6926	NIGMS, National Institutes of Health [GM072631, GM103427]; NHLBI, National Institutes of Health [HL131712]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427, R01GM072631] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grants GM072631 and GM103427 and by Grant HL131712 from NHLBI, National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrosi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157073; ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; ATKINSON MM, 1988, AM J PHYSIOL, V255, pC674, DOI 10.1152/ajpcell.1988.255.5.C674; BURT JM, 1988, AM J PHYSIOL, V254, pH1206, DOI 10.1152/ajpheart.1988.254.6.H1206; Chanson M, 1998, J CELL BIOL, V141, P1267, DOI 10.1083/jcb.141.5.1267; Coulthard MG, 2012, AM J PATHOL, V181, P1493, DOI 10.1016/j.ajpath.2012.06.043; Davy A, 2006, PLOS BIOL, V4, P1763, DOI 10.1371/journal.pbio.0040315; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diez JA, 1995, ANN NY ACAD SCI, V766, P477, DOI 10.1111/j.1749-6632.1995.tb26699.x; Diez JA, 1998, MOL CELL BIOCHEM, V187, P201, DOI 10.1023/A:1006884600724; Fowler SL, 2009, CELL COMMUN ADHES, V16, P117, DOI 10.3109/15419060903267539; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Ishii M, 2011, BASIC RES CARDIOL, V106, P1057, DOI 10.1007/s00395-011-0219-3; Jacobsen NL, 2017, J CELL SCI, V130, P3308, DOI 10.1242/jcs.202572; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; King TJ, 2004, CARCINOGENESIS, V25, P669, DOI 10.1093/carcin/bgh071; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Lau AF, 1996, J BIOENERG BIOMEMBR, V28, P359, DOI 10.1007/BF02110112; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Li HJ, 2016, J BIOL CHEM, V291, P15867, DOI 10.1074/jbc.M116.727008; Li HJ, 2014, J CELL SCI, V127, P3269, DOI 10.1242/jcs.145193; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu HJ, 2011, P NATL ACAD SCI USA, V108, P18536, DOI 10.1073/pnas.1111597108; Locke D, 2006, FASEB J, V20, P1221, DOI 10.1096/fj.05-5309fje; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Peracchia C, 2000, J MEMBRANE BIOL, V178, P55, DOI 10.1007/s002320010015; Peracchia C, 2000, J BIOL CHEM, V275, P26220, DOI 10.1074/jbc.M004007200; Peters GH, 2000, J BIOL CHEM, V275, P18201, DOI 10.1074/jbc.M910273199; Peters NS, 2000, J CARDIOVASC ELECTR, V11, P488, DOI 10.1111/j.1540-8167.2000.tb00348.x; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Remo BF, 2011, CIRC RES, V108, P1459, DOI 10.1161/CIRCRESAHA.111.244046; Ren LG, 2011, BIOCHEMISTRY-US, V50, P2339, DOI 10.1021/bi1014453; SAEZ JC, 1990, EUR J BIOCHEM, V192, P263, DOI 10.1111/j.1432-1033.1990.tb19223.x; Scherer SS, 1998, GLIA, V24, P8, DOI 10.1002/(SICI)1098-1136(199809)24:1<8::AID-GLIA2>3.0.CO;2-3; Scherer Steven S, 2012, J Peripher Nerv Syst, V17 Suppl 3, P9, DOI 10.1111/j.1529-8027.2012.00424.x; Seo MS, 2006, J VET MED SCI, V68, P567, DOI 10.1292/jvms.68.567; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Solan JL, 2007, J CELL BIOL, V179, P1301, DOI 10.1083/jcb.200707060; Solan JL, 2016, SEMIN CELL DEV BIOL, V50, P40, DOI 10.1016/j.semcdb.2015.12.010; Solan JL, 2014, FEBS LETT, V588, P1423, DOI 10.1016/j.febslet.2014.01.049; Spagnol G, 2016, J BIOL CHEM, V291, P7637, DOI 10.1074/jbc.M115.701417; Stauch K, 2012, J BIOL CHEM, V287, P27771, DOI 10.1074/jbc.M112.382572; TAKEDA A, 1987, FEBS LETT, V210, P169, DOI 10.1016/0014-5793(87)81330-3; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; Temme A, 2001, PFLUG ARCH EUR J PHY, V442, P961, DOI 10.1007/s004240100623; Thul PJ, 2018, PROTEIN SCI, V27, P233, DOI 10.1002/pro.3307; Trease AJ, 2017, J MOL CELL CARDIOL, V111, P69, DOI 10.1016/j.yjmcc.2017.07.010; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Veen TAB, 2000, CARDIOVASC RES, V46, P496, DOI 10.1016/S0008-6363(00)00047-X	52	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					341	350		10.1074/jbc.RA118.003883	http://dx.doi.org/10.1074/jbc.RA118.003883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30401746	hybrid, Green Published			2022-12-26	WOS:000455105500035
J	Hu, S; Han, RH; Shi, JS; Zhu, XD; Qin, WS; Zeng, CH; Bao, H; Liu, ZH				Hu, Shuai; Han, Runhong; Shi, Jingsong; Zhu, Xiaodong; Qin, Weisong; Zeng, Caihong; Bao, Hao; Liu, Zhihong			The long noncoding RNA LOC105374325 causes podocyte injury in individuals with focal segmental glomerulosclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nephrology; podocyte; long noncoding RNA (long ncRNA; lncRNA); microRNA (miRNA); apoptosis; focal segmental glomerulosclerosis; kidney disease; nephrotic syndrome; posttranscriptional regulation	PROMOTES CELL-PROLIFERATION; DOWN-REGULATION; ANGIOTENSIN-II; P38 MAPK; ACTIVATION; KIDNEY; APOPTOSIS; PROTEINURIA; INHIBITION; MALAT1	Focal segmental glomerulosclerosis (FSGS) is a common kidney disease that results in nephrotic syndrome. FSGS arises from dysfunction and apoptosis of podocytes in the glomerulus of the kidney, leading to podocytopathy. The molecular mechanisms underlying podocyte apoptosis remain incompletely understood. Using an array of gene expression profiling, PCR, and in situ hybridization assay, we found here that the levels of the long noncoding RNA LOC105374325 were elevated in the renal podocytes of individuals with FSGS. We also observed that the microRNAs miR-34c and miR-196a/b down-regulated the expression of the apoptosis regulators BCL2-associated X, apoptosis regulator (Bax), and BCL2 antagonist/killer 1 (Bak) in podocytes. Competitive binding between LOC105374325 and miR-34c or miR-196a/b increased Bax and Bak levels and caused podocyte apoptosis. Of note, the mitogen-activated protein kinase P38 and the transcription factor CCAAT enhancer-binding protein (C/EBP) up-regulated LOC105374325 expression. P38 inhibition or C/EBP silencing decreased LOC105374325 levels and inhibited apoptosis in adriamycin-treated podocytes. LOC105374325 overexpression decreased miR-34c and miR-196a/b levels, increased Bax and Bak levels, and induced proteinuria and focal segmental lesions in mice. In conclusion, activation of the P38/C/EBP pathway stimulates the expression of LOC105374325, which, in turn, increases Bax and Bak levels and causes apoptosis by competitively binding to miR-34c and miR-196a/b in the podocytes of individuals with FSGS.	[Hu, Shuai; Han, Runhong; Shi, Jingsong; Zhu, Xiaodong; Qin, Weisong; Zeng, Caihong; Bao, Hao; Liu, Zhihong] Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, 305 East Zhong Shan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Han, Runhong] Southeast Univ, Sch Med, Nanjing 210009, Peoples R China	Nanjing University; Southeast University - China	Bao, H; Liu, ZH (corresponding author), Nanjing Univ, Sch Med, Natl Clin Res Ctr Kidney Dis, Jinling Hosp, 305 East Zhong Shan Rd, Nanjing 210002, Jiangsu, Peoples R China.	bhao@nju.edu.cn; zhihong-liu@hotmail.com			National Natural Science Foundation of China [81873610, 81200516]; Natural Science Foundation of Jiangsu Province [BK20171330, BK2012372]; Fundamental Research Funds for the Central Universities [021414380347]; National Key Research and Development Program of China [2016YFC0904100]; Major International (Regional) Joint Research Project [81320108007]; Key Research and Development Program of Jiangsu Province [BE2016747]; Nanjing University [2015-105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Key Research and Development Program of China; Major International (Regional) Joint Research Project; Key Research and Development Program of Jiangsu Province; Nanjing University(Nanjing University)	This work was supported by National Natural Science Foundation of China Grants 81873610 and 81200516, Natural Science Foundation of Jiangsu Province Grants BK20171330 and BK2012372, Deng Feng Scholars of Nanjing University Grant 2015-105, Fundamental Research Funds for the Central Universities Grant 021414380347, National Key Research and Development Program of China Grant 2016YFC0904100, Major International (Regional) Joint Research Project Grant 81320108007, and Key Research and Development Program of Jiangsu Province Grant BE2016747. The authors declare that they have no conflicts of interest with the contents of this article.	Adams BD, 2017, J CLIN INVEST, V127, P761, DOI 10.1172/JCI84424; Alexopoulos E, 2000, NEPHROL DIAL TRANSPL, V15, P1348, DOI 10.1093/ndt/15.9.1348; Bao H, 2014, KIDNEY INT, V85, P624, DOI 10.1038/ki.2013.469; Bao H, 2014, BIOCHEM BIOPH RES CO, V444, P455, DOI 10.1016/j.bbrc.2014.01.065; Bao H, 2012, KIDNEY INT, V81, P662, DOI 10.1038/ki.2011.443; Bao WDN, 2016, SCI REP-UK, V6, DOI 10.1038/srep22579; Burlaka I, 2016, KIDNEY INT, V90, P135, DOI 10.1016/j.kint.2016.03.026; Cao DL, 2015, BIOCHEM BIOPH RES CO, V457, P1, DOI 10.1016/j.bbrc.2014.11.085; Catuogno S, 2013, ONCOGENE, V32, P341, DOI 10.1038/onc.2012.51; Chen HH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27945; Chen YT, 2017, BIOCHEM BIOPH RES CO, V486, P423, DOI 10.1016/j.bbrc.2017.03.057; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Floege J, 2016, LANCET, V387, P2036, DOI 10.1016/S0140-6736(16)00272-5; Gong RJ, 2008, LIFE SCI, V83, P725, DOI 10.1016/j.lfs.2008.09.015; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hu MS, 2017, J CELL MOL MED, V21, P2732, DOI 10.1111/jcmm.13189; Hu S, 2015, FEBS LETT, V589, P4019, DOI 10.1016/j.febslet.2015.10.033; Ilatovskaya DV, 2014, KIDNEY INT, V86, P506, DOI 10.1038/ki.2014.71; Ilatovskaya DV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00406-2; Jiang XY, 2017, EPIGENOMICS-UK, V9, P1233, DOI 10.2217/epi-2017-0020; Koshikawa M, 2005, J AM SOC NEPHROL, V16, P2690, DOI 10.1681/ASN.2004121084; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lei J, 2018, CELL PHYSIOL BIOCHEM, V45, P2431, DOI 10.1159/000488231; Li CB, 2016, J PATHOL, V239, P23, DOI 10.1002/path.4692; Li ZG, 2015, MOL GENET GENOMICS, V290, P863, DOI 10.1007/s00438-014-0960-z; Ling L, 2018, INT J MOL MED, V41, P2704, DOI 10.3892/ijmm.2018.3457; Liu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071366; Liu WT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.335; Liu XD, 2015, INT J CLIN EXP PATHO, V8, P4525; Long JY, 2016, J CLIN INVEST, V126, P4205, DOI 10.1172/JCI87927; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; Ma MZ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.541; Maidannyk V. G., 2014, PHARM INNOVATION J, V3, P43, DOI [10.7897/2277-4572.031104, DOI 10.7897/2277-4572.031104]; Meng J, 2016, J AM SOC NEPHROL, V27, P3006, DOI 10.1681/ASN.2015040422; Nonne N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1100; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Tang X, 2013, CLIN NEPHROL, V80, P130, DOI 10.5414/CN107607; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Van Laethem A, 2004, FASEB J, V18, P1946, DOI 10.1096/fj.04-2285fje; Wang HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11248-3; Wang P, 2015, CELL SIGNAL, V27, P275, DOI 10.1016/j.cellsig.2014.11.011; Wu JB, 2014, J ETHNOPHARMACOL, V151, P1124, DOI 10.1016/j.jep.2013.12.028; Wu JN, 2014, J AM SOC NEPHROL, V25, P92, DOI 10.1681/ASN.2012111101; Xiao B, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0569-y; Zea AH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157907; Zhang CM, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1470-2; Zhang WF, 2014, CLIN J AM SOC NEPHRO, V9, P1545, DOI 10.2215/CJN.11561113	51	19	21	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20227	20239		10.1074/jbc.RA118.005579	http://dx.doi.org/10.1074/jbc.RA118.005579			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389788	Green Published, hybrid			2022-12-26	WOS:000454685900028
J	Abdelaziz, DH; Thapa, S; Brandon, J; Maybee, J; Vankuppeveld, L; McCorkell, R; Schatzl, HM				Abdelaziz, Dalia H.; Thapa, Simrika; Brandon, Jenna; Maybee, Justine; Vankuppeveld, Lauren; McCorkell, Robert; Schaetzl, Hermann M.			Recombinant prion protein vaccination of transgenic elk PrP mice and reindeer overcomes self-tolerance and protects mice against chronic wasting disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prion; prion disease; vaccine; neurodegeneration; transgenic mice; bovine spongiform encephalopathy; cervid prion protein; chronic wasting disease; Creutzfeldt-Jakob disease; transgenic elk mice	WHITE-TAILED DEER; MULE DEER; IMMUNIZATION; TRANSMISSION; REPLICATION; ANTIBODIES; EMERGENCE	Chronic wasting disease (CWD) is a fatal neurodegenerative disease that affects cervids in North America and now Europe. No effective measures are available to control CWD. We hypothesized that active vaccination with homologous and aggregation-prone recombinant prion protein (PrP) could overcome self-tolerance and induce autoantibody production against the cellular isoform of PrP (PrPC), which would be protective against CWD infection from peripheral routes. Five groups of transgenic mice expressing elk PrP (TgElk) were vaccinated with either the adjuvant CpG alone or one of four recombinant PrP immunogens: deer dimer (Ddi); deer monomer (Dmo); mouse dimer (Mdi); and mouse monomer (Mmo). Mice were then challenged intraperitoneally with elk CWD prions. All vaccinated mice developed ELISA-detectable antibody titers against PrP. Importantly, all four vaccinated groups survived longer than the control group, with the Mmo-immunized group exhibiting 60% prolongation of mean survival time compared with the control group (183 versus 114 days post-inoculation). We tested for prion infection in brain and spleen of all clinically sick mice. Notably, the attack rate was 100% as revealed by positive CWD signals in all tested tissues when assessed with Western blotting, real-time quaking-induced conversion, and immunohistochemistry. Our pilot study in reindeer indicated appreciable humoral immune responses to Mdi and Ddi immunogens, and the post-immune sera from the Ddi-vaccinated reindeer mitigated CWD propagation in a cell culture model (CWD-RK13). Taken together, our study provides very promising vaccine candidates against CWD, but further studies in cervids are required to investigate vaccine efficacy in the natural CWD hosts.	[Abdelaziz, Dalia H.; Thapa, Simrika; Brandon, Jenna; Maybee, Justine; Vankuppeveld, Lauren; McCorkell, Robert; Schaetzl, Hermann M.] Univ Calgary, Dept Comparat Biol & Expt Med, Calgary, AB T2N 4Z6, Canada; [Abdelaziz, Dalia H.; Thapa, Simrika; Schaetzl, Hermann M.] Univ Calgary, Calgary Prion Res Unit, Calgary, AB T2N 4Z6, Canada; [Abdelaziz, Dalia H.] Helwan Univ, Fac Pharm, Dept Biochem & Mol Biol, Cairo 11795, Egypt; [Abdelaziz, Dalia H.; Thapa, Simrika] Univ Calgary Eyes High, Calgary, AB, Canada	University of Calgary; University of Calgary; Egyptian Knowledge Bank (EKB); Helwan University	Schatzl, HM (corresponding author), Univ Calgary, Fac Vet Med, TRW 2D10,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	hschaetz@ucalgary.ca		Schatzl, Hermann/0000-0003-4972-8740	Alberta Prion Research Institute (APRI) [201300013, 201600013]; APRI [201600010]	Alberta Prion Research Institute (APRI); APRI	This work was supported by Alberta Prion Research Institute (APRI) Grants 201300013 and 201600013 and was performed within the framework of the Calgary Prion Research Unit through APRI Grant 201600010. The authors declare that they have no conflicts of interest with the contents of this article.	Abdelaziz DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11235-8; Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Argue CK, 2007, CAN VET J, V48, P1241; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Bian JF, 2014, P NATL ACAD SCI USA, V111, P6028, DOI 10.1073/pnas.1322377111; Carreno JM, 2016, VACCINE, V34, P4263, DOI 10.1016/j.vaccine.2016.05.036; DeVivo MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186512; Edmunds DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161127; Ertmer A, 2004, J BIOL CHEM, V279, P41918, DOI 10.1074/jbc.M405652200; Gilch S, 2003, J BIOL CHEM, V278, P18524, DOI 10.1074/jbc.M210723200; Gilch S, 2011, TOP CURR CHEM, V305, P51, DOI 10.1007/128_2011_159; Goni F, 2015, VACCINE, V33, P726, DOI 10.1016/j.vaccine.2014.11.035; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Hannaoui S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006553; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Herbst A, 2017, EMERG INFECT DIS, V23, P1598, DOI [10.3201/eid2309.161474, 10.3201/eid2309.161747]; Jeon YC, 2013, J VET SCI, V14, P21, DOI 10.4142/jvs.2013.14.1.21; John TR, 2013, PRION, V7, P253, DOI 10.4161/pri.24430; Kaiser-Schulz G, 2007, J IMMUNOL, V179, P2797, DOI 10.4049/jimmunol.179.5.2797; Kim TY, 2005, J VET MED SCI, V67, P753, DOI 10.1292/jvms.67.753; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; LaFauci G, 2006, J GEN VIROL, V87, P3773, DOI 10.1099/vir.0.82137-0; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Mitchell GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039055; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; Pilon JL, 2013, J WILDLIFE DIS, V49, P694, DOI 10.7589/2012-07-200; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Pulford B, 2012, J WILDLIFE DIS, V48, P425, DOI 10.7589/0090-3558-48.2.425; Race B, 2018, J VIROL, V92, DOI [10.1128/JVI.00550-18, 10.1128/jvi.00550-18]; Race B, 2014, EMERG INFECT DIS, V20, P833, DOI 10.3201/eid2005.130778; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Saunders SE, 2012, EMERG INFECT DIS, V18, P369, DOI 10.3201/eid1803.110685; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Sigurdsson EM, 2003, NEUROSCI LETT, V336, P185, DOI 10.1016/S0304-3940(02)01192-8; Taschuk R, 2017, PRION, V11, P368, DOI 10.1080/19336896.2017.1367083; Velasquez CD, 2015, J VIROL, V89, P12362, DOI 10.1128/JVI.02010-15; Waddell L, 2018, TRANSBOUND EMERG DIS, V65, P37, DOI 10.1111/tbed.12612; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; WILLIAMS ES, 1982, J WILDLIFE DIS, V18, P465, DOI 10.7589/0090-3558-18.4.465; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; WILLIAMS ES, 1980, J WILDLIFE DIS, V16, P89, DOI 10.7589/0090-3558-16.1.89; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; Zabel MD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004624	48	10	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19812	19822		10.1074/jbc.RA118.004810	http://dx.doi.org/10.1074/jbc.RA118.004810			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30397182	Green Published, hybrid			2022-12-26	WOS:000454294900025
J	Arrive, E; Viard, JP; Salanave, B; Dollfus, C; Matheron, S; Reliquet, V; Arezes, E; Nailler, L; Vigouroux, C; Warszawski, J				Arrive, Elise; Viard, Jean-Paul; Salanave, Benoit; Dollfus, Catherine; Matheron, Sophie; Reliquet, Veronique; Arezes, Elisa; Nailler, Laura; Vigouroux, Corinne; Warszawski, Josiane		ANRS CO19 COVERTE ENNS Study Grp	Metabolic risk factors in young adults infected with HIV since childhood compared with the general population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; HEALTH SURVEY ENNS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; FRENCH NUTRITION; ASSOCIATION; OBESITY; SEX; ABNORMALITIES; ADOLESCENTS	Aim Metabolic risk factors are poorly documented for the first generation of young adults who have lived with HIV since childhood. We compared their metabolic profile with that of adults of same age from the general population. Methods We conducted a cross-sectional analysis of data from two populations: (1) COVERTE (ANRS-CO19), a French national cohort of 18 to 30-year-old patients HIV-infected since childhood, and (2) ENNS, a national cross-sectional population-based household survey on nutrition. Body mass index (BMI), blood pressure, waist circumference, fasting glucose, triglycerides, and HDL-, LDL- and total cholesterol were measured in both studies. Direct standardization on overweight and education level and logistic regression were used to compare the prevalence of metabolic abnormalities between the two populations. Results Data from 268 patients from COVERTE and 245 subjects from ENNS were analyzed. Tobacco use was similar in both groups. HIV-infected patients had increased mean waist-to-hip ratio and triglycerides to HDL-cholesterol ratio and decreased mean HDL-cholesterol as compared to their counterparts from the general population in both genders. In HIV-infected patients, metabolic syndrome was identified in 13.2% of men (95% confidence interval [CI]: 7.1-19.2) and 10.4% (95% CI: 5.4-15.3) of women versus 10.6% (95% CI: 1.5-19.7) and 1.7% (95% CI: 0-4.1) in subjects from the general population, respectively. Conclusion Young adults infected with HIV since childhood had a higher prevalence of dyslipidemia and metabolically detrimental fat distribution than adults of same age of the general population, supporting close monitoring for cardiometabolic diseases.	[Arrive, Elise; Arezes, Elisa; Nailler, Laura; Warszawski, Josiane] INSERM, Ctr Res Epidemiol & Populat Hlth, Paris, France; [Arrive, Elise] Univ Bordeaux, Unite Format & Rech Odontol, Bordeaux, France; [Arrive, Elise] CHU Bordeaux, Bordeaux, France; [Viard, Jean-Paul] Hop Hotel Dieu, AP HP, Ctr Diagnost & Therapeut, Paris, France; [Viard, Jean-Paul] Fac Med Paris Descartes, Unite Rech EA 7327, Paris, France; [Salanave, Benoit] Univ Paris 13, Ctr Rech Epidemiol & Stat COMUE, Sante Publ France, ESEN,Sorbonne Paris Cite, Bobigny, France; [Dollfus, Catherine] Hop Trousseau, AP HP, Pediat Hematooncol, Paris, France; [Matheron, Sophie] Hop Bichat Claude Bernard, AP HP, Paris, France; [Matheron, Sophie] Univ Paris 07, INSERM, Unite Mixte Rech 1137, Paris, France; [Reliquet, Veronique] CHU Nantes, Dept Infect Dis, Nantes, France; [Reliquet, Veronique] CHU Nantes, CIC UIC INSERM 1413, Nantes, France; [Vigouroux, Corinne] Sorbonne Univ, Inserm Unite Mixte Rech S 938, St Antoine Res Ctr, Inst Cardiometab & Nutr ICAN, Paris, France; [Vigouroux, Corinne] St Antoine Hosp, AP HP, Biol & Mol Genet Dept, Natl Reference Ctr Rare Dis Insulin Secret & Insu, Paris, France; [Vigouroux, Corinne] St Antoine Hosp, AP HP, Dept Endocrinol, Natl Reference Ctr Rare Dis Insulin Secret & Insu, Paris, France; [Warszawski, Josiane] Univ Paris Sud, Le Kremlin Bicetre, France; [Warszawski, Josiane] Hop Bicetre, AP HP, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institute of Public Health Surveillance; UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Arrive, E (corresponding author), INSERM, Ctr Res Epidemiol & Populat Hlth, Paris, France.; Arrive, E (corresponding author), Univ Bordeaux, Unite Format & Rech Odontol, Bordeaux, France.; Arrive, E (corresponding author), CHU Bordeaux, Bordeaux, France.; Vigouroux, C (corresponding author), Sorbonne Univ, Inserm Unite Mixte Rech S 938, St Antoine Res Ctr, Inst Cardiometab & Nutr ICAN, Paris, France.; Vigouroux, C (corresponding author), St Antoine Hosp, AP HP, Biol & Mol Genet Dept, Natl Reference Ctr Rare Dis Insulin Secret & Insu, Paris, France.; Vigouroux, C (corresponding author), St Antoine Hosp, AP HP, Dept Endocrinol, Natl Reference Ctr Rare Dis Insulin Secret & Insu, Paris, France.	elise.anive@u-bordeaux.fr; corinne.vigouroux@inserm.fr	Arrivé, Elise/T-9126-2019; SALANAVE, Benoit/F-3062-2017	Arrive, Elise/0000-0002-5502-2069; RELIQUET, Veronique/0000-0003-2473-2858; SALANAVE, Benoit/0000-0002-4573-3166; Vigouroux, Corinne/0000-0002-8181-4721	Agence Nationale de Recherche sur le SIDA et les hepatites virales ANRS [ANRS CO19 COVERTE, CESP INSERM U1018]; Universite de Bordeaux; Centre Hospitalier Universitaire de Bordeaux in France; Sante Publique France; French Public Health Agency; Paris-13 University	Agence Nationale de Recherche sur le SIDA et les hepatites virales ANRS(ANRSFrench National Research Agency (ANR)); Universite de Bordeaux; Centre Hospitalier Universitaire de Bordeaux in France; Sante Publique France; French Public Health Agency; Paris-13 University	The COVERTE cohort was supported by the Agence Nationale de Recherche sur le SIDA et les hepatites virales ANRS (Award number: ANRS CO19 COVERTE; Grant Recipient: CESP INSERM U1018). EA was supported by the Universite de Bordeaux and the Centre Hospitalier Universitaire de Bordeaux in France. The ENNS study was funded by Sante Publique France, the French Public Health Agency and Paris-13 University.	Abd-Elmoniem KZ, 2014, CLIN INFECT DIS, V59, P1779, DOI 10.1093/cid/ciu672; Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Aldrovandi GM, 2009, AIDS, V23, P661, DOI 10.1097/QAD.0b013e3283269dfb; Araujo S, 2014, EUR J ENDOCRINOL, V171, P545, DOI 10.1530/EJE-14-0337; Bays HE, 2016, J CLIN LIPIDOL, V10, pS1, DOI 10.1016/j.jacl.2015.08.002; Blazquez D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0853-8; Boccara F, 2017, AIDS, V31, pS157, DOI 10.1097/QAD.0000000000001384; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; Dimock D, 2011, METABOLISM, V60, P874, DOI 10.1016/j.metabol.2010.08.007; Johnsen S, 2005, J CLIN ENDOCR METAB, V90, P5596, DOI 10.1210/jc.2005-1083; Karim R, 2013, J CLIN ENDOCR METAB, V98, pE610, DOI 10.1210/jc.2012-3195; Klein DB, 2015, CLIN INFECT DIS, V60, P1278, DOI 10.1093/cid/civ014; Koskinen J, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005632; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lipshultz SE, 2011, J AM COLL CARDIOL, V57, P76, DOI 10.1016/j.jacc.2010.08.620; McCutchan JA, 2012, NEUROLOGY, V78, P485, DOI 10.1212/WNL.0b013e3182478d64; Mikhail IJ, 2011, PEDIATR INFECT DIS J, V30, P710, DOI 10.1097/INF.0b013e31820f6575; NCEP, 2001, ATP 3 GUID AT A GLAN; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Nou E, 2016, LANCET DIABETES ENDO, V4, P598, DOI 10.1016/S2213-8587(15)00388-5; Pucci G, 2017, PHARMACOL RES, V120, P34, DOI 10.1016/j.phrs.2017.03.008; Quispe R, 2016, CURR OPIN ENDOCRINOL, V23, P150, DOI 10.1097/MED.0000000000000241; Rasmussen LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044575; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sattler FR, 2015, JAIDS-J ACQ IMM DEF, V68, P281, DOI 10.1097/QAI.0000000000000458; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Schulte-Hermann K, 2016, J INFECT CHEMOTHER, V22, P248, DOI 10.1016/j.jiac.2016.01.007; Sitruk-Ware R, 2011, REV ENDOCR METAB DIS, V12, P63, DOI 10.1007/s11154-011-9182-4; Smith CJ, 2014, LANCET, V384, P241, DOI 10.1016/S0140-6736(14)60604-8; Vernay M, 2013, INT J PUBLIC HEALTH, V58, P855, DOI 10.1007/s00038-013-0501-2; Vernay M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-215; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Xiang J, 2014, EXP CELL RES, V327, P318, DOI 10.1016/j.yexcr.2014.07.002	36	22	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206745	10.1371/journal.pone.0206745	http://dx.doi.org/10.1371/journal.pone.0206745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408056	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300036
J	Cannon, L; Vargas-Garcia, CA; Jagarapu, A; Piovoso, MJ; Zurakowski, R				Cannon, LaMont; Vargas-Garcia, Cesar A.; Jagarapu, Aditya; Piovoso, Michael J.; Zurakowski, Ryan			HIV 2-LTR experiment design optimization	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SUSTAINED VIRAL SUPPRESSION; RALTEGRAVIR INTENSIFICATION; HIV-1-INFECTED PATIENTS; CLINICAL-TRIALS; PLASMA VIREMIA; REPLICATION; RESERVOIRS; DYNAMICS; REDUCE	Clinical trials are necessary in order to develop treatments for diseases; however, they can often be costly, time consuming, and demanding to the patients. This paper summarizes several common methods used for optimal design that can be used to address these issues. In addition, we introduce a novel method for optimizing experiment designs applied to HIV 2-LTR clinical trials. Our method employs Bayesian techniques to optimize the experiment outcome by maximizing the Expected Kullback-Leibler Divergence (EKLD) between the a priori knowledge of system parameters before the experiment and the a posteriori knowledge of the system parameters after the experiment. We show that our method is robust and performs equally well if not better than traditional optimal experiment design techniques.	[Cannon, LaMont; Jagarapu, Aditya; Zurakowski, Ryan] Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA; [Vargas-Garcia, Cesar A.; Piovoso, Michael J.; Zurakowski, Ryan] Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA; [Cannon, LaMont] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Vargas-Garcia, Cesar A.] Fdn Univ Konrad Lorenz, Bogota, Colombia	University of Delaware; University of Delaware; University of Pennsylvania	Zurakowski, R (corresponding author), Univ Delaware, Dept Biomed Engn, Newark, DE 19716 USA.; Zurakowski, R (corresponding author), Univ Delaware, Dept Elect & Comp Engn, Newark, DE 19716 USA.	ryanz@udel.edu	Vargas-Garcia, Cesar/J-8090-2017	Vargas-Garcia, Cesar/0000-0002-4286-8882; Zurakowski, Ryan/0000-0003-3726-3114	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R21AI110288, R03AI136710]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI136710] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (niaid.nih.gov) under Award Numbers R21AI110288 and R03AI136710. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham G, 2016, IEEE DECIS CONTR P, P5597, DOI 10.1109/CDC.2016.7799129; Atkinson A.C., 1992, OXFORD STAT SCI SERI; Back T, 1993, EVOL COMPUT, V1, P1, DOI 10.1162/evco.1993.1.1.1; Bankert EA., 2006, I REV BOARD MANAGEME, V2; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cannon L, 2016, P AMER CONTR CONF, P1295, DOI 10.1109/ACC.2016.7525096; Cardozo EF, 2014, J THEOR BIOL, V345, P61, DOI 10.1016/j.jtbi.2013.12.020; Chaloner K, 1995, STAT SCI, V10, P273, DOI 10.1214/ss/1177009939; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Eisele E, 2012, IMMUNITY, V37, P377, DOI 10.1016/j.immuni.2012.08.010; Ellis LM, 2014, J CLIN ONCOL, V32, P1277, DOI 10.1200/JCO.2013.53.8009; Emery AF, 1998, MEAS SCI TECHNOL, V9, P864, DOI 10.1088/0957-0233/9/6/003; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; Fletcher CV, 2014, P NATL ACAD SCI USA, V111, P2307, DOI 10.1073/pnas.1318249111; Gandhi RT, 2012, JAIDS-J ACQ IMM DEF, V59, P229, DOI 10.1097/QAI.0b013e31823fd1f2; Hatano H, 2000, AIDS, V14, P1357, DOI 10.1097/00002030-200007070-00008; Hatano H, 2013, J INFECT DIS, V208, P1436, DOI 10.1093/infdis/jit453; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Josefsson L, 2013, P NATL ACAD SCI USA, V110, pE4987, DOI 10.1073/pnas.1308313110; Julier SJ, 2004, P IEEE, V92, P401, DOI 10.1109/JPROC.2003.823141; Kearney MF, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004010; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lafeuillade A, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-33; Lewin S., 2000, DOLUTEGRAVIR IMPACT; Luo RT, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0186; Luo RT, 2012, J CLIN MICROBIOL, V50, P3381, DOI 10.1128/JCM.01254-12; Luo RT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040198; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Martin L, 2017, NAT REV DRUG DISCOV, V16, P381, DOI 10.1038/nrd.2017.70; Martinez-Picado J, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0398-1; Martinez-Picado J, 2016, CURR OPIN HIV AIDS, V11, P417, DOI 10.1097/COH.0000000000000287; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; Persaud D, 2004, J VIROL, V78, P968, DOI 10.1128/JVI.78.2.968-979.2004; Schervish MJ, 2012, THEORY STAT; Sivanandam SN, 2008, GENETIC ALGORITHMS I; Smith MZ, 2012, CURR HIV-AIDS REP, V9, P5, DOI 10.1007/s11904-011-0108-2; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Thierry S, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0153-9; Trinite B, 2013, J VIROL, V87, P12701, DOI 10.1128/JVI.01939-13; Tsujimura Y, 1998, 1998 SECOND INTERNATIONAL CONFERENCE ON KNOWLEDGE-BASED INTELLIGENT ELECTRONIC SYSTEMS, KES '98, PROCEEDINGS, VOL 2, P285, DOI 10.1109/KES.1998.725924; Vandergeeten C, 2014, J VIROL, V88, P12385, DOI 10.1128/JVI.00609-14; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	47	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206700	10.1371/journal.pone.0206700	http://dx.doi.org/10.1371/journal.pone.0206700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408070	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300031
J	Li, JH; Wu, YK; Zhang, Q; Li, HQ; Pan, HS; Lu, W; Wang, DM; Zhang, JP; Lu, YH				Li, Jinhua; Wu, Yuekun; Zhang, Qian; Li, Haiqiang; Pan, Hongsheng; Lu, Wei; Wang, Dongmei; Zhang, Jianping; Lu, Yanhui			Aphid parasitism and parasitoid diversity in cotton fields in Xinjiang, China	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; POPULATION-DYNAMICS; GOSSYPII GLOVER; MYZUS-PERSICAE; INTERSPECIFIC INTERACTIONS; MOLECULAR METHODS; NATURAL ENEMIES; TROPHIC LINKS; SOYBEAN APHID; HYMENOPTERA	Aphids are major pests of cotton crops in the Xinjiang Uygur Autonomous Region in China, and parasitoids are considered as important natural enemies in regulating aphid populations. However, information on aphid parasitoids in the Xinjiang cotton fields is limited, which hinders the study of aphid-parasitoid interactions and the application of conservation biological control against cotton aphids. In this study, a 3-year survey was conducted in a large geographical range that included three primary cotton planting areas in southern and northern Xinjiang. The population dynamics and the parasitism levels of an assemblage of aphids in the cotton fields were investigated along with the composition of the parasitoid community associated with these aphids. Aphid parasitization varied significantly within both years and seasons, with parasitism levels ranging from 0 to 26%, indicating that there is less effective biological control of parasitoids on aphids under field conditions. Among the primary parasitoids described, Binodoxys communis (Gahan) constituted 95.19% of the parasitoid species, followed by Praon barbatum Mackauer (3.15%), Trioxys asiaticus Telenga (1.01%) and Lysiphlebus fabarum Marshall (0.65%). Significant differences were found in the composition of the primary parasitoid species between the cotton seedling period (June) and the flowering period (July-August), and two more primary aphid parasitoids were found in the seedling period. Twelve hyperparasitoid species belonging to six genera were found in our study, of which Pachyneuron aphidis (Bouche), Syrphophagus species and Dendro-cerus laticeps (Hedicke) were the dominant species. The composition of the hyperparasitoid community also differed significantly between the seedling and the flowering periods. The description of this parasitoid community-associated assemblage of aphids in cotton fields will facilitate the study of aphid-parasitoid interactions and promote the development of effective cotton aphid management strategies in Xinjiang.	[Li, Jinhua; Zhang, Jianping] Shihezi Univ, Xinjiang Prod & Construct Corps Key Lab Special F, Key Lab Univ Xinjiang Uygur Autonomous Reg Oasis, Shihezi, Peoples R China; [Li, Jinhua; Wu, Yuekun; Zhang, Qian; Lu, Yanhui] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Li, Haiqiang; Pan, Hongsheng; Wang, Dongmei] Xinjiang Acad Agr Sci, Inst Plant Protect, Urumqi, Peoples R China; [Lu, Wei] Xinjiang Agr Univ, Urumqi, Peoples R China	Shihezi University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Xinjiang Agricultural University	Zhang, JP (corresponding author), Shihezi Univ, Xinjiang Prod & Construct Corps Key Lab Special F, Key Lab Univ Xinjiang Uygur Autonomous Reg Oasis, Shihezi, Peoples R China.; Lu, YH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	zhjp_agr@shzu.edu.cn; yhlu@ippcaas.cn		Lu, Yanhui/0000-0002-6552-0248	National Key Research and Development Program of China [2017YFD0201900]; China Agriculture Research System [CARS-15-19]; Fundamental Research Funds for Central Non-profit Scientific Institution [Y2018PT73]	National Key Research and Development Program of China; China Agriculture Research System; Fundamental Research Funds for Central Non-profit Scientific Institution	This work was supported by the National Key Research and Development Program of China (2017YFD0201900), China Agriculture Research System (CARS-15-19), Fundamental Research Funds for Central Non-profit Scientific Institution (Y2018PT73). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebes AL, 2013, BIOCONTROL, V58, P635, DOI 10.1007/s10526-013-9528-9; Alekseev V.N., 2001, Vestnik Zoologii, V35, P3; Alikhani M, 2013, BIOLOGIA, V68, P966, DOI 10.2478/s11756-013-0234-y; [Anonymous], 2014, AGR OUTLOOK; Boivin G, 2006, PROG BIOL CONTROL, V3, P123; Brodeur J, 2000, ENTOMOL EXP APPL, V97, P93, DOI 10.1023/A:1004013232410; Buitenhuis R, 2005, ENTOMOL EXP APPL, V114, P107, DOI 10.1111/j.1570-7458.2005.00234.x; Chen J.H., 2001, SYSTEMATIC STUDIES A; Chow A, 1999, J APPL ENTOMOL, V123, P83, DOI 10.1046/j.1439-0418.1999.00322.x; De Mendoza AH, 2001, J ECON ENTOMOL, V94, P439, DOI 10.1603/0022-0493-94.2.439; Deng YX, 1998, FLA ENTOMOL, V81, P415, DOI 10.2307/3495931; Derocles SAP, 2012, MOL ECOL RESOUR, V12, P634, DOI 10.1111/j.1755-0998.2012.03131.x; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Doganlar, 1986, FEN BIL DERG, V4, P23; Feng Li-Kai, 2015, Chinese Journal of Applied Entomology, V52, P557, DOI 10.7679/j.issn.2095-1353.2015.064; Ferrer-Suay M, 2013, ANN ENTOMOL SOC AM, V106, P26, DOI 10.1603/AN12022; Ferrer-Suay M, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-41; Fulop D, 2013, ZOOTAXA, V3637, P394, DOI 10.11646/zootaxa.3637.3.11; Gao GZ, 2013, J PEST SCI, V86, P167, DOI 10.1007/s10340-012-0470-x; Gao Gui-zhen, 2012, Yingyong Shengtai Xuebao, V23, P506; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Gariepy TD, 2012, BIOL CONTROL, V60, P26, DOI 10.1016/j.biocontrol.2011.06.011; Gariepy T, 2008, J APPL ECOL, V45, P708, DOI 10.1111/j.1365-2664.2007.01451.x; Gibson Gary A.P., 1998, Journal of Hymenoptera Research, V7, P209; Greenstone MH, 2006, B ENTOMOL RES, V96, P1, DOI 10.1079/BER2005402; HAGEN KS, 1968, ANNU REV ENTOMOL, V13, P325, DOI 10.1146/annurev.en.13.010168.001545; Hawro V, 2015, BIOCONTROL, V60, P451, DOI 10.1007/s10526-015-9660-9; He FD, 1985, J SHIHEZI AGR COLL, V2, P75; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Huang J., 1994, CLASSIFICATION APHEL; INAIZUMI M, 1981, Kontyu, V49, P219; Ja ZL, 2011, J TARIM U, V23, P37; Kersting U, 1999, J APPL ENTOMOL, V123, P23, DOI 10.1046/j.1439-0418.1999.00309.x; KINGSOLVER JG, 1989, PHYSIOL ZOOL, V62, P314, DOI 10.1086/physzool.62.2.30156173; Komazaki S, 2008, ANN ENTOMOL SOC AM, V101, P565, DOI 10.1603/0013-8746(2008)101[565:DIHPLC]2.0.CO;2; Lafferty KD, 2002, TRENDS ECOL EVOL, V17, P507, DOI 10.1016/S0169-5347(02)02615-0; Lan JiangLin, 2004, Plant Protection, V30, P37; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Leius K., 1968, CAN ENTOMOL, V14, P419; Li Hao-bin, 2008, Xinjiang Nongye Kexue, V45, P670; [李进步 Li Jinbu], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P261; Liu J, 2004, ANN ENTOMOL SOC AM, V97, P235, DOI 10.1603/0013-8746(2004)097[0235:PDOAGH]2.0.CO;2; Lu ZZ, 2015, ANN APPL BIOL, V166, P249, DOI 10.1111/aab.12178; Luo SP, 2014, BIOL CONTROL, V68, P6, DOI 10.1016/j.biocontrol.2013.06.004; Lv ZZ, 2002, CHINA COTTON, V29, P11; MATEJKO I, 1979, J NEW YORK ENTOMOL S, V87, P275; Matin Shahla Baghery, 2009, Munis Entomology & Zoology, V4, P193; Muller CB, 1999, RES POPUL ECOL, V41, P93, DOI 10.1007/PL00011986; Muller CB, 1999, J ANIM ECOL, V68, P346, DOI 10.1046/j.1365-2656.1999.00288.x; Pike KS, 2000, P ENTOMOL SOC WASH, V102, P688; Roh HS, 2015, J PEST SCI, V88, P621, DOI 10.1007/s10340-014-0631-1; Shang QL, 2012, CROP PROT, V31, P15, DOI 10.1016/j.cropro.2011.09.014; Shi ZY, 1995, PARASITOID IDENTIFIC; Stephens MJ, 1998, BIOCONTROL SCI TECHN, V8, P547, DOI 10.1080/09583159830063; [孙艳 Sun Yan], 2017, [植物保护, Plant Protection], V43, P114; Takada H, 2002, APPL ENTOMOL ZOOL, V37, P237, DOI 10.1303/aez.2002.237; Traugott M, 2008, MOL ECOL, V17, P3928, DOI 10.1111/j.1365-294X.2008.03878.x; Volkl W, 1998, J APPL ENTOMOL, V122, P201, DOI 10.1111/j.1439-0418.1998.tb01484.x; WALTON MP, 1990, ENTOMOL EXP APPL, V54, P271, DOI 10.1007/BF00186796; Wang S. C., 1990, COTTON WHEAT INTERCR; Wei JN, 2003, BIOCONTROL SCI TECHN, V13, P87, DOI 10.1080/0958315021000054412; Wyckhuys KAG, 2008, B ENTOMOL RES, V98, P361, DOI 10.1017/S000748530800566X; Xia J. Y., 1994, P WORLD COTT RES C 1, P511; Xiao Hui, 2000, Entomologia Sinica, V7, P193; Xiao H, 2009, ORIENT INSECTS, V43, P341, DOI 10.1080/00305316.2009.10417593; Yang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10345-7; Yang F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04029-5; Yang HF, 1985, XINJIANG AGR SCI, V1, P23; Yang S, 2009, BIOCONTROL SCI TECHN, V19, P219, DOI 10.1080/09583150802696525; Yang S, 2011, J ENTOMOL RES SOC, V13, P87; Zheng CR, 1997, PLANT PROTECTION TEC, V17, P12; Zhou QS, 2014, INSECT SCI, V21, P363, DOI 10.1111/1744-7917.12095; Zhou SQ, 2012, HYDROL PROCESS, V26, P1169, DOI 10.1002/hyp.8208; [No title captured]	74	2	4	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207034	10.1371/journal.pone.0207034	http://dx.doi.org/10.1371/journal.pone.0207034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408098	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300068
J	Pegan, TM; Craig, DP; Gulson-Castillo, ER; Gabrielson, RM; Kerr, WB; MacCurdy, R; Powell, SP; Winkler, DW				Pegan, Teresa M.; Craig, David P.; Gulson-Castillo, Eric R.; Gabrielson, Richard M.; Kerr, Wayne Bezner; MacCurdy, Robert; Powell, Steven P.; Winkler, David W.			Solar-powered radio tags reveal patterns of post-fledging site visitation in adult and juvenile Tree Swallows Tachycineta bicolor	PLOS ONE			English	Article							NATAL DISPERSAL; MIGRATION; MOVEMENTS; SURVIVAL; PASSERINES; OCCUPANCY; MIGRANTS; BEHAVIOR; RADAR; SEX	The availability of small, lightweight tracking devices enhances our ability to study birds during mobile phases of their lives. Tree Swallows Tachycineta bicolor, a model species of wild songbird, are well-studied during their breeding season; but our understanding of their biology at other times of the year, when they are not tied to the fixed location of a nest, is more limited. We developed a lightweight radio tag with no battery (solar nanotag) to study the movements of small animals, and we deployed it to explore the behavior of Tree Swallows after the end of their summer breeding season. We tagged 32 breeding adult swallows and 36 juveniles and monitored their presence and absence at the breeding site during the post-fledging period. Although our observations are based on very small sample sizes, the tags revealed previously unknown patterns in Tree Swallow behavior during the post-breeding season. Some Tree Swallow fledglings continued to visit the site repeatedly in the months following the nesting season, with the latest detection occurring on September 30th; by contrast, all adults had permanently departed by the end of July. These results inform future hypotheses about post-breeding movements in Tree Swallows. But, more generally, the detection of tagged swallows on their distant wintering grounds, seven months after tagging, indicates the potential of studying small passerine movements throughout their entire lifetimes, and suggests a rich array of applications for these "Life Tags" to study the movements of small animals world-wide.	[Pegan, Teresa M.; Gulson-Castillo, Eric R.; Winkler, David W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Craig, David P.] Willamette Univ, Dept Biol, Salem, OR 97301 USA; [Gabrielson, Richard M.; Kerr, Wayne Bezner; MacCurdy, Robert; Powell, Steven P.; Winkler, David W.] Cornell Univ, TABER, Ithaca, NY 14850 USA; [MacCurdy, Robert] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Pegan, Teresa M.; Gulson-Castillo, Eric R.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Cornell University; Willamette University; Cornell University; University of Colorado System; University of Colorado Boulder; University of Michigan System; University of Michigan	Winkler, DW (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.; Winkler, DW (corresponding author), Cornell Univ, TABER, Ithaca, NY 14850 USA.	dww4@cornell.edu	Pegan, Teresa/AAF-8612-2021; MacCurdy, Robert/AAC-6749-2021; Craig, David/J-1168-2016	MacCurdy, Robert/0000-0002-1726-151X; Craig, David/0000-0002-6933-272X; Gabrielson, Richard/0000-0001-9794-1429	Cornell University; NSF LTREB grant [DEB 1242573]	Cornell University; NSF LTREB grant	The tag development work took place under Program Support funds from Cornell University, and the field work on swallows was supported in part by an NSF LTREB grant (DEB 1242573) to DWW. Neither source of funds had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; BAKER RR, 1993, ORNIS SCAND, V24, P71, DOI 10.2307/3676413; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Benson AM, 2001, AUK, V118, P513, DOI 10.1642/0004-8038(2001)118[0513:TOBROA]2.0.CO;2; Brown C.R., 1978, Bulletin of the Texas Ornithological Society, V11, P25; BROWN CR, 1978, WILSON BULL, V90, P376; Burness GP, 1998, PHYSIOL ZOOL, V71, P247, DOI 10.1086/515917; Burney C. W, 2002, THESIS; Carlisle JD, 2005, AUK, V122, P1070, DOI 10.1642/0004-8038(2005)122[1070:MSAADI]2.0.CO;2; Cox WA, 2014, J WILDLIFE MANAGE, V78, P183, DOI 10.1002/jwmg.670; Ferretti V, 2009, J AVIAN BIOL, V40, P289, DOI 10.1111/j.1600-048X.2008.04519.x; Gruebler MU, 2014, ECOL EVOL, V4, P756, DOI 10.1002/ece3.984; Jones J, 2003, AUK, V120, P591, DOI 10.1642/0004-8038(2003)120[0591:TSTBAN]2.0.CO;2; Kershner EL, 2004, AUK, V121, P1146, DOI 10.1642/0004-8038(2004)121[1146:PMASOJ]2.0.CO;2; Laughlin AJ, 2016, ECOGRAPHY, V39, P1017, DOI 10.1111/ecog.01988; Laughlin AJ, 2013, AUK, V130, P230, DOI 10.1525/auk.2013.12229; LOMBARDO MP, 1987, CONDOR, V89, P138, DOI 10.2307/1368768; McCarty JP, 2001, AUK, V118, P176, DOI 10.1642/0004-8038(2001)118[0176:VIGONT]2.0.CO;2; MEDVIN MB, 1986, ANIM BEHAV, V34, P1627, DOI 10.1016/S0003-3472(86)80251-2; Mitchell GW, 2010, CONDOR, V112, P644, DOI 10.1525/cond.2010.090136; MORTON ML, 1992, CONDOR, V94, P117, DOI 10.2307/1368802; Naef-Daenzer B, 2016, J FIELD ORNITHOL, V87, P227, DOI 10.1111/jofo.12157; Nebel S, 2010, AVIAN CONSERV ECOL, V5; Pegan TM, ARXIV180800864; Poole, 2011, BIRDS N AM; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Razavi B., 2012, RF MICROELECTRONICS; Reed J. Michael, 1999, Current Ornithology, V15, P189; Rivera JHV, 1999, AUK, V116, P458; Smith W. P., 1937, Auk, V1937, P65; Whittingham LA, 2000, MOL ECOL, V9, P1123, DOI 10.1046/j.1365-294x.2000.00980.x; Winkler DW, 2013, OECOLOGIA, V173, P129, DOI 10.1007/s00442-013-2605-z; Winkler David W., 2006, Hornero, V21, P85; Winkler DW, 1996, ECOLOGY, V77, P922, DOI 10.2307/2265512; Winkler DW, 2005, J ANIM ECOL, V74, P1080, DOI 10.1111/j.1365-2656.2005.01007.x; Winkler DW, 2004, CONDOR, V106, P768, DOI 10.1650/7634	36	9	9	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206258	10.1371/journal.pone.0206258	http://dx.doi.org/10.1371/journal.pone.0206258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408052	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300016
J	Bomfim, RA; Frias, AC; Pannuti, CM; Zilbovicius, C; Pereira, AC				Bomfim, Rafael Aiello; Frias, Antonio Carlos; Pannuti, Claudio Mendes; Zilbovicius, Celso; Pereira, Antonio Carlos			Socio-economic factors associated with periodontal conditions among Brazilian elderly people - Multilevel analysis of the SBSP-15 study	PLOS ONE			English	Article							ORAL-HEALTH; SOCIAL GRADIENTS; GLOBAL BURDEN; RISK-FACTORS; POPULATION; DISEASES; ADULTS; NEED	The objective of the present study was to analyze individual, contextual and social support factors associated with periodontal condition among 2332 dentate elderly Brazilian participants from the Sao Paulo State Oral Health Survey 2015 (SBSP-15). Methods: This study used the database compiled by the SBSP-15, conducted from January to December in 2015. The associations were made by relative risk (RR), with Multilevel Poisson Regressions, among individual, contextual and social support variables, and had periodontal diseases as outcomes. Results: The mean age of elders was 70.13 years (SD 5.67). The risk factors for all outcomes of periodontal diseases were male gender and self-perceived color of non-white skin. Regarding social support, feeling unhappy was a risk factor for the presence of shallow periodontal pockets (3-5mm) RR 1.43(CI 95% 1.10-1.86). The coverage of the Family Health Strategy (FHS) was a protective factor for gingival bleeding RR = 0.7(CI 95% 0.44-0.99) and calculus RR = 0.75(CI 95% 0.60-0.95), and a risk factor for the number of lost sextants (sextants with only one tooth or without any teeth) RR = 1.12(CI 95% 1.001.28). Living in municipalities with more than 90% fluoridation coverage was a protective factor for the number of lost sextants RR = 0.89(CI 95% 0.78-0.99). Conclusions: The study showed evidence that individual (gender and self-perceived skin color), contextual (coverage of the family health strategy and water fluoridation) and social support factors (feeling unhappy) are associated with the clinical outcomes of periodontal diseases in Brazilian elders. This reinforces the need for transdisciplinary actions in the FHS, stimulating work together and intersectoral collaboration between FHS and NASF (Family Health Support Center).	[Bomfim, Rafael Aiello] Fed Univ Mato Grosso do Sul UFMS, Sch Dent, Dept Community Hlth, Campo Grande, MS, Brazil; [Frias, Antonio Carlos; Zilbovicius, Celso] Univ Sao Paulo, Sch Dent, Dept Community Hlth, Sao Paulo, SP, Brazil; [Pannuti, Claudio Mendes] Univ Sao Paulo, Sch Dent, Dept Periodontol, Sao Paulo, SP, Brazil; [Pereira, Antonio Carlos] State Univ Campinas UNICAMP, Sch Dent, Dept Community Hlth, Piracicaba, SP, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Bomfim, RA (corresponding author), Fed Univ Mato Grosso do Sul UFMS, Sch Dent, Dept Community Hlth, Campo Grande, MS, Brazil.	aiello.rafael@gmail.com	Pannuti, Cláudio/B-8972-2011; ZILBOVICIUS, CELSO/ABG-7607-2020; Bomfim, Rafael Aiello/I-9539-2016	Pannuti, Cláudio/0000-0003-4181-3975; Bomfim, Rafael Aiello/0000-0002-6478-8664; Pereira, Antonio Carlos/0000-0003-1703-8171; Frias, Antonio Carlos/0000-0002-4017-2195	Sao Paulo Research Foundation (FAPESP) [14/50109-1]; Brazilian Coordination for the Improvement of Higher Education and Graduate Training Personnel (CAPES); Federal University of Mato Grosso do Sul [23104.043101/2018-40]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Coordination for the Improvement of Higher Education and Graduate Training Personnel (CAPES); Federal University of Mato Grosso do Sul	We would like to thank the following Brazilian research grant agencies for their support: Sao Paulo Research Foundation (FAPESP) Process 14/50109-1; Brazilian Coordination for the Improvement of Higher Education and Graduate Training Personnel (CAPES); and Federal University of Mato Grosso do Sul for financing publication fees, process number 23104.043101/2018-40.	Aguiar VR, 2018, COMMUNITY DENT ORAL, V46, P245, DOI 10.1111/cdoe.12356; Aida J, 2011, COMMUNITY DENT ORAL, V39, P239, DOI 10.1111/j.1600-0528.2010.00590.x; Bomfim RA, 2018, GERODONTOLOGY, V35, P51, DOI 10.1111/ger.12317; Bomfim RA, 2017, DENT TRAUMATOL, V33, P358, DOI 10.1111/edt.12348; Bomfim RA, 2018, GERODONTOLOGY, V35, P350, DOI 10.1111/ger.12355; Chalub LLFH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148859; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Dalazen CE, 2018, CIENC SAUDE COLETIVA, V23, P1119, DOI 10.1590/1413-81232018234.27462015; Dalazen CE, 2018, CIENC SAUDE COLETIVA, V23, P945, DOI 10.1590/1413-81232018233.09682016; Dalazen CE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156231; Fonseca EPD, PLOS ONE, V12, DOI [10.1371/journal.pone.0183310, DOI 10.1371/JOURNAL.PONE.0183310]; Genco RJ, 2013, PERIODONTOL 2000, V62, P59, DOI 10.1111/j.1600-0757.2012.00457.x; Geyer S, 2010, COMMUNITY DENT ORAL, V38, P120, DOI 10.1111/j.1600-0528.2009.00520.x; Grootaert C., 2004, MEASURING SOCIAL CAP, DOI DOI 10.1007/978-90-481-9606-7_3; Haas AN, 2012, J CLIN PERIODONTOL, V39, P1, DOI 10.1111/j.1600-051X.2011.01818.x; Harford J, 2009, COMMUNITY DENT ORAL, V37, P97, DOI 10.1111/j.1600-0528.2008.00441.x; Institute Brasileiro de Geografia e Estatistica, 2015, MEASURING SOCIAL CAP; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; de Carvalho JAM, 2008, CAD SAUDE PUBLICA, V24, P597, DOI 10.1590/S0102-311X2008000300013; Morris AJ, 2001, BRIT DENT J, V191, P186, DOI 10.1038/sj.bdj.4801135a; Papapanou PN, 2017, PERIODONTOL 2000, V75, P45, DOI 10.1111/prd.12200; Papapanou PN, 2015, CLIN PERIODONTOLOGY; Pereira AC, 2015, PEDRO ADS; Petersen PE, 2005, B WORLD HEALTH ORGAN, V83, P661; Sabbah W, 2007, J DENT RES, V86, P992, DOI 10.1177/154405910708601014; Sanz M, 2018, J CLIN PERIODONTOL, V45, P138, DOI 10.1111/jcpe.12808; Sehnem Alyne, 2015, Organ. Soc., V22, P309, DOI 10.1590/1984-9230741; Steele J, 2015, J DENT RES, V94, P19, DOI 10.1177/0022034514553978; Tsakos G, 2011, AM J PUBLIC HEALTH, V101, P1892, DOI 10.2105/AJPH.2011.300215; United Nations Development Programme, 2013, BRAZ ATL HUM DEV; Valente MIB, 2017, COMMUNITY DENT ORAL, DOI 10.1111/cdoe.12349; Watt RG, 2012, PERIODONTOL 2000, V60, P147, DOI 10.1111/j.1600-0757.2011.00426.x; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19	33	5	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206730	10.1371/journal.pone.0206730	http://dx.doi.org/10.1371/journal.pone.0206730			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403725	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500072
J	DeGroat, AR; Fleming, CK; Dunlay, SM; Hagood, KL; Moorman, JP; Peterson, JM				DeGroat, Ashley R.; Fleming, Christina K.; Dunlay, Samantha M.; Hagood, Kendra L.; Moorman, Jonathan P.; Peterson, Jonathan M.			The sex specific effect of alcohol consumption on circulating levels of CTRP3	PLOS ONE			English	Article							C1Q/TNF-RELATED PROTEIN-3 CTRP-3; CHRONIC ETHANOL-CONSUMPTION; LIVER-DISEASE PATHOGENESIS; ADIPOSE-TISSUE; FATTY LIVER; ADIPONECTIN SECRETION; THERAPEUTIC TARGETS; OXIDATIVE STRESS; LEPTIN SECRETION; KUPFFER CELLS	The goal of this project was to establish the effect of alcohol consumption on the circulating levels of the adipose tissue derived protein C1q TNF Related Protein 3 (CTRP3). Adipose tissue secretes several adipokines, such as adiponectin and leptin, which exert a multitude of biological effects important for human health. However, adipose tissue is extremely sensitive to alcohol consumption, leading not only to disrupted fat storage, but also to disruptions in adipokine production. Changes to adipokine secretion could have widespread biological effects and potentially contribute to alcohol-induced ailments, such as alcoholic fatty liver disease (ALD). CTRP3 has been previously demonstrated to attenuate fatty liver disease, and suppression of CTRP3 with alcohol consumption could contribute to development of and progression to alcoholic fatty liver disease. To examine the effect of ethanol consumption on circulating adipokine levels, male and female mice were fed an ethanol containing diet (Lieber-DeCarli 5% (v/v) ethanol diet) for 10-days followed by a single gavage of 5 g/kg ethanol (the NIAAA model), or for 6-weeks with no binge added (chronic model). In female mice, adiponectin levels increased -2-fold in both models of ethanol feeding, but in male mice increased adiponectin levels were only observed after chronic ethanol feeding. On the other hand, in female mice, circulating CTRP3 levels decreased by -75% and -50% in the NIAAA and chronic model, respectively, with no changes observed in the male mice in either feeding model. Leptin levels were unchanged with ethanol feeding regardless of model or sex of mice. Lastly, chronic ethanol feeding led to a significant increase in mortality (-50%) in female mice, with no difference in relative ethanol consumption. These findings indicate that ethanol consumption can dysregulate adipokine secretion, but that the effects vary by sex of animal, method of ethanol consumption, and adipokine examined. These findings also indicate that female mice are more sensitive to the chronic effects of ethanol than male mice. Notably, this is the first study to document the effects of ethanol consumption on the circulating levels of CTRP3. Understanding the impact of excessive alcohol consumption on adipokine production and secretion could identify novel mechanisms of alcohol-induced human disease. However, the mechanism responsible for the increased sensitivity remains elusive.	[DeGroat, Ashley R.; Hagood, Kendra L.; Peterson, Jonathan M.] East Tennessee State Univ, Dept Biomed Sci, Johnson City, TN 37614 USA; [Fleming, Christina K.; Dunlay, Samantha M.; Peterson, Jonathan M.] East Tennessee State Univ, Coll Publ Hlth, Dept Hlth Sci, Johnson City, TN 37614 USA; [Moorman, Jonathan P.; Peterson, Jonathan M.] East Tennessee State Univ, James H Quillen Coll Med, Ctr Excellence Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA; [Moorman, Jonathan P.] East Tennessee State Univ, Quillen Coll Med, Dept Internal Med, Div Infect Inflammatory & Immunol Dis, Johnson City, TN USA; [Moorman, Jonathan P.] James H Quillen VA Med Ctr, Hepatitis HCV HIV Program, Dept Vet Affairs, Johnson City, TN USA	East Tennessee State University; East Tennessee State University; East Tennessee State University; East Tennessee State University	Peterson, JM (corresponding author), East Tennessee State Univ, Dept Biomed Sci, Johnson City, TN 37614 USA.; Peterson, JM (corresponding author), East Tennessee State Univ, Coll Publ Hlth, Dept Hlth Sci, Johnson City, TN 37614 USA.; Peterson, JM (corresponding author), East Tennessee State Univ, James H Quillen Coll Med, Ctr Excellence Inflammat Infect Dis & Immun, Johnson City, TN 37614 USA.	petersonjm1@etsu.edu	Peterson, Jonathan M./H-3122-2019	Peterson, Jonathan M./0000-0002-9873-3880	National Institute on Alcohol Abuse and Alcoholism [R03AA023612]; National Institute of Diabetes and Digestive and Kidney Diseases [1R15DK114740-01A1]; East Tennessee State University research development committee; National Institute of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK114740] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); East Tennessee State University research development committee; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work received support from the National Institute of Health, National Institute on Alcohol Abuse and Alcoholism R03AA023612, National Institute of Diabetes and Digestive and Kidney Diseases 1R15DK114740-01A1, and East Tennessee State University research development committee to JMP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY MJ, 1977, ARCH INTERN MED, V137, P883, DOI 10.1001/archinte.137.7.883; BARAONA E, 1979, J LIPID RES, V20, P289; Baumeister SE, 2018, EUR J PREV CARDIOL, V25, P164, DOI 10.1177/2047487317738594; Becker U, 1996, HEPATOLOGY, V23, P1025, DOI 10.1002/hep.510230513; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Byerly MS, 2014, J BIOL CHEM, V289, P4055, DOI 10.1074/jbc.M113.506956; Calissendorff J, 2004, ALCOHOL ALCOHOLISM, V39, P281, DOI 10.1093/alcalc/agh054; Chen XC, 2007, AM J PHYSIOL-ENDOC M, V292, pE621, DOI 10.1152/ajpendo.00387.2006; Choi YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185778; Cohen JI, 2010, GASTROENTEROLOGY, V139, P664, DOI 10.1053/j.gastro.2010.04.041; Compton SA, 2010, ENDOCRINOLOGY, V151, P5095, DOI 10.1210/en.2010-0916; Eguchi A, 2013, EXPERT OPIN THER TAR, V17, P773, DOI 10.1517/14728222.2013.789502; Enomoto N, 1999, AM J PHYSIOL-GASTR L, V277, pG671, DOI 10.1152/ajpgi.1999.277.3.G671; Fulham MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164225; Gao Bin, 2017, Gene Expression, V17, P173, DOI 10.3727/105221617X695519; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; He Z, 2015, BRIT J NUTR, V113, P1355, DOI 10.1017/S000711451500077X; Hiney JK, 1999, ALCOHOL CLIN EXP RES, V23, P1785, DOI 10.1111/j.1530-0277.1999.tb04074.x; Hofmann C, 2011, INFLAMM BOWEL DIS, V17, P2462, DOI 10.1002/ibd.21647; Ikejima K, 1998, AM J PHYSIOL-GASTR L, V274, pG669, DOI 10.1152/ajpgi.1998.274.4.G669; Imhof A, 2009, DIABETES CARE, V32, P1101, DOI 10.2337/dc08-1723; Kema VH, 2015, ADIPOCYTE, V4, P225, DOI 10.1080/21623945.2015.1017170; Kono H, 2000, AM J PHYSIOL-GASTR L, V278, pG652, DOI 10.1152/ajpgi.2000.278.4.G652; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Kopp A, 2010, CYTOKINE, V49, P51, DOI 10.1016/j.cyto.2009.10.001; Lee Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185134; Li Y, 2017, COMPR PHYSIOL, V7, P863, DOI 10.1002/cphy.c160044; LOFT S, 1987, SCAND J GASTROENTERO, V22, P1251, DOI 10.3109/00365528708996472; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Maher JJ, 1998, HEPATOLOGY, V28, P1720, DOI 10.1002/hep.510280638; MARBET UA, 1987, J HEPATOL, V4, P364, DOI 10.1016/S0168-8278(87)80547-0; Matsumoto C, 2014, J CARDIOPULM REHABIL, V34, P159, DOI 10.1097/HCR.0000000000000042; MEZEY E, 1988, AM J CLIN NUTR, V48, P148, DOI 10.1093/ajcn/48.1.148; MORGAN MY, 1977, BRIT MED J, V1, P939, DOI 10.1136/bmj.1.6066.939; Nagy LE, 2016, GASTROENTEROLOGY, V150, P1756, DOI 10.1053/j.gastro.2016.02.035; Nanji AA, 2001, AM J PHYSIOL-GASTR L, V281, pG1348, DOI 10.1152/ajpgi.2001.281.6.G1348; Obradovic T, 2002, ALCOHOL CLIN EXP RES, V26, P255, DOI 10.1097/00000374-200202000-00014; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Otaka M, 2007, DIGEST DIS SCI, V52, P3066, DOI 10.1007/s10620-006-9635-x; PARES A, 1986, J HEPATOL, V2, P33, DOI 10.1016/S0168-8278(86)80006-X; Parker R, 2018, NAT REV GASTRO HEPAT, V15, P50, DOI 10.1038/nrgastro.2017.116; Petersen PS, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12735; Peterson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088535; Peterson JM, 2013, AM J PHYSIOL-REG I, V305, pR522, DOI 10.1152/ajpregu.00110.2013; Peterson JM, 2013, AM J PHYSIOL-GASTR L, V305, pG214, DOI 10.1152/ajpgi.00102.2013; Peterson JM, 2012, J BIOL CHEM, V287, P1576, DOI 10.1074/jbc.M111.278333; Peterson JM, 2010, J BIOL CHEM, V285, P39691, DOI 10.1074/jbc.M110.180695; Pravdova E, 2009, Endocr Regul, V43, P117; Rehm J, 2010, DRUG ALCOHOL REV, V29, P437, DOI 10.1111/j.1465-3362.2009.00153.x; Rojdmark S, 2001, CLIN ENDOCRINOL, V55, P639, DOI 10.1046/j.1365-2265.2001.01401.x; Sanyal AJ, 2015, CLIN RES HEPATOL GAS, V39, pS46, DOI 10.1016/j.clinre.2015.05.012; Schenker S, 1998, Adv Intern Med, V43, P27; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schmid A, 2013, EXP CLIN ENDOCR DIAB, V121, P310, DOI 10.1055/s-0032-1333299; Schmid A, 2012, EXP CLIN ENDOCR DIAB, V120, P611, DOI 10.1055/s-0032-1323803; Schmid A, 2014, BIOCHEM BIOPH RES CO, V452, P8, DOI 10.1016/j.bbrc.2014.06.054; Seldin MM, 2014, REV ENDOCR METAB DIS, V15, P111, DOI 10.1007/s11154-013-9255-7; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shoreibah M, 2016, ANN HEPATOL, V15, P183, DOI 10.5604/16652681.1193707; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Steiner JL, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010016; Stickel F, 2010, BEST PRACT RES CL GA, V24, P683, DOI 10.1016/j.bpg.2010.07.003; Strbak V, 1998, METABOLISM, V47, P1269, DOI 10.1016/S0026-0495(98)90335-3; Szkudelski T, 2004, J ANIM PHYSIOL AN N, V88, P251, DOI 10.1111/j.1439-0396.2004.00478.x; Tan XB, 2012, AM J PATHOL, V181, P1279, DOI 10.1016/j.ajpath.2012.06.013; Tang H, 2012, ALCOHOL CLIN EXP RES, V36, P214, DOI 10.1111/j.1530-0277.2011.01607.x; Thurman R G, 2000, Can J Gastroenterol, V14 Suppl D, p129D; Tietge UJF, 2004, AM J PHYSIOL-ENDOC M, V287, pE82, DOI 10.1152/ajpendo.00494.2003; Trogen G, 2018, AM J PHYSIOL-ENDOC M, V315, pE949, DOI 10.1152/ajpendo.00050.2018; Wei ZK, 2013, J BIOL CHEM, V288, P10214, DOI 10.1074/jbc.M113.458711; Wei ZK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201087; Wolf RM, 2016, AM J PHYSIOL-ENDOC M, V310, pE332, DOI 10.1152/ajpendo.00248.2015; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Yoo MG, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111133; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; Yu HC, 2010, ACTA PHARMACOL SIN, V31, P461, DOI 10.1038/aps.2010.12; Zhang JX, 2018, CYTOKINE, V106, P131, DOI 10.1016/j.cyto.2017.10.023	81	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207011	10.1371/journal.pone.0207011	http://dx.doi.org/10.1371/journal.pone.0207011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403751	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500092
J	Oh, SY; Park, MS; Cho, HJ; Lim, YW				Oh, Seung-Yoon; Park, Myung Soo; Cho, Hae Jin; Lim, Young Woon			Diversity and effect of Trichoderma isolated from the roots of Pinus densiflora within the fairy ring of pine mushroom (Tricholoma matsutake)	PLOS ONE			English	Article							GREEN MOLD; SECONDARY METABOLITES; LACCARIA-LACCATA; IN-VITRO; BIOCONTROL; ECTOMYCORRHIZAL; SYSTEMATICS; BACTERIA; GROWTH; FUNGI	Pine mushroom (PM, Tricholoma matsutake) is an important ectomycorrhizal fungus in Asia primarily due to its value as a food delicacy. Recent studies have shown that fairy rings of PM have distinctive fungal communities, which suggests that other fungi influence the growth of PM. Trichoderma is a well-known saprotrophic fungus commonly found in pine roots within PM fairy rings; however, little is known about the diversity of Trichoderma associated with PM and how these species influence PM growth. This study focused on diversity of Trichoderma isolated from pine roots within PM fairy rings and how these species affect the growth of PM isolate. Based on tefl a phylogenetic analyses, nine Trichoderma species (261 isolates) were identified. Trichoderma songyi and T. spirale were the dominant species, and Trichoderma community varied geographically. Growth experiments indicated that metabolites from five Trichoderma species had a significant influence on the growth of PM isolates. Metabolites of two Trichoderma species increased PM growth, while those of three Trichoderma species suppressed the growth. Within the fairy rings, Trichoderma that had a positive or neutral effect comprised the majority of Trichoderma communities. The results of this study suggest that various Trichoderma species co-exist within PM fairy rings and that these species influence PM growth.	[Lim, Young Woon] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; Seoul Natl Univ, Inst Microbiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lim, YW (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	ywlim@snu.ac.kr	Oh, Seung-Yoon/H-4958-2018	Oh, Seung-Yoon/0000-0002-9745-1849				BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bissett J, 2015, IMA FUNGUS, V6, P263, DOI 10.5598/imafungus.2015.06.02.02; Brimner TA, 2003, AGR ECOSYST ENVIRON, V100, P3, DOI 10.1016/S0167-8809(03)00200-7; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Chaverri P, 2015, MYCOLOGIA, V107, P558, DOI 10.3852/14-147; Chaverri P, 2013, EVOLUTION, V67, P2823, DOI 10.1111/evo.12169; Chen K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07807-3; CHET I, 1981, PHYTOPATHOLOGY, V71, P286, DOI 10.1094/Phyto-71-286; Deveau A, 2018, FEMS MICROBIOL REV, V42, P335, DOI 10.1093/femsre/fuy008; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; El-Hassan Said A., 2013, Journal of Plant Protection Research, V53, P12, DOI 10.2478/jppr-2013-0002; GHISALBERTI EL, 1991, SOIL BIOL BIOCHEM, V23, P1011, DOI 10.1016/0038-0717(91)90036-J; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Hong JH, 2015, MAR DRUGS, V13, P4137, DOI 10.3390/md13074137; Hur Tae-Chul, 2001, Journal of Korean Forestry Society, V90, P767; Ingham E. R., 1991, MICROBIAL MEDIATION, P169; Jaklitsch WM, 2013, PERSOONIA, V31, P112, DOI 10.3767/003158513X672234; Jaklitsch WM, 2013, MYCOTAXON, V126, P143, DOI 10.5248/126.143; Jaklitsch WM, 2011, FUNGAL DIVERS, V48, P1, DOI 10.1007/s13225-011-0088-y; Jaklitsch WM, 2009, STUD MYCOL, P1, DOI 10.3114/sim.2009.63.01; 허태철, 2004, [Journal of Korean Society of Forest Science, 한국산림과학회지], V93, P26; Kataoka R, 2012, J MICROBIOL, V50, P199, DOI 10.1007/s12275-012-1371-7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keswani C, 2014, APPL MICROBIOL BIOT, V98, P533, DOI 10.1007/s00253-013-5344-5; Khair H. Abd-El, 2010, J AM SCI, V6, P122; Kim Jang-Han, 2009, Mycobiology, V37, P317, DOI 10.4489/MYCO.2009.37.4.317; Landeweert R, 2001, TRENDS ECOL EVOL, V16, P248, DOI 10.1016/S0169-5347(01)02122-X; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Lu BH, 2016, PLANT DIS, V100, P2525, DOI 10.1094/PDIS-04-16-0422-PDN; Malyshkin P.E., 1955, MYCOTROPHY PLANTS, P211; Matsushita Norihisa, 2005, Mycoscience, V46, P90, DOI 10.1007/s10267-004-0220-x; Minchin RF, 2012, ANN APPL BIOL, V161, P57, DOI 10.1111/j.1744-7348.2012.00552.x; 김인엽, 2005, [The Korean Journal of Mycology, 한국균학회지], V33, P22; Mucha J, 2011, ANTON LEEUW INT J G, V100, P155, DOI 10.1007/s10482-011-9556-3; Mumpuni A, 1998, APPL ENVIRON MICROB, V64, P5053; Mutawila C, 2016, PLANT PATHOL, V65, P104, DOI 10.1111/ppa.12385; Nishino K, 2017, BIOSCI BIOTECH BIOCH, V81, P102, DOI 10.1080/09168451.2016.1238298; Oh SY, 2018, J MICROBIOL, V56, P399, DOI 10.1007/s12275-018-7491-y; Oh SY, 2018, MYCORRHIZA, V28, P411, DOI 10.1007/s00572-018-0828-x; Oh SY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190948; Oh SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168573; OHARA H, 1967, NATURE, V213, P528, DOI 10.1038/213528a0; Ospina-Giraldo MD, 1998, MYCOLOGIA, V90, P76, DOI 10.2307/3761014; Park MS, 2014, ANTON LEEUW INT J G, V106, P593, DOI 10.1007/s10482-014-0230-4; Park Myung Soo, 2006, Mycobiology, V34, P111, DOI 10.4489/MYCO.2006.34.3.111; Reddy MS, 2006, SOIL BIOL, V7, P245; Reino Jose Luis, 2008, Phytochemistry Reviews, V7, P89, DOI 10.1007/s11101-006-9032-2; 유영현, 2011, [The Korean Journal of Mycology, 한국균학회지], V39, P223; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Saba H, 2012, MYCOSPHERE, V3, P524, DOI 10.5943/mycosphere/3/4/14; Sadfi-Zouaoui N, 2009, CAN J MICROBIOL, V55, P154, DOI [10.1139/W08-101, 10.1139/w08-101]; Samuels G, 2002, MYCOLOGIA, V94, P146, DOI 10.2307/3761854; Samuels GJ, 2006, PHYTOPATHOLOGY, V96, P195, DOI 10.1094/PHYTO-96-0195; Samuels GJ, 1996, MYCOL RES, V100, P923, DOI 10.1016/S0953-7562(96)80043-8; Sharma RR, 2009, BIOL CONTROL, V50, P205, DOI 10.1016/j.biocontrol.2009.05.001; SHAW TM, 1995, MYCOL RES, V99, P159, DOI 10.1016/S0953-7562(09)80880-0; SONG H-S, 1991, Korean Journal of Mycology, V19, P109; SUMMERBELL RC, 1987, NEW PHYTOL, V105, P437, DOI 10.1111/j.1469-8137.1987.tb00881.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarkka MT, 2009, CURR GENET, V55, P233, DOI 10.1007/s00294-009-0241-2; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Vinale F., 2014, OPEN MYCOL J, V8, P127, DOI [10.2174/1874437001408010127, DOI 10.2174/1874437001408010127]; Voznyakovskaya Y.M., 1955, MYCOTROPHY WOODY PLA, P320; Wang Yun, 1997, Economic Botany, V51, P311, DOI 10.1007/BF02862101; Werner A, 2002, MYCORRHIZA, V12, P139, DOI 10.1007/s00572-002-0159-8; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yamanaka T, 2014, MYCOLOGIA, V106, P397, DOI 10.3852/13-197; Zadworny M, 2004, MYCORRHIZA, V14, P401, DOI 10.1007/s00572-004-0323-4; Zhang CL, 2005, FEMS MICROBIOL LETT, V251, P251, DOI 10.1016/j.femsle.2005.08.034	69	9	10	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205900	10.1371/journal.pone.0205900	http://dx.doi.org/10.1371/journal.pone.0205900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403694	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500033
J	Wang, LP; Li, Q; Liu, ZY; Surendra, A; Pan, YL; Li, YF; Zaharia, LI; Ouellet, T; Fobert, PR				Wang, Lipu; Li, Qiang; Liu, Ziying; Surendra, Anu; Pan, Youlian; Li, Yifeng; Zaharia, L. Irina; Ouellet, Therese; Fobert, Pierre R.			Integrated transcriptome and hormone profiling highlight the role of multiple phytohormone pathways in wheat resistance against fusarium head blight	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ABSCISIC-ACID; ANTAGONISTIC INTERACTION; RNA-SEQ; GRAMINEARUM; INFECTION; ETHYLENE; HOST; DEFENSE; MECHANISMS	Fusarium head blight (FHB or scab) caused by Fusarium spp. is a destructive disease of wheat. Since the most effective sources of FHB resistance are typically associated with unfavorable agronomic traits, breeding commercial cultivars that combine desired agronomic traits and a high level of FHB resistance remains a considerable challenge. A better understanding of the molecular mechanisms governing FHB resistance will help to design more efficient and precise breeding strategies. Here, multiple molecular tools and assays were deployed to compare the resistant variety Sumai3 with three regionally adapted Canadian cultivars. Macroscopic and microscopic disease evaluation established the relative level of Type II FHB resistance of the four varieties and revealed that the F. graminearum infection process displayed substantial temporal differences among organs. The rachis was found to play a critical role in preventing F. graminearum spread within spikes. Large-scale, organ-specific RNA-seq at different times after F. graminearum infection demonstrated that diverse defense mechanisms were expressed faster and more intensely in the spikelet of resistant varieties. The roles of plant hormones during the interaction of wheat with F. graminearum was inferred based on the transcriptomic data obtained and the quantification of the major plant hormones. Salicylic acid and jasmonic acid were found to play predominantly positive roles in FHB resistance, whereas auxin and ABA were associated with susceptibility, and ethylene appeared to play a dual role during the interaction with F. graminearum.	[Wang, Lipu; Zaharia, L. Irina; Fobert, Pierre R.] Natl Res Council Canada, Saskatoon, SK, Canada; [Wang, Lipu; Li, Qiang] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK, Canada; [Liu, Ziying; Surendra, Anu; Pan, Youlian; Li, Yifeng; Fobert, Pierre R.] Natl Res Council Canada, Ottawa, ON, Canada; [Ouellet, Therese] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada	National Research Council Canada; University of Saskatchewan; National Research Council Canada; Agriculture & Agri Food Canada	Fobert, PR (corresponding author), Natl Res Council Canada, Saskatoon, SK, Canada.; Fobert, PR (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	pierre.fobert@nrc-cnrc.gc.ca		Pan, Youlian/0000-0002-0158-0081				Alcazar R, 2011, TRENDS PLANT SCI, V16, P666, DOI 10.1016/j.tplants.2011.09.001; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; ANDERSON WK, 2000, WHEAT BOOK PRINCIPLE; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Beltrano J, 1999, J PLANT GROWTH REGUL, V18, P59, DOI 10.1007/PL00007049; Boddu J, 2006, MOL PLANT MICROBE IN, V19, P407, DOI 10.1094/MPMI-19-0407; Boenisch MJ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-110; Brewer HC, 2015, TRENDS PLANT SCI, V20, P651, DOI 10.1016/j.tplants.2015.06.011; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Brown NA, 2010, FUNGAL BIOL-UK, V114, P555, DOI 10.1016/j.funbio.2010.04.006; Buhrow LM, 2016, PHYTOPATHOLOGY, V106, P986, DOI 10.1094/PHYTO-01-16-0033-R; Chen X, 2009, NEW PHYTOL, V182, P975, DOI 10.1111/j.1469-8137.2009.02821.x; Comeau A., 2011, Plant Breeding and Seed Science, V63, P39, DOI 10.2478/v10129-011-0014-1; Cuperlovic-Culf M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153642; De Wit P, 2012, MOL ECOL RESOUR, V12, P1058, DOI 10.1111/1755-0998.12003; DePauw RM, 2011, CAN J PLANT SCI, V91, P797, DOI [10.4141/cjps10188, 10.4141/CJPS10188]; DePauw RM, 2009, CAN J PLANT SCI, V89, P945, DOI 10.4141/CJPS08227; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fu J, 2011, INSIGHT AUXIN SIGNAL, V74, P1, DOI DOI 10.3389/FPLS.2011.00074; Fu ZQ, 2013, ANNU REV PLANT BIOL, V64, P839, DOI 10.1146/annurev-arplant-042811-105606; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Golkari S, 2007, PLANT BIOTECHNOL J, V5, P38, DOI 10.1111/j.1467-7652.2006.00213.x; Gonzalez-Lamothe R, 2012, PLANT CELL, V24, P762, DOI 10.1105/tpc.111.095190; Gottwald S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-369; Gunnaiah R, 2014, PLANT PHYSIOL BIOCH, V83, P40, DOI 10.1016/j.plaphy.2014.07.002; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kang ZS, 2000, MYCOL RES, V104, P1083, DOI 10.1017/S0953756200002495; Kazan K, 2018, MOL PLANT PATHOL, V19, P764, DOI 10.1111/mpp.12561; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kondhare KR, 2015, J CEREAL SCI, V63, P95, DOI 10.1016/j.jcs.2015.03.004; Lahlali R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00910; Li GL, 2008, CROP SCI, V48, P1888, DOI 10.2135/cropsci2008.02.0097; Li HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023145; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo K, 2016, FUNGAL BIOL-UK, V120, P1135, DOI 10.1016/j.funbio.2016.06.002; Makandar R, 2006, MOL PLANT MICROBE IN, V19, P123, DOI 10.1094/MPMI-19-0123; Makandar R, 2012, MOL PLANT MICROBE IN, V25, P431, DOI 10.1094/MPMI-09-11-0232; Melotto M, 2008, ANNU REV PHYTOPATHOL, V46, P101, DOI 10.1146/annurev.phyto.121107.104959; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; Naik PK, 1999, PLANT GROWTH REGUL, V28, P29, DOI 10.1023/A:1006285615853; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pritsch C, 2000, MOL PLANT MICROBE IN, V13, P159, DOI 10.1094/MPMI.2000.13.2.159; Qi PF, 2016, PHYSIOL MOL PLANT P, V93, P39, DOI 10.1016/j.pmpp.2015.12.004; Ravensdale M, 2014, MOL PLANT PATHOL, V15, P948, DOI 10.1111/mpp.12145; Rodriguez PL, 2016, MOL PLANT, V9, P1448, DOI 10.1016/j.molp.2016.09.009; Sorahinobar M, 2016, J PLANT GROWTH REGUL, V35, P477, DOI 10.1007/s00344-015-9554-1; Tchagang AB, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-229; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; van der Ent SaP C. M. J., 2012, ANN PLANT REV ONLINE; Vanstraelen M, 2012, ANNU REV CELL DEV BI, V28, P463, DOI 10.1146/annurev-cellbio-101011-155741; Walter S, 2010, NEW PHYTOL, V185, P54, DOI 10.1111/j.1469-8137.2009.03041.x; Wanjiru WM, 2002, EUROPEAN J PLANT PAT, V108; Weijers D, 2016, ANNU REV PLANT BIOL, V67, P539, DOI 10.1146/annurev-arplant-043015-112122; Weng JK, 2016, CELL, V166, P881, DOI 10.1016/j.cell.2016.06.027; Worley B, 2013, ANAL BIOCHEM, V433, P102, DOI 10.1016/j.ab.2012.10.011; Xiao J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-197; Yasuda M, 2008, PLANT CELL, V20, P1678, DOI 10.1105/tpc.107.054296; Zhang WT, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-017-0761-2	61	36	36	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207036	10.1371/journal.pone.0207036	http://dx.doi.org/10.1371/journal.pone.0207036			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403737	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500097
J	Cofie, LE; Barrington, C; Sodzi-Tettey, S; Ennett, S; Maman, S; Singh, K				Cofie, Leslie E.; Barrington, Clare; Sodzi-Tettey, Sodzi; Ennett, Susan; Maman, Suzzane; Singh, Kavita			A qualitative study of women's network social support and facility delivery in rural Ghana	PLOS ONE			English	Article							DECISION-MAKING; HEALTH FACILITIES; CHILDBIRTH; MOTHERS; CARE	Similar to many sub-Saharan African countries, maternal mortality in Ghana ranks among the highest (39th) globally. Prior research has demonstrated the impact of social network characteristics on health facility delivery in sub-Saharan Africa. However, in-depth examination of the function of all members in a woman's network, in providing various types of support for the woman's pregnancy and related care, is limited. We qualitatively explore how women's network social support influences facility delivery. Qualitative data came from a mixed methods evaluation of a Maternal and Newborn Health Referral project in Ghana. In 2015 we conducted in-depth interviews with mothers (n = 40) and husbands (n = 20), and 4 focus group interviews with mothers-in-law. Data were analyzed using narrative summaries and thematic coding procedures to first examine women's network composition during their pregnancy and childbirth experiences. We then compared those who had homebirths versus facility births on how network social support influenced their place of childbirth. Various network members were involved in providing women with social support. We found differences in how informational and instrumental support impacted women's place of childbirth. Network members of women who had facility delivery mobilized resources to support women's facility delivery. Among women who had homebirth but their network members advocated for them to have facility delivery, members delayed making arrangements for the women's facility delivery. Women who had homebirth, and their network members advocated homebirth, received support to give birth at home. Network support for women's pregnancy-related care affects their place of childbirth. Hence, maternal health interventions must develop strategies to prioritize informational and instrumental support for facility-based pregnancy and delivery care.	[Cofie, Leslie E.] East Carolina Univ, Dept Hlth Educ & Promot, Greenville, NC 27858 USA; [Barrington, Clare; Ennett, Susan; Maman, Suzzane] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC 27515 USA; [Barrington, Clare; Singh, Kavita] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Sodzi-Tettey, Sodzi] Inst Healthcare Improvement, Accra, Ghana; [Singh, Kavita] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Maternal & Child Hlth, Chapel Hill, NC 27515 USA	University of North Carolina; East Carolina University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Cofie, LE (corresponding author), East Carolina Univ, Dept Hlth Educ & Promot, Greenville, NC 27858 USA.	Cofiel18@ecu.edu	Barrington, Clare/AAM-4909-2021		Bill & Melinda Gates Foundation [OPP48930]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Maternal and Newborn Referrals Project was funded by the Bill & Melinda Gates Foundation (OPP48930).	Akazili J, 2011, AFRICAN J HLTH SCI, V18, P62; Alexander A, 2014, J BIOSOC SCI, V46, P669, DOI 10.1017/S0021932013000412; Balaji AB, 2007, J WOMENS HEALTH, V16, P1386, DOI 10.1089/jwh.2007.CDC10; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Carrington P. J., 2005, MODELS METHODS SOCIA; Carter M, 2002, SOC SCI MED, V55, P437, DOI 10.1016/S0277-9536(01)00175-7; Central Intelligence Agency (CIA), 2015, WORLD FACTBOOK; Cofie LE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0604-2; Crissman Halley P, 2013, Afr J Reprod Health, V17, P15; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; Danforth EJ, 2009, J HEALTH POPUL NUTR, V27, P696; Doku D, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-29; Fischer C. S., 1982, DWELL FRIENDS PERSON; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gething PW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-991; Ghana Statistical Service, 2014, GHANA DEMOGRAPHIC HL; Ghana Statistical Service, 2013, 2010 POPULATION HOUS, P1; Guest G, 2006, FIELD METHOD, V18, P59, DOI 10.1177/1525822X05279903; Gupta ML, 2015, GLOB PUBLIC HEALTH, V10, P1078, DOI 10.1080/17441692.2014.1002413; Gupta S, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju032; HOUSE JS, 1988, ANNU REV SOCIOL, V14, P293, DOI 10.1146/annurev.so.14.080188.001453; House JS, 1981, WORK STRESS SOCIAL S; ISRAEL BA, 1982, PATIENT COUNS HEALTH, V4, P65, DOI 10.1016/S0190-2040(82)80002-5; Jansen I, 2006, INT NURS REV, V53, P41, DOI 10.1111/j.1466-7657.2006.00448.x; Kruk ME, 2010, HEALTH POLICY, V97, P209, DOI 10.1016/j.healthpol.2010.05.002; Kwambai TK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-134; LAUMANN EO, 1973, BONDS PLURALISM FORM; Levy P., 2010, GHANAS TRANSPORTATIO; Luke DA, 2007, ANNU REV PUBL HEALTH, V28, P69, DOI 10.1146/annurev.publhealth.28.021406.144132; McCarty C, 2002, J SOCIAL STRUCTURE; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Mills S, 2005, STUD FAMILY PLANN, V36, P45, DOI 10.1111/j.1728-4465.2005.00040.x; MITCHELL RE, 1980, COMMUNITY MENT HLT J, V16, P27, DOI 10.1007/BF00780665; Morse J., CRITICAL ISSUES QUAL, P23; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Ono M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-214; Parkhurst JO, 2006, J HEALTH POPUL NUTR, V24, P438; Sakeah E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-344; SANDELOWSKI M, 1995, RES NURS HEALTH, V18, P371, DOI 10.1002/nur.4770180411; Say L, 2007, PUBLIC HLTH REV; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; SEEMAN TE, 1988, SOC SCI MED, V26, P737, DOI 10.1016/0277-9536(88)90065-2; Speizer IS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/s12884-014-0398-7; Stephenson R, 2006, AM J PUBLIC HEALTH, V96, P84, DOI 10.2105/AJPH.2004.057422; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; Tey NP, 2013, SCI WORLD J, DOI 10.1155/2013/423403; THOITS PA, 1995, J HEALTH SOC BEHAV, V35, P53, DOI 10.2307/2626957; United Nations Children's Fund (UNICEF), 2014, UNICEF DAT MON SIT C; Valente TW, 1997, SOC SCI MED, V45, P677, DOI 10.1016/S0277-9536(96)00385-1; White D, 2013, INT PERSPECT SEX R H, V39, P58, DOI 10.1363/3905813; WHO, 2016, WORLD HLTH STAT 2016; Who UUWBG Division atUNP., 2015, TRENDS MAT MORT 1990	53	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206429	10.1371/journal.pone.0206429	http://dx.doi.org/10.1371/journal.pone.0206429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399180	Green Published, Green Submitted			2022-12-26	WOS:000449374000012
J	Grenyer, BFS; Lewis, KL; Fanaian, M; Kotze, B				Grenyer, Brin F. S.; Lewis, Kate L.; Fanaian, Mahnaz; Kotze, Beth			Treatment of personality disorder using a whole of service stepped care approach: A cluster randomized controlled trial	PLOS ONE			English	Article							PSYCHIATRIC OUTPATIENTS; PREVALENCE	Background and objectives People with personality disorders are prevalent in emergency and inpatient mental health services. We examined whether implementing a stepped care model of psychological therapy reduces demand on hospital units by people with personality disorder, in a cluster randomized controlled trial. Method A total of 642 inpatients (average age 36.8, 50.5% female) with a primary ICD-10 personality disorder were recruited during 18 months baseline, then monitored during an 18 month active trial phase. In the active trial phase two equivalent sites were randomised to either treatment as usual (TAU), or a whole of service intervention that diverted people away from hospital and into stepped care psychological therapy clinics. The study design was cost neutral, with no additional staff or resources deployed between sites. A linear mixed models analysis evaluated outcomes. Results As predicted, demand on hospital services reduced significantly in the intervention compared to TAU site. The intervention site evidenced shorter bed days, from an average of 13.46 days at baseline to 4.28 days per admission, and patients were 1.3 times less likely to re-present to the emergency department compared to TAU. Direct cost savings for implementing the approach was estimated at USD$2,720 per patient per year. Limitations included not directly comparing individual symptom changes. Conclusions Using a whole of service stepped care model of treatment for personality disorder significantly reduced demand on hospital services.	[Grenyer, Brin F. S.; Lewis, Kate L.; Fanaian, Mahnaz] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Grenyer, Brin F. S.; Lewis, Kate L.] Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia; [Fanaian, Mahnaz] Univ Wollongong, Sch Nursing, Wollongong, NSW, Australia; [Kotze, Beth] NSW Minist Hlth, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	Grenyer, BFS (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.; Grenyer, BFS (corresponding author), Univ Wollongong, Sch Psychol, Wollongong, NSW, Australia.	grenyer@uow.edu.au	Grenyer, Brin FS/AAB-6452-2020	Grenyer, Brin FS/0000-0003-1501-4336; Fanaian, Mahnaz/0000-0003-2613-8465	New South Wales Ministry of Health	New South Wales Ministry of Health	This study is part of a larger project funded by New South Wales Ministry of Health (to Professor Brin F.S. Grenyer). The funding body provided the authors with the data, however had no role in the design, data analysis, or preparation of the manuscript. The funding body gave approval for the manuscript to be published.	Australian Institute of Health and Welfare, 2014, AUSTR REF DIAGN REL; Bailey RC, 2014, J PERS DISORD, V28, P796, DOI 10.1521/pedi_2014_28_136; Beckwith H, 2014, PERSONAL MENT HEALTH, V8, P91, DOI 10.1002/pmh.1252; Bender DS, 2001, AM J PSYCHIAT, V158, P295, DOI 10.1176/appi.ajp.158.2.295; Bland J Martin, 2004, BMC Med Res Methodol, V4, P21, DOI 10.1186/1471-2288-4-21; Borschmann R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009353.pub2; Bourke ME, 2017, J PSYCHIATR PRACT, V23, P246, DOI 10.1097/PRA.0000000000000247; Bower P, 2005, BRIT J PSYCHIAT, V186, P11, DOI 10.1192/bjp.186.1.11; Cailhol L, 2013, J PERS DISORD, V27, P252, DOI 10.1521/pedi.2013.27.2.252; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Commonwealth of Australia, 1993, NAT MENT HLTH PLAN; Cristea IA, 2017, JAMA PSYCHIAT, V74, P319, DOI 10.1001/jamapsychiatry.2016.4287; Day NJS, 2018, PERSONAL MENT HEALTH, V12, P309, DOI 10.1002/pmh.1429; Fanaian M, 2013, INT J MENT HEALTH NU, V22, P465, DOI 10.1111/inm.12009; Grenyer BFS., 2014, ACPARIAN, V9, P8; Grenyer BFS, 2018, AUST NZ J PSYCHIAT, V52, P202, DOI 10.1177/0004867417741984; Grenyer BFS, 2013, MED J AUSTRALIA, V198, P464, DOI 10.5694/mja13.10470; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Holmes Alex, 2006, Australas Psychiatry, V14, P272, DOI 10.1111/j.1440-1665.2006.02284.x; Kealy D, 2010, J PSYCHIATR PRACT, V16, P145, DOI 10.1097/01.pra.0000375710.39713.4d; Korzekwa MI, 2008, COMPR PSYCHIAT, V49, P380, DOI 10.1016/j.comppsych.2008.01.007; Laporte L, 2018, PERSONAL MENT HEALTH, V12, P252, DOI 10.1002/pmh.1421; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Leontieva L, 2013, J PERS DISORD, V27, P222, DOI 10.1521/pedi.2013.27.2.222; Meuldijk D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171592; Milner AJ, 2015, BRIT J PSYCHIAT, V206, P184, DOI 10.1192/bjp.bp.114.147819; *NAT I MENT HLTH E, 2003, PERS DIS NO LONG DIA; National Centre for Classification in Health, 2010, AUSTR CLASS HLTH INT; National Health and Medical Research Council, 2012, CLIN PRACT GUID MAN; National Institute for Health and Care Excellence, 2009, BORDERLINE PERSONALI; New South Wales Department of Health, 2001, YOUR GUID MH OAT CLI; Paris J, 2013, PSYCHIAT SERV, V64, P1035, DOI 10.1176/appi.ps.201200451; Project Air Strategy for Personality Disorders, 2015, TREATM GUID PERS DIS, DOI [10.1037/per0000091, DOI 10.1037/PER0000091]; Project Air Strategy for Personality Disorders, 2015, PROJ AIR STRAT PERS; Reserve Bank of Australia, 2018, EXCH RAT DAIL 2010 2; Shaikh U, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00136; Tyrer P, 2010, WORLD PSYCHIATRY, V9, P56; Wilhelm K, 2007, AUSTRALAS PSYCHIATRY, V15, P35, DOI 10.1080/10398560601083068; World Health Organization, 1992, INT STAT CLASS DIS R; Zimmerman M, 2005, AM J PSYCHIAT, V162, P1911, DOI 10.1176/appi.ajp.162.10.1911	40	28	29	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206472	10.1371/journal.pone.0206472	http://dx.doi.org/10.1371/journal.pone.0206472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399184	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000013
J	Hsieh, CY; Huang, CW; Wu, DP; Sung, SF				Hsieh, Cheng-Yang; Huang, Chin-Wei; Wu, Darren Philbert; Sung, Sheng-Feng			Risk of ischemic stroke after discharge from inpatient surgery: Does the type of surgery matter?	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TOTAL HIP-REPLACEMENT; BYPASS GRAFT-SURGERY; PERIOPERATIVE STROKE; NONCARDIAC SURGERY; ATRIAL-FIBRILLATION; CARDIAC-SURGERY; CLAIMS DATABASE; CASE-CROSSOVER; MECHANISMS	Objective Stroke is a well-known and devastating complication during the perioperative period. How- ever, detailed stroke risk profiles within 90 days in patients discharged without stroke after inpatient surgery are not fully understood. Using the case-crossover design, we aimed to evaluate the risk of ischemic stroke in these patients. Methods We included adult patients with the first hospitalization for ischemic stroke between 2011 and 2012 from 23 million enrollees in the National Health Insurance Research Database. Admission date of the hospitalization was defined as the case day and exactly 365 days before the admission date as the control day. The exposure was the last hospitalization for surgery within 1-30, 31-60, or 61-90 days (case period) before the case day or similar time intervals (control period) before the control day. Surgical types were grouped based on the International Classification of Diseases procedure codes. We performed conditional logistic regression adjusting for time-varying variables to determine the relationship between surgery and subsequent stroke, and case-time-control analyses to examine whether the results were confounded by the time-trend in surgery. Results A total of 56596 adult patients (41% female, mean age 69 years) comprised the study population. After adjustment was made for confounding variables, an association between stroke and prior inpatient surgery within 30 days was observed (adjusted odds ratio 1.44; 95% confidence interval 1.29-1.61). Cardiothoracic, vascular, digestive surgery, and musculoskeletal surgery within 30 days independently predicted ischemic stroke in the case-crossover analysis. In the case-time-control analysis, inpatient surgery remained an independent risk factor for ischemic stroke, whereas only cardiothoracic, vascular, and digestive surgery independently predicted ischemic stroke. Conclusions Surgery as a whole independently increased the risk of ischemic stroke within 30 days. Among various types of surgery, cardiothoracic, vascular, and digestive surgery significantly increased the risk of ischemic stroke.	[Hsieh, Cheng-Yang] Tainan Sin Lau Hosp, Dept Neurol, Tainan, Taiwan; [Hsieh, Cheng-Yang] Natl Cheng Kung Univ, Coll Med, Sch Pharm, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan; [Huang, Chin-Wei] Natl Cheng Kung Univ Hosp, Dept Neurol, Tainan, Taiwan; [Huang, Chin-Wei] Coll Med, Tainan, Taiwan; [Wu, Darren Philbert; Sung, Sheng-Feng] Ditmanson Med Fdn Chiayi Christian Hosp, Div Neurol, Dept Internal Med, Chiayi, Taiwan; [Sung, Sheng-Feng] Natl Chung Cheng Univ, Dept Informat Management, Minxiong, Chiayi County, Taiwan; [Sung, Sheng-Feng] Natl Chung Cheng Univ, Inst Healthcare Informat Management, Minxiong, Chiayi County, Taiwan	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; Chia-Yi Christian Hospital; National Chung Cheng University; National Chung Cheng University	Sung, SF (corresponding author), Ditmanson Med Fdn Chiayi Christian Hosp, Div Neurol, Dept Internal Med, Chiayi, Taiwan.; Sung, SF (corresponding author), Natl Chung Cheng Univ, Dept Informat Management, Minxiong, Chiayi County, Taiwan.; Sung, SF (corresponding author), Natl Chung Cheng Univ, Inst Healthcare Informat Management, Minxiong, Chiayi County, Taiwan.	sfsung@cych.org.tw	Hsieh, Cheng-Yang/W-4841-2019	Hsieh, Cheng-Yang/0000-0002-8772-4073; Sung, Sheng-Feng/0000-0002-6253-8813	Ditmanson Medical Foundation Chia-Yi Christian Hospital Research Program [R106-021]; Ministry of Science and Technology, Taiwan [MOST 107-2314-B-705-001]	Ditmanson Medical Foundation Chia-Yi Christian Hospital Research Program; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported in part by the Ditmanson Medical Foundation Chia-Yi Christian Hospital Research Program (R106-021) to SFS and the Ministry of Science and Technology (grant number MOST 107-2314-B-705-001), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. There was no additional external funding received for this study.	Bastian D, 2008, EUR SURG RES, V41, P334, DOI 10.1159/000157176; Bateman BT, 2009, ANESTHESIOLOGY, V110, P231, DOI 10.1097/ALN.0b013e318194b5ff; Blacker DJ, 2004, MAYO CLIN PROC, V79, P223, DOI 10.4065/79.2.223; Chang CH, 2010, STROKE, V41, P1884, DOI 10.1161/STROKEAHA.110.585828; Chen WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179424; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Echahidi N, 2008, J AM COLL CARDIOL, V51, P793, DOI 10.1016/j.jacc.2007.10.043; Ekeloef S, 2017, BRIT J ANAESTH, V118, P200, DOI 10.1093/bja/aew410; Elkind MSV, 2010, STROKE, V41, pS3, DOI 10.1161/STROKEAHA.110.594945; Fallouh N, 2012, J HOSP MED, V7, P573, DOI 10.1002/jhm.1945; Garcia-Poza P, 2015, J THROMB HAEMOST, V13, P708, DOI 10.1111/jth.12855; Gialdini G, 2014, JAMA-J AM MED ASSOC, V312, P616, DOI 10.1001/jama.2014.9143; Grau AJ, 2017, CEREBROVASC DIS, V43, P242, DOI 10.1159/000460827; Hallas J, 2014, J INTERN MED, V275, P581, DOI 10.1111/joim.12186; Hedberg M, 2013, SCAND CARDIOVASC J, V47, P136, DOI 10.3109/14017431.2012.737016; Hsieh CY, 2015, J FORMOS MED ASSOC, V114, P254, DOI 10.1016/j.jfma.2013.09.009; Huang CJ, 2010, BRIT J ANAESTH, V105, P818, DOI 10.1093/bja/aeq266; Ko SB, 2018, KOREAN J ANESTHESIOL, V71, P3, DOI 10.4097/kjae.2018.71.1.3; Lahtinen J, 2004, ANN THORAC SURG, V77, P1241, DOI 10.1016/j.athoracsur.2003.09.077; Lalmohamed A, 2012, STROKE, V43, P3225, DOI 10.1161/STROKEAHA.112.668509; Likosky DS, 2003, STROKE, V34, P2830, DOI 10.1161/01.STR.0000098650.12386.B3; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mashour GA, 2014, J NEUROSURG ANESTH, V26, P273, DOI 10.1097/ANA.0000000000000087; Mashour GA, 2011, ANESTHESIOLOGY, V114, P1289, DOI 10.1097/ALN.0b013e318216e7f4; Memtsoudis SG, 2013, ANESTHESIOLOGY, V118, P1046, DOI 10.1097/ALN.0b013e318286061d; Mrkobrada M, 2016, BRIT J ANAESTH, V117, P191, DOI 10.1093/bja/aew179; Nah HW, 2014, ANN NEUROL, V76, P347, DOI 10.1002/ana.24238; Ng JLW, 2011, ANESTHESIOLOGY, V115, P879, DOI 10.1097/ALN.0b013e31822e9499; Shin JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119931; SUISSA S, 1995, EPIDEMIOLOGY, V6, P248, DOI 10.1097/00001648-199505000-00010; Sung SF, 2016, INT J CARDIOL, V215, P277, DOI 10.1016/j.ijcard.2016.04.069; Takeuchi Y, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-017-0457-7; Tan CN, 2007, ANESTHESIOLOGY, V107, P333, DOI 10.1097/01.anes.0000270733.26234.56; Urbanek C, 2014, CEREBROVASC DIS, V38, P370, DOI 10.1159/000368596; Vasivej T, 2016, J STROKE CEREBROVASC, V25, P1172, DOI 10.1016/j.jstrokecerebrovasdis.2016.01.051; Vlisides P, 2016, CAN J ANESTH, V63, P193, DOI 10.1007/s12630-015-0494-9; Wolff G, 2018, INT J CARDIOL, V258, P59, DOI 10.1016/j.ijcard.2017.12.088; Yoshida T, 2018, J CRIT CARE, V44, P267, DOI 10.1016/j.jcrc.2017.11.040	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206990	10.1371/journal.pone.0206990	http://dx.doi.org/10.1371/journal.pone.0206990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395587	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400071
J	Werlang, ICR; Mueller, NT; Pizoni, A; Wisintainer, H; Matte, U; Costa, SHDM; Ramos, JGL; Goldoni, MZ; Dominguez-Bello, MG; Goldoni, HAS				Ribas Werlang, Isabel Cristina; Mueller, Noel Theodore; Pizoni, Aline; Wisintainer, Henrique; Matte, Ursula; de Almeida Martins Costa, Sergio Hofmeister; Lopes Ramos, Jose Geraldo; Goldoni, Marcelo Zubaran; Dominguez-Bello, Maria Gloria; Sueno Goldoni, Helena Ayako			Associations of birth mode with cord blood cytokines, white blood cells, and newborn intestinal bifidobacteria	PLOS ONE			English	Article							CESAREAN-SECTION; CHILDHOOD OBESITY; DELIVERY; MICROBIOTA; TERM; INTERLEUKIN-6; OVERWEIGHT; CHILDREN; RISK	The associations of Cesarean delivery with offspring metabolic and immune-mediated diseases are believed to derive from lack of mother-to-newborn transmission of specific microbes at birth. Bifidobacterium spp., in particular, has been hypothesized to play a health-promoting role, yet little is known about how delivery mode modifies colonization of the newborn by this group of microbes. The aim of this research was to examine the presence of Bifidobacterium in meconium and in the transitional stool, and to assess cytokine levels and hematological parameters in the venous cord blood of infants born by elective, pre-labor Cesarean section vs. vaginal delivery in Southern Brazil. We recruited 89 mother-newborn pairs (23 vaginal delivery and 66 elective cesarean delivery), obtained demographic information from a structured questionnaire and clinical information from medical records. We obtained umbilical cord venous blood and meconium samples following delivery and the transitional stool (the first defecation after meconium) before discharge. We determined plasma levels of IL-1 beta, IL-10, IL-6, GM-CSF, IL-5, IFN-gamma, TNF-alpha, IL-2, IL-4 and IL-8 in the cord blood, and presence of stool Bifidobacterium by real time PCR. Compared to vaginally-delivered neonates, Cesarean-delivered neonates had a lower leukocyte count (p = 0.037), lower hemoglobin (p = 0.04), and lower levels of the cytokine GM-CSF (p = 0.009) in the cord blood. Moreover, Bifidobacterium was detected less often in the transitional stool of Cesarean-delivered neonates compared to vaginally-delivered neonates (p = 0.001). The results indicate that pre-labor Cesarean birth may be associated with microbial and hematological alterations in the neonate. The clinical significance of these findings remains to be determined in larger prospective birth cohort studies.	[Ribas Werlang, Isabel Cristina; Pizoni, Aline; Goldoni, Marcelo Zubaran; Sueno Goldoni, Helena Ayako] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Translat Pediat, Porto Alegre, RS, Brazil; [Ribas Werlang, Isabel Cristina; Goldoni, Marcelo Zubaran; Sueno Goldoni, Helena Ayako] Univ Fed Rio Grande do Sul, Fac Med, Postgrad Program Hlth Child & Adolescent, Porto Alegre, RS, Brazil; [Mueller, Noel Theodore] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mueller, Noel Theodore] Johns Hopkins Med Inst, Welch Ctr Epidemiol Prevent & Clin Res, Baltimore, MD 21205 USA; [Pizoni, Aline; Sueno Goldoni, Helena Ayako] Univ Fed Rio Grande do Sul, Fac Med, Postgrad Program Sci Gastroenterol & Hepatol, Porto Alegre, RS, Brazil; [Wisintainer, Henrique] Univ Luterana Brasil ULBRA, Porto Alegre, RS, Brazil; [Matte, Ursula] Univ Fed Rio Grande do Sul, Dept Genet, Porto Alegre, RS, Brazil; [de Almeida Martins Costa, Sergio Hofmeister; Lopes Ramos, Jose Geraldo] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Dept Gynecol & Obstet, Porto Alegre, RS, Brazil; [de Almeida Martins Costa, Sergio Hofmeister; Lopes Ramos, Jose Geraldo] Hosp Mae Deus, Porto Alegre, RS, Brazil; [Dominguez-Bello, Maria Gloria] Rutgers State Univ, Dept Biochem & Microbiol & Anthropol, New Brunswick, NJ USA	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Universidade Federal do Rio Grande do Sul; Universidade Luterana do Brasil; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Rutgers State University New Brunswick	Goldoni, HAS (corresponding author), Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Translat Pediat, Porto Alegre, RS, Brazil.; Goldoni, HAS (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Postgrad Program Hlth Child & Adolescent, Porto Alegre, RS, Brazil.; Goldoni, HAS (corresponding author), Univ Fed Rio Grande do Sul, Fac Med, Postgrad Program Sci Gastroenterol & Hepatol, Porto Alegre, RS, Brazil.	hgoldani@hcpa.edu.br	Da Silveira Matte umatte, Ursula/U-3912-2019; Martins-Costa, Sérgio/AAA-5807-2021; Wisintainer, Henrique/ABE-8738-2021; Ramos, Jose/U-3787-2019	Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; Ramos, Jose/0000-0002-3789-885X; Mueller, Noel/0000-0002-7412-8352; Ribas Werlang, Isabel Cristina/0000-0001-8556-868X; Goldani, Helena Ayako Sueno/0000-0002-0088-7639	Hospital de Clinicas de Porto Alegre Research and Event Support Fund (FIPE-HCPA); National Heart, Lung, and Blood Institute [K01HL141589]; Foundation for Gender Specific Medicine; C D fund; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Mid-Atlantic Nutrition Obesity Research Center [P30DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER	Hospital de Clinicas de Porto Alegre Research and Event Support Fund (FIPE-HCPA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Foundation for Gender Specific Medicine; C D fund; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Mid-Atlantic Nutrition Obesity Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support was provided by Hospital de Clinicas de Porto Alegre Research and Event Support Fund (FIPE-HCPA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. NTM has been supported by National Heart, Lung, and Blood Institute/K01HL141589, Mid-Atlantic Nutrition Obesity Research Center/P30DK072488 and Foundation for Gender Specific Medicine. MGDB has been supported by C& D fund. ICRW has been supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES).	ABLES IN, 2005, J PERINAT MED, V33, P42, DOI DOI 10.1515/JPM.2005; Almanzar G, 2015, EARLY HUM DEV, V91, P663, DOI 10.1016/j.earlhumdev.2015.09.010; Arntzen KJ, 1997, ACTA OBSTET GYN SCAN, V76, P55, DOI 10.3109/00016349709047785; Bernardi JR, 2012, BMC PREGNANCY CHILDB, V12, P25, DOI DOI 10.1186/1471-2393-12-25; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Darmasseelane K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087896; Devereaux J, 2015, CHILD OBES, V11, P227, DOI 10.1089/chi.2015.29000.nm; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Evans KC, 2003, ARCH DIS CHILD-FETAL, V88, pF380, DOI 10.1136/fn.88.5.F380; Glasser L, 2015, J PERINATOL, V35, P469, DOI 10.1038/jp.2014.241; Goldani HAS, 2011, AM J CLIN NUTR, V93, P1344, DOI 10.3945/ajcn.110.010033; Greig PC, 1997, OBSTET GYNECOL, V90, P465, DOI 10.1016/S0029-7844(97)00294-9; Gueimonde M, 2006, J PEDIATR GASTR NUTR, V42, P166, DOI 10.1097/01.mpg.0000189346.25172.fd; Hyde MJ, 2012, BIOL REV, V87, P229, DOI 10.1111/j.1469-185X.2011.00195.x; J ZAKJ, INFLUENCE; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kuhle S, 2015, OBES REV, V16, P295, DOI 10.1111/obr.12267; LaTuga MS, 2014, SEMIN REPROD MED, V32, P68, DOI 10.1055/s-0033-1361824; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Lim FTH, 2000, AM J OBSTET GYNECOL, V183, P1144, DOI 10.1067/mob.2000.108848; Luoto R, 2011, J PEDIATR GASTR NUTR, V52, P90, DOI 10.1097/MPG.0b013e3181f3457f; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Malamitsi-Puchner A, 2005, EARLY HUM DEV, V81, P387, DOI 10.1016/j.earlhumdev.2004.10.017; Mueller NT, 2015, INT J OBESITY, V39, P665, DOI 10.1038/ijo.2014.180; Mueller NT, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120364; Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002; Nikischin W, 1997, GYNECOL OBSTET INVES, V43, P104, DOI 10.1159/000291831; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; de Jesus GR, 2015, BJOG-INT J OBSTET GY, V122, P606, DOI 10.1111/1471-0528.13119; Soto A, 2014, J PEDIATR GASTR NUTR, V59, P78, DOI 10.1097/MPG.0000000000000347; STALLMACH T, 1995, LAB INVEST, V73, P384; Steinborn A, 1999, CLIN EXP IMMUNOL, V117, P147; UMESAKI N, 1995, GYNECOL OBSTET INVES, V40, P5, DOI 10.1159/000292291; Yuan C, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.2385	35	11	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0205962	10.1371/journal.pone.0205962	http://dx.doi.org/10.1371/journal.pone.0205962			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388115	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800019
J	Tariku, EZ; Abebe, GA; Melketsedik, ZA; Gutema, BT				Tariku, Eshetu Zerihun; Abebe, Getaneh Alemu; Melketsedik, Zeleke Aschalew; Gutema, Befikadu Tariku			Prevalence and factors associated with stunting and thinness among school-age children in Arba Minch Health and Demographic Surveillance Site, Southern Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; NUTRITIONAL-STATUS; UNDERNUTRITION; GROWTH	Introduction Despite consistent economic growth in the country, malnutrition remains one of the major public health problems in Ethiopia. The prevalence of malnutrition and its associated factors are well studied among under-five children. However, there is a paucity of evidence among older children in developing countries including Ethiopia. The aim of the study was to assess the prevalence of stunting and thinness and their associated factors among school-age children. Methods A community-based cross-sectional study was conducted among randomly selected 389 school-age children in Arba Minch Health and Demographic Surveillance Site, Southern Ethiopia, during April and May 2017. Height for age and body mass index for age z scores were calculated using WHO Anthro Plus software as indicators of stunting and thinness respectively. A binary logistic regression model was used to assess the association between independent and outcome variables. Results The prevalence of stunting and thinness were 41.9% (95% CI: 37-47) and 8.0% (95% CI: 5.4-10.8) respectively. The likelihood of stunting was significantly higher among children within the age group of 12-14 years old (AOR = 2.97, 95% CI: 1.78-4.95); children who were male (AOR = 1.94, 95% CI: 1.21-3.10); children living in households with medium wealth terciles (AOR = 2.90, 95%CI: 1.39-6.04); and children who were non-enrolled in schools (AOR = 2.25, 95% CI: (1.37-3.70). Moreover, thinness was 63% less common among children who had a dietary diversity score of <4 food groups (AOR = 0.37, 95%CI: 0.16-0.89). Conclusion The prevalence of thinness is low when compared to the prevalence reported by a single national school health and nutrition survey in Ethiopia. Stunting is a major public health concern. Therefore, this finding warrants the need to implement school health and nutrition programs to improve the nutritional status of school-age children in the study area. The interventions should focus towards both gender and special emphasis should also be given to increase the enrollment of children in schools. In addition, effort should be taken by stakeholders in different hierarchies to improve the family wealth status.	[Tariku, Eshetu Zerihun; Gutema, Befikadu Tariku] Arba Minch Univ, Dept Publ Hlth, Arba Minch, Ethiopia; [Abebe, Getaneh Alemu] Bahir Dar Univ, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Melketsedik, Zeleke Aschalew] Arba Minch Univ, Dept Nursing, Arba Minch, Ethiopia	Arba Minch University; Bahir Dar University; Arba Minch University	Tariku, EZ (corresponding author), Arba Minch Univ, Dept Publ Hlth, Arba Minch, Ethiopia.	eshetu.zerihun@amu.edu.et	Gutema, Befikadu Tariku/AAD-7023-2020	Gutema, Befikadu Tariku/0000-0003-0574-6074; Tariku, Eshetu Zerihun/0000-0002-5390-0411	Arba Minch University [Gov/AMU/TH.2-1/CMHS/NUR/01/09]	Arba Minch University	Arba Minch University is funding this research work with a project grant code of Gov/AMU/TH.2-1/CMHS/NUR/01/09. The website of the university is http://www.amu.edu.et/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenuga W U, 2017, Ann Ib Postgrad Med, V15, P7; Akseer N, 2017, ANN NY ACAD SCI, V1393, P3, DOI 10.1111/nyas.13336; Amare B, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-108; [Anonymous], 2013, GUIDE MEASURING DIET; [Anonymous], STAT WORLDS CHILDR F; Ara R, 2011, J DHAKA MED COLL, V20, P97; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Central Statistical Agency-CSA/Ethiopia ICF, 2012, ICF ETH DEM HLTH SUR; Central Statistical Agency-CSA/Ethiopia ICF, 2017, ICF ETH DEM HLTH SUR; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Cora B., FOOD NUTR B, V31; Das S., 2012, ONLINE J ANTHR, V8, P1973; De Hoop J, 2017, POLICY RES WORKING P; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Degarege D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1714-5; Demissie T, 2009, J HEALTH POPUL NUTR, V27, P666; Division of Nutrition and Physical Activity, 2007, DIV NUTR PHYS ACT RE, V4; Drake L., 2002, SCN News, P4; Egata G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-864; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gutema Bekele, 2014, BMC Hematol, V14, P13, DOI 10.1186/2052-1839-14-13; Hall A, 2008, TROP MED INT HEALTH, V13, P1518, DOI 10.1111/j.1365-3156.2008.02168.x; Hawkins SS, 2006, INT J PEDIATR OBES, V1, P195, DOI 10.1080/17477160600943351; Herrador Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105880; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jukes M., 2002, NUTR FDN DEV, P1; Medhi G. K., 2006, Journal of Human Ecology, V19, P83; Mekonnen H., 2013, NUTR DISORDERS THE S, VS12, DOI DOI 10.4172/2161-0509.S12-002; Mesfin F, 2015, NUTR DIET SUPPL, V7, P61, DOI 10.2147/NDS.S80803; Mesfin F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123615; Monarrez-Espino J, 2004, EUR J CLIN NUTR, V58, P532, DOI 10.1038/sj.ejcn.1601840; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; Mushtaq MU, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-790; National Health and Nutrition Examination Survey (NHANES), 2007, ANTHR PROC MAN; Novotny R, 2007, J AM DIET ASSOC, V107, P1743, DOI 10.1016/j.jada.2007.07.018; Prince K., 2014, EUROPEAN SCI J, V10, P1857; Raya R., 2010, ASIA S PACIFIC ED WA, V10; Roba KT, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.163.9387; Senbanjo IO, 2011, J HEALTH POPUL NUTR, V29, P364, DOI 10.3329/jhpn.v29i4.8452; Situation Analysis on School Health and Nutrition in Ethiopia Ministry of Education (MoE), 2008, SIT AN SCH HLTH NUTR; Srivastava A, 2012, ARCH PUBLIC HEALTH, V70, DOI 10.1186/0778-7367-70-8; STINSON S, 1985, YEARB PHYS ANTHROPOL, V28, P123, DOI 10.1002/ajpa.1330280507; UNICEF, 2011, LEV TRENDS CHILD MOR; United Nations International Children Educational Fund (UNICEF), 1990, GOALS CHILDR DEV; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082500; Woldehanna T., 2008, YOUNG LIVES ETHIOPIA; World Health Organization, 2011, OB OV FACT SHEET 311; World Health Organization, 1995, PHYS STAT US INT ANT	49	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206659	10.1371/journal.pone.0206659	http://dx.doi.org/10.1371/journal.pone.0206659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388149	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800050
J	You, YH; Wang, JC; Teng, WJ; Ma, GF; Liu, PT				You, Yinghui; Wang, Jincai; Teng, Wenjie; Ma, Guifeng; Liu, Pengtao			Blood pressure and noncommunicable diseases in middle-aged and older adults in China	PLOS ONE			English	Article							CARDIOVASCULAR MORTALITY; GLOBAL BURDEN; HYPERTENSION; PREVALENCE; RISK; HEALTH; AWARENESS; TRENDS	Background There are few studies examining the association between blood pressure (BP) and noncommunicable diseases (NCDs) in consideration of the new hypertension guidelines in China. Methods Data were drawn from the China Health and Retirement Longitudinal Study. 14 390 eligible participants (aged 45 years and older) were selected through four-stage, stratified, and cluster sampling. Hypertension was considered as a mean systolic blood pressure (SBP) of 130 mm Hg (old definition: 140 mm Hg) or higher, a mean diastolic blood pressure (DBP) of 80 mm Hg (old definition: 90 mm Hg) or higher or taking anti-hypertensive medication. Cochran-Armitage trend test and logistic regression analyses were conducted to test the association between BP level and NCDs. Results The prevalence of hypertension based on the latest definition was 56.35% (while by old definition: 42.75%). The awareness, treatment, and control among hypertensive participants were 38.62% (51.18%), 43.10% (56.81%), and 9.91% (13.06%), respectively. An increasing rate of NCDs (diabetes, heart disease, stroke, and memory-related disease) among participants were found with the ascending of BP level. After adjusted for demographics and behavioral risks, the following 3 NCDs had been shown to correlate with hypertension: diabetes (adjusted OR 1.15, 0.91-1.45 for elevated BP; 1.20, 0.97-1.49 for hypertension stage 1; 1.55, 1.28-1.86 hypertension stage 2), heart disease (0.94, 0.79-1.12; 1.05, 0.90-1.22; 1.28, 1.12-1.47), and stroke (1.77, 1.25-2.51; 1.32, 0.93-1.87; 1.85, 1.37-2.49). Conclusions The association between hypertension and the risk of NCDs is of concern in China. The combined efforts on NCDs prevention and lowered blood pressure should be made by nationally integrated strategies, especially in middle-aged and older adults.	[You, Yinghui; Wang, Jincai; Teng, Wenjie; Ma, Guifeng; Liu, Pengtao] Weifang Med Univ, Weifang, Shandong, Peoples R China	Weifang Medical University	Liu, PT (corresponding author), Weifang Med Univ, Weifang, Shandong, Peoples R China.	lpt1978@126.com	Liu, Pengtao/P-7242-2018	Liu, Pengtao/0000-0003-0190-0935	National Natural Science Foundation of China [71673202]; Shandong medical and health science technology development program [2017WS410]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong medical and health science technology development program	This study was supported by grants from the National Natural Science Foundation of China (71673202), and Shandong medical and health science technology development program (2017WS410).	Chen X, 2014, AM J HYPERTENS, V27, P1503, DOI 10.1093/ajh/hpu026; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Gu H, 2015, J HUM HYPERTENS, V29, P555, DOI 10.1038/jhh.2014.123; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Gupta P, 2012, SAUDI J KIDNEY DIS T, V23, P223; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Jingi AM, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.09.38; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Ladwig KH, 2014, BUNDESGESUNDHEITSBLA, V57, P1083, DOI 10.1007/s00103-014-2020-6; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2016, JAMA INTERN MED, V176, P524, DOI 10.1001/jamainternmed.2016.0190; Li GJ, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2965-5; Ning M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009836; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang JW, 2014, AM J HYPERTENS, V27, P1355, DOI 10.1093/ajh/hpu053; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006; Wong ND, 2016, JAMA INTERN MED, V176, P532, DOI 10.1001/jamainternmed.2016.0213; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang ZJ, 2012, EUR HEART J, V33, P213, DOI 10.1093/eurheartj/ehr205; Zhao YH, 2014, LANCET, V384, P723, DOI 10.1016/S0140-6736(14)61292-7; Zhao YH, 2014, INT J EPIDEMIOL, V43, P61, DOI 10.1093/ije/dys203; Zhou DH, 2016, JAMA INTERN MED, V176, P1233, DOI 10.1001/jamainternmed.2016.3819	30	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206635	10.1371/journal.pone.0206635	http://dx.doi.org/10.1371/journal.pone.0206635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388163	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800047
J	Harvey, DJ; Vuts, J; Hooper, A; Finch, P; Woodcock, CM; Caulfield, JC; Kadej, M; Smolis, A; Withall, DM; Henshall, S; Pickett, JA; Gange, AC; Birkett, MA				Harvey, Deborah J.; Vuts, Jozsef; Hooper, Antony; Finch, Paul; Woodcock, Christine M.; Caulfield, John C.; Kadej, Marcin; Smolis, Adrian; Withall, David M.; Henshall, Sarah; Pickett, John A.; Gange, Alan C.; Birkett, Michael A.			Environmentally vulnerable noble chafers exhibit unusual pheromone-mediated behaviour	PLOS ONE			English	Article							CHEMICAL COMMUNICATION; OSMODERMA-EREMITA; SEX-PHEROMONE; STAG BEETLE; AGGREGATION; ATTRACTION; CUES; PREY; RARE	Conserving populations of environmentally vulnerable insect species requires a greater understanding of the factors that determine their abundance and distribution, which requires detailed knowledge of their population and community ecology. Chemical ecological tools such as pheromones can be used for non-destructive monitoring of scarab beetle populations, enabling European countries to detect and, in some cases, map the range of some of these species, proving a valuable technique for monitoring elusive saproxylic beetles. In this paper, we investigated the behavioural and chemical ecology of the noble chafer, Gnorimus nobilis L., a model insect species of conservation concern across a Europe-wide distribution, and a red-listed UK Biodiversity Action Plan priority species. We identified a potential pheromone of adult beetles using electrophysiological recordings, behavioural measurements and field trials in the UK. Gnorimus nobilis is highly unusual in that although both sexes produce, at high metabolic cost, the natural product 2-propyl (E)-3-hexenoate, it only attracts males. This pattern of chemical signalling makes the classification of the compound, based on current semiochemical terminology, somewhat problematic, but in our view, it should be termed an aggregation pheromone as a consequence of the production pattern. Since both sexes emit it, but apparently only males respond positively to it, 2-propyl (E)-3-hexenoate may reflect an intermediate evolutionary stage towards developing into a sex-specific signal. From an applied perspective, our study provides a model for the non-invasive surveillance of cryptic vulnerable insect species, without the need for habitat searching or disturbance, and continuous human monitoring.	[Harvey, Deborah J.; Finch, Paul; Gange, Alan C.] Univ London, Sch Biol Sci, Egham, Surrey, England; [Vuts, Jozsef; Woodcock, Christine M.; Caulfield, John C.; Withall, David M.; Birkett, Michael A.] Rothamsted Res, Dept Biointeract & Crop Protect, Harpenden, Herts, England; [Hooper, Antony] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Kadej, Marcin; Smolis, Adrian] Univ Wroclaw, Fac Biol Sci, Inst Environm Biol, Dept Invertebrate Biol Evolut & Conservat, Wroclaw, Poland; [Pickett, John A.] Cardiff Univ, Sch Chem, Cardiff, S Glam, Wales; [Henshall, Sarah] Buglife Invertebrate Conservat Trust, Peterborough, Cambs, England	University of London; Royal Holloway University London; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of London; Queen Mary University London; University of Wroclaw; Cardiff University	Harvey, DJ (corresponding author), Univ London, Sch Biol Sci, Egham, Surrey, England.	d.harvey@rhul.ac.uk	Adrian, Smolis/AAJ-1129-2021; pickett, john/X-3235-2019; Kadej, Marcin/E-5916-2018	Adrian, Smolis/0000-0002-8117-0268; pickett, john/0000-0002-8386-3770; FINCH, PAUL/0000-0001-5531-4523; Birkett, Michael/0000-0002-3302-2025; Withall, David/0000-0001-5042-0183; Kadej, Marcin/0000-0001-5983-0402; Harvey, Deborah/0000-0002-0928-2636	Leverhulme Trust [RPG-2012-617]; People's Trust for Endangered Species; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom; BBSRC [BBS/E/C/00005194] Funding Source: UKRI	Leverhulme Trust(Leverhulme Trust); People's Trust for Endangered Species; Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Work at Royal Holloway was supported by a Leverhulme Trust (https://leverhulme.ac.uk/) grant number RPG-2012-617 and funding from the People's Trust for Endangered Species (ptes.org) both awarded to ACG and DJH. Rothamsted Research receives grant-aided support from the Biotechnology and Biological Sciences Research Council (BBSRC; https://bbsrc.ukri.org/) of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander K, 2008, ORCHARDS GROVES THEI, P11; Alexander K, 2004, ENGLISH NAT RES REPO, P467; Alexander K. N. A., 2002, ENGLISH NATURE RES R; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Blaho M, 2012, PHYSIOL BEHAV, V105, P1067, DOI 10.1016/j.physbeh.2011.11.020; BRIG, 2007, REP SPEC HAB REV UK; Campanaro A, 2016, INSECT CONSERV DIVER, V9, P574, DOI 10.1111/icad.12194; Carde RT, 2014, J CHEM ECOL, V40, P519, DOI 10.1007/s10886-014-0465-6; EEA, 2010, 122020 EEA; Fombong AT, 2012, J CHEM ECOL, V38, P1463, DOI 10.1007/s10886-012-0211-x; Harvey DJ, 2017, INSECT CONSERV DIVER, V10, P1, DOI 10.1111/icad.12227; Harvey DJ, 2017, INSECT CONSERV DIVER, V10, P161, DOI 10.1111/icad.12214; Harvey DJ, 2011, INSECT CONSERV DIVER, V4, P23, DOI 10.1111/j.1752-4598.2010.00107.x; Holdcraft R, 2016, INSECTS, V7, DOI 10.3390/insects7020017; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Kadej M, 2015, J INSECT CONSERV, V19, P25, DOI 10.1007/s10841-014-9735-4; Kosi AZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183279; Lachat Thibault, 2018, IMPORTANCE PRIMARY F, DOI [10.1007/978-3-319-75937-1_17, DOI 10.1007/978-3-319-75937-1_17]; Lamellicornia Endrodi S, 1956, FAUNA HUNGARIAE 9 4; Larsson MC, 2009, CONSERV BIOL, V23, P1516, DOI 10.1111/j.1523-1739.2009.01263.x; Larsson MC, 2003, J CHEM ECOL, V29, P575, DOI 10.1023/A:1022850704500; Leal WS, 1996, J CHEM ECOL, V22, P1557, DOI 10.1007/BF02027731; Leal WS, 1997, INSECT PHEROMONE RESEARCH, P505; MADDRELL SH, 1969, J EXP BIOL, V51, P71; Millar JG, 2010, J CHEM ECOL, V36, P923, DOI 10.1007/s10886-010-9831-1; NBN Gateway, 2017, NBN GAT GNOR NOB REC; Nieto A, 2010, EUROPEAN RED LIST SA, P1, DOI DOI 10.2779/84561; NIST/EPA/NIH, 2008, MASS SPECTR LIB SEAR; Schmera D, 2004, CROP PROT, V23, P939, DOI 10.1016/j.cropro.2004.02.006; Speight M. C. D., 1989, NATURE ENV SERIES, V42; Svensson GP, 2004, J CHEM ECOL, V30, P353, DOI 10.1023/B:JOEC.0000017982.51642.8c; Toth M, 2015, CHEMOECOLOGY, V25, P1, DOI 10.1007/s00049-014-0170-5; Vuts J, 2014, J CHEM ECOL, V40, P190, DOI 10.1007/s10886-014-0377-5; Vuts J, 2012, PHYSIOL ENTOMOL, V37, P92, DOI 10.1111/j.1365-3032.2011.00820.x; Weiss I, 2013, NAT COMMUN, V4, P1767, DOI [10.1038/ncomms2748, DOI 10.1038/NCOMMS2748]; Wertheim B, 2005, ANNU REV ENTOMOL, V50, P321, DOI 10.1146/annurev.ento.49.061802.123329; Wyatt TD, 2010, J COMP PHYSIOL A, V196, P685, DOI 10.1007/s00359-010-0564-y; Xu H, 2018, TRENDS PLANT SCI, V23, P100, DOI 10.1016/j.tplants.2017.11.004	39	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206526	10.1371/journal.pone.0206526	http://dx.doi.org/10.1371/journal.pone.0206526			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383860	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000449027600060
J	Zhang, JX; Tan, P; Guo, L; Gong, J; Ma, JJ; Li, J; Lee, M; Fang, SH; Jing, J; Johnson, G; Sun, DQ; Cao, WM; Dashwood, R; Han, L; Zhou, YB; Dong, WG; Huang, Y				Zhang, Jixiang; Tan, Peng; Guo, Lei; Gong, Jing; Ma, Jingjing; Li, Jia; Lee, Minjung; Fang, Shaohai; Jing, Ji; Johnson, Gavin; Sun, Deqiang; Cao, Wen-ming; Dashwood, Roderick; Han, Leng; Zhou, Yubin; Dong, Wei-Guo; Huang, Yun			p53-dependent autophagic degradation of TET2 modulates cancer therapeutic resistance	ONCOGENE			English	Article							DNA-DAMAGE; STEM-CELLS; P53; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; ANTICANCER; MUTATIONS; MOUSE; REPLICATION; METHYLATION	Tumor cells with p53 inactivation frequently exhibit chemotherapy resistance, which poses a long-standing challenge to cancer treatment. Here we unveiled a previously unrecognized role of TET2 in mediating p53-loss induced chemotherapy resistance in colon cancer. Deletion of TET2 in p53-null colon cancer cells enhanced DNA damage and restored chemotherapy sensitivity. By taking a two-pronged approach that combined pharmacological inhibition with genetic depletion, we discovered that p53 destabilized TET2 at the protein level by promoting its autophagic degradation. At the molecular level, we further revealed a physical association between TET2 and p53 that facilitated the nucleoplasmic shuttling of TET2, as well as its recruitment to the autophagosome for degradation. Our study has unveiled a functional interplay between TET2 and p53 during anti-cancer therapy. Our findings establish the rationale for targeting TET2 to overcome chemotherapy resistance associated with mutant p53 tumors.	[Zhang, Jixiang; Guo, Lei; Li, Jia; Lee, Minjung; Fang, Shaohai; Johnson, Gavin; Sun, Deqiang; Dashwood, Roderick; Huang, Yun] Texas A&M Univ, Ctr Epigenet & Dis Prevent, Inst Biosci & Technol, Houston, TX 77030 USA; [Zhang, Jixiang; Ma, Jingjing; Dong, Wei-Guo] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China; [Tan, Peng; Guo, Lei; Jing, Ji; Zhou, Yubin] Texas A&M Univ, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Gong, Jing; Han, Leng] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Cao, Wen-ming] Zhejiang Canc Hosp, Dept Breast Med Oncol, Hangzhou 310022, Zhejiang, Peoples R China; [Dashwood, Roderick; Huang, Yun] Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA; [Zhou, Yubin] Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Texas A&M University System; Wuhan University; Texas A&M University System; University of Texas System; University of Texas Health Science Center Houston; Zhejiang Cancer Hospital; Texas A&M University System; Texas A&M University College Station; Texas A&M University System	Huang, Y (corresponding author), Texas A&M Univ, Ctr Epigenet & Dis Prevent, Inst Biosci & Technol, Houston, TX 77030 USA.; Dong, WG (corresponding author), Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430060, Hubei, Peoples R China.; Zhou, YB (corresponding author), Texas A&M Univ, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA.; Huang, Y (corresponding author), Texas A&M Univ, Coll Med, Dept Mol & Cellular Med, College Stn, TX 77843 USA.; Zhou, YB (corresponding author), Texas A&M Univ, Coll Med, Dept Med Physiol, Temple, TX 76504 USA.	yzhou@ibt.tamhsc.edu; dwg@whu.edu.cn; yun.huang@ibt.tamhsc.edu	Tan, Peng/HGD-6812-2022; Dashwood, Roderick/AAF-2025-2020; Han, Leng/HCH-3491-2022; Zhou, Yubin/D-4748-2011; Tan, Peng/ABD-8190-2020	Han, Leng/0000-0002-7380-2640; Zhou, Yubin/0000-0001-7962-0517; sun, deqiang/0000-0002-5806-7289; Fang, Shaohai/0000-0003-3940-9586; Tan, Peng/0000-0001-6992-9000; Cao, Wen-Ming/0000-0002-5644-3156	Cancer Prevention and Research Institute of Texas [RR140053, RP170660, RR150085]; American Heart Association [16IRG27250155]; John S. Dunn Foundation; Center for Translational Environmental Health Research (CTEHR); National Institute of Health [R01HL134780, R01GM112003]; Welch Foundation [BE-1913]; American Cancer Society [RSG-18-043-01-LIB, RSG-16-215-01-TBE]; Texas AM University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112003] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; American Heart Association(American Heart Association); John S. Dunn Foundation; Center for Translational Environmental Health Research (CTEHR); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); American Cancer Society(American Cancer Society); Texas AM University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Cancer Prevention and Research Institute of Texas (RR140053 to YH, to RP170660 to YZ, RR150085 to LH), the Innovation Award from American Heart Association (16IRG27250155 to YH), the John S. Dunn Foundation Collaborative Research Award (to YH), the Center for Translational Environmental Health Research (CTEHR) Seed Grant to YH, the National Institute of Health grants (R01HL134780 to YH, R01GM112003 to YZ), the Welch Foundation (BE-1913 to YZ), the American Cancer Society (RSG-18-043-01-LIB to YH, RSG-16-215-01-TBE to YZ), and by an allocation from the Texas A&M University start-up funds (YH).	Abdel-Wahab O, 2009, BLOOD, V114, P144, DOI 10.1182/blood-2009-03-210039; An J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10071; Bejar R, 2012, J CLIN ONCOL, V30, P3376, DOI 10.1200/JCO.2011.40.7379; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Dunkern TR, 2003, DNA REPAIR, V2, P49, DOI 10.1016/S1568-7864(02)00185-4; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hientz K, 2017, ONCOTARGET, V8, P8921, DOI 10.18632/oncotarget.13475; Huang Y, 2014, TRENDS GENET, V30, P464, DOI 10.1016/j.tig.2014.07.005; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jiang DW, 2017, EMBO REP, V18, P781, DOI 10.15252/embr.201643179; Kafer GR, 2016, CELL REP, V14, P1283, DOI 10.1016/j.celrep.2016.01.035; Ko M, 2013, NATURE, V497, P122, DOI 10.1038/nature12052; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lemonnier F, 2012, BLOOD, V120, P1466, DOI 10.1182/blood-2012-02-408542; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liang SH, 2001, EUR J BIOCHEM, V268, P2779, DOI 10.1046/j.1432-1327.2001.02227.x; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nakagawa T, 2015, MOL CELL, V57, P247, DOI 10.1016/j.molcel.2014.12.002; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Quivoron C, 2011, CANCER CELL, V20, P25, DOI 10.1016/j.ccr.2011.06.003; Shetzer Y, 2014, CARCINOGENESIS, V35, P1196, DOI 10.1093/carcin/bgu073; Tacar O, 2013, J PHARM PHARMACOL, V65, P157, DOI 10.1111/j.2042-7158.2012.01567.x; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tefferi A, 2009, LEUKEMIA, V23, P1343, DOI 10.1038/leu.2009.59; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang Y, 2014, CELL REP, V6, P278, DOI 10.1016/j.celrep.2013.12.031; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yeung TM, 2010, P NATL ACAD SCI USA, V107, P3722, DOI 10.1073/pnas.0915135107; Zhang YW, 2017, MOL CELL, V65, P323, DOI 10.1016/j.molcel.2016.12.013	44	13	14	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1905	1919		10.1038/s41388-018-0524-5	http://dx.doi.org/10.1038/s41388-018-0524-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30390073	Green Accepted			2022-12-26	WOS:000461164400009
J	Zhao, GY; Cheng, YB; Gui, P; Cui, MY; Liu, W; Wang, WW; Wang, XY; Ali, M; Dou, Z; Niu, LW; Liu, HY; Anderson, L; Ruan, K; Hong, JJ; Yao, XB				Zhao, Gangyin; Cheng, Yubao; Gui, Ping; Cui, Meiying; Liu, Wei; Wang, Wenwen; Wang, Xueying; Ali, Mahboob; Dou, Zhen; Niu, Liwen; Liu, Haiyan; Anderson, Leonard; Ruan, Ke; Hong, Jingjun; Yao, Xuebiao			Dynamic acetylation of the kinetochore-associated protein HEC1 ensures accurate microtubule-kinetochore attachment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitosis; microtubule; kinetochore; protein acylation; mitotic spindle; chromosomal segregation; HEC1; NDC80 complex; NUF2; TIP60; spindle assembly	NDC80 COMPLEX; AURORA-B; SKA COMPLEX; KINASE; BINDING; PHOSPHORYLATION; MPS1; ACTIVATION; IDENTIFICATION; ARCHITECTURE	Faithful chromosome segregation during mitosis is critical for maintaining genome integrity in cell progeny and relies on accurate and robust kinetochore-microtubule attachments. The NDC80 complex, a tetramer comprising kinetochore protein HEC1 (HEC1), NDC80 kinetochore complex component NUF2 (NUF2), NDC80 kinetochore complex component SPC24 (SPC24), and SPC25, plays a critical role in kinetochore-microtubule attachment. Mounting evidence indicates that phosphorylation of HEC1 is important for regulating the binding of the NDC80 complex to microtubules. However, it remains unclear whether other post-translational modifications, such as acetylation, regulate NDC80-microtubule attachment during mitosis. Here, using pulldown assays with HeLa cell lysates and site-directed mutagenesis, we show that HEC1 is a bona fide substrate of the lysine acetyltransferase Tat-interacting protein, 60 kDa (TIP60) and that TIP60-mediated acetylation of HEC1 is essential for accurate chromosome segregation in mitosis. We demonstrate that TIP60 regulates the dynamic interactions between NDC80 and spindle microtubules during mitosis and observed that TIP60 acetylates HEC1 at two evolutionarily conserved residues, Lys-53 and Lys-59. Importantly, this acetylation weakened the phosphorylation of the N-terminal HEC1(1-80) region at Ser-55 and Ser-62, which is governed by Aurora B and regulates NDC80-microtubule dynamics, indicating functional cross-talk between these two post-translation modifications of HEC1. Moreover, the TIP60-mediated acetylation was specifically reversed by sirtuin 1 (SIRT1). Taken together, our results define a conserved signaling hierarchy, involving HEC1, TIP60, Aurora B, and SIRT1, that integrates dynamic HEC1 acetylation and phosphorylation for accurate kinetochore-microtubule attachment in the maintenance of genomic stability during mitosis.	[Zhao, Gangyin; Cheng, Yubao; Gui, Ping; Cui, Meiying; Liu, Wei; Wang, Wenwen; Wang, Xueying; Ali, Mahboob; Dou, Zhen; Niu, Liwen; Liu, Haiyan; Ruan, Ke; Hong, Jingjun; Yao, Xuebiao] Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Sci Ctr Phys Sci Microscale, Sch Life Sci,Ctr Excellence Mol Cell Sci,Div Mol, Hefei 230027, Anhui, Peoples R China; [Gui, Ping; Liu, Wei; Wang, Wenwen; Wang, Xueying; Dou, Zhen; Anderson, Leonard] Morehouse Sch Med, Keck Ctr Cellular Dynam & Organoids Plast, Atlanta, GA 30310 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine	Hong, JJ; Yao, XB (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Sci Ctr Phys Sci Microscale, Sch Life Sci,Ctr Excellence Mol Cell Sci,Div Mol, Hefei 230027, Anhui, Peoples R China.	jjhong@ustc.edu.cn; yaoxb@ustc.edu.cn	Hong, Jingjun/V-7281-2019; WANG, WENWEN/AAF-1080-2020; Ruan, Ke/N-1995-2013; Yao, Xuebiao/P-5771-2014; DOU, ZHEN/N-2022-2013	WANG, WENWEN/0000-0002-1545-4369; Gui, Ping/0000-0003-2049-3001; Cheng, Yubao/0000-0001-6967-1433; DOU, ZHEN/0000-0003-3303-9393; Ruan, Ke/0000-0001-9358-0451; Zhao, Gangyin/0000-0003-2872-8143	National Key Research and Development Program of China [2017YFA0503600, 2016YFA0100500]; Natural Science Foundation of China [31320103904, 31430054, 91313303, 31470792, 31621002, 31301120, 31671405, 31601097, B1661138004]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB19000000, XDB08030102]; 973 project [2012CB917204, 2014CB964803, 2002CB713703, 2012CB910304]; Chinese Academy of Sciences Center of Excellence in Molecular and Cell Sciences Grant [2015HSC-UE010]; MOE Innovative Team Grant [IRT_17R102]; National Institutes of Health [DK56292, DK115812, CA146133]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK115812] Funding Source: NIH RePORTER	National Key Research and Development Program of China; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); 973 project(National Basic Research Program of China); Chinese Academy of Sciences Center of Excellence in Molecular and Cell Sciences Grant; MOE Innovative Team Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Key Research and Development Program of China Grants 2017YFA0503600 and 2016YFA0100500; Natural Science Foundation of China Grants 31320103904, 31430054, 91313303, 31470792, 31621002, 31301120, 31671405, 31601097, and B1661138004; "Strategic Priority Research Program" of the Chinese Academy of Sciences Grants XDB19000000 and XDB08030102; 973 project Grants 2012CB917204, 2014CB964803, 2002CB713703, and 2012CB910304; Chinese Academy of Sciences Center of Excellence in Molecular and Cell Sciences Grant 2015HSC-UE010; MOE Innovative Team Grant IRT_17R102; and National Institutes of Health Grants DK56292, DK115812, and CA146133. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akram S, 2018, J MOL CELL BIOL, V10, P527, DOI 10.1093/jmcb/mjy040; Bao XL, 2018, J MOL CELL BIOL, V10, P18, DOI 10.1093/jmcb/mjx045; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bharadwaj R, 2004, J BIOL CHEM, V279, P13076, DOI 10.1074/jbc.M310224200; Black BE, 2010, COLD SH Q B, V75, P403, DOI 10.1101/sqb.2010.75.038; Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039; Cheng Z, 2008, ONCOGENE, V27, P931, DOI 10.1038/sj.onc.1210710; Ciferri C, 2005, J BIOL CHEM, V280, P29088, DOI 10.1074/jbc.M504070200; Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020; Ciferri C, 2007, FEBS LETT, V581, P2862, DOI 10.1016/j.febslet.2007.05.012; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DALZIEL K, 1962, NATURE, V196, P1203, DOI 10.1038/1961203b0; DeLuca JG, 2006, CELL, V127, P969, DOI 10.1016/j.cell.2006.09.047; DeLuca KF, 2011, J CELL SCI, V124, P622, DOI 10.1242/jcs.072629; Dou Z, 2015, P NATL ACAD SCI USA, V112, pE4546, DOI 10.1073/pnas.1508791112; Du J, 2008, ONCOGENE, V27, P4107, DOI 10.1038/onc.2008.34; Emanuele MJ, 2008, J CELL BIOL, V181, P241, DOI 10.1083/jcb.200710019; Fang C, 2017, J MOL CELL BIOL, V9, P504, DOI 10.1093/jmcb/mjx043; Guimaraes GJ, 2008, CURR BIOL, V18, P1778, DOI 10.1016/j.cub.2008.08.012; Helgeson LA, 2018, P NATL ACAD SCI USA, V115, P2740, DOI 10.1073/pnas.1718553115; Hiruma Y, 2015, SCIENCE, V348, P1264, DOI 10.1126/science.aaa4055; Hua SS, 2011, J BIOL CHEM, V286, P1627, DOI 10.1074/jbc.M110.174946; Janke C, 2001, EMBO J, V20, P777, DOI 10.1093/emboj/20.4.777; Ji ZJ, 2015, SCIENCE, V348, P1260, DOI 10.1126/science.aaa4029; Jiang H, 2015, J BIOL CHEM, V290, P28272, DOI 10.1074/jbc.M115.668855; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Liu D, 2016, J MOL CELL BIOL, V8, P144, DOI 10.1093/jmcb/mjv066; Long AF, 2017, CURR BIOL, V27, P1692, DOI 10.1016/j.cub.2017.04.058; Maure JF, 2011, CURR BIOL, V21, P207, DOI 10.1016/j.cub.2010.12.050; McCleland ML, 2004, CURR BIOL, V14, P131, DOI 10.1016/j.cub.2003.12.058; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; Miller SA, 2008, CURR BIOL, V18, P1785, DOI 10.1016/j.cub.2008.11.007; Mo F, 2016, NAT CHEM BIOL, V12, P226, DOI [10.1038/NCHEMBIO.2017, 10.1038/nchembio.2017]; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Patel H, 2016, J MOL CELL BIOL, V8, P338, DOI 10.1093/jmcb/mjw009; Petrovic A, 2010, J CELL BIOL, V190, P835, DOI 10.1083/jcb.201002070; Rack JGM, 2015, MOL CELL, V59, P309, DOI 10.1016/j.molcel.2015.06.013; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Umbreit NT, 2012, P NATL ACAD SCI USA, V109, P16113, DOI 10.1073/pnas.1209615109; Wang HW, 2008, J MOL BIOL, V383, P894, DOI 10.1016/j.jmb.2008.08.077; Wei RR, 2007, NAT STRUCT MOL BIOL, V14, P54, DOI 10.1038/nsmb1186; Wei RR, 2005, P NATL ACAD SCI USA, V102, P5363, DOI 10.1073/pnas.0501168102; Wigge PA, 2001, J CELL BIOL, V152, P349, DOI 10.1083/jcb.152.2.349; Wu Q, 2009, J BIOL CHEM, V284, P8738, DOI 10.1074/jbc.M807590200; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yan MM, 2015, SCI REP-UK, V5, DOI 10.1038/srep10449; Yang Y, 2018, J MOL CELL BIOL, V10, P89, DOI 10.1093/jmcb/mjx048; Yu TT, 2017, J MOL CELL BIOL, V9, P144, DOI 10.1093/jmcb/mjw042; Zaytsev AV, 2015, MOL BIOL CELL, V26, P1829, DOI 10.1091/mbc.E14-11-1539; Zhang G, 2012, J CELL SCI, V125, P3243, DOI 10.1242/jcs.104208; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zheng L, 1999, MOL CELL BIOL, V19, P5417; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200; Zhu TG, 2013, J BIOL CHEM, V288, P36149, DOI 10.1074/jbc.M113.507970	58	12	13	0	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					576	592		10.1074/jbc.RA118.003844	http://dx.doi.org/10.1074/jbc.RA118.003844			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HI2GP	30409912	Green Published, hybrid			2022-12-26	WOS:000456263600016
J	Loke, SC; Kasmiran, KA; Haron, SA				Loke, Seng Cheong; Kasmiran, Khairul A.; Haron, Sharifah A.			A new method of mark detection for software-based optical mark recognition	PLOS ONE			English	Article							SYSTEM	Software optical mark recognition (SOMR) is the process whereby information entered on a survey form or questionnaire is converted using specialized software into a machine-readable format. SOMR normally requires input fields to be completely have no internal labels, or be filled with a soft pencil, otherwise mark detection will be inaccurate. Forms can also have print and scan artefacts that further increase the error rate. This article presents a new method of mark detection that improves over existing techniques based on pixel counting and simple thresholding. Its main advantage is that it can be used under a variety of conditions and yet maintain a high level of accuracy that is sufficient for scientific applications. Field testing shows no software misclassification in 5695 samples filled by trained personnel, and only two misclassifications in 6000 samples filled by untrained respondents. Sensitivity, specificity, and accuracy were 99.73%, 99.98%, and 99.94% respectively, even in the presence of print and scan artefacts, which was superior to other methods tested. A separate direct comparison for mark detection showed a sensitivity, specificity, and accuracy respectively of 99.7%, 100.0%, 100.0% (new method), 96.3%, 96.0%, 96.1% (pixel counting), and 99.9%, 99.8%, 99.8% (simple thresholding) on clean forms, and 100.0%, 99.1%, 99.3% (new method), 98.4%, 95.6%, 96.2% (pixel counting), 100.0%, 38.3%, 51.4% (simple thresholding) on forms with print artefacts. This method is designed for bubble and box fields, while other types such as handwriting fields require separate error control measures.	[Loke, Seng Cheong] Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand; [Loke, Seng Cheong; Haron, Sharifah A.] Univ Putra Malaysia, Malaysian Res Inst Ageing MyAgeing, Serdang, Malaysia; [Kasmiran, Khairul A.] Univ Putra Malaysia, Fac Comp Sci & Informat Technol, Serdang, Malaysia; [Haron, Sharifah A.] Univ Putra Malaysia, Fac Human Ecol, Serdang, Malaysia	University of Auckland; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Loke, SC (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Auckland, New Zealand.; Loke, SC (corresponding author), Univ Putra Malaysia, Malaysian Res Inst Ageing MyAgeing, Serdang, Malaysia.	lokesengcheong@gmail.com	Haron, Sharifah Azizah/AAN-6909-2020; Loke, Seng/AAG-3182-2020	Haron, Sharifah Azizah/0000-0003-2179-6338; Loke, Seng/0000-0002-5339-9305	Swan Foundation	Swan Foundation	This work was supported by a grant from the Swan Foundation (http://www.swanbag.com/html/swanfoundation.aspx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron BP, 1998, POSTGRAD MED, V104, P23, DOI 10.3810/pgm.1998.08.550; Chai D., 2016, AUTOMATED MARKING PR, P145; Chinnasarn K, 1999, J SOC PHOTO OPTICAL, V3808; Chouvatut V, 2014, FLEXIBLE ADAPTIVE X, P433; Cip P, 2011, ANN DAAAM P, P849; DRS Data Services Limited, 2014, OMR STOCK FORM ORD S; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Haskins B, 2015, PROCEEDINGS OF THE 2015 PATTERN RECOGNITION ASSOCIATION OF SOUTH AFRICA AND ROBOTICS AND MECHATRONICS INTERNATIONAL CONFERENCE (PRASA-ROBMECH), P233, DOI 10.1109/RoboMech.2015.7359528; Hewlett-Packard Development Company, 2017, TEL; Huei TJ, 2016, NEPHROLOGY CARLTON; Hussmann S, 2005, REAL-TIME IMAGING, V11, P19, DOI 10.1016/j.rti.2005.03.001; Jenkins TM, 2014, COMPUT BIOL MED, V49, P15, DOI 10.1016/j.compbiomed.2014.03.002; Loke SC, 2015, J AGING HLTH; Loke SC, 2017, SOFTWARE APPL SURVEY; Loke SC, 2017, IEEE ACCESS, V5, P11867, DOI 10.1109/ACCESS.2017.2719284; Loke SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016490; Loke SC, 2009, ANN ACAD MED SINGAP, V38, P1074; Modesti PA, 2012, COMPUT BIOL MED, V42, P778, DOI 10.1016/j.compbiomed.2012.05.003; Powers D, 2011, J MACH LEARN TECHNOL, V2, P37; PrinterTechs. com, 2016, VISUAL CHART HP LASE; Rakesh S., 2013, INT J COMPUTER SCI A, V3, P44, DOI DOI 10.5963/IJCSAI0302002; Sattayakawee N., 2013, INT J INF ED TECHNOL, P273; Society for Clinical Data Management, 2015, GOOD CLIN DAT MAN PR	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206420	10.1371/journal.pone.0206420	http://dx.doi.org/10.1371/journal.pone.0206420			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412588	Green Submitted, Green Published, gold			2022-12-26	WOS:000449772600016
J	Wei, SQ; Sun, YJ; Xi, GS; Zhang, HJ; Xiao, MY; Yin, R				Wei, Shuqin; Sun, Yajuan; Xi, Guangsheng; Zhang, Huijuan; Xiao, Mingya; Yin, Rui			Development of a single-tube nested PCR-lateral flow biosensor assay for rapid and accurate detection of Alternaria panax Whetz	PLOS ONE			English	Article							AMERICAN GINSENG; QUINQUEFOLIUM; PATHOGENS; PLANTS; SOIL	Alternaria panax Whetz causes one of the most commonly occurring and serious diseases in ginseng cultivation, and may cause significant production and economic losses in the ginseng industry. Rapid, early, and accurate identification of Alternaria panax Whetz is an essential prerequisite for the effective prevention and control of further infection spread. In this work, a rapid and accurate molecular diagnostic method, a single-tube nested PCR-lateral flow biosensor assay (STNPCR-LFBA), was developed for rapid identification of Alternaria panax Whetz. The STNPCR-LFBA was 100 times more sensitive than the traditional PCR-LFBA. Besides that, the PCR product was checked by a lateral flow biosensor assay, which provided a basis for the migration of the detection technology to a point-of-care test (POCT) format. STNPCR-LFBA was specific to Alternaria panax Whetz, and no cross-reactions were observed in other non-target samples; the limit of detection was up to 0.01 pg of Alternaria panax Whetz genomic DNA. STNPCR-LFBA could also be used for specific identification of Alternaria panax Whetz in real samples. STNPCR-LFBA is useful for identifying Alternaria panax Whetz due to its rapidity, accuracy, and simple manipulation.	[Wei, Shuqin] Jilin Coll Agr Sci & Technol, Coll Agron, Jilin, Jilin, Peoples R China; [Sun, Yajuan] Jilin Univ, Dept Neurol, China Japan Union Hosp, Changchun, Jilin, Peoples R China; [Xi, Guangsheng] Jilin Coll Agr Sci & Technol, Coll Tradit Chinese Med, Jilin, Jilin, Peoples R China; [Zhang, Huijuan; Xiao, Mingya; Yin, Rui] Jilin Coll Agr Sci & Technol, Coll Biol & Pharmaceut Engn, Jilin, Jilin, Peoples R China	Jilin University	Yin, R (corresponding author), Jilin Coll Agr Sci & Technol, Coll Biol & Pharmaceut Engn, Jilin, Jilin, Peoples R China.	542977965@qq.com		Yin, Rui/0000-0002-4852-5063	China Natural Science Foundation [31470420]; Jilin Ginseng High Scientific and Technological Innovation Platform, Jilin Provincial Key Laboratory of Technological Innovation in Production and Utilization of Genuine Regional Drug; Project of Scientific and Technological Innovation Team of Key Cultivation Technology of Changbai Mountain's genuine medicinal herbs	China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Jilin Ginseng High Scientific and Technological Innovation Platform, Jilin Provincial Key Laboratory of Technological Innovation in Production and Utilization of Genuine Regional Drug; Project of Scientific and Technological Innovation Team of Key Cultivation Technology of Changbai Mountain's genuine medicinal herbs	This work was financially supported by the China Natural Science Foundation (31470420 to SW), http://www.nsfc.gov.cn/; Jilin Ginseng High Scientific and Technological Innovation Platform, Jilin Provincial Key Laboratory of Technological Innovation in Production and Utilization of Genuine Regional Drug, the Project of Scientific and Technological Innovation Team of Key Cultivation Technology of Changbai Mountain's genuine medicinal herbs, http://www.nsfc.gov.cn/.	Atkinson C, 2014, J VIROL METHODS, V196, P40, DOI 10.1016/j.jviromet.2013.10.029; Briskin DP, 2000, PLANT PHYSIOL, V124, P507, DOI 10.1104/pp.124.2.507; Chen CF, 2008, ACTA PHARMACOL SIN, V29, P1103, DOI 10.1111/j.1745-7254.2008.00868.x; Choi YE, 2007, J PLANT BIOL, V50, P198, DOI 10.1007/BF03030630; Costa J, 2012, J AGR FOOD CHEM, V60, P8103, DOI 10.1021/jf302898z; Deng JX, 2013, MYCOL PROG, V12, P383, DOI 10.1007/s11557-012-0844-8; Han Y, 2007, J AGR FOOD CHEM, V55, P9373, DOI 10.1021/jf070354a; Kim SK, 2011, J GINSENG RES, V35, P389, DOI 10.5142/jgr.2011.35.4.389; Li TSC, 1997, CAN J PLANT PATHOL, V19, P297, DOI 10.1080/07060669709500527; Mourato S, 2000, IMPLICATIONS DESIGN, P1456; Moustafa HE, 2009, J BIOTECHNOL, V8, P53; Nicol RW, 2003, PHYTOCHEMISTRY, V64, P257, DOI 10.1016/S0031-9422(03)00271-1; O'Hara M, 1998, ARCH FAM MED, V7, P523, DOI 10.1001/archfami.7.6.523; Papura D, 2016, BIOL CONTROL, V103, P95, DOI 10.1016/j.biocontrol.2016.08.005; Park JY, 2013, AQUACULTURE, V410, P225, DOI 10.1016/j.aquaculture.2013.06.036; Pitz AD, 2013, REV SOC BRAS MED TRO, V46, P783, DOI 10.1590/0037-8682-1625-2013; Punja ZK, 1997, CAN J PLANT PATHOL, V19, P301, DOI 10.1080/07060669709500528; Seifert KA, 2003, PHYTOPATHOLOGY, V93, P1533, DOI 10.1094/PHYTO.2003.93.12.1533; Sun YJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186985; Tran TL, 2014, BIOORGAN MED CHEM, V22, P499, DOI 10.1016/j.bmc.2013.11.002; Wang Y, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-014-4126-6; Yang X, 2017, CROP PROT, V91, P8, DOI 10.1016/j.cropro.2016.09.012; Yin R, 2016, FOOD CONTROL, V60, P146, DOI 10.1016/j.foodcont.2015.07.030; Zhang W, 2017, J GEN PLANT PATHOL, V83, P33, DOI 10.1007/s10327-016-0688-1; Ziezold M., 1998, J GINSENG RES, V22, P237	25	10	10	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206462	10.1371/journal.pone.0206462	http://dx.doi.org/10.1371/journal.pone.0206462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408825	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300020
J	Menninghaus, W; Wagner, V; Knoop, CA; Scharinger, M				Menninghaus, Winfried; Wagner, Valentin; Knoop, Christine A.; Scharinger, Mathias			Poetic speech melody: A crucial link between music and language	PLOS ONE			English	Article							RHYTHM; FEATURES	Research on the music-language interface has extensively investigated similarities and differences of poetic and musical meter, but largely disregarded melody. Using a measure of melodic structure in music-autocorrelations of sound sequences consisting of discrete pitch and duration values-, we show that individual poems feature distinct and text-driven pitch and duration contours, just like songs and other pieces of music. We conceptualize these recurrent melodic contours as an additional, hitherto unnoticed dimension of parallelistic patterning. Poetic speech melodies are higher order units beyond the level of individual syntactic phrases, and also beyond the levels of individual sentences and verse lines. Importantly, auto-correlation scores for pitch and duration recurrences across stanzas are predictive of how melodious naive listeners perceive the respective poems to be, and how likely these poems were to be set to music by professional composers. Experimentally removing classical parallelistic features characteristic of prototypical poems (rhyme, meter, and others) led to decreased autocorrelation scores of pitches, independent of spoken renditions, along with reduced ratings for perceived melodiousness. This suggests that the higher order parallelistic feature of poetic melody strongly interacts with the other parallelistic patterns of poems. Our discovery of a genuine poetic speech melody has great potential for deepening the understanding of the music-language interface.	[Menninghaus, Winfried; Wagner, Valentin; Knoop, Christine A.; Scharinger, Mathias] Max Planck Inst Empir Aesthet, Dept Language & Literature, Frankfurt, Germany; [Scharinger, Mathias] Philipps Univ Marburg, Phonet Res Grp, Dept German Linguist, Marburg, Germany; [Scharinger, Mathias] Philipps Univ Marburg, Marburg Ctr Mind Brain & Behav, Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Scharinger, M (corresponding author), Max Planck Inst Empir Aesthet, Dept Language & Literature, Frankfurt, Germany.; Scharinger, M (corresponding author), Philipps Univ Marburg, Phonet Res Grp, Dept German Linguist, Marburg, Germany.; Scharinger, M (corresponding author), Philipps Univ Marburg, Marburg Ctr Mind Brain & Behav, Marburg, Germany.	mathias.scharinger@staff.uni-marburg.de	Wagner, Valentin/C-9642-2015	Wagner, Valentin/0000-0001-9510-351X; Knoop, Christine Angela/0000-0002-1481-9207	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The research presented here was funded by the Max Planck Society.	[Anonymous], 1974, STUDIES NEW EXPT AES; Barlow H, 2011, P ROY SOC B-BIOL SCI, V278, P2069, DOI 10.1098/rspb.2010.2170; BEVER TG, 1991, VISIBLE LANG, V25, P74; Bretz F., 2010, MULTIPLE COMP USING; Campbell DA, 1991, GREEK LYRIC POETRY; Chandrasekaran B, 2009, BRAIN LANG, V108, P1, DOI 10.1016/j.bandl.2008.02.001; Cutler A., 2014, SEGMENTS EXPT LINGUI, P71, DOI [10.1075/z.189.06cut, DOI 10.1075/Z.189.06CUT]; de la Mora DM, 2013, ATTEN PERCEPT PSYCHO, V75, P92, DOI 10.3758/s13414-012-0371-3; Dellwo V, 2015, J ACOUST SOC AM, V137, P1513, DOI 10.1121/1.4906837; Edgeworth Butler H., 1920, I ORATORIA QUINTILIA; Fabb Nigel, 1997, LINGUISTICS LIT LANG; FAGEL WPF, 1983, SPEECH COMMUN, V2, P315, DOI 10.1016/0167-6393(83)90048-1; Fant G., 1991, MUSIC LANGUAGE SPEEC, P380, DOI [10.1007/978-1-349-12670-5_36, DOI 10.1007/978-1-349-12670-5_36]; Glaser S, 2000, CONTEMP MUSIC REV, V19, P129, DOI DOI 10.1080/07494467.2000.11689734; Halle John., 1993, CURR MUSICOLOGY, V55, P3; Hanauer D, 1998, POETICS, V26, P63, DOI 10.1016/S0304-422X(98)00011-4; Hay JSF, 2007, PERCEPT PSYCHOPHYS, V69, P113, DOI 10.3758/BF03194458; Hayes Bruce, 1995, METRICAL STRESS THEO; Hirst D. J., 2011, J SPEECH SCI, V1, P55; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Jakobson R., 1960, STYLE LANG, P350; Kentner G, 2012, COGNITION, V123, P1, DOI 10.1016/j.cognition.2011.11.012; Kimball C, 2013, ART SONG LINKING POE; KIPARSKY P, 1973, DAEDALUS-US, P231; Korotkov E. V., 2003, Molekulyarnaya Biologiya (Moscow), V37, P436; Large EW, 2002, COGNITIVE SCI, V26, P1, DOI 10.1207/s15516709cog2601_1; Lausberg H., 1973, HDB LIT RHETORIK GRU, V3e; LERDAHL F, 1977, J MUSIC THEORY, V21, P111, DOI 10.2307/843480; Lerdahl F, 2001, ANN NY ACAD SCI, V930, P337, DOI 10.1111/j.1749-6632.2001.tb05743.x; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058710; Margulis E.H., 2014, REPEAT MUSIC PLAYS M; Menninghaus W, 2017, POETICS, V63, P47, DOI 10.1016/j.poetic.2016.12.001; Menninghaus W, 2015, COGNITION, V143, P48, DOI 10.1016/j.cognition.2015.05.026; Mullensiefen D, 2014, MUSIC PERCEPT, V31, P418, DOI 10.1525/MP.2014.31.5.418; Mullensiefen D, 2007, MUSIC SCI, P183; Nolan F, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0396; Palmer C, 2006, PSYCHOL LEARN MOTIV, V46, P245, DOI 10.1016/S0079-7421(06)46007-2; PALMER SE, 1978, J EXP PSYCHOL HUMAN, V4, P691, DOI 10.1037/0096-1523.4.4.691; Patel AD, 2003, COGNITION, V87, pB35, DOI 10.1016/S0010-0277(02)00187-7; Patel AD, 2006, J ACOUST SOC AM, V119, P3034, DOI 10.1121/1.2179657; Patel Aniruddh D, 2010, MUSIC LANGUAGE BRAIN; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Reichl K, 2000, INTERCULT MUSIC STUD, V12, P1; Ross Jaan., 2011, TEMPORAL STRUCTURE E; ShattuckHufnagel S, 1996, J PSYCHOLINGUIST RES, V25, P193, DOI 10.1007/BF01708572; Sievers E., 1912, RHYTHMISCH MELODISCH; Steele, 1775, ESSAY ESTABLISHING M; Stevens Kenneth N., 1998, ACOUSTIC PHONETICS; 't Hart J., 1990, PERCEPTUAL STUDY INT; Tolstoy L, 2006, SOBRANIYE; VANSANTEN JPH, 1992, SPEECH COMMUN, V11, P513, DOI 10.1016/0167-6393(92)90027-5; VOS PG, 1994, PERCEPTION, V23, P965, DOI 10.1068/p230965; Weihs C, 2007, ADV DATA ANAL CLASSI, V1, P255, DOI 10.1007/s11634-007-0016-x; WIGHTMAN CW, 1992, J ACOUST SOC AM, V91, P1707, DOI 10.1121/1.402450; Yost WA, 2009, ATTEN PERCEPT PSYCHO, V71, P1701, DOI 10.3758/APP.71.8.1701	56	10	10	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205980	10.1371/journal.pone.0205980	http://dx.doi.org/10.1371/journal.pone.0205980			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403677	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500041
J	Samra, S; Cascone, P; Noyes, J; Ghanim, M; Protasov, A; Guerrieri, E; Mendel, Z				Samra, Shahar; Cascone, Pasquale; Noyes, John; Ghanim, Murad; Protasov, Alex; Guerrieri, Emilio; Mendel, Zvi			Diversity of Ooencyrtus spp. (Hymenoptera: Encyrtidae) parasitizing the eggs of Stenozygum coloratum (Klug) (Hemiptera: Pentatomidae) with description of two new species	PLOS ONE			English	Article							THAUMETOPOEA-WILKINSONI; NATURAL ENEMIES; PARASITOIDS; LEP; DNA; DIFFERENTIATION; POPULATIONS; BRACONIDAE; BUGS	Ooencyrtus spp. (Hymenoptera, Chalci doi dea, Encyrtidae) are important natural enemies of agricultural and forest insect pests, and are distributed worldwide. Their reduced dimensions, highly variable morphological characters and possible effect of wide host range and abiotic factors, make correct identification at the species level particularly difficult. This paper combined molecular, morphological, and biological data to characterize a group of Ooencyrtus spp. emerging from the eggs of the variegated caper bug, Stenozygum coloratura in the east Mediterranean area. COI and ITS2 sequencing revealed the presence of six and five divergent clades, respectively. Three clades were identified as Ooencyrtus telenomicida, Ooencyrtus pityocampae and O. pistaciae. Two clades represent new species which are here described and named Ooencyrtus zoeae and Ooencyrtus mevalbelus. These features were combined with reliable morphological characters to facilitate the separation of these species. A dichotomous key and a new synonymy are proposed. Ooencyrtus pistaciae had two distinct COI clades but only one ITS2 Glade. Crossbreeding trials that included Ooencyrtus telenomicida, Ooencyrtus melvabelus sp. nov. and Ooencyrtus zoeae sp. nov. confirmed their reproductive isolation. COI sequences showed 0-0.8% and 4-9% within and between-species genetic differences, respectively. ITS2 showed 0.4-5.9% genetic differences between species, with no genetic differences within species. Haplotype diversity of Israeli and Turkish populations of the various species was 0-0.98 and was particularly low in Ooencyrtus pityocampae, whose Israeli population showed no diversity. The discovery of the Ooencyrtus spp. on the eggs of the caper bug, and their abundance support the idea that the bug can be used as an alternative host for augmentation of populations of these parasitoids in agricultural and forestry systems.	[Samra, Shahar; Ghanim, Murad; Protasov, Alex; Mendel, Zvi] Volcani Ctr, Dept Entomol, Bet Dagan, Israel; [Samra, Shahar] Hebrew Univ Jerusalem, Fac Agr, Rehovot, Israel; [Cascone, Pasquale; Guerrieri, Emilio] Natl Res Council Italy, Inst Sustainable Plant Protect, Portici, NA, Italy; [Noyes, John; Guerrieri, Emilio] Nat Hist Museum, Dept Life Sci, London, England; [Samra, Shahar] Minist Agr & Rural Dev, Agr Ctr, Plant Protect & Inspect Serv, Rishon Leziyyon, Beit Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Natural History Museum London	Samra, S (corresponding author), Volcani Ctr, Dept Entomol, Bet Dagan, Israel.; Samra, S (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Rehovot, Israel.; Guerrieri, E (corresponding author), Natl Res Council Italy, Inst Sustainable Plant Protect, Portici, NA, Italy.; Guerrieri, E (corresponding author), Nat Hist Museum, Dept Life Sci, London, England.; Samra, S (corresponding author), Minist Agr & Rural Dev, Agr Ctr, Plant Protect & Inspect Serv, Rishon Leziyyon, Beit Dagan, Israel.	shahars@moag.gov.il; emilio.guerrieri@ipsp.cnr.it	Guerrieri, Emilio/ABB-7498-2020; Cascone, Pasquale/J-7992-2016	Cascone, Pasquale/0000-0002-4097-1974; Samra, Shahar/0000-0003-1873-8647	Keren Kayemeth LeIsrael (Jewish National fund) Project [131-1619-13]	Keren Kayemeth LeIsrael (Jewish National fund) Project	Research was funded by the Keren Kayemeth LeIsrael (Jewish National fund) Project 131-1619-13 to SS.	Abe Y, 2013, EUR J ENTOMOL, V110, P627, DOI 10.14411/eje.2013.085; Avci M, 2003, PHYTOPARASITICA, V31, P118, DOI 10.1007/BF02980780; BATTISTI A, 1988, Redia, V71, P321; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Binazzi F, 2013, REDIA, V96, P79; BROWN MW, 1984, ENTOMOPHAGA, V29, P249, DOI 10.1007/BF02372112; BUXTON RD, 1983, OUTLOOK AGR, V12, P34, DOI 10.1177/003072708301200106; Derjanschi V, 2013, HEMIPTERES PENTATOMO; Desneux N, 2009, ANN ENTOMOL SOC AM, V102, P925, DOI 10.1603/008.102.0603; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; HALPERIN J, 1990, J APPL ENTOMOL, V110, P1, DOI 10.1111/j.1439-0418.1990.tb00088.x; HALPERIN J, 1990, J APPL ENTOMOL, V109, P425, DOI 10.1111/j.1439-0418.1990.tb00073.x; HALPERIN J, 1980, PHYTOPARASITICA, V8, P83, DOI 10.1007/BF02994502; Hayat M, 2016, ZOOTAXA, V4117, P198, DOI 10.11646/zootaxa.4117.2.4; Hirose Y, 1996, BIOL CONTROL, V7, P84, DOI 10.1006/bcon.1996.0069; Hodar JA, 2004, BIODIVERS CONSERV, V13, P493, DOI 10.1023/B:BIOC.0000009495.95589.a7; Hoy MA, 2000, BIOL CONTROL, V17, P1, DOI 10.1006/bcon.1999.0775; Huang DW, 1994, B BR MUSEUM NATURAL, P63; Iranipour S, 1998, P 13 IR PLANT PROT C, P4; Jiggins FM, 2003, GENETICS, V164, P5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kolaczan CR, 2009, J EVOLUTION BIOL, V22, P1275, DOI 10.1111/j.1420-9101.2009.01742.x; Laraichi M., 1979, Bulletin SROP, V11, P87; LARAICHI M, 1978, ENTOMOL EXP APPL, V23, P237, DOI 10.1007/BF00334158; Lopez-Sebastian E., 2004, Graellsia, V60, P121; Masutti L, 1964, ANN CTR EC MONT VEN, V4, P205; Mirehev P, 2014, ACTA ZOOL BULGAR, V66, P109; Mohammadpour Marzieh, 2016, Zoology and Ecology, V26, P28, DOI 10.1080/21658005.2015.1120544; Noyes JS, 1990, CHALCID PARASITOIDS, P247; Peri E, 2011, BIOCONTROL, V56, P163, DOI 10.1007/s10526-010-9323-9; Polaszek A, 2012, BIOCONTROL, V57, P21, DOI 10.1007/s10526-011-9361-y; Prado JR, 2014, ANNU REV PLANT BIOL, V65, P769, DOI 10.1146/annurev-arplant-050213-040039; Prinsloo GL., 1987, REVISION GENUS OOENC; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Samra S, 2014, ALON HANOTEA, V68, P38; Samra S, 2015, EUR J ENTOMOL, V112, P362, DOI 10.14411/eje.2015.041; Samra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122788; Simonato M, 2007, MOL ECOL, V16, P2273, DOI 10.1111/j.1365-294X.2007.03302.x; Simonato M, 2010, GENETICS AND GENOMIC; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Smith MA, 2008, P NATL ACAD SCI NATL; Stary P, 1999, J APPL ENTOMOL, V123, P231, DOI 10.1046/j.1439-0418.1999.00345.x; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; Swirski E, 2002, PROD MARK, P284; Tiberi R., 1991, Redia, V74, P467	46	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205245	10.1371/journal.pone.0205245	http://dx.doi.org/10.1371/journal.pone.0205245			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403678	gold, Green Submitted, Green Published			2022-12-26	WOS:000449379500014
J	Broekgaarden, C; Pelgrom, KTB; Bucher, J; van Dam, NM; Grosser, K; Pieterse, CMJ; van Kaauwen, M; Steenhuis, G; Voorrips, RE; de Vos, M; Vosman, B; Worrich, A; van Wees, SCM				Broekgaarden, Colette; Pelgrom, Koen T. B.; Bucher, Johan; van Dam, Nicole M.; Grosser, Katharine; Pieterse, Corne M. J.; van Kaauwen, Martijn; Steenhuis, Greet; Voorrips, Roeland E.; de Vos, Martin; Vosman, Ben; Worrich, Anja; van Wees, Saskia C. M.			Combining QTL mapping with transcriptome and metabolome profiling reveals a possible role for ABA signaling in resistance against the cabbage whitefly in cabbage	PLOS ONE			English	Article							INSECT-RESISTANCE; BRASSICA-OLERACEA; PLANT-RESISTANCE; TOMATO; GENE; TOLERANCE; DEFENSES; MYC2; IDENTIFICATION; PERFORMANCE	Whiteflies are among the world's most significant agricultural pests and chemical insecticides are extensively used to reduce crop damage to acceptable levels. However, nearly all insecticides pose a threat to the environment and alternative control methods, such as breeding of crop varieties that are inherently insect-resistant, are needed. Previously, a strong source of plant-age dependent resistance to the cabbage whitefly (Aleyrodes proletella) has been identified in the modern white cabbage (Brassica oleracea var. capitata) variety Rivera. However, nothing is known about the molecular mechanisms or the genes involved in this resistance. In the present study, a multidisciplinary approach combining transcriptome and metabolome profiling with genetic mapping was used to identify the molecular players of whitefly resistance in cabbage. Transcriptome profiles of young (susceptible) and older (resistant) Rivera plants were analyzed using RNA sequencing. While many genes involved in general processes were differentially expressed between both ages, several defense-related processes were overrepresented in the transcriptome profile of older plants. Hormone measurements revealed that jasmonic acid (JA) levels decreased upon whitefly infestation at both plant ages. Interestingly, abscisic acid (ABA) levels showed contrasting effects in response to whitefly infestation: ABA levels were reduced in young plants but induced in older plants upon whitefly feeding. Auxin levels were significantly lower in older plants compared with young plants, independent of whitefly presence, while glucosinolate levels were higher. Additionally, whitefly performance was monitored in an F-2 population derived from a cross between Rivera and the susceptible white cabbage variety Christmas Drumhead. Significant QTL intervals were mapped on chromosome 2 and 9 for oviposition rate and whitefly adult survival, respectively. Several genes that were higher expressed in older plants and located in the identified QTL intervals were orthologous to Arabidopsis genes that have been related to ABA signaling, suggesting a role for ABA in the regulation of resistance towards whiteflies. Our results show that combining different omics approaches is a useful strategy to identify candidate genes underlying insect resistance.	[Broekgaarden, Colette; Pieterse, Corne M. J.; van Wees, Saskia C. M.] Univ Utrecht, Dept Biol, Science4Life, Plant Microbe Interact, Utrecht, Netherlands; [Broekgaarden, Colette; Pelgrom, Koen T. B.; Bucher, Johan; van Kaauwen, Martijn; Steenhuis, Greet; Voorrips, Roeland E.; Vosman, Ben] Wageningen Univ, Wageningen UR Plant Breeding, Wageningen, Netherlands; [Broekgaarden, Colette; Pelgrom, Koen T. B.; Bucher, Johan; van Kaauwen, Martijn; Steenhuis, Greet; Voorrips, Roeland E.; Vosman, Ben] Res Ctr, Wageningen, Netherlands; [Broekgaarden, Colette; de Vos, Martin] Keygene NV, Wageningen, Netherlands; [van Dam, Nicole M.; Grosser, Katharine; Worrich, Anja] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [van Dam, Nicole M.; Grosser, Katharine; Worrich, Anja] Friedrich Schiller Univ Jena, Inst Biodivers, Jena, Germany; [Worrich, Anja] UFZ Helmholtz Ctr Environm Res, Permoserstr 15, Leipzig, Germany	Utrecht University; Wageningen University & Research; Keygene N.V.; Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Broekgaarden, C (corresponding author), Univ Utrecht, Dept Biol, Science4Life, Plant Microbe Interact, Utrecht, Netherlands.; Broekgaarden, C (corresponding author), Wageningen Univ, Wageningen UR Plant Breeding, Wageningen, Netherlands.; Broekgaarden, C (corresponding author), Res Ctr, Wageningen, Netherlands.; Broekgaarden, C (corresponding author), Keygene NV, Wageningen, Netherlands.	colette.broekgaarden@keygene.com	Pieterse, Corné/A-9326-2011; Vosman, Ben/C-5494-2013; van Dam, Nicole M./B-3281-2008; Van Wees, Saskia/B-8595-2011; Worrich, Anja/C-3989-2017	Pieterse, Corné/0000-0002-5473-4646; Vosman, Ben/0000-0003-4942-8342; van Dam, Nicole M./0000-0003-2622-5446; Van Wees, Saskia/0000-0002-2295-7271; Worrich, Anja/0000-0002-3116-2964	VENI grant - Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO) [13087]; EU 7th framework program for the PGR Secure project [266394]; Ministry of Economic Affairs of the Netherlands [BO-26.03-009-001]	VENI grant - Dutch Technology Foundation STW, Netherlands Organization for Scientific Research (NWO); EU 7th framework program for the PGR Secure project; Ministry of Economic Affairs of the Netherlands(Ministry of Economic Affairs, Netherlands)	The project was funded by a VENI grant (no. 13087 to CB) funded by the Dutch Technology Foundation STW, which is part of the Netherlands Organization for Scientific Research (NWO), a grant from the EU 7th framework program for the PGR Secure project (Grant agreement no: 266394), and a grant from the Ministry of Economic Affairs of the Netherlands (project no. BO-26.03-009-001). The funders provided support in the form of salaries for authors (VENI & Keygene N.V. for CB, EU program and Ministry for KTBP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Bodenhausen N, 2007, MOL PLANT MICROBE IN, V20, P1406, DOI 10.1094/MPMI-20-11-1406; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; Bohmer M, 2011, PLANT J, V67, P105, DOI 10.1111/j.1365-313X.2011.04579.x; Boissot N, 2010, THEOR APPL GENET, V121, P9, DOI 10.1007/s00122-010-1287-8; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Broekgaarden C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145124; Broekgaarden C, 2015, PLANT PHYSIOL, V169, P2371, DOI 10.1104/pp.15.01020; Broekgaarden C, 2012, ENTOMOL EXP APPL, V142, P153, DOI 10.1111/j.1570-7458.2011.01210.x; Broekgaarden C, 2011, PLANT BIOTECHNOL J, V9, P819, DOI 10.1111/j.1467-7652.2011.00635.x; Broekgaarden C, 2010, J EXP BOT, V61, P807, DOI 10.1093/jxb/erp347; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Dixon DP, 2009, J EXP BOT, V60, P1207, DOI 10.1093/jxb/ern365; Elbaz M, 2012, MOL ECOL, V21, P4533, DOI 10.1111/j.1365-294X.2012.05713.x; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Firdaus S, 2013, THEOR APPL GENET, V126, P1487, DOI 10.1007/s00122-013-2067-z; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gelli M, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-015-0696-x; Grosser K., 2017, JOVE-J VIS EXP, V121; Hickman R, 2017, PLANT CELL, V29, P2086, DOI 10.1105/tpc.16.00958; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Khakimov B, 2015, PLANT J, V84, P478, DOI 10.1111/tpj.13012; Kuromori T, 2011, PLANT J, V67, P885, DOI 10.1111/j.1365-313X.2011.04641.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Li JY, 2016, PLANT BIOTECHNOL J, V14, P1956, DOI 10.1111/pbi.12554; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lucatti AF, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0142-3; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mao Y-B, 2015, NATURE COMM, V8, P13925, DOI DOI 10.1038/ncomms13925; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; Markovich O, 2013, J CHEM ECOL, V39, P1361, DOI 10.1007/s10886-013-0358-0; Nijveen H, 2013, NUCLEIC ACIDS RES, V41, pW587, DOI 10.1093/nar/gkt333; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Pandit A, 2010, MOL GENET GENOMICS, V284, P121, DOI 10.1007/s00438-010-0551-6; Papadopoulou GV, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply031; Pappas ML, 2017, PEST MANAG SCI, V73, P1780, DOI 10.1002/ps.4587; Parkin IAP, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r77; Pelgrom KTB, 2015, EUPHYTICA, V202, P297, DOI 10.1007/s10681-014-1306-y; Perez-Hedo M, 2015, J PEST SCI, V88, P543, DOI 10.1007/s10340-014-0640-0; Perez-Sackett PT, 2011, J CROP IMPROV, V25, P134, DOI 10.1080/15427528.2011.546093; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Seo PJ, 2009, PLANT PHYSIOL, V151, P275, DOI 10.1104/pp.109.144220; Smeds L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026314; Tang JF, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-438; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; van den Oever-van den Elsen F, 2016, J INTEGR PLANT BIOL, V58, P397, DOI 10.1111/jipb.12449; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J.W., 2009, MAPQTL6 SOFTWARE MAP; Verhage A, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00047; Vishwakarma K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00161; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Vos IA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00539; Vosman B, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2124-4; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Wang XW, 2017, CURR OPIN INSECT SCI, V19, P70, DOI 10.1016/j.cois.2017.02.001; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhang D, 2017, PLANT MOL BIOL, V93, P137, DOI 10.1007/s11103-016-0552-x; Zust T, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.206, 10.1038/nplants.2015.206]; Zwanepol S, 1996, TEELT VAN SLUITKOOL	64	7	8	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206103	10.1371/journal.pone.0206103	http://dx.doi.org/10.1371/journal.pone.0206103			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399182	Green Submitted, gold, Green Published			2022-12-26	WOS:000449374000008
J	Martinez-Paz, JM; Gomariz-Castillo, F; Pellicer-Martinez, F				Miguel Martinez-Paz, Jose; Gomariz-Castillo, Francisco; Pellicer-Martinez, Francisco			Appraisal of the water footprint of irrigated agriculture in a semi-arid area: The Segura River Basin	PLOS ONE			English	Article							RETURN FLOWS; WASTE-WATER; GROUNDWATER; MANAGEMENT; QUALITY; SCARCITY; SUSTAINABILITY; VALUATION; INDICATOR; SURFACE	Irrigated agriculture is a key activity in water resources management at the river basin level in arid and semi-arid areas, since this sector consumes the largest part of the water resources overall. The current study proposes a methodology to evaluate the water footprint (WF) of the irrigated agriculture sector at the river basin level, through a simulation of the anthropised water cycle combining a hydrological model and a decision support system. The main difference from the approaches that have already been used is that the new methodology includes the limitations of the system for the exploitation of water resources where the irrigated areas are located, and it considers the hydrological principles governed by the law of continuity of mass. Water footprint accounting was carried out for the Segura River Basin (South-eastern Spain), applying the methodology proposed and another that is usually applied. The results of the two methodologies were compared, revealing significant differences in the values of the WF, basically due to the blue component. The methodology that is usually applied overestimated the WF of the agriculture in the basin since supply deficits were not taken into account, providing results that would only be possible if there were no spatial or temporal restrictions to water use. So, in order to make the WF indicator useful in water resources management plans, it is necessary to adapt the computations to the main characteristics of the water exploitation system of the whole basin under study, respecting the hydrological principles of the water cycle: regulation and transport infrastructure, the real water resources available and the priority of access to water between concurrent water uses.	[Miguel Martinez-Paz, Jose] Univ Murcia, Dept Appl Econ, Murcia, Spain; [Gomariz-Castillo, Francisco] Univ Murcia, Dept Geog, Murcia, Spain; [Pellicer-Martinez, Francisco] Catholic Univ Murcia, Dept Civil Engn, Murcia, Spain	University of Murcia; University of Murcia; Universidad Catolica de Murcia	Pellicer-Martinez, F (corresponding author), Catholic Univ Murcia, Dept Civil Engn, Murcia, Spain.	fpellicer@ucam.edu	Gomariz-Castillo, Francisco/E-2846-2017; MARTINEZ-PAZ, JOSE M./G-2508-2010; Pellicer-Martinez, Francisco/S-7265-2018	Gomariz-Castillo, Francisco/0000-0003-4306-6643; MARTINEZ-PAZ, JOSE M./0000-0001-8412-7647; Pellicer-Martinez, Francisco/0000-0002-0962-6136	Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia [19342/PI/14]	Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia(Fundacion Seneca)	This paper is a result of the research project 19342/PI/14 funded by "Fundacion Seneca-Agencia de Ciencia y Tecnologia de la Region de Murcia" in the framework of PCTIRM 2011-2014 (to JMMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ababaei B, 2014, ENVIRON PROCESS, V1, P193, DOI 10.1007/s40710-014-0017-7; Alcon F, 2010, SPAN J AGRIC RES, V8, pS187; Alcon F, 2014, ENVIRON SCI POLICY, V44, P226, DOI 10.1016/j.envsci.2014.08.012; Aldaya MM, 2010, WATER RESOUR MANAG, V24, P941, DOI 10.1007/s11269-009-9480-8; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Almansa C, 2012, LAND USE POLICY, V29, P294, DOI 10.1016/j.landusepol.2011.06.013; Andreu J, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P3223; [Anonymous], 2000, NON TRADITIONAL REF; Ayala LM, 2016, SCI TOTAL ENVIRON, V569, P1159, DOI 10.1016/j.scitotenv.2016.06.191; Barros R, 2012, AGR ECOSYST ENVIRON, V155, P161, DOI 10.1016/j.agee.2012.04.004; BOE, 2008, B OF EST BOE, V71, P12820; Causape J, 2006, ENVIRON MONIT ASSESS, V117, P451, DOI 10.1007/s10661-006-0763-8; Chavez-Jimenez A, 2015, WATER RESOUR MANAG, V29, P1413, DOI 10.1007/s11269-014-0882-x; CHS, 2017, MON AN SURF WAT QUAL; CHS, 2008, ESQ PROV TEM IMP DEM; CHS (Confederacion Hydrografica del Segura), 1998, PLAN HIDR CUENC SEG; Custodio E, 2016, SCI TOTAL ENVIRON, V559, P302, DOI 10.1016/j.scitotenv.2016.02.107; D'Ambrosio E, 2018, J CLEAN PROD, V200, P454, DOI 10.1016/j.jclepro.2018.07.229; de Miguel A, 2015, SUSTAINABILITY-BASEL, V7, P6759, DOI 10.3390/su7066759; Dechmi F, 2013, 31 C NAC RIEG ORIH A; Dourte DR, 2014, AGR SYST, V125, P33, DOI 10.1016/j.agsy.2013.11.006; Fereres E, 2017, IRRIGATION SCI, V35, P83, DOI 10.1007/s00271-017-0535-y; Franke N.A., 2013, VALUE WATER RES REPO; Fulton J, 2014, WATER RESOUR MANAG, V28, P3637, DOI 10.1007/s11269-014-0692-1; Galiano SG, 2015, WATER-SUI, V7, P5458, DOI 10.3390/w7105458; Garcia-Barron L, 2015, J HYDROL, V525, P747, DOI 10.1016/j.jhydrol.2015.04.036; Greene W.H., 2007, ECONOMETRIC ANAL; Grindlay AL, 2011, LAND USE POLICY, V28, P242, DOI 10.1016/j.landusepol.2010.06.005; Gu BJ, 2013, GLOBAL ENVIRON CHANG, V23, P1112, DOI 10.1016/j.gloenvcha.2013.05.004; Gunkel A, 2017, J HYDROL-REG STUD, V12, P136, DOI 10.1016/j.ejrh.2017.04.004; Hernandez-Bedolla J, 2017, WATER-SUI, V9, DOI 10.3390/w9030213; Hoekstra A., 2003, VALUE WATER RES REPO, V12; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Jin C, 2016, WATER-SUI, V8, DOI 10.3390/w8110513; Kroll SA, 2013, ECOHYDROLOGY, V6, P878, DOI 10.1002/eco.1311; Lapuente E, 2012, DESALINATION, V300, P40, DOI 10.1016/j.desal.2012.06.002; Liu JG, 2010, J HYDROL, V384, P187, DOI 10.1016/j.jhydrol.2009.11.024; Madugundu R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192830; MAPA, 2001, PLAN NAC REG HOR 200; MARM-Ministerio De Medio Ambiente y Medio Rural yMarino, 2011, GUIA PRACT FERT RAC; Martinez-Alcala I, 2018, WATER RES, V135, P278, DOI 10.1016/j.watres.2018.02.033; MARTINEZ-PAZ J.M., 2016, REV ESPANOLA ESTUDIO, V244, P35; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Metulini R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153982; Mishra A. K., 2010, J HYDROL, V391, P202, DOI [DOI 10.1016/J.JHYDROL.2010.07.012, 10.1016/j.jhydrol.2010.07.012, DOI 10.1016/j.jhydrol.2010.07.012]; Paredes-Arquiola J, 2014, HYDROLOG SCI J, V59, P878, DOI 10.1080/02626667.2013.821573; Pedro-Monzonis M, 2016, J HYDROL, V533, P1, DOI 10.1016/j.jhydrol.2015.11.034; Pedro-Monzonis M, 2015, J HYDROL, V527, P482, DOI 10.1016/j.jhydrol.2015.05.003; Pellicer-Martinez F, 2018, HYDROL EARTH SYST SC, DOI [10.5194/hess-2018-258, DOI 10.5194/HESS-2018-258]; Pellicer-Martinez F, 2016, SCI TOTAL ENVIRON, V571, P561, DOI 10.1016/j.scitotenv.2016.07.022; Pellicer-Martinez F, 2016, ECOL INDIC, V60, P1173, DOI 10.1016/j.ecolind.2015.08.032; Pellicer-Martinez F, 2014, J HYDROL, V519, P1848, DOI 10.1016/j.jhydrol.2014.09.067; Perni A, 2017, J ENVIRON MANAGE, V203, P40, DOI 10.1016/j.jenvman.2017.07.049; Perni A, 2012, WATER ENVIRON J, V26, P274, DOI 10.1111/j.1747-6593.2011.00286.x; Perry C, 2014, AGR WATER MANAGE, V134, P119, DOI 10.1016/j.agwat.2013.12.004; Pulido-Velazquez M, 2013, J WATER RES PLAN MAN, V139, P583, DOI 10.1061/(ASCE)WR.1943-5452.0000262; Reif J, 2016, AGR ECOSYST ENVIRON, V232, P208, DOI 10.1016/j.agee.2016.08.007; Rodenas MA, 2014, J WATER REUSE DESAL, V4, P50, DOI 10.2166/wrd.2013.044; Salla MR, 2014, LAT AM J AQUAT RES, V42, P224, DOI 10.3856/vol42-issue1-fulltext-19; Salmoral G, 2017, LAND USE POLICY, V61, P24, DOI 10.1016/j.landusepol.2016.09.027; Seckler D, 2000, P C HELD WAG NETH, P147; Shiklomanov IA, 2000, WATER INT, V25, P11, DOI 10.1080/02508060008686794; Steduto P, 2009, AGRON J, V101, P426, DOI 10.2134/agronj2008.0139s; Stockle CO, 2003, EUR J AGRON, V18, P289, DOI 10.1016/S1161-0301(02)00109-0; Tabari MMR, 2014, WATER RESOUR MANAG, V28, P1887, DOI 10.1007/s11269-014-0578-2; Tian Y, 2015, ENVIRON MODELL SOFTW, V63, P170, DOI 10.1016/j.envsoft.2014.10.011; Velthof G.L., 2009, J ENVIRON QUAL, V38, P1, DOI DOI 10.2134/JEQ2008.0108; Wang LL, 2014, ECOL INDIC, V41, P131, DOI 10.1016/j.ecolind.2014.01.039; Wichelns D, 2015, ECOL INDIC, V52, P277, DOI 10.1016/j.ecolind.2014.12.013; Zeng Z, 2012, HYDROL EARTH SYST SC, V16, P2771, DOI 10.5194/hess-16-2771-2012; Zhuo L, 2016, ADV WATER RESOUR, V87, P29, DOI 10.1016/j.advwatres.2015.11.002	71	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206852	10.1371/journal.pone.0206852	http://dx.doi.org/10.1371/journal.pone.0206852			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399163	gold, Green Published, Green Submitted			2022-12-26	WOS:000449374000027
J	Ravi, R; Zulkrnin, NSH; Rozhan, NN; Yusoff, NRN; Rasat, MSM; Ahmad, MI; Ishak, IH; Amin, MFM				Ravi, Rajiv; Zulkrnin, Nor Shaida Husna; Rozhan, Nurul Nadiah; Yusoff, Nik Raihan Nik; Rasat, Mohd Sukhairi Mat; Ahmad, Muhammad Iqbal; Ishak, Intan H.; Amin, Mohamad Faiz Mohd			Chemical composition and larvicidal activities of Azolla pinnata extracts against Aedes (Diptera:Culicidae)	PLOS ONE			English	Article							COMMERCIAL BOTANICAL INSECTICIDES; OREOCHROMIS-NILOTICUS; VOLATILE COMPONENTS; AZADIRACHTA-INDICA; PLANT-EXTRACTS; CONSTITUENTS; MOSQUITO; ACID; PHYTOCHEMISTRY; OVIPOSITION	Background The resistance problem of dengue vectors to different classes of insecticides that are used for public health has raised concerns about vector control programmes. Hence, the discovery of alternative compounds that would enhance existing tools is important for overcoming the resistance problem of using insecticides in vectors and ensuring a chemical-free environment. The larvicidal effects of Azolla pinnata extracts by using two different extraction methods with methanol solvent against Aedes in early 4th instar larvae was conducted. Methods The fresh Azolla pinnata plant from Kuala Krai, Kelantan, Malaysia was used for crude extraction using Soxhlet and maceration methods. Then, the chemical composition of extracts and its structure were identified using GCMS-QP2010 Ultra (Shimadzu). Next, following the WHO procedures for larval bioassays, the extracts were used to evaluate the early 4th instar larvae of Aedes mosquito vectors. Results The larvicidal activity of Azolla pinnata plant extracts evidently affected the early 4th instar larvae of Aedes aegypti mosquito vectors. The Soxhlet extraction method had the highest larvicidal effect against Ae. aegypti early 4th instar larvae, with LC50 and LC95 values of 1093 and 1343 mg/L, respectively. Meanwhile, the maceration extraction compounds were recorded with the LC50 and LC95 values of 1280 and 1520 mg/L, respectively. The larvae bioassay test for Ae. albopictus showed closely similar values in its Soxhlet extraction, with LC50 and LC95 values of 1035 and 1524 mg/L, compared with the maceration extraction LC50 and LC95 values of 1037 and 1579 mg/L, respectively. The non-target organism test on guppy fish, Poecilia reticulata, showed no mortalities and posed no toxic effects. The chemical composition of the Azolla pinnata plant extract has been found and characterized as having 18 active compounds for the Soxhlet method and 15 active compounds for the maceration method. Conclusions Our findings showed that the crude extract of A. pinnata bioactive molecules are effective and have the potential to be developed as biolarvicides for Aedes mosquito vector control. This study recommends future research on the use of active ingredients isolated from A. pinnata extracts and their evaluation against larvicidal activity of Aedes in small-scale field trials for environmentally safe botanical insecticide invention.	[Ravi, Rajiv; Zulkrnin, Nor Shaida Husna; Rozhan, Nurul Nadiah; Yusoff, Nik Raihan Nik; Amin, Mohamad Faiz Mohd] Univ Malaysia Kelantan, Fac Earth Sci, Jeli Campus, Jeli, Kelantan, Malaysia; [Rasat, Mohd Sukhairi Mat; Ahmad, Muhammad Iqbal] Univ Malaysia Kelantan, Fac Bioengn & Technol, Jeli Campus, Jeli, Kelantan, Malaysia; [Ishak, Intan H.] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia; [Ishak, Intan H.] Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Minden, Penang, Malaysia	Universiti Malaysia Kelantan; Universiti Malaysia Kelantan; Universiti Sains Malaysia; Universiti Sains Malaysia	Amin, MFM (corresponding author), Univ Malaysia Kelantan, Fac Earth Sci, Jeli Campus, Jeli, Kelantan, Malaysia.; Ishak, IH (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia.; Ishak, IH (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Minden, Penang, Malaysia.	intanishak@usm.my; mohamadfaiz@umk.edu.my	Ahmad, Dr. Muhammad Iqbal/AAX-3791-2021; Ishak, Intan H./C-8723-2016; , Ravi/X-7522-2019; Amin, Mohamad Faiz Mohd/AAL-6357-2020; Yusoff, Nik Raihan Nik/Q-4215-2019	Ishak, Intan H./0000-0002-8916-0451; Amin, Mohamad Faiz Mohd/0000-0002-4283-1975; Yusoff, Nik Raihan Nik/0000-0002-6879-3006; Ravi, Rajiv/0000-0003-4386-3810	Ministry of Higher Education, Malaysia [R/FRGS/A08.00/00425A/002/2017/000440]	Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This work was funded by the Ministry of Higher Education, Malaysia in support of this study through the Fundamental Research Grant Scheme (R/FRGS/A08.00/00425A/002/2017/000440).	Abou Y, 2007, AQUAC RES, V38, P595, DOI 10.1111/j.1365-2109.2007.01700.x; Adebowale KO, 2006, AFR J BIOTECHNOL, V5, P901; AhbiRami R, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu042; Akhtar Y., 2008, Phytochemistry Reviews, V7, P77, DOI 10.1007/s11101-006-9048-7; Akpuaka A, 2013, NAT SCI, V11, P141; [Anonymous], 2017, UPD DENG SIT W PAC R; Aparna V, 2012, CHEM BIOL DRUG DES, V80, P434, DOI 10.1111/j.1747-0285.2012.01418.x; Atanasova D, 2018, MAYFEB J AGR SCI, V1, P10; Barakat D. A., 2011, Australian Journal of Basic and Applied Sciences, V5, P693; Baranitharan M, 2017, PROCESS SAF ENVIRON, V106, P23, DOI 10.1016/j.psep.2016.12.003; Bashir Ahmad, 2012, Journal of Medicinal Plants Research, V6, P4653; Bekele D, 2016, J FERTIL PESTIC, V7, P2; Bekele J, 2001, PHYTOCHEMISTRY, V57, P385, DOI 10.1016/S0031-9422(01)00067-X; Bindhu K. B., 2013, International Research Journal of Biological Sciences, V2, P88; Caceres LA, 2015, J ANAL APPL PYROL, V112, P333, DOI 10.1016/j.jaap.2015.01.003; Chen Y, 2018, ARCH BIOL SCI, V70, P349, DOI 10.2298/ABS170729052C; Cruz-Estrada A, 2013, ELECTRON J BIOTECHN, V16, DOI 10.2225/vol16-issue1-fulltext-6; Cuadrado V, 2010, INT J SYST EVOL MICR, V60, P2606, DOI 10.1099/ijs.0.018341-0; Cui SF, 2009, J CHROMATOGR B, V877, P1901, DOI 10.1016/j.jchromb.2009.05.022; Ekanayake T.H., 2007, P PERADENIYA U RES S, V12, P98; El-Sayed A.-F.M., 1992, Aquaculture and Fisheries Management, V23, P167, DOI 10.1111/j.1365-2109.1992.tb00607.x; Falodun A, 2009, TROPICAL J PHARM RES, V8; FENG R, 1995, EXPERIENTIA, V51, P831, DOI 10.1007/BF01922438; Fernando GKAW, 2018, BMC ECOL, V18, DOI 10.1186/s12898-018-0180-1; Gherraf N, 2017, ARAB J CHEM, V10, pS2476, DOI 10.1016/j.arabjc.2013.09.013; Ghosh A, 2012, INDIAN J MED RES, V135, P581; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Isman MB, 1996, RECENT ADV PHYTOCHEM, V30, P155; Jiang C. H., 2012, J MED PLANTS RES, V6, P3464; Kannathasan K, 2008, PARASITOL RES, V103, P999, DOI 10.1007/s00436-008-1078-1; Karabay-Yavasoglu NU, 2007, PHYTOTHER RES, V21, P153, DOI 10.1002/ptr.2045; Katsvanga C. A. T., 2004, Tropical and Subtropical Agroecosystems, V4, P101; KENAGA E E, 1969, Bulletin of the Entomological Society of America, V15, P85; Kisa A, 2018, REC NAT PROD, V12, P201, DOI 10.25135/rnp.23.17.07.126; Kumar A, 2011, NAT PROD RES, V25, P1680, DOI 10.1080/14786419.2010.511620; Kumar P. P., 2010, African Journal of Biochemistry Research, V4, P191; Kusumawathie PHD, 2006, J MED ENTOMOL, V43, P79, DOI 10.1603/0022-2585(2006)043[0079:LPOFSF]2.0.CO;2; Larvicides M., 2005, GUIDELINES LAB FIELD; Lu XM, 2018, APPL MICROBIOL BIOT, V102, P475, DOI 10.1007/s00253-017-8596-7; Lucie A.T., 2013, J LIFE SCI, V7, P1030; Truong MX, 2017, J ESSENT OIL BEAR PL, V20, P1157, DOI [10.1080/0972060x.2016.1259590, 10.1080/0972060X.2016.1259590]; McKerr C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003639; Medhi SM, 2010, ASIAN PAC J TROP MED, V3, P841, DOI 10.1016/S1995-7645(10)60203-9; Michielin EMZ, 2009, BIORESOURCE TECHNOL, V100, P6615, DOI 10.1016/j.biortech.2009.07.061; Mohammad Shaheen Khan, 2016, Journal of Applied Pharmaceutical Science, V6, P157; Navarro-Silva MA, 2009, REV BRAS ENTOMOL, V53, P1, DOI 10.1590/S0085-56262009000100002; Nazni W, 2009, SUSCEPTIBILITY STATU; Ogunlesi M, 2009, AFRICAN J BIOTECHNOL, V8; Ojekale AB, 2013, IOSR J PHARM, V3; Olaoluwa OO, 2016, WORLD J PHARM PHARM, V5, P224; Paitan Y, 2004, ANAL BIOCHEM, V335, P175, DOI 10.1016/j.ab.2004.08.032; Pasdaran A., 2013, Pharmaceutical Sciences, V19, P1; Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS; Peng ZK, 2004, J ALLERGY CLIN IMMUN, V114, P1189, DOI 10.1016/j.jaci.2004.08.014; Pereira Boscolli Barbosa, 2014, Cad. saúde colet., V22, P241, DOI 10.1590/1414-462X201400030004; Qian H, 2018, J CHROMATOGR A, V1559, P86, DOI 10.1016/j.chroma.2018.04.031; Ranson H., 2010, TROPIKA NET, V1, P0; Riaz M. A., 2018, Bangladesh Journal of Scientific and Industrial Research, V53, P169, DOI 10.3329/bjsir.v53i3.38262; SAWAGUCHI T, 1995, MACROMOL CHEM PHYSIC, V196, P4139, DOI 10.1002/macp.1995.021961221; Shadrach AU, 2018, AM J MICROBIOLOGY BI, V5, P12; Siddiqui BS, 2009, NAT PROD RES, V23, P271, DOI 10.1080/14786410802006082; Sivakumar R, 2011, ASIAN PAC J TROP MED, V4, P706, DOI 10.1016/S1995-7645(11)60178-8; Smaoui S, 2012, WORLD J MICROB BIOT, V28, P793, DOI 10.1007/s11274-011-0872-6; Ullah Z, 2018, CULEX QUIN QUEFASCIA; Villanes A, 2018, AM J TROP MED HYG, V98, P181, DOI 10.4269/ajtmh.17-0253; Ware GW, 2004, PESTICIDE BOOK, V6; Yayli N, 2006, TURK J CHEM, V30, P71; Zellagui Amar, 2012, Org Med Chem Lett, V2, P2, DOI 10.1186/2191-2858-2-2; Zulkrnin H, 2018, J PARASITOLOGY RES, V2018	69	14	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206982	10.1371/journal.pone.0206982	http://dx.doi.org/10.1371/journal.pone.0206982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399167	gold, Green Submitted, Green Published			2022-12-26	WOS:000449374000038
J	Schneidman-Duhovny, D; Khuri, N; Dong, GQ; Winter, MB; Shifrut, E; Friedman, N; Craik, CS; Pratt, KP; Paz, P; Aswad, F; Sali, A				Schneidman-Duhovny, Dina; Khuri, Natalia; Dong, Guang Qiang; Winter, Michael B.; Shifrut, Eric; Friedman, Nir; Craik, Charles S.; Pratt, Kathleen P.; Paz, Pedro; Aswad, Fred; Sali, Andrej			Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition	PLOS ONE			English	Article							MASS-SPECTROMETRY; FACTOR-VIII; PROTEIN; IDENTIFICATION; POTENTIALS; SEQUENCES; AFFINITY; PLATFORM	Accurate predictions of T-cell epitopes would be useful for designing vaccines, immunotherapies for cancer and autoimmune diseases, and improved protein therapies. The humoral immune response involves uptake of antigens by antigen presenting cells (APCs), APC processing and presentation of peptides on MHC class II (pMHCII), and T-cell receptor (TCR) recognition of pMHCI I complexes. Most in silico methods predict only peptide-MHCII binding, resulting in significant over-prediction of CD4 T-cell epitopes. We present a method, ITCeII, for prediction of T-cell epitopes within an input protein antigen sequence for given MHCII and TCR sequences. The method integrates information about three stages of the immune response pathway: antigen cleavage, MHCII presentation, and TCR recognition. First, antigen cleavage sites are predicted based on the cleavage profiles of cathepsins S, B, and H. Second, for each 12-mer peptide in the antigen sequence we predict whether it will bind to a given MHCII, based on the scores of modeled peptide-MHCII complexes. Third, we predict whether or not any of the top scoring peptide-MHCII complexes can bind to a given TCR, based on the scores of modeled ternary peptide-MHCII-TCR complexes and the distribution of predicted cleavage sites. Our benchmarks consist of epitope predictions generated by this algorithm, checked against 20 peptide-MHCII-TCR crystal structures, as well as epitope predictions for four peptide-MHCII-TCR complexes with known epitopes and TCR sequences but without crystal structures. ITCell successfully identified the correct epitopes as one of the 20 top scoring peptides for 22 of 24 benchmark cases. To validate the method using a clinically relevant application, we utilized five factor VIII-specific TCR sequences from hemophilia A subjects who developed an immune response to factor VIII replacement therapy. The known HLA-DR1-restricted factor VIII epitope was among the six top-scoring factor VIII peptides predicted by ITCaII to bind HLA-DR1 and all five TCRs. Our integrative approach is more accurate than current single-stage epitope prediction algorithms applied to the same benchmarks. It is freely available as a web server server (http://salilab.org/itcell).	[Schneidman-Duhovny, Dina; Khuri, Natalia; Dong, Guang Qiang; Sali, Andrej] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Schneidman-Duhovny, Dina; Khuri, Natalia; Dong, Guang Qiang; Winter, Michael B.; Craik, Charles S.; Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Khuri, Natalia; Sali, Andrej] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA; [Shifrut, Eric; Friedman, Nir] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel; [Craik, Charles S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci QB3, San Francisco, CA 94143 USA; [Pratt, Kathleen P.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Paz, Pedro; Aswad, Fred] Bayer HealthCare, San Francisco, CA 94158 USA; [Schneidman-Duhovny, Dina] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Inst Life Sci, Jerusalem, Israel	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Weizmann Institute of Science; University of California System; University of California San Francisco; Uniformed Services University of the Health Sciences - USA; Bayer AG; Bayer Healthcare Pharmaceuticals; Hebrew University of Jerusalem	Schneidman-Duhovny, D; Sali, A (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Schneidman-Duhovny, D; Sali, A (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.; Sali, A (corresponding author), Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94143 USA.; Paz, P; Aswad, F (corresponding author), Bayer HealthCare, San Francisco, CA 94158 USA.; Schneidman-Duhovny, D (corresponding author), Hebrew Univ Jerusalem, Sch Comp Sci & Engn, Inst Life Sci, Jerusalem, Israel.	dina@salilab.org; pedro.paz@bayer.com; fred.aswad@bayer.com; sali@salilab.org	Shifrut, Eric/AAK-9263-2021; Pratt, Kathleen P/E-9489-2019; Schneidman, Dina/ABH-6654-2020	Shifrut, Eric/0000-0001-6827-0128; Schneidman, Dina/0000-0003-0480-0438; Pratt, Kathleen/0000-0001-6837-6133	National Institute of Health [F32CA168150, R21CA186077, R01 GM083960, P41GM103481]; NHLBI [1RC2 HL101851, R01 HL130448]; Bayer Healthcare Pharmaceuticals; NATIONAL CANCER INSTITUTE [F32CA168150, R21CA186077] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130448, RC2HL101851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083960, P41GM103481] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bayer Healthcare Pharmaceuticals(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institute of Health (F32CA168150 to M.B.W., R21CA186077 to C.S.C. and A.S., R01 GM083960 to A.S., and P41GM103481 to C.S.C.), NHLBI (1RC2 HL101851 and R01 HL130448 to K. P.), Bayer Healthcare Pharmaceuticals (to K.P., D. S. and A.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuka Y, 1999, TISSUE ANTIGENS, V53, P122, DOI 10.1034/j.1399-0039.1999.530202.x; Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; Barkan DT, 2010, BIOINFORMATICS, V26, P1714, DOI 10.1093/bioinformatics/btq267; Beringer DX, 2015, NAT IMMUNOL, V16, P1153, DOI 10.1038/ni.3271; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Casrouge A, 2000, J IMMUNOL, V164, P5782, DOI 10.4049/jimmunol.164.11.5782; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Dong GQ, 2013, BIOINFORMATICS, V29, P3158, DOI 10.1093/bioinformatics/btt560; Duhovny D, 2002, 2 INT WORKSH WABI 20; Elder ME, 2013, J PEDIATR-US, V163, P847, DOI 10.1016/j.jpeds.2013.03.002; Ettinger RA, 2016, BLOOD; Ettinger RA, 2018, BLOOD ADV, V2, P309, DOI 10.1182/bloodadvances.2017013482; Ettinger RA, 2009, BLOOD, V114, P1423, DOI 10.1182/blood-2009-01-200725; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fornes O, 2014, ADV PROTEIN CHEM STR, V94, P77, DOI 10.1016/B978-0-12-800168-4.00004-4; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hartman IZ, 2010, NAT MED, V16, P1333, DOI 10.1038/nm.2248; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Khan JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017194; Kim A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6369; Kim Y, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-241; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Madi A, 2014, GENOME RES, V24, P1603, DOI 10.1101/gr.170753.113; Michels AW, 2015, J ALLERGY CLIN IMMUN, V136, P252, DOI 10.1016/j.jaci.2015.06.024; Murphy K, 2008, GARL SCI, V7, P887, DOI DOI 10.1086/596249; Newell EW, 2014, NAT BIOTECHNOL, V32, P149, DOI 10.1038/nbt.2783; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Nguyen PCT, 2014, BLOOD, V123, P2732, DOI 10.1182/blood-2013-09-527275; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen Morten, 2010, Immunome Res, V6, P9, DOI 10.1186/1745-7580-6-9; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; O'Donoghue AJ, 2015, P NATL ACAD SCI USA, V112, P7478, DOI 10.1073/pnas.1507082112; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Sadegh-Nasseri Scheherazade, 2016, F1000Res, V5, DOI 10.12688/f1000research.7664.1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schuster-Bockler Benjamin, 2007, Curr Protoc Bioinformatics, VAppendix 3, p3A, DOI 10.1002/0471250953.bia03as18; Shao W., 2017, NUCL ACIDS RES; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Shifrut E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00379; Song JN, 2011, J BIOINF COMPUT BIOL, V9, P149, DOI 10.1142/S0219720011005288; Stoeckle C, 2010, RESULTS PROBL CELL D, V51, P149, DOI 10.1007/400_2009_22; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Tye-Din JA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001012; Vider-Shalit T, 2009, BIOINFORMATICS, V25, pI39, DOI 10.1093/bioinformatics/btp221; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; Warren RL, 2011, GENOME RES, V21, P790, DOI 10.1101/gr.115428.110; Woodsworth DJ, 2013, GENOME MED, V5, DOI 10.1186/gm502; Yin YY, 2011, EMBO J, V30, P1137, DOI 10.1038/emboj.2011.21	61	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206654	10.1371/journal.pone.0206654	http://dx.doi.org/10.1371/journal.pone.0206654			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399156	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000018
J	Jaime, R; Alcantara, JM; Manzaneda, AJ; Rey, PJ				Jaime, Rafael; Alcantara, Julio M.; Manzaneda, Antonio J.; Rey, Pedro J.			Climate change decreases suitable areas for rapeseed cultivation in Europe but provides new opportunities for white mustard as an alternative oilseed for biofuel production	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL RESPONSES; BIODIESEL PRODUCTION; EXTINCTION RISK; FOOD-PRODUCTION; CHANGE IMPACTS; RANGE SHIFTS; OIL; DISTRIBUTIONS; ENERGY	Oilseed crops, including several mustards, are cultivated as biofuel sources worldwide. However, common mustard crops (e.g., the rapeseed Brassica napus) grow naturally in mesic temperate regions, which are expected to be impaired by global warming and increased aridity. In particular, increased aridity is predicted to reduce the oil concentration and seed yield of rapeseed crops. There is therefore an urgent need to identify alternative bioenergy crops that are preadapted to future climatic conditions. An alternative to conventional Brassica species for biodiesel production is the white mustard Sinapis alba, which is native to the circum-Mediterranean region and has a high seed lipid content. S. alba grows spontaneously in olive groves and other widespread Mediterranean crops; accordingly, it could be easily cultivated by companion planting to improve ecosystem function by decreasing soil loss, controlling microbial disease, and assisting in the maintenance of biodiversity. In this study, using species distribution modeling, we predicted climatically suitable areas for the cultivation of S. alba in Western Europe across the Mediterranean Basin under present climatic conditions and several climate change scenarios. We show that current climatically suitable areas for S. alba cultivation do not overlap with those for B. napus. Unlike B. napus, S. alba could be cultivated throughout most of the circum-Mediterranean region. According to our models, increases in aridity and annual mean temperatures will expand the climatically suitable areas for S. alba in the Mediterranean Basin. However, suitable areas for the cultivation of B. napus will decrease significantly in Western Europe. Our results indicate that S. alba is a strong, environmentally safe candidate for biofuel production throughout the Mediterranean Basin and other Western European countries, especially under climate change scenarios that are expected to impair current oilseed crops.	[Jaime, Rafael; Alcantara, Julio M.; Manzaneda, Antonio J.; Rey, Pedro J.] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Jaen, Andalucia, Spain; [Jaime, Rafael; Alcantara, Julio M.; Manzaneda, Antonio J.; Rey, Pedro J.] Univ Jaen, CEAEMA, Jaen, Andalucia, Spain	Universidad de Jaen; Universidad de Jaen	Rey, PJ (corresponding author), Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Jaen, Andalucia, Spain.; Rey, PJ (corresponding author), Univ Jaen, CEAEMA, Jaen, Andalucia, Spain.	prey@ujaen.es	Alcantara, Julio M./O-4400-2017; Manzaneda, Antonio/AAG-1776-2019; Rey Zamora, Pedro/I-2165-2015	Alcantara, Julio M./0000-0002-8003-7844; Manzaneda Avila, Antonio Jose/0000-0001-9384-7910; Rey Zamora, Pedro/0000-0001-5550-0393	CEAEMA funds program of the Universidad de Jaen [UJA 2013/00093/001]; Fundacion ONCE; European Social Fund (European Commission)	CEAEMA funds program of the Universidad de Jaen; Fundacion ONCE; European Social Fund (European Commission)	Research of this paper was funded by CEAEMA funds program of the Universidad de Jaen, ref. project, UJA 2013/00093/001. Rafael Jaime was further funded by a postdoctoral fellowship "Oportunidad al Talento" of Fundacion ONCE and the European Social Fund (European Commission). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajanovic A, 2011, ENERGY, V36, P2070, DOI 10.1016/j.energy.2010.05.019; Al-Jasass FM, 2012, SCI WORLD J, DOI 10.1100/2012/859892; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; [Anonymous], 2016, BP STAT REV WORLD EN; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Baka J, 2009, ENERG POLICY, V37, P2505, DOI 10.1016/j.enpol.2008.09.050; Beukema H, 2007, AGROFOREST SYST, V70, P217, DOI 10.1007/s10457-007-9037-x; Blackshaw RE, 2011, CAN J PLANT SCI, V91, P889, DOI [10.4141/CJPS2011-002, 10.4141/cjps2011-002]; Bojnansky V, 2007, ATLAS SEEDS FRUITS C, P175; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chloupek O, 2004, FIELD CROP RES, V85, P167, DOI 10.1016/S0378-4290(03)00162-X; Ciubota-Rosie C, 2013, BIOMASS BIOENERG, V51, P83, DOI 10.1016/j.biombioe.2013.01.008; Collins W.J., 2008, 74 HCTN MET OFF HADL, DOI DOI 10.1088/1748-9326/8/2/024024; Demirbas B, 2009, ENER EDUC SCI TECH-A, V22, P117; Donatelli M, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/7/075005; Dorado MP, 2004, ENERG FUEL, V18, P77, DOI 10.1021/ef0340110; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Firrisa MT, 2014, ENERG EFFIC, V7, P79, DOI 10.1007/s12053-013-9201-2; Fletcher RJ, 2011, FRONT ECOL ENVIRON, V9, P161, DOI 10.1890/090091; Frohlich A, 2005, IND CROP PROD, V21, P25, DOI 10.1016/j.indcrop.2003.12.004; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Giorgetta MA, 2012, ATMOSPHERIC GEN CIRC; Gomez Campo C., 1993, FLORA IBERICA PLANTA, VIV; Groom MJ, 2008, CONSERV BIOL, V22, P602, DOI 10.1111/j.1523-1739.2007.00879.x; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Hemingway JS, 1995, EVOLUTION CROP PLANT, P82; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; IIASA and FAO, 2012, GLOB AGR ZON GAEZ V3, P196; Issariyakul T, 2011, J AM OIL CHEM SOC, V88, P391, DOI 10.1007/s11746-010-1679-6; Jaime R, 2015, J PLANT ECOL, V8, P457, DOI 10.1093/jpe/rtu044; Jha P, 2017, CROP PROT, V95, P31, DOI 10.1016/j.cropro.2016.06.021; Jham GN, 2009, J AM OIL CHEM SOC, V86, P917, DOI 10.1007/s11746-009-1431-2; Laderach P, 2013, CLIMATIC CHANGE, V119, P841, DOI 10.1007/s10584-013-0774-8; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Lee JSH, 2014, CONSERV LETT, V7, P25, DOI 10.1111/conl.12039; Leng GY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01599-2; Lewis SC, 2014, AUST METEOROL OCEAN, V64, P87, DOI 10.22499/2.6402.001; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; Maloney ED, 2014, J CLIMATE, V27, P2230, DOI 10.1175/JCLI-D-13-00273.1; Mandal S, 2002, GENET RESOUR CROP EV, V49, P551, DOI 10.1023/A:1021210800414; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Mason AS, 2016, PLANT BIOLOGY, V18, P883, DOI 10.1111/plb.12462; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; Mestre F, 2017, ECOL MODEL, V359, P406, DOI 10.1016/j.ecolmodel.2017.06.013; Namazkar S, 2016, J EXP BOT, V67, P4117, DOI 10.1093/jxb/erw180; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Olesen JE, 2006, CLIMATE CHANGE DRIVE; Parry ML, 2004, GLOBAL ENVIRON CHANG, V14, P53, DOI 10.1016/j.gloenvcha.2003.10.008; PATTERSON DT, 1995, WEED SCI, V43, P483, DOI 10.1017/S0043174500081510; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Popp J, 2014, RENEW SUST ENERG REV, V32, P559, DOI 10.1016/j.rser.2014.01.056; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Requena-Mullor JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172107; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Rosenzweig C., 1998, CLIMATE CHANGE GLOBA; Rosenzweig Cynthia, 2014, Proc Natl Acad Sci U S A, V111, P3268, DOI 10.1073/pnas.1222463110; Saavedra M., 2015, CARACTERISTICAS SINA, P1; Scheffran J, 2010, BIOTECH AGR FOREST, V66, P409, DOI 10.1007/978-3-642-13440-1_16; Si P, 2004, AUST J AGR RES, V55, P367, DOI 10.1071/AR03151; Smith AB, 2013, ECOGRAPHY, V36, P1017, DOI 10.1111/j.1600-0587.2013.00107.x; Smith EG, 2007, CAN J PLANT SCI, V87, P793, DOI 10.4141/CJPS06067; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Thuiller W, 2003, GLOBAL ECOL BIOGEOGR, V12, P313, DOI 10.1046/j.1466-822X.2003.00033.x; Tuck G, 2006, BIOMASS BIOENERG, V30, P183, DOI 10.1016/j.biombioe.2005.11.019; Vernon L, 2006, 303 DEP AGR FOOD; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Walton G, 1999, CANOLA AUSTR 1 30 YE; Webber H, 2015, EUR J AGRON, V71, P123, DOI 10.1016/j.eja.2015.09.002; Wheeler T, 2013, SCIENCE, V341, P508, DOI 10.1126/science.1239402; Wich SA, 2014, CURR BIOL, V24, P1659, DOI 10.1016/j.cub.2014.05.077; Winter H, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES - OILSEEDS, P275, DOI 10.1007/978-3-642-14871-2_17; Yaniv Z., 2002, Journal of Herbs, Spices & Medicinal Plants, V9, P319, DOI 10.1300/J044v09n04_09; Yaniv Z, 1998, IND CROP PROD, V9, P1, DOI 10.1016/S0926-6690(98)00005-3; Yukimoto S, 2012, J METEOROL SOC JPN, V90A, P23, DOI 10.2151/jmsj.2012-A02; Zimmermann N. E., 2017, HABITAT SUITABILITY, DOI [10.1017/9781139028271, DOI 10.1017/9781139028271]; Ziska LH, 2011, CLIMATIC CHANGE, V105, P13, DOI 10.1007/s10584-010-9879-5	83	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0207124	10.1371/journal.pone.0207124	http://dx.doi.org/10.1371/journal.pone.0207124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395645	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400078
J	Kamata, K; Tokuda, Y; Gu, Y; Ohmagari, N; Yanagihara, K				Kamata, Kazuhiro; Tokuda, Yasuharu; Gu, Yoshiaki; Ohmagari, Norio; Yanagihara, Katsunori			Public knowledge and perception about antimicrobials and antimicrobial resistance in Japan: A national questionnaire survey in 2017	PLOS ONE			English	Article							ANTIBIOTICS; ATTITUDES	Background Antimicrobial resistance (AMR) is a threat to global health. To increase public awareness about AMR and encourage the prudent use of antimicrobials is one of the goals of the National Action Plan in Japan. Methods A nationwide online cross-sectional survey was conducted to evaluate the existing knowledge and perception of AMR in Japan, based on the Antimicrobial Resistance Eurobarometer Survey. Participants included Japanese adults aged 20-69 years, who were not medical professionals. Results Among a total of 3,390 participants, about half had taken antibiotics over the past 12 months, and majority of them obtained the antimicrobials from healthcare institutions for the common cold. While 11.7% of the participants kept leftover antibiotics, 23.6% of them have adjusted doses by themselves. About 10% of the participants have requested antibiotics from their doctors, and nearly 30% of them preferred doctors who prescribed antibiotics when had a cold. The common informational sources were TV news and newspapers, and more than 40% of the participants reported receiving some information over the past year. However, approximately 80% of the participants did not know that antibiotics do not kill viruses and that antibiotics are ineffective against cold and flu. Conclusion Not many Japanese have adequate information about antimicrobials and AMR, and many have taken antimicrobials inappropriately. Greater educational interventions are, therefore, necessary to increase public awareness and develop effective countermeasures against AMR in Japan.	[Kamata, Kazuhiro; Ohmagari, Norio] Natl Ctr Global Hlth & Med Hosp, Dis Control & Prevent Ctr, Tokyo, Japan; [Kamata, Kazuhiro] Natl Inst Infect Dis Lazzaro Spallanzani, Emerging & Reemerging Infect Dis Unit, Rome, Italy; [Tokuda, Yasuharu] Muribushi Project Okinawa Residency Programs, Uruma, Okinawa, Japan; [Gu, Yoshiaki] Natl Ctr Global Hlth & Med Hosp, AMR Clin Reference Ctr, Tokyo, Japan; [Yanagihara, Katsunori] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki, Japan	National Center for Global Health & Medicine - Japan; IRCCS Lazzaro Spallanzani; National Center for Global Health & Medicine - Japan; Nagasaki University	Kamata, K (corresponding author), Natl Ctr Global Hlth & Med Hosp, Dis Control & Prevent Ctr, Tokyo, Japan.; Kamata, K (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Emerging & Reemerging Infect Dis Unit, Rome, Italy.	kamata-kazuhiro@umin.ac.ip	Ohmagari, Norio/GLN-5290-2022; Gu, Yoshiaki/AHC-8671-2022	Ohmagari, Norio/0000-0002-4622-8970; Kamata, Kazuhiro/0000-0002-3479-2961	Ministry of Health, Labour and Welfare, Japan	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health and Labour Sciences Research Grants (Research on Emerging and Re-emerging Infectious Diseases and Immunization) in fiscal year 2016, Ministry of Health, Labour and Welfare, Japan (In Japanese Site) (https://mhlw-grants.niph.go.jp/niph/search/NIDD00.do? resrchNum= 201617008A#selectGaiyou). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Carter RR, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw112; Centers for Disease Control and Prevention, 2015, ANT ANT RES; Earnshaw S, 2014, EURO SURVEILL, V19; Gu Y, 2015, KANSEN ZAS-J JPN ASS, V89, P235; Manabu Hasegawa, PUBL AW RAIS ACT AMR; Mazinska B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172146; McCullough AR, 2016, J ANTIMICROB CHEMOTH, V71, P27, DOI 10.1093/jac/dkv310; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; Ministry of Internal Affairs and Communications, 2010, NAT CENS 2010; Ministry of Internal Affairs and Communications, COMM US TREND SURV 2; Ministry of Internal Affairs and Communications Statistics Bureau, 2015, NAT CENS 2015; Napolitano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084177; ONeill J., 2016, TACKLING DRUG RESIST; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; The Government of Japan, 2016, VETFUTURES ACTION PL; The Government of Japan. Ministry of Health Labour and Welfare Health Service Bureau Tuberculosis and Infectious Diseases Control Division, MAN ANT STEW; TNS Opinion and Social, 2016, SPEC EUR 445 ANT RES; Vallin M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152160; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Zoorob R, 2016, ANTIMICROB AGENTS CH, V60, P5527, DOI 10.1128/AAC.00528-16	21	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0207017	10.1371/journal.pone.0207017	http://dx.doi.org/10.1371/journal.pone.0207017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395640	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400075
J	Turkosi, E; Darko, E; Rakszegi, M; Molnar, I; Molnar-Lang, M; Cseh, A				Turkosi, Edina; Darko, Eva; Rakszegi, Marianna; Molnar, Istvan; Molnar-Lang, Marta; Cseh, Andras			Development of a new 7BS.7HL winter wheat-winter barley Robertsonian translocation line conferring increased salt tolerance and (1,3;1,4)-beta-D-glucan content	PLOS ONE			English	Article							BETA-GLUCAN CONTENT; SUCROSE-SYNTHASE GENES; HORDEUM-VULGARE L.; SALINITY TOLERANCE; THINOPYRUM-BESSARABICUM; STRIPE RUST; IDENTIFICATION; CHROMOSOMES; RESISTANCE; PLANTS	Interspecific hybridization between bread wheat (Triticum aestivum, 2n = 42) and related species allows the transfer of agronomic and quality traits, whereby subsequent generations comprise an improved genetic background and can be directly applied in wheat breeding programmes. While wild relatives are frequently used as sources of agronomically favourable traits, cultivated species can also improve wheat quality and stress resistance. A salt-tolerant 'Asakaze'/'Manas' 7H disomic addition line (2n = 44) with elevated beta-glucan content, but with low fertility and an unstable genetic background was developed in an earlier whea-tbarley prebreeding programme. The aim of the present study was to take this hybridization programme further and transfer the favourable barley traits into a more stable genetic background. Taking advantage of the breakage-fusion mechanism of univalent chromosomes, the 'Rannaya' winter wheat 7B monosomic line was used as female partner to the 7H addition line male, leading to the development of a compensating wheat/barley Robertsonian translocation line (7BS.7HL centric fusion, 2n = 42) exhibiting higher salt tolerance and elevated grain beta-glucan content. Throughout the crossing programme, comprising the F-1-F-4 generations, genomic in situ hybridization, fluorescence in situ hybridization and chromosome-specific molecular markers were used to trace and identify the wheat and barley chromatin. Investigations on salt tolerance during germination and on the (1,3;1,4)-beta-D-glucan (mixed-linkage glucan [MLG]) content of the seeds confirmed the salt tolerance and elevated grain MLG content of the translocation line, which can be directly applied in current wheat breeding programmes.	[Turkosi, Edina; Molnar-Lang, Marta] Hungarian Acad Sci, Dept Plant Genet Resources, Agr Inst, Ctr Agr Res, Martonvasar, Hungary; [Darko, Eva] Hungarian Acad Sci, Dept Plant Physiol, Agr Inst, Ctr Agr Res, Martonvasar, Hungary; [Rakszegi, Marianna] Hungarian Acad Sci, Cereal Breeding Dept, Agr Inst, Ctr Agr Res, Martonvasar, Hungary; [Molnar, Istvan] Hungarian Acad Sci, Maize Breeding Dept, Agr Inst, Ctr Agr Res, Martonvasar, Hungary; [Cseh, Andras] Hungarian Acad Sci, Mol Breeding Dept, Agr Inst, Ctr Agr Res, Martonvasar, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Molnar-Lang, M (corresponding author), Hungarian Acad Sci, Dept Plant Genet Resources, Agr Inst, Ctr Agr Res, Martonvasar, Hungary.; Cseh, A (corresponding author), Hungarian Acad Sci, Mol Breeding Dept, Agr Inst, Ctr Agr Res, Martonvasar, Hungary.	langne.molnar.marta@gmail.com; cseh.andras@agrar.mat.hu	Rakszegi, Marianna/B-2904-2013; Darkó, Éva/AAR-8167-2021; Cseh, Andras/AAP-3999-2021; Türkösi, Edina/AAD-2512-2022; Molnar, istvan/L-9779-2019	Cseh, Andras/0000-0002-8681-6654; Molnar, Istvan/0000-0002-7167-9319; Turkosi, Edina/0000-0002-3689-8516	European Community's Seventh Framework Programme (FP7/2007-2013) [FP7-613556]; Whealbi project; Hungarian National Research, Development and Innovation Office [K112226, K129221]; Marie Sklodowska-Curie Fellowship Grant from the European Union [H2020-MSCA-IF-2016-752453-LANDRACES]; Marie Sklodowska-Curie Fellowship Grant 'AEGILWHEAT' from the European Union [H2020-MSCA-IF-2016-746253]	European Community's Seventh Framework Programme (FP7/2007-2013); Whealbi project; Hungarian National Research, Development and Innovation Office; Marie Sklodowska-Curie Fellowship Grant from the European Union; Marie Sklodowska-Curie Fellowship Grant 'AEGILWHEAT' from the European Union	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-613556, from the Whealbi project (http://www.whealbi.eu/project/project) and from the Hungarian National Research, Development and Innovation Office (K112226 and K129221). A.C. gratefully acknowledges a Marie Sklodowska-Curie Fellowship Grant (H2020-MSCA-IF-2016-752453-LANDRACES) from the European Union. I. M. gratefully acknowledges support a Marie Sklodowska-Curie Fellowship Grant 'AEGILWHEAT' [H2020-MSCA-IF-2016-746253] from the European Union.	BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Braun H. J., 1998, Proceedings of the Ninth International Wheat Genetics Symposium, Saskatoon, Saskatchewan, Canada, 2-7 August 1998., P33; Burton RA, 2006, SCIENCE, V311, P1940, DOI 10.1126/science.1122975; Burton RA, 2008, PLANT PHYSIOL, V146, P1821, DOI 10.1104/pp.107.114694; Cseh A, 2013, ANN APPL BIOL, V163, P142, DOI 10.1111/aab.12043; Cseh A, 2011, GENOME, V54, P795, DOI 10.1139/g11-044; Danilova TV, 2018, THEOR APPL GENET, V131, P377, DOI 10.1007/s00122-017-3008-z; Darko E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174170; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; DELAHOZ PS, 1992, FEBS LETT, V310, P46, DOI 10.1016/0014-5793(92)81143-A; Diab AA, 2004, THEOR APPL GENET, V109, P1417, DOI 10.1007/s00122-004-1755-0; Friebe B, 2005, CYTOGENET GENOME RES, V109, P293, DOI 10.1159/000082412; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; Ghazali S, 2015, CYTOL GENET+, V49, P378, DOI 10.3103/S0095452715060031; Grewal S, 2018, THEOR APPL GENET, V131, P389, DOI 10.1007/s00122-017-3009-y; HESLOPHARRISON JS, 1991, J CELL SCI, V100, P15; Houston K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-907; Islam A.K.M.R., 1990, BIOTECHNOLOGY AGR FO, V13, P128; Islamovic E, 2013, MOL BREEDING, V31, P15, DOI 10.1007/s11032-012-9764-1; Ivanizs L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198758; Jaradat AA, 2004, CROP SCI, V44, P304, DOI 10.2135/cropsci2004.3040; Kerckhoffs DAJM, 2003, AM J CLIN NUTR, V78, P221, DOI 10.1093/ajcn/78.2.221; King IP, 1997, NEW PHYTOL, V137, P75, DOI 10.1046/j.1469-8137.1997.00828.x; Kleines M, 1999, PLANTA, V209, P13, DOI 10.1007/s004250050602; Koba T, 1997, EUPHYTICA, V96, P289, DOI 10.1023/A:1003081619338; Lang T, 2018, GENOME, V61, P177, DOI 10.1139/gen-2017-0229; Li K, 2016, THEOR APPL GENET, V129, P845, DOI 10.1007/s00122-015-2663-1; Liu WX, 2016, THEOR APPL GENET, V129, P2359, DOI 10.1007/s00122-016-2774-3; Liu WX, 2011, THEOR APPL GENET, V122, P1537, DOI 10.1007/s00122-011-1553-4; Lukaszewski A. J., 1994, P US JAP S CLASS MOL, P136; Lukaszewski AJ, 2004, GENOME, V47, P36, DOI [10.1139/g03-089, 10.1139/G03-089]; LUKASZEWSKI AJ, 1990, CROP SCI, V30, P1151, DOI 10.2135/cropsci1990.0011183X003000050041x; Mantri N, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P1, DOI 10.1007/978-1-4614-0634-1_1; MCCLEARY BV, 1991, J SCI FOOD AGR, V55, P303, DOI 10.1002/jsfa.2740550215; Molina-Cano JL, 2007, MOL BREEDING, V19, P275, DOI 10.1007/s11032-006-9075-5; Molnar-Lang M, 2012, GENOME, V55, P302, DOI [10.1139/G2012-013, 10.1139/g2012-013]; MUNNS R, 1988, AUST J PLANT PHYSIOL, V15, P529, DOI 10.1071/PP9880529; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; Negrao S, 2017, ANN BOT-LONDON, V119, P1, DOI 10.1093/aob/mcw191; Nemeth C, 2010, PLANT PHYSIOL, V152, P1209, DOI 10.1104/pp.109.151712; Pareek A, 2010, PHYSL MOL GENOMIC FD; Rahmatov M, 2016, THEOR APPL GENET, V129, P1383, DOI 10.1007/s00122-016-2710-6; Ramsay L, 2000, GENETICS, V156, P1997; Schlegel R, 1997, PLANT BREEDING, V116, P537, DOI 10.1111/j.1439-0523.1997.tb02186.x; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Shelat KJ, 2010, CARBOHYD POLYM, V82, P46, DOI 10.1016/j.carbpol.2010.04.019; Shu XL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00197; SLAVICH PG, 1990, AUST J EXP AGR, V30, P551, DOI 10.1071/EA9900551; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Taketa S, 2012, J EXP BOT, V63, P381, DOI 10.1093/jxb/err285; Turkosi E, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0393-2; Widodo, 2009, J EXP BOT, V60, P4089, DOI 10.1093/jxb/erp243; Wilson J. K., 2008, THESIS; Wilson SM, 2015, PLANT CELL, V27, P754, DOI 10.1105/tpc.114.135970; Wu HH, 2013, PHYSIOL PLANTARUM, V149, P515, DOI 10.1111/ppl.12056; Zeller FJ, 1983, P 6 INT WHEAT GEN S, P161; Zhao WC, 2010, EUPHYTICA, V175, P343, DOI 10.1007/s10681-010-0177-0; Zhou GF, 2012, MOL BREEDING, V29, P427, DOI 10.1007/s11032-011-9559-9	61	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206248	10.1371/journal.pone.0206248	http://dx.doi.org/10.1371/journal.pone.0206248			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395616	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400018
J	Debowska, M; Poleszczuk, J; Dabrowski, W; Wojcik-Zaluska, A; Zaluska, W; Waniewski, J				Debowska, Malgorzata; Poleszczuk, Jan; Dabrowski, Wojciech; Wojcik-Zaluska, Alicja; Zaluska, Wojciech; Waniewski, Jacek			Impact of hemodialysis on cardiovascular system assessed by pulse wave analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CENTRAL BLOOD-PRESSURE; GENERALIZED TRANSFER-FUNCTION; CHRONIC-RENAL-FAILURE; ARTERIAL STIFFNESS; SUBENDOCARDIAL ISCHEMIA; CENTRAL HEMODYNAMICS; CARDIORENAL SYNDROME; CONSENSUS DOCUMENT; VALIDATION	Valuable information about cardiovascular system can be derived from the shape of aortic pulse wave being the result of reciprocal interaction between heart and vasculature. Pressure profiles in ascending aorta were obtained from peripheral waveforms recorded noninvasively (SphygmoCor, AtCor Medical, Australia) before, during and after hemodialysis sessions performed after 3-day and 2-day interdialytic intervals in 35 anuric, prevalent hemodialysis patients. Fluid status was assessed by Body Composition Monitor (Fresenius Medical Care, Bad Homburg, Germany) and online hematocrit monitoring device (CritLine, HemaMetrics, Utah). Systolic pressure and ejection duration decreased during dialysis. Augmentation index remained stable at 30 +/- 13% throughout hemodialysis session despite the decrease of augmented pressure and pulse height. Subendocardial viability ratio (SEVR) determined after 3-day and 2-day interdialytic intervals increased during the sessions by 43.8 +/- 26.6% and 26.1 +/- 25.4%, respectively. Hemodialysis performed after 3-day and 2-day interdialytic periods reduced significantly overhydration by 2.4 +/- 1.0 L and 1.8 +/- 1.2 L and blood volume by 16.3 +/- 9.7% and 13.7 +/- 8.9%, respectively. Intradialytic increase of SEVR correlated with ultrafiltration rate (R = 0.39, p-value < 0.01), reduction in overhydration (R = -0.57, p-value < 0.001) and blood volume drop (R = -0.38, p-value < 0.01). The strong correlation between the decrease of overhydration during hemodialysis and increase in SEVR confirmed that careful fluid management is crucial for proper cardiac function. Hemodialysis affected cardiovascular system with the parameters derived from pulsewave-analysis (systolic and augmented pressures, pulse height, ejection duration, SEVR) being significantly different at the end of dialysis from those before the session. Combination of pulse-wave-analysis with the monitoring of overhydration provides a new insight into the impact of hemodialysis on cardiovascular system.	[Debowska, Malgorzata; Poleszczuk, Jan; Waniewski, Jacek] Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Dept Math Modeling Physiol Proc, Warsaw, Poland; [Dabrowski, Wojciech] Med Univ Lublin, Dept Anesthesiol & Intens Therapy, Lublin, Poland; [Wojcik-Zaluska, Alicja] Med Univ Lublin, Dept Phys Therapy & Rehabil, Lublin, Poland; [Zaluska, Wojciech] Med Univ Lublin, Dept Nephrol, Lublin, Poland	Polish Academy of Sciences; Nalecz Institute of Biocybernetics & Biomedical Engineering of the Polish Academy of Sciences; Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Debowska, M (corresponding author), Polish Acad Sci, Nalecz Inst Biocybernet & Biomed Engn, Dept Math Modeling Physiol Proc, Warsaw, Poland.	mdebowska@ibib.waw.pl	Stefanadis, Christodoulos/ABH-2232-2020; Dabrowski, Wojciech/AAN-8425-2020; Debowska, Malgorzata/F-3035-2015	Stefanadis, Christodoulos/0000-0001-5974-6454; Dabrowski, Wojciech/0000-0003-0449-2375; Debowska, Malgorzata/0000-0001-8741-7930; Zaluska, Wojciech/0000-0001-6043-3236; Poleszczuk, Jan/0000-0001-8758-7200; Wojcik-Zaluska, Alicja/0000-0001-7971-0141; Jacek, Waniewski/0000-0002-2705-504X	National Science Centre (Poland) [2013/11/B/ST7/01704]	National Science Centre (Poland)	The study was supported by the National Science Centre (Poland, www.ncn.gov.pl), project 2013/11/B/ST7/01704. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Bjallmark A, 2011, HEART VESSELS, V26, P289, DOI 10.1007/s00380-010-0050-z; Borlaug Barry A, 2008, Heart Fail Clin, V4, P23, DOI 10.1016/j.hfc.2007.10.001; Boutouyrie P, 2014, NEPHROL DIAL TRANSPL, V29, P232, DOI 10.1093/ndt/gft309; Buchanan C, 2017, J AM SOC NEPHROL, V28, P1269, DOI 10.1681/ASN.2016060686; BUCKBERG GD, 1972, CIRC RES, V30, P67, DOI 10.1161/01.RES.30.1.67; Burton JO, 2009, CLIN J AM SOC NEPHRO, V4, P914, DOI 10.2215/CJN.03900808; Carlsen RK, 2016, KIDNEY INT, V90, P869, DOI 10.1016/j.kint.2016.05.014; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chen CH, 1997, CIRCULATION, V95, P1827; Covic A, 2005, AM J KIDNEY DIS, V45, P965, DOI 10.1053/j.ajkd.2005.02.026; Covic A, 2000, KIDNEY INT, V57, P2634, DOI 10.1046/j.1523-1755.2000.00124.x; Dasselaar JJ, 2009, NEPHROL DIAL TRANSPL, V24, P604, DOI 10.1093/ndt/gfn501; Davies JI, 2003, J HYPERTENS, V21, P463, DOI 10.1097/00004872-200303000-00004; De Blasio A, 2013, G ITAL NEFROL, V30, P2; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Di Micco L, 2013, BLOOD PURIFICAT, V36, P26, DOI 10.1159/000350582; Frimodt-Moller M, 2008, NEPHROL DIAL TRANSPL, V23, P594, DOI 10.1093/ndt/gfm470; Georgianos PI, 2013, NEPHROL DIAL TRANSPL, V28, P2160, DOI 10.1093/ndt/gft085; Guo JB, 2017, AM J PHYSIOL-HEART C, V313, pH1, DOI 10.1152/ajpheart.00787.2016; Hashimoto J, 2014, TOHOKU J EXP MED, V233, P1, DOI 10.1620/tjem.233.1; HOFFMAN JIE, 1975, BRIT MED J, V1, P76, DOI 10.1136/bmj.1.5949.76; Hoffman JIE, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000285; Hughes Alun D., 2013, PLOS ONE, V8, P1; Karpetas A, 2015, CLIN J AM SOC NEPHRO, V10, P630, DOI 10.2215/CJN.08180814; Koutroumbas G, 2015, NEPHROL DIAL TRANSPL, V30, P2046, DOI 10.1093/ndt/gfv090; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lentner C., 1984, GEIGY SCI TABLES; Locatelli F, 2003, NEPHROL DIAL TRANSPL, V18, P2, DOI 10.1093/ndt/gfg1072; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Loutradis C, 2018, J AM SOC NEPHROL, V29, P1372, DOI 10.1681/ASN.2017101102; Maisel AS, 2011, NEPHROL DIAL TRANSPL, V26, P62, DOI 10.1093/ndt/gfq647; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; Pietribiasi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159748; Poleszczuk J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190972; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Sarafidis PA, 2017, NEPHROL DIAL TRANSPL, V32, P1402, DOI 10.1093/ndt/gfw345; Savage MT, 2002, AM J KIDNEY DIS, V40, P753, DOI 10.1053/ajkd.2002.35686; Savage MT, 2002, CLIN SCI, V103, P59; Sharman JE, 2017, ARTERY RES, V20, P35, DOI 10.1016/j.artres.2017.11.001; Sharman JE, 2006, HYPERTENSION, V47, P1203, DOI 10.1161/01.HYP.0000223013.60612.72; Stenvinkel P, 2010, J INTERN MED, V268, P456, DOI 10.1111/j.1365-2796.2010.02269.x; Stenvinkel P, 2008, CLIN J AM SOC NEPHRO, V3, P505, DOI 10.2215/CJN.03670807; Takahama H, 2017, AM J PHYSIOL-HEART C, V313, pH715, DOI 10.1152/ajpheart.00215.2017; Thomas G, 2018, CLIN J AM SOC NEPHRO, V13, P1124, DOI 10.2215/CJN.12551117; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Townsend RR, 2015, J CLIN HYPERTENS, V17, P503, DOI 10.1111/jch.12574; Tyberg JV, 2013, J PHYSIOL-LONDON, V591, P1171, DOI 10.1113/jphysiol.2012.249557; Vlachopoulos C, 2010, EUR HEART J, V31, P1865, DOI 10.1093/eurheartj/ehq024; WITTKOWSKI KM, 1988, J AM STAT ASSOC, V83, P1163, DOI 10.2307/2290150	50	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206446	10.1371/journal.pone.0206446	http://dx.doi.org/10.1371/journal.pone.0206446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388141	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800032
J	Dou, TH; Coroller, TP; van Griethuysen, JJM; Mak, RH; Aerts, HJWL				Dou, Tai H.; Coroller, Thibaud P.; van Griethuysen, Joost J. M.; Mak, Raymond H.; Aerts, Hugo J. W. L.			Peritumoral radiomics features predict distant metastasis in locally advanced NSCLC	PLOS ONE			English	Article							CELL LUNG-CANCER; EARLY-STAGE; PATHOLOGICAL RESPONSE; TUMOR HETEROGENEITY; AIR SPACES; ADENOCARCINOMA; SIGNATURE; SURVIVAL; TEXTURE; EXTENSION	Purpose Radiomics provides quantitative tissue heterogeneity profiling and is an exciting approach to developing imaging biomarkers in the context of precision medicine. Normal-appearing parenchymal tissues surrounding primary tumors can harbor microscopic disease that leads to increased risk of distant metastasis (DM). This study assesses whether computed-tomography (CT) imaging features of such peritumoral tissues can predict DM in locally advanced non-small cell lung cancer (NSCLC). Material and methods 200 NSCLC patients of histological adenocarcinoma were included in this study. The investigated lung tissues were tumor rim, defined to be 3mm of tumor and parenchymal tissue on either side of the tumor border and the exterior region extended from 3 to 9mm outside of the tumor. Fifteen stable radiomic features were extracted and evaluated from each of these regions on pre-treatment CT images. For comparison, features from expert-delineated tumor contours were similarly prepared. The patient cohort was separated into training and validation datasets for prognostic power evaluation. Both univariable and multivariable analyses were performed for each region using concordance index (CI). Results Univariable analysis reveals that six out of fifteen tumor rim features were significantly prognostic of DM (p-value < 0.05), as were ten features from the visible tumor, and only one of the exterior features was. Multivariablely, a rim radiomic signature achieved the highest prognostic performance in the independent validation sub-cohort (CI = 0.64, p-value = 2.4x10(-5)) significantly over a multivariable clinical model (CI = 0.53), a visible tumor radiomics model (CI = 0.59), or an exterior tissue model (CI = 0.55). Furthermore, patient stratification by the combined rim signature and clinical predictor led to a significant improvement on the clinical predictor alone and also outperformed stratification using the combined tumor signature and clinical predictor. Conclusions We identified peritumoral rim radiomic features significantly associated with DM. This study demonstrated that peritumoral imaging characteristics may provide additional valuable information over the visible tumor features for patient risk stratification due to cancer metastasis.	[Dou, Tai H.; Coroller, Thibaud P.; van Griethuysen, Joost J. M.; Mak, Raymond H.; Aerts, Hugo J. W. L.] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [van Griethuysen, Joost J. M.] Netherlands Canc Inst NKI, Amsterdam, Netherlands	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Netherlands Cancer Institute	Dou, TH (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA.	tdou@partners.org	Aerts, Hugo/ABF-2821-2020	Aerts, Hugo/0000-0002-2122-2003; Mak, Raymond/0000-0002-8754-0565; Coroller, Thibaud/0000-0001-7662-8724	National Cancer Institute (Bethesda, United States) [U24CA194354, U01CA190234]; Dana-Farber Cancer Institute; Kaye Scholar Award; DFCI Clinical-Translational Award; National Institute of Health [NIH-USA U24CA194354, NIH-USA U01CA190234]; NATIONAL CANCER INSTITUTE [U01CA190234, U24CA194354] Funding Source: NIH RePORTER	National Cancer Institute (Bethesda, United States); Dana-Farber Cancer Institute; Kaye Scholar Award; DFCI Clinical-Translational Award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by: the National Cancer Institute (Bethesda, United States) 2015-04 to 2020-03, Grant: U24CA194354 (HA) (https://grants.uberresearch.com/100000054/U24CA194354/Quantitative-Radiomics-System-Decoding-the-Tumor-Phenotype); National Cancer Institute (Bethesda, United States) 2015-01 to 2019-12, Grant: U01CA190234 (HA)(https://grants.uberresearch. com/100000054/U01CA190234/Genotype-and-Imaging-Phenotype-Biomarkers-in-Lung-Cancer); and the Dana-Farber Cancer Institute (HA), the Kaye Scholar Award, and the DFCI Clinical-Translational Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support from National Institute of Health (NIH-USA U24CA194354, and NIH-USA U01CA190234), the Kaye Scholar Award, and the DFCI Clinical-Translational Award.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; American Cancer Society, 2017, SURV RAT NONSM CELL; [Anonymous], 2022, AM CANC SOC; Bae JM, 2017, ONCOTARGET, V8, P523, DOI 10.18632/oncotarget.13476; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Coroller TP, 2017, J THORAC ONCOL, V12, P467, DOI 10.1016/j.jtho.2016.11.2226; Coroller TP, 2016, RADIOTHER ONCOL, V119, P480, DOI 10.1016/j.radonc.2016.04.004; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Craigie M, CLIN RADIOLOGY, V72; Crino L, 2010, ANN ONCOL, V21, pv103, DOI 10.1093/annonc/mdq207; Cunliffe A, 2015, INT J RADIAT ONCOL, V91, P1048, DOI 10.1016/j.ijrobp.2014.11.030; Fried DV, 2014, INT J RADIAT ONCOL, V90, P834, DOI 10.1016/j.ijrobp.2014.07.020; Gamer M, 2012, IRR VARIOUS COEFFICI; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Giraud P, 2000, INT J RADIAT ONCOL, V48, P1015, DOI 10.1016/S0360-3016(00)00750-1; Govindan R, 2008, J THORAC ONCOL, V3, P917, DOI 10.1097/JTO.0b013e318180270b; Grills IS, 2007, INT J RADIAT ONCOL, V69, P334, DOI 10.1016/j.ijrobp.2007.03.023; Grossmann P, 2017, ELIFE, V6, DOI 10.7554/eLife.23421; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang YQ, 2016, RADIOLOGY, V281, P947, DOI 10.1148/radiol.2016152234; Huynh E, 2016, RADIOTHER ONCOL, V120, P258, DOI 10.1016/j.radonc.2016.05.024; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kadota K, 2015, CHEST, V148, P711, DOI 10.1378/chest.14-3005; Kadota K, 2015, J THORAC ONCOL, V10, P806, DOI 10.1097/JTO.0000000000000486; Koukourakis MI, 2000, CANCER RES, V60, P3088; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Leijenaar RTH, 2015, ACTA ONCOL, V54, P1423, DOI 10.3109/0284186X.2015.1061214; Lowekamp BC, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00045; Mahmood MQ, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0900-y; Matsumura Y, 2012, CANCER SCI, V103, P1342, DOI 10.1111/j.1349-7006.2012.02275.x; Onozato ML, 2013, AM J SURG PATHOL, V37, P287, DOI 10.1097/PAS.0b013e31826885fb; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Saijo T, 2007, LUNG CANCER, V55, P61, DOI 10.1016/j.lungcan.2006.09.027; Schroder MS, 2011, BIOINFORMATICS, V27, P3206, DOI 10.1093/bioinformatics/btr511; Shimada Y, 2010, J THORAC ONCOL, V5, P970, DOI 10.1097/JTO.0b013e3181dd1803; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Team RDC, 2010, R LANG ENV STAT COMP; Uruga H, 2017, J THORAC ONCOL, V12, P1046, DOI 10.1016/j.jtho.2017.03.019; van Griethuysen JJM, 2017, CANCER RES, V77, pE104, DOI 10.1158/0008-5472.CAN-17-0339; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307; Wu J, 2016, RADIOLOGY, V281, P270, DOI 10.1148/radiol.2016151829; Yamaguchi Y, 2010, J THORAC ONCOL, V5, P1361, DOI 10.1097/JTO.0b013e3181eaf2f3; Yip SSF, 2017, J NUCL MED, V58, P569, DOI 10.2967/jnumed.116.181826; Zhang B, 2017, CLIN CANCER RES, V23, P4259, DOI 10.1158/1078-0432.CCR-16-2910; Zhao BS, 2009, RADIOLOGY, V252, P263, DOI 10.1148/radiol.2522081593	54	70	71	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206108	10.1371/journal.pone.0206108	http://dx.doi.org/10.1371/journal.pone.0206108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388114	Green Published			2022-12-26	WOS:000449289800021
J	Fuelkell, P; Langner, S; Friedrich, N; Kromrey, ML; Radosa, CG; Platzek, I; Mensel, B; Kuhn, JP				Fuelkell, Philipp; Langner, Soenke; Friedrich, Nele; Kromrey, Marie-Luise; Radosa, Christoph G.; Platzek, Ivan; Mensel, Birger; Kuehn, Jens-Peter			Software-based noise reduction in cranial magnetic resonance imaging: Influence on image quality	PLOS ONE			English	Article							ACOUSTIC-NOISE; HEARING-LOSS; MRI; SCAN	Objectives To investigate acoustic noise reduction, image quality and white matter lesion detection rates of cranial magnetic resonance imaging (MRI) scans acquired with and without sequence-based acoustic noise reduction software. Material and methods Thirty-one patients, including 18 men and 13 women, with a mean age of 58.3 +/- 14.5 years underwent cranial MRI. A fluid-attenuated inversion recovery (FLAIR) sequence was acquired with and without acoustic noise reduction using the Quiet Suite (QS) software (Siemens Healthcare). During data acquisition, peak sound pressure levels were measured with a sound level meter (Testo, Typ 815). In addition, two observers assessed subjective image quality for both sequences using a five-point scale (1 very good-5 inadequate). Signal-to-noise ratio (SNR) was measured for both sequences in the following regions: white matter, gray matter, and cerebrospinal fluid. Furthermore, lesion detection rates in white matter pathologies were evaluated by two observers for both sequences. Acoustic noise, image quality including SNR and white matter lesion detection rates were compared using the Mann-Whitney-U-test. Results Peak sound pressure levels were slightly but significantly reduced using QS, P <= 0.017. Effective sound pressure, measured in Pascal, was decreased by 19.7%. There was no significant difference in subjective image quality between FLAIR sequences acquired without/with QS: observer 1: 2.03/2.07, P = 0.730; observer 2: 1.98/2.10, P = 0.362. In addition, SNR was significantly increased in white matter, P <= 0.001, and gray matter, P = 0.006, using QS. The lesion detection rates did not decline utilizing QS: observer 1: P = 0.944 observer 2: P = 0.952. Conclusions Sequence-based noise reduction software such as QS can significantly reduce peak sound pressure levels, without a loss of subjective image quality and increase SNR at constant lesion detection rates.	[Fuelkell, Philipp; Kromrey, Marie-Luise; Mensel, Birger; Kuehn, Jens-Peter] Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Langner, Soenke] Univ Med Rostock, Dept Radiol, Rostock, Germany; [Friedrich, Nele] Univ Med Greifswald, Dept Lab Med, Greifswald, Germany; [Radosa, Christoph G.; Platzek, Ivan; Kuehn, Jens-Peter] Carl Gustav Carus Univ, Clin & Policlin Radiol & Intervent Radiol, Dresden, Germany	Greifswald Medical School; University of Rostock; Greifswald Medical School; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Kuhn, JP (corresponding author), Univ Med Greifswald, Dept Diagnost Radiol & Neuroradiol, Greifswald, Germany.; Kuhn, JP (corresponding author), Carl Gustav Carus Univ, Clin & Policlin Radiol & Intervent Radiol, Dresden, Germany.	jens-peter.kuehn@uniklinikum-dresden.de	Radosa, Christoph/AFT-9924-2022; Platzek, Ivan/AAZ-8124-2020; Langner, Soenke/ABB-6744-2021	Radosa, Christoph/0000-0002-1127-4408; Platzek, Ivan/0000-0002-5933-8108; Langner, Soenke/0000-0001-7241-1173				Alibek S, 2014, DIAGN INTERV RADIOL, V20, P360, DOI 10.5152/dir.2014.13458; Baker MA, 2013, RADIOGRAPHY, V19, P11, DOI 10.1016/j.radi.2012.09.004; BRUMMETT RE, 1988, RADIOLOGY, V169, P539, DOI 10.1148/radiology.169.2.3175004; Cho ZH, 1998, MAGN RESON MED, V39, P317, DOI 10.1002/mrm.1910390221; Corcuera-Solano I, 2015, AM J NEURORADIOL, V36, P1124, DOI 10.3174/ajnr.A4235; de Zwart JA, 2002, NEUROIMAGE, V16, P1151, DOI 10.1006/nimg.2002.1119; Edelstein WA, 2005, MAGN RESON MED, V53, P1013, DOI 10.1002/mrm.20472; Edelstein WA, 2002, MAGN RESON IMAGING, V20, P155, DOI 10.1016/S0730-725X(02)00475-7; Fischer S, 2017, RADIOL MED, V122, P194, DOI 10.1007/s11547-016-0710-x; Goerner FL, 2011, MED PHYS, V38, P5049, DOI 10.1118/1.3618730; Grodzki DM, 2012, MAGN RESON MED, V67, P510, DOI 10.1002/mrm.23017; Hamernik RP, 2003, J ACOUST SOC AM, V114, P386, DOI 10.1121/1.1582446; Heismann B, 2015, MAGN RESON MED, V73, P1104, DOI 10.1002/mrm.25229; Hennel F, 1999, MAGNET RESON MED, V42, P6, DOI 10.1002/(SICI)1522-2594(199907)42:1<6::AID-MRM2>3.0.CO;2-D; Hoiting GJ, 2005, MEASURING MRI NOISE; Ireland CM, 2015, CONCEPT MAGN RESON B, V45, P107, DOI 10.1002/cmr.b.21287; Jin C, 2018, RADIOLOGY, V286, P602, DOI 10.1148/radiol.2017161622; Katsunuma A, 2002, MAGN RESON MATER PHY, V13, P139, DOI 10.1016/S1352-8661(01)00142-9; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Mansfield P, 2001, MAGNET RESON MED, V46, P807, DOI 10.1002/mrm.1261; McJury M, 2000, J MAGN RESON IMAGING, V12, P37, DOI 10.1002/1522-2586(200007)12:1<37::AID-JMRI5>3.0.CO;2-I; Ott M, 2015, ACOUSTIC NOISE REDUC; Ott M, 2016, MAGN RESON MATER PHY, V29, P5, DOI 10.1007/s10334-015-0502-7; Ott M, 2015, MAGN RESON MATER PHY, V28, P511, DOI 10.1007/s10334-015-0492-5; Pierre EY, 2014, INVEST RADIOL, V49, P620, DOI 10.1097/RLI.0000000000000062; Pierre EY, MAKING MRI SCANNING; Price DL, 2001, J MAGN RESON IMAGING, V13, P288, DOI 10.1002/1522-2586(200102)13:2<288::AID-JMRI1041>3.0.CO;2-P; QUIRK ME, 1989, RADIOLOGY, V173, P759, DOI 10.1148/radiology.173.3.2682775; Setsompop K, 2012, MAGN RESON MED, V67, P1210, DOI 10.1002/mrm.23097; Sinkkila L, 2008, IFMBE PROC, V20, P327	30	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206196	10.1371/journal.pone.0206196	http://dx.doi.org/10.1371/journal.pone.0206196			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383774	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600031
J	Yagi, M; Nakatsuji, Y; Maeda, A; Ota, H; Kamikubo, R; Miyoshi, N; Nakamura, Y; Akagawa, M				Yagi, Miho; Nakatsuji, Yukiko; Maeda, Ayumi; Ota, Hiroki; Kamikubo, Ryosuke; Miyoshi, Noriyuki; Nakamura, Yoshimasa; Akagawa, Mitsugu			Phenethyl isothiocyanate activates leptin signaling and decreases food intake	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE 1B; GROWTH-FACTOR RECEPTOR; HUMAN HEPG2 HEPATOCYTES; DIABETIC KK-A(Y) MICE; COLON-CANCER CELLS; PYRROLOQUINOLINE QUINONE; DIETARY ISOTHIOCYANATES; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; C2C12 MYOTUBES	Obesity, a principal risk factor for the development of diabetes mellitus, heart disease, and hypertension, is a growing and serious health problem all over the world. Leptin is a weight-reducing hormone produced by adipose tissue, which decreases food intake via hypothalamic leptin receptors (Ob-Rb) and the Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway. Protein tyrosine phosphatase 1B (PTP1B) negatively regulates leptin signaling by dephosphorylating JAK2, and the increased activity of PTP1B is implicated in the pathogenesis of obesity. Hence, inhibition of PTP1B may help prevent and reduce obesity. In this study, we revealed that phenethyl isothiocyanate (PEITC), a naturally occurring isothiocyanate in certain cruciferous vegetables, potently inhibits recombinant PTP1B by binding to the reactive cysteinyl thiol. Moreover, we found that PEITC causes the ligand-independent phosphorylation of Ob-Rb, JAK2, and STAT3 by inhibiting cellular PTP1B in differentiated human SH-SY5Y neuronal cells. PEITC treatment also induced nuclear accumulation of phosphorylated STAT3, resulting in enhanced anorexigenic POMC expression and suppressed orexigenic NPY/AGRP expression. We demonstrated that oral administration of PEITC to mice significantly reduces food intake, and stimulates hypothalamic leptin signaling. Our results suggest that PEITC might help prevent and improve obesity.	[Yagi, Miho; Nakatsuji, Yukiko; Maeda, Ayumi; Ota, Hiroki; Kamikubo, Ryosuke; Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka, Japan; [Miyoshi, Noriyuki] Univ Shizuoka, Grad Sch Integrated Pharmaceut & Nutr Sci, Shizuoka, Japan; [Nakamura, Yoshimasa] Okayama Univ, Grad Sch Environm & Life Sci, Okayama, Japan; [Maeda, Ayumi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo, Japan; [Kamikubo, Ryosuke] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Food Chem, Tokyo, Japan	Osaka Metropolitan University; University of Shizuoka; Okayama University; Kobe University; University of Tokyo	Akagawa, M (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Sakai, Osaka, Japan.	akagawa@biochem.osakafu-u.ac.jp	Miyoshi, Noriyuki/F-4554-2010	Miyoshi, Noriyuki/0000-0002-4233-4282	JSPS KAKENHI [JP16K00859]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP16K00859 (M.A.).	Aragones G, 2016, MOL NUTR FOOD RES, V60, P1789, DOI 10.1002/mnfr.201500964; Bakke J, 2015, SEMIN CELL DEV BIOL, V37, P58, DOI 10.1016/j.semcdb.2014.09.020; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Benomar Y, 2005, BIOCHEM J, V388, P929, DOI 10.1042/BJ20041621; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Boivin B, 2008, P NATL ACAD SCI USA, V105, P9959, DOI 10.1073/pnas.0804336105; Burdick AD, 2003, CANCER RES, V63, P7825; Carbone CJ, 2012, P NATL ACAD SCI USA, V109, P19226, DOI 10.1073/pnas.1211491109; Cheng A, 2002, DEV CELL, V2, P497, DOI 10.1016/S1534-5807(02)00149-1; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; CHUNG FL, 1992, CANCER EPIDEM BIOMAR, V1, P383; Conaway CC, 1999, DRUG METAB DISPOS, V27, P13; Cook WS, 2002, DEV CELL, V2, P385, DOI 10.1016/S1534-5807(02)00158-2; Cross JV, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-183; Cui HX, 2017, NAT REV ENDOCRINOL, V13, P338, DOI 10.1038/nrendo.2016.222; Dadke Shrikrishna, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P299; Dinkova-Kostova AT, 2013, TOP CURR CHEM, V329, P179, DOI 10.1007/128_2012_337; Dube N, 2005, BBA-PROTEINS PROTEOM, V1754, P108, DOI 10.1016/j.bbapap.2005.07.030; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fu CH, 2016, J AGR FOOD CHEM, V64, P9571, DOI 10.1021/acs.jafc.6b04468; Gupta P, 2014, BBA-REV CANCER, V1846, P405, DOI 10.1016/j.bbcan.2014.08.003; Gupta P, 2014, MOL NUTR FOOD RES, V58, P1685, DOI 10.1002/mnfr.201300684; Ishii M, 2015, ARCH BIOCHEM BIOPHYS, V566, P26, DOI 10.1016/j.abb.2014.12.009; Iwamoto N, 2007, J BIOL CHEM, V282, P33396, DOI 10.1074/jbc.M705224200; Ji Y, 2003, ANAL BIOCHEM, V323, P39, DOI 10.1016/j.ab.2003.08.011; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Kamikubo R, 2016, MOL NUTR FOOD RES, V60, P2228, DOI 10.1002/mnfr.201600197; Kaszubska W, 2002, MOL CELL ENDOCRINOL, V195, P109, DOI 10.1016/S0303-7207(02)00178-8; Keum YS, 2004, MUTAT RES-FUND MOL M, V555, P191, DOI 10.1016/j.mrfmmm.2004.05.024; Kimura K, 2012, FREE RADICAL BIO MED, V53, P1239, DOI 10.1016/j.freeradbiomed.2012.07.015; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kumari V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163821; Lewis SM, 2015, BIOORG MED CHEM LETT, V25, P4549, DOI 10.1016/j.bmcl.2015.08.065; Lin RK, 2011, J BIOL CHEM, V286, P33591, DOI 10.1074/jbc.M111.258137; Liu Haibo, 2011, Wei Sheng Yan Jiu, V40, P283; Liu XY, 2017, BIOCHEM BIOPH RES CO, V491, P209, DOI 10.1016/j.bbrc.2017.07.078; Maeda A, 2014, MOL NUTR FOOD RES, V58, P1177, DOI 10.1002/mnfr.201300675; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; MAURO LJ, 1994, TRENDS BIOCHEM SCI, V19, P151, DOI 10.1016/0968-0004(94)90274-7; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Miyoshi N, 2012, ANAL BIOCHEM, V429, P124, DOI 10.1016/j.ab.2012.07.018; Morris DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE1247, DOI 10.1152/ajpendo.00274.2009; Morrison CD, 2007, ENDOCRINOLOGY, V148, P433, DOI 10.1210/en.2006-0672; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; Nakamura T, 2018, J CLIN BIOCHEM NUTR, V62, P11, DOI 10.3164/jcbn.17-91; Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6; Peninsula K, 2010, J CLIN INVEST, V126, P4727, DOI [10.1172/JCI91578, DOI 10.1172/JCI91578]; Picardi PK, 2008, ENDOCRINOLOGY, V149, P3870, DOI 10.1210/en.2007-1506; Popov D, 2011, BIOCHEM BIOPH RES CO, V410, P377, DOI 10.1016/j.bbrc.2011.06.009; Shibata T, 2011, J BIOL CHEM, V286, P42150, DOI 10.1074/jbc.M111.308049; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Swart I, 2002, AM J PHYSIOL-REG I, V283, pR1020, DOI 10.1152/ajpregu.00501.2001; Takada M, 2012, BIOCHEM BIOPH RES CO, V428, P315, DOI 10.1016/j.bbrc.2012.10.055; Talalay P, 2001, J NUTR, V131, p3027S, DOI 10.1093/jn/131.11.3027S; Ungureanu D, 2011, NAT STRUCT MOL BIOL, V18, P971, DOI 10.1038/nsmb.2099; White CL, 2009, AM J PHYSIOL-ENDOC M, V296, pE291, DOI 10.1152/ajpendo.90513.2008; Yip SC, 2010, TRENDS BIOCHEM SCI, V35, P442, DOI 10.1016/j.tibs.2010.03.004; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zabolotny JM, 2002, DEV CELL, V2, P489, DOI 10.1016/S1534-5807(02)00148-X; Zhang ZY, 2015, TRENDS PHARMACOL SCI, V36, P661, DOI 10.1016/j.tips.2015.07.003; Zhou YJ, 2013, FRONT MED-PRC, V7, P207, DOI 10.1007/s11684-013-0263-5	61	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206748	10.1371/journal.pone.0206748	http://dx.doi.org/10.1371/journal.pone.0206748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383868	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600092
J	Zhu, FX; Yi, G; Liu, X; Zhu, FM; Zhao, AN; Wang, AT; Zhu, RH; Chen, ZJ; Zhao, BB; Fang, SJ; Yu, X; Lin, RR; Liang, R; Li, D; Zhao, WY; Zhang, ZZ; Guo, WZ; Zhang, SJ; Ge, SF; Fan, XQ; Zhao, G; Li, B				Zhu, Fuxiang; Yi, Gang; Liu, Xu; Zhu, Fangming; Zhao, Anna; Wang, Aiting; Zhu, Ruihong; Chen, Zuojia; Zhao, Binbin; Fang, Sijie; Yu, Xiao; Lin, Ruirong; Liang, Rui; Li, Dan; Zhao, Wenyi; Zhang, Zizhen; Guo, Wenzhi; Zhang, Shuijun; Ge, Shengfang; Fan, Xianqun; Zhao, Gang; Li, Bin			Ring finger protein 31-mediated atypical ubiquitination stabilizes forkhead box P3 and thereby stimulates regulatory T-cell function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						forkhead box P3 (FOXP3); T-cell; gastric cancer; immunosuppression; protein stability; human regulatory T cells; multi-monoubiquitination; Positive regulator; RNF31	NF-KAPPA-B; TRANSCRIPTION FACTOR FOXP3; LUBAC; ACTIVATION; EXPRESSION; COMPLEX; GENE; INFLAMMATION; INSTABILITY; GENERATION	The CD4(+)CD25(+)FOXP3(+) regulatory T (Treg) cells are critical for maintaining immune tolerance in healthy individuals and are reported to restrict anti-inflammatory responses and thereby promote tumor progression, suggesting them as a target in the development of antitumor immunotherapy. Forkhead box P3 (FOXP3) is a key transcription factor governing Treg lineage differentiation and their immune-suppressive function. Here, using Treg cells, as well as HEK-293T and Jurkat T cells, we report that the stability of FOXP3 is directly and positively regulated by the E3 ubiquitin ligase ring finger protein 31 (RNF31), which catalyzes the conjugation of atypical ubiquitin chains to the FOXP3 protein. We observed that shRNA-mediated RNF31 knockdown in human Treg cells decreases FOXP3 protein levels and increases levels of interferon-, resulting in a Th1 helper cell-like phenotype. Human Treg cells that ectopically expressed RNF31 displayed stronger immune-suppressive capacity, suggesting that RNF31 positively regulates both FOXP3 stability and Treg cell function. Moreover, we found that RNF31 is up-regulated in Treg cells that infiltrate human gastric tumor tissues compared with their counterparts residing in peripheral and normal tissue. We also found that elevated RNF31 expression in intratumoral Treg cells is associated with poor survival of gastric cancer patients, suggesting that RNF31 supports the immune-suppressive functions of Treg cells. Our results suggest that RNF31 could be a potential therapeutic target in immunity-based interventions against human gastric cancer.	[Zhu, Fuxiang; Yi, Gang; Zhao, Anna; Wang, Aiting; Zhao, Binbin; Liang, Rui; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai 200025, Peoples R China; [Zhu, Fuxiang; Yi, Gang; Zhao, Anna; Wang, Aiting; Zhao, Binbin; Liang, Rui; Li, Dan; Li, Bin] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai 200025, Peoples R China; [Zhu, Fuxiang; Wang, Aiting; Zhu, Ruihong; Chen, Zuojia; Zhao, Binbin] Univ Chinese Acad Sci, Inst Pasteur Shanghai, Unit Mol Immunol, Shanghai 200025, Peoples R China; [Yi, Gang; Zhu, Fangming] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai 200025, Peoples R China; [Liu, Xu; Zhao, Wenyi; Zhang, Zizhen; Zhao, Gang] Shanghai Jiao Tong Univ, Sch Med, RenJi Hosp, Dept Gastrointestinal Surg, Shanghai 200025, Peoples R China; [Fang, Sijie; Ge, Shengfang; Fan, Xianqun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Ophthalmol, Shanghai 200025, Peoples R China; [Yu, Xiao; Guo, Wenzhi; Zhang, Shuijun] Zhengzhou Univ, Henan Key Lab Digest Organ Transplantat, Affiliated Hosp 1, Dept Hepatobiliary & Pancreat Surg, Zhengzhou 450052, Henan, Peoples R China; [Lin, Ruirong] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Shanghai University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhengzhou University; Shanghai Jiao Tong University	Zhao, G (corresponding author), 160 Pujian Rd, Shanghai 200127, Peoples R China.; Li, B (corresponding author), 280 South Chongqing Rd, Shanghai 200026, Peoples R China.	Zhaogang74313@126.com; binli@shsmu.edu.cn	Fang, Sijie/AAD-5505-2019; Chen, Zuojia/AAM-9465-2020; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884	National Natural Science Foundation of China [NSFC 31525008, 81330072, 3187050011, 31670911, 31370863]; Science and Technology Commission of Shanghai Municipality (SMCST) [14JC1406100]; Shanghai Academic Research Leader [16XD1403800]; National Institutes of Health NSFC collaborative Grant [81161120417]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (SMCST); Shanghai Academic Research Leader; National Institutes of Health NSFC collaborative Grant	This work was supported by National Natural Science Foundation of China NSFC 31525008, 81330072, 3187050011, 31670911, and 31370863, Science and Technology Commission of Shanghai Municipality (SMCST) Grant 14JC1406100, Shanghai Academic Research Leader Grant 16XD1403800, and National Institutes of Health NSFC collaborative Grant 81161120417. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Cho JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13373; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Dubois SM, 2014, BLOOD, V123, P2199, DOI 10.1182/blood-2013-05-504019; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Gao YY, 2015, P NATL ACAD SCI USA, V112, pE3246, DOI 10.1073/pnas.1421463112; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jana S, 2009, EUR J IMMUNOL, V39, P2571, DOI 10.1002/eji.200939201; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kindlund B, 2017, GASTRIC CANCER, V20, P116, DOI 10.1007/s10120-015-0591-z; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li YY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13559; Luo XR, 2015, J BIOL CHEM, V290, P28675, DOI 10.1074/jbc.M115.661611; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Overacre-Delgoffe AE, 2017, CELL, V169, P1130, DOI 10.1016/j.cell.2017.05.005; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Rodgers MA, 2014, J EXP MED, V211, P1331, DOI 10.1084/jem.20132486; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Smit JJ, 2012, EMBO J, V31, P3833, DOI 10.1038/emboj.2012.217; Stieglitz B, 2012, EMBO REP, V13, P840, DOI 10.1038/embor.2012.105; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wang XW, 2015, J BIOL CHEM, V290, P29086, DOI 10.1074/jbc.M115.664573; Wei TF, 2015, AM J CANCER RES, V5, P2190; Zeng H, 2008, J BIOL CHEM, V283, P24392, DOI 10.1074/jbc.M802344200; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zhu J, 2014, ONCOGENE, V33, P4340, DOI 10.1038/onc.2013.573; Zinngrebe J, 2016, J EXP MED, V213, P2671, DOI 10.1084/jem.20160041	41	28	30	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20099	20111		10.1074/jbc.RA118.005802	http://dx.doi.org/10.1074/jbc.RA118.005802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30389786	Green Published, hybrid			2022-12-26	WOS:000454685900019
J	Holiga, S; Sambataro, F; Luzy, C; Greig, G; Sarkar, N; Renken, RJ; Marsman, JBC; Schobel, SA; Bertolino, A; Dukart, J				Holiga, Stefan; Sambataro, Fabio; Luzy, Cecile; Greig, Gerard; Sarkar, Neena; Renken, Remco J.; Marsman, Jan-Bernard C.; Schobel, Scott A.; Bertolino, Alessandro; Dukart, Juergen			Test-retest reliability of task-based and resting-state blood oxygen level dependence and cerebral blood flow measures	PLOS ONE			English	Article							FUNCTIONAL MRI; PHARMACOLOGICAL MRI; FMRI; BOLD; CBF; CONNECTIVITY; ACTIVATION	Despite their wide-spread use, only limited information is available on the comparative test-retest reliability of task-based functional and resting state magnetic resonance imaging measures of blood oxygen level dependence (tb-fMRI and rs-fMRI) and cerebral blood flow (CBF) using arterial spin labeling. This information is critical to designing properly powered longitudinal studies. Here we comprehensively quantified and compared the test-retest reliability and reproducibility performance of 8 commonly applied fMRI tasks, 6 rs-fMRI metrics and CBF in 30 healthy volunteers. We find large variability in test-retest reliability performance across the different tb-fMRI paradigms and rs-fMRI metrics, ranging from poor to excellent. A larger extent of activation in tb-fMRI is linked to higher between-subject reliability of the respective task suggesting that differences in the amount of activation may be used as a first reliability estimate of novel tb-fMRI paradigms. For rs-fMRI, a good reliability of local activity estimates is paralleled by poor performance of global connectivity metrics. Evaluated CBF measures provide in general a good to excellent test-reliability matching or surpassing the best performing tb-fMRI and rs-fMRI metrics. This comprehensive effort allows for direct comparisons of test-retest reliability between the evaluated MRI domains and measures to aid the design of future tb-fMRI, rs-fMRI and CBF studies.	[Holiga, Stefan; Sambataro, Fabio; Luzy, Cecile; Greig, Gerard; Sarkar, Neena; Schobel, Scott A.; Bertolino, Alessandro; Dukart, Juergen] F Hoffmann La Roche Ltd, Roche Pharma & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland; [Sambataro, Fabio] Univ Udine, Dept Expt & Clin Med Sci, Piazzale Massimiliano Kolbe 3, Udine, Italy; [Renken, Remco J.; Marsman, Jan-Bernard C.] Univ Med Ctr Groningen, Sect Neuroimaging Ctr, Dept Neurosci, Antonius Deusinglaan 1, Groningen, Netherlands; [Bertolino, Alessandro] Bari Univ Hosp, Psychiat Unit, Bari, Italy	Roche Holding; University of Udine; University of Groningen; Universita degli Studi di Bari Aldo Moro	Dukart, J (corresponding author), F Hoffmann La Roche Ltd, Roche Pharma & Early Dev, Roche Innovat Ctr Basel, Basel, Switzerland.	juergen.dukart@gmail.com		Dukart, Juergen/0000-0003-0492-5644; Renken, Remco Jan/0000-0002-7777-9484	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	SH, FS, CL, GG, NS SAS, AB and JD are current or former full-time employees of F. Hoffmann-La Roche, Basel Switzerland. The authors received no specific funding for this work. F. Hoffmann-La Roche provided financial contribution in the form of salary for all authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027; Braun U, 2012, NEUROIMAGE, V59, P1404, DOI 10.1016/j.neuroimage.2011.08.044; Bruns A, 2015, NEUROIMAGE, V112, P70, DOI 10.1016/j.neuroimage.2015.02.032; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Chen YF, 2011, J MAGN RESON IMAGING, V33, P940, DOI 10.1002/jmri.22345; Chen YF, 2009, NEUROIMAGE, V46, P577, DOI 10.1016/j.neuroimage.2009.03.012; Cicchetti DV, 1981, AM J MENT DEFIC; De Simoni S, 2013, NEUROIMAGE, V64, P75, DOI 10.1016/j.neuroimage.2012.09.037; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Fazlollahi A, 2015, NEUROIMAGE, V117, P191, DOI 10.1016/j.neuroimage.2015.05.048; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Friedman L, 2008, HUM BRAIN MAPP, V29, P958, DOI 10.1002/hbm.20440; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gianaros PJ, 2004, PSYCHOPHYSIOLOGY, V41, P521, DOI 10.1111/1469-8986.2004.00179.x; Handley R, 2013, HUM BRAIN MAPP, V34, P272, DOI 10.1002/hbm.21436; Jann K, 2015, NEUROIMAGE, V106, P111, DOI 10.1016/j.neuroimage.2014.11.028; Kanyongo GY, 2007, J MOD APPL STAT METH, V6, P81, DOI 10.22237/jmasm/1177992480; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Klomp A, 2013, NEUROIMAGE, V75, P108, DOI 10.1016/j.neuroimage.2013.03.002; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Manoach DS, 2001, AM J PSYCHIAT, V158, P955, DOI 10.1176/appi.ajp.158.6.955; Matthews PM, 2006, NAT REV NEUROSCI, V7, P732, DOI 10.1038/nrn1929; Maxim V, 2005, NEUROIMAGE, V25, P141, DOI 10.1016/j.neuroimage.2004.10.044; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Newberg AB, 2005, NEUROIMAGE, V28, P500, DOI 10.1016/j.neuroimage.2005.06.040; Plichta MM, 2012, NEUROIMAGE, V60, P1746, DOI 10.1016/j.neuroimage.2012.01.129; Schwarz AJ, 2011, NEUROIMAGE, V55, P1132, DOI 10.1016/j.neuroimage.2010.12.047; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Tancredi FB, 2015, J MAGN RESON IMAGING, V42, P1144, DOI 10.1002/jmri.24878; Telesford Qawi K, 2010, Front Neuroinform, V4, P117, DOI 10.3389/fninf.2010.00117; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WILLIAMS EJ, 1949, AUST J SCI RES SER A, V2, P149, DOI 10.1071/CH9490149; Wink AM, 2012, BRAIN CONNECT, V2, P265, DOI 10.1089/brain.2012.0087; Yan CG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00910; Zou QH, 2015, NEUROIMAGE, V121, P91, DOI 10.1016/j.neuroimage.2015.07.044	44	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206583	10.1371/journal.pone.0206583	http://dx.doi.org/10.1371/journal.pone.0206583			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408072	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300026
J	Page, M; Ridge, L; Diaz, DG; Tsogbayar, T; Scambler, PJ; Ivins, S				Page, Mahalia; Ridge, Liam; Diaz, Diana Gold; Tsogbayar, Tsolmon; Scambler, Peter J.; Ivins, Sarah			Loss of CXCL12/CXCR4 signalling impacts several aspects of cardiovascular development but does not exacerbate Tbx1 haploinsufficiency	PLOS ONE			English	Article							CREST CELL-MIGRATION; CHEMOKINE RECEPTOR CXCR4; NEURAL CREST; OUTFLOW TRACT; EXPRESSION; DIGEORGE; PAX3; DEFECTS; GENE; MICE	The CXCL12-CXCR4 pathway has crucial roles in stem cell homing and maintenance, neuronal guidance, cancer progression, inflammation, remote-conditioning, cell migration and development. Recently, work in chick suggested that signalling via CXCR4 in neural crest cells (NCCs) has a role in the 22q11.2 deletion syndrome (22q11.2DS), a disorder where haploinsufficiency of the transcription factor TBX1 is responsible for the major structural defects. We tested this idea in mouse models. Our analysis of genes with altered expression in Tbx1 mutant mouse models showed down-regulation of Cxcl12 in pharyngeal surface ectoderm and rostral mesoderm, both tissues with the potential to signal to migrating NCCs. Conditional mutagenesis of Tbx1 in the pharyngeal surface ectoderm is associated with hypo/aplasia of the 4th pharyngeal arch artery (PAA) and interruption of the aortic arch type B (IAA-B), the cardiovascular defect most typical of 22q11.2DS. We therefore analysed constitutive mouse mutants of the ligand (CXCL12) and receptor (CXCR4) components of the pathway, in addition to ectodermal conditionals of Cxcl12 and NCC conditionals of Cxcr4. However, none of these typical 22q11.2DS features were detected in constitutively or conditionally mutant embryos. Instead, duplicated carotid arteries were observed, a phenotype recapitulated in Tie-2Cre (endothelial) conditional knock outs of Cxcr4. Previous studies have demonstrated genetic interaction between signalling pathways and Tbx1 haploinsufficiency e.g. FGF, WNT, SMAD-dependent. We therefore tested for possible epistasis between Tbx1 and the CXCL12 signalling axis by examining Tbx1 and Cxcl12 double heterozygotes as well as Tbx1/Cxcl12/Cxcr4 triple heterozygotes, but failed to identify any exacerbation of the Tbx1 haploinsufficient arch artery phenotype. We conclude that CXCL12 signalling via NCC/CXCR4 has no major role in the genesis of the Tbx1 loss of function phenotype. Instead, the pathway has a distinct effect on remodelling of head vessels and interventricular septation mediated via CXCL12 signalling from the pharyngeal surface ectoderm and second heart field to endothelial cells.	[Page, Mahalia; Ridge, Liam; Diaz, Diana Gold; Tsogbayar, Tsolmon; Scambler, Peter J.; Ivins, Sarah] UCL Inst Child Hlth, Dev Biol Birth Defects, London, England	University of London; University College London	Ivins, S (corresponding author), UCL Inst Child Hlth, Dev Biol Birth Defects, London, England.	s.ivins@ucl.ac.uk	Scambler, Peter/AAZ-6026-2020	Scambler, Peter/0000-0002-1487-4628; Ridge, Liam/0000-0002-7210-9596	British Heart Foundation [RG/15/14/31880, PG/14/35/30837]	British Heart Foundation(British Heart Foundation)	This work was funded by grants RG/15/14/31880, and PG/14/35/30837 awarded to Peter J. Scambler by the British Heart Foundation; https://www.bhf.org.uk/research.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590; Bonnard C, 2012, NAT GENET, V44, P709, DOI 10.1038/ng.2259; Calmont A, 2009, DEVELOPMENT, V136, P3173, DOI 10.1242/dev.028902; Cavallero S, 2015, DEV CELL, V33, P469, DOI 10.1016/j.devcel.2015.03.018; Chen L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002571; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dilg D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161096; Dona E, 2013, NATURE, V503, P285, DOI 10.1038/nature12635; Engleka KA, 2005, DEV BIOL, V280, P396, DOI 10.1016/j.ydbio.2005.02.002; Escot S, 2016, DEVELOPMENT, V143, P582, DOI 10.1242/dev.126573; Escot S, 2013, CIRC RES, V113, P505, DOI 10.1161/CIRCRESAHA.113.301333; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Ivins S, 2016, JOVE-J VIS EXP, DOI 10.3791/54800; Ivins S, 2015, DEV CELL, V33, P455, DOI 10.1016/j.devcel.2015.03.026; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Kau Thomas, 2007, Semin Intervent Radiol, V24, P141, DOI 10.1055/s-2007-980040; Killian ECO, 2009, DEV BIOL, V333, P161, DOI 10.1016/j.ydbio.2009.06.031; Kim BG, 2017, CARDIOVASC RES, V113, P1677, DOI 10.1093/cvr/cvx188; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Lewin MB, 1997, AM J CARDIOL, V80, P493, DOI 10.1016/S0002-9149(97)00401-3; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Macatee TL, 2003, DEVELOPMENT, V130, P6361, DOI 10.1242/dev.00850; Mommersteeg MTM, 2015, CARDIOVASC RES, V106, P55, DOI 10.1093/cvr/cvv040; Muller RORaF, 2001, HUMAN EMBRYOLOGY TER; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nelms BL, 2011, GENESIS, V49, P10, DOI 10.1002/dvg.20686; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nogare DD, 2014, DEVELOPMENT, V141, P3188, DOI 10.1242/dev.106690; Olaopa M, 2011, DEV BIOL, V356, P308, DOI 10.1016/j.ydbio.2011.05.583; Papangeli I, 2013, WIRES DEV BIOL, V2, P393, DOI 10.1002/wdev.75; Papangeli I, 2013, CIRC RES, V112, P90, DOI 10.1161/CIRCRESAHA.112.270223; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; TREMBLAY P, 1995, DEV BIOL, V171, P317, DOI 10.1006/dbio.1995.1284; van Bueren KL, 2010, DEV BIOL, V340, P369, DOI 10.1016/j.ydbio.2010.01.020; Venkiteswaran G, 2013, CELL, V155, P674, DOI 10.1016/j.cell.2013.09.046; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Vitelli F, 2002, HUM MOL GENET, V11, P915, DOI 10.1093/hmg/11.8.915; WILKINSON DG, 1992, IN SITU HYBRIDISATIO; Zhang Z, 2008, HUM MOL GENET, V17, P150, DOI 10.1093/hmg/ddm291; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	48	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207251	10.1371/journal.pone.0207251	http://dx.doi.org/10.1371/journal.pone.0207251			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408103	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300094
J	Smith, ME; Takwoingi, Y; Deeks, J; Alper, C; Bence, ML; Bhutta, MF; Donnelly, N; Poe, D; Tysome, JR				Smith, Matthew E.; Takwoingi, Yemisi; Deeks, Jon; Alper, Cuneyt; Bence, Manohar L.; Bhutta, Mahmood F.; Donnelly, Neil; Poe, Dennis; Tysome, James R.			Eustachian tube dysfunction: A diagnostic accuracy study and proposed diagnostic pathway	PLOS ONE			English	Article							OTITIS-MEDIA; MODELS; TESTS; PREDICTION; SONOTUBOMETRY; TUBOMANOMETRY; MANAGEMENT; SELECTION; CHILDREN	Background and aims Eustachian tube dysfunction (ETD) is a commonly diagnosed disorder of Eustachian tube opening and closure, which may be associated with severe symptoms and middle ear disease. Currently the diagnosis of obstructive and patulous forms of ETD is primarily based on non-specific symptoms or examination findings, rather than measurement of the underlying function of the Eustachian tube. This has proved problematic when selecting patients for treatment, and when designing trial inclusion criteria and outcomes. This study aims to determine the correlation and diagnostic value of various tests of ET opening and patient reported outcome measures (PROMs), in order to generate a recommended diagnostic pathway for ETD. Methods Index tests included two PROMs and 14 tests of ET opening (nine for obstructive, five for patulous ETD). In the absence of an accepted reference standard two methods were adopted to establish index test accuracy: expert panel diagnosis and latent class analysis. Index test results were assessed with Pearson correlation and principle component analysis, and test accuracy was determined. Logistic regression models assessed the predictive value of grouped test results. Results The expert panel diagnosis and PROMs results correlated with each other, but not with ET function measured by tests of ET opening. All index tests were found to be feasible in clinic, and acceptable to patients. PROMs had very poor specificity, and no diagnostic value. Combining the results of tests of ET function appeared beneficial. The latent class model suggested tympanometry, sonotubometry and tubomanometry have the best diagnostic performance for obstructive ETD, and these are included in a proposed diagnostic pathway. Conclusions ETD should be diagnosed on the basis of clinical assessment and tests of ET opening, as PROMs have no diagnostic value. Currently diagnostic uncertainty exists for some patients who appear to have intermittent ETD clinically, but have negative index test results.	[Smith, Matthew E.; Bence, Manohar L.; Donnelly, Neil; Tysome, James R.] Univ Cambridge, Cambridge Ear Inst, Cambridge, England; [Takwoingi, Yemisi; Deeks, Jon] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Alper, Cuneyt] Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Bhutta, Mahmood F.] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Poe, Dennis] Boston Childrens Hosp, Boston, MA USA	University of Cambridge; University of Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Harvard University; Boston Children's Hospital	Tysome, JR (corresponding author), Univ Cambridge, Cambridge Ear Inst, Cambridge, England.	jrt20@cam.ac.uk	Deeks, Jon/AAV-5745-2020	Deeks, Jon/0000-0002-8850-1971; Smith, Matthew E/0000-0001-8147-1549; Bhutta, Mahmood/0000-0002-4688-1670; Takwoingi, Yemisi/0000-0002-5828-9746	Cambridge Hearing Trust	Cambridge Hearing Trust	M.S. received funding from the Cambridge Hearing Trust. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG., 1999, PRACTICAL STAT MED R; [Anonymous], 2005, EUSTACHIAN TUBE STRU; Asenov DR, 2010, ACTA OTO-LARYNGOL, V130, P1242, DOI 10.3109/00016489.2010.492481; Casselbrant ML, 2011, ACTA OTO-LARYNGOL, V131, P1150, DOI 10.3109/00016489.2011.603137; Doyle WJ, 2013, JAMA OTOLARYNGOL, V139, P719, DOI 10.1001/jamaoto.2013.3559; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Ikeda R, 2011, OTOL NEUROTOL, V32, P790, DOI 10.1097/MAO.0b013e3182184e23; Jenckel F, 2015, EUR ARCH OTO-RHINO-L, V272, P3677, DOI 10.1007/s00405-014-3443-2; Kitajima N, 2014, OTOL NEUROTOL, V35, P850, DOI 10.1097/MAO.0000000000000329; Kobayashi T, 2018, AURIS NASUS LARYNX, V45, P1, DOI 10.1016/j.anl.2017.09.017; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Liu PP, 2016, EUR ARCH OTO-RHINO-L, V273, P3109, DOI 10.1007/s00405-016-3938-0; McCoul ED, 2012, LARYNGOSCOPE, V122, P1137, DOI 10.1002/lary.23223; Mikolajczak S, 2015, UNDERSEA HYPERBAR M, V42, P593; Miyazawa T, 1996, ANN OTO RHINOL LARYN, V105, P887, DOI 10.1177/000348949610501109; Poe DS, 2007, OTOL NEUROTOL, V28, P668; Poe DS, 2001, OTOL NEUROTOL, V22, P590, DOI 10.1097/00129492-200109000-00005; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Rutjes Anne W S, 2006, CMAJ, V174, P469, DOI 10.1503/cmaj.050090; Rutjes AWS., 2007, HEALTH TECHNOL ASSES, V11, P1; Schilder AGM, 2015, CLIN OTOLARYNGOL, V40, P407, DOI 10.1111/coa.12475; Schroder S, 2015, LARYNGOSCOPE, V125, P703, DOI 10.1002/lary.24922; Singh T, 2017, J IND ENG INT, P1, DOI [10.1017/S0022215116009889, DOI 10.1017/S0022215116009889]; Smith GCS, 2014, AM J EPIDEMIOL, V180, P318, DOI 10.1093/aje/kwu140; Smith ME, 2015, CLIN OTOLARYNGOL, V40, P300, DOI 10.1111/coa.12428; Smith ME, 2018, OTOL NEUROTOL, V39, P1129, DOI 10.1097/MAO.0000000000001931; Smith ME, 2017, LARYNGOSCOPE, V127, P2619, DOI 10.1002/lary.26534; Smith ME, 2017, OTOL NEUROTOL, V38, P714, DOI 10.1097/MAO.0000000000001375; Steyerberg EW, 2000, STAT MED, V19, P1059, DOI 10.1002/(SICI)1097-0258(20000430)19:8<1059::AID-SIM412>3.0.CO;2-0; Steyerberg EW, 2014, EUR HEART J, V35, P1925, DOI 10.1093/eurheartj/ehu207; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Takata I, 2017, OTOL NEUROTOL, V38, P846, DOI 10.1097/MAO.0000000000001413; Teixeira MS, 2018, OTOLARYNG HEAD NECK, V158, P83, DOI 10.1177/0194599817731729; Teixeira MS, 2014, INT J PEDIATR OTORHI, V78, P593, DOI 10.1016/j.ijporl.2014.01.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; van Smeden M, 2014, AM J EPIDEMIOL, V179, P423, DOI 10.1093/aje/kwt286; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	38	33	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206946	10.1371/journal.pone.0206946	http://dx.doi.org/10.1371/journal.pone.0206946			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408100	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300054
J	Bieberich, J; Lauerer, M; Drachsler, M; Heinrichs, J; Muller, S; Feldhaar, H				Bieberich, Judith; Lauerer, Marianne; Drachsler, Maria; Heinrichs, Julian; Mueller, Stefanie; Feldhaar, Heike			Species- and developmental stage-specific effects of allelopathy and competition of invasive Impatiens glandulifera on co-occurring plants	PLOS ONE			English	Article							RIPARIAN HABITATS; IMPACT; DIVERSITY; GROWTH; NAPHTHOQUINONES; CONSEQUENCES; AUTOTOXICITY; GERMINATION; COMPONENTS; RICHNESS	Background Impacts of invasive species on native communities are often difficult to assess, because they depend on a range of factors, such as species identity and traits. Such context-dependencies are poorly understood yet, but knowledge is required to predict the impact of invasions. Materials and methods We assessed species- and developmental stage-specificity of competitive and allelopathic effects of the invasive plant Impatiens glandulifera on different developmental stages of four native plant species. While some studies have shown a reduction in plant growth caused by I. glandulifera, the magnitude of its impact is ambiguous. For our study we used seedlings and juveniles of I. glandulifera and the native target species Geum urbanum, Filipendula ulmaria, Urtica dioica, and Salix fragilis (seedlings only of the latter), which often co-occur with I. glandulifera in different habitats. Plants were grown in competition with I. glandulifera or treated with I. glandulifera leaf material, or 2-metoxy-1,4-naphtoquinone (2-MNQ), its supposedly main allelochemical. Results and conclusion Overall I. glandulifera had a negative effect on the growth of all target species depending on the species and on the plant's developmental stage. F. ulmaria was the least affected and U. dioica the most, and seedlings were less affected than juveniles. The species-specific response to I. glandulifera may lead to an altered community composition in the field, while growth reduction of seedlings and juveniles should give I. glandulifera an advantage in cases where plant recruitment is crucial. 2-MNQ led to minor reductions in plant growth, suggesting that it may not be the only allelopathic substance of I. glandulifera. Surprisingly, I. glandulifera was not fully tolerant to 2-MNQ. This autotoxicity could contribute to I. glandulifera population dynamics. We conclude that I. glandulifera reduces the growth of native vegetation and alters early successional stages without fully hindering it.	[Bieberich, Judith; Lauerer, Marianne; Drachsler, Maria; Heinrichs, Julian; Mueller, Stefanie] Univ Bayreuth, Ecol Bot Gardens, BayCEER Bayreuth Ctr Ecol & Environm Res, Bayreuth, Germany; [Bieberich, Judith; Feldhaar, Heike] Univ Bayreuth, Dept Anim Ecol 1, BayCEER Bayreuth Ctr Ecol & Environm Res, Bayreuth, Germany	University of Bayreuth; University of Bayreuth	Bieberich, J (corresponding author), Univ Bayreuth, Ecol Bot Gardens, BayCEER Bayreuth Ctr Ecol & Environm Res, Bayreuth, Germany.; Bieberich, J (corresponding author), Univ Bayreuth, Dept Anim Ecol 1, BayCEER Bayreuth Ctr Ecol & Environm Res, Bayreuth, Germany.	judith.bieberich@uni-bayreuth.de	Feldhaar, Heike/AAB-8678-2020	Bieberich, Judith/0000-0002-8644-6577; Feldhaar, Heike/0000-0001-6797-5126	Bayreuth Center for Ecology and Environmental Science (BayCEER); Bayreuth University Graduate School; Cusanuswerk (Bischofliche Studienforderung); University of Bayreuth; German Research Foundation (DFG)	Bayreuth Center for Ecology and Environmental Science (BayCEER); Bayreuth University Graduate School; Cusanuswerk (Bischofliche Studienforderung); University of Bayreuth; German Research Foundation (DFG)(German Research Foundation (DFG))	JB was funded by the Bayreuth Center for Ecology and Environmental Science (BayCEER; https://www.bayceer.uni-bayreuth.de/), the Bayreuth University Graduate School (http://www.graduateschool.uni-bayreuth.de/de/index.html) and the Cusanuswerk (Bischofliche Studienforderung; https://www.cusanuswerk.de/startseite.html).This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing (http://www.ub.uni-ayreuth.de/de/digitale_bibliothek/open_ access/index. html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Lionel S. Vailshery for proofreading the manuscript and the gardeners of the Ecological Botanical Garden for their support in plant cultivation.	Ammer C, 2011, EUR J FOREST RES, V130, P107, DOI 10.1007/s10342-010-0413-0; Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEERLING DJ, 1993, J ECOL, V81, P367, DOI 10.2307/2261507; BOHM B. A., 1962, CANADIAN JOUR BOT, V40, P677, DOI 10.1139/b62-065; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Canals RM, 2005, J THEOR BIOL, V235, P402, DOI 10.1016/j.jtbi.2005.01.020; CHAPELLE JP, 1974, PHYTOCHEMISTRY, V13, P662, DOI 10.1016/S0031-9422(00)91379-7; Cimmino A, 2016, FITOTERAPIA, V109, P138, DOI 10.1016/j.fitote.2015.12.016; Cockel CP, 2014, RIVER RES APPL, V30, P217, DOI 10.1002/rra.2633; Cuda J, 2017, BIOL INVASIONS, V19, P3051, DOI 10.1007/s10530-017-1508-z; Cuda J, 2017, DIVERS DISTRIB, V23, P342, DOI 10.1111/ddi.12524; Cuda J, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv033; Del Fabbro C, 2014, BIOL INVASIONS, V16, P1035, DOI 10.1007/s10530-013-0555-3; Diekmann M, 2016, PLANT ECOL, V217, P1503, DOI 10.1007/s11258-016-0663-0; Dogra K.S., 2010, J ECOLOGY NATURAL EN, V2, P175, DOI DOI 10.5897/JENE.9000012; Ellenberg H, 2010, VEGETATION MITTELEUR; European Union, 2017, INV AL SPEC UN; FALINSKA K, 1995, J ECOL, V83, P9, DOI 10.2307/2261146; Fox J., 2018, R COMPANION APPL REG, VThird; Fujii Yoshiharu, 2004, Weed Biology and Management, V4, P19, DOI 10.1111/j.1445-6664.2003.00113.x; Fukami T, 2015, ANNU REV ECOL EVOL S, V46, P1, DOI 10.1146/annurev-ecolsys-110411-160340; Gioria M, 2018, J PLANT ECOL, V11, P4, DOI 10.1093/jpe/rtw105; Gioria M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00501; Goldberg D. E., 1990, Perspectives on plant competition., P27; Goodale KM, 2018, PLANT ECOL, V219, P429, DOI 10.1007/s11258-018-0806-6; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Gruntman M, 2017, J ECOL, V105, P255, DOI 10.1111/1365-2745.12660; Gruntman M, 2014, BIOL INVASIONS, V16, P141, DOI 10.1007/s10530-013-0509-9; Hager HA, 2004, OECOLOGIA, V139, P140, DOI 10.1007/s00442-004-1494-6; Hegi G., 1995, ILLUSTRIERTE FLORA V, VIV; Hejda M, 2006, BIOL CONSERV, V132, P143, DOI 10.1016/j.biocon.2006.03.025; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Hope R.M., 2013, RMISC RYAN MISCELLAN; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hulme PE, 2006, J APPL ECOL, V43, P43, DOI 10.1111/j.1365-2664.2005.01102.x; Inderjit, 1997, BOT REV, V63, P221, DOI 10.1007/BF02857949; Info Flora, 2014, NAT DAT INF CTR SWIS; Kasperek G., 2004, NEOBIOTA, V3, P27; Kueffer C, 2013, NEW PHYTOL, V200, P615, DOI 10.1111/nph.12415; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; Lobstein A, 2001, PHYTOCHEM ANALYSIS, V12, P202, DOI 10.1002/pca.574; Loydi A, 2015, BIOL INVASIONS, V17, P581, DOI 10.1007/s10530-014-0750-x; Macias FA, 2000, J AGR FOOD CHEM, V48, P2512, DOI 10.1021/jf9903051; Malikova L., 2010, Ecohydrology and Hydrobiology, V10, P81, DOI 10.2478/v10104-009-0050-8; Mitchell MJ, 2007, ARCH INSECT BIOCHEM, V66, P45, DOI 10.1002/arch.20196; Nehring S., 2013, NATURSCHUTZFACHLICHE; Neuwirth E., 2014, RCOLORBREWER COLOR B; PERRINS J, 1993, J BIOGEOGR, V20, P33, DOI 10.2307/2845737; PYSEK P, 1995, BIOL CONSERV, V74, P41, DOI 10.1016/0006-3207(95)00013-T; PYSEK P, 1993, J BIOGEOGR, V20, P413, DOI 10.2307/2845589; Quinger B., 1990, FARN BL00FCTENPFLANZ, V2, P135; R Core Team, 2021, R LANGUAGE ENV STAT; Ruckli R, 2016, PERSPECT PLANT ECOL, V19, P12, DOI 10.1016/j.ppees.2016.01.005; Ruckli R, 2014, J CHEM ECOL, V40, P371, DOI 10.1007/s10886-014-0421-5; Ruckli R, 2014, FOREST ECOL MANAG, V318, P285, DOI 10.1016/j.foreco.2014.01.015; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Silge J., 2017, TEXT MINING R TIDY A; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Singh HP, 1999, CRIT REV PLANT SCI, V18, P757, DOI 10.1080/07352689991309478; Skalova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062842; Szewczyk K, 2016, MOLECULES, V21, DOI 10.3390/molecules21091162; Szewczyk K, 2016, IND CROP PROD, V86, P262, DOI 10.1016/j.indcrop.2016.03.053; Tanner RA, 2013, PLANT ECOL, V214, P423, DOI 10.1007/s11258-013-0179-9; Tickner DP, 2001, PLANT INVASIONS: SPECIES ECOLOGY AND ECOSYSTEM MANAGEMENT, P159; Tiska J., 2013, MOLECULES, V18, P8429, DOI [10.3390/molecules18078429, DOI 10.3390/MOLECULES18078429]; Vieira MN, 2016, PHYTOCHEM ANALYSIS, V27, P116, DOI 10.1002/pca.2606; Vrchotova N, 2011, PLANT SOIL ENVIRON, V57, P57, DOI 10.17221/156/2010-PSE; WHITTAKER RH, 1971, SCIENCE, V171, P757, DOI 10.1126/science.171.3973.757; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wilke C.O., 2017, cowplot: Streamlined plot theme and plot annotations for ``ggplot2''. R package version 0.8.0	73	14	15	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205843	10.1371/journal.pone.0205843	http://dx.doi.org/10.1371/journal.pone.0205843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403696	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500029
J	Le, J; Zhang, H; Gao, C; Zhou, Q				Le, Jian; Zhang, Hao; Gao, Chao; Zhou, Qian			Harmonic voltage measurement error of the capacitor voltage transformer	PLOS ONE			English	Article							SYSTEM	This paper explores the mechanism for the harmonic voltage measurement error (HVME) of a capacitor voltage transformer (CVT) in a comprehensive way and develops a practical error correction method to improve the harmonic measurement performance of a CVT. The harmonic equivalent circuit (HEC) of CVTs with different types of dampers are established and the parameter value calculation methods of the circuit elements are presented. Characteristics of the individual inherent resonance mode of the HEC, including the resonant frequency, the resonant type and the circuit elements involved, are analyzed systematically. Centered on resonance mode formulation, an universal error correction method for CVTs in measuring harmonic voltage is proposed based on the piecewise fitting of the transformation ratio. A physical experimental platform available for low-voltage CVTs is developed in laboratory, which utilizes a 10-kV harmonic generator and a step-up transformer to provide harmonic signals with high voltage level. Moreover, a novel experimental scheme for testing the HVME of high-voltage CVTs is proposed based on alternating current/direct current (AC/DC) filters. Experiments are conducted on these experimental platforms to test the HVME of a 35-kV CVT in laboratory and a 525-kV CVT in a back-to-back DC converter station. The experimental results verify the validity of the built HECs of CVTs, the resonant mode analysis results and the resonant frequency calculation method. Finally, the effectiveness of the proposed harmonic error correction method is proved by several examples.	[Le, Jian; Zhang, Hao; Gao, Chao; Zhou, Qian] Wuhan Univ, Sch Elect Engn, Wuhan, Hubei, Peoples R China	Wuhan University	Le, J (corresponding author), Wuhan Univ, Sch Elect Engn, Wuhan, Hubei, Peoples R China.	lej01@mails.tsinghua.edu.cn						Baba Y, 2004, IEEE T POWER DELIVER, V19, P21, DOI 10.1109/TPWRD.2003.820415; Daryani N, 2016, IET GENER TRANSM DIS, V10, P3646, DOI 10.1049/iet-gtd.2016.0540; [郜洪亮 Gao Hongliang], 2013, [电网技术, Power System Technology], V37, P3125; Ghassemi F, 2005, IEEE T POWER DELIVER, V20, P443, DOI 10.1109/TPWRD.2004.837675; Ghassemi F, 2002, IEEE T POWER DELIVER, V17, P915, DOI 10.1109/TPWRD.2002.803739; Han B, 2014, 2014 INTERNATIONAL CONFERENCE ON POWER SYSTEM TECHNOLOGY (POWERCON); He BT, 2006, IEEE T POWER DELIVER, V21, P1856, DOI 10.1109/TPWRD.2006.877098; He J H., 2016, COMPUT MATH APPL, DOI [10.1016/j.camwa.2016.04.010, DOI 10.1016/J.CAMWA.2016.04.010]; KOJOVIC L, 1994, IEEE T POWER DELIVER, V9, P1907, DOI 10.1109/61.329523; Li Y, 2012, IEEE T POWER ELECTR, V27, P2273, DOI 10.1109/TPEL.2011.2171998; Lin D, 2016, 2016 IEEE INT C HIGH, P1; Miao YC, 2016, IEEE T SMART GRID, V7, P392, DOI 10.1109/TSG.2014.2377191; Ryu J, 2016, IEEE T INSTRUM MEAS, V65, P680, DOI 10.1109/TIM.2015.2510551; Sakamuri J., 2011, 2011 IEEE TRONDHEIM, P1; Seljeseth H, 1998, INT C HARMON QUAL PO, P820, DOI 10.1109/ICHQP.1998.760148; Tziouvaras DA, 2000, IEEE T POWER DELIVER, V15, P62, DOI 10.1109/61.847230; VERMEULEN HJ, 1995, IEEE T POWER DELIVER, V10, P1743, DOI 10.1109/61.473385; Vermeulen HJ, 1996, AFRICON '96 - 1996 IEEE AFRICON : 4TH AFRICON CONFERENCE IN AFRICA, VOLS I & II, P1012, DOI 10.1109/AFRCON.1996.563035; Wu XE., 2017, NONLINEAR SCI LETT A, V8, P77; Xiao Y, 2004, IEEE T POWER DELIVER, V19, P1483, DOI 10.1109/TPWRD.2004.829947; Zhu LY, 2015, IEEE T DIELECT EL IN, V22, P925, DOI 10.1109/TDEI.2015.7076793	21	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0205231	10.1371/journal.pone.0205231	http://dx.doi.org/10.1371/journal.pone.0205231			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399155	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000002
J	Liang, WZ; Zhao, GY; Luo, SZ				Liang, Weizhang; Zhao, Guoyan; Luo, Suizhi			Linguistic neutrosophic Hamacher aggregation operators and the application in evaluating land reclamation schemes for mines	PLOS ONE			English	Article							INTUITIONISTIC FUZZY NUMBERS; OPTIMAL ENVIRONMENTAL RECLAMATION; DECISION-SUPPORT-SYSTEM; COMPREHENSIVE EVALUATION; SUITABILITY; RESOURCES	Land reclamation has become a significant way for the improvement of ecological environment in mining areas. When selecting the optimal land reclamation scheme, LNNs (linguistic neutrosophic numbers) are suitable to describe the complex fuzzy evaluation information through linguistic truth, indeterminacy and falsity membership degrees. Furthermore, the Hamacher aggregation operators are good tools to handle multi-criteria decision making problems. Accordingly, the aim of this paper is to extend Hamacher aggregation operators with LNNs and then build a decision making framework for evaluating land reclamation schemes in mining areas. First, new operational laws of LNNs based on Hamacher t-norm and t-conorm are defined. Then, several linguistic neutrosophic Hamacher aggregation operators, including the linguistic neutrosophic Hamacher weighted mean aggregation operators and linguistic neutrosophic Hamacher hybrid weighted mean aggregation operators are developed. Meanwhile, their desirable properties are proved. Thereafter, a method for decision making with linguistic neutrosophic information based on these operators is proposed to deal with complex decision problems. At last, the validity of this method is confirmed by an illustrative example of evaluating the land reclamation schemes in mining areas. In addition, the impact of the parameter in extended Hamacher aggregation operators is discussed. The merits of the proposed method are also highlighted by comparing with other decision making methods. The results show that the proposed linguistic neutrosophic Hamacher aggregation operators have great flexibility and advantages, and can provide powerful ways for the evaluation of land reclamation schemes.	[Liang, Weizhang; Zhao, Guoyan] Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China; [Luo, Suizhi] Natl Univ Def Technol, Sch Syst Engn, Changsha, Hunan, Peoples R China	Central South University; National University of Defense Technology - China	Zhao, GY (corresponding author), Cent S Univ, Sch Resources & Safety Engn, Changsha, Hunan, Peoples R China.	gyzhao@csu.edu.cn	Liang, Weizhang/HHZ-1494-2022		National Key Research Development Program of China [2018YFC0604606]; National Natural Science Foundation of China [51774321]	National Key Research Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research Development Program of China (2018YFC0604606), and National Natural Science Foundation of China (51774321) (GZ).	Ali SH, 2017, NATURE, V543, P367, DOI 10.1038/nature21359; Bascetin A, 2007, ENVIRON GEOL, V52, P663, DOI 10.1007/s00254-006-0495-7; Calas G, 2017, ELEMENTS, V13, P301, DOI 10.2138/gselements.13.5.301; Cheng LL, 2017, INT J MIN RECLAM ENV, V31, P212, DOI 10.1080/17480930.2016.1167305; Fan CX, 2017, INFORMATION, V8, DOI 10.3390/info8030107; Fang ZB, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9070111; Gao H, 2018, IEEE ACCESS, V6, P11508, DOI 10.1109/ACCESS.2017.2784963; Garg H, 2017, SCI IRAN, V24, P2581, DOI 10.24200/sci.2017.4386; GARG H, 2018, SYMMETRY-BASEL, V10, DOI DOI 10.3390/SYM10070280; Garg H, 2018, ARAB J SCI ENG, V43, P3213, DOI 10.1007/s13369-017-2986-0; Garg H, 2018, APPL INTELL, V48, P2199, DOI 10.1007/s10489-017-1070-5; Garg H, 2018, APPL INTELL, V48, P4871, DOI 10.1007/s10489-018-1244-9; Garg H, 2018, J AMB INTEL HUM COMP, V9, P1975, DOI 10.1007/s12652-018-0723-5; Garg H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2591-9; Ioannis P, 2017, INT J MIN SCI TECHNO, V27, P491, DOI 10.1016/j.ijmst.2017.03.008; Jahan A, 2011, MATER DESIGN, V32, P4918, DOI 10.1016/j.matdes.2011.05.050; Li BL, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/2432167; Liang WZ, 2018, J CLEAN PROD, V196, P1365, DOI 10.1016/j.jclepro.2018.06.147; Liang WZ, 2019, B ENG GEOL ENVIRON, V78, P3767, DOI 10.1007/s10064-018-1340-4; Liang WZ, 2019, NEURAL COMPUT APPL, V31, P5871, DOI 10.1007/s00521-018-3405-5; Liang WZ, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10070283; Liang WZ, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9080149; Liu PD, 2018, INT J FUZZY SYST, V20, P970, DOI 10.1007/s40815-018-0450-2; Liu PD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193027; Liu PD, 2018, APPL SOFT COMPUT, V62, P395, DOI 10.1016/j.asoc.2017.10.017; Liu PD, 2017, J EXP THEOR ARTIF IN, V29, P1173, DOI 10.1080/0952813X.2017.1310309; Liu PD, 2014, IEEE T FUZZY SYST, V22, P83, DOI 10.1109/TFUZZ.2013.2248736; Liu PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179321; Luo SZ, 2019, J OPER RES SOC, V70, P2039, DOI 10.1080/01605682.2018.1510806; Luo SZ, 2017, SYMMETRY-BASEL, V9, DOI 10.3390/sym9080151; Ma LH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189835; Nancy, 2016, INT J UNCERTAIN QUAN, V6, P361, DOI 10.1615/Int.J.UncertaintyQuantification.2016018603; Oussalah M, 2003, INFORM SCIENCES, V153, P107, DOI 10.1016/S0020-0255(03)00072-0; Pavloudakis F, 2009, INT J MIN RECLAM ENV, V23, P291, DOI 10.1080/17480930902731935; Shi LL, 2017, INFORMATION, V8, DOI 10.3390/info8040117; Soltanmohammadi H, 2010, LAND USE POLICY, V27, P364, DOI 10.1016/j.landusepol.2009.05.001; Swab RM, 2017, ECOL ENG, V108, P525, DOI 10.1016/j.ecoleng.2017.05.012; Tang J, 2019, GRANULAR COMPUT, V4, P109, DOI 10.1007/s41066-018-0089-2; Tiwari AK, 2018, EXPERT SYST APPL, V101, P205, DOI 10.1016/j.eswa.2018.02.009; Wang SD, 2011, T NONFERR METAL SOC, V21, pS506, DOI 10.1016/S1003-6326(12)61633-1; Wang WZ, 2011, INT J INTELL SYST, V26, P1049, DOI 10.1002/int.20498; Wood BJ, 2017, ELEMENTS, V13, P291, DOI 10.2138/gselements.13.5.291; Wu Q, 2018, COMPUT IND ENG, V116, P144, DOI 10.1016/j.cie.2017.12.024; Xu ZS, 2005, OMEGA-INT J MANAGE S, V33, P249, DOI 10.1016/j.omega.2004.04.008; Yan HB, 2011, EXPERT SYST APPL, V38, P812, DOI 10.1016/j.eswa.2010.07.039; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhang ST, 2017, APPL SOFT COMPUT, V60, P30, DOI 10.1016/j.asoc.2017.06.028; Zhou W, 2018, INT J MIN RECLAM ENV, V32, P93, DOI 10.1080/17480930.2016.1228031	48	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206178	10.1371/journal.pone.0206178	http://dx.doi.org/10.1371/journal.pone.0206178			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399171	Green Published, gold			2022-12-26	WOS:000449374000009
J	Urbanski, G; Caillon, A; Poli, C; Kauffenstein, G; Begorre, MA; Loufrani, L; Henrion, D; Belizna, C				Urbanski, Geoffrey; Caillon, Antoine; Poli, Caroline; Kauffenstein, Gilles; Begorre, Marc-Antoine; Loufrani, Laurent; Henrion, Daniel; Belizna, Cristina			Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BETA(2)-GLYCOPROTEIN I; OXIDATIVE STRESS; THROMBOGENIC PROPERTIES; THROMBOSIS MODEL; TETRAHYDROBIOPTERIN; BETA-2-GLYCOPROTEIN-I; CELLS; IGG	Background Antiphospholipid syndrome is associated with endothelial dysfunction, which leads to thrombosis and early atheroma. Given that hydroxychloroquine has anti-thrombotic properties in lupus, we hypothesized that it could reduce endothelial dysfunction in an animal model of antiphospholipid syndrome. We evaluated the effect of hydroxychloroquine in preventing endothelial dysfunction in a mouse model of antiphospholipid syndrome. Methods Antiphospholipid syndrome was induced by an injection of monoclonal anti-beta-2-GPI antibodies. Vascular reactivity was evaluated in mesenteric resistance arteries isolated from mice 3 weeks (APL3W) after receiving a single injection of anti-beta-2-GPI antibodies and after 3 weeks of daily oral hydroxychloroquine treatment (HCQ3W) compared to control mice (CT3W). We evaluated endothelial dysfunction by measuring acetylcholine-mediated vasodilation. A pharmacological approach was used to evaluate NO synthase uncoupling (tetrahydrobiopterin) and the generation of reactive oxygen species (Tempol). Results Impaired acetylcholine-mediated dilation was evidenced in mice 3 weeks after anti-beta-2GPI antibodies injection compared to CT3W, by reduced maximal dilation (p<0.0001) and sensitivity (pKd) (p = 0.01) to acetylcholine. Hydroxychloroquine improved acetylcholine-dependent dilation, on pKd (p = 0.02) but not maximal capacity compared to untreated mice. The addition of tetrahydrobiopterin (p = 0.02) and/or Tempol (p = 0.0008) improved acetylcholine-mediated dilation in APL3W but not in HCQ3W. Conclusions We demonstrated that endothelial dysfunction in mouse resistance arteries persisted at 3 weeks after a single injection of monoclonal anti-beta-2-GPI antibodies, and that hydroxychloroquine improved endothelium-dependent dilation at 3 weeks, through improvement of NO synthase coupling and oxidative stress reduction.	[Urbanski, Geoffrey; Caillon, Antoine; Kauffenstein, Gilles; Begorre, Marc-Antoine; Loufrani, Laurent; Henrion, Daniel; Belizna, Cristina] Univ Angers, UMR CNRS INSERM U1083 6015, MITOVASC Inst, Fac Med, Batiment IRIS 2, Angers, France; [Urbanski, Geoffrey] CHU Angers, Serv Med Interne & Malad Vasc, Angers, France; [Poli, Caroline] CHU Angers, Lab Immunol & Allergol, Angers, France; [Belizna, Cristina] CHU Angers, Ctr Vasc & Coagulat, Angers, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Urbanski, G (corresponding author), Univ Angers, UMR CNRS INSERM U1083 6015, MITOVASC Inst, Fac Med, Batiment IRIS 2, Angers, France.; Urbanski, G (corresponding author), CHU Angers, Serv Med Interne & Malad Vasc, Angers, France.	urbanskigeoffrey@gmail.com	Caillon, antoine/AAN-6321-2020; Henrion, Daniel/J-8141-2015; Urbanski, Geoffrey/AAO-8343-2021; Kauffenstein, Gilles/K-2867-2015; Henrion, Daniel/N-7023-2015; Henrion, Daniel/AAK-1995-2021	Henrion, Daniel/0000-0003-1094-0285; Urbanski, Geoffrey/0000-0001-5719-8423; Kauffenstein, Gilles/0000-0003-4994-8305; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; POLI, Caroline/0000-0002-4145-5373				Alves JD, 2005, RHEUMATOLOGY, V44, P1238, DOI 10.1093/rheumatology/keh722; Ames PRJ, 2010, J RHEUMATOL, V37, P2523, DOI 10.3899/jrheum.100494; Arad A, 2011, BLOOD, V117, P3453, DOI 10.1182/blood-2010-08-300715; Belizna C, 2008, LUPUS, V17, P185, DOI 10.1177/0961203307086931; Belizna CC, 2008, SEMIN ARTHRITIS RHEU, V37, P373, DOI 10.1016/j.semarthrit.2007.08.002; Casian A, 2018, AUTOIMMUN REV, V17, P660, DOI 10.1016/j.autrev.2018.01.016; Cervera R, 2015, ANN RHEUM DIS, V74, P1011, DOI 10.1136/annrheumdis-2013-204838; Cosentino F, 2008, HEART, V94, P487, DOI 10.1136/hrt.2007.122184; Cosentino F, 1999, CARDIOVASC RES, V43, P274, DOI 10.1016/S0008-6363(99)00134-0; Cugno M, 2010, J AUTOIMMUN, V34, P105, DOI 10.1016/j.jaut.2009.07.004; DelPapa N, 1997, ARTHRITIS RHEUM-US, V40, P551; Dowell FJ, 1996, BRIT J PHARMACOL, V117, P341, DOI 10.1111/j.1476-5381.1996.tb15196.x; Dueymes M, 1996, ANN MED INTERNE, V147, P22; Edwards MH, 1997, CIRCULATION, V96, P4380; Frank M, 2009, AUTOIMMUN REV, V9, P5, DOI 10.1016/j.autrev.2009.02.025; George J, 1998, CIRCULATION, V97, P900, DOI 10.1161/01.CIR.97.9.900; Harrison DG, 2010, ADV PHARMACOL, V60, P107, DOI [10.1016/S1054-3589(10)60005-1, 10.1016/B978-0-12-385061-4.00005-2]; Jankowski M, 2003, BLOOD, V101, P157, DOI 10.1182/blood-2002-05-1310; Jimenez R, 2014, CHRONIC HYDROXYCHLOR, DOI [10.1161/HYPERTENSIONAHA.114, DOI 10.1161/HYPERTENSIONAHA.114]; Kaiser R, 2009, ANN RHEUM DIS, V68, P238, DOI 10.1136/ard.2008.093013; LERMAN A, 1992, CIRCULATION, V86, P12; MATSUURA E, 1991, INT IMMUNOL, V3, P1217; Matsuura E, 2006, RHEUM DIS CLIN N AM, V32, P537, DOI 10.1016/j.rdc.2006.05.006; MCNEIL HP, 1990, P NATL ACAD SCI USA, V87, P4120, DOI 10.1073/pnas.87.11.4120; Meroni PL, 1996, LUPUS, V5, P448, DOI 10.1177/096120339600500523; Mineo C, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0324-4; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Nishimura Misato, 2013, J Nephropathol, V2, P114, DOI 10.12860/JNP.2013.19; Olee TW, 1996, P NATL ACAD SCI USA, V93, P8606, DOI 10.1073/pnas.93.16.8606; Pengo V, 2009, J THROMB HAEMOST, V7, P1737, DOI 10.1111/j.1538-7836.2009.03555.x; Pierangeli SS, 2008, SEMIN THROMB HEMOST, V34, P236, DOI 10.1055/s-0028-1082267; Pierangeli SS, 1999, CIRCULATION, V99, P1997, DOI 10.1161/01.CIR.99.15.1997; PIERANGELI SS, 1995, THROMB HAEMOSTASIS, V74, P1361; PIERANGELI SS, 1994, THROMB HAEMOSTASIS, V71, P670; Pierangeli SS, 1996, CIRCULATION, V94, P1746, DOI 10.1161/01.CIR.94.7.1746; Ramesh S, 2011, J CLIN INVEST, V121, P120, DOI 10.1172/JCI39828; Rand JH, 2008, BLOOD, V112, P1687, DOI 10.1182/blood-2008-03-144204; Rochette L, 2013, PHARMACOL THERAPEUT, V140, P239, DOI 10.1016/j.pharmthera.2013.07.004; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Schmidt-Tanguy A, 2013, J THROMB HAEMOST, V11, P1927, DOI 10.1111/jth.12363; Schreiber K, 2018, RHEUMATOLOGY, V57, P120, DOI 10.1093/rheumatology/kex378; Takeda M, 2009, CIRC J, V73, P955, DOI 10.1253/circj.CJ-08-0850; Tektonidou MG, 2009, ARTHRIT RHEUM-ARTHR, V61, P29, DOI 10.1002/art.24232; Tincani A, 1996, J IMMUNOL, V157, P5732; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Vessieres E, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00145; Virdis A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0790-3; Williams FMK, 2000, THROMB HAEMOSTASIS, V84, P742; Willis R, 2012, SEMIN THROMB HEMOST, V38, P305, DOI 10.1055/s-0032-1311827	49	12	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206814	10.1371/journal.pone.0206814	http://dx.doi.org/10.1371/journal.pone.0206814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399161	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000021
J	Wu, C; Jiao, Y; Shen, ML; Pan, C; Cheng, G; Jia, DM; Zhu, J; Zhang, L; Zheng, M; Jia, JL				Wu, Chao; Jiao, Yang; Shen, Manli; Pan, Chen; Cheng, Guo; Jia, Danmei; Zhu, Jing; Zhang, Long; Zheng, Min; Jia, Junling			Clustering-local-unique-enriched-signals (CLUES) promotes identification of novel regulators of ES cell self-renewal and pluripotency	PLOS ONE			English	Article							BIVALENT HISTONE MODIFICATIONS; CHIP-SEQ; TRANSCRIPTION FACTORS; SUPER-ENHANCERS; GENETIC SCREENS; READ ALIGNMENT; BINDING-SITES; PROTEIN; EXPRESSION; IDENTITY	Background Key regulators of developmental processes can be prioritized through integrated analysis of ChIP-Seq data of master transcriptional factors (TFs) such as Nanog and Oct4, active histone modifications (HMs) such as H3K4me3 and H3K27ac, and repressive HMs such as H3K27me3. Recent studies show that broad enrichment signals such as super-enhancers and broad H3K4me3 enrichment signals play more dominant roles than short enrichment signals of the master TFs and H3K4me3 in epigenetic regulatory mechanism. Besides the broad enrichment signals, up to ten thousands of short enrichment signals of these TFs and HMs exist in genome. Prioritization of these broad enrichment signals from ChIP-Seq data is a prerequisite for such integrated analysis. Results Here, we present a method named Clustering-Local-Unique-Enriched-Signals (CLUES), which uses an adaptive-size-windows strategy to identify enriched regions (ERs) and cluster them into broad enrichment signals. Tested on 62 ENCODE ChIP-Seq datasets of Ctcf and Nrsf, CLUES performs equally well as MACS2 regarding prioritization of ERs with the TF's motif. Tested on 165 ENCODE ChIP-Seq datasets of H3K4me3, H3K27me3, and H3K36me3, CLUES performs better than existing algorithms on prioritizing broad enrichment signals implicating cell functions influenced by epigenetic regulatory mechanism in cells. Most importantly, CLUES helps to confirm several novel regulators of mouse ES cell self-renewal and pluripotency through integrated analysis of prioritized broad enrichment signals of H3K4me3, H3K27me3, Nanog and Oct4 with the support of a CRISPR/Cas9 negative selection genetic screen. Conclusions CLUES holds promise for prioritizing broad enrichment signals from ChIP-Seq data.	[Wu, Chao; Jiao, Yang; Shen, Manli; Pan, Chen; Cheng, Guo; Jia, Danmei; Zhang, Long; Jia, Junling] Zhejiang Univ, Life Sci Inst, Hangzhou, Zhejiang, Peoples R China; [Wu, Chao; Jiao, Yang; Shen, Manli; Pan, Chen; Cheng, Guo; Jia, Danmei; Zhang, Long; Jia, Junling] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China; [Zhu, Jing] Beijing Ming Tian Genet Ltd, Beijing, Peoples R China; [Zheng, Min; Jia, Junling] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China; [Zheng, Min; Jia, Junling] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University	Wu, C; Jia, JL (corresponding author), Zhejiang Univ, Life Sci Inst, Hangzhou, Zhejiang, Peoples R China.; Wu, C; Jia, JL (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou, Zhejiang, Peoples R China.; Zheng, M; Jia, JL (corresponding author), Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.; Zheng, M; Jia, JL (corresponding author), Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.	wuchao1984@zju.edu.cn; minzheng@zju.edu.cn; junlingjia@zju.edu.cn	Zhang, Long/AAT-6571-2021	Zhang, Long/0000-0001-8139-0474	Zhejiang Provincial Natural Science Funds [R15C060001]; Beijing Ming-tian Genetics Ltd.	Zhejiang Provincial Natural Science Funds; Beijing Ming-tian Genetics Ltd.	Junling Jia is supported by the Zhejiang Provincial Natural Science Funds (R15C060001, http://www.zjnsf.gov.cn/). Jing Zhu is from Beijing Ming-tian Genetics Ltd. Beijing Ming-tian Genetics Ltd. provided support in the form of salary for author JZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barbaric Ivana, 2012, Int J Dev Biol, V56, P197, DOI 10.1387/ijdb.123503ib; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cinghu S, 2014, P NATL ACAD SCI USA, V111, pE1581, DOI 10.1073/pnas.1318598111; Costa Y, 2013, NATURE, V495, P370, DOI 10.1038/nature11925; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Feng X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-139; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Harikumar A, 2015, EMBO REP, V16, P1609, DOI 10.15252/embr.201541011; Harmanci A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0474-3; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Jia JL, 2012, CELL, V151, P576, DOI 10.1016/j.cell.2012.09.023; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kile BT, 2005, NAT REV GENET, V6, P557, DOI 10.1038/nrg1636; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kumar V, 2013, NAT BIOTECHNOL, V31, P615, DOI 10.1038/nbt.2596; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee H, 2012, BIOINFORMATICS, V28, P2097, DOI 10.1093/bioinformatics/bts330; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2012, NAT REV MOL CELL BIO, V13, P524, DOI 10.1038/nrm3393; Liang GN, 2004, P NATL ACAD SCI USA, V101, P7357, DOI 10.1073/pnas.0401866101; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Maher B, 2012, NATURE, V489, P46, DOI 10.1038/489046a; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Nag A, 2013, ELIFE, V2, DOI 10.7554/eLife.01256; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Oda T, 2000, MOL CELL BIOL, V20, P1407, DOI 10.1128/MCB.20.4.1407-1418.2000; Qin ZHS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-369; Rashid NU, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r67; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Smith KT, 2012, MOL CELL PROTEOMICS, V11, P1815, DOI 10.1074/mcp.M112.020255; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vastenhouw NL, 2012, CURR OPIN CELL BIOL, V24, P374, DOI 10.1016/j.ceb.2012.03.009; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xing H, 2012, PLOS COMPUT BIOL, V8, P7; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang BJ, 2016, NATURE, V537, P553, DOI 10.1038/nature19361; Zhang Y., 2008, GENOME BIOL, V9; Zhou YX, 2014, NATURE, V509, P487, DOI 10.1038/nature13166	59	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206844	10.1371/journal.pone.0206844	http://dx.doi.org/10.1371/journal.pone.0206844			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399165	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000025
J	Liu, LL; Song, ZQ; Zhao, YC; Li, C; Wei, H; Ma, J; Du, YW				Liu, Lingling; Song, Zhaoquan; Zhao, Yingchun; Li, Chao; Wei, Hua; Ma, Ji; Du, Yaowu			HAVCR1 expression might be a novel prognostic factor for gastric cancer	PLOS ONE			English	Article							KIDNEY INJURY MOLECULE-1; RENAL-CELL CARCINOMA; HEPATITIS-A VIRUS; PROGRESSION; ACTIVATION; RECEPTOR; PATHWAY; BINDING; TIM-3	Hepatitis A virus cellular receptor 1 (HAVCR1), which is also known as T-cell immunoglobulin and mucin domain 1 (TIM-1) is a TIM gene family member. In this study, we aimed to characterize the expression profile of HAVCR1 in GC, its prognostic value and the potential epigenetic mechanism leading to its dysregulation. Bioinformatic analysis was performed by using genomic, clinicopathological and survival data in the human protein atlas (HPA) and the Cancer Genome Atlas (TCGA). Results showed that HAVCR1 was significantly upregulated at the mRNA and protein level in GC tissues compared to the adjacent normal tissues. In addition, HAVCR1 upregulation was an independent indicator of shorter OS (HR: 1.698, 95%CI: 1.221-2.361, p = 0.002), after adjustment of older age, differentiation status, pathological stages and the presence of residual tumor and was also an independent indicator of shorter RFS (HR: 2.577, 95%CI: 1.583-4.197, p<0.001), after adjustment of gender and histological grade. The methylation level of two CpG sites (cg11188031 and cg07320595) was negatively correlated with HAVCR1 expression. However, only high methylation level of cg07320595 was associated with significantly longer OS (p = 0.018) and RFS (p = 0.021). Based on these findings, we infer that HAVCR1 upregulation might serve as a valuable prognostic marker in terms of OS and RFS in GC patients. Cg07320595 might be a critical CpG site influencing HAVCR1 expression.	[Liu, Lingling] Shandong Univ, Shandong Prov Hosp, Dept Clin Lab, Jinan, Shandong, Peoples R China; [Song, Zhaoquan] Linyi Luozhuang Cent Hosp, Clin Lab, Linyi, Shandong, Peoples R China; [Zhao, Yingchun] Zhangqiu Peoples Hosp, Dept Paediat, Ward 1, Jinan, Shandong, Peoples R China; [Li, Chao] Heilongjiang Prov Hosp, Dept NMR, Harbin, Heilongjiang, Peoples R China; [Wei, Hua; Ma, Ji] Henan Univ, Huaihe Hosp, Dept Endoscopy, Kaifeng, Peoples R China; [Du, Yaowu] Henan Univ, Sch Basic Med Sci, Lab Nanomed, Kaifeng, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Henan University; Henan University	Li, C (corresponding author), Heilongjiang Prov Hosp, Dept NMR, Harbin, Heilongjiang, Peoples R China.	chaolilee@foxmail.com						Bailly V, 2002, J BIOL CHEM, V277, P39739, DOI 10.1074/jbc.M200562200; Cuadros T, 2014, CANCER RES, V74, P1416, DOI 10.1158/0008-5472.CAN-13-1671; Famulski KS, 2012, J AM SOC NEPHROL, V23, P948, DOI 10.1681/ASN.2011090887; Han WK, 2005, J AM SOC NEPHROL, V16, P1126, DOI 10.1681/ASN.2004070530; Jiang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081799; Kaplan G, 1996, EMBO J, V15, P4282, DOI 10.1002/j.1460-2075.1996.tb00803.x; Kim HY, 2011, J CLIN INVEST, V121, P1111, DOI 10.1172/JCI44182; Lai QH, 2018, EUR J MED CHEM, V156, P162, DOI 10.1016/j.ejmech.2018.05.010; Lu X, 2017, CELL IMMUNOL, V313, P43, DOI 10.1016/j.cellimm.2017.01.001; Manangeeswaran M, 2012, GASTROENTEROLOGY, V142, P1516, DOI 10.1053/j.gastro.2012.02.039; Martin TA, 2011, ANTICANCER RES, V31, P467; Meyers JH, 2005, TRENDS MOL MED, V11, P362, DOI 10.1016/j.molmed.2005.06.008; Sun HW, 2012, HEPATO-GASTROENTEROL, V59, P2677, DOI 10.5754/hge11620; Telford EJA, 2017, HISTOL HISTOPATHOL, V32, P121, DOI 10.14670/HH-11-817; Thomas LJ, 2016, MOL CANCER THER, V15, P2946, DOI 10.1158/1535-7163.MCT-16-0393; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186; Wang ZX, 2017, IMMUNOL INVEST, V46, P134, DOI 10.1080/08820139.2016.1229790; Wu XY, 2017, ONCOTARGET, V8, P20741, DOI 10.18632/oncotarget.15119; Yang ZY, 2015, ONCOTARGET, V6, P5072, DOI 10.18632/oncotarget.3241; Yao YQ, 2015, J CONTROL RELEASE, V220, P5, DOI 10.1016/j.jconrel.2015.09.058; Zhu Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.263	23	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206423	10.1371/journal.pone.0206423	http://dx.doi.org/10.1371/journal.pone.0206423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388143	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800030
J	Ahmed, I; Roy, BC; Raach, RMT; Owens, SM; Xia, LJ; Anent, S; Sampath, V; Umar, S				Ahmed, Ishfaq; Roy, Badal C.; Raach, Rita-Marie T.; Owens, Sarah M.; Xia, Lijun; Anent, Shrikant; Sampath, Venkatesh; Umar, Shahid			Enteric infection coupled with chronic Notch pathway inhibition alters colonic mucus composition leading to dysbiosis, barrier disruption and colitis	PLOS ONE			English	Article							HYPERPLASIA AND/OR COLITIS; REGULATORY T-CELLS; KAPPA-B ACTIVITY; AKKERMANSIA-MUCINIPHILA; INTESTINAL MICROBIOTA; TISSUE REGENERATION; GUT MICROBIOTA; CROSS-TALK; IN-VIVO; BACTERIAL	Intestinal mucus layer disruption and gut microflora modification in conjunction with tight junction (TJ) changes can increase colonic permeability that allows bacterial dissemination and intestinal and systemic disease. We showed previously that Citrobacter rodentium (CR)-induced colonic crypt hyperplasia and/or colitis is regulated by a functional cross-talk between the Notch and Wnt/beta-catenin pathways. In the current study, mucus analysis in the colons of CR-infected (10(8) CFUs) and Notch blocker Dibenzazepine (DBZ, i.p.; 10 mu mol/Kg b.w.)-treated mice revealed significant alterations in the composition of trace O-glycans and complex type and hybrid N-glycans, compared to CR-infected mice alone that preceded/accompanied alterations in 16S rDNA microbial community structure and elevated EUB338 staining. While mucin-degrading bacterium, Akkermansia muciniphila (A. muciniphila) along with Enterobacteriaceae belonging to Proteobacteria phyla increased in the feces, antimicrobial peptides Angiogenin-4, Intelectin-1 and Intelectin-2, and ISC marker Dclk1, exhibited dramatic decreases in the colons of CR-infected/DBZ-treated mice. Also evident was a loss of TJ and adherens junction protein immuno-staining within the colonic crypts that negatively impacted paracellular barrier. These changes coincided with the loss of Notch signaling and exacerbation of mucosal injury. In response to a cocktail of antibiotics (Metronidazole/ciprofloxacin) for 10 days, there was increased survival that coincided with: i) decreased levels of Proteobacteria, ii) elevated Dclk1 levels in the crypt and, iii) reduced paracellular permeability. Thus, enteric infections that interfere with Notch activity may promote mucosal dysbiosis that is preceded by changes in mucus composition. Controlled use of antibiotics seems to alleviate gut dysbiosis but may be insufficient to promote colonic crypt regeneration.	[Ahmed, Ishfaq; Roy, Badal C.; Anent, Shrikant; Umar, Shahid] Univ Kansas, Dept Surg, Med Ctr, Kansas City, KS 66103 USA; [Raach, Rita-Marie T.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA; [Owens, Sarah M.] Argonne Natl Lab, Biosci Div, Lemont, IL USA; [Xia, Lijun] Univ Oklahoma, Oklahoma Med Res Fdn, Hlth Sci Ctr, Oklahoma City, OK USA; [Sampath, Venkatesh] Childrens Mercy Hosp, Div Neonatol, Kansas City, MO 64108 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; United States Department of Energy (DOE); Argonne National Laboratory; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Children's Mercy Hospital	Umar, S (corresponding author), Univ Kansas, Dept Surg, Med Ctr, Kansas City, KS 66103 USA.	sumar@kumc.edu		Umar, Shahid/0000-0003-0579-6813	National Institute of Health [R01-CA185322]; University of Kansas Medical Center, Kansas City, Kansas; NATIONAL CANCER INSTITUTE [R01CA185322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103638] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center, Kansas City, Kansas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institute of Health grant R01-CA185322 and startup funds from the University of Kansas Medical Center, Kansas City, Kansas.	Ahmed I, 2016, CARCINOGENESIS, V37, P385, DOI 10.1093/carcin/bgw009; Ahmed I, 2013, AM J PHYSIOL-GASTR L, V304, pG356, DOI 10.1152/ajpgi.00372.2012; Ahmed I, 2012, INFECT IMMUN, V80, P3107, DOI 10.1128/IAI.00236-12; An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Backhed F, 2012, NUTR REV, V70, pS14, DOI 10.1111/j.1753-4887.2012.00496.x; BARTHOLD SW, 1977, LAB ANIM SCI, V27, P938; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandrakesan P, 2014, ONCOGENE, V33, P2639, DOI 10.1038/onc.2013.210; Chandrakesan P, 2012, INFECT IMMUN, V80, P753, DOI 10.1128/IAI.06101-11; Chandrakesan P, 2010, J BIOL CHEM, V285, P33485, DOI 10.1074/jbc.M110.129353; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021; Dahan S, 2011, GASTROENTEROLOGY, V140, P550, DOI 10.1053/j.gastro.2010.10.057; Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07; Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166; Dickman KG, 2000, AM J PHYSIOL-GASTR L, V279, pG757, DOI 10.1152/ajpgi.2000.279.4.G757; Earle KA, 2015, CELL HOST MICROBE, V18, P478, DOI 10.1016/j.chom.2015.09.002; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fedwick JP, 2005, INFECT IMMUN, V73, P7844, DOI 10.1128/IAI.73.12.7844-7852.2005; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Ganesh BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074963; Gonzalez MA, 2009, GASTROENTEROLOGY, V136, P978, DOI 10.1053/j.gastro.2008.11.041; Greenbloom SL, 1998, CAN J GASTROENTEROL, V12, P53, DOI 10.1155/1998/349460; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Guttman JA, 2006, INFECT IMMUN, V74, P6075, DOI 10.1128/IAI.00721-06; Hakansson A, 2015, CLIN EXP MED, V15, P107, DOI 10.1007/s10238-013-0270-5; Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002; Hansson GC, 2012, CURR OPIN MICROBIOL, V15, P57, DOI 10.1016/j.mib.2011.11.002; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520; Khalil PN, 2007, GASTROENTEROLOGY, V132, P944, DOI 10.1053/j.gastro.2006.12.029; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lord JD, 2012, DIGEST DIS SCI, V57, P2846, DOI 10.1007/s10620-012-2292-3; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; Napolitano LM, 1996, SHOCK, V5, P202, DOI 10.1097/00024382-199603000-00006; OHKUSA T, 1987, Japanese Journal of Gastroenterology, V84, P2337; Olsan EE, 2017, J BIOL CHEM, V292, P8577, DOI 10.1074/jbc.R116.752295; Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623; Pemberton AD, 2004, J IMMUNOL, V173, P1894, DOI 10.4049/jimmunol.173.3.1894; Philpott DJ, 1996, AM J PHYSIOL-GASTR L, V270, pG634, DOI 10.1152/ajpgi.1996.270.4.G634; Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281; Pope JL, 2014, GUT, V63, P622, DOI 10.1136/gutjnl-2012-304241; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d; Rengifo-Cam W, 2007, CANCER RES, V67, P7266, DOI 10.1158/0008-5472.CAN-07-1206; Roy BC, 2015, ONCOGENE, V34, P4519, DOI 10.1038/onc.2014.386; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Scaldaferri F, 2012, J CLIN GASTROENTEROL, V46, pS12, DOI 10.1097/MCG.0b013e31826ae849; Sellin JH, 2001, CANCER RES, V61, P2899; Sellin JH, 2009, EXP CELL RES, V315, P97, DOI 10.1016/j.yexcr.2008.10.019; Shajahan A, 2017, ANAL BIOANAL CHEM, V409, P4483, DOI 10.1007/s00216-017-0406-7; Staubach F, 2012, ISME J, V6, P1345, DOI 10.1038/ismej.2011.204; Thomsson KA, 2012, GLYCOBIOLOGY, V22, P1128, DOI 10.1093/glycob/cws083; Tremaroli V, 2010, GUT, V59, P1589, DOI 10.1136/gut.2010.223594; Tsuji S, 2009, GLYCOBIOLOGY, V19, P518, DOI 10.1093/glycob/cwp013; Umar S, 2003, CELL PROLIFERAT, V36, P361, DOI 10.1046/j.1365-2184.2003.00291.x; Vallance BA, 2002, INFECT IMMUN, V70, P2070, DOI 10.1128/IAI.70.4.2070-2081.2002; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang Y, 2006, BRIT J PHARMACOL, V148, P814, DOI 10.1038/sj.bjp.0706784; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yu QT, 2007, INFLAMM BOWEL DIS, V13, P191, DOI 10.1002/ibd.20053; Zhou QQ, 2012, J CELL MOL MED, V16, P1900, DOI 10.1111/j.1582-4934.2011.01485.x	72	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206701	10.1371/journal.pone.0206701	http://dx.doi.org/10.1371/journal.pone.0206701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383855	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600086
J	Baey, C; Yang, JP; Ronchese, F; Harper, JL				Baey, Camille; Yang, Jianping; Ronchese, Franca; Harper, Jacquie L.			Hyperuricaemic Urah(Plt2/Plt2) mice show altered T cell proliferation and defective tumor immunity after local immunotherapy with Poly I:C	PLOS ONE			English	Article							METABOLIC SYNDROME; URIC-ACID; MEDIATED CYTOTOXICITY; DENDRITIC CELLS; CANCER; RISK; ACTIVATION; MODULATOR; OBESITY	Hyperuricaemia is associated with various metabolic dysfunctions including obesity, type 2 diabetes mellitus, hypertension and in general metabolic syndrome, which are all associated with increased risk of cancer. However, the direct association between elevated uricemia and cancer mortality still remains unclear. In this study, we used a mouse model of hyperuricemia, the Urah(plt2/plt2) (PLT2) mouse, to investigate the effect of high uric acid levels on antitumor immune responses and tumor growth. In normo-uricaemic C57BL/6 mice injected with B16 melanomas, immunotherapy by treatment with Poly I:C at the tumor site delayed tumor growth compared to PBS treatment. In contrast, Poly I:C-treated hyper-uricaemic PLT2 mice were unable to delay tumor growth. Conventional and monocyte-derived dendritic cells in the tumor-draining lymph nodes (dLN) of C57BL/6 and PLT2 mice were similarly increased after Poly I:C immunotherapy, and expressed high levels of CD40 and CD86. CD8(+) T cells in the tumor-dLN and tumor of both WT and PLT2 mice were also increased after Poly I:C immunotherapy, and were able to secrete increased IFN gamma upon in vitro restimulation. Surprisingly, tumor-specific CD8(+) T cells in dLN were less abundant in PLT2 mice compared to C57BL/6, but showed a greater ability to proliferate even in the absence of cognate antigen. These data suggest that hyperuricaemia may affect the functionality of CD8(+) T cells in vivo, leading to dysregulated T cell proliferation and impaired antitumor activity.	[Baey, Camille; Yang, Jianping; Ronchese, Franca; Harper, Jacquie L.] Malaghan Inst Med Res, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington	Ronchese, F (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	fronchese@malaghan.org.nz		Yang, Jianping/0000-0001-5336-6530	Health Research Council of New Zealand [14-285]	Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was funded from Project grant 14-285 from the Health Research Council of New Zealand (http://www.hrc.govt.nz) to FR and JH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataera H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017515; Baldwin W, 2011, DIABETES, V60, P1258, DOI 10.2337/db10-0916; Ben Salem C, 2017, RHEUMATOLOGY, V56, P679, DOI 10.1093/rheumatology/kew293; Bhandari R, 2014, INT J BREAST CANCER, V2014, DOI 10.1155/2014/189384; Braga TT, 2017, SCI REP-UK, V7, DOI 10.1038/srep39884; Caravaca-Fontan F, 2017, MED CLIN-BARCELONA, V148, P121, DOI 10.1016/j.medcli.2016.10.040; Chen CJ, 2014, SCAND J RHEUMATOL, V43, P385, DOI 10.3109/03009742.2013.878387; Esposito K, 2014, ENDOCRINE, V45, P362, DOI 10.1007/s12020-013-0056-2; Esposito K, 2013, ENDOCRINE, V44, P634, DOI 10.1007/s12020-013-9939-5; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Fini MA, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-16; Gacci M, 2017, PROSTATE CANCER P D, V20, P146, DOI 10.1038/pcan.2017.1; Hauner D, 2014, BREAST CARE, V9, P277, DOI 10.1159/000365951; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Ishino K, 2013, CANCER LETT, V334, P56, DOI 10.1016/j.canlet.2012.10.012; Kemp RA, 2001, J IMMUNOL, V167, P6497, DOI 10.4049/jimmunol.167.11.6497; Kim Hyo Jin, 2015, Korean J Gastroenterol, V66, P202, DOI 10.4166/kjg.2015.66.4.202; Kuhn S, 2013, J IMMUNOL, V191, P1984, DOI 10.4049/jimmunol.1301135; Lima WG, 2015, BIOCHIMIE, V116, P17, DOI 10.1016/j.biochi.2015.06.025; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lu WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep12144; Lugade AA, 2005, J IMMUNOL, V174, P7516, DOI 10.4049/jimmunol.174.12.7516; Ma JW, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0046096, 10.1371/journal.pone.0041560]; Ma XJ, 2007, WORLD J GASTROENTERO, V13, P1060, DOI 10.3748/wjg.v13.i7.1060; Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009; Mendonca FM, 2015, METABOLISM, V64, P182, DOI 10.1016/j.metabol.2014.10.008; Micucci C, 2016, ONCOTARGET, V7, P38959, DOI 10.18632/oncotarget.8341; OEHLER JR, 1978, INT J CANCER, V21, P210, DOI 10.1002/ijc.2910210213; Olson OC, 2017, SCIENCE, V358, P1130, DOI 10.1126/science.aao5801; Sangkop F, 2016, MOL CELL BIOCHEM, V414, P187, DOI 10.1007/s11010-016-2671-8; Shi Y, 2006, J IMMUNOL, V176, P3905, DOI 10.4049/jimmunol.176.7.3905; Simpson ER, 2013, J MOL ENDOCRINOL, V51, pT51, DOI 10.1530/JME-13-0217; Smyth MJ, 2016, NAT REV CLIN ONCOL, V13, P143, DOI 10.1038/nrclinonc.2015.209; Steiger S, 2015, J IMMUNOL, V195, P5495, DOI 10.4049/jimmunol.1401755; Stevenson WS, 2010, P NATL ACAD SCI USA, V107, P16625, DOI 10.1073/pnas.1010390107; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Wang WJ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/680853	37	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206827	10.1371/journal.pone.0206827	http://dx.doi.org/10.1371/journal.pone.0206827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383838	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600100
J	Hall, JE; Greene, CM; Stefankiv, O; Anderson, JH; Timpane-Padgham, B; Beechie, TJ; Pess, GR				Hall, Jason E.; Greene, Correigh M.; Stefankiv, Oleksandr; Anderson, Joseph H.; Timpane-Padgham, Britta; Beechie, Timothy J.; Pess, George R.			Large river habitat complexity and productivity of Puget Sound Chinook salmon	PLOS ONE			English	Article							JUVENILE COHO SALMON; NORTH PACIFIC RIM; ONCORHYNCHUS-KISUTCH; LANDSCAPE CHARACTERISTICS; FLOODPLAIN HABITATS; SPECIES-DIVERSITY; ABUNDANCE; RESTORATION; SURVIVAL; GROWTH	While numerous studies have shown that floodplain habitat complexity can be important to fish ecology, few quantify how watershed-scale complexity influences productivity. This scale mismatch complicates population conservation and recovery strategies that evaluate recovery at regional or multi-basin scales. We used outputs from a habitat status and trends monitoring program for ten of Puget Sound's large river systems to examine whether juvenile Chinook salmon productivity relates to watershed-scale habitat complexity. We derived habitat complexity metrics that quantified wood jam densities, side and braid to main channel ratios, and node densities from a remote sensing census of Puget Sound's large river systems. Principal component analysis revealed that 91% of variance in these metrics could be explained by two principal components. These metrics revealed gradients in habitat complexity across Puget Sound which were sensitive to changes in complexity as a result of restoration actions in one watershed. Mixed effects models revealed that the second principle component term (PC2) describing habitat complexity was positively related to log transformed subyearling Chinook per spawner productivity rates from 6-18 cohorts per watershed. Total subyearling productivity (subyearlings per spawner) and fry productivity (subyearling fry per spawner) rates were best described by models that included a positive effect of habitat complexity (PC2) and negative relationships with log transformed peak flow recurrence interval, suggestive of reduced survival due to egg destruction during floods. Total subyearling productivity (subyearlings per spawner) and parr productivity (subyearling parr per spawner) rates were best described by models that included a positive effect of habitat complexity (PC2) and negative relationships with log transformed spawner density, suggestive of density dependent limits on juvenile rearing habitat. We also found that coefficient of variation for log transformed subyearling productivity and subyearling fry productivity rates declined with increasing habitat complexity, supporting the idea that habitat complexity buffers populations from annual variation in environmental conditions. Therefore, we conclude that our watershed-scale census-based approach provided habitat complexity metrics that explained some of the variability in productivity of subyearling juveniles among Chinook salmon populations. Furthermore, this approach may provide a useful means to track and evaluate aggregate effects of habitat changes on the productivity of Endangered Species Act (ESA) listed Chinook salmon populations over time.	[Hall, Jason E.; Greene, Correigh M.; Beechie, Timothy J.; Pess, George R.] NOAA, Natl Marine Fisheries Serv, Fish Ecol Div, Northwest Fisheries Sci Ctr, Seattle, WA 98115 USA; [Stefankiv, Oleksandr; Timpane-Padgham, Britta] NOAA, Ocean Associates Inc, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Anderson, Joseph H.] Washington Dept Fish & Wildlife, Olympia, WA USA; [Hall, Jason E.] Cramer Fish Sci, Issaquah, WA 98027 USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Washington Department of Fish & Wildlife (WDFW)	Hall, JE (corresponding author), NOAA, Natl Marine Fisheries Serv, Fish Ecol Div, Northwest Fisheries Sci Ctr, Seattle, WA 98115 USA.; Hall, JE (corresponding author), Cramer Fish Sci, Issaquah, WA 98027 USA.	Jason.Hall@fishsciences.net		Hall, Jason/0000-0001-5368-044X	National Oceanic and Atmospheric Administration (NOAA) Northwest Regional Office; Ocean Associates, Inc.; Cramer Fish Sciences	National Oceanic and Atmospheric Administration (NOAA) Northwest Regional Office; Ocean Associates, Inc.; Cramer Fish Sciences	Funding for this research was primarily provided by the National Oceanic and Atmospheric Administration (NOAA) Northwest Regional Office, and work was completed by Northwest Fisheries Science Center's Watershed Program staff and contractors. The NOAA Northwest Regional Office had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Additional support in preparing the manuscript and for conducting the analysis and research was provided in the form of salary by Ocean Associates, Inc. for authors OS and BTP. Cramer Fish Sciences also provided funding in the form of salary for the primary author JEH to prepare and revise the manuscript. Ocean Associates, Inc. and Cramer Fish Sciences provided support in the form of salaries but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbe TB, 1996, REGUL RIVER, V12, P201, DOI 10.1002/(SICI)1099-1646(199603)12:2/3<201::AID-RRR390>3.0.CO;2-A; Almany GR, 2004, OIKOS, V106, P275, DOI 10.1111/j.0030-1299.2004.13193.x; Amoros C, 2002, FRESHWATER BIOL, V47, P761, DOI 10.1046/j.1365-2427.2002.00905.x; Anderson JH, N AM J FISH MANA, V38, P180; Anlauf-Dunn KJ, 2014, CAN J FISH AQUAT SCI, V71, P1864, DOI 10.1139/cjfas-2014-0162; [Anonymous], 1982, ESTIMATION ANIMAL AB; Barton K., 2012, MUMIN MULTIMODEL INF; Bartz KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124415; Bates D, 2014, FITTING LINEAR MIXED; Beamer E, 2005, SKAGIT CHINOOK REC S; BECK MW, 1995, ECOLOGY, V76, P968, DOI 10.2307/1939360; Beechie T, 2013, RIVER RES APPL, V29, P939, DOI 10.1002/rra.2590; Beechie T., 1994, North American Journal of Fisheries Management, V14, P797, DOI 10.1577/1548-8675(1994)014<0797:ECSRHA>2.3.CO;2; Beechie T., 2017, NMFSNWFSC137 NOAA; Beechie TJ, 2006, GEOMORPHOLOGY, V78, P124, DOI 10.1016/j.geomorph.2006.01.030; Beechie TJ, 2015, RESTOR ECOL, V23, P75, DOI 10.1111/rec.12131; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Bottom D. L, 2005, NMFSNWFSC68 NOAA; Burnham K P, 2003, MODEL SELECT MULTIMO; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Carlson Stan R., 1998, Alaska Fishery Research Bulletin, V5, P88; City of Renton, 2009, SWP273046; Collins BD, 2002, RESTOR ECOL, V10, P237, DOI 10.1046/j.1526-100X.2002.01023.x; Dunne T., 1978, WATER ENV PLANNING; Ellings CS, 2016, RESTOR ECOL, V24, P415, DOI 10.1111/rec.12333; Flitcroft RL, 2012, AQUAT CONSERV, V22, P288, DOI 10.1002/aqc.2228; Fox J., 2007, R FDN STAT COMP; Fullerton AH, 2010, FRESHWATER BIOL, V55, P2215, DOI 10.1111/j.1365-2427.2010.02448.x; Hamman JJ, 2016, NORTHWEST SCI, V90, P57; Healey M. C., 1980, ECOLOGY JUVENILE SAL; Hojesjo J, 2004, BEHAV ECOL SOCIOBIOL, V56, P286, DOI 10.1007/s00265-004-0784-7; Jeffres CA, 2008, ENVIRON BIOL FISH, V83, P449, DOI 10.1007/s10641-008-9367-1; Konrad C.P., 2015, 20155033 US GEOL SUR; Latterell JJ, 2016, MONITORING MAINTENAN; Lowery ED, 2017, SEASONAL DISTRIBUTIO; Luck M, 2010, EARTH SURF PROC LAND, V35, P1330, DOI 10.1002/esp.2044; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; Mantua N, 2010, CLIMATIC CHANGE, V102, P187, DOI 10.1007/s10584-010-9845-2; Martens KD, 2014, T AM FISH SOC, V143, P757, DOI 10.1080/00028487.2014.880740; Montgomery DR, 1996, CAN J FISH AQUAT SCI, V53, P1061, DOI 10.1139/cjfas-53-5-1061; Myers J, 1998, NOAA TECH MEMO, P443; Naiman R.J., 2002, PSWGTR181 USDA FOR S; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Ogston L, 2015, CAN J FISH AQUAT SCI, V72, P479, DOI 10.1139/cjfas-2014-0189; Pess George R., 2005, P127; Pess GR, 2002, CAN J FISH AQUAT SCI, V59, P613, DOI 10.1139/F02-035; Quinn TP, 1996, CAN J FISH AQUAT SCI, V53, P1555, DOI 10.1139/cjfas-53-7-1555; Roni P., 2015, CANADIAN J FISHERIES, V73, P1047; Roni P, 2010, N AM J FISH MANAGE, V30, P1469, DOI 10.1577/M09-162.1; Rosenfeld JS, 2008, N AM J FISH MANAGE, V28, P1108, DOI 10.1577/M07-027.1; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Simenstad CA, 1982, ESTUARINE COMP, P343; Sommer TR, 2001, CAN J FISH AQUAT SCI, V58, P325, DOI 10.1139/cjfas-58-2-325; Steel EA, 2012, CAN J FISH AQUAT SCI, V69, P457, DOI 10.1139/F2011-161; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Volkhardt Gregory C., 2007, P235; Waples RS, 2009, ECOL SOC, V14; Ward EJ, 2015, GLOBAL CHANGE BIOL, V21, P2500, DOI 10.1111/gcb.12847; Whited D, 2002, RIVER RES APPL, V18, P583, DOI 10.1002/rra.695; Whited DC, 2012, FISHERIES, V37, P305, DOI 10.1080/03632415.2012.696009; Zimmerman MS, 2015, T AM FISH SOC, V144, P627, DOI 10.1080/00028487.2015.1017658	62	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205127	10.1371/journal.pone.0205127	http://dx.doi.org/10.1371/journal.pone.0205127			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383778	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600016
J	Sottimano, I; Guidetti, G; Converso, D; Viotti, S				Sottimano, Ilaria; Guidetti, Gloria; Converso, Daniela; Viotti, Sara			We cannot be "forever young," but our children are: A multilevel intervention to sustain nursery school teachers' resources and well-being during their long work life cycle	PLOS ONE			English	Article							SPANISH BURNOUT INVENTORY; EMPLOYEE MENTAL-HEALTH; OCCUPATIONAL-HEALTH; PSYCHOMETRIC PROPERTIES; PHYSICAL-EXERCISE; JOB-SATISFACTION; SOCIAL SUPPORT; ABILITY; STRESS; PROFESSIONALS	Introduction The aging of workers generally implies an increased number of workers with health problems or psychological diseases because of the growing distance between personal resources and job demands; the first may decrease, while the second are stable. In the preschool setting, the demands remain constant because children are always aged 0-3 years, while the preschool teacher's personal resources decrease with age. It is, therefore, necessary to propose multilevel interventions aimed at supporting work sustainability and workers' resources. Method This study involved twenty-seven preschools (324 teachers with an average age of 48.7 years): the control group included seventeen schools (190 teachers with an average age of 48.5 years), five schools were assigned to experimental group one (69 teachers with an average age of 48.8), and five schools were assigned to experimental group two (65 teachers with an average age of 49.1). In this context, we proposed two protocols of multilevel intervention comprising three solutions; two of these were common to both experimental groups: psychological counseling and psychosocial intervention. The third solution differed between groups: environmental redefinition (for group one); gymnastic and vocal hygiene (for group two). We hypothesized that the interventions improve teachers' work abilities, increase well-being, and decrease stress and burnout. Furthermore we hypothesized that there would be an improvement in the organizational climate of trust and in social job resources. Results Data analysis showed that the interventions were effective. In particular, the experimental groups reported significant decreases in psychological exhaustion (EG2: beta = -1.48; p = .00), indolence (EG1: beta = -1.36; p = .00), and stress (EG2: beta = -0.94; p = .00). Furthermore, the experimental groups significantly increased their enthusiasm towards work (EG2: beta = 1.21; p = .01), vertical trust (EG1: beta = 0.54; p = .01), and the perception of coworker social support (EG2: beta = 0.54; p = .01). The protocol that involved the GC2 was particularly effective. Conclusions These results demonstrate the effectiveness of the intervention in a particular job setting (preschool classroom), emphasizing the need for implementing solutions aimed at supporting workers' well-being, especially in light of an aging workforce.	[Sottimano, Ilaria; Guidetti, Gloria; Converso, Daniela; Viotti, Sara] Univ Turin, Dept Psychol, Turin, Italy	University of Turin	Converso, D (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	daniela.converso@unito.it	Converso, Daniela/K-6369-2017; viotti, sara/L-2650-2015	Converso, Daniela/0000-0002-6780-4746; viotti, sara/0000-0001-9026-9334; Guidetti, Gloria/0000-0002-7157-658X	Italian Association of Psychology (AIP); University of Turin	Italian Association of Psychology (AIP); University of Turin	The Italian Association of Psychology (AIP) awarded and granted Ilaria Sottimano for its Phd Thesis in 2017. The University of Turin funded Prof. Daniela Converso (Local Funds for Scientific Research 2016).	[Anonymous], 2007, OECD J BUDGETING, DOI [10.1787/budget-v7-art23-en, DOI 10.1787/BUDGET-V7-ART23-EN]; Arnetz BB, 2011, J OCCUP ENVIRON MED, V53, P34, DOI 10.1097/JOM.0b013e3181ffo5b; Avallone F., 2005, SALUTE ORGANIZZATIVA; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Baruch-Feldman Caren, 2002, J Occup Health Psychol, V7, P84, DOI 10.1037/1076-8998.7.1.84; Bright KA, 1999, OCCUP MED-OXFORD, V49, P427, DOI 10.1093/occmed/49.7.427; Burford EM, 2017, ERGONOMICS, V60, P1718, DOI 10.1080/00140139.2017.1340673; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Clipa O, 2015, PROCD SOC BEHV, V180, P907, DOI 10.1016/j.sbspro.2015.02.241; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Converso D, 2015, MED LAV, V106, P91; Cooley E, 1996, EXCEPT CHILDREN, V62, P336, DOI 10.1177/001440299606200404; de Jonge J, 2006, J APPL PSYCHOL, V91, P1359, DOI 10.1037/0021-9010.91.5.1359; de Lange AH, 2015, SIOP ORGAN FRONT SER, P50; dell'educatore dei Servizi della Prima Infanzia, 2002, RIC NELL REG UMBR RU; Drabe D, 2015, INT J HUM RESOUR MAN, V26, P783, DOI 10.1080/09585192.2014.939101; Foni A, 2015, LA RELAZIONE CON LE; Gibson JA, 2009, J AUTISM DEV DISORD, V39, P1024, DOI 10.1007/s10803-009-0709-4; Gil-Monte PR, 2017, LIBERABIT-LIMA, V23, P153, DOI 10.24265/liberabit.2017.v23n2.01; Gil-Monte PR, 2011, SPAN J PSYCHOL, V14, P441, DOI 10.5209/rev_SJOP.2011.v14.n1.40; Godinho Marluce Rodrigues, 2016, BMC Res Notes, V9, P1, DOI 10.1186/s13104-015-1837-x; Grant KA, 1995, APPL ERGON, V26, P405, DOI 10.1016/0003-6870(95)00057-7; Gratz RR., 2002, EARLY CHILD DEV CARE, V172, P531, DOI [10.1080/03004430215109, DOI 10.1080/03004430215109]; Hargrove MB, 2011, STRESS HEALTH, V27, P182, DOI 10.1002/smi.1417; Harvey Steve, 2003, J Occup Health Psychol, V8, P306, DOI 10.1037/1076-8998.8.4.306; Hatinen M., 2007, INT J STRESS MANAG, V14, P227, DOI DOI 10.1037/1072-5245.14.3.227; Hedderich I, 2017, IJHSS, V3, P38; Ilmarinen J., 1997, SCAND J WORK ENV HEA, V23, P19; Ilmarinen J., 2015, MULTIAGE WORKFORCE U; Jungbauer J, 2014, GESUNDHEITSWESEN, V76, P1; Kaiser J, 1993, EARLY CHILD RES Q, V87, P15, DOI DOI 10.1080/0300443930870102; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; King Phyllis M, 2006, Work, V26, P13; Kobayashi Y, 2008, J OCCUP HEALTH, V50, P455, DOI 10.1539/joh.L7166; Kooij DTAM, 2014, PSYCHOL AGING, V29, P319, DOI 10.1037/a0036768; Kristensen TS, 2005, SCAND J WORK ENV HEA, V31, P438, DOI 10.5271/sjweh.948; Kwok C, 2016, J NURS MANAGE, V24, P500, DOI 10.1111/jonm.12350; Labaj A, 2016, INT J IND ERGONOM, V54, P83, DOI 10.1016/j.ergon.2016.05.003; Lambert MJ., 2013, BERGING GARFIELDS HD; Loch CH, 2010, HARVARD BUSINESS REV; Maatouk I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191000; Macciocu L, 2005, ISPESL PREV OGGI, V2-3, P59; Martin A, 2016, STRESS HEALTH, V32, P201, DOI 10.1002/smi.2593; Matzolumi A., 2012, J OCCUP HEALTH, V54, P112, DOI [10.1539/joh.11-0150-OA, DOI 10.1539/JOH.11-0150-OA]; McDermott HJ, 2010, OCCUP MED-OXFORD, V60, P193, DOI 10.1093/occmed/kqq026; McGonagle AK, 2014, EUR J WORK ORGAN PSY, V23, P830, DOI 10.1080/1359432X.2013.819158; Mikkelsen A., 2003, INT J STRESS MANAGE, V10, P91, DOI [10.1037/1072-5245.10.2.91, DOI 10.1037/1072-5245.10.2.91]; Monteiro MS, 2006, INT J OCCUP SAF ERGO, V12, P417, DOI 10.1080/10803548.2006.11076703; Naczenski LM, 2017, J OCCUP HEALTH, V59, P477, DOI 10.1539/joh.17-0050-RA; Narumoto J, 2008, PSYCHIAT CLIN NEUROS, V62, P174, DOI 10.1111/j.1440-1819.2008.01751.x; OECD, 2007, PUBL SECT PENS CHALL; OECD [Organization for Economic Cooperation and Development], 2014, ED IND FOC; Ono Y, 2002, IND HEALTH, V40, P149, DOI 10.2486/indhealth.40.149; Pignata S, 2015, STRESS HEALTH, V31, P24, DOI 10.1002/smi.2517; Poscia A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1518-z; Rentzou K, 2015, EDUC 3-13, V43, P249, DOI 10.1080/03004279.2013.804853; Rivilis I, 2008, APPL ERGON, V39, P342, DOI 10.1016/j.apergo.2007.08.006; Rothermund E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169559; Schalk R, 2010, EUR J WORK ORGAN PSY, V19, P76, DOI 10.1080/13594320802674629; Schwarz UV, 2008, SCAND J WORK ENV HEA, V34, P179, DOI 10.5271/sjweh.1227; Shimaoka M, 1998, EUR J APPL PHYSIOL O, V77, P10; Sjogren T, 2005, PAIN, V116, P119, DOI 10.1016/j.pain.2005.03.031; Snyder J, 2009, SOUTH COMMUN J, V74, P373, DOI 10.1080/10417940802516834; Solem PE, 2008, IJAL, V3, P43, DOI DOI 10.3384/IJAL.1652-8670.083243; Sottimano I., 2017, OCCUP MED; Sparks K, 2001, J OCCUP ORGAN PSYCH, V74, P489, DOI 10.1348/096317901167497; Stouten J., 2002, SOC JUSTICE RES, V16, P41, DOI [10.1023/A:1022974027023, DOI 10.1023/A:1022974027023]; Timms C, 2007, ADV ORG PSYCHOL; Truxillo DM, 2012, ORGAN PSYCHOL REV, V2, P340, DOI 10.1177/2041386612454043; TUOMI K, 1991, SCAND J WORK ENV HEA, V17, P128; Tuomi K, 2001, OCCUP MED-OXFORD, V51, P318, DOI 10.1093/occmed/51.5.318; Viotti S, 2017, PSICOLOGIA SALUTE, V22, P123; Viotti S, 2017, INT J OCCUP SAF ERGO, V23, P544, DOI 10.1080/10803548.2016.1267976; Viotti S, 2015, REV ESC ENFERM USP, V49, P819, DOI 10.1590/S0080-623420150000500016; Wergeland EL, 2003, SCAND J WORK ENV HEA, V29, P27, DOI 10.5271/sjweh.701; Yurur S, 2012, ADMIN SOC WORK, V36, P457, DOI 10.1080/03643107.2011.613365; Zacher H, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01007; ZHANG L, 2016, BMC PUBLIC HEALTH, V16, DOI DOI 10.1186/S12889-016-2800-Z	78	8	8	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206627	10.1371/journal.pone.0206627	http://dx.doi.org/10.1371/journal.pone.0206627			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383801	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600075
J	Vitale, F; Shen, W; Driscoll, N; Burrell, JC; Richardson, AG; Adewole, O; Murphy, B; Ananthakrishnan, A; Oh, H; Wang, T; Lucas, TH; Cullen, DK; Allen, MG; Litt, B				Vitale, Flavia; Shen, Wendy; Driscoll, Nicolette; Burrell, Justin C.; Richardson, Andrew G.; Adewole, Oladayo; Murphy, Brendan; Ananthakrishnan, Akshay; Oh, Hanju; Wang, Theodore; Lucas, Timothy H.; Cullen, D. Kacy; Allen, Mark G.; Litt, Brian			Biomimetic extracellular matrix coatings improve the chronic biocompatibility of microfabricated subdural microelectrode arrays	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; RESPONSIVE NEUROSTIMULATION; NEURONAL DENSITY; NEURAL PROBES; ELECTRODES; IMPEDANCE; TETRAPLEGIA; IMPLANTS; ADHESION; SURFACE	Intracranial electrodes are a vital component of implantable neurodevices, both for acute diagnostics and chronic treatment with open and closed-loop neuromodulation. Their performance is hampered by acute implantation trauma and chronic inflammation in response to implanted materials and mechanical mismatch between stiff synthetic electrodes and pulsating, natural soft host neural tissue. Flexible electronics based on thin polymer films patterned with microscale conductive features can help alleviate the mechanically induced trauma; however, this strategy alone does not mitigate inflammation at the device-tissue interface. In this study, we propose a biomimetic approach that integrates microscale extracellular matrix (ECM) coatings on microfabricated flexible subdural microelectrodes. Taking advantage of a high-throughput process employing micro-transfer molding and excimer laser micromachining, we fabricate multi-channel subdural microelectrodes primarily composed of ECM protein material and demonstrate that the electrochemical and mechanical properties match those of standard, uncoated controls. In vivo ECoG recordings in rodent brain confirm that the ECM microelectrode coatings and the protein interface do not alter signal fidelity. Astrogliotic, foreign body reaction to ECM coated devices is reduced, compared to uncoated controls, at 7 and 30 days, after subdural implantation in rat somatosensory cortex. We propose microfabricated, flexible, biomimetic electrodes as a new strategy to reduce inflammation at the device-tissue interface and improve the long-term stability of implantable subdural electrodes.	[Vitale, Flavia; Driscoll, Nicolette; Murphy, Brendan; Lucas, Timothy H.; Litt, Brian] Univ Penn, Ctr Neu Roengn & Therapeut, Philadelphia, PA 19104 USA; [Vitale, Flavia; Litt, Brian] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Vitale, Flavia] Univ Penn, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA; [Vitale, Flavia; Burrell, Justin C.; Adewole, Oladayo; Cullen, D. Kacy] Corporal Michael J Crescenz VA Med Ctr, Ctr Neu Rotrauma, Philadelphia, PA 19104 USA; [Shen, Wendy; Ananthakrishnan, Akshay; Oh, Hanju] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA; [Driscoll, Nicolette; Burrell, Justin C.; Adewole, Oladayo; Murphy, Brendan; Wang, Theodore; Cullen, D. Kacy; Litt, Brian] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Burrell, Justin C.; Richardson, Andrew G.; Lucas, Timothy H.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Allen, Mark G.] Univ Penn, Dept Elect & Syst Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Vitale, F (corresponding author), Univ Penn, Ctr Neu Roengn & Therapeut, Philadelphia, PA 19104 USA.; Vitale, F (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.; Vitale, F (corresponding author), Univ Penn, Dept Phys Med & Rehabil, Philadelphia, PA 19104 USA.; Vitale, F (corresponding author), Corporal Michael J Crescenz VA Med Ctr, Ctr Neu Rotrauma, Philadelphia, PA 19104 USA.	vitalef@pennmedicine.upenn.edu	Ananthakrishnan, Akshay/Y-7819-2018; Driscoll, Nicolette/AAR-3699-2021; Vitale, Flavia/AAS-1918-2020; Richardson, Andrew G./AAI-1645-2020; Burrell, Justin C./AAW-2310-2020; Ananthakrishnan, Akshay/ABG-8007-2020	Driscoll, Nicolette/0000-0001-8364-460X; Richardson, Andrew G./0000-0002-4752-3867; Burrell, Justin C./0000-0002-5361-9224; Ananthakrishnan, Akshay/0000-0002-2791-9514; Vitale, Flavia/0000-0001-8644-550X; Murphy, Brendan/0000-0003-3021-6286	National Institutes of Health [U01-NS094340, R01NS099348]; Department of Veterans Affairs [BLRD Merit Review] [I01-BX003748]; Citizens United for Research in Epilepsy Taking Flight Award; Mirowski Family Foundation; National Science Foundation [DGE 1321851, 1542153]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS094340, R01NS099348] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs [BLRD Merit Review]; Citizens United for Research in Epilepsy Taking Flight Award; Mirowski Family Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the National Institutes of Health [U01-NS094340 (Cullen) & R01NS099348 (Litt)], Department of Veterans Affairs [BLR&D Merit Review I01-BX003748 (Cullen)], Citizens United for Research in Epilepsy Taking Flight Award (Vitale), Mirowski Family Foundation, and Neil and Barbara Smit (Litt), National Science Foundation [DGE 1321851 (Driscoll), (Murphy) & REU Program, Award #1542153 (Murphy). Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; ANDERSON JC, 1968, NATURE, V218, P166, DOI 10.1038/218166a0; Azemi E, 2011, BIOMATERIALS, V32, P681, DOI 10.1016/j.biomaterials.2010.09.033; Baldermann JC, 2016, BRAIN STIMUL, V9, P957, DOI 10.1016/j.brs.2016.09.003; Bergey GK, 2015, NEUROLOGY, V84, P810, DOI 10.1212/WNL.0000000000001280; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Bouafsoun A, 2007, MACROMOL BIOSCI, V7, P599, DOI 10.1002/mabi.200600263; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Carrette S, 2015, EXPERT REV NEUROTHER, V15, P1445, DOI 10.1586/14737175.2015.1113875; Chen R, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.93; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; De Faveri Sara, 2014, Front Neuroeng, V7, P7, DOI 10.3389/fneng.2014.00007; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Fong JS, 2012, AM J CLIN PATHOL, V138, P506, DOI 10.1309/AJCPGSNL9VDVNJMX; Franks W, 2005, IEEE T BIO-MED ENG, V52, P1295, DOI 10.1109/TBME.2005.847523; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Goodno B. J., 2017, MECH MAT; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Gunasekera B, 2015, ACS CHEM NEUROSCI, V6, P68, DOI 10.1021/cn5002864; Gutowski SM, 2014, J BIOMED MATER RES A, V102, P1486, DOI 10.1002/jbm.a.34799; He W, 2006, J NEURAL ENG, V3, P316, DOI 10.1088/1741-2560/3/4/009; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jarosiewicz B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7328; Karumbaiah L, 2013, BIOMATERIALS, V34, P8061, DOI 10.1016/j.biomaterials.2013.07.016; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; Kim DH, 2004, J BIOMED MATER RES A, V71A, P577, DOI 10.1002/jbm.a.30124; Kovacs GTA, 1994, ENABLING TECHNOLOGIE; Kumar VA, 2014, BIOMED MATER, V9, DOI 10.1088/1748-6041/9/1/011002; Lacour SP, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.63; Lau LW, 2013, NAT REV NEUROSCI, V14, P722, DOI 10.1038/nrn3550; Lazarov-Spiegler O, 1997, NEUROSCI LETT, pS32; Lecomte A, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aa8b4f; Lempka SF, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045006; Lipsman N, 2013, LANCET, V381, P1361, DOI 10.1016/S0140-6736(12)62188-6; Lozano A, 2015, BRAIN STIMUL, V8, P432, DOI DOI 10.1016/J.BRS.2015.01.378; Luan L, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601966; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Moisel M, 2008, ADV ENG MATER, V10, pB33, DOI 10.1002/adem.200800184; Nagaraj V, 2015, J CLIN NEUROPHYSIOL, V32, P194, DOI 10.1097/WNP.0000000000000139; Obien MEJ, 2014, REVEALING NEURONAL F, P1, DOI [10.3389/fnins.2014.00423/abstract, DOI 10.3389/FNINS.2014.00423/ABSTRACT]; Potter KA, 2014, ACTA BIOMATER, V10, P2209, DOI 10.1016/j.actbio.2014.01.018; Rush AJ, 2000, BIOL PSYCHIAT, V47, P276, DOI 10.1016/S0006-3223(99)00304-2; Schendel AA, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/4/046011; Shen W, 2015, MICROSYST NANOENG, V1, DOI 10.1038/micronano.2015.10; Shi YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep40000; Sillay KA, 2013, BRAIN STIMUL, V6, P718, DOI 10.1016/j.brs.2013.02.001; Sommakia S, 2014, CURR OPIN SOLID ST M, V18, P319, DOI 10.1016/j.cossms.2014.07.005; Stephan CL, 2001, EPILEPSIA, V42, P895, DOI 10.1046/j.1528-1157.2001.042007895.x; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Subbaroyan J, 2005, J NEURAL ENG, V2, P103, DOI 10.1088/1741-2560/2/4/006; Tate CC, 2007, EXP NEUROL, V207, P13, DOI 10.1016/j.expneurol.2007.05.008; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; Ung HM, 2017, J NEURAL ENG, V14, DOI 10.1088/1741-2552/aa7f40; Vitale F., 2018, BIOELECTRON MED, V1, P3, DOI 10.2217/bem-2017-0010; Vitale F, 2018, NANO LETT, V18, P326, DOI 10.1021/acs.nanolett.7b04184; Vitale F, 2015, ACS NANO, V9, P4465, DOI 10.1021/acsnano.5b01060; Viventi J, 2011, NAT NEUROSCI, V14, P1599, DOI 10.1038/nn.2973; Wu C, 2012, NEUROMODULATION, V16, P46, DOI [10.1111/j.1525-1403.2012, DOI 10.1111/J.1525-1403.2012]; Yu KJ, 2016, NAT MATER, V15, P782, DOI [10.1038/nmat4624, 10.1038/NMAT4624]; Zhong YH, 2007, BRAIN RES, V1148, P15, DOI 10.1016/j.brainres.2007.02.024	64	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206137	10.1371/journal.pone.0206137	http://dx.doi.org/10.1371/journal.pone.0206137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383805	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600029
J	Karsch-Bluman, A; Feiglin, A; Arbib, E; Stern, T; Shoval, H; Schwob, O; Berger, M; Benny, O				Karsch-Bluman, Adi; Feiglin, Ariel; Arbib, Eliran; Stern, Tal; Shoval, Hila; Schwob, Ouri; Berger, Michael; Benny, Ofra			Tissue necrosis and its role in cancer progression	ONCOGENE			English	Article							CELL SURVIVAL; TUMOR-CELLS; MOLECULAR-PATTERNS; METABOLIC STRESS; HYPOXIA; ADHESION; EXPRESSION; MEDIATORS; INVASION; PROLIFERATION	Great efforts have been made in revealing the mechanisms governing cancer resistance and recurrence. The in-situ effects of cell death, caused by hypoxia and metabolic stress, were largely studied in association with inflammation. However, in this work, we focused on the direct effects of necrosis on cancer promotion and on the tumor microenvironment. The conditions leading to cell necrosis, upon nutrient and oxygen deprivation, were recapitulated in-vitro and were used to generate samples for computational proteomic analysis. Under these conditions, we identified clusters of enriched pathways that may be involved in tumor resistance, leading to cancer recurrence. We show that the content of necrotic cells enhances angiogenesis and proliferation of endothelial cells, induces vasculature, as well as increases migration, invasion, and cell-cell interactions. In-vivo studies, where MDA-MB-231 xenografts were exposed to necrotic lysates, resulted in an increase in both proliferation and angiogenesis. Histological analysis of tumor tissues revealed high expression levels of key mediators that were identified by proteomic analysis. Moreover, when cells were injected systemically, coupled with necrotic lysates, a higher number of large lesions was detected in the lung. Finally, using xenografts, we demonstrated that combining an antagonist of a necrotic signal with an anticancer treatment potentiates the prolonged therapeutic effect. This approach suggests a paradigm shift in which targeting late necrotic-secreted factors may increase survival and enhance the efficacy of anticancer therapy.	[Karsch-Bluman, Adi; Stern, Tal; Shoval, Hila; Schwob, Ouri; Benny, Ofra] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, Jerusalem, Israel; [Feiglin, Ariel] Harvard Med Sch, Dept Biomed Informat, Boston, MA 02115 USA; [Arbib, Eliran; Berger, Michael] Hebrew Univ Jerusalem, Fac Med, Lautenberg Ctr Immunol & Canc Res, IMRIC,Concern Fdn Labs, Jerusalem, Israel	Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Hebrew University of Jerusalem	Benny, O (corresponding author), Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res, Jerusalem, Israel.	ofrab@ekmd.huji.ac.il	Benny, Ofra/AAB-3294-2021		Marie Curie Career Integration Grants (CIG) [0305116]; Israel Cancer Association (ICA) [0394691]; Israel Foundation of Science (ISF) [0394883]; David R. Blum Center for Pharmacy at The Hebrew University; Shukor Gladi fund; Frances Brody fund; Eliyahu Pen Fund	Marie Curie Career Integration Grants (CIG); Israel Cancer Association (ICA); Israel Foundation of Science (ISF); David R. Blum Center for Pharmacy at The Hebrew University; Shukor Gladi fund; Frances Brody fund; Eliyahu Pen Fund	This study was kindly supported by grants from the Marie Curie Career Integration Grants (CIG) (No. 0305116), Israel Cancer Association (ICA) (No. 0394691), Israel Foundation of Science (ISF) (No. 0394883), David R. Blum Center for Pharmacy at The Hebrew University, The Shukor Gladi fund, The Frances Brody fund, and Eliyahu Pen Fund. We thank Dr. Gil Hornung and The De Botton Protein Profiling Institute of the Nancy and Stephen Grand Israel National Center for Personalized Medicine, Weizmann Institute of Science, for their support of the proteomic data generating process.	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Ahn SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24552; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Bredholt G, 2015, ONCOTARGET, V6, P39676, DOI 10.18632/oncotarget.5344; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Chung TW, 2017, J ETHNOPHARMACOL, V195, P309, DOI 10.1016/j.jep.2016.11.036; Comito G, 2014, ONCOGENE, V33, P2423, DOI 10.1038/onc.2013.191; Crowley LC, 2016, COLD SPRING HARB PRO, V2016; Cuvier C, 1997, CLIN EXP METASTAS, V15, P19; Eales KL, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.50; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Esmatabadi MJD, 2016, J BIOSCIENCES, V41, P497, DOI 10.1007/s12038-016-9624-y; Eustace A, 2013, RADIOTHER ONCOL, V108, P40, DOI 10.1016/j.radonc.2013.05.017; Festjens N, 2006, BBA-BIOENERGETICS, V1757, P1371, DOI 10.1016/j.bbabio.2006.06.014; Forte D, 2017, ONCOTARGET, V8, P2261, DOI 10.18632/oncotarget.13664; Franco M, 2011, BLOOD, V118, P2906, DOI 10.1182/blood-2011-01-331694; Gho YS, 2001, CANCER RES, V61, P4253; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hernandez C, 2016, ONCOGENE, V35, P5931, DOI 10.1038/onc.2016.104; Herszenyi L, 2012, DIGEST DIS, V30, P249, DOI 10.1159/000336914; Housman G, 2014, CANCERS, V6, P1769, DOI 10.3390/cancers6031769; Howard K, 2014, J SURG RES, V187, P19, DOI 10.1016/j.jss.2013.11.001; Indovina P, 2008, ANTICANCER RES, V28, P1013; Janakiram NB, 2009, CURR MOL MED, V9, P565, DOI 10.2174/156652409788488748; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Karsch-Bluman A, 2017, ONCOTARGET, V8, P32706, DOI 10.18632/oncotarget.16188; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kevil CG, 2004, J BIOL CHEM, V279, P19230, DOI 10.1074/jbc.M312025200; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Land Walter G, 2015, Sultan Qaboos Univ Med J, V15, pe157; Li W, 2013, MOL MED, V19, P203, DOI 10.2119/molmed.2013.00064; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu R, 2009, MOL CELL PROTEOMICS, V8, P70, DOI 10.1074/mcp.M800195-MCP200; Liu WD, 2012, ONCOL LETT, V4, P1315, DOI 10.3892/ol.2012.940; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Maurer AJ, 2015, INFLAMM RES, V64, P185, DOI 10.1007/s00011-015-0796-y; McIntosh A, 2007, AM J CLIN ONCOL-CANC, V30, P146, DOI 10.1097/01.coc.0000251357.45879.7f; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Polychronidis Alexandros C, 2003, Folia Med (Plovdiv), V45, P20; Rahman M, 2015, METABOLITES, V5, P571, DOI 10.3390/metabo5040571; Riffle S, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3319-0; Rosette C, 2005, CARCINOGENESIS, V26, P943, DOI 10.1093/carcin/bgi070; Rundqvist H, 2013, J INTERN MED, V274, P105, DOI 10.1111/joim.12091; Schroder C, 2011, J CANCER RES CLIN, V137, P1193, DOI 10.1007/s00432-011-0984-2; Shoval H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10699-y; Simard S, 2013, J CANCER SURVIV, V7, P300, DOI 10.1007/s11764-013-0272-z; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Sun Y, 2016, CANCER LETT, V380, P205, DOI 10.1016/j.canlet.2015.07.044; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Tomes L, 2003, BREAST CANCER RES TR, V81, P61, DOI 10.1023/A:1025476722493; Wellen KE, 2010, MOL CELL, V40, P323, DOI 10.1016/j.molcel.2010.10.004; Yang DG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35316; Yang M, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.144; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Yodkeeree S, 2010, EUR J PHARMACOL, V627, P8, DOI 10.1016/j.ejphar.2009.09.052; Zhang Q, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00071	62	53	53	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 14	2019	38	11					1920	1935		10.1038/s41388-018-0555-y	http://dx.doi.org/10.1038/s41388-018-0555-y			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	HO7XX	30390074				2022-12-26	WOS:000461164400010
J	Hur, WS; Mazinani, N; Lu, XJD; Byrnes, JR; Ho, L; Yeon, JH; Filipenko, S; Wolberg, AS; Jefferies, WA; Kastrup, CJ				Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Byrnes, James R.; Ho, Laura; Yeon, Ju Hun; Filipenko, Sam; Wolberg, Alisa S.; Jefferies, Wilfred A.; Kastrup, Christian J.			Coagulation factor XIIIa cross-links amyloid beta into dimers and oligomers and to blood proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CEREBRAL-HEMORRHAGE; MUTATION; PEPTIDE; PRECURSOR; TRANSGLUTAMINASE; ACCUMULATION; ACTIVATION; FIBRINOGEN; PLATELETS	In cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD), the amyloid beta (A beta) peptide deposits along the vascular lumen, leading to degeneration and dysfunction of surrounding tissues. Activated coagulation factor XIIIa (FXIIIa) covalently cross-links proteins in blood and vasculature, such as in blood clots and on the extracellular matrix. Although FXIIIa co-localizes with A beta in CAA, the ability of FXIIIa to cross-link A beta has not been demonstrated. Using Western blotting, kinetic assays, and micro-fluidic analyses, we show that FXIIIa covalently cross-links A beta 40 into dimers and oligomers (k(cat)/K-m = 1.5 x 10(5) M-1 s(-1)), as well as to fibrin, platelet proteins, and blood clots under flow in vitro. A beta 40 also increased the stiffness of platelet-rich plasma clots in the presence of FXIIIa. These results suggest that FXIIIa-mediated cross-linking may contribute to the formation of A beta deposits in CAA and Alzheimer's disease.	[Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Ho, Laura; Yeon, Ju Hun; Filipenko, Sam; Jefferies, Wilfred A.; Kastrup, Christian J.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Ho, Laura; Yeon, Ju Hun; Filipenko, Sam; Jefferies, Wilfred A.; Kastrup, Christian J.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V6T 1Z4, Canada; [Hur, Woosuk S.; Mazinani, Nima; Lu, X. J. David; Kastrup, Christian J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Microbiol & Immunol, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Med Genet, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Zool, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Jefferies, Wilfred A.] Univ British Columbia, Dept Urol, Djavad Mowafaghian Ctr Brain Hlth, Vancouver Prostate Ctr, Vancouver, BC V6T 1Z4, Canada; [Byrnes, James R.; Wolberg, Alisa S.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill	Kastrup, CJ (corresponding author), 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.	ckastrup@msl.ubc.ca		Hur, Woosuk Steve/0000-0001-5074-6423; Yefet, Leo/0000-0003-1504-1772	Canadian Foundation for Innovation [31928, 36305]; BC Knowledge Development Fund [31928]; Natural Sciences and Engineering Research Council [2018-04918]; Canadian Institutes of Health Research [FDN-148370, MOP-119426, MSH-130166, GSD-146294, OP-133635]; Michael Smith Foundation for Health Research [16498]; National Institutes of Health [R01HL126974]; National Science Foundation [DGE-1144081]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126974] Funding Source: NIH RePORTER	Canadian Foundation for Innovation(Canada Foundation for Innovation); BC Knowledge Development Fund(General Electric); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by Canadian Foundation for Innovation Grants 31928 and 36305 (to C. J. K.); BC Knowledge Development Fund Grant 31928 (to C. J. K.); Natural Sciences and Engineering Research Council Grant 2018-04918 (to C. J. K.); Canadian Institutes of Health Research Grants FDN-148370, MOP-119426, and MSH-130166 (to C. J. K.), GSD-146294 (to W. S. H. and C. J. K.), and OP-133635 (to W. A. J.); Michael Smith Foundation for Health Research Grant 16498 (to C. J. K.); National Institutes of Health Grant R01HL126974 (to A. S. W.); and National Science Foundation Grant DGE-1144081 (to J. R. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahn HJ, 2014, J EXP MED, V211, P1049, DOI 10.1084/jem.20131751; Ahn HJ, 2010, P NATL ACAD SCI USA, V107, P21812, DOI 10.1073/pnas.1010373107; Alonzo NC, 1998, J NEUROPATH EXP NEUR, V57, P353, DOI 10.1097/00005072-199804000-00008; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Biere AL, 1996, J BIOL CHEM, V271, P32916, DOI 10.1074/jbc.271.51.32916; Bochsen L, 2011, BLOOD COAGUL FIBRIN, V22, P167, DOI 10.1097/MBC.0b013e3283424911; Bugiani O, 2010, ARCH NEUROL-CHICAGO, V67, P987, DOI 10.1001/archneurol.2010.178; Canobbio I, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00065; Dale GL, 2002, NATURE, V415, P175, DOI 10.1038/415175a; de Jager M, 2016, NEUROPATH APPL NEURO, V42, P255, DOI 10.1111/nan.12244; Donner L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf6240; FERNANDEZMADRID I, 1991, ANN NEUROL, V30, P730, DOI 10.1002/ana.410300516; Gerardino L, 2006, NEUROL RES, V28, P807, DOI 10.1179/016164106X110454; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Hur WS, 2015, BLOOD, V126, P2329, DOI 10.1182/blood-2015-07-650713; Kucheryavykh LY, 2017, BRAIN RES BULL, V128, P98, DOI 10.1016/j.brainresbull.2016.11.008; Lewis KB, 1997, BIOCHEMISTRY-US, V36, P995, DOI 10.1021/bi961636z; LI QX, 1994, BLOOD, V84, P133, DOI 10.1182/blood.V84.1.133.133; Love S, 2009, FRONT BIOSCI-LANDMRK, V14, P4778, DOI 10.2741/3567; Milojevic J, 2014, J ALZHEIMERS DIS, V38, P753, DOI 10.3233/JAD-131169; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Sonkar VK, 2014, FASEB J, V28, P1819, DOI 10.1096/fj.13-243691; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yeon JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42119; Zamolodchikov D, 2016, J THROMB HAEMOST, V14, P995, DOI 10.1111/jth.13209; Zamolodchikov D, 2012, BLOOD, V119, P3342, DOI 10.1182/blood-2011-11-389668	30	15	15	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2019	294	2					390	396		10.1074/jbc.RA118.005352	http://dx.doi.org/10.1074/jbc.RA118.005352			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HO9XB	30409906	Green Published, hybrid			2022-12-26	WOS:000461318000001
J	Audia, S; Bach, B; Samson, M; Lakomy, D; Bour, JB; Burlet, B; Guy, J; Duvillard, L; Branger, M; Leguy-Seguin, V; Berthier, S; Michel, M; Bonnotte, B				Audia, Sylvain; Bach, Benoit; Samson, Maxime; Lakomy, Daniela; Bour, Jean-Baptiste; Burlet, Benedicte; Guy, Julien; Duvillard, Laurence; Branger, Marine; Leguy-Seguin, Vanessa; Berthier, Sabine; Michel, Marc; Bonnotte, Bernard			Venous thromboembolic events during warm autoimmune hemolytic anemia	PLOS ONE			English	Article							HEALTH-ORGANIZATION CLASSIFICATION; THROMBOTIC COMPLICATIONS; 2016 REVISION; RISK; CRITERIA; DISEASES; HEMOGLOBIN; COLLEGE; ADULTS	Thrombotic manifestations are a hallmark of many auto-immune diseases (AID), specially of warm autoimmune hemolytic anemia (wAIHA), as 15 to 33% of adults with wAIHA experience venous thromboembolic events (VTE). However, beyond the presence of positive antiphospholipid antibodies and splenectomy, risk factors for developing a VTE during wAIHA have not been clearly identified. The aim of this retrospective study was to characterize VTEs during wAIHA and to identify risk factors for VTE. Forty-eight patients with wAIHA were included, among whom 26 (54%) had secondary wAIHA. Eleven (23%) patients presented at least one VTE, that occurred during an active phase of the disease for 10/11 patients (90%). The frequency of VTE was not different between primary and secondary AIHA (23.7 vs. 19.2%; p = 0.5). The Padua prediction score based on traditional risk factors was not different between patients with and without VTE. On multivariate analysis, total bilirubin >= 40 mu mol/L [odds ratio (OR) = 7.4; p = 0.02] and leucocyte count above 7x10(9)/L (OR = 15.7; p = 0.02) were significantly associated with a higher risk of thrombosis. Antiphospholipid antibodies were screened in 9 out the 11 patients who presented a VTE and were negative. Thus, the frequency of VTE is high (23%) during wAIHA and VTE preferentially occur within the first weeks of diagnosis. As no clinically relevant predictive factors of VTE could be identified, the systematic use of a prophylactic anticoagulation should be recommended in case of active hemolysis and its maintenance after hospital discharge should be considered. The benefit of a systematic screening for VTE and its procedure remain to be determined.	[Audia, Sylvain; Bach, Benoit; Samson, Maxime; Leguy-Seguin, Vanessa; Berthier, Sabine; Bonnotte, Bernard] Univ Hosp, Dept Internal Med & Clin Immunol, Constitut Referral Ctr Autoimmune Cytopenias, Dijon, France; [Lakomy, Daniela] Univ Hosp, Immunol Lab, Dijon, France; [Bour, Jean-Baptiste] Univ Hosp, Dept Virol, Dijon, France; [Burlet, Benedicte; Guy, Julien] Univ Hosp, Hematobiol, Dijon, France; [Duvillard, Laurence] Univ Hosp, Biochemestry Lab, Dijon, France; [Branger, Marine] French Natl Blood Serv, Dijon, France; [Michel, Marc] Henri Mondor Univ Hosp, Dept Internal Med, Referral Ctr Autoimmune Cytopenias, Creteil, France	CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; CHU Dijon Bourgogne; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Audia, S (corresponding author), Univ Hosp, Dept Internal Med & Clin Immunol, Constitut Referral Ctr Autoimmune Cytopenias, Dijon, France.	sylvain.audia@u-bourgogne.fr	Audia, Sylvain/H-3366-2019; Samson, Maxime/ABE-1461-2021; Bonnotte, Bernard/ABA-2525-2021	Audia, Sylvain/0000-0003-1772-1392; Samson, Maxime/0000-0002-6547-232X; Bonnotte, Bernard/0000-0002-1098-4598; Guy, Julien/0000-0003-3594-1882	Direction de la Recherche Clinique du CHU de Dijon; Conseil Regional de Bourgogne 2012 (SA) [2012-A001154-39, NCT02158195]	Direction de la Recherche Clinique du CHU de Dijon; Conseil Regional de Bourgogne 2012 (SA)	This work was supported by a grant from the Direction de la Recherche Clinique du CHU de Dijon and the Conseil Regional de Bourgogne 2012 (SA, grant number: 2012-A001154-39; NCT02158195).	ALLGOOD JW, 1967, AM J MED, V43, P254, DOI 10.1016/0002-9343(67)90168-4; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Ataga KI, 2009, HAEMATOL-HEMATOL J, V94, P1481, DOI 10.3324/haematol.2009.013672; Baek Seung-Woo, 2011, Korean J Hematol, V46, P111, DOI 10.5045/kjh.2011.46.2.111; Barbar S, 2010, J THROMB HAEMOST, V8, P2450, DOI 10.1111/j.1538-7836.2010.04044.x; Barcellini W, 2014, BLOOD, V124, P2930, DOI 10.1182/blood-2014-06-583021; Bongarzoni V, 2005, HAEMATOLOGICA, V90, P711; Cappellini Maria Domenica, 2007, Hematology Am Soc Hematol Educ Program, P74; Chen G, 2014, BLOOD, V123, P3818, DOI 10.1182/blood-2013-10-529982; CROSBY WH, 1956, BLOOD, V11, P380, DOI 10.1182/blood.V11.4.380.380; Hendrick A M, 2003, Hematology, V8, P53, DOI 10.1080/1024533021000059474; Hill A, 2013, BLOOD, V121, P4985, DOI 10.1182/blood-2012-09-311381; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Johannesdottir SA, 2012, J THROMB HAEMOST, V10, P815, DOI 10.1111/j.1538-7836.2012.04666.x; Kokori SIG, 2000, AM J MED, V108, P198, DOI 10.1016/S0002-9343(99)00413-1; L'Acqua C, 2015, BRIT J HAEMATOL, V168, P175, DOI 10.1111/bjh.13183; Lecouffe-Desprets M, 2015, AUTOIMMUN REV, V14, P1023, DOI 10.1016/j.autrev.2015.07.001; Lundberg IE, 2017, ARTHRITIS RHEUMATOL, V69, P2271, DOI 10.1002/art.40320; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Peacock-Young B, 2018, HAEMATOLOGICA, V103, P9, DOI 10.3324/haematol.2017.177618; Pullarkat V, 2002, BRIT J HAEMATOL, V118, P1166, DOI 10.1046/j.1365-2141.2002.03729.x; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Ramagopalan SV, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-1; Roumier M, 2014, AM J HEMATOL, V89, pE150, DOI 10.1002/ajh.23767; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Ungprasert P, 2015, THROMB RES, V136, P1013, DOI 10.1016/j.thromres.2015.09.004; van Zaane B, 2010, J THROMB HAEMOST, V8, P2483, DOI 10.1111/j.1538-7836.2010.04034.x; Vardi M, 2013, J THROMB HAEMOST, V11, P467, DOI 10.1111/jth.12108; Weinkle TK, 2005, JAVMA-J AM VET MED A, V226, P1869, DOI 10.2460/javma.2005.226.1869; Yusuf HR, 2015, THROMB RES, V135, P50, DOI 10.1016/j.thromres.2014.10.012; Zoller B, 2012, AM J CARDIOVASC DIS, V2, P171; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	32	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207218	10.1371/journal.pone.0207218	http://dx.doi.org/10.1371/journal.pone.0207218			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408135	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300091
J	Chen, YC; Her, OS; Yen, NS				Chen, Ying-Chun; Her, One-Soon; Yen, Nai-Shing			Quantity processing of Chinese numeral classifiers: Distance and congruity effects	PLOS ONE			English	Article							MEASURE WORDS; NUMBER; REPRESENTATION; MAGNITUDE; SIZE; JUDGMENTS; ACCOUNT; BRAIN; TASK	A numeral classifier is required between a numeral and a noun in Chinese, which comes in two varieties, sortal classifier (C) and mensural classifier (M). A recent linguistic theory suggests that C/Ms carry quantity information, where C and M converge as the multiplicand, with numeral as the multiplier, but C and M diverge in the mathematical values they denote. However, previous empirical studies were sparse and presented inconsistent results. This study aimed to investigate the mathematical function of C/Ms using the number-size task in which participants had to choose from two C/M phrases the one that represents a larger quantity or in a larger font size. If C/M phrases engage quantity processing like numbers, distance and congruity effects should emerge. As expected, participants performed more accurately and faster at comparing two distant stimuli than two proximate ones, indicating that the mathematical values of C/M were represented like a mental number line. Moreover, participants' performance was partially influenced by the irrelevant information from the other dimension, suggesting that the mathematical values of C/Ms and the physical font size interfere with each other. These results corroborated that C/Ms play a role in magnitude cognition.	[Chen, Ying-Chun; Her, One-Soon] Natl Chengchi Univ, Grad Inst Linguist, Taipei, Taiwan; [Her, One-Soon; Yen, Nai-Shing] Natl Chengchi Univ, Res Ctr Mind Brain & Learning, Taipei, Taiwan; [Yen, Nai-Shing] Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan	National Chengchi University; National Chengchi University; National Chengchi University	Yen, NS (corresponding author), Natl Chengchi Univ, Res Ctr Mind Brain & Learning, Taipei, Taiwan.; Yen, NS (corresponding author), Natl Chengchi Univ, Dept Psychol, Taipei, Taiwan.	nsy@nccu.edu.tw	chen, ying/HHS-8254-2022		Ministry of Science and Technology [MOST 103-2410-H-004-136-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by the Ministry of Science and Technology (https://www.most.gov.tw/).Grant number: MOST 103-2410-H-004-136-MY3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BESNER D, 1979, NEUROPSYCHOLOGIA, V17, P467, DOI 10.1016/0028-3932(79)90053-8; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Cheng CC, 2005, DIGITAL RESOURCES CT; Chignell M., 2014, P HUM FACT ERG SOC A, V58, P1442, DOI [10.1177/1541931214581301, DOI 10.1177/1541931214581301]; Cui JX, 2013, NEUROPSYCHOLOGY, V27, P583, DOI 10.1037/a0033630; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; FOLTZ GS, 1984, J EXP PSYCHOL LEARN, V10, P442, DOI 10.1037/0278-7393.10.3.442; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; Her OS, 2018, BRAIN LANG, V176, P11, DOI 10.1016/j.bandl.2017.10.007; Her OS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185047; Her OS, 2012, LINGUA, V122, P1668, DOI 10.1016/j.lingua.2012.08.012; Her OS, 2012, LANG LINGUIST-TAIWAN, V13, P1211; Her OS, 2010, LANG LINGUIST-TAIWAN, V11, P527; Hsieh ML, 2008, INTERNAL STRUCTURE N; Kaufmann L, 2005, NEUROIMAGE, V25, P888, DOI 10.1016/j.neuroimage.2004.12.041; Li XP, 2012, LANG LINGUIST-TAIWAN, V13, P693; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Schwarz W, 2003, J EXP PSYCHOL HUMAN, V29, P507, DOI 10.1037/0096-1523.29.3.507; Walsh V, 2003, CURR BIOL, V13, pR447, DOI 10.1016/S0960-9822(03)00368-3; Zhou X, 2008, STUDY POLITENESS LAN	25	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206308	10.1371/journal.pone.0206308	http://dx.doi.org/10.1371/journal.pone.0206308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403734	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500063
J	Chiou, PY; Chien, CY; Lai, YH; Chun, CF				Chiou, Piao-Yi; Chien, Chih-Yin; Lai, Yi-Horng; Chun, Chang Feng			The effect evaluation of advanced penlight	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GLASGOW COMA SCALE; PUPIL SIZE; CARE-UNIT; PREDICTION; IMPACT	Pupil diameter measurement is crucial for physical assessment and disease monitoring in a health and nursing care situation. A general penlights (GPLs) is frequently used and allow for an approximate and indirect measurement of the pupil diameter. Health caregivers or nurses generally have less confidence in the value of the pupil diameter measured using the GPL. The Advanced Penlight (APL) is a new device designed for accurate measurement of the pupil diameter. The purpose of the presented research was to compare the accuracies and operational times of the pupil diameter measurements by means of the GPL and APL. One-group post-test and single-blind study designed was used in this study. The innovation of the APL is the addition of a perspective measurement ruler (PMR) attached to one side of the penlight that allows precise measurement of the pupil diameter before and after pupillary contraction. The PMR can be rotated by any angle for adaptation to the measurement conditions. After standard pupil diameter measurements by a refractometer (RM) were performed on a subjects, ninety study participants measured the pupil diameters of the same subject separately by the GPL and APL. A self-administered questionnaire was used to assess the opinions of the participants after using the GPL compare to the APL. The mean age of the participants was 20.01 (SD = 0.47) years and 83% of them were female senior nursing students. There were no statistically significant differences between the average values of pupil diameters measured by the APL and the RM. Compared to the GPL, the pupil diameter measured by APL was much similar to the RM measurement. The average operational time was 8.72 seconds shorter (t = -3.81, p = 0.001) for the APL measurement compared to the GPL measurement. The average scores of convenience and confidence on pupil diameter measurements of questionnaire were higher for the APL compared to the GPL. The APL can increase the accuracy and save operating time of pupil diameter measurement and thereby promote the quality of health assessment and nursing care practice.	[Chiou, Piao-Yi] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Chien, Chih-Yin] Mackay Med Nursing & Management Coll, Dept Nursing, Taipei, Taiwan; [Lai, Yi-Horng] Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan; [Chun, Chang Feng] Mackay Med Nursing & Management Coll, Dept Optometry, Taipei, Taiwan	National Taipei University of Nursing & Health Science (NTUNHS); Mackay Junior College of Medicine, Nursing & Management; Asia Eastern University of Science & Technology; Mackay Junior College of Medicine, Nursing & Management	Lai, YH (corresponding author), Oriental Inst Technol, Dept Hlth Care Adm, New Taipei, Taiwan.	FL006@mail.oit.edu.tw		Chiou, Piao-Yi/0000-0002-8255-6285				Adler G, 2015, AM J OPHTHALMOL, V159, P940, DOI 10.1016/j.ajo.2015.01.025; Anderson M, 2018, J NEUROSCI NURS, V50, P30, DOI 10.1097/JNN.0000000000000333; Ball JW, 2015, SEIDELS GUIDE PHYS E, P204; Bootsma S, 2007, ACTA OPHTHALMOL SCAN, V85, P324, DOI 10.1111/j.1600-0420.2006.00823.x; Broadway David C, 2016, Community Eye Health, V29, P68; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Damkliang J, 2014, AUSTRALAS EMERG NURS, V17, P152, DOI 10.1016/j.aenj.2014.05.005; Hoffmann M, 2012, BRIT J SURG, V99, P122, DOI 10.1002/bjs.7707; Iankova Andriana, 2006, Emerg Nurse, V14, P30; Jain S, 2008, INJURY, V39, P598, DOI 10.1016/j.injury.2007.06.003; Kloosterman NA, 2015, EUR J NEUROSCI, V41, P1068, DOI 10.1111/ejn.12859; Kobashi H, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/124327; LOWENSTEIN O, 1950, ARCH NEURO PSYCHIATR, V64, P313, DOI 10.1001/archneurpsyc.1950.02310270002001; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nowak W, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-69; Omburo L, 2017, J PERIANESTH NURS, V32, P219, DOI 10.1016/j.jopan.2015.05.117; Otero SC, 2011, PSYCHOPHYSIOLOGY, V48, P1346, DOI 10.1111/j.1469-8986.2011.01217.x; Pearce JMS, 1996, J NEUROL NEUROSUR PS, V61, P520, DOI 10.1136/jnnp.61.5.520; Rhoads J, 2018, ADV HLTH ASSSESSMENT, P92; Servadei F, 1998, J TRAUMA, V44, P868, DOI 10.1097/00005373-199805000-00021; Twa MD, 2004, J CATARACT REFR SURG, V30, P381, DOI 10.1016/S0886-3350(03)00619-9; Vizmanos JG, 2004, OPHTHAL PHYSL OPT, V24, P464, DOI 10.1111/j.1475-1313.2004.00230.x; Waterhouse C, 2005, NURSING STANDARD 201, V19, P56, DOI 10.7748/ns2005.04.19.33.56.c3857	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205978	10.1371/journal.pone.0205978	http://dx.doi.org/10.1371/journal.pone.0205978			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403695	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500040
J	Wang, XH; Hailing, RE; Hofstetter, V; Lebel, T; Buyck, B				Wang, Xiang-Hua; Hailing, Roy E.; Hofstetter, Valerie; Lebel, Teresa; Buyck, Bart			Phylogeny, biogeography and taxonomic re-assessment of Multifurca (Russulaceae, Russulales) using three-locus data	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; NORTH-AMERICAN; SPECIES RECOGNITION; MOLECULAR PHYLOGENY; RIBOSOMAL DNA; EASTERN ASIA; FUNGAL TREE; THIN LINE; SP NOV.; EVOLUTION	Multifurca is a small genus newly established to accommodate lactarioid and russuloid species with some characters reminiscent of corticoid members of Russulaceae. It shows an amphi-pacific distribution with strong preference for the tropical zone of the Northern Hemisphere and thus has particular significance for biogeographical study. Using worldwide samples and three loci (ITS, 28S rDNA and rpb2), we demonstrated that Multifurca is split into two highly supported major clades that are here recognized at the subgeneric level: subg. Furcata subg. nov. exclusively includes lactarioid species, while subg. Multifurca includes species with a russuloid habit. Using phylogenetic species recognition and comparison of genetic distances we recognize five new and six previously described species, almost double the known number of species before this study. Molecular dating using a Bayesian method suggested that Multifurca originated in early Paleocene and diversified in the Eocene. The most recent interspecific divergences occurred both in Asia and America, roughly at the same time around the Pliocene. Ancestral area reconstruction and comparisons of genetic distances and morphology suggested an early divergence within Australasia or tropical Asia. From the early Miocene to Pliocene, multiple dispersals/migrations to Australasia and North America by island hopping or land bridge likely happened. Vicariance at the late Tertiary might be the most likely mechanism accounting for the eastern Asia-southeastern North America and Australasia-tropical Asia disjunct distributions. The shared polymorphisms in the ITS alignment, numerous degenerated base pairs in the rpb2 sequences and weak conflict between the ITS and LSU genealogies of M. subg. Furcata suggest recent speciation. Host specificity of Multifurca species or species pairs is relatively low. Host shifts are believed to have aided establishment in new territories during the dispersals and migrations.	[Wang, Xiang-Hua] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Hailing, Roy E.] New York Bot Garden, Inst Systemat Bot, Bronx, NY 10458 USA; [Hofstetter, Valerie] Agroscope Plant Protect Mycol & Biotechnol Lab, Nyon, Switzerland; [Lebel, Teresa] Royal Bot Gardens Victoria, Natl Herbarium Victoria, Melbourne, Vic, Australia; [Buyck, Bart] Sorbonne Univ, CNRS, Museum Natl Hist Nat, Inst Systemat Ecol Biodiversite ISYEB, Paris, France	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; New York Botanical Garden; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Wang, XH (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming, Yunnan, Peoples R China.	xhwang@mail.kib.ac.cn		Lebel, Teresa/0000-0002-8592-1102	National Natural Science Foundation of China (NSFC) [30970020, 31093440, 31493010, 31493011]; Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-Z-0926]; National Science Foundation (US) [1020421]; Friends of the Royal Botanic Gardens Victoria	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Innovation Program of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Science Foundation (US)(National Science Foundation (NSF)); Friends of the Royal Botanic Gardens Victoria	This research was supported by the National Natural Science Foundation of China (NSFC): 30970020, 31093440, 31493010, 31493011, to XHW; the Innovation Program of the Chinese Academy of Sciences: No. KSCX2-YW-Z-0926, to XHW; the National Science Foundation (US): DEB #1020421, to REH; and Friends of the Royal Botanic Gardens Victoria, to TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon CD, 2015, P NATL ACAD SCI USA, V112, pE3631, DOI 10.1073/pnas.1511204112; Berbee Mary L., 2010, Fungal Biology Reviews, V24, P1, DOI 10.1016/j.fbr.2010.03.001; Berkeley MJ., 1859, BOT ANTARCTIC VOYA 3, P241; BILLS GF, 1984, MYCOLOGIA, V76, P975, DOI 10.2307/3793015; Binder M, 2006, MYCOLOGIA, V98, P971, DOI 10.3852/mycologia.98.6.971; Bonito G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052765; Buyck B, 2008, FUNGAL DIVERS, V28, P15; Buyck B, 2004, CRYPTOGAMIE MYCOL, V25, P127; Buyck B, 2003, CRYPTOGAMIE MYCOL, V24, P111; Buyck B, 2018, FUNGAL DIVERS, V89, P267, DOI 10.1007/s13225-018-0397-5; Buyck B, 2017, CRYPTOGAMIE MYCOL, V38, P101, DOI 10.7872/crym/v38.iss1.2017.101; Buyck B, 2014, FUNGAL DIVERS, V64, P101, DOI 10.1007/s13225-013-0272-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; COKER WC, 1918, J E MITCHELL SCI SOC, V34, P1; Das K, 2017, CRYPTOGAMIE MYCOL, V38, P527, DOI 10.7872/crym/v38.iss4.2017.527; De Crop E, 2017, PERSOONIA, V38, P58, DOI 10.3767/003158517X693255; Dentinger BTM, 2010, MOL PHYLOGENET EVOL, V57, P1276, DOI 10.1016/j.ympev.2010.10.004; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eberhardt U, 2004, MYCOL RES, V108, P1042, DOI 10.1017/S0953756204000784; Feng B, 2016, SCI REP-UK, V6, DOI 10.1038/srep25586; Feng B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037567; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Halling RE, 2008, MYCOL RES, V112, P437, DOI 10.1016/j.mycres.2007.11.021; Han LH, 2018, J BIOGEOGR, V45, P201, DOI 10.1111/jbi.13094; Heads M, 2006, J BIOGEOGR, V33, P1066, DOI 10.1111/j.1365-2699.2006.01479.x; Hesler L.R., 1979, N AM SPECIES LACTARI; Hibbett DS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-13; Hibbett DS, 1997, AM J BOT, V84, P981, DOI 10.2307/2446289; Hosaka K, 2008, MYCOL RES, V112, P448, DOI 10.1016/j.mycres.2007.06.004; Jairus T, 2011, NEW PHYTOL, V192, P179, DOI 10.1111/j.1469-8137.2011.03775.x; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KORNERUP A, 1961, FARVER I FARVER; Kropp BR, 2016, MYCOLOGIA, V108, P405, DOI 10.3852/15-171; Larsson KH, 2007, MYCOL RES, V111, P1040, DOI 10.1016/j.mycres.2007.08.001; Lebel T, 2013, MYCOL PROG, V12, P497, DOI 10.1007/s11557-012-0856-4; LePage BA, 1997, AM J BOT, V84, P410, DOI 10.2307/2446014; Li YC, 2009, FUNGAL DIVERS, V38, P85; Liu YJJ, 1999, MOL BIOL EVOL, V16, P1799, DOI 10.1093/oxfordjournals.molbev.a026092; Looney BP, 2016, MOL ECOL, V25, P630, DOI 10.1111/mec.13506; Lucking R, 2009, MYCOLOGIA, V101, P810, DOI 10.3852/09-016; Lutzoni F, 2004, AM J BOT, V91, P1446, DOI 10.3732/ajb.91.10.1446; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; Matheny PB, 2007, MOL PHYLOGENET EVOL, V43, P430, DOI 10.1016/j.ympev.2006.08.024; Miller SL, 2001, MYCOLOGIA, V93, P344, DOI 10.2307/3761656; Miller SL, 2006, MYCOLOGIA, V98, P960, DOI 10.3852/mycologia.98.6.960; Moncalvo JM, 2000, SYST BIOL, V49, P278, DOI 10.1093/sysbio/49.2.278; Montoya L, 2003, MYCOTAXON, V87, P311; Morozova O. V., 2013, Mikologiya i Fitopatologiya, V47, P92; Mueller GM, 2001, J BIOGEOGR, V28, P271, DOI 10.1046/j.1365-2699.2001.00540.x; Nie ZL, 2006, AM J BOT, V93, P1343, DOI 10.3732/ajb.93.9.1343; Nie ZL, 2010, AM J BOT, V97, P1342, DOI 10.3732/ajb.1000085; Nuytinck J, 2004, BELG J BOT, V136, P145; Nylander JAA, 2004, MRMODELTEST 2 3; Petersen Ronald H., 2007, Mycoscience, V48, P1, DOI 10.1007/s10267-006-0333-5; Peterson KR, 2010, MYCOLOGIA, V102, P1417, DOI 10.3852/10-048; Rambaut A, 2017, SYST BIOL, V2017; Ran JH, 2018, MOL PHYLOGENET EVOL, V129, P106, DOI 10.1016/j.ympev.2018.08.011; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stubbe D, 2010, FUNGAL BIOL-UK, V114, P271, DOI 10.1016/j.funbio.2010.01.008; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Taylor TN, 2005, MYCOLOGIA, V97, P269, DOI 10.3852/mycologia.97.1.269; Taylor TN, 2004, MYCOLOGIA, V96, P1403, DOI 10.2307/3762157; Trappe JM, 2013, MYCOLOGIA, V105, P888, DOI 10.3852/12-046; Trierveiler-Pereira L, 2015, MYCOLOGIA, V107, P90, DOI 10.3852/13-302; Verbeken A, 2014, PERSOONIA, V32, P13, DOI 10.3767/003158514X679119; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang XH, 2015, MYCOLOGIA, V107, P941, DOI 10.3852/13-393; Wang XH, 2012, CRYPTOGAMIE MYCOL, V33, P181, DOI 10.7872/crym.v33.iss2.2012.181; Wang XH, 2010, CRYPTOGAMIE MYCOL, V31, P9; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wisitrassameewong K, 2016, FUNGAL BIOL-UK, V120, P1554, DOI 10.1016/j.funbio.2016.08.004; Wu QX, 1997, CAN J BOT, V75, P2108, DOI 10.1139/b97-922; Xiang QY, 1998, MOL PHYLOGENET EVOL, V10, P178, DOI 10.1006/mpev.1998.0524; Yu Y, 2015, MOL PHYLOGENET EVOL, V87, P46, DOI 10.1016/j.ympev.2015.03.008; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	85	9	12	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205840	10.1371/journal.pone.0205840	http://dx.doi.org/10.1371/journal.pone.0205840			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403698	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500028
J	Hao, ZG; Ge, HW; Wang, L				Hao, Zhangang; Ge, Hongwei; Wang, Long			Visual attention mechanism and support vector machine based automatic image annotation	PLOS ONE			English	Article								Automatic image annotation not only has the efficiency of text-based image retrieval but also achieves the accuracy of content-based image retrieval. Users of annotated images can locate images they want to search by providing keywords. Currently most automatic image annotation algorithms do not consider the relative importance of each region in the image, and some algorithms extract the image features as a whole. This makes it difficult for annotation words to reflect salient versus non-salient areas of the image. Users searching for images are usually only interested in the salient areas. We propose an algorithm that integrates a visual attention mechanism with image annotation. A preprocessing step divides the image into two parts, the salient regions and everything else, and the annotation step places a greater weight on the salient region. When the image is annotated, words relating to the salient region are given first. The support vector machine uses particle swarm optimization to annotate the images automatically. Experimental results show the effectiveness of the proposed algorithm.	[Hao, Zhangang] Shandong Technol & Business Univ, Sch Business Adm, Yantai, Shandong, Peoples R China; [Ge, Hongwei; Wang, Long] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China	Shandong Technology & Business University; Dalian University of Technology	Hao, ZG (corresponding author), Shandong Technol & Business Univ, Sch Business Adm, Yantai, Shandong, Peoples R China.	zghao2000@sina.com		Hao, Zhangang/0000-0002-2145-4920	Shandong Provincial Natural Science Foundation, China [ZR2017MG022]	Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province)	This work was supported by the Shandong Provincial Natural Science Foundation, China, by grant no. ZR2017MG022.	Bala A, 2016, ENG SCI TECHNOL, V19, P101, DOI 10.1016/j.jestch.2015.06.008; Chang S F, 2017, RAPID IMAGE ANNOTATI; Choi D, 2017, AUTOMATIC IMAGE ANNO, V7465, P479; Cusano C., 2003, Proceedings of the SPIE - The International Society for Optical Engineering, V5304, P330, DOI 10.1117/12.526746; Gao Y., 2006, PROC 14 ACM INT C MU, P901; Hao ZG, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/8493267; Jin C, 2017, PROC SPIE, V10225, DOI 10.1117/12.2266104; Jin C, 2016, J VIS COMMUN IMAGE R, V34, P167, DOI 10.1016/j.jvcir.2015.10.017; Jing XY, 2016, IEEE T IMAGE PROCESS, V25, P2712, DOI 10.1109/TIP.2016.2549459; Johnson J, 2015, IEEE I CONF COMP VIS, P4624, DOI 10.1109/ICCV.2015.525; Liu WF, 2016, NEUROCOMPUTING, V172, P3, DOI 10.1016/j.neucom.2014.06.096; Liu WF, 2013, IEEE T IMAGE PROCESS, V22, P2676, DOI 10.1109/TIP.2013.2255302; Majidpour J., 2015, INF KNOWL TECHN IKT, P1, DOI DOI 10.1109/IKT.2015.7288777; Makadia A, 2008, LECT NOTES COMPUT SC, V5304, P316, DOI 10.1007/978-3-540-88690-7_24; Min YU, 2016, TRANSDUCER MICROSYST; Nie J., 2014, J INF COMPUT SCI, V11, P4987; Rad R, 2017, J VIS COMMUN IMAGE R, V46, P1, DOI 10.1016/j.jvcir.2017.03.005; Samet N, 2016, 2016 24TH SIGNAL PROCESSING AND COMMUNICATION APPLICATION CONFERENCE (SIU), P1321, DOI 10.1109/SIU.2016.7495991; Shin HC, 2016, PROC CVPR IEEE, P2497, DOI 10.1109/CVPR.2016.274; Sze KW, 2003, 2003 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL 2, PROCEEDINGS, P1017; Tariq A, 2015, PROC CVPR IEEE, P1958, DOI 10.1109/CVPR.2015.7298806; Tax DMJ, 2004, MACH LEARN, V54, P45, DOI 10.1023/B:MACH.0000008084.60811.49; Tian Q, 2017, P SOC PHOTO-OPT INS, V91, P425; Tommasi T, 2008, CLEF2008 IMAGE ANNOT; Uricchio T, 2016, ARXIV160504770, P1; Uricchio T, 2017, PATTERN RECOGN, V71, P144, DOI 10.1016/j.patcog.2017.05.019; Verma Y, 2013, BMVC, P251; Wu BY, 2015, PATTERN RECOGN, V48, P2279, DOI 10.1016/j.patcog.2015.01.022; Xia Z., 2017, IEEE T INF FOREN SEC, V11, P2594; Yu J, 2006, INT C PATT RECOG, P165	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206971	10.1371/journal.pone.0206971	http://dx.doi.org/10.1371/journal.pone.0206971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399159	gold, Green Submitted, Green Published			2022-12-26	WOS:000449374000037
J	Helfen, T; Siebenburger, G; Fleischhacker, E; Biermann, N; Bocker, W; Ockert, B				Helfen, Tobias; Siebenbuerger, Georg; Fleischhacker, Evi; Biermann, Niklas; Boecker, Wolfgang; Ockert, Ben			Open reduction and internal fixation of displaced proximal humeral fractures. Does the surgeon's experience have an impact on outcomes?	PLOS ONE			English	Article							PLATE FIXATION; PHILOS PLATE; COMPLICATIONS; STRATEGIES; QUALITY	Introduction To evaluate outcomes following open reduction and internal fixation of displaced proximal humeral fractures with regards to the surgeon's experience. Material and methods Patients were included undergoing ORIF by use of locking plates for displaced two-part surgical neck type proximal humeral fractures. Reduction and functional outcomes were compared between procedures that were conducted by trauma surgeons [TS], senior (>2 years after board certified) trauma surgeons [STS] and trauma surgeons performing >= 50 shoulder surgeries per year [SS]. Quality of reduction was measured on postoperative x-rays. Functional outcomes were assessed by gender- and age-related Constant Score (nCS). Secondary outcome measures were complication and revision rates. Results Between 2002-2014 (12.5 years) n = 278 two-part surgical neck type humeral fractures (AO 11-A2, 11-A3) were included. Open reduction and internal fixation was performed with the following educational levels: [TS](n = 68, 25.7%), [STS](n = 110, 41.5%) and [SS](n = 77, 29.1%). Functional outcome (nCS) increased with each higher level of experience and was significantly superior in [SS] (93.3) vs. [TS] (79.6; p = 0.01) vs. [STS] (83.0; p = 0.05). [SS] (7.8%) had significantly less complications compared with [TS] (11.3%; p = 0.003) and [STS](11.7%; p = 0.01) moreover significantly less revision rates (3.9%) vs. [TS](8.2%) and [STS](7.4%) (p<0.001). Primary revision was necessary in 13 cases (4.7%) due to malreduction of the fracture. Conclusion Quality of reduction and functional outcomes following open reduction and internal fixation of displaced two-part surgical neck fractures are related to the surgeon's experience. In addition, complications and revision rates are less frequent if surgery is conducted by a trauma surgeon performing >= 50 shoulder surgeries per year.	[Helfen, Tobias; Siebenbuerger, Georg; Fleischhacker, Evi; Biermann, Niklas; Boecker, Wolfgang; Ockert, Ben] Ludwig Maximilians Univ Munchen, Munich Univ Hosp, Dept Gen Trauma & Reconstruct Surg, Munich, Germany	University of Munich	Helfen, T (corresponding author), Ludwig Maximilians Univ Munchen, Munich Univ Hosp, Dept Gen Trauma & Reconstruct Surg, Munich, Germany.	tobias.helfen@med.uni-muenchen.de	Siebenbürger, Georg/ADL-6367-2022; Helfen, Tobias/AAG-7498-2021					Abson S, 2016, J PEDIATR ORTHOPED, V36, P478, DOI 10.1097/BPO.0000000000000491; Agudelo J, 2007, J ORTHOP TRAUMA, V21, P676, DOI 10.1097/BOT.0b013e31815bb09d; CONSTANT CR, 1987, CLIN ORTHOP RELAT R, P160; Erasmo R, 2014, INJURY, V45, pS43, DOI 10.1016/j.injury.2014.10.022; Gavaskar AS, 2015, J SHOULDER ELB SURG, V24, P908, DOI 10.1016/j.jse.2014.10.003; Gerber C, 2004, J BONE JOINT SURG BR, V86B, P848, DOI 10.1302/0301-620X.86B6.14577; Haasters F, 2016, J SHOULDER ELB SURG, V25, pE295, DOI 10.1016/j.jse.2016.02.015; Hertel R, 2004, J SHOULDER ELB SURG, V13, P427, DOI 10.1016/j.jse.2004.01.034; Jost B, 2013, J SHOULDER ELB SURG, V22, P542, DOI 10.1016/j.jse.2012.06.008; Katolik LI, 2005, J SHOULDER ELB SURG, V14, P279, DOI 10.1016/j.jse.2004.10.009; Lee CW, 2009, J SHOULDER ELB SURG, V18, P83, DOI 10.1016/j.jse.2008.06.014; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; Moonot P, 2007, J BONE JOINT SURG BR, V89B, P1206, DOI 10.1302/0301-620X.89B9.18528; Neuhaus V, 2015, J HAND SURG-EUR VOL, V40, P796, DOI 10.1177/1753193414555284; Ockert B, 2014, J SHOULDER ELB SURG, V23, P1223, DOI 10.1016/j.jse.2013.11.009; Ockert B, 2010, J TRAUMA, V69, P1545, DOI 10.1097/TA.0b013e3181c9b8a7; Palm H, 2007, INJURY, V38, P775, DOI 10.1016/j.injury.2006.07.043; Schnetzke M, 2016, J BONE JOINT SURG AM, V98, P1777, DOI 10.2106/JBJS.16.00112; Spross C, 2017, J SHOULDER ELB SURG, V26, P1566, DOI 10.1016/j.jse.2017.02.026; Spross C, 2012, J TRAUMA ACUTE CARE, V72, P783, DOI 10.1097/TA.0b013e31822c1b5b; Sudkamp N, 2009, J BONE JOINT SURG AM, V91A, P1320, DOI 10.2106/JBJS.H.00006; Suedkamp NP, 2011, J SHOULDER ELB SURG, V20, P1207, DOI 10.1016/j.jse.2011.06.009; Tepass A, 2013, J SHOULDER ELB SURG, V22, pE8, DOI 10.1016/j.jse.2012.04.002	23	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207044	10.1371/journal.pone.0207044	http://dx.doi.org/10.1371/journal.pone.0207044			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399160	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000042
J	Rensing, N; Moy, B; Friedman, JL; Galindo, R; Wong, M				Rensing, Nicholas; Moy, Brianna; Friedman, Joseph L.; Galindo, Rafael; Wong, Michael			Longitudinal analysis of developmental changes in electroencephalography patterns and sleep-wake states of the neonatal mouse	PLOS ONE			English	Article							SLOW-WAVE SLEEP; INFANTILE SPASMS; REM-SLEEP; HYPOXIA; EEG; ONTOGENY; SEIZURES; RHYTHMS; MODEL; RATS	The neonatal brain undergoes rapid maturational changes that facilitate the normal development of the nervous system and also affect the pathological response to brain injury. Electroencephalography (EEG) and analysis of sleep-wake vigilance states provide important insights into the function of the normal and diseased immature brain. While developmental changes in EEG and vigilance states are well-described in people, less is known about the normal maturational properties of rodent EEG, including the emergence and evolution of sleep-awake vigilance states. In particular, a number of developmental EEG studies have been performed in rats, but there is limited comparable research in neonatal mice, especially as it pertains to longitudinal EEG studies performed within the same mouse. In this study, we have attempted to provide a relatively comprehensive assessment of developmental changes in EEG background activity and vigilance states in wild-type mice from postnatal days 9-21. A novel EEG and EMG method allowed serial recording from the same mouse pups. EEG continuity and power and vigilance states were analyzed by quantitative assessment and fast Fourier transforms. During this developmental period, we demonstrate the timing of maturational changes in EEG background continuity, frequencies, and power and the emergence of identifiable wake, NREM, and REM sleep states. These results should serve as important control data for physiological studies of mouse models of normal brain development and neurological disease.	[Wong, Michael] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Wong, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	wong_m@wustl.edu		Wong, Michael/0000-0002-3796-743X	National Institutes of Health [R01 NS056872]; Hope Center for Neurological Disorders at Washington University [S10 RR027552]; Intellectual and Developmental Disabilities Research Center at Washington University [U54 HD087011]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087011] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027552] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056872] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hope Center for Neurological Disorders at Washington University; Intellectual and Developmental Disabilities Research Center at Washington University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (R01 NS056872 to MW), the Hope Center for Neurological Disorders at Washington University (S10 RR027552), and the Intellectual and Developmental Disabilities Research Center (U54 HD087011 to MW) at Washington University.	Andre M, 2010, NEUROPHYSIOL CLIN, V40, P59, DOI 10.1016/j.neucli.2010.02.002; Blumberg MS, 2007, EUR J NEUROSCI, V25, P512, DOI 10.1111/j.1460-9568.2006.05292.x; Blumberg MS, 2005, P NATL ACAD SCI USA, V102, P14860, DOI 10.1073/pnas.0506340102; Britton J.W., 2016, ELECTROENCEPHALOGRAP; Cirelli C, 2015, BIOL PSYCHIAT, V77, P1071, DOI 10.1016/j.biopsych.2014.12.017; DASZUTA A, 1985, DEV BRAIN RES, V22, P39, DOI 10.1016/0165-3806(85)90066-5; DUX M, 1992, CHRONOBIOLOGIA, V19, P163; Frank MG, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw077; Frank MG, 2005, J SLEEP RES, V14, P98, DOI 10.1111/j.1365-2869.2004.00430_2.x; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; Frank MG, 1997, AM J PHYSIOL-REG I, V273, pR472, DOI 10.1152/ajpregu.1997.273.2.R472; Gall AJ, 2008, J BIOL RHYTHM, V23, P232, DOI 10.1177/0748730408316954; Gataullina S, 2016, EPILEPSIA, V57, P648, DOI 10.1111/epi.13325; GRAMSBERGEN A, 1970, Developmental Psychobiology, V3, P267, DOI 10.1002/dev.420030407; GRAMSBERGEN A, 1976, DEV PSYCHOBIOL, V9, P501, DOI 10.1002/dev.420090604; IBUKA N, 1984, BEHAV BRAIN RES, V11, P185, DOI 10.1016/0166-4328(84)90210-9; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; Kang SK, 2018, NEUROBIOL DIS, V116, P1, DOI 10.1016/j.nbd.2018.04.012; Karlsson KAE, 2005, PLOS BIOL, V3, P891, DOI 10.1371/journal.pbio.0030143; Khazipov R, 2006, TRENDS NEUROSCI, V29, P414, DOI 10.1016/j.tins.2006.05.007; KLEITMAN N, 1953, J APPL PHYSIOL, V6, P269, DOI 10.1152/jappl.1953.6.5.269; Lamblin MD, 2013, NEUROPHYSIOL CLIN, V43, P267, DOI 10.1016/j.neucli.2013.07.001; LEVIN R, 1975, J COMP PHYSIOL PSYCH, V89, P711, DOI 10.1037/h0077038; Mang Geraldine Morgane, 2012, Curr Protoc Mouse Biol, V2, P55, DOI 10.1002/9780470942390.mo110126; MARKS GA, 1995, BEHAV BRAIN RES, V69, P1, DOI 10.1016/0166-4328(95)00018-O; MIRMIRAN M, 1982, DEV BRAIN RES, V3, P37, DOI 10.1016/0165-3806(82)90074-8; Nelson AB, 2013, BRAIN SCI, V3, P318, DOI 10.3390/brainsci3010318; Pirone A, 2017, NEUROBIOL DIS, V98, P149, DOI 10.1016/j.nbd.2016.11.002; Price MG, 2009, J NEUROSCI, V29, P8752, DOI 10.1523/JNEUROSCI.0915-09.2009; Rakhade SN, 2011, EPILEPSIA, V52, P753, DOI 10.1111/j.1528-1167.2011.02992.x; Ranasinghe S, 2015, J NEUROSCI, V35, P11946, DOI 10.1523/JNEUROSCI.2682-14.2015; Rodriguez-Alvarez N, 2015, NEUROBIOL DIS, V83, P100, DOI 10.1016/j.nbd.2015.08.023; Scantlebury MH, 2010, NEUROBIOL DIS, V37, P604, DOI 10.1016/j.nbd.2009.11.011; Seelke AMH, 2008, SLEEP, V31, P691, DOI 10.1093/sleep/31.5.691; Spangenberg EMF, 2014, LAB ANIM-UK, V48, P193, DOI 10.1177/0023677214531569; THIELS E, 1990, DEV PSYCHOBIOL, V23, P495, DOI 10.1002/dev.420230605; Vanhatalo S, 2006, SEMIN FETAL NEONAT M, V11, P471, DOI 10.1016/j.siny.2006.07.008; Vecchierini MF, 2007, NEUROPHYSIOL CLIN, V37, P311, DOI 10.1016/j.neucli.2007.10.008; Vogel GW, 2000, PHYSIOL BEHAV, V68, P453, DOI 10.1016/S0031-9384(99)00207-3; Zanelli S, 2014, NEUROBIOL DIS, V68, P37, DOI 10.1016/j.nbd.2014.03.005	40	22	22	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207031	10.1371/journal.pone.0207031	http://dx.doi.org/10.1371/journal.pone.0207031			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399187	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000041
J	Backenkohler, A; Eisenschmidt, D; Schneegans, N; Strieker, M; Brandt, W; Wittstock, U				Backenkoehler, Anita; Eisenschmidt, Daniela; Schneegans, Nicola; Strieker, Matthias; Brandt, Wolfgang; Wittstock, Ute			Iron is a centrally bound cofactor of specifier proteins involved in glucosinolate breakdown	PLOS ONE			English	Article							THIOCYANATE-FORMING PROTEIN; ARABIDOPSIS-THALIANA; EPITHIOSPECIFIER PROTEIN; CRYSTAL-STRUCTURE; THLASPI-ARVENSE; HYDROLYSIS; ISOTHIOCYANATES; MYROSINASE; ACCUMULATION; MECHANISMS	Glucosinolates, a group of sulfur-rich thioglucosides found in plants of the order Brassicales, have attracted a lot of interest as chemical defenses of plants and health promoting substances in human diet. They are accumulated separately from their hydrolyzing enzymes, myrosinases, within the intact plant, but undergo myrosinase-catalyzed hydrolysis upon tissue disruption. This results in various biologically active products, e.g. isothiocyanates, simple nitrites, epithionitriles, and organic thiocyanates. While formation of isothiocyanates proceeds by a spontaneous rearrangement of the glucosinolate aglucone, aglucone conversion to the other products involves specifier proteins under physiological conditions. Specifier proteins appear to act with high specificity, but their exact roles and the structural bases of their specificity are presently unknown. Previous research identified the motif EXXXDXXXH as potential iron binding site required for activity, but crystal structures of recombinant specifier proteins lacked the iron cofactor. Here, we provide experimental evidence for the presence of iron (most likely Fe2+) in purified recombinant thiocyanate-forming protein from Thlaspi antense (TaTFP) using a Ferene S-based photometric assay as well as Inductively Coupled Plasma-Mass Spectrometry. Iron binding and activity depend on E266, D270, and H274 suggesting a direct interaction of Fe2+ with these residues. Furthermore, we demonstrate presence of iron in epithiospecifier protein and nitrile-specifier protein 3 from Arabidopsis thaliana (AtESP and AtNSP3). We also present a homology model of AtNSP3. In agreement with this model, iron binding and activity of AtNSP3 depend on E386, D390, and H394. The homology model further suggests that the active site of AtNSP3 imposes fewer restrictions to the glucosinolate aglucone conformation than that of TaTFP and AtESP due to its larger size. This may explain why AtNSP3 does not support epithionitrile or thiocyanate formation, which likely requires exact positioning of the aglucone thiolate relative to the side chain.	[Backenkoehler, Anita; Schneegans, Nicola; Strieker, Matthias; Wittstock, Ute] Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany; [Eisenschmidt, Daniela; Brandt, Wolfgang] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Saale, Germany	Braunschweig University of Technology; Leibniz Institut fur Pflanzenbiochemie	Wittstock, U (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Pharmaceut Biol, Braunschweig, Germany.	u.wittstock@tu-bs.de		Wittstock, Ute/0000-0002-0914-8453	Deutsche Forschungsgemeinschaft [WI2668/3]; Open Access Publication Funds of the Technische Universitat Braunschweig	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Funds of the Technische Universitat Braunschweig	Deutsche Forschungsgemeinschaft (http://www.dfg.de/en/index.jsp) (project WI2668/3). We acknowledge support by the Open Access Publication Funds of the Technische Universitat Braunschweig. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja I, 2010, AGRON SUSTAIN DEV, V30, P311, DOI 10.1051/agro/2009025; Aissani N, 2013, J AGR FOOD CHEM, V61, P4723, DOI 10.1021/jf4008949; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Brandt W, 2014, PLANT MOL BIOL, V84, P173, DOI 10.1007/s11103-013-0126-0; BROCKER ER, 1983, PHYTOCHEMISTRY, V22, P770, DOI 10.1016/S0031-9422(00)86982-4; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Burow M, 2009, PLANT PHYSIOL, V149, P561, DOI 10.1104/pp.108.130732; Burow M, 2007, PLANT MOL BIOL, V64, P173, DOI 10.1007/s11103-007-9143-1; Burow M, 2006, FEBS J, V273, P2432, DOI 10.1111/j.1742-4658.2006.05252.x; Burow M, 2007, PLANT MOL BIOL, V63, P49, DOI 10.1007/s11103-006-9071-5; Capuano E, 2017, CURR PHARM DESIGN, V23, P2697, DOI 10.2174/1381612823666170120160832; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; COLE RA, 1976, PHYTOCHEMISTRY, V15, P759, DOI 10.1016/S0031-9422(00)94437-6; Dinkova-Kostova AT, 2012, TRENDS MOL MED, V18, P337, DOI 10.1016/j.molmed.2012.04.003; ETTLINGER MG, 1961, P NATL ACAD SCI USA, V47, P1875, DOI 10.1073/pnas.47.12.1875; Fahey JW, 2001, PHYTOCHEMISTRY, V56, P5, DOI 10.1016/S0031-9422(00)00316-2; Falk KL, 2007, PLANT BIOLOGY, V9, P573, DOI 10.1055/s-2007-965431; Foo HL, 2000, FEBS LETT, V468, P243, DOI 10.1016/S0014-5793(00)01176-5; Gumz F, 2015, PLANT MOL BIOL, V89, P67, DOI 10.1007/s11103-015-0351-9; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; HENNESSY DJ, 1984, CAN J CHEM, V62, P721, DOI 10.1139/v84-121; Kissen R, 2009, J BIOL CHEM, V284, P12057, DOI 10.1074/jbc.M807500200; Kong XY, 2012, PHYTOCHEMISTRY, V84, P7, DOI 10.1016/j.phytochem.2012.08.004; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kuchernig JC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-127; Kuchernig JC, 2011, PHYTOCHEMISTRY, V72, P1699, DOI 10.1016/j.phytochem.2011.06.013; Lambrix V, 2001, PLANT CELL, V13, P2793, DOI 10.1105/tpc.13.12.2793; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Matusheski NV, 2006, J AGR FOOD CHEM, V54, P2069, DOI 10.1021/jf0525277; Moiseyev G, 2006, J BIOL CHEM, V281, P2835, DOI 10.1074/jbc.M508903200; Nakano RT, 2017, PLANT J, V89, P204, DOI 10.1111/tpj.13377; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Rossiter JT, 2007, PHYTOCHEMISTRY, V68, P1384, DOI 10.1016/j.phytochem.2007.02.030; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Stein RJ, 2012, J EXP BOT, V63, P1039, DOI 10.1093/jxb/err343; Stotz HU, 2011, PLANT J, V67, P81, DOI 10.1111/j.1365-313X.2011.04578.x; TOOKEY HL, 1973, CAN J BIOCHEM CELL B, V51, P1654, DOI 10.1139/o73-222; Traka MH, 2013, NEW PHYTOL, V198, P1085, DOI 10.1111/nph.12232; UDA Y, 1986, AGR BIOL CHEM TOKYO, V50, P2735, DOI 10.1080/00021369.1986.10867832; Urzica EI, 2012, PLANT CELL, V24, P3921, DOI 10.1105/tpc.112.102491; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wedderhoff I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071579; Wentzell AM, 2008, PLANT PHYSIOL, V147, P415, DOI 10.1104/pp.107.115279; Wittstock U, 2016, ADV BOT RES, V80, P125, DOI 10.1016/bs.abr.2016.06.006; Wittstock U, 2003, RECENT ADV PHYTOCHEM, V37, P101; Wittstock U, 2007, IUBMB LIFE, V59, P744, DOI 10.1080/15216540701736277; Yang N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00999; Zhang WW, 2017, BIOCHEM BIOPH RES CO, V488, P147, DOI 10.1016/j.bbrc.2017.05.027; Zhang WW, 2016, BIOCHEM BIOPH RES CO, V478, P746, DOI 10.1016/j.bbrc.2016.08.019	52	18	18	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205755	10.1371/journal.pone.0205755	http://dx.doi.org/10.1371/journal.pone.0205755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395611	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400011
J	Bang, JY; Kim, SO; Kim, SG; Song, JG; Kang, J; Kim, JW; Ha, S				Bang, Ji-Yeon; Kim, Seon-Ok; Kim, Sae-Gyeol; Song, Jun-Gol; Kang, Jiwon; Kim, Jong-Wook; Ha, Seungil			Impact of the serum albumin level on acute kidney injury after cerebral artery aneurysm clipping	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; BYPASS SURGERY; RAT-KIDNEY; MORTALITY; RISK; HYPOALBUMINEMIA; RESUSCITATION; DYSFUNCTION; CELLS	Background Although hypoalbuminemia is a known risk factor for acute kidney injury (AKI) following surgery, little is known about its effects following aneurysm clipping surgery. We aimed to investigate the predictors of AKI and overall mortality and assessed the relationship between preoperative albumin and postoperative outcomes after aneurysm clipping surgery. Methods This study included 2,339 patients who underwent aneurysm clipping surgery. According to the criteria updated by the Kidney Disease: Improving Global Outcomes (KDIGO), patients were classified into AKI and no AKI group. Independent AKI predictors were analyzed by multivariate methods, and the influence of AKI on the outcome variables was assessed with by propensity score matching analysis. Survival in relation to AKI was analyzed using the Kaplan-Meier method. Results The total proportion of patients who developed AKI was 1.9%. The cutoff value of preoperative albumin for predicting AKI was 3.9 g/dL. Multivariate analyses showed that preoperative albumin <= 3.9 g/dL, aneurysmal subarachnoid hemorrhage, male sex, phenylephrine use, and hemoglobin were associated with postoperative AKI development. In multivariate analysis, mortality was increased in AKI patients (p< 0.01). After propensity score matching, preoperative albumin <= 3.9 g/dL was significantly related to AKI and overall mortality. Conclusion Preoperative albumin <= 3.9 g/dL is associated with postoperative AKI and mortality.	[Bang, Ji-Yeon; Kim, Sae-Gyeol; Song, Jun-Gol; Kang, Jiwon; Kim, Jong-Wook; Ha, Seungil] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Seon-Ok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Ha, S (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul, South Korea.	seungilha@amc.seoul.kr		Saratzis, Athanasios/0000-0002-3399-094X				Bellomo R, 2008, CRIT CARE MED, V36, pS179, DOI 10.1097/CCM.0b013e318169167f; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; BREZIS M, 1995, NEW ENGL J MED, V332, P647, DOI 10.1056/NEJM199503093321006; CONTRERAS AM, 1994, REV INVEST CLIN, V46, P37; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Dixon R, 1999, J AM SOC NEPHROL, V10, P1487; Doi K, 2004, KIDNEY INT, V65, P1714, DOI 10.1111/j.1523-1755.2004.00567.x; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Grams ME, 2016, AM J KIDNEY DIS, V67, P872, DOI 10.1053/j.ajkd.2015.07.022; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Heyman S N, 1995, New Horiz, V3, P597; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; Igleslas J, 1999, AM J PHYSIOL-RENAL, V277, pF711, DOI 10.1152/ajprenal.1999.277.5.F711; Jeffcote T, 2010, ANAESTH INTENS CARE, V38, P274, DOI 10.1177/0310057X1003800208; Karkouti K, 2009, CIRCULATION, V119, P495, DOI 10.1161/CIRCULATIONAHA.108.786913; KAUFMANN MA, 1995, J PHARMACOL EXP THER, V273, P855; Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group, 2012, KIDNEY INT S, V2, P19, DOI DOI 10.1038/KISUP.2011.32; Kim CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082289; Lee EH, 2016, ANESTHESIOLOGY, V124, P1001, DOI 10.1097/ALN.0000000000001051; Lee EH, 2014, J CARDIOTHOR VASC AN, V28, P936, DOI 10.1053/j.jvca.2013.12.006; Lee EH, 2012, INTENS CARE MED, V38, P1478, DOI 10.1007/s00134-012-2599-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Margarson MP, 1998, ANAESTHESIA, V53, P789, DOI 10.1046/j.1365-2044.1998.00438.x; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Sear JW, 2005, BRIT J ANAESTH, V95, P20, DOI 10.1093/bja/aei018; SOLENSKI NJ, 1995, CRIT CARE MED, V23, P1007, DOI 10.1097/00003246-199506000-00004; Wiedermann CJ, 2010, INTENS CARE MED, V36, P1657, DOI 10.1007/s00134-010-1928-z; Wu HC, 2016, RENAL FAILURE, V38, P330, DOI 10.3109/0886022X.2015.1128790; Zacharia BE, 2009, STROKE, V40, P2375, DOI 10.1161/STROKEAHA.108.545210	30	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206731	10.1371/journal.pone.0206731	http://dx.doi.org/10.1371/journal.pone.0206731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395651	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400045
J	Holland, I; McCormick, C; Connolly, P				Holland, Ian; McCormick, Christopher; Connolly, Patricia			Towards non-invasive characterisation of coronary stent re-endothelialisation - An in-vitro, electrical impedance study	PLOS ONE			English	Article							DRUG-ELUTING STENTS; BARRIER FUNCTION; RESTENOSIS; ELECTRODE; GROWTH; THROMBOSIS; BEHAVIOR; MONITOR; CULTURE; REPAIR	The permanent implantation of a stent has become the most common method for ameliorating coronary artery narrowing arising from atherosclerosis. Following the procedure, optimal arterial wall healing is characterised by the complete regrowth of an Endothelial Cell monolayer over the exposed stent surface and surrounding tissue, thereby reducing the risk of thrombosis. However, excessive proliferation of Smooth Muscle Cells, within the artery wall can lead to unwanted renarrowing of the vessel lumen. Current imaging techniques are unable to adequately identify re-endothelialisation, and it has previously been reported that the stent itself could be used as an electrode in combination with electrical impedance spectroscopic techniques to monitor the post-stenting recovery phase. The utility of such a device will be determined by its ability to characterise between vascular cell types. Here we present in-vitro impedance spectroscopy measurements of pulmonary artery porcine Endothelial Cells, Human Umbilical Vein Endothelial Cells and coronary artery porcine Smooth Muscle Cells grown to confluence over platinum black electrodes in clinically relevant populations. These measurements were obtained, using a bespoke impedance spectroscopy system that autonomously performed impedance sweeps in the 1 kHz to 100kHz frequency range. Analysis of the reactance component of impedance revealed distinct frequency dependent profiles for each cell type with post confluence reactance declines in Endothelial Cell populations that have not been previously reported. Such profiles provide a means of non-invasively characterising between the cell types and give an indication that impedance spectroscopic techniques may enable the non-invasive characterisation of the arterial response to stent placement.	[Holland, Ian; McCormick, Christopher; Connolly, Patricia] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland	University of Strathclyde	Holland, I (corresponding author), Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland.	ian.holland@strath.ac.uk		Holland, Ian/0000-0003-2815-5082	Engineering and Phyiscal Sciences Research Council as part of an Engineering Doctorate [EP/F50036X/1]	Engineering and Phyiscal Sciences Research Council as part of an Engineering Doctorate	This work has been funded by the Engineering and Phyiscal Sciences Research Council (www.epsrc.ac.uk, grant number: EP/F50036X/1) as part of an Engineering Doctorate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Alfonso F, 2014, J AM COLL CARDIOL, V63, P2659, DOI 10.1016/j.jacc.2014.02.545; Andreini D, 2012, RADIOLOGY, V265, P410, DOI 10.1148/radiol.12112363; Angstmann M, 2011, CYTOTHERAPY, V13, P1074, DOI 10.3109/14653249.2011.584863; Arndt S, 2004, BIOSENS BIOELECTRON, V19, P583, DOI 10.1016/S0956-5663(03)00269-0; Bagnaninchi PO, 2011, P NATL ACAD SCI USA, V108, P6462, DOI 10.1073/pnas.1018260108; Barakat A., 2016, [No title captured], Patent No. [WO 2016/050972 A1, 2016050972, WO2016/050972 A1]; Benson K, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-5; Bischoff I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23671; Bouafsoun A, 2008, MAT SCI ENG C-BIO S, V28, P653, DOI 10.1016/j.msec.2007.10.073; Byrne RA, 2015, EUR HEART J, V36, P2608, DOI 10.1093/eurheartj/ehv203; Cho SB, 2008, MICROELECTRON ENG, V85, P1272, DOI 10.1016/j.mee.2008.01.004; COTE KR, 1987, ANN BIOMED ENG, V15, P419, DOI 10.1007/BF02363562; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; Ehret R, 1997, BIOSENS BIOELECTRON, V12, P29, DOI 10.1016/0956-5663(96)89087-7; Eker B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057423; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Franks W, 2005, IEEE T BIO-MED ENG, V52, P1295, DOI 10.1109/TBME.2005.847523; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; GIAEVER I, 1991, P NATL ACAD SCI USA, V88, P7896, DOI 10.1073/pnas.88.17.7896; Haas S, 2010, LAB CHIP, V10, P2965, DOI [10.1039/c0lc00008f, 10.1039/c01c00008f]; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; Iqbal J, 2016, ANN BIOMED ENG, V44, P453, DOI 10.1007/s10439-015-1414-4; Jahnke HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068971; Kusuma S, 2012, FASEB J, V26, P4925, DOI 10.1096/fj.12-209296; Lee R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06319; LIND R, 1991, BIOSENS BIOELECTRON, V6, P359, DOI 10.1016/0956-5663(91)85023-P; Luscher TF, 2007, CIRCULATION, V115, P1051, DOI 10.1161/CIRCULATIONAHA.106.675934; Malleo D, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3284516; Manoharan G, 2007, CONTEMP CARDIOL, P29, DOI 10.1007/978-1-59745-001-0_3; McCormick C, 2010, EUR J PHARMACOL, V641, P160, DOI 10.1016/j.ejphar.2010.04.035; McKittrick CM, 2016, ANN BIOMED ENG, V44, P477, DOI 10.1007/s10439-015-1456-7; Michaelis S, 2013, BIOSENS BIOELECTRON, V49, P63, DOI 10.1016/j.bios.2013.04.042; Mitra AK, 2006, J CLIN PATHOL, V59, P232, DOI 10.1136/jcp.2005.025742; Nichols M., 2012, EUROPEAN CARDIOVASCU; O'Brien B, 2016, ANN BIOMED ENG, V44, P523, DOI 10.1007/s10439-015-1380-x; Oz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059895; Opie NL, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/046020; Oxley TJ, 2016, NAT BIOTECHNOL, V34, P320, DOI 10.1038/nbt.3428; Padmaraj D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101793; Park SJ, 2012, J AM COLL CARDIOL, V59, P2051, DOI 10.1016/j.jacc.2011.10.909; PETHIG R, 1987, PHYS MED BIOL, V32, P933, DOI 10.1088/0031-9155/32/8/001; Piraino D, INT J CARDIOL, DOI [10.1016/j.ijcard.2016.12, DOI 10.1016/J.IJCARD.2016.12]; Rahman ARA, 2008, PHYSIOL MEAS, V29, pS227, DOI 10.1088/0967-3334/29/6/S20; Rivas-Marchena D, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17081737; Rodriguez S, 2016, IEEE T BIOMED CIRC S, V10, P533, DOI 10.1109/TBCAS.2015.2456242; Rumenapp C, 2009, BIOSENS BIOELECTRON, V24, P2915, DOI 10.1016/j.bios.2009.02.030; Sakamoto N, 2011, ANN BIOMED ENG, V39, P2750, DOI 10.1007/s10439-011-0372-8; Sandison ME, 2016, J PHYSIOL-LONDON, V594, P6189, DOI 10.1113/JP272729; Sarno G, 2012, EUR HEART J, V33, P606, DOI 10.1093/eurheartj/ehr479; Seebach J, 2007, CARDIOVASC RES, V75, P596, DOI 10.1016/j.cardiores.2007.04.017; Sharma AK, 2009, WORLD J UROL, V27, P687, DOI 10.1007/s00345-009-0391-3; Shedden L, 2009, Patent No. [WO2009/GB01132, GB01132]; Shedden L, 2010, BIOSENS BIOELECTRON, V26, P661, DOI 10.1016/j.bios.2010.06.073; Sigwart U, 1987, NEW ENGL J MED, DOI [10.1056/NEJM198703193161201, DOI 10.1056/NEJM198703193161201]; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stolwijk JA, 2013, ELECT CELL SUBSTRATE, P85; Stolwijk JA, 2015, PFLUG ARCH EUR J PHY, V467, P2193, DOI 10.1007/s00424-014-1674-0; Streitner I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035405; Sun T, 2010, LAB CHIP, V10, P1611, DOI 10.1039/c000699h; Suselbeck T, 2005, BASIC RES CARDIOL, V100, P28, DOI 10.1007/s00395-004-0501-8; Szulcek R, 2014, JOVE-J VIS EXP, V85, P1; Tesfamariam B, 2016, J CARDIOVASC TRANSL, V9, P91, DOI 10.1007/s12265-016-9677-1; Tillman BW, 2012, J VASC SURG, V56, P783, DOI 10.1016/j.jvs.2012.02.030; Truskey G a., 2011, INT J HIGH THROUGHPU, V2010, P171; Tsang HG, 2016, CELL BIOCHEM FUNCT, V34, P113, DOI 10.1002/cbf.3173; van Geuns RJM, 2007, CONTEMP CARDIOL, P277; Wang K, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.15; Wegener J., 2008, NANOTECHNOLOGY, P325; Wegener J, 2014, CELL TISSUE RES, V355, P485, DOI 10.1007/s00441-014-1810-3; Witzel F, 2015, BIOINFORMATICS, V31, P2705, DOI 10.1093/bioinformatics/btv216; Xu YC, 2016, BIOSENS BIOELECTRON, V77, P824, DOI 10.1016/j.bios.2015.10.027	72	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206758	10.1371/journal.pone.0206758	http://dx.doi.org/10.1371/journal.pone.0206758			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395632	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000449291400050
J	Sato, H; Honma, T; Nozawa, Y; Owaki, T; Imai, M; Sano, T; Iwanaga, A; Seki, K; Ishikawa, T; Yoshida, T; Terai, S				Sato, Hiroki; Honma, Terasu; Nozawa, Yujiro; Owaki, Takashi; Imai, Michitaka; Sano, Tomoe; Iwanaga, Akito; Seki, Keiichi; Ishikawa, Toru; Yoshida, Toshiaki; Terai, Shuji			Eosinophilic esophagitis in Japanese patients: A mild and slow-progressing disorder	PLOS ONE			English	Article							FEATURES; DISEASE	Background and aim Awareness of eosinophilic esophagitis (EoE) has gradually increased in Japan, therefore the characteristics of this disease in the Japanese patient population need to be elucidated. This study aimed to investigate the features of EoE in the Japanese population. Methods During a 2-year period, all gastrointestinal endoscopies were performed with maximum attention being paid to identify EoE through endoscopic findings. Clinical features and findings were analyzed among this population. Results Among a total of 8589 patients (general gastrointestinal endoscopy, performed for evaluation of symptoms or disease follow-up: 3669; medical check-up endoscopy, routinely performed in asymptomatic patients: 4920), 17 patients (0.20%) were diagnosed with esophageal eosinophilia (mean age +/- standard deviation: 44 +/- 11.9 years; 1 female). Only 6 patients with esophageal eosinophilia were diagnosed by general gastrointestinal endoscopy; among them, 3 patients had dysphagia and 3 were asymptomatic. The remaining 11 patients were diagnosed by medical check-up endoscopy. All patients were treated with a proton pump inhibitor (PPI); 5 were diagnosed with EoE and 12 with PPI responsive esophageal eosinophilia. Chronological endoscopy analysis showed that EoE findings could be observed for a mean of 6.1 years prior to diagnosis, and the disease did not significantly progress in severity. Conclusions Most Japanese patients with EoE have mild and slowly progressing disease, which can be diagnosed when close attention is paid to the endoscopic findings. Medical check-up endoscopy in Japan could be a great opportunity for the early diagnosis of EoE.	[Sato, Hiroki; Honma, Terasu; Nozawa, Yujiro; Owaki, Takashi; Imai, Michitaka; Sano, Tomoe; Iwanaga, Akito; Seki, Keiichi; Ishikawa, Toru; Yoshida, Toshiaki] Saiseikai Niigata Daini Hosp, Dept Gastroenterol, Niigata, Japan; [Sato, Hiroki; Owaki, Takashi; Terai, Shuji] Niigata Univ Med & Dent Hosp, Div Gastroenterol & Hepatol, Niigata, Japan	Niigata University	Sato, H (corresponding author), Saiseikai Niigata Daini Hosp, Dept Gastroenterol, Niigata, Japan.; Sato, H (corresponding author), Niigata Univ Med & Dent Hosp, Div Gastroenterol & Hepatol, Niigata, Japan.	pyloki-sato@med.niigata-u.ac.jp						Dellon ES, 2014, GASTROENTEROL CLIN N, V43, P201, DOI 10.1016/j.gtc.2014.02.002; Dellon ES, 2013, AM J GASTROENTEROL, V108, P1854, DOI 10.1038/ajg.2013.363; Furuta K, 2006, J GASTROENTEROL, V41, P706, DOI 10.1007/s00535-006-1827-9; Greuter T, 2017, AM J GASTROENTEROL, V112, P1527, DOI 10.1038/ajg.2017.202; Hirano I, 2013, GUT, V62, P489, DOI 10.1136/gutjnl-2011-301817; Ishimura N, 2017, J GASTROEN HEPATOL, DOI [10.1111/jgh.1407929278655, DOI 10.1111/JGH.1407929278655]; Ishimura N, 2015, J GASTROEN HEPATOL, V30, P71, DOI 10.1111/jgh.12746; Jensen ET, 2015, AM J GASTROENTEROL, V110, P626, DOI 10.1038/ajg.2014.316; Kinoshita Y, 2016, DIGESTION, V93, P7, DOI 10.1159/000441668; Kinoshita Y, 2013, J GASTROENTEROL, V48, P333, DOI 10.1007/s00535-012-0640-x; Rothenberg ME, 2015, GASTROENTEROLOGY, V148, P1143, DOI 10.1053/j.gastro.2015.02.002; Sato H, 2018, EUR J GASTROEN HEPAT, DOI [10.1097/MEG.000000000001241, DOI 10.1097/MEG.000000000001241]; Straumann A, 2018, GASTROENTEROLOGY, V154, P346, DOI 10.1053/j.gastro.2017.05.066; TALLEY NJ, 1990, GUT, V31, P54, DOI 10.1136/gut.31.1.54; Wen T, 2015, J ALLERGY CLIN IMMUN, V135, P187, DOI 10.1016/j.jaci.2014.08.043	15	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206621	10.1371/journal.pone.0206621	http://dx.doi.org/10.1371/journal.pone.0206621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388148	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800044
J	Lambers, C; Kornauth, C; Oberndorter, F; Boehm, PM; Tamm, M; Klepetko, W; Roth, M				Lambers, Christopher; Kornauth, Christoph; Oberndorter, Felicitas; Boehm, Panja M.; Tamm, Michael; Klepetko, Walter; Roth, Michael			Mechanism of anti-remodelling action of treprostinil in human pulmonary arterial smooth muscle cells	PLOS ONE			English	Article							PROSTACYCLIN ANALOGS; C/EBP-ALPHA; GLUCOCORTICOID-RECEPTOR; INHALED TREPROSTINIL; IP RECEPTOR; PROLIFERATION; ACTIVATION; CAMP; HYPERTENSION; SAFETY	Treprostinil is applied for pulmonary arterial hypertension (PAH) therapy. However, the mechanism by which the drug achieves its beneficial effects in PAH vessels is not fully understood. This study investigated the effects of treprostinil on PDGF-BB induced remodelling parameters in isolated human pulmonary arterial smooth muscle cells (PASMC) of four PAH patients. The production of TGF-beta 1, CTGF, collagen type-I and -IV, and of fibronectin were determined by ELISA and PCR. The role of cAMP was determined by ELISA and di-deoxyadenosine treatment. Proliferation was determined by direct cell count. Treprostinil increased cAMP levels dose and time dependently, which was not affected by PDGF-BB. Treprostinil significantly reduced PDGF-BB induced secretion of TGF-beta 1 and CTGF, both was counteracted when cAMP generation was blocked. Similarly, the PDGF-BB induced proliferation of PASMC was dose dependently reduced by treprostinil through signalling via cAMP-C/EBP-alpha p42-p21((WAf1/Cip1)). In regards to extracellular matrix remodelling, treprostinil significantly reduced PDGF-BB-TGF-beta 1-CTGF induced synthesis and deposition of collagen type I and fibronectin, in a cAMP sensitive manner. In contrast, the deposition of collagen IV was not affected. The data suggest that this action of treprostinil in vessel wall remodelling may benefit patients with PAH and may reduce arterial wall remodelling.	[Lambers, Christopher; Boehm, Panja M.; Klepetko, Walter] Univ Hosp Vienna, Thorac Surg, Vienna, Austria; [Kornauth, Christoph; Oberndorter, Felicitas] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Tamm, Michael; Roth, Michael] Univ & Univ Hosp Basel, Pulm Cell Res & Pneumol Clin, Basel, Switzerland	University Hospital Vienna; Medical University of Vienna	Roth, M (corresponding author), Univ & Univ Hosp Basel, Pulm Cell Res & Pneumol Clin, Basel, Switzerland.	micheal.roth@usb.ch	Roth, Michael/H-8657-2019; Kornauth, Christoph/AAA-3935-2022	Roth, Michael/0000-0002-8139-2821; Kornauth, Christoph/0000-0003-0443-3498	United Therapeutic Corp. (Silver Spring, MA, USA)	United Therapeutic Corp. (Silver Spring, MA, USA)	The study was funded by investigator driven unrestricted Research grant from United Therapeutic Corp. (Silver Spring, MA, USA). The funder has no role in the study design, data collection and analysis, decision to publish nor preparation of the manuscript.	Benza RL, 2011, J HEART LUNG TRANSPL, V30, P982, DOI 10.1016/j.healun.2011.03.011; Bubb KJ, 2014, CIRCULATION, V130, P496, DOI 10.1161/CIRCULATIONAHA.114.009751; Buckley MS, 2014, CORE EVID, V9, P71, DOI 10.2147/CE.S50607; Clapp LH, 2002, AM J RESP CELL MOL, V26, P194, DOI 10.1165/ajrcmb.26.2.4695; Damico R, 2015, AM J RESP CRIT CARE, V191, P208, DOI 10.1164/rccm.201409-1742OC; Du H, 2014, THROMB RES, V134, P111, DOI 10.1016/j.thromres.2014.05.005; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; Falcetti E, 2007, BIOCHEM BIOPH RES CO, V360, P821, DOI 10.1016/j.bbrc.2007.06.135; Falcetti E, 2010, AM J RESP CRIT CARE, V182, P1161, DOI 10.1164/rccm.201001-0011OC; Golob MJ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12815; Gomez-Arroyo J, 2015, EUR RESPIR J, V45, P449, DOI 10.1183/09031936.00188013; Gore B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100310; Hiremath J, 2010, J HEART LUNG TRANSPL, V29, P137, DOI 10.1016/j.healun.2009.09.005; Lambers C, 2015, PHARMACOL RES, V102, P310, DOI 10.1016/j.phrs.2015.09.010; Lambers C, 2014, BIOCHEM PHARMACOL, V91, P400, DOI 10.1016/j.bcp.2014.07.026; Lambers C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073399; Liu G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/595872; Liu HL, 2016, CHEST; Liu NC, 2009, ENDOCRINE, V36, P211, DOI 10.1007/s12020-009-9220-0; Liu QQ, 2015, THER CLIN RISK MANAG, V11, P1731, DOI 10.2147/TCRM.S49026; Miglino N, 2011, EUR RESPIR J, V38, P50, DOI 10.1183/09031936.00068010; Nikam VS, 2011, AM J RESP CELL MOL, V45, P692, DOI 10.1165/rcmb.2010-0240OC; O'Connell C, 2016, DRUG SAFETY, V39, P287, DOI 10.1007/s40264-015-0365-x; Ogo T, 2013, AM J RESP CELL MOL, V48, P733, DOI 10.1165/rcmb.2012-0049OC; Ohlsson E, 2016, LEUKEMIA, V30, P767, DOI 10.1038/leu.2015.324; Parikh KS, 2016, J CARDIOVASC PHARM, V67, P322, DOI 10.1097/FJC.0000000000000357; Preston IR, 2014, PULM CIRC, V4, P456, DOI 10.1086/677360; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Safdar Z, 2014, JACC-HEART FAIL, V2, P412, DOI 10.1016/j.jchf.2014.03.013; Sanada F, 2016, ARTERIOSCL THROM VAS, V36, P545, DOI 10.1161/ATVBAHA.115.307011; Sprague RS, 2008, MICROCIRCULATION, V15, P461, DOI 10.1080/10739680701833804; Takahashi J, 2016, FEBS LETT, V590, P101, DOI 10.1002/1873-3468.12038; Tapson VF, 2013, CHEST, V144, P952, DOI 10.1378/chest.12-2875; Tuder RM, 2013, CLIN CHEST MED, V34, P639, DOI 10.1016/j.ccm.2013.08.009; Wang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078569; Yamamura Aya, 2014, J Smooth Muscle Res, V50, P8; Yang J, 2010, CIRC RES, V107, P252, DOI 10.1161/CIRCRESAHA.109.209940	40	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205195	10.1371/journal.pone.0205195	http://dx.doi.org/10.1371/journal.pone.0205195			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383775	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600018
J	Shih, AJ; Menzin, A; Whyte, J; Lovecchio, J; Liew, A; Khalili, H; Bhuiya, T; Gregersen, PK; Lee, AT				Shih, Andrew J.; Menzin, Andrew; Whyte, Jill; Lovecchio, John; Liew, Anthony; Khalili, Houman; Bhuiya, Tawfiqul; Gregersen, Peter K.; Lee, Annette T.			Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq	PLOS ONE			English	Article							CXCL12-CXCR4 AXIS PROMOTES; COLLAGEN TYPE-IV; BREAST-CANCER; MONOCLONAL-ANTIBODY; COMPLEMENT-SYSTEM; GENE-EXPRESSION; S100 PROTEINS; IFN-GAMMA; PROLIFERATION; CHEMOTHERAPY	Here we investigated different cell populations within ovarian cancer using single-cell RNA seq: fourteen samples from nine patients with differing grades (high grade, low grade and benign) as well as different origin sites (primary and metastatic tumor site, ovarian in origin and fallopian in origin). We were able to identify sixteen distinct cell populations with specific cells correlated to high grade tumors, low grade tumors, benign and one population unique to a patient with a breast cancer relapse. Furthermore the proportion of these populations changes from primary to metastatic in a shift from mainly epithelial cells to leukocytes with few cancer epithelial cells in the metastases. Differential gene expression shows myeloid lineage cells are the primary cell group expressing soluble factors in primary samples while fibroblasts do so in metastatic samples. The leukocytes that were captured did not seem to be suppressed through known pro-tumor cytokines from any of the cell populations. Single cell RNA-seq is necessary to de-tangle cellular heterogeneity for better understanding of ovarian cancer progression.	[Shih, Andrew J.; Liew, Anthony; Khalili, Houman; Gregersen, Peter K.; Lee, Annette T.] Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA; [Menzin, Andrew; Whyte, Jill; Lovecchio, John; Bhuiya, Tawfiqul; Gregersen, Peter K.; Lee, Annette T.] Hofstra Northwell, Donald & Barbara Zucker Sch Med, Hempstead, NY USA	Northwell Health; Northwell Health	Shih, AJ (corresponding author), Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA.	ashih@northwell.edu			Feinstein Institute: Linda; Dr. Myron Teitelbaum Foundation; Monter Cancer Center at Northwell Health Cancer Institute; Moms Who Kick, Manhasset Women's Coalition Against Breast Cancer; Henry Gabbay; Stand Up 2 Cancer; John L. Lovecchio, MD Gynecologic Oncology Research Fund	Feinstein Institute: Linda; Dr. Myron Teitelbaum Foundation; Monter Cancer Center at Northwell Health Cancer Institute; Moms Who Kick, Manhasset Women's Coalition Against Breast Cancer; Henry Gabbay; Stand Up 2 Cancer; John L. Lovecchio, MD Gynecologic Oncology Research Fund	This study was funded by the following private funders to The Feinstein Institute: Linda and Dr. Myron Teitelbaum Foundation, Monter Cancer Center at Northwell Health Cancer Institute, Moms Who Kick, Manhasset Women's Coalition Against Breast Cancer, Henry Gabbay, Stand Up 2 Cancer, and the John L. Lovecchio, MD Gynecologic Oncology Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiko K, 2015, BRIT J CANCER, V112, P1501, DOI 10.1038/bjc.2015.101; Afshar-Kharghan V, 2017, J CLIN INVEST, V127, P780, DOI 10.1172/JCI90962; Bahramsoltani M, 2014, ANAT HISTOL EMBRYOL, V43, P103, DOI 10.1111/ahe.12052; BAST RC, 1981, J CLIN INVEST, V68, P1331, DOI 10.1172/JCI110380; Bellone S, 2013, BRIT J CANCER, V109, P462, DOI 10.1038/bjc.2013.315; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; Burgos-Ojeda D, 2012, CANCER LETT, V322, P1, DOI 10.1016/j.canlet.2012.02.002; Burke F, 1999, BRIT J CANCER, V80, P1236, DOI 10.1038/sj.bjc.6690491; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cho MS, 2014, CELL REP, V6, P1085, DOI 10.1016/j.celrep.2014.02.014; Cooke SL, 2011, LANCET ONCOL, V12, P1169, DOI 10.1016/S1470-2045(11)70123-1; Davidson B, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00104; Della Pepa C, 2015, CANCER TREAT REV, V41, P136, DOI 10.1016/j.ctrv.2014.12.003; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duner P, 2015, ATHEROSCLEROSIS, V240, P26, DOI 10.1016/j.atherosclerosis.2015.02.043; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gonzalez VD, 2018, CELL REP, V22, P1875, DOI 10.1016/j.celrep.2018.01.053; Guo Q, 2015, ONCOL RES, V22, P247, DOI 10.3727/096504015X14343704124430; Guo YJ, 2017, BIOCHEM BIOPH RES CO, V493, P1159, DOI 10.1016/j.bbrc.2017.09.113; Hellstrom I, 2003, CANCER RES, V63, P3695; Howlader N., 2017, SEER CANC STAT REV 1; Junnikkalla S, 2002, BRIT J CANCER, V87, P1119, DOI 10.1038/sj.bjc.6600614; Kaldawy A, 2016, GYNECOL ONCOL, V143, P433, DOI 10.1016/j.ygyno.2016.08.320; Kobayashi D, 2017, DEV BIOL, V430, P69, DOI 10.1016/j.ydbio.2017.08.016; Kristiansen G, 2002, AM J PATHOL, V161, P1215, DOI 10.1016/S0002-9440(10)64398-2; Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110064; Lim J, 2014, ARCH BIOCHEM BIOPHYS, V558, P120, DOI 10.1016/j.abb.2014.06.022; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Lukanidin E, 2012, SEMIN CANCER BIOL, V22, P216, DOI 10.1016/j.semcancer.2012.02.006; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; MARTH C, 1989, ANTICANCER RES, V9, P461; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Moore RG, 2014, SCI REP-UK, V4, DOI 10.1038/srep03574; Morgan RJ, 2016, J NATL COMPR CANC NE, V14, P1134, DOI 10.6004/jnccn.2016.0122; Nunez-Cruz S, 2012, NEOPLASIA, V14, P994, DOI 10.1593/neo.121262; Ohlsson L, 2016, BRIT J CANCER, V114, P697, DOI 10.1038/bjc.2016.4; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Onoufriadis A, 2014, HUM MOL GENET, V23, P3362, DOI 10.1093/hmg/ddu046; Paget S, 1989, LANCET, V8, P98, DOI [DOI 10.1016/S0140-6736(00)49915-0, 10.1016/S0140-6736(00)49915-0]; Parmar MKB, 2003, LANCET, V361, P2099; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pio R, 2014, ADV EXP MED BIOL, V772, P229, DOI 10.1007/978-1-4614-5915-6_11; Pohler E, 2004, MOL CELL PROTEOMICS, V3, P534, DOI 10.1074/mcp.M300089-MCP200; Popple A, 2012, BRIT J CANCER, V106, P1306, DOI 10.1038/bjc.2012.49; Qi XC, 2016, TUMOR BIOL, V37, P11099, DOI 10.1007/s13277-016-4791-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rai U, 2015, PHARMACOL THERAPEUT, V152, P98, DOI 10.1016/j.pharmthera.2015.05.007; Ruigrok YM, 2006, HUM MOL GENET, V15, P3361, DOI 10.1093/hmg/ddl412; Rybinski B, 2014, PHYSIOL GENOMICS, V46, P223, DOI 10.1152/physiolgenomics.00158.2013; Santoiemma PP, 2015, CANCER BIOL THER, V16, P807, DOI 10.1080/15384047.2015.1040960; Sarvaria A, 2017, CELL MOL IMMUNOL, V14, P662, DOI 10.1038/cmi.2017.35; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Shen B, 2013, ASIAN PAC J CANCER P, V14, P5403, DOI 10.7314/APJCP.2013.14.9.5403; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Stuart GCE, 2011, INT J GYNECOL CANCER, V21, P750, DOI 10.1097/IGC.0b013e31821b2568; Sun LC, 2011, CURR DRUG DELIV, V8, P2, DOI 10.2174/156720111793663633; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Sun YN, 2014, TUMOR BIOL, V35, P7765, DOI 10.1007/s13277-014-1816-1; Tian SB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15757-z; Tol P., 2018, PAUL TOLS NOTES COLO; Waldron L, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju049; Wang GH, 2015, INT J CLIN EXP PATHO, V8, P4705; Winterhoff BJ, 2017, GYNECOL ONCOL, V144, P598, DOI 10.1016/j.ygyno.2017.01.015; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Ye KP, 2017, J CANCER, V8, P1750, DOI 10.7150/jca.18943; Yue XH, 2017, HEPATOLOGY, V65, P1948, DOI 10.1002/hep.29036	74	50	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206785	10.1371/journal.pone.0206785	http://dx.doi.org/10.1371/journal.pone.0206785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383866	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600096
J	Hill, BL; Mascarenhas, R; Patel, HP; Diez, MDA; Wu, R; Iglesias, AA; Liu, DL; Ballicora, MA				Hill, Benjamin L.; Mascarenhas, Romila; Patel, Hiral P.; Asencion Diez, Matias D.; Wu, Rui; Iglesias, Alberto A.; Liu, Dali; Ballicora, Miguel A.			Structural analysis reveals a pyruvate-binding activator site in the Agrobacterium tumefaciens ADP-glucose pyrophosphorylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycogen; allosteric regulation; glucose; enzyme structure; pyruvate; allosterism; glucose-1-phosphate adenylyltransferase; glycogen biosynthesis; pyruvate; starch biosynthesis; enzyme evolution; pyrophosphorylase; polyglucan synthesis	ESCHERICHIA-COLI; DIRECTED MUTAGENESIS; REGULATORY ENZYME; SYNTHETASE; STARCH	The pathways for biosynthesis of glycogen in bacteria and starch in plants are evolutionarily and biochemically related. They are regulated primarily by ADP-glucose pyrophosphorylase, which evolved to satisfy metabolic requirements of a particular organism. Despite the importance of these two pathways, little is known about the mechanism that controls pyrophosphorylase activity or the location of its allosteric sites. Here, we report pyruvate-bound crystal structures of ADP-glucose pyrophosphorylase from the bacterium Agrobacterium tumefaciens, identifying a previously elusive activator site for the enzyme. We found that the tetrameric enzyme binds two molecules of pyruvate in a planar conformation. Each binding site is located in a crevice between the C-terminal domains of two subunits where they stack via a distinct beta-helix region. Pyruvate interacts with the side chain of Lys-43 and with the peptide backbone of Ser-328 and Gly-329 from both subunits. These structural insights led to the design of two variants with altered regulatory properties. In one variant (K43A), the allosteric effect was absent, whereas in the other (G329D), the introduced Asp mimicked the presence of pyruvate. The latter generated an enzyme that was preactivated and insensitive to further activation by pyruvate. Our study furnishes a deeper understanding of how glycogen biosynthesis is regulated in bacteria and the mechanism by which transgenic plants increased their starch production. These insights will facilitate rational approaches to enzyme engineering for starch production in crops of agricultural interest and will promote further study of allosteric signal transmission and molecular evolution in this important enzyme family.	[Hill, Benjamin L.; Mascarenhas, Romila; Patel, Hiral P.; Asencion Diez, Matias D.; Wu, Rui; Liu, Dali; Ballicora, Miguel A.] Loyola Univ, Dept Chem & Biochem, 1068 W Sheridan Rd, Chicago, IL 60660 USA; [Asencion Diez, Matias D.; Iglesias, Alberto A.] UNL, Consejo Nacl Invest Cient & Tecn,Inst Agrobiotech, Ctr Cient Tecnol CCT Santa Fe,Inst Agrobiotecnol, CONICET,Fac Bioquim & Ciencias Biol FBCB Paraje E, Colectora Ruta Nacl,168 Km 0, RA-3000 Santa Fe, Argentina; [Mascarenhas, Romila] Univ Michigan, Med Sch, Dept Biol Chem, Ann Arbor, MI 48109 USA	Loyola University Chicago; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; University of Michigan System; University of Michigan	Ballicora, MA (corresponding author), Loyola Univ, Dept Chem & Biochem, 1068 W Sheridan Rd, Chicago, IL 60660 USA.	mballic@luc.edu	; Liu, Dali/D-2571-2014	Iglesias, Alberto/0000-0001-9729-7338; Liu, Dali/0000-0002-7587-703X; Asencion Diez, Matias Damian/0000-0001-6495-387X	United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]	United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE))	For some of this work, we thank Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by the University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357. We thank John C. Hawkins (Writing Center, Loyola University Chicago) for assistance in proofreading the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Asencion Diez M. D., 2014, PLOS ONE, V9; Diez MDA, 2012, J BACTERIOL, V194, P1485, DOI 10.1128/JB.06377-11; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALL K, 1994, J BIOL CHEM, V269, P24706; Ballicora MA, 2005, J BIOL CHEM, V280, P10189, DOI 10.1074/jbc.M413540200; Ballicora MA, 1998, PLANT PHYSIOL, V118, P265, DOI 10.1104/pp.118.1.265; Ballicora MA, 2004, PHOTOSYNTH RES, V79, P1, DOI 10.1023/B:PRES.0000011916.67519.58; Ballicora MA, 2002, BIOCHEMISTRY-US, V41, P9431, DOI 10.1021/bi025793b; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; Batsanov SS, 2001, INORG MATER+, V37, P871, DOI 10.1023/A:1011625728803; Bejar CM, 2006, J BIOL CHEM, V281, P40473, DOI 10.1074/jbc.M607088200; Cereijo AE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00830; Cifuente JO, 2016, STRUCTURE, V24, P1613, DOI 10.1016/j.str.2016.06.023; Comino N, 2017, J BIOL CHEM, V292, P6255, DOI 10.1074/jbc.M116.773408; Cupp-Vickery JR, 2008, BIOCHEMISTRY-US, V47, P4439, DOI 10.1021/bi701933q; DeLano W.L., 2015, PYMOL MOL GRAPHICS S; Ebrecht AC, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00041; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Figueroa CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066824; Figueroa CM, 2011, BIOCHIMIE, V93, P1816, DOI 10.1016/j.biochi.2011.06.029; Frueauf JB, 2001, J BIOL CHEM, V276, P46319, DOI 10.1074/jbc.M107408200; Fusari C, 2006, ANAL BIOCHEM, V352, P145, DOI 10.1016/j.ab.2006.01.024; GARDIOL A, 1990, ARCH BIOCHEM BIOPHYS, V280, P175, DOI 10.1016/0003-9861(90)90533-5; Gomez-Casati DF, 2001, BIOCHEMISTRY-US, V40, P10169, DOI 10.1021/bi002615e; Hill BL, 2015, PROTEIN SCI, V24, P714, DOI 10.1002/pro.2644; Jin XS, 2005, EMBO J, V24, P694, DOI 10.1038/sj.emboj.7600551; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YM, 1986, J BIOL CHEM, V261, P1058; Meyer CR, 1998, ARCH BIOCHEM BIOPHYS, V353, P152, DOI 10.1006/abbi.1998.0648; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sheng J, 1996, BIOCHEMISTRY-US, V35, P3115, DOI 10.1021/bi952359j; STARK DM, 1992, SCIENCE, V258, P287, DOI 10.1126/science.258.5080.287; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	38	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1338	1348		10.1074/jbc.RA118.004246	http://dx.doi.org/10.1074/jbc.RA118.004246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30401744	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000457879500024
J	Chatterjee, S; Prados-Rosales, R; Tan, S; Phan, VC; Chrissian, C; Itin, B; Wang, H; Khajo, A; Magliozzo, RS; Casadevall, A; Stark, RE				Chatterjee, Subhasish; Prados-Rosales, Rafael; Tan, Sindy; Van Chanh Phan; Chrissian, Christine; Itin, Boris; Wang, Hsin; Khajo, Abdelahad; Magliozzo, Richard S.; Casadevall, Arturo; Stark, Ruth E.			The melanization road more traveled by: Precursor substrate effects on melanin synthesis in cell-free and fungal cell systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						melanogenesis; fungi; biophysics; catecholamine; cell wall; nuclear magnetic resonance (NMR); polysaccharide; solid state NMR; electron paramagnetic resonance (EPR); melanin; melanization; pigment formation	SOLID-STATE NMR; MAGNETIC-RESONANCE-SPECTROSCOPY; HUMAN HAIR MELANIN; CRYPTOCOCCUS-NEOFORMANS; CROSS-POLARIZATION; EUMELANINS; C-13; CATECHOLAMINES; ORGANIZATION; ACID	Natural brown-black eumelanin pigments confer structural coloration in animals and potently block ionizing radiation and antifungal drugs. These functions also make them attractive for bioinspired materials design, including coating materials for drug-delivery vehicles, strengthening agents for adhesive hydrogel materials, and free-radical scavengers for soil remediation. Nonetheless, the molecular determinants of the melanin developmental road traveled and the resulting architectural features have remained uncertain because of the insoluble, heterogeneous, and amorphous characteristics of these complex polymeric assemblies. Here, we used 2D solid-state NMR, EPR, and dynamic nuclear polarization spectroscopic techniques, assisted in some instances by the use of isotopically enriched precursors, to address several open questions regarding the molecular structures and associated functions of eumelanin. Our findings uncovered: 1) that the identity of the available catecholamine precursor alters the structure of melanin pigments produced either in Cryptococcus neoformans fungal cells or under cell-free conditions; 2) that the identity of the available precursor alters the scaffold organization and membrane lipid content of melanized fungal cells; 3) that the fungal cells are melanized preferentially by an l-DOPA precursor; and 4) that the macromolecular carbon- and nitrogen-based architecture of cell-free and fungal eumelanins includes indole, pyrrole, indolequinone, and open-chain building blocks that develop depending on reaction time. In conclusion, the availability of catecholamine precursors plays an important role in eumelanin development by affecting the efficacy of pigment formation, the melanin molecular structure, and its underlying scaffold in fungal systems.	[Chatterjee, Subhasish; Tan, Sindy; Chrissian, Christine; Wang, Hsin; Stark, Ruth E.] CUNY City Coll, Dept Chem & Biochem, MR-1024, New York, NY 10031 USA; [Chatterjee, Subhasish; Tan, Sindy; Chrissian, Christine; Wang, Hsin; Stark, Ruth E.] CUNY, Inst Macromol Assemblies, New York, NY 10031 USA; [Prados-Rosales, Rafael] Yeshiva Univ, Dept Microbiol & Immunol, Albert Einstein Coll Med, Bronx, NY 10461 USA; [Prados-Rosales, Rafael] CIC bioGUNE, Vizcaya 48160, Spain; [Van Chanh Phan] CUNY Hostos Community Coll, Dept Nat Sci, Bronx, NY 10451 USA; [Chrissian, Christine; Magliozzo, Richard S.; Stark, Ruth E.] CUNY, PhD Program Biochem, New York, NY 10036 USA; [Itin, Boris] New York Struct Biol Ctr, New York, NY 10027 USA; [Khajo, Abdelahad; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Khajo, Abdelahad; Magliozzo, Richard S.; Stark, Ruth E.] CUNY, PhD Program Chem, New York, NY 10036 USA; [Casadevall, Arturo] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; Yeshiva University; Albert Einstein College of Medicine; CIC bioGUNE; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Stark, RE (corresponding author), CUNY City Coll, Dept Chem & Biochem, MR-1024, New York, NY 10031 USA.; Chatterjee, S (corresponding author), Columbia Univ, Dept Chem, Barnard Coll, New York, NY 10027 USA.	rstark@ccny.cuny.edu	Prados-Rosales, Rafael/D-5840-2019; Chatterjee, Subhasish/AAT-6069-2020	Prados-Rosales, Rafael/0000-0001-5964-0166; Chatterjee, Subhasish/0000-0003-1351-3537; Chrissian, Christine/0000-0003-2858-4864	National Institute on Minority Health and Health Disparities of the National Institutes of Health [3G12MD007603-30S2]; New York State Office of Science, Technology and Academic Research; National Institutes of Health Office of Research Infrastructure Program Facility Improvement Grant [CO6RR015495]; National Institutes of Health Equipment Grant [S10RR029249]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015495, S10RR029249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052733] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities of the National Institutes of Health; New York State Office of Science, Technology and Academic Research; National Institutes of Health Office of Research Infrastructure Program Facility Improvement Grant; National Institutes of Health Equipment Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The 600 MHz NMR facilities used in this work are operated by The City College and the CUNY Institute for Macromolecular Assemblies, with additional infrastructural support provided by National Institutes of Health Grant 3G12MD007603-30S2 from the National Institute on Minority Health and Health Disparities of the National Institutes of Health. R. E. S. is a member of the New York Structural Biology Center (NYSBC); data collection at that facility was made possible by a grant from the New York State Office of Science, Technology and Academic Research, an National Institutes of Health Office of Research Infrastructure Program Facility Improvement Grant CO6RR015495, and an National Institutes of Health Equipment Grant S10RR029249.	Adhyaru BB, 2003, MAGN RESON CHEM, V41, P466, DOI 10.1002/mrc.1193; Aime S, 1996, ADV NEUROL, V69, P263; Alfieri ML, 2018, ACS APPL MATER INTER, V10, P7670, DOI 10.1021/acsami.7b09662; Banks IR, 2005, EUKARYOT CELL, V4, P1902, DOI 10.1128/EC.4.11.1902-1912.2005; Buszman E, 2003, APPL MAGN RESON, V24, P401, DOI 10.1007/BF03166942; Camacho E, 2017, MICROBIOL-SGM, V163, P1540, DOI 10.1099/mic.0.000552; Chatterjee S, 2015, J BIOL CHEM, V290, P13779, DOI 10.1074/jbc.M114.618389; Chatterjee S, 2014, ORG BIOMOL CHEM, V12, P6730, DOI 10.1039/c4ob01066c; Chatterjee S, 2012, BIOCHEMISTRY-US, V51, P6080, DOI 10.1021/bi300325m; CRAWFORD TB, 1970, BRIT J PHARMACOL, V38, P56, DOI 10.1111/j.1476-5381.1970.tb10336.x; CRESCENZI O, 1994, LIEBIGS ANN CHEM, P563; d'Ischia M, 2009, ANGEW CHEM INT EDIT, V48, P3914, DOI 10.1002/anie.200803786; Della Vecchia NF, 2013, ADV FUNCT MATER, V23, P1331, DOI 10.1002/adfm.201202127; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Eisenman HC, 2012, APPL MICROBIOL BIOT, V93, P931, DOI 10.1007/s00253-011-3777-2; Eisenman HC, 2009, MICROBIOL-SGM, V155, P3860, DOI 10.1099/mic.0.032854-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Frost R., 1920, MOUNTAIN INTERVAL; FUKAMIZO T, 1986, ARCH BIOCHEM BIOPHYS, V249, P15, DOI 10.1016/0003-9861(86)90555-2; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Garcia-Rivera J, 2005, FUNGAL GENET BIOL, V42, P989, DOI 10.1016/j.fgb.2005.09.003; Ghiani S, 2008, MAGN RESON CHEM, V46, P471, DOI 10.1002/mrc.2202; Gow NAR, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0035-2016; Grossman NT, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02108-16; Harris RK, 2001, PURE APPL CHEM, V73, P1795, DOI 10.1351/pac200173111795; Henson JM, 1999, ANNU REV PHYTOPATHOL, V37, P447, DOI 10.1146/annurev.phyto.37.1.447; HING AW, 1992, J MAGN RESON, V96, P205, DOI 10.1016/0022-2364(92)90305-Q; Ito S, 2003, PIGM CELL RES, V16, P230, DOI 10.1034/j.1600-0749.2003.00037.x; Jaroniec CP, 2002, J AM CHEM SOC, V124, P10728, DOI 10.1021/ja026385y; Jastrzebska M, 2002, J PHOTOCH PHOTOBIO B, V66, P201, DOI 10.1016/S1011-1344(02)00268-3; Ju KY, 2011, BIOMACROMOLECULES, V12, P625, DOI 10.1021/bm101281b; Kang X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05199-0; Kramer KJ, 1995, INSECT BIOCHEM MOLEC, V25, P1067, DOI 10.1016/0965-1748(95)00053-4; LI KL, 1993, BIOCHEMISTRY-US, V32, P9926, DOI 10.1021/bi00089a008; Meng S, 2008, BIOPHYS J, V94, P2095, DOI 10.1529/biophysj.107.121087; Meredith P, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/3/034501; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; Morcombe CR, 2003, J MAGN RESON, V162, P479, DOI 10.1016/S1090-7807(03)00082-X; Napolitano A, 1996, RAPID COMMUN MASS SP, V10, P468, DOI 10.1002/(SICI)1097-0231(19960315)10:4<468::AID-RCM506>3.3.CO;2-Y; Nosanchuk JD, 2000, LANCET, V355, P2049, DOI 10.1016/S0140-6736(00)02356-4; Nosanchuk JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01463; Panzella L, 2013, ANGEW CHEM INT EDIT, V52, P12684, DOI 10.1002/anie.201305747; POLACHECK I, 1990, INFECT IMMUN, V58, P2919, DOI 10.1128/IAI.58.9.2919-2922.1990; Proks V, 2013, MACROMOL CHEM PHYS, V214, P499, DOI 10.1002/macp.201200505; Prota G., 1992, MELANINS MELANOGENES, P88; Rosas AL, 2000, INFECT IMMUN, V68, P2845, DOI 10.1128/IAI.68.5.2845-2853.2000; Simon JD, 2010, ACCOUNTS CHEM RES, V43, P1452, DOI 10.1021/ar100079y; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Tian SY, 2003, BIOCHEMISTRY-US, V42, P8105, DOI 10.1021/bi0341859; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Watt AAR, 2009, SOFT MATTER, V5, P3754, DOI 10.1039/b902507c; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	57	13	13	2	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20157	20168		10.1074/jbc.RA118.005791	http://dx.doi.org/10.1074/jbc.RA118.005791			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385508	Green Published, hybrid			2022-12-26	WOS:000454685900023
J	Fink, BD; Bai, F; Yu, LP; Sheldon, RD; Sharma, A; Taylor, EB; Sivitz, WI				Fink, Brian D.; Bai, Fan; Yu, Liping; Sheldon, Ryan D.; Sharma, Arpit; Taylor, Eric B.; Sivitz, William I.			Oxaloacetic acid mediates ADP-dependent inhibition of mitochondrial complex II-driven respiration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; mitochondria; mitochondrial metabolism; mitochondrial respiratory chain complex; skeletal muscle; ADP; ATP; nuclear magnetic resonance (NMR); oxaloacetate; succinate; succinate dehydrogenase	REACTIVE OXYGEN; OXIDATIVE-PHOSPHORYLATION; EXTRA-MITOCHONDRIAL; ELECTRON-TRANSPORT; BRAIN; LIVER; DYSFUNCTION; SUPEROXIDE; ACTIVATION; GENERATION	We recently reported a previously unrecognized mitochondrial respiratory phenomenon. When [ADP] was held constant (clamped) at sequentially increasing concentrations in succinate-energized muscle mitochondria in the absence of rotenone (commonly used to block complex I), we observed a biphasic, increasing then decreasing, respiratory response. Here we investigated the mechanism. We confirmed decades-old reports that oxaloacetate (OAA) inhibits succinate dehydrogenase (SDH). We then used an NMR method to assess OAA concentrations (known as difficult to measure by MS) as well as those of malate, fumarate, and citrate in isolated succinate-respiring mitochondria. When these mitochondria were incubated at varying clamped ADP concentrations, respiration increased at low [ADP] as expected given the concurrent reduction in membrane potential. With further increments in [ADP], respiration decreased associated with accumulation of OAA. Moreover, a low pyruvate concentration, that alone was not enough to drive respiration, was sufficient to metabolize OAA to citrate and completely reverse the loss of succinate-supported respiration at high [ADP]. Further, chemical or genetic inhibition of pyruvate uptake prevented OAA clearance and preserved respiration. In addition, we measured the effects of incremental [ADP] on NADH, superoxide, and H2O2 (a marker of reverse electron transport from complex II to I). In summary, our findings, taken together, support a mechanism (detailed within) wherein succinate-energized respiration as a function of increasing [ADP] is initially increased by [ADP]-dependent effects on membrane potential but subsequently decreased at higher [ADP] by inhibition of succinate dehydrogenase by OAA. The physiologic relevance is discussed.	[Fink, Brian D.; Bai, Fan; Sivitz, William I.] Univ Iowa, Dept Internal Med Endocrinol & Metab, Iowa City, IA 52242 USA; [Yu, Liping; Sheldon, Ryan D.; Sharma, Arpit; Taylor, Eric B.] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, NMR Core Facil, Iowa City, IA 52242 USA; [Yu, Liping] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52242 USA; [Bai, Fan] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Emory University	Sivitz, WI (corresponding author), 422GH,200 Hawkins Dr, Iowa City, IA 52242 USA.	william-sivitz@uiowa.edu	Sharma, Arpit/AAE-2638-2022	Sheldon, Ryan/0000-0002-1573-9719; SHARMA, ARPIT/0000-0002-6132-1129; Fink, Brian/0000-0002-1149-7935; Sivitz, William/0000-0002-7829-0189	National Institutes of Health [R01 DK104998, F32 DK116522]; Fraternal Order of the Eagles; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK116522, R01DK104998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fraternal Order of the Eagles; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by resources and the use of facilities at the Department of Veterans Affairs Iowa City Health Care System, by National Institutes of Health Grants R01 DK104998 and F32 DK116522 (to E. B. H.), and by the Fraternal Order of the Eagles (to W. I. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Kadhi O, 2017, J ANAL METHODS CHEM, V2017, DOI 10.1155/2017/5391832; AZZONE GF, 1960, NATURE, V188, P552, DOI 10.1038/188552a0; Bai F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154982; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; BRAWAND F, 1980, BIOCHIM BIOPHYS ACTA, V590, P285, DOI 10.1016/0005-2728(80)90199-1; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; CHANCE B, 1955, J BIOL CHEM, V217, P409; CHANCE B, 1962, J BIOL CHEM, V237, P3540; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fink BD, 2016, AM J PHYSIOL-REG I, V311, pR756, DOI 10.1152/ajpregu.00232.2016; Gray LR, 2015, CELL METAB, V22, P669, DOI 10.1016/j.cmet.2015.07.027; Herlein JA, 2009, ENDOCRINOLOGY, V150, P46, DOI 10.1210/en.2008-0404; Hildyard JCW, 2005, BBA-BIOENERGETICS, V1707, P221, DOI 10.1016/j.bbabio.2004.12.005; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KUSTER U, 1976, BIOCHIM BIOPHYS ACTA, V440, P391, DOI 10.1016/0005-2728(76)90073-6; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; MCEVILY AJ, 1985, ARCH BIOCHEM BIOPHYS, V238, P229, DOI 10.1016/0003-9861(85)90160-2; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Panov AV, 2010, B EXP BIOL MED+, V149, P187, DOI 10.1007/s10517-010-0904-5; Panov A, 2009, J BIOL CHEM, V284, P14448, DOI 10.1074/jbc.M900985200; Panov AV, 2011, AM J PHYSIOL-REG I, V300, pR844, DOI 10.1152/ajpregu.00528.2010; PRIEGNITZ A, 1973, BIOCHEM BIOPH RES CO, V51, P1034, DOI 10.1016/0006-291X(73)90031-4; Rhee SG, 2010, MOL CELLS, V29, P539, DOI 10.1007/s10059-010-0082-3; SCHOLLMEYER P, 1961, BIOCHEM BIOPH RES CO, V4, P43, DOI 10.1016/0006-291X(61)90252-2; Scialo F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00428; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Skulachev VP, 1998, BBA-BIOENERGETICS, V1363, P100, DOI 10.1016/S0005-2728(97)00091-1; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; WANDERS RJA, 1984, EUR J BIOCHEM, V142, P417, DOI 10.1111/j.1432-1033.1984.tb08303.x; WOJTCZAK L, 1972, ACTA BIOCHIM POL, V19, P227; Yu Liping, 2015, Methods Mol Biol, V1264, P149, DOI 10.1007/978-1-4939-2257-4_14; Yu LP, 2014, J BIOENERG BIOMEMBR, V46, P33, DOI 10.1007/s10863-013-9530-z; Yu LP, 2013, DIABETES, V62, P1833, DOI 10.2337/db12-1152; Zimmermann M, 2014, ANAL CHEM, V86, P3232, DOI 10.1021/ac500472c	37	18	18	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19932	19941		10.1074/jbc.RA118.005144	http://dx.doi.org/10.1074/jbc.RA118.005144			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385511	hybrid, Green Published			2022-12-26	WOS:000454294900036
J	Chu, RX; Kim, G; Tauhid, S; Khalid, F; Healy, BC; Bakshi, R				Chu, Renxin; Kim, Gloria; Tauhid, Shahamat; Khalid, Fariha; Healy, Brian C.; Bakshi, Rohit			Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; SURFACE-BASED ANALYSIS; GREY-MATTER; CLINICAL PROGRESSION; WHITE-MATTER; CORTICAL ATROPHY; CEREBRAL ATROPHY; VOLUME LOSS; DISABILITY; RELEVANCE	Background Cerebral atrophy is common in multiple sclerosis (MS) and selectively involves gray matter (GM). Several fully automated methods are available to measure whole brain and regional deep GM (DGM) atrophy from MRI. Objective To assess the sensitivity of fully automated MRI segmentation pipelines in detecting brain atrophy in patients with relapsing-remitting (RR) MS and normal controls (NC) over five years. Methods Consistent 3D T1-weighted sequences were performed on a 3T GE unit in 16 mildly disabled patients with RRMS and 16 age-matched NC at baseline and five years. All patients received disease-modifying immunotherapy on-study. Images were applied to two pipelines to assess whole brain atrophy [brain parenchymal fraction (BPF) from SPM12; percentage brain volume change (PBVC) from SIENA] and two other pipelines (FSL-FIRST; FreeSurfer) to assess DGM atrophy (thalamus, caudate, globus pallidus, putamen). MRI change was compared by two sample t-tests. Expanded Disability Status Scale (EDSS) and timed 25-foot walk (T25FW) change was compared by repeated measures proportional odds models. Results Using FreeSurfer, the MS group had a similar to 10-fold acceleration in on-study volume loss than NC in the caudate (mean decrease 0.51 vs. 0.05 ml, p = 0.022). In contrast, caudate atrophy was not detected by FSL-FIRST (mean decrease 0.21 vs. 0.12 ml, p = 0.53). None of the other pipelines showed any difference in volume loss between groups, for whole brain or regional DGM atrophy (all p>0.38). The MS group showed on-study stability on EDSS (p = 0.47) but slight worsening of T25FW (p = 0.054). Conclusions In this real-world cohort of mildly disabled treated patients with RRMS, we identified ongoing atrophy of the caudate nucleus over five years, despite the lack of any significant whole brain atrophy, compared to healthy controls. The detectability of caudate atrophy was dependent on the MRI segmentation pipeline employed. These findings underscore the increased sensitivity gained when assessing DGM atrophy in monitoring MS.	[Chu, Renxin; Kim, Gloria; Tauhid, Shahamat; Khalid, Fariha; Healy, Brian C.; Bakshi, Rohit] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA; [Bakshi, Rohit] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bakshi, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA.; Bakshi, R (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA.	rbakshi@post.harvard.edu		Bakshi, Rohit/0000-0001-8601-5534	National Multiple Sclerosis Society [RG3798A2]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This study was supported in part by a research grant to RB from the National Multiple Sclerosis Society (nmss.org) (RG3798A2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kawaz M, 2017, J NEUROIMAGING, V27, P333, DOI 10.1111/jon.12393; Bakshi R, 2008, ARCH NEUROL-CHICAGO, V65, P1449, DOI 10.1001/archneur.65.11.1449; Bergsland N, 2012, AM J NEURORADIOL, V33, P1573, DOI 10.3174/ajnr.A3086; Bermel RA, 2006, LANCET NEUROL, V5, P158, DOI 10.1016/S1474-4422(06)70349-0; Calabrese M, 2012, AM J NEURORADIOL, V33, P1507, DOI 10.3174/ajnr.A3011; Calabrese M, 2011, NEUROLOGY, V77, P257, DOI 10.1212/WNL.0b013e318220abd4; Calabrese M, 2007, J NEUROL, V254, P1212, DOI 10.1007/s00415-006-0503-6; Ceccarelli A, 2012, AM J NEURORADIOL, V33, P1579, DOI 10.3174/ajnr.A3083; Ceccarelli A, 2008, NEUROIMAGE, V42, P315, DOI 10.1016/j.neuroimage.2008.04.173; Chard DT, 2004, MULT SCLER J, V10, P387, DOI 10.1191/1352458504ms1050oa; Chu RX, 2017, BMC NEUROL, V17, DOI 10.1186/s12883-017-0949-4; Chu RX, 2016, J NEUROIMAGING, V26, P62, DOI 10.1111/jon.12271; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dalton CM, 2004, BRAIN, V127, P1101, DOI 10.1093/brain/awh126; De Stefano N, 2003, NEUROLOGY, V60, P1157, DOI 10.1212/01.WNL.0000055926.69643.03; Dell'Oglio E, 2015, J NEUROIMAGING, V25, P191, DOI 10.1111/jon.12194; Dupuy SL, 2016, NEUROL THER, V5, P215, DOI 10.1007/s40120-016-0054-4; Eshaghi A, 2018, ANN NEUROL, V83, P210, DOI 10.1002/ana.25145; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fisher E, 2008, ANN NEUROL, V64, P255, DOI 10.1002/ana.21436; Gajofatto A, 2013, DIS MARKERS, V2013, P687, DOI 10.1155/2013/484959; Giannetti P, 2015, BRAIN, V138, P110, DOI 10.1093/brain/awu331; Giorgio A, 2008, NEUROIMAG CLIN N AM, V18, P675, DOI 10.1016/j.nic.2008.06.007; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Haider L, 2014, J NEUROL NEUROSUR PS, V85, P1386, DOI 10.1136/jnnp-2014-307712; Harrison DM, 2015, MULT SCLER J, V21, P1139, DOI 10.1177/1352458514558134; Hemond CC, 2018, BRAIN BEHAV, V8, DOI 10.1002/brb3.1068; Rojas JI, 2015, J NEUROIMAGING, V25, P68, DOI 10.1111/jon.12182; Kim G, 2017, INT J NEUROSCI, V127, P971, DOI 10.1080/00207454.2017.1283313; Kipp M, 2015, CELL MOL LIFE SCI, V72, P1127, DOI 10.1007/s00018-014-1787-9; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Meier DS, 2018, J NEUROIMAGING, V28, P36, DOI 10.1111/jon.12491; Meijerman A, 2018, AM J NEURORADIOL, V39, P46, DOI 10.3174/ajnr.A5459; Neema M, 2009, J NEUROIMAGING, V19, P3, DOI 10.1111/j.1552-6569.2008.00296.x; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Popescu V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143942; Radue EW, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000390; Raz E, 2010, RADIOLOGY, V257, P448, DOI 10.1148/radiol.10100626; Rocca MA, 2008, J NEUROL, V255, P683, DOI 10.1007/s00415-008-0776-z; Sailer M, 2001, EUR J NEUROL, V8, P37, DOI 10.1046/j.1468-1331.2001.00147.x; Sastre-Garriga J, 2017, NEUROIMAG CLIN N AM, V27, P289, DOI 10.1016/j.nic.2017.01.002; Shinohara RT, 2017, AM J NEURORADIOL, V38, P1501, DOI 10.3174/ajnr.A5254; Steenwijk MD, 2017, NEUROIMAGE-CLIN, V15, P843, DOI 10.1016/j.nicl.2017.06.034; Tovar-Moll F, 2009, AM J NEURORADIOL, V30, P1380, DOI 10.3174/ajnr.A1564; Uher T, 2017, J NEUROIMAGING, V27, P620, DOI 10.1111/jon.12445; Vidal-Jordana A, 2016, J NEUROIMAGING, V26, P532, DOI 10.1111/jon.12337; Wolinsky JS, 2013, MULT SCLER J, V19, P1310, DOI 10.1177/1352458513475723	49	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206939	10.1371/journal.pone.0206939	http://dx.doi.org/10.1371/journal.pone.0206939			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408094	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300053
J	Jakobsen, LS; Georgiadis, S; Nielsen, BF; Bokkers, BGH; Boriani, E; Duedahl-Olesen, L; Hald, T; Nauta, MJ; Stockmarr, A; Pires, SM				Jakobsen, Lea Sletting; Georgiadis, Stylianos; Nielsen, Bo Friis; Bokkers, Bas G. H.; Boriani, Elena; Duedahl-Olesen, Lene; Hald, Tine; Nauta, Maarten J.; Stockmarr, Anders; Pires, Sara M.			Probabilistic approach for assessing cancer risk due to benzo[a] pyrene in barbecued meat: Informing advice for population groups	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; EXPOSURE ASSESSMENT; COLORECTAL-CANCER; DIETARY EXPOSURE; PAHS; FOOD; UNCERTAINTY; ACRYLAMIDE; HOME	Background Consumption of meat prepared by barbecuing is associated with risk of cancer due to formation of carcinogenic compounds including benzo[a] pyrene (BaP). Assessment of a population's risk of disease and people's individual probability of disease given specific consumer attributes may direct food safety strategies to where impact on public health is largest. The aim of this study was to propose a model that estimates the risk of cancer caused by exposure to BaP from barbecued meat in Denmark, and to estimate the probability of developing cancer in subgroups of the population given different barbecuing frequencies. Methods We developed probabilistic models applying two dimensional Monte Carlo simulation to take into account the variation in exposure given age and sex and in the individuals' sensitivity to develop cancer after exposure to BaP, and the uncertainty in the dose response model. We used the Danish dietary consumption survey, monitoring data of chemical concentrations, data on consumer behavior of frequency of barbecuing, and animal dose response data. Findings We estimated an average extra lifetime risk of cancer due to BaP from barbecued meat of 6.8 x 10(-5) (95% uncertainty interval 2.6 x 10(-7) - 7.0 x 10(-4)) in the Danish population. This corresponds to approximately one to 4,074 extra cancer cases over a lifetime, reflecting wide uncertainty. The impact per barbecuing event on the risk of cancer for men and women of low body weight was higher compared to higher bodyweight. However, the difference due to sex and bodyweight between subgroups are dwarfed by the uncertainty. Interpretation This study proposes a model that can be applied to other substances and routes of exposure, and allows for deriving the change in risk following a specific change in behaviour. The presented methodology can serve as a valuable tool for risk management, allowing for the formulation of behaviour advice targeted to specific sub-groups in the population.	[Jakobsen, Lea Sletting; Georgiadis, Stylianos; Boriani, Elena; Duedahl-Olesen, Lene; Hald, Tine; Nauta, Maarten J.; Pires, Sara M.] Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark; [Georgiadis, Stylianos; Nielsen, Bo Friis; Stockmarr, Anders] Tech Univ Denmark, Dept Appl Math & Comp Sci, Lyngby, Denmark; [Bokkers, Bas G. H.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Technical University of Denmark; Technical University of Denmark; Netherlands National Institute for Public Health & the Environment	Jakobsen, LS (corresponding author), Tech Univ Denmark, Natl Food Inst, Lyngby, Denmark.	leaja@food.dtu.dk	Nauta, Maarten J./B-4376-2017; Jakobsen, Lea Sletting/S-6273-2019; Pires, Sara/M-2506-2019; Hald, Tine/B-5477-2016	Nauta, Maarten J./0000-0001-8738-4251; Jakobsen, Lea Sletting/0000-0001-9666-348X; Pires, Sara/0000-0002-7751-1509; Hald, Tine/0000-0002-1115-9792; Boriani, Elena/0000-0001-9676-7297; Duedahl-Olesen, Lene/0000-0002-3162-0101; Georgiadis, Stylianos/0000-0003-3485-9457; Nielsen, Bo Friis/0000-0001-9146-9733; Stockmarr, Anders/0000-0002-8681-2370				Aaslyng MD, 2013, MEAT SCI, V93, P85, DOI 10.1016/j.meatsci.2012.08.004; Abramsson-Zetterberg L, 2014, FOOD CHEM TOXICOL, V74, P107, DOI 10.1016/j.fct.2014.09.004; Alomirah H, 2011, FOOD CONTROL, V22, P2028, DOI 10.1016/j.foodcont.2011.05.024; Amarillo AC, 2014, ENVIRON POLLUT, V195, P157, DOI 10.1016/j.envpol.2014.08.027; [Anonymous], 2009, EFSA J, V7; Barlow S, 2006, FOOD CHEM TOXICOL, V44, P1636, DOI 10.1016/j.fct.2006.06.020; Benford D, 2010, FOOD CHEM TOXICOL, V48, pS2, DOI 10.1016/j.fct.2009.11.003; Boesten J, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2839; Bokkers BGH, 2017, FOOD CHEM TOXICOL, V110, P408, DOI 10.1016/j.fct.2017.10.038; Boon PE, 2015, FOOD CHEM TOXICOL, V79, P13, DOI 10.1016/j.fct.2014.08.004; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Chiu WA, 2015, ENVIRON HEALTH PERSP, V123, P1241, DOI 10.1289/ehp.1409385; Christensen, 2015, CHEM CONTAMINANTS FO; Culp SJ, 1998, CARCINOGENESIS, V19, P117, DOI 10.1093/carcin/19.1.117; Danish Veterinary and Food Administration, 2016, SAD UNDG TJAER PAH D; Demeyer D, 2016, CRIT REV FOOD SCI, V56, P2747, DOI 10.1080/10408398.2013.873886; Duedahl-Olesen L, 2015, FOOD CONTROL, V57, P169, DOI 10.1016/j.foodcont.2015.04.012; EFSA, 2005, EFSA J, V282, P1, DOI [10.2903/j.efsa.2005.282, DOI 10.2903/J.EFSA.2005.282]; Food Standards Agency, 2007, 0613 FD FOOD STAND A; Frewer LJ, 2016, CRIT REV FOOD SCI, V56, P1728, DOI 10.1080/10408398.2013.801337; Havelaar A. H., 2008, TRENDS FOOD SCI TECH, V19, pS26; Hogervorst JGF, 2010, CRIT REV TOXICOL, V40, P485, DOI 10.3109/10408440903524254; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; International Programme on Chemical Safety (IPCS), 2018, GUID DOC EV EXPR UNC; Jagerstad M, 2005, MUTAT RES-FUND MOL M, V574, P156, DOI 10.1016/j.mrfmmm.2005.01.030; Joint FAO/WHO Expert Committe on Food Additives (JECFA), 2006, EV CERT CONT FOOD 64; Kamal NHA, 2018, FOOD ADDIT CONTAM A, V35, P848, DOI 10.1080/19440049.2018.1425553; Lawless J. F., 2003, STAT MODELS METHODS; McAfee AJ, 2010, MEAT SCI, V84, P1, DOI 10.1016/j.meatsci.2009.08.029; McLachlan G., 2000, WILEY SER PROB STAT; Miller PE, 2013, NUTR CANCER, V65, P202, DOI 10.1080/01635581.2013.756534; MORGAN MG, 1993, SCI AM, V269, P32, DOI 10.1038/scientificamerican0793-32; National Food Agency Sweden (Livsmedels Verket), 2013, HALT POLYC AR KOLV P; Nauta MJ, 2000, INT J FOOD MICROBIOL, V57, P9, DOI 10.1016/S0168-1605(00)00225-7; Pedersn AN, 2017, SUNDHEDSADFAERD VAEG; Pouzou JG, 2018, FOOD CHEM TOXICOL, V114, P361, DOI 10.1016/j.fct.2018.02.004; R Core Team, 2013, R LANG ENV STAT COMP; Roland T, 2016, DANSKERNES MADVANER; Rose M, 2015, FOOD CHEM TOXICOL, V78, P1, DOI 10.1016/j.fct.2014.12.018; Schneider K, 2002, J APPL TOXICOL, V22, P73, DOI 10.1002/jat.828; Scientific Committee on Food, 2002, OP SCI COMM FOOD RIS; Slob W, 2016, PROAST 65 5 BENCHMAR; Slob W, 2011, 3201210022011 RIVM; Slob W, 2014, RISK ANAL, V34, P1401, DOI 10.1111/risa.12194; Tornqvist M, 2008, J AGR FOOD CHEM, V56, P6004, DOI 10.1021/jf800490s; US Environmental Protection Agency (USEPA), 2014, EPA100R09001A; van der Voet H, 2007, RISK ANAL, V27, P351, DOI 10.1111/j.1539-6924.2007.00887.x; van der Voet H, 2009, FOOD CHEM TOXICOL, V47, P2926, DOI 10.1016/j.fct.2008.12.027; Vitenskapskomiteen for Mattryghet (VKM), 2007, VURD HELS VED KONS G; Xia ZH, 2010, SCI TOTAL ENVIRON, V408, P5331, DOI 10.1016/j.scitotenv.2010.08.008; 2008, EFSA J, V6	51	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207032	10.1371/journal.pone.0207032	http://dx.doi.org/10.1371/journal.pone.0207032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408084	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300067
J	Li, T; Du, X; Shewade, HD; Soe, KT; Zhang, H				Li, Tao; Du, Xin; Shewade, Hemant Deepak; Soe, Kyaw Thu; Zhang, Hui			What happens to migrant tuberculosis patients who are transferred out using a web-based system in China?	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; METAANALYSIS	Background In China, internal migrants constitute one-fifth of tuberculosis (TB) patients registered for treatment in web-based TB information management system (TBIMS). Though China added a specific module in the web-based TBIMS in 2009, web-based transfer-out is not specifically recommended in the national guidelines. Objective In this country wide study among all registered migrant TB patients (2014-2015) that were transferred out using web-based TBIMS in China, to determine the i) timing of transfer-out in relation to period of treatment; ii) delay and attrition during transfer interval (between transfer-out and transfer-in); and iii) extent and risk factors for 'not evaluated' as the treatment outcome. Methods This was a cohort study involving review of web-based TBIMS data. Modified Poisson regression was used to build a predictive model for risk factors of 'not evaluated' as the treatment outcome. Results Among 7 284 patients, 5 900 (81.0%) were transferred out during the first two months after initiation of treatment or before treatment initiation and 7 088 (97.3%) patients had arrived at transfer-in unit. The median transfer interval was three (interquartile range: 0-14) days. Sixteen percent (1 176/7 284) patients had 'not evaluated' as their treatment outcome. 'Not evaluated' contributed to 66% of the unfavourable outcomes. Patients transferred from referral hospitals, migrated from out of prefecture, transferred out of prefecture, with sputum smear negative pulmonary TB, with TB pleurisy and with long delay between symptom onset and treatment initiation had significantly higher risk of 'not evaluated' as the outcome. Conclusion Web-based transfer helped as the delay and attrition during the transfer interval was quite short and treatment outcomes of more than four-fifths of transferred out migrant TB patients were available with transfer-out BMU. Once strategies to address the independent predictors of 'not evaluated' treatment outcome are devised, China may consider mandatory use of web-based TBIMS for transferring out migrant TB patients.	[Li, Tao; Du, Xin; Zhang, Hui] China CDC, Natl Ctr TB Control & Prevent, Beijing, Peoples R China; [Shewade, Hemant Deepak] Int Union TB & Lung Dis Union, South East Asia Off, New Delhi, India; [Shewade, Hemant Deepak] Int Union TB & Lung Dis Union, Paris, France; [Soe, Kyaw Thu] Minist Hlth & Sports, Dept Med Res, Pyin Oo Lwin Branch, Pyin Oo Lwin, Myanmar	Chinese Center for Disease Control & Prevention	Zhang, H (corresponding author), China CDC, Natl Ctr TB Control & Prevent, Beijing, Peoples R China.	zhanghui@chinatb.org		SOE, KYAW THU/0000-0003-0969-8815	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	Department for International Development (DFID), UK; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The author(s) received no specific funding for this work. The training programme and open access publications costs were funded by the Department for International Development (DFID), UK and La Fondation Veuve Emile Metz-Tesch (Luxembourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tomas BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082440; [Anonymous], 2016, CHINA STAT YB 2015; Arshad S, 2010, EUR RESPIR J, V35, P1336, DOI 10.1183/09031936.00054709; Belayneh Tadesse, 2016, Tuberc Res Treat, V2016, P1294876, DOI 10.1155/2016/1294876; Bozorgmehr K, 2017, EUROSURVEILLANCE, V22, P8, DOI 10.2807/1560-7917.ES.2017.22.12.30491; Chan IHY, 2017, LANCET INFECT DIS, V17, P770, DOI 10.1016/S1473-3099(17)30194-9; Chinese Center for Diseases Control and Prevention, 2015, GLOB FUND TUB PROGR; Dara M, 2017, INT J TUBERC LUNG D, V21, P727, DOI 10.5588/ijtld.16.0940; Ge L, 2007, CHINESE J PUBLIC HEA, V23, P701; Huang F, 2014, J AM MED INFORM ASSN, V21, P938, DOI 10.1136/amiajnl-2013-002001; Jiang S, 2014, CHIN J ANTITUBERC, V36, P798; Jie L, 2011, PREV MED TRIB, V17, P438; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Li X, 2009, CHIN J ANTITUBERC, V31, P561; Lin ShuFang, 2011, China Tropical Medicine, V11, P1334; Liu X, 2010, CHIN J ANTITUBER, V32, P775; Ministry of Health, 2009, GUID IMPL NAT TUB CO; Scotto Gaetano, 2017, Infez Med, V25, P199; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Sun YX, 2016, CHINESE MED J-PEKING, V129, P1856, DOI 10.4103/0366-6999.186650; Takarinda KC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-981; United Nations Office for Project Services, 2015, PAR SHIFT 2016 2020; White PJ, 2017, LANCET INFECT DIS, V17, P1124, DOI 10.1016/S1473-3099(17)30567-4; WHO, 2012, WHOHTMTB201122; WHO, 2015, IMPLEMENTING END TB; WHO, 2017, GUIDELINES TREATMENT; World Health Organization, 2006, STOP TB STRAT BUILD; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2017, WHOHTMTB201723; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387; World Health Organization Executive Board, 2007, HLTH MIGR MIGR FLOWS; World Health Organization Regional Office for the Western Pacific, 2016, TUB CONTR MIGR POP G; Zhou Y., 2012, CHIN J DIS CONTR, V16, P874	33	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206580	10.1371/journal.pone.0206580	http://dx.doi.org/10.1371/journal.pone.0206580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408131	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300025
J	Velcheti, V; Patwardhan, PD; Liu, FX; Chen, X; Cao, XT; Burke, T				Velcheti, Vamsidhar; Patwardhan, Pallavi D.; Liu, Frank Xiaoqing; Chen, Xin; Cao, Xiting; Burke, Thomas			Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States	PLOS ONE			English	Article							LIGAND 1 IMMUNOHISTOCHEMISTRY; PD-1/PD-L1 INHIBITORS; SQUAMOUS-CELL; PEMBROLIZUMAB; DOCETAXEL; CHEMOTHERAPY; NIVOLUMAB	Background The anti-programmed death receptor-1 (anti-PD-1) pembrolizumab is approved as first-line monotherapy for metastatic non-small cell lung cancer (mNSCLC) with PD-ligand 1 (PD-L1) tumor expression. >= 50%. Most studies comparing PD-L1 results by immunohistochemistry (IHC) assay type have been conducted by prespecified and, in most cases, highly experienced, trained pathologists; however, knowledge is limited regarding the current use and concordance of PD-L1 assays in the real-world clinical setting. Our aim was to study the distribution of PD-L1 tumor expression by IHC assay type among patients with mNSCLC in US oncology practices. Methods This retrospective observational study utilized de-identified, longitudinal data from a large US electronic medical record database. Eligible patients were adults (>= 18 years) with histologically/cytologically confirmed initial diagnosis of metastatic or recurrent NSCLC from October 2015 through December 2017. We determined PD-L1 testing trends and distribution of PD-L1 tumor expression (percentage of tumor cells staining for PD-L1) by IHC assay type. Results The 12,574 eligible patients (mean age, 69 years) included 6,620 (53%) men and 86% with positive smoking history. Of 4,868 evaluable tests, 3,799 (78%), 195 (4%), 165 (3%), and 709 (15%) used the Agilent 22C3 pharmDx, Agilent 28-8 pharmDx, Ventana PD-L1 (SP142) Assay, and laboratory-developed tests (LDTs, including SP263), respectively. The percentages of tests scoring PD-L1 tumor expression of. 50% were 33%, 32%, 10%, and 23%, respectively. Measured PD-L1 tumor expression varied across the four assay types (chi(2) p < 0.001) and across three assay types excluding SP142 (p < 0.001), with no significant difference between 22C3 and 28-8 assays (p = 0.96). The PD-L1 testing rate increased from 18% in the fourth quarter of 2015 to 71% in the fourth quarter of 2017. Conclusions In the real-world clinical setting, we observed that measured PD-L1 tumor expression is concordant using the 22C3 and 28-8 assays; however, the SP142 assay and LDTs appear discordant and could underestimate high PD-L1 positivity. Further study is needed to evaluate the association between PD-L1 tumor expression and response to therapy.	[Velcheti, Vamsidhar] NYU, Perlmutter Canc Ctr, Hematol & Oncol, 550 1St Ave, New York, NY 10003 USA; [Patwardhan, Pallavi D.; Liu, Frank Xiaoqing; Chen, Xin; Cao, Xiting; Burke, Thomas] Merck & Co Inc, CORE, Kenilworth, NJ USA	New York University; Merck & Company	Velcheti, V (corresponding author), NYU, Perlmutter Canc Ctr, Hematol & Oncol, 550 1St Ave, New York, NY 10003 USA.	velchv01@nyumc.org			Merck & Co., Inc., Kenilworth NJ, USA; Merck Sharp & Dohme Corp. of Merck & Co., Inc., Kenilworth, NJ, USA	Merck & Co., Inc., Kenilworth NJ, USA; Merck Sharp & Dohme Corp. of Merck & Co., Inc., Kenilworth, NJ, USA	This study was funded by Merck & Co., Inc., Kenilworth NJ, USA. The funder of the study participated in the study design, data analysis, decision to publish, and preparation of the manuscript. The funder also provided support in the form of salaries for authors PDP, FXL, XC, XC, and TB. All authors, including those employed by Merck, participated in the data interpretation and writing of the report. All authors had full access to study results and had final responsibility for the decision to submit for publication.; We gratefully acknowledge the help of Qian Xia (Merck & Co., Inc., Kenilworth, NJ, USA) for providing statistical programming support. Medical writing and editorial assistance was provided by Elizabeth V. Hillyer, DVM. This assistance was funded by Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.	Adam J, 2018, ANN ONCOL, V29, P953, DOI 10.1093/annonc/mdy014; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Buttner R, 2017, J CLIN ONCOL, V35, P3867, DOI 10.1200/JCO.2017.74.7642; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Hendry S, 2018, J THORAC ONCOL, V13, P367, DOI 10.1016/j.jtho.2017.11.112; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Hiley CT, 2016, LANCET, V388, P1002, DOI 10.1016/S0140-6736(16)31340-X; Hirsch FR, 2017, J THORAC ONCOL, V12, P208, DOI 10.1016/j.jtho.2016.11.2228; Ilie M, 2018, CANCER CYTOPATHOL, V126, P264, DOI 10.1002/cncy.21977; Kerr KM, 2015, J THORAC ONCOL, V10, P985, DOI 10.1097/JTO.0000000000000526; Khunger M, 2018, CLIN LUNG CANCER, V19, pE335, DOI 10.1016/j.cllc.2018.01.002; Khunger M, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.16.00030; Marchetti A, 2017, J THORAC ONCOL, V12, P1654, DOI 10.1016/j.jtho.2017.07.031; McLaughlin J, 2016, JAMA ONCOL, V2, P46, DOI 10.1001/jamaoncol.2015.3638; National Comprehensive Cancer Network (NCCN), NCCN CLINICAL PRACTI; Notsuda H, 2017, J THORAC ONCOL, V12, P422, DOI 10.1016/j.jtho.2017.01.007; Pai-Scherf L, 2017, ONCOLOGIST, V22, P1392, DOI 10.1634/theoncologist.2017-0078; Ratcliffe MJ, 2017, CLIN CANCER RES, V23, P3585, DOI 10.1158/1078-0432.CCR-16-2375; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rimm DL, 2017, JAMA ONCOL, V3, P1051, DOI 10.1001/jamaoncol.2017.0013; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Sacher AG, 2016, JAMA ONCOL, V2, P1217, DOI 10.1001/jamaoncol.2016.0639; Scheel AH, 2018, HISTOPATHOLOGY, V72, P449, DOI 10.1111/his.13375; Scheel AH, 2016, MODERN PATHOL, V29, P1165, DOI 10.1038/modpathol.2016.117; Yu H, 2016, J THORAC ONCOL, V11, P964, DOI 10.1016/j.jtho.2016.04.014	26	49	50	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206370	10.1371/journal.pone.0206370	http://dx.doi.org/10.1371/journal.pone.0206370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408065	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300019
J	Danielsen, TK; Manotheepan, R; Sadredini, M; Leren, IS; Edwards, AG; Vincent, KP; Lehnart, SE; Sejersted, OM; Sjaastad, I; Haugaa, KH; Stokke, MK				Danielsen, Tore K.; Manotheepan, Ravinea; Sadredini, Mani; Leren, Ida S.; Edwards, Andrew G.; Vincent, Kevin P.; Lehnart, Stephan E.; Sejersted, Ole M.; Sjaastad, Ivar; Haugaa, Kristina H.; Stokke, Mathis K.			Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; CA2+ RELEASE; FLECAINIDE; THERAPY; MYOCYTE; KINASE; MICE; DENERVATION; CAMKII; MODEL	Aims Catecholaminergic polymorphic ventricular tachycardia type 1 (CPVT1) predisposes to ventricular tachyarrhythmias (VTs) during high heart rates due to physical or psychological stress. The essential role of catecholaminergic effects on ventricular cardiomyocytes in this situation is well documented, but the importance of heart rate per se for arrhythmia initiation in CPVT1 is largely unexplored. Methods and results Sixteen CPVT1 patients performed a bicycle stress-test. Occurrence of VT triggers, i.e. premature ventricular complexes (PVC), depended on high heart rate, with individual thresholds. Atrial pacing above the individual PVC threshold in three patients did not induce PVCs. The underlying mechanism for the clinical observation was explored using cardiomyocytes from mice with the RyR2-R24745 (RyR2-RS) mutation, which exhibit exercise-induced VTs. While rapid pacing increased the number of Ca2+ waves in both RyR2-RS and wild-type (p<0.05), beta-adrenoceptor (beta AR) stimulation induced more Ca2+ waves in RyR2RS (p<0.05). Notably, Ca2+ waves occurred despite decreased sarcoplasmic reticulum (SR) Ca2+ content in RyR2-RS (p<0.05), suggesting increased cytosolic RyR2 Ca2+ sensitivity. A computational model of mouse ventricular cardiomyocyte electrophysiology reproduced the cellular CPVT1 phenotype when RyR2 Ca2+ sensitivity was increased. Importantly, diastolic fluctuations in phosphorylation of RyR2 and SR Ca2+ content determined Ca2+ wave initiation. These factors were modulated towards increased propensity for arrhythmia initiation by increased pacing rates, but even more by beta AR stimulation. Conclusion In CPVT1, VT propensity depends on individual heart rate thresholds for PVCs. Through converging data from clinical exercise stress-testing, cellular studies and computational modelling, we confirm the heart rate-independent pro-arrhythmic effects of beta AR stimulation in CPVT1, but also identify an independent and synergistic contribution from effects of high heart rate.	[Danielsen, Tore K.; Manotheepan, Ravinea; Sadredini, Mani; Edwards, Andrew G.; Sejersted, Ole M.; Sjaastad, Ivar; Stokke, Mathis K.] Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway; [Danielsen, Tore K.; Manotheepan, Ravinea; Sadredini, Mani; Leren, Ida S.; Edwards, Andrew G.; Sejersted, Ole M.; Sjaastad, Ivar; Haugaa, Kristina H.; Stokke, Mathis K.] Univ Oslo, Oslo, Norway; [Danielsen, Tore K.; Manotheepan, Ravinea; Sadredini, Mani; Sejersted, Ole M.; Sjaastad, Ivar; Stokke, Mathis K.] Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway; [Leren, Ida S.; Haugaa, Kristina H.; Stokke, Mathis K.] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Ctr Cardiol Innovat, Oslo, Norway; [Edwards, Andrew G.; Vincent, Kevin P.] Simula Res Lab, Oslo, Norway; [Lehnart, Stephan E.] Univ Med Ctr Gottingen, Dept Cardiol & Pulmonol, Heart Res Ctr Gottingen, Gottingen, Germany; [Lehnart, Stephan E.] DZHK German Ctr Cardiovasc Res, Partner site Gottingen, Gottingen, Germany; [Haugaa, Kristina H.] Univ Oslo, Oslo Univ Hosp, Rikshosp, Inst Surg Res, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Gottingen; German Centre for Cardiovascular Research; University of Oslo; National Hospital Norway	Stokke, MK (corresponding author), Oslo Univ Hosp, Inst Expt Med Res, Oslo, Norway.; Stokke, MK (corresponding author), Univ Oslo, Oslo, Norway.; Stokke, MK (corresponding author), Univ Oslo, KG Jebsen Ctr Cardiac Res, Oslo, Norway.; Stokke, MK (corresponding author), Oslo Univ Hosp, Rikshosp, Dept Cardiol, Ctr Cardiol Innovat, Oslo, Norway.	m.k.stokke@medisin.uio.no	Stokke, Mathis/AAJ-9111-2020; Haugaa, Kristina/S-8023-2019; Vincent, Kevin P/AAX-9083-2020	Stokke, Mathis/0000-0002-8869-8153; Vincent, Kevin P/0000-0002-7384-7259; Haugaa, Kristina/0000-0002-4900-0453; Sadredini, Mani/0000-0001-6015-7411	Deutsche Forschungsgemeinschaft [SFB 1002]; German Center for Cardiovascular Research (DZHK arrhythmia modeling)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Center for Cardiovascular Research (DZHK arrhythmia modeling)	This work was supported by Deutsche Forschungsgemeinschaft SFB 1002 (project A09) (S.E.L., http://www.dfg.de); and German Center for Cardiovascular Research (DZHK arrhythmia modeling) (S.E.L., https://dzhk.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa Y, 2006, INT HEART J, V47, P381, DOI 10.1536/ihj.47.381; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Curran J, 2007, CIRC RES, V100, P391, DOI 10.1161/01.RES.0000258172.74570.e6; De Ferrari GM, 2015, CIRCULATION, V131, P2185, DOI 10.1161/CIRCULATIONAHA.115.015731; Gonano LA, 2011, CIRC-ARRHYTHMIA ELEC, V4, P947, DOI 10.1161/CIRCEP.111.964908; Haugaa KH, 2010, EUROPACE, V12, P417, DOI 10.1093/europace/eup448; Kannankeril PJ, 2017, JAMA CARDIOL, V2, P759, DOI 10.1001/jamacardio.2017.1320; Kashimura T, 2010, CIRC RES, V107, P1483, DOI 10.1161/CIRCRESAHA.110.227744; Khoury A, 2013, HEART RHYTHM, V10, P1671, DOI 10.1016/j.hrthm.2013.08.011; Krahn AD, 2005, CIRCULATION, V112, P2228, DOI 10.1161/CIRCULATIONAHA.105.552166; Lehnart SE, 2004, CIRCULATION, V109, P3208, DOI 10.1161/01.CIR.0000132472.98675.EC; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Liu NA, 2011, J MOL CELL CARDIOL, V50, P214, DOI 10.1016/j.yjmcc.2010.10.001; Manotheepan R, 2016, CARDIOVASC RES, V111, P295, DOI 10.1093/cvr/cvw095; Manotheepan R, 2014, AM J CARDIOL, V113, P1829, DOI 10.1016/j.amjcard.2014.03.012; MOAK JP, 1984, CIRCULATION, V69, P149, DOI 10.1161/01.CIR.69.1.149; Morotti S, 2014, J PHYSIOL-LONDON, V592, P1181, DOI 10.1113/jphysiol.2013.266676; Pieske B, 1999, CIRC RES, V85, P38; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; PRIORI SG, 1990, AM J PHYSIOL, V258, pH1796, DOI 10.1152/ajpheart.1990.258.6.H1796; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Roses-Noguer F, 2014, HEART RHYTHM, V11, P58, DOI 10.1016/j.hrthm.2013.10.027; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; van der Werf C, 2011, J AM COLL CARDIOL, V57, P2244, DOI 10.1016/j.jacc.2011.01.026; Watanabe H, 2009, NAT MED, V15, P380, DOI 10.1038/nm.1942; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wilde AAM, 2008, NEW ENGL J MED, V358, P2024, DOI 10.1056/NEJMoa0708006	29	11	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207100	10.1371/journal.pone.0207100	http://dx.doi.org/10.1371/journal.pone.0207100			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399185	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000046
J	Enriquez, MMM; Felix, AJ; Ciudad, CJ; Noe, V				Medina Enriquez, Miriam Marlene; Felix, Alex J.; Ciudad, Carlos J.; Noe, Veronique			Cancer immunotherapy using PolyPurine Reverse Hoogsteen hairpins targeting the PD-1/PD-L1 pathway in human tumor cells	PLOS ONE			English	Article							PD-L1 EXPRESSION; PHAGOCYTOSIS; MACROPHAGES; THERAPY	Immunotherapy approaches stand out as innovative strategies to eradicate tumor cells. Among them, PD-1/PD-L1 immunotherapy is considered one of the most successful advances in the history of cancer immunotherapy. We used our technology of Polypurine reverse Hoogsteen hairpins (PPRHs) for silencing both genes with the aim to provoke the elimination of tumor cells by macrophages in co-culture experiments. Incubation of PPRHs against PD-1 and PD-L1 decreased the levels of mRNA and protein in THP-1 monocytes and PC3 prostate cancer cells, respectively. Viability of THP-1 cells and macrophages obtained by PMA-differentiation of THP-1 cells was not affected upon incubation with the different PPRHs. On the other hand, PC3 cell survival was partially decreased by PPRHs against PD-L1. The greatest effect in decreasing cell viability was obtained in macrophages/ PC3 co-culture experiments by combining PPRHs against PD-1 and PD-L1. This effect was also observed in other cancer cell lines: HeLa, SKBR3 and to a minor extent in M21. Apoptosis was not detected when macrophages were treated with the different PPRHs. However, co-cultures of macrophages with the four cancer cell lines treated with PPRHs showed an increase in apoptosis. The order of fold-increase in apoptosis was HeLa > PC3 > SKBR3 > M21. This study demonstrates that PPRHs could be powerful pharmacological agents to use in immunotherapy approaches for the inhibition of PD-1 and PD-L1.	[Noe, Veronique] Univ Barcelona, Sch Pharm, Dept Biochem & Physiol, Barcelona, Spain; Univ Barcelona, Inst Nanosci & Nanotechnol, Barcelona, Spain	University of Barcelona; University of Barcelona	Noe, V (corresponding author), Univ Barcelona, Sch Pharm, Dept Biochem & Physiol, Barcelona, Spain.	vnoe@ub.edu	Ciudad, Carlos J./D-7917-2014; Enríquez, Miriam Marlene Medina/K-9029-2019; Enriquez, Miriam Marlene Medina/K-3020-2017; Noe, Veronica/K-3615-2014	Ciudad, Carlos J./0000-0002-7855-392X; Enríquez, Miriam Marlene Medina/0000-0001-9454-9114; Enriquez, Miriam Marlene Medina/0000-0001-9454-9114; Noe, Veronica/0000-0001-7937-8038; J. Felix, Alex/0000-0002-7145-7169	Ministerio de Economia y Competitividad [SAF2014-51825-R]; CONACYT fellowship from Mexico [CVU 232495]; Ministerio de Educacion (Spain)	Ministerio de Economia y Competitividad(Spanish Government); CONACYT fellowship from Mexico; Ministerio de Educacion (Spain)(Spanish Government)	This research was funded by the Ministerio de Economia y Competitividad (SAF2014-51825-R to VN and CC), http://www.mineco.gob.es/.MMM is the recipient of a CONACYT fellowship (CVU 232495) from Mexico. AJF is the recipient of an FPU fellowship from Ministerio de Educacion (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561; Bener G, 2016, BMC IMMUNOL, V17, DOI 10.1186/s12865-016-0170-z; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Cerignoli F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193498; Ciudad CJ, 2017, CURR MED CHEM, V24, P2809, DOI 10.2174/0929867324666170301114127; Clark CA, 2016, CANCER RES, V76, P6964, DOI 10.1158/0008-5472.CAN-16-0258; de Almagro MC, 2011, HUM GENE THER, V22, P451, DOI 10.1089/hum.2010.102; de Almagro MC, 2009, J BIOL CHEM, V284, P11579, DOI 10.1074/jbc.M900981200; Deng J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111713; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Felix AJ, 2018, BIOCHEM PHARMACOL, V155, P8, DOI 10.1016/j.bcp.2018.06.020; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0316-z; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Gordon SR, 2017, NATURE, V545, P495, DOI 10.1038/nature22396; Guan J, 2017, ARCH PATHOL LAB MED, V141, P851, DOI 10.5858/arpa.2016-0361-RA; Iwamura K, 2012, GENE THER, V19, P959, DOI 10.1038/gt.2011.185; Jadus MR, 1996, BLOOD, V87, P5232, DOI 10.1182/blood.V87.12.5232.bloodjournal87125232; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Juneja VR, 2017, J EXP MED, V214, P895, DOI 10.1084/jem.20160801; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Kwak G, 2017, ACS NANO, V11, P10135, DOI 10.1021/acsnano.7b04717; Li J, 2017, CELL PHYSIOL BIOCHEM, V41, P907, DOI [10.1159/00460504, 10.1159/000460504]; Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; MUNN DH, 1990, J EXP MED, V172, P231, DOI 10.1084/jem.172.1.231; Qian XL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/525913; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rodriguez L, 2015, MOL PHARMACEUT, V12, P867, DOI 10.1021/mp5007008; Rodriguez L, 2013, BIOCHEM PHARMACOL, V86, P1541, DOI 10.1016/j.bcp.2013.09.013; Rosenberg SA, 2011, CLIN CANCER RES, V17, P4550, DOI 10.1158/1078-0432.CCR-11-0116; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Shi SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076012; Song X, 2014, ONCOL REP, V31, P1191, DOI 10.3892/or.2013.2955; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Villalobos X, 2015, NUCLEIC ACID THER, V25, P198, DOI 10.1089/nat.2015.0531; Villalobos X, 2014, MOL PHARMACEUT, V11, P254, DOI 10.1021/mp400431f; Wang X, 2016, ONCOTARGETS THER, V9, P5023, DOI 10.2147/OTT.S105862; Weiskopf K, 2017, EUR J CANCER, V76, P100, DOI 10.1016/j.ejca.2017.02.013; Yaddanapudi K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.23403; Yee C, 2013, CLIN CANCER RES, V19, P4550, DOI 10.1158/1078-0432.CCR-13-1367	40	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206818	10.1371/journal.pone.0206818	http://dx.doi.org/10.1371/journal.pone.0206818			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399174	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000022
J	Yang, LH; Wang, J; Deng, Y; Gong, CS; Li, Q; Chen, Q; Li, H; Jiang, CL; Zhou, RH; Hai, KR; Wu, W; Li, T				Yang, Linghui; Wang, Jing; Deng, Yan; Gong, Cansheng; Li, Qin; Chen, Qiu; Li, Huan; Jiang, Chunling; Zhou, Ronghua; Hai, Kerong; Wu, Wei; Li, Tao			Melatonin improves neurological outcomes and preserves hippocampal mitochondrial function in a rat model of cardiac arrest	PLOS ONE			English	Article							REDUCES OXIDATIVE STRESS; COGNITIVE IMPAIRMENT; BRAIN-INJURY; HEXOKINASE; METABOLISM; PATHWAY; DISEASE; DAMAGE	Cerebral injury after cardiac arrest (CA)/cardiopulmonary resuscitation (CPR) has been implicated in the poor prognosis of CA survivors. This study was designed to evaluate the impact of melatonin on postresuscitation neurological outcomes and to explore the underlying mechanism. Sprague-Dawley rats were randomly assigned to four groups: sham group, CPR group, melatonin pretreatment group (Pre-M) and posttreatment group (Post-M). For the last 2 groups, daily melatonin gavage was performed for 12 consecutive days before or 24 hours after rat survival from CA/CPR. No statistical differences were observed in heart rate (HR), mean arterial blood pressure (MAP), and end-tidal carbon dioxide (ETCO2) at baseline and after restoration of spontaneous circulation (ROSC) among groups. However, melatonin pretreatment or posttreatment significantly improved neurological deficit score and memory and spatial learning ability after CA/CPR. Further studies demonstrated that the complex I- and complex-II supported mitochondrial respiration were greatly increased under melatonin treatment. In addition, melatonin treatment preserved the mitochondrialbinding hexokinase II (HKII) and ATP levels and suppressed the upregulated protein lysine acetylation in hippocampus after CA/CPR. In conclusion, using a rat asphyxial CA model we have demonstrated that treatment with melatonin either before or after CA/CPR provides a promising neuroprotective effect, and this protection was mediated by increasing mitochondrial HKII expression, suppressing protein acetylation and improving mitochondrial function in hippocampus.	[Yang, Linghui; Wang, Jing; Deng, Yan; Gong, Cansheng; Li, Qin; Chen, Qiu; Li, Huan; Jiang, Chunling; Zhou, Ronghua; Hai, Kerong; Li, Tao] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu, Sichuan, Peoples R China; [Deng, Yan; Chen, Qiu; Li, Tao] Sichuan Univ, West China Hosp, West China Washington Mitochondria & Metab Ctr, Chengdu, Sichuan, Peoples R China; [Deng, Yan; Jiang, Chunling; Zhou, Ronghua; Li, Tao] Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China; [Li, Qin; Wu, Wei] Chengdu Mil Area Command, Gen Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, T (corresponding author), Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesia & Crit Care Med, Chengdu, Sichuan, Peoples R China.; Li, T (corresponding author), Sichuan Univ, West China Hosp, West China Washington Mitochondria & Metab Ctr, Chengdu, Sichuan, Peoples R China.; Li, T (corresponding author), Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu, Sichuan, Peoples R China.	scutaoli1981@scu.edu.cn	Li, Tao/ADA-1377-2022		National Key Research and Development Program of China [2018YFC1106502]; National Natural Science Foundation of China [81471042, 81770815, 81770087]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Key Research and Development Program of China (2018YFC1106502 to T.L.) and the National Natural Science Foundation of China (81471042 and 81770815 to T.L., and 81770087 to L.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergt Stefan, 2017, JACC Basic Transl Sci, V2, P149, DOI 10.1016/j.jacbts.2017.01.009; Cheng AW, 2016, CELL METAB, V23, P128, DOI 10.1016/j.cmet.2015.10.013; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cortese M, 2014, CELL METAB, V19, P737, DOI 10.1016/j.cmet.2014.04.012; Coute RA, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005239; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Farez MF, 2015, CELL, V162, P1338, DOI 10.1016/j.cell.2015.08.025; Feng Z, 2006, FREE RADICAL BIO MED, V40, P101, DOI 10.1016/j.freeradbiomed.2005.08.014; Furio AM, 2007, J PINEAL RES, V43, P404, DOI 10.1111/j.1600-079X.2007.00491.x; Gimenez-Cassina A, 2009, J BIOL CHEM, V284, P3001, DOI 10.1074/jbc.M808698200; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Hardeland R, 2017, CELL MOL LIFE SCI, V74, P3883, DOI 10.1007/s00018-017-2615-9; Hickey RW, 2000, CRIT CARE MED, V28, P3511, DOI 10.1097/00003246-200010000-00027; KATZ L, 1995, J CEREBR BLOOD F MET, V15, P1032, DOI 10.1038/jcbfm.1995.129; Kilbaugh TJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002232; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kragholm K, 2017, NEW ENGL J MED, V376, P1737, DOI 10.1056/NEJMoa1601891; Lee CF, 2016, CIRCULATION, V134, P883, DOI 10.1161/CIRCULATIONAHA.116.022495; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ramos E, 2017, FREE RADICAL BIO MED, V104, P32, DOI 10.1016/j.freeradbiomed.2017.01.005; Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Schaefer M, 2009, J PINEAL RES, V46, P49, DOI 10.1111/j.1600-079X.2008.00614.x; Sims NR, 2008, NAT PROTOC, V3, P1228, DOI 10.1038/nprot.2008.105; Suofu Y, 2017, P NATL ACAD SCI USA, V114, pE7997, DOI 10.1073/pnas.1705768114; Varanita T, 2015, CELL METAB, V21, P834, DOI 10.1016/j.cmet.2015.05.007; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Yang L, 2011, J PROTEOME RES, V10, P4134, DOI 10.1021/pr200313x; Zhang L, 2013, BEHAV BRAIN RES, V256, P72, DOI 10.1016/j.bbr.2013.07.051; Zhang S, 2015, EUROPACE, V17, P14, DOI 10.1093/europace/euv143	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207098	10.1371/journal.pone.0207098	http://dx.doi.org/10.1371/journal.pone.0207098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399193	gold, Green Submitted, Green Published			2022-12-26	WOS:000449374000045
J	Zhao, M; Ji, HM; Gao, Y; Cao, XX; Mao, HY; Ouyang, SQ; Liu, P				Zhao, Min; Ji, Hui-Min; Gao, Ying; Cao, Xin-Xin; Mao, Hui-Ying; Ouyang, Shou-Qiang; Liu, Peng			An integrated analysis of mRNA and sRNA transcriptional profiles in tomato root: Insights on tomato wilt disease	PLOS ONE			English	Article							FUSARIUM-OXYSPORUM; NUCLEOTIDE-BINDING; RESISTANCE GENE; PLANT DEFENSE; LRR PROTEIN; ARABIDOPSIS; EXPRESSION; MICRORNA; SUPERFAMILY; ANNOTATION	Tomato wilt disease caused by Fusarium oxysporum f. sp. lycopersici (FOL) is a worldwide destructive disease of tomato. As exploring gene expression and function approaches constitute an initial point for investigating pathogen-host interaction, we performed RNA-seq and sRNA-seq analysis to investigate the transcriptome of tomato root under FOL infection. Differentially expressed (DE) protein-coding gene and miRNA gene profiles upon inoculation with FOL were presented at twenty-four hours post-inoculation in four treatments. A total of more than 182.6 million and 132.2 million high quality clean reads were obtained by RNA-seq and sRNA-seq, respectively. A large overlap was found in DE mRNAs between susceptible cultivar Moneymaker and resistant cultivar Motelle. Gene Ontology terms were mainly classified into catalytic activity, metabolic process and binding. Combining with qRT-PCR and Northern blot, we validated the transcriptional profile of five genes and five miRNAs conferred to FOL infection. Our work allowed comprehensive understanding of different transcriptional reaction of genes/miRNAs between the susceptible and resistant cultivars tomato to the FOL challenge, which could offer us with a future direction to generate models of mediated resistance responses.	[Zhao, Min; Ji, Hui-Min; Gao, Ying; Cao, Xin-Xin; Mao, Hui-Ying; Ouyang, Shou-Qiang] Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Ouyang, Shou-Qiang] Yangzhou Univ, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China; [Liu, Peng] Yangzhou Univ, Texting Ctr, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Ouyang, SQ (corresponding author), Yangzhou Univ, Coll Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.; Ouyang, SQ (corresponding author), Yangzhou Univ, Joint Int Res Lab Agr & Agriprod Safety, Yangzhou, Jiangsu, Peoples R China.; Liu, P (corresponding author), Yangzhou Univ, Texting Ctr, Yangzhou, Jiangsu, Peoples R China.	oysq@yzu.edu.cn; pengliu@yzu.edu.cn	Ouyang, Shouqiang/ACA-1229-2022		Science Foundation of Jiangsu Province, Jiangsu Province, China [BK20161330]	Science Foundation of Jiangsu Province, Jiangsu Province, China	This work was supported by grant of Science Foundation of Jiangsu Province: BK20161330, Jiangsu Province, China.	Andolfo G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094963; Axtell MJ, 2018, PLANT CELL, V30, P272, DOI 10.1105/tpc.17.00851; Baldrich P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1083; Birkenbihl RP, 2017, CURR OPIN PLANT BIOL, V38, P1, DOI 10.1016/j.pbi.2017.04.004; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Buscaill P, 2014, CURR OPIN PLANT BIOL, V20, P35, DOI 10.1016/j.pbi.2014.04.004; Catanzariti AM, 2015, NEW PHYTOL, V207, P106, DOI 10.1111/nph.13348; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Ilarduya OM, 2001, PLANT J, V27, P417, DOI 10.1046/j.1365-313X.2001.01112.x; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Gonzalez-Cendales Y, 2016, MOL PLANT PATHOL, V17, P448, DOI 10.1111/mpp.12294; Guo LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095543; Gupta KJ, 2014, MOL PLANT MICROBE IN, V27, P307, DOI 10.1094/MPMI-06-13-0160-R; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Inal B, 2014, PLANTA, V240, P1287, DOI 10.1007/s00425-014-2153-8; Jannot AS, 2015, J CLIN EPIDEMIOL, V68, P460, DOI 10.1016/j.jclinepi.2015.01.001; Ji HM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00026; Krishnamurthy P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10730-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Liu F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01443; Liu N, 2016, MOL GENET GENOMICS, V291, P621, DOI 10.1007/s00438-015-1132-5; Llave C, 2002, PLANT CELL, V14, P1605, DOI 10.1105/tpc.003210; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Mithofer A, 2012, ANNU REV PLANT BIOL, V63, P431, DOI 10.1146/annurev-arplant-042110-103854; Mohorianu I, 2011, PLANT J, V67, P232, DOI 10.1111/j.1365-313X.2011.04586.x; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Narusaka M, 2009, PLANT J, V60, P218, DOI 10.1111/j.1365-313X.2009.03949.x; Okuyama Y, 2011, PLANT J, V66, P467, DOI 10.1111/j.1365-313X.2011.04502.x; Ori N, 1997, PLANT CELL, V9, P521, DOI 10.1105/tpc.9.4.521; Ouyang SQ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004464; Padmanabhan C, 2009, CURR OPIN PLANT BIOL, V12, P465, DOI 10.1016/j.pbi.2009.06.005; Paul JY, 2011, PLANT BIOTECHNOL J, V9, P1141, DOI 10.1111/j.1467-7652.2011.00639.x; Peart JR, 2005, CURR BIOL, V15, P968, DOI 10.1016/j.cub.2005.04.053; Qiao YL, 2013, NAT GENET, V45, P330, DOI 10.1038/ng.2525; Radwan O, 2011, MOL PLANT MICROBE IN, V24, P958, DOI 10.1094/MPMI-11-10-0271; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Simons G, 1998, PLANT CELL, V10, P1055, DOI 10.1105/tpc.10.6.1055; Sinapidou E, 2004, PLANT J, V38, P898, DOI 10.1111/j.1365-313X.2004.02099.x; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Spoel SH, 2008, CELL HOST MICROBE, V3, P348, DOI 10.1016/j.chom.2008.05.009; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsuda K, 2015, NEW PHYTOL, V206, P932, DOI 10.1111/nph.13286; van Ooijen G, 2007, ANNU REV PHYTOPATHOL, V45, P43, DOI 10.1146/annurev.phyto.45.062806.094430; Wang Y, 2011, PLANT CELL, V23, P3185, DOI 10.1105/tpc.111.088013; Weiberg A, 2013, SCIENCE, V342, P118, DOI 10.1126/science.1239705; Wong J, 2014, PLANT J, V79, P928, DOI 10.1111/tpj.12590; Xing MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148048; Yang L, 2014, J INTEGR PLANT BIOL, V56, P962, DOI 10.1111/jipb.12200; Yu Shuan-Cang, 2008, Yichuan, V30, P926, DOI 10.3724/SP.J.1005.2008.00926	64	11	12	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206765	10.1371/journal.pone.0206765	http://dx.doi.org/10.1371/journal.pone.0206765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395631	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400051
J	Bru, A; Gomez-Castro, D; Vila, L; Bru, I; Souto, JC				Bru, Antonio; Gomez-Castro, David; Vila, Luis; Bru, Isabel; Carlos Souto, Juan			Study of tumor growth indicates the existence of an "immunological threshold" separating states of pro- and antitumoral peritumoral inflammation	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; POLYMORPHONUCLEAR NEUTROPHILS; RANDOMIZED-TRIAL; CALMETTE-GUERIN; BLADDER-CANCER; METASTASIS; CELLS; ADENOCARCINOMA; IMMUNOTHERAPY; REGRESSION	Background Peritumoral inflammation-a response mainly involving polimorphonuclear neutrophils-has traditionally been thought protumoral in its effects. In recent years, however, a number of studies have indicated that it may play an important antitumoral role. This discrepancy has been difficult to explain. Methods and findings This work describes a tool for simulating tumor growth that obeys the universal model of tumor growth dynamics, and shows through its use that low intensity peritumoral inflammation exerts a protumoral effect, while high intensity inflammation exerts a potent antitumoral effect. Indeed, the simulation results obtained indicate that a sufficiently strong antitumoral effect can reverse tumor growth, as has been suggested several times in the clinical literature. Conclusions The present result indicate that an 'immunological threshold' must exist, marking the boundary between states in which peritumoral inflammation is either harmful or beneficial. These findings lend support to the idea that stimulating intense peritumoral inflammation could be used as a treatment against solid tumors.	[Bru, Antonio; Gomez-Castro, David] Univ Complutense Madrid, Appl Math Dept, Madrid, Spain; [Gomez-Castro, David] Univ Complutense Madrid, Inst Matemat Interdisciplinar, Madrid, Spain; [Vila, Luis] Hosp Santa Creu & Sant Pau, IIB St Pau, Lab Angiol Vasc Biol & Inflammat, Barcelona, Spain; [Bru, Isabel] Ctr Salud La Estn, Talavera De La Reina, Spain; [Carlos Souto, Juan] Hosp Santa Creu & Sant Pau, IIB St Pau, Dept Hematol, Barcelona, Spain; [Carlos Souto, Juan] Inst Josep Carreras Leucemia, Barcelona, Spain	Complutense University of Madrid; Complutense University of Madrid; Hospital of Santa Creu i Sant Pau; Hospital of Santa Creu i Sant Pau; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Bru, A (corresponding author), Univ Complutense Madrid, Appl Math Dept, Madrid, Spain.	antonio.bru@mat.ucm.es	Mas, Maria Teresa/AAC-2082-2020; Gomez-Castro, David/B-2166-2017	Mas, Maria Teresa/0000-0001-6914-5329; Gomez-Castro, David/0000-0001-8360-3250	FPU fellowship from the Spanish government [FPU14/03702]	FPU fellowship from the Spanish government(Spanish Government)	The research of D. Gomez-Castro was supported by a FPU fellowship from the Spanish government ref. FPU14/03702.	Amgen, 2016, NEUP PROD INF; Bhome R, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00033; Bru A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.238101; Bru A, 2003, BIOPHYS J, V85, P2948, DOI 10.1016/S0006-3495(03)74715-8; Bru A, 1998, PHYS REV LETT, V81, P4008, DOI 10.1103/PhysRevLett.81.4008; Bru A, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/817498; Cancer Research UK, 2016, CAUS CANC STRESS; Cann SAH, 2003, POSTGRAD MED J, V79, P672; Cann SAH, 2002, MED HYPOTHESES, V58, P115, DOI 10.1054/mehy.2001.1469; Souto JC, 2011, MED RES REV, V31, P311, DOI 10.1002/med.20185; CAVALLO F, 1992, J IMMUNOL, V149, P3627; Coffelt SB, 2016, NAT REV CANCER, V16, P431, DOI 10.1038/nrc.2016.52; COLOMBO MP, 1992, J IMMUNOL, V149, P113; Coumans, 2015, BULLET 283 PHYS SDK; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; DUFFY MJ, 1992, CLIN EXP METASTAS, V10, P145, DOI 10.1007/BF00132746; HERRING WB, 1974, AM J MED, V56, P729, DOI 10.1016/0002-9343(74)90642-1; Hoeller C, 2001, J INVEST DERMATOL, V117, P371, DOI 10.1046/j.0022-202x.2001.01427.x; Ince H, 2005, CIRCULATION, V112, P3097, DOI 10.1161/CIRCULATIONAHA.105.541433; Kokura S, 1992, Gan To Kagaku Ryoho, V19, P1655; Kurbacher Christian M, 2005, Oncology (Williston Park), V19, P23; LAMM DL, 1991, NEW ENGL J MED, V325, P1205, DOI 10.1056/NEJM199110243251703; MATSUMOTO Y, 1991, INT J CANCER, V49, P444, DOI 10.1002/ijc.2910490323; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; NICOLSON GL, 1988, BIOCHIM BIOPHYS ACTA, V948, P175, DOI 10.1016/0304-419X(88)90010-8; Piccard H, 2012, CRIT REV ONCOL HEMAT, V82, P296, DOI 10.1016/j.critrevonc.2011.06.004; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rentsch CA, 2014, EUR UROL, V66, P677, DOI 10.1016/j.eururo.2014.02.061; RUCKDESCHEL JC, 1972, NEW ENGL J MED, V287, P1013, DOI 10.1056/NEJM197211162872004; Saint F, 2001, UROLOGY, V57, P617, DOI 10.1016/S0090-4295(01)00921-9; Siders WM, 2010, LEUKEMIA LYMPHOMA, V51, P1293, DOI 10.3109/10428191003777963; Siracusano S, 2007, EUR UROL, V51, P1589, DOI 10.1016/j.eururo.2006.11.045; SPRINGER TA, 1995, ANNU REV PHYSIOL, V57, P827, DOI 10.1146/annurev.ph.57.030195.004143; Su YB, 2006, CANCER J, V12, P182, DOI 10.1097/00130404-200605000-00005; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; TABUCHI T, 1995, ANTICANCER RES, V15, P985; Tamamori Y, 2002, INT J ONCOL, V21, P649; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; WARD HN, 1971, ANN INTERN MED, V75, P193, DOI 10.7326/0003-4819-75-2-193; World Health Organization & International Union against Cancer, 2005, GLOB ACT CANC; Yan J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/15384101.2014.950163; [No title captured]	42	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0202823	10.1371/journal.pone.0202823	http://dx.doi.org/10.1371/journal.pone.0202823			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388111	Green Submitted, gold, Green Published			2022-12-26	WOS:000449289800004
J	Raghav, PK; Singh, AK; Gangenahalli, G				Raghav, Pawan Kumar; Singh, Ajay Kumar; Gangenahalli, Gurudutta			Stem cell factor and NSC87877 combine to enhance c-Kit mediated proliferation of human megakaryoblastic cells	PLOS ONE			English	Article							TYROSINE-PHOSPHATASE SHP-1; DOWN-REGULATION; FACTOR-RECEPTOR; MAST-CELLS; DIFFERENTIATION; KINASE; LIGAND; ACTIVATION; EXPRESSION; INHIBITOR	Enhancement of hematopoietic stem cells (HSCs) proliferation is a central aim in bone marrow transplantation (BMT). A stem cell factor (SCF) and c-Kit mediated extracellular signaling trigger proliferation of HSCs. This signaling is negatively regulated by protein tyrosine phosphatases (PTPs), SHP-1 and SHP-2. Although NSC87877 (N) is known to inhibit SHP-1/SHP-2, c-Kit-mediated HSCs proliferation by inhibiting SHP-1/SHP-2 has not been reported. This study investigated the combined effect of SCF (S) and N in c-Kit mediated proliferation and underlying mechanisms. The growth of human megakaryoblastic cell line, MO7e and HSCs, upon treatment with S and N alone, and in combination was assessed by PrestoBlue staining. The expression of c-Kit, phosphorylated c-Kit, SHP-1/SHP-2 and HePTP inhibition using S and N treatment were evaluated in the MO7e cells. Megakaryoblast cell proliferation was determined by quantification of Ki-67(+), S-phase, BrdU(+) and CFDA-SE+ cells using flow cytometry. The combination of S and N leads to enhanced cell growth compared with either S or N alone. Collectively, the results reveal a novel mechanism by which S in combination with N significantly enhances proliferation of human megakaryoblast cells. The pretreatment of N before S enhances proliferation of cells than S alone. This promising combination would likely play an essential role in enhancing the proliferation of cells.	[Raghav, Pawan Kumar; Singh, Ajay Kumar; Gangenahalli, Gurudutta] INMAS, Div Stem Cell & Gene Therapy Res, Delhi, India	Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Gangenahalli, G (corresponding author), INMAS, Div Stem Cell & Gene Therapy Res, Delhi, India.	gugdutta@rediffmail.com	Singh, Ajay/AAF-4414-2020; SINGH, ANIL KUMAR/M-4786-2017; RAGHAV, PAWAN KUMAR/AAN-8774-2020	SINGH, ANIL KUMAR/0000-0003-2933-4058; RAGHAV, PAWAN KUMAR/0000-0002-2440-7134	Defence Research and Development Organisation	Defence Research and Development Organisation(Defence Research & Development Organisation (DRDO))	This study was supported by Defence Research and Development Organisation to GG.	Ali S, 2007, GENE, V401, P38, DOI 10.1016/j.gene.2007.06.017; AVANZI GC, 1988, BRIT J HAEMATOL, V69, P359, DOI 10.1111/j.1365-2141.1988.tb02374.x; AVANZI GC, 1990, J CELL PHYSIOL, V145, P458, DOI 10.1002/jcp.1041450310; Baghestanian M, 1996, EXP HEMATOL, V24, P1377; BLUMEJENSEN P, 1995, J BIOL CHEM, V270, P14192, DOI 10.1074/jbc.270.23.14192; BLUMEJENSEN P, 1994, J BIOL CHEM, V269, P21793; Bruecher-Encke B, 2001, LEUKEMIA, V15, P1424, DOI 10.1038/sj.leu.2402214; Chen LW, 2006, MOL PHARMACOL, V70, P562, DOI 10.1124/mol.106.025536; Cruse G, 2014, IMMUNOL ALLERGY CLIN, V34, P219, DOI 10.1016/j.iac.2014.01.002; Horinouchi CDD, 2017, J ETHNOPHARMACOL, V195, P298, DOI 10.1016/j.jep.2016.11.035; De Sepulveda P, 1999, EMBO J, V18, P904; Drexler HG, 1997, LEUKEMIA, V11, P701, DOI 10.1038/sj.leu.2400633; Feridooni T, 2017, AM J PHYSIOL-HEART C, V312, pH919, DOI 10.1152/ajpheart.00425.2016; Ilangumaran S, 2003, J BIOL CHEM, V278, P41871, DOI 10.1074/jbc.M308382200; Khoo CP, 2017, SCI REP-UK, V7, DOI 10.1038/srep44137; Konig A, 1997, BLOOD, V90, P148; Kozawa O, 1997, EUR J BIOCHEM, V248, P149, DOI 10.1111/j.1432-1033.1997.00149.x; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Liu HL, 2007, EMBO J, V26, P891, DOI 10.1038/sj.emboj.7601545; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Paul SP, 2000, BLOOD, V96, P483; Raghav PK, 2018, MUTAT RES-FUND MOL M, V808, P28, DOI 10.1016/j.mrfmmm.2018.02.001; Rassidakis GZ, 2004, MODERN PATHOL, V17, P946, DOI 10.1038/modpathol.3800144; Ratajczak MZ, 2016, STEM CELL REV REP, V12, P121, DOI 10.1007/s12015-015-9625-5; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Scappini B, 2001, CLIN CANCER RES, V7, P3884; Yang J, 1998, J BIOL CHEM, V273, P28199, DOI 10.1074/jbc.273.43.28199; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350	30	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206364	10.1371/journal.pone.0206364	http://dx.doi.org/10.1371/journal.pone.0206364			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388134	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800028
J	Avni, E; Montoya, D; Lopez, D; Modlin, R; Pellegrini, M; Snir, S				Avni, Eliran; Montoya, Dennis; Lopez, David; Modlin, Robert; Pellegrini, Matteo; Snir, Sagi			A phylogenomic study quantifies competing mechanisms for pseudogenization in prokaryotes-The Mycobacterium leprae case	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; SEQUENCE; EVOLUTION; ACCURACY; DYNAMICS; GENOMES; FAMILY; DECAY	Background Pseudogenes are non-functional sequences in the genome with homologous sequences that are functional (i.e. genes). They are abundant in eukaryotes where they have been extensively investigated, while in prokaryotes they are significantly scarcer and less well studied. Here we conduct a comprehensive analysis of the evolution of orthologs of Mycobacterium leprae pseudogenes in prokaryotes. The leprosy pathogen M. leprae is of particular interest since it contains an unusually large number of pseudogenes, comprising approximately 40% of its entire genome. The analysis is conducted in both broad and narrow phylogenetic ranges. Results We have developed an informatics-based approach to characterize the evolution of pseudogenes. This approach combines tools from phylogenomics, genomics, and transcriptomics. The results we obtain are used to assess the contributions of two mechanisms for pseudogene formation: failed horizontal gene transfer events and disruption of native genes. Conclusions We conclude that, although it was reported that in most bacteria the former is most likely responsible for the majority of pseudogenization events, in mycobacteria, and in particular in M. leprae with its exceptionally high pseudogene numbers, the latter predominates. We believe that our study sheds new light on the evolution of pseudogenes in bacteria, by utilizing new methodologies that are applied to the unusually abundant M. leprae pseudogenes and their orthologs.	[Avni, Eliran; Snir, Sagi] Univ Haifa, Dept Evolutionary Biol, Haifa, Israel; [Avni, Eliran; Snir, Sagi] Univ Haifa, Inst Evolut, Haifa, Israel; [Montoya, Dennis; Lopez, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Modlin, Robert] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Modlin, Robert] Univ Calif Los Angeles, David Geffen Sch Med, Div Dermatol, Los Angeles, CA 90095 USA	University of Haifa; University of Haifa; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Snir, S (corresponding author), Univ Haifa, Dept Evolutionary Biol, Haifa, Israel.; Snir, S (corresponding author), Univ Haifa, Inst Evolut, Haifa, Israel.	ssagi@research.haifa.ac.il	Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X				Adato O, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004408; Avni E, 2015, SYST BIOL, V64, P233, DOI 10.1093/sysbio/syu087; Belda E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-449; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Campbell MA, 2013, MYCOLOGIA, V105, P1126, DOI 10.3852/12-390; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole ST, 2001, LEPROSY REV, V72, P449; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dagan T, 2006, MOL BIOL EVOL, V23, P310, DOI 10.1093/molbev/msj036; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ESTABROOK GF, 1985, SYST ZOOL, V34, P193, DOI 10.2307/2413326; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gomez-Valero L, 2007, GENOME RES, V17, P1178, DOI 10.1101/gr.6360207; Goodhead I, 2018, BIORXIV; GRAY GS, 1983, MOL BIOL EVOL, V1, P57; Harrison PM, 2002, J MOL BIOL, V318, P1155, DOI 10.1016/S0022-2836(02)00109-2; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Kapopoulou A, 2011, TUBERCULOSIS, V91, P8, DOI 10.1016/j.tube.2010.09.006; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koonin EV, 2015, J MOL EVOL, V80, P244, DOI 10.1007/s00239-015-9679-7; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Lew JM, 2011, TUBERCULOSIS, V91, P1, DOI 10.1016/j.tube.2010.09.008; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; Loguercio LL, 1998, CURR GENET, V34, P241, DOI 10.1007/s002940050393; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Madan BM, 2003, TRENDS MICROBIOL, V11, P59, DOI [10.1016/S0966-842X(02)00031-8, DOI 10.1016/S0966-842X(02)00031-8]; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Montoya D, 2018, BIORXIV; Nakhleh L, 2005, LECT NOTES COMPUT SC, V3595, P84, DOI 10.1007/11533719_11; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Ramos-Onsins S, 1998, GENETICS, V150, P157; Roch Sebastien, 2012, Research in Computational Molecular Biology. Proceedings 16th Annual International Conference, RECOMB 2012, P224, DOI 10.1007/978-3-642-29627-7_23; Shifman A, 2014, NUCLEIC ACIDS RES, V42, P2391, DOI 10.1093/nar/gkt1138; Singh P, 2011, FUTURE MICROBIOL, V6, P57, DOI 10.2217/FMB.10.153; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Torrents D, 2003, GENOME RES, V13, P2559, DOI 10.1101/gr.1455503; van Berkum P, 2003, J BACTERIOL, V185, P2988, DOI 10.1128/JB.185.10.2988-2998.2003; VANIN EF, 1985, ANNU REV GENET, V19, P253, DOI 10.1146/annurev.genet.19.1.253; Wellner A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r156; Zhaxybayeva O, 2006, GENOME RES, V16, P1099, DOI 10.1101/gr.5322306	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0204322	10.1371/journal.pone.0204322	http://dx.doi.org/10.1371/journal.pone.0204322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383852	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600010
J	Katsel, P; Roussos, P; Beeri, MS; Gama-Sosa, MA; Gandy, S; Khan, S; Haroutunian, V				Katsel, P.; Roussos, P.; Beeri, M. S.; Gama-Sosa, M. A.; Gandy, S.; Khan, S.; Haroutunian, V			Parahippocampal gyrus expression of endothelial and insulin receptor signaling pathway genes is modulated by Alzheimer's disease and normalized by treatment with anti-diabetic agents	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MILD COGNITIVE IMPAIRMENT; SMALL VESSEL DISEASE; MITOCHONDRIAL DYSFUNCTION; NEUROVASCULAR MECHANISMS; VASCULAR CONTRIBUTIONS; AMYLOID PEPTIDES; APOLIPOPROTEIN-E; MOUSE MODEL; BRAIN	A large body of literature links risk of cognitive decline, mild cognitive impairment (MCI) and dementia with Type 2 Diabetes (T2D) or pre-diabetes. Accumulating evidence implicates a close relationship between the brain insulin receptor signaling pathway (IRSP) and the accumulation of amyloid beta and hyperphosphorylated and conformationally abnormal tau. We showed previously that the neuropathological features of Alzheimer's disease (AD were reduced in patients with diabetes who were treated with insulin and oral antidiabetic medications. To understand better the neurobiological substrates of T2D and T2D medications in AD, we examined IRSP and endothelial cell markers in the parahippocampal gyrus of controls (N = 30), of persons with AD (N = 19), and of persons with AD and T2D, who, in turn, had been treated with anti-diabetic drugs (insulin and or oral agents; N = 34). We studied the gene expression of selected members of the IRSP and selective endothelial cell markers in bulk postmortem tissue from the parahippocampal gyrus and in endothelial cell enriched isolates from the same brain region. The results indicated that there are considerable abnormalities and reductions in gene expression (bulk tissue homogenates and endothelial cell isolates) in the parahippocampal gyri of persons with AD that map directly to genes associated with the microvasculature and the IRSP. Our results also showed that the numbers of abnormally expressed microvasculature and IRSP associated genes in diabetic AD donors who had been treated with anti-diabetic agents were reduced significantly. These findings suggest that anti-diabetic treatments may reduce or normalize compromised microvascular and IRSP functions in AD.	[Katsel, P.; Roussos, P.; Beeri, M. S.; Gandy, S.; Khan, S.; Haroutunian, V] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Roussos, P.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Roussos, P.] Icahn Sch Med Mt Sinai, Inst Multiscale Biol, New York, NY 10029 USA; [Roussos, P.; Haroutunian, V] JJ Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr, Bronx, NY 10468 USA; [Beeri, M. S.] Joseph Sagol Neurosci Ctr, Sheba Med Ctr, Tel Aviv, Israel; [Gama-Sosa, M. A.; Haroutunian, V] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Gama-Sosa, M. A.; Gandy, S.] JJ Peters VA Med Ctr, Div Neurol, Bronx, NY USA; [Gandy, S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Gandy, S.] JJ Peters VA Med Ctr, Gen Med Res Serv, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Chaim Sheba Medical Center; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Haroutunian, V (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Haroutunian, V (corresponding author), JJ Peters VA Med Ctr, Mental Illness Res Educ & Clin Ctr, Bronx, NY 10468 USA.; Haroutunian, V (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	vahram.haroutunian@mssm.edu		khan, sonia/0000-0002-8182-687X; Haroutunian, Vahram/0000-0001-5860-2512	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service [1 I21 RX002069-01, 1 I21 RX002876-01]; VA Merit [BX002267, NIH-N01HHSN 271201300031, P50 AG005138-31, R01 AG034087, R01 AG053446, R01 AG051545]; NATIONAL INSTITUTE ON AGING [P50AG005138, R01AG051545, R01AG053446] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service(US Department of Veterans Affairs); VA Merit(US Department of Veterans Affairs); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1 I21 RX002069-01 and 1 I21 RX002876-01 (MAGS); VA Merit BX002267, NIH- N01HHSN 271201300031, P50 AG005138-31 (VH); R01 AG034087, R01 AG053446, R01 AG051545 (MSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMO M, 1989, MOL NEUROBIOL, V3, P71, DOI 10.1007/BF02935589; AKRAM A, 2010, MOL NEURODEGENER, V5, P7; Anderton BH, 2000, MOL MED TODAY, V6, P54, DOI 10.1016/S1357-4310(99)01640-8; Arnold SE, 2018, NAT REV NEUROL, V14, P168, DOI 10.1038/nrneurol.2017.185; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Arvanitakis Z, 2006, NEUROLOGY, V67, P1960, DOI 10.1212/01.wnl.0000247053.45483.4e; Bailey TL, JOURNAL OF NEUROPATH, V5, P467; Barrett EJ, 2017, J CLIN ENDOCR METAB, V102, P4343, DOI 10.1210/jc.2017-01922; Beeri MS, 2008, NEUROLOGY, V71, P750, DOI 10.1212/01.wnl.0000324925.95210.6d; Beeri MS, 2005, J GERONTOL A-BIOL, V60, P471, DOI 10.1093/gerona/60.4.471; Bell RD, 2007, J CEREBR BLOOD F MET, V27, P909, DOI 10.1038/sj.jcbfm.9600419; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bouras C, 2006, J NEUROPATH EXP NEUR, V65, P235, DOI 10.1097/01.jnen.0000203077.53080.2c; Brayne C, 2009, J ALZHEIMERS DIS, V18, P645, DOI 10.3233/JAD-2009-1182; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Clegg LE, 2015, INTEGR BIOL-UK, V7, P498, DOI 10.1039/c4ib00296b; Craft S, 2003, PSYCHONEUROENDOCRINO, V28, P809, DOI 10.1016/S0306-4530(02)00087-2; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Craft S, 2017, J ALZHEIMERS DIS, V57, P1325, DOI 10.3233/JAD-161256; Craft S, 2012, J GERONTOL A-BIOL, V67, P754, DOI 10.1093/gerona/gls112; Craft S, 2012, NAT REV NEUROL, V8, P360, DOI 10.1038/nrneurol.2012.112; Craft S, 2012, ARCH NEUROL-CHICAGO, V69, P29, DOI 10.1001/archneurol.2011.233; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; De Felice FG, 2009, P NATL ACAD SCI USA, V106, P1971, DOI 10.1073/pnas.0809158106; de la Monte SM, 2005, J ALZHEIMERS DIS, V7, P45; De Silva TM, 2016, CELL MOL NEUROBIOL, V36, P241, DOI 10.1007/s10571-015-0308-1; Di Marco LY, 2015, NEUROBIOL DIS, V82, P593, DOI 10.1016/j.nbd.2015.08.014; Eelen G, 2015, CIRC RES, V116, P1231, DOI 10.1161/CIRCRESAHA.116.302855; FERRARELLI LK, 2017, SCI SIGNAL, V10, P7, DOI DOI 10.1126/SCISIGNAL.AAM6836; Gama-Sosa M, 2016, MICROVASCULAR RES; Giannakopoulos P, 2007, ACTA NEUROPATHOL, V113, P1, DOI 10.1007/s00401-006-0144-y; Giannakopoulos P, 2009, STROKE, V40, P983, DOI 10.1161/STROKEAHA.108.530337; Gorelick PB, 2011, STROKE, V42, P2672, DOI 10.1161/STR.0b013e3182299496; Gray SM, 2014, DIABETES, V63, P3992, DOI 10.2337/db14-0340; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Haroutunian V, 2009, NEUROBIOL AGING, V30, P561, DOI 10.1016/j.neurobiolaging.2007.07.021; Hayashi K, 2011, DIABETES RES CLIN PR, V94, P180, DOI 10.1016/j.diabres.2011.07.002; Ho Lap, 2012, Int J Alzheimers Dis, V2012, P321280, DOI 10.1155/2012/321280; Hsu TM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00088; Hughes TM, 2016, BBA-MOL BASIS DIS, V1862, P983, DOI 10.1016/j.bbadis.2015.11.013; Imfeld P, 2012, J AM GERIATR SOC, V60, P916, DOI 10.1111/j.1532-5415.2012.03916.x; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jellinger KA, 2010, ACTA NEUROPATHOL, V119, P421, DOI 10.1007/s00401-010-0654-5; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Katsel P, 2009, PLOS ONE, V4, P7642; Kerti L, 2013, NEUROLOGY, V81, P1746, DOI 10.1212/01.wnl.0000435561.00234.ee; Knight EM, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0282-y; Lee CC, 2011, NEUROPHARMACOLOGY, V61, P867, DOI 10.1016/j.neuropharm.2011.06.003; Lubitz I, 2014, NEUROBIOL AGING, V35, pE19, DOI 10.1016/j.neurobiolaging.2014.01.138; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Neth BJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00345; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P1354, DOI 10.1038/jcbfm.2011.43; Ostergaard L, 2015, DIABETOLOGIA, V58, P666, DOI 10.1007/s00125-014-3461-z; Picone P, 2016, AGING-US, V8, P1718, DOI 10.18632/aging.101004; Picone P, 2015, BBA-MOL CELL RES, V1853, P1046, DOI 10.1016/j.bbamcr.2015.01.017; Qin WP, 2009, ARCH NEUROL-CHICAGO, V66, P352, DOI 10.1001/archneurol.2008.588; Ravona-Springer R, 2012, J ALZHEIMERS DIS, V30, P299, DOI 10.3233/JAD-2012-120106; Ravona-Springer R, 2010, DEMENT GERIATR COGN, V29, P68, DOI 10.1159/000265552; Risner ME, 2006, PHARMACOGENOMICS J, V6, P246, DOI 10.1038/sj.tpj.6500369; Ruiz HH, 2016, ALZHEIMERS DEMENT, V12, P851, DOI 10.1016/j.jalz.2016.01.008; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Salameh TS, 2015, J ALZHEIMERS DIS, V47, P715, DOI 10.3233/JAD-150307; Salvado L, 2012, EXPERT OPIN THER TAR, V16, P209, DOI 10.1517/14728222.2012.658370; Sanahuja J, 2016, DIABETES CARE, V39, P1614, DOI 10.2337/dc15-2671; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Snyder HM, 2015, ALZHEIMERS DEMENT, V11, P710, DOI 10.1016/j.jalz.2014.10.008; Sosa MAG, 2010, AM J PATHOL, V176, P353, DOI 10.2353/ajpath.2010.090482; Starr JM, 2009, PSYCHIAT RES-NEUROIM, V171, P232, DOI 10.1016/j.pscychresns.2008.04.003; Stirban A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0541-x; Stoeckel L, 2016, F1000RESEARCH, V5; Talbot K, 2012, J CLIN INVEST, V122, P1316, DOI 10.1172/JCI59903; Thomas T, 2015, BRAIN, V138, P1059, DOI 10.1093/brain/awv025; van Bussel FC, 2015, DIABETES CARE, V38, P876, DOI 10.2337/dc14-2043; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Wang MH, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0355-3; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Willette AA, 2015, ALZHEIMERS DEMENT, V11, P504, DOI 10.1016/j.jalz.2014.03.011; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; Xie L, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-10-j0001.2002; Xu WL, 2007, DIABETES, V56, P211, DOI 10.2337/db06-0879; Xu WL, 2010, DIABETES, V59, P2928, DOI 10.2337/db10-0539; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao WQ, 2008, FASEB J, V22, P246, DOI 10.1096/fj.06-7703com; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893; Zimmerman RS, 2017, DIABETES OBES METAB, V19, P1555, DOI 10.1111/dom.12969; Zlokovic BV, 2005, TRENDS NEUROSCI, V28, P202, DOI 10.1016/j.tins.2005.02.001	88	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206547	10.1371/journal.pone.0206547	http://dx.doi.org/10.1371/journal.pone.0206547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383799	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600063
J	Pfeiffer, MB; Blackwell, BF; DeVault, TL				Pfeiffer, Morgan B.; Blackwell, Bradley F.; DeVault, Travis L.			Quantification of avian hazards to military aircraft and implications for wildlife management	PLOS ONE			English	Article							RISK; RANKING	Collisions between birds and military aircraft are common and can have catastrophic effects. Knowledge of relative wildlife hazards to aircraft (the likelihood of aircraft damage when a species is struck) is needed before estimating wildlife strike risk (combined frequency and severity component) at military airfields. Despite annual reviews of wildlife strike trends with civil aviation since the 1990s, little is known about wildlife strike trends for military aircraft. We hypothesized that species relative hazard scores would correlate positively with aircraft type and avian body mass. Only strike records identified to species that occurred within the U.S. (n = 36,979) and involved United States Navy or United States Air Force aircraft were used to calculate relative hazard scores. The most hazardous species to military aircraft was the snow goose (Anser caerulescens), followed by the common loon (Gavia immer), and a tie between Canada goose (Branta canadensis) and black vulture (Coragyps atratus). We found an association between avian body mass and relative hazard score (r(2) = 0.76) for all military airframes. In general, relative hazard scores per species were higher for military than civil airframes. An important consideration is that hazard scores can vary depending on aircraft type. We found that avian body mass affected the probability of damage differentially per airframe. In the development of an airfield wildlife management plan, and absent estimates of species strike risk, airport wildlife biologists should prioritize management of species with high relative hazard scores.	[Pfeiffer, Morgan B.; Blackwell, Bradley F.; DeVault, Travis L.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr,Ohio Field Stn, Sandusky, OH 44870 USA; [Pfeiffer, Morgan B.] Nelson Mandela Univ, Sch Nat Resource Management, George Campus, George, South Africa	United States Department of Agriculture (USDA); Nelson Mandela University	Pfeiffer, MB (corresponding author), USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr,Ohio Field Stn, Sandusky, OH 44870 USA.; Pfeiffer, MB (corresponding author), Nelson Mandela Univ, Sch Nat Resource Management, George Campus, George, South Africa.	morgan.b.pfeiffer@aphis.usda.gov		DeVault, Travis/0000-0001-6413-1104; Pfeiffer, Morgan/0000-0002-1079-5295	Navy Installations Command (CNIC) Airfield Operations Program	Navy Installations Command (CNIC) Airfield Operations Program	This study was funded by the Comannder, Navy Installations Command (CNIC) Airfield Operations Program. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, CNIC INSTRUCTION 375; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 91204 AFI; [Anonymous], 91202 AFI US AIR FOR; Blackwell BF, 2013, WILDL MANAGE CONSERV, P153; Burnham K P, 2003, MODEL SELECT MULTIMO; Conover M., 2002, RESOLVING HUMAN WILD; CONOVER W. J, 1980, PRACTICAL NONPARAMET; DeVault TL, 2018, CAN J ZOOL, V96, P441, DOI 10.1139/cjz-2017-0142; DeVault TL, 2013, WILDL MANAGE CONSERV, P1; DeVault TL, 2018, WILDLIFE SOC B, V42, P94, DOI 10.1002/wsb.859; DeVault TL, 2016, J WILDLIFE MANAGE, V80, P746, DOI 10.1002/jwmg.1041; Devault TL, 2011, WILDLIFE SOC B, V35, P394, DOI 10.1002/wsb.75; Dolbeer R.A., 2016, WILDLIFE STRIKES CIV; Dolbeer RA, 2000, WILDLIFE SOC B, V28, P372; Dolbeer RA, 2003, INT BIRD STRIK COMM; Dolbeer RA, 2006, J WILDLIFE MANAGE, V70, P1345, DOI 10.2193/0022-541X(2006)70[1345:HDOBRB]2.0.CO;2; Dolbeer Richard A., 2009, Human-Wildlife Conflicts, V3, P167; Domencich T. A., 1975, MONOGRAPH; Dunning Jr JB, 1992, CRC HDB AVIAN BODY M; Efroymson RA, 2001, RISK ANAL, V21, P263, DOI 10.1111/0272-4332.212110; Einstein A., 1922, MEANING RELATIVITY; Federal Aviation Administration, 2017, ROT BIRD STRIK WORK; Fernandez-Juricic E, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00017; Lovell CD, 1999, WILDLIFE SOC B, V27, P167; Marra PP, 2009, FRONT ECOL ENVIRON, V7, P297, DOI 10.1890/090066; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Poole A., 2005, BIRDS N AM ONLINE; Seiler A, 2006, ENVIRONM POLLUT SER, V10, P165, DOI 10.1007/1-4020-4504-2_8; Zakrajsek EJ, 2005, WILDLIFE SOC B, V33, P258, DOI 10.2193/0091-7648(2005)33[258:RTROWS]2.0.CO;2	30	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206599	10.1371/journal.pone.0206599	http://dx.doi.org/10.1371/journal.pone.0206599			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383828	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600071
J	Zhu, C; Wang, HQ; Mahmood, Z; Wang, Q; Ma, HR				Zhu, Chao; Wang, Huiqin; Mahmood, Zarak; Wang, Qing; Ma, Hongrui			Biocompatibility and biodegradability of polyacrylate/ZnO nanocomposite during the activated sludge treatment process	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; WASTE-WATER; PERFORMANCE; DIVERSITY; TOXICITY; LEATHER; NANOPARTICLES; BIOREACTOR; MECHANISM; POLYMERS	Polymer nanocomposites have been widely used in the preparation of coating agents in the leather industry. Considering the complex bio-effect and ecological risk of nanomaterial, research on the biodegradability and biocompatibility of polyacrylate/metal nanocomposites in activated sludge system is of specific significance. We investigated the change of the bacterial community and diversity of activated sludge fed with polyacrylate/ZnO nanocomposites in both low (500 mg COD /L) and high (1000 mg COD/L) doses. COD removal, dehydrogenase activity, and total protein of activated sludge system were monitored in all treatments over 30 days. The results demonstrated that the exposure to both polyacrylate/ZnO nanocomposite and polyacrylate decreased the dehydrogenase activity at early stage comparing to the control, but had no significant influence on COD removal. Overall, the bacterial communities in activated sludge were resistant to polyacrylate/ZnO nanocomposites, and had higher levels of metabolic activity, protein accumulation and bioavailability when exposed to these chemicals comparing to the control especially at later stages of incubation (15-30 days), which indicated that these polyacrylate/ZnO nanocomposites of certain amount were biocompatible to activated sludge system.	[Zhu, Chao; Wang, Huiqin; Mahmood, Zarak; Wang, Qing; Ma, Hongrui] Shaanxi Univ Sci & Technol, Coll Environm Sci & Engn, Dept Environm Engn, Xian, Shaanxi, Peoples R China	Shaanxi University of Science & Technology	Zhu, C (corresponding author), Shaanxi Univ Sci & Technol, Coll Environm Sci & Engn, Dept Environm Engn, Xian, Shaanxi, Peoples R China.	304545693@qq.com	wang, huimin/HDM-8421-2022; wang, hui/GRS-4730-2022	Mahmood, Zarak/0000-0002-5353-8563	major science and technology program for water pollution control and treatment [2017ZX07602-001]; special research project of the education department of Shaanxi provincial government [16JK1081]; doctoral research fund Shaanxi University of Science and Technology [BJ12-29]	major science and technology program for water pollution control and treatment; special research project of the education department of Shaanxi provincial government; doctoral research fund Shaanxi University of Science and Technology	Funding was provided by the major science and technology program for water pollution control and treatment (2017ZX07602-001) to MHR (http://nwpcp.mep.gov.cn/zxdt/bgs/), special research project of the education department of Shaanxi provincial government (16JK1081) to ZC (http://www.snedu.gov.cn/), and doctoral research fund Shaanxi University of Science and Technology (BJ12-29) to ZC (http://www.sust.edu.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Ahmed F, 2013, WATER RES, V47, P3966, DOI 10.1016/j.watres.2012.10.055; *AM PUBL HLTH ASS, 1997, STAND METH EX WAT WA; Armentano I, 2010, POLYM DEGRAD STABIL, V95, P2126, DOI 10.1016/j.polymdegradstab.2010.06.007; Bakke I, 2011, J MICROBIOL METH, V84, P349, DOI 10.1016/j.mimet.2010.12.015; Balazs AC, 2006, SCIENCE, V314, P1107, DOI 10.1126/science.1130557; Bao Y, 2017, COLLOID SURFACE A, V518, P232, DOI 10.1016/j.colsurfa.2017.01.033; Bettencourt AF, 2010, DENT MATER, V26, pE171, DOI 10.1016/j.dental.2010.01.006; Blackall LL, 1998, WATER SCI TECHNOL, V37, P451, DOI 10.1016/S0273-1223(98)00144-9; Chacko L, 2018, J MATER CHEM B, V6, P3048, DOI 10.1039/c8tb00142a; Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Decker C, 1999, POLYM DEGRAD STABIL, V64, P293, DOI 10.1016/S0141-3910(98)00205-5; Foltete AS, 2011, ENVIRON POLLUT, V159, P2515, DOI 10.1016/j.envpol.2011.06.020; Haggstrom JA, 2010, NANOSCALE, V2, P399, DOI 10.1039/b9nr00245f; Hua LU, 2007, LEATHER SCI ENG; Iborra JL, 1992, BIOTECHNOL TECH, V6, P319, DOI 10.1007/BF02439319; Jiang YP, 2015, POLYM DEGRAD STABIL, V115, P110, DOI 10.1016/j.polymdegradstab.2015.02.018; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Keylock CJ, 2005, OIKOS, V109, P203, DOI 10.1111/j.0030-1299.2005.13735.x; LAKSHMINARAYANA Y, 1984, J AM LEATHER CHEM AS, V79, P398; Liu BB, 2006, FEMS MICROBIOL ECOL, V55, P274, DOI 10.1111/j.1574-6941.2005.00033.x; Liu JL, 2014, INT J POLYM MATER PO, V63, P809, DOI 10.1080/00914037.2014.886217; Liu JL, 2011, MATER SCI FORUM, V694, P430, DOI 10.4028/www.scientific.net/MSF.694.430; Liu Y, 2005, BIORESOURCE TECHNOL, V96, P1205, DOI 10.1016/j.biortech.2004.11.003; Lu B, 2011, J COMPOS MATER, V45, P2573, DOI 10.1177/0021998311401110; [逯敏飞 LU Minfei], 2006, [材料科学与工程学报, Journal of materials Science and engineering], V24, P894; Madaleno L, 2010, COMPOS SCI TECHNOL, V70, P804, DOI 10.1016/j.compscitech.2010.01.016; Manier N, 2013, ENVIRON POLLUT, V180, P63, DOI 10.1016/j.envpol.2013.04.040; MCNEILL IC, 1995, POLYM DEGRAD STABIL, V48, P175, DOI 10.1016/0141-3910(95)00030-P; Palmer MW, 2008, ECOLOGY, V89, P1769, DOI 10.1890/07-0842.1; Rao CNR, 2007, J AM CHEM SOC, V2, P45; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Rousk J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034197; Sangeetha S, 2012, COLLOID SURFACE B, V100, P36, DOI 10.1016/j.colsurfb.2012.05.015; Santhiya D, 1999, J COLLOID INTERF SCI, V216, P143, DOI 10.1006/jcis.1999.6289; Schaefer DW, 2007, MACROMOLECULES, V40, P8501, DOI 10.1021/ma070356w; Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265; SEIFODDINI H, 1991, COMPUT IND ENG, V21, P263, DOI 10.1016/0360-8352(91)90099-R; Thill A, 2006, ENVIRON SCI TECHNOL, V40, P6151, DOI 10.1021/es060999b; Vaishnav D., 2014, MATER SCI ENG, V64; WAGNER M, 1993, APPL ENVIRON MICROB, V59, P1520, DOI 10.1128/AEM.59.5.1520-1525.1993; Wagner M, 2002, CURR OPIN BIOTECH, V13, P218, DOI 10.1016/S0958-1669(02)00315-4; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Xue CH, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/41/415603; Yang C, 2011, ENVIRON SCI TECHNOL, V45, P7408, DOI 10.1021/es2010545; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yilmaz O, 2014, PROG ORG COAT, V77, P110, DOI 10.1016/j.porgcoat.2013.08.008; Zhao X, 2011, CHEM ENG J, V170, P381, DOI 10.1016/j.cej.2011.02.071; Zhifu W, 2012, CHINESE J SPECTROSCO, V29, P2072	51	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205990	10.1371/journal.pone.0205990	http://dx.doi.org/10.1371/journal.pone.0205990			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383763	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600024
J	Nehete, PN; Wilkerson, G; Nehete, BP; Chitta, S; Ruiz, JC; Scholtzova, H; Williams, LE; Abee, CR; Vanchiere, JA				Nehete, Pramod N.; Wilkerson, Gregory; Nehete, Bharti P.; Chitta, Sriram; Ruiz, Julio C.; Scholtzova, Henrieta; Williams, Lawrence E.; Abee, Christian R.; Vanchiere, John A.			Cellular immune responses in peripheral blood lymphocytes of Giardia infected squirrel monkey (Saimiri boliviensis boliviensis) treated with Fenbendazole	PLOS ONE			English	Article							PEPTIDE COCKTAIL VACCINE; GIARDIA-LAMBLIA; TRICHOSTRONGYLUS-COLUBRIFORMIS; COLORIMETRIC ASSAY; INFECTED MICE; T-CELLS; LEVAMISOLE; MODEL; EFFICACY; PROLIFERATION	Cellular immune responses were tested to determine the effect of fenbendazole on the function of lymphocytes from Bolivian squirrel monkeys (Samiri boliviensis boliviensis). Giardia-infected squirrel monkeys were treated with commercially available fenbendazole (FBZ)-medicated monkey chow. Immune responses were compared between historical controls (Giardia naive, untreated with FBZ (control animals)) and Giardia-infected, FBZ-treated squirrel monkeys (study animals). Peripheral blood lymphocytes from study monkeys had significantly lower stimulation indices compared to control animals when cultured in vitro with concanavalin A (Con A) (p<0.0001), phytohaemagglutinin (PHA) (p<0.0001) and lipopolysaccharide (LPS) (p<0.0001). PBMCs were also analyzed for IFN-gamma producing cells in response to stimulation with Con A, PHA, PWM, and LPS by the cytokine ELISPOT assay. Significantly higher responses to Con A- (p<0.0001), and PHA- (p<0.001) stimulated cultures from Giardia-infected and fenbendazole treated compared to controls. Flow cytometric analysis for expression of cell surface markers revealed a significant increase in B- and NKT-lymphocytes and significant decrease in CD14+CD16+ monocytes after FBZ treatment. Also, circulating plasma cytokines IFN-gamma, TNF-alpha, IL-12p40, IL-1 beta, IL-10, IL-13, IL-1ra, IL-6 and IL-4 were significantly decreased after FBZ treatment. Comparison of hematologic parameters between controls and FBZ-treated squirrel monkeys revealed significantly lower numbers of total leukocytes, neutrophils, monocytes, and eosinophils compared to controls. However, erythrocyte indices (red cell count, hemoglobin and hematocrit were significantly higher in FBZ-treated monkeys. Our findings suggest that fenbendazole treatment may alter sensitive immune and molecular measures of inflammation. Postponing the experimental use of squirrel monkeys until at least 6 weeks after FBZ treatment should be considered.	[Nehete, Pramod N.; Wilkerson, Gregory; Nehete, Bharti P.; Chitta, Sriram; Ruiz, Julio C.; Williams, Lawrence E.; Abee, Christian R.; Vanchiere, John A.] Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA; [Nehete, Pramod N.; Williams, Lawrence E.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Scholtzova, Henrieta] NYU, Sch Med, Dept Neurol, New York, NY USA; [Vanchiere, John A.] Louisiana State Univ, Hlth Sci Ctr, Sect Pediat Infect Dis, Shreveport, LA 71105 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; New York University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Nehete, PN (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Vet Sci, Bastrop, TX 78602 USA.; Nehete, PN (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA.	pnehete@mdanderson.org	Williams, Lawrence/AAD-6685-2020; Vanchiere, John/AAD-8979-2019	Williams, Lawrence/0000-0003-2267-9918; Nehete, Pramod/0000-0002-2815-2677	Cattleman for Cancer Research; Squirrel Monkey Breeding and Research Resource grant at the Michale E Keeling Center for Comparative Medicine and Research at the MD Anderson Cancer Center [P40 ODO10938-38]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010938] Funding Source: NIH RePORTER	Cattleman for Cancer Research; Squirrel Monkey Breeding and Research Resource grant at the Michale E Keeling Center for Comparative Medicine and Research at the MD Anderson Cancer Center; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is partly supported by the Cattleman for Cancer Research (PNN) and the Squirrel Monkey Breeding and Research Resource grant P40 ODO10938-38 (CRA) at the Michale E Keeling Center for Comparative Medicine and Research at the MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaei Z, 2016, MICROBES INFECT, V18, P687, DOI 10.1016/j.micinf.2016.06.009; Barr SC, 1998, AM J VET RES, V59, P1134; BELL CA, 1993, ANTIMICROB AGENTS CH, V37, P2668, DOI 10.1128/AAC.37.12.2668; Bugarski D, 2006, PARASITOL INT, V55, P91, DOI 10.1016/j.parint.2005.10.005; CABAJ W, 1994, NEW ZEAL VET J, V42, P216, DOI 10.1080/00480169.1994.35826; Cai YP, 2009, IMMUNOL CELL BIOL, V87, P623, DOI 10.1038/icb.2009.47; COGHLAN LG, 1993, LAB ANIM SCI, V43, P481; Dvoroznakova E, 1998, CHANGES CELLULAR IMM; Graham SP, 2001, INFECT IMMUN, V69, P4313, DOI 10.1128/IAI.69.7.4313-4319.2001; Grit GH, 2014, PARASITE IMMUNOL, V36, P157, DOI 10.1111/pim.12095; GUERRERO J, 1981, AM J VET RES, V42, P425; Heraud JM, 2002, IMMUNOGENETICS, V54, P20, DOI 10.1007/s00251-002-0443-y; HERSEY P, 1981, CLIN EXP IMMUNOL, V46, P340; Holcombe RF, 1998, BIOTHERAPY, V11, P255, DOI 10.1023/A:1008099612354; HOLDEN HE, 1980, ENVIRON MUTAGEN, V2, P67, DOI 10.1002/em.2860020110; Hunter RL, 2007, COMPARATIVE MED, V57, P487; KAMBARA T, 1993, INT J PARASITOL, V23, P471, DOI 10.1016/0020-7519(93)90035-W; KIMBALL ES, 1993, ANN NY ACAD SCI, V685, P259, DOI 10.1111/j.1749-6632.1993.tb35874.x; Kullberg MC, 1996, J IMMUNOL, V156, P1482; Lopez-Romero G, 2015, PARASITE IMMUNOL, V37, P394, DOI 10.1111/pim.12210; Lopez-Romero G, 2017, IMMUNOBIOLOGY, V222, P884, DOI 10.1016/j.imbio.2017.05.008; Marshall MM, 1997, CLIN MICROBIOL REV, V10, P67, DOI 10.1128/CMR.10.1.67; MCCURDY HD, 1977, VET MED SM ANIM CLIN, V72, P1731; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nehete P, 2017, J AM ASS LAB ANIMAL; Nehete PN, 2005, VACCINE, V23, P2154, DOI 10.1016/j.vaccine.2005.01.052; Nehete PN, 2003, J MED PRIMATOL, V32, P67, DOI 10.1034/j.1600-0684.2003.00011.x; Nehete PN, 2017, COMPARATIVE MED, V67, P67; Nehete PN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079836; Onkoba N, 2016, OPEN VET J, V6, P178, DOI 10.4314/ovj.v6i3.6; Papich MG, 2016, SAUNDERS HDB VET DRU, P315; Reichard MV, 2008, J AM ASSOC LAB ANIM, V47, P51; REISS CS, 1987, LAB ANIM SCI, V37, P773; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Sajid MS, 2006, PARASITOLOGY, V132, P301, DOI 10.1017/S0031182005009108; Singer SM, 2000, INFECT IMMUN, V68, P170, DOI 10.1128/IAI.68.1.170-175.2000; Sj Parish, 1996, EFFECT FENBENDAZOLE; Stankiewicz M, 1996, INT J PARASITOL, V26, P97, DOI 10.1016/0020-7519(95)00088-7; Szeto CC, 2000, IMMUNOLOGY, V100, P217, DOI 10.1046/j.1365-2567.2000.00042.x; Tankovic J, 2000, ANTIMICROB AGENTS CH, V44, P608, DOI 10.1128/AAC.44.3.608-613.2000; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Varga M., 2014, TXB RABBIT MED, P137; Villar D, 2007, J AM ASSOC LAB ANIM, V46, P8	43	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0198497	10.1371/journal.pone.0198497	http://dx.doi.org/10.1371/journal.pone.0198497			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412580	Green Published, gold, Green Submitted			2022-12-26	WOS:000449772600001
J	Ashton, JR; Gottlin, EB; Patz, EF; West, JL; Badea, CT				Ashton, Jeffrey R.; Gottlin, Elizabeth B.; Patz, Edward F., Jr.; West, Jennifer L.; Badea, Cristian T.			A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; NONSMALL CELL LUNG; TUMOR VASCULATURE; PARTICLE-SIZE; MICRO-CT; EXPRESSION; THERAPY; QUANTIFICATION; DIAGNOSIS; LIGANDS	Computed tomography (CT) is the standard imaging test used for the screening and assessment of suspected lung cancer, but distinguishing malignant from benign nodules by CT is an ongoing challenge. Consequently, a large number of avoidable invasive procedures are performed on patients with benign nodules in order to exclude malignancy. Improving cancer discrimination by non-invasive imaging could reduce the need for invasive diagnostics. In this work we focus on developing a gold nanoparticle contrast agent that targets the epidermal growth factor receptor (EGFR), which is expressed on the cell surface of most lung adenocarcinomas. Three different contrast agents were compared for their tumor targeting effectiveness: non-targeted nanoparticles, nanoparticles conjugated with full-sized anti-EGFR antibodies (cetuximab), and nanoparticles conjugated with a single-domain llama-derived anti-EGFR antibody, which is smaller than the cetuximab, but has a lower binding affinity. Nanoparticle targeting effectiveness was evaluated in vitro by EGFR-binding assays and in cell culture with A431 cells, which highly express EGFR. In vivo CT imaging performance was evaluated in both C57BL/6 mice and in nude mice with A431 subcutaneous tumors. The cetuximab nanoparticles had a significantly shorter blood residence time than either the non-targeted or the single-domain antibody nanoparticles. All of the nanoparticle contrast agents demonstrated tumor accumulation; however, the cetuximab-targeted group had significantly higher tumor gold accumulation than the other two groups, which were statistically indistinguishable from one another. In this study we found that the relative binding affinity of the targeting ligands had more of an effect on tumor accumulation than the circulation half life of the nanoparticles. This study provides useful insight into targeted nanoparticle design and demonstrates that nanoparticle contrast agents can be used to detect tumor receptor overexpression. Combining receptor status data with traditional imaging characteristics has the potential for better differentiation of malignant lung tumors from benign lesions.	[Ashton, Jeffrey R.; West, Jennifer L.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Ashton, Jeffrey R.; Gottlin, Elizabeth B.; Patz, Edward F., Jr.; Badea, Cristian T.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Patz, Edward F., Jr.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA.	cristian.badea@duke.edu	Badea, Cristian T/M-3323-2019; Badea, Cristian/B-6681-2011	Badea, Cristian T/0000-0002-1850-2522; Badea, Cristian/0000-0002-1850-2522; Gottlin, Elizabeth/0000-0003-0886-0024; Patz, Edward/0000-0003-3374-1596	NIH/NIBIB national Biomedical Technology Resource Center [P41 EB015897]; NIH National Cancer Institute [R01 CA196667, U24 CA220245]; NIH/NIBIB F30 Fellowship [5 F30 EB020512]; NATIONAL CANCER INSTITUTE [R01CA196667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015897] Funding Source: NIH RePORTER	NIH/NIBIB national Biomedical Technology Resource Center; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIBIB F30 Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	All small animal imaging work was performed at the Duke Center for In Vivo Microscopy, an NIH/NIBIB national Biomedical Technology Resource Center (P41 EB015897) The work was also supported by the NIH National Cancer Institute (R01 CA196667, U24 CA220245). JA was supported by an NIH/NIBIB F30 Fellowship (5 F30 EB020512). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Allijn IE, 2013, ACS NANO, V7, P9761, DOI 10.1021/nn403258w; Arruebo M, 2009, J NANOMATER, V2009, DOI 10.1155/2009/439389; Ashton JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088129; Badea C, 2008, DUAL MICRO CT SYSTEM; Badea C, 2011, P SPIE, V7961; Badea CT, 2012, AM J PHYSIOL-LUNG C, V302, pL1088, DOI 10.1152/ajplung.00359.2011; Beningo KA, 2002, J CELL SCI, V115, P849; Chan BA, 2015, TRANSL LUNG CANCER R, V4, P36, DOI 10.3978/j.issn.2218-6751.2014.05.01; Chanda N, 2010, P NATL ACAD SCI USA, V107, P8760, DOI 10.1073/pnas.1002143107; Clark D, 2012, P SPIE, V8314; Clark DP, 2013, PHYS MED BIOL, V58, P1683, DOI 10.1088/0031-9155/58/6/1683; Cole LE, 2014, BIOMATERIALS, V35, P2312, DOI 10.1016/j.biomaterials.2013.11.077; Cronin P, 2008, RADIOLOGY, V246, P772, DOI 10.1148/radiol.2463062148; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Gad SC, 2012, INT J TOXICOL, V31, P584, DOI 10.1177/1091581812465969; Gottlin EB, 2009, J BIOMOL SCREEN, V14, P77, DOI 10.1177/1087057108327064; Hainfeld JF, 2011, BRIT J RADIOL, V84, P526, DOI 10.1259/bjr/42612922; Haiss W, 2007, ANAL CHEM, V79, P4215, DOI 10.1021/ac0702084; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Jemal A., 2017, J NATL CANC I, V109; Kim George P, 2008, Biologics, V2, P223; Li X, 2013, J NANOMATER; Li X, 2014, ADV DRUG DELIVER REV, V76, P116, DOI 10.1016/j.addr.2014.07.013; Maeda H, 2001, ADV ENZYME REGUL, V41, P189, DOI 10.1016/S0065-2571(00)00013-3; Markowitz SB, 2007, CHEST, V131, P1028, DOI 10.1378/chest.05-3014; Mieszawska AJ, 2013, MOL PHARMACEUT, V10, P831, DOI 10.1021/mp3005885; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Patel D, 2007, ANTICANCER RES, V27, P3355; Reuveni T, 2011, INT J NANOMED, V6, P2859, DOI 10.2147/IJN.S25446; RUSCH V, 1993, CANCER RES, V53, P2379; Salmaso S, 2013, J DRUG DELIV, V2013, DOI 10.1155/2013/374252; Sun XL, 2014, ACS NANO, V8, P8438, DOI 10.1021/nn502950t; Toy R, 2013, ACS NANO, V7, P3118, DOI 10.1021/nn3053439; Wang H, 2013, BIOMATERIALS, V34, P470, DOI 10.1016/j.biomaterials.2012.09.054; Zhang FN, 2015, ANAL CHEM, V87, P9960, DOI 10.1021/acs.analchem.5b02572; Zhang GD, 2009, BIOMATERIALS, V30, P1928, DOI 10.1016/j.biomaterials.2008.12.038; Zhao L, 2013, J MATER CHEM B, V1, P5806, DOI 10.1039/c3tb20933d	39	35	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206950	10.1371/journal.pone.0206950	http://dx.doi.org/10.1371/journal.pone.0206950			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408128	Green Submitted, gold, Green Published			2022-12-26	WOS:000449512300055
J	Bruurs, LJM; van der Net, MC; Zwakenberg, S; Zwartkruis, FJT; Bos, JL				Bruurs, Lucas J. M.; van der Net, Mirjam C.; Zwakenberg, Susan; Zwartkruis, Fried J. T.; Bos, Johannes L.			A Tuba/Cdc42/Par6A complex is required to ensure singularity in apical domain formation during enterocyte polarization	PLOS ONE			English	Article							POLARITY PROTEIN PAR6; SYMMETRY-BREAKING; CDC42 GEF; LINKS; TUBA; RAC	Apico-basal polarity establishment is a seminal process in tissue morphogenesis. To function properly it is often imperative that epithelial cells limit apical membrane formation to a single domain. We previously demonstrated that signaling by the small GTPase Cdc42, together with its guanine nucleotide exchange factor (GEF) Tuba, is required to prevent the formation of multiple apical domains in polarized Ls174T:W4 cells, a single cell model for enterocyte polarization. To further chart the molecular signaling mechanisms that safeguard singularity during enterocyte polarization we generated knockout cells for the Cdc42 effector protein Par6A. Par6A loss results in the formation of multiple apical domains, similar to loss of Cdc42. In Par6A knockout cells, we find that active Cdc42 is more mobile at the apical membrane compared to control cells and that wild type Cdc42 is more diffusely localized throughout the cell, indicating that Par6A is required to restrict Cdc42 signaling. Par6A, Cdc42 and its GEF Tuba bind in a co-immunoprecipitation experiment and they partially colocalize at the apical membrane in polarized Ls174T:W4 cells, suggesting the formation of a trimeric complex. Indeed, in a rescue experiment using Par6A mutants, we show that the ability to establish this trimeric complex correlates with the ability to restore singularity in Par6A knockout cells. Together, these experiments therefore indicate that a Tuba/Cdc42/Par6A complex is required to ensure the formation of a single apical domain during enterocyte polarization.	[Bruurs, Lucas J. M.; van der Net, Mirjam C.; Zwakenberg, Susan; Zwartkruis, Fried J. T.; Bos, Johannes L.] Univ Utrecht, Oncode Inst, Ctr Mol Med, Univ Med Ctr Utrecht, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Bos, JL (corresponding author), Univ Utrecht, Oncode Inst, Ctr Mol Med, Univ Med Ctr Utrecht, Utrecht, Netherlands.	J.L.Bos@umcutrecht.nl			gravitation program "Cancer GenomiCs.nl" of the Netherlands Organization for Scientific Research (NWO); Dutch Cancer Society	gravitation program "Cancer GenomiCs.nl" of the Netherlands Organization for Scientific Research (NWO); Dutch Cancer Society(KWF Kankerbestrijding)	This work was supported by the gravitation program "Cancer GenomiCs.nl" of the Netherlands Organization for Scientific Research (NWO). The Oncode Institute is supported by the Dutch Cancer Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bruurs LJM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00547-16; Bruurs LJM, 2015, J CELL BIOL, V210, P1055, DOI 10.1083/jcb.201505118; Butty AC, 2002, EMBO J, V21, P1565, DOI 10.1093/emboj/21.7.1565; Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299; Durgan J, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.174235; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Gao L, 2004, J BIOL CHEM, V279, P41557, DOI 10.1074/jbc.M403723200; Garbett D, 2012, J CELL BIOL, V198, P195, DOI 10.1083/jcb.201204008; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Gon H, 2013, MOL BIOL CELL, V24, P3764, DOI 10.1091/mbc.E13-07-0357; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Qin Y, 2010, J CELL BIOL, V189, P661, DOI 10.1083/jcb.201002097; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2	23	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207159	10.1371/journal.pone.0207159	http://dx.doi.org/10.1371/journal.pone.0207159			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408122	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300086
J	Jafari, SMS; Wiedmer, C; Cazzaniga, S; Frangez, Z; Shafighi, M; Beltraminelli, H; Weber, B; Simon, HU; Hunger, RE				Jafari, S. Morteza Seyed; Wiedmer, Christina; Cazzaniga, Simone; Frangez, Ziva; Shafighi, Maziar; Beltraminelli, Helmut; Weber, Benedikt; Simon, Hans-Uwe; Hunger, Robert E.			Correlation of Vascular Endothelial Growth Factor subtypes and their receptors with melanoma progression: A next-generation Tissue Microarray (ngTMA) automated analysis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; FACTOR-C EXPRESSION; TUMOR LYMPHANGIOGENESIS; VEGF-C; CUTANEOUS MELANOMA; TYROSINE KINASES; ANGIOGENESIS; CANCER; PROMOTES; DENSITY	Introduction Finding new markers to assess prognosis of melanoma without the necessity to perform a surgical interventions is an important goal in melanoma research. The current study aimed to assess the correlation of clinical course and prognosis of primary and metastatic melanoma with expression of VEGF family and their receptors. Methods A ngTMA block was made from the randomly selected paraffin tissue blocks of the patients with melanocytic nevi, primary and metastatic melanoma. Then sections cut from ngTMA-block were immunohistochemically stained with proper antibodies. Expression of these proteins was investigated using automated image analysis and compared among the study groups. Results We analyzed the tissue of 238 patients with following diagnoses: 101 (42.4%) with a diagnosis of nevus, 86 (36.1%) Malignant melanoma and 51 (21.4%) metastasis. Median follow-up time for the malignant lesions was 5.71 years. Among the tested antigen, VEGF-C (p = 0.016), VEGF-R2 (p<0.001) and VEGF-R3 (p = 0.002) were significantly higher expressed in the metastatic tissues. When these scores were assessed in multiple regression models, the only independent factor linked to patient's diagnosis was VEGF-R2 (p<0.001). In addition, groups of highly correlated variables (VEGF-C and VEGF-R3, VEGF-A and VEGF-R1) were found to form separate sub-clusters. On the other side, high values of VEGF-C were associated with both overall and disease-free survival with a statically significant HR of 2.76 (95% CI: 1.27, 5.98; p = 0.01) and 2.82 (95% CI: 1.62, 4.91; p<0.001), respectively. Conclusions This study shows that VEGF-C and VEGF-R2 might represent new prognostic marker in MM. However, further prospective studies are warranted to test their real efficacy as a prognostic marker.	[Jafari, S. Morteza Seyed; Wiedmer, Christina; Cazzaniga, Simone; Beltraminelli, Helmut; Weber, Benedikt; Hunger, Robert E.] Univ Bern, Univ Hosp Bern, Inselspital, Dept Dermatol, Bern, Switzerland; [Cazzaniga, Simone] Ctr Studi GISED, Bergamo, Italy; [Frangez, Ziva; Simon, Hans-Uwe] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Shafighi, Maziar] Univ Bern, Dept Biomed Res, Bern, Switzerland; [Weber, Benedikt] Med Univ Vienna, Dept Dermatol, Vienna, Austria	University of Bern; University Hospital of Bern; University of Bern; University of Bern; Medical University of Vienna	Jafari, SMS (corresponding author), Univ Bern, Univ Hosp Bern, Inselspital, Dept Dermatol, Bern, Switzerland.	seyedjafarism@yahoo.com	Simon, Hans-Uwe/AAU-7410-2020; Jafari, S. Morteza Seyed/AAV-9160-2020	Simon, Hans-Uwe/0000-0002-9404-7736; Jafari, S. Morteza Seyed/0000-0002-6466-2199; Cazzaniga, Simone/0000-0001-8161-6138; beltraminelli, helmut/0000-0002-8179-1793; Frangez, Ziva/0000-0002-9164-7656	Swiss National Science Foundation [310030_166473]; Bern Cancer League; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [642295]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bern Cancer League; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant	This study was supported by Swiss National Science Foundation (grant 310030_166473), Bern Cancer League, the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 642295 (MEL-PLEX).	Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Agostino NM, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0951-5; Akagi K, 2000, BRIT J CANCER, V83, P887, DOI 10.1054/bjoc.2000.1396; Andre T, 2000, INT J CANCER, V86, P174, DOI 10.1002/(SICI)1097-0215(20000415)86:2<174::AID-IJC5>3.3.CO;2-5; Balch CM, 2011, J SURG ONCOL, V104, P379, DOI 10.1002/jso.21876; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Beasley NJP, 2002, CANCER RES, V62, P1315; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennassar A, 2012, DERMATOL THER, V25, P432, DOI 10.1111/j.1529-8019.2012.01537.x; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Bunone G, 1999, AM J PATHOL, V155, P1967, DOI 10.1016/S0002-9440(10)65515-0; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Dadras SS, 2005, MODERN PATHOL, V18, P1232, DOI 10.1038/modpathol.3800410; Dhondt J, 2011, FASEB J, V25, P1461, DOI 10.1096/fj.10-170944; Dummer R, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13320; Eggert A, 2000, CLIN CANCER RES, V6, P1900; Ellis MC, 2010, AM J SURG, V199, P663, DOI 10.1016/j.amjsurg.2010.01.019; Emmett MS, 2011, AM J CANCER RES, V1, P852; Felcht M, 2015, J DTSCH DERMATOL GES, V13, P125, DOI 10.1111/ddg.12580; Fellmer PT, 1999, SURGERY, V126, P1056, DOI 10.1067/msy.2099.101432; Garbe C, 2012, EUR J CANCER, V48, P2375, DOI 10.1016/j.ejca.2012.06.013; Griffioen AW, 2000, PHARMACOL REV, V52, P237; Hoshida T, 2006, CANCER RES, V66, P8065, DOI 10.1158/0008-5472.CAN-06-1392; Hunger RE, 2015, EUR J DERMATOL, V25, P472, DOI 10.1684/ejd.2015.2626; Hunger RE, 2015, J AM ACAD DERMATOL, V72, P1054, DOI 10.1016/j.jaad.2015.03.029; Jafari SMS, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14358; Jafari SMS, 2017, APPL IMMUNOHISTO M M, V25, pE12, DOI 10.1097/PAI.0000000000000370; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Korpelainen EI, 1998, CURR OPIN CELL BIOL, V10, P159, DOI 10.1016/S0955-0674(98)80137-3; Kozlowski M, 2010, EUR J CARDIO-THORAC, V38, P260, DOI 10.1016/j.ejcts.2010.01.061; Kurebayashi J, 1999, JPN J CANCER RES, V90, P977, DOI 10.1111/j.1349-7006.1999.tb00844.x; Liu WB, 2011, INT J ONCOL, V39, P1213, DOI 10.3892/ijo.2011.1138; Massi D, 2006, J CLIN PATHOL, V59, P166, DOI 10.1136/jcp.2005.028431; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Niki T, 2000, CLIN CANCER RES, V6, P2431; Ohta Y, 1999, BRIT J CANCER, V81, P54, DOI 10.1038/sj.bjc.6690650; Ohta Y, 2000, J THORAC CARDIOV SUR, V119, P804, DOI 10.1016/S0022-5223(00)70017-1; Pepper MS, 2003, J CELL BIOL, V163, P209, DOI 10.1083/jcb.200308082; Pradeep C R, 2005, Integr Cancer Ther, V4, P315, DOI 10.1177/1534735405282557; Rokach L, 2005, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, P321, DOI 10.1007/0-387-25465-X_15; Ruggeri B, 2003, CANCER RES, V63, P5978; Saharinen P, 2004, TRENDS IMMUNOL, V25, P387, DOI 10.1016/j.it.2004.05.003; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shushanov S, 2000, INT J CANCER, V86, P47, DOI 10.1002/(SICI)1097-0215(20000401)86:1<47::AID-IJC7>3.0.CO;2-R; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Sladden MJ, 2009, COCHRANE DATABASE SY, V4; Sotiropoulou N, 2010, PATHOLOGY, V42, P629, DOI 10.3109/00313025.2010.522174; Squires MH, 2013, CURR ONCOL REP, V15, P465, DOI 10.1007/s11912-013-0333-5; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Streit M, 2003, ONCOGENE, V22, P3172, DOI 10.1038/sj.onc.1206457; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Tsurusaki T, 1999, BRIT J CANCER, V80, P309, DOI 10.1038/sj.bjc.6690356; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Warne R.T., 2014, PRACTICAL ASSESSMENT, V19; Weigel RJ, 1999, SURGERY, V126, P1061; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yonemura Y, 1999, CLIN CANCER RES, V5, P1823; Zhang F, 2009, P NATL ACAD SCI USA, V106, P6152, DOI 10.1073/pnas.0813061106; Zlobec Inti, 2014, J Vis Exp, P51893, DOI 10.3791/51893	65	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207019	10.1371/journal.pone.0207019	http://dx.doi.org/10.1371/journal.pone.0207019			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408085	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300064
J	Kumera, G; Haile, K; Abebe, N; Marie, T; Eshete, T				Kumera, Gemechu; Haile, Kalkidan; Abebe, Nurilgn; Marie, Tefera; Eshete, Tewodros			Anemia and its association with coffee consumption and hookworm infection among pregnant women attending antenatal care at Debre Markos Referral Hospital, Northwest Ethiopia	PLOS ONE			English	Article							IRON-DEFICIENCY; MATERNAL ANEMIA; RISK-FACTORS; LOW-INCOME; PREVALENCE; TRICHURIS; SEVERITY	Background Anemia in pregnancy is a major public health concern worldwide, especially in developing countries. Thus, there is a need of having current information and local data on the prevalence of anemia and associated factors during pregnancy to help inform preventive programmes. The aim of this study was to assess the prevalence of anemia and associated factors among pregnant women attending antenatal care at Debre Markos Referral Hospital, Northwest Ethiopia. Methods An institution based cross-sectional study was conducted at Debre Markos Referral Hospital in July and August 2016. A total of 234 randomly-selected pregnant women took part in the study. Data on sociodemographic factors, environmental and sanitation factors, reproductive factors, and nutrition related characteristics were collected using a structured questionnaire. Hemoglobin level was determined using hematological analyzer (Cell Dyn 1800) machine. The stool sample was collected to identify intestinal parasitic infections. Statistical analysis was done using logistic regression. The p value of less than 0.05 at 95% confidence interval was considered statistically significant. Results The overall prevalence of anemia among pregnant women was 11.5% (95% CI: 8.2%14.9%). The result of multivariable analysis revealed that, coffee consumption [AOR = 2.91; 95% CI (1.63, 8.78)], and hookworm infection [AOR = 2.65; 95% CI (1.48, 4.72)] were factors significantly associated with anemia among pregnant women. Conclusion Anemia is of public health concern among pregnant women in the study area. All pregnant women coming to antenatal clinics should be screened and treated routinely for intestinal parasitic infection. Pregnant women should limit coffee consumption, and avoid drinking coffee with meals.	[Kumera, Gemechu; Abebe, Nurilgn] Debre Markos Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Haile, Kalkidan] Debre Markos Referral Hosp, Debre Markos, Ethiopia; [Marie, Tefera] Debre Markos Univ, Dept Midwifery, Coll Med & Hlth Sci, Debre Markos, Ethiopia; [Eshete, Tewodros] Debre Markos Univ, Dept Hlth Informat, Coll Med & Hlth Sci, Debre Markos, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Kumera, G (corresponding author), Debre Markos Univ, Dept Publ Hlth, Coll Med & Hlth Sci, Debre Markos, Ethiopia.	geme.dmu@gmail.com	Haile, Kalkidan/GLN-5912-2022	Wonde, Tewodros/0000-0003-3323-8202; Marie, Tefera/0000-0003-1809-5098	Debre Markos University	Debre Markos University	This study was supported by Debre Markos University for the data collection material. However, the University had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam I, 2008, J TROP PEDIATRICS, V54, P202, DOI 10.1093/tropej/fmm110; Alem M., 2013, J INTERDISCIP HISTOP, V1, P137, DOI [10.5455/jihp.20130122042052, DOI 10.5455/JIHP.20130122042052]; Alene KA, 2014, ANEMIA, V2014, DOI 10.1155/2014/561567; Allen Henrietta E., 2002, Trends in Parasitology, V18, P381, DOI 10.1016/S1471-4922(02)02386-3; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2001, IRON DEFICIENCY ANAE; [Anonymous], 1992, J APPL TOXICOL, V12, P191; Antelman G, 2000, J NUTR, V130, P1950, DOI 10.1093/jn/130.8.1950; Badham J, 2007, GUIDEBOOK NUTR ANEMI; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bekele A, 2016, ANEMIA, V2016, DOI 10.1155/2016/1073192; Benoist B., 2008, WORLDWIDE PREVALENCE; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bondevik GT, 2000, EUR J CLIN NUTR, V54, P3, DOI 10.1038/sj.ejcn.1600883; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; CASEMORE DP, 1985, J CLIN PATHOL, V38, P1337, DOI 10.1136/jcp.38.12.1337; Central Statistical Agency (Ethiopia) and ICF International, 2012, ETH DEM HLTH SURV 20, P430; Cogill B., 2003, ANTHROPOMETRIC INDIC; CROMPTON DWT, 1993, PARASITOLOGY, V107, pS137, DOI 10.1017/S0031182000075569; Ejeta E, 2014, FOOD SCI QUALITY MAN, V31, P82; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POP PROJ ETH ALL REG; FerroLuzzi A, 1996, BRIT J NUTR, V75, P3, DOI 10.1079/BJN19960105; Gebremedhin S, 2014, AFR J REPROD HEALTH, V18, P44; Gedefaw L, 2015, ETHIOP J HEALTH SCI, V25, P155, DOI 10.4314/ejhs.v25i2.8; Getachew M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-296; Gyorkos TW, 2011, TROP MED INT HEALTH, V16, P531, DOI 10.1111/j.1365-3156.2011.02727.x; Haggaz AD, 2010, T ROY SOC TROP MED H, V104, P234, DOI 10.1016/j.trstmh.2009.07.013; Idowu O A, 2005, Afr Health Sci, V5, P295; Jufar AH, 2014, J HEMATOL THROMBOEMB, V2, P2; Kefiyalew Filagot, 2014, BMC Res Notes, V7, P771, DOI 10.1186/1756-0500-7-771; Kennedy G, 2011, GUID MEAS HOUS IND D; Kidanto HL, 2009, SAMJ S AFR MED J, V99, P98; LAYRISSE M, 1967, AM J TROP MED HYG, V16, P613, DOI 10.4269/ajtmh.1967.16.613; LAYRISSE M, 1964, AM J HYG, V79, P279, DOI 10.1093/oxfordjournals.aje.a120383; Lebso M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188783; Lee AI, 2011, HEMATOL ONCOL CLIN N, V25, P241, DOI 10.1016/j.hoc.2011.02.001; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; McClure EM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002724; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mengist Hylemariam Mihiretie, 2017, BMC Res Notes, V10, P440, DOI 10.1186/s13104-017-2770-y; Mihiretie H., 2015, J MEDICAL MICROBIOLO, V4, P1, DOI DOI 10.4172/21610703.1000197; Msuya Sia E, 2011, Tanzan J Health Res, V13, P33; MUNOZ LM, 1988, AM J CLIN NUTR, V48, P645, DOI 10.1093/ajcn/48.3.645; Nestel P., 2002, ADJUSTING HEMOGLOBIN; Nurdiati Detty Siti, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P14; Obse N, 2013, ETHIOP J HEALTH SCI, V23, P165; Okube O.T., 2016, OPEN J OBSTET GYNECO, V6, P16; Olds GR, 2003, ACTA TROP, V86, P185, DOI 10.1016/S0001-706X(03)00033-0; Olusanya O., 1985, W AFR J MED, V4, P205; Onoh R, 2015, SAHEL MED J, V18, P182, DOI DOI 10.4103/1118-8561.176588; Ononge Sam, 2014, BMC Res Notes, V7, P712, DOI 10.1186/1756-0500-7-712; PRITCHARD DI, 1991, T ROY SOC TROP MED H, V85, P235, DOI 10.1016/0035-9203(91)90038-Z; RIDLEY DS, 1956, J CLIN PATHOL, V9, P74, DOI 10.1136/jcp.9.1.74; ROCHE M, 1966, AM J TROP MED HYG, V15, P1032, DOI 10.4269/ajtmh.1966.15.1032; SCHOLL TO, 1994, AM J CLIN NUTR, V59, p492S, DOI 10.1093/ajcn/59.2.492S; Shah Binay Kumar, 2005, J Ayub Med Coll Abbottabad, V17, P5; Stephenson L, 2003, CURR TREAT OPTIONS I, V5, P291; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Swindale Anne, 2006, HOUSEHOLD DIETARY DI, DOI DOI 10.1017/CBO9781107415324.004; Uneke CJ, 2007, J HEALTH POPUL NUTR, V25, P328; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, P119, DOI 10.1080/00034989958609; World Health Organization, 1993, PREV MAN SEV AN PREG; World Health Organization, 2008, MICR DEF IR DEF AN; World Health Organization, 1988, REQ VIT A IR FOL VIT; World Health Organization (WHO), 1994, BENCH AIDS DIAGN INT	65	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206880	10.1371/journal.pone.0206880	http://dx.doi.org/10.1371/journal.pone.0206880			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408080	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300050
J	Maekawa, T; Osawa, Y; Okada, Y; Tachi, N; Teramoto, M; Kawamura, T; Horiuchi, T; Kato, S; Kobayashi, A; Kobayashi, S; Sato, K; Kimura, F				Maekawa, Takaaki; Osawa, Yukiko; Okada, Yosuke; Tachi, Noriaki; Teramoto, Masahiro; Kawamura, Toshikuni; Horiuchi, Toshikatsu; Kato, Shoichiro; Kobayashi, Ayako; Kobayashi, Shinichi; Sato, Ken; Kimura, Fumihiko			Low mucosal-associated invariant T-cell number in peripheral blood of patients with immune thrombocytopenia and their response to prednisolone	PLOS ONE			English	Article							MAIT CELLS; DEXAMETHASONE; SUBSETS; DISEASE; PURPURA; INNATE	Mucosal-associated invariant T (MAIT) cells help protect against certain infections and are related to some autoimmune diseases. Immune thrombocytopenia (ITP) is a relatively rare hematological autoimmune disease associated with low platelet count. We designed a cross-sectional study wherein we examined peripheral blood samples of patients with ITP for the number of MAIT cells (CD3(+)TCR-V alpha 7.2(+)CD161(+)IL-18R alpha(+) lymphocytes) and their CD4/8 subsets (by flow cytometry) and levels of cytokines (by multiplex assays). The study cohort included 18 patients with ITP and 20 healthy controls (HCs). We first compared the number of MAIT cells between HCs and patients with ITP and then performed subgroup analysis in patients with ITP. The number of total MAIT cells in patients with ITP was significantly lower than that in HCs (p < 0.0001), and the CD4(-)CD8(+) subset of MAIT cells showed the same trend. Moreover, patients with ITP refractory to prednisolone exhibited a significantly lower number of total MAIT and CD4(-)CD8(+) MAIT cells than patients sensitive to prednisolone. The number of total MAIT and CD4(-)CD8(+) MAIT cells was not correlated with the response to thrombopoietin receptor agonist treatment or with Helicobacter pylori infection. We found no relation between cytokine levels and response to prednisolone treatment, although the levels of IP-10 and RANTES showed a correlation with the number of total MAIT and CD4(-)CD8(+) MAIT cells. In conclusion, total MAIT and CD4(-)CD8(+) MAIT cells in peripheral blood were decreased in patients with ITP, correlating with their response to prednisolone.	[Maekawa, Takaaki; Osawa, Yukiko; Okada, Yosuke; Tachi, Noriaki; Teramoto, Masahiro; Kawamura, Toshikuni; Horiuchi, Toshikatsu; Kato, Shoichiro; Kobayashi, Ayako; Kobayashi, Shinichi; Sato, Ken; Kimura, Fumihiko] Natl Def Med Coll, Div Hematol, Dept Internal Med, Tokorozawa, Saitama, Japan	National Defense Medical College - Japan	Maekawa, T (corresponding author), Natl Def Med Coll, Div Hematol, Dept Internal Med, Tokorozawa, Saitama, Japan.	doc00064@ndmc.ac.jp		Maekawa, Takaaki/0000-0002-8611-0862				Bajnok A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-1023-2; Bhattacharyya A, 2018, BIOL BLOOD MARROW TR, V24, P242, DOI 10.1016/j.bbmt.2017.10.003; Booth JS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00466; Bottcher K, 2018, HEPATOLOGY, V68, P172, DOI 10.1002/hep.29782; Cho YN, 2014, J IMMUNOL, V193, P3891, DOI 10.4049/jimmunol.1302701; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Gudbrandsdottir S, 2013, BLOOD, V121, P1976, DOI 10.1182/blood-2012-09-455691; Haga K, 2016, J GASTROEN HEPATOL, V31, P965, DOI 10.1111/jgh.13242; Hinks Timothy, 2015, Lancet, V385 Suppl 1, pS42, DOI 10.1016/S0140-6736(15)60357-9; Hinks TSC, 2016, IMMUNOLOGY, V148, P1, DOI 10.1111/imm.12582; Hinks TSC, 2015, J ALLERGY CLIN IMMUN, V136, P323, DOI 10.1016/j.jaci.2015.01.014; Hu Y, 2015, EXPERT OPIN THER TAR, V19, P723, DOI 10.1517/14728222.2015.1016499; Illes Z, 2004, INT IMMUNOL, V16, P223, DOI 10.1093/intimm/dxh018; Ji LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050909; Ji XB, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0072-6; Johnsen J, 2012, HEMATOL-AM SOC HEMAT, P306, DOI 10.1182/asheducation-2012.1.306; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2011, TRENDS IMMUNOL, V32, P212, DOI 10.1016/j.it.2011.02.005; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Leeansyah E, 2013, BLOOD, V121, P1124, DOI 10.1182/blood-2012-07-445429; Li JQ, 2013, IMMUNOL LETT, V154, P42, DOI 10.1016/j.imlet.2013.08.006; Liu HY, 2013, THROMB RES, V132, P196, DOI 10.1016/j.thromres.2013.04.025; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Stasi R, 2009, BLOOD, V113, P1231, DOI 10.1182/blood-2008-07-167155; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Wakao H, 2013, CELL STEM CELL, V12, P546, DOI 10.1016/j.stem.2013.03.001; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Xiao RJ, 2012, HEPATO-GASTROENTEROL, V59, P762, DOI 10.5754/hge11432; Zhang YC, 2018, INT J HEMATOL, V107, P442, DOI 10.1007/s12185-017-2392-0; Zhao ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126601	35	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207149	10.1371/journal.pone.0207149	http://dx.doi.org/10.1371/journal.pone.0207149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408105	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300084
J	Xiong, Y; Zhang, Q; Ye, JX; Pan, S; Ge, LY				Xiong, Yao; Zhang, Qian; Ye, Jiaxiang; Pan, Shan; Ge, Lianying			Associations between three XRCC1 polymorphisms and hepatocellular carcinoma risk: A meta-analysis of case-control studies	PLOS ONE			English	Article							DNA-REPAIR GENES; HEPATITIS-B; CAPACITY; XPD; PROGNOSIS; ENZYMES; CANCER; DAMAGE	Conflicting results have been obtained regarding the association between X-ray repair cross complementation group 1 (XRCC1) and susceptibility to hepatocellular carcinoma (HCC). In this study, associations between HCC and three polymorphisms (Arg194Trp, Arg280His, and Arg399Gln) were evaluated using a meta-analysis approach. PubMed, Web of Science, Cochrane Library, the Chinese National Knowledge Infrastructure, and the Wanfang standard database were systematically searched to identify all relevant case-control studies published through March 2018. A total of 32 case-control studies, including 13 that evaluated Arg194Trp, 14 that evaluated Arg280His, and 26 that evaluated Arg399Gln, were analyzed. In the entire study population, XRCC1 Arg399Gln was significantly associated not only with overall risk of HCC (homozygous model, OR = 1.61, 95% CI: 1.40-1.85, P < 0.05; recessive model, OR = 1.40, 95% CI: 1.23-1.59, P < 0.05) but also with the risk of HCC in Chinese patients (homozygous model, OR = 1.78, 95% CI: 1.53-2.08, P < 0.05; recessive model, OR = 1.47, 95% CI: 1.27-1.70, P < 0.05). Limiting the analysis to studies demonstrating Hardy-Weinberg equilibrium (HWE), the results were consistent and robust. Similarly, a significant association between XRCC1 Arg399Gln and HCC risk was found in healthy controls in the general population but not in hospital controls. Trial sequential analysis (TSA), false-positive report probabilities (FPRP), and combined genotype analysis revealed that XRCC1 Arg399Gln is mainly associated with susceptibility to liver cancer. However, there was no association between Arg194Trp or Arg280His and the risk of HCC. These results, indicating that the Arg399Gln polymorphism of XRCC1 is associated with the risk of HCC in the Chinese population, provide a basis for the development of improved detection and treatment approaches.	[Xiong, Yao; Ye, Jiaxiang; Pan, Shan; Ge, Lianying] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Med Oncol, Nanning, Guangxi Zhuang, Peoples R China; [Zhang, Qian] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Gynecol Oncol, Nanning, Guangxi Zhuang, Peoples R China	Guangxi Medical University; Guangxi Medical University	Ge, LY (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Med Oncol, Nanning, Guangxi Zhuang, Peoples R China.	Gelianying196606@163.com			Guangxi Scientific Research and Technology Development Plan [14124003-4]	Guangxi Scientific Research and Technology Development Plan	This work was supported by grants from Guangxi Scientific Research and Technology Development Plan (Grant No. 14124003-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazgir Afsaneh, 2018, Middle East J Dig Dis, V10, P40, DOI 10.15171/mejdd.2017.89; Bo W, 2011, XIANDAI ZHONGLIU YIX, V19, P1724; Bo W, 2012, ZHONGHUA LAO DONG WE, V22, P45; Bo WL, 2012, HARBIN MED J, V01, P43, DOI [10.3969/j.issn.1000-1905.2012.01.011, DOI 10.3969/J.ISSN.1000-1905.2012.01.011]; Borentain P, 2007, EUR J CANCER, V43, P2479, DOI 10.1016/j.ejca.2007.08.006; Bose S, 2013, GENE, V519, P231, DOI 10.1016/j.gene.2013.02.025; Devi SM, 2013, DIGEST DIS SCI, V58, P759, DOI 10.1007/s10620-012-2409-8; Feki-Tounsi M, 2017, ENVIRON SCI POLLUT R, V24, P22476, DOI 10.1007/s11356-017-9767-x; Guan QH, 2017, ONCOL LETT, V14, P2783, DOI 10.3892/ol.2017.6522; Gulnaz A, 2013, EUR J GASTROEN HEPAT, V25, P166, DOI 10.1097/MEG.0b013e328359a775; Guo LY, 2012, ASIAN PAC J CANCER P, V13, P4423, DOI 10.7314/APJCP.2012.13.9.4423; Han XC, 2012, HEPATO-GASTROENTEROL, V59, P2285, DOI 10.5754/hge12096; He ChengCheng, 2015, Chinese Journal of Cancer Biotherapy, V22, P348; He G, 2012, J GUANGXI U CHINESE, V15, P1; HE J, 2014, SCI REP UK, V4; Huang X, 2017, ONCOL LETT, V13, P704, DOI 10.3892/ol.2016.5496; Isakova J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3762-y; Jia ZF, 2010, CHINESE J CANCER RES, V22, P260, DOI 10.1007/s11670-010-0260-z; Kiran M, 2009, MOL CELL BIOCHEM, V327, P7, DOI 10.1007/s11010-009-0035-3; Kirk GD, 2005, CANCER EPIDEM BIOMAR, V14, P373, DOI 10.1158/1055-9965.EPI-04-0161; Krupa R, 2017, DNA CELL BIOL, V36, P693, DOI 10.1089/dna.2017.3664; Kuptsova N, 2007, BLOOD, V109, P3936, DOI 10.1182/blood-2006-05-022111; Li J, 2013, TUMOR BIOL, V34, P261, DOI 10.1007/s13277-012-0546-5; Li QW, 2012, ASIAN PAC J CANCER P, V13, P191, DOI 10.7314/APJCP.2012.13.1.191; Liu J, 2015, AER ADV ENG RES, V23, P399; Long XD, 2004, J GUANGXI MED U, V21, P313; Pan HZ, 2011, ASIAN PAC J CANCER P, V12, P2947; Reinardy HC, 2015, MUTAGENESIS, V30, P829, DOI 10.1093/mutage/gev052; Ren Y, 2008, CHIN J CLIN HEPATOL, V24, P361; Rybarova S, 2012, Klin Onkol, V25, P370; Santonocito C, 2017, INT J BIOL MARKER, V32, pE190, DOI 10.5301/jbm.5000241; Santos JC, 2014, INT J MOL SCI, V13, P2549, DOI [10.3892/ol.2017.5780, DOI 10.3892/OL.2017.5780]; Segui N, 2015, GASTROENTEROLOGY, V149, P563, DOI 10.1053/j.gastro.2015.05.056; Shi YH, 2016, J CELL MOL MED, V20, P2056, DOI 10.1111/jcmm.12896; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Su HY, 2008, CASE CONTROL STUDY A; Tang YunTian, 2011, Shandong Medical Journal, V51, P19; Tasnim T, 2017, TUMOR BIOL, V39, DOI [10.1177/1010428317729270, DOI 10.1177/1010428317729270]; Wang SY, 2012, CLIN CANCER RES, V18, P2987, DOI 10.1158/1078-0432.CCR-11-2863; Wang XC, 2016, GENET TEST MOL BIOMA, V20, P176, DOI 10.1089/gtmb.2015.0267; [吴昊 WU Hao], 2009, [中国现代医学杂志, China Journal of Modern Medicine], V19, P2737; Wu JS, 2014, GENET MOL RES, V13, P3812, DOI 10.4238/2014.May.16.5; Xu W, 2015, GENET MOL RES, V14, P7122, DOI 10.4238/2015.June.29.5; Xuan CX, 2016, AKT AND XRCC1 MUTUAL; [杨金龙 Yang Jinlong], 2004, [肿瘤, Tumor], V24, P322; Yang ZH, 2015, INT J CLIN EXP MED, V8, P9931; Yao JG, 2014, INT J CLIN EXP PATHO, V7, P6231; Yu MW, 2003, J NATL CANCER I, V95, P1485, DOI 10.1093/jnci/djg051; Yuan T, 2012, DIGEST DIS SCI, V57, P2451, DOI 10.1007/s10620-012-2192-6; Yuan T, 2012, EXP THER MED, V4, P285, DOI 10.3892/etm.2012.581; Zeng X, 2010, CHIN J DIS CONTROL P, V14, P760; Zeng XY, 2012, DNA CELL BIOL, V31, P1384, DOI 10.1089/dna.2012.1646; Zhang Y, 2017, J EXP MED, V214, P2523, DOI 10.1084/jem.20161427; Zhu YM, 2008, DNA REPAIR, V7, P141, DOI 10.1016/j.dnarep.2007.08.006; Zuo TT, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0056-0	55	4	4	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206853	10.1371/journal.pone.0206853	http://dx.doi.org/10.1371/journal.pone.0206853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408066	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300043
J	Auersperg, AMI; Kock, C; O'Hara, M; Huber, L				Auersperg, A. M., I; Koeck, C.; O'Hara, M.; Huber, L.			Tool making cockatoos adjust the lengths but not the widths of their tools to function	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CALEDONIAN CROWS; EVOLUTIONARY; INTELLIGENCE; MANUFACTURE; INNOVATION; CORVIDS; CONTEXT; ORIGINS; BRAINS	The ability to innovatively use or even manufacture different tools depending on a current situation can be silhouetted against examples of stereotyped, inborn tool use/manufacture and is thus often associated to advanced cognitive processing. In this study we confronted non-specialized, yet innovative tool making birds, Goffin's cockatoos (Cacatua goffiniana), with an apparatus featuring an out-of-reach food reward that could be placed at different distances from a tool opening. Alternatively, the food stayed at a constant distance but the tool opening in the front of the apparatus had different diameters. We used a novel material for tool manufacture (cardboard) that demanded an incrementally increased manufacturing effort from the actor, depending on the length of the tool required. We found that our subjects used two strategies to succeed in this tasks: either by making carboard-stripe tools using the full length of the material sheets originally offered or by adjusting the lengths of their tools to different goal distances. Subjects also discarded cardboard stripes that were too short to reach the goal prior to use and discarded longer pieces when the goal was further away than when it was close. Nevertheless, likely due to morphological constraints, the birds failed to adjust the widths of their tools depending on the diameter of the tool opening.	[Auersperg, A. M., I; O'Hara, M.; Huber, L.] Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Koeck, C.] Univ Vienna, Dept Cognit Biol, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Vienna	Auersperg, AMI (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria.	alice.auersperg@vetmeduni.ac.at		Auersperg, Alice/0000-0001-7405-9791	FWF: the Austrian Science Fund [P 29084, P 29075]	FWF: the Austrian Science Fund(Austrian Science Fund (FWF))	Alice Auersperg, the maintenance of the Goffin Lab, and the materials to conduct this experiment were funded by Projects P 29084 and P 29075 from FWF: the Austrian Science Fund (https://www.fwf.ac.at/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg AMI, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0972; Auersperg AMI, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0689; Auersperg AMI, 2015, J COMP PSYCHOL, V129, P62, DOI 10.1037/a0038314; Auersperg AMI, 2012, CURR BIOL, V22, pR903, DOI 10.1016/j.cub.2012.09.002; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Call J, 2013, TOOL USE IN ANIMALS: COGNITION AND ECOLOGY, P3; Chappell J, 2002, ANIM COGN, V5, P71, DOI 10.1007/s10071-002-0130-2; Chappell J, 2004, ANIM COGN, V7, P121, DOI 10.1007/s10071-003-0202-y; Cnotka J, 2008, NEUROSCI LETT, V433, P241, DOI 10.1016/j.neulet.2008.01.026; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Forshaw J. M, 2001, PARROTS WORLD; Habl C, 2017, PLOS ONE; Hansell M, 2008, TRENDS ECOL EVOL, V23, P73, DOI 10.1016/j.tree.2007.10.006; Hunt GR, 2006, ANIM COGN, V9, P307, DOI 10.1007/s10071-006-0047-2; Hunt GR, 2013, TOOL USE IN ANIMALS: COGNITION AND ECOLOGY, P89; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Kenward B, 2011, BIOL J LINN SOC, V102, P870, DOI 10.1111/j.1095-8312.2011.01613.x; Knaebe B, 2017, BEHAVIOUR, V154, P65, DOI 10.1163/1568539X-00003411; Laumer I, 2017, P ROY SOC B; Laumer IB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28380; Lefebvre L, 2004, BRAIN BEHAV EVOLUT, V63, P233, DOI 10.1159/000076784; Mulcahy NJ, 2005, J COMP PSYCHOL, V119, P23, DOI 10.1037/0735-7036.119.1.23; Osuna-Mascaro AJO, ANIM BEHAV COGN; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Rutz C, 2012, BEHAV PROCESS, V89, P153, DOI 10.1016/j.beproc.2011.11.005; Shumaker RW, 2001, ANIMAL TOOL BEHAV US; Silva FJ, 2010, LEARN BEHAV, V38, P87, DOI 10.3758/LB.38.1.87; Tebbich S, 2004, ANIM BEHAV, V67, P689, DOI 10.1016/j.anbehav.2003.08.003; Weir AAS, 2006, ANIM COGN, V9, P317, DOI 10.1007/s10071-006-0052-5; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	34	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205429	10.1371/journal.pone.0205429	http://dx.doi.org/10.1371/journal.pone.0205429			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403673	gold, Green Submitted, Green Published			2022-12-26	WOS:000449379500016
J	Bittar, C; Machado, RRG; Comelis, MT; Bueno, LM; Morielle-Versute, E; Beguelini, MR; de Souza, RP; Nogueira, ML; Rahal, P				Bittar, Cintia; Machado, Rafael R. G.; Comelis, Manuela T.; Bueno, Larissa M.; Morielle-Versute, Eliana; Beguelini, Matheus R.; de Souza, Renato P.; Nogueira, Mauricio L.; Rahal, Paula			Lack of serological and molecular evidence of arbovirus infections in bats from Brazil	PLOS ONE			English	Article							LOUIS ENCEPHALITIS-VIRUS; DENGUE VIRUS; NO EVIDENCE; SEROTYPES 1; HOST-RANGE; SAO-PAULO; TRANSMISSION; FEVER; REPLICATION; EVOLUTION	Viruses are important agents of emerging zoonoses and are a substantial public health issue. Among emerging viruses, an important group are arboviruses, which are characterized by being maintained in nature in cycles involving hematophagous arthropod vectors and a wide range of vertebrate hosts. Recently, bats have received increasing attention as an important source for the emergence of zoonoses and as possible viral reservoirs. Among the arboviruses, there are many representatives of the genera Fla vi virus and Alpha virus, which are responsible for important epidemics such as Dengue virus, Zika virus and Chikungunya virus. Due to the importance of analyzing potential viral reservoirs for zoonosis control and expanding our knowledge of bat viruses, this study aimed to investigate the presence of viruses of the Alpha virus and Fla vi virus genera in bats. We analyzed serum, liver, lungs and intestine from 103 bats sampled in northeast and southern Brazil via Nested-PCR and the hemagglutination inhibition test. All samples tested in this study were negative for arboviruses, suggesting that no active or past infection was present in the captured bats. These data indicate that the bats examined herein probably do not constitute a reservoir for these viruses in the studied areas. Further studies are needed to clarify the role of bats as reservoirs and sources of infection of these viral zoonoses.	[Bittar, Cintia; Machado, Rafael R. G.; Rahal, Paula] Univ Estadual Paulista, UNESP, Inst Biociencias Letras & Ciencias Exatas, Lab Estudos Genom, Sao Jose Do Rio Preto, SP, Brazil; [Comelis, Manuela T.; Bueno, Larissa M.; Morielle-Versute, Eliana; Beguelini, Matheus R.] Univ Estadual Paulista, Lab Chiroptera, Inst Biociencias Letras & Ciencias Exatas, Sao Jose Do Rio Preto, SP, Brazil; [Beguelini, Matheus R.] UFOB, Ctr Ciencias Biol & Saude, Barreiras, BA, Brazil; [de Souza, Renato P.] Adolfo Lutz Inst, Nucleo Doencas Transmissao Vetorial, Sao Paulo, Brazil; [Nogueira, Mauricio L.] FAMERP Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Federal do Oeste da Bahia; Instituto Adolfo Lutz; Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	Machado, RRG (corresponding author), Univ Estadual Paulista, UNESP, Inst Biociencias Letras & Ciencias Exatas, Lab Estudos Genom, Sao Jose Do Rio Preto, SP, Brazil.	rafarahalmachado@gmail.com	Bittar, Cintia/A-5042-2015; Rahal, Paula/D-3871-2012; Beguelini, Mateus Rodrigues/N-5063-2018; Nogueira, Mauricio L/B-7599-2012	Bittar, Cintia/0000-0002-2048-4589; Rahal, Paula/0000-0001-5693-6148; Nogueira, Mauricio L/0000-0003-1102-2419; Beguelini, Mateus/0000-0002-9568-4446; Rahal Guaragna Machado, Rafael/0000-0001-6974-5092; Pereira de Souza, Renato/0000-0003-1315-7085	FAPESP (Sao Paulo Research Foundation) [2015/09704-6]; CNPq (National Council for Scientific and Technological Development) [165802/2015-4]	FAPESP (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financially supported by FAPESP (Sao Paulo Research Foundation -http://www.fapesp.br/) grant number 2015/09704-6, received by RRGM and by CNPq (National Council for Scientific and Technological Development http://cnpq.br/) grant number 165802/2015-4, received by CB.; The authors would also like to thank all members of the Laboratory of Genomics Studies (IBILCE-UNESP, BR) for their helpful suggestions and discussions. This work was financially supported by FAPESP (Sao Paulo Research Foundation) grant number 2015/09704-6 and by CNPq (National Council for Scientific and Technological Development) grant number 165802/2015-4.	Aguilar-Setien A, 2008, EPIDEMIOL INFECT, V136, P1678, DOI 10.1017/S0950268808000460; Bahia S da S do E da, 2017, B EPIDEMIOLOGICO FEB, P3; Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200; Cabrera-Romo S, 2016, ZOONOSES PUBLIC HLTH, V63, P579, DOI 10.1111/zph.12276; Cabrera-Romo S, 2014, AM J TROP MED HYG, V91, P1227, DOI 10.4269/ajtmh.14-0361; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Casseb Alexandre do Rosario, 2013, Veterinaria e Zootecnia, V20, P391; Chen LH, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau021; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002; Colombo TE, 2016, ACTA TROP, V164, P84, DOI 10.1016/j.actatropica.2016.09.004; Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009; Dash AP, 2013, J VECTOR DIS, V50, P77; Estofolete CF, 2016, REV SOC BRAS MED TRO, V49, P648, DOI 10.1590/0037-8682-0093-2016; Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012; Feldhamer GA., 2015, MAMMALOGY ADAPTATION, V4th; Gregorim R., 2016, B SOC BRASILEIRA EST, P28; Hill J., 1984, BATS NATURAL HIST; Institute for Laboratory Animal Resources Comission on Life Sciences National Research Council, 2011, GUIDE CARE USE LAB A, DOI [10.1163/1573-3912_islam_DUM_3825, DOI 10.1163/1573-3912_ISLAM_DUM_3825]; Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005; Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998; Kuno G, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070185; LaVal R.K., 1973, Science Bull nat Hist Mus Los Ang Cty, V15, P1; Lopez-Roig M, 2014, VIRUSES-BASEL, V6, P3386, DOI 10.3390/v6093386; Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753; Machain-williams C, 2014, J WILDLIFE DIS, V49, P1, DOI [10.7589/2012-12-318.Serologic, DOI 10.7589/2012-12-318.SEROLOGIC]; Maher-Sturgess SL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-16; Miranda JMD, 2006, ZOOTAXA, P57, DOI 10.11646/zootaxa.1383.1.4; Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007; Mondini A, 2007, EMERG INFECT DIS, V13, P176, DOI 10.3201/eid1301.060905; Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016; Moreira-Soto A, 2017, COMP IMMUNOL MICROB, V50, P101, DOI 10.1016/j.cimid.2016.12.004; Moreno ES, 2011, REV SOC BRAS MED TRO, V44, P290, DOI 10.1590/S0037-86822011005000041; Nogueira Marcelo Rodrigues, 2014, Check List, V10, P808; Nogueira ML, 2017, EUROPEAN SOC CLIN MI, DOI DOI 10.1016/J.CMI.2017.11.004; Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975; Mota MTO, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01341-15; Perea-Martinez L, 2013, COMP IMMUNOL MICROB, V36, P193, DOI 10.1016/j.cimid.2012.12.002; Costa IMP, 2016, EPIDEMIOL SERV SAUDE, V25, P735, DOI [10.5123/S1679-49742016000400007, 10.5123/s1679-49742016000400007]; Saad LD, 2016, EPIDEMIOL SERV SAUDE, V25, P531, DOI [10.5123/s1679-49742016000300009, 10.5123/S1679-49742016000300009]; Saude S de V em M da, 2017, B EPIDEMIOLOGICO, V48, P1; Serra-Cobo J, 2017, ADV EXP MED BIOL, V972, P35, DOI 10.1007/5584_2016_131; Serra-Cobo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064467; SHEPHERD R. C, 1964, ZOONOSES RES, V3, P125; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; SULKIN SE, 1966, SCIENCE, V152, P223, DOI 10.1126/science.152.3719.223; Thompson NN, 2015, ZOONOSES PUBLIC HLTH, V62, P53, DOI 10.1111/zph.12118; Vicente-Santos A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005537; Vizotto LD, 1973, CHAVE DETERMINAC SP; Wang L.F., 2015, BATS VIRUSES NEW FRO, P1, DOI [10.1002/9781118818824, DOI 10.1002/9781118818824]; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; WILLIAMS M. C., 1964, ZOONOSES HITS, V3, P141; WILLIAMS MC, 1964, NATURE, V203, P670, DOI 10.1038/203670a0; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207010	10.1371/journal.pone.0207010	http://dx.doi.org/10.1371/journal.pone.0207010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403749	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500091
J	Realegeno, S; Niezgoda, M; Yager, PA; Kumar, A; Hogue, L; Orciari, L; Sambhara, S; Olson, VA; Satheshkumar, PS				Realegeno, Susan; Niezgoda, Michael; Yager, Pamela A.; Kumar, Amrita; Hogue, Laboni; Orciari, Lillian; Sambhara, Suryaprakash; Olson, Victoria A.; Satheshkumar, Panayampalli Subbian			An ELISA-based method for detection of rabies virus nucleoprotein-specific antibodies in human antemortem samples	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; NEUTRALIZING ANTIBODY; PROTECTIVE IMMUNITY; CEREBROSPINAL-FLUID; GLYCOPROTEIN; DIAGNOSIS; RIBONUCLEOPROTEIN; VACCINATION; INDUCTION; IMMUNIZATION	Rabies is a fatal encephalitic disease in humans and animals caused by lyssaviruses, most commonly rabies virus (RABV). Human antemortem diagnosis of rabies is a complex process involving multiple sample types and tests for the detection of antibodies, antigen (protein), and nucleic acids (genomic RNA). Serological diagnosis of human rabies includes the detection of either neutralizing or binding antibodies in the cerebrospinal fluid (CSF) or serum samples from unimmunized individuals without prior rabies vaccination or passive immunization with purified immunoglobulins. While neutralizing antibodies are targeted against the surface-expressed glycoprotein (G protein), binding antibodies to viral antigens are predominantly against the nucleoprotein (N protein), although there can be antibodies against all RABV-expressed proteins. To determine N protein-specific antibody responses in the CSF and serum during RABV infection, we developed an enzyme-linked immunosorbent assay (ELISA) with purified recombinant N protein expressed in E. coll. N protein-specific immunoglobulin (Ig) subtypes IgG and IgM were detected in the CSF or serum of previously diagnosed human rabies cases. In addition, anti-N protein seroconversion was demonstrated over the course of illness in individual rabies cases. We compared the N protein ELISA results to those of an indirect fluorescent antibody (IFA) test, the current binding antibody assay used in diagnosis, and show that our ELISA is consistent with the IFA test. Sensitivity and specificity of the N protein ELISA ranged from 78.38-100% and 75.76-96.77% with respect to the IFA results. Our data provide evidence for the use of an N protein ELISA as an additional option for the detection of RABV-specific IgG or IgM antibodies in human CSF or serum specimens.	[Realegeno, Susan; Niezgoda, Michael; Yager, Pamela A.; Hogue, Laboni; Orciari, Lillian; Olson, Victoria A.; Satheshkumar, Panayampalli Subbian] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA; [Kumar, Amrita; Sambhara, Suryaprakash] Ctr Dis Control & Prevent, Immunol & Pathogenesis Branch, Influenza Div, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Satheshkumar, PS (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	spanayampalli@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021					Albertini AAV, 2011, ADV VIRUS RES, V79, P1, DOI 10.1016/B978-0-12-387040-7.00001-9; [Anonymous], 2006, WHO TECH REP SER; Brown CM, 2010, 10ID16 COUNC STAT TE; Carol Glaser, 2012, MMWR MORB MORTAL WKL, V61; Carrieri ML, 2015, ANTIGENIC TYPING LYS; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V60, P1734; Cliquet F, 1998, J IMMUNOL METHODS, V212, P79, DOI 10.1016/S0022-1759(97)00212-3; Coetzer A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003189; COX JH, 1977, INFECT IMMUN, V16, P754, DOI 10.1128/IAI.16.3.754-759.1977; Crepin P, 1998, J CLIN MICROBIOL, V36, P1117, DOI 10.1128/JCM.36.4.1117-1121.1998; Dacheux L, 2008, CLIN INFECT DIS, V47, P1410, DOI 10.1086/592969; DIETZSCHOLD B, 1987, P NATL ACAD SCI USA, V84, P9165, DOI 10.1073/pnas.84.24.9165; DIETZSCHOLD B, 1987, VIROLOGY, V161, P29, DOI 10.1016/0042-6822(87)90167-X; ERTL HCJ, 1989, J VIROL, V63, P2885, DOI 10.1128/JVI.63.7.2885-2892.1989; Feyssaguet M, 2007, VACCINE, V25, P2244, DOI 10.1016/j.vaccine.2006.12.012; FLAMAND A, 1980, J GEN VIROL, V48, P97, DOI 10.1099/0022-1317-48-1-97; FU ZF, 1991, P NATL ACAD SCI USA, V88, P2001, DOI 10.1073/pnas.88.5.2001; FUJII H, 1994, J GEN VIROL, V75, P1339, DOI 10.1099/0022-1317-75-6-1339; GOLDWASSER RA, 1958, P SOC EXP BIOL MED, V98, P219, DOI 10.3181/00379727-98-23996; GRASSI M, 1989, J CLIN MICROBIOL, V27, P899, DOI 10.1128/JCM.27.5.899-902.1989; HATTWICK MA, 1972, ANN INTERN MED, V76, P931, DOI 10.7326/0003-4819-76-6-931; Hemachudha T, 2004, CLIN INFECT DIS, V39, P1085, DOI 10.1086/423813; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3; Holzmann-Pazgal G., 2010, Morbidity and Mortality Weekly Report, V59, P185; HOOPER DC, 1994, P NATL ACAD SCI USA, V91, P10908, DOI 10.1073/pnas.91.23.10908; HUMMELER K, 1968, J VIROL, V2, P1191, DOI 10.1128/JVI.2.10.1191-1199.1968; Inoue S, 2003, JPN J INFECT DIS, V56, P158; Jackson AC, 2007, RABIES; KASEMPIMOLPORN S, 1991, CLIN EXP IMMUNOL, V84, P195, DOI 10.1111/j.1365-2249.1991.tb08148.x; Kim HH, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0789-2; KING AA, 1984, J GEN VIROL, V65, P1091, DOI 10.1099/0022-1317-65-6-1091; LAFON M, 1992, NATURE, V358, P507, DOI 10.1038/358507a0; Lyles DS, 2007, FIELDS VIROLOGY, P1361; Ma XY, 2018, JAVMA-J AM VET MED A, V252, P945, DOI 10.2460/javma.252.8.945; Ma XY, 2012, VACCINE, V30, P5358, DOI 10.1016/j.vaccine.2012.06.037; Mani RS, 2014, J MED VIROL, V86, P1804, DOI 10.1002/jmv.23814; Mayes B, 2015, 8 DIRECT FLUORESCENT; Meslin FX, 1996, LAB TECHNIQUES RABIE; Messenger S, 2015, INDIRECT FLUORESCENT; Moore SM, 2007, RABIES SEROLOGY, P11; Muhamuda K, 2006, J CLIN VIROL, V37, P162, DOI 10.1016/j.jcv.2006.06.010; Muhamuda K, 2007, INT J INFECT DIS, V11, P441, DOI 10.1016/j.ijid.2006.09.013; Nadin-Davis SA, 2007, MOL EPIDEMIOLOGY, P3; Petersen BW, 2011, HUMAN RABIES EPIDEMI; PRABHAKAR BS, 1981, NATURE, V290, P590, DOI 10.1038/290590a0; Rudd RJ, 2013, J CLIN MICROBIOL, V51, P4079, DOI 10.1128/JCM.01818-13; Rupprecht CE, 2013, MMWR-MORBID MORTAL W, V62, P642; SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535; THOMAS JB, 1963, J IMMUNOL, V91, P721; TOLLIS M, 1991, VACCINE, V9, P134, DOI 10.1016/0264-410X(91)90270-G; Tursunov K, 2017, IRAN J VET RES, V18, P36; Velasco-Villa A, 2008, EMERG INFECT DIS, V14, P1906, DOI 10.3201/eid1412.080671; Vora NM, 2018, MMWR-MORBID MORTAL W, V67, P161, DOI 10.15585/mmwr.mm6705a3; Welch RJ, 2009, J MED MICROBIOL, V58, P806, DOI 10.1099/jmm.0.006064-0; WIKTOR TJ, 1973, J IMMUNOL, V110, P269; Willoughby RE, 2005, NEW ENGL J MED, V352, P2508, DOI 10.1056/NEJMoa050382; World Health Organization, 2018, TECH REP SER, V1012, P195; Wunner WH, 2007, RABIES VIRUS, P2	60	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207009	10.1371/journal.pone.0207009	http://dx.doi.org/10.1371/journal.pone.0207009			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403742	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500090
J	Wakabayashi, M; Futagami, S; Yamawaki, H; Tatsuguchi, A; Kaneko, K; Agawa, S; Higuchi, K; Sakasegawa, N; Murakami, M; Akimoto, T; Kodaka, Y; Ueki, N; Gudis, K; Kawamoto, C; Akamizu, T; Sakamoto, C; Lwakiri, K				Wakabayashi, Mako; Futagami, Seiji; Yamawaki, Hiroshi; Tatsuguchi, Atsushi; Kaneko, Keiko; Agawa, Shuhei; Higuchi, Kazutoshi; Sakasegawa, Noriko; Murakami, Makoto; Akimoto, Teppei; Kodaka, Yasuhiro; Ueki, Nobue; Gudis, Kaya; Kawamoto, Chiaki; Akamizu, Takashi; Sakamoto, Choitsu; Lwakiri, Katsuhiko			Comparison of clinical symptoms, gastric motility and fat intake in the early chronic pancreatitis patients with anti-acid therapy-resistant functional dyspepsia patients	PLOS ONE			English	Article							DOUBLE-BLIND; PRACTICE GUIDELINES; HEALTHY-SUBJECTS; EUS; DEGRANULATION; LANSOPRAZOLE; DIAGNOSIS; EFFICACY; DISEASE; MEALS	Background There was no available data concerning the clinical differentiation between the updated definition of early chronic pancreatitis (ECP) and anti-acid therapy-resistant functional dyspepsia (RFD). Aims We aimed to determine whether clinical symptoms, gastric motility, psychogenic factors and fat intake can help distinguish early chronic pancreatitis (ECP) from anti-acid therapy-resistant functional dyspepsia patients with pancreatic enzyme abnormalities (RFD-P) and anti-acid therapy-resistant functional dyspepsia (RFD) patients using endosonography. Methods We enrolled 102 consecutive patients presenting with typical symptoms of RFD patients (n = 52), ECP patients (n = 25) and RFD-P patients (n = 25). ECP patients were diagnosed based on the criteria recommended by the Japan Pancreatic Association. Gastric motility was evaluated by C-13-acetate breath tests. Severity of duodenal inflammation was examined. Results 24.5% of RFD patients were determined as ECP using endosonography. Abdominal pain score in Gastrointestinal Symptom Rating Scale (GSRS) in the patients with ECP was significantly lower compared to that in the patients with RFD-P. There were no significant differences in State-Trait Inventory (STAI)-state/-trait scores, Self-Rating Questionnaire for Depression (SRQ-D) scores and clinical symptoms for fat intake among three groups. The early phase of gastric emptying (AUC(5); AUC(15)) in ECP and RFD-P patients were significantly disturbed compared to those in RFD patients. Conclusions Evaluation of severity of abdominal pain and measurement of the early phase of gastric emptying will be useful tools to distinguish ECP patients from RFD patients. Accurate diagnosis of ECP patients may contribute to the prevention from advancing of chronic pancreatitis.	[Wakabayashi, Mako; Futagami, Seiji; Yamawaki, Hiroshi; Tatsuguchi, Atsushi; Kaneko, Keiko; Agawa, Shuhei; Higuchi, Kazutoshi; Sakasegawa, Noriko; Murakami, Makoto; Akimoto, Teppei; Kodaka, Yasuhiro; Ueki, Nobue; Gudis, Kaya; Kawamoto, Chiaki; Sakamoto, Choitsu; Lwakiri, Katsuhiko] Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Tokyo, Japan; [Akamizu, Takashi] Wakayama Med Unvers, Dept Med 1, Wakayama, Japan	Nippon Medical School	Futagami, S (corresponding author), Nippon Med Sch, Dept Internal Med, Div Gastroenterol, Tokyo, Japan.	seiji.futagami@gmail.com		Akamizu, Takashi/0000-0003-4960-8271	Ministry of Education, Culture, and Science; Ministry of Health, Japan [16K09294]	Ministry of Education, Culture, and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Japan	This study was supported by the Ministry of Education, Culture, and Science and from the Ministry of Health, Japan (16K09294) (SF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 1972, PSYCHOSOM MED JPN, V12, P243; ANDERSEN BN, 1982, HEPATO-GASTROENTEROL, V29, P35; Ashizawa N, 2006, J GASTROEN HEPATOL, V21, P767, DOI 10.1111/j.1440-1746.2005.04041.x; Castineira-Alvarino M, 2013, CLIN NUTR, V32, P830, DOI 10.1016/j.clnu.2013.02.002; Catalano MF, 2009, GASTROINTEST ENDOSC, V69, P1251, DOI 10.1016/j.gie.2008.07.043; Catalano MF, 1998, GASTROINTEST ENDOSC, V48, P11, DOI 10.1016/S0016-5107(98)70122-1; Chong AKH, 2007, GASTROINTEST ENDOSC, V65, P808, DOI 10.1016/j.gie.2006.09.026; Chowdhury RS, 2003, PANCREAS, V26, P235, DOI 10.1097/00006676-200304000-00005; DeWitt J, 2005, GASTROINTEST ENDOSC, V62, P76, DOI 10.1016/S0016-5107(05)00504-3; Doi Y, 2000, J Epidemiol, V10, P79; Doi Y, 1998, JPN J PSYCHIAT TREAT, V13, P755; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Du LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34305; ELTA GH, 1989, AM J GASTROENTEROL, V84, P643; ELTA GH, 1987, AM J GASTROENTEROL, V82, P749; Engbers LH, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-253; Feinle-Bisset C, 2013, AM J GASTROENTEROL, V108, P737, DOI 10.1038/ajg.2013.76; Fried M, 2002, GUT               S1, V51, pi54, DOI [10.1136/gut.51.suppl_1.i54, DOI 10.1136/GUT.51.SUPPL_1.I54]; Futagami S, 2010, AM J GASTROENTEROL, V105, P1835, DOI 10.1038/ajg.2010.151; Hellmig S, 2006, J GASTROEN HEPATOL, V21, P1832, DOI 10.1111/j.1440-1746.2006.04449.x; Hellstrom PM, 2008, NEUROGASTROENT MOTIL, V20, P649, DOI 10.1111/j.1365-2982.2007.01079.x; Holtmann G, 1996, AM J GASTROENTEROL, V91, P485; Ito T, 2016, J GASTROENTEROL, V51, P85, DOI 10.1007/s00535-015-1149-x; Kusano M, 2011, J GASTROEN HEPATOL, V26, P75, DOI 10.1111/j.1440-1746.2011.06627.x; Lindkvist B, 2013, WORLD J GASTROENTERO, V19, P7258, DOI 10.3748/wjg.v19.i42.7258; LONG WB, 1974, GASTROENTEROLOGY, V67, P920; Lunding JA, 2006, SCAND J GASTROENTERO, V41, P1028, DOI 10.1080/00365520600590513; Meyer JH, 1996, DIGEST DIS SCI, V41, P1691, DOI 10.1007/BF02088732; MEZEY E, 1988, AM J CLIN NUTR, V48, P148, DOI 10.1093/ajcn/48.1.148; Miwa H, 2015, J GASTROENTEROL, V50, P125, DOI 10.1007/s00535-014-1022-3; Peura DA, 2004, AM J MED, V116, P740, DOI 10.1016/j.amjmed.2004.01.008; Pezzilli R, 2000, DIGEST LIVER DIS, V32, P233, DOI 10.1016/S1590-8658(00)80826-9; Pilichiewicz A, 2003, J CLIN ENDOCR METAB, V88, P3829, DOI 10.1210/jc.2003-030199; Pilichiewicz AN, 2008, AM J GASTROENTEROL, V103, P2613, DOI 10.1111/j.1572-0241.2008.02041.x; Sahai AV, 2000, GASTROINTEST ENDOSC, V52, P153, DOI 10.1067/mge.2000.107910; Sahai AV, 1998, GASTROINTEST ENDOSC, V48, P18, DOI 10.1016/S0016-5107(98)70123-3; Schirra J, 2000, GUT, V46, P622, DOI 10.1136/gut.46.5.622; Shimpuku M, 2011, NEUROGASTROENT MOTIL, V23, P1073, DOI 10.1111/j.1365-2982.2011.01781.x; Shimpuku M, 2014, INT J GASTROENTEROL, V1, P106; Shindo T, 2009, DIGESTION, V79, P65, DOI 10.1159/000205740; SMITH RC, 1991, INT J PANCREATOL, V8, P253; Spielberger C. D., 1973, MANUAL STATE TRAIT I; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Takahashi Y, 2006, J GASTROEN HEPATOL, V21, P1664, DOI 10.1111/j.1440-1746.2006.04270.x; Talley NJ, 1998, ALIMENT PHARM THER, V12, P1055; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Wang WH, 2007, CLIN GASTROENTEROL H, V5, P178, DOI 10.1016/j.cgh.2006.09.012; WILSON JS, 1985, GUT, V26, P882, DOI 10.1136/gut.26.9.882; Wong WM, 2002, GUT, V51, P502, DOI 10.1136/gut.51.4.502; Yamawaki H, 2015, J NEUROGASTROENTEROL, V21, P93, DOI 10.5056/jnm14086; Yuan HP, 2015, INT J CLIN EXP MED, V8, P8010	53	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205165	10.1371/journal.pone.0205165	http://dx.doi.org/10.1371/journal.pone.0205165			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403664	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500012
J	Galzitskaya, OV; Lobanov, MY				Galzitskaya, Oxana, V; Lobanov, Mihail Yu			Proteome-scale understanding of relationship between homo-repeat enrichments and protein aggregation properties	PLOS ONE			English	Article							TANDEM REPEATS; SEQUENCE DETERMINANTS; HOMOREPEATS; PREDICTION; PATTERNS	Expansion of homo-repeats is a molecular basis for human neurological diseases. We are the first who studied the influence of homo-repeats with lengths larger than four amino acid residues on the aggregation properties of 1449683 proteins across 122 eukaryotic and bacterial proteomes. Only 15% of proteins (215481) include homo-repeats of such length. We demonstrated that RNA-binding proteins with a prion-like domain are enriched with homo-repeats in comparison with other non-redundant protein sequences and those in the PDB. We performed a bioinformatics analysis for these proteins and found that proteins with homo-repeats are on average two times longer than those in the whole database. Moreover, we are first to discover that as a rule, homo-repeats appear in proteins not alone but in pairs: hydrophobic and aromatic homo-repeats appear with similar ones, while homo-repeats with small, polar and charged amino acids appear together with different preferences. We elaborated a new complementary approach to demonstrate the influence of homo-repeats on their host protein aggregation properties. We have shown that addition of artificial homo-repeats to natural and random proteins results in intensification of aggregation properties of the proteins. The maximal effect is observed for the insertion of artificial homo-repeats with 5-6 residues, which is consistent with the minimal length of an amyloidogenic region. We have also demonstrated that the ability of proteins with homo-repeats to aggregate cannot be explained only by the presence of long homo-repeats in them. There should be other characteristics of proteins intensifying the aggregation property including such as the appearance of homo-repeats in pairs in the same protein. We are the first who elaborated a new approach to study the influence of homo-repeats present in proteins on their aggregation properties and performed an appropriate analysis of the large number of proteomes and proteins.	[Galzitskaya, Oxana, V; Lobanov, Mihail Yu] Russian Acad Sci, Inst Prot Res, Grp Bioinformat, Moscow, Russia	Russian Academy of Sciences	Galzitskaya, OV (corresponding author), Russian Acad Sci, Inst Prot Res, Grp Bioinformat, Moscow, Russia.	ogalzit@vega.protres.ru			program of Russian Academy of Science "Molecular and Cellular Biology [01201353567]; Russian Science Foundation [18-14-00321]	program of Russian Academy of Science "Molecular and Cellular Biology; Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the program of Russian Academy of Science "Molecular and Cellular Biology," Grant number 01201353567, awarded to OG. This study was also supported by Russian Science Foundation, Grant number 18-14-00321, awarded to OG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AB, 2015, ALZHEIMERS DEMENT, V11, P681, DOI 10.1016/j.jalz.2014.06.007; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Belli M, 2011, EMBO REP, V12, P657, DOI 10.1038/embor.2011.116; Cascarina SM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006256; Darling AL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122027; de Groot NS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009383; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dovidchenko NV, 2015, ADV EXP MED BIOL, V855, P213, DOI 10.1007/978-3-319-17344-3_9; Emily M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079722; Fan XP, 2001, HUM MOL GENET, V10, P2341, DOI 10.1093/hmg/10.21.2341; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Galzitskaya OV, 2006, PLOS COMPUT BIOL, V2, P1639, DOI 10.1371/journal.pcbi.0020177; Galzitskaya OV, 2015, MOL BIOSYST, V11, P2210, DOI 10.1039/c5mb00273g; Garbuzynskiy SO, 2010, BIOINFORMATICS, V26, P326, DOI 10.1093/bioinformatics/btp691; Gasior P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-55; Jorda J, 2010, FEBS J, V277, P2673, DOI [10.1111/j.1742-4658.2010.07684.x, 10.1111/j.1742-464X.2010.07684.x]; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; Lobanov MY, 2012, MOL BIOSYST, V8, P327, DOI 10.1039/c1mb05318c; Lobanov MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26941; Lobanov MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027142; Lobanov MY, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000958; Lobanov MY, 2015, INT J MOL SCI, V16, P19490, DOI 10.3390/ijms160819490; Lobanov MY, 2014, NUCLEIC ACIDS RES, V42, pD273, DOI 10.1093/nar/gkt927; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Monsellier E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000199; Mularoni L, 2010, GENOME RES, V20, P745, DOI 10.1101/gr.101261.109; Pallares I, 2019, CURR MED CHEM, V26, P3911, DOI 10.2174/0929867324666170705121754; Prusiner SB, 2004, PRION BIOL DIS; Robertson AL, 2011, NUCLEIC ACIDS RES, V39, pD272, DOI 10.1093/nar/gkq1100; de Groot NS, 2007, BIOPHYS J, V92, P1732, DOI 10.1529/biophysj.106.096677; Siwach P, 2008, FRONT BIOSCI-LANDMRK, V13, P4467, DOI 10.2741/3017; Tartaglia GG, 2007, PROTEINS, V68, P273, DOI 10.1002/prot.21427; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tsolis AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054175; Walsh I, 2014, NUCLEIC ACIDS RES, V42, pW301, DOI 10.1093/nar/gku399; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206941	10.1371/journal.pone.0206941	http://dx.doi.org/10.1371/journal.pone.0206941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399196	gold, Green Published, Green Submitted			2022-12-26	WOS:000449374000032
J	Yousefi, S; Yousefi, E; Takahashi, H; Hayashi, T; Tampo, H; Inoda, S; Arai, Y; Asbell, P				Yousefi, Siamak; Yousefi, Ebrahim; Takahashi, Hidenori; Hayashi, Takahiko; Tampo, Hironobu; Inoda, Satoru; Arai, Yusuke; Asbell, Penny			Keratoconus severity identification using unsupervised machine learning	PLOS ONE			English	Article							DECISION TREE CLASSIFICATION; CORNEAL TOPOGRAPHY; PROGRESSION; VIDEOKERATOGRAPHY; SPECIFICITY; SENSITIVITY; ANTERIOR; INDEXES; VOLUME; SHAPE	We developed an unsupervised machine learning algorithm and applied it to big corneal parameters to identify and monitor keratoconus stages. A big dataset of corneal swept source optical coherence tomography (OCT) images of 12,242 eyes acquired from SS-1000 CASIA OCT Imaging Systems in multiple centers across Japan was assembled. A total of 3,156 eyes with valid Ectasia Status Index (ESI) between zero and 100% were selected for the downstream analysis. Four hundred and twenty corneal topography, elevation, and pachymetry parameters (excluding ESI Keratoconus indices) were selected. The algorithm included three major steps. 1) Principal component analysis (PCA) was used to linearly reduce the dimensionality of the input data from 420 to eight significant principal components. 2) Manifold learning was used to further reducing the selected principal components nonlinearly to two eigen-parameters. 3) Finally, a density-based clustering was applied to the eigen-parameters to identify eyes with keratoconus. Visualization of clusters in 2-D space was used to validate the quality of learning subjectively and ESI was used to assess the accuracy of the identified clusters objectively. The proposed method identified four clusters; I: a cluster composed of mostly normal eyes (224 eyes with ESI equal to zero, 23 eyes with ESI between five and 29, and nine eyes with ESI greater than 29), II: a cluster composed of mostly healthy eyes and eyes with forme fruste keratoconus (1772 eyes with ESI equal to zero, 698 eyes with ESI between five and 29, and 117 eyes with ESI greater than 29), III: a cluster composed of mostly eyes with mild keratoconus stage (184 eyes with ESI greater than 29, 74 eyes with ESI between five and 29, and 6 eyes with ESI equal to zero), and IV: a cluster composed of eyes with mostly advanced keratoconus stage (80 eyes had ESI greater than 29 and 1 eye had ESI between five and 29). We found that keratoconus status and severity can be well identified using unsupervised machine learning algorithms along with linear and non-linear corneal data transformation. The proposed method can better identify and visualize the keratoconus stages.	[Yousefi, Siamak; Yousefi, Ebrahim; Asbell, Penny] Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA; [Yousefi, Siamak] Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Takahashi, Hidenori; Tampo, Hironobu; Inoda, Satoru; Arai, Yusuke] Jichi Med Univ, Dept Ophthalmol, Shimotsuke, Tochigi, Japan; [Hayashi, Takahiko] Yokohama Minami Kyosai Hosp, Dept Ophthalmol, Yokohama, Kanagawa, Japan	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Jichi Medical University	Yousefi, S (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Ophthalmol, Memphis, TN 38163 USA.; Yousefi, S (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Genet Genom & Informat, Memphis, TN 38163 USA.	siamak.yousefi@uthsc.edu	Hayashi, Takahiko/ABB-7168-2020	Hayashi, Takahiko/0000-0001-8704-680X; Takahashi, Hidenori/0000-0001-5331-4730; Inoda, Satoru/0000-0003-4577-8169; Yousefi, Ebrahim/0000-0002-8777-4011; Yousefi, Siamak/0000-0001-8633-5730	Research to Prevent Blindness (RPB), New York, NY	Research to Prevent Blindness (RPB), New York, NY(Research to Prevent Blindness (RPB))	The authors were funded by an unrestricted grant from Research to Prevent Blindness (RPB), New York, NY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio R, 2006, J CATARACT REFR SURG, V32, P1851, DOI 10.1016/j.jcrs.2006.06.025; Ambrosio R, 2011, J REFRACT SURG, V27, P753, DOI 10.3928/1081597X-20110721-01; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; Arbelaez MC, 2012, OPHTHALMOLOGY, V119, P2231, DOI 10.1016/j.ophtha.2012.06.005; Brown SE, 2014, EYE CONTACT LENS, V40, P331, DOI 10.1097/ICL.0000000000000085; Carvalho LA, 2005, OPTOMETRY VISION SCI, V82, P151, DOI 10.1097/01.OPX.0000153193.41554.A1; Chastang PJ, 2000, J CATARACT REFR SURG, V26, P675, DOI 10.1016/S0886-3350(00)00303-5; de Sanctis U, 2008, OPHTHALMOLOGY, V115, P1534, DOI 10.1016/j.ophtha.2008.02.020; Perez JF, 2014, BRIT J OPHTHALMOL, V98, P1465, DOI 10.1136/bjophthalmol-2014-305120; Gordon-Shaag A, 2012, OPTOMETRY VISION SCI, V89, P411, DOI 10.1097/OPX.0b013e318249d727; Holladay JT, 2009, J REFRACT SURG, V25, pS958, DOI 10.3928/1081597X-20090915-11; Li XH, 2009, J CATARACT REFR SURG, V35, P1597, DOI 10.1016/j.jcrs.2009.03.050; Luz A., 2012, INT J KERATOCO ECTAT, V1, P92, DOI DOI 10.5005/jp-journals-10025-1018; MAEDA N, 1994, INVEST OPHTH VIS SCI, V35, P2749; Pinero DP, 2010, J CATARACT REFR SURG, V36, P814, DOI 10.1016/j.jcrs.2009.11.012; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rehioui H, 2016, PROCEDIA COMPUT SCI, V83, P560, DOI 10.1016/j.procs.2016.04.265; Rocha LM, 2009, INT J IMAG SYST TECH, V19, P50, DOI 10.1002/ima.20191; Saad A, 2010, INVEST OPHTH VIS SCI, V51, P5546, DOI 10.1167/iovs.10-5369; Sander Jorg, 1996, DENSITY BASED ALGORI, P226; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Smadja D, 2013, AM J OPHTHALMOL, V156, P237, DOI 10.1016/j.ajo.2013.03.034; Smolek MK, 1997, INVEST OPHTH VIS SCI, V38, P2290; Spira C, 2015, OPHTHALMOLOGE, V112, P353, DOI 10.1007/s00347-014-3135-8; Tomidokoro A, 2000, OPHTHALMOLOGY, V107, P1328, DOI 10.1016/S0161-6420(00)00159-7; Twa MD, 2005, OPTOMETRY VISION SCI, V82, P1038, DOI 10.1097/01.opx.0000192350.01045.6f; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Yousefi S, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.3.2; Yousefi S, 2014, IEEE T BIO-MED ENG, V61, P2112, DOI 10.1109/TBME.2014.2314714; Zhao Y, 2005, DATA MIN KNOWL DISC, V10, P141, DOI 10.1007/s10618-005-0361-3	30	42	45	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0205998	10.1371/journal.pone.0205998	http://dx.doi.org/10.1371/journal.pone.0205998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399144	gold, Green Published, Green Submitted			2022-12-26	WOS:000449374000005
J	Chen, JN; Samadi, S; Chen, WJ				Chen, Jhen-Nien; Samadi, Sarah; Chen, Wei-Jen			Rhodopsin gene evolution in early teleost fishes	PLOS ONE			English	Article							EEL ANGUILLA-JAPONICA; ROD VISUAL PIGMENTS; RAY-FINNED FISH; FRESH-WATER; PROVIDES INSIGHTS; GENOME DUPLICATION; MOLECULAR-BASIS; OPSIN GENES; 6 NUCLEAR; VISION	Rhodopsin mediates an essential step in image capture and is tightly associated with visual adaptations of aquatic organisms, especially species that live in dim light environments (e.g., the deep sea). The rh1 gene encoding rhodopsin was formerly considered a single-copy gene in genomes of vertebrates, but increasing exceptional cases have been found in teleost fish species. The main objective of this study was to determine to what extent the visual adaptation of teleosts might have been shaped by the duplication and loss of rh1 genes. For that purpose, homologous rh1/rh1-like sequences in genomes of ray-finned fishes from a wide taxonomic range were explored using a PCR-based method, data mining of public genetic/genomic databases, and subsequent phylogenomic analyses of the retrieved sequences. We show that a second copy of the fish-specific intron-less rh1 is present in the genomes of most anguillids (Elopomorpha), Hiodon alosoides (Osteoglossomorpha), and several clupeocephalan lineages. The phylogenetic analysis and comparisons of alternative scenarios for putative events of gene duplication and loss suggested that fish rh1 was likely duplicated twice during the early evolutionary history of teleosts, with one event coinciding with the hypothesized fish-specific genome duplication and the other in the common ancestor of the Clupeocephala. After these gene duplication events, duplicated genes were maintained in several teleost lineages, whereas some were secondarily lost in specific lineages. Alternative evolutionary schemes of rh1 and comparison with previous studies of gene evolution are also reviewed.	[Chen, Jhen-Nien; Chen, Wei-Jen] Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan; [Samadi, Sarah] Sorbonne Univ, EPHE, CNRS, Museum Natl Hist Nat,Inst Syst Evolut Biodiversit, Paris, France	National Taiwan University; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite	Chen, WJ (corresponding author), Natl Taiwan Univ, Inst Oceanog, Taipei, Taiwan.	wjchen.actinops@gmail.com	samadi, sarah/G-5011-2010; CHEN, Wei-Jen/A-2605-2008	samadi, sarah/0000-0003-0725-9368; CHEN, Wei-Jen/0000-0003-4751-7632	bilateral cooperation research entitled "Taiwan France marine diversity exploration and evolution of deepsea fauna, TFDeepEvo" - Ministry of Science and Technology, Taiwan [MOST 102-2923-B-002-001 -MY3, MOST 107-2611-M-002-007]; French National Research Agency [ANR 12-ISV7-0005-01]	bilateral cooperation research entitled "Taiwan France marine diversity exploration and evolution of deepsea fauna, TFDeepEvo" - Ministry of Science and Technology, Taiwan; French National Research Agency(French National Research Agency (ANR))	This work was supported by bilateral cooperation research entitled "Taiwan France marine diversity exploration and evolution of deepsea fauna, TFDeepEvo" funded by the Ministry of Science and Technology, Taiwan (MOST 102-2923-B-002-001 -MY3 and MOST 107-2611-M-002-007, both to WJC) and the French National Research Agency (ANR 12-ISV7-0005-01 to SS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; Archer S, 1995, P ROY SOC B-BIOL SCI, V262, P289, DOI 10.1098/rspb.1995.0208; Arnegard ME, 2010, P NATL ACAD SCI USA, V107, P22172, DOI 10.1073/pnas.1011803107; Beaudry FEG, 2017, J EXP ZOOL PART B, V328, P685, DOI 10.1002/jez.b.22773; Bellingham J, 2003, J EXP ZOOL PART B, V297B, P1, DOI 10.1002/jez.b.00018; Braasch I, 2008, J FISH BIOL, V73, P1891, DOI 10.1111/j.1095-8649.2008.02011.x; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Carleton KL, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-22; Chen J.-N., 2015, EVOLUTIONARY BIOL BI, P329, DOI DOI 10.1007/978-3-319-19932-0; Chen JN, 2014, MOL PHYLOGENET EVOL, V70, P152, DOI 10.1016/j.ympev.2013.09.002; Chen W.-J., 2001, REPETITIVITE CLADES; Chen WJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00053; Chen WJ, 2010, BIOSCIENCE, V60, P421, DOI 10.1525/bio.2010.60.6.6; Chen WJ, 2009, MOL PHYLOGENET EVOL, V52, P544, DOI 10.1016/j.ympev.2009.01.006; Chen WJ, 2003, MOL PHYLOGENET EVOL, V26, P262, DOI 10.1016/S1055-7903(02)00371-8; Collin SP, 2005, CURR BIOL, V15, P794, DOI [10.1016/j.cub.2005.03.044, DOI 10.1016/J.CUB.2005.03.044]; de Busserolles F, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0070; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Eilertsen M, 2014, J COMP NEUROL, V522, P4003, DOI 10.1002/cne.23652; Eschmeyer WN, 2017, SPECIES FAMILY SUBFA; Faircloth BC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITZGIBBON J, 1995, GENE, V164, P273, DOI 10.1016/0378-1119(95)00458-I; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hofmann CM, 2012, J MOL EVOL, V75, P79, DOI 10.1007/s00239-012-9525-0; Hofmann CM, 2009, INTEGR COMP BIOL, V49, P630, DOI 10.1093/icb/icp079; Hope AJ, 1997, P ROY SOC B-BIOL SCI, V264, P155, DOI 10.1098/rspb.1997.0023; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hunt DM, 2014, VISUAL NEUROSCI, V31, P115, DOI 10.1017/S0952523813000242; Hunt DM, 2001, J EXP BIOL, V204, P3333; Imamoto Y, 2014, BBA-BIOENERGETICS, V1837, P664, DOI 10.1016/j.bbabio.2013.08.009; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kai W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-233; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Lagman D, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-238; Lim J, 1997, BBA-GENE STRUCT EXPR, V1352, P8, DOI 10.1016/S0167-4781(97)00038-9; LIN JJ, 2017, SCI REP, V7, P1, DOI DOI 10.1038/srep41722; Liu ZJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11757; Maddison D. R., 2005, MACCLADE 4 08A ANAL, DOI [DOI 10.1046/J.1420-9101.1996.9020153.X, DOI 10.1007/s13592-012-0141-1]; Maddison WP, 2009, MESQUITE MODULAR SYS; Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9; Miller M.A., 2010, P GAT COMP ENV WORKS; Morrow JM, 2017, J EXP BIOL, V220, P294, DOI 10.1242/jeb.145953; Morrow JM, 2011, VISUAL NEUROSCI, V28, P325, DOI 10.1017/S0952523811000010; Morshedian A, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0074; Nakamura Y, 2017, ZOOL LETT, V3, DOI 10.1186/s40851-017-0079-2; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Ohno S., 1970, EVOLUTION GENE DUPLI; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pointer MA, 2007, J EXP BIOL, V210, P2829, DOI 10.1242/jeb.006064; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rennison DJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0242; Sabbah S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-133; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; Santini F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-194; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shiao JC, 2014, DEEP-SEA RES PT I, V84, P50, DOI 10.1016/j.dsr.2013.10.006; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Varela AI, 2015, ENVIRON BIOL FISH, V98, P193, DOI 10.1007/s10641-014-0249-4; Venkatesh B, 1999, P NATL ACAD SCI USA, V96, P10267, DOI 10.1073/pnas.96.18.10267; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Yang JX, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0223-4; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yokoyama S, 1997, ANNU REV GENET, V31, P315, DOI 10.1146/annurev.genet.31.1.315; Yokoyama S, 2008, P NATL ACAD SCI USA, V105, P13480, DOI 10.1073/pnas.0802426105; Zhang H, 2000, FEBS LETT, V469, P39, DOI 10.1016/S0014-5793(00)01233-3; Zhang H, 2002, J FISH BIOL, V61, P313, DOI 10.1006/jfbi.2002.2020	75	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206918	10.1371/journal.pone.0206918	http://dx.doi.org/10.1371/journal.pone.0206918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395593	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400065
J	Ernst, HA; Jorgensen, LJ; Bukh, C; Piontek, K; Plattner, DA; Ostergaard, LH; Larsen, S; Bjerrum, MJ				Ernst, Heidi A.; Jorgensen, Lise J.; Bukh, Christian; Piontek, Klaus; Plattner, Dietmar A.; Ostergaard, Lars H.; Larsen, Sine; Bjerrum, Morten J.			A comparative structural analysis of the surface properties of asco-laccases	PLOS ONE			English	Article							MELANOCARPUS-ALBOMYCES LACCASE; MULTIPLE PROTEIN-SEQUENCE; CRYSTAL-STRUCTURE; COPRINUS-CINEREUS; FUNGAL LACCASE; RIGIDOPORUS-LIGNOSUS; CATALYTIC-PROPERTIES; STRUCTURE ALIGNMENTS; ANGSTROM RESOLUTION; REACTION-MECHANISM	Laccases of different biological origins have been widely investigated and these studies have elucidated fundamentals of the generic catalytic mechanism. However, other features such as surface properties and residues located away from the catalytic centres may also have impact on enzyme function. Here we present the crystal structure of laccase from Myceliophthora thermophila (MtL) to a resolution of 1.62 angstrom together with a thorough structural comparison with other members of the CAZy family AA1_3 that comprises fungal laccases from ascomycetes. The recombinant protein produced in A. oryzae has a molecular mass of 75 kDa, a pl of 4.2 and carries 13.5 kDa N-linked glycans. In the crystal, MtL forms a dimer with the phenolic substrate binding pocket blocked, suggesting that the active form of the enzyme is monomeric. Overall, the MtL structure conforms with the canonical fold of fungal laccases as well as the features specific for the asco-laccases. However, the structural comparisons also reveal significant variations within this taxonomic subgroup. Notable differences in the T1-Cu active site topology and polar motifs imply molecular evolution to serve different functional roles. Very few surface residues are conserved and it is noticeable that they encompass residues that interact with the N-glycans and/or are located at domain interfaces. The N-glycosylation sites are surprisingly conserved among asco-laccases and in most cases the glycan displays extensive interactions with the protein. In particular, the glycans at Asn88 and Asn210 appear to have evolved as an integral part of the asco-laccase structure. An uneven distribution of the carbohydrates around the enzyme give unique properties to a distinct part of the surface of the asco-laccases which may have implication for laccase function-in particular towards large substrates.	[Ernst, Heidi A.; Jorgensen, Lise J.; Bukh, Christian; Larsen, Sine; Bjerrum, Morten J.] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Bukh, Christian] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Piontek, Klaus; Plattner, Dietmar A.] Univ Freiburg, Inst Organ Chem & Biochem, Freiburg, Germany; [Ostergaard, Lars H.] Novozymes AS, Dept Agile Prot Screening, Bagsvaerd, Denmark	University of Copenhagen; University of Copenhagen; University of Freiburg; Novozymes	Larsen, S; Bjerrum, MJ (corresponding author), Univ Copenhagen, Dept Chem, Copenhagen, Denmark.	sine@chem.ku.dk; mobj@chem.ku.dk	Ostergaard, Lars/AAA-3020-2020; Østergaard, Lars/H-1427-2014; Larsen, Sine/A-4487-2017; Bjerrum, Morten Jannik/E-6344-2015; Ernst, Heidi Asschenfeldt/R-2335-2016	Ostergaard, Lars/0000-0003-2459-0511; Østergaard, Lars/0000-0003-4210-2374; Larsen, Sine/0000-0003-3848-1789; Ostergaard, Lars/0000-0002-7619-605X; Bjerrum, Morten Jannik/0000-0002-8410-627X; Ernst, Heidi Asschenfeldt/0000-0001-5458-2454	Danish Council for Independent Research [DFF-4184-00355]; Commission of the European Communities within the BIORENEW project of the Sixth European Framework Programme; DANSCATT [5072 -00011B]	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Commission of the European Communities within the BIORENEW project of the Sixth European Framework Programme; DANSCATT	HAE: The Danish Council for Independent Research (Project-ref DFF-4184-00355). https://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/who-has-received-funding/2015/dff-research-project-grants-from-the-danish-council-for-independent-research-technology-and-production-sciences-may-2015. KP: grant from the Commission of the European Communities within the BIORENEW project of the Sixth European Framework Programme. DANSCATT (http://www.danscatt.dk/; grant #5072 -00011B) provided financial support in relation to the collection of X-ray data at synchrotron facilities. Novozymes A/S has supplied the project with relevant enzymes and funding. Novozymes A/S as such has not been influencing the outcome of this study. The funder provided support in the form of salaries to author LHO and to author LJJ as part of her Ph.D, but did not have any additional role in the study design, data collection Powered by Editorial Manager (R) and ProduXion Manager (R) from Aries Systems Corporation and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andberg M, 2009, FEBS J, V276, P6285, DOI 10.1111/j.1742-4658.2009.07336.x; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; BAUER R, 1971, ANAL CHEM, V43, P421, DOI 10.1021/ac60298a003; Berka RM, 1997, APPL ENVIRON MICROB, V63, P3151, DOI 10.1128/AEM.63.8.3151-3157.1997; Bonomo RP, 1998, J INORG BIOCHEM, V71, P205, DOI 10.1016/S0162-0134(98)10057-0; Bowler MW, 2015, J SYNCHROTRON RADIAT, V22, P1540, DOI 10.1107/S1600577515016604; Bukh C., 2009, THESIS; Bukh C, 2006, J INORG BIOCHEM, V100, P1547, DOI 10.1016/j.jinorgbio.2006.05.007; Bukh C, 2010, J INORG BIOCHEM, V104, P1029, DOI 10.1016/j.jinorgbio.2010.05.010; De la Mora E, 2012, ACTA CRYSTALLOGR D, V68, P564, DOI 10.1107/S0907444912005343; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Ducros V, 2001, ACTA CRYSTALLOGR D, V57, P333, DOI 10.1107/S0907444900013779; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Dwivedi UN, 2011, J MOL CATAL B-ENZYM, V68, P117, DOI 10.1016/j.molcatb.2010.11.002; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferraroni M., 2017, BIOCATALYSIS, V3, P1, DOI [10.1515/boca-2017-0001, DOI 10.1515/BOCA-2017-0001]; Floch C, 2007, J MICROBIOL METH, V71, P319, DOI 10.1016/j.mimet.2007.09.020; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Guo FF, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-38; Hakulinen N, 2008, J STRUCT BIOL, V162, P29, DOI 10.1016/j.jsb.2007.12.003; Hakulinen N, 2015, CELL MOL LIFE SCI, V72, P857, DOI 10.1007/s00018-014-1827-5; Hakulinen N, 2002, NAT STRUCT BIOL, V9, P601, DOI 10.1038/nsb823; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Hilgers R, 2018, ACS SUSTAIN CHEM ENG, V6, P2037, DOI 10.1021/acssuschemeng.7b03451; Jones SM, 2015, CELL MOL LIFE SCI, V72, P869, DOI 10.1007/s00018-014-1826-6; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kallio JP, 2009, J MOL BIOL, V392, P895, DOI 10.1016/j.jmb.2009.06.053; Kallio JP, 2011, FEBS J, V278, P2283, DOI 10.1111/j.1742-4658.2011.08146.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li X, 2017, BIOTECHNOL ADV, V35, P466, DOI 10.1016/j.biotechadv.2017.03.010; Liu ZC, 2016, ACTA CRYSTALLOGR F, V72, P328, DOI 10.1107/S2053230X1600426X; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lyashenko AV, 2006, J BIOL INORG CHEM, V11, P963, DOI 10.1007/s00775-006-0158-x; Maestre-Reyna M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120601; Mattinen ML, 2005, FEBS J, V272, P3640, DOI 10.1111/j.1742-4658.2005.04786.x; Munk L, 2017, RSC ADV, V7, P3358, DOI 10.1039/c6ra26106j; Munk L, 2017, ENZYME MICROB TECH, V106, P88, DOI 10.1016/j.enzmictec.2017.07.006; Munk L, 2015, BIOTECHNOL ADV, V33, P13, DOI 10.1016/j.biotechadv.2014.12.008; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Osipov EM, 2015, ACTA CRYSTALLOGR F, V71, P1465, DOI 10.1107/S2053230X1502052X; Osipov E, 2014, ACTA CRYSTALLOGR D, V70, P2913, DOI 10.1107/S1399004714020380; Pardo I, 2015, CELL MOL LIFE SCI, V72, P897, DOI 10.1007/s00018-014-1824-8; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; PIONTEK K, 1993, FEBS LETT, V315, P119, DOI 10.1016/0014-5793(93)81146-Q; Piontek K, 2013, J BIOL CHEM, V288, P34767, DOI 10.1074/jbc.M113.514521; Polyakov KM, 2017, ACTA CRYSTALLOGR D, V73, P388, DOI 10.1107/S2059798317003667; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Saarinen T, 2009, BIORESOURCES, V4, P94; Schrodinger LLC, 2015, JYMOL MOL GRAPH DEV; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Strittmatter E, 2013, J BIOL CHEM, V288, P4095, DOI 10.1074/jbc.M112.400176; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Warren JJ, 2012, COORDIN CHEM REV, V256, P2478, DOI 10.1016/j.ccr.2012.03.032; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Winkler JR, 2015, Q REV BIOPHYS, V48, P411, DOI 10.1017/S0033583515000062; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xds Kabsch W., 2010, ACTA CRYSTALLOGR D, V66, P125, DOI DOI 10.1107/S0907444909047337; Xu F, 1998, BIOCHEM J, V334, P63, DOI 10.1042/bj3340063	63	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206589	10.1371/journal.pone.0206589	http://dx.doi.org/10.1371/journal.pone.0206589			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395580	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400033
J	Jong, YT; Lin, SY; Hu, HY; Lee, OK; Kuo, LL				Jong, Yu-Ting; Lin, Shu-Yi; Hu, Hsiao-Yun; Lee, Oscar K.; Kuo, Li-Lin			Osteoporosis and dry eye syndrome: A previously unappreciated association that may alert active prevention of fall	PLOS ONE			English	Article							BONE-MINERAL DENSITY; VITAMIN-D; P2Y(2) RECEPTOR; NUCLEOTIDE RECEPTORS; ANDROGEN DEFICIENCY; REPLACEMENT THERAPY; SJOGRENS-SYNDROME; GENE-EXPRESSION; MEIBOMIAN GLAND; VISUAL-ACUITY	Objective Osteoporosis is a multifactorial disease associated with inflammation and hormone imbalance. It is noteworthy that dry eye syndrome shares a similar pathophysiology with osteoporosis. Both diseases are more prevalent among the elderly and females. Dry eye syndrome can result in impaired vision, which increases the risk of fall and fracture when osteoporosis exists. In this study, we investigated whether osteoporosis is associated with an increased risk of developing dry eye syndrome. Methods Claims data from the National Health Insurance Research Database (NHIRD) of Taiwan were used to conduct a retrospective population-based cohort study covering the period from January 1, 2000, to December 31, 2011. Multiple logistic regression was used to determine whether osteoporosis is an independent factor in the risk of developing dry eye syndrome, with risk estimates presented in the form of odds ratios (ORs). Results The exclusion of patients with specific autoimmune diseases and those younger than 50 years old resulted in 42,365 patients in the osteoporosis group and 147,460 patients in the comparison group during the study period. The number of patients newly diagnosed with dry eye syndrome was 6,478 (15.29%) in the osteoporosis group and 15,396 (10.44%) in the comparison group. The crude OR of patients with osteoporosis developing dry eye syndrome was 1.55 and the 95% confidence interval (95% CI) was 1.50-1.60. After adjusting for patients' age, sex, and underlying comorbidities, the adjusted OR was 1.26 and the 95% CI was 1.22-1.30. Subgroup analysis revealed this association in each age group and among females but not among males. Conclusions Our results demonstrate that osteoporosis is a risk factor for the subsequent development of dry eye syndrome. Clinicians should be aware of the early symptoms of dry eye syndrome in osteoporotic patients in order to prevent further complications.	[Jong, Yu-Ting; Kuo, Li-Lin] Taipei City Hosp, Dept Ophthalmol, Taipei, Taiwan; [Lin, Shu-Yi; Hu, Hsiao-Yun; Lee, Oscar K.] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Hu, Hsiao-Yun] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Hu, Hsiao-Yun] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Lee, Oscar K.] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan; [Kuo, Li-Lin] Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan; [Kuo, Li-Lin] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan	Taipei City Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taipei University of Nursing & Health Science (NTUNHS)	Kuo, LL (corresponding author), Taipei City Hosp, Dept Ophthalmol, Taipei, Taiwan.; Kuo, LL (corresponding author), Taipei City Hosp, Zhongxiao Branch, Taipei, Taiwan.; Kuo, LL (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.	DAC50@tpech.gov.tw		Kuo, Li-Lin/0000-0001-5412-578X	Ministry of Science and Technology, Taiwan [MOST 106-3114-B-010-002, MOST 107-2911-I-010-501, MOST 107-2321-B-010-007]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors received research grant support from the Ministry of Science and Technology, Taiwan (MOST 106-3114-B-010-002, MOST 107-2911-I-010-501 and MOST 107-2321-B-010-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Adler RA, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.1; Asli IN, 2010, HELL J NUCL MED, V13, P261; Azizieh F, 2016, J INFLAMM RES, V9, P51, DOI 10.2147/JIR.S103298; Bae SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep33083; Barker T, 2014, CYTOKINE, V65, P134, DOI 10.1016/j.cyto.2013.12.004; Burnstock Geoffrey, 2011, Front Biosci (Elite Ed), V3, P896; Clarke BL, 2009, STEROIDS, V74, P296, DOI 10.1016/j.steroids.2008.10.003; Compston J, 2010, RADIOL CLIN N AM, V48, P477, DOI 10.1016/j.rcl.2010.02.010; Cowlen MS, 2003, EXP EYE RES, V77, P77, DOI 10.1016/S0014-4835(03)00068-X; Davidson HJ, 2004, VET OPHTHALMOL, V7, P71, DOI 10.1111/j.1463-5224.2004.00325.x; Esmaeli B, 2000, OPHTHALMOLOGY, V107, P180, DOI 10.1016/S0161-6420(99)00040-8; Feng YH, 2016, CONTACT LENS ANTERIO, V39, P124, DOI 10.1016/j.clae.2015.09.002; Gambacciani M, 2014, MENOPAUSE REV, V13, P213, DOI 10.5114/pm.2014.44996; Goto E, 2002, AM J OPHTHALMOL, V133, P181, DOI 10.1016/S0002-9394(01)01365-4; Gravani F, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0613-6; Guggenbuhl P, 2009, JOINT BONE SPINE, V76, P595, DOI 10.1016/j.jbspin.2009.10.001; Guillon M, 2010, CONTACT LENS ANTERIO, V33, P171, DOI 10.1016/j.clae.2010.03.002; Guzman-Aranguez A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/320906; Jakob F, 2014, INTERNIST, V55, P755, DOI 10.1007/s00108-014-3468-z; Javadi Mohammad-Ali, 2011, J Ophthalmic Vis Res, V6, P192; Jo DG, 2013, YONSEI MED J, V54, P1331, DOI 10.3349/ymj.2013.54.6.1331; Johnell O, 2005, OSTEOPOROSIS INT, V16, pS3, DOI 10.1007/s00198-004-1702-6; Jorgensen NR, 2012, J INTERN MED, V272, P385, DOI 10.1111/j.1365-2796.2012.02535.x; Jumblatt JE, 1998, EXP EYE RES, V67, P341, DOI 10.1006/exer.1998.0520; Khanna D, 2011, INDIAN J OPHTHALMOL, V59, P151, DOI 10.4103/0301-4738.77044; Lau OCF, 2014, CLIN OPHTHALMOL, V8, P327, DOI 10.2147/OPTH.S39699; Lee AJ, 2002, BRIT J OPHTHALMOL, V86, P1347, DOI 10.1136/bjo.86.12.1347; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Lips P, 2011, BEST PRACT RES CL EN, V25, P585, DOI 10.1016/j.beem.2011.05.002; Nanavaty MA, 2014, BRIT J OPHTHALMOL, V98, P567, DOI 10.1136/bjophthalmol-2013-304637; Nichols KK, 2016, INVEST OPHTH VIS SCI, V57, P2975, DOI 10.1167/iovs.16-19419; Orriss IR, 2007, ENDOCRINOLOGY, V148, P4208, DOI 10.1210/en.2007-0066; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Paz HB, 2003, EXP EYE RES, V77, P69, DOI 10.1016/S0014-4835(03)00084-8; Putney JW, 2014, CELL CALCIUM, V55, P290, DOI 10.1016/j.ceca.2014.01.001; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Riggs BL, 2000, J CLIN INVEST, V106, P1203, DOI 10.1172/JCI11468; Rocha EM, 2000, BRIT J OPHTHALMOL, V84, P76, DOI 10.1136/bjo.84.1.76; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schirra F, 2006, EXP EYE RES, V83, P291, DOI 10.1016/j.exer.2005.11.026; Sendecka Marta, 2004, Przegl Epidemiol, V58, P227; Sharma A, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/781683; Smith JA, 2004, ARCH OPHTHALMOL-CHIC, V122, P151, DOI 10.1001/archopht.122.2.151; Stahl U, 2012, CLIN EXP OPTOM, V95, P3, DOI 10.1111/j.1444-0938.2011.00634.x; Stern ME, 2013, INT REV IMMUNOL, V32, P19, DOI 10.3109/08830185.2012.748052; Sullivan DA, 2002, ANN NY ACAD SCI, V966, P211, DOI 10.1111/j.1749-6632.2002.tb04217.x; Suzuki T, 2008, INVEST OPHTH VIS SCI, V49, P1797, DOI 10.1167/iovs.07-1458; Syberg S, 2012, J BONE MINER RES, V27, P2373, DOI 10.1002/jbmr.1690; Terakado K, 2014, VET J, V202, P48, DOI 10.1016/j.tvjl.2014.05.022; Toniato E, 2015, J BIOL REG HOMEOS AG, V29, P563; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P767, DOI 10.1136/bjo.83.7.767; Villani E, 2013, INVEST OPHTH VIS SCI, V54, P4735, DOI 10.1167/iovs.13-11914; Wesselius A, 2013, PURINERG SIGNAL, V9, P41, DOI 10.1007/s11302-012-9326-3; Wobke TK, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00244; Worda C, 2001, MATURITAS, V37, P209, DOI 10.1016/S0378-5122(00)00181-X; Yen JC, 2015, INT J ENV RES PUB HE, V12, P7647, DOI 10.3390/ijerph120707647; Yildirim P, 2016, INT J RHEUM DIS, V19, P49, DOI 10.1111/1756-185X.12727; Yip JLY, 2014, BRIT J OPHTHALMOL, V98, P377, DOI 10.1136/bjophthalmol-2013-304179; Yu JH, 2011, CORNEA, V30, P379, DOI 10.1097/ICO.0b013e3181f7f363	61	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0207008	10.1371/journal.pone.0207008	http://dx.doi.org/10.1371/journal.pone.0207008			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395639	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400073
J	Klyuzhin, IS; Fu, GJF; Hong, A; Sacheli, M; Shenkov, N; Matarazzo, M; Rahmim, A; Stoessl, AJ; Sossi, V				Klyuzhin, Ivan S.; Fu, Jessie F. G.; Hong, Andy; Sacheli, Matthew; Shenkov, Nikolay; Matarazzo, Michele; Rahmim, Arman; Stoessl, A. Jon; Sossi, Vesna			Data-driven, voxel-based analysis of brain PET images: Application of PCA and LASSO methods to visualize and quantify patterns of neurodegeneration	PLOS ONE			English	Article							PARKINSONS-DISEASE; SELECTION	Spatial patterns of radiotracer binding in positron emission tomography (PET) images may convey information related to the disease topology. However, this information is not captured by the standard PET image analysis that quantifies the mean radiotracer uptake within a region of interest (ROI). On the other hand, spatial analyses that use more advanced radiomic features may be difficult to interpret. Here we propose an alternative data-driven, voxel-based approach to spatial pattern analysis in brain PET, which can be easily interpreted. We apply principal component analysis (PCA) to identify voxel covariance patterns, and optimally combine several patterns using the least absolute shrinkage and selection operator (LASSO). The resulting models predict clinical disease metrics from raw voxel values, allowing for inclusion of clinical covariates. The analysis is performed on high-resolution PET images from healthy controls and subjects affected by Parkinson's disease (PD), acquired with a pre-synaptic and a post-synaptic dopaminergic PET tracer. We demonstrate that PCA identifies robust and tracer-specific binding patterns in sub-cortical brain structures; the patterns evolve as a function of disease progression. Principal component LASSO (PC-LASSO) models of clinical disease metrics achieve higher predictive accuracy compared to the mean tracer binding ratio (BR) alone: the cross-validated test mean squared error of adjusted disease duration (motor impairment score) was 16.3 +/- 0.17 years(2) (9.7 +/- 0.15) with mean BR, versus 14.4 +/- 0.18 years(2) (8.9 +/- 0.16) with PC-LASSO. We interpret the best-performing PC-LASSO models in the spatial sense and discuss them with reference to the PD pathology and somatotopic organization of the striatum. PC-LASSO is thus shown to be a useful method to analyze clinically-relevant tracer binding patterns, and to construct interpretable, imaging-based predictive models of clinical metrics.	[Klyuzhin, Ivan S.] Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC, Canada; [Fu, Jessie F. G.; Hong, Andy; Shenkov, Nikolay; Sossi, Vesna] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Sacheli, Matthew; Matarazzo, Michele; Stoessl, A. Jon] Univ British Columbia, Pacific Parkinsons Res Ctr, Vancouver, BC, Canada; [Rahmim, Arman] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA	University of British Columbia; University of British Columbia; University of British Columbia; Johns Hopkins University	Klyuzhin, IS (corresponding author), Univ British Columbia, Dept Med, Div Neurol, Vancouver, BC, Canada.	ivansk@physics.ubc.ca	Rahmim, Arman/ACS-4963-2022; Klyuzhin, Ivan/AAA-5019-2019; Fu, Jessie Fang Lu/ABB-5990-2020	Rahmim, Arman/0000-0002-9980-2403; Klyuzhin, Ivan/0000-0003-0141-7628; Fu, Jessie Fang Lu/0000-0002-4970-7811; Hong, Andy Wing Keung/0000-0001-6500-6866	Natural Sciences and Engineering Research Council of Canada [240670-13]; Brain Canada [64457]; Canadian Institutes of Health Research [125989]; Parkinson Canada Clinical Research Fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Brain Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Canada Clinical Research Fellowship	The study was financially supported by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca, grant number 240670-13), Brain Canada (https://braincanada.ca, grant number 64457), and Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/, grant number 125989) to VS. MM is supported by the Parkinson Canada Clinical Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avanzo M, 2017, PHYS MEDICA, V38, P122, DOI 10.1016/j.ejmp.2017.05.071; Bailly C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159984; Berk R, 2013, ANN STAT, V41, P802, DOI 10.1214/12-AOS1077; Blinder SAL, 2014, 2014 IEEE NUCLEAR SCIENCE SYMPOSIUM AND MEDICAL IMAGING CONFERENCE (NSS/MIC); Bzdok D, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00543; Bzdok D, 2017, NEUROIMAGE, V155, P549, DOI 10.1016/j.neuroimage.2017.04.061; Bzdok D, 2017, EDUC PSYCHOL MEAS, V77, P868, DOI 10.1177/0013164416667982; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Comtat Bataille F, 2004, IEEE S C REC NUCL SC, V6, P3492; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; de la Fuente-Fernandez R, 2011, ANN NEUROL, V69, P803, DOI 10.1002/ana.22284; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Doder M, 2003, NEUROLOGY, V60, P601, DOI 10.1212/01.WNL.0000031424.51127.2B; Eidelberg D, 2009, TRENDS NEUROSCI, V32, P548, DOI 10.1016/j.tins.2009.06.003; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Gonzalez ME, 2013, NEUROIMAGE, V68, P11, DOI 10.1016/j.neuroimage.2012.11.055; Gunn RN, 1997, NEUROIMAGE, V6, P279, DOI 10.1006/nimg.1997.0303; Hatt M, 2017, EUR J NUCL MED MOL I, V44, P151, DOI 10.1007/s00259-016-3427-0; Jain Saurabh, 2014, 2014 IEEE Nuclear Science Symposium and Medical Imaging Conference (NSS/MIC), P1, DOI 10.1109/NSSMIC.2014.7430772; Klyuzhin IS, 2016, J CEREBR BLOOD F MET, V36, P1122, DOI 10.1177/0271678X15606718; Lambin P, 2015, P SPIE INT SOC OPTIC, V73, P389, DOI DOI 10.1016/J.EJCA.2011.11.036.RADI0MICS; Lammertsma AA, 1996, J CEREBR BLOOD F MET, V16, P42, DOI 10.1097/00004647-199601000-00005; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Loane C, 2011, AM J TRANSL RES, V3, P323; Lombaert H, 2014, INT J COMPUT VISION, V107, P254, DOI 10.1007/s11263-013-0681-5; Martinez-Murcia FJ, 2014, MED PHYS, V41, DOI 10.1118/1.4845115; Morris E, 2016, EUR J NUCL MED MOL I, V43, P374, DOI 10.1007/s00259-015-3228-x; Nambu A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00026; Nandhagopal R, 2009, BRAIN, V132, P2970, DOI 10.1093/brain/awp209; Niethammer M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009274; Pagano G, 2017, ANN NEUROL, V81, P171, DOI 10.1002/ana.24859; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13087; Politis M, 2017, NEUROIMAGE-CLIN, V16, P455, DOI 10.1016/j.nicl.2017.08.013; Poston KL, 2010, PET CLIN, V5, P55, DOI 10.1016/j.cpet.2009.12.004; Rahmim A, 2017, NEUROIMAGE-CLIN, V16, P539, DOI 10.1016/j.nicl.2017.08.021; Suwijn SR, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0087-1; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vidal R, 2005, IEEE T PATTERN ANAL, V27, P1945, DOI 10.1109/TPAMI.2005.244; Villemagne VL, 2012, NEURODEGENER DIS, V10, P161, DOI 10.1159/000334535; Vingerhoets FJG, 1997, ANN NEUROL, V41, P58, DOI 10.1002/ana.410410111; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34; Yip SSF, 2016, PHYS MED BIOL, V61, pR150, DOI 10.1088/0031-9155/61/13/R150; Zou H, 2006, J COMPUT GRAPH STAT, V15, P265, DOI 10.1198/106186006X113430	46	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206607	10.1371/journal.pone.0206607	http://dx.doi.org/10.1371/journal.pone.0206607			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395576	Green Published, gold			2022-12-26	WOS:000449291400034
J	McLester, CN; Nickerson, BS; Kliszczewicz, BM; Hicks, CS; Williamson, CM; Bechke, EE; McLester, JR				McLester, Cherilyn N.; Nickerson, Brett S.; Kliszczewicz, Brian M.; Hicks, Courtenay S.; Williamson, Cassie M.; Bechke, Emily E.; McLester, John R.			Validity of DXA body volume equations in a four-compartment model for adults with varying body mass index and waist circumference classifications	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; X-RAY ABSORPTIOMETRY; IN-VIVO; FAT; WOMEN; MEN; VALIDATION; SEX	The purpose of this investigation was to determine the validity of 4-compartment (4C) model body fat percent (BF%) estimates when using dual energy x-ray absorptiometry (DXA) derived body volume (BV) equations (4C-DXA1 and 4C-DXA2) in adults with varying body mass index (BMI) and waist circumference (WC) classifications. Each model was compared to a criterion 4C model with air-displacement plethysmography (ADP) generated BV (4C-ADP). Participants were categorized as normal weight (n = 40; NW = BMI<25.0 kg/m(2)); overweight (n = 40; OWBMI = BMI >= 25.0 kg/m(2)); and overweight with at-risk WC (n = 35; OWBMI+WC = BMI >= 25.0 kg/m(2) and WC >= 88.0cm for women and 102.0cm for men). 4C-DXA1 produced lower BF% than that derived using the 4C-ADP in NW (CE = -3.0%; p<0.001) while 4C-DXA2 was significantly higher (CE = 4.8%; p<0.001). The SEE and 95% limits of agreement (LOA) were lower for 4C-DXA2 (1.24% and +/- 2.5%, respectively) than 4C-DXA1 (2.59% and +/- 5.0%, respectively) and proportional bias was present for both (p<0.05). 4C-DXA1 BF% was not significant in OWBMI (CE = -0.5%; p = 0.112) whereas 4C-DXA2 was higher (CE = 4.5%; p<0.001). The SEE and 95% LOA were lower for 4C-DXA2 (1.20% and +/- 2.9%, respectively) than 4C-DXA1 (1.92% and +/- 3.9%, respectively) in OWBMI. Proportional bias was present for 4C-DXA1 (p = 0.007), but not 4C-DXA2 (p = 0.832). 4C-DXA1 and 4C-DXA2 produced significantly higher BF% in OWBMI+WC (CE = 2.2 and 2.3%, respectively; both p<0.001). The SEE and 95% LOA remained lower for 4C-DXA2 (1.15% and +/- 2.5%, respectively) than 4C-DXA1 (1.84% and +/- 3.8%, respectively). There was proportional bias for 4C-DXA2 (p = 0.020), but not 4C-DXA1 (p = 0.183) in OWBMI+WC. Only one prediction model (i.e., 4C-DXA1 in OWBMI+WC) revealed valid estimates of BF%. Practitioners are encouraged to use criteria for both BMI and WC when utilizing DXA-derived BV in 4C-models for normal and overweight populations.	[McLester, Cherilyn N.; Kliszczewicz, Brian M.; Hicks, Courtenay S.; Williamson, Cassie M.; Bechke, Emily E.; McLester, John R.] Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA; [Nickerson, Brett S.] Texas A&M Int Univ, Coll Nursing & Hlth Sci, Laredo, TX USA	University System of Georgia; Kennesaw State University; Texas A&M University System; Texas A&M International University	McLester, CN (corresponding author), Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	cmclest1@kennesaw.edu		Kliszczewicz, Brian/0000-0003-0692-3407				American College of Sports Medicine, 2017, ACSMS GUIDELINES EXE, P70; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blue MNM, 2018, APPL PHYSL NUTR META; Camhi SM, 2014, INT J OBESITY, V38, P1142, DOI 10.1038/ijo.2013.208; Cloetens L, 2015, METAB SYNDR RELAT D, V13, P91, DOI 10.1089/met.2014.0130; Coin A, 2000, OSTEOPOROSIS INT, V11, P1043, DOI 10.1007/s001980070026; DEURENBERG P, 1991, INT J OBESITY, V15, P17; HEYMSFIELD SB, 1989, AM J CLIN NUTR, V49, P1283, DOI 10.1093/ajcn/49.6.1283; Heyward VH, 2004, APPL BODY COMPOSITIO, P17; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kendall KL, 2017, J SPORT SCI, V35, P624, DOI 10.1080/02640414.2016.1183802; Kyle UG, 2001, NUTRITION, V17, P248, DOI 10.1016/S0899-9007(00)00553-0; Nickerson B, 2018, J CLIN DENSITOM; Nickerson BS, 2018, J STRENGTH COND RES, V32, P121, DOI 10.1519/JSC.0000000000001774; Nickerson BS, 2017, INT J SPORT NUTR EXE, V27, P520, DOI 10.1123/ijsnem.2017-0076; Nickerson BS, 2017, J STRENGTH COND RES, V31, P2519, DOI 10.1519/JSC.0000000000001698; Nickerson BS, 2017, J STRENGTH COND RES, V31, P1963, DOI 10.1519/JSC.0000000000001648; Schoeller DA, 2005, AM J CLIN NUTR, V81, P1018; Schumacker RE, 2010, BEGINNERS GUIDE STRU; Smith-Ryan AE, 2017, CLIN NUTR, V36, P825, DOI 10.1016/j.clnu.2016.05.006; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Tinsley GM, 2017, NUTR RES, V42, P85, DOI 10.1016/j.nutres.2017.05.003; Wang ZM, 2002, AM J CLIN NUTR, V76, P968, DOI 10.1093/ajcn/76.5.968; Wilson JP, 2013, J CLIN DENSITOM, V16, P368, DOI 10.1016/j.jocd.2012.11.001	24	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206866	10.1371/journal.pone.0206866	http://dx.doi.org/10.1371/journal.pone.0206866			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395588	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400062
J	Tuominen, H; Rautava, S; Collado, MC; Syrjanen, S; Rautava, J				Tuominen, Heidi; Rautava, Samuli; Carmen Collado, Maria; Syrjanen, Stina; Rautava, Jaana			HPV infection and bacterial microbiota in breast milk and infant oral mucosa	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TRANSMISSION; RISK; MODE; PLACENTA; DELIVERY; DNA	Objective We investigated the association between bacterial microbiota in breast milk and the infant mouth. The influence of human papilloma virus (HPV) infection on infant oral microbiota was also assessed. Material and methods Altogether 35 breast milk and 35 infant oral samples with known HPV status were selected from the Finnish Family HPV Study cohort. In total, there were 31 mother-infant pairs. The microbiota composition was characterized by 16S rRNA gene sequencing (V3-V4 region). Results HPV DNA was present in 8.6% (3/35) of the breast milk and 40% (14/35) of the infant oral samples. Eight shared genera between breast milk and infant oral were found; these included Streptococcus, Staphylococcus, Unclassified Gemellaceae, Rothia, Veillonella, Haemophilus, Propionibacterium and Corynebacterium. HPV status was not associated with either microbiota richness or diversity in the infant mouth. However, the infant oral microbiota clustered in different groups according to HPV status. We detected higher abundance of Veillonella dispar (p = 0.048) at species level in HPV negative infant oral samples. We did not detect differences in the breast milk microbiota composition related to HPV infection due to only three HPV positive milk samples. Conclusions HPV infection is associated with distinct oral bacterial microbiota composition in infants. The direction of causality underlying the phenomenon remains unclear.	[Tuominen, Heidi; Syrjanen, Stina; Rautava, Jaana] Univ Turku, Fac Med, Inst Dent, Dept Oral Pathol & Oral Radiol, Turku, Finland; [Rautava, Samuli] Univ Turku, Dept Paediat, Turku, Finland; [Rautava, Samuli] Turku Univ Hosp, Turku, Finland; [Carmen Collado, Maria] Spanish Natl Res Council IATA CSIC, Inst Agrochem & Food Sci, Dept Biotechnol, Valencia, Spain; [Syrjanen, Stina; Rautava, Jaana] Turku Univ Hosp, Dept Pathol, Turku, Finland	University of Turku; University of Turku; University of Turku; Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); University of Turku	Tuominen, H (corresponding author), Univ Turku, Fac Med, Inst Dent, Dept Oral Pathol & Oral Radiol, Turku, Finland.	heemtu@utu.fi	COLLADO, MARIA CARMEN/H-4924-2012	COLLADO, MARIA CARMEN/0000-0002-6204-4864; Syrjanen, Stina/0000-0003-0738-5698; Rautava, Samuli/0000-0003-0935-3593; Tuominen, Heidi/0000-0002-4808-4851	Finnish Women Dentists' Association; Finnish Doctoral Programme in Oral Sciences (FINDOS); Academy of Finland; Finnish Cancer Foundation; Finnish Dental Society; Government Special Foundation (EVO); Sohlberg Foundation	Finnish Women Dentists' Association; Finnish Doctoral Programme in Oral Sciences (FINDOS); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Finnish Dental Society; Government Special Foundation (EVO); Sohlberg Foundation	This study was funded by the Finnish Women Dentists' Association and Finnish Doctoral Programme in Oral Sciences (FINDOS). Finnish Family HPV Study has been supported by the Academy of Finland, Finnish Cancer Foundation, Sohlberg Foundation, Finnish Dental Society, and the Government Special Foundation (EVO) to Turku University Hospital. The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Aakko J, 2017, BENEF MICROBES, V8, P563, DOI 10.3920/BM2016.0185; Aujoulat F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0325-0; Betiol J, 2013, BRAZ J MED BIOL RES, V46, P217, DOI 10.1590/1414-431X20132703; Biagi E, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01214; Cacho NT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01470; Caporaso J.G., 2010, NAT METHODS; Chatzistamatiou K, 2016, J OBSTET GYNAECOL, V36, P10, DOI 10.3109/01443615.2015.1030606; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Doyle RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180167; Drell T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09278-y; Giuliano AR, 2014, INT J CANC       JUN; Gomez-Arango LF, 2017, SCI REP-UK, V7, DOI 10.1038/srep43481; Hahn HS, 2013, EUR J OBSTET GYN R B, V169, P202, DOI 10.1016/j.ejogrb.2013.02.024; Hong Y, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-109; Jiang S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121978; Kononen E, 1999, J DENT RES, V78, P1634, DOI 10.1177/00220345990780100801; Koskimaa HM, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0733-4; Koskimaa HM, 2012, J PEDIATR-US, V160, P837, DOI 10.1016/j.jpeds.2011.10.027; Lee ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057708; Li SW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00965; Louvanto K, 2017, PEDIATR INFECT DIS J, V36, P627, DOI 10.1097/INF.0000000000001546; Mammas IN, 2011, ACTA PAEDIATR, V100, P705, DOI 10.1111/j.1651-2227.2010.02129.x; Mashima I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185274; Miller SA, 1988, NUCL ACIDS RES; Mosca Fabio, 2017, Pediatr Med Chir, V39, P155, DOI 10.4081/pmc.2017.155; Nakashima K, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-43; Nelson-Filho Paulo, 2013, Braz. Dent. J., V24, P415, DOI 10.1590/0103-6440201302266; Otgonjargala B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173283; Park H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-80; PEARCE C, 1995, J MED MICROBIOL, V42, P67, DOI 10.1099/00222615-42-1-67; Rintala MAM, 2005, CLIN INFECT DIS, V41, P1728, DOI 10.1086/498114; Rintala MAM, 2005, J CLIN MICROBIOL; Sarkola M, 2008, PEDIATR INFECT DIS J, V27, P557, DOI 10.1097/INF.0b013e318169ef47; Sarkola M, 2008, ACTA OBSTET GYN SCAN, V87, P1181, DOI 10.1080/00016340802468308; Timby N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169831; Trottier H, 2016, PAPILLOMAVIRUS RES, V2, P145, DOI 10.1016/j.pvr.2016.07.001; Trottier H, 2009, PUBLIC HEALTH GENOM, V12, P291, DOI 10.1159/000214920; Tuominen H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27980-3; Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14; Xu W, 2017, J OBSTET GYNECO 1014; Yoshida K, 2011, J OBSTET GYNAECOL, V31, P503, DOI 10.3109/01443615.2011.570814	42	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0207016	10.1371/journal.pone.0207016	http://dx.doi.org/10.1371/journal.pone.0207016			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395655	Green Submitted, gold, Green Published			2022-12-26	WOS:000449291400074
J	Guan, XG; Luo, ZM; Sun, WJ				Guan, Xingang; Luo, Zhimin; Sun, Wujin			A peptide delivery system sneaks CRISPR into cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								The CRISPR-Cas9 system has developed into a powerful platform for genome editing in various types of cells and tissues with single-nucleotide precision, but limited delivery options hamper its application in real-world settings. A new study by Shen et al. describes the use of an amphipathic peptide to deliver Cas9/sgRNA ribonucleoprotein complexes, leading to the disruption of GFP genes in cells and mice. Disruption of the Nrip1 gene in isolated pre-adipocytes led to a browning phenotype, pointing to new options in the fight against diabetes and obesity.	[Guan, Xingang; Luo, Zhimin; Sun, Wujin] Univ Calif Los Angeles, Ctr Minimally Invas Therapeut, Calif Nanosyst Inst, Dept Bioengn, Los Angeles, CA 90095 USA; [Guan, Xingang] Beihua Univ, Coll Med Technol, Jilin 132013, Jilin, Peoples R China; [Luo, Zhimin] Xi An Jiao Tong Univ, Sch Pharm, Xian 710061, Shanxi, Peoples R China	University of California System; University of California Los Angeles; Beihua University; Xi'an Jiaotong University	Sun, WJ (corresponding author), Univ Calif Los Angeles, Ctr Minimally Invas Therapeut, Calif Nanosyst Inst, Dept Bioengn, Los Angeles, CA 90095 USA.	sunwj@ucla.edu	Luo, Zhi-min/ACN-2648-2022; Guan, Xingang/A-9307-2016	Luo, Zhi-min/0000-0001-5071-4325; Guan, Xingang/0000-0003-3776-1818				Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Liu C, 2017, J CONTROL RELEASE, V266, P17, DOI 10.1016/j.jconrel.2017.09.012; Shen YF, 2018, J BIOL CHEM, V293, P17291, DOI 10.1074/jbc.RA118.004554; Staahl BT, 2017, NAT BIOTECHNOL, V35, P431, DOI 10.1038/nbt.3806; Sun WJ, 2015, ANGEW CHEM INT EDIT, V54, P12029, DOI 10.1002/anie.201506030; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Wang HX, 2017, CHEM REV, V117, P9874, DOI 10.1021/acs.chemrev.6b00799	10	8	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2018	293	44					17306	17307		10.1074/jbc.H118.006147	http://dx.doi.org/10.1074/jbc.H118.006147			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GZ5MI	30389791	Green Published, hybrid			2022-12-26	WOS:000449466500028
J	Mallawarachchi, CH; Chandrasena, NTGA; Wickramasinghe, S; Premaratna, R; Gunawardane, NYIS; Mallawarachchi, NSMSM; de Silva, NR				Mallawarachchi, Chandana H.; Chandrasena, Nilmini T. G. A.; Wickramasinghe, Susiji; Premaratna, Ranjan; Gunawardane, Nilmini Y. I. S.; Mallawarachchi, Navoda S. M. S. M.; de Silva, Nilanthi R.			A preliminary survey of filarial parasites in dogs and cats in Sri Lanka	PLOS ONE			English	Article							DIROFILARIA-REPENS; BRUGIA-MALAYI; MICROFILARIAE; TRANSMISSION; INFECTION; VECTOR; HOST	Human brugian filariasis has re-emerged in Sri Lanka after a quiescent period of four decades. This study investigated the prevalence of canine and feline filarial parasites in three localities with human sub-periodic brugian filariasis, in order to determine their potential reservoir status. All reachable dogs and cats, both stray and domestic, within a 350m radius of an index case of brugian filariasis in three locations (Madampe, Wattala and Weliweriya) were screened for microfilariae using Giemsa stained thick blood smears. A representative sample of canine and feline blood samples positive for Brugia spp. microfilariae by microscopy, from each of the three locations, were further analyzed by PCR with specific primers for internal transcribed spacer region 2 (ITS2) of the ribosomal DNA. A total of 250 dogs and 134 cats were screened. The overall microfilaraemia rates were high among both dogs (68.8%) and cats (47.8%). The prevalence of microfilaraemia was significantly higher among dogs than cats (p<0.05). Two filarial species were identified based on morphology of microfilariae: Dirofilaria (Nochtiella) repens (dogs, 54.4% and cats, 34.3%) and Brugia spp. (dogs, 51.6% and cats, 30.6%). PCR analysis of canine (n = 53) and feline (n = 24) samples elicited bands in the region of 615bp, which confirmed Brugia malayi infection. Co-infection with D. (N.) repens was detected by PCR with an additional band at 484bp, in 36 canine and 17 feline samples. Overall microfilaraemia rates of dogs (81.8%) and cats (75%) in Madampe (rural) were significantly higher than in urbanized Wattala (dogs, 62.4% and cats, 26.0%) (p<0.05). High rates of zoonotic filarial infections strongly implicate dogs and cats as potential reservoirs for human dirofilariasis and brugian filariasis in Sri Lanka.	[Mallawarachchi, Chandana H.; Mallawarachchi, Navoda S. M. S. M.] Univ Colombo, Postgrad Inst Med, Colombo, Sri Lanka; [Chandrasena, Nilmini T. G. A.; de Silva, Nilanthi R.] Univ Kelaniya, Fac Med, Dept Parasitol, Kelaniya, Sri Lanka; [Wickramasinghe, Susiji] Univ Peradeniya, Fac Med, Dept Parasitol, Peradeniya, Sri Lanka; [Premaratna, Ranjan] Univ Kelaniya, Fac Med, Dept Med, Kelaniya, Sri Lanka; [Gunawardane, Nilmini Y. I. S.] Univ Kelaniya, Fac Med, Mol Med Unit, Kelaniya, Sri Lanka	University of Colombo; University Kelaniya; University of Peradeniya; University Kelaniya; University Kelaniya	Chandrasena, NTGA (corresponding author), Univ Kelaniya, Fac Med, Dept Parasitol, Kelaniya, Sri Lanka.	nilminicha64@gmail.com		Mallawarachchi, Maleesha/0000-0001-5323-3367; Mallawarachchi, Chandana Harendra/0000-0003-4238-8931; SILVA GUNAWARDENE, Yasanthi/0000-0002-2528-4236; chandrasena, nilmini/0000-0002-2010-7636	University of Kelaniya	University of Kelaniya	This project was funded by a grant from the University of Kelaniya.	Abd Rani PAM, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-30; Al-Abd NM, 2015, ASIAN PAC J TROP MED, V8, P693, DOI 10.1016/j.apjtm.2015.07.034; Ambily VR, 2011, VET PARASITOL, V181, P210, DOI 10.1016/j.vetpar.2011.04.041; Casiraghi M, 2006, VET PARASITOL, V141, P368, DOI 10.1016/j.vetpar.2006.06.006; Chandrasena NTGA, 2016, T ROY SOC TROP MED H, V110, P620, DOI 10.1093/trstmh/trw067; Chansiri K, 2002, MOL CELL PROBE, V16, P129, DOI 10.1006/mcpr.2001.0402; Conrad PA, 2013, COMP IMMUNOL MICROB, V36, P211, DOI 10.1016/j.cimid.2013.03.006; Dissanaike A. S., 1997, Parassitologia (Rome), V39, P375; DISSANAIKE AS, 1979, B WORLD HEALTH ORGAN, V57, P349; Genchi C, 2011, VET PARASITOL, V176, P295, DOI 10.1016/j.vetpar.2011.01.012; Ghosh SK, 2015, INDIAN J MED MICROBI, V6; Iddawela D, 2015, ASIAN PAC J TROP MED, V8, P996, DOI 10.1016/j.apjtm.2015.11.010; Irwin PJ, 2002, INT J PARASITOL, V32, P581, DOI 10.1016/S0020-7519(01)00361-7; Irwin PJ, 2004, TRENDS PARASITOL, V20, P27, DOI 10.1016/j.pt.2003.11.004; Jayasinghe RD, 2015, CASE REP INFECT DIS, V2015, DOI 10.1155/2015/648278; Kanjanopas Kobkan, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P585; Kini Reshma G, 2015, J Parasit Dis, V39, P349, DOI 10.1007/s12639-013-0348-8; KNOTT J., 1939, TRANS ROY SOC TROP MED AND HYG, V33, P191, DOI 10.1016/S0035-9203(39)90101-X; Liotta JL, 2013, J PARASITOL, V99, P421, DOI 10.1645/12-10.1; Macpherson CNL, 2013, DOGS, ZOONOSES AND PUBLIC HEALTH, 2ND EDITION, P1, DOI 10.1079/9781845938352.0000; MAK JW, 1980, TROP GEOGR MED, V32, P259; Mallawarachchi CH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2649-3; Muslim A, 2013, TROP BIOMED, V30, P727; Orihel TC, 1997, BENCH AIDS DIAGNOSIS; PALMIERI JR, 1985, J HELMINTHOL, V59, P277, DOI 10.1017/S0022149X00008099; Pampiglione S., 2001, Parassitologia (Rome), V42, P231; Poppert S, 2009, EMERG INFECT DIS, V15, P1844, DOI 10.3201/eid1511.090936; Rajapakshe R. P. A. S., 2005, Ceylon Medical Journal, V50, P58; Ravindran R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/630160; Rishniw M, 2006, VET PARASITOL, V135, P303, DOI 10.1016/j.vetpar.2005.10.013; Schweinfurth U., 1983, Ecology of Disease, V2, P309; Tilakaratne WM, 2003, J ORAL PATHOL MED, V32, P502, DOI 10.1034/j.1600-0714.2003.00183.x; World Health Organization, WHO OFF DECL SRI LAN	33	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206633	10.1371/journal.pone.0206633	http://dx.doi.org/10.1371/journal.pone.0206633			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388188	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800045
J	Silk, JB; Roberts, ER; Stadele, V; Strum, SC				Silk, Joan B.; Roberts, Eila R.; Staedele, Veronika; Strum, Shirley C.			To grunt or not to grunt: Factors governing call production in female olive baboons, Papio anubis	PLOS ONE			English	Article							VOCAL RECOGNITION; ACOUSTIC FEATURES; NATAL ATTRACTION; LOUD CALLS; URSINUS; AGE; QUALITY; SCREAMS; FORM; CUES	Vocal signals often play an important role in synchronizing the activities of group members, coordinating decisions about when and where to travel, and facilitating social interactions in which there are potential conflicts of interest. Here, we show that when female olive baboons (Papio anubis) give low amplitude grunts after approaching other females, they are less likely to behave aggressively toward their partners and more likely to handle their partners' infants and interact affiliatively with them. In addition, females are more likely to grunt after they approach lower ranking females than after they approach higher ranking females and are less likely to grunt after they approach their own mothers and daughters than after they approach other females. These patterns, which are strikingly similar to patterns previously reported in chacma baboons (Papio ursinus) support the hypothesis that grunts function as signals of benign intent. Moreover, they suggest that actors' decisions about whether to grunt or remain silent are influenced by the social context, particularly their partners' likely response to their approach. Taken together, the patterning of grunts in olive and chacma baboon suggests that these vocalizations play an important in reducing uncertainty about actors' intentions and facilitate nonaggressive social interactions.	[Silk, Joan B.; Roberts, Eila R.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA; [Silk, Joan B.] Arizona State Univ, Inst Human Origins, Tempe, AZ 85281 USA; [Staedele, Veronika] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Strum, Shirley C.] Univ Calif San Diego, Dept Anthropol, San Diego, CA 92103 USA; [Strum, Shirley C.] Uaso Ngiro Baboon Project, Nairobi, Kenya; [Strum, Shirley C.] Kenya Wildlife Serv, Nairobi, Kenya; [Strum, Shirley C.] African Conservat Ctr, Nairobi, Kenya	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Max Planck Society; University of California System; University of California San Diego	Silk, JB (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85281 USA.; Silk, JB (corresponding author), Arizona State Univ, Inst Human Origins, Tempe, AZ 85281 USA.	joansilk@gmail.com	Städele, Veronika/AAP-6818-2020		Arizona Sate University	Arizona Sate University	Work was funded with startup funds from Arizona Sate University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlet M, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0711; Baotic A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177411; Bousquet CAH, 2011, P ROY SOC B-BIOL SCI, V278, P1482, DOI 10.1098/rspb.2010.1739; Cheney DL, 1997, ANIM BEHAV, V54, P409, DOI 10.1006/anbe.1996.0438; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; CHENEY DL, 1995, ANIM BEHAV, V50, P249, DOI 10.1006/anbe.1995.0237; Cheney DL, 2018, P NATL ACAD SCI USA, V115, P1974, DOI 10.1073/pnas.1717572115; Crockford C, 2012, CURR BIOL, V22, P142, DOI 10.1016/j.cub.2011.11.053; Engh AL, 2006, ANIM BEHAV, V71, P381, DOI 10.1016/j.anbehav.2005.05.009; Ey E, 2007, PRIMATES, V48, P253, DOI 10.1007/s10329-006-0033-y; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; Fischer J, 2004, BEHAV ECOL SOCIOBIOL, V56, P140, DOI 10.1007/s00265-003-0739-4; Fischer J, 2017, PSYCHON B REV, V24, P72, DOI 10.3758/s13423-016-1076-8; Fischer J, 2011, INT J PRIMATOL, V32, P1279, DOI 10.1007/s10764-011-9542-7; Foerster S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35404; Frank RE, 2009, BEHAVIOUR, V146, P889, DOI 10.1163/156853908X396656; Gall GEC, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170004; Henzi SP, 2002, ANIM BEHAV, V63, P915, DOI 10.1006/anbe.2001.1986; Janik VM, 2000, ANIM BEHAV, V60, P1, DOI 10.1006/anbe.2000.1410; Kamilar JM, 2006, DEV PRIMATOL, P169, DOI 10.1007/0-387-31710-4_6; Kitchen DM, 2003, BEHAV ECOL SOCIOBIOL, V53, P374, DOI 10.1007/s00265-003-0588-1; Maciej P, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-58; Mathevon N, 2017, CURR BIOL, V27, P2352, DOI 10.1016/j.cub.2017.06.035; Mathevon Nicolas, 2010, BMC Ecology, V10, P9, DOI 10.1186/1472-6785-10-9; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; Meise K, 2011, J ACOUST SOC AM, V129, P1631, DOI 10.1121/1.3531944; Owren MJ, 1997, J ACOUST SOC AM, V101, P2951, DOI 10.1121/1.418523; Palombit RA, 1999, BEHAVIOUR, V136, P221, DOI 10.1163/156853999501298; Pradhan GR, 2006, BEHAV ECOL SOCIOBIOL, V59, P333, DOI 10.1007/s00265-005-0075-y; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 2009, J ACOUST SOC AM, V125, P1792, DOI 10.1121/1.3068453; Schamberg I, 2016, ANIM BEHAV, V122, P109, DOI 10.1016/j.anbehav.2016.10.003; SHIPLEY C, 1981, ANIM BEHAV, V29, P12, DOI 10.1016/S0003-3472(81)80147-9; Silk JB, 1996, ANIM BEHAV, V52, P259, DOI 10.1006/anbe.1996.0171; Silk JB, 2000, ANIM BEHAV, V59, P423, DOI 10.1006/anbe.1999.1312; Silk JB, 2003, ETHOLOGY, V109, P627, DOI 10.1046/j.1439-0310.2003.00907.x; Silk JB, 2017, ANIM BEHAV, V131, P89, DOI 10.1016/j.anbehav.2017.07.015; Silk JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163978; Slocombe KE, 2005, J COMP PSYCHOL, V119, P67, DOI 10.1037/0735-7036.119.1.67; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Strum SC, 2005, AM J PRIMATOL, V65, P117, DOI 10.1002/ajp.20103; Strum SC, 2015, J ARID ENVIRON, V118, P37, DOI 10.1016/j.jaridenv.2015.02.015; Sueur Cedric, 2011, BMC Ecology, V11, P26, DOI 10.1186/1472-6785-11-26; Welch AM, 1998, SCIENCE, V280, P1928, DOI 10.1126/science.280.5371.1928; Wittig RM, 2007, P R SOC B, V274, P1109, DOI 10.1098/rspb.2006.0203	47	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0204601	10.1371/journal.pone.0204601	http://dx.doi.org/10.1371/journal.pone.0204601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388127	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800008
J	Dong, G; Wang, ZZ; Mao, XQ				Dong, Gang; Wang, Zhengzao; Mao, Xianqiang			Production efficiency and GHG emissions reduction potential evaluation in the crop production system based on emergy synthesis and nonseparable undesirable output DEA: A case study in Zhejiang Province, China	PLOS ONE			English	Article							DATA ENVELOPMENT ANALYSIS; ENVIRONMENTAL EFFICIENCY; AGRICULTURAL SECTOR; ECO-EFFICIENCY; ENERGY; SUSTAINABILITY	Maintaining crop outputs to feed its large population with limited resources while simultaneously mitigating carbon emissions are great challenges for China. Improving the efficiency of resource use in crop production is important in reducing carbon emissions. This paper constructs a methodological framework combining emergy-based indicator accounting and a nonseparable undesirable output slack-based measurement (SBM) data envelopment analysis (DEA) model. This framework is used to explore the efficiency of inputs and outputs and the greenhouse gas (GHG) emissions reduction potential for crop production systems, using Zhejiang province, China, as a case study. It is found that an emergy synthesis and a nonseparable undesirable output SBM-DEA framework is compatible with the case study. Crop production in Zhejiang province has relied heavily on an increase in agro-chemical inputs to maintain agricultural output. Energy and chemical fertilizer use are determined as the province's major carbon emissions sources. Although carbon emissions per unit of monetary output has decreased sharply, the carbon emissions per unit emergy output has increased, demonstrating a high carbon intensity reality. The DEA highlighted the differences in crop production efficiency, resource factor redundancy and carbon mitigation potential in the different prefectures of the province. To conclude this research, policies to support low carbon agriculture development, including subsidizing low carbon agriculture technology development and expansion and the cancellation of subsidies to high carbon production factors, such as chemical fertilizer production and sales, are discussed to conclude the research.	[Dong, Gang; Wang, Zhengzao; Mao, Xianqiang] Beijing Normal Univ, Sch Environm, Beijing, Peoples R China; [Dong, Gang] Anhui Univ Finance & Econ, Econ Res Inst, Bengbu, Peoples R China	Beijing Normal University; Anhui University of Finance & Economics	Mao, XQ (corresponding author), Beijing Normal Univ, Sch Environm, Beijing, Peoples R China.	maoxq@bnu.edu.cn			National Social Science Fund [10CJY030]; Center for Global Environmental Policy (CGEP)	National Social Science Fund; Center for Global Environmental Policy (CGEP)	This work was supported by the National Social Science Fund (Grant No. 10CJY030) to GD (http://www.npopss-cn.gov.cn/) and a senior research fellowship from the Center for Global Environmental Policy (CGEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner D., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; Alene AD, 2005, AGR EC REV, V06; [Anonymous], SHAOX STAT YB 1995 2; [Anonymous], HUZH STAT YB 2002 20; [Anonymous], 2001, LISH STAT YB 2001 20; [Anonymous], 1995, HANGZH STAT YB 1995; [Anonymous], QUZH STAT YB 2007 20; [Anonymous], NINGB STAT YB 1996 2; [Anonymous], WENZH STAT YB 1998 2; [Anonymous], 2011, J CENT CATHEDRA, DOI DOI 10.7835/JCC-BERJ-2011-0061; [Anonymous], ZHOUSH STAT YB 1997; [Anonymous], JIAX STAT YB 1997 20; [Anonymous], TAIZH STAT YB 1998 2; [Anonymous], JINH STAT YB 1996 20; Bastianoni S, 2009, ECOL MODEL, V220, P40, DOI 10.1016/j.ecolmodel.2008.09.003; Beinhocker E., 2008, CARBON PRODUCTIVITY; Beltran-Esteve M, 2014, J PROD ANAL, V41, P69, DOI 10.1007/s11123-012-0334-7; Bennetzen EH, 2016, GLOBAL ENVIRON CHANG, V37, P43, DOI 10.1016/j.gloenvcha.2015.12.004; Bonfiglio A, 2017, AGR SYST, V151, P114, DOI 10.1016/j.agsy.2016.11.008; Campbell DE, 1998, ENVIRON MONIT ASSESS, V51, P531, DOI 10.1023/A:1006043721115; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; China carbon trading network, 2014, INT ACC METH IND CON; Coelli TJ, 1995, AUST J AGR ECON, V39, P219, DOI 10.1111/j.1467-8489.1995.tb00552.x; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; Cui ZL, 2018, NATURE, V555, P363, DOI 10.1038/nature25785; Daly H.E., 2011, ECOLOGICAL EC PRINCI; De Koeijer TJ, 2002, J ENVIRON MANAGE, V66, P9, DOI 10.1006/jema.2002.0578; Deng XZ, 2015, LAND USE POLICY, V45, P1, DOI 10.1016/j.landusepol.2015.01.007; Dong G, 2013, ECOL ECON, V91, P38, DOI 10.1016/j.ecolecon.2013.04.003; Falavigna G, 2013, AGR SYST, V121, P73, DOI 10.1016/j.agsy.2013.07.003; Fei RL, 2017, ENERGY, V135, P865, DOI 10.1016/j.energy.2017.06.173; Fei RL, 2016, TECHNOL FORECAST SOC, V109, P25, DOI 10.1016/j.techfore.2016.05.012; Gancone A, 2017, ENRGY PROCED, V128, P309, DOI 10.1016/j.egypro.2017.08.318; Geng Y, 2013, SCIENCE, V339, P1526, DOI 10.1126/science.1227059; He J, 2016, ECOL INDIC, V70, P23, DOI 10.1016/j.ecolind.2016.05.042; Ingwersen WW, 2011, J IND ECOL, V15, P550, DOI 10.1111/j.1530-9290.2011.00333.x; IPCC, 2014, 2013 SUPPLEMENT 2006; Lansink AO, 2014, ECON BUS LETT, V3, P43; Lin BQ, 2015, EUR J AGRON, V70, P33, DOI 10.1016/j.eja.2015.06.009; MOA (Minister of Agriculture), 2009, NEW CHIN AGR STAT 60; Murty S, 2012, J ENVIRON ECON MANAG, V64, P117, DOI 10.1016/j.jeem.2012.02.005; NBSC (National Bureau of Statistics of China), 2002, CHIN STAT YB; NDRC. P. R. China, 2012, 2 NAT COMM CLIM CHA; NDRC P. R. China, 2003, NAT COMP DAT AGR PRO; Odum H. T., 1996, ENV ACCOUNTING EMERG; Odum H.T., 2000, EMERGY GLOBAL PROCES; Parry M. L, 2007, J ENVIRON QUAL, V37, P2407, DOI [10.2134/jeq2008.0015br, DOI 10.2134/JEQ2008.0015BR]; PiotLepetit I, 1997, APPL ECON, V29, P331, DOI 10.1080/000368497327100; Reinhard S, 2000, EUR J OPER RES, V121, P287, DOI 10.1016/S0377-2217(99)00218-0; Rydberg T, 2006, AGR ECOSYST ENVIRON, V117, P145, DOI 10.1016/j.agee.2006.03.025; Smith P, 2007, AGR ECOSYST ENVIRON, V118, P6, DOI 10.1016/j.agee.2006.06.006; Soddy F, 1933, AM J SOCIOL; Tone K, 2001, EUR J OPER RES, V130, P498, DOI 10.1016/S0377-2217(99)00407-5; Tone K, 2006, UTILITIES; Tone K., DEALING UNDESIRABLE, P44; TPGZP The People's Government of Zhejiang Province, 2013, AGR MACH PURCH SUBS; TPGZP The People's Government of Zhejiang Province, 2016, ZHEJ MOD EC CIRC AGR; ULGIATI S, 1994, ECOL MODEL, V73, P215, DOI 10.1016/0304-3800(94)90064-7; Vlontzos G, 2014, RENEW SUST ENERG REV, V40, P91, DOI 10.1016/j.rser.2014.07.153; Zhang LX, 2013, J CLEAN PROD, V47, P415, DOI 10.1016/j.jclepro.2012.06.021; ZSB, 1985, ZHEJ STAT YB 1998 20	61	19	20	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206680	10.1371/journal.pone.0206680	http://dx.doi.org/10.1371/journal.pone.0206680			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383842	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600084
J	Salazar, JCS; Melgarejo, LM; Casanoves, F; Di Rienzo, JA; DaMatta, FM; Armas, C				Suarez Salazar, Juan Carlos; Marina Melgarejo, Luz; Casanoves, Fernando; Di Rienzo, Julio A.; DaMatta, Fabio M.; Armas, Cristina			Photosynthesis limitations in cacao leaves under different agroforestry systems in the Colombian Amazon	PLOS ONE			English	Article							LIGHT-RESPONSE CURVES; THEOBROMA-CACAO; GAS-EXCHANGE; IRRADIANCE LEVEL; WATER RELATIONS; GROWTH; SHADE; COCOA; L.; TEMPERATURE	Cacao (Theobroma cacao L.) has traditionally been considered a crop that requires shade, and consequently it is implemented under agroforestry systems (AFs) in order to regulate the level of incident solar radiation. However, optimal shade levels for this tree crop may vary depending on the climate conditions of where it is grown. Here we analyzed the physiological performance of cacao under three different AFs in the Colombian Amazon that differed in solar radiation patterns: high (H-PAR), medium (M-PAR), or low (L-PAR) mean daily incident radiation. The physiological performance was characterized using photosynthetic variables in leaves such as light-and CO2-response curves, chlorophyll a fluorescence parameters, and total chlorophyll and carotenoid contents, in conjunction with other leaf functional traits. Cacao trees exposed to H-PAR showed an improved physiological performance as compared to those from the other two AFs. Compared to M-PAR and L-PAR, cacao trees in H-PAR doubled the rate of net carbon assimilation and reached higher maximum rates of RuBisCO carboxylation and RuBP regeneration. Moreover, cacao trees in H-PAR presented photoprotection mechanisms that avoided photoinhibition, which was accompanied by a greater non-photochemical quenching coefficient and biochemical and morphological adjustments (low chlorophyll but higher carotenoid contents and low specific leaf area) compared to cacao trees from the other AFs. Overall, our results show that, due to the high cloud cover in the Colombian Amazon, cacao plantations under conditions of sparse shade maximized their carbon use, showing an improved physiological performance as a result of higher photosynthetic rates and energy dissipation mechanisms. If the crop were managed with sparse shade, the paradigm that favors the cultivation of cacao under shade would be called into question in the Colombian Amazon and other regions with similar climatic conditions.	[Suarez Salazar, Juan Carlos] Univ Amazonia, Fac Ingn, Programa Ingn Agroecol, Florencia Caqueta, Colombia; [Suarez Salazar, Juan Carlos; Marina Melgarejo, Luz] Univ Nacl Colombia, Sede Bogota, Dept Biol, Lab Fisiol & Bioquim Vegetal, Bogota, Colombia; [Casanoves, Fernando] CATIE, Turrialba, Costa Rica; [Di Rienzo, Julio A.] Univ Nacl Cordoba, Fac Ciencias Agr, Cordoba, Argentina; [DaMatta, Fabio M.] Univ Fed Vicosa, Dept Biol Vegetal, Vicosa, MG, Brazil; [Armas, Cristina] CSIC, Estn Expt Zonas Aridas, La Canada De San Urbano, Almeria, Spain	Universidad Nacional de Colombia; National University of Cordoba; Universidade Federal de Vicosa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Salazar, JCS (corresponding author), Univ Amazonia, Fac Ingn, Programa Ingn Agroecol, Florencia Caqueta, Colombia.; Salazar, JCS (corresponding author), Univ Nacl Colombia, Sede Bogota, Dept Biol, Lab Fisiol & Bioquim Vegetal, Bogota, Colombia.	ju.suarez@udla.edu.co	Rodrigues, Fabricio/AAH-7572-2020; Melgarejo, Luz/AAZ-5918-2020; suárez salazar, juan carlos/GXH-2202-2022; Armas, Cristina/A-1128-2012; Casanoves, Fernando/I-3588-2016; DaMatta, Fabio/AAZ-1515-2020	Armas, Cristina/0000-0003-0356-8075; Casanoves, Fernando/0000-0001-8765-9382; DaMatta, Fabio/0000-0002-9637-8475; Suarez Salazar, Juan Carlos/0000-0001-5928-1837; Melgarejo, Luz Marina/0000-0003-3148-1911	COLCIENCIAS; Amazon University [1301]	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Amazon University	This study was conducted with the financial collaboration of COLCIENCIAS (http://www.colciencias.gov.co/) using BID funds (Inter-American Development Bank) under the framework of the project "Characterization and typification of traditional plantations of Theobroma cacao L. as a strategy for the design and implementation of agroforestry systems in the Bajo Caguan (Cartagena del Chaira)," implemented by Universidad de la Amazonia (Colombia) under the special contract 590 of 2010 to JCSS, as well as using Doctoral Training funds from Amazon University under the stamp "Pro-development of Amazon University" Law No. 1301 of 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acheampong K, 2013, EXP AGR, V49, P31, DOI 10.1017/S0014479712001007; Almeida AAF, 2014, PHOTOSYNTHETICA, V52, P16, DOI 10.1007/s11099-013-0048-8; Araque O, 2012, EXP AGR, V48, P513, DOI 10.1017/S0014479712000427; Armbruster U, 2017, CURR OPIN PLANT BIOL, V37, P56, DOI 10.1016/j.pbi.2017.03.012; Avila-Lovera E, 2016, EXP AGR, V52, P137, DOI 10.1017/S0014479714000593; Baker R, 1952, REPR ARCH COCOA RES, V1; Balasimha D., 2013, J PLANT CROP, V41, P40; Bauerle WL, 2006, ANN FOREST SCI, V63, P833, DOI 10.1051/forest:2006066; Bentley JW, 2004, HUM ECOL, V32, P241, DOI 10.1023/B:HUEC.0000019759.46526.4d; Brooks MD, 2011, METHODS MOL BIOL, V775, P299, DOI 10.1007/978-1-61779-237-3_16; Carr MKV, 2011, EXP AGR, V47, P653, DOI 10.1017/S0014479711000421; Chaves ARM, 2008, TREES-STRUCT FUNCT, V22, P351, DOI 10.1007/s00468-007-0190-7; Chmura DJ, 2017, PLANT BIOLOGY, V19, P172, DOI 10.1111/plb.12531; Cornelissen JHC, AUST J BOT, V51; Branco MCD, 2017, SCI HORTIC-AMSTERDAM, V217, P243, DOI 10.1016/j.scienta.2017.01.038; DaMatta Fábio M., 2006, Braz. J. Plant Physiol., V18, P55, DOI 10.1590/S1677-04202006000100006; Daymond AJ, 2011, BIOL PLANTARUM, V55, P99, DOI 10.1007/s10535-011-0013-y; Daymond AJ, 2004, ANN APPL BIOL, V145, P257, DOI 10.1111/j.1744-7348.2004.tb00381.x; de Araujo RP, 2017, SCI HORTIC-AMSTERDAM, V224, P188, DOI 10.1016/j.scienta.2017.06.008; Di Rienzo J, 2018, GRUPO INFOSTAT; Duursma RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143346; Jaimez RE, 2018, ACTA BIOL COLOMB, V23, P95, DOI 10.15446/abc.v23n1.64962; FARQUHAR GD, 1980, PLANTA, V149, P78, DOI 10.1007/BF00386231; Flexas J, 2007, J EXP BOT, V58, P1533, DOI 10.1093/jxb/erm027; Fu YM, 2017, SCI HORTIC-AMSTERDAM, V214, P51, DOI 10.1016/j.scienta.2016.11.020; Galyuon IKA, 1996, TROP AGRIC, V73, P29; Galyuon IKA, 1996, TROP AGRIC, V73, P23; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; ICCO (International Cocoa Organization), 2015, Q B COCOA STAT, VXL; IDEAM, 2018, ATL CLIM COL; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Liu YJ, 2016, ANN BOT-LONDON, V118, P1329, DOI 10.1093/aob/mcw180; Lobo FD, 2013, PHOTOSYNTHETICA, V51, P445, DOI 10.1007/s11099-013-0045-y; Long SP, 2003, J EXP BOT, V54, P2393, DOI 10.1093/jxb/erg262; Mielke MS, 2005, BRAZ ARCH BIOL TECHN, V48, P815, DOI 10.1590/S1516-89132005000600018; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Pinheiro J, 2012, R PACKAGE VERSION, V3, P1; Pompelli MF, 2010, J PLANT PHYSIOL, V167, P1052, DOI 10.1016/j.jplph.2010.03.001; R Core Team, 2013, R LANG ENV STAT COMP; Russo SE, 2016, TREE PHYSIOL-NETH, V6, P357, DOI 10.1007/978-3-319-27422-5_17; Salazar JCS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191003; Tezara W, 2015, INVESTIG SABERES, V4, P563; Tezara W, 2016, BOT SCI, V94, P563, DOI 10.17129/botsci.552; Vialet-Chabrand S, 2017, PLANT PHYSIOL, V173, P2163, DOI 10.1104/pp.16.01767; Martins SCV, 2013, THEOR EXP PLANT PHYS, V25, P62, DOI 10.1590/S2197-00252013000100008	45	20	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206149	10.1371/journal.pone.0206149	http://dx.doi.org/10.1371/journal.pone.0206149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383815	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600030
J	Lu, M; Banetta, L; Young, LJ; Smith, EJ; Bates, GP; Zaccone, A; Schierle, GSK; Tunnacliffe, A; Kaminski, CF				Lu, Meng; Banetta, Luca; Young, Laurence J.; Smith, Edward J.; Bates, Gillian P.; Zaccone, Alessio; Schierle, Gabriele S. Kaminski; Tunnacliffe, Alan; Kaminski, Clemens F.			Live-cell super-resolution microscopy reveals a primary role for diffusion in polyglutamine-driven aggresome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein aggregation; transport; molecular dynamics; molecular imaging; molecular modeling; protein misfolding; aggresome formation; amyloid protein; live cell SIM; passive transport	HUNTINGTIN FRAGMENTS; DNA-DAMAGE; AGGREGATION; ACCUMULATION; DEGRADATION; ELONGATION; PROTEINS; KINETICS; FIBRILS; DISEASE	The mechanisms leading to self-assembly of misfolded proteins into amyloid aggregates have been studied extensively in the test tube under well-controlled conditions. However, to what extent these processes are representative of those in the cellular environment remains unclear. Using super-resolution imaging of live cells, we show here that an amyloidogenic polyglutamine-containing protein first forms small, amorphous aggregate clusters in the cytosol, chiefly by diffusion. Dynamic interactions among these clusters limited their elongation and led to structures with a branched morphology, differing from the predominantly linear fibrils observed in vitro. Some of these clusters then assembled via active transport at the microtubule-organizing center and thereby initiated the formation of perinuclear aggresomes. Although it is widely believed that aggresome formation is entirely governed by active transport along microtubules, here we demonstrate, using a combined approach of advanced imaging and mathematical modeling, that diffusion is the principal mechanism driving aggresome expansion. We found that the increasing surface area of the expanding aggresome increases the rate of accretion caused by diffusion of cytosolic aggregates and that this pathway soon dominates aggresome assembly. Our findings lead to a different view of aggresome formation than that proposed previously. We also show that aggresomes mature over time, becoming more compacted as the structure grows. The presence of large perinuclear aggregates profoundly affects the behavior and health of the cell, and our super-resolution imaging results indicate that aggresome formation and development are governed by highly dynamic processes that could be important for the design of potential therapeutic strategies.	[Lu, Meng; Young, Laurence J.; Schierle, Gabriele S. Kaminski; Tunnacliffe, Alan; Kaminski, Clemens F.] Univ Cambridge, Cambridge Infinitus Res Ctr, Dept Chem Engn & Biotechnol, Cambridge CB3 0AS, England; [Banetta, Luca; Zaccone, Alessio] Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB3 0AS, England; [Smith, Edward J.; Bates, Gillian P.] UCL, Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London WC1N 3BG, England; [Smith, Edward J.; Bates, Gillian P.] UCL, Inst Neurol, Huntingtons Dis Ctr, London WC1N 3BG, England; [Young, Laurence J.] Fluid Analyt, Unit 5,Frenchs Rd, Cambridge CB4 3NP, England	University of Cambridge; University of Cambridge; University of London; University College London; University of London; University College London	Kaminski, CF (corresponding author), Univ Cambridge, Dept Chem Engn & Biotechnol, Cambridge CB2 3RA, England.	cfk23@cam.ac.uk	Banetta, Luca/GYV-1359-2022; Kaminski, Clemens/G-7488-2016; Bates, Gillian/E-1146-2012	Zaccone, Alessio/0000-0002-6673-7043; Kaminski, Clemens/0000-0002-5194-0962; Tunnacliffe, Alan/0000-0001-8570-125X; Banetta, Luca/0000-0003-2055-9584; Bates, Gillian/0000-0002-4041-6305	BBSRC [BB/H023917/1] Funding Source: UKRI; EPSRC [EP/H018301/1] Funding Source: UKRI; MRC [MR/K02292X/1, G0902243, MR/K015850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H023917/1] Funding Source: Medline; Medical Research Council [MR/K015850/1, MR/K02292X/1, G0902243] Funding Source: Medline; Wellcome Trust [203249/Z/16/Z, 3-3249/Z/16/Z, 089703/Z/09/Z] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Balint S, 2013, P NATL ACAD SCI USA, V110, P3375, DOI 10.1073/pnas.1219206110; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duim WC, 2014, ACS CHEM BIOL, V9, P2767, DOI 10.1021/cb500335w; Gandy S, 2005, PLOS MED, V2, P1228, DOI 10.1371/journal.pmed.0020417; Giuliano P, 2003, HUM MOL GENET, V12, P2301, DOI 10.1093/hmg/ddg242; Hoffner G, 2014, BRAIN SCI, V4, P91, DOI 10.3390/brainsci4010091; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Huynen C, 2015, BBA-PROTEINS PROTEOM, V1854, P239, DOI 10.1016/j.bbapap.2014.12.002; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; JULLIEN R, 1987, CONTEMP PHYS, V28, P477, DOI 10.1080/00107518708213736; Kaminski CF, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.4.041807; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Leitman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3753; Li L, 2016, ELIFE, V5, DOI 10.7554/eLife.17056; Li X, 2010, HUM MOL GENET, V19, P2445, DOI 10.1093/hmg/ddq127; Lu M, 2015, J BIOL CHEM, V290, P27986, DOI 10.1074/jbc.M115.676437; Lu M, 2015, BIOTECHNOL BIOENG, V112, P1883, DOI 10.1002/bit.25606; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Pinotsi D, 2016, P NATL ACAD SCI USA, V113, P3815, DOI 10.1073/pnas.1516546113; Pinotsi D, 2014, NANO LETT, V14, P339, DOI 10.1021/nl4041093; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Streets AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054541; Strohl F, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/1/014002; Strtohl F, 2016, OPTICA, V3, P667, DOI 10.1364/OPTICA.3.000667; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Walters RH, 2012, J MOL BIOL, V421, P329, DOI 10.1016/j.jmb.2012.03.017; Wang HF, 2012, J BIOL CHEM, V287, P28576, DOI 10.1074/jbc.M111.299990; Young LJ, 2016, JOVE-J VIS EXP, DOI 10.3791/53988	40	13	13	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					257	268		10.1074/jbc.RA118.003500	http://dx.doi.org/10.1074/jbc.RA118.003500			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30401748	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000455105500028
J	Benmachiche, M; Marques-Vidal, P; Waeber, G; Mean, M				Benmachiche, Malik; Marques-Vidal, Pedro; Waeber, Gerard; Mean, Marie			In-hospital mortality is associated with high NT-proBNP level	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; LONG-TERM MORTALITY; LENGTH-OF-STAY; HEART-FAILURE; RISK STRATIFICATION; BNP; DYSFUNCTION; PREDICTORS; DIAGNOSIS; EVENTS	Objective To compare in-hospital mortality in unselected adult patients according to N-terminal probrain natriuretic peptide (NT-proBNP) levels. Method Retrospective study including 3833 adult patients (median age 72 years, 45% women) hospitalized between January 2013 and April 2015 in a Swiss university hospital, with at least one NT-proBNP level measurement during hospitalization. Patients were categorized in quintiles regarding their highest NT-proBNP level. In-hospital mortality and length of stay (LOS) were compared between the highest and the other quintiles. Results In-hospital mortality rate and LOS (average +/- standard deviation) were higher in the fifth quintile than in the others (6.5% vs 20.3%, and 20.8 +/- 24.0 vs. 14.9 +/- 26.5 days respectively, both p<0.001). After multivariate adjustment on age, gender, principal diagnoses, stage 5 renal failure and type of management, patients in the fifth quintile had a hazard ratio [95% confidence interval] of 1.97 [1.57-2.46] for in-hospital mortality and an adjusted LOS (average +/- standard error) of 20.4 +/- 1.0 vs. 14.9 +/- 0.5 days for the other quintiles (p<0.001). Further stratification on the main diagnosis at discharge led to similar findings. Conclusion Patients with high levels of NT-proBNP are at higher risk of in-hospital mortality and longer LOS, regardless of their clinical characteristics. NT-proBNP level can be a helpful tool for predicting in-hospital patient outcome in unselected adult patients.	[Benmachiche, Malik; Marques-Vidal, Pedro; Waeber, Gerard; Mean, Marie] Lausanne Univ Hosp, Dept Internal Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Benmachiche, M (corresponding author), Lausanne Univ Hosp, Dept Internal Med, Lausanne, Switzerland.	Malik.Benmachiche@chuv.ch	; Marques-Vidal, Pedro/C-9449-2009	Benmachiche, Malik/0000-0003-1870-9109; Mean, Marie/0000-0003-0477-7899; Waeber, Gerard/0000-0003-4193-788X; Marques-Vidal, Pedro/0000-0002-4548-8500				Brandimarte F, 2013, HEART FAIL REV, V18, P167, DOI 10.1007/s10741-012-9317-z; Christ-Crain M, 2008, J INTERN MED, V264, P166, DOI 10.1111/j.1365-2796.2008.01934.x; Clark Michael, 2014, J Insur Med, V44, P7; Clerico A, 2015, CRIT REV CL LAB SCI, V52, P56, DOI 10.3109/10408363.2014.987720; Clerico A, 2015, CLIN CHIM ACTA, V443, P17, DOI 10.1016/j.cca.2014.06.003; Clerico A, 2011, CLIN CHEM LAB MED, V49, P1949, DOI 10.1515/CCLM.2011.686; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Escande M, 2009, ANN CARDIOL ANGEIOL, V58, P284, DOI 10.1016/j.ancard.2009.09.002; Fabbian F, 2013, DIS MARKERS, V2013, P735, DOI 10.1155/2013/687467; Fellahi JL, 2011, J CARDIOTHOR VASC AN, V25, P256, DOI 10.1053/j.jvca.2010.05.009; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; Fox AA, 2010, ANESTHESIOLOGY, V112, P842, DOI 10.1097/ALN.0b013e3181d23168; Fulks Michael, 2017, J Insur Med, V47, P107, DOI 10.17849/insm-47-02-107-113.1; Gimeno E, 2011, LEUKEMIA RES, V35, P715, DOI 10.1016/j.leukres.2011.01.018; Hall C, 2004, EUR J HEART FAIL, V6, P257, DOI 10.1016/j.ejheart.2003.12.015; Hedinger D, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1725-7; HUANG YP, 2016, SCI REP UK, V6; Idris I, 2010, AGE AGEING, V39, P752, DOI 10.1093/ageing/afq098; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Kragelund C, 2005, NEW ENGL J MED, V352, P666, DOI 10.1056/NEJMoa042330; Levin A, 2014, KIDNEY INT, V85, P49, DOI 10.1038/ki.2013.444; Lu FP, 2016, GERIATR GERONTOL INT, V16, P345, DOI 10.1111/ggi.12480; Lupon J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085466; Madamanchi C, 2014, INT J CARDIOL, V176, P611, DOI 10.1016/j.ijcard.2014.08.007; Marengoni A, 2010, REJUV RES, V13, P469, DOI 10.1089/rej.2009.1002; McDonagh TA, 2001, HEART, V86, P21, DOI 10.1136/heart.86.1.21; Miro O, 2017, ANN INTERN MED; Nowak A, 2012, CHEST, V141, P974, DOI 10.1378/chest.11-0824; Nunez J, 2008, REV ESP CARDIOL, V61, P1332, DOI 10.1016/S0300-8932(08)75743-9; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Schlitt A, 2014, DTSCH ARZTEBL INT, V111, DOI 10.3238/arztebl.2014.0161; Shah MR, 2007, AM J CARDIOL, V100, P1427, DOI 10.1016/j.amjcard.2007.06.035; Stolz D, 2008, CHEST, V133, P1088, DOI 10.1378/chest.07-1959; Svensson M, 2009, CLIN NEPHROL, V71, P380; Takada JY, 2012, SCI WORLD J, V2012, P1, DOI [10.1097/ALN.0b013e3181d23168, DOI 10.1097/ALN.0B013E3181D23168]; Troughton RW, 2000, LANCET, V355, P1126, DOI 10.1016/S0140-6736(00)02060-2; Tsuchida K, 2008, J CARDIOL, V52, P212, DOI 10.1016/j.jjcc.2008.07.007; Waldum B, 2013, CLIN KIDNEY J, V6, P55, DOI 10.1093/ckj/sfs174; Wallen T, 1997, HEART, V77, P264, DOI 10.1136/hrt.77.3.264; Whellan DJ, 2011, J CARD FAIL, V17, P649, DOI 10.1016/j.cardfail.2011.04.005; Zhu QW, 2016, CLIN INTERV AGING, V11, P245, DOI 10.2147/CIA.S98151	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207118	10.1371/journal.pone.0207118	http://dx.doi.org/10.1371/journal.pone.0207118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408101	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300078
J	Koblihova, J; Srutova, K; Krutska, M; Klamova, H; Polakova, KM				Koblihova, Jitka; Srutova, Klara; Krutska, Monika; Klamova, Hana; Polakova, Katerina Machova			AFLP-AFLP in silico-NGS approach reveals polymorphisms in repetitive elements in the malignant genome	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; GENETIC-VARIATION; RESISTANCE; MARKERS; HOMOPLASY; THERAPY	The increasing interest in exploring the human genome and identifying genetic risk factors contributing to the susceptibility to and outcome of diseases has supported the rapid development of genome-wide techniques. However, the large amount of obtained data requires extensive bioinformatics analysis. In this work, we established an approach combining amplified fragment length polymorphism (AFLP), AFLP in silico and next generation sequencing (NGS) methods to map the malignant genome of patients with chronic myeloid leukemia. We compared the unique DNA fingerprints of patients generated by the AFLP technique approach with those of healthy donors to identify AFLP markers associated with the disease and/or the response to treatment with imatinib, a tyrosine kinase inhibitor. Among the statistically significant AFLP markers selected for NGS analysis and virtual fingerprinting, we identified the sequences of three fragments in the region of DNA repeat element OldhAT1, LINE L1M7, LTR MER90, and satellite ALR/Alpha among repetitive elements, which may indicate a role of these non-coding repetitive sequences in hematological malignancy. SNPs leading to the presence/absence of these fragments were confirmed by Sanger sequencing. When evaluating the results of AFLP analysis for some fragments, we faced the frequently discussed size homoplasy, resulting in co-migration of non-identical AFLP fragments that may originate from an insertion/deletion, SNP, somatic mutation anywhere in the genome, or combination thereof. The AFLP-AFLP in silico-NGS procedure represents a smart alternative to microarrays and relatively expensive and bioinformatically challenging whole-genome sequencing to detect the association of variable regions of the human genome with diseases.	[Koblihova, Jitka; Srutova, Klara; Krutska, Monika; Klamova, Hana; Polakova, Katerina Machova] Inst Hematol & Blood Transfus, Prague, Czech Republic	Institute of Hematology Prague	Polakova, KM (corresponding author), Inst Hematol & Blood Transfus, Prague, Czech Republic.	katerina.machava@uhkt.cz	Srutova, Klara/ABF-3478-2020	Srutova, Klara/0000-0001-8246-5925	Ministry of Health of CZ [IGA NT11555]; Institute of Hematology and Blood Transfusion [00023736]	Ministry of Health of CZ; Institute of Hematology and Blood Transfusion	This work was supported by Ministry of Health of CZ (grant IGA NT11555 to KMP) and Institute of Hematology and Blood Transfusion (project 00023736 to KMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baccarani M, 2013, BLOOD, V122, P872, DOI 10.1182/blood-2013-05-501569; Bahador A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01249; Caballero A, 2010, MOL BIOL EVOL, V27, P1139, DOI 10.1093/molbev/msq001; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cortes JE, 2003, BLOOD, V101, P3794, DOI 10.1182/blood-2002-09-2790; Datta Sibnarayan, 2015, World J Virol, V4, P265, DOI 10.5501/wjv.v4.i3.265; de Brevern AG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/904541; Donato NJ, 2004, CANCER RES, V64, P672, DOI 10.1158/0008-5472.CAN-03-1484; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Gort G, 2009, THEOR APPL GENET, V119, P397, DOI 10.1007/s00122-009-1047-9; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hubley R, 2016, NUCLEIC ACIDS RES, V44, pD81, DOI 10.1093/nar/gkv1272; Jaruskova M, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0523-3; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim Yeong C, 2010, BMC Res Notes, V3, P341, DOI 10.1186/1756-0500-3-341; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Mendelson TC, 2005, METHOD ENZYMOL, V395, P161; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Nakato R, 2017, BRIEF BIOINFORM, V18, P279, DOI 10.1093/bib/bbw023; Ng PC, 2010, METHODS MOL BIOL, V628, P215, DOI 10.1007/978-1-60327-367-1_12; Prochazka M, 2001, HUM GENET, V108, P59, DOI 10.1007/s004390000438; Ramsay L, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3568-y; Rodic N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003402; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Valent P, 2007, BIOL-TARGETS THER, V1, P433; vanderVoort JNAMR, 1997, MOL GEN GENET, V255, P438, DOI 10.1007/s004380050516; Veenemans J, 2014, J CLIN MICROBIOL, V52, P2454, DOI 10.1128/JCM.00313-14; Vekemans X, 2002, MOL ECOL, V11, P139, DOI 10.1046/j.0962-1083.2001.01415.x; Vesela P, 2016, MOL ECOL RESOUR, V16, P933, DOI 10.1111/1755-0998.12506; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Zhang ZF, 2014, MOL BREEDING, V34, P1245, DOI 10.1007/s11032-014-0113-4	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206620	10.1371/journal.pone.0206620	http://dx.doi.org/10.1371/journal.pone.0206620			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408048	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300028
J	Klusener, R; Hurtado, R; Parsons, NJ; Vanstreels, RET; Stander, N; van der Spuy, S; Ludynia, K				Klusener, Romy; Hurtado, Renata; Parsons, Nola J.; Vanstreels, Ralph Eric Thijl; Stander, Nicola; van der Spuy, Stephen; Ludynia, Katrin			From incubation to release: Hand-rearing as a tool for the conservation of the endangered African penguin	PLOS ONE			English	Article							TREASURE OIL-SPILL; SPHENISCUS-DEMERSUS; SOUTH-AFRICA; ROBBEN ISLAND; EL-NINO; REHABILITATION; CHICKS; MORTALITY; ECOSYSTEM; SURVIVAL	The African penguin (Spheniscus demersus) population is estimated at 25,000 breeding pairs, approximately 5% of that at the start of the 20th century, and the species is currently classified as Endangered. In the last two decades, the hand-rearing of penguin chicks that were abandoned by their parents due to oil spills or other circumstances has become a valuable conservation tool to limit mortality and to bolster the population at specific colonies. We summarize and evaluate the techniques employed by the Southern African Foundation for the Conservation of Coastal Birds (SANCCOB) to incubate and hand-rear African penguin eggs and chicks. From 2012 to 2016, a total of 694 eggs and 2819 chicks were received by SANCCOB's Chick Rearing Unit. It was estimated that 13% of the eggs were infertile, and 81% of the fertile eggs hatched successfully. The overall release rate for chicks was 77%, with a higher release rate for chicks that were pre-emptively removed (93%) followed by chicks that had been abandoned by their parents (78%), chicks admitted due to avian pox lesions (61%), chicks that hatched from artificially-incubated eggs (57%), and chicks admitted due to injuries or deformities (25%). Rescuing and hand-rearing eggs and chicks has been a successful strategy for African penguins, and might be also applicable for the conservation of other threatened seabird species whose population are critically low or during natural or anthropogenic events that could have disastrous population impacts (e.g. oil spills, disease outbreaks, catastrophic weather events, strong El Nino years, etc.).	[Klusener, Romy; Hurtado, Renata; Parsons, Nola J.; Stander, Nicola; van der Spuy, Stephen; Ludynia, Katrin] Southern African Fdn Conservat Coastal Birds, Cape Town, Western Cape, South Africa; [Hurtado, Renata] Inst Res & Rehabil Marine Anim, Cariacica, Es, Brazil; [Vanstreels, Ralph Eric Thijl] Nelson Mandela Univ, Inst Coastal & Marine Res, Marine Apex Predator Res Unit, Port Elizabeth, Eastern Cape, South Africa; [Vanstreels, Ralph Eric Thijl] Nelson Mandela Univ, Dept Zool, FitzPatrick Inst African Ornithol, DST NRF Ctr Excellence, Port Elizabeth, Eastern Cape, South Africa; [Ludynia, Katrin] Univ Cape Town, Dept Biol Sci, Cape Town, Western Cape, South Africa	Nelson Mandela University; National Research Foundation - South Africa; Nelson Mandela University; University of Cape Town	Klusener, R (corresponding author), Southern African Fdn Conservat Coastal Birds, Cape Town, Western Cape, South Africa.	romyk23@hotmail.com						Barham PJ, 2008, BIRD CONSERV INT, V18, P144, DOI 10.1017/S0959270908000142; Barham PJ, 2007, EMU, V107, P7, DOI 10.1071/MU06028; Barham PJ, 2006, OSTRICH, V77, P202, DOI 10.2989/00306520609485534; BirdLife International, 2016, IUCN RED LIST THREAT, DOI [0.2305/IUCN.UK.2016-3.RLTS.T22697810A93641269.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22697810A93641269.EN]; Boersma PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085602; Boersma PD, 2010, J FIELD ORNITHOL, V81, P442, DOI 10.1111/j.1557-9263.2010.00300.x; Boersma PD, 1998, CONDOR, V100, P245, DOI 10.2307/1370265; Campbell T.W., 2013, AVIAN EXOTIC ANIMAL; Crawford RJM, 2011, AFR J MAR SCI, V33, P139, DOI 10.2989/1814232X.2011.572377; Crawford RJM, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P211; Crawford Robert J. M., 1999, Marine Ornithology, V27, P139; Darby J.T., 1990, P45; David JHM, 2003, BIOL CONSERV, V114, P289, DOI 10.1016/S0006-3207(03)00018-1; Boersma PD, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P285; Department of Environmental Affairs, 2013, AFR PENG BIOD MAN PL, P64; Durant JM, 2010, MAR ECOL PROG SER, V420, P263, DOI 10.3354/meps08857; FROST P G H, 1976, Biological Conservation, V9, P79, DOI 10.1016/0006-3207(76)90042-2; Gartrell B, 2017, AVIAN PATHOL, V46, P278, DOI 10.1080/03079457.2016.1264568; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HEATH RGM, 1985, J ZOOL, V205, P91; Kane OJ, 2012, J WILDLIFE DIS, V48, P790, DOI 10.7589/0090-3558-48.3.790; Kemper J., 2007, FINAL REPORT BCLME B, P101; LACOCK GD, 1987, BIOL CONSERV, V40, P117, DOI 10.1016/0006-3207(87)90062-0; Moore PJ, 1994, WHAT IS BAD SEASON Y; Nel Deon C., 2003, P1; Parsons NJ, 2005, AFR J MAR SCI, V27, P289, DOI 10.2989/18142320509504087; Parsons NJ, 2018, J WILDLIFE DIS, V54, P54, DOI 10.7589/2017-06-146; Payne A.I.L., 1989, OCEANS LIFE SO AFRIC; PETERSEN SL, 2005, MARINE ORNITHOLOGY, V33, pE1; RAHN H, 1974, CONDOR, V76, P147, DOI 10.2307/1366724; Randall R. M., 1983, THESIS; Renner M, 2001, IBIS, V143, P369, DOI 10.1111/j.1474-919X.2001.tb04938.x; Schwitzer C, 2013, WAZA MAG, V14, P23; Seddon PJ, 2013, PENGUINS: NATURAL HISTORY AND CONSERVATION, P91; SEDDON PJ, 1991, AUK, V108, P548, DOI 10.2307/4088094; Sherley RB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0237; Sherley RB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110794; Sherley RB, 2012, EMU, V112, P97, DOI 10.1071/MU11055; Tollini J, 2007, HAND REARING BIRDS, P67; Turner Wendy A., 1998, Penguin Conservation, V11, P2; Underhill LG, 1999, IBIS, V141, P29; Vargas FH, 2006, BIOL CONSERV, V127, P107, DOI 10.1016/j.biocon.2005.08.001; Wallace R, 2005, PENGUIN TAXON ADVISO, P87; Wolfaardt AC, 2008, AFR J MAR SCI, V30, P421, DOI 10.2989/AJMS.2008.30.2.14.564; Wolfaardt Anton C., 2003, P18	45	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205126	10.1371/journal.pone.0205126	http://dx.doi.org/10.1371/journal.pone.0205126			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403662	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500011
J	Toulis, KA; Jiang, CQ; Hemming, K; Nirantharakumar, K; Cheng, KK; Lam, TH; Thomas, GN				Toulis, Konstantinos A.; Jiang, Chao Q.; Hemming, Karla; Nirantharakumar, Krishnarajah; Cheng, Kar K.; Lam, Tai H.; Thomas, G. Neil			Discriminatory performance of adiponectin and leptin in the identification of impaired glucose tolerance: The Guangzhou Biobank Cohort Study - Cardiovascular Disease Subcohort	PLOS ONE			English	Article							INSULIN-RESISTANCE; RISK; ADIPOCYTOKINES; WOMEN; COMPLICATIONS; BIOMARKERS; GLYCEMIA; ALPHA; RATIO	Background To evaluate the additional discriminatory performance of adiponectin, leptin, and their ratio in the identification of impaired glucose tolerance (IGT) in men and women without diabetes on top of conventional risk factors. Methods & results A total of 698 subjects underwent an oral glucose tolerance test (oGTT) and adipocytokine measurements. A comprehensive stepwise selection procedure was performed, followed by c-statistics and integrated discrimination improvement (IDI) analysis. In males, adiponectin levels were significantly lower in the IGT group compared to the non-IGT group (Whitney U test, p < 10-4), whereas leptin levels were significantly higher (p = 0.009) in IGT group. In females, adiponectin and leptin levels were not significantly different between groups (Mann-Whitney U test, p = 0.073 and p = 0.08, respectively). Adjusting for the most informative, sex-specific, clinical and biochemical factors, adiponectin, leptin and their ratio were not found to be significant predictors of the response to the glucose load, when modelled as continuous terms or tertiles. In males, the area-under-the-curve (AUC) for adiponectin was estimated at 0.620 (95% CI: 0.558-0.682) and the addition of adiponectin into the basic model provided a Delta AUC benefit of 0.004, showing no additional discriminatory benefit on top of conventional risk factors (IDI p-value: 0.27), nor did the addition of leptin or their ratio. The results were similar in females. Conclusions In Chinese individuals without diabetes, no significant evidence for the potential discriminatory value of adiponectin, leptin or their ratio in the identification of IGT on top of conventional risk factors was observed.	[Toulis, Konstantinos A.; Hemming, Karla; Nirantharakumar, Krishnarajah; Cheng, Kar K.; Thomas, G. Neil] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Toulis, Konstantinos A.] Dept Endocrinol, Thessaloniki, Greece; [Jiang, Chao Q.] Guangzhou Occupat Dis Prevent & Treatment Ctr, Guangzhou, Guangdong, Peoples R China; [Lam, Tai H.] Univ Hong Kong, Dept Community Med, Pokfulam, Hong Kong, Peoples R China; [Thomas, G. Neil] Heidelberg Univ, Mannheim Med Fac, Inst Publ Hlth Social & Prevent Med, Mannheim, Germany	University of Birmingham; University of Hong Kong; Ruprecht Karls University Heidelberg	Hemming, K (corresponding author), Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England.	k.hemming@bham.ac.uk	Hemming, karla/AAB-3391-2021; Cheng, Kar/AAL-8899-2021; Lam, Tai Hing/C-4317-2009	Hemming, karla/0000-0002-2226-6550; Cheng, Kar/0000-0002-1516-1857; Lam, Tai Hing/0000-0002-2033-9971	European Society of Endocrinology (ENDO ESE International Endocrine Scholarship); University of Hong KongFoundation for Education Development and Research; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau; Graduate School for Health Research at the University of Groningen (SHARE); University of Birmingham	European Society of Endocrinology (ENDO ESE International Endocrine Scholarship); University of Hong KongFoundation for Education Development and Research; Guangzhou Public Health Bureau; Guangzhou Science and Technology Bureau; Graduate School for Health Research at the University of Groningen (SHARE); University of Birmingham	KAT was supported by the European Society of Endocrinology (ENDO ESE International Endocrine Scholarship) during the preparation of the manuscript. This study was supported by the University of Hong KongFoundation for Education Development and Research, the Guangzhou Public Health Bureau, the Guangzhou Science and Technology Bureau, Graduate School for Health Research at the University of Groningen (SHARE), and the University of Birmingham. The authors received no specific funding for this work.	Abbasi F, 2004, DIABETES, V53, P585, DOI 10.2337/diabetes.53.3.585; Ceriello A, 2005, DIABETES, V54, P1, DOI 10.2337/diabetes.54.1.1; Cheung BMY, 2009, CLIN ENDOCRINOL, V70, P561, DOI 10.1111/j.1365-2265.2008.03361.x; Choi YS, 2012, STEROIDS, V77, P1352, DOI 10.1016/j.steroids.2012.08.005; Esteve E, 2009, DIABETES CARE, V32, pS362, DOI 10.2337/dc09-S340; Faerch K, 2008, DIABETOLOGIA, V51, P853, DOI 10.1007/s00125-008-0951-x; Faerch K, 2009, DIABETOLOGIA, V52, P1714, DOI 10.1007/s00125-009-1443-3; Gavin JR, 1997, DIABETES CARE, V20, P1183; HOSMER DW, 2000, WILEY PS TX, P1; Inoue M, 2005, METABOLISM, V54, P281, DOI 10.1016/j.metabol.2004.09.006; Jiang CQ, 2010, J HUM HYPERTENS, V24, P139, DOI 10.1038/jhh.2009.52; Kadowaki T, 2005, ENDOCR REV, V26, P439, DOI 10.1210/er.2005-0005; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Ko GTC, 2010, DIABETES METAB, V36, P192, DOI 10.1016/j.diabet.2009.11.007; Kolberg JA, 2009, DIABETES CARE, V32, P1207, DOI 10.2337/dc08-1935; Lee YH, 2011, METABOLISM, V60, P1664, DOI 10.1016/j.metabol.2011.04.008; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Mantzoros CS, 2011, AM J PHYSIOL-ENDOC M, V301, pE567, DOI 10.1152/ajpendo.00315.2011; Mente A, 2010, DIABETES CARE, V33, P1629, DOI 10.2337/dc09-1392; Nakashima Y, 2008, METABOLISM, V57, P1350, DOI 10.1016/j.metabol.2008.05.001; Nishizawa H, 2002, DIABETES, V51, P2734, DOI 10.2337/diabetes.51.9.2734; Ong KL, 2011, DIABETOLOGIA, V54, P2552, DOI 10.1007/s00125-011-2227-0; Otsuka F, 2007, CIRC J, V71, P1703, DOI 10.1253/circj.71.1703; Ozeki N, 2009, METABOLISM, V58, P1470, DOI 10.1016/j.metabol.2009.04.042; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Rasmussen JJ, 2017, CLIN ENDOCRINOL, V87, P249, DOI 10.1111/cen.13372; Rasouli N, 2008, J CLIN ENDOCR METAB, V93, pS64, DOI 10.1210/jc.2008-1613; Raz I, 2011, DIABETES CARE, V34, P1511, DOI 10.2337/dc10-2375; Thorand B, 2010, DIABETIC MED, V27, P1004, DOI 10.1111/j.1464-5491.2010.03043.x; Tominaga M, 1999, DIABETES CARE, V22, P920, DOI 10.2337/diacare.22.6.920; Toulis KA, 2018, CAN J DIABETES, V42, P245, DOI 10.1016/j.jcjd.2017.06.001; Tso AWK, 2006, DIABETOLOGIA, V49, P1806, DOI 10.1007/s00125-006-0324-2; Wu HY, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000191; Ziemke F, 2010, AM J CLIN NUTR, V91, p258S, DOI 10.3945/ajcn.2009.28449C	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206964	10.1371/journal.pone.0206964	http://dx.doi.org/10.1371/journal.pone.0206964			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399195	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000035
J	Elie, AGIM; Bloksgaard, M; Sun, WY; Yang, KM; Man, AWC; Xu, AM; Irmukhamedov, A; Riber, LP; Wang, Y; De Mey, JGR				Elie, Atlanta G. I. M.; Bloksgaard, Maria; Sun, Wai Y.; Yang, Kangmin; Man, Andy W. C.; Xu, Aimin; Irmukhamedov, Akhmadjon; Riber, Lars P.; Wang, Yu; De Mey, Jo G. R.			Local enrichment of fatty acid-binding protein 4 in the pericardial cavity of cardiovascular disease patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; EPICARDIAL ADIPOSE-TISSUE; NATRIURETIC PEPTIDE LEVELS; CORONARY-ARTERY-DISEASE; CHRONIC HEART-FAILURE; INSULIN-RESISTANCE; HUMAN ADIPOCYTES; IN-VIVO; ADIPONECTIN; FLUID	Background The pericardial fluid may be representative of the interstitium of the heart. The aim of this study was to discriminate in cardiovascular disease patients between adipocytokines that are produced locally by the heart and those supplied by the circulation. Methods Enzyme-linked immunosorbent assays (ELISA) were used to determine levels of N-terminal pro-brain natriuretic peptide (NT-pBNP), fatty acid-binding protein 4 (FABP4), leptin, lipocalin-2, neutrophil elastase, proteinase-3, high sensitivity C-reactive protein (hsCRP) and adiponectin in venous plasma and pericardial fluid harvested during elective cardio-thoracic surgery (n = 132-152). Results In pericardial fluid compared to plasma, the levels were significantly smaller (p < 0.001) for leptin, lipocalin-2, neutrophil elastase, proteinase-3, hsCRP and adiponectin. For these biomarkers, the ratio of pericardial fluid-to-plasma level ([PF]/[P], median (interquartile range)) was 0.65 (0.47-1.01), 0.78 (0.56-1.09), 0.23 (0.11-0.60), 0.17 (0.09-0.36), 0.14 (0.08-0.35), and 0.25 (0.15-0.34), respectively. In contrast, pericardial fluid was significantly enriched (p < 0.001) in NT-pBNP ([PF]/[P]: 1.9 (1.06-2.73)) and even more so for FABP4 ([PF]/[P]: 3.90 (1.47-9.77)). Moreover, in pericardial fluid, the adipocytokines interrelated all significantly positive and correlated negative to hsCRP, whereas for NT-pBNP only a significantly positive correlation with adiponectin was found. These interrelations were distinct from those in the plasma, as were the correlations of the pericardial biomarkers with patient characteristics compared to plasma. Conclusions In cardiovascular disease patients, the pericardial cavity is a distinct adipocytokine microenvironment in which especially FABP4 is mainly derived from the heart.	[Elie, Atlanta G. I. M.; Bloksgaard, Maria; De Mey, Jo G. R.] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense C, Denmark; [Sun, Wai Y.; Yang, Kangmin; Man, Andy W. C.; Xu, Aimin; Wang, Yu] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Pharmaceut Biotechnol, Hong Kong, Hong Kong, Peoples R China; [Sun, Wai Y.; Yang, Kangmin; Man, Andy W. C.; Wang, Yu] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Irmukhamedov, Akhmadjon; Riber, Lars P.; De Mey, Jo G. R.] Odense Univ Hosp, Dept Cardiac Thorac & Vasc Surg, Odense C, Denmark	University of Southern Denmark; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Southern Denmark; Odense University Hospital	De Mey, JGR (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense C, Denmark.; De Mey, JGR (corresponding author), Odense Univ Hosp, Dept Cardiac Thorac & Vasc Surg, Odense C, Denmark.	jdemey@health.sdu.dk	Riber, Lars Peter Schødt/GRR-9540-2022; Riber, Lars/GWZ-4712-2022	Riber, Lars Peter Schødt/0000-0001-6898-2715; Man, Andy WC/0000-0002-4113-6479; wang, yu/0000-0001-8697-2940; De Mey, Jo G. R./0000-0001-6274-8071	Odense University Hospital; University of Southern Denmark; Danish Council for Independent Research [DFF-4092-00098]; Direktor Kurt Bonnelycke og hustru fru Grethe Bonnelyckes Fond; Hong Kong Research Grant Council [17121714, HKU780613M, HKU763312M]; Collaborative Research Funds of Hong Kong [C7055-14G]; National Basic Research Program of China [973 Program] [2015CB553603]	Odense University Hospital; University of Southern Denmark; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Direktor Kurt Bonnelycke og hustru fru Grethe Bonnelyckes Fond; Hong Kong Research Grant Council(Hong Kong Research Grants Council); Collaborative Research Funds of Hong Kong; National Basic Research Program of China [973 Program](National Basic Research Program of China)	This work was supported by the Odense University Hospital, the University of Southern Denmark, the Danish Council for Independent Research [DFF-4092-00098], the Direktor Kurt Bonnelycke og hustru fru Grethe Bonnelyckes Fond and by grants from the Hong Kong Research Grant Council [17121714, HKU780613M and HKU763312M]; Collaborative Research Funds [C7055-14G] of Hong Kong; and National Basic Research Program of China [973 Program 2015CB553603]. It was conducted within the frame of the elite research centre CIMA - Centre for Individualized Medicine in Arterial Diseases of the Odense University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonopoulos AS, 2016, CIRC RES, V118, P842, DOI 10.1161/CIRCRESAHA.115.307856; Birkenfeld AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043238; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Chiu CZ, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-014-0109-8; CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244; Gomes RAD, 2008, ARQ BRAS CARDIOL, V91, P172, DOI 10.1590/S0066-782X2008001500006; Ding GL, 2007, J MOL CELL CARDIOL, V43, P73, DOI 10.1016/j.yjmcc.2007.04.014; Ding LM, 2010, CIRC J, V74, P523, DOI 10.1253/circj.CJ-09-0485; Ebinuma H, 2006, CLIN CHIM ACTA, V372, P47, DOI 10.1016/j.cca.2006.03.014; El-Eshmawy MM, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-1; Elie AGIM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154693; Essick EE, 2011, AM J PHYSIOL-HEART C, V301, pH984, DOI 10.1152/ajpheart.00428.2011; Furuhashi M, 2016, ARTERIOSCL THROM VAS, V36, P825, DOI 10.1161/ATVBAHA.116.307225; GIBSON AT, 1978, J PHYSIOL-LONDON, V277, P367, DOI 10.1113/jphysiol.1978.sp012277; Haider DG, 2006, CLIN EXP IMMUNOL, V146, P533, DOI 10.1111/j.1365-2249.2006.03224.x; Horkay F, 1997, LIFE SCI, V62, P267, DOI 10.1016/S0024-3205(97)01105-3; JANOFF A, 1985, ANNU REV MED, V36, P207; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Klemola R, 2001, EUR J HEART FAIL, V3, P21, DOI 10.1016/S1388-9842(00)00090-8; Kotulak T, 2014, PHYSIOL RES, V63, P83, DOI 10.33549/physiolres.932574; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Laham RJ, 2003, CATHETER CARDIO INTE, V58, P375, DOI 10.1002/ccd.10378; Li L, 2009, CYTOKINE, V45, P12, DOI 10.1016/j.cyto.2008.10.006; Li ZY, 2011, CLIN EXP PHARMACOL P, V38, P888, DOI 10.1111/j.1440-1681.2011.05602.x; Liu MY, 2013, CLIN SCI, V124, P115, DOI 10.1042/CS20120004; McGaffin KR, 2009, CIRC-HEART FAIL, V2, P676, DOI 10.1161/CIRCHEARTFAILURE.109.869909; Mueller T, 2004, CLIN CHIM ACTA, V341, P41, DOI 10.1016/j.cccn.2003.10.027; Neeland IJ, 2013, J AM COLL CARDIOL, V62, P752, DOI 10.1016/j.jacc.2013.03.038; Nemeth Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135498; OSMAND AP, 1977, P NATL ACAD SCI USA, V74, P739, DOI 10.1073/pnas.74.2.739; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Selmeci L, 2000, CORONARY ARTERY DIS, V11, P53, DOI 10.1097/00019501-200002000-00010; Sharony R, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-45; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Teijeira-Fernandez E, 2008, J HUM HYPERTENS, V22, P856, DOI 10.1038/jhh.2008.75; Teijeira-Fernandez E, 2011, CYTOKINE, V54, P185, DOI 10.1016/j.cyto.2011.01.016; Tsukamoto O, 2009, J AM COLL CARDIOL, V53, P2070, DOI 10.1016/j.jacc.2009.02.038; Visser M, 1999, JAMA-J AM MED ASSOC, V282, P2131, DOI 10.1001/jama.282.22.2131; Von Eynatten M, 2006, CLIN CHEM, V52, P853, DOI 10.1373/clinchem.2005.060509; Watanabe M, 2009, CLIN CARDIOL, V32, P159, DOI 10.1002/clc.20306; Wu GY, 2014, ARTERIOSCL THROM VAS, V34, P2457, DOI 10.1161/ATVBAHA.114.303718; Xiang F, 2013, PROTEOMICS, V13, P2692, DOI 10.1002/pmic.201200317; Xu AM, 2012, AM J PHYSIOL-HEART C, V302, pH1231, DOI 10.1152/ajpheart.00765.2011; Yang K, 2017, ESC HEART FAILURE; YASUE H, 1994, CIRCULATION, V90, P195, DOI 10.1161/01.CIR.90.1.195; Yndestad A, 2009, EUR HEART J, V30, P1229, DOI 10.1093/eurheartj/ehp088	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206802	10.1371/journal.pone.0206802	http://dx.doi.org/10.1371/journal.pone.0206802			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395653	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400055
J	Hussain, A; Zaheer, S; Shafique, K				Hussain, Azmina; Zaheer, Sidra; Shafique, Kashif			School-based behavioral intervention to reduce the habit of smokeless tobacco and betel quid use in high-risk youth in Karachi: A randomized controlled trial	PLOS ONE			English	Article							ORAL-CANCER; METAANALYSIS; BIOLOGY; HEALTH	There have been recent surges in the use of smokeless tobacco (SLT) and betel quid (BQ) chew among adolescents in South East Asian countries, with an increase, on average, of 7% to 15% between 2004 and 2013, necessitating interventional investigations to modify this behavior. The current intervention was aimed towards changing adolescents' perceptions regarding the harmful effects of SLT and BQ use and encouraging them to quit. This randomized control trial involved 2140 adolescents from 26 private and public-sector schools in Karachi, Pakistan. After randomization, 1185 individuals were placed in the intervention group and administered a behavior changing intervention (BCI), while 955 individuals constituted the control group. A generalized estimating equation was employed to measure differences in repeated measures for both groups. The beta coefficients were reported after adjusting the covariates with the 95% confidence interval, and the p-value was considered significant at <0.050. Cohen's d was employed to report the effect size of the intervention. The BCI resulted in a 0.176-unit (95% CI 0.078-0.274, p-value <0.001) increase in knowledge scores regarding the health hazards of SLT and BQ, a 0.141-unit (95% CI 0.090-0.192, p-value <0.001) increase in use perception scores, and a 0.067-unit (95% CI 0.006-0.129, p-value 0.031) increase in quit perception scores in the intervention group compared with those in the control group. A knowledge related module (p-value 0.024) and quit preparation module (p-value 0.005) were found to be helpful by adolescents in either changing their perceptions regarding SLT and/or BQ chew use or in quitting. The role of BCI is promising in improving adolescents' knowledge and changing their perceptions in a positive manner regarding their harmful SLT and BQ use. Convincing results may be achieved if interventions are tailored, with an emphasis on the identification of the products that are used by adolescents in addition to highlighting their ill effects and how students may manage to quit them. If included in the schools' curricula, this BCI method may help in developing schools that are free of SLT and BQ use.	[Hussain, Azmina] Dow Univ Hlth Sci, Dr Ishrat Ul Ibad Khan Inst Oral Hlth Sci, Karachi, Pakistan; [Zaheer, Sidra; Shafique, Kashif] Dow Univ Hlth Sci, Sch Publ Hlth, Karachi, Pakistan; [Shafique, Kashif] Univ Glasgow, Inst Hlth & Wellbeing, Publ Hlth, Glasgow, Lanark, Scotland	Dow University of Health Sciences; Dow University of Health Sciences; University of Glasgow	Hussain, A (corresponding author), Dow Univ Hlth Sci, Dr Ishrat Ul Ibad Khan Inst Oral Hlth Sci, Karachi, Pakistan.	azmina.hussain@duhs.edu.pk		Shafique, Kashif/0000-0001-7151-5122; , AZMINA/0000-0001-5244-5333				Ali TS, 2013, INT J BEHAV MED, V20, P131, DOI 10.1007/s12529-011-9201-6; Anwar Shahid, 2005, Prim Dent Care, V12, P5, DOI 10.1308/1355761052894176; Arrazola Rene A, 2017, MMWR Morb Mortal Wkly Rep, V66, P533, DOI 10.15585/mmwr.mm6620a3; Bennett S, 1991, SIMPLIFIED GEN METHO; Biglan A, 2000, TOB CONTROL, V9, P24, DOI 10.1136/tc.9.1.24; Boucher BJ, 2002, ADDICT BIOL, V7, P103, DOI 10.1080/13556210120091464; Cai YD, 2015, CURR BIOINFORM, V10, P3, DOI 10.2174/157489361001150309120940; Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Danaher Brian G, 2015, Internet Interv, V2, P143, DOI 10.1016/j.invent.2015.02.005; Ebbert J, 2011, COCHRANE DATABASE SY, V2; Ebbert JO, 2007, COCHRANE DATABASE SY, V4; Ebbert JO, 2015, INTERVENTIONS SMOKEL; Gansky SA, 2005, J ATHL TRAINING, V40, P76; Gupta PC, 2003, RESPIROLOGY, V8, P419, DOI 10.1046/j.1440-1843.2003.00507.x; Gupta R, 2018, RISK CORONARY HEART; Hussain A, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4916-1; Macy JT, 2016, NICOTINE TOB RES, V18, P186, DOI 10.1093/ntr/ntv070; Mbongwe B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175640; Michie S, 2011, ADDICT BEHAV, V36, P315, DOI 10.1016/j.addbeh.2010.11.016; Moher D, 2001, CONSORT STATEMENT RE; Nair U, 2004, MUTAGENESIS, V19, P251, DOI 10.1093/mutage/geh036; NICE, SMOKL TOB CESS S AS; Organization WH, 2018, CATCH APPR SMOK TOB; Siddiqi K, 2015, NICOTINE TOB RES; Siddiqi K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3177-8; Siddiqi K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0424-2; Siddiqi K, 2013, LANCET GLOB HEALTH, V1, pE71, DOI 10.1016/S2214-109X(13)70021-4; Sinha DN, 2016, INT J CANCER, V138, P1368, DOI 10.1002/ijc.29884; Sundquist E, ROLE TUMOR MICROENVI; Thomas RE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006976; Thomas SJ, 2007, INT J CANCER, V120, P1318, DOI 10.1002/ijc.22304; Walsh MM, 2010, NICOTINE TOB RES, V12, P543, DOI 10.1093/ntr/ntq022; Walsh MM, 1999, AM J PUBLIC HEALTH, V89, P228, DOI 10.2105/AJPH.89.2.228; Walsh MM, 2003, ADDICT BEHAV, V28, P1095, DOI 10.1016/S0306-4603(02)00228-9; Warnakulasuriya S, 2002, ADDICT BIOL, V7, P75, DOI 10.1080/13556210020091428; Warren CW, 2006, LANCET, V367, P749, DOI 10.1016/S0140-6736(06)68192-0; WHO, 2010, GLOBAL YOUTH TOBACCO; Winstock A, 2002, ADDICT BIOL, V7, P133, DOI 10.1080/13556210120091509; Wray JM, 2017, NICOTINE TOBACCO RES; Zhu CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080482	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206919	10.1371/journal.pone.0206919	http://dx.doi.org/10.1371/journal.pone.0206919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388182	Green Published, Green Accepted, gold			2022-12-26	WOS:000449289800070
J	McMenamin, SB; Cummins, SE; Zhuang, YL; Gamst, AC; Ruiz, CG; Mayoral, A; Zhu, SH				McMenamin, Sara B.; Cummins, Sharon E.; Zhuang, Yue-Lin; Gamst, Anthony C.; Ruiz, Carlos G.; Mayoral, Antonio; Zhu, Shu-Hong			Evaluation of the Tobacco-Use Prevention Education (TUPE) program in California	PLOS ONE			English	Article							UNITED-STATES; DRUG-ABUSE; SMOKING; PROJECT	Background and aims The California Tobacco-Use Prevention Education (TUPE) program promotes the use of evidence-based tobacco-specific prevention and cessation programs for adolescents within the school setting. Through a competitive grant process, schools are funded to provide programs for grades 6-12. This research evaluates the association between TUPE funding and tobacco prevention activities and tobacco use prevalence. Methods This study utilized two data sources: (1) 2016 California Educator Tobacco Survey (CETS), and (2) 2015-2016 California Student Tobacco Survey (CSTS). The CETS collected data from educators about school prevention efforts, priority of tobacco prevention, and confidence in addressing tobacco issues with students. A total of 3,564 educators from 590 schools participated in CETS. The CSTS collected data from 8th, 10th, and 12th graders in California on their exposure to, attitudes about, and utilization of tobacco products. A total of 47,981 students from 117 schools participated in CSTS. Results This study found that TUPE-funded schools were more likely to provide tobacco-specific health education programs, to place a priority on tobacco-prevention efforts, and to prepare educators to address tobacco use than non-TUPE schools. Educators at both types of schools felt better prepared to talk with students about traditional tobacco products than about emerging products such as e-cigarettes. Overall, students at TUPE-funded schools were more likely to report receiving anti-tobacco messages from school-based programs than those at non-TUPE schools. The former were also less likely to use tobacco products, even when the analysis controlled for demographics and school-level characteristics (OR = 0.82 [95% CI = 0.70-0.96]). Conclusions TUPE funding was associated with an increase in schools' tobacco-specific prevention activities and these enhanced activities were associated with lower tobacco use among students. This study also found that education and prevention efforts regarding emerging tobacco products need to be strengthened across all schools.	[McMenamin, Sara B.; Cummins, Sharon E.; Zhu, Shu-Hong] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Cummins, Sharon E.; Zhuang, Yue-Lin; Ruiz, Carlos G.; Mayoral, Antonio; Zhu, Shu-Hong] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Gamst, Anthony C.] Univ Calif San Diego, Dept Math, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhu, SH (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.; Zhu, SH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.	szhu@ucsd.edu	Zhu, Shu-Hong/AAF-5164-2019; Gamst, Anthony/AAH-9440-2019	Cummins, Sharon/0000-0003-3481-8436	Tobacco-Related Disease Research Program (TRDRP) [24GT-0040H]; California Department of Public Health [CDPH-15-10249, CDPH-18-10074, CDPH-14-10383, CDPH-16-10109]; California Department of Education [CN150358, CN170384]	Tobacco-Related Disease Research Program (TRDRP)(University of California System); California Department of Public Health; California Department of Education	This study was jointly funded by the Tobacco-Related Disease Research Program (TRDRP) grant number 24GT-0040H, the California Department of Public Health (contract numbers CDPH-15-10249 and CDPH-18-10074), and the California Department of Education (contract numbers CN150358 and CN170384). The California Student Tobacco Survey (CSTS) was supported by a contract from the California Department of Public Health (contract numbers CDPH-14-10383 and CDPH-16-10109). The study funders did not play any role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Bast LS, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0490-7; BOTVIN GJ, 1990, J CONSULT CLIN PSYCH, V58, P437, DOI 10.1037/0022-006X.58.4.437; California Department of Education, 2016, REQ APPL TOB US PREV; California Department of Public Health California Tobacco Control Program, 2010, 2 DEC CAL TOB CONTR; Chen A., 2017, TEENAGERS EMBRACE JU; de Kleijn MJJ, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0082-7; Flay Brian R, 2009, Tob Induc Dis, V5, P6, DOI 10.1186/1617-9625-5-6; Food and Drug Administration HHS, 2016, Fed Regist, V81, P28973; Lee YO, 2014, PREV MED, V62, P14, DOI 10.1016/j.ypmed.2014.01.014; Loken B., 2008, TOBACCO CONTROL MONO, V19; McCarthy WJ, 2005, EVALUATION OF THE IN; McNeill A., 2015, REPORT COMMISSIONED; Messer K, 2010, AM J PUBLIC HEALTH, V100, P1298, DOI 10.2105/AJPH.2009.160416; Park HY, 2010, TOB CONTROL, V19, pI43, DOI 10.1136/tc.2009.030700; Peterson AV, 2000, JNCI-J NATL CANCER I, V92, P1979, DOI 10.1093/jnci/92.24.1979; Singh T, 2016, MMWR-MORBID MORTAL W, V65, P361, DOI 10.15585/mmwr.mm6514a1; Skara S, 2003, PREV MED, V37, P451, DOI 10.1016/S0091-7435(03)00166-X; Sullum J., 2016, FORBES; Sussman S, 2002, AM J HEALTH BEHAV, V26, P354, DOI 10.5993/AJHB.26.5.4; Thomas RE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006976; Thomas RE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001293.pub3; Tobacco-Related Disease Research Program (TRDRP), 2014, REQ APPL RFA SCI EV; US Department of Health and Human Services (USD-HHS), 2012, PREV TOB UYOUTH YO; Wiehe SE, 2005, J ADOLESCENT HEALTH, V36, P162, DOI 10.1016/j.jadohealth.2004.12.003	24	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206921	10.1371/journal.pone.0206921	http://dx.doi.org/10.1371/journal.pone.0206921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388176	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800071
J	Gilannejad, N; Martinez-Rodriguez, G; Yufera, M; Moyano, FJ				Gilannejad, Neda; Martinez-Rodriguez, Gonzalo; Yufera, Manuel; Moyano, Francisco J.			Modelling digestive hydrolysis of nutrients in fish using factorial designs and desirability function	PLOS ONE			English	Article							RESPONSE-SURFACE METHODOLOGY; IN-VITRO DIGESTIBILITY; SEABREAM SPARUS-AURATA; GILTHEAD SEABREAM; GASTROINTESTINAL MODEL; CHEMICAL REACTORS; DAILY RHYTHMS; MARINE FISH; PH-STAT; PROTEIN	Models simulating the in vitro digestive hydrolysis of nutrients by different animal species are frequently used to obtain a better understanding of factors affecting this process. Optimization algorithm of a model may be used to prospect the more favourable combination of selected factors resulting in the higher performance. This study was conducted to determine the combination of factors (pH, enzyme: substrate ratio, and reaction time) leading to highest bioavailability of proteins and carbohydrates in the gilthead seabream gastrointestinal tract. Besides, a novel multi-objective algorithm, desirability function, was introduced for optimization of the digestive hydrolysis of nutrients within the simulated gut of the species, using models based on the Response Surface Methodology. Design of experiment was defined based on the physiology and culture conditions of the species, and in vitro assays were performed in a two-phase (stomach ad intestine) digestion process, using the species-specific enzyme extract. According to results, intestinal phase of digestion makes the major contribution to the total protein hydrolysis, being the efficiency of the process directly correlated to all the three studied factors. In contrast, the efficiency of carbohydrate hydrolysis was directly correlated to the amount of substrate and inversely to the pH, while reaction time did not exert a significant effect. The physiological range of the factors studied in the assays favoured the hydrolysis of proteins over carbohydrates, a similar scenario to that observed in the live fish. Results from the mathematical models and their simultaneous optimization obtained from this work may have practical applications in design of feeds for this species.	[Gilannejad, Neda; Martinez-Rodriguez, Gonzalo; Yufera, Manuel] CSIC, Inst Ciencias Marinas Andalucia ICMAN, Puerto Real, Spain; [Moyano, Francisco J.] Univ Almeria, Dept Biol & Geol, Fac Ciencias, Campus Excelencia Int Mar CEI MAR, La Canada De San Urbano, Almeria, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Almeria	Moyano, FJ (corresponding author), Univ Almeria, Dept Biol & Geol, Fac Ciencias, Campus Excelencia Int Mar CEI MAR, La Canada De San Urbano, Almeria, Spain.	fjmoyano@ual.es	Gilannejad, Neda/G-8096-2018; Moyano, Francisco Javier/K-9997-2017; MARTINEZ-RODRIGUEZ, GONZALO/A-2564-2009	Moyano, Francisco Javier/0000-0002-0754-1809; MARTINEZ-RODRIGUEZ, GONZALO/0000-0003-3379-580X; Yufera, Manuel/0000-0003-2999-4611; Gilannejad, Neda/0000-0003-0843-2484	Spanish Ministry of Economy, Industry and Competitiveness (MINECO); FEDER/ERDF [AGL2014-52888-R]; project WISEFEED - European Union [691150]; MINECO [BES-2015-071662]	Spanish Ministry of Economy, Industry and Competitiveness (MINECO)(Spanish Government); FEDER/ERDF; project WISEFEED - European Union; MINECO(Spanish Government)	This research was funded by the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) with FEDER/ERDF contribution by project EFISHDIGEST (AGL2014-52888-R) to MY. Additional funding from project WISEFEED funded by the European Union's H2020 programme (Marie Sklodowska-Curie grant No 691150). NG is supported by a grant from MINECO (BES-2015-071662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon FJ, 1999, AQUACULT NUTR, V5, P107; Alarcon FJ, 2002, J SCI FOOD AGR, V82, P697, DOI 10.1002/jsfa.1100; Alarcon FJ, 2001, HYDROBIOLOGIA, V445, P199, DOI 10.1023/A:1017521900442; Anderson-Cook C.M., 2016, RESPONSE SURFACE MET; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; Arun VV, 2017, SCI REP-UK, V7, DOI 10.1038/srep40394; BERNFELD P, 1955, METHOD ENZYMOL, V1, P149, DOI 10.1016/0076-6879(55)01021-5; Candioti LV, 2014, TALANTA, V124, P123, DOI 10.1016/j.talanta.2014.01.034; CHURCH FC, 1983, J DAIRY SCI, V66, P1219, DOI 10.3168/jds.S0022-0302(83)81926-2; Ciesielski W, 2003, CARBOHYD POLYM, V51, P47, DOI 10.1016/S0144-8617(02)00108-X; Clements Kendall D., 2006, P47; de Jonge LH, 2009, ANIM FEED SCI TECH, V153, P249, DOI 10.1016/j.anifeedsci.2009.06.016; DERRINGER G, 1980, J QUAL TECHNOL, V12, P214, DOI 10.1080/00224065.1980.11980968; Dey SS, 2014, J FOOD SCI TECH MYS, V51, P16, DOI 10.1007/s13197-011-0455-4; Diaz-Lopez M, 1998, COMP BIOCHEM PHYS B, V121, P369, DOI 10.1016/S0305-0491(98)10123-2; Fernandez-Pardo A, 2016, AQUACULTURE, V452, P283, DOI 10.1016/j.aquaculture.2015.11.005; Franco OL, 2002, EUR J BIOCHEM, V269, P397, DOI 10.1046/j.0014-2956.2001.02656.x; FRUTON JS, 1970, ADV ENZYMOL REL S BI, V33, P401; Gao W, 2015, ARTIF CELL NANOMED B, V43, P196, DOI 10.3109/21691401.2015.1011807; German DP, 2009, J COMP PHYSIOL B, V179, P759, DOI 10.1007/s00360-009-0359-z; Gilannejad N, 2017, AQUACULTURE, V477, P28, DOI 10.1016/j.aquaculture.2017.04.037; GRANATO D, 2014, MATH STAT METHODS FO, P3; Hamdan M, 2009, J SCI FOOD AGR, V89, P1195, DOI 10.1002/jsfa.3574; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hemre GI, 2002, AQUACULT NUTR, V8, P175, DOI 10.1046/j.1365-2095.2002.00200.x; Higuera C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041122; Hollebeeck S, 2013, FOOD CHEM, V138, P1936, DOI 10.1016/j.foodchem.2012.11.041; HORN MH, 1992, MAR BIOL, V113, P527, DOI 10.1007/BF00349695; KARASOV WH, 1983, AM J PHYSIOL, V245, pG443, DOI 10.1152/ajpgi.1983.245.4.G443; Krogdahl A, 2005, AQUACULT NUTR, V11, P103, DOI 10.1111/j.1365-2095.2004.00327.x; Kumar S, 2007, AQUACULT NUTR, V13, P381, DOI 10.1111/j.1365-2095.2007.00488.x; KUNITZ M, 1947, J GEN PHYSIOL, V30, P291, DOI 10.1085/jgp.30.4.291; Marquez L, 2012, FISH PHYSIOL BIOCHEM, V38, P859, DOI 10.1007/s10695-011-9573-1; MATTHEWS RJ, 1981, ANAL CHIM ACTA-COMP, V5, P169, DOI 10.1016/S0003-2670(01)93491-9; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Montoya A, 2010, AQUACULTURE, V306, P315, DOI 10.1016/j.aquaculture.2010.06.023; Morales GA, 2010, AQUACULTURE, V306, P244, DOI 10.1016/j.aquaculture.2010.05.014; Moyano FJ, 2001, COMP BIOCHEM PHYS A, V128, P359, DOI 10.1016/S1095-6433(00)00315-9; Moyano FJ, 2015, REV AQUACULT, V7, P223, DOI 10.1111/raq.12065; Nikolopoulou D, 2011, COMP BIOCHEM PHYS A, V158, P406, DOI 10.1016/j.cbpa.2010.11.021; Pena E, 2017, AQUACULT NUTR, V23, P1204, DOI 10.1111/anu.12489; PENRY DL, 1986, BIOSCIENCE, V36, P310, DOI 10.2307/1310235; PENRY DL, 1987, AM NAT, V129, P69, DOI 10.1086/284623; Pujante IM, 2018, FISH PHYSIOL BIOCHEM, V44, P349, DOI 10.1007/s10695-017-0440-6; Rodriguez-Nogales JM, 2007, FOOD CHEM, V101, P634, DOI 10.1016/j.foodchem.2006.01.055; Roman-Gavilanes AI, 2015, J WORLD AQUACULT SOC, V46, P409, DOI 10.1111/jwas.12204; de Rodriganez MAS, 2011, AQUACULT NUTR, V17, P429, DOI 10.1111/j.1365-2095.2010.00820.x; Smeets-Peeters M, 1998, NUTR RES REV, V11, P45, DOI 10.1079/NRR19980005; Teixeira RSS, 2012, CARBOHYD RES, V363, P33, DOI 10.1016/j.carres.2012.09.024; Thongprajukaew K, 2013, J SCI FOOD AGR, V93, P3832, DOI 10.1002/jsfa.6314; Ulleberg Ellen K, 2011, Food Dig, V2, P52; Walter H.E., 1984, METHOD ENZYMAT AN, P270; Whelan Christopher J., 2007, P141; Yasumaru F, 2014, AQUACULTURE, V426, P74, DOI 10.1016/j.aquaculture.2014.01.012; Yufera M, 2004, MAR BIOL, V144, P863, DOI 10.1007/s00227-003-1255-9; Yufera M, 2014, CHRONOBIOL INT, V31, P1024, DOI 10.3109/07420528.2014.944265; Yufera M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033687	57	12	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206556	10.1371/journal.pone.0206556	http://dx.doi.org/10.1371/journal.pone.0206556			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383874	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600065
J	Masclee, GMC; Straatman, H; Arfe, A; Castellsague, J; Garbe, E; Herings, R; Kollhorst, B; Lucchi, S; Perez-Gutthann, S; Romio, S; Schade, R; Schink, T; Schuemie, MJ; Scotti, L; Varas-Lorenzo, C; Valkhote, VE; Villa, M; Sturkenboom, MCJM				Masclee, Gwen M. C.; Straatman, Huub; Arfe, Andrea; Castellsague, Jordi; Garbe, Edeltraut; Herings, Ron; Kollhorst, Bianca; Lucchi, Silvia; Perez-Gutthann, Susana; Romio, Silvana; Schade, Rene; Schink, Tania; Schuemie, Martijn J.; Scotti, Lorenza; Varas-Lorenzo, Cristina; Valkhote, Vera E.; Villa, Marco; Sturkenboom, Miriam C. J. M.			Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GASTROINTESTINAL TOXICITY; CARDIOVASCULAR EVENTS; CELECOXIB; HOSPITALIZATION; METAANALYSIS; ROFECOXIB; NAPROXEN; SAFETY; TRIAL	Background Use of selective COX-2 non-steroidal anti-inflammatory drugs (NSAIDs) (coxibs) has been associated with an increased risk of acute myocardial infarction (AMI). However, the risk of AMI has only been studied for very few NSAIDs that are frequently used. Objectives To estimate the risk of AMI for individual NSAIDs. Methods A nested case-control study was performed from a cohort of new NSAID users. 18 years (1999-2011) matching cases to a maximum of 100 controls on database, sex, age, and calendar time. Data were retrieved from six healthcare databases. Adjusted odds ratios (ORs) of current use of individual NSAIDs compared to past use were estimated per database. Pooling was done by two-stage pooling using a random effects model (ORmeta) and by one-stage pooling (ORpool). Results Among 8.5 million new NSAID users, 79,553 AMI cases were identified. The risk was elevated for current use of ketorolac (ORmeta 2.06; 95% CI 1.83-2.32, ORpool 1.80; 1.49-2.18) followed, in descending order of point estimate, by indometacin, etoricoxib, rofecoxib, diclofenac, fixed combination of diclofenac with misoprostol, piroxicam, ibuprofen, naproxen, celecoxib, meloxicam, nimesulide and ketoprofen (ORmeta 1.12; 1.03-1.22, ORpool 1.00; 0.86-1.16). Higher doses showed higher risk estimates than lower doses. Conclusions The relative risk estimates of AMI differed slightly between 28 individual NSAIDs. The relative risk was highest for ketorolac and was correlated with COX-2 potency, but not restricted to coxibs.	[Masclee, Gwen M. C.] Deventer Hosp, Dept Gastroenterol & Hepatol, Deventer, Netherlands; [Straatman, Huub; Herings, Ron] PHARMO Inst, Utrecht, Netherlands; [Arfe, Andrea; Romio, Silvana; Scotti, Lorenza] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Unit Biostat Epidemiol & Publ Hlth, Milan, Italy; [Castellsague, Jordi; Perez-Gutthann, Susana; Varas-Lorenzo, Cristina] RTI Hlth Solut, Barcelona, Spain; [Garbe, Edeltraut; Kollhorst, Bianca; Schink, Tania] Leibniz Inst Prevent Res & Epidemiol, Bremen, Germany; [Lucchi, Silvia; Villa, Marco] Local Hlth Author ASL Cremona, Cremona, Italy; [Romio, Silvana; Schade, Rene; Schuemie, Martijn J.] Erasmus Univ, Dept Med Informat, Med Ctr, Rotterdam, Netherlands; [Valkhote, Vera E.] Erasmus Univ, Dept Gastroenterol & Hepatol, Med Ctr, Rotterdam, Netherlands; [Sturkenboom, Miriam C. J. M.] Julius Global Hlth, Utrecht, Netherlands	Deventer Hospital; University of Milano-Bicocca; Research Triangle Institute; Leibniz Institute for Prevention Research & Epidemiology (BIPS); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Sturkenboom, MCJM (corresponding author), Julius Global Hlth, Utrecht, Netherlands.	m.c.j.sturkenboom@umcutrecht.nl	Schink, Tania/A-4585-2017; Herings, Ron/AAE-4096-2021; Scotti, Lorenza/AAB-9544-2019	Schink, Tania/0000-0002-0224-1866; Herings, Ron/0000-0002-2561-8734; Scotti, Lorenza/0000-0002-3861-9058; Perez-Gutthann, Susana/0000-0001-5798-3691	European Community [223495]	European Community(European Commission)	The research leading to the results of this study has received funding from the European Community's Seventh Framework Programme under grant agreement number 223495 - the SOS project. The funding agency had no role in the design and conduct of the study; nor in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Abraham NS, 2007, ALIMENT PHARM THER, V25, P913, DOI 10.1111/j.1365-2036.2007.03292.x; Andersohn F, 2006, CIRCULATION, V113, P1950, DOI 10.1161/CIRCULATIONAHA.105.602425; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Arfe A, 2016, BMJ, V28; Avillach P, 2009, STUD HEALTH TECHNOL, V150, P190, DOI 10.3233/978-1-60750-044-5-190; Bally M, 2017, BMJ, V357; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; BROSS IDJ, 1966, J CHRON DIS, V19, P637, DOI 10.1016/0021-9681(66)90062-2; Cannon CP, 2006, LANCET, V368, P1771, DOI 10.1016/S0140-6736(06)69666-9; Coloma PM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002862; Coloma PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072148; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; European Medicines Agency, SAF REP DICL; Farkouh ME, 2004, LANCET, V364, P675, DOI 10.1016/S0140-6736(04)16894-3; Rodriguez LAG, 2008, J AM COLL CARDIOL, V52, P1628, DOI 10.1016/j.jacc.2008.08.041; Goldstein JL, 2000, AM J GASTROENTEROL, V95, P1681; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; GROVE JS, 1991, AM J EPIDEMIOL, V134, P942, DOI 10.1093/oxfordjournals.aje.a116178; Helin-Salmivaara A, 2006, EUR HEART J, V27, P1657, DOI 10.1093/eurheartj/ehl053; Herings R, 1993, THESIS; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2007, BRIT J CLIN PHARMACO, V64, P662, DOI 10.1111/j.1365-2125.2007.02942.x; Johnsen SP, 2005, ARCH INTERN MED, V165, P978, DOI 10.1001/archinte.165.9.978; KREMER D, 1973, BMJ-BRIT MED J, V2, P216, DOI 10.1136/bmj.2.5860.216; LAMBERTS H, 1992, FAM PRACT, V9, P330, DOI 10.1093/fampra/9.3.330; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; MacDonald TM, 2017, EUR HEART J, V38, P1843, DOI 10.1093/eurheartj/ehw387; McGettigan P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001098; Nissen SE, 2016, NEW ENGL J MED, V375, P2519, DOI 10.1056/NEJMoa1611593; Olsen AMS, 2015, JAMA-J AM MED ASSOC, V313, P805, DOI 10.1001/jama.2015.0809; Olsen AMS, 2011, CIRCULATION, V123, P2226, DOI 10.1161/CIRCULATIONAHA.110.004671; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Patrignani P, 1997, J PHYSIOL PHARMACOL, V48, P623; Pigeot I, 2008, PHARMACOEPIDEM DR S, V17, P215, DOI 10.1002/pds.1545; Rahme E, 2004, DRUG SAFETY, V27, P1019, DOI 10.2165/00002018-200427130-00004; Rassen JA, 2010, MED CARE, V48, pS83, DOI 10.1097/MLR.0b013e3181d59541; Ray WA, 2009, CIRC-CARDIOVASC QUAL, V2, P155, DOI 10.1161/CIRCOUTCOMES.108.805689; Salvo F, 2011, CLIN PHARMACOL THER, V89, P855, DOI 10.1038/clpt.2011.45; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Simmonds MC, 2005, CLIN TRIALS, V2, P209, DOI 10.1191/1740774505cn087oa; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Strom BL, 2006, TXB PHARMACOEPIDEMIO; Valkhoff VE, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-192; Varas-Lorenzo C, 2013, PHARMACOEPIDEM DR S, V22, P559, DOI 10.1002/pds.3437; Vlug AE, 1999, METHOD INFORM MED, V38, P339	51	19	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0204746	10.1371/journal.pone.0204746	http://dx.doi.org/10.1371/journal.pone.0204746			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383755	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600012
J	Fu, JS; Xiong, ZH; Huang, CZ; Li, J; Yang, WJ; Han, YN; Paiboonrungruan, C; Major, MB; Chen, KN; Kang, XZ; Chen, XX				Fu, Junsheng; Xiong, Zhaohui; Huang, Caizhi; Li, Jing; Yang, Wenjun; Han, Yuning; Paiboonrungruan, Chorlada; Major, Michael B.; Chen, Ke-Neng; Kang, Xiaozheng; Chen, Xiaoxin			Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; epithelium; Nuclear factor 2 (erythroid-derived 2-like factor) (NFE2L2) (Nrf2); pentose phosphate pathway (PPP); proliferation; Esophagus; Keap1; PKM2	PYRUVATE-KINASE; CANCER METABOLISM; SIGNALING PATHWAY; BINDING-SITES; LUNG-CANCER; KEAP1; ISOFORM; IDENTIFICATION; SURVIVAL; PROTEIN	Mutations in the genes encoding nuclear factor (erythroid-derived 2)-like 2 (NRF2), Kelch-like ECH-associated protein 1 (KEAP1), and cullin 3 (CUL3) are commonly observed in human esophageal squamous cell carcinoma (ESCC) and result in activation of the NRF2 signaling pathway. Moreover, hyperactivity of the transcription factor Nrf2 has been found to cause esophageal hyperproliferation and hyperkeratosis in mice. However, the underlying mechanism is unclear. In this study, we aimed to understand the molecular mechanisms of esophageal hyperproliferation in mice due to hyperactive Nrf2. Esophageal tissues were obtained from genetically modified mice that differed in the status of the Nrf2 gene and genes in the same pathway (Nrf2(-/-), Keap1(-/-), K5Cre;Pkm2(fl/fl);Keap1(-/-), and WT) and analyzed for metabolomic profiles, Nrf2 ChIP-seq, and gene expression. We found that hyperactive Nrf2 causes metabolic reprogramming and up-regulation of metabolic genes in the mouse esophagus. One of the glycolysis genes encoding pyruvate kinase M2 (Pkm2) was not only differentially up-regulated, but also glycosylated and oligomerized, resulting in increased ATP biosynthesis. However, constitutive knockout of Pkm2 failed to inhibit this esophageal phenotype in vivo, and this failure may have been due to compensation by Pkm1 up-regulation. Transient inhibition of NRF2 or glycolysis inhibited the growth of human ESCC cells in which NRF2 is hyperactive in vitro. In summary, hyperactive Nrf2 causes metabolic reprogramming in the mouse esophagus through its transcriptional regulation of metabolic genes. Blocking glycolysis transiently inhibits cell proliferation and may therefore have therapeutically beneficial effects on NRF2(high) ESCC in humans.	[Fu, Junsheng] Fujian Agr & Forestry Univ, Coll Life Sci, Fuzhou 350002, Fujian, Peoples R China; [Fu, Junsheng; Xiong, Zhaohui; Huang, Caizhi; Paiboonrungruan, Chorlada; Chen, Xiaoxin] North Carolina Cent Univ, Canc Res Program, Julius L Chambers Biomed Biotechnol Res Inst, 700 George St, Durham, NC 27707 USA; [Li, Jing; Han, Yuning] Ningxia Med Univ, Gen Hosp, Dept Thorac Surg, Yinchuan 750004, Ningxia, Peoples R China; [Yang, Wenjun] Ningxia Med Univ, Key Lab Fertil Preservat & Maintenance, Minist Educ, Canc Inst,Gen Hosp, Yinchuan 750004, Ningxia, Peoples R China; [Major, Michael B.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Chen, Ke-Neng; Kang, Xiaozheng] Peking Univ, Dept Thorac Surg 1, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China; [Chen, Xiaoxin] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Ctr Esophageal Dis & Swallowing, Chapel Hill, NC 27599 USA	Fujian Agriculture & Forestry University; University of North Carolina; North Carolina Central University; Ningxia Medical University; Ningxia Medical University; University of North Carolina; University of North Carolina Chapel Hill; Peking University; University of North Carolina; University of North Carolina Chapel Hill	Chen, XX (corresponding author), North Carolina Cent Univ, Canc Res Program, Julius L Chambers Biomed Biotechnol Res Inst, 700 George St, Durham, NC 27707 USA.; Kang, XZ (corresponding author), Peking Univ, Dept Thorac Surg 1, Key Lab Carcinogenesis & Translat Res, Minist Educ,Canc Hosp & Inst, Beijing 100142, Peoples R China.	kangxz@hsc.pku.edu.cn; lchen@nccu.edu	Kang, Xiaozheng/CAF-6485-2022	Kang, Xiaozheng/0000-0003-0334-1487; Yang, Wenjun/0000-0001-5671-1344; Major, Michael/0000-0002-6753-8513	China Scholarship Council [201608350016]; National Institutes of Health Research [U54 AA019765, U54 CA156735, U54 MD012392]; Beijing Municipal Administration of Hospitals Youth Program Grant [QML20171106]; NATIONAL CANCER INSTITUTE [U54CA156735, U54CA156733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U54AA019765] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD012392] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beijing Municipal Administration of Hospitals Youth Program Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by China Scholarship Council Grant 201608350016, National Institutes of Health Research Grants U54 AA019765, U54 CA156735, and U54 MD012392, and Beijing Municipal Administration of Hospitals Youth Program Grant QML20171106. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Camp ND, 2012, J BIOL CHEM, V287, P6539, DOI 10.1074/jbc.M111.316471; Chen H, 2014, GUT, V63, P711, DOI 10.1136/gutjnl-2012-303731; Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036504; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen M, 2012, NAT STRUCT MOL BIOL, V19, P346, DOI 10.1038/nsmb.2219; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Cortes-Cros M, 2013, P NATL ACAD SCI USA, V110, P489, DOI 10.1073/pnas.1212780110; Dayton TL, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0179-2; Dayton TL, 2016, EMBO REP, V17, P1721, DOI 10.15252/embr.201643300; Dayton TL, 2016, GENE DEV, V30, P1020, DOI 10.1101/gad.278549.116; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Du PN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14909-5; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Hayes JD, 2006, MOL CELL, V21, P732, DOI 10.1016/j.molcel.2006.03.004; Hirotsu Y, 2012, NUCLEIC ACIDS RES, V40, P10228, DOI 10.1093/nar/gks827; Holmstrom Kira M., 2016, Current Opinion in Toxicology, V1, P80, DOI 10.1016/j.cotox.2016.10.002; Israelsen WJ, 2013, CELL, V155, P397, DOI 10.1016/j.cell.2013.09.025; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kamburov A, 2011, NUCLEIC ACIDS RES, V39, pD712, DOI 10.1093/nar/gkq1156; Kamburov A, 2009, NUCLEIC ACIDS RES, V37, pD623, DOI 10.1093/nar/gkn698; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2013, TOP CURR CHEM, V329, P163, DOI 10.1007/128_2012_339; Khan AU, 2016, EBIOMEDICINE, V3, P43, DOI 10.1016/j.ebiom.2015.11.045; Kitamura H, 2018, CANCER SCI, V109, P900, DOI 10.1111/cas.13537; Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Krail EB, 2017, ELIFE, V6, DOI [10.7554/eLife.18970, 10.7554/eLife.33173]; Lan AX, 2016, ONCOTARGET, V7, P53502, DOI 10.18632/oncotarget.10609; Lau AN, 2017, CANCER METAB, V5, DOI 10.1186/s40170-017-0172-1; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Ludtmann MHR, 2014, BIOCHEM J, V457, P415, DOI 10.1042/BJ20130863; Lunt SY, 2015, MOL CELL, V57, P95, DOI 10.1016/j.molcel.2014.10.027; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Ma Q, 2012, PHARMACOL REV, V64, P1055, DOI 10.1124/pr.110.004333; Ma SH, 2018, ANN NY ACAD SCI, V1434, P164, DOI 10.1111/nyas.13681; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mayers JR, 2017, CANCER RES, V77, P3131, DOI 10.1158/0008-5472.CAN-17-0165; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Mulvaney KM, 2016, J BIOL CHEM, V291, P23719, DOI 10.1074/jbc.M116.729418; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Ramadori P, 2016, FREE RADICAL BIO MED, V91, P114, DOI 10.1016/j.freeradbiomed.2015.12.014; Rolfs F, 2015, CANCER RES, V75, P4817, DOI 10.1158/0008-5472.CAN-15-0614; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; Sabouny R, 2017, ANTIOXID REDOX SIGN, V27, P1447, DOI 10.1089/ars.2016.6855; Saito T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12030; Sano S, 1999, EMBO J, V18, P4657, DOI 10.1093/emboj/18.17.4657; Sayin VI, 2017, ELIFE, V6, DOI 10.7554/eLife.28083; Shibata T, 2011, NEOPLASIA, V13, P864, DOI 10.1593/neo.11750; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Su CH, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00466-16; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Suzuki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14577; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vander Heiden MG, 2017, CELL, V168, DOI 10.1016/j.cell.2016.12.039; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Wang H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6095; Wang Y, 2017, P NATL ACAD SCI USA, V114, P13732, DOI 10.1073/pnas.1704145115; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wu XC, 2007, CANCER CAUSE CONTROL, V18, P585, DOI 10.1007/s10552-007-9000-1; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zhu JY, 2016, FREE RADICAL BIO MED, V99, P544, DOI 10.1016/j.freeradbiomed.2016.09.010	71	31	31	1	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					327	340		10.1074/jbc.RA118.005963	http://dx.doi.org/10.1074/jbc.RA118.005963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409900	Green Published, hybrid			2022-12-26	WOS:000455105500034
J	Tandon, A; Pathak, M; Harioudh, MK; Ahmad, S; Sayeed, M; Afshan, T; Siddiqi, MI; Mitra, K; Bhattacharya, SM; Ghosh, JK				Tandon, Anshika; Pathak, Manisha; Harioudh, Munesh Kumar; Ahmad, Sabahuddin; Sayeed, Mohd; Afshan, Tayyaba; Siddiqi, M. I.; Mitra, Kalyan; Bhattacharya, Shailja M.; Ghosh, Jimut Kanti			A TLR4-derived non-cytotoxic, self-assembling peptide functions as a vaccine adjuvant in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toll-like receptor 4 (TLR4); vaccine; NF-kappaB (NF-KB); peptide; antibody; adjuvant; pro-inflammatory cytokine; self-assembly of peptide; TEM; TLR4-agonist; antibody	MONOPHOSPHORYL-LIPID-A; IMMUNE-RESPONSES; NANOPARTICLES; AGONIST; ANTIGEN; POTENT; ENDOTOXIN; INJECTION; PROGRAM; DISPLAY	Vaccination is devised/formulated to stimulate specific and prolonged immune responses for long-term protection against infection or disease. A vaccine component, namely adjuvant, enhances antigen recognition by the host immune system and thereby stimulates its cellular and adaptive responses. Especially synthetic Toll-like receptor (TLR) agonists having self-assembling properties are considered as good candidates for adjuvant development. Here, a human TLR4-derived 20-residue peptide (TR-433), present in the dimerization interface of the TLR4-myeloid differentiation protein-2 (MD2) complex, displayed self-assembly and adopted a nanostructure. Both in vitro studies and in vivo experiments in mice indicated that TR-433 is nontoxic. TR-433 induced pro-inflammatory responses in THP-1 monocytes and HEK293T cells that were transiently transfected with TLR4/CD14/MD2 and also in BALB/c mice. In light of the self-assembly and pro-inflammatory properties of TR-433, we immunized with a mixture of TR-433 and either ovalbumin or filarial antigen trehalose-6-phosphate phosphatase (TPP). A significant amount of IgG titers was produced, suggesting adjuvanting capability of TR-433 that was comparable with that of Freund's complete adjuvant (FCA) and appreciably higher than that of alum. We found that TR-433 preferentially activates type 1 helper T cell (T(h)1) response rather than type 2 helper T cell (T(h)2) response. To our knowledge, this is the first report on the identification of a short TLR4-derived peptide that possesses both self-assembling and pro-inflammatory properties and has significant efficacy as an adjuvant, capable of activating cellular responses in mice. These results indicate that TR-433 possesses significant potential for development as a new adjuvant in therapeutic application.	[Tandon, Anshika; Harioudh, Munesh Kumar; Ahmad, Sabahuddin; Sayeed, Mohd; Afshan, Tayyaba; Siddiqi, M. I.; Ghosh, Jimut Kanti] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Pathak, Manisha; Bhattacharya, Shailja M.] Cent Drug Res Inst, CSIR, Div Parasitol, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Mitra, Kalyan] Cent Drug Res Inst, CSIR, SAIF Div, Electron Microscopy Unit, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ghosh, JK (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	jk_ghosh@cdri.res.in		Ahmad, Sabahuddin/0000-0002-8762-4670	CSIR network project BioDiscovery	CSIR network project BioDiscovery	This work was supported by the CSIR network project BioDiscovery. This is CSIR-CDRI communication number 9759. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Bakou M, 2017, J BIOL CHEM, V292, P14587, DOI 10.1074/jbc.M117.774893; BenMohamed L, 1997, EUR J IMMUNOL, V27, P1242, DOI 10.1002/eji.1830270528; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Boato F, 2007, ANGEW CHEM INT EDIT, V46, P9015, DOI 10.1002/anie.200702805; Bortolini C, 2014, SOFT MATTER, V10, P5656, DOI 10.1039/c4sm01065e; Brown F., 1998, MODULATION IMMUNE RE, P13; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Cauwelaert ND, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146372; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Chiu YC, 2016, ACS APPL MATER INTER, V8, P18722, DOI 10.1021/acsami.6b06275; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Reboucas JD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/474605; Dunne A, 2015, MUCOSAL IMMUNOL, V8, P607, DOI 10.1038/mi.2014.93; Duthie MS, 2011, IMMUNOL REV, V239, P178, DOI 10.1111/j.1600-065X.2010.00978.x; Freund J, 1937, P SOC EXP BIOL MED, V37, P509; Huang ZH, 2012, J AM CHEM SOC, V134, P8730, DOI 10.1021/ja211725s; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Kurihara Y, 2013, MOL MED REP, V7, P1739, DOI 10.3892/mmr.2013.1419; Kushwaha S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072585; Kushwaha S, 2012, MICROBES INFECT, V14, P1330, DOI 10.1016/j.micinf.2012.08.006; Li M, 2016, MOL PHARMACEUT, V13, P885, DOI 10.1021/acs.molpharmaceut.5b00802; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Means TK, 2000, LIFE SCI, V68, P241, DOI 10.1016/S0024-3205(00)00939-5; Miconnet I, 2001, J IMMUNOL, V166, P4612, DOI 10.4049/jimmunol.166.7.4612; Moyle PM, 2013, CHEMMEDCHEM, V8, P360, DOI 10.1002/cmdc.201200487; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; O'Garra A, 2000, TRENDS CELL BIOL, V10, P542, DOI 10.1016/S0962-8924(00)01856-0; Othoro C, 2009, INFECT IMMUN, V77, P739, DOI 10.1128/IAI.00974-08; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Petrovsky N, 2004, IMMUNOL CELL BIOL, V82, P488, DOI 10.1111/j.0818-9641.2004.01272.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Puffer EB, 2007, ACS CHEM BIOL, V2, P252, DOI 10.1021/cb600489g; Rahimian S, 2015, J CONTROL RELEASE, V203, P16, DOI 10.1016/j.jconrel.2015.02.006; Rallabhandi Prasad, 2010, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1416s91; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Rudra JS, 2012, BIOMATERIALS, V33, P6476, DOI 10.1016/j.biomaterials.2012.05.041; Rudra JS, 2012, ACS NANO, V6, P1557, DOI 10.1021/nn204530r; Rudra JS, 2010, P NATL ACAD SCI USA, V107, P622, DOI 10.1073/pnas.0912124107; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schijns VEJC, 2000, CURR OPIN IMMUNOL, V12, P456, DOI 10.1016/S0952-7915(00)00120-5; SCHNEERSON R, 1991, J IMMUNOL, V147, P2136; Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Shanmugam A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030839; Steinhagen F, 2011, VACCINE, V29, P3341, DOI 10.1016/j.vaccine.2010.08.002; Stills HF, 2005, ILAR J, V46, P280, DOI 10.1093/ilar.46.3.280; Stoll LL, 2006, CURR PHARM DESIGN, V12, P4229, DOI 10.2174/138161206778743501; STUARTHA.CH, 1969, B WORLD HEALTH ORGAN, V41, P617; Tian J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S45; Vogel F.R., 1995, VACCINE DESIGN SUBUN, P234; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zhang L, 2016, ACS APPL MATER INTER, V8, P34933, DOI 10.1021/acsami.6b10470	58	12	13	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19874	19885		10.1074/jbc.RA118.002768	http://dx.doi.org/10.1074/jbc.RA118.002768			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30385503	Green Published, hybrid			2022-12-26	WOS:000454294900031
J	Best, KA; Bone, DB; Vilas, G; Gros, R; Hammond, JR				Best, K. Arielle; Bone, Derek B.; Vilas, Gonzalo; Gros, Robert; Hammond, James R.			Changes in aortic reactivity associated with the loss of equilibrative nucleoside transporter 1 (ENT1) in mice	PLOS ONE			English	Article							VASCULAR REACTIVITY; ADENOSINE METABOLISM; REPERFUSION INJURY; PROLONGED HYPOXIA; SPINAL TISSUES; CARDIOPROTECTION; HYPOXANTHINE; ACTIVATION; REPRESSION; INHIBITORS	Slc29a1 encodes for equilibrative nucleoside transporter subtype 1 (ENT1), the primary mechanism of adenosine transfer across cell membranes. Previous studies showed that tissues isolated from Slc29a1-null mice are relatively resistant to injury caused by vascular ischemia-reperfusion. To determine if there are similar changes in the microvasculature, and investigate underlying mechanism, we examined aortas isolated from wildtype and Slc29a1-null mice. Aorta macrostructure and gene expression were examined histologically and by qPCR, respectively. Wire myography was used to assess the contractile properties of isolated thoracic aortic rings and their response to adenosine under both normoxic and hypoxic conditions. In vivo haemodynamic parameters were assessed using the tail-cuff method. Slc29a1-null mice had significantly (P<0.05) increased plasma adenosine (2.75-fold) and lower blood pressure (similar to 15% down arrow) than wild-type mice. Aortas from Slc29a1-null mice were stiffer with a smaller circumference (11% down arrow), and had an enhanced contractile response to KCl and receptor-mediated stimuli. Blockade of ENT1 with nitrobenzylthioinosine significantly enhanced (by similar to 3.5-fold) the response of aorta from wild-type mice to phenylephrine, but had minimal effect on aortas from Slc29a1-null mice. Adenosine enhanced phenylephrine-mediated constriction in the wild-type tissue under both normoxic (11.7-fold) and hypoxic (3.6-fold) conditions, but had no effect on the Slc29a1-null aortic aorta. In conclusion, aortas from Slc29a1-null mice respond to hypoxic insult in a manner comparable to wild-type tissues that have been pharmacologically preconditioned with adenosine. These data also support a role for ENT1 in the regulation of the protective effects of adenosine on contractile function in elastic conduit arteries such as thoracic aorta.	[Best, K. Arielle; Bone, Derek B.; Gros, Robert; Hammond, James R.] Western Univ, Dept Physiol & Pharmacol, London, ON, Canada; [Vilas, Gonzalo; Hammond, James R.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Gros, Robert] Roberts Res Inst, Mol Med Res Grp, London, ON, Canada	Western University (University of Western Ontario); University of Alberta; Western University (University of Western Ontario)	Hammond, JR (corresponding author), Western Univ, Dept Physiol & Pharmacol, London, ON, Canada.; Hammond, JR (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada.	james.hammond@ualberta.ca	Gros, Robert/AAV-2237-2020; Gros, Robert/A-3010-2009	Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011; Bone, Derek/0000-0002-8962-0307; Hammond, James/0000-0002-9006-7529	Heart and Stroke Foundation of Canada [T7275, G-16-00012740]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by operating grants to JRH [Grant #T7275 and G-16-00012740] from the Heart and Stroke Foundation of Canada (http://www.heartandstroke.ca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Elfattah AS, 1998, MOL CELL BIOCHEM, V180, P179, DOI 10.1023/A:1006828115191; ABDELFATTAH AS, 1988, CIRCULATION, V78, P224; Andersson R, 2009, SCAND J GASTROENTERO, P1; Arai M, 2000, HEPATOLOGY, V32, P297, DOI 10.1053/jhep.2000.8896; Auer G, 1998, J APPL PHYSIOL, V85, P411, DOI 10.1152/jappl.1998.85.2.411; Besse S, 2002, MECH AGEING DEV, V123, P275, DOI 10.1016/S0047-6374(01)00327-X; Birnbaum Y, 2016, CARDIOVASC DRUG THER, V30, P539, DOI 10.1007/s10557-016-6701-2; Boswell-Casteel RC, 2017, NUCLEOS NUCLEOT NUCL, V36, P7, DOI 10.1080/15257770.2016.1210805; Casanello P, 2005, CIRC RES, V97, P16, DOI 10.1161/01.RES.0000172568.49367.f8; Chen J, 2007, GENES BRAIN BEHAV, V6, P776, DOI 10.1111/j.1601-183X.2007.00311.x; Choi DS, 2004, NAT NEUROSCI, V7, P855, DOI 10.1038/nn1288; de Jong JW, 2000, PHARMACOL THERAPEUT, V87, P141, DOI 10.1016/S0163-7258(00)00044-9; De Moudt S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00157; Deussen A, 2000, N-S ARCH PHARMACOL, V362, P351, DOI 10.1007/s002100000318; Deussen A, 1999, CIRCULATION, V99, P2041, DOI 10.1161/01.CIR.99.15.2041; Dobson GP, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00824; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Farthing D, 2007, J CHROMATOGR B, V854, P158, DOI 10.1016/j.jchromb.2007.04.013; Figueredo VM, 2014, INT J CARDIOL, V176, P822, DOI 10.1016/j.ijcard.2014.08.013; FLAMENG W, 1984, CARDIOVASC RES, V18, P528, DOI 10.1093/cvr/18.9.528; GROS R, 1994, HYPERTENSION, V23, P551, DOI 10.1161/01.HYP.23.5.551; Headrick John P, 2009, Handb Exp Pharmacol, P189, DOI 10.1007/978-3-540-89615-9_7; Headrick JP, 2003, AM J PHYSIOL-HEART C, V285, pH1797, DOI 10.1152/ajpheart.00407.2003; Hinton DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088818; Ii H, 2016, BONE, V90, P37, DOI 10.1016/j.bone.2016.05.008; Kalsi KK, 1998, MOL CELL BIOCHEM, V180, P193, DOI 10.1023/A:1006880132030; Kaneda T, 2016, PHARMACOLOGY, V97, P171, DOI 10.1159/000443894; Kudo M, 2002, AM J PHYSIOL-HEART C, V283, pH296, DOI 10.1152/ajpheart.01087.2001; Li LL, 2013, AM J PHYSIOL-RENAL, V304, pF382, DOI 10.1152/ajprenal.00581.2012; Li RWS, 2012, J CARDIOVASC PHARM, V59, P10, DOI 10.1097/FJC.0b013e31820eb788; Liu SL, 2003, CIRCULATION, V108, P2400, DOI 10.1161/01.CIR.0000093188.53554.44; Liu Z, 2014, PLOS ONE, V9; MASUDA M, 1993, ARCH INT PHARMACOD T, V322, P45; McIntosh VJ, 2012, J CARDIOVASC PHARM T, V17, P21, DOI 10.1177/1074248410396877; Morote-Garcia JC, 2013, AM J RESP CELL MOL, V49, P296, DOI 10.1165/rcmb.2012-0457OC; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Ottervanger Jan Paul, 1999, Int J Cardiovasc Intervent, V2, P181; Paproski RJ, 2010, J NUCL MED, V51, P1447, DOI 10.2967/jnumed.110.076356; Pastor-Anglada M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00013; Peart J, 2001, CARDIOVASC RES, V52, P120, DOI 10.1016/S0008-6363(01)00360-1; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ralevic V, 2015, AUTON NEUROSCI-BASIC, V191, P48, DOI 10.1016/j.autneu.2015.04.007; Ramakers BP, 2008, CURR DRUG METAB, V9, P679, DOI 10.2174/138920008786049249; Riksen NP, 2008, EUR J PHARMACOL, V585, P220, DOI 10.1016/j.ejphar.2008.01.053; Rose JB, 2011, LIFE SCI, V89, P621, DOI 10.1016/j.lfs.2011.08.007; Rose JB, 2010, AM J PHYSIOL-HEART C, V298, pH771, DOI 10.1152/ajpheart.00711.2009; Russell A, 2000, J PHARMACOL EXP THER, V294, P598; Sadigh B, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-52; Shaikh G, 2016, PURINERG SIGNAL, V12, P191, DOI 10.1007/s11302-016-9498-3; Sousa JB, 2017, MOLECULES, V22, DOI 10.3390/molecules22050752; Talukder MAH, 2002, AM J PHYSIOL-HEART C, V282, pH49, DOI 10.1152/ajpheart.2002.282.1.H49; Thijssen DHJ, 2016, EXP PHYSIOL, V101, P677, DOI 10.1113/EP085566; VANBELLE H, 1987, AM J PHYSIOL, V252, pH886, DOI 10.1152/ajpheart.1987.252.5.H886; Vanhoutte PM, 2017, ACTA PHYSIOL, V219, P22, DOI 10.1111/apha.12646; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Warraich S, 2013, J BONE MINER RES, V28, P1135, DOI 10.1002/jbmr.1826; Watson A, 2017, CIRC RES, V120, P1889, DOI 10.1161/CIRCRESAHA.116.310022; Wu J, 2014, CIRC RES, V114, P616, DOI 10.1161/CIRCRESAHA.114.302157; Zhang J, 2007, CANCER METAST REV, V26, P85, DOI 10.1007/s10555-007-9044-4; Zhao TC, 2002, J MOL CELL CARDIOL, V34, P263, DOI 10.1006/jmcc.2001.1510; Zimmerman MA, 2013, HEPATOLOGY, V58, P1766, DOI 10.1002/hep.26505; ZUGHAIB ME, 1993, CIRCULATION, V88, P2359, DOI 10.1161/01.CIR.88.5.2359	62	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207198	10.1371/journal.pone.0207198	http://dx.doi.org/10.1371/journal.pone.0207198			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408123	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300089
J	Stefopoulou, A; Balatsos, G; Petraki, A; LaDeau, SL; Papachristos, D; Michaelakis, A				Stefopoulou, Angeliki; Balatsos, George; Petraki, Angeliki; LaDeau, Shannon L.; Papachristos, Dimitrios; Michaelakis, Antonios			Reducing Aedes albopictus breeding sites through education: A study in urban area	PLOS ONE			English	Article							ASIAN TIGER MOSQUITO; DIPTERA-CULICIDAE; SOURCE REDUCTION; KNOWLEDGE; AEGYPTI; IMPACT; POPULATIONS; PREVENTION; MANAGEMENT; STRATEGY	Aedes albopictus tends to proliferate in small, often man-made bodies of water, largely present in urban private areas. For this reason, education and community participation are considered crucial for source reduction and mosquito control. In the current study, we identify mosquito breeding habitat and evaluate the effectiveness of resident education. Since 2010 several outbreaks of West Nile virus infection occurred in Greece however urban population has no previous experience with mosquito-borne disease related to Aedes species, such as Dengue, Zika and Chikungunya. After the introduction of Ae. albopictus in Greece, urban areas have been considered to be at risk of epidemic arboviral outbreaks and identifying effective control strategies is imperative. Our study examines the relationship between mosquito breeding sources and socioeconomic or demographic characteristics of different households in a Greek municipality and evaluates efficacy of resident education. The results revealed that only a minority of residents knew where mosquitoes breed (18.6%) and only 46% felt that residents had any responsibility for managing breeding habitat. Our findings strongly suggest that only the presence of scientific staff inspecting possible habitats in their properties, could be enough to stimulate practices towards source reduction. However, educational interventions alone with printed education material cannot enhance significant community participation and source reduction.	[Stefopoulou, Angeliki; Balatsos, George; Petraki, Angeliki; Papachristos, Dimitrios; Michaelakis, Antonios] Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece; [LaDeau, Shannon L.] Cary Inst Ecosyst Studies, Millbrook, NY USA	Cary Institute of Ecosystem Studies	Michaelakis, A (corresponding author), Benaki Phytopathol Inst, Dept Entomol & Agr Zool, Kifisia, Greece.	a.michaelakis@bpi.gr	Papachristos, Dimitrios/AHC-0813-2022; Michaelakis, Antonios/AAL-1594-2020	STEFOPOULOU, ANGELIKI/0000-0003-4442-2531; Papachristos, Dimitrios/0000-0002-0524-0180; LaDeau, Shannon/0000-0003-4825-5435	Region of Attica; LIFE CONOPS project; European Commission [LIFE12 ENV/GR/000466]	Region of Attica; LIFE CONOPS project; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by Region of Attica and LIFE CONOPS project. The project "A systematic surveillance of vector mosquitoes for the control of mosquito-borne diseases in the Region of Attica" financed by the Region of Attica. The project LIFE CONOPS (LIFE12 ENV/GR/000466), "Development & demonstration of management plans against -the climate change enhanced-invasive mosquitoes in South Europe", funded by the European Commission in the framework of the programme LIFE + Environment Policy and Governance (www.conops.gr; http://ec.europa.eu/environment/life/index.htm).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Ali Arshad, 1997, Medical Entomology and Zoology, V48, P1; [Anonymous], 2003, MOSQUITOES THEIR CON; Badieritakis E, 2018, PARASITOL RES, V117, P453, DOI 10.1007/s00436-017-5721-6; Baldacchino F, 2017, PEST MANAG SCI, V73, P87, DOI 10.1002/ps.4417; Bartlett-Healy K, 2011, INT J ENV RES PUB HE, V8, P1358, DOI 10.3390/ijerph8051358; Bellini R, 2016, VECTOR BIOL J, V1, P2; Bodner D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155011; Dowling Z, 2013, ECOHEALTH, V10, P36, DOI 10.1007/s10393-013-0818-6; Elsinga J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2371-6; Estrada-Franco J. G., 1995, Technical Paper - Pan American Health Organization; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Giangaspero A, 2013, PARASITOL RES, V112, P1357, DOI 10.1007/s00436-012-3206-1; Giatropoulos A, 2013, PARASITOL RES, V112, P1113, DOI 10.1007/s00436-012-3239-5; Giatropoulos A, 2012, PARASITOL RES, V111, P2253, DOI 10.1007/s00436-012-3074-8; Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096; Grantham A, 2009, INT J ENV RES PUB HE, V6, P2150, DOI 10.3390/ijerph6082150; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Huber K, 2014, PARASITOL RES, V113, P3201, DOI 10.1007/s00436-014-4000-z; Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; Mahroum N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197337; Manica M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.44.17-00685; McNaughton D, 2010, ACTA TROP, V116, P74, DOI 10.1016/j.actatropica.2010.05.012; Samanidou-Voyadjoglou A., 2005, European Mosquito Bulletin, V19, P10; SCHREIBER ET, 1995, J AM MOSQUITO CONTR, V11, P186; Soedarmo Sumarmo Poorwo, 1993, Tropical Medicine, V35, P161; Tsiodras S, 2016, PATHOG GLOB HEALTH, V110, P68, DOI 10.1080/20477724.2016.1176311; Unlu I, 2011, PEST MANAG SCI, V67, P965, DOI 10.1002/ps.2140; Warner DG, 2005, J MED LIBR ASSOC, V93, P243; Wheeler AS, 2009, J AM MOSQUITO CONTR, V25, P251, DOI 10.2987/08-5794.1; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363; World Health Organisation, 2013, REG FRAM SURV CONTR; World Health Organization, 2015, WORLD MAL REP 2015; Zeller H, 2013, CLIN MICROBIOL INFEC, V19, P693, DOI 10.1111/1469-0691.12230	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0202451	10.1371/journal.pone.0202451	http://dx.doi.org/10.1371/journal.pone.0202451			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408031	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300004
J	Villegas, LR; Rivard, CJ; Hunter, B; You, ZY; Roncal, C; Joy, MS; Le, MT				Villegas, Leah R.; Rivard, Christopher J.; Hunter, Brandi; You, Zhiying; Roncal, Carlos; Joy, Melanie S.; Le, MyPhuong T.			Effects of fructose-containing sweeteners on fructose intestinal, hepatic, and oral bioavailability in dual-catheterized rats	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; DIETARY FRUCTOSE; INTRAVENOUS FRUCTOSE; CORN SYRUP; ABSORPTION; MALABSORPTION; GLUCOSE; CONSUMPTION; SUCROSE; METABOLISM	Objective Fructose is commonplace in Western diets and is consumed primarily through added sugars as sucrose or high fructose corn syrup. High consumption of fructose has been linked to the development of metabolic disorders, such as cardiovascular diseases. The majority of the harmful effects of fructose can be traced to its uncontrolled and rapid metabolism, primarily within the liver. It has been speculated that the formulation of fructose-containing sweeteners can have varying impacts on its adverse effects. Unfortunately, there is limited data supporting this hypothesis. The objective of this study was to examine the impact of different fructose-containing sweeteners on the intestinal, hepatic, and oral bioavailability of fructose. Methods Portal and femoral vein catheters were surgically implanted in male Wistar rats. Animals were gavaged with a 1 g/kg carbohydrate solution consisting of fructose, 45% glucose/55% fructose, sucrose, glucose, or water. Blood samples were then collected from the portal and systemic circulation. Fructose levels were measured and pharmacokinetic parameters were calculated. Results Compared to animals that were gavaged with 45% glucose/55% fructose or sucrose, fructose-gavaged animals had a 40% greater fructose area under the curve and a 15% greater change in maximum fructose concentration in the portal circulation. In the systemic circulation of fructose-gavaged animals, the fructose area under the curve was 17% and 24% higher and the change in the maximum fructose concentration was 15% and 30% higher than the animals that received 45% glucose/55% fructose or sucrose, respectively. After the oral administration of fructose, 45% glucose/55% fructose, and sucrose, the bioavailability of fructose was as follows: intestinal availability was 0.62, 0.53 and 0.57; hepatic availability was 0.33, 0.45 and 0.45; and oral bioavailability was 0.19, 0.23 and 0.24, respectively. Conclusions Our studies show that the co-ingestion of glucose did not enhance fructose absorption, rather, it decreased fructose metabolism in the liver. The intestinal, hepatic, and oral bioavailability of fructose was similar between 45% glucose/55% fructose and sucrose.	[Villegas, Leah R.] Univ Colorado, Dept Pediat, Cardiovasc Pulm Res Labs, Anschutz Med Campus, Aurora, CO USA; [Villegas, Leah R.] Univ Colorado, Dept Med, Cardiovasc Pulm Res Labs, Anschutz Med Campus, Aurora, CO USA; [Rivard, Christopher J.; Hunter, Brandi; You, Zhiying; Roncal, Carlos; Joy, Melanie S.; Le, MyPhuong T.] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO 80045 USA; [Joy, Melanie S.] Univ Colorado, Skaggs Sch Pharm, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Le, MT (corresponding author), Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO 80045 USA.	myphuong.le@ucdenver.edu			NIH/NCCIH [K01AT007926]; National Center for Complementary & Integrative Health [K01AT007926] Funding Source: NIH RePORTER	NIH/NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by funding from NIH/NCCIH K01AT007926 (MTL) and from an unrestricted gift to the Division of Renal Diseases and Hypertension from the Sugar Foundation. The funders provided support in the form of research materials and/or salaries for authors [MTL]. They did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aeberli I, 2013, DIABETES CARE, V36, P150, DOI 10.2337/dc12-0540; Barone S, 2009, J BIOL CHEM, V284, P5056, DOI 10.1074/jbc.M808128200; Barthe L, 1999, FUND CLIN PHARMACOL, V13, P154, DOI 10.1111/j.1472-8206.1999.tb00334.x; Berg LK, 2013, SCAND J GASTROENTERO, V48, P936, DOI 10.3109/00365521.2013.812139; BERGSTROM J, 1968, ACTA MED SCAND, V184, P359; BISMUT H, 1993, EUR J BIOCHEM, V213, P721, DOI 10.1111/j.1432-1033.1993.tb17812.x; BOESIGER P, 1994, PEDIATR RES, V36, P436, DOI 10.1203/00006450-199410000-00004; Bollman JL, 1931, AM J PHYSIOL, V96, P683, DOI 10.1152/ajplegacy.1931.96.3.683; Born P, 1995, HEPATO-GASTROENTEROL, V42, P778; Borza T, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-51; Bray GA, 2004, AM J CLIN NUTR, V79, P537; CHAMBERS RA, 1956, LANCET, V271, P340; CHONG MFF, 2007, THE AMERICAN JOURNAL, V85, P1511, DOI DOI 10.1093/AJCN/85.6.1511; Cirillo P, 2009, J AM SOC NEPHROL, V20, P545, DOI 10.1681/ASN.2008060576; Cori CF, 1925, J BIOL CHEM, V66, P691; Dabritz J, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-59; DAVID ES, 1995, PEDIATR RES, V37, P777, DOI 10.1203/00006450-199506000-00017; DENCKER H, 1973, DIGESTION, V9, P514, DOI 10.1159/000197480; DENCKER H, 1972, SCAND J GASTROENTERO, V7, P701, DOI 10.3109/00365527209180981; Devlin TM, 2002, TEXTBOOK OF BIOCHEMI, Vxxiv; DiPiro JT, 2010, AMERICAN SOCIETY OF, Vxii; Ebert Karolin, 2016, Mol Cell Pediatr, V3, P10, DOI 10.1186/s40348-016-0035-9; FUJISAWA T, 1991, GASTROENTEROLOGY, V101, P360, DOI 10.1016/0016-5085(91)90012-A; GROEN J, 1937, THE JOURNAL OF CLINI, V16, P245, DOI DOI 10.1172/JCI100854; Hammer HF, 2012, GASTROENTEROL CLIN N, V41, P611, DOI 10.1016/j.gtc.2012.06.003; Hinderling PH, 1997, PHARMACOL REV, V49, P279; HOEKSTRA JH, 1995, EUR J PEDIATR, V154, P362, DOI 10.1007/BF02072103; HOFFMAN DJ, 1995, PHARMACEUT RES, V12, P889, DOI 10.1023/A:1016221322886; Ishimoto T, 2013, HEPATOLOGY, V58, P1632, DOI 10.1002/hep.26594; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Kawasaki T, 2002, DIABETES CARE, V25, P353, DOI 10.2337/diacare.25.2.353; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; KNEEPKENS CMF, 1984, ARCH DIS CHILD, V59, P735, DOI 10.1136/adc.59.8.735; Kosaka K, 2011, DRUG METAB DISPOS, V39, P1495, DOI 10.1124/dmd.111.040030; Kuze J, 2009, XENOBIOTICA, V39, P871, DOI 10.3109/00498250903215382; Lambertz J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01159; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; LE KA, 2006, METABOLIC EFFECTS OF, V9, P469, DOI DOI 10.1097/01.MCO.0000232910.61612.4D; Le MT, 2012, METABOLISM, V61, P641, DOI 10.1016/j.metabol.2011.09.013; LOZINSKY Adriana Chebar, 2013, Arq. Gastroenterol., V50, P226, DOI 10.1590/S0004-28032013000200040; MACDONALD I, 1978, AM J CLIN NUTR, V31, P1305, DOI 10.1093/ajcn/31.8.1305; Marek G, 2015, DIABETES, V64, P508, DOI 10.2337/db14-0411; Matsuda Y, 2012, DRUG METAB DISPOS, V40, P2231, DOI 10.1124/dmd.112.048223; Mattioli LF, 2010, PEDIATR RES, V67, P352, DOI 10.1203/PDR.0b013e3181d00c41; Melchior C, 2014, UNITED EUR GASTROENT, V2, P131, DOI 10.1177/2050640614521124; Mirtschink P, 2018, EUR HEART J, V39, P2497, DOI 10.1093/eurheartj/ehx518; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290; Patel C, 2015, AM J PHYSIOL-GASTR L, V309, pG779, DOI 10.1152/ajpgi.00188.2015; Putkonen L, 2013, CURR OPIN CLIN NUTR, V16, P473, DOI 10.1097/MCO.0b013e328361c556; RAIVIO KO, 1975, METABOLISM, V24, P861, DOI 10.1016/0026-0495(75)90133-X; Rao SSC, 2007, CLIN GASTROENTEROL H, V5, P959, DOI 10.1016/j.cgh.2007.04.008; RAVICH WJ, 1983, GASTROENTEROLOGY, V84, P26; RIBY JE, 1993, AM J CLIN NUTR, V58, P748, DOI 10.1093/ajcn/58.5.748S; Roman CL, 2014, BBA-GEN SUBJECTS, V1840, P3475, DOI 10.1016/j.bbagen.2014.09.011; Ruff JS, 2015, J NUTR, V145, P434, DOI 10.3945/jn.114.202531; RUMESSEN JJ, 1986, GUT, V27, P1161, DOI 10.1136/gut.27.10.1161; RUMESSEN JJ, 1988, GASTROENTEROLOGY, V95, P694, DOI 10.1016/S0016-5085(88)80016-7; Sander Petra, 2006, Hum Mutat, V27, P119, DOI 10.1002/humu.9392; Sharma A, 2014, INDIAN J GASTROENTER, V33, P466, DOI 10.1007/s12664-014-0492-9; Sluik D, 2015, EUR J CLIN NUTR, V69, P475, DOI 10.1038/ejcn.2014.267; SMITH LH, 1953, J CLIN INVEST, V32, P273, DOI 10.1172/JCI102736; Steinmann B, 2001, METABOLIC MOL BASES, P1489; Sugimoto K, 2010, J CLIN BIOCHEM NUTR, V46, P205, DOI 10.3164/jcbn.09-93; Szilagyi A, 2007, DIGEST DIS SCI, V52, P2999, DOI 10.1007/s10620-006-9652-9; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Taskinen MR, 2017, J INTERN MED, V282, P187, DOI 10.1111/joim.12632; TERRIER F, 1989, RADIOLOGY, V171, P557, DOI 10.1148/radiology.171.2.2704824; Theytaz F, 2014, NUTRIENTS, V6, P2632, DOI 10.3390/nu6072632; TRUSWELL AS, 1988, AM J CLIN NUTR, V48, P1424, DOI 10.1093/ajcn/48.6.1424; Tsampalieros A, 2008, ARCH DIS CHILD, V93, P1078, DOI 10.1136/adc.2008.137521; Tuck CJ, 2017, J HUM NUTR DIET, V30, P73, DOI 10.1111/jhn.12409; Ueda S, 1999, J PHARM PHARMACOL, V51, P585, DOI 10.1211/0022357991772682; Vonk RJ, 1998, GUT, V43, pS20, DOI 10.1136/gut.43.2008.S20; Vos Miriam B, 2008, Medscape J Med, V10, P160; Wirth S, 2014, KLIN PADIATR, V226, P268, DOI 10.1055/s-0034-1383653; WOOD M, 1991, CLIN PHARMACOKINET, V21, P285, DOI 10.2165/00003088-199121040-00005; Yu SX, 2005, RAPID COMMUN MASS SP, V19, P250, DOI 10.1002/rcm.1777	79	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207024	10.1371/journal.pone.0207024	http://dx.doi.org/10.1371/journal.pone.0207024			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408104	gold, Green Submitted, Green Published			2022-12-26	WOS:000449512300066
J	Wu, XJ; Xie, SW; Wang, LR; Fan, PH; Ge, SW; Xie, XQ; Wu, W				Wu, Xiaojun; Xie, Siwei; Wang, Lirong; Fan, Peihao; Ge, Songwei; Xie, Xiang-Qun; Wu, Wei			A computational strategy for finding novel targets and therapeutic compounds for opioid dependence	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; DOPAMINE NEURONS; NEUROIMMUNE ACTIVATION; CONNECTIVITY MAP; DRUG-ADDICTION; UNITED-STATES; RECEPTOR; MORPHINE; RAT; ABUSE	Opioids are widely used for treating different types of pains, but overuse and abuse of prescription opioids have led to opioid epidemic in the United States. Besides analgesic effects, chronic use of opioid can also cause tolerance, dependence, and even addiction. Effective treatment of opioid addiction remains a big challenge today. Studies on addictive effects of opioids focus on striatum, a main component in the brain responsible for drug dependence and addiction. Some transcription regulators have been associated with opioid addiction, but relationship between analgesic effects of opioids and dependence behaviors mediated by them at the molecular level has not been thoroughly investigated. In this paper, we developed a new computational strategy that identifies novel targets and potential therapeutic molecular compounds for opioid dependence and addiction. We employed several statistical and machine learning techniques and identified differentially expressed genes over time which were associated with dependence-related behaviors after exposure to either morphine or heroin, as well as potential transcription regulators that regulate these genes, using time course gene expression data from mouse striatum. Moreover, our findings revealed that some of these dependence-associated genes and transcription regulators are known to play key roles in opioid-mediated analgesia and tolerance, suggesting that an intricate relationship between opioid-induce pain-related pathways and dependence may develop at an early stage during opioid exposure. Finally, we determined small compounds that can potentially target the dependence-associated genes and transcription regulators. These compounds may facilitate development of effective therapy for opioid dependence and addiction. We also built a database (http://daportals.org) for all opioid-induced dependence- associated genes and transcription regulators that we discovered, as well as the small compounds that target those genes and transcription regulators.	[Wu, Xiaojun; Xie, Siwei; Wu, Wei] Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA; [Wang, Lirong; Fan, Peihao; Xie, Xiang-Qun] Univ Pittsburgh, Chem Genom Screening Ctr, Sch Pharm, Dept Pharmaceut Sci & Computat, Pittsburgh, PA USA; [Wang, Lirong; Xie, Xiang-Qun] Univ Pittsburgh, Drug Discovery Inst, Pittsburgh, PA USA; [Ge, Songwei] Renmin Univ China, Sch Informat, Beijing, Peoples R China; [Xie, Xiang-Qun] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA USA; [Xie, Xiang-Qun] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Renmin University of China; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, W (corresponding author), Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA.	weiwu2@cs.cmu.edu		Wu, Xiaojun/0000-0002-7613-8415; Ge, Songwei/0000-0001-9710-4698	National Institutes of Health [P30DA035778, R01GM114311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was conducted with the support of grants from the National Institutes of Health P30DA035778 and R01GM114311.	Andersen JM, 2009, J PHARMACOL EXP THER, V331, P153, DOI 10.1124/jpet.109.152462; Asensio-Juan E, 2012, NUCLEIC ACIDS RES, V40, P9429, DOI 10.1093/nar/gks716; Auerbach RK, 2013, BIOINFORMATICS, V29, P1922, DOI 10.1093/bioinformatics/btt316; Badiani A, 2011, NAT REV NEUROSCI, V12, P685, DOI 10.1038/nrn3104; Bailey CP, 2014, EXPERT OPIN DRUG DIS, V9, P1333, DOI 10.1517/17460441.2014.964203; Blattler A, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-13; Brady KT, 2016, AM J PSYCHIAT, V173, P18, DOI 10.1176/appi.ajp.2015.15020262; Buchanan MM, 2010, J NEUROCHEM, V114, P13, DOI 10.1111/j.1471-4159.2010.06736.x; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; GLAUM SR, 1994, J NEUROSCI, V14, P4965; Godino A, 2015, EPIGENETICS-US, V10, P574, DOI 10.1080/15592294.2015.1055441; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; GRUDT TJ, 1994, J NEUROSCI, V14, P1646, DOI 10.1523/JNEUROSCI.14-03-01646.1994; Guegan T, 2016, ADDICT BIOL, V21, P1113, DOI 10.1111/adb.12281; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; GYSLING K, 1983, BRAIN RES, V277, P119, DOI 10.1016/0006-8993(83)90913-7; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Higgins GA, 2015, PHARMACOGENOMICS, V16, P1565, DOI 10.2217/pgs.15.105; Hong J, 2010, J BIOL CHEM, V285, P39447, DOI 10.1074/jbc.M110.132522; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jacobsen JHW, 2016, CURR OPIN PHARMACOL, V26, P131, DOI 10.1016/j.coph.2015.10.010; JOHNSON SW, 1992, J NEUROSCI, V12, P483; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; KOSTEN TA, 1991, J NERV MENT DIS, V179, P583, DOI 10.1097/00005053-199110000-00001; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Loader C., 1999, LOCAL REGRESSION LIK, Vxiii; Manchikanti L, 2012, PAIN PHYSICIAN, V15, pES9; Margolis EB, 2014, J NEUROSCI, V34, P14707, DOI 10.1523/JNEUROSCI.2144-14.2014; MATTHEWS RT, 1984, NEUROSCIENCE, V11, P617, DOI 10.1016/0306-4522(84)90048-4; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Mulligan MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034586; Ndengele MM, 2009, J PHARMACOL EXP THER, V329, P64, DOI 10.1124/jpet.108.146290; Nutt D, 2007, LANCET, V369, P1047, DOI 10.1016/S0140-6736(07)60464-4; Nutt DJ, 2015, NAT REV NEUROSCI, V16, P305, DOI 10.1038/nrn3939; OLDENDORF WH, 1972, SCIENCE, V178, P984, DOI 10.1126/science.178.4064.984; Parsadaniantz SM, 2015, NAT REV NEUROSCI, V16, P69, DOI 10.1038/nrn3858; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Piechota M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r48; Popovic R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004566; Raghavendra V, 2002, J NEUROSCI, V22, P9980, DOI 10.1523/jneurosci.22-22-09980.2002; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Ron Dorit, 2005, Sci STKE, V2005, pre14, DOI 10.1126/stke.3092005re14; Russo SJ, 2010, TRENDS NEUROSCI, V33, P267, DOI 10.1016/j.tins.2010.02.002; Schoofs T, 2013, BLOOD, V121, P178, DOI 10.1182/blood-2012-08-448860; Soyka M, 2016, PROG NEURO-PSYCHOPH, V70, P148, DOI 10.1016/j.pnpbp.2015.11.003; Steidl S, 2017, NEUROSCI BIOBEHAV R, V83, P72, DOI 10.1016/j.neubiorev.2017.09.022; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Stowe GN, 2011, CNS NEUROL DISORD-DR, V10, P865; SUAREZROCA H, 1992, BRAIN RES, V579, P187, DOI 10.1016/0006-8993(92)90050-J; SUN JY, 1994, ANN STAT, V22, P1328, DOI 10.1214/aos/1176325631; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tanga FY, 2004, NEUROCHEM INT, V45, P397, DOI 10.1016/j.neuint.2003.06.002; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Wu W, 2014, J ALLERGY CLIN IMMUN, V133, P1280, DOI 10.1016/j.jaci.2013.11.042; Wu W, 2008, PHYSIOL GENOMICS, V36, P24, DOI 10.1152/physiolgenomics.00258.2007; Yager LM, 2015, NEUROSCIENCE, V301, P529, DOI 10.1016/j.neuroscience.2015.06.033; Zhang N, 2004, J IMMUNOL, V173, P594, DOI 10.4049/jimmunol.173.1.594; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023	66	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207027	10.1371/journal.pone.0207027	http://dx.doi.org/10.1371/journal.pone.0207027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403753	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500095
J	Gonzalez-Gallina, A; Hidalgo-Mihart, MG; Castelazo-Calva, V				Gonzalez-Gallina, Alberto; Hidalgo-Mihart, Mircea G.; Castelazo-Calva, Victor			Conservation implications for jaguars and other neotropical mammals using highway underpasses	PLOS ONE			English	Article							BANFF NATIONAL-PARK; PANTHERA-ONCA; CROSSING STRUCTURES; TERRESTRIAL MAMMALS; PUMA-CONCOLOR; CAMERA TRAPS; MOVEMENT; EXTRAPOLATION; RAREFACTION; POPULATION	The Nuevo Xcan-Playa del Carmen highway in Quintana Roo, bisects the vegetation corridor connecting two Jaguar Conservation Units (JCUs): Yum Balaam (north) and Sian Ka'an (south). The project's main goal was to describe differential use of available crossing structures (wildlife underpasses and culverts) by mammals present along this highway. We set 28 camera traps along the 54km stretch of the highway covering wildlife underpasses (10), and culverts such as box culverts (9) and pipes (9) from September 2016 until March 2017. A total of 24 jaguar crossings have been recorded exclusively using wildlife underpasses, including four males and two females. At least 18 other mammal species including five of the target priority species (protected by Mexican law) were documented, all of which were native except for two invasive species. In terms of species using the crossing structures, we identified 13 species using wildlife underpasses, nine using concrete box culverts and 10 using concrete pipes. Wildlife underpasses show higher diversity values (Shannon's exponential index = 5.8 and Inverse Simpson's index = 4.66) compared to culverts because they allow bigger species to cross. We recommend more highways along the jaguar's distribution should develop mitigation measures to allow for wildlife connectivity. Wildlife underpasses, along with retrofitted culverts, could help secure not only the permanence of this species by facilitating the functional connectivity between populations but have positive impacts on other neotropical mammalian fauna as well.	[Gonzalez-Gallina, Alberto] Inst Ecol AC, Red Ambiente & Sustentabilidad, Xalapa, Veracruz, Mexico; [Hidalgo-Mihart, Mircea G.] Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico; [Castelazo-Calva, Victor] Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico	Instituto de Ecologia - Mexico; Universidad Juarez Autonoma de Tabasco; Instituto de Ecologia - Mexico	Hidalgo-Mihart, MG (corresponding author), Univ Juarez Autonoma Tabasco, Div Acad Ciencias Biol, Villahermosa, Tabasco, Mexico.	mhidalgo@yahoo.com		Hidalgo Mihart, Mircea G/0000-0002-8779-6886	Conservacion Panthera Mexico A.C.; Rufford Foundation [22395-1]; CONACYT [335814/232663]	Conservacion Panthera Mexico A.C.; Rufford Foundation; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was carried out with financial support provided to the first author A.G.G. by Conservacion Panthera Mexico A.C. (https://www.panthera.org/), Rufford Foundation, Small Grants number 22395-1 (https://www.rufford.org/) and CONACYT PhD grant number 335814/232663 for his studies at INECOL. (www.conacyt.mx).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews KM, 2015, WILDL MANAGE CONSERV, P273; de la Torre JA, 2017, BIOL CONSERV, V206, P270, DOI 10.1016/j.biocon.2016.11.034; Araya-Gamboa Daniela, 2015, Infraestructura Vial, V17, P5; Artavia A., 2015, DIAGNOSTICO ESTUDIOS, P75; Avila-Najera DM, 2018, ANIM BIODIV CONSERV, V41, P257, DOI 10.32800/abc.2018.41.0257; Barnum SA, 2003, CDOTDTDUCD20039; Beckmann JP, 2010, SAFE PASSAGES, P396; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Campos-Camara B.L, 2007, PROCESOS URBANIZACIO, P212; Chao A, 2015, METHODS ECOL EVOL, V6, P873, DOI 10.1111/2041-210X.12349; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chavez Cuauhtemoc, 2009, Revista Mexicana de Mastozoologia, V13, P46; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Clevenger AP, 2000, CONSERV BIOL, V14, P47, DOI 10.1046/j.1523-1739.2000.00099-085.x; Clevenger AP, 2001, WILDLIFE SOC B, V29, P646; Clevenger AP, 2010, SAFE PASSAGES HIGHWA, P17; Colchero F, 2011, ANIM CONSERV, V14, P158, DOI 10.1111/j.1469-1795.2010.00406.x; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Conde Ovando D.A., 2008, ROAD IMPACT DEFOREST; Cramer P, 2015, HANDBOOK OF ROAD ECOLOGY, P344; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cullen L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167372; Da Silveira R, 2010, J HERPETOL, V44, P418, DOI 10.1670/08-340.1; de Azevedo FCC, 2007, J WILDLIFE MANAGE, V71, P2379, DOI 10.2193/2006-520; de la Tijera CP, 1999, REV BIOL TROP, V47, P251; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Duarte JC, 2012, 16 C ARG VIAL TRANS; Ellis EA, 2017, TROP CONSERV SCI, V10, DOI 10.1177/1940082917697259; Espinosa S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189740; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; FERRERAS P, 1992, BIOL CONSERV, V61, P197, DOI 10.1016/0006-3207(92)91116-A; Figueroa O. A., 2013, THESIS U FLORIDA; Forman RTT, 2003, ROAD ECOLOGY SCI SOL, P396; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Gloyne CC, 2001, WILDLIFE BIOL, V7, P117, DOI 10.2981/wlb.2001.009; Gonzalez A., 2017, HIGH EDUC, P1, DOI [10.1007/s10734-017-0160- y, DOI 10.1007/S10734-017-0160-Y]; González-Gallina Alberto, 2018, Therya, V9, P147, DOI 10.12933/therya-18-584; Grilo C, 2008, BIODIVERS CONSERV, V17, P1685, DOI 10.1007/s10531-008-9374-8; Grilo C, 2015, HANDBOOK OF ROAD ECOLOGY, P300; Gubbi S, 2015, HANDBOOK OF ROAD ECOLOGY, P317; Hernandez-Diaz M, 2012, REV MEX BIODIVERS, V83, P790, DOI 10.7550/rmb.33596; Hidalgo-Mihart MG, 2018, ORYX, V52, P292, DOI 10.1017/S0030605316001083; Holbrook JD, 2011, WILDLIFE SOC B, V35, P504, DOI 10.1002/wsb.63; Huijser MP, 2016, BIOL CONSERV, V197, P61, DOI 10.1016/j.biocon.2016.02.002; Ingenieros Civiles y Asociados (ICA), 2014, REP INT ACT; Jaeger JAG, 2015, HANDBOOK OF ROAD ECOLOGY, P32; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Kintsch J., 2015, P 2015 INT C EC TRAN; Klar N, 2009, J WILDLIFE MANAGE, V73, P631, DOI 10.2193/2007-574; Kusak J, 2009, EUR J WILDLIFE RES, V55, P7, DOI 10.1007/s10344-008-0208-5; Avila-Najere DM, 2015, REV BIOL TROP, V63, P799, DOI 10.15517/rbt.v63i3.15410; Mata C, 2005, BIOL CONSERV, V124, P397, DOI 10.1016/j.biocon.2005.01.044; Matthews SM, 2015, RECOMMENDATIONS ROAD, P34; Medellin RA, 2016, JAGUAR SIGLO 21 PERS, P533; Mendes-Oliveira AC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187650; Pallares E, 2015, HANDBOOK OF ROAD ECOLOGY, P313; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Payan E, 2017, P 2017 INT C EC TRAN; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Ramesh T, 2015, J NAT CONSERV, V23, P9, DOI 10.1016/j.jnc.2014.12.001; Ramirez-Pulido J, 2014, SPECIAL PUBLICATIONS, V63, P76; Reid F, 2009, FIELD GUIDE MAMMALS, P346; Remolina-Suarez J. F., 2014, REPORTE REUBICACION; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roberts K, 2015, HANDBOOK OF ROAD ECOLOGY, P27; Rodriguez-Soto C, 2013, J NAT CONSERV, V21, P438, DOI 10.1016/j.jnc.2013.07.002; Rytwinski T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166941; Rytwinski T, 2015, HANDBOOK OF ROAD ECOLOGY, P237; Rzedowski J., 2006, VEGETACION MEXICO 1R; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Secretaria de Comunicaciones y Transportes (SCT), 2020, DAT VIAL VOL TRANS; Secretaria de Comunicaciones y Transportes (SCT), 1994, REGL PES DIM CAP VEH; Secretaria de Comunicaciones y Transportes (SCT), 2017, MAN EST GEST AT AMB, P364; Seiler A., 2003, THESIS; Siegel S., 1995, ESTADISTICA PARAMETR, P437; Silver SC, 2004, ORYX, V38, P148, DOI 10.1017/S0030605304000286; Smith DJ, 2015, HANDBOOK OF ROAD ECOLOGY, P172; Smith DJ, 2015, WILDL MANAGE CONSERV, P208; Sparks JL, 2017, HUM-WILDL INTERACT, V11, P182; Taylor SK, 2002, J WILDLIFE DIS, V38, P107, DOI 10.7589/0090-3558-38.1.107; Thornton D, 2016, ECOL APPL, V26, P1112, DOI 10.1890/15-0602; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Urquiza-Haas T, 2011, ANIM CONSERV, V14, P271, DOI 10.1111/j.1469-1795.2010.00426.x; van der Grift EA, 2015, HANDBOOK OF ROAD ECOLOGY, P129; van der Ree R, 2015, HANDBOOK OF ROAD ECOLOGY, pXXII	89	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206614	10.1371/journal.pone.0206614	http://dx.doi.org/10.1371/journal.pone.0206614			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399179	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000017
J	Dibaji, SAR; Guha, S; Arab, A; Murray, BT; Myers, MR				Dibaji, Seyed Ahmad Reza; Guha, Suvajyoti; Arab, Aarthi; Murray, Bruce T.; Myers, Matthew R.			Accuracy of commercial electronic nicotine delivery systems (ENDS) temperature control technology	PLOS ONE			English	Article							E-CIGARETTE AEROSOLS; PUFF TOPOGRAPHY; HEATING COIL; DNA-REPAIR; PARAMETERS; EMISSIONS; ACROLEIN; YIELD	Objectives For electronic nicotine delivery systems (ENDS), also commonly called e-cigarettes, coil temperature is a factor in the potential production of toxic chemical constituents. However, data are lacking regarding the temperatures that are achieved in the latest generation of these devices. Fourth-generation ENDS are capable of producing heating coil temperatures well above e-liquid boiling points, and allow the user to monitor and set the heating coil temperature during a puff. In this study, we evaluate the accuracy and consistency of the temperature measurement and control settings for different brands of fourth-generation ENDS. Methods A study was performed using three commercially available, fourth-generation ENDS. The atomizer coil temperatures were obtained from the device (using the EScribe software) reading and from thermocouples attached to the coils during simulated puffing conditions. In addition, aerosol temperatures were measured inside the atomizer and at the mouthpiece. Results Measured temperatures varied widely across samples taken from the same brand. For example, thermocouple measurements for one unit were 40 Celsius (degrees C) below the 300 degrees C set point, while another unit of the same brand exceeded the set point by more than 100 degrees C. We observed a significant variation in temperature (approximately 100 degrees C) along the length of the coil in some cases. Conclusions The possibility of wide temperature variation across ENDS samples, as well as variations between maximum coil temperatures and internal temperature readings, may have implications for studies that seek to determine correlations between coil temperature and toxin generation.	[Dibaji, Seyed Ahmad Reza; Guha, Suvajyoti; Myers, Matthew R.] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA; [Arab, Aarthi] US FDA, Ctr Tobacco Prod, Silver Spring, MD USA; [Murray, Bruce T.] SUNY Binghamton, Dept Mech Engn, Binghamton, NY USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); FDA Center for Tobacco Products (CTP); State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Myers, MR (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA.	Matthew.Myers@fda.hhs.gov		Arab, Aarthi/0000-0002-3711-1789; Dibaji, Seyed Ahmad Reza/0000-0002-7654-1183	Center for Tobacco Products of the U.S. Food and Drug Administration	Center for Tobacco Products of the U.S. Food and Drug Administration	This work was supported by the Center for Tobacco Products of the U.S. Food and Drug Administration.	Baassiri M, 2017, AEROSOL SCI TECH, V51, P1231, DOI 10.1080/02786826.2017.1341040; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Chen WH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195925; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Garner C, 2014, ELECT CIGARETTE AERO; Geiss O, 2016, INT J HYG ENVIR HEAL, V219, P268, DOI 10.1016/j.ijheh.2016.01.004; Gillman IG, 2016, REGUL TOXICOL PHARM, V75, P58, DOI 10.1016/j.yrtph.2015.12.019; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2006, IARC Monogr Eval Carcinog Risks Hum, V88, P1; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kaisar MA, 2016, TOXICOLOGY, V365, P67, DOI 10.1016/j.tox.2016.07.020; Kasap S.O., 2006, PRINCIPLES ELECT MAT; Lendvay AT., 1974, BEITR GE TABAKFORSCH, V7; Norton KJ, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-17; Robinson R J, 2015, PLoS One, V10, pe0129296, DOI 10.1371/journal.pone.0129296; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Talih S, 2016, NICOTINE TOB RES, V18, P453, DOI 10.1093/ntr/ntv080; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wang P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169811; Zhao TK, 2016, ATMOS ENVIRON, V134, P61, DOI 10.1016/j.atmosenv.2016.03.027	20	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206937	10.1371/journal.pone.0206937	http://dx.doi.org/10.1371/journal.pone.0206937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395592	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400069
J	Schumacher, K; Buttner, P; Dagres, N; Sommer, P; Dinov, B; Hindricks, G; Bollmann, A; Kornej, J				Schumacher, Katja; Buettner, Petra; Dagres, Nikolaos; Sommer, Philipp; Dinov, Borislav; Hindricks, Gerhard; Bollmann, Andreas; Kornej, Jelena			Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation	PLOS ONE			English	Article							LOW-VOLTAGE AREAS; CATHETER ABLATION; RENAL-FUNCTION; RISK; METAANALYSIS; RECURRENCE; MORTALITY; FIBROSIS; OUTCOMES; DISEASE	Background Atrial fibrillation (AF) is the most common sustained arrhythmia in clinical routine. Left atrial (LA) electro-anatomical remodelling in AF patients indicates disease progression and is associated with poor therapeutic success. PR interval prolongation is associated with an increased risk for AF, however, the association between LA remodelling measured as low voltage areas (LVA) during catheter ablation and PR interval is unknown. The aim of this study was to investigate the association between PR interval prolongation and LVA in AF patients. Methods We studied 103 patients (62 +/- 12 years, 59% males, 34% persistent AF) undergoing first AF catheter ablation and presenting with sinus rhythm. PR interval prolongation was defined as PR >200ms and analysed in resting ECG before intervention. LVA were determined using high-density maps and defined as <0.5 mV. Results There were 24 patients (23%) with PR interval prolongation and 18 patients (17%) with LVA. There were significant correlations between PR prolongation with LVA, CHA(2)DS(2)-VASc score and eGFR (r(2) = 0.230, 0.216, and 0.307, all p<0.05). PR interval prolongation (OR 3.450, p = 0.024), persistent AF (OR 5.391, p = 0.002), and LA size (OR 1.117, p = 0.018) were significant predictors for LVA, while age (OR 1.072, p = 0.005), LVA (OR 3.450 p = 0.024) and eGFR (OR 0.962, p = 0.004) were associated with PR interval prolongation. Conclusions Beside persistent AF and LA size, PR interval prolongation might be useful for the prediction of electro-anatomical substrate in AF patients. Larger studies are needed to confirm these results.	[Schumacher, Katja; Buettner, Petra; Dagres, Nikolaos; Sommer, Philipp; Dinov, Borislav; Hindricks, Gerhard; Bollmann, Andreas; Kornej, Jelena] Heart Ctr, Dept Electrophysiol, Leipzig, Germany; [Kornej, Jelena] Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University	Kornej, J (corresponding author), Heart Ctr, Dept Electrophysiol, Leipzig, Germany.; Kornej, J (corresponding author), Univ Leipzig, Inst Med Informat Stat & Epidemiol, Leipzig, Germany.	jelena.kornej@gmx.de	Büttner, Petra/ADR-1721-2022; Sommer, Philipp/AAV-3133-2020	Buttner, Petra/0000-0003-0799-4725				Aro AL, 2014, EUR HEART J, V35, P123, DOI 10.1093/eurheartj/eht176; Badarau S, 2015, INT UROL NEPHROL, V47, P1703, DOI 10.1007/s11255-015-1063-4; Bidstrup Signe, 2013, J Atr Fibrillation, V6, P956, DOI 10.4022/jafib.956; Blandino A, 2017, PACE, V40, P199, DOI 10.1111/pace.13015; Cheng M, 2015, J CARDIOVASC ELECTR, V26, P36, DOI 10.1111/jce.12539; Damman K, 2014, EUR HEART J, V35, P455, DOI 10.1093/eurheartj/eht386; Deo R, 2016, J AM SOC NEPHROL, V27, P559, DOI 10.1681/ASN.2014101045; Dinov B, 2014, CIRC-ARRHYTHMIA ELEC, V7, P483, DOI 10.1161/CIRCEP.113.001185; Hundae A, 2014, NEPHRON CLIN PRACT, V127, P106, DOI 10.1159/000363705; Iwasaki YK, 2011, CIRCULATION, V124, P2264, DOI 10.1161/CIRCULATIONAHA.111.019893; Kircher S, 2017, EUROPACE; Kirchhof P, 2016, KARDIOL POL, V74, P1359, DOI 10.5603/KP.2016.0172; Kornej J, 2015, HEART, V101, P126, DOI 10.1136/heartjnl-2014-306013; Magnani JW, 2013, CIRC-ARRHYTHMIA ELEC, V6, P84, DOI 10.1161/CIRCEP.112.975342; Majima S, 2015, ATHEROSCLEROSIS, V240, P105, DOI 10.1016/j.atherosclerosis.2015.03.001; Marcos EG, 2017, EUROPACE, V19, P1930, DOI 10.1093/europace/euw373; Marrouche NF, 2014, JAMA-J AM MED ASSOC, V311, P498, DOI 10.1001/jama.2014.3; Nielsen JB, 2013, HEART RHYTHM, V10, P1249, DOI 10.1016/j.hrthm.2013.04.012; Ohyama Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079717; Park J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001277; Rolf S, 2014, CIRC-ARRHYTHMIA ELEC, V7, P825, DOI 10.1161/CIRCEP.113.001251; Schmidt M, 2010, AM J CARDIOL, V105, P368, DOI 10.1016/j.amjcard.2009.09.037; Sciacqua A, 2014, INT J CARDIOL, V175, P90, DOI 10.1016/j.ijcard.2014.04.259; Watanabe H, 2009, AM HEART J, V158, P629, DOI 10.1016/j.ahj.2009.06.031; Wu JT, 2014, INT HEART J, V55, P126, DOI 10.1536/ihj.13-231; Yagishita A, 2017, J CARDIOVASC ELECTR, V28, P642, DOI 10.1111/jce.13211	26	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206933	10.1371/journal.pone.0206933	http://dx.doi.org/10.1371/journal.pone.0206933			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395598	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400067
J	Sunny, BS; DeStavola, B; Dube, A; Kondowe, S; Crampin, AC; Glynn, JR				Sunny, Bindu S.; DeStavola, Bianca; Dube, Albert; Kondowe, Scotch; Crampin, Amelia C.; Glynn, Judith R.			Does early linear growth failure influence later school performance? A cohort study in Karonga district, northern Malawi	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; EARLY-CHILDHOOD NUTRITION; 1ST 2 YEARS; LONGITUDINAL ANALYSIS; PRESCHOOL-CHILDREN; ADULT HEALTH; WEIGHT-GAIN; EARLY-LIFE; CONSEQUENCES; AGE	Introduction Stunting or linear growth retardation in childhood is associated with delayed cognitive development due to related causes (malnutrition, illness, poor stimulation), which leads to poor school outcomes at later ages, although evidence of the association between the timing and persistence of stunting and school outcomes within the sub-Saharan African context is limited. Methods Anthropometric data around birth (0-4 months), early (11-16 months) and late childhood (ages 4-8 years) along with school outcomes up until the age of 11 were analysed for a cohort of 1,044 respondents, born between 2002-2004 in Karonga district, northern Malawi. The schooling outcomes were age at school enrolment, grade repetition in Standard 1 and age-for-grade by age 11. Height-for-Age Z-scores (HAZ) and growth trajectories were examined as predictors, based on stunting (<-25D HAZ) and on trajectories between early and late childhood (never stunted, improvers, decliners or persistently stunted). Multinomial and logistic regression were used to estimate the association between stunting/trajectories and schooling, adjusted for socioeconomic confounders. Results The effects of stunting on schooling were evident in early childhood but were more pronounced in late childhood. Children who were stunted in early childhood (9.3%) were less likely to be underage at enrolment, more likely to repeat Standard 1 and were 2-3 times more likely to be overage for their grade by the age of 11, compared to their non-stunted peers. Those persistently stunted between early and late childhood (7.3%) faced the worst consequences on schooling, being three times as likely to enrol late and 3-5 times more likely to be overage for their grade by the age of 11, compared to those never stunted. Compared to improvers, those persistently stunted were three times as likely to be overage by two or more years by the age of 11, with no effect on enrolment or repetition. Conclusion Our findings confirm the importance of early childhood stunting on schooling outcomes and suggest some mitigation by improvements in growth by the age of starting school. The nutritional and learning needs of those persistently stunted may need to be prioritised in future interventions.	[Sunny, Bindu S.; Crampin, Amelia C.; Glynn, Judith R.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England; [DeStavola, Bianca] UCL Great Ormond St Inst Child Hlth, Populat Practice & Policy Programme, London, England; [Dube, Albert; Crampin, Amelia C.] Malawi Epidemiol & Intervent Res Unit, Chilumba, Malawi; [Kondowe, Scotch] Dist Educ Off, Karonga, Malawi	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Malawi Epidemiology and Intervention Research Unit	Sunny, BS (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England.	bsunny@gmail.com	Sunny, Boris Rodriguez/Y-3173-2018	Sunny, Boris Rodriguez/0000-0002-8616-8183	Wellcome Trust [079828/Z/06/C, 098610/Z/12/Z]; UK Economic and Social Research Council [ES/L013967/1]; ESRC [ES/L013967/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	Data collection was funded by The Wellcome Trust (grant numbers 079828/Z/06/C and 098610/Z/12/Z). The analysis and write-up was funded by the UK Economic and Social Research Council (grant number ES/L013967/1). The funders had no role in study design, data collection and analysis or decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Alderman H, 2001, J HUM RESOUR, V36, P185, DOI 10.2307/3069675; Alderman H, 2009, ECON DEV CULT CHANGE, V57, P239, DOI 10.1086/592875; Alderman H, 2006, OXFORD ECON PAP, V58, P450, DOI 10.1093/oep/gpl008; Beasley NMR, 2000, ACTA TROP, V76, P223, DOI 10.1016/S0001-706X(00)00101-7; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bommier A, 2000, J HUM RESOUR, V35, P177, DOI 10.2307/146360; Brown JL, 1996, SCI AM; Casale D, 2014, CHILD CARE HLTH DEV, V40, P900, DOI 10.1111/cch.12143; Chang SM, 2002, J CHILD PSYCHOL PSYC, V43, P775, DOI 10.1111/1469-7610.00088; Cogill, 2003, ANTHROPOMETRIC INDIC; Crookston BT, 2011, MATERN CHILD NUTR, V7, P397, DOI 10.1111/j.1740-8709.2010.00255.x; Crookston BT, 2010, J NUTR, V140, P1996, DOI 10.3945/jn.109.118927; Daniels MC, 2004, J NUTR, V134, P1439, DOI 10.1093/jn/134.6.1439; de Onis M, 2016, MATERN CHILD NUTR, V12, P12, DOI 10.1111/mcn.12231; Engle PL, 2010, FOOD NUTR BULL, V31, P83, DOI 10.1177/156482651003100109; Fentiman A, 1999, COMP EDUC, V35, P331, DOI 10.1080/03050069927865; Fink G, 2014, AM J CLIN NUTR, V100, P182, DOI 10.3945/ajcn.113.080960; Gandhi M, 2011, ACTA PAEDIATR, V100, P1113, DOI 10.1111/j.1651-2227.2011.02254.x; Glewwe P, 2001, J PUBLIC ECON, V81, P345, DOI 10.1016/S0047-2727(00)00118-3; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; GranthamMcGregor SM, 1996, NUTR RES, V16, P1821, DOI 10.1016/S0271-5317(96)00206-0; Hoddinott J, 2011, 1073 INT FOOD POL RE, DOI [10.1111/nure.12102, DOI 10.1111/NURE.12102]; Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; JAMISON DT, 1986, J DEV ECON, V20, P299, DOI 10.1016/0304-3878(86)90026-X; Leroy JL, 2014, J NUTR, V144, P1460, DOI 10.3945/jn.114.191981; Martorell R, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22952; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Mendez MA, 1999, J NUTR, V129, P1555, DOI 10.1093/jn/129.8.1555; Nonoyama-Tarumi Y, 2014, INT REV EDUC, V56, P103, DOI [10.1186/1742-7622-5-3, DOI 10.1186/1742-7622-5-3]; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Prendergast AJ, 2014, PAEDIATR INT CHILD H, V34, P250, DOI 10.1179/2046905514Y.0000000158; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Prost MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002684; Rosales FJ, 2009, NUTR NEUROSCI, V12, P190, DOI 10.1179/147683009X423454; Sudfeld CR, 2015, J NUTR, V145, P2705, DOI 10.3945/jn.115.215996; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Sunny BS, 2017, INT J EDUC DEV, V52, P68, DOI 10.1016/j.ijedudev.2016.10.004; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Walker SP, 2007, J NUTR, V137, P2464, DOI 10.1093/jn/137.11.2464; Walker SP, 2015, J NUTR, V145, P823, DOI 10.3945/jn.114.200261; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; World Health Organization (WHO), 2009, WHO ANTHROPLUS PERS; Yamauchi F, 2008, ECON DEV CULT CHANGE, V56, P657, DOI 10.1086/533542	47	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0200380	10.1371/journal.pone.0200380	http://dx.doi.org/10.1371/journal.pone.0200380			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395573	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000449291400002
J	Bhattacharjee, P; Musyoki, H; Prakash, R; Malaba, S; Dallabetta, G; Wheeler, T; Moses, S; Isac, S; Steen, R				Bhattacharjee, Parinita; Musyoki, Helgar; Prakash, Ravi; Malaba, Serah; Dallabetta, Gina; Wheeler, Tisha; Moses, Stephen; Isac, Shajy; Steen, Richard			Micro-planning at scale with key populations in Kenya: Optimising peer educator ratios for programme outreach and HIV/STI service utilisation	PLOS ONE			English	Article							FEMALE SEX WORKERS; HUMAN-IMMUNODEFICIENCY-VIRUS; HIV PREVENTION; TRANSMISSION; INTERVENTIONS; COUNTRIES; AFRICA; INDIA; RISK	Peer education with micro-planning has been integral to scaling up key population (KP) HIV/STI programmes in Kenya since 2013. Micro-planning reinforces community cohesion within peer networks and standardizes programme inputs, processes and targets for out-reach, including peer educator (PE) workloads. We assessed programme performance for outreach-in relation to the mean number of KPs for which one PE is responsible (KP:PE ratio)-and effects on HIV/STI service utilisation. Quarterly programmatic monitoring data were analysed from October 2013 to September 2016 from implementing partners working with female sex workers (FSWs) and men who have sex with men (MSM) across the country. All implementing partners are expected to follow national guidelines and receive micro-planning training for PEs with support from a Technical Support Unit for KP programmes. We examined correlations between KP: PE ratios and regular outreach contacts, condom distribution, risk reduction counselling, STI screening, HIV testing and violence reporting by KPs. Kenya conducted population size estimates (PSEs) of KPs in 2012. From 2013 to 2016, KP programmes were scaled up to reach 85% of FSWs (PSE 133,675) and 90% of MSM (PSE 18,460). Overall, mean KP: PE ratios decreased from 147 to 91 for FSWs, and from 79 to 58 for MSM. Lower KP: PE ratios, up to 90:1 for FSW and 60:1 for MSM, were significantly associated with more regular outreach contacts (p<0.001), as well as more frequent risk reduction counselling (p<0.001), STI screening (p<0.001) and HIV testing (p<0.001). Condom distribution and reporting of violence by KPs did not differ significantly between the two groups over all time periods. Micro-planning with adequate KP: PE ratios is an effective approach to scaling up HIV prevention programmes among KPs, resulting in high levels of programme uptake and service utilisation.	[Bhattacharjee, Parinita; Moses, Stephen; Isac, Shajy] Univ Manitoba, Ctr Global Publ Hlth, Winnipeg, MB, Canada; [Musyoki, Helgar] Minist Hlth, Natl AIDS & STI Control Programme, Nairobi, Kenya; [Prakash, Ravi] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Malaba, Serah] Partners Hlth & Dev Africa, Nairobi, Kenya; [Dallabetta, Gina] Bill & Melinda Gates Fdn, Washington, DC USA; [Wheeler, Tisha] US Agcy Int Dev, Off HIV AIDS, Bur Global Hlth, Washington, DC 20523 USA; [Steen, Richard] Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	University of Manitoba; Bill & Melinda Gates Foundation; United States Agency for International Development (USAID); Erasmus University Rotterdam; Erasmus MC	Steen, R (corresponding author), Univ Med Ctr Rotterdam, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands.	steenr7@gmail.com	Prakash, Ravi/ABB-8711-2020	Prakash, Ravi/0000-0003-3715-5789	University of Manitoba from the Bill and Melinda Gates Foundation [OPP1032367]	University of Manitoba from the Bill and Melinda Gates Foundation	This work was supported by the University of Manitoba from the Bill and Melinda Gates Foundation OPP1032367 to SM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The authors would like to thank NASCOP for making the data available. Thanks to Shem Kaosa and Japheth Kioko for organizing the monitoring data and sharing the same in a friendly format for analysis. We acknowledge the support received by the University of Manitoba from the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org; grant no. OPP1032367). The views expressed herein are those of the authors and do not necessarily reflect the official policy and position of NASCOP, the Bill & Melinda Gates Foundation or USAID.	Alary M, 2014, SEX TRANSM DIS, V41, P380, DOI 10.1097/OLQ.0000000000000138; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bhattacharjee P, J INT AIDS SOC; Bhattacharjee P, 2013, AIDS CARE, V25, pS46, DOI 10.1080/09540121.2012.736607; Bill and Melinda Gates Foundation, 2013, MICR PEER LED OUTR P; CAMERON DW, 1989, LANCET, V2, P403; Kerrigan D, 2015, LANCET, V385, P172, DOI 10.1016/S0140-6736(14)60973-9; Krishnamurthy P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159656; Leclerc PM, 2008, INT J STD AIDS, V19, P660, DOI 10.1258/ijsa.2008.008099; LINKAGES, ACC IMPL SCAL COMPR; McClarty LM, 2018, SEX TRANSM INFECT, V94, P346, DOI 10.1136/sextrans-2017-053228; Medley A, 2009, AIDS EDUC PREV, V21, P181, DOI 10.1521/aeap.2009.21.3.181; Mishra S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032324; MOSES S, 1991, AIDS, V5, P407, DOI 10.1097/00002030-199104000-00008; NASCOP, 2014, NAT GUID HIV STI PRO; National AIDS and STI Control Programme (NASCOP), 2017, 3 NAT BEH ASS KEY PO; National AIDS and STI Control Programme (NASCOP), 2016, REACH UNR EV KEN HIV; National AIDS and STI Control Programme (NASCOP), 2013, KEN MOST RISK POP SI; National AIDS and STI Control Programme (NASCOP), OUTR MICR LEARN SIT; National AIDS and STI Control Programme (NASCOP), 2016, Q PROGR REP OCT 2013; National AIDS Control Council (NACC), 2014, KEN AIDS STRAT FRAM; National AIDS Control Council (NACC), 2009, KEN HIV PREV RESP MO; National AIDS Control Council (NACC) and National AIDS and STI Control Programme (NASCOP), 2016, POL PREV HIV INF KEY; National AIDS Control Council (NACC) and National AIDS and STI Control Programme (NASCOP), 2012, GEOGR MAPP MOST RISK; NGUGI EN, 1988, LANCET, V2, P887, DOI 10.1016/S0140-6736(88)92480-4; Ngugi EN, 1996, J INFECT DIS, V174, pS240, DOI 10.1093/infdis/174.Supplement_2.S240; Prakash R, 2018, AJAR-AFR J AIDS RES, V17, P99, DOI 10.2989/16085906.2017.1377268; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Steen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121145; Thompson LH, 2012, SYSTEMATIC APPROACH; UNAIDS, 2014, 90 90 90 AMB TREATM; United Nations Population Fund Global Forum on MSM & HIV United Nations Development Programme World Health Organization United States Agency for International Development World Bank, 2015, IMPL COMPR HIV STI P; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization  United Nations Population Fund  Joint United Nations Programme on HIV/AIDS  Global Network of Sex Work Projects  & The World Bank, 2013, IMPL COMPR HIV STI P	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0205056	10.1371/journal.pone.0205056	http://dx.doi.org/10.1371/journal.pone.0205056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383786	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600015
J	Dahmash, EZ; Al-khattawi, A; Iyire, A; Al-Yami, H; Dennison, TJ; Mohammed, AR				Dahmash, Eman Z.; Al-khattawi, Ali; Iyire, Affiong; Al-Yami, Hamad; Dennison, Thomas J.; Mohammed, Afzal R.			Quality by Design (QbD) based process optimisation to develop functionalised particles with modified release properties using novel dry particle coating technique	PLOS ONE			English	Article							PHARMACEUTICAL QUALITY; INTERACTIVE MIXTURES; SURFACE MODIFICATION; DISSOLUTION RATE; POWDERS; ENHANCEMENT; IMPROVEMENT; FINE	Quality by Design (QbD), a current trend employed to develop and optimise various critical pharmaceutical processes, is a systematic approach based on the ethos that quality should be designed into the product itself, not just end tested after manufacture. The present work details a step-wise application of QbD principles to optimise process parameters for production of particles with modified functionalities, using dry particle coating technology. Initial risk assessment identified speed, air pressure, processing time and batch size (independent factors) as having high-to-medium impact on the dry coating process. A design of experiments (DOE) using MODDE software employed a D-optimal design to determine the effect of variations in these factors on identified responses (content uniformity, dissolution rate, particle size and intensity of Fourier transform infrared (FTIR) C = O spectrum). Results showed that batch size had the most significant effect on dissolution rate, particle size and FTIR; with an increase in batch size enhancing dissolution rate, decreasing particle size (depicting absence of coated particles) and increasing the FTIR intensity. While content uniformity was affected by various interaction terms, with speed and batch size having the highest negative effect. Optimal design space for producing functionalised particles with optimal properties required maximum air pressure (40psi), low batch size (6g), speed between 850 to 1500 rpm and processing times between 15 to 60 minutes. The validity and predictive ability of the revised model demonstrated reliability for all experiments. Overall, QbD was demonstrated to provide an expedient and cost effective tool for developing and optimising processes in the pharmaceutical industry.	[Dahmash, Eman Z.; Al-khattawi, Ali; Iyire, Affiong; Al-Yami, Hamad; Dennison, Thomas J.; Mohammed, Afzal R.] Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England	Aston University	Al-khattawi, A; Mohammed, AR (corresponding author), Aston Univ, Aston Sch Pharm, Birmingham, W Midlands, England.	a.al-khattawi@aston.ac.uk; a.u.rmohammed@aston.ac.uk	Iyire, Affiong/GXG-8775-2022	Al-khattawi, Ali/0000-0002-2498-2817; Dahmash, Eman/0000-0002-9815-3720; Mohammed, Afzal-Ur-Rahman/0000-0002-5212-3040	Aston University; UK government; MRC; Viridian Pharma LTD; Saudi Arabian Government	Aston University; UK government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Viridian Pharma LTD; Saudi Arabian Government	The work was funded by Aston University through a post graduate overseas bursary awarded to Eman Z. Dahmash and Ali Al-Khattawi. Affiong Iyire was a Commonwealth Scholar funded by the UK government. MRC and Viridian Pharma LTD provided funding for Tom J. Dennison, and Research grant from Saudi Arabian Government, in particular Najran University for Hamad Al-Yami. The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khattawi A, 2014, CURR DRUG DELIV, V11, P486, DOI 10.2174/1567201811666140323201650; AlHusban Farhan, 2010, Pharmaceutics, V2, P1; Allahham A, 2007, EUR J PHARM BIOPHARM, V67, P732, DOI 10.1016/j.ejpb.2007.04.013; Anderson M. J., 1974, DESIGN EXPT; BP, 2012, BRIT PHARM 2012; Bridgwater J, 2012, PARTICUOLOGY, V10, P397, DOI 10.1016/j.partic.2012.06.002; Dahmash EZ, 2015, EXPERT OPIN DRUG DEL, V12, P1867, DOI 10.1517/17425247.2015.1071351; Eriksson L., 2008, DESIGN EXPT PRINCIPL, V3rd ed.; FDA, 2012, PHARM DEV REP EX QBD; Ghoroi C, 2013, CHEM ENG SCI, V85, P11, DOI 10.1016/j.ces.2012.02.038; Gohel M, 2004, AAPS PHARMSCITECH, V5, DOI 10.1208/pt050336; HERSEY JA, 1975, POWDER TECHNOL, V11, P41, DOI 10.1016/0032-5910(75)80021-0; HONDA H, 1994, COLLOID SURFACE A, V82, P117, DOI 10.1016/0927-7757(93)02620-T; ICH, 2008, PHARM QUALITY SYST Q, V10; ICH, 2005, QUALITY RISK MANAG Q, V9; ICH, 2009, PHARM DEV Q, V8; ISHIZAKA T, 1988, CHEM PHARM BULL, V36, P2562; ISHIZAKA T, 1989, J PHARM PHARMACOL, V41, P361, DOI 10.1111/j.2042-7158.1989.tb06478.x; Jallo LJ, 2012, INT J PHARMACEUT, V423, P213, DOI 10.1016/j.ijpharm.2011.12.012; Jia N, 2011, BIORESOURCES, V6, P1186; Khan F, 2008, P CRESOL CARBON TETR; Lionberger RA, 2008, AAPS J, V10, P268, DOI 10.1208/s12248-008-9026-7; Montgomery D. C., 2005, DESIGN ANAL EXPT; Pfeffer R, 2001, POWDER TECHNOL, V117, P40, DOI 10.1016/S0032-5910(01)00314-X; Ramukutty S, 2012, CRYST RES TECHNOL, V47, P31, DOI 10.1002/crat.201100394; ROMERO AJ, 1993, INT J PHARMACEUT, V99, P125, DOI 10.1016/0378-5173(93)90354-I; Saharan V.A., 2008, ASIAN J PHARM SCI, V3, P240, DOI DOI 10.1002/JPS.3080030220; Saharan VA, 2011, ACTA PHARMACEUT, V61, P323, DOI 10.2478/v10007-011-0021-7; Stewart P, 1995, PARTICUL SCI TECHNOL, V13, P213, DOI 10.1080/02726359508906679; Supabphol R., 1996, PHARM PHARM COMMUN, V2, P233; Terinte N., 2011, LENZINGER BERICHTE, V89, P118, DOI DOI 10.1163/156856198X00740; Triefenbach F, 2008, DESIGN EXPT D OPTIMA; UCLA, 2013, DO I INT SIGN QUADR; United States Pharmacopeia Commission The United States Pharmacopeia and the National Formulary, 2008, US PHARM NAT FORM US; Watson DG, 2012, PHARM ANAL TXB PHARM, V2012; Yang J, 2005, POWDER TECHNOL, V158, P21, DOI 10.1016/j.powtec.2005.04.032; YIP CW, 1977, POWDER TECHNOL, V16, P189; Yu L.X., 2004, J GENERIC MED, V4, P239, DOI [10.1057/palgrave.jgm.4950073, DOI 10.1057/PALGRAVE.JGM.4950073]; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Yu LX, 2014, AAPS J, V16, P771, DOI 10.1208/s12248-014-9598-3; Zheng J., 2009, FORMULATION ANAL DEV	41	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206651	10.1371/journal.pone.0206651	http://dx.doi.org/10.1371/journal.pone.0206651			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383810	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000449027600078
J	Noble, A; O'Reilly, J; Glaves, DJ; Crowle, A; Palmer, SM; Holden, J				Noble, Alice; O'Reilly, John; Glaves, David J.; Crowle, Alistair; Palmer, Sheila M.; Holden, Joseph			Impacts of prescribed burning on Sphagnum mosses in a long-term peatland field experiment	PLOS ONE			English	Article							BLANKET-BOG; SOIL-WATER; MANAGEMENT; UK; INTENSITY; CARBON; DEPOSITION; RECOVERY; QUALITY; TRENDS	Understanding fire impacts on peatland vegetation can inform management to support function and prevent degradation of these important ecosystems. However, time since burn, interval between burns and number of past burns all have the potential to modify impacts. Grazing regime may also affect vegetation directly or via an interaction with burning. We used new, comprehensive survey data from a hillslope-scale field experiment initiated in 1954 to investigate the effects of burning and grazing treatments on Sphagnum. Historical data were consulted to aid interpretation of the results. The unburned reference and the most frequently burned (10-year rotation) treatments had greater Sphagnum abundance and hummock height than intermediate treatments (20-year rotation and no-burn since 1954). Abundance of the most common individual species (S. capillifolium, S. subnitens and S. papillosum) followed similar patterns. Light grazing had no impact on Sphagnum-related variables, nor did it interact with the burning treatments. These results suggest that in some cases fire has a negative impact on Sphagnum, and this can persist for several decades. However, fire return interval and other factors such as atmospheric pollution may alter effects, and in some cases Sphagnum abundance may recover. Fire severity and site specific conditions may also influence effects, so we advise consideration of these factors, and caution when using fire as a management tool on peatlands where Sphagnum is considered desirable.	[Noble, Alice; Palmer, Sheila M.; Holden, Joseph] Univ Leeds, Sch Geog, Water Leeds, Leeds, W Yorkshire, England; [O'Reilly, John] Ptyx Ecol, Lambley, Brampton, England; [Glaves, David J.; Crowle, Alistair] Nat England, Foss House, York, N Yorkshire, England	University of Leeds	Noble, A (corresponding author), Univ Leeds, Sch Geog, Water Leeds, Leeds, W Yorkshire, England.	gyakn@leeds.ac.uk		Holden, Joseph/0000-0002-1108-4831; Noble, Alice/0000-0001-8096-4448; Glaves, David/0000-0002-8923-1280	Natural Environment Research Council [NE/L008572/1]; Natural England	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural England	AN was funded by a Natural Environment Research Council studentship [NE/L008572/1], awarded to JH, SMP, DJG and AC in open competition and supported by Natural England. Ptyxis Ecology was commissioned to carry out the 2015/16 survey by Natural England, and provided financial support in the form of salary for JO. Natural England also provided financial support in the form of salaries for AC and DJG. None of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors employed by each funder are articulated in the 'author contributions' section.	Alday JG, 2015, PERSPECT PLANT ECOL, V17, P388, DOI 10.1016/j.ppees.2015.06.007; ALLEN S. E., 1964, J APPL ECOL, V1, P347, DOI 10.2307/2401318; Ayres JG, 1997, ALLERGY, V52, P7, DOI 10.1111/j.1398-9995.1997.tb04863.x; Brown LE., 2014, EFFECTS MOORLAND BUR; Brown LE, 2015, FRESHW SCI, V34, P1406, DOI 10.1086/683426; Brown LE, 2015, J ENVIRON MANAGE, V154, P166, DOI 10.1016/j.jenvman.2015.02.037; Clay GD, 2010, J HYDROL, V380, P135, DOI 10.1016/j.jhydrol.2009.10.030; Clay GD, 2009, J HYDROL, V376, P486, DOI 10.1016/j.jhydrol.2009.07.055; CLYMO RS, 1984, PHILOS T R SOC B, V303, P605, DOI 10.1098/rstb.1984.0002; Curtis CJ, 2014, ECOL INDIC, V37, P274, DOI 10.1016/j.ecolind.2012.10.023; Davies G., 2005, THESIS; Douglas DJT, 2015, BIOL CONSERV, V191, P243, DOI 10.1016/j.biocon.2015.06.014; Eppinga MB, 2009, PLANT ECOL, V200, P53, DOI 10.1007/s11258-007-9309-6; Evans CD, 2014, ECOSYST SERV, V9, P5, DOI 10.1016/j.ecoser.2014.06.013; FERGUSON P, 1978, ENVIRON POLLUT, V16, P151, DOI 10.1016/0013-9327(78)90129-5; Garnett MH, 2000, HOLOCENE, V10, P729, DOI 10.1191/09596830094971; Geron C, 2013, ATMOS ENVIRON, V64, P192, DOI 10.1016/j.atmosenv.2012.09.065; Glaves DJ, 2013, NATURAL ENGLAND EVID; Granath G, 2009, OECOLOGIA, V161, P481, DOI 10.1007/s00442-009-1406-x; Grau-Andres R, 2017, PLANT ECOL DIVERS, V10, P353, DOI 10.1080/17550874.2017.1394394; Hamilton A, 2000, THESIS; Hayward, 1982, BRYOPHYTE ECOLOGY, P229, DOI DOI 10.1007/978-94-009-5891-3_8; HAYWARD PM, 1982, PROC R SOC SER B-BIO, V215, P299, DOI 10.1098/rspb.1982.0044; HOBBS RJ, 1984, VEGETATIO, V57, P129, DOI 10.1007/BF00047309; Hochkirch A, 2007, ENVIRON CONSERV, V34, P225, DOI 10.1017/S0376892907004006; Holden J, 2015, WATER RESOUR RES, V51, P6472, DOI 10.1002/2014WR016782; Holden J, 2014, HYDROL PROCESS, V28, P2868, DOI 10.1002/hyp.9875; Holden J, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006052; Kasischke ES., 2006, GEOPHYS RES LETT, V33; Kettridge N, 2014, J HYDROL, V513, P335, DOI 10.1016/j.jhydrol.2014.03.019; Lee H, 2013, BIOL CONSERV, V165, P187, DOI 10.1016/j.biocon.2013.05.023; Lee H, 2013, J APPL ECOL, V50, P625, DOI 10.1111/1365-2664.12078; Lindsay R, 2010, PEATBOGS CARBON A CR; Met Office, 2017, NO ENGL MONTHL MEAN; Noble A, 2018, J APPL ECOL, V55, P559, DOI 10.1111/1365-2664.12994; Noble A, 2017, PLANT SOIL, V419, P41, DOI 10.1007/s11104-017-3325-7; Pouliot R, 2015, J ENVIRON MANAGE, V157, P118, DOI 10.1016/j.jenvman.2015.04.019; RAWES M, 1979, J ECOL, V67, P789, DOI 10.2307/2259215; Renard SM, 2016, FOREST ECOL MANAG, V359, P147, DOI 10.1016/j.foreco.2015.09.037; RoTAP, 2012, REV TRANSB AIR POLL; Taylor ES, 2017, PLANT ECOL DIVERS, V10, P77, DOI 10.1080/17550874.2017.1302017; Taylor P, 1974, MOOR HOUSE OCCASIONA, P6; Thacker JI, 2015, BURNING ENGLISH UPLA; Turetsky MR, 2015, NAT GEOSCI, V8, P11, DOI [10.1038/ngeo2325, 10.1038/NGEO2325]; VANBREEMEN N, 1995, TRENDS ECOL EVOL, V10, P270, DOI 10.1016/0169-5347(95)90007-1; Walker TN, 2015, OECOLOGIA, V178, P141, DOI 10.1007/s00442-015-3254-1; Ward SE, 2007, ECOSYSTEMS, V10, P1069, DOI 10.1007/s10021-007-9080-5; Worrall F, 2007, J HYDROL, V339, P1, DOI 10.1016/j.jhydrol.2006.12.025; Worrall F., 2010, IMPACTS BURNING MANA; Xu JR, 2018, CATENA, V160, P134, DOI 10.1016/j.catena.2017.09.010; Yallop AR, 2006, J APPL ECOL, V43, P1138, DOI 10.1111/j.1365-2664.2006.01222.x; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	52	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206320	10.1371/journal.pone.0206320	http://dx.doi.org/10.1371/journal.pone.0206320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383788	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600038
J	Xu, JR; Tan, PP; Li, H; Cui, YY; Qiu, Y; Wang, H; Zhang, X; Li, J; Zhu, L; Zhou, W; Chen, HZ				Xu, Jianrong; Tan, Panpan; Li, Hui; Cui, Yongyao; Qiu, Yu; Wang, Hao; Zhang, Xuan; Li, Juan; Zhu, Liang; Zhou, Wei; Chen, Hongzhuan			Direct SUMOylation of M1 muscarinic acetylcholine receptor increases its ligand-binding affinity and signal transduction	FASEB JOURNAL			English	Article						site-directed mutagenesis; GPCR; agonist; radio-ligand binding	POSTTRANSLATIONAL MODIFICATIONS; SUMO; INTERNALIZATION; TRAFFICKING; MODULATION; COMPLEX	SUMOylation is a significant post-translational modification (PTM) by the small ubiquitin-related modifier (SUMO). Increasing evidence shows SUMOylation regulates GPCR signaling; however, very few GPCRs have been shown to be SUMOylation targets to date. In this study, we identified M1 muscarinic acetylcholine receptor (M1 mAChR), a member of the GPCRs, as a new SUMO substrate. When the mAChR was activated by the agonist carbachol, the colocalization of the M1 mAChR and SUMO-1 protein markedly decreased in immunoprecipitation and immunofluorescence assays. SUMOylation of the M1 mAChR played an important role in increasing the ligand-binding affinity to M1 mAChR, signaling efficiencies, and receptor endocytosis. Through the site-directed mutagenesis approach, K327 was identified as the SUMOylation site of the M1 mAChR. Mutation of the consensus SUMOylation site of the M1 mAChR reduces not only the colocalization of SUMO-1, but also the ligand-binding affinity and signal transduction. The function of M1 mAChR was regulated by SUMOylation through the stabilization of active-state conformation revealed by molecular dynamics simulations. Our results provide evidence that M1 SUMOylation is an important PTM involved in regulation of the affinity for agonists and for activation of signaling pathways.Xu, J., Tan, P., Li, H., Cui, Y., Qiu, Y., Wang, H., Zhang, X., Li, J., Zhu, L., Zhou, W., Chen, H. Direct SUMOylation of M1 muscarinic acetylcholine receptor increases its ligand-binding affinity and signal transduction.	[Xu, Jianrong; Tan, Panpan; Li, Hui; Cui, Yongyao; Qiu, Yu; Wang, Hao; Zhang, Xuan; Li, Juan; Zhu, Liang; Zhou, Wei; Chen, Hongzhuan] Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Inst Med Sci, Shanghai 200025, Peoples R China; [Zhou, Wei] Shanghai Jiao Tong Univ, Sch Med, Coll Stomatol, Shanghai, Peoples R China; [Zhou, Wei] Shanghai Ninth Peoples Hosp, Lab Oral Microbiota & Syst Dis, Shanghai, Peoples R China; [Zhou, Wei] Natl Clin Res Ctr Oral Dis, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Zhou, Wei] Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Zhou, Wei] Shanghai Res Inst Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Chen, Hongzhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201203, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Traditional Chinese Medicine	Chen, HZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharmacol & Chem Biol, Inst Med Sci, Shanghai 200025, Peoples R China.; Zhou, W (corresponding author), Natl Clin Res Ctr Oral Dis, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Zhou, W (corresponding author), Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Zhou, W (corresponding author), Shanghai Res Inst Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Chen, HZ (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201203, Peoples R China.; Zhou, W (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Coll Stomatol, Lab Oral Microbiota & System Dis,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.	sweetzw@hotmail.com; hongzhuan_chen@hotmail.com	ZHU, Liang/O-5270-2019	ZHU, Liang/0000-0002-9383-392X	National Natural Science Foundation of China [81273519, 81503174, 81670992, 81573415]; Shanghai Municipal Science and Technology Commission [11ZR1419300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Natural Science Foundation of China grants 81273519 (to W.Z.), 81503174 (to J.X.), 81670992 (to W.Z.), and 81573415 (to H.C.); and Shanghai Municipal Science and Technology Commission Grant 11ZR1419300 (to W.Z.). The authors declare no conflicts of interest.	ALLARD WJ, 1987, NUCLEIC ACIDS RES, V15, P10604, DOI 10.1093/nar/15.24.10604; Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; [Anonymous], 2010, MOL OP ENV MOE; Barry J, 2011, INT J BIOCHEM CELL B, V43, P37, DOI 10.1016/j.biocel.2010.09.022; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Bradley SJ, 2017, J CLIN INVEST, V127, P487, DOI 10.1172/JCI87526; BUCKLEY NJ, 1989, MOL PHARMACOL, V35, P469; Case D.A., 2022, AMBER 2020; Choi JH, 2016, NEUROPHARMACOLOGY, V102, P229, DOI 10.1016/j.neuropharm.2015.11.021; Coelho-Silva Leticia, 2017, Neuronal Signal, V1, pNS20160010, DOI 10.1042/NS20160010; Daaka Y, 2012, BBA-GEN SUBJECTS, V1820, P743, DOI 10.1016/j.bbagen.2011.03.007; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Felberbaum R, 2012, MOL CELL BIOL, V32, P64, DOI 10.1128/MCB.05878-11; Feligioni M, 2009, EUR J NEUROSCI, V29, P1348, DOI 10.1111/j.1460-9568.2009.06692.x; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Fox JEM, 2012, CAN J PHYSIOL PHARM, V90, P765, DOI 10.1139/Y11-134; Freiman RN, 2003, CELL, V112, P11, DOI 10.1016/S0092-8674(02)01278-3; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Grimsey N, 2011, IUBMB LIFE, V63, P403, DOI 10.1002/iub.442; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kruse AC, 2014, NAT REV DRUG DISCOV, V13, P549, DOI 10.1038/nrd4295; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Li Q, 2013, PSYCHONEUROENDOCRINO, V38, P2542, DOI 10.1016/j.psyneuen.2013.05.016; Li Q, 2013, PSYCHONEUROENDOCRINO, V38, P1145, DOI 10.1016/j.psyneuen.2012.11.005; Luo J, 2013, NEUROMOL MED, V15, P692, DOI 10.1007/s12017-013-8253-y; Ma GQ, 2016, DEV CELL, V39, P438, DOI 10.1016/j.devcel.2016.09.014; Marcelli S, 2018, PHARMACOL RES, V130, P420, DOI 10.1016/j.phrs.2017.12.023; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Norskov-Lauritsen L, 2015, EUR J PHARMACOL, V763, P233, DOI 10.1016/j.ejphar.2015.05.015; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Salom D, 2012, BIOCHEMISTRY-US, V51, P214, DOI 10.1021/bi201707v; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schorova Lenka, 2016, Front Synaptic Neurosci, V8, P9, DOI 10.3389/fnsyn.2016.00009; Teng SL, 2012, AMINO ACIDS, V43, P447, DOI 10.1007/s00726-011-1100-2; Thal DM, 2016, NATURE, V531, P335, DOI 10.1038/nature17188; Torrecilla I, 2006, CURR PHARM DESIGN, V12, P1797, DOI 10.2174/138161206776873716; Uwada J, 2014, J CELL SCI, V127, P3131, DOI 10.1242/jcs.148478; van Koppen CJ, 2004, MOL PHARMACOL, V66, P365, DOI 10.1124/mol.104.003822; Xu JR, 2012, J BIOMOL STRUCT DYN, V30, P30, DOI 10.1080/07391102.2012.674188; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhang J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42749; Zhou W, 2008, CELL MOL NEUROBIOL, V28, P263, DOI 10.1007/s10571-007-9251-0	46	9	9	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2019	33	3					3237	3251		10.1096/fj.201800936R	http://dx.doi.org/10.1096/fj.201800936R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HM9HS	30407877	Bronze			2022-12-26	WOS:000459794800014
J	Montero, N; dei Marcovaldi, MAG; Lopez-Mendilaharsu, M; Santos, AS; Santos, AJB; Fuente, MMPB				Montero, Natalie; dei Marcovaldi, Maria A. G.; Lopez-Mendilaharsu, Milagros; Santos, Alexsandro S.; Santos, Armando J. B.; Fuente, Mariana M. P. B.			Warmer and wetter conditions will reduce offspring production of hawksbill turtles in Brazil under climate change	PLOS ONE			English	Article							DEPENDENT SEX DETERMINATION; NEST-SITE SELECTION; ERETMOCHELYS-IMBRICATA; CARETTA-CARETTA; INCUBATION-TEMPERATURE; SAND TEMPERATURE; HATCHLINGS; EMBRYOS; BEACH; MANAGEMENT	Climate change is expected to impact animals that are heavily reliant on environmental factors, such as sea turtles, since the incubation of their eggs, hatching success and sex ratio are influenced by the environment in which eggs incubate. As climate change progresses it is therefore important to understand how climatic conditions influence their reproductive output and the ramifications to population stability. Here, we examined the influences of five climatic variables (air temperature, accumulated and average precipitation, humidity, solar radiation, and wind speed) at different temporal scales on hawksbill sea turtle (Eretmochelys imbricata) hatchling production at ten nesting beaches within two regions of Brazil (five nesting beaches in Rio Grande do Norte and five in Bahia). Air temperature and accumulated precipitation were the main climatic drivers of hawksbill hatching success (number of eggs hatched within a nest) across Brazil and in Rio Grande do Norte, while air temperature and average precipitation were the main climatic drivers of hatching success at Bahia. Solar radiation was the main climatic driver of emergence success (number of hatchlings that emerged from total hatched eggs within a nest) at both regions. Warmer temperatures and higher solar radiation had negative effects on hatchling production, while wetter conditions had a positive effect. Conservative and extreme climate scenarios show air temperatures are projected to increase at this site, while precipitation projections vary between scenarios and regions throughout the 21st century. We predicted hatching success of undisturbed nests (no recorded depredation or storm-related impacts) will decrease in Brazil by 2100 as a result of how this population is influenced by local climate. This study shows the determining effects of different climate variables and their combinations on an important and critically endangered marine species.	[Montero, Natalie; Fuente, Mariana M. P. B.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [dei Marcovaldi, Maria A. G.; Lopez-Mendilaharsu, Milagros; Santos, Alexsandro S.; Santos, Armando J. B.] Fundacao Protamar, Salvador, BA, Brazil	State University System of Florida; Florida State University	Fuente, MMPB (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	mfuentes@fsu.edu	Santos, Alexsandro/HCI-9028-2022		Sea Turtle License Plate Grants Program [18-025R]	Sea Turtle License Plate Grants Program	MMPBF and NM received a grant from the Sea Turtle License Plate Grants Program (grant number: 18-025R-http://www.helpingseaturtles.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman Ralph A., 1997, P83; Santos AJB, 2016, CHELONIAN CONSERV BI, V15, P109, DOI 10.2744/CCB-1136.1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Booth DT, 2017, INTEGR ZOOL, V12, P352, DOI 10.1111/1749-4877.12255; Butt N, 2016, BIOL CONSERV, V204, P189, DOI 10.1016/j.biocon.2016.10.012; Davenport J., 1989, British Herpetological Society Bulletin, P11; dei Marcovaldi MAG, 2016, J EXP MAR BIOL ECOL, V477, P14, DOI 10.1016/j.jembe.2016.01.001; del Monte-Luna P, 2012, J EXP MAR BIOL ECOL, V412, P103, DOI 10.1016/j.jembe.2011.11.005; Fish MR, 2008, OCEAN COAST MANAGE, V51, P330, DOI 10.1016/j.ocecoaman.2007.09.002; Fuentes MMPB, 2013, ECOL MODEL, V251, P150, DOI 10.1016/j.ecolmodel.2012.12.020; Fuentes MMPB, 2012, MITIG ADAPT STRAT GL, V17, P51, DOI 10.1007/s11027-011-9308-8; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Fuentes MMPB, 2010, AQUAT CONSERV, V20, P132, DOI 10.1002/aqc.1088; Fuentes MMPB, 2016, ECOL APPL, V26, P2706, DOI 10.1002/eap.1386; Fuentes MMPB, 2013, GLOBAL CHANGE BIOL, V19, P1399, DOI 10.1111/gcb.12138; Godfrey MH, 1999, CAN J ZOOL, V77, P1465, DOI 10.1139/cjz-77-9-1465; Godfrey MH, 1996, CAN J ZOOL, P74; Griffith GP, 2018, GLOBAL CHANGE BIOL, V24, pE90, DOI 10.1111/gcb.13891; Hamann M, 2013, CRC MAR BIOL SER, P353; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Hawkes Lucy A., 2014, Conservation Biology Series (Cambridge), V19, P287; Hawkes Lucy A., 2009, Endangered Species Research, V7, P137, DOI 10.3354/esr00198; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; HAYS GC, 1993, ANIM BEHAV, V45, P47, DOI 10.1006/anbe.1993.1006; HORROCKS JA, 1991, MAR ECOL PROG SER, V69, P1, DOI 10.3354/meps069001; Houghton JDR, 2007, J EXP MAR BIOL ECOL, V345, P71, DOI 10.1016/j.jembe.2007.02.001; Howard R, 2015, J EXP BIOL, V218, P3330, DOI 10.1242/jeb.118778; Howard R, 2014, ENDANGER SPECIES RES, V26, P75, DOI 10.3354/esr00636; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Kamel SJ, 2005, ANIM BEHAV, V70, P819, DOI 10.1016/j.anbehav.2005.01.006; Kamel SJ, 2006, ECOL APPL, V16, P923, DOI 10.1890/1051-0761(2006)016[0923:DROSRD]2.0.CO;2; Kamel SJ, 2013, ENDANGER SPECIES RES, V20, P41, DOI 10.3354/esr00489; Kobayashi S, 2017, J EXP MAR BIOL ECOL, V486, P274, DOI 10.1016/j.jembe.2016.10.020; KRAEMER JE, 1980, HERPETOLOGICA, V36, P72; Laloe JO, 2017, GLOBAL CHANGE BIOL, V23, P4922, DOI 10.1111/gcb.13765; Laloe JO, 2016, J EXP MAR BIOL ECOL, V474, P92, DOI 10.1016/j.jembe.2015.09.015; Lamont MM, 2014, J EXP MAR BIOL ECOL, V453, P98, DOI 10.1016/j.jembe.2013.11.006; Lara-Ruiz P, 2006, CONSERV GENET, V7, P773, DOI 10.1007/s10592-005-9102-9; Lolavar A, 2017, ZOOLOGY, V123, P64, DOI 10.1016/j.zool.2017.06.007; Lolavar A, 2015, ENDANGER SPECIES RES, V28, P235, DOI 10.3354/esr00684; Lomberk J, 2017, LESS THAN FEE BEACHF; Mafalda P. O., 2004, TROPICAL OCEANOGRAPH, V32, P143; Marcovaldi MA, 2007, CHELONIAN CONSERV BI, V6, P223, DOI 10.2744/1071-8443(2007)6[223:FYOHST]2.0.CO;2; Marcovaldi MAGD, 2014, J THERM BIOL, V44, P70, DOI 10.1016/j.jtherbio.2014.06.010; Matsuzawa Y, 2002, MAR BIOL, V140, P639, DOI 10.1007/s00227-001-0724-2; MCGEHEE MA, 1990, HERPETOLOGICA, V46, P251; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; McNeill JB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160911; Miller J.D., 1985, Biology of Reptilia, V14, P269; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; Montero N, CLIMATE CHANGE, DOI [10.3354/esr00489, DOI 10.3354/ESR00489]; Montero N, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00262; Morjan CL, 2003, AM NAT, V162, P205, DOI 10.1086/376583; Mota MJ, 2009, BEACH RESTORATION FL; MROSOVSKY N, 1980, AM ZOOL, V20, P531; Pike DA, 2014, GLOBAL CHANGE BIOL, V20, P7, DOI 10.1111/gcb.12397; Pike DA, 2013, GLOBAL CHANGE BIOL, V19, P3082, DOI 10.1111/gcb.12282; Poloczanska ES, 2009, ADV MAR BIOL, V56, P151, DOI 10.1016/S0065-2881(09)56002-6; Reneker JL, 2016, ECOLOGY, V97, P3257, DOI 10.1002/ecy.1603; Rivas ML, 2018, ANIM CONSERV, V21, P387, DOI 10.1111/acv.12404; Saba VS, 2012, NAT CLIM CHANGE, V2, P814, DOI 10.1038/NCLIMATE1582; Sabeur ZA, 2017, INT S ENV SOFTW SYST; Tomillo PS, 2015, SCI REP-UK, V5, DOI 10.1038/srep16789; Santos AJB, 2013, ENDANGER SPECIES RES, V21, P25, DOI 10.3354/esr00505; Schofield G, 2009, J ANIM ECOL, V78, P14, DOI 10.1111/j.1365-2656.2008.01454.x; Schwanz LE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P826, DOI 10.1086/590220; Segura LN, 2010, HERPETOL CONSERV BIO, V5, P196; Serafini Thiago Zagonel, 2009, Phyllomedusa, V8, P3; Soares LS, 2017, MAR BIOL, V164, DOI 10.1007/s00227-016-3035-3; Spotila J, 1985, COPEIA, V1985; Swiggs J, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3350-y; Telemeco RS, 2009, ECOLOGY, V90, P17, DOI 10.1890/08-1452.1; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Valverde Roldan A., 2010, Endangered Species Research, V12, P77, DOI 10.3354/esr00296; Weber SB, 2012, P ROY SOC B-BIOL SCI, V279, P1077, DOI 10.1098/rspb.2011.1238; Weishampel JF, 2004, GLOBAL CHANGE BIOL, V10, P1424, DOI 10.1111/j.1529-8817.2003.00817.x; Weishampel John F., 2010, Endangered Species Research, V12, P41, DOI 10.3354/esr00290; Wyneken J, 2015, J EXP ZOOL PART B, V324, P295, DOI 10.1002/jez.b.22620; YNTEMA CL, 1980, HERPETOLOGICA, V36, P33; Yun K, 2017, ECOL MODEL, V362, P54, DOI 10.1016/j.ecolmodel.2017.08.003	81	15	15	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0204188	10.1371/journal.pone.0204188	http://dx.doi.org/10.1371/journal.pone.0204188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408043	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300005
J	Vila, MF; Trudeau, MP; Hung, YT; Zeng, ZK; Urriola, PE; Shurson, GC; Saqui-Salces, M				Vila, Marta Ferrandis; Trudeau, Michaels P.; Hung, Yuan-Tai; Zeng, Zhikai; Urriola, Pedro E.; Shurson, Gerald C.; Saqui-Salces, Milena			Dietary fiber sources and non-starch polysaccharide-degrading enzymes modify mucin expression and the immune profile of the swine ileum	PLOS ONE			English	Article							GROWTH-PERFORMANCE; GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; HEALTH; IL-4; RECEPTOR; PIGS; DIFFERENTIATION; PROLIFERATION	Due to their complex chemical and physical properties, the effects and mechanisms of action of natural sources of dietary fiber on the intestine are unclear. Pigs are commonly fed high-fiber diets to reduce production costs and non-starch polysaccharide (NSP)-degrading enzymes have been used to increase fiber digestibility. We evaluated the expression of mucin 2 (MUC2), presence of goblet cells, and ileal immune profile of pigs housed individually for 28 days and fed either a low fiber diet based on corn-soybean meal (CSB, n = 9), or two high fiber diets formulated adding 40% corn distillers' dried grains with solubles (DDGS, n = 9) or 30% wheat middlings (WM, n = 9) to CSB-based diet. Pigs were also fed those diets supplemented with a NSP enzymes mix (E) of xylanase, beta-glucanase, mannanase, and galactosidase (n = 8, 10, and 9 for CSB+E, DDGS+E and WM+E, respectively). Feeding DDGS and WM diets increased ileal MUC2 expression compared with CSB diet, and this effect was reversed by the addition of enzymes. There were no differences in abundance of goblet cells among treatments. In general, enzyme supplementation increased gene expression and concentrations of IL-1 beta, and reduced the concentrations of IL-4, IL-17A and IL-11. The effects of diet-induced cytokines on modulating intestinal MUC2 were assessed in vitro by treating mouse and swine enteroids with 1 ng/ml of IL-4 and IL-1 beta. In accordance with previous studies, treatment with II-4 induced Muc2 and expansion of goblet cells in mouse enteroids. However, swine enteroids did not change MUC2 expression or number of goblet cells when treated with IL-4 or IL-1 beta. Our results suggest that mucin and immune profile are regulated by diet in the swine intestine, but by mechanisms different to mouse, emphasizing the need for using appropriate models to study responses to dietary fiber in swine.	[Vila, Marta Ferrandis; Trudeau, Michaels P.; Hung, Yuan-Tai; Zeng, Zhikai; Urriola, Pedro E.; Shurson, Gerald C.; Saqui-Salces, Milena] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Urriola, Pedro E.] Univ Minnesota, Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Saqui-Salces, M (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	msaquisa@umn.edu		Shurson, Gerald/0000-0001-7095-4799; Saqui-Salces, Milena/0000-0001-5848-0092; Hung, Yuan-Tai/0000-0002-4078-444X	National Institute of Food and Agriculture [11980260, MIN-16-101]; National Pork Board [14-045]	National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Pork Board	This study was partially funded by the National Institute of Food and Agriculture (https://www.nifa.usda.gov/) grants 11980260 (MSS) and MIN-16-101 (MSS); and the National Pork Board (https://www.pork.org/) grant 14-045 (PEU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyekum AK, 2015, J ANIM SCI, V93, P3483, DOI 10.2527/jas.2015-9027; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Ayoola AA, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00045; Bedford A, 2015, J BIOTECHNOL, V196, P9, DOI 10.1016/j.jbiotec.2015.01.007; Blanchard C, 2004, J IMMUNOL, V172, P3775, DOI 10.4049/jimmunol.172.6.3775; Bohan AE, 2014, ADIPOCYTE, V3, P322, DOI 10.4161/21623945.2014.981434; BONSCH D, 1995, J BIOL CHEM, V270, P8452, DOI 10.1074/jbc.270.15.8452; Brownawell AM, 2012, J NUTR, V142, P962, DOI 10.3945/jn.112.158147; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Chuang SC, 2011, BIOMARKERS, V16, P504, DOI 10.3109/1354750X.2011.599042; Dabbagh K, 1999, J IMMUNOL, V162, P6233; Estrada A, 1998, IMMUNOPHARM IMMUNOT, V20, P217, DOI 10.3109/08923979809038541; Estrada A, 1997, MICROBIOL IMMUNOL, V41, P991, DOI 10.1111/j.1348-0421.1997.tb01959.x; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Gonzalez LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066465; Grabitske HA, 2008, J AM DIET ASSOC, V108, P1677, DOI 10.1016/j.jada.2008.07.010; Hino S, 2013, J NUTR, V143, P34, DOI 10.3945/jn.112.167064; Ito H, 2009, J NUTR, V139, P1640, DOI 10.3945/jn.109.110171; Iwashita J, 2003, IMMUNOL CELL BIOL, V81, P275, DOI 10.1046/j.1440-1711.2003.t01-1-01163.x; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Khalil HA, 2016, CELL TISSUE RES, V365, P123, DOI 10.1007/s00441-016-2367-0; Kiarie EG, 2010, ANIM SCI J, V81, P63, DOI 10.1111/j.1740-0929.2009.00716.x; Knudsen KEB, 2012, ANIM FEED SCI TECH, V173, P41, DOI 10.1016/j.anifeedsci.2011.12.020; Koltes DA, 2016, J ANIM SCI, V94, P335, DOI 10.2527/jas.2015-9793; Kuo SM, 2013, ADV NUTR, V4, P16, DOI 10.3945/an.112.003046; Lan R, EFFECTS XYLANASE SUP, DOI [10.1111/asj.12771, DOI 10.1111/ASJ.12771]; Lapthorne S, 2015, WORLD J GASTROENTERO, V21, P4150, DOI 10.3748/wjg.v21.i14.4150; Lindberg JE, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-15; Lu H, 2016, CAN J ANIM SCI, V96, P243, DOI 10.1139/cjas-2015-0078; Luo X, 2008, FOOD CHEM, V111, P357, DOI 10.1016/j.foodchem.2008.03.076; Luo Y, 2015, VET RES, V46, DOI 10.1186/s13567-015-0264-2; Mahe Maxime M, 2013, Curr Protoc Mouse Biol, V3, P217, DOI 10.1002/9780470942390.mo130179; Masure D, 2013, PLOS NEGLECT TROP D, V7, P1, DOI DOI 10.1371/J0URNAL.PNTD.0002588); Mehri M, 2010, AFR J BIOTECHNOL, V9, P6221; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Nie Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071372; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Pagano AR, 2007, J ANIM SCI, V85, P1444, DOI 10.2527/jas.2006-111; Pariza MW, 2010, REGUL TOXICOL PHARM, V56, P332, DOI 10.1016/j.yrtph.2009.10.005; Petrov AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088222; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Saqui-Salces M, 2017, J ANIM SCI, V95, P1179, DOI 10.2527/jas.2016.0947; Saqui-Salces M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048039; SATCHITHANANDAM S, 1990, J NUTR, V120, P1179, DOI 10.1093/jn/120.10.1179; Schepetkin IA, 2008, INT IMMUNOPHARMACOL, V8, P1455, DOI 10.1016/j.intimp.2008.06.003; Smith AG, 2011, BRIT J NUTR, V105, P669, DOI 10.1017/S0007114510004277; Stein HH, 2009, J ANIM SCI, V87, P1292, DOI 10.2527/jas.2008-1290; Stepanova H, 2012, CYTOKINE, V58, P152, DOI 10.1016/j.cyto.2012.01.004; Sweeney T, 2012, BRIT J NUTR, V108, P1226, DOI 10.1017/S0007114511006751; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Viladomiu M, 2013, J NUTR BIOCHEM, V24, P929, DOI 10.1016/j.jnutbio.2013.01.006; Waghray M, 2010, GASTROENTEROLOGY, V138, P562, DOI 10.1053/j.gastro.2009.10.043; Weber TE, 2008, J ANIM SCI, V86, P871, DOI 10.2527/jas.2007-0330; Wenk C, 2001, ANIM FEED SCI TECH, V90, P21, DOI 10.1016/S0377-8401(01)00194-8; Wilberts BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114741; Xun WJ, 2015, INT IMMUNOPHARMACOL, V27, P46, DOI 10.1016/j.intimp.2015.04.038; Yaghobfar A, 2017, BRAZ J POULTRY SCI, V19, P629, DOI 10.1590/1806-9061-2016-0441; Zarlenga DS, 2004, VET IMMUNOL IMMUNOP, V101, P223, DOI 10.1016/j.vetimm.2004.05.003; Zhang JZ, 2017, PROTEOME SCI, V15, DOI 10.1186/s12953-016-0109-6	59	24	25	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207196	10.1371/journal.pone.0207196	http://dx.doi.org/10.1371/journal.pone.0207196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408134	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300088
J	Vossen, DM; Verhagen, CVM; Grenman, R; Kluin, RJC; Verheij, M; van den Brekel, MWM; Wessels, LFA; Vens, C				Vossen, David M.; Verhagen, Caroline V. M.; Grenman, Reidar; Kluin, Roelof J. C.; Verheij, Marcel; van den Brekel, Michiel W. M.; Wessels, Lodewyk F. A.; Vens, Conchita			Role of variant allele fraction and rare SNP filtering to improve cellular DNA repair endpoint association	PLOS ONE			English	Article							COPY NUMBER ALTERATION; CROSS-LINK REPAIR; FANCONI-ANEMIA; DRUG-SENSITIVITY; CANCER GENES; HEAD; MUTATIONS; RADIOSENSITIVITY; DISCOVERY; PATHWAY	Background Large cancer genome studies continue to reveal new players in treatment response and tumorigenesis. The discrimination of functional alterations from the abundance of passenger genetic alterations still poses challenges and determines DNA sequence variant selection procedures. Here we evaluate variant selection strategies that select homozygous variants and rare SNPs and assess its value in detecting tumor cells with DNA repair defects. Methods To this end we employed a panel of 29 patient-derived head and neck squamous cell carcinoma (HNSCC) cell lines, of which a subset harbors DNA repair defects. Mitomycin C (MMC) sensitivity was used as functional endpoint of DNA crosslink repair deficiency. 556 genes including the Fanconi anemia (FA) and homologous recombination (HR) genes, whose products strongly determine MMC response, were capture-sequenced. Results We show a strong association between MMC sensitivity, thus loss of DNA repair function, and the presence of homozygous and rare SNPs in the relevant FA/HR genes. Excluding such selection criteria impedes the discrimination of crosslink repair status by mutation analysis. Applied to all KEGG pathways, we find that the association with MMC sensitivity is strongest in the KEGG FA pathway, therefore also demonstrating the value of such selection strategies for exploratory analyses. Variant analyses in 56 clinical samples demonstrate that homozygous variants occur more frequently in tumor suppressor genes than oncogenes further supporting the role of a homozygosity criterion to improve gene function association or tumor suppressor gene identification studies. Conclusion Together our data show that the detection of relevant genes or of repair pathway defected tumor cells can be improved by the consideration of allele zygosity and SNP allele frequencies.	[Vossen, David M.; Verhagen, Caroline V. M.; Vens, Conchita] Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands; [Vossen, David M.; Verhagen, Caroline V. M.] Netherlands Canc Inst, Dept Head & Neck Oncol & Surg, Amsterdam, Netherlands; [Grenman, Reidar] Hosp & Univ Turku, Dept Otorhinolaryngol Head & Neck Surg, Turku, Finland; [Grenman, Reidar] Turku Univ, Dept Med Biochem & Genet, Turku, Finland; [Kluin, Roelof J. C.] Netherlands Canc Inst, Genom Core Facil, Amsterdam, Netherlands; [Verheij, Marcel; Vens, Conchita] Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands; [van den Brekel, Michiel W. M.] Univ Amsterdam, Inst Phonet Sci, Amsterdam, Netherlands; [van den Brekel, Michiel W. M.] Acad Med Ctr, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Netherlands Canc Inst, Div Mol Carcinogenesis, Amsterdam, Netherlands; [Wessels, Lodewyk F. A.] Delft Univ Technol, Dept EEMCS, Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; University of Turku; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute; Delft University of Technology	Vens, C (corresponding author), Netherlands Canc Inst, Div Cell Biol, Amsterdam, Netherlands.; Vens, C (corresponding author), Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands.	c.vens@nki.nl	Verheij, Marcel/O-9652-2018	van den Brekel, Michiel/0000-0002-6338-6743; Kluin, Roel/0000-0002-5133-142X; Vens, Conchita/0000-0002-8608-7236	Dutch Cancer Society [WF-A6C7072]; Brunel fund; Verwelius fund; Netherlands Cancer Institute	Dutch Cancer Society(KWF Kankerbestrijding); Brunel fund; Verwelius fund; Netherlands Cancer Institute	CV and MWMvdB received financial support from the Dutch Cancer Society (Design - WF-A6C7072), the Brunel fund, the Verwelius fund and The Netherlands Cancer Institute. No grant numbers are applicable for the latter three. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for advice and support by Floor Hageman, Magali Michaut and Paul Essers. We would like to acknowledge the NKI-AVL Core Facility Molecular Pathology & Biobanking (CFMPB) for supplying NKI-AVL Biobank material.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; de Haan R, 2018, RADIOTHER ONCOL, V126, P443, DOI 10.1016/j.radonc.2017.10.017; Demuth I, 2000, EUR J HUM GENET, V8, P861, DOI 10.1038/sj.ejhg.5200552; Eilbeck K, 2017, NAT REV GENET, V18, P599, DOI 10.1038/nrg.2017.52; Farnebo L, 2008, ONCOL REP, V20, P453, DOI 10.3892/or_00000028; Gao H, 2015, NAT MED, V21, P1318, DOI 10.1038/nm.3954; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hauser U, 2002, HEAD NECK-J SCI SPEC, V24, P868, DOI 10.1002/hed.10128; Hofree M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12096; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Joenje H, 2000, AM J HUM GENET, V67, P759, DOI 10.1086/303067; Jung H, 2013, NAT BIOTECHNOL, V31, P787, DOI 10.1038/nbt.2681; Kim H, 2012, GENE DEV, V26, P1393, DOI 10.1101/gad.195248.112; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mahmood K, 2017, HUM GENOMICS, V11, DOI 10.1186/s40246-017-0104-8; Maxwell KN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00388-9; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; PekkolaHeino K, 1996, ACTA OTO-LARYNGOL, V116, P341, DOI 10.3109/00016489609137854; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Riaz N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00921-w; Rieckmann T, 2013, RADIOTHER ONCOL, V107, P242, DOI 10.1016/j.radonc.2013.03.013; Riester M, 2016, SOURCE CODE BIOL MED, V11, DOI 10.1186/s13029-016-0060-z; Safaei R, 2005, CRIT REV ONCOL HEMAT, V53, P13, DOI 10.1016/j.critrevonc.2004.09.007; SASAKI MS, 1973, CANCER RES, V33, P1829; Sousa FG, 2015, DNA REPAIR, V28, P107, DOI 10.1016/j.dnarep.2015.01.011; Takebayashi S, 2004, GENE CHROMOSOME CANC, V41, P145, DOI 10.1002/gcc.20066; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Verhagen Caroline V M, 2018, Oncotarget, V9, P18198, DOI 10.18632/oncotarget.24797; Verhagen CVM, 2015, RADIOTHER ONCOL, V116, P358, DOI 10.1016/j.radonc.2015.03.028; Wang AT, 2015, CELL, V160, DOI 10.1016/j.cell.2014.12.031; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206632	10.1371/journal.pone.0206632	http://dx.doi.org/10.1371/journal.pone.0206632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408064	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300029
J	Martisius, NL; Sidera, I; Grote, MN; Steele, TE; McPherron, SP; Schulz-Kornas, E				Martisius, Naomi L.; Sidera, Isabelle; Grote, Mark N.; Steele, Teresa E.; McPherron, Shannon P.; Schulz-Kornas, Ellen			Time wears on: Assessing how bone wears using 3D surface texture analysis	PLOS ONE			English	Article							MIDDLE STONE-AGE; RESTRICTED MAXIMUM-LIKELIHOOD; EL HARHOURA 2; HOOFED MAMMALS; TOOL RESEARCH; TECHNOLOGY; MICROWEAR; MODEL; IDENTIFICATION; ARCHAEOLOGY	Use-wear analysis provides a means of studying traces produced on animal bone during manufacture and use in an effort to reconstruct these processes. Often, these analyses are qualitative and based on experience and expertise. Previous studies have focused on interpreting final traces, but little is known about how these traces develop and change over time. We propose the use of an innovative quantitative method for studying bone surface traces that aims to reduce any unreliable or non-replicable results that can confound more traditional qualitative analyses. We seek to understand the basics of use-wear formation over Time by taking incremental molds of bone specimens subjected to a controlled, mechanical experiment. This study assesses how bone wears during extended use on three Material types (fresh skin, processed leather, or dry bark), from three initial Manufacturing states (unworked, ground with sandstone, or scraped with flint). With data obtained from a confocal disc-scanning microscope, we then apply 3D surface texture analysis using ISO 25178 parameters: surface roughness [Sa], autocorrelation length [Sal], peak curvature [Spc], and upper material ratio [Smr1]. We employ a multilevel multivariate Bayesian model to explain parameter variation under experimental conditions. Our findings show how duration of use strongly affects the transformation of the bone's surface. Unworked bone is completely distinguishable from bone used for long time intervals and those modified by scraping. Interestingly, material wear does not often produce type-specific traces, but does affect the rate of bone alteration and how it is transformed. Specifically, fresh skin transforms bone at a faster rate than other materials. This novel quantitative and experimental approach enhances our understanding of the use of bone as a raw material for making and using tools and provides a foundation for future exploration of archaeological materials and questions.	[Martisius, Naomi L.; Grote, Mark N.; Steele, Teresa E.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Sidera, Isabelle] Univ Paris Quest Nanterre, CNRS, Maison Archeol Ethnol Rene Ginouves, Nanterre, France; [Steele, Teresa E.; McPherron, Shannon P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Schulz-Kornas, Ellen] Max Planck Inst Evolutionary Anthropol, Max Planck Weizmann Ctr Integrat Archaeol & Anthr, Leipzig, Germany	University of California System; University of California Davis; Centre National de la Recherche Scientifique (CNRS); Max Planck Society; Max Planck Society	Martisius, NL (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	nlmartisius@ucdavis.edu	Schulz-Kornas, Ellen/B-8505-2013	Schulz-Kornas, Ellen/0000-0003-1657-8256; Steele, Teresa/0000-0002-3091-6488; Martisius, Naomi/0000-0002-4671-9366	NSF-DDRI [1550161]; NSF-GRFP; NSF-GROW [1650042]; Wenner-Gren Foundation [9214]; Chateaubriand Fellowship	NSF-DDRI; NSF-GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF-GROW(National Science Foundation (NSF)NSF - Office of the Director (OD)); Wenner-Gren Foundation; Chateaubriand Fellowship	This research was primarily supported by NSF-DDRI (Award ID: 1550161), NSF-GRFP and NSF-GROW (Award ID: 1650042) (www.nsf.gov), Wenner-Gren Foundation (Gr. 9214.) (www.wennergren.org), Chateaubriand Fellowship (www.chateaubriand-fellowship.org) funding to NLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Equipment and facilities provided by the Prehistoire et Technologie UMR 7055 and the Maison Archeologie et Ethnologie, Rene-Ginouves, the Department of Human Evolution at the Max Planck Institute for Evolutionary Anthropology, the Max Planck Weizmann Center for Integrative Archaeology and Anthropology, and the Department of Anthropology, University of California, Davis.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldeias V, 2016, J ARCHAEOL SCI, V67, P64, DOI 10.1016/j.jas.2016.01.016; Amemiya Y, 1994, INST MATH S, V24, P83, DOI 10.1214/lnms/1215463787; [Anonymous], 2017, R LANG ENV STAT COMP; Archer W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0069899, 10.1371/annotation/c313df3a-52bd-4cbe-af14-6676480d1a43]; Backwell LR, 2001, P NATL ACAD SCI USA, V98, P1358, DOI 10.1073/pnas.021551598; Backwell L, 2008, J ARCHAEOL SCI, V35, P2880, DOI 10.1016/j.jas.2008.05.017; Backwell L, 2016, VERTEBR PALEOBIOL PA, P15, DOI 10.1007/978-94-024-0899-7_2; Bello SM, 2008, J ARCHAEOL SCI, V35, P1542, DOI 10.1016/j.jas.2007.10.018; Bello SM, 2011, SCANNING, V33, P316, DOI 10.1002/sca.20248; Beyene Y, 2013, P NATL ACAD SCI USA, V110, P1584, DOI 10.1073/pnas.1221285110; Binford L., 1967, AM ANTIQUITY, V32, P1, DOI [DOI 10.2307/278774, 10.2307/278774]; Binford L.R., 1981, BONES ANCIENT MEN MO; Blateyron F, 2013, CHARACTERIZATION ARE; Bradfield J, 2013, J ARCHAEOL SCI, V40, P2606, DOI 10.1016/j.jas.2013.02.007; BROMAGE TG, 1984, AM J PHYS ANTHROPOL, V64, P161, DOI 10.1002/ajpa.1330640210; Buc N., 2007, BAR INT SERIES, V1622, P143; Buc N, 2011, J ARCHAEOL SCI, V38, P546, DOI 10.1016/j.jas.2010.10.009; Campana DV., 1989, BAR INT SERIES; Campmas E, 2015, J HUM EVOL, V78, P122, DOI 10.1016/j.jhevol.2014.08.008; Christidou R, 2003, HOOVES HORNS MOLLUSC; Christidou R., 1999, THESIS U PARIS NANTE; Christidou R, 2008, J ARCHAEOL SCI, V35, P733, DOI 10.1016/j.jas.2007.05.017; Coles JM., 1997, EXPT ARCHAEOLOGY; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; Cristiani E, 2003, HOOVES HORNS MOLLUSC; D'Errico F., 2003, CHRONOLOGY AURIGNACI, P247; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; d'Errico F, 2012, J ARCHAEOL SCI, V39, P2479, DOI 10.1016/j.jas.2012.01.040; d'Errico F, 2012, QUATERN INT, V259, P59, DOI 10.1016/j.quaint.2011.03.039; d'Errico F, 2009, J ARCHAEOL SCI, V36, P1764, DOI 10.1016/j.jas.2009.04.005; dErrico F., 1984, INT J SKELETAL RES, V9-10, P29; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; ElHajraoui AM, 2012, VILLES SITES ARCHAEO, P179; Eren MI, 2016, ETHNOARCHAEOLOGY, V8, P103, DOI 10.1080/19442890.2016.1213972; Evans AA, 2011, SCANNING, V33, P294, DOI 10.1002/sca.20272; Evans AA, 2008, J ARCHAEOL SCI, V35, P2223, DOI 10.1016/j.jas.2008.02.006; Evans AA, 2014, MICRON, V65, P69, DOI 10.1016/j.micron.2014.04.006; Fisher J.W., 1995, J ARCHAEOL METHOD TH, V2, P7, DOI [10.1007/bf02228434, DOI 10.1007/BF02228434]; Gaudzinski S, 1999, J ARCHAEOL SCI, V26, P125, DOI 10.1006/jasc.1998.0311; Giusca C E.A., 2012, EFFECT USE DURATION; Goodall RH, 2015, SCI REP-UK, V5, DOI 10.1038/srep10800; Guo J, 2017, R INTERFACE TO STAN; Harris JA, 2017, J HUM EVOL, V110, P69, DOI 10.1016/j.jhevol.2017.06.011; Jacobs Z, 2012, J HUM EVOL, V62, P377, DOI 10.1016/j.jhevol.2011.12.001; Kaiser TM, 2016, SURF TOPOGR-METROL, V4, DOI 10.1088/2051-672X/4/1/014003; Karr LP, 2015, INT J OSTEOARCHAEOL, V25, P201, DOI 10.1002/oa.2275; Katz DC, 2016, AM J PHYS ANTHROPOL, V160, P593, DOI 10.1002/ajpa.22896; Kubo MO, 2017, BIOSURF BIOTRIBOL; Langley MC, 2016, QUATERNARY SCI REV, V154, P199, DOI 10.1016/j.quascirev.2016.11.006; Legrand A., 2007, BONES TOOLS CURRENT, V1622, P67; Legrand A., 2007, BAR INT SERIES; Legrand-Pineau A, 2014, P 9 M ICAZ WORK BON, P2; Lemoine G.M., 1997, BAR INT SERIES; LEMOINE GM, 1994, AM ANTIQUITY, V59, P316, DOI 10.2307/281935; Lesnik Julie J., 2011, Paleoanthropology, V2011, P268; Lin SC, 2018, J ARCHAEOL METHOD TH, V25, P663, DOI 10.1007/s10816-017-9351-1; Lyman R. L., 2004, J TAPHON, V2, P15; Macdonald DA, 2014, J ARCHAEOL SCI, V48, P26, DOI 10.1016/j.jas.2013.10.003; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; Martinez-Maza C, 2010, AM J PHYS ANTHROPOL, V143, P313, DOI 10.1002/ajpa.21352; MEYER K, 1991, GENET SEL EVOL, V23, P67, DOI 10.1051/gse:19910106; Meyer K, 1997, LIVEST PROD SCI, V47, P185, DOI 10.1016/S0301-6226(96)01414-5; Murdoch D., 2013, FUNCTIONS DRAWING EL; Olsen S.L., 1984, ANAL APPROACHES MANU; Otarola-Castillo E, 2018, J ARCHAEOL SCI, V89, P56, DOI 10.1016/j.jas.2017.10.004; Outram AK., 2005, EUROREA, V2, P107; Outram AK, 2008, WORLD ARCHAEOL, V40, P1, DOI 10.1080/00438240801889456; Pante MC, 2017, J HUM EVOL, V102, P1, DOI 10.1016/j.jhevol.2016.10.002; Peterson A, 2018, J HUM EVOL, V119, P42, DOI 10.1016/j.jhevol.2018.02.004; RAAB LM, 1984, AM ANTIQUITY, V49, P255, DOI 10.2307/280018; Rosso DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177298; Roth M, 2013, LITHISYR3059; SCHIFFER MB, 1988, AM ANTIQUITY, V53, P461, DOI 10.2307/281212; Schulz E, 2013, WEAR, V300, P169, DOI 10.1016/j.wear.2013.01.115; Schulz E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056167; Schulz E, 2010, SCANNING, V32, P162, DOI 10.1002/sca.20181; Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006; Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822; Seetah K, 2008, WORLD ARCHAEOL, V40, P135, DOI 10.1080/00438240701843652; Sidera I, 2017, B SOC PREHISTORIQUE, V103, P291; Sidera I., 1993, THESIS; Soressi M, 2013, P NATL ACAD SCI USA, V110, P14186, DOI 10.1073/pnas.1302730110; Stemp WJ, 2015, SURF TOPOGR-METROL, V3, DOI 10.1088/2051-672X/3/3/034006; Stemp WJ, 2011, SCANNING, V33, P279, DOI 10.1002/sca.20250; Stevens NE, 2010, J ARCHAEOL SCI, V37, P2671, DOI 10.1016/j.jas.2010.06.004; Stone E., 2009, N EUROPEAN S ARCHAEO, P225; Stone E.A., 2011, THESIS U NEW MEXICO; Team SD, 2017, STAN MOD LANG US GUI; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Vincent A., 1987, PREHISTOIRE POITOU C; Watson AS, 2016, SURF TOPOGR-METROL, V4, DOI 10.1088/2051-672X/4/2/024002; Werner JJ, 2018, J ARCHAEOL SCI-REP, V17, P597, DOI 10.1016/j.jasrep.2017.12.008; YELLEN JE, 1995, SCIENCE, V268, P553, DOI 10.1126/science.7725100; Zhang SQ, 2018, J ARCHAEOL SCI, V93, P82, DOI 10.1016/j.jas.2018.03.003; Zhang SQ, 2016, J ARCHAEOL SCI, V65, P57, DOI 10.1016/j.jas.2015.11.004	96	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206078	10.1371/journal.pone.0206078	http://dx.doi.org/10.1371/journal.pone.0206078			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4PQ	30403706	gold, Green Published, Green Submitted			2022-12-26	WOS:000449379500050
J	Merida, LAD; Mattos, EBA; Correa, ACNTF; Pereira, PR; Paschoalin, VMF; Pinho, MFB; Vericimo, MA				Merida, Lyris A. D.; Mattos, Erika B. A.; Correa, Anna C. N. T. F.; Pereira, Patricia R.; Paschoalin, Vania M. F.; Pinho, Maria F. B.; Vericimo, Mauricio A.			Tarin stimulates granulocyte growth in bone marrow cell cultures and minimizes immunosuppression by cyclo-phosphamide in mice	PLOS ONE			English	Article							COLOCASIA-ESCULENTA; HEMATOPOIETIC STEM; PLANT-LECTINS; IN-VITRO; NEUTROPENIA; POOL	Chemotherapeutic drugs, such as cyclophosphamide, cause severe immunosuppression and patients become susceptible to infections. Based on this, the immunomodulatory potential of tarin, a lectin from Colocasia esculenta, was evaluated in bone marrow cell cultures and in cyclophosphamide-immunosuppressed mice. Tarin promoted maintenance of hematopoietic progenitors and repopulation of Gr1 cells in vitro which was supported by in vivo results. In immunosuppressed mice, tarin increased bone marrow cell numbers and altered cell profile distribution by enhancing the frequency of Gr1 + progenitors, including Ly6-C(int)Ly6-G(lo), and anticipating their proliferation/differentiation in mature cells, especially Ly6-C(lo)Ly6-G(hi) . Bone marrow cells harvested from tarin-treated immunosuppressed mice proliferated in response to GM-CSF or G-CSF in vitro and, the low numbers of bone marrow cells in the GO phase, combined with a high number cells undergoing apoptosis confirmed that tarin promoted a faster and intense proliferation/differentiation, even in the presence of CY-induced toxicity. As a result, tarin minimized leukopenia in immunosuppressed mice promoting a faster recovery of peripheral leucocytes and protected erythroid bone marrow cells from CY-cytotoxicity in a dose-dependent manner. Data suggest that tarin could be considered a potential adjuvant to decrease leukopenia and possibly ameliorate anemia, if carefully evaluated in human cancer cell lineages and in clinical trials.	[Merida, Lyris A. D.; Mattos, Erika B. A.; Pinho, Maria F. B.; Vericimo, Mauricio A.] UFF, Dept Immunobiol, Biol Inst, Rio De Janeiro, Brazil; [Correa, Anna C. N. T. F.; Pereira, Patricia R.; Paschoalin, Vania M. F.] Univ Fed Rio de Janeiro, Dept Biochem, Chem Inst, Rio de Janeiro, Brazil	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro	Paschoalin, VMF (corresponding author), Univ Fed Rio de Janeiro, Dept Biochem, Chem Inst, Rio de Janeiro, Brazil.	paschv@iq.ufrj.br	Pereira, Patricia Ribeiro/AAM-7440-2020; Paschoalin, Vania/Q-4997-2019; Vericimo, Mauricio/V-2270-2019; Corrêa, Anna Carolina Nitzsche Teixeira Fernandes/P-9986-2019; Paschoalin, Vania M F/J-1746-2014; de Aquino Mattos, Érika Bertozzi/J-6634-2014	Pereira, Patricia Ribeiro/0000-0002-9008-9904; Corrêa, Anna Carolina Nitzsche Teixeira Fernandes/0000-0002-8614-8166; Paschoalin, Vania M F/0000-0001-6093-134X; de Aquino Mattos, Érika Bertozzi/0000-0002-4407-1068; Vericimo, Mauricio/0000-0002-9240-2925				[Anonymous], 2017, J EVIDENCE BASED COM; Cao Y, 2001, GLYCOBIOLOGY, V11, P677, DOI 10.1093/glycob/11.8.677; Condamine T, 2015, ANNU REV MED, V66, P97, DOI 10.1146/annurev-med-051013-052304; Dale DC, 2002, DRUGS, V62, P1, DOI 10.2165/00003495-200262001-00001; Dettke M, 2000, J LEUKOCYTE BIOL, V68, P511; Heyworth C. M., 1993, V111, P37; Hinge A, 2010, STEM CELLS DEV, V19, P163, DOI 10.1089/scd.2009.0128; Hinge AS, 2010, TRANSFUSION, V50, P1815, DOI 10.1111/j.1537-2995.2010.02647.x; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Kumar U. A., 2012, Indian Journal of Novel Drug Delivery, V4, P93; Kumar VP, 2016, J ETHNOPHARMACOL, V186, P280, DOI 10.1016/j.jep.2016.04.006; Kundu N, 2012, ANTI-CANCER DRUG, V23, P200, DOI 10.1097/CAD.0b013e32834b85e8; Leishman W B, 1901, Br Med J, V2, P757; Li K, 2008, BRIT J HAEMATOL, V140, P90, DOI 10.1111/j.1365-2141.2007.06838.x; Liu B, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0260-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lustberg Maryam B, 2012, Clin Adv Hematol Oncol, V10, P825; Parker KH, 2015, ADV CANCER RES, V128, P95, DOI 10.1016/bs.acr.2015.04.002; Pereira PR, 2017, GLYCOBIOLOGY, V27, P50, DOI 10.1093/glycob/cww083; Pereira PR, 2015, BBA-PROTEINS PROTEOM, V1854, P20, DOI 10.1016/j.bbapap.2014.10.013; Pereira PR, 2018, COMPR REV FOOD SCI F, V17, P878, DOI 10.1111/1541-4337.12358; Pereira PR, 2014, PROTEIN J, V33, P92, DOI 10.1007/s10930-013-9541-y; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roy A, 2002, J AGR FOOD CHEM, V50, P6775, DOI 10.1021/jf025660x; Souza MA, 2013, GLYCOCONJUGATE J, V30, P641, DOI 10.1007/s10719-012-9464-4; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; Ueha S, 2011, INT IMMUNOPHARMACOL, V11, P783, DOI 10.1016/j.intimp.2011.03.003; Vehmeyer K, 1998, EUR J HAEMATOL, V60, P16; Wright JD, 2013, JAMA INTERN MED, V173, P559, DOI 10.1001/jamainternmed.2013.2921; Zar JH, 1999, BIOSTATISTICAL ANAL	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206240	10.1371/journal.pone.0206240	http://dx.doi.org/10.1371/journal.pone.0206240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403726	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500060
J	Stone, CL; Frederick, RD; Tooley, PW; Luster, DG; Campos, B; Winegar, RA; Melcher, U; Fletcher, J; Blagden, T				Stone, Christine L.; Frederick, Reid D.; Tooley, Paul W.; Luster, Douglas G.; Campos, Brittany; Winegar, Richard A.; Melcher, Ulrich; Fletcher, Jacqueline; Blagden, Trenna			Annotation and analysis of the mitochondrial genome of Coniothyrium glycines, causal agent of red leaf blotch of soybean, reveals an abundance of homing endonucleases	PLOS ONE			English	Article							GROUP-I INTRON; TRANSFER-RNA GENES; DACTULIOCHAETA-GLYCINES; SEQUENCE ALIGNMENT; PROTEIN; PROGRAM; FUNGUS; PYRENOCHAETA; ORGANIZATION; PHYLOGENIES	Coniothyrium glycines, the causal agent of soybean red leaf blotch, is a USDA APHIS-listed Plant Pathogen Select Agent and potential threat to US agriculture. Sequencing of the C. glycines mt genome revealed a circular 98,533-bp molecule with a mean GC content of 29.01%. It contains twelve of the mitochondrial genes typically involved in oxidative phosphorylation (atp6, cob, cox1-3, nad1-6, and nad4L), one for a ribosomal protein (rps3), four for hypothetical proteins, one for each of the small and large subunit ribosomal RNAs (ms and ml) and a set of 30 tRNAs. Genes were encoded on both DNA strands with cox/ and cox2 occurring as adjacent genes having no intergenic spacers. Likewise, nad2 and nad3 are adjacent with no intergenic spacers and nad5 is immediately followed by nad4L with an overlap of one base. Thirty-two introns, comprising 54.1% of the total mt genome, were identified within eight protein-coding genes and the ml. Eighteen of the introns contained putative intronic ORFs with either LAGLIDADG or GIY-YIG homing endonuclease motifs, and an additional eleven introns showed evidence of truncated or degenerate endonuclease motifs. One intron possessed a degenerate N-acetyl-transferase domain. C. glycines shares some conservation of gene order with other members of the Pleosporales, most notably nad6-rnl-atp6 and associated conserved tRNA clusters. Phylogenetic analysis of the twelve shared protein coding genes agrees with commonly accepted fungal taxonomy. C. glycines represents the second largest mt genome from a member of the Pleosporales sequenced to date. This research provides the first genomic information on C. glycines, which may provide targets for rapid diagnostic assays and population studies.	[Stone, Christine L.; Frederick, Reid D.; Tooley, Paul W.; Luster, Douglas G.] USDA ARS, Foreign Dis Weed Sci Res Unit, Ft Detrick, MD 21702 USA; [Campos, Brittany; Winegar, Richard A.] MRIGlobal, Global Hlth Surveillance & Diagnost, Palm Bay, FL USA; [Melcher, Ulrich] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Fletcher, Jacqueline; Blagden, Trenna] Oklahoma State Univ, Natl Inst Microbial Forens & Food & Agr Biosecur, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA	United States Department of Agriculture (USDA); Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Frederick, RD (corresponding author), USDA ARS, Foreign Dis Weed Sci Res Unit, Ft Detrick, MD 21702 USA.	reid.frederick@ars.usda.gov	Frederick, Reid/AAC-7488-2021		U.S. Department of Homeland Security, Science & Technology Directorate [HSHQDC-13-C-B0009]; MRIGlobal	U.S. Department of Homeland Security, Science & Technology Directorate(United States Department of Homeland Security (DHS)); MRIGlobal	The genome referenced in this publication was sequenced at MRI Global through funding provided by U.S. Department of Homeland Security, Science & Technology Directorate through Contract No. HSHQDC-13-C-B0009 "Capturing Global Biodiversity of Pathogens by Whole Genome Sequencing". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MRIGlobal provided support in the form of salaries for authors (BC and RAW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Aguileta G, 2014, GENOME BIOL EVOL, V6, P451, DOI 10.1093/gbe/evu028; Andrews S., 2010, FASTQC QUALITY CONTR; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beck N., 2010, MFANNOT ORGANELLE GE; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boerema G. H., 2004, PHOMA IDENTIFICATION; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; CUMMINGS DJ, 1990, CURR GENET, V17, P375, DOI 10.1007/BF00334517; Cusimano N, 2008, MOL BIOL EVOL, V25, P265, DOI 10.1093/molbev/msm241; DATNOFF LE, 1986, T BRIT MYCOL SOC, V87, P297, DOI 10.1016/S0007-1536(86)80033-X; DATNOFF LE, 1987, PLANT DIS, V71, P132, DOI 10.1094/PD-71-0132; de Gruyter J, 2013, STUD MYCOL, P1, DOI 10.3114/sim0004; De Gruyter J, 2002, PERSOONIA, V17, P541; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ferandon C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014048; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Hartman GL, 1996, PLANT PATHOL, V45, P332, DOI 10.1046/j.1365-3059.1996.d01-122.x; HARTMAN GL, 1992, PLANT DIS, V76, P847, DOI 10.1094/PD-76-0847; HARTMAN GL, 1988, MYCOLOGIA, V80, P696, DOI 10.2307/3807721; Hartman GL, 2009, RECOVERY PLAN RED LE, P4; James TY, 2013, CURR BIOL, V23, P1548, DOI 10.1016/j.cub.2013.06.057; Koren S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-126; Kouvelis VN, 2004, FUNGAL GENET BIOL, V41, P930, DOI 10.1016/j.fgb.2004.07.003; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; LEAKEY C. L. A., 1964, TRANS BRIT MYCOL SOC, V47, P341; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Litter J, 2005, ANTON LEEUW INT J G, V88, P249, DOI 10.1007/s10482-005-8544-x; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mardanov AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107536; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Punithalingam E, 1990, CMI DESCRIPTIONS FUN; Quaedvlieg W, 2013, STUD MYCOL, P307, DOI 10.3114/sim0017; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Saguez C, 2000, NUCLEIC ACIDS RES, V28, P1299, DOI 10.1093/nar/28.6.1299; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sethuraman J, 2009, MOL BIOL EVOL, V26, P2299, DOI 10.1093/molbev/msp145; Shen XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116466; STEWART RB, 1957, MYCOLOGIA, V49, P115, DOI 10.2307/3755736; Stone CL, 2010, MYCOLOGIA, V102, P887, DOI 10.3852/09-198; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352	54	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0207062	10.1371/journal.pone.0207062	http://dx.doi.org/10.1371/journal.pone.0207062			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403741	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500100
J	Zachut, M; Kra, G; Moallem, U; Livshitz, L; Levin, Y; Udi, S; Nemirovski, A; Tam, J				Zachut, Maya; Kra, Gitit; Moallem, Uzi; Livshitz, Lilya; Levin, Yishai; Udi, Shiran; Nemirovski, Aline; Tam, Joseph			Characterization of the endocannabinoid system in subcutaneous adipose tissue in periparturient dairy cows and its association to metabolic profiles	PLOS ONE			English	Article							CANNABINOID RECEPTORS; OXIDATIVE STRESS; ENERGY HOMEOSTASIS; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; OBESITY; DYSREGULATION; LIVER; CB1; PERFORMANCE	Adipose tissue (AT) plays a major role in metabolic adaptations in postpartum (PP) dairy cows. The endocannabinoid (eCB) system is a key regulator of metabolism and energy homeostasis; however, information about this system in ruminants is scarce. Therefore, this work aimed to assess the eCB system in subcutaneous AT, and to determine its relation to the metabolic profile in peripartum cows. Biopsies of AT were performed at 14 d prepartum, and 4 and 30 d PP from 18 multiparous peripartum cows. Cows were categorized retrospectively according to those with high body weight (BW) loss (HWL, 8.5 +/- 1.7% BW loss) or low body weight loss (LWL, 2.9 +/- 2.5% BW loss) during the first month PP. The HWL had higher plasma non-esterified fatty acids and a lower insulin/glucagon ratio PP than did LWL. Two-fold elevated AT levels of the main eCBs, N-arachidonoylethanolamine (AEA) and 2-arachidonoylglycerol (2-AG), were found 4 d PP compared with prepartum in HWL, but not in LWL cows. AT levels of the eCB-like molecules oleoylethanolamide, palmitoylethanolamide, and of arachidonic acid were elevated PP compared with prepartum in all cows. The abundance of monoglyceride lipase (MGLL), the 2-AG degrading enzyme, was lower in HWL vs. LWL AT PP. The relative gene expression of the cannabinoid receptors CNR1 and CNR2 in AT tended to be higher in HWL vs. LWL PP. Proteomic analysis of AT showed an enrichment of the inflammatory pathways' acute phase signaling and complement system in HWL vs. LWL cows PP. In summary, eCB levels in AT were elevated at the onset of lactation as part of the metabolic adaptations in PP dairy cows. Furthermore, activating the eCB system in AT is most likely associated with a metabolic response of greater BW loss, lipolysis, and AT inflammation in PP dairy cows.	[Zachut, Maya; Kra, Gitit; Moallem, Uzi; Livshitz, Lilya] Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, Rishon Leziyyon, Israel; [Levin, Yishai] Weizmann Inst Sci, Nancy & Stephen Grand Israel Natl Ctr Personalize, Rehovot, Israel; [Udi, Shiran; Nemirovski, Aline; Tam, Joseph] Hebrew Univ Jerusalem, Fac Med, Sch Pharm, Inst Drug Res,Obes & Metab Lab, Jerusalem, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Weizmann Institute of Science; Hebrew University of Jerusalem	Zachut, M (corresponding author), Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, Rishon Leziyyon, Israel.	mayak@volcani.agri.gov.il		Nemirovski, Alina/0000-0002-2598-0119	Israeli Dairy Council (Yehud, Israel) [362-0460]; Israel Science Foundation (ISF) [617/14]	Israeli Dairy Council (Yehud, Israel); Israel Science Foundation (ISF)(Israel Science Foundation)	This work was funded by the Israeli Dairy Council (#362-0460, Yehud, Israel) grant to M. Zachut, and by the Israel Science Foundation (ISF) (#617/14) grant to J. Tam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annuzzi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-43; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bennetzen MF, 2011, INT J OBESITY, V35, P1377, DOI 10.1038/ijo.2011.8; Bensaid M, 2003, MOL PHARMACOL, V63, P908, DOI 10.1124/mol.63.4.908; Bernabucci U, 2005, J DAIRY SCI, V88, P2017, DOI 10.3168/jds.S0022-0302(05)72878-2; Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Bonsale R, 2018, REPROD DOMEST ANIM, V53, P769, DOI 10.1111/rda.13169; Bradford BJ, 2015, J DAIRY SCI, V98, P6631, DOI 10.3168/jds.2015-9683; Cable JC, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-43; Ceciliani F, 2007, CURR PROTEIN PEPT SC, V8, P91, DOI 10.2174/138920307779941497; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Contreras GA, 2018, J DAIRY SCI, V101, P2737, DOI 10.3168/jds.2017-13340; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Cota D, 2008, FRONT HORM RES, V36, P135, DOI 10.1159/000115362; Cristino L, 2014, BIOFACTORS, V40, P389, DOI 10.1002/biof.1168; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Di Marzo V, 2009, EUR J ENDOCRINOL, V161, P715, DOI 10.1530/EJE-09-0643; Drackley JK, 1999, J DAIRY SCI, V82, P2259, DOI 10.3168/jds.S0022-0302(99)75474-3; Feise Ronald J, 2002, BMC Med Res Methodol, V2, P8, DOI 10.1186/1471-2288-2-8; Feldman E., 2004, ANIMAL MODELS DIABET; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Honig H, 2012, J DAIRY SCI, V95, P3736, DOI 10.3168/jds.2011-5054; HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pharmtox.35.1.607; Izzo AA, 2009, BRIT J PHARMACOL, V158, P451, DOI 10.1111/j.1476-5381.2009.00183.x; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Khan MJ, 2012, J ANIM PHYSIOL AN N, V96, P907, DOI 10.1111/j.1439-0396.2011.01204.x; Knani I, 2016, MOL METAB, V5, P1187, DOI 10.1016/j.molmet.2016.10.004; Lau BK, 2017, NEUROPHARMACOLOGY, V124, P38, DOI 10.1016/j.neuropharm.2017.05.033; Lipina C, 2012, BIOESSAYS, V34, P681, DOI 10.1002/bies.201200031; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Mallat A, 2008, DRUG NEWS PERSPECT, V21, P363, DOI 10.1358/dnp.2008.21.7.1255306; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Oliveros J. C., INTERACTIVE TOOL COM; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Pagano C, 2007, J CLIN ENDOCR METAB, V92, P4810, DOI 10.1210/jc.2007-0768; Pertwee RG, 2002, PROSTAG LEUKOTR ESS, V66, P101, DOI 10.1054/plef.2001.0341; Roche R, 2006, HISTOCHEM CELL BIOL, V126, P177, DOI 10.1007/s00418-005-0127-4; Shalit T, 2015, J PROTEOME RES, V14, P1979, DOI 10.1021/pr501045t; Sidibeh CO, 2017, ENDOCRINE, V55, P839, DOI 10.1007/s12020-016-1172-6; Silvestri C, 2013, CELL METAB, V17, P475, DOI 10.1016/j.cmet.2013.03.001; Silvestri C, 2011, REV ENDOCR METAB DIS, V12, P153, DOI 10.1007/s11154-011-9167-3; Starowicz KM, 2008, OBESITY, V16, P553, DOI 10.1038/oby.2007.106; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tam J, 2018, EUR J INTERN MED, V49, P23, DOI 10.1016/j.ejim.2018.01.009; Tsutahara NM, 2011, PROSTAG OTH LIPID M, V94, P17, DOI 10.1016/j.prostaglandins.2010.11.002; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Weems YS, 2009, PROSTAG OTH LIPID M, V90, P89, DOI 10.1016/j.prostaglandins.2009.09.003; Zachut M, 2017, J DAIRY SCI, V100, P3143, DOI 10.3168/jds.2016-11750; Zachut M, 2017, J PROTEOMICS, V158, P52, DOI 10.1016/j.jprot.2017.02.011; Zachut M, 2013, J DAIRY SCI, V96, P5656, DOI 10.3168/jds.2012-6142; Zachut M, 2015, J PROTEOME RES, V14, P2863, DOI 10.1021/acs.jproteome.5b00190	59	18	19	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205996	10.1371/journal.pone.0205996	http://dx.doi.org/10.1371/journal.pone.0205996			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403679	Green Published, gold, Green Submitted			2022-12-26	WOS:000449379500043
J	Bassey, IE; Gali, RM; Udoh, AE				Bassey, Iya Eze; Gali, Rebecca Mtaku; Udoh, Alphonsus Ekpe			Fertility hormones and vitamin E in active and passive adult male smokers in Calabar, Nigeria	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; SEMEN PARAMETERS; CIGARETTE-SMOKING; TESTOSTERONE LEVEL; EXPOSURE; FOCUS	Smoking is an extremely lethal act and is associated with many illnesses. Lately, major concerns that passive smokers face the same health risks as (if not higher than) active smokers have been raised. Some studies have shown that active smoking is associated with low serum levels of vitamins and testosterone. Are these facts also valid in passive smokers? This study investigated the levels of cotinine, testosterone, follicle stimulating (FSH), Luteinizing Hormone (LH), prolactin and vitamin E in male active smokers and compare these with male passive smokers. Serum levels of cotinine, testosterone, FSH, LH, prolactin and vitamin E were determined in 60 cigarette smokers, 60 passive smokers and 60 non-smokers recruited from Calabar metropolis. The hormones were assayed using ELISA and Vitamin E using high performance liquid chromatography. Socio-demographic and anthropometric indices were obtained and data analyzed using PAWstatistic 18. Cotinine levels were significantly (p<0.05) higher in active smokers than in passive smokers and controls. Vitamin E and testosterone were significantly lower in both active (p<0.05) and passive smokers (p<0.05) when compared to non-smokers. The FSH of the active smokers was significantly higher (p = 0.034) than that of the controls while the passive smokers had the highest LH values (p = 0.0001). However, there were no significant variations in the prolactin levels among the three groups. Both passive and active smoking depletes serum vitamins E and lowers testosterone levels. Lower serum vitamin E is pointer to increased oxidative stress which in conjunction with lower testosterone levels may lead to increased incidence of infertility in both active and passive male smokers.	[Bassey, Iya Eze; Udoh, Alphonsus Ekpe] Univ Calabar, Coll Med Sci, Fac Allied Med Sci, Dept Med Lab Sci, Calabar, Cross River Sta, Nigeria; [Gali, Rebecca Mtaku] Univ Maiduguri, Coll Med Sci, Dept Med Lab Sci, Maiduguri, Borno State, Nigeria	University of Calabar	Bassey, IE (corresponding author), Univ Calabar, Coll Med Sci, Fac Allied Med Sci, Dept Med Lab Sci, Calabar, Cross River Sta, Nigeria.	iyantui@yahoo.com	BASSEY, IYA EZE/P-3508-2016	BASSEY, IYA EZE/0000-0001-7644-2508				Abdrabo A, 2013, INT J THER APPL, V10, P19; Ahmadi S, 2016, INT J REPROD BIOMED, V14, P729; Araujo AB, 2011, BEST PRACT RES CL EN, V25, P303, DOI 10.1016/j.beem.2010.11.004; Asare-Anane H, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0207-z; Bakheet M. S., 2014, African Journal of Pharmacy and Pharmacology, V8, P81, DOI 10.5897/AJPP2013.3777; Benedict MD, 2012, ENVIRON TOXICOL PHAR, V34, P761, DOI 10.1016/j.etap.2012.09.010; Blanco-Munoz J, 2012, SCI TOTAL ENVIRON, V426, P100, DOI 10.1016/j.scitotenv.2012.03.071; Bonnie RJ, 2015, PUBLIC HLTH IMPLICAT; Chaouachi K, 2009, INT J ENV RES PUB HE, V6, P798, DOI 10.3390/ijerph6020798; Chen CZ, 2005, ENVIRON HEALTH PERSP, V113, P412, DOI 10.1289/ehp.7436; Dai JB, 2015, ASIAN J ANDROL, V17, P954, DOI 10.4103/1008-682X.150847; Florescu A, 2009, THER DRUG MONIT, V31, P14, DOI 10.1097/FTD.0b013e3181957a3b; Fraietta R, 2013, CLINICS, V68, P81, DOI 10.6061/clinics/2013(Sup01)09; Halmenschlager G, 2009, J SEX MED, V6, P1743, DOI [10.1111/j.1743-6109.2009.01235.x, DOI 10.1111/J.1743-6109.2009.01235.X]; Hosen MB, 2015, INT J REPROD BIOMED, V13, P525; Hull MGR, 2000, FERTIL STERIL, V74, P725, DOI 10.1016/S0015-0282(00)01501-6; Kinnula VL, 2005, THORAX, V60, P693, DOI 10.1136/thx.2004.037473; Majzoub A, 2018, ARAB J UROL, V16, P113, DOI 10.1016/j.aju.2017.11.013; Mitra A, 2012, SYST BIOL REPROD MED, V58, P255, DOI 10.3109/19396368.2012.684195; Muhammad Zubair, 2017, Asian Pacific Journal of Reproduction, V6, P145; Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c; Northrop-Clewes CA, 2007, CLIN CHIM ACTA, V377, P14, DOI 10.1016/j.cca.2006.08.028; Okoye RC, 2005, PREVENTING INFERTILI; Oni A, 2007, J NUTR, V6; Oyeyipo Ibukun P, 2013, J Hum Reprod Sci, V6, P40, DOI 10.4103/0974-1208.112380; Park MG, 2012, J SEX MED, V9, P472, DOI 10.1111/j.1743-6109.2011.02555.x; Pasqualotto FF, 2006, BJU INT, V97, P324, DOI 10.1111/j.1464-410X.2005.05906.x; Saadat M, 2009, MOL BIOL REP, V36, P1353, DOI 10.1007/s11033-008-9319-z; Salem AK, 2014, INT CURR PHARM J, V3, P291; Sansone A, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0320-7; Trummer H, 2002, HUM REPROD, V17, P1554, DOI 10.1093/humrep/17.6.1554	33	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206504	10.1371/journal.pone.0206504	http://dx.doi.org/10.1371/journal.pone.0206504			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399168	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000014
J	Pfammatter, JA; Bergstrom, RA; Wallace, EP; Maganti, RK; Jones, MV				Pfammatter, Jesse A.; Bergstrom, Rachel A.; Wallace, Eli P.; Maganti, Rama K.; Jones, Mathew, V			A predictive epilepsy index based on probabilistic classification of interictal spike waveforms	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; EEG; AGREEMENT; SLEEP	Quantification of interictal spikes in EEG may provide insight on epilepsy disease burden, but manual quantification of spikes is time-consuming and subject to bias. We present a probability-based, automated method for the classification and quantification of interictal events, using EEG data from kainate- and saline-injected mice (C57BL/6J background) several weeks post-treatment. We first detected high-amplitude events, then projected event waveforms into Principal Components space and identified clusters of spike morphologies using a Gaussian Mixture Model. We calculated the odds-ratio of events from kainate- versus saline-treated mice within each cluster, converted these values to probability scores, P (kainate), and calculated an Hourly Epilepsy Index for each animal by summing the probabilities for events where the cluster P(kainate) > 0.5 and dividing the resultant sum by the record duration. This Index is predictive of whether an animal received an epileptogenic treatment (i.e., kainate), even if a seizure was never observed. We applied this method to an out-of-sample dataset to assess epileptiform spike morphologies in five kainate mice monitored for similar to 1 month. The magnitude of the Index increased over time in a subset of animals and revealed changes in the prevalence of epileptiform (P(kainate) > 0.5) spike morphologies. Importantly, in both data sets, animals that had electrographic seizures also had a high Index. This analysis is fast, unbiased, and provides information regarding the salience of spike morphologies for disease progression. Future refinement will allow a better understanding of the definition of interictal spikes in quantitative and unambiguous terms.	[Pfammatter, Jesse A.; Wallace, Eli P.; Jones, Mathew, V] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Bergstrom, Rachel A.] Beloit Coll, Dept Biol, Beloit, WI 53511 USA; [Maganti, Rama K.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Beloit College; University of Wisconsin System; University of Wisconsin Madison	Pfammatter, JA (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.	pfammatter@wisc.edu		Maganti, Rama/0000-0001-5472-1645; Pfammatter, Jesse/0000-0001-8352-2979; Wallace, Eli/0000-0003-2119-1056	National Institute for Health [RO1 NS075366]; Department of Defense [PR161864]	National Institute for Health; Department of Defense(United States Department of Defense)	This work was funded in part by the National Institute for Health RO1 NS075366 (MVJ) and the Department of Defense PR161864 (RKM).	[Anonymous], 1974, Electroencephalogr Clin Neurophysiol, V37, P538; Avoli M, 2013, NEUROPHARMACOLOGY, V69, P37, DOI 10.1016/j.neuropharm.2012.06.044; Barkmeier DT, 2012, NEUROBIOL DIS, V47, P92, DOI 10.1016/j.nbd.2012.03.026; Bergstrom RA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01483; Boly M, 2014, BRAIN INJURY, V28, P1151, DOI 10.3109/02699052.2014.920525; CASCINO GD, 1992, EPILEPSIA, V33, P639, DOI 10.1111/j.1528-1157.1992.tb02340.x; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fisher RS, 2014, ADV EXP MED BIOL, V813, P3, DOI 10.1007/978-94-017-8914-1_1; Gerber PA, 2008, J CLIN NEUROPHYSIOL, V25, P241, DOI 10.1097/WNP.0b013e318182ed67; GOODIN DS, 1984, LANCET, V1, P837; GOTMAN J, 1989, ELECTROEN CLIN NEURO, V72, P7, DOI 10.1016/0013-4694(89)90026-6; Hotelling H, 1933, J EDUC PSYCHOL, V24, P417, DOI 10.1037/h0071325; Kane N, 2017, CLIN NEUROPHYS PRACT, V2, P170, DOI 10.1016/j.cnp.2017.07.002; Krendl R, 2008, NEUROLOGY, V71, P413, DOI 10.1212/01.wnl.0000310775.87331.90; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Lodder SS, 2013, CLIN NEUROPHYSIOL, V124, P2328, DOI 10.1016/j.clinph.2013.05.019; Malik MH, 2016, IEEE ENG MED BIO, P774, DOI 10.1109/EMBC.2016.7590816; McLachlan G., 2000, WILEY SER PROB STAT; Miller JW, 2008, NEUROLOGY, V71, P392, DOI 10.1212/01.wnl.0000324256.00488.69; Mukhopadhyay S, 1998, IEEE T BIO-MED ENG, V45, P180, DOI 10.1109/10.661266; National Research Council, 2010, GUIDE CARE USE LAB A; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Noachtar S, 2010, EPILEPSY BEHAV, V19, P95, DOI 10.1016/j.yebeh.2010.06.034; Nonclercq A, 2012, J NEUROSCI METH, V210, P259, DOI 10.1016/j.jneumeth.2012.07.015; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Pearson K., 2010, LONDON EDINBURGH DUB, V2, P559, DOI DOI 10.1080/14786440109462720; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Scheuer ML, 2017, CLIN NEUROPHYSIOL, V128, P243, DOI 10.1016/j.clinph.2016.11.005; Souza BC, 2018, BIORXIV; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; Tassinari CA, 2000, CLIN NEUROPHYSIOL, V111, pS94, DOI 10.1016/S1388-2457(00)00408-9; Thomas J, 2016, INT CONF ACOUST SPEE, P749, DOI 10.1109/ICASSP.2016.7471775; Tomlinson SB, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00229; Tse K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096622; Twele Friederike, 2017, Epilepsia Open, V2, P180, DOI 10.1002/epi4.12044; TWYMAN RE, 1991, J PHYSIOL-LONDON, V435, P303, DOI 10.1113/jphysiol.1991.sp018512; Umpierre AD, 2016, EXP NEUROL, V279, P116, DOI 10.1016/j.expneurol.2016.02.014; Wahlberg P, 2000, IEEE T BIO-MED ENG, V47, P857, DOI 10.1109/10.846679; Wallace E, 2015, BRAIN RES, V1615, P116, DOI 10.1016/j.brainres.2015.04.037; Webber WRS, 2017, CLIN NEUROPHYSIOL, V128, P241, DOI 10.1016/j.clinph.2016.11.018; WEBBER WRS, 1993, ELECTROEN CLIN NEURO, V87, P364, DOI 10.1016/0013-4694(93)90149-P; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; Wilson SB, 2002, CLIN NEUROPHYSIOL, V113, P1873, DOI 10.1016/S1388-2457(02)00297-3	43	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207158	10.1371/journal.pone.0207158	http://dx.doi.org/10.1371/journal.pone.0207158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399183	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000047
J	Affuso, O; Pradhan, L; Zhang, CC; Gao, S; Wiener, HW; Gower, B; Heymsfield, SB; Allison, DB				Affuso, Olivia; Pradhan, Ligaj; Zhang, Chengcui; Gao, Song; Wiener, Howard W.; Gower, Barbara; Heymsfield, Steven B.; Allison, David B.			A method for measuring human body composition using digital images	PLOS ONE			English	Article							WEIGHT; FAT; VALIDITY; RISK	Background/Objectives Body mass index (BMI) is a proxy for obesity that is commonly used in spite of its limitation in estimating body fatness. Trained observers with repeated exposure to different body types can estimate body fat (BF) of individuals compared to criterion methods with reasonable accuracy. The purpose of this study was to develop and validate a computer algorithm to provide a valid estimate %BF using digital photographs. Subjects/Methods Our sample included 97 children and 226 adults (age in years: 11.3 +/- 3.3; 38.1 +/- 11.6, respectively). Measured height and weight were used (BMI in kg/m(2): 20.4 +/- 4.4; 28.7 +/- 6.6 for children and adults, respectively). Dual x-ray absorptiometry (DXA) was the criterion method. Body volume (BVPHOTO) and body shape (BSPHOTO) were derived from two digital images. Final support vector regression (SVR) models were trained using age, sex, race, BMI for % BFNOPHOTO, plus BVPHOTO and BSPHOTO for %BFPHOTO. Separate validation models were used to evaluate the learning algorithm in children and adults. The differences in correlations between %BFDXA, %BFNOPHOTO and %BFPHOTO were tested using the Fisher's Z-score transformation. Results Mean BFDXA and BFPHOTO were 27.0%+/- 9.2 vs. 26.7%+/- 7.4 in children and 32.9 +/- 10.4% vs. 32.8%+/- 9.3 in adults. SVR models produced %BFPHOTO values strongly correlated with % BFDXA. Our final model produced correlations of r(DP)= 0.80 and r(DP)= 0.87 in children and adults, respectively for %BFPHOTO vs. %BFDXA. The correlation between %BFNOPHOTO and %BFDXA was moderate, yet statistically significant in both children r(DB) = 0.70; p <0.0001 and adults r(DB) = 0.86; p<0.0001. However, the correlations for r(DP) were statistically higher than r(DB) (%BFDXA vs. %BFNOPHOTO) in both children and adults (children: Z = 5.95, p<0.001; adults: Z = 3.27, p<0.0001). Conclusions Our photographic method produced valid estimates of BF in both children and adults. Further research is needed to create norms for subgroups by sex, race/ethnicity, and mobility status.	[Affuso, Olivia; Wiener, Howard W.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Affuso, Olivia; Gower, Barbara] Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA; [Pradhan, Ligaj; Zhang, Chengcui; Gao, Song] Univ Alabama Birmingham, Coll Arts & Sci, Dept Comp & Informat Sci, Birmingham, AL USA; [Gower, Barbara] Univ Alabama Birmingham, Dept Nutr Sci, Sch Hlth Profess, Birmingham, AL 35294 USA; [Heymsfield, Steven B.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Allison, David B.] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Indiana University System; Indiana University Bloomington	Affuso, O (corresponding author), Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA.; Affuso, O (corresponding author), Univ Alabama Birmingham, Nutr Obes Res Ctr, Birmingham, AL 35294 USA.; Allison, DB (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN 47405 USA.	Oaffuso@uab.edu; Allison@iu.edu		Affuso, Olivia/0000-0003-2268-5074	National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01HL107916, P30DK056336]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107916] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the National Heart, Lung, and Blood Institute and the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under Award Numbers R01HL107916 and P30DK056336. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or any other organization.	Affuso F, 2010, INT J BODY COMPOS RE, V8, P117; Affuso O, 2013, P 31 ANN SCI M OB SO; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Blanchard J. M., 1979, VISUAL APPRAISAL MET; BLAND JM, 1995, LANCET, V346, P1085, DOI 10.1016/S0140-6736(95)91748-9; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; ECKERSON JM, 1992, MED SCI SPORT EXER, V24, P615; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Geoghegan B, 1953, AM J PHYS ANTHROP-NE, V11, P97, DOI 10.1002/ajpa.1330110118; Hunter GR, 2004, SPORTS MED, V34, P329, DOI 10.2165/00007256-200434050-00005; Ivanescu AE, 2016, INT J OBESITY, V40, P887, DOI 10.1038/ijo.2015.214; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; Knox TA, 2003, CLIN INFECT DIS, V36, pS63, DOI 10.1086/367560; Lin L, 2012, STATISTICAL TOOLS FOR MEASURING AGREEMENT, P1, DOI 10.1007/978-1-4614-0562-7; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; MENG XL, 1992, PSYCHOL BULL, V111, P172, DOI 10.1037/0033-2909.111.1.172; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; PIERSON WR, 1961, ERGONOMICS, V4, P213; POLLOCK ML, 1984, MED SCI SPORT EXER, V16, P606; Pradhan L, 2015, IEEE INT SYM MULTIM, P45, DOI 10.1109/ISM.2015.117; Presley A.B., 2006, CLOTH TEXT RES J, V24, P80, DOI DOI 10.1177/0887302X0602400203; SEGAL KR, 1987, J CLIN INVEST, V80, P1050, DOI 10.1172/JCI113159; STERNER MTG, 1986, PHYSICIAN SPORTSMED, V14, P101, DOI 10.1080/00913847.1986.11709047; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; VAISMAN N, 1988, J PEDIATR-US, V113, P925, DOI 10.1016/S0022-3476(88)80033-7; Vogel JA, 1988, USARIEMT1788 ARM RES; WEINBACH A. P., 1938, HUMAN BIOL, V10, P356; WILLIAMS DP, 1992, AM J PUBLIC HEALTH, V82, P358, DOI 10.2105/AJPH.82.3.358; Xu BG, 2009, OPT ENG, V48, DOI 10.1117/1.3250191	35	9	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206430	10.1371/journal.pone.0206430	http://dx.doi.org/10.1371/journal.pone.0206430			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395607	gold, Green Published, Green Submitted			2022-12-26	WOS:000449291400022
J	Bennett, JA; Singh, KP; Welle, SL; Boole, LA; Lawrence, BP; Gasiewicz, TA				Bennett, John A.; Singh, Kameshwar P.; Welle, Stephen L.; Boole, Lisbeth A.; Lawrence, B. Paige; Gasiewicz, Thomas A.			Conditional deletion of Ahr alters gene expression profiles in hematopoietic stem cells	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; TRANSGENIC MICE; ACTIVATION; NICHE; LEUKEMOGENESIS; MAINTENANCE; QUIESCENCE; PHENOTYPE; INFECTION; PROTEINS	The aryl hydrocarbon receptor (AHR) is a ligand activated bHLH transcription factor that belongs to the Per-Arnt-Sim (PAS) superfamily of proteins involved in mediating responses to cellular environment regulating normal physiological and developmental pathways. The AHR binds a broad range of naturally derived and synthetic compounds, and plays a major role in mediating effects of certain environmental chemicals. Although our understanding of the physiological roles of the AHR in the immune system is evolving, there is little known about its role in hematopoiesis and hematopoietic diseases. Prior studies demonstrated that AHR null (AHR-KO) mice have impaired hematopoietic stem cell (HSC) function; they develop myeloproliferative changes in peripheral blood cells, and alterations in hematopoietic stem and progenitor cell populations in the bone marrow. We hypothesized mice lacking AHR expression only within hematopoietic cells (AHR(vav1 )mice) would develop similar changes. However, we did not observe a complete phenocopy of AHR-KO and AHR(vav1) animals at 2 or 18 months of age. To illuminate the signaling mechanisms underlying the alterations in hematopoiesis observed in these mice, we sorted a population of cells highly enriched for HSC function (LSK cells: CD34-CD48-CD150+) and performed microarray analyses. Ingenuity Pathway and Gene Set Enrichment Analyses revealed that that loss of AHR within HSCs alters several gene and signaling networks important for HSC function. Differences in gene expression networks among HSCs from AHR-KO and AHR(vav1) mice suggest that AHR in bone marrow stromal cells also contributes to HSC function. In addition, numerous studies have suggested a role for AHR in both regulation of hematopoietic cells, and in the development of blood diseases. More work is needed to define what these signals are, and how they act upon HSCs.	[Bennett, John A.; Singh, Kameshwar P.; Boole, Lisbeth A.; Lawrence, B. Paige; Gasiewicz, Thomas A.] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA; [Welle, Stephen L.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Gasiewicz, TA (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	tom_gasiewicz@urmc.rochester.edu			NIH [P30 ES01247, T32ES07026, ES023068, ES04862]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH Grants P30 ES01247, T32ES07026, ES023068 and ES04862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrenhoerster LS, 2015, TOXICOL APPL PHARM, V283, P99, DOI 10.1016/j.taap.2014.12.017; Akada H, 2014, STEM CELLS, V32, P1878, DOI 10.1002/stem.1711; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Beerman I, 2010, P NATL ACAD SCI USA, V107, P5465, DOI 10.1073/pnas.1000834107; Bell DR, 2004, ONCOGENE, V23, P7290, DOI 10.1038/sj.onc.1207949; Boulais PE, 2015, BLOOD; Boule LA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20197-4; Boyd AL, 2013, EXP HEMATOL, V41, P858, DOI 10.1016/j.exphem.2013.05.287; Casado FL, 2011, MOL PHARMACOL, V80, P673, DOI 10.1124/mol.111.071381; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Charbord P, 2014, CELL STEM CELL, V15, P376, DOI 10.1016/j.stem.2014.06.005; Chiaro CR, 2008, BIOCHEMISTRY-US, V47, P8445, DOI 10.1021/bi800712f; Contador-Troca M, 2013, CARCINOGENESIS, V34, P2683, DOI 10.1093/carcin/bgt248; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001; Esser C, 2009, BIOCHEM PHARMACOL, V77, P597, DOI 10.1016/j.bcp.2008.10.002; Garrett RW, 2006, MOL PHARMACOL, V69, P2076, DOI 10.1124/mol.105.021006; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Gordon SM, 2005, J BIOL CHEM, V280, P36118, DOI 10.1074/jbc.M507758200; Gori JL, 2015, J CLIN INVEST, V125, P1243, DOI 10.1172/JCI79328; Hayes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106955; Hooker RA, 2015, J MUSCULOSKEL NEURON, V15, P83; Iyer S, 2014, SHIP1 EXPRESSING MES; Jin GB, 2014, EUR J IMMUNOL, V44, P1685, DOI 10.1002/eji.201343980; Kawajiri K, 2017, EXP ANIM TOKYO, V66, P75, DOI 10.1538/expanim.16-0092; Kawasaki H, 2014, ALLERGY, V69, P445, DOI 10.1111/all.12346; Kong CS, 2013, OR SURG OR MED OR PA, V115, P95, DOI 10.1016/j.oooo.2012.10.017; Lam K, 2012, FRONT BIOSCI-LANDMRK, V17, P1120, DOI 10.2741/3977; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lee SY, 2012, J BIOL CHEM, V287, P31342, DOI 10.1074/jbc.M112.387266; Liebermann DA, 1998, INT J ONCOL, V12, P685; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu H, 2011, TOXICOL APPL PHARM, V256, P122, DOI 10.1016/j.taap.2011.07.019; Narasimhan SD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001377; Nguyen LP, 2009, CHEM RES TOXICOL, V22, P1897, DOI 10.1021/tx900043s; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schepers K, 2012, BLOOD, V120, P3425, DOI 10.1182/blood-2011-11-395418; Schlafli AM, 2012, EXP HEMATOL ONCOL, V1, DOI 10.1186/2162-3619-1-25; Singh KP, 2014, STEM CELLS DEV, V23, P95, DOI 10.1089/scd.2013.0346; Singh KP, 2011, STEM CELLS DEV, V20, P769, DOI 10.1089/scd.2010.0333; Singh KP, 2009, CARCINOGENESIS, V30, P11, DOI 10.1093/carcin/bgn224; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Till JE, 2012, RADIAT RES, V178, pAV3, DOI 10.1667/RRAV01.1; Unnisa Z, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/4536187; Vercherat C, 2009, HUM MOL GENET, V18, P4304, DOI 10.1093/hmg/ddp383; Vezina CM, 2009, BIOCHEM PHARMACOL, V77, P566, DOI 10.1016/j.bcp.2008.09.039; Walisser JA, 2005, P NATL ACAD SCI USA, V102, P17858, DOI 10.1073/pnas.0504757102; Wheeler JLH, 2013, J IMMUNOL, V190, P659, DOI 10.4049/jimmunol.1201341; Winans B, 1950, J IMMUNOLOGY; ZIPFEL PF, 1994, IMMUNOL TODAY, V15, P121, DOI 10.1016/0167-5699(94)90155-4	51	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206407	10.1371/journal.pone.0206407	http://dx.doi.org/10.1371/journal.pone.0206407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388136	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800029
J	Li, XY; Doroshenko, A; Osgood, ND				Li, Xiaoyan; Doroshenko, Alexander; Osgood, Nathaniel D.			Applying particle filtering in both aggregated and age-structured population compartmental models of pre-vaccination measles	PLOS ONE			English	Article							EPIDEMICS; DYNAMICS; CHAOS	Measles is a highly transmissible disease and is one of the leading causes of death among young children under 5 globally. While the use of ongoing surveillance data and-recently- dynamic models offer insight on measles dynamics, both suffer notable shortcomings when applied to measles outbreak prediction. In this paper, we apply the Sequential Monte Carlo approach of particle filtering, incorporating reported measles incidence for Saskatchewan during the pre-vaccination era, using an adaptation of a previously contributed measles compartmental model. To secure further insight, we also perform particle filtering on an age structured adaptation of the model in which the population is divided into two interacting age groups-children and adults. The results indicate that, when used with a suitable dynamic model, particle filtering can offer high predictive capacity for measles dynamics and outbreak occurrence in a low vaccination context. We have investigated five particle filtering models in this project. Based on the most competitive model as evaluated by predictive accuracy, we have performed prediction and outbreak classification analysis. The prediction results demonstrate that this model could predict measles outbreak evolution and classify whether there will be an outbreak or not in the next month (Area under the ROC Curve of 0.89). We conclude that anticipating the outbreak dynamics of measles in low vaccination regions by applying particle filtering with simple measles transmission models, and incorporating time series of reported case counts, is a valuable technique to assist public health authorities in estimating risk and magnitude of measles outbreaks. It is to be emphasized that particle filtering supports estimation of (via sampling from) the entire state of the dynamic model-both latent and observable-for each point in time. Such approach offers a particularly strong value proposition for other pathogens with little-known dynamics, critical latent drivers, and in the context of the growing number of high-velocity electronic data sources. Strong additional benefits are also likely to be realized from extending the application of this technique to highly vaccinated populations.	[Li, Xiaoyan; Osgood, Nathaniel D.] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada; [Doroshenko, Alexander] Univ Alberta, Dept Med, Div Prevent Med, Edmonton, AB, Canada	University of Saskatchewan; University of Alberta	Li, XY (corresponding author), Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada.	xiaoyan.li@usask.ca	li, xiaofeng/GXF-9442-2022; li, xiao/GSN-6181-2022	Li, Xiaoyan/0000-0002-4206-098X	Alberta Health, University of Alberta project [RES0022828]	Alberta Health, University of Alberta project	This study was funded by the grant from Alberta Health, University of Alberta project number RES0022828. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 1921, ANN REPORT DEP PUBLI; [Anonymous], 2017, FACT SHEET MEASLES W; [Anonymous], 2016, HIST AGE PYRAMID STA; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Bartlett M., 1956, P 3 BERK S MATH STAT, V4, P109; Bjornstad O.N., 2002, ECOL MONOGR, V72, P169, DOI DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blake A, 1997, ADV NEUR IN, V9, P361; Chen S, 2012, J R STAT SOC C-APPL, V61, P117, DOI 10.1111/j.1467-9876.2011.01001.x; Deodhar S, 2014, ACM TRANS MANAG INF, V5, DOI 10.1145/2629692; Dorigatti I, 2012, EPIDEMICS-NETH, V4, P9, DOI 10.1016/j.epidem.2011.11.001; Doucet A., 2009, HDB NONLINEAR FILTER, V12, P656; Dukic V, 2012, J AM STAT ASSOC, V107, P1410, DOI 10.1080/01621459.2012.713876; Dureau J, 2013, BIOSTATISTICS, V14, P541, DOI 10.1093/biostatistics/kxs052; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Grenfell BT, 2002, ECOL MONOGR, V72, P185, DOI 10.1890/0012-9615(2002)072[0185:DOMESN]2.0.CO;2; GRENFELL BT, 1992, J ROY STAT SOC B MET, V54, P383; Hamborsky J, 2015, EPIDEMIOLOGY PREVENT; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; HETHCOTE HW, 1983, AM J EPIDEMIOL, V117, P2, DOI 10.1093/oxfordjournals.aje.a113511; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hubbard TP, 2006, LECT NOTES; Kreuger K, 2015, WINT SIMUL C PROC, P737, DOI 10.1109/WSC.2015.7408211; Moss R, 2016, INFLUENZA OTHER RESP, V10, P314, DOI 10.1111/irv.12376; OLSEN LF, 1988, THEOR POPUL BIOL, V33, P344, DOI 10.1016/0040-5809(88)90019-6; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Oraji R, 2016, 2016 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI), P392, DOI 10.1109/ICHI.2016.70; Osgood N, 2014, WINT SIMUL C PROC, P829, DOI 10.1109/WSC.2014.7019944; Rodeiro CLV, 2006, STAT METHODS MED RES, V15, P423, DOI 10.1177/0962280206071640; Safarishahrbijari A, 2015, WINT SIMUL C PROC, P1240, DOI 10.1109/WSC.2015.7408249; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Tabataba FS, 2017, IEEE DATA MINING, P1099, DOI 10.1109/ICDM.2017.145; Tang WC, 2017, INT CONF ACOUST SPEE, P4094, DOI 10.1109/ICASSP.2017.7952926; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583	35	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206529	10.1371/journal.pone.0206529	http://dx.doi.org/10.1371/journal.pone.0206529			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388138	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800037
J	Yu, JW; Bhattacharya, S; Yanamandra, N; Kilian, D; Shi, H; Yadavilli, S; Katlinskaya, Y; Kaczynski, H; Conner, M; Benson, W; Hahn, A; Seestaller-Wehr, L; Bi, MX; Vitali, NJ; Tsvetkov, L; Halsey, W; Hughes, A; Traini, C; Zhou, H; Jing, JP; Lee, T; Figueroa, DJ; Brett, S; Hopson, CB; Smothers, JF; Hoos, A; Srinivasan, R				Yu, Jong W.; Bhattacharya, Sabyasachi; Yanamandra, Niranjan; Kilian, David; Shi, Hong; Yadavilli, Sapna; Katlinskaya, Yuliya; Kaczynski, Heather; Conner, Michael; Benson, William; Hahn, Ashleigh; Seestaller-Wehr, Laura; Bi, Meixia; Vitali, Nicholas J.; Tsvetkov, Lyuben; Halsey, Wendy; Hughes, Ashley; Traini, Christopher; Zhou, Hui; Jing, Junping; Lee, Tae; Figueroa, David J.; Brett, Sara; Hopson, Christopher B.; Smothers, James F.; Hoos, Axel; Srinivasan, Roopa			Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; T-CELL INFILTRATION; PD-1 BLOCKADE; SUPPRESSOR-CELLS; LYMPHOCYTE INFILTRATION; YERSINIA-ENTEROCOLITICA; CTLA-4 BLOCKADE; MOUSE MODELS; IMMUNOTHERAPY; EXPRESSION	Mouse syngeneic tumor models are widely used tools to demonstrate activity of novel anticancer immunotherapies. Despite their widespread use, a comprehensive view of their tumor-immune compositions and their relevance to human tumors has only begun to emerge. We propose each model possesses a unique tumor-immune infiltrate profile that can be probed with immunotherapies to inform on anti-tumor mechanisms and treatment strategies in human tumors with similar profiles. In support of this endeavor, we characterized the tumor microenvironment of four commonly used models and demonstrate they encompass a range of immunogenicities, from highly immune infiltrated RENCA tumors to poorly infiltrated B16F10 tumors. Tumor cell lines for each model exhibit different intrinsic factors in vitro that likely influence immune infiltration upon subcutaneous implantation. Similarly, solid tumors in vivo for each model are unique, each enriched in distinct features ranging from pathogen response elements to antigen presentation machinery. As RENCA tumors progress in size, all major T cell populations diminish while myeloid-derived suppressor cells become more enriched, possibly driving immune suppression and tumor progression. In CT26 tumors, CD8 T cells paradoxically increase in density yet are restrained as tumor volume increases. Finally, immunotherapy treatment across these different tumorimmune landscapes segregate into responders and non-responders based on features partially dependent on pre-existing immune infiltrates. Overall, these studies provide an important resource to enhance our translation of syngeneic models to human tumors. Future mechanistic studies paired with this resource will help identify responsive patient populations and improve strategies where immunotherapies are predicted to be ineffective.	[Yu, Jong W.; Bhattacharya, Sabyasachi; Yanamandra, Niranjan; Kilian, David; Shi, Hong; Yadavilli, Sapna; Katlinskaya, Yuliya; Kaczynski, Heather; Conner, Michael; Hahn, Ashleigh; Seestaller-Wehr, Laura; Bi, Meixia; Vitali, Nicholas J.; Tsvetkov, Lyuben; Figueroa, David J.; Brett, Sara; Hopson, Christopher B.; Smothers, James F.; Srinivasan, Roopa] GlaxoSmithKline, Immunooncol & Combinat Res Unit, Collegeville, PA 19426 USA; [Benson, William; Halsey, Wendy; Hughes, Ashley; Traini, Christopher; Zhou, Hui; Jing, Junping; Lee, Tae] GlaxoSmithKline, Target Sci R&D, Collegeville, PA USA; [Hoos, Axel] GlaxoSmithKline, Oncol R&D, Collegeville, PA 19426 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Srinivasan, R (corresponding author), GlaxoSmithKline, Immunooncol & Combinat Res Unit, Collegeville, PA 19426 USA.; Hoos, A (corresponding author), GlaxoSmithKline, Oncol R&D, Collegeville, PA 19426 USA.	axel.x.hoos@gsk.com; roopa.x.srinivasan@gsk.com		Yu, Jong/0000-0003-4602-3585	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	GlaxoSmithKline provided support in the form of salaries for authors JWY, SB, NY, DK, HS, SY, YK, HK, MC, WB, AH, LS, MB, NV, LT, WH, AH, CT, HZ, JJ, TL, DJF, SB, CBH, JFS, AH, and RS but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aguilera TA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13898; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; ARENCIBIA I, 1989, EUR J IMMUNOL, V19, P929, DOI 10.1002/eji.1830190521; AUTENRIETH IB, 1994, J INFECT DIS, V169, P562, DOI 10.1093/infdis/169.3.562; AUTENRIETH IB, 1994, INFECT IMMUN, V62, P2590, DOI 10.1128/IAI.62.6.2590-2599.1994; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Callahan MK, 2013, J LEUKOCYTE BIOL, V94, P41, DOI 10.1189/jlb.1212631; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chen DS, 2012, CLIN CANCER RES, V18, P6580, DOI 10.1158/1078-0432.CCR-12-1362; Chew V, 2012, GUT, V61, P427, DOI 10.1136/gutjnl-2011-300509; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Devaud C, 2014, MOL THER, V22, P18, DOI 10.1038/mt.2013.219; Dietlin TA, 2007, J LEUKOCYTE BIOL, V81, P1205, DOI 10.1189/jlb.1006640; DuPage M, 2013, CURR OPIN IMMUNOL, V25, P192, DOI 10.1016/j.coi.2013.02.005; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 1999, CLIN CANCER RES, V5, P2963; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Garbe AI, 2006, CANCER RES, V66, P508, DOI 10.1158/0008-5472.CAN-05-2383; Gould SE, 2015, NAT MED, V21, P431, DOI 10.1038/nm.3853; Harlin H, 2009, CANCER RES, V69, P3077, DOI 10.1158/0008-5472.CAN-08-2281; Hawley CA, 2018, J IMMUNOL, V200, P2209, DOI 10.4049/jimmunol.1701488; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hirano S, 2007, J GASTROEN HEPATOL, V22, P690, DOI 10.1111/j.1440-1746.2006.04551.x; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang YH, 2012, P NATL ACAD SCI USA, V109, P17561, DOI 10.1073/pnas.1215397109; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kondo T, 2006, CANCER SCI, V97, P780, DOI 10.1111/j.1349-7006.2006.00231.x; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; KUNZ M, 1999, THE JOURNAL OF PATHO, V189, P552, DOI DOI 10.1002/(SICI)1096-9896(199912)189:4<552::AID-PATH469>3.0.CO;2-I; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lechner MG, 2013, J IMMUNOTHER, V36, P477, DOI 10.1097/01.cji.0000436722.46675.4a; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Miller LD, 2016, CANCER IMMUNOL RES, V4, P600, DOI 10.1158/2326-6066.CIR-15-0149; Mlecnik B, 2010, GASTROENTEROLOGY, V138, P1429, DOI 10.1053/j.gastro.2009.10.057; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mosely SIS, 2017, CANCER IMMUNOL RES, V5, P29, DOI 10.1158/2326-6066.CIR-16-0114; Ock CY, 2016, CLIN CANCER RES, V22, P2261, DOI 10.1158/1078-0432.CCR-15-2834; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Pylayeva-Gupta Y, 2012, CANCER CELL, V21, P836, DOI 10.1016/j.ccr.2012.04.024; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Selby MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161779; Shindo Y, 2015, ANTICANCER RES, V35, P129; Shrimali RK, 2010, CANCER RES, V70, P6171, DOI 10.1158/0008-5472.CAN-10-0153; Simpson KD, 2012, J IMMUNOL, V189, P5533, DOI 10.4049/jimmunol.1201161; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Strachan DC, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26968; Sweis RF, 2016, CANCER IMMUNOL RES, V4, P563, DOI 10.1158/2326-6066.CIR-15-0274; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Teng MWL, 2015, CANCER RES, V75, P2139, DOI 10.1158/0008-5472.CAN-15-0255; Tsujikawa T, 2017, CELL REP, V19, P203, DOI 10.1016/j.celrep.2017.03.037; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x; Watanabe H, 2004, SHOCK, V22, P460, DOI 10.1097/01.shk.0000142249.08135.e9; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Yaddanapudi K, 2016, CANCER IMMUNOL RES, V4, P101, DOI 10.1158/2326-6066.CIR-15-0070-T; Zhang Li, 2003, CHINESE LANGUAGE LEA, V1, P17, DOI DOI 10.1056/NEJM0A020177; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	69	85	91	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206223	10.1371/journal.pone.0206223	http://dx.doi.org/10.1371/journal.pone.0206223			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388137	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800023
J	Fraser, C; Herron, K; Dalton, L; Gilbert, R; Oddie, SJ				Fraser, Caroline; Herron, Katie; Dalton, Laura; Gilbert, Ruth; Oddie, Sam J.		PREVAIL Study	Variation in infection prevention practices for peripherally inserted central venous catheters: A survey of neonatal units in England and Wales	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; CARE-ASSOCIATED INFECTIONS; PARENTERAL-NUTRITION; MATCHING MICHIGAN; POVIDONE-IODINE; SKIN ANTISEPSIS; PRETERM INFANTS; CHEMICAL BURNS; CHLORHEXIDINE; SEPSIS	Background There is uncertainty about the variation in infection prevention practices for central venous catheters (CVC) in neonatal units (NNUs) and how practices relate to national guidance. Aim To evaluate evidence supporting infection prevention practices for CVCs recommended in national guidelines and to compare with reported practices for peripherally inserted central catheters (PICC), a type of CVC widely used in NNUs. Design We searched national guidelines for neonates and children to identify infection prevention practices for CVCs and conducted an overview of studies to determine the quality of evidence underpinning recommendations. We surveyed 134 NNUs in England and Wales to ascertain reported practice. Results We found low quality evidence supporting CVC care bundles and use of 2% alcoholic chlorhexidine to decontaminate catheter ports and skin before insertion. Moderate quality evidence supported recommendations against routinely replacing CVCs and against chlorhexidine-impregnated dressings. 90% (44/49) of NICUs and 40% (34/85) of LNUs responded. 66% (48/73) of NNUs reported using CVC care bundles for insertion; 62% (45/73) used bundles for maintenance. 63% (32/51) of those using bundles reported monitoring adherence. 85% (61/72) of NNUs did not routinely replace PICCs and 89% (63/71) did not use chlorhexidine-impregnated dressings. Antiseptic use varied with alcoholic 2% chlorhexidine used for skin preparation in 33% (23/71) of NNUs and for catheter ports in 52% (37/71). Conclusions Lack of consistency across NNUs in antiseptic use and low rates of reported CVC care bundle use may reflect the low quality of evidence of the effectiveness and safety of these interventions in NNUs. Clinical trials are needed to quantify benefits and harms of infection prevention practices in NNUs.	[Fraser, Caroline; Herron, Katie; Gilbert, Ruth] UCL Great Ormond St Inst Child Hlth, London, England; [Dalton, Laura; Oddie, Sam J.] Bradford Royal Infirm, Bradford Neonatol, Bradford, W Yorkshire, England; [Oddie, Sam J.] Univ York, Ctr Reviews & Disseminat, York, N Yorkshire, England	University of London; University College London; Bradford Royal Infirmary; University of York - UK	Fraser, C (corresponding author), UCL Great Ormond St Inst Child Hlth, London, England.	caroline.fraser@ucl.ac.uk		Harron, Katie/0000-0002-3418-2856; Gilbert, Ruth/0000-0001-9347-2709	National Institute for Health Research Health Technology Assessment Programme [12/167/02]; Wellcome Trust [103975/Z/14/Z]; NIHR GOSH BRC	National Institute for Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); NIHR GOSH BRC	The study was funded by the National Institute for Health Research Health Technology Assessment Programme (12/167/02). KH is funded by the Wellcome Trust (grant number 103975/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would also like to acknowledge the PREVAIL Trial Management Group: Naomi Bacon, Michaela Blundell, Sue Howlin, Chloe Donohue, Zoe Craig & Tracy Moitt (Clinical Trials Research Centre, University of Liverpool); Ruth Gilbert, Katie Harron & Caroline Fraser (Great Ormond Street Institute of Child Health, University College London); Sam Oddie (Bradford Royal Infirmary); Alessandro Grosso, Laura Bojke & Rita Faria (Centre for Health Economics, University of York); Vanshree Patel, Poonam Karambelkar & Thomas Lewis (Great Ormond Street Hospital); Jon Dorling (Nottingham University Hospital); Jim Gray (Birmingham Children's Hospital); William McGuire (Hull York Medical School); Ajay Sinha (Royal London Hospital); Berit Muller-Pebody (Public Health England); & Mehali Patel (Bliss). This work is supported by the NIHR GOSH BRC. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Advani S, 2011, CLIN INFECT DIS, V52, P1108, DOI 10.1093/cid/cir145; AGGETT PJ, 1981, ARCH DIS CHILD, V56, P878, DOI 10.1136/adc.56.11.878; Ainsworth S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004219.pub4; Alcock G, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0855-3; Balkhy HH, 2017, AM J INFECT CONTROL, V45, pE49, DOI 10.1016/j.ajic.2017.01.027; Bion J, 2013, BMJ QUAL SAF, V22, P110, DOI 10.1136/bmjqs-2012-001325; Bishay M, 2011, J PEDIATR SURG, V46, P1064, DOI 10.1016/j.jpedsurg.2011.03.028; Espuny XB, 2010, PEDIATR DERMATOL, V27, P676, DOI 10.1111/j.1525-1470.2010.01178.x; Carson Sheri M, 2004, J Pediatr Nurs, V19, P74, DOI 10.1016/j.pedn.2003.09.007; Casey AL, 2003, J HOSP INFECT, V54, P288, DOI 10.1016/S0195-6701(03)00130-0; Cook D, 1997, CRIT CARE MED, V25, P1417, DOI 10.1097/00003246-199708000-00033; COWEN J, 1979, ARCH DIS CHILD, V54, P379, DOI 10.1136/adc.54.5.379; Datta MK, 2008, ARCH DIS CHILD-FETAL, V93, pF328, DOI 10.1136/adc.2008.137430; de Almeida CC, 2017, J MATERN-FETAL NEO M, V30, P2036, DOI 10.1080/14767058.2016.1236245; Edwards PJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000008.pub4; England N, 2015, SERVICE SPECIFICATIO; Garland JS, 2009, J PERINATOL, V29, P808, DOI 10.1038/jp.2009.161; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Harron K, 2015, CRIT CARE MED, V43, P1070, DOI 10.1097/CCM.0000000000000941; Health Research Authority (HRA), 2017, UK POL FRAM HLTH SOC; Helder O, 2013, INT J NURS STUD, V50, P819, DOI 10.1016/j.ijnurstu.2012.02.009; Heron TJ, 2013, ARCH DIS CHILD-FETAL, V98, pF466, DOI 10.1136/archdischild-2013-304378; HRA, 2017, APPL PROP APPR PROC; Ista E, 2016, LANCET INFECT DIS, V16, P724, DOI 10.1016/S1473-3099(15)00409-0; Kalia YN, 1998, J INVEST DERMATOL, V111, P320, DOI 10.1046/j.1523-1747.1998.00289.x; Khashu Minesh, 2005, J Pediatr Surg, V40, pE1, DOI 10.1016/j.jpedsurg.2004.10.028; Kieran EA, 2018, ARCH DIS CHILD-FETAL, V103, pF101, DOI 10.1136/archdischild-2016-312193; Kutsch J, 2014, NEONATAL NETW, V33, P19, DOI 10.1891/0730-0832.33.1.19; Lai NM, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010140.pub2; Lashkari HP, 2012, ARCH DIS CHILD-FETAL, V97, pF64, DOI 10.1136/adc.2011.215145; Loveday HP, 2014, J HOSP INFECT, V86, pS1, DOI 10.1016/S0195-6701(13)60012-2; Fortaleza CMCB, 2017, J HOSP INFECT, V96, P139, DOI 10.1016/j.jhin.2017.03.024; Mannan K, 2007, ACTA PAEDIATR, V96, P1536, DOI 10.1111/j.1651-2227.2007.00376.x; Mermel LA, 2011, CLIN INFECT DIS, V52, P211, DOI 10.1093/cid/ciq108; Milstone AM, 2014, PEDIATR RES, V75, P8, DOI 10.1038/pr.2013.175; Milstone AM, 2013, PEDIATRICS, V132, pE1609, DOI 10.1542/peds.2013-1645; Mitha A, 2013, PEDIATRICS, V132, pE372, DOI 10.1542/peds.2012-3979; Ng YY, 2015, SINGAP MED J, V56, P506, DOI 10.11622/smedj.2015135; NHS, 2007, SAV LIV RED INF DEL; NNAP, 2016, NAT NEON AUD PROGR 2; Payne V, 2018, ARCH DIS CHILD-FETAL, V103, pF422, DOI 10.1136/archdischild-2017-313362; Piazza AJ, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2014-3642; Piening BC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180134; Ponnusamy V, 2014, ACTA PAEDIATR, V103, P1233, DOI 10.1111/apa.12779; Ponnusamy V, 2014, CURR OPIN INFECT DIS, V27, P244, DOI 10.1097/QCO.0000000000000064; Rallis D, 2016, AM J INFECT CONTROL, V44, P485, DOI 10.1016/j.ajic.2015.10.040; Reynolds PR, 2005, ARCH DIS CHILD-FETAL, V90, pF10, DOI 10.1136/adc.2004.054338; Ruschman K L, 1993, J Intraven Nurs, V16, P304; Safdar N, 2004, INTENS CARE MED, V30, P62, DOI 10.1007/s00134-003-2045-z; SITGESSERRA A, 1984, JPEN-PARENTER ENTER, V8, P668, DOI 10.1177/0148607184008006668; Smulders CA, 2013, INTENS CARE MED, V39, P1352, DOI 10.1007/s00134-013-2927-7; Taylor JE, 2017, EUR J PEDIATR, V176, P639, DOI 10.1007/s00431-017-2888-x; Vrijens F, 2010, J HOSP INFECT, V75, P158, DOI 10.1016/j.jhin.2009.12.006; WILSON CB, 1990, REV INFECT DIS, V12, pS410; Wynn JL, 2010, CLIN PERINATOL, V37, P307, DOI 10.1016/j.clp.2010.04.001	55	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0204894	10.1371/journal.pone.0204894	http://dx.doi.org/10.1371/journal.pone.0204894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383769	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600014
J	Amaya, J; Ryan, VH; Fawzi, NL				Amaya, Joshua; Ryan, Veronica H.; Fawzi, Nicolas L.			The SH3 domain of Fyn kinase interacts with and induces liquid-liquid phase separation of the low-complexity domain of hnRNPA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear magnetic resonance (NMR); intrinsically disordered protein; heterogeneous nuclear ribonucleoprotein (hnRNP); RNA transport; structural biology; protein-protein interaction; liquid-liquid phase separation (LLPS); membraneless organelle; prion-like domain; stress granule; aggregation; hnRNPA2; Fyn-SH3	RNA-BINDING PROTEINS; NUCLEAR IMPORT RECEPTOR; PRION-LIKE DOMAINS; TRANSITIONS; MUTATIONS; FUS	Liquid-liquid phase separation of proteins and nucleic acids into membraneless organelles (MLOs) spatially organizes cellular components and reactions. The RNA-binding protein heterogeneous nuclear ribonucleoprotein A2 (hnRNPA2) carries mRNA targets in MLOs called transport granules in neurons and oligodendrocytes. At sites of local translation, hnRNPA2 is phosphorylated by the tyrosine protein kinase Fyn, releasing the mRNA for translation. Fyn recognizes targets through its SH3 domain (Fyn-SH3). However, hnRNPA2 lacks canonical SH3-binding sequences, raising the question of how Fyn-SH3 binds hnRNPA2 in phase-separated transport granules. Here, we characterize the structural details of the interaction of the hnRNPA2 low-complexity domain (LC) with Fyn-SH3 and the effect of Fyn-SH3 on hnRNPA2 phase separation. We combined in vitro microscopy and solution NMR spectroscopy to evaluate assembly of hnRNPA2 and Fyn-SH3 into in vitro phase-separated granules and probe the structural details of their interaction. We observed that Fyn-SH3 induces hnRNPA2 LC phase separation and that Fyn-SH3 is incorporated into in vitro hnRNPA2 LC granules. Moreover, we identified hnRNPA2 LC interaction sites on the surface of Fyn-SH3. Our data offer a structural view of how hnRNPA2 LC may interact with Fyn. To our knowledge, our study provides the first example of a single globular domain inducing phase separation of a disordered MLO scaffold protein.	[Amaya, Joshua; Fawzi, Nicolas L.] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA; [Ryan, Veronica H.] Brown Univ, Grad Program Neurosci, Providence, RI 02912 USA	Brown University; Brown University	Fawzi, NL (corresponding author), Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA.	nicolas_fawzi@brown.edu	Fawzi, Nicolas/E-2555-2013	Fawzi, Nicolas/0000-0001-5483-0577; Ryan, Veronica/0000-0001-5121-4672; Amaya, Joshua/0000-0003-2214-0429	NIGMS, National Institutes of Health [R01GM118530, P20GM104937]; Karen T. Romer Undergraduate Teaching and Research Awards; Robert J. and Nancy D. Carney Institute for Brain Science at Brown University [T32MH020068]; NINDS, National Institutes of Health [F31NS110301]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118530, P20GM104937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS110301] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Karen T. Romer Undergraduate Teaching and Research Awards; Robert J. and Nancy D. Carney Institute for Brain Science at Brown University; NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by NIGMS, National Institutes of Health, Grants R01GM118530 (to N.L.F.) and P20GM104937. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by two summer Karen T. Romer Undergraduate Teaching and Research Awards.; Supported in part by T32MH020068, a Graduate Award from the Robert J. and Nancy D. Carney Institute for Brain Science at Brown University, and NINDS, National Institutes of Health, Grant F31NS110301.	Aguilera-Gomez A, 2017, DEV BIOL, V428, P310, DOI 10.1016/j.ydbio.2017.03.029; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Guo L, 2015, MOL CELL, V60, P189, DOI 10.1016/j.molcel.2015.10.006; Harmon TS, 2017, ELIFE, V6, DOI 10.7554/eLife.30294; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Kang H, 2000, EMBO J, V19, P2889, DOI 10.1093/emboj/19.12.2889; Kapeli K, 2017, HUM GENET, V136, P1193, DOI 10.1007/s00439-017-1830-7; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kramer-Albers EM, 2011, CELL MOL LIFE SCI, V68, P2003, DOI 10.1007/s00018-010-0616-z; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Monahan Z, 2017, EMBO J, V36, P2951, DOI 10.15252/embj.201696394; Nott TJ, 2016, NAT CHEM, V8, P570, DOI [10.1038/NCHEM.2519, 10.1038/nchem.2519]; Polverini E, 2008, BIOCHEMISTRY-US, V47, P267, DOI 10.1021/bi701336n; Prusiner SB, 2013, ANNU REV GENET, V47, P601, DOI 10.1146/annurev-genet-110711-155524; Renzoni DA, 1996, BIOCHEMISTRY-US, V35, P15646, DOI 10.1021/bi9620969; Ryan VH, 2018, MOL CELL, V69, P465, DOI 10.1016/j.molcel.2017.12.022; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Shan JG, 2000, J BIOL CHEM, V275, P38286, DOI 10.1074/jbc.M007642200; Sheu-Gruttadauria J, 2018, CELL, V173, P946, DOI 10.1016/j.cell.2018.02.051; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Shrestha P, 2017, BIOCHEM BIOPH RES CO, V490, P594, DOI 10.1016/j.bbrc.2017.06.083; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; White R, 2008, J CELL BIOL, V181, P579, DOI 10.1083/jcb.200706164; White R, 2014, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00284; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	34	25	25	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2018	293	51					19522	19531		10.1074/jbc.RA118.005120	http://dx.doi.org/10.1074/jbc.RA118.005120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HF5SW	30397184	Green Published, hybrid			2022-12-26	WOS:000454294900002
J	Heinen, MC; Babler, A; Weis, J; Elsas, J; Nolte, K; Kipp, M; Jahnen-Dechent, W; Hausler, M				Heinen, Miriam Christina; Babler, Anne; Weis, Joachim; Elsas, Johannes; Nolte, Kay; Kipp, Markus; Jahnen-Dechent, Willi; Haeusler, Martin			Fetuin-A protein distribution in mature inflamed and ischemic brain tissue	PLOS ONE			English	Article							SIGNAL AMPLIFICATION; DEVELOPING NEOCORTEX; CEREBROSPINAL-FLUID; GLYCOPROTEIN; NEURONS; ORIGIN; PLASMA; CELLS; SHEEP; TNF	Background The liver-derived plasma protein fetuin-A is strongly expressed during fetal life, hence its name. Fetuin-A protein is normally present in most fetal organs and tissues, including brain tissue. Fetuin-A was neuroprotective in animal models of cerebral ischemia and lethal chronic inflammation, suggesting a role beyond the neonatal period. Little is known, how-ever, on the presence of fetuin-A in mature human brain tissue under different physiological and pathological conditions. Methods We studied by immunohistochemistry (IHC) the distribution of fetuin-A protein in mature human brain autopsy tissues from patients without neurological disease, patients with inflammatory brain disorders, and patients with ischemic brain lesions. To identify fetuin-A-positive cells in these tissues we co-localized fetuin-A with GFAP (astrocytes) and CD68 (macrophages, activated microglia). Results and discussion Unlike previous reports, we detected fetuin-A protein also in mature human brain as would be expected from an abundant plasma protein also present in cerebrospinal fluid. Fetuin-A immunoreactivity was increased in ischemic white matter and decreased in inflamed cerebellar tissue. Fetuin-A immunostaining was predominantly associated with neurons and astrocytes. Unlike the developing brain, the adult brain lacked fetuin-A immunostaining in CD68-positive microglia. Our findings suggest a role for fetuin-A in tissue remodeling of neonatal brain, which becomes obsolete in the adult brain, but is re-activated in damaged brain tissue. To further assess the role of fetuin-A in the mature brain, animal models involving ischemia and inflammation need to be studied.	[Heinen, Miriam Christina; Elsas, Johannes; Haeusler, Martin] RWTH Aachen Univ Hosp, Dept Pediat, Aachen, Germany; [Heinen, Miriam Christina; Babler, Anne; Elsas, Johannes; Jahnen-Dechent, Willi] RWTH Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Biointerface Lab, Aachen, Germany; [Heinen, Miriam Christina; Weis, Joachim; Nolte, Kay] RWTH Aachen Univ Hosp, Inst Neuropathol, Aachen, Germany; [Weis, Joachim] JARA BRAIN, Inst Neuropathol, Julich, Germany; [Kipp, Markus] RWTH Aachen Univ Hosp, Inst Neuroanat, Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital	Heinen, MC (corresponding author), RWTH Aachen Univ Hosp, Dept Pediat, Aachen, Germany.; Heinen, MC (corresponding author), RWTH Aachen Univ Hosp, Helmholtz Inst Biomed Engn, Biointerface Lab, Aachen, Germany.; Heinen, MC (corresponding author), RWTH Aachen Univ Hosp, Inst Neuropathol, Aachen, Germany.	Miriam.Heinen@rwth-aachen.de	Babler, Anne/AAA-7250-2021; Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773	START program of the Medical faculty of RWTH Aachen University; IZKF Aachen of the Medical Faculty or RWTH Aachen University; German Research Foundation [DFG SFB/TRR219-Project C-03]	START program of the Medical faculty of RWTH Aachen University; IZKF Aachen of the Medical Faculty or RWTH Aachen University; German Research Foundation(German Research Foundation (DFG))	This work was supported by the START program of the Medical faculty of RWTH Aachen University and by grants awarded to W-JD by the IZKF Aachen of the Medical Faculty or RWTH Aachen University, the German Research Foundation (DFG SFB/TRR219-Project C-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare no conflict of interest.	Brylka LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187030; BUERGI W, 1961, J BIOL CHEM, V236, P1066; DAVEAU M, 1988, FEBS LETT, V241, P191, DOI 10.1016/0014-5793(88)81059-7; Dziegielewska KM, 1998, BIOL NEONATE, V74, P372, DOI 10.1159/000014055; DZIEGIELEWSKA KM, 1993, J NEUROCYTOL, V22, P266, DOI 10.1007/BF01187125; DZIEGIELEWSKA KM, 1993, FETAL DIAGN THER, V8, P22, DOI 10.1159/000263743; DZIEGIELEWSKA KM, 1987, CELL TISSUE RES, V248, P33, DOI 10.1007/BF01239959; Dziegielewska KM, 2000, J COMP NEUROL, V423, P373, DOI 10.1002/1096-9861(20000731)423:3<373::AID-CNE2>3.0.CO;2-D; Elsas J, 2013, DEV NEUROBIOL, V73, P354, DOI 10.1002/dneu.22064; Hausler M, 2009, PEDIATR RES, V66, P660, DOI 10.1203/PDR.0b013e3181bc3f60; Harris VK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175575; Harris VK, 2013, MULT SCLER J, V19, P1462, DOI 10.1177/1352458513477923; Heremans J., 1960, GLOBULINES SERIQUES; Hunyady B, 1996, J HISTOCHEM CYTOCHEM, V44, P1353, DOI 10.1177/44.12.8985127; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; LEBRETON JP, 1979, J CLIN INVEST, V64, P1118, DOI 10.1172/JCI109551; Li W, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016945, 10.1371/journal.pone.0021082]; MOLLGARD K, 1984, J NEUROCYTOL, V13, P497, DOI 10.1007/BF01148077; Nawratil P, 1996, J BIOL CHEM, V271, P31735, DOI 10.1074/jbc.271.49.31735; Ombrellino M, 2001, SHOCK, V15, P181, DOI 10.1097/00024382-200115030-00004; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; SAUNDERS NR, 1992, ANAT EMBRYOL, V186, P477; SAUNDERS NR, 1994, HISTOCHEMISTRY, V102, P457, DOI 10.1007/BF00269578; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; SCHULTZE HE, 1962, NATURWISSENSCHAFTEN, V49, P15, DOI 10.1007/BF00632835; Seto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047338; Terkelsen OBF, 1998, ANAT EMBRYOL, V197, P125, DOI 10.1007/s004290050124; Wang GJ, 1999, METHODS, V18, P459, DOI 10.1006/meth.1999.0813; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Wang HC, 1997, LANCET, V350, P861, DOI 10.1016/S0140-6736(05)62030-2	31	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206597	10.1371/journal.pone.0206597	http://dx.doi.org/10.1371/journal.pone.0206597			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412582	Green Submitted, Green Published, gold			2022-12-26	WOS:000449772600018
J	Neece, BD; Loeb, SC; Jachowski, DS				Neece, Benjamin D.; Loeb, Susan C.; Jachowski, David S.			Variation in regional and landscape effects on occupancy of temperate bats in the southeastern US	PLOS ONE			English	Article							LASIURUS-CINEREUS; WIND TURBINES; UNITED-STATES; EARED BATS; LAND-COVER; FOREST; HABITAT; POPULATIONS; SELECTION; MODELS	Habitat loss, wind energy development, and the disease white-nose syndrome are major threats contributing to declines in bat populations in North America. In the southeastern US in particular, the recent arrival of white-nose syndrome and changes in landscape composition and configuration have driven shifts in bat species populations and distributions. Effective management strategies which address these large-scale, community-level threats require landscape-scale analyses. Our objective was to model the relationship between ecoregional and landscape factors and occupancy by all bat species in South Carolina, USA, during summer. We conducted acoustic surveys from mid-May through July 2015 and 2016 and evaluated temporally dynamic occupancy models for eight bat species or species groups at the 100 km(2) level. We found significant effects of landscape factors such as ecoregion and forest edge density for three species, but habitat condition effects were not statistically significant for five other species. Thus, for some species, site-use analyses may be more appropriate than larger scale occupancy analyses. However, our occupancy predictions generally matched statewide historical distributions for all species, suggesting our approach could be useful for monitoring landscape-level trends in bat species. Thus, while our scale of study was likely too coarse for assessing fine-scale habitat associations for all bat species, our findings can improve future monitoring efforts, inform conservation priorities, and guide subsequent landscape-scale studies for bat species and community-level responses to global change.	[Neece, Benjamin D.; Jachowski, David S.] Clemson Univ, Dept Forestry & Environm Conservat, Clemson, SC USA; [Loeb, Susan C.] US Forest Serv, Southern Res Stn, Clemson, SC 29634 USA	Clemson University; United States Department of Agriculture (USDA); United States Forest Service	Loeb, SC (corresponding author), US Forest Serv, Southern Res Stn, Clemson, SC 29634 USA.	sloeb@fs.fed.us		Loeb, Susan/0000-0002-9264-3614	U.S. Fish and Wildlife Service Competitive State Wildlife Grant through South Carolina Department of Natural Resources [SC-U2-F14APoo958]	U.S. Fish and Wildlife Service Competitive State Wildlife Grant through South Carolina Department of Natural Resources	This study was funded by a U.S. Fish and Wildlife Service Competitive State Wildlife Grant (SC-U2-F14APoo958) through South Carolina Department of Natural Resources to Clemson University (DSJ). South Carolina Department of Natural Resources personnel assisted in data collection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alig RJ, 2004, LANDSCAPE URBAN PLAN, V69, P219, DOI 10.1016/j.landurbplan.2003.07.004; Arnett Edward B., 2016, P295; Barlow KE, 2015, BIOL CONSERV, V182, P14, DOI 10.1016/j.biocon.2014.11.022; Bender MJ, 2015, FOREST ECOL MANAG, V336, P1, DOI 10.1016/j.foreco.2014.10.004; Bennett VJ, 2013, J WILDLIFE MANAGE, V77, P93, DOI 10.1002/jwmg.467; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Britzke ER, 2011, J WILDLIFE MANAGE, V75, P660, DOI 10.1002/jwmg.68; Broders HG, 2006, J WILDLIFE MANAGE, V70, P1174, DOI 10.2193/0022-541X(2006)70[1174:REASSF]2.0.CO;2; Brooks JD, 2017, FOREST ECOL MANAG, V400, P19, DOI 10.1016/j.foreco.2017.05.045; Burnham K P, 2003, MODEL SELECT MULTIMO; Carver BD, 2008, AM MIDL NAT, V160, P364, DOI 10.1674/0003-0031(2008)160[364:RTUBSR]2.0.CO;2; Corcoran AJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0441; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Cumming GS, 2000, J BIOGEOGR, V27, P441, DOI 10.1046/j.1365-2699.2000.00408.x; Duchamp JE, 2008, LANDSCAPE ECOL, V23, P849, DOI 10.1007/s10980-008-9241-8; Ethier K, 2011, LANDSCAPE ECOL, V26, P865, DOI 10.1007/s10980-011-9614-2; Farrow LJ, 2011, MAMM BIOL, V76, P172, DOI 10.1016/j.mambio.2010.04.004; Fensome AG, 2016, MAMMAL REV, V46, P311, DOI 10.1111/mam.12072; Ford WM, 2005, BIOL CONSERV, V126, P528, DOI 10.1016/j.biocon.2005.07.003; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Frick WF, 2017, BIOL CONSERV, V209, P172, DOI 10.1016/j.biocon.2017.02.023; Gorresen PM, 2017, ECOL EVOL, V7, P6669, DOI 10.1002/ece3.3196; Grider JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166512; Grindal SD, 1999, CAN J ZOOL, V77, P972, DOI 10.1139/cjz-77-6-972; Hammerson GA, 2017, BIOL CONSERV, V212, P144, DOI 10.1016/j.biocon.2017.05.025; Hawbaker TJ, 2005, LANDSCAPE ECOL, V20, P609, DOI 10.1007/s10980-004-5647-0; Hein CD, 2009, FOREST ECOL MANAG, V257, P1200, DOI 10.1016/j.foreco.2008.09.054; Henderson LE, 2008, J MAMMAL, V89, P952, DOI 10.1644/07-MAMM-A-214.1; Henderson LE, 2008, BIOL CONSERV, V141, P1819, DOI 10.1016/j.biocon.2008.04.028; Homer C, 2015, PHOTOGRAMM ENG REM S, V81, P345, DOI 10.14358/PERS.81.5.345; Jantzen MK, 2013, CAN J ZOOL, V91, P287, DOI 10.1139/cjz-2012-0282; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Kalcounis MC, 1999, J MAMMAL, V80, P673, DOI 10.2307/1383311; Kalcounis-Rueppell MC, 2007, BIOL CONSERV, V138, P120, DOI 10.1016/j.biocon.2007.04.009; Kalcounis-Rueppell MC, 2013, WILDLIFE SOC B, DOI [10.1002/wsb.374, DOI 10.1002/WSB.374]; Kitzes J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096341; Kunz TH, 1982, ROOSTING ECOLOGY BAT, P1; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Law BS, 1999, BIOL CONSERV, V88, P333, DOI 10.1016/S0006-3207(98)00118-9; Li H, 2018, ECOL EVOL, V8, P667, DOI 10.1002/ece3.3693; LOEB S. C., 2015, GEN TECHNICAL REPORT; Loeb SC, 2006, J WILDLIFE MANAGE, V70, P1210, DOI 10.2193/0022-541X(2006)70[1210:HUBFBI]2.0.CO;2; Loeb Susan C., 2016, Bat Research News, V57, P76; Martinuzzi S, 2015, ECOL APPL, V25, P160, DOI 10.1890/13-2078.1; McGarigal K., 2012, TECH REP; MENZEL MA, 2003, SRS68 USDA FOR SERV; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; NEECE B. D., 2017, THESIS; Pauli BP, 2015, LANDSCAPE ECOL, V30, P2015, DOI 10.1007/s10980-015-0228-y; Plummer M., 2016, RJAGS BAYESIAN GRAPH; Pourshoushtari RD, 2018, NORTHEAST NAT, V25, P236, DOI 10.1656/045.025.0206; Reid F.A., 2006, FIELD GUIDE MAMMALS; Reiter G, 2013, MAMM BIOL, V78, P283, DOI 10.1016/j.mambio.2012.11.003; Roche N, 2009, IR WILDL MAN, V39; Roche N, 2012, IRISH WILDL MANUALS, V60, P5; Rodhouse TJ, 2015, DIVERS DISTRIB, V21, P1401, DOI 10.1111/ddi.12372; Rodhouse TJ, 2012, ECOL APPL, V22, P1098, DOI 10.1890/11-1662.1; Schimpp SA, 2018, URBAN ECOSYST, V21, P541, DOI 10.1007/s11252-018-0737-y; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Starbuck CA, 2015, WILDLIFE SOC B, V39, P20, DOI 10.1002/wsb.512; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; U. S. Environmental Protection Agency, 2011, US LEV 3 4 EC; U. S. Geological Survey, 2016, US FOR SERV ROADS; U. S. Geological Survey, 2014, USGS NAT TRANSP DAT; US Geological Survey National Geospatial Program, 2017, USGS NAT HYDR DAT NH; USGS, 2014, NLCD 2001 LAND COV; Vehtari A., 2016, LOO EFFICIENT LEAVE; Veilleux JP, 2009, NORTHEAST NAT, V16, P148, DOI 10.1656/045.016.0113; Wear DN, FORECASTS LAND USES, P45; Yates MD, 2006, J WILDLIFE MANAGE, V70, P1238, DOI 10.2193/0022-541X(2006)70[1238:EOFSAF]2.0.CO;2; Zipkin EF, 2012, ECOL APPL, V22, P1962, DOI 10.1890/11-1936.1; Zurcher AA, 2010, ACTA CHIROPTEROL, V12, P337, DOI 10.3161/150811010X537918	73	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206857	10.1371/journal.pone.0206857	http://dx.doi.org/10.1371/journal.pone.0206857			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408058	Green Published, gold			2022-12-26	WOS:000449512300044
J	Suijkerbuijk, AWM; van Hoek, AJ; Koopsen, J; de Man, RA; Mangen, MJJ; de Melker, HE; Polder, JJ; de Wit, GA; Veldhuijzen, IK				Suijkerbuijk, Anita W. M.; van Hoek, Albert Jan; Koopsen, Jelle; de Man, Robert A.; Mangen, Marie-Josee J.; de Melker, Hester E.; Polder, Johan J.; de Wit, G. Ardine; Veldhuijzen, Irene K.			Cost-effectiveness of screening for chronic hepatitis B and C among migrant populations in a low endemic country	PLOS ONE			English	Article							CHINESE MIGRANTS; VIRAL-HEPATITIS; VIRUS-INFECTION; PREVALENCE; ACCESS; IMPACT; CARE	Background Chronic infection with hepatitis B or C virus (HBV/HCV) can progress to cirrhosis, liver cancer, and even death. In a low endemic country as the Netherlands, migrants are a key risk group and could benefit from early diagnosis and antiviral treatment. We assessed the cost-effectiveness of screening foreign-born migrants for chronic HBV and/or HCV using a societal perspective. Methods The cost-effectiveness was evaluated using a Markov model. Estimates on prevalence, screening programme costs, participation and treatment uptake, transition probabilities, healthcare costs, productivity losses and utilities were derived from the literature. The cost per Quality Adjusted Life Year (QALY) gained was estimated and sensitivity analyses were performed. Results For most migrant groups with an expected high number of chronically infected cases in the Netherlands combined screening is cost-effective, with incremental cost-effectiveness ratios (ICERs) ranging from (sic)4,962/QALY gained for migrants originating from the Former Soviet Union and Vietnam to (sic)9,375/QALY gained for Polish migrants. HBV and HCV screening proved to be cost-effective for migrants from countries with chronic HBV or HCV prevalence of >= 0.41% and >= 0.22%, with ICERs below the Dutch cost-effectiveness reference value of (sic)20,000/QALY gained. Sensitivity analysis showed that treatment costs influenced the ICER for both infections. Conclusions For most migrant populations in a low-endemic country offering combined HBV and HCV screening is cost-effective. Implementation of targeted HBV and HCV screening programmes to increase early diagnosis and treatment is important to reduce the burden of chronic hepatitis B and C among migrants.	[Suijkerbuijk, Anita W. M.; Polder, Johan J.; de Wit, G. Ardine] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [van Hoek, Albert Jan; Koopsen, Jelle; Mangen, Marie-Josee J.; de Melker, Hester E.; Veldhuijzen, Irene K.] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [van Hoek, Albert Jan] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England; [de Man, Robert A.] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Polder, Johan J.] Tilburg Univ, Tilburg Sch Social & Behav Sci, Tranzo Sci Ctr Care & Welf, Tilburg, Netherlands; [de Wit, G. Ardine] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Hlth Care, Utrecht, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; University of London; London School of Hygiene & Tropical Medicine; Erasmus University Rotterdam; Erasmus MC; Tilburg University; Utrecht University; Utrecht University Medical Center	Suijkerbuijk, AWM (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	Anita.suijkerbuijk@rivm.nl		Koopsen, Jelle/0000-0002-5723-6933; de Wit, G. Ardine/0000-0002-1375-7657; Suijkerbuijk, Anita/0000-0002-5680-5989; Veldhuijzen, Irene/0000-0002-3132-4070				Aggarwal R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176503; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Bil JP, 2018, EUROSURVEILLANCE, V23, P24, DOI 10.2807/1560-7917.ES.2018.23.11.17-00491; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; CBS/Statline, DEATHS 2015; Coenen S, 2016, LIVER INT, V36, P1425, DOI 10.1111/liv.13125; Deuffic-Burban S, 2016, J VIRAL HEPATITIS, V23, P767, DOI 10.1111/jvh.12546; Duffell Erika F, 2017, Euro Surveill, V22, DOI 10.2807/1560-7917.ES.2017.22.9.30476; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; European Assoc Study Liver, 2018, J HEPATOL, V69, P461, DOI 10.1016/j.jhep.2018.03.026; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Falla A, 2015, ESCAIDE 2015 11 13 N, P69; Falla AM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2988-x; Garssen J, 2003, BEVOLKINGSTRENDS, V51, P12; Ghinea N, 2017, LANCET, V389, P1268, DOI 10.1016/S0140-6736(16)32051-7; Helsper CW, 2012, EPIDEMIOL INFECT, V140, P58, DOI 10.1017/S0950268811000112; Hill A, 2017, J VIRUS ERAD, V3, P200; Hofman R, 2018, NEDERLANDS TIJDSCHRI, V162; Hofstraat SHI, 2017, EPIDEMIOL INFECT, V145, P2873, DOI [10.1017/S0950268817001947, 10.1017/s0950268817001947]; Husereau Don, 2013, Cost Eff Resour Alloc, V11, P6, DOI 10.1186/1478-7547-11-6; Jazwa A, 2015, VACCINE, V33, P1393, DOI 10.1016/j.vaccine.2015.01.010; Koopsen J, 2018, EPIDEMIOLOGY INFECT; Kowdley KV, 2012, HEPATOLOGY, V56, P422, DOI 10.1002/hep.24804; Mangen MJJ, 2017, VACCINE, V35, P3215, DOI 10.1016/j.vaccine.2017.04.068; Mangen MJ, 2017, 20170097 RIVM; Miners AH, 2014, J VIRAL HEPATITIS, V21, P616, DOI 10.1111/jvh.12190; Richter C, 2014, EPIDEMIOL INFECT, V142, P2140, DOI 10.1017/S0950268813003415; Rossi C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078548; Scalone L, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2014-000025; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Sharma S, 2015, J HEPATOL, V63, P515, DOI 10.1016/j.jhep.2015.04.026; Stahmeyer JT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169401; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; van Santen DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163488; Vedio A, 2017, J VIRAL HEPATITIS, V24, P526, DOI 10.1111/jvh.12673; Veldhuijzen IK, 2012, J HEPATOL, V57, P1171, DOI 10.1016/j.jhep.2012.07.036; Veldhuijzen IK, 2010, GASTROENTEROLOGY, V138, P522, DOI 10.1053/j.gastro.2009.10.039; Veldhuijzen Irene K, 2009, Int J Infect Dis, V13, pe9, DOI 10.1016/j.ijid.2008.05.1224; Westbrook RH, 2014, J HEPATOL, V61, pS58, DOI 10.1016/j.jhep.2014.07.012; WHO, 2017, ACT PLAN HLTH SECT R; Willemse SB, 2015, NETH J MED, V73; WODC, 2015, SCHATT ILL NED VERBL; Young J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2106-x; Zhou K, 2016, LANCET INFECT DIS, V16, P1409, DOI 10.1016/S1473-3099(16)30208-0; Zorginstituut Nederland, 2015, RICHTL UITV EC EV GE; Zuure FR, 2013, LIVER INT, V33, P727, DOI 10.1111/liv.12131; Zwaap J, 2015, KOSTENEFFECTIVITEIT	47	19	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207037	10.1371/journal.pone.0207037	http://dx.doi.org/10.1371/journal.pone.0207037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408079	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000449512300069
J	Surendran, RP; Udayyapan, SD; Clemente-Postigo, M; Havik, SR; Schimmel, AWM; Tinahones, F; Nieuwdorp, M; Dallinga-Thie, GM				Surendran, R. Preethi; Udayyapan, Shanti D.; Clemente-Postigo, Mercedes; Havik, Stefan R.; Schimmel, Alinda W. M.; Tinahones, Fransisco; Nieuwdorp, Max; Dallinga-Thie, Geesje M.			Decreased GPIHBP1 protein levels in visceral adipose tissue partly underlie the hypertriglyceridemic phenotype in insulin resistance	PLOS ONE			English	Article							LIPOPROTEIN-LIPASE; PATHOPHYSIOLOGY; BINDING; CHYLOMICRONEMIA; DYSLIPIDEMIA; METABOLISM; MUTATIONS; LIVER	GPIHBP1 is a protein localized at the endothelial cell surface that facilitates triglyceride (TG) lipolysis by binding lipoprotein lipase (LPL). Whether Glycosyl Phosphatidyl Inositol high density lipoprotein binding protein 1 (GPIHBP1) function is impaired and may underlie the hyperTG phenotype observed in type 2 diabetes is not yet established. To elucidate the mechanism underlying impaired TG homeostasis in insulin resistance state we studied the effect of insulin on GPIHBP1 protein expression in human microvascular endothelial cells (HMVEC) under flow conditions. Next, we assessed visceral adipose tissue GPIHBP1 protein expression in type 2 diabetes Lepr(db/db) mouse model as well as in subjects with ranging levels of insulin resistance. We report that insulin reduces the expression of GPIHBP1 protein in HMVECs. Furthermore, GPIHBP1 protein expression in visceral adipose tissue in Lepr(db/db) mice is significantly reduced as is the active monomeric form of GPIHBP1 as compared to Lepr(db/m) mice. A similar decrease in GPIHBP1 protein was observed in subjects with increased body weight. GPIHBP1 protein expression was negatively associated with insulin and HOMA-IR. In conclusion, our data suggest that decreased GPIHBP1 availability in insulin resistant state may hamper peripheral lipolysis capacity.	[Surendran, R. Preethi; Udayyapan, Shanti D.; Havik, Stefan R.; Schimmel, Alinda W. M.; Dallinga-Thie, Geesje M.] Univ Amsterdam, Dept Expt Vasc Med, Med Ctr, Locat AMC, Amsterdam, Netherlands; [Clemente-Postigo, Mercedes; Tinahones, Fransisco; Dallinga-Thie, Geesje M.] Univ Malaga, Unidad Gest Clin Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Complejo Hosp Malaga Virgen de la Victoria, Malaga, Spain; [Clemente-Postigo, Mercedes; Tinahones, Fransisco] CIBER Fisiopatol Obesidad & Nutr CB06 03, Barcelona, Spain; [Nieuwdorp, Max] Univ Amsterdam, Dept Vasc Med, Med Ctr, Locat AMC, Amsterdam, Netherlands	University of Amsterdam; Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Amsterdam	Dallinga-Thie, GM (corresponding author), Univ Amsterdam, Dept Expt Vasc Med, Med Ctr, Locat AMC, Amsterdam, Netherlands.; Dallinga-Thie, GM (corresponding author), Univ Malaga, Unidad Gest Clin Endocrinol & Nutr, Inst Invest Biomed Malaga IBIMA, Complejo Hosp Malaga Virgen de la Victoria, Malaga, Spain.	G.M.Dallinga@amc.nl	Tinahones, Francisco José/AAB-2882-2020; Clemente-Postigo, Mercedes/AAA-1102-2020	Tinahones, Francisco J/0000-0001-6871-4403; Clemente-Postigo, Mercedes/0000-0002-4146-6662; dallinga-thie, geesje/0000-0001-5412-5923	Dutch Heart Association [2010B242]; ZONMW-VIDI grant 2013 [016.146.327]; Dutch Heart Foundation CVON Young Talent Grant 2013; FPU (Formacion de Profesorado Universitario) Grant from the Education Ministry, Madrid (Spain) [AP2009-4537]; Centros de Investigacion Biomedica En Red of the Instituto de Salud Carlos III (ISCIII) Madrid, Spain [CB06/03/0018]	Dutch Heart Association; ZONMW-VIDI grant 2013; Dutch Heart Foundation CVON Young Talent Grant 2013; FPU (Formacion de Profesorado Universitario) Grant from the Education Ministry, Madrid (Spain); Centros de Investigacion Biomedica En Red of the Instituto de Salud Carlos III (ISCIII) Madrid, Spain	RPS was supported by a grant of the Dutch Heart Association (2010B242). MN is supported by a ZONMW-VIDI grant 2013 [016.146.327] and a Dutch Heart Foundation CVON Young Talent Grant 2013. MCP was supported by a FPU (Formacion de Profesorado Universitario) Grant (AP2009-4537) from the Education Ministry, Madrid (Spain) and by Centros de Investigacion Biomedica En Red (CB06/03/0018) of the Instituto de Salud Carlos III (ISCIII) Madrid, Spain.	Beigneux AP, 2008, J LIPID RES, V49, P1312, DOI 10.1194/jlr.M700593-JLR200; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2015, CIRC RES, V116, P624, DOI 10.1161/CIRCRESAHA.116.305085; Beigneux AP, 2009, ARTERIOSCL THROM VAS, V29, P956, DOI 10.1161/ATVBAHA.109.186577; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; Chi X, 2015, J BIOL CHEM, V290, P11865, DOI 10.1074/jbc.M114.623769; Coca-Prieto I, 2011, J INTERN MED, V270, P224, DOI 10.1111/j.1365-2796.2011.02361.x; Dallinga-Thie GM, 2010, ATHEROSCLEROSIS, V211, P1, DOI 10.1016/j.atherosclerosis.2009.12.027; Davies BSJ, 2008, MOL ENDOCRINOL, V22, P2496, DOI 10.1210/me.2008-0146; Franssen R, 2010, CIRC-CARDIOVASC GENE, V3, P169, DOI 10.1161/CIRCGENETICS.109.908905; Goulbourne CN, 2014, CELL METAB, V19, P849, DOI 10.1016/j.cmet.2014.01.017; Haas ME, 2013, TRENDS ENDOCRIN MET, V24, P391, DOI [10.101, 10.1016/j.tem.2013.04.001]; Haffner S M, 2000, Manag Care Interface, V13, P52; KISSEBAH AH, 1976, DIABETOLOGIA, V12, P563, DOI 10.1007/BF01220632; Kroupa Olessia, 2012, BMC Physiology, V12, P13, DOI 10.1186/1472-6793-12-13; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Mooij HL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001274; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Peterfy M, 2012, BBA-MOL CELL BIOL L, V1821, P790, DOI 10.1016/j.bbalip.2011.10.006; Ruge T, 2012, METABOLISM, V61, P652, DOI 10.1016/j.metabol.2011.09.014; SEMENKOVICH CF, 1989, J BIOL CHEM, V264, P9030; Sondergaard E, 2017, METABOLISM, V75, P25, DOI 10.1016/j.metabol.2017.07.002; Sonnenburg WK, 2009, J LIPID RES, V50, P2421, DOI 10.1194/jlr.M900145-JLR200; Subramanian S, 2012, BBA-MOL CELL BIOL L, V1821, P819, DOI 10.1016/j.bbalip.2011.10.003; Surendran RP, 2012, J INTERN MED, V272, P185, DOI 10.1111/j.1365-2796.2012.02516.x; Taskinen MR, 2015, ATHEROSCLEROSIS, V239, P483, DOI 10.1016/j.atherosclerosis.2015.01.039; Taskinen MR, 2003, DIABETOLOGIA, V46, P733, DOI 10.1007/s00125-003-1111-y; Taskinen MR, 2002, ATHEROSCLEROSIS SUPP, V3, P47, DOI 10.1016/S1567-5688(01)00006-X; Twickler ThB, 2005, Curr Atheroscler Rep, V7, P140, DOI 10.1007/s11883-005-0037-x; Vallerie SN, 2015, CIRC RES, V116, P560, DOI 10.1161/CIRCRESAHA.115.305819; Verges B, 2015, DIABETOLOGIA, V58, P886, DOI 10.1007/s00125-015-3525-8; Weinstein MM, 2012, ARTERIOSCL THROM VAS, V32, P230, DOI 10.1161/ATVBAHA.111.241406; Willecke F, 2015, ARTERIOSCL THROM VAS, V35, P102, DOI 10.1161/ATVBAHA.114.304615; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0205858	10.1371/journal.pone.0205858	http://dx.doi.org/10.1371/journal.pone.0205858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408040	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300011
J	Woroszylo, C; Choi, B; Profitos, JH; Lee, J; Garabed, R; Rempala, GA				Woroszylo, Casper; Choi, Boseung; Profitos, Jessica Healy; Lee, Jiyoung; Garabed, Rebecca; Rempala, Grzegorz A.			Modeling household transmission dynamics: Application to waterborne diarrheal disease in Central Africa	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; ALLERGIC SENSITIZATION; STATISTICAL-INFERENCE; DRINKING-WATER; HAY-FEVER; CHILDREN; METAANALYSIS; INFECTIONS; SANITATION; EXPOSURE	Introduction We describe a method for analyzing the within-household network dynamics of a disease transmission. We apply it to analyze the occurrences of endemic diarrheal disease in Cameroon, Central Africa based on observational, cross-sectional data available from household health surveys. Methods To analyze the data, we apply formalism of the dynamic SID (susceptible-infected-diseased) process that describes the disease steady-state while adjusting for the household age-structure and environment contamination, such as water contamination. The SID transmission rates are estimated via MCMC method with the help of the so-called synthetic likelihood approach. Results The SID model is fitted to a dataset on diarrhea occurrence from 63 households in Cameroon. We show that the model allows for quantification of the effects of drinking water contamination on both transmission and recovery rates for household diarrheal disease occurrence as well as for estimation of the rate of silent (unobserved) infections. Conclusions The new estimation method appears capable of genuinely capturing the complex dynamics of disease transmission across various human, animal and environmental compartments at the household level. Our approach is quite general and can be used in other epidemiological settings where it is desirable to fit transmission rates using cross-sectional data. Software sharing The R-scripts for carrying out the computational analysis described in the paper are available at https://github.com/cbskust/SID.	[Woroszylo, Casper; Rempala, Grzegorz A.] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Choi, Boseung] Korea Univ, Dept Natl Stat, Sejong 30019, South Korea; [Profitos, Jessica Healy; Lee, Jiyoung] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH 43210 USA; [Lee, Jiyoung] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH 43210 USA; [Garabed, Rebecca] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Rempala, Grzegorz A.] Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Korea University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Rempala, GA (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.; Rempala, GA (corresponding author), Ohio State Univ, Div Biostat, Coll Publ Hlth, Columbus, OH 43210 USA.	rempala.3@osu.edu			Mathematical Biosciences Institute at The Ohio State University through its National Science Foundation [NSF-DMS1440386]; National Research Foundation of Korea grant [NRF-2017R1D1A3B03031008]	Mathematical Biosciences Institute at The Ohio State University through its National Science Foundation; National Research Foundation of Korea grant(National Research Foundation of Korea)	The funders include the Mathematical Biosciences Institute at The Ohio State University through its National Science Foundation grant (NSF-DMS1440386 to GR) and the National Research Foundation of Korea grant (NRF-2017R1D1A3B03031008 to BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2000, STOCHASTIC EPIDEMIC; [Anonymous], 2017, DIARRH DIS FACT SHEE; Braun-Fahrlander C, 1999, CLIN EXP ALLERGY, V29, P28, DOI 10.1046/j.1365-2222.1999.00479.x; Brooks S, 2011, CH CRC HANDB MOD STA, pXIX; Brown J, 2013, ARCH DIS CHILD, V98, P629, DOI 10.1136/archdischild-2011-301528; Garrett V, 2008, EPIDEMIOL INFECT, V136, P1463, DOI 10.1017/S095026880700026X; GILKS WR, 1995, J R STAT SOC C-APPL, V44, P455, DOI 10.2307/2986138; Hartig F, 2011, ECOL LETT, V14, P816, DOI 10.1111/j.1461-0248.2011.01640.x; Headey D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160590; Healy-Profitos J, 2016, J WATER HEALTH, V14, P559, DOI 10.2166/wh.2016.204; Julian TR, 2016, ENVIRON SCI-PROC IMP, V18, P944, DOI [10.1039/c6em00222f, 10.1039/C6EM00222F]; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Kurtz TG, 2005, MARKOV PROCESSES CHA; Medina DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001181; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Profitos JMH, 2014, INT J ENV RES PUB HE, V11, P12454, DOI 10.3390/ijerph111212454; Saidi SM, 1997, MICROBIOL IMMUNOL, V41, P773, DOI 10.1111/j.1348-0421.1997.tb01925.x; Schmidt WP, 2011, INT J EPIDEMIOL, V40, P1678, DOI 10.1093/ije/dyr152; Simpson A, 2005, CURR ALLERGY ASTHM R, V5, P212, DOI 10.1007/s11882-005-0040-x; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; Waser M, 2005, ALLERGY, V60, P177, DOI 10.1111/j.1398-9995.2004.00645.x; Watson CH, 2015, VACCINE, V33, pC42, DOI 10.1016/j.vaccine.2015.04.013; Wood SN, 2010, NATURE, V466, P1102, DOI 10.1038/nature09319; World Health Organization, 2005, TREATM DIARRH MAN PH; Zambrano LD, 2014, T ROY SOC TROP MED H, V108, P313, DOI 10.1093/trstmh/tru056	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206418	10.1371/journal.pone.0206418	http://dx.doi.org/10.1371/journal.pone.0206418			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403729	gold, Green Submitted, Green Published			2022-12-26	WOS:000449379500066
J	Nandan, D; Zhang, NX; Yu, Y; Schwartz, B; Chen, S; Kima, PE; Reiner, NE				Nandan, Devki; Zhang, Naixin; Yu, Yi; Schwartz, Brian; Chen, Stella; Kima, Peter E.; Reiner, Neil E.			Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania	PLOS ONE			English	Article							INTRACELLULAR SURVIVAL; AUTOPHAGY; CELLS; MACROPHAGES; DOWNSTREAM; RESISTANCE; INFECTION; APOPTOSIS; MEXICANA; KINASE	Leishmaniasis is amongst the most important neglected diseases, afflicting more than 12 million people in 88 countries. There is an urgent need for safe orally bioavailable and costeffective drugs for the treatment of leishmaniasis. It has recently been shown that Leishmania activates host macrophage serine/threonine kinase Akt, to promote survival of both parasites and infected cells. Here, we sought to evaluate a compound, Miransertib (ARQ 092), an orally bioavailable and selective allosteric Akt inhibitor currently in clinical trials for patients with PI3K/Akt-driven tumors or Proteus syndrome. Miransertib was tested against Leishmania donovani and Leishmania amazonensis, causative agents of visceral and cutaneous leishmaniasis, respectively. Cultured promastigotes were susceptible to Miransertib. In addition, Miransertib was markedly effective against intracellular amastigotes of L. donovani or L. amazonensis-infected macrophages. Miransertib also enhanced mTOR dependent autophagy in Leishmania-infected macrophages, which may represent one mechanism of Miransertib-mediated killing of intracellular Leishmania. Whereas parasite clearance in the spleen of mice infected with L. donovani and treated with Miransertib was comparable to that when treated with miltefosine, Miransertib caused a greater reduction in the parasite load in the liver. In the cutaneous leishmaniasis infection model, lesions were reduced by 40% as compared to mock treated mice. Together, these results provide direct evidence to support the conclusion that Miransertib is an excellent lead compound for the development of a new oral drug therapy for visceral and cutaneous leishmaniasis.	[Nandan, Devki; Chen, Stella; Reiner, Neil E.] Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada; [Zhang, Naixin; Kima, Peter E.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Yu, Yi; Schwartz, Brian] ArQule Inc, Burlington, MA USA; [Reiner, Neil E.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada	University of British Columbia; State University System of Florida; University of Florida; University of British Columbia	Reiner, NE (corresponding author), Univ British Columbia, Dept Med, Div Infect Dis, Vancouver, BC, Canada.; Reiner, NE (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada.	nreiner@mail.ubc.ca		Zhang, Naixin/0000-0001-8036-6835; Schwartz, Brian/0000-0003-2632-6351	ArQule; Canadian Institute of Health Research (CIHR)	ArQule; Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The authors declare a financial interest to ArQule, Inc. ArQule provided partial support in the form of salary (DN) and supplies for the project and played a role in the study design and data analysis. The decision to publish was jointly agreed upon between three parties (ArQule, NR and PK). DN, NR and PK prepared the manuscript. Funding support for this project was also provided, in part, to Neil Reiner by Canadian Institute of Health Research (CIHR). CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Calegari-Silva TC, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150118; Colineau L, 2017, MED MICROBIOL IMMUN, V206, P235, DOI 10.1007/s00430-017-0500-7; Crauwels P, 2015, AUTOPHAGY, V11, P285, DOI 10.1080/15548627.2014.998904; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Cyrino LT, 2012, TISSUE CELL, V44, P401, DOI 10.1016/j.tice.2012.08.003; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; DOYLE PS, 1989, PARASITOLOGY, V99, P311, DOI 10.1017/S003118200005900X; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Gupta G, 2013, ADV APPL MICROBIOL, V82, P155, DOI 10.1016/B978-0-12-407679-2.00005-3; Henard CA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003000; Kima PE, 2016, CELL IMMUNOL, V309, P19, DOI 10.1016/j.cellimm.2016.09.004; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lindhurst MJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17162; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Ndjamen B, 2010, CELL MICROBIOL, V12, P1480, DOI 10.1111/j.1462-5822.2010.01483.x; Nitulescu GM, 2016, INT J ONCOL, V48, P869, DOI 10.3892/ijo.2015.3306; Pal SK, 2010, EXPERT OPIN INV DRUG, V19, P1355, DOI 10.1517/13543784.2010.520701; Patel TR, 2004, J SURG RES, V116, P116, DOI 10.1016/j.jss.2003.07.006; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Reis-Sobreiro M, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.15; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Ruhland A, 2009, EXP PARASITOL, V122, P28, DOI 10.1016/j.exppara.2008.12.010; Thomas SA, 2017, J BIOL CHEM; Thomas SA, 2018, J BIOL CHEM, V293, P2617, DOI 10.1074/jbc.M117.808675; Tirado-Duarte D, 2018, ACTA TROP, V177, P171, DOI 10.1016/j.actatropica.2017.10.008; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Varela-M RE, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2379-y; Vazquez-Lopez R, 2015, PARASITE IMMUNOL, V37, P579, DOI 10.1111/pim.12275; Villa-Pulgarin JA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005805; Yu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140479; Zhang NX, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12889	33	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206920	10.1371/journal.pone.0206920	http://dx.doi.org/10.1371/journal.pone.0206920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399177	Green Submitted, Green Published, gold			2022-12-26	WOS:000449374000030
J	Zeng, W; Zhang, YC; Wang, L; Wei, YL; Lu, R; Xia, JJ; Chai, B; Liang, X				Zeng, Wei; Zhang, Yingcong; Wang, Liang; Wei, Yonglan; Lu, Rong; Xia, Jinjie; Chai, Bing; Liang, Xian			Ambient fine particulate pollution and daily morbidity of stroke in Chengdu, China	PLOS ONE			English	Article							OUTDOOR AIR-POLLUTION; LONG-TERM EXPOSURE; CARDIOVASCULAR-DISEASES; DAILY MORTALITY; PM2.5; SHANGHAI; HEALTH; RISK; PARTICLES; EVENTS	Introduction Association has been reported between ambient fine particulate matter (PM) and adverse outcomes of cerebrovascular events. However, it remains unclear that whether short-term exposure to PM relates to stroke and the lag of health effects. This triggers us to examine the relationship between PM and population stroke morbidity in Chengdu. Methods The daily average concentration of atmospheric pollutants and meteorological factors and daily morbidity of stroke in Chengdu (2013-2015) were collected. Based on time series analysis-generalized additive models (GAM), single-pollutant, two-pollutant and multi-pollutant model were established. The effects of atmospheric PM2.5 (defined as PM less than 2.5 mu m in aerodynamic diameter), PMc(defined as PM less than 10 mu m and more than 2.5 mu m in aerodynamic diameter) and PM10 (defined as PM less than 10 mu m in aerodynamic diameter) concentration on the daily mortality of stroke were analyzed, respectively. Results The three-year mean concentrations of PM2.5, PMc and PM10 for air pollutants were 75.9, 43.9 and 119.7 mu g/m(3), respectively. PM2.5 on the current day (lagO) and with a moving average of 0-1 days were significantly associated with the increasing risk of stroke morbidity, and PM2.5 with a lag of 0-1 days had greater association, whereas for PMc and PM 10 there were no significant association observed. In our study, every 10 mu g/m(3) increase of PM2.5 was associated with 0.69% percent change in stroke morbidity (95%CI: 0.01 similar to 1.38). For females, every 10 mu g/m(3) increase of PM2.5 contributes to 0.80% percent change of onset. And for the group of age less than 65, we observed 0.78% higher risk every 10 mu g/m(3) increase of PM2.5. Conclusions These findings suggest that short-term exposure to PM2.5 within 1 day is associated with the onset of stroke, and the younger people (age<65) and females are more sensitive than older people and males.	[Zeng, Wei; Zhang, Yingcong; Wang, Liang; Wei, Yonglan; Lu, Rong; Xia, Jinjie; Liang, Xian] Chengdu Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Zhang, Yingcong] Chengdu High Tech Zone Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China; [Chai, Bing] Chengdu Tianfu New Area Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China		Liang, X (corresponding author), Chengdu Ctr Dis Control & Prevent, Chengdu, Sichuan, Peoples R China.	Zengwei0623@126.com		Zeng, Wei/0000-0002-4287-7877	Science Foundation of Chengdu Science and Technology Bureau [2015-HM01-00576-SF]; Department of Science and Technology of Sichuan Province (CN) [2018YJ0352]	Science Foundation of Chengdu Science and Technology Bureau; Department of Science and Technology of Sichuan Province (CN)	This study was supported by Science Foundation of Chengdu Science and Technology Bureau (Award Number: 2015-HM01-00576-SF) and Department of Science and Technology of Sichuan Province (CN) (Award Number: 2018YJ0352). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P167, DOI 10.1289/ehp.0900994; Cortez-Lugo M, 2015, INT J ENV RES PUB HE, V12, P10635, DOI 10.3390/ijerph120910635; Dai JP, 2015, ENVIRON POLLUT, V203, P116, DOI 10.1016/j.envpol.2015.03.050; Dai LZ, 2014, ENVIRON HEALTH PERSP, V122, P837, DOI 10.1289/ehp.1307568; Gold DR, 2000, CIRCULATION, V101, P1267, DOI 10.1161/01.CIR.101.11.1267; Guo P, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091091; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kan HD, 2007, ENVIRON INT, V33, P376, DOI 10.1016/j.envint.2006.12.001; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; Larrieu S, 2007, SCI TOTAL ENVIRON, V387, P105, DOI 10.1016/j.scitotenv.2007.07.025; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin HL, 2016, INT J HYG ENVIR HEAL, V219, P204, DOI 10.1016/j.ijheh.2015.11.002; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Ma JH, 2017, BIOCHEM BIOPH RES CO, V493, P1122, DOI 10.1016/j.bbrc.2017.09.013; Ma YJ, 2011, SCI TOTAL ENVIRON, V409, P2473, DOI 10.1016/j.scitotenv.2011.03.017; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Mannucci PM, 2015, INTERN EMERG MED, V10, P657, DOI 10.1007/s11739-015-1276-7; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Morakinyo OM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060592; Peters A, 1997, LANCET, V349, P1582, DOI 10.1016/S0140-6736(97)01211-7; Sorensen M, 2003, ENVIRON HEALTH PERSP, V111, P161, DOI 10.1289/ehp.5646; Villeneuve PJ, 2012, SCI TOTAL ENVIRON, V430, P193, DOI 10.1016/j.scitotenv.2012.05.002; Wang XJ, 2018, SCI TOTAL ENVIRON, V628-629, P1037, DOI 10.1016/j.scitotenv.2018.02.100; Wang XJ, 2018, ENVIRON POLLUT, V239, P812, DOI 10.1016/j.envpol.2018.04.102; Wang Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000983; Wellenius GA, 2005, STROKE, V36, P2549, DOI 10.1161/01.STR.0000189687.78760.47; Wellenius GA, 2012, ARCH INTERN MED, V172, P229, DOI 10.1001/archinternmed.2011.732; Xu Q, 2017, ENVIRON POLLUT, V220, P317, DOI 10.1016/j.envpol.2016.09.065; YU X, 2014, PLOS ONE; Zanobetti A, 2000, ENVIRON HEALTH PERSP, V108, P841, DOI 10.2307/3434991; Zhang QX, 2013, PROCEDIA ENVIRON SCI, V18, P290, DOI 10.1016/j.proenv.2013.04.038; Zhou MG, 2015, ENVIRON RES, V136, P396, DOI 10.1016/j.envres.2014.09.038	32	15	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206836	10.1371/journal.pone.0206836	http://dx.doi.org/10.1371/journal.pone.0206836			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399151	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000024
J	Babadjouni, R; Patel, A; Liu, Q; Shkirkova, K; Lamorie-Foote, K; Connor, M; Hodis, DM; Cheng, H; Sioutas, C; Morgan, TE; Finch, CE; Mack, WJ				Babadjouni, Robin; Patel, Arati; Liu, Qinghai; Shkirkova, Kristina; Lamorie-Foote, Krista; Connor, Michelle; Hodis, Drew M.; Cheng, Hank; Sioutas, Constantinos; Morgan, Todd E.; Finch, Caleb E.; Mack, William J.			Nanoparticulate matter exposure results in neuroinflammatory changes in the corpus callosum	PLOS ONE			English	Article							DIESEL EXHAUST PARTICLES; CENTRAL-NERVOUS-SYSTEM; AIR-POLLUTION; PARTICULATE MATTER; C5A RECEPTOR; DOPAMINERGIC NEURODEGENERATION; MICROGLIAL ACTIVATION; MULTIPLE-SCLEROSIS; COGNITIVE FUNCTION; NADPH OXIDASE	Epidemiological studies have established an association between air pollution particulate matter exposure (PM2.5) and neurocognitive decline. Experimental data suggest that microglia play an essential role in air pollution PM-induced neuroinflammation and oxidative stress. This study examined the effect of nano-sized particulate matter (nPM) on complement C5 deposition and microglial activation in the corpus callosum of mice (C57BLJ6J males). nPM was collected in an urban Los Angeles region impacted by traffic emissions. Mice were exposed to 10 weeks of re-aerosolized nPM or filtered air for a cumulative 150 hours. nPM-exposed mice exhibited reactive microglia and 2-fold increased local deposition of complement C5/ C5a proteins and complement component C5a receptor 1 (CD88) in the corpus callosum. However, serum C5 levels did not differ between nPM and filtered air cohorts. These findings demonstrate white matter C5 deposition and microglial activation secondary to nPM exposure. The C5 upregulation appears to be localized to the brain.	[Babadjouni, Robin; Patel, Arati; Liu, Qinghai; Shkirkova, Kristina; Lamorie-Foote, Krista; Connor, Michelle; Hodis, Drew M.; Mack, William J.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA; [Mack, William J.] Univ Southern Calif, Keck Sch Med, Dept Neurosurg, Los Angeles, CA USA; [Sioutas, Constantinos] Univ Southern Calif, Viterbi Sch Engn, Dept Civil & Environm Engn, Los Angeles, CA USA; [Cheng, Hank; Morgan, Todd E.; Finch, Caleb E.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lamorie-Foote, K (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90007 USA.	lamorief@usc.edu	Finch, Caleb/AAA-7250-2022; Sioutas, Constantinos/R-1968-2019	Lamorie-Foote, Krista/0000-0003-1665-9849; Sioutas, Constantinos/0000-0001-5146-0857; Cheng, Hank/0000-0003-3793-0394	National Institutes of Health (NIH)/National Institute of Environmental Health Science (NIEHS) [R01ES024936]; NIH [R01AG051521]; NIH/National Institute on Aging (NIA) [R21AG050201]; University of Southern California Alzheimer Disease Research Center (National Institutes of health grant) [P50AG05142]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024936, P30ES007048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG050201] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Environmental Health Science (NIEHS); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Southern California Alzheimer Disease Research Center (National Institutes of health grant); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a grant awarded to WJM through the National Institutes of Health (NIH)/National Institute of Environmental Health Science (NIEHS): grant #R01ES024936, URLs: nih. gov and niehs. nih. gov. CEF was supported by the NIH: grant #R01AG051521 and the NIH/National Institute on Aging (NIA): grant #R21AG050201. The study was supported by the University of Southern California Alzheimer Disease Research Center (National Institutes of health grant: #P50AG05142). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mousawi AM, 2010, SHOCK, V34, P261, DOI 10.1097/SHK.0b013e3181d8e2a6; Allen JL, 2017, NEUROTOXICOLOGY, V59, P140, DOI 10.1016/j.neuro.2015.12.014; BARNUM SR, 1995, CRIT REV ORAL BIOL M, V6, P132, DOI 10.1177/10454411950060020301; Biran R, 1996, INT J ENVIRON AN CH, V63, P315, DOI 10.1080/03067319608028327; Block ML, 2009, TRENDS NEUROSCI, V32, P506, DOI 10.1016/j.tins.2009.05.009; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Calderon-Garciduenas L, 2002, TOXICOL PATHOL, V30, P373, DOI 10.1080/01926230252929954; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Calderon-Garciduenas L, 2017, J ALZHEIMERS DIS, V58, P613, DOI 10.3233/JAD-161299; Calderon-Garciduenas L, 2011, BRAIN COGNITION, V77, P345, DOI 10.1016/j.bandc.2011.09.006; Campbell A, 2005, NEUROTOXICOLOGY, V26, P133, DOI 10.1016/j.neuro.2004.08.003; Chen JC, 2015, ANN NEUROL, V78, P466, DOI 10.1002/ana.24460; Cheng H, 2016, ENVIRON HEALTH PERSP, V124, P1537, DOI 10.1289/EHP134; Costa LG, 2004, ANNU REV PHARMACOL, V44, P87, DOI 10.1146/annurev.pharmtox.44.101802.121424; Crehan H, 2012, INT J ALZHEIMERS DIS, V2012; Cudrici C, 2006, J REHABIL RES DEV, V43, P123, DOI 10.1682/JRRD.2004.08.0111; Davis DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064128; DeWalt GJ, 2018, NEUROSCI LETT, V664, P160, DOI 10.1016/j.neulet.2017.11.016; Dominguez R, 2018, J STROKE CEREBROVASC, V27, P1743, DOI 10.1016/j.jstrokecerebrovasdis.2018.01.030; Eggen BJL, 2013, J NEUROIMMUNE PHARM, V8, P807, DOI 10.1007/s11481-013-9490-4; Farkas I, 1998, J PHYSIOL-LONDON, V507, P679, DOI 10.1111/j.1469-7793.1998.679bs.x; Finch GL, 2002, INHAL TOXICOL, V14, P1017, DOI 10.1080/08958370290084764; Fruin S, 2008, ATMOS ENVIRON, V42, P207, DOI 10.1016/j.atmosenv.2007.09.057; Gasque P, 1997, AM J PATHOL, V150, P31; GERMAN DC, 1985, NEUROSCI LETT, V61, P1, DOI 10.1016/0304-3940(85)90391-X; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hovens IB, 2015, NEUROBIOL LEARN MEM, V118, P74, DOI 10.1016/j.nlm.2014.11.009; Hu XM, 2008, J IMMUNOL, V181, P7194, DOI 10.4049/jimmunol.181.10.7194; Johnston MV, 2009, BRAIN DEV-JPN, V31, P1, DOI 10.1016/j.braindev.2008.03.014; Kam W, 2012, ATMOS ENVIRON, V55, P90, DOI 10.1016/j.atmosenv.2012.03.028; Kam W, 2012, ATMOS ENVIRON, V61, P378, DOI 10.1016/j.atmosenv.2012.07.072; Kanemitsu H, 1998, BIOL PHARM BULL, V21, P129; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kilburn KH, 2000, ARCH ENVIRON HEALTH, V55, P11, DOI 10.1080/00039890009603379; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; Levesque S, 2013, J NEUROCHEM, V125, P756, DOI 10.1111/jnc.12231; Levesque S, 2011, ENVIRON HEALTH PERSP, V119, P1149, DOI 10.1289/ehp.1002986; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Li RS, 2013, J LIPID RES, V54, P1608, DOI 10.1194/jlr.M035014; Long TC, 2007, ENVIRON HEALTH PERSP, V115, P1631, DOI 10.1289/ehp.10216; Misra C, 2002, J AEROSOL SCI, V33, P735, DOI 10.1016/S0021-8502(01)00210-5; Moisse K, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-29; Moller T, 1997, J NEUROSCI, V17, P615; Morgan TE, 2011, ENVIRON HEALTH PERSP, V119, P1003, DOI 10.1289/ehp.1002973; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Onoda A, 2017, PART FIBRE TOXICOL, V14, DOI 10.1186/s12989-017-0184-6; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Peters A, 1991, FINE STRUCTURE NERVO, Vxviii; Power MC, 2011, ENVIRON HEALTH PERSP, V119, P682, DOI 10.1289/ehp.1002767; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Ransom BR, 2015, WHITE MATTER PATHOPH; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Shapiro LA, 2009, BRAIN RES, V1266, P29, DOI 10.1016/j.brainres.2009.02.031; Sriram S, 1997, NEUROLOGY, V48, P464, DOI 10.1212/WNL.48.2.464; Stahel PF, 1997, J IMMUNOL, V159, P861; Stahel PF, 2000, J NEUROIMMUNOL, V109, P164, DOI 10.1016/S0165-5728(00)00304-0; Tamagawa E, 2008, AM J PHYSIOL-LUNG C, V295, pL79, DOI 10.1152/ajplung.00048.2007; Trapp BD, 1999, J NEUROIMMUNOL, V98, P49, DOI 10.1016/S0165-5728(99)00081-8; Van Beek J, 2000, EXP NEUROL, V161, P373, DOI 10.1006/exnr.1999.7273; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Villa A, 2016, ENDOCR REV, V37, P372, DOI 10.1210/er.2016-1007; WALKER DG, 1995, J NEUROSCI RES, V40, P478, DOI 10.1002/jnr.490400407; Walters DM, 2001, AM J RESP CRIT CARE, V164, P1438, DOI 10.1164/ajrccm.164.8.2007121; Wang Y, 2016, PROG NEUROBIOL, V141, P45, DOI [10.1016/j.pneurobio.2016.04.00, 10.1016/j.pneurobio.2016.04.005]; Ward JL, 2011, J TRAUMA, V70, P1471, DOI 10.1097/TA.0b013e31821c38bd; Wellenius GA, 2012, J AM GERIATR SOC, V60, P2075, DOI 10.1111/j.1532-5415.2012.04195.x; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; Woodruff TM, 2010, NEUROMOL MED, V12, P179, DOI 10.1007/s12017-009-8085-y; Woodruff TM, 2008, J IMMUNOL, V181, P8727, DOI 10.4049/jimmunol.181.12.8727; Woodward NC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0858-x; Woodward NC, 2017, NEUROBIOL AGING, V53, P48, DOI 10.1016/j.neurobiolaging.2017.01.007; WRIGHT SD, 1989, J EXP MED, V170, P1231, DOI 10.1084/jem.170.4.1231; ZAJICEK JP, 1992, BRAIN, V115, P1611, DOI 10.1093/brain/115.6.1611; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532	79	31	31	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206934	10.1371/journal.pone.0206934	http://dx.doi.org/10.1371/journal.pone.0206934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395590	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400068
J	Forel, JM; Guervilly, C; Farnarier, C; Donati, SY; Hraiech, S; Persico, N; Allardet-Servent, J; Coiffard, B; Gainnier, M; Loundou, A; Sylvestre, A; Roch, A; Bourenne, J; Papazian, L				Forel, Jean-Marie; Guervilly, Christophe; Farnarier, Catherine; Donati, Stephane-Yannis; Hraiech, Sami; Persico, Nicolas; Allardet-Servent, Jerome; Coiffard, Benjamin; Gainnier, Marc; Loundou, Anderson; Sylvestre, Aude; Roch, Antoine; Bourenne, Jeremy; Papazian, Laurent			Transforming Growth Factor-beta 1 in predicting early lung fibroproliferation in patients with acute respiratory distress syndrome	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; III PROCOLLAGEN PEPTIDE; MECHANICALLY VENTILATED PATIENTS; TGF-BETA; PULMONARY-FIBROSIS; AMINOTERMINAL PROPEPTIDE; BRONCHOALVEOLAR LAVAGE; INJURY; SERUM; ACTIVATION	Background Fibroproliferative repair phase of the acute respiratory distress syndrome (ARDS) is followed by a restitutio ad integrum of lung parenchyma or by an irreversible lung fibrosis and patients' death. Transforming Growth Factor-beta 1 (TGF-beta 1) is involved in collagen production and lung repair. We investigated whether alveolar TGF-beta 1 was associated with the presence of fibroproliferation and the outcome of ARDS patients. Methods Sixty-two patients were included the first day of moderate-to-severe ARDS. Bronchoalveolar lavage fluid (BALF) was collected at day 3 (and day 7 when the patients were still receiving invasive mechanical ventilation) from the onset of ARDS. Survival was evaluated at day 60. TGF-beta 1 was measured by immunoassay. The patients were classified as having lung fibroproliferation when the alveolar N-terminal peptide for type III procollagen (NT-PCP-III) measured on day 3 was > 9 mu g/L as recently reported. The main objective of this study was to compare the alveolar levels of total TGF-beta 1 according to the presence or not a lung fibroproliferation at day 3. Results Forty-three patients (30.6%) presented a fibroproliferation at day 3. BALF levels of total TGF-beta 1 were not statistically different at day 3 (and at day 7) according to the presence or not lung fibroproliferation. Mortality at day 60 was higher in the group of patients with fibroproliferation as compared with patients with no fibroproliferation (68.4% vs. 18.6% respectively; p< 0.001). Total TGF-beta 1 measured on BALF at day 3 was not associated with the outcome. Multiple logistic regression showed that the presence of lung fibroproliferation was associated with death. In contrast, TGF-beta 1 was not independently associated with death. Conclusions Pulmonary levels of TGF-beta 1 during the first week of ARDS were not associated nor with the presence of fibroproliferation neither with death. TGF-beta 1 should not be used as a biomarker to direct anti-fibrotic therapies.	[Forel, Jean-Marie; Guervilly, Christophe; Hraiech, Sami; Coiffard, Benjamin; Sylvestre, Aude; Roch, Antoine; Papazian, Laurent] Hop Nord Marseille, AP HP, Med Intens Reanimat, Marseille, France; [Forel, Jean-Marie; Guervilly, Christophe; Hraiech, Sami; Persico, Nicolas; Coiffard, Benjamin; Loundou, Anderson; Sylvestre, Aude; Roch, Antoine; Papazian, Laurent] Aix Marseille Univ, Fac Med Marseille, CEReSS Ctr Etud & Rech Serv Sante & Qualite Vie, Marseille, France; [Farnarier, Catherine] Hop Conception, AP HP, Lab Immunol, Marseille, France; [Donati, Stephane-Yannis] Hop St Musse, Reanimat, Toulon, France; [Persico, Nicolas] Hop Nord Marseille, AP HP, Serv Accueil Urgences, Marseille, France; [Allardet-Servent, Jerome] Hop Europeen, Serv Reanimat, Marseille, France; [Gainnier, Marc; Bourenne, Jeremy] Hop La Timone, AP HP, Reanimat Urgences & Med, Marseille, France	Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Papazian, L (corresponding author), Hop Nord Marseille, AP HP, Med Intens Reanimat, Marseille, France.; Papazian, L (corresponding author), Aix Marseille Univ, Fac Med Marseille, CEReSS Ctr Etud & Rech Serv Sante & Qualite Vie, Marseille, France.	laurent.papazian@ap-hm.fr	Coiffard, Benjamin/AAX-1250-2020; guervilly, christophe/C-1083-2016	Guervilly, Christophe/0000-0001-9066-6591	Assistance Publique Hopitaux de Marseille (Direction de la Recherche et de l'Innovation)	Assistance Publique Hopitaux de Marseille (Direction de la Recherche et de l'Innovation)	The study was supported by an academic grant from the Assistance Publique Hopitaux de Marseille (Direction de la Recherche et de l'Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON WR, 1992, ULTRASTRUCT PATHOL, V16, P615, DOI 10.3109/01913129209023751; Armstrong L, 1999, AM J RESP CRIT CARE, V160, P1910, DOI 10.1164/ajrccm.160.6.9811084; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Budinger GRS, 2005, INTENS CARE MED, V31, P121, DOI 10.1007/s00134-004-2503-2; Buhling F, 1999, J INTERF CYTOK RES, V19, P271, DOI 10.1089/107999099314207; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; CLARK JG, 1995, ANN INTERN MED, V122, P17, DOI 10.7326/0003-4819-122-1-199501010-00003; Coker RK, 1997, AM J PATHOL, V150, P981; Deheinzelin D, 1997, CHEST, V112, P1184, DOI 10.1378/chest.112.5.1184; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; ENTZIAN P, 1990, AM REV RESPIR DIS, V142, P1079, DOI 10.1164/ajrccm/142.5.1079; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Forel JM, 2015, INTENS CARE MED, V41, P1, DOI 10.1007/s00134-014-3524-0; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; GAULDIE J, 1993, THORAX, V48, P931, DOI 10.1136/thx.48.9.931; Gleizes PE, 1997, STEM CELLS, V15, P190, DOI 10.1002/stem.150190; HEINE UI, 1990, DEVELOPMENT, V109, P29; Hurst V, 1999, AM J PHYSIOL-LUNG C, V276, pL582, DOI 10.1152/ajplung.1999.276.4.L582; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Jensen LT, 1997, DAN MED BULL, V44, P70; KIRK JME, 1984, THORAX, V39, P726, DOI 10.1136/thx.39.10.726; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; LOW RB, 1992, AM REV RESPIR DIS, V146, P701, DOI 10.1164/ajrccm/146.3.701; Marshall RP, 2000, AM J RESP CRIT CARE, V162, P1783, DOI 10.1164/ajrccm.162.5.2001061; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; Meduri GU, 1998, AM J RESP CRIT CARE, V158, P1432; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Pugin J, 1999, CRIT CARE MED, V27, P304, DOI 10.1097/00003246-199902000-00036; RAGHU G, 1989, AM REV RESPIR DIS, V140, P95, DOI 10.1164/ajrccm/140.1.95; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; SHENKAR R, 1994, AM J RESP CELL MOL, V11, P351, DOI 10.1165/ajrcmb.11.3.8086171; SPORN MB, 1983, SCIENCE, V219, P1329, DOI 10.1126/science.6572416; Sporn MB, 2006, CYTOKINE GROWTH F R, V17, P3, DOI 10.1016/j.cytogfr.2005.09.012; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wesselkamper SC, 2005, AM J RESP CRIT CARE, V172, P1399, DOI 10.1164/rccm.200502-286OC; WESTERGRENTHORSSON G, 1993, J CLIN INVEST, V92, P632, DOI 10.1172/JCI116631	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206105	10.1371/journal.pone.0206105	http://dx.doi.org/10.1371/journal.pone.0206105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395619	Green Published, Green Submitted, gold			2022-12-26	WOS:000449291400016
J	Bulysheva, AA; Sori, N; Francis, MP				Bulysheva, Anna A.; Sori, Nardos; Francis, Michael P.			Direct crystal formation from micronized bone and lactic acid: The writing on the wall for calcium-containing crystal pathogenesis in osteoarthritis?	PLOS ONE			English	Article							SYNOVIAL-FLUID; DEPOSITION; DISEASE; ARTHRITIS	Introduction Pathological calcium-containing crystals accumulating in the joints, synovial fluid, and soft tissues are noted in most elderly patients, yet arthritic crystal formation remains idiopathic. Interestingly, elevated lactic acid and bone erosion are frequently among the comorbidities and clinical features of patients with highest incidence of crystal arthropathies. This work shows that bone particulates (modeling bone erosion) dissolve in lactic acid and directly generate crystals, possibly presenting a mechanism for crystal accumulation in osteoarthritis. Methods and results Micronized human bone (average particle size of 160 mu m x 79 mu m ) completely dissolved in lactic acid in 48 hours, and in synovial fluid with 500 mMol lactic acid in 5 days, generating birefringent rhomboid and rod-shaped crystals. SEM analysis with energy dispersive x-ray spectroscopy of these crystals showed average dimensions of around 2 mu m x 40 mu m, which contained oxygen, calcium and phosphorous at 8.64:1.85:1. Raman spectroscopy of the generated crystals further showed 910/cm and 1049/cm peaks, aligning with calcium oxalate monohydrate and calcium pyrophosphate, respectively. Conclusions This work shows that lactic acid and micronized mineralized bone together directly generate calcium-containing crystals. These observations may provide insights into the elusive etiology of arthritis with crystal involvement, possibly indicating lactic acid as a clinical target for treatment.	[Bulysheva, Anna A.] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Sori, Nardos] Old Dominion Univ, Dept Hlth Sci, Norfolk, VA USA; [Sori, Nardos; Francis, Michael P.] Eastern Virginia Med Sch, Dept Biomed Sci, Norfolk, VA 23501 USA; [Francis, Michael P.] Embody, Norfolk, VA 23508 USA	Old Dominion University; Old Dominion University; Eastern Virginia Medical School	Francis, MP (corresponding author), Eastern Virginia Med Sch, Dept Biomed Sci, Norfolk, VA 23501 USA.; Francis, MP (corresponding author), Embody, Norfolk, VA 23508 USA.	mpf3b@virginia.edu		Francis, Michael/0000-0002-5551-9358; Bulysheva, Anna/0000-0002-7287-9371				Barrere F, 2006, INT J NANOMED, V1, P317; Derfus BA, 2002, J RHEUMATOL, V29, P570; Ea HK, 2009, CURR OPIN RHEUMATOL, V21, P150, DOI 10.1097/BOR.0b013e3283257ba9; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; GOBELET C, 1984, ANN RHEUM DIS, V43, P742, DOI 10.1136/ard.43.5.742; Halverson Paul B., 1996, Current Opinion in Rheumatology, V8, P259, DOI 10.1097/00002281-199605000-00016; Hurter K, 2005, VET J, V169, P281, DOI 10.1016/j.tvjl.2004.01.027; McCarthy Geraldine M, 2009, Curr Rheumatol Rep, V11, P141; Molloy ES, 2006, RHEUM DIS CLIN N AM, V32, P383, DOI 10.1016/j.rdc.2006.02.001; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Qvist P, 2008, PHARMACOL RES, V58, P1, DOI 10.1016/j.phrs.2008.06.001; Rosenthal AK, 2006, RHEUM DIS CLIN N AM, V32, P401, DOI 10.1016/j.rdc.2006.02.004; Rosenthal AK, 2011, NAT REV RHEUMATOL, V7, P257, DOI 10.1038/nrrheum.2011.50; Rosenthal AK, 2009, JCR-J CLIN RHEUMATOL, V15, P42, DOI 10.1097/RHU.0b013e3181953a8e; Rothschild BM, 2013, WORLD J ORTHOP, V4, P29, DOI 10.5312/wjo.v4.i2.29; Singhvi M, 2018, APPL MICROBIOL BIOT, V102, P5911, DOI 10.1007/s00253-018-9092-4	16	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0202373	10.1371/journal.pone.0202373	http://dx.doi.org/10.1371/journal.pone.0202373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388106	gold, Green Published, Green Submitted			2022-12-26	WOS:000449289800001
J	Farh, HMH; Eltamaly, AM; Othman, MF				Farh, Hassan M. H.; Eltamaly, Ali M.; Othman, Mohd F.			Hybrid PSO-FLC for dynamic global peak extraction of the partially shaded photovoltaic system	PLOS ONE			English	Article							POWER POINT TRACKING; PARTICLE SWARM OPTIMIZATION; PV SYSTEMS; MPPT; ALGORITHM; COLONY; PERTURB	Particle Swarm Optimization (PSO) is widely used in maximum power point tracking (MPPT) of photovoltaic (PV) energy systems. Nevertheless, this technique suffers from two main problems in the case of partial shading conditions (PSCs). The first problem is that PSO is a time invariant optimization technique that cannot follow the dynamic global peak (GP) under time variant shading patterns (SPs) and sticks to the first GP that occurs at the beginning. This problem can be solved by dispersing the PSO particles using two new techniques introduced in this paper. The two new proposed PSO re-initialization techniques are to disperse the particles upon the SP changes and the other one is upon a predefined time (PDT). The second problem is regarding the high oscillations around steady state, which can be solved by using fuzzy logic controller (FLC) to fine-tune the output power and voltage from the PV system. The new contribution of this paper is the hybrid PSO-FLC with two PSO particles dispersing techniques that is able to solve the two previous mentioned problems effectively and improve the performance of the PV system in both normal and PSCs. A detailed list of comparisons between hybrid PSO-FLC and original PSO using the two proposed methodologies are achieved. The results prove the superior performance of hybrid PSO-FLC compared to PSO in terms of efficiency, accuracy, oscillations reduction around steady state and soft tuning of the GP tracked.	[Farh, Hassan M. H.; Othman, Mohd F.] Univ Teknologi Malaysia, Malaysia Japan Int Inst Technol, Kuala Lumpur, Malaysia; [Farh, Hassan M. H.] King Saud Univ, Coll Engn, Elect Engn Dept, Riyadh, Saudi Arabia; [Eltamaly, Ali M.] King Saud Univ, Sustainable Energy Technol Ctr, Riyadh, Saudi Arabia; [Eltamaly, Ali M.] Mansoura Univ, Elect Engn Dept, Mansoura, Egypt	Universiti Teknologi Malaysia; King Saud University; King Saud University; Egyptian Knowledge Bank (EKB); Mansoura University	Eltamaly, AM (corresponding author), King Saud Univ, Sustainable Energy Technol Ctr, Riyadh, Saudi Arabia.; Eltamaly, AM (corresponding author), Mansoura Univ, Elect Engn Dept, Mansoura, Egypt.	eltamaly@ksu.edu.sa	Farh, Hassan M. Hussein/AAH-3644-2020; Othman, Mohd Fauzi/A-2390-2013; Eltamaly, Ali M/E-6486-2016	Farh, Hassan M. Hussein/0000-0002-5524-5887; Eltamaly, Ali M/0000-0002-9831-7182	Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia [RG-1439-66]	Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia	The authors extend their appreciation to the Deanship of Scientific Research at King Saud University, Riyadh, Saudi Arabia for funding this work through research group No (RG-1439-66).	Ahmed J, 2014, APPL ENERG, V119, P118, DOI 10.1016/j.apenergy.2013.12.062; Babu TS, 2015, APPL SOFT COMPUT, V34, P613, DOI 10.1016/j.asoc.2015.05.029; Bendib B, 2014, ENRGY PROCED, V50, P383, DOI 10.1016/j.egypro.2014.06.046; Benyoucef AS, 2015, APPL SOFT COMPUT, V32, P38, DOI 10.1016/j.asoc.2015.03.047; Chao KH, 2015, APPL ENERG, V158, P609, DOI 10.1016/j.apenergy.2015.08.047; Chekired F, 2014, SOL ENERGY, V101, P83, DOI 10.1016/j.solener.2013.12.026; Dileep G, 2017, SOL ENERGY, V158, P1006, DOI 10.1016/j.solener.2017.10.027; El Khateb AH, 2013, PROCEDIA ENVIRON SCI, V17, P529, DOI 10.1016/j.proenv.2013.02.068; Eltamaly A. M, 2010, POW EL EL DRIV AUT M; Eltamaly A.M., 2011, RES REV J TRENDS ELE, V1, P1; Eltamaly AM, 2015, J RENEW SUSTAIN ENER, V7, DOI 10.1063/1.4929665; Farh HM, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4798739; Farh HMH, 2017, 2017 SAUDI ARABIA SMART GRID CONFERENCE (SASG); Farh Hassan M. H, 2018, NON TRADITIONAL REF, V11, P2543; Huang C, 2018, IEEE T SUSTAIN ENERG, V9, P45, DOI 10.1109/TSTE.2017.2714705; Ishaque K, 2012, APPL ENERG, V99, P414, DOI 10.1016/j.apenergy.2012.05.026; Jiang LL, 2013, ENERG BUILDINGS, V58, P227, DOI 10.1016/j.enbuild.2012.12.001; Kamarzaman NA, 2014, RENEW SUST ENERG REV, V37, P585, DOI 10.1016/j.rser.2014.05.045; Lian KL, 2014, IEEE J PHOTOVOLT, V4, P626, DOI 10.1109/JPHOTOV.2013.2297513; Liu YH, 2012, IEEE T ENERGY CONVER, V27, P1027, DOI 10.1109/TEC.2012.2219533; Mahamudul H, 2013, INT J PHOTOENERGY, V2013, DOI 10.1155/2013/762946; Messai A, 2011, SOL ENERGY, V85, P265, DOI 10.1016/j.solener.2010.12.004; Rajasekar N, 2014, ENRGY PROCED, V61, P2633, DOI 10.1016/j.egypro.2014.12.265; Ram JP, 2017, APPL ENERG, V201, P45, DOI 10.1016/j.apenergy.2017.05.102; Ram JP, 2017, ENERGY, V118, P512, DOI 10.1016/j.energy.2016.10.084; Rezk H, 2015, SOL ENERGY, V112, P1, DOI 10.1016/j.solener.2014.11.010; Shi JY, 2015, ELECTR POW SYST RES, V123, P100, DOI 10.1016/j.epsr.2015.02.001; Sundareswaran K, 2015, RENEW ENERG, V75, P308, DOI 10.1016/j.renene.2014.09.044; Sundareswaran K, 2015, IEEE T SUSTAIN ENERG, V6, P198, DOI 10.1109/TSTE.2014.2363521; Sundareswaran K, 2014, IEEE T ENERGY CONVER, V29, P463, DOI 10.1109/TEC.2014.2298237; Teshome DF, 2017, IEEE J EM SEL TOP P, V5, P661, DOI 10.1109/JESTPE.2016.2581858; Wu ZQ, 2018, APPL SOFT COMPUT, V62, P101, DOI 10.1016/j.asoc.2017.10.039	32	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206171	10.1371/journal.pone.0206171	http://dx.doi.org/10.1371/journal.pone.0206171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388119	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800022
J	Kiapour, AM; Cao, JX; Young, M; Capellini, TD				Kiapour, Ata M.; Cao, Jiaxue; Young, Mariel; Capellini, Terence D.			The role of Gdf5 regulatory regions in development of hip morphology	PLOS ONE			English	Article							DOUBLE MUTATIONS; OSTEOARTHRITIS; POPULATION; JOINT; CARTILAGE; MICE; SUSCEPTIBILITY; ASSOCIATION; DYSPLASIA; SINGLE	Given GDF5 involvement in hip development, and osteoarthritis (OA) and developmental hip dysplasia (DDH) risk, here we sought to assess the role(s) of GDF5 and its regulatory sequence on the development of hip morphology linked to injury risk. The brachypodism (bp) mouse, which harbors a Gdf5 inactivating mutation, was used to survey how Gdf5 loss of function impacts the development of hip morphology. Two transgenic Gdf5 reporter BAC lines were used to assess the spatiotemporal expression of Gdf5 regulatory sequences. Each BAC line was also used to assess the functional roles of upstream and downstream sequence on hip morphology. bp/bp mice had shorter femora with smaller femoral heads and necks as well as larger alpha angles, smaller anterior offsets, and smaller acetabula, compared to bp/+ mice (p<0.04). Regulatory sequences downstream of Gdf5 drove strong prenatal (E17) expression and low postnatal (6 months) expression across regions of femoral head and acetabulum. Conversely, upstream regulatory sequences drove very low expression at E17 and no detectable expression at 6 months. Importantly, downstream, but not upstream Gdf5 regulatory sequences fully restored all the key morphologic features disrupted in bp/bp mice. Hip morphology is profoundly affected by Gdf5 absence, and downstream regulatory sequences mediate its effects by controlling Gdf5 expression during development. This downstream region contains numerous enhancers harboring risk variants related to hip OA, DDH, and dislocation. We posit that subtle alterations to morphology driven by changes in downstream regulatory sequence underlie this locus' role in hip injury risk.	[Kiapour, Ata M.] Harvard Med Sch, Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA USA; [Cao, Jiaxue; Young, Mariel; Capellini, Terence D.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Capellini, Terence D.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Cao, Jiaxue] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Sichuan, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Sichuan Agricultural University	Capellini, TD (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA.; Capellini, TD (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	tcapellini@fas.harvard.edu		Capellini, Terence/0000-0003-3842-8478	Milton Fund; Harvard University; NIH NIAMS [R01AR070139, R01AR065462]; Department of Orthopaedic Surgery at Boston Children's Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261, R01AR065462, R01AR070139] Funding Source: NIH RePORTER	Milton Fund; Harvard University; NIH NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Department of Orthopaedic Surgery at Boston Children's Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by the Milton Fund (https://vpr.harvard.edu/milton-fund) and Dean's Competitive Fund of Harvard University (https://research.fas.harvard.edu/deans-competitive-fund-promising-scholarship) to TDC, as well as NIH NIAMS grants (https://www.niams.nih.gov/) to TDC (R01AR070139) and AMK (R01AR065462), as well as the Department of Orthopaedic Surgery at Boston Children's Hospital (AMK). The views expressed are those of the authors and not necessarily those of the funding agencies. None of the Sponsors/Funders had any involvement in the design, collection, analysis or interpretation of the data and no role in writing or submitting this manuscript for publication.	Ahedi HG, 2017, ARTHRIT CARE RES, V69, P1566, DOI 10.1002/acr.23166; An H, 2016, OSTEOARTHR CARTILAGE, V24, P640, DOI 10.1016/j.joca.2015.11.013; Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Chen H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006454; Daans M, 2011, ANN RHEUM DIS, V70, P208, DOI 10.1136/ard.2010.134619; Dai J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2540; Faiyaz-Ul-Haque M, 2002, CLIN GENET, V61, P454, DOI 10.1034/j.1399-0004.2002.610610.x; Harada M, 2007, OSTEOARTHR CARTILAGE, V15, P468, DOI 10.1016/j.joca.2006.09.003; Hosnijeh FS, 2017, ARTHRITIS RHEUMATOL, V69, P86, DOI 10.1002/art.39929; LANDAUER W, 1952, J HERED, V43, P293, DOI 10.1093/oxfordjournals.jhered.a106335; LANGER LO, 1989, HUM GENET, V81, P323, DOI 10.1007/BF00283684; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Nelson AE, 2016, OSTEOARTHR CARTILAGE, V24, P443, DOI 10.1016/j.joca.2015.10.007; Pregizer SK, 2018, ANN RHEUM DIS, V77, P450, DOI 10.1136/annrheumdis-2017-212475; Rawal BR, 2012, INDIAN J ORTHOP, V46, P46, DOI 10.4103/0019-5413.91634; Rouault K, 2010, OSTEOARTHR CARTILAGE, V18, P1144, DOI 10.1016/j.joca.2010.05.018; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shwartz Y, 2016, CELL REP, V15, P2577, DOI 10.1016/j.celrep.2016.05.055; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Storm EE, 1996, DEVELOPMENT, V122, P3969; Sun Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120212; Thomas JT, 1997, NAT GENET, V17, P58, DOI 10.1038/ng0997-58; Toogood PA, 2009, CLIN ORTHOP RELAT R, V467, P876, DOI 10.1007/s11999-008-0473-3; Unnanuntana A, 2010, J ORTHOP RES, V28, P1399, DOI 10.1002/jor.21119; Young EY, 2013, CLIN ORTHOP RELAT R, V471, P1593, DOI 10.1007/s11999-012-2704-x; Zhang R, 2015, INFLAMM RES, V64, P405, DOI 10.1007/s00011-015-0818-9	28	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0202785	10.1371/journal.pone.0202785	http://dx.doi.org/10.1371/journal.pone.0202785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388100	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800002
J	Sarker, U; Islam, MT; Oba, S				Sarker, Umakanta; Islam, Md Tofazzal; Oba, Shinya			Salinity stress accelerates nutrients, dietary fiber, minerals, phytochemicals and antioxidant activity in Amaranthus tricolor leaves	PLOS ONE			English	Article							VEGETABLE AMARANTH; CHEMICAL-COMPOSITION; SALT-STRESS; BIOACTIVE COMPOUNDS; AGRONOMIC TRAITS; LEAFY VEGETABLES; FRUIT EXTRACTS; L.; VARIABILITY; TOLERANCE	Impact of salinity stress were investigated in three selected Amaranthus tricolor accessions in terms of nutrients, dietary fiber, minerals, antioxidant phytochemicals and total antioxidant activity in leaves. Salinity stress enhanced biochemical contents and antioxidant activity in A. tricolor leaves. Protein, ash, energy, dietary fiber, minerals (Ca, Mg, Fe, Mn, Cu, Zn, and Na), beta-carotene, ascorbic acid, total polyphenol content (TPC), total flavonoid content (TFC), total antioxidant capacity (TAC) (DPPH and ABTS(+)) in leaves were increased by 18%, 6%, 5%, 16%, 9%, 16%, 11%, 17%, 38%, 20%, 64%, 31%, 22%, 16%, 16%, 25% and 17%, respectively at 50 mM NaCl concentration and 31%, 12%, 6%, 30%, 57%, 35%, 95%, 96%, 82%, 87%, 27%, 63%, 82%, 39%, 30%, 58% and 47%, respectively at 100 mM NaCl concentration compared to control condition. Contents of vitamins, polyphenols and flavonoids showed a good antioxidant activity due to positive and significant interrelationships with total antioxidant capacity. It revealed that A. tricolor can tolerate a certain level of salinity stress without compromising the nutritional quality of the final product. This report for the first time demonstrated that salinity stress at certain level remarkably enhances nutritional quality of the leafy vegetable A. tricolor. Taken together, our results suggest that A. tricolor could be a promising alternative crop for farmers in salinity prone areas-in the tropical and sub-tropical regions with enriched nutritional contents and antioxidant activity.	[Sarker, Umakanta; Oba, Shinya] Gifu Univ, Fac Appl Biol Sci, United Grad Sch Agr Sci, Lab Field Sci, Yanagi, Gifu, Japan; [Sarker, Umakanta] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Fac Agr, Dept Genet & Plant Breeding, Gazipur, Bangladesh; [Islam, Md Tofazzal] Bangabandhu Sheikh Mujibur Rahman Agr Univ, Fac Agr, Dept Biotechnol, Gazipur, Bangladesh	Gifu University; Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU); Bangabandhu Sheikh Mujibur Rahman Agricultural University (BSMRAU)	Sarker, U (corresponding author), Gifu Univ, Fac Appl Biol Sci, United Grad Sch Agr Sci, Lab Field Sci, Yanagi, Gifu, Japan.; Sarker, U (corresponding author), Bangabandhu Sheikh Mujibur Rahman Agr Univ, Fac Agr, Dept Genet & Plant Breeding, Gazipur, Bangladesh.	umakanta@bsmrau.edu.bd	Sarker, umakanta/AAC-4361-2020; Islam, Tofazzal/F-2563-2010	Sarker, umakanta/0000-0002-6814-8816; Islam, Tofazzal/0000-0002-7613-0261				Abogadallah GM, 2010, PLANT SIGNAL BEHAV, V5, P369, DOI 10.4161/psb.5.4.10873; Ahmed IM, 2013, FOOD CHEM, V141, P2743, DOI 10.1016/j.foodchem.2013.05.101; Alam MA, 2015, FOOD CHEM, V169, P439, DOI 10.1016/j.foodchem.2014.08.019; AOAC, 2000, OFFICIAL METHODS ANA; ASAE, 1983, S3521 ASAE; Ashraf M, 2009, BIOTECHNOL ADV, V27, P84, DOI 10.1016/j.biotechadv.2008.09.003; Bader N.R., 2011, RASAYAN J CHEM, V4, P49, DOI DOI 10.1016/0584-8547(96)01507-8; Dasgupta N, 2007, FOOD CHEM, V101, P471, DOI 10.1016/j.foodchem.2006.02.003; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Giorgi A, 2009, FOOD CHEM, V114, P204, DOI 10.1016/j.foodchem.2008.09.039; Guillet D., 2004, GRAIN AMARANTHUS HIS; Huerta-Ocampo JA, 2014, J PROTEOME RES, V13, P3607, DOI 10.1021/pr500153m; Isabelle M, 2010, FOOD CHEM, V123, P77, DOI 10.1016/j.foodchem.2010.04.002; ISO (International Standards Organization), 1981, 54981981 ISO; Jia WS, 2002, J EXP BOT, V53, P2201, DOI 10.1093/jxb/erf079; Jimenez-Aguilar DM, 2017, J FOOD COMPOS ANAL, V58, P33, DOI 10.1016/j.jfca.2017.01.005; Kim HJ, 2006, J AGR FOOD CHEM, V54, P7263, DOI 10.1021/jf060568c; Lim JH, 2012, FOOD CHEM, V135, P1065, DOI 10.1016/j.foodchem.2012.05.068; Liu LiPing, 2006, Plant Physiology Communications, V42, P847; Macrae R, 1993, ENCY FOOD SCI FOOD T, V8, P53; Madruga MS, 2000, FOOD CHEM, V68, P41, DOI 10.1016/S0308-8146(99)00152-1; Munne-Bosch S, 2004, PLANT SCI, V166, P1105, DOI 10.1016/j.plantsci.2003.12.034; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Neffati M, 2011, FOOD CHEM, V124, P221, DOI 10.1016/j.foodchem.2010.06.022; NIELSEN FH, 1984, ANNU REV NUTR, V4, P21, DOI 10.1146/annurev.nu.04.070184.000321; Pedranzani H, 2007, PLANT GROWTH REGUL, V52, P111, DOI 10.1007/s10725-007-9166-2; Petropoulos SA, 2017, FOOD CHEM, V214, P129, DOI 10.1016/j.foodchem.2016.07.080; Piku Sen, 2014, International Journal of Plant Research, V4, P56; Rana J.C., 2007, INDIAN FARMING, V57, P27; Repo-Carrasco-Valencia R, 2010, FOOD CHEM, V120, P128, DOI 10.1016/j.foodchem.2009.09.087; Sarker U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30897-6; Sarker U, 2018, GENETIKA-BELGRADE, V50, P209, DOI 10.2298/GENSR1801209S; Sarker U, 2018, APPL BIOCHEM BIOTECH, V186, P999, DOI 10.1007/s12010-018-2784-5; Sarker U, 2018, J INTEGR AGR, V17, P1145, DOI 10.1016/S2095-3119(17)61778-7; Sarker U, 2018, FOOD CHEM, V252, P72, DOI 10.1016/j.foodchem.2018.01.097; Sarker U, 2018, ACTA AGR SCAND B-S P, V68, P67, DOI 10.1080/09064710.2017.1367029; Sarker U, 2017, INDIAN J GENET PL BR, V77, P173, DOI 10.5958/0975-6906.2017.00025.6; Sarker U, 2016, TURK J AGRIC FOR, V40, P526, DOI 10.3906/tar-1405-83; Sarker U, 2015, SPAN J AGRIC RES, V13, DOI 10.5424/sjar/2015132-6843; Sarker U, 2015, GENETIKA-BELGRADE, V47, P85, DOI 10.2298/GENSR1501085S; Selmar D, 2013, IND CROP PROD, V42, P558, DOI 10.1016/j.indcrop.2012.06.020; Shahidi F, 1999, FOOD CHEM, V64, P39, DOI 10.1016/S0308-8146(98)00097-1; Shukla S, 2006, PLANT FOOD HUM NUTR, V61, P23, DOI 10.1007/s11130-006-0004-x; Steffensen SK, 2011, FOOD CHEM, V129, P131, DOI 10.1016/j.foodchem.2011.04.044; Sun HN, 2014, FOOD CHEM, V156, P380, DOI 10.1016/j.foodchem.2014.01.079; Temminghoff E. E. J. M, 2006, PLANT ANAL PROCEDURE; Thaipong K, 2006, J FOOD COMPOS ANAL, V19, P669, DOI 10.1016/j.jfca.2006.01.003; Umakanta Sarker, 2014, Journal of Food, Agriculture & Environment, V12, P168; US Department of Agriculture Agricultural Research Service, 2019, USDA NATL NUTR DATAB; Venskutonis PR, 2013, COMPR REV FOOD SCI F, V12, P381, DOI 10.1111/1541-4337.12021; Wang Y, 2015, J HORTIC SCI, V75, P623; Wouyou A. D., 2017, African Journal of Biotechnology, V16, P2106, DOI 10.5897/ajb2017.16203	52	87	91	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206388	10.1371/journal.pone.0206388	http://dx.doi.org/10.1371/journal.pone.0206388			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383779	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600045
J	Mi, JQ; Hooker, E; Balog, S; Zeng, H; Johnson, DT; He, YF; Yu, EJ; Wu, HQ; Le, V; Lee, DH; Aldahl, J; Gonzalgo, ML; Sun, ZJ				Mi, Jiaqi; Hooker, Erika; Balog, Steven; Zeng, Hong; Johnson, Daniel T.; He, Yongfeng; Yu, Eun-Jeong; Wu, Huiqing; Vien Le; Lee, Dong-Hoon; Aldahl, Joseph; Gonzalgo, Mark L.; Sun, Zijie			Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						prostate cancer; transgenic mice; gene knockout; tumor cell biology; androgen receptor; phosphatase and tensin homolog (PTEN); hepatocyte growth factor; scatter factor (HGF; SF); HGF; SF; Met; metastasis; tumorigenesis; PB-Cre4; prostatic intraepithelial neoplasia; epithelial-to-mesenchymal transition	C-MET; ANDROGEN RECEPTOR; GENE-EXPRESSION; MOUSE MODEL; MESENCHYMAL TRANSITION; GASTRIC-CANCER; N-CADHERIN; CELLS; METASTASIS; CARCINOMA	Emerging evidence has shown that the hepatocyte growth factor (HGF) and its receptor, MET proto-oncogene, receptor tyrosine kinase (MET), promote cell proliferation, motility, morphogenesis, and angiogenesis. Whereas up-regulation of MET expression has been observed in aggressive and metastatic prostate cancer, a clear understanding of MET function in prostate tumorigenesis remains elusive. Here, we developed a conditional Met transgenic mouse strain, H11(Met/+):PB-Cre4, to mimic human prostate cancer cells with increased MET expression in the prostatic luminal epithelium. We found that these mice develop prostatic intraepithelial neoplasia after HGF administration. To further assess the biological role of MET in prostate cancer progression, we bred H11(Met/+)/Pten(LoxP/LoxP):PBCre4 compound mice, in which transgenic Met expression and deletion of the tumor suppressor gene Pten occurred simultaneously only in prostatic epithelial cells. These compound mice exhibited accelerated prostate tumor formation and invasion as well as increased metastasis compared with Pten(LoxP/LoxP):PB-Cre4 mice. Moreover, prostatic sarcomatoid carcinomas and lesions resembling the epithelial-to-mesenchymal transition developed in tumor lesions of the compound mice. RNA-Seq and qRT-PCR analyses revealed a robust enrichment of known tumor progression and metastasis-promoting genes in samples isolated from H11(Met/+)/Pten(LoxP/LoxP):PB-Cre4 compound mice compared with those from Pten(LoxP/LoxP):PB-Cre4 littermate controls. HGF-induced cell proliferation and migration also increased in mouse embryonic fibroblasts (MEFs) from animals with both Met transgene expression and Pten deletion compared with Pten-null MEFs. The results from these newly developed mouse models indicate a role for MET in hastening tumorigenesis and metastasis when combined with the loss of tumor suppressors.	[Mi, Jiaqi; Hooker, Erika; Balog, Steven; He, Yongfeng; Yu, Eun-Jeong; Vien Le; Lee, Dong-Hoon; Aldahl, Joseph; Sun, Zijie] City Hope Natl Med Ctr, Dept Canc Biol, Beckman Res Inst, Duarte, CA 91010 USA; [Wu, Huiqing] City Hope Natl Med Ctr, Dept Pathol, Beckman Res Inst, Duarte, CA 91010 USA; [Hooker, Erika; Johnson, Daniel T.; He, Yongfeng; Yu, Eun-Jeong; Sun, Zijie] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Zeng, Hong] Stanford Univ, Sch Med, Transgen Knockout & Tumor Model Ctr, Stanford, CA 94305 USA; [Gonzalgo, Mark L.] Univ Miami, Miller Sch Med, Dept Urol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Stanford University; Stanford University; University of Miami	Sun, ZJ (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Rm 2311,Beckman Bldg, Duarte, CA 91010 USA.	zjsun@coh.org	He, Yongfeng/AAR-8257-2020; Mi, Jiaqi/GVU-4732-2022	Mi, Jiaqi/0000-0002-6537-7795; Lee, Dong-Hoon/0000-0001-7466-6997; Hooker, Erika/0000-0002-4515-4041; Johnson, Daniel/0000-0003-4669-037X	National Institutes of Health [R01CA070297, R01CA151623, R01CA166894, R21CA190021, R01DK104941]; NATIONAL CANCER INSTITUTE [R01CA151623, R01CA166894, R01CA070297, R21CA190021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104941] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants R01CA070297, R01CA151623, R01CA166894, R21CA190021, and R01DK104941. The authors declare that they have no conflicts of inter est with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adissu HA, 2015, PROSTATE, V75, P1831, DOI 10.1002/pros.23056; Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; American Cancer Society, 2017, CANC FACTS FIG 2017; Armenia J, 2018, NAT GENET, V50, P645, DOI 10.1038/s41588-018-0078-z; Barbieri A, 2015, INT J ONCOL, V47, P527, DOI 10.3892/ijo.2015.3038; Beliakoff J, 2008, MOL CELL BIOL, V28, P282, DOI 10.1128/MCB.00771-07; Berish RB, 2018, NAT REV UROL, V15, P403, DOI 10.1038/s41585-018-0020-2; Bhardwaj A, 2008, MOL CELL BIOL, V28, P2138, DOI 10.1128/MCB.01170-07; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BISCHOF P, 1986, ARCH ANDROLOGY, V16, P155, DOI 10.3109/01485018608986936; Boccaccio C, 2006, NAT REV CANCER, V6, P637, DOI 10.1038/nrc1912; Cannistraci A, 2017, ONCOGENE, V36, P3718, DOI 10.1038/onc.2016.505; Chang Wei-Chao, 2010, Int J Proteomics, V2010, P726968, DOI 10.1155/2010/726968; Chen C, 2015, PROSTATE, V75, P883, DOI 10.1002/pros.22971; Chen K, 2011, CANCER BIOL THER, V12, P1114, DOI 10.4161/cbt.12.12.18435; Chimento A, 2012, MOL CELL ENDOCRINOL, V355, P49, DOI 10.1016/j.mce.2012.01.017; Conant JL, 2011, J CLIN PATHOL, V64, P1088, DOI 10.1136/jclinpath-2011-200216; Das DK, 2016, EXP CELL RES, V348, P190, DOI 10.1016/j.yexcr.2016.09.021; Daudigeos-Dubus E, 2017, INT J ONCOL, V50, P203, DOI 10.3892/ijo.2016.3792; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; de Reynies A, 2014, CLIN CANCER RES, V20, P1323, DOI 10.1158/1078-0432.CCR-13-2429; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Gong ZK, 2014, MOL GENET GENOMICS, V289, P1157, DOI 10.1007/s00438-014-0877-6; Grano M, 1996, P NATL ACAD SCI USA, V93, P7644, DOI 10.1073/pnas.93.15.7644; Gupta S, 2017, CLIN CANCER RES, V23, P1346, DOI 10.1158/1078-0432.CCR-16-1211; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; HOHAUS S, 1995, MOL CELL BIOL, V15, P5830; Hu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024988; Hu ZQ, 2014, CELL REPROGRAM, V16, P266, DOI 10.1089/cell.2013.0086; HUMPHREY PA, 1995, AM J PATHOL, V147, P386; Ittmann M, 2013, CANCER RES, V73, P2718, DOI 10.1158/0008-5472.CAN-12-4213; Jeffers M, 1996, J MOL MED-JMM, V74, P505, DOI 10.1007/BF00204976; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kasai S, 1996, BIOCHEM BIOPH RES CO, V228, P646, DOI 10.1006/bbrc.1996.1710; Katoh M, 2003, INT J MOL MED, V11, P683; Kim JH, 2011, BMB REP, V44, P523, DOI 10.5483/BMBRep.2011.44.8.523; Knudsen BS, 2002, UROLOGY, V60, P1113, DOI 10.1016/S0090-4295(02)01954-4; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kosuga M, 2000, CELL TRANSPLANT, V9, P675, DOI 10.1177/096368970000900513; Kozakowski N, 2014, TARGET ONCOL, V9, P359, DOI 10.1007/s11523-013-0298-1; Kurashige Junji, 2013, Fukuoka Acta Medica, V104, P344; Kwak MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053476; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee AS, 2013, KIDNEY INT, V83, P50, DOI 10.1038/ki.2012.312; Lee JW, 2007, APMIS, V115, P47, DOI 10.1111/j.1600-0463.2007.apm_554.x; Lee SH, 2016, ONCOGENE, V35, P702, DOI 10.1038/onc.2015.117; Liu GL, 2014, ASIAN PAC J TROP MED, V7, P76, DOI 10.1016/S1995-7645(13)60196-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto K, 1996, J BIOCHEM-TOKYO, V119, P591; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Nalla AK, 2011, EXP CELL RES, V317, P2512, DOI 10.1016/j.yexcr.2011.07.024; Nauseef JT, 2011, NAT REV UROL, V8, P428, DOI 10.1038/nrurol.2011.85; Nishi N, 1996, PROSTATE, V28, P139; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Peng Y, 2011, J BIOL CHEM, V286, P40331, DOI 10.1074/jbc.M111.302059; PISTERS LL, 1995, J UROLOGY, V154, P293, DOI 10.1016/S0022-5347(01)67297-5; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Russo AL, 2009, CLIN CANCER RES, V15, P4292, DOI 10.1158/1078-0432.CCR-09-0599; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Sasnauskiene A, 2014, MED LITH, V50, P14, DOI 10.1016/j.medici.2014.05.002; Sathyanarayana UG, 2003, CLIN CANCER RES, V9, P6395; Schalken JA, 2003, UROLOGY, V62, P11, DOI 10.1016/S0090-4295(03)00758-1; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Singh V, 2015, OMICS, V19, P688, DOI 10.1089/omi.2015.0121; Stucke VM, 2007, MOL BIOL CELL, V18, P1744, DOI 10.1091/mbc.E06-11-0980; Su Q, 2017, ONCOGENE, V36, P618, DOI 10.1038/onc.2016.232; Sung CO, 2013, J CLIN PATHOL, V66, P601, DOI 10.1136/jclinpath-2012-201271; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Vadnais C, 2014, BIOL OPEN, V3, P937, DOI 10.1242/bio.20148193; van Leenders G, 2002, PROSTATE, V51, P98, DOI 10.1002/pros.10073; van Leenders GJLH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026753; Varkaris A, 2011, EXPERT OPIN INV DRUG, V20, P1677, DOI 10.1517/13543784.2011.631523; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Watanabe M, 1999, CANCER LETT, V141, P173, DOI 10.1016/S0304-3835(99)00102-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Xie L, 2004, WORLD J GASTROENTERO, V10, P1286; Xu CJ, 2017, BIOMED PHARMACOTHER, V91, P1167, DOI 10.1016/j.biopha.2017.05.056; Yan GB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09951-2; Yu EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174357; Zhu CF, 2011, J BIOL CHEM, V286, P33478, DOI 10.1074/jbc.M111.269894	82	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20123	20136		10.1074/jbc.RA118.005395	http://dx.doi.org/10.1074/jbc.RA118.005395			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30401749	hybrid, Green Published			2022-12-26	WOS:000454685900021
J	Sirivongrangson, P; Girdthep, N; Sukwicha, W; Buasakul, P; Tongtoyai, J; Weston, E; Papp, J; Wi, T; Cherdtrakulkiat, T; Dunne, EF				Sirivongrangson, Pachara; Girdthep, Natnaree; Sukwicha, Wichuda; Buasakul, Prisana; Tongtoyai, Jaray; Weston, Emily; Papp, John; Wi, Teodora; Cherdtrakulkiat, Thitima; Dunne, Eileen F.		EGASP Thailand Workgrp	The first year of the global Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in Bangkok, Thailand, 2015-2016	PLOS ONE			English	Article							RESISTANT NEISSERIA-GONORRHOEAE; DRUG-RESISTANT; SUSCEPTIBILITY SURVEILLANCE; CHLAMYDIA-TRACHOMATIS; TREATMENT FAILURE; ANATOMIC SITE; CEFTRIAXONE; CEFIXIME; PROJECT; INFECTIONS	Antimicrobial-resistant Neisseria gonorrhoeae (NG) infection is a global public health threat, and there is a critical need to monitor patterns of resistance and risk factors. In collaboration with the World Health Organization (WHO), the U.S. Centers for Disease Control and Prevention (CDC), and the Thailand Department of Disease Control (DDC), Ministry of Public Health (MoPH) implemented the first Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) in November 2015. Men presenting with urethritis at two clinical settings in Bangkok, Thailand (Bangrak Hospital [BH] and Silom Community Clinic @TropMed [SCC @TropMed]) provided demographic and behavioral information and had a urethral swab for Gram's stain and NG culture collected. The NG isolates were evaluated for antimicrobial susceptibility by the Epsilometer test (Etest) to determine minimum inhibitory concentrations (MICs) for cefixime (CFM), ceftriaxone (CRO), azithromycin (AZI), gentamicin (GEN), and ciprofloxacin (CIP). From November 2015-October 2016, 1,102 specimens were collected from 1,026 symptomatic men; 861 (78.1%) specimens were from BH and 241 (21.9%) specimens were from SCC @TropMed. Among the 1,102 specimens, 582 (52.8%) had intracellular Gram-negative diplococci and 591 (53.6%) had NG growth (i.e., NG infection); antimicrobial susceptibility testing (AST) was performed on 590 (99.8%) NG isolates. Among all symptomatic men, 293 (28.6%) had sex with men only, 430 (41.9%) were ages 18-29 years, 349 (34.0%) had antibiotic use in the last 2 weeks, and 564 (55.0%) had NG infection. Among 23 men with repeat NG infection during this first year of surveillance, 20 (87.0%) were infected twice, 2 (8.7%) were infected three times, and 1 (4.3%) was infected more than four times. All NG isolates were susceptible to CFM and CRO, and had MICs below 2 mu g/mL for AZI and below 16 mu g/mL for GEN. Overall, 545 (92.4%) isolates were resistant to CIP. This surveillance activity assessed individual patients, and included demographic and behavioral data linked to laboratory data. The inclusion of both individual and laboratory information in EGASP could help identify possible persistent infection and NG treatment failures. Expansion of EGASP to additional global settings is critical to assess trends and risk factors for NG, and to monitor for the emergence of resistance.	[Sirivongrangson, Pachara; Girdthep, Natnaree; Buasakul, Prisana] Thailand Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Sukwicha, Wichuda; Tongtoyai, Jaray; Cherdtrakulkiat, Thitima; Dunne, Eileen F.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand; [Buasakul, Prisana] Bur AIDS TB&STIs, Bangrak STIs Ctr, Bangkok, Thailand; [Weston, Emily; Papp, John] US Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Wi, Teodora] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Dunne, Eileen F.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; World Health Organization; Centers for Disease Control & Prevention - USA	Dunne, EF (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Nonthaburi, Thailand.; Dunne, EF (corresponding author), US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	dde9@cdc.gov	Papp, John/AAA-3073-2019	Papp, John/0000-0002-7495-5454; Cherdtrakulkiat, Thitima/0000-0001-5006-6145; Tongtoyai, Jaray/0000-0002-6929-6298	WHO [WHO APW: 2015/539306-0]; U.S. CDC	WHO(World Health Organization); U.S. CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	WHO provided support to the Thailand MOPH for this activity (WHO APW: 2015/539306-0). WHO supported study design, data analysis, and preparation of the manuscript. U.S. CDC provided funding for this activity to the Silom Community Clinic. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002366; Allen VG, 2013, JAMA-J AM MED ASSOC, V309, P163, DOI 10.1001/jama.2012.176575; Allen VG, 2011, ANTIMICROB AGENTS CH, V55, P703, DOI 10.1128/AAC.00788-10; Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837; Bignell C, 2011, INT J STD AIDS, V22, P541, DOI 10.1258/ijsa.2011.011267; Bureau of AIDS TB and STIs Department of Disease Control Ministry of Public Health of Thailand, 2015, GUID TREATM SEX TRAN; Camara J, 2012, J ANTIMICROB CHEMOTH, V67, P1858, DOI 10.1093/jac/dks162; CLENDENNEN TE, 1992, ANTIMICROB AGENTS CH, V36, P1682, DOI 10.1128/AAC.36.8.1682; Clinical & Laboratory Standards Institute (CLSI), 2017, PERFORMANCE STANDARD; CRUM JW, 1980, ANTIMICROB AGENTS CH, V18, P360, DOI 10.1128/AAC.18.2.360; Daly CC, 1997, J CLIN MICROBIOL, V35, P2985, DOI 10.1128/JCM.35.11.2985-2988.1997; Deguchi Takashi, 2003, Journal of Infection and Chemotherapy, V9, P35, DOI 10.1007/s10156-002-0204-8; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; Division of STD Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Centers for Disease Control and Prevention, 2017, 2016 SEX TRANSM DIS; ECDC, 2017, ECDC ANN EP REP 2015; Eyre DW, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.27.1800323; Golparian D, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.30.20862; Ison CA, 2010, EUROSURVEILLANCE, V2011, P16; Katz AR, 2017, CLIN INFECT DIS, V65, P918, DOI 10.1093/cid/cix485; Kirkcaldy RD, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6507a1; Kirkcaldy RD, 2013, ANN INTERN MED, V158, P321, DOI 10.7326/0003-4819-158-5-201303050-00004; Knapp JS, 1997, SEX TRANSM DIS, V24, P142, DOI 10.1097/00007435-199703000-00004; Lahra MM, 2017, COMMUN DIS INTELL, V41, pE109; Lefebvre B, 2018, EMERG INFECT DIS, V24, P381, DOI 10.3201/eid2402.171756; Lewis DA, 2015, SEX TRANSM INFECT, V91, P234, DOI 10.1136/sextrans-2014-051731; Lewis DA, 2013, J ANTIMICROB CHEMOTH, V68, P1267, DOI 10.1093/jac/dkt034; Liu H, 2014, J CLIN MICROBIOL, V52, P1435, DOI 10.1128/JCM.02131-13; Mann LM, 2018, SEX TRANSM DIS, V45, P96, DOI 10.1097/OLQ.0000000000000693; MORAN JS, 1995, SEX TRANSM DIS, V22, P39, DOI 10.1097/00007435-199501000-00007; Nabu S, 2017, EXCLI J, V16, P1207, DOI 10.17179/excli2017-832; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Papp JR, 2018, J MED MICROBIOL, V67, P68, DOI 10.1099/jmm.0.000651; Siritrapanan M, 2017, SEXUALLY TRANSMIT S2, V93, pA28; Srifeungfung S, 2009, JPN J INFECT DIS, V62, P467; Thakur SD, 2014, J ANTIMICROB CHEMOTH, V69, P1510, DOI 10.1093/jac/dkt543; Tongtoyai J, 2015, SEX TRANSM DIS, V42, P440, DOI 10.1097/OLQ.0000000000000311; Town K, 2017, SEX TRANSM INFECT, V93, P39, DOI 10.1136/sextrans-2016-052583; TRAISUPA A, 1990, CLIN THER, V12, P101; Trecker MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089458; Unemo M, 2012, EUROSURVEILLANCE, V17, P2; Unemo M, 2011, EUROSURVEILLANCE, V16, P5; Unemo M, 2010, EUROSURVEILLANCE, V2010, P15; Unemo M, 2011, EUROSURVEILLANCE, V2011, P16; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; Unemo M, 2014, CLIN MICROBIOL REV, V27, P587, DOI 10.1128/CMR.00010-14; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/FMB.12.117, 10.2217/fmb.12.117]; Unemo M, 2012, ANTIMICROB AGENTS CH, V56, P1273, DOI 10.1128/AAC.05760-11; Weston EJ, 2017, EMERG INFECT DIS, V23, pS47, DOI 10.3201/eid2313.170443; Whiley DM, 2010, J ANTIMICROB CHEMOTH, V65, P1615, DOI 10.1093/jac/dkq187; WHO, 2015, WHO GUIDELINES TREAT; Wi T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002344; Chen M, 2013, J ANTIMICROB CHEMOTH, V68, P1445, DOI 10.1093/jac/dkt017	53	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206419	10.1371/journal.pone.0206419	http://dx.doi.org/10.1371/journal.pone.0206419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412586	Green Published, gold, Green Submitted			2022-12-26	WOS:000449772600015
J	De Oliveira, B; Prasanna, M; Lemyze, M; Tronchon, L; Thevenin, D; Mallet, J				De Oliveira, Bruno; Prasanna, Malligere; Lemyze, Malcolm; Tronchon, Laurent; Thevenin, Didier; Mallet, Jihad			A comparison between measured and calculated central venous oxygen saturation in critically ill patients	PLOS ONE			English	Article							HEMOGLOBIN; AGREEMENT; AFFINITY	Background Central venous oxygen saturation (ScvO(2)) is often used to help to guide resuscitation of critically ill patients. The standard gold technique for ScvO(2) measurement is the co-oximetry (Co-oximetry_ScvO(2)), which is usually incorporated in most recent blood gas analyzers. However, in some hospitals, those machines are not available and only calculated ScvO(2) (Calc_ScvO(2)) is provided. Therefore, we aimed to investigate the agreement between Co-noximetry_ScvO(2) and Calc_ScvO(2) in a general population of critically ill patients and septic shock patients. Methods A total of 100 patients with a central venous catheter were included in the study. One hundred central venous blood samples were collected and analyzed using the same point-of-care blood gas analyzer, which provides both the calculated and measured ScvO(2) values. Bland and Altman plot, intra-class correlation coefficient (ICC), and Cohen's Kappa coefficient were used to assess the agreement between Co-oximetry_ScvO(2) and Calc_ScvO(2). Multiple linear regression analysis was performed to investigate the independent explanatory variables of the difference between Co-oximetry_ScvO(2) and Calc_ScvO(2). Results In all population, Bland and Altman's analysis showed poor agreement (+4.5 [-7.1, +16.1]%) between the two techniques. The ICC was 0.754 [(95% CI: 0.393-0.880), P< 0.001], and the Cohen's Kappa coefficient, after categorizing the two variables into two groups using a cutoff value of 70%, was 0.470 (P < 0.001). In septic shock patients (49%), Bland and Altman's analysis also showed poor agreement (+5.6 [-6.7 to 17.8]%). The ICC was 0.720 [95% CI: 0.222-0.881], and the Cohen's Kappa coefficient was 0.501 (P < 0.001). Four independent variables (PcvO(2), Co-oximetry_ScvO(2), venous pH, and Hb) were found to be associated with the difference between the measured and calculated ScvO(2) (adjusted R-2 = 0.8, P<0.001), with PcvO(2) being the main independent explanatory variable because of its highest absolute standardized coefficient. The area under the receiver operator characteristic curves (AUC) of PcvO(2) to predict Co-oximetry_ScvO(2) 70% was 0.911 [95% CI: 0.837-0.959], in all patients, and 0.903 [95% CI: 0.784-0.969], in septic shock patients. The best cutoff value was >= 36 mmHg (sensitivity, 88%; specificity, 83%), in all patients, and >= 35 mmHg (sensitivity, 94%; specificity, 71%) in septic shock patients. Conclusions The discrepancy between the measured and calculated ScvO(2) is clinically not acceptable. We do not recommend the use of calculated ScvO(2) to guide resuscitation in critically ill patients. In situations where the Co-oximetry technique is not available, relying on PcvO(2) to predict the measured ScvO(2) value above or below 70% could be an option.	[De Oliveira, Bruno; Prasanna, Malligere; Mallet, Jihad] Cleveland Clin Abu Dhabi, Crit Care Inst, Dept Crit Care Med, Abu Dhabi, U Arab Emirates; [Lemyze, Malcolm; Tronchon, Laurent; Thevenin, Didier; Mallet, Jihad] Ctr Hosp Dr Schaffner Lens, Dept Anesthesiol & Crit Care Med, Lens, France	Cleveland Clinic Foundation	Mallet, J (corresponding author), Cleveland Clin Abu Dhabi, Crit Care Inst, Dept Crit Care Med, Abu Dhabi, U Arab Emirates.; Mallet, J (corresponding author), Ctr Hosp Dr Schaffner Lens, Dept Anesthesiol & Crit Care Med, Lens, France.	mallatjihad@gmail.com		Mallat, Jihad/0000-0001-6372-7360				BELLINGHAM AJ, 1971, J CLIN INVEST, V50, P700, DOI 10.1172/JCI106540; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Davis GE, 1927, ARCH INTERN MED, V40, P226, DOI 10.1001/archinte.1927.00130080100009; Dueck MH, 2005, ANESTHESIOLOGY, V103, P249, DOI 10.1097/00000542-200508000-00007; GOTHGEN IH, 1990, SCAND J CLIN LAB INV, V50, P87, DOI 10.3109/00365519009087495; Horecker BL, 1943, J BIOL CHEM, V148, P173; JOHNSON PA, 1993, ANAESTH INTENS CARE, V21, P72, DOI 10.1177/0310057X9302100117; Lu MJ, 2016, INT J BIOSTAT, V12, DOI 10.1515/ijb-2015-0039; MAGILLIGAN DJ, 1987, ANN THORAC SURG, V44, P260, DOI 10.1016/S0003-4975(10)62068-1; Mallat J, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000415; Ray P, 2010, ANESTHESIOLOGY, V112, P1023, DOI 10.1097/ALN.0b013e3181d47604; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; RIGGS TE, 1973, J CLIN INVEST, V52, P2660, DOI 10.1172/JCI107459; Romero Carlos M, 2014, Am J Emerg Med, V32, P1275, DOI 10.1016/j.ajem.2014.07.027; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Subramanian G, 2013, INDIAN J CRIT CARE M, V17, P82, DOI 10.4103/0972-5229.114824	18	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206868	10.1371/journal.pone.0206868	http://dx.doi.org/10.1371/journal.pone.0206868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408074	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300045
J	Koster, M; Kartner, J				Koester, Moritz; Kaertner, Joscha			Context-sensitive attention is socialized via a verbal route in the parent-child interaction	PLOS ONE			English	Article							CULTURE	The way humans perceive and attend to visual scenes differs profoundly between individuals. This is most compellingly demonstrated for context-sensitivity, the relative attentional focus on focal objects and background elements of a scene, in cross-cultural comparisons. Differences in context-sensitivity have been reported in verbal accounts (e.g. picture descriptions) and in visual attention (e.g., eye-tracking paradigms). The present study investigates (1) if the way parents verbally guide the attention of their children in visual scenes is associated with differences in children's context-sensitivity and (2) if verbal descriptions of scenes are related to early visual attention (i.e., gaze behavior) in 5-year-old children and their parents. Importantly, the way parents verbally described visual scenes to their children was related to children's context-sensitivity, when describing these scenes themselves. This is, we found a correlation in the number of references made to the object versus the background as well as the number of relations made between different elements of a scene. Furthermore, verbal descriptions were closely related to visual attention in adults, but not in children. These findings support our hypotheses that context-sensitivity is socialized via a verbal route and that visual attention processes align with acquired narrative structures only later in development, after the preschool years.	[Koester, Moritz; Kaertner, Joscha] Univ Munster, Dept Psychol, Fliednerstr 21, Munster, Germany; [Koester, Moritz] Free Univ Berlin, Inst Psychol, Habelschwerdter Allee 45, Berlin, Germany	University of Munster; Free University of Berlin	Koster, M (corresponding author), Univ Munster, Dept Psychol, Fliednerstr 21, Munster, Germany.; Koster, M (corresponding author), Free Univ Berlin, Inst Psychol, Habelschwerdter Allee 45, Berlin, Germany.	moritz.koester@fu-berlin.de	Köster, Moritz/AAO-3276-2020; Kärtner, Joscha/AFF-7996-2022; Kärtner, Joscha/AAE-9952-2022	Köster, Moritz/0000-0002-0572-0061; Kärtner, Joscha/0000-0003-4139-5339; Kärtner, Joscha/0000-0003-4139-5339; Koster, Moritz/0000-0002-9951-7741	Open Access Publication Fund of University of Munster	Open Access Publication Fund of University of Munster	The authors received financial support by Open Access Publication Fund of University of Munster.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bremner AJ, 2016, CHILD DEV, V87, P962, DOI 10.1111/cdev.12511; CHIU LH, 1972, INT J PSYCHOL, V7, P235, DOI 10.1080/00207597208246604; Chua HF, 2005, P NATL ACAD SCI USA, DOI [10.1073/pnas0506162102, DOI 10.1073/PNAS0506162102]; Cohen AS, 2015, COG SCI, DOI [10.1111/cogs12329, DOI 10.1111/COGS12329]; Doherty MJ, 2008, PERCEPTION, V37, P1426, DOI 10.1068/p5946; Duffy S, 2009, J EXP CHILD PSYCHOL, DOI [10.1016/jjecp200806006, DOI 10.1016/JJECP200806006]; Fernald A, 1993, CHILD DEV; Gauthier I, 1997, VISION RES, DOI [10.1016/S0042-69899600286-6, DOI 10.1016/S0042-69899600286-6]; Imada T, 2013, DEVELOPMENTAL SCI, DOI [10.1111/desc12016, DOI 10.1111/DESC12016]; Ji L, 2000, J PERS SOC PSYCHOL, DOI [10.1037/0022-3514785943, DOI 10.1037/0022-3514785943]; Kaspar K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021719; Koster M, 2018, PLOS ONE; Koster M, 2017, NEUROIMAGE, DOI [10.1016/j.neuroimage.2017.08, DOI 10.1016/J.NEUROIMAGE.2017.08]; Kuwabara M, 2016, J EXP CHILD PSYCHOL, V147, P22, DOI 10.1016/j.jecp.2016.02.006; Kuwabara M, 2012, J EXP CHILD PSYCHOL, V113, P20, DOI 10.1016/j.jecp.2012.04.009; Kuwabara M, 2011, J COGN DEV, V12, P502, DOI 10.1080/15248372.2011.554927; Majid A, 2004, TRENDS COGN SCI, V8, P108, DOI 10.1016/j.tics.2004.01.003; Masuda T, 2001, J PERS SOC PSYCHOL, DOI [10.1037/0022-3514815922, DOI 10.1037/0022-3514815922]; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2003, P NATL ACAD SCI USA, DOI [10.1073/pnas1934527100, DOI 10.1073/PNAS1934527100]; Senzaki S, 2014, COG SCI; Senzaki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147199; Varnum MEW, 2010, CURR DIR PSYCHOL SCI, V19, P9, DOI 10.1177/0963721409359301	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207113	10.1371/journal.pone.0207113	http://dx.doi.org/10.1371/journal.pone.0207113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408099	Green Submitted, Green Published, gold			2022-12-26	WOS:000449512300076
J	Schechtman, E; Shelef, A				Schechtman, Edna; Shelef, Amit			Correlation and the time interval over which the variables are measured - A non-parametric approach	PLOS ONE			English	Article							REGRESSION	It is known that when one (or both) variable is multiplicative, the choice of differencing intervals (n) (for example, differencing interval of n = 7 means a weekly datum which is the product of seven daily data) affects the Pearson correlation coefficient (rho) between variables (often asset returns) and that rho converges to zero as n increases. This fact can cause the resulting correlation to be arbitrary, hence unreliable. We suggest using Spearman correlation (r) and prove that as n increases Spearman correlation tends to a limit which only depends on Pearson correlation based on the original data (i.e., the value for a single period). In addition, we show, via simulation, that the relative variability (CV) of the estimator of rho increases with n and that r does not share this disadvantage. Therefore, we suggest using Spearman when one (or both) variable is multiplicative.	[Schechtman, Edna] Ben Gurion Univ Negev, Dept Ind Engn & Management, Beer Sheva, Israel; [Shelef, Amit] Sapir Acad Coll, Dept Ind Management, Sderot, Israel	Ben Gurion University	Shelef, A (corresponding author), Sapir Acad Coll, Dept Ind Management, Sderot, Israel.	amitshe@mail.sapir.ac.il	Schechtman, Edna/F-1160-2012	Schechtman, Edna/0000-0001-7350-9068				Jea R, 2005, EUR J OPER RES, V162, P433, DOI 10.1016/j.ejor.2003.07.020; KRUSKAL WH, 1958, J AM STAT ASSOC, V53, P814, DOI 10.2307/2281954; LEVHARI D, 1977, REV ECON STAT, V59, P92, DOI 10.2307/1924908; Levy H, 1997, J ECONOMETRICS, V76, P341, DOI 10.1016/0304-4076(95)01795-X; Levy H, 2001, MANAGE SCI, V47, P1150, DOI 10.1287/mnsc.47.8.1150.10225; Levy H., 2016, STOCHASTIC DOMINANCE, VThird, DOI 10.1007/978-3-319-21708-6; Nelsen R. B, 2006, INTRO COPULAS; Nwogugu M., 2017, ANOMALIES NET PRESEN, DOI [10.2139/ssrn.2375022, DOI 10.2139/SSRN.2375022]; Sklar M., 1959, FONCTIONS REPARTITIO	9	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206929	10.1371/journal.pone.0206929	http://dx.doi.org/10.1371/journal.pone.0206929			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408091	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300052
J	Roston, TM; Haji-Ghassemi, O; LaPage, MJ; Batra, AS; Bar-Cohen, Y; Anderson, C; Lau, YR; Maginot, K; Gebauer, RA; Etheridge, SP; Potts, JE; Van Petegem, F; Sanatani, S				Roston, Thomas M.; Haji-Ghassemi, Omid; LaPage, Martin J.; Batra, Anjan S.; Bar-Cohen, Yaniv; Anderson, Chris; Lau, Yung R.; Maginot, Kathleen; Gebauer, Roman A.; Etheridge, Susan P.; Potts, James E.; Van Petegem, Filip; Sanatani, Shubhayan			Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry	PLOS ONE			English	Article							CARDIAC RYANODINE RECEPTOR; OF-FUNCTION MUTATION; LONG QT SYNDROME; BETA-STRAND; ARRHYTHMIAS; CONTAINS; COMPOUND; OUTCOMES; RELEASE; PROTEIN	Background Catecholaminergic polymorphic ventricular tachycardia (CPVT) is often a life-threatening arrhythmia disorder with variable penetrance and expressivity. Little is known about the incidence or outcomes of CPVT patients with >= 2 variants. Methods The phenotypes, genotypes and outcomes of patients in the Pediatric and Congenital Electrophysiology Society CPVT Registry with >= 2 variants in genes linked to CPVT were ascertained. The American College of Medical Genetics & Genomics (ACMG) criteria and structural mapping were used to predict the pathogenicity of variants (3D model of pig RyR2 in open-state). Results Among 237 CPVT subjects, 193 (81%) had genetic testing. Fifteen patients (8%) with a median age of 9 years (IQR 5-12) had >= 2 variants. Sudden cardiac arrest occurred in 11 children (73%), although none died during a median follow-up of 4.3 years (IQR 2.5-6.1). Thirteen patients (80%) had at least two RYR2 variants, while the remaining two patients had RYR2 variants plus variants in other CPVT-linked genes. Among all variants identified, re-classification of the commercial laboratory interpretation using ACMG criteria led to the upgrade from variant of unknown significance (VUS) to pathogenic/likely pathogenic (P/LP) for 5 variants, and downgrade from P/LP to VUS for 6 variants. For RYR2 variants, 3D mapping using the RyR2 model suggested that 2 VUS by ACMG criteria were P/LP, while 2 variants were downgraded to likely benign. Conclusions This severely affected cohort demonstrates that a minority of CPVT cases are related to >= 2 variants, which may have implications on family-based genetic counselling. While multi-variant CPVT patients were at high-risk for sudden cardiac arrest, there are insufficient data to conclude that this genetic phenomenon has prognostic implications at present. Further research is needed to determine the significance and generalizability of this observation. This study also shows that a rigorous approach to variant re-classification using the ACMG criteria and 3D mapping is important in reaching an accurate diagnosis, especially in the multi-variant population.	[Roston, Thomas M.; Haji-Ghassemi, Omid; Potts, James E.; Van Petegem, Filip; Sanatani, Shubhayan] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Roston, Thomas M.; Haji-Ghassemi, Omid; Potts, James E.; Van Petegem, Filip; Sanatani, Shubhayan] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada; [Roston, Thomas M.; Haji-Ghassemi, Omid; Potts, James E.; Van Petegem, Filip; Sanatani, Shubhayan] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Roston, Thomas M.] Univ Alberta, Dept Med, Edmonton, AB, Canada; [LaPage, Martin J.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Batra, Anjan S.] Univ Calif Irvine, Dept Pediat, Med Ctr, Irvine, CA 92717 USA; [Bar-Cohen, Yaniv] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Anderson, Chris] Providence Sacred Heart Childrens Hosp, Spokane, WA USA; [Lau, Yung R.] Univ Alabama Birmingham, Div Pediat Cardiol, Birmingham, AL USA; [Maginot, Kathleen] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Gebauer, Roman A.] Univ Leipzig, Dept Pediat Cardiol, Leipzig, Germany; [Etheridge, Susan P.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Etheridge, Susan P.] Primary Childrens Med Ctr, Salt Lake City, UT USA	University of British Columbia; University of British Columbia; University of British Columbia; University of Alberta; University of Michigan System; University of Michigan; University of California System; University of California Irvine; Children's Hospital Los Angeles; University of Alabama System; University of Alabama Birmingham; University of Wisconsin System; University of Wisconsin Madison; Leipzig University; Utah System of Higher Education; University of Utah	Sanatani, S (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Sanatani, S (corresponding author), Univ British Columbia, Dept Pediat, Vancouver, BC, Canada.; Sanatani, S (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	ssanatani@cw.bc.ca		Sanatani, Shubhayan/0000-0001-9296-7400; Haji-Ghassemi, Omid/0000-0003-0116-005X	Rare Disease Foundation; British Columbia Children's Hospital Foundation; University of Alberta; Heart and Stroke Foundation of Canada [G-15-0008870]; Canadian Institutes of Health Research [G-125893]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002538] Funding Source: NIH RePORTER	Rare Disease Foundation; British Columbia Children's Hospital Foundation; University of Alberta(University of Alberta); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by the Rare Disease Foundation and British Columbia Children's Hospital Foundation (Drs. Roston & Sanatani). Dr. Roston holds the Queen Elizabeth II Graduate Scholarship from the University of Alberta. Dr. Sanatani receives funding from the Heart and Stroke Foundation of Canada (G-15-0008870), and Dr. Van Petegem is supported by the Canadian Institutes of Health Research (G-125893). The funders had no role in study design, data collection, analysis, manuscript writing or the decision to submit for publication.	Amador FJ, 2013, J MOL BIOL, V425, P4034, DOI 10.1016/j.jmb.2013.08.015; Blair E, 2001, J MED GENET, V38, P385, DOI 10.1136/jmg.38.6.385; Burns C, 2017, CIRCULATION CARDIOVA, V10, P42, DOI [10.1161/CIRCGENETICS.113.000288, DOI 10.1161/CIRCGENETICS.113.000288]; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Francia P, 2015, J CARDIOVASC ELECTR, V26, P656, DOI 10.1111/jce.12658; Giudicessi JR, 2018, CIRCULATION, V137, P619, DOI 10.1161/CIRCULATIONAHA.117.030142; Gomez-Hurtado N, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004161; Ingles J, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.033886; Kaab S, 2012, CIRC-CARDIOVASC GENE, V5, P91, DOI 10.1161/CIRCGENETICS.111.960930; Kapplinger JD, 2018, CIRCULATION GENOMIC, V11; Kimlicka L, 2013, STRUCTURE, V21, P1440, DOI 10.1016/j.str.2013.06.012; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Lane CM, 2018, HEART RHYTHM, V15, P1223, DOI 10.1016/j.hrthm.2018.03.038; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lieve KV, 2017, INT J CARDIOL, V236, P187, DOI 10.1016/j.ijcard.2017.01.113; Lobo PA, 2011, STRUCTURE, V19, P790, DOI 10.1016/j.str.2011.03.016; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Mullally J, 2013, HEART RHYTHM, V10, P378, DOI 10.1016/j.hrthm.2012.11.006; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Rigato I, 2013, CIRC-CARDIOVASC GENE, V6, P533, DOI 10.1161/CIRCGENETICS.113.000288; Rohatgi RK, 2017, J AM COLL CARDIOL, V70, P453, DOI 10.1016/j.jacc.2017.05.046; Roston TM, 2015, CIRC-ARRHYTHMIA ELEC, V8, P633, DOI 10.1161/CIRCEP.114.002217; Roston TM, 2017, EUROPACE; Roux-Buisson N, 2012, HUM MOL GENET, V21, P2759, DOI 10.1093/hmg/dds104; Schwartz PJ, 2016, J AM COLL CARDIOL, V67, P1639, DOI 10.1016/j.jacc.2015.12.063; Swan H, 2014, CIRC-CARDIOVASC GENE, V7, P771, DOI 10.1161/CIRCGENETICS.114.000703; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tung CC, 2010, NATURE, V468, P585, DOI 10.1038/nature09471; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yuchi ZG, 2016, CELL CALCIUM, V59, P209, DOI 10.1016/j.ceca.2016.04.003; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950	34	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205925	10.1371/journal.pone.0205925	http://dx.doi.org/10.1371/journal.pone.0205925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403697	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500034
J	Laimer, J; Henn, R; Helten, T; Sprung, S; Zelger, B; Zelger, B; Steiner, R; Schnabl, D; Offermanns, V; Bruckmoser, E; Huck, CW				Laimer, Johannes; Henn, Raphael; Helten, Tom; Sprung, Susanne; Zelger, Bettina; Zelger, Bernhard; Steiner, Rene; Schnabl, Dagmar; Offermanns, Vincent; Bruckmoser, Emanuel; Huck, Christian W.			Amalgam tattoo versus melanocytic neoplasm - Differential diagnosis of dark pigmented oral mucosa lesions using infrared spectroscopy	PLOS ONE			English	Article							DENTAL AMALGAM; MELANOMA; FEATURES; HEAD; PIGMENTATIONS; CHILDREN	Background Dark pigmented lesions of the oral mucosa can represent a major diagnostic challenge. A biopsy is usually required to determine the nature of such intraoral discolorations. This study investigates the potential use of infrared spectroscopy for differential diagnosis of amalgam tattoos versus benign or malignant melanocytic neoplasms. Materials and methods For this retrospective study, formalin-fixed paraffin-embedded tissue (FFPE) specimens of dark pigmented lesions concerning the oral mucosa or the lip were investigated using mid infrared spectroscopy. The samples were chosen from patients who had undergone a mucosal biopsy at the University Hospital Innsbruck (Austria) between the years 2000 and 2017. Principal component analysis was used for data exploration. Evaluation was based on the superimposition of the recorded spectra and the corresponding histologic slides. Results In total, 22 FFPE specimens were analyzed. Clear differences were found between amalgam and non-amalgam samples. A general weakening of the penetrating infrared radiation allowed for unspecific discrimination between these two classes. An overall accuracy in predicting the correct class of 95.24% was achieved. Conclusion Infrared spectroscopy appears to be a suitable technique to differentiate between amalgam tattoos and melanocytic lesions in FFPE samples. It could potentially be applied in vivo, too, serving as a non-invasive diagnostic tool for intraoral dark pigmented lesions.	[Laimer, Johannes; Helten, Tom; Offermanns, Vincent] Univ Hosp Craniomaxillofacial & Oral Surg, Innsbruck, Austria; [Henn, Raphael; Huck, Christian W.] Inst Analyt Chem & Radiochem, Innsbruck, Austria; [Sprung, Susanne; Zelger, Bettina] Med Univ, Inst Pathol, Innsbruck, Austria; [Zelger, Bernhard] Univ Hosp Dermatol Venereol & Allergol, Innsbruck, Austria; [Steiner, Rene; Schnabl, Dagmar] Univ Hosp Dent Prosthet & Restorat Dent, Innsbruck, Austria	University of Innsbruck; Medical University of Innsbruck		office@bruckmoser.info	Zelger, Bernhard/AAF-6671-2021	Huck, Christian/0000-0002-6272-3242				Alawi Faizan, 2013, Dent Clin North Am, V57, P699, DOI 10.1016/j.cden.2013.07.006; Amano H, 2011, J DERMATOL, V38, P101, DOI 10.1111/j.1346-8138.2010.01007.x; Beck-Mannagetta J, 2012, HAUTARZT, V63, P704, DOI 10.1007/s00105-012-2351-x; Bellinger DC, 2006, JAMA-J AM MED ASSOC, V295, P1775, DOI 10.1001/jama.295.15.1775; Bengtsson UG, 2017, BIOMETALS, V30, P277, DOI 10.1007/s10534-017-0004-3; Bhargava R, 2006, BBA-BIOMEMBRANES, V1758, P830, DOI 10.1016/j.bbamem.2006.05.007; BUCHNER A, 1979, ORAL SURG ORAL MED O, V48, P244, DOI 10.1016/0030-4220(79)90011-2; Chan RCL, 2012, LARYNGOSCOPE, V122, P2749, DOI 10.1002/lary.23625; Fernandez DC, 2005, NAT BIOTECHNOL, V23, P469, DOI 10.1038/nbt1080; Ferreira L, 2015, OR SURG OR MED OR PA, V120, P358, DOI 10.1016/j.oooo.2015.05.008; Gaeta GM, 2002, CLIN DERMATOL, V20, P286, DOI 10.1016/S0738-081X(02)00225-0; Gondak RO, 2012, MED ORAL PATOL ORAL, V17, pE919, DOI 10.4317/medoral.17679; Griffith P. R., 2009, INFRARED RAMAN SPECT, P3, DOI DOI 10.1002/9783527628230.CH1; Hassona Y, 2016, INT J DERMATOL, V55, P1005, DOI 10.1111/ijd.13133; JOHANSSON C, 1991, SCAND J DENT RES, V99, P246; Joska L, 2009, CLIN ORAL INVEST, V13, P1, DOI 10.1007/s00784-008-0206-8; KAUGARS GE, 1993, ORAL SURG ORAL MED O, V76, P59, DOI 10.1016/0030-4220(93)90295-F; Kauzman Adel, 2004, J Can Dent Assoc, V70, P682; Kendall C, 2010, ANALYST, V135, P3038, DOI 10.1039/c0an00536c; Kessler W., 2007, MULTIVARIATE DATENAN, P21; Kyriakidou M, 2017, IN VIVO, V31, P1131, DOI 10.21873/invivo.11179; Lambertini M, 2018, J EUR ACAD DERMATOL, V32, P209, DOI 10.1111/jdv.14574; Lau JC, 2001, ARCH ORAL BIOL, V46, P1015, DOI 10.1016/S0003-9969(01)00069-3; Leslie LS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127238; Lundin K, 2013, CASE REP DENT, V2013, DOI 10.1155/2013/787294; Mackanos MA, 2010, TRENDS BIOTECHNOL, V28, P317, DOI 10.1016/j.tibtech.2010.04.001; Maserejian NN, 2012, J DENT RES, V91, P1019, DOI 10.1177/0022034512458691; Masilana A, 2017, J INVESTIG CLIN DENT, V8, DOI 10.1111/jicd.12258; Massart D, 2003, CHEMOMETRICS TXB, P387; McGarrity TJ, 1993, GENEREVIEWS; McLean N, 2008, ORAL ONCOL, V44, P1039, DOI 10.1016/j.oraloncology.2008.01.014; Mendenhall WM, 2005, AM J CLIN ONCOL-CANC, V28, P626, DOI 10.1097/01.coc.0000170805.14058.d3; Mohan M, 2013, OR SURG OR MED OR PA, V116, pE247, DOI 10.1016/j.oooo.2011.11.034; Muller S, 2010, DERMATOL THER, V23, P220, DOI 10.1111/j.1529-8019.2010.01319.x; Pais S, 2004, J Indian Soc Pedod Prev Dent, V22, P73; Pallua JD, 2012, ANALYST, V137, P3965, DOI 10.1039/c2an35483g; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Petter CH, 2009, CURR MED CHEM, V16, P318, DOI 10.2174/092986709787002664; Pezzei C, 2010, MOL BIOSYST, V6, P2287, DOI 10.1039/c0mb00041h; Postow MA, 2012, CURR ONCOL REP, V14, P441, DOI 10.1007/s11912-012-0244-x; Romeo M, 1998, CELL MOL BIOL, V44, P179; Saghravanian Nasrollah, 2014, J Dent (Tehran), V11, P721; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Sharaf MA, 1986, CHEMOMETRICS, P155; Sutow EJ, 2006, DENT MATER, V22, P325, DOI 10.1016/j.dental.2005.06.001; Sutow EJ, 2004, DENT MATER, V20, P823, DOI 10.1016/j.dental.2003.10.012; Venugopal M, 2013, J Oral Maxillofac Pathol, V17, P113, DOI 10.4103/0973-029X.110699; Vera-Kellet C, 2016, NEW ENGL J MED, V374, pE21, DOI 10.1056/NEJMicm1510216; Wood BR, 1998, BIOSPECTROSCOPY, V4, P75, DOI 10.1002/(SICI)1520-6343(1998)4:2<75::AID-BSPY1>3.0.CO;2-R; Woods JS, 2008, ENVIRON RES, V108, P393, DOI 10.1016/j.envres.2008.07.003; Yelamos Oriol, 2017, Dermatol Pract Concept, V7, P13, DOI 10.5826/dpc.0704a04; Zhang XQ, 2011, J SURG RES, V171, P650, DOI 10.1016/j.jss.2010.05.031	53	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0207026	10.1371/journal.pone.0207026	http://dx.doi.org/10.1371/journal.pone.0207026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399191	Green Published, Green Submitted, gold			2022-12-26	WOS:000449374000040
J	Corrion, K; Morales, V; Bergamaschi, A; Massiera, B; Morin, JB; d'Arripe-Longueville, F				Corrion, Karine; Morales, Valerie; Bergamaschi, Alessandro; Massiera, Bernard; Morin, Jean-Benoit; d'Arripe-Longueville, Fabienne			Psychosocial factors as predictors of dropout in ultra-trailers	PLOS ONE			English	Article							SELF-TALK; PHYSICAL PERFORMANCE; RUNNING PERFORMANCE; BRIEF COPE; MOTIVATION; MARATHON; SPORT; RACE; EXPERIENCES; VALIDATION	Objective Although research on the physiological and psychological factors of endurance performance has been extensive, the factors related to dropping out of ultra-trail races have not been well documented. The aim of this study was to examine psychosocial factors as predictors of dropout in ultra-trail runners. Methods Two hundred and twenty-one volunteer athletes completed a survey that included measures of: (a) motivational variables (self-determined motivation, basic needs satisfaction, achievement goals), (b) theory of planned behavior constructs (attitudes, subjective norms, self-efficacy and intention to finish the race), and (c) coping strategies in sport. Results The results showed that finishers had higher scores for self-efficacy and intention to finish the race than withdrawers, whereas withdrawers had higher scores for avoidance coping. Multiple logistic regression showed that the number of started and finished ultra-trail races (OR, 0.44; 95% CI 0.22-0.88; p<0.02), self-efficacy (OR, 2.03; 95% CI 1.06-3.89; p<0.04), intention to finish the race (OR, 0.34; 95% CI 0.16-0.71; p<0.004), mastery-approach goals (OR, 0.56; 95% CI 0.31-1.00; p<0.05), and coping strategies of seeking social support (OR, 0.43; 95% CI 0.26-0.71; p<0.001) were associated with a lower risk of race dropout, whereas avoidance coping strategies (OR, 2.26; 95% CI 1.46-3.52; p<0.001) were associated with an increased dropout rate. Conclusion Interventions promoting self-efficacy constructs and specific coping strategies might contribute to preventing dropout in ultra-trailers.	[Corrion, Karine; Massiera, Bernard; Morin, Jean-Benoit; d'Arripe-Longueville, Fabienne] Univ Cote Azur, LAMHESS, Nice, France; [Morales, Valerie] Univ Orleans, ERCAE, Orleans, France; [Bergamaschi, Alessandro] Univ Cote Azur, URMIS, Nice, France	UDICE-French Research Universities; Universite Cote d'Azur; Universite de Orleans; UDICE-French Research Universities; Universite Cote d'Azur; Universite Paris Cite	Corrion, K (corresponding author), Univ Cote Azur, LAMHESS, Nice, France.	Karine.CORRION@univ-cotedazur.fr		Morin, Jean-Benoit/0000-0003-3808-6762				AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1981, CANADIAN RUNNER  JAN; Antonini-Philippe R, 2016, SPORT PSYCHOL, V30, DOI [10.1186/s12955-016-0581-9, DOI 10.1186/S12955-016-0581-9]; Arbuckle J.L., 2008, AMOS 17 USERS GUIDE; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Baker J, 2005, PSYCHOL SPORT EXERC, V6, P551, DOI 10.1016/j.psychsport.2004.04.005; Baker J, 2005, SPORT PSYCHOL LIB TR; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Baumstarck K, 2017, HEALTH QUAL LIFE OUT, V15, DOI 10.1186/s12955-016-0581-9; Blanchfield AW, 2014, MED SCI SPORT EXER, V46, P998, DOI 10.1249/MSS.0000000000000184; Bowen RL, 2006, INTJ SPORT PHYSIOL, V1, P176, DOI 10.1123/ijspp.1.2.176; Buck K, 2018, WILD ENVIRON MED, V29, P66, DOI 10.1016/j.wem.2017.09.003; Buman MP, 2008, J APPL SPORT PSYCHOL, V20, P282, DOI 10.1080/10413200802078267; BURHANS RS, 1988, INT J SPORT PSYCHOL, V19, P26; Carmack M. A., 1979, J SPORT EXERCISE PSY, V1, P25, DOI [10.1123/jsp.1.1.25, DOI 10.1123/JSP.1.1.25]; Crane J, 2015, EUR PHYS EDUC REV, V21, P114, DOI 10.1177/1356336X14555294; Cury F, 2006, J PERS SOC PSYCHOL, V90, P666, DOI 10.1037/0022-3514.90.4.666; da Fonseca-Engelhardt K, 2013, EXTREME PHYSIOL MED, V2, DOI 10.1186/2046-7648-2-15; Degache F, 2016, INT J SPORT PHYSIOL, V11, P608, DOI 10.1123/ijspp.2015-0238; Degache F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084554; Doppelmayr M, 2004, BIOL SPORT, V21, P319; Eichenberger E, 2012, OPEN ACCESS J SPORTS, V3, P73, DOI 10.2147/OAJSM.S33836; Elliot AJ, 2001, J PERS SOC PSYCHOL, V80, P501, DOI 10.1037//0022-3514.80.3.501; Gillet N, 2008, CAN J BEHAV SCI, V40, P230, DOI 10.1037/a0013201; Hamilton RA, 2007, J APPL SPORT PSYCHOL, V19, P226, DOI 10.1080/10413200701230613; Hatzigeorgiadis A, 2011, PERSPECT PSYCHOL SCI, V6, P348, DOI 10.1177/1745691611413136; Heazlewood I, 2011, J HUM SPORT EXERC, V6, P328, DOI 10.4100/jhse.2011.62.14; Hoffman MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083867; Hoffman MD, 2012, RES SPORTS MED, V20, P59, DOI 10.1080/15438627.2012.634707; Hoffman MD, 2010, INT J HIST SPORT, V27, P1877, DOI 10.1080/09523367.2010.494385; Hoffman MD, 2009, MED SCI SPORT EXER, V41, P2191, DOI 10.1249/MSS.0b013e3181a8d553; Holt NL, 2014, SPORT PSYCHOL, V28, P22, DOI 10.1123/tsp.2013-0008; Houston M, 2011, J SPORT MED PHYS FIT, V51, P583; Hulleman M, 2007, MED SCI SPORT EXER, V39, P709, DOI 10.1249/mss.0b013e31802eff36; Hulton AT, 2010, INT J SPORTS MED, V31, P463, DOI 10.1055/s-0030-1251992; Hurdiel R, 2015, J SPORT SCI, V33, P670, DOI 10.1080/02640414.2014.960883; JOHNSGARD K, 1985, J SPORT MED PHYS FIT, V25, P135; Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136; Knechtle B, 2016, PEERJ, V4, DOI 10.7717/peerj.2509; Knechtle B, 2012, AGE, V34, P1033, DOI 10.1007/s11357-011-9290-9; Knoth C, 2012, EXTREME PHYSIOL MED, V1, DOI 10.1186/2046-7648-1-13; Koronios K, 2016, BUSINESS ENTREPRENEU, V2, P17; Kress J.L., 2007, J SPORT BEHAV, V30, P428; Lane AM, 2011, J SCI MED SPORT, V14, P358, DOI 10.1016/j.jsams.2011.03.001; Laursen PB, 2001, SPORTS MED, V31, P195, DOI 10.2165/00007256-200131030-00004; LERNER BS, 1995, J SPORT EXERCISE PSY, V17, P138, DOI 10.1123/jsep.17.2.138; Li P, 2015, JAMA-J AM MED ASSOC, V314, P1966, DOI 10.1001/jama.2015.15281; MacMahon C, 2014, J SPORT EXERCISE PSY, V36, P375, DOI 10.1123/jsep.2013-0249; MASTERS KS, 1989, J SPORT EXERCISE PSY, V11, P161, DOI 10.1123/jsep.11.2.161; McCormick A, 2015, SPORTS MED, V45, P997, DOI 10.1007/s40279-015-0319-6; Millet GY, 2012, J APPL PHYSIOL, V113, P507, DOI 10.1152/japplphysiol.00016.2012; Millet GP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-77; MOFFATT RJ, 1994, J SPORT MED PHYS FIT, V34, P45; Moritz SE, 2000, RES Q EXERCISE SPORT, V71, P280, DOI 10.1080/02701367.2000.10608908; Muller L, 2003, ENCEPHALE, V29, P507; Nicholls AR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01674; Nicolas M, 2011, PSYCHOL SPORT EXERC, V12, P368, DOI 10.1016/j.psychsport.2011.03.005; Noakes TD, 2006, BASIC RES CARDIOL, V101, P408, DOI 10.1007/s00395-006-0607-2; Ogles B. M., 1993, IMAGINATION COGNITIO, V13, P163, DOI DOI 10.2190/P1DG-KKKJ-AGD0-A216; OGLES BM, 1995, INT J SPORT PSYCHOL, V26, P233; Pageaux B, 2014, EUR J APPL PHYSIOL, V114, P1095, DOI 10.1007/s00421-014-2838-5; Pearson H, 2006, NATURE, V444, P1000, DOI 10.1038/4441000a; Pedlar C. R., 2007, WILDERNESS ENV MED, V18, P13; Pelletier LG, 2013, PSYCHOL SPORT EXERC, V14, P329, DOI 10.1016/j.psychsport.2012.12.002; Reilly T, 2007, PHYSIOL BEHAV, V90, P274, DOI 10.1016/j.physbeh.2006.09.017; Riou F, 2012, EUR J PSYCHOL ASSESS, V28, P313, DOI 10.1027/1015-5759/a000112; Rochat N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173667; Saugy J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065596; Schumacher YO, 2011, MED SCI SPORT EXER, V43, P885, DOI 10.1249/MSS.0b013e3181fec009; Simpson D, 2014, SPORT PSYCHOL, V28, P176, DOI 10.1123/tsp.2013-0064; Smith R. S., 1998, J SLEEP, V22, P303; Tenenbaum G, 1999, AUST J PSYCHOL, V51, P6, DOI 10.1080/00049539908255328; Theodorakis Y, 1998, PERCEPT MOTOR SKILL, V86, P1035, DOI 10.2466/pms.1998.86.3.1035; Vernillo G, 2014, EUR J APPL PHYSIOL, V114, P929, DOI 10.1007/s00421-014-2824-y; Wang CKJ, 2007, PSYCHOL SPORT EXERC, V8, P147, DOI 10.1016/j.psychsport.2005.08.012; Williams K, 2011, CURR MED CHEM, V18, P3446, DOI 10.2174/092986711796642616; Zaryski Calvin, 2005, Curr Sports Med Rep, V4, P165; Zingg M, 2014, SWISS MED FORUM, V14, P105, DOI DOI 10.5167/UZH-95148; Zingg MA, 2014, CLINICS, V69, P203, DOI 10.6061/clinics/2014(03)11	79	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206498	10.1371/journal.pone.0206498	http://dx.doi.org/10.1371/journal.pone.0206498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MT	30395613	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400027
J	da Silva, MR; Schapochnik, A; Leal, MP; Esteves, J; Hebeda, CB; Sandri, S; Pavani, C; Horliana, ACRT; Farsky, SHP; Lino-dos-Santos-Franco, A				da Silva, Marcia Rodrigues; Schapochnik, Adriana; Leal, Mayara Peres; Esteves, Janete; Hebeda, Cristina Bichels; Sandri, Silvana; Pavani, Christiane; Ratto Tempestini Horliana, Anna Carolina; Farsky, Sandra H. P.; Lino-dos-Santos-Franco, Adriana			Beneficial effects of ascorbic acid to treat lung fibrosis induced by paraquat	PLOS ONE			English	Article							PULMONARY-FIBROSIS; OXIDATIVE STRESS; VITAMIN-C; POLYMORPHONUCLEAR LEUKOCYTES; UP-REGULATION; IN-VIVO; DEFICIENCY; THERAPY; MATRIX; INFLAMMATION	Paraquat (PQ) is one of the most widely employed herbicides that is used worldwide and it causes severe toxic effects in humans and animals. A PQ exposition can lead to pulmonary fibrosis (PF) and the mechanisms seem to be linked to oxidative stress, although other pathways have been suggested. Antioxidants can be useful as a therapy, although interventions with this kind of system are still controversial. Hence, this study has investigated the role of ascorbic acid (vitamin C) post-treatment on PQ-induced PF in male C57/BL6 mice. Pulmonary fibrosis was induced by a single PQ injection (10mg/kg; i.p.). The control group received a PQ vehicle. Seven days after the PQ or vehicle injections, the mice received vitamin C (150 mg/kg, ip, once a day) or the vehicle, over the following 7 days. Twenty-four hours after the last dose of vitamin C or the vehicle, the mice were euthanized and their bronchoalveolar lavage fluid (BALF) and their lungs were collected. The data obtained showed that vitamin C reduced the cellular recruitment, the secretion of IL-17 -a cytokine involved in neutrophils migration, TGF-beta-a pro-fibrotic mediator and the collagen deposition. Moreover, vitamin C elevated the superoxide dismutase (SOD) and catalase levels, both antioxidant enzymes, but it did not alter the tracheal contractile response that was evoked by methacholine. Therefore, the researchers have highlighted the mechanisms of vitamin C as being non-invasive and have suggested it as a promising tool to treat lung fibrosis when it is induced by a PQ intoxication.	[da Silva, Marcia Rodrigues; Schapochnik, Adriana; Leal, Mayara Peres; Esteves, Janete; Hebeda, Cristina Bichels; Pavani, Christiane; Ratto Tempestini Horliana, Anna Carolina; Lino-dos-Santos-Franco, Adriana] Univ Nove de Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil; [Sandri, Silvana; Farsky, Sandra H. P.] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil	Universidade Nove de Julho; Universidade de Sao Paulo	Lino-dos-Santos-Franco, A (corresponding author), Univ Nove de Julho UNINOVE, Post Grad Program Biophoton Appl Hlth Sci, Sao Paulo, Brazil.	alsantosfranco@gmail.com	Sandri, Silvana/A-1650-2015; Farsky, Sandra HP/C-4044-2012; Horliana, Anna Carolina Ratto Tempestini/J-3257-2015; Franco, Adriana Lino dos Santos/AAA-7081-2019; Horliana, Anna/ABH-9640-2020; PAVANI, Christiane/G-5869-2012	Horliana, Anna Carolina Ratto Tempestini/0000-0003-3476-9064; Franco, Adriana Lino dos Santos/0000-0002-7854-2833; PAVANI, Christiane/0000-0001-8275-7370	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2017/06444-9]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was sponsored by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2017/06444-9).	ANDERSON R, 1979, S AFR MED J, V56, P429; Baltazar T, 2013, BRIT J PHARMACOL, V168, P44, DOI 10.1111/j.1476-5381.2012.02017.x; Beeh KM, 2002, EUR RESPIR J, V19, P1119, DOI 10.1183/09031936.02.00262402; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; Brochetti RA, 2017, LASER MED SCI, V32, P1825, DOI 10.1007/s10103-017-2281-z; Carr AC, 2017, NUTRIENTS, V9, DOI 10.3390/nu9111211; Chang JB, 2013, FREE RADICAL RES, V47, P991, DOI 10.3109/10715762.2013.838321; Chen H, 2018, TOXICOL LETT, V284, P1, DOI 10.1016/j.toxlet.2017.11.030; Cockx M, 2017, CELL MOL IMMUNOL; Colle D, 2018, NEUROTOX RES; CORBERAND J, 1982, ARCH OTOLARYNGOL, V108, P122; ENGLARD S, 1986, ANNU REV NUTR, V6, P365, DOI 10.1146/annurev.nu.06.070186.002053; Feitosa CM, 2018, CURRENT CLIN PHARM; Fisher BJ, 2012, AM J PHYSIOL-LUNG C, V303, pL20, DOI 10.1152/ajplung.00300.2011; Fu RQ, 2011, EXP BIOL MED, V236, P291, DOI 10.1258/ebm.2010.010231; GANGULY R, 1976, AM J CLIN NUTR, V29, P762, DOI 10.1093/ajcn/29.7.762; GOLDSCHMIDT MC, 1991, AM J CLIN NUTR, V54, pS1214, DOI 10.1093/ajcn/54.6.1214s; GOLDSCHMIDT MC, 1988, INT J VITAM NUTR RES, V58, P326; Guo L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/386952; Gupta I, 2016, P NATL ACAD SCI USA, V113, pE4208, DOI 10.1073/pnas.1600056113; HARLEY JB, 1977, YALE J BIOL MED, V50, P481; Hua XF, 2017, J THORAC DIS, V9, P4376, DOI 10.21037/jtd.2017.10.42; Huang M, 2016, ENVIRON TOXICOL, V31, P1407, DOI 10.1002/tox.22146; Ibrahim BS, 2016, TOXICOL APPL PHARM, V300, P77, DOI 10.1016/j.taap.2016.03.010; Kikuchi N, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-31; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kinnula VL, 2008, ANTIOXID REDOX SIGN, V10, P727, DOI 10.1089/ars.2007.1942; Li TG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01069-9; Lin JL, 2006, CRIT CARE MED, V34, P368, DOI 10.1097/01.CCM.0000195013.47004.A8; Liu B, 2016, TOXICOL APPL PHARM, V309, P111, DOI 10.1016/j.taap.2016.08.004; Lohitnavy M, 2017, IEEE ENG MED BIO, P2732, DOI 10.1109/EMBC.2017.8037422; MacNee W, 2001, TRENDS MOL MED, V7, P55, DOI 10.1016/S1471-4914(01)01912-8; Mandl J, 2009, BRIT J PHARMACOL, V157, P1097, DOI 10.1111/j.1476-5381.2009.00282.x; Martinez FJ, 2014, NEW ENGL J MED, V370, P2093, DOI 10.1056/NEJMoa1401739; MEYER KC, 1995, J LAB CLIN MED, V126, P530; NOWAK D, 1989, ARCH IMMUNOL THER EX, V37, P213; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Phan Sem H, 2012, Proc Am Thorac Soc, V9, P148, DOI 10.1513/pats.201201-011AW; Pouokam GB, 2017, TOXICS, V5, DOI 10.3390/toxics5040030; Radomska-Lesniewska DM, 2017, CENT EUR J IMMUNOL, V42, P370, DOI 10.5114/ceji.2017.72804; Ramirez A, 2007, AM J PHYSIOL-LUNG C, V293, pL972, DOI 10.1152/ajplung.00010.2007; Seifirad S, 2012, CLIN TOXICOL, V50, P754, DOI 10.3109/15563650.2012.718783; Shao X, 2015, J ZHEJIANG UNIV-SC B, V16, P52, DOI 10.1631/jzus.B1400229; Sharma P, 2004, J LEUKOCYTE BIOL, V75, P1070, DOI 10.1189/jlb.0903415; SHILOTRI PG, 1977, J NUTR, V107, P1507, DOI 10.1093/jn/107.8.1507; Shukla S, 2015, PESTIC BIOCHEM PHYS, V123, P74, DOI 10.1016/j.pestbp.2015.03.007; STANKOVA L, 1975, INFECT IMMUN, V12, P252, DOI 10.1128/IAI.12.2.252-256.1975; Vissers MCM, 2007, J LEUKOCYTE BIOL, V81, P1236, DOI 10.1189/jlb.0806541; Weng CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082695; Yeung YT, 2018, CURR PHARM DESIGN, V24, P1449, DOI 10.2174/1381612824666180327165604; Zerin T, 2012, TOXICOL LETT, V208, P101, DOI 10.1016/j.toxlet.2011.10.019; Zhao GJ, 2017, INT J BIOL SCI, V13, P888, DOI 10.7150/ijbs.18468; Zhu Y, 2017, INT J NANOMED, V12, P7143, DOI 10.2147/IJN.S143192; Zyoud SH, 2018, AM J IND MED, V61, P462, DOI 10.1002/ajim.22835	55	33	33	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205535	10.1371/journal.pone.0205535	http://dx.doi.org/10.1371/journal.pone.0205535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395570	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400007
J	Zhang, CF; Su, SY; Li, XY; Li, B; Yang, BJ; Zhu, J; Wang, WM				Zhang, Chengfeng; Su, Shengyan; Li, Xinyuan; Li, Bing; Yang, Baojuan; Zhu, Jian; Wang, Weimin			Comparative transcriptomics identifies genes differentially expressed in the intestine of a new fast-growing strain of common carp with higher unsaturated fatty acid content in muscle	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; WEB SERVER; PROTEIN; GROWTH; DATABASE; GENOMICS; DUPLICATION; ABSORPTION; SEQUENCE; UNIPROT	We have created a new, fast-growing strain of common carp with higher unsaturated fatty acid content in muscle. To better understand the impacts of gene regulation in intestinal tissue on growth and unsaturated fatty acid content, we conducted a comparative RNA-Seq transcriptome analysis between intestine samples of Selected and Control groups (and corroborated selected results by PCR). After eight weeks of cage culture, weight gain of the Selected group was 20.84% higher. In muscles of the control group, monounsaturated fatty acids (FAs) were more abundant, whereas polyunsaturated FAs were more abundant in muscles of the Selected group. In total, we found 106 differentially expressed genes (DEGs) between the two groups. Only the endocytosis pathway was significantly enriched in DEGs, with two upregulated genes: il2rb and ehd1. The latter is involved in the growth hormone/insulin-like growth factor (Gh/lgf) axis, which plays a key role in the regulation of growth in animals. tll2, which is known to be associated with intestinal regeneration, was extremely highly upregulated in both transcriptomic (infinite) and qPCR (610.70) analyses. Two of the upregulated genes are associated with the fatty acid metabolism, several genes are likely to be indicators of heightened transcription levels, several are associated with metabolic and developmental roles, several with neuronal functions (including two with vision), several with the immune system, and two downregulated genes with the development of vasculature. The higher growth rate of the Selected group is likely to be at least partially attributed to increased endocytosis efficiency and genetically-driven behavioural differences (higher aggression levels). There are some indications that this new strain might have slightly impaired immune responses, and a higher propensity for inherited diseases leading to sight impairment, as well for neurodegenerative diseases in general, but these indications still need to be confirmed.	[Zhang, Chengfeng; Wang, Weimin] Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China; [Zhang, Chengfeng; Su, Shengyan; Li, Bing; Yang, Baojuan; Zhu, Jian] Minist Agr, Key Lab Genet Breeding & Aquaculture Biol Freshwa, Wuxi, Peoples R China; [Zhang, Chengfeng; Su, Shengyan; Li, Bing; Yang, Baojuan; Zhu, Jian] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Wuxi, Peoples R China; [Su, Shengyan; Li, Xinyuan] Nanjing Agr Univ, Wuxi Fisheries Coll, Wuxi, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Nanjing Agricultural University	Wang, WM (corresponding author), Huazhong Agr Univ, Coll Fisheries, Wuhan, Hubei, Peoples R China.; Zhu, J (corresponding author), Minist Agr, Key Lab Genet Breeding & Aquaculture Biol Freshwa, Wuxi, Peoples R China.; Zhu, J (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Wuxi, Peoples R China.	zhuj@ffrc.cn; wangwm@mail.hzau.edu.cn			Central Public-Interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences (CAFS) [2016RC-LX03]; Key Projects in the National Science & Technology Pillar Program during the twelfth Five-Year Plan Period [2012BAD26B02]; National Nonprofit Institute Research Grant of CATAS-TCGRI [2013JBFM14]	Central Public-Interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences (CAFS); Key Projects in the National Science & Technology Pillar Program during the twelfth Five-Year Plan Period; National Nonprofit Institute Research Grant of CATAS-TCGRI	This work was supported by grants from Central Public-Interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences (CAFS) (2016RC-LX03 to SS); the Key Projects in the National Science & Technology Pillar Program during the twelfth Five-Year Plan Period (2012BAD26B02); and the National Nonprofit Institute Research Grant of CATAS-TCGRI (2013JBFM14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves RN, 2010, AQUACULTURE, V299, P57, DOI 10.1016/j.aquaculture.2009.11.014; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betancor MB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175415; Blazie SM, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0116-6; Boeuf G., 1999, Journal of Fish Biology, V55, P128, DOI 10.1111/j.1095-8649.1999.tb01051.x; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Brouillard P, 2002, AM J HUM GENET, V70, P866, DOI 10.1086/339492; Buchtova H, 2010, ACTA VET BRNO, V79, P551, DOI 10.2754/avb201079040551; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126492; Connors SA, 1999, DEVELOPMENT, V126, P3119; David L, 2003, MOL BIOL EVOL, V20, P1425, DOI 10.1093/molbev/msg173; de Mooij-van Malsen JG, 2013, GENES BRAIN BEHAV, V12, P653, DOI 10.1111/gbb.12055; De Santis C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140964; Duan CM, 1997, AM ZOOL, V37, P491; FAO, 2014, FAO FISHERIES P; Farmanfarmaian A, 1999, GENET ANAL-BIOMOL E, V15, P107, DOI 10.1016/S1050-3862(99)00012-1; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fonseca NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107026; Fu BD, 2016, COMP BIOCHEM PHYS D, V20, P111, DOI 10.1016/j.cbd.2016.08.006; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; Gilmour AR, 2006, P 8 WORLD C GEN APPL, P12; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Harder W, 1975, ANATOMY FISHES 1; Harrell FE, 2001, REGRESSION MODELING; He LB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1427-2; Henderson CR., 1984, APPL LINEAR MODELS A, P384, DOI [10.1002/9780470316856.ch7, DOI 10.1002/9780470316856.CH7]; Howe K, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160009; Huang GH, 2017, PEERJ, V5, DOI 10.7717/peerj.3758; Husain S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002653; Jakovlic I, 2016, GENE EXPR PATTERNS, V21, P63, DOI 10.1016/j.gep.2016.07.001; Jakovlic I, 2016, DEV COMP IMMUNOL, V62, P89, DOI 10.1016/j.dci.2016.05.002; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolder ICRM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3038-y; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kostic C, 2016, J PATHOL, V238, P300, DOI 10.1002/path.4641; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001628; Lencer ES, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3810-7; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Liu XM, 2015, INT J MOL SCI, V16, P5975, DOI 10.3390/ijms16035975; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Logan MA, 2005, DEV DYNAM, V234, P802, DOI 10.1002/dvdy.20618; Lunn J, 2006, NUTR BULL, V31, P178, DOI 10.1111/j.1467-3010.2006.00571.x; Ma DY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149414; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; Madsen P., 2006, WORLD C GENETICS APP; Martin SAM, 2016, DEV COMP IMMUNOL, V64, P103, DOI 10.1016/j.dci.2016.03.014; Mashanov VS, 2012, GENE EXPR PATTERNS, V12, P24, DOI 10.1016/j.gep.2011.10.003; Matsumoto Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-808; Mir Z, 2000, CAN J ANIM SCI, V80, P195, DOI 10.4141/A98-113; Miyadera K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051598; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mraz J, 2011, NEUROENDOCRINOL LETT, V32, P3; Mullis PE, 2005, EUR J ENDOCRINOL, V152, P11, DOI 10.1530/eje.1.01797; Ozdemir S, 2018, TOXICOL REP, V5, P125, DOI 10.1016/j.toxrep.2017.12.019; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Pechstein A, 2010, BIOCHEM SOC T, V38, P181, DOI 10.1042/BST0380181; Popovic NT, 2012, J APPL ICHTHYOL, V28, P553, DOI 10.1111/j.1439-0426.2012.01950.x; Prisingkorn W, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4246-9; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Puig-Oliveras A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099720; Ranganathan S, 2011, J NEUROSCI, V31, P10836, DOI 10.1523/JNEUROSCI.5065-10.2011; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Reinecke M, 2010, J FISH BIOL, V76, P1233, DOI 10.1111/j.1095-8649.2010.02605.x; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; Shengyan Su., 2018, J YANGZHOU U AGR LIF, V39, P63; SIRE MF, 1992, COMP BIOCHEM PHYS A, V103, P771, DOI 10.1016/0300-9629(92)90180-X; Sneddon LU, 2003, J FISH BIOL, V62, P971, DOI 10.1046/j.1095-8649.2003.00084.x; Sneddon LU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018181; Stancheva M., 2011, Agricultural Science and Technology, V3, P285; Steffens W, 2016, AQUACULT INT, V24, P787, DOI 10.1007/s10499-015-9885-8; Suarez-Castillo EC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-23; Sun LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069441; Sun Y, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0328-y; Szabo T, 2014, TURK J FISH AQUAT SC, V14, P841, DOI 10.4194/1303-2712-v14_3_28; Tang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128396; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; The Human Protein Atlas, ATP10B; Tymchuk W, 2009, GEN COMP ENDOCR, V164, P175, DOI 10.1016/j.ygcen.2009.05.015; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Rossum G, 2015, PYTHON 2 7 10 LANGUA; Velez EJ, 2017, AQUACULTURE, V467, P28, DOI 10.1016/j.aquaculture.2016.07.004; Wang YD, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101693; Wei JF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1795-8; Williams CM, 2000, ANN ZOOTECH, V49, P165, DOI 10.1051/animres:2000116; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Yeganeh S, 2012, CZECH J FOOD SCI, V30, P503, DOI 10.17221/455/2011-CJFS; Yue HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127332; Zhang ChengFeng, 2017, Acta Hydrobiologica Sinica, V41, P79; Zhang WW, 2016, PAK J ZOOL, V48, P1615; Zomer AWM, 2000, EUR J BIOCHEM, V267, P4063, DOI 10.1046/j.1432-1327.2000.01451.x	104	4	4	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206615	10.1371/journal.pone.0206615	http://dx.doi.org/10.1371/journal.pone.0206615			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395585	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400035
J	Berthold, D; Joyce, G; Wharton, W; Kehoe, P; Zissimopoulos, J				Berthold, Douglas; Joyce, Geoffrey; Wharton, Whitney; Kehoe, Patrick; Zissimopoulos, Julie			The association of multiple anti-hypertensive medication classes with Alzheimer's disease incidence across sex, race, and ethnicity	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MILD COGNITIVE IMPAIRMENT; BLOOD-PRESSURE; RECEPTOR BLOCKERS; A-BETA; DEMENTIA; LOSARTAN; BRAIN; HYPERTENSION; SYSTEM	Background Antihypertensive treatments have been shown to reduce the risk of Alzheimer's disease (AD). The renin-angiotensin system (RAS) has been implicated in AD, and thus RAS-acting AHTs (angiotensin converting enzyme inhibitors (ACEIs), and angiotensin-II receptor blockers (ARBs)) may offer differential and additional protective benefits against AD compared with other AHTs, in addition to hypertension management. Methods In a retrospective cohort design, we examined the medical and pharmacy claims of a 20% sample of Medicare beneficiaries from 2007 to 2013, and compared rates of AD diagnosis for 1,343,334 users of six different AHT drug treatments, 65 years of age or older (4,215,338 person-years). We compared AD risk between RAS and non-RAS AHT drug users, and between ACEI users and ARB users, by sex and race/ethnicity. Models adjusted for age, socioeconomic status, underlying health, and comorbidities. Findings RAS-acting AHTs were slightly more protective against onset of AD than non-RAS-acting AHTs for males, (male OR = 0.931 (CI: 0.895-0.969)), but not so for females (female OR = 0.985 (CI: 0.963-1.007)). Relative to other AHTs, ARBs were superior to ACEIs for both men (male ARB OR = 0.834 (CI: 0.788-0.884); male ACEI OR = 0.978 (CI: 0.939-1.019)) and women (female ARB OR = 0.941 (CI: 0.913-0.969); female ACEI OR = 1.022 (CI: 0.997-1.048)), but only in white men and white and black women. No association was shown for Hispanic men and women. Conclusion Hypertension management treatments that include RAS-acting ARBs may, in addition to lowering blood pressure, reduce AD risk, particularly for white and black women and white men. Additional studies and clinical trials that include men and women from different racial and ethnic groups are needed to confirm these findings. Understanding the potentially beneficial effects of certain RAS-acting AHTs in high-risk populations is of great importance.	[Berthold, Douglas] Univ Washington, Dept Pharm, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA; [Joyce, Geoffrey] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Sch Pharm, Los Angeles, CA USA; [Wharton, Whitney] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Kehoe, Patrick] Univ Bristol, Translat Hlth Sci, Bristol Med Sch, Bristol, Avon, England; [Zissimopoulos, Julie] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Price Sch Publ Policy, Los Angeles, CA USA	University of Washington; University of Washington Seattle; University of Southern California; Emory University; University of Bristol; University of Southern California	Berthold, D (corresponding author), Univ Washington, Dept Pharm, Comparat Hlth Outcomes Policy & Econ CHOICE Inst, Seattle, WA 98195 USA.	barthold@uw.edu	Kehoe, Patrick/P-8760-2018	Kehoe, Patrick/0000-0002-7542-1139	National Institutes of Health (NIH) [R01AG055401, RC4AG039036-01, P30AG043073-01, K01AG042498, R01HL126804, R01HL130462]; University of Southern California Zumberge Research Fund [1R34AG049652]; Schaeffer-Amgen Fellowship Program - Amgen; Sigmund Gestetner Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130462, R01HL126804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG043073, K01AG042498, R01AG055401] Funding Source: NIH RePORTER; MRC [MC_PC_13088] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Southern California Zumberge Research Fund; Schaeffer-Amgen Fellowship Program - Amgen(Amgen); Sigmund Gestetner Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by the National Institutes of Health (NIH), awards R01AG055401, RC4AG039036-01, P30AG043073-01, K01AG042498, R01HL126804, and R01HL130462, and the University of Southern California Zumberge Research Fund, 1R34AG049652. Douglas Barthold was supported through the Schaeffer-Amgen Fellowship Program funded by Amgen. Patrick Kehoe was supported by a Fellowship from the Sigmund Gestetner Foundation. Sponsors' role: The sponsors had no role in the design, methods, analysis, interpretation, or preparation of the paper.	Alzheimer's A., 2017, ALZHEIMERS DEMENT, V13, P325, DOI DOI 10.1016/J.JALZ.2017.02.001; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; Bonito AJ, 2008, CREATION NEW RACE ET; Chen E. S., 2017, CURRENT ALZHEIMER RE; Cifu AS, 2017, JAMA-J AM MED ASSOC, V318, P2132, DOI 10.1001/jama.2017.18706; Colby S. L., 2015, CENSUS, VP25- 1143, P1, DOI DOI 10.1073/PNAS.1602413113; Davies NM, 2011, J ALZHEIMERS DIS, V26, P699, DOI 10.3233/JAD-2011-110347; de Oliveira FF, 2016, DEMENT GERIATR COGN, V41, P314, DOI 10.1159/000447585; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Guzman NJ, 2012, AM J CARDIOVASC DRUG, V12, P165, DOI 10.2165/11631520-000000000-00000; Hajar I, 2013, J AM GERIATR SOC, V61, P194, DOI 10.1111/jgs.12100; Hajjar I, 2012, ARCH NEUROL-CHICAGO, V69, P1632, DOI 10.1001/archneurol.2012.1010; Hanon O, 2008, J HYPERTENS, V26, P1642, DOI 10.1097/HJH.0b013e328301a280; Hemming ML, 2005, J BIOL CHEM, V280, P37644, DOI 10.1074/jbc.M508460200; Hou DR, 2008, CHINESE MED J-PEKING, V121, P2320, DOI 10.1097/00029330-200811020-00019; Hu JG, 2001, J BIOL CHEM, V276, P47863, DOI 10.1074/jbc.M104068200; Jiang T, 2016, MOL NEUROBIOL, V53, P2489, DOI 10.1007/s12035-015-9260-9; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Kehoe PG, 2018, J ALZHEIMERS DIS, V61, P803, DOI 10.3233/JAD-170101; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Kehoe PG, 2018, J ALZHEIMERS DIS, V62, P1443, DOI 10.3233/JAD-171119; Kehoe PG, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0217-7; Kumaran D, 2008, NEUROSCIENCE, V155, P626, DOI 10.1016/j.neuroscience.2008.06.023; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Li NC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5465; Li PX, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-245; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Mangravite LM, 2006, PHARMACOGENOMICS J, V6, P360, DOI 10.1038/sj.tpj.6500384; Marpillat NL, 2013, J HYPERTENS, V31, P1073, DOI 10.1097/HJH.0b013e3283603f53; Mather M, 2015, POPULATION B, V70; McGuinness B, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004034.pub2; Merai R, 2016, MMWR-MORBID MORTAL W, V65, P1261, DOI 10.15585/mmwr.mm6545a3; National Center for Health Statistics, 2017, HLTH US 2016 CHARTB; O'Hagan Thomas Simon, 2012, Am J Neurodegener Dis, V1, P266; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Poon IO, 2008, PHARMACOTHERAPY, V28, P366, DOI 10.1592/phco.28.3.366; Raghavendra V, 1998, NEUROPEPTIDES, V32, P417, DOI 10.1016/S0143-4179(98)90065-8; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; Rifkin DE, 2014, AM J HYPERTENS, V27, P801, DOI 10.1093/ajh/hpt276; Rouch L, 2015, CNS DRUGS, V29, P113, DOI 10.1007/s40263-015-0230-6; Tang MX, 2001, NEUROLOGY, V56, P49, DOI 10.1212/WNL.56.1.49; Tedesco MA, 1999, AM J HYPERTENS, V12, P1130, DOI 10.1016/S0895-7061(99)00156-9; Torika N, 2018, CNS NEUROSCI THER, V24, P231, DOI 10.1111/cns.12802; U. S. Department of Commerce, 2017, PROJECTED AGE GROUPS; van Charante EPM, 2016, LANCET, V388, P797, DOI 10.1016/S0140-6736(16)30950-3; Wharton W., 2017, ALZH ASS INT C LOND; Wharton W., 2016, AM NEUR ASS C BALT M; Wharton W, 2018, J ALZHEIMERS DIS, V61, P815, DOI 10.3233/JAD-161198; Wharton W, 2015, J AM GERIATR SOC, V63, P1749, DOI 10.1111/jgs.13627; Wharton W, 2012, J ALZHEIMERS DIS, V32, P147, DOI 10.3233/JAD-2012-120763; Whelton PK, 2017, J AM COLL CARDIOL, DOI [10.1016/j.jacc.2017.11.006, DOI 10.1016/J.JACC.2017.11.006]; Wrenger E, 2003, BRIT MED J, V327, P147, DOI 10.1136/bmj.327.7407.147; Zissimopoulos J. M., 2016, JAMA NEUROLOGY; Zissimopoulos Julie, 2014, Forum Health Econ Policy, V18, P25; Zou K, 2007, J NEUROSCI, V27, P8628, DOI 10.1523/JNEUROSCI.1549-07.2007	59	39	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206705	10.1371/journal.pone.0206705	http://dx.doi.org/10.1371/journal.pone.0206705			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383807	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600088
J	Joseph, D; Gonsky, JP; Blain, SW				Joseph, Danielle; Gonsky, Jason P.; Blain, Stacy W.			Macrophage Inhibitory Factor-1 (MIF-1) controls the plasticity of multiple myeloma tumor cells	PLOS ONE			English	Article							DRUG-RESISTANCE; STEM-CELLS; EXPRESSION; PATHOGENESIS; SURVIVAL; GROWTH; CD74	Multiple Myeloma (MM) is the second most common hematological malignancy with a median survival of 5-10 years. While current treatments initially cause remission, relapse almost always occurs, leading to the hypothesis that a chemotherapy-resistant cancer stem cell (CSC) remains dormant, and undergoes self-renewal and differentiation to reestablish disease. Our finding is that the mature cancer cell (CD138+, rapidly proliferating and chemosensitive) has developmental plasticity; namely, the ability to dedifferentiate back into its own chemoresistant CSC progenitor, the CD138-, quiescent pre-plasma cell. We observe multiple cycles of differentiation and dedifferentiation in the absence of niche or supportive accessory cells, suggesting that soluble cytokines secreted by the MM cells themselves are responsible for this bidirectional interconversion and that stemness and chemoresistance are dynamic characteristics that can be acquired or lost and thus may be targetable. By examining cytokine secretion of CD138- and CD138+ RPMI-8226 cells, we identified that concomitant with interconversion, Macrophage Migration Inhibitory Factor (MIF-1) is secreted. The addition of a small molecule MIF-1 inhibitor (4-IPP) or MIF-1 neutralizing antibodies to CD138+ cells accelerated dedifferentiation back into the CD138- progenitor, while addition of recombinant MIF-1 drove cells towards CD138+ differentiation. A similar increase in the CD138- population is seen when MM tumor cells isolated from primary bone marrow aspirates are cultured in the presence of 4-IPP. As the CD138+ MM cell is chemosensitive, targeting MIF-1 and/or the pathways that it regulates could be a viable way to modulate stemness and chemosensitivity, which could in turn transform the treatment of MM.	[Joseph, Danielle] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11203 USA; [Gonsky, Jason P.] Kings Cty Hosp Ctr, Dept Med, Div Hematol & Oncol, Brooklyn, NY USA; [Gonsky, Jason P.] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Blain, Stacy W.] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Blain, SW (corresponding author), Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA.; Blain, SW (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.	stacy.blain@downstate.edu			CCLM Research Fund, Dean's Council Fund	CCLM Research Fund, Dean's Council Fund	This work was supported by CCLM Research Fund, Dean's Council Fund.	Bataille R, 2006, HAEMATOLOGICA, V91, P1234; Bergsagel PL, 2005, J CLIN ONCOL, V23, P6333, DOI 10.1200/JCO.2005.05.021; Bianchi G, 2015, BLOOD, V125, P3049, DOI 10.1182/blood-2014-11-568881; Buckner CM, 2014, J ALLERGY CLIN IMMUN, V133, P1676, DOI 10.1016/j.jaci.2013.10.050; Burness ML, 2010, SEMIN CANCER BIOL, V20, P107, DOI 10.1016/j.semcancer.2010.05.006; Burton JD, 2004, CLIN CANCER RES, V10, P6606, DOI 10.1158/1078-0432.CCR-04-0182; Chaidos A, 2013, BLOOD, V121, P318, DOI 10.1182/blood-2012-06-436220; Cheng QA, 2010, J IMMUNOL, V185, P1238, DOI 10.4049/jimmunol.0904104; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Franqui-Machin R, 2015, ONCOTARGET, V6, P40496, DOI 10.18632/oncotarget.5800; Fuhler GM, 2010, EXP CELL RES, V316, P1816, DOI 10.1016/j.yexcr.2010.03.013; Hajek R, 2013, BRIT J HAEMATOL, V163, P551, DOI 10.1111/bjh.12563; Hideshima T, 2001, CANCER RES, V61, P3071; Huff CA, 2008, J CLIN ONCOL, V26, P2895, DOI 10.1200/JCO.2007.15.8428; Kawano Y, 2012, INT J ONCOL, V41, P876, DOI 10.3892/ijo.2012.1545; Mahindra A, 2010, BLOOD REV, V24, pS5, DOI 10.1016/S0268-960X(10)70003-5; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Matsui W, 2008, CANCER RES, V68, P190, DOI 10.1158/0008-5472.CAN-07-3096; O'Reilly C, 2016, MED RES REV, V36, P440, DOI 10.1002/med.21385; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Otvos B, 2016, STEM CELLS, V34, P2026, DOI 10.1002/stem.2393; Rajkumar SV, 2014, AM J HEMATOL, V89, P999, DOI 10.1002/ajh.23810; Reghunathan R, 2013, ONCOTARGET, V4, P1230, DOI 10.18632/oncotarget.1145; Robak P, 2018, CANCER TREAT REV, V70, P199, DOI 10.1016/j.ctrv.2018.09.001; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sanchez-Nino MD, 2013, CYTOKINE GROWTH F R, V24, P23, DOI 10.1016/j.cytogfr.2012.08.001; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Subbannayya T, 2016, J CELL COMMUN SIGNAL, V10, P165, DOI 10.1007/s12079-016-0326-x; Tan BT, 2006, LAB INVEST, V86, P1203, DOI 10.1038/labinvest.3700488; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Xia WZ, 2015, MOL CELL BIOCHEM, V404, P11, DOI 10.1007/s11010-015-2361-y; Yaccoby S, 2005, CLIN CANCER RES, V11, P7599, DOI 10.1158/1078-0432.CCR-05-0523; Zhan FH, 2002, BLOOD, V99, P1745, DOI 10.1182/blood.V99.5.1745; Zheng YH, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw131	36	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206368	10.1371/journal.pone.0206368	http://dx.doi.org/10.1371/journal.pone.0206368			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383785	gold, Green Published, Green Submitted			2022-12-26	WOS:000449027600043
J	Rossi, MEG; Shi, BW; Tziortziotis, N; Malliaros, FD; Giatsidis, C; Vazirgiannis, M				Rossi, Maria-Evgenia G.; Shi, Bowen; Tziortziotis, Nikolaos; Malliaros, Fragkiskos D.; Giatsidis, Christos; Vazirgiannis, Michalis			MATI: An efficient algorithm for influence maximization in social networks	PLOS ONE			English	Article							IDENTIFICATION	Influence maximization has attracted a lot of attention due to its numerous applications, including diffusion of social movements, the spread of news, viral marketing and outbreak of diseases. The objective is to discover a group of users that are able to maximize the spread of influence across a network. The greedy algorithm gives a solution to the Influence Maximization problem while having a good approximation ratio. Nevertheless it does not scale well for large scale datasets. In this paper, we propose Matrix Influence, MATI, an efficient algorithm that can be used under both the Linear Threshold and Independent Cascade diffusion models. MATI is based on the precalculation of the influence by taking advantage of the simple paths in the node's neighborhood. An extensive empirical analysis has been performed on multiple real-world datasets showing that MATI has competitive performance when compared to other well-known algorithms with regards to running time and expected influence spread.	[Rossi, Maria-Evgenia G.; Shi, Bowen; Tziortziotis, Nikolaos; Giatsidis, Christos; Vazirgiannis, Michalis] Ecole Polytech, Palaiseau, France; [Malliaros, Fragkiskos D.] Univ Paris Saclay, Ctr Supelec, Gif Sur Yvette, France; [Malliaros, Fragkiskos D.] Inria Saclay, Gif Sur Yvette, France	Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay	Rossi, MEG (corresponding author), Ecole Polytech, Palaiseau, France.	maria.rossi@polytechnique.edu			DigiCosme Ph.D. Fellowship; Ecole Polytechnique AXA Chair (DaSciS)	DigiCosme Ph.D. Fellowship; Ecole Polytechnique AXA Chair (DaSciS)	This work was partially supported by a DigiCosme Ph.D. Fellowship and the Ecole Polytechnique AXA Chair (DaSciS).	[Anonymous], 2017, S JOHN SOCIAL NETWOR; Balog K., 2006, P 29 ANN INT ACM SIG; Bishop C. M, 2006, PATTERN RECOGNITION; Boldi P, 2014, INTERNET MATH, V10, P222, DOI 10.1080/15427951.2013.865686; Borgs C., P 25 ANN ACM SIAM S P 25 ANN ACM SIAM S, P946; Chen W., P 15 ACM SIGKDD INT, P199; Cohen E, 1997, J COMPUT SYST SCI, V55, P441, DOI 10.1006/jcss.1997.1534; Cohen E, P 23 ACM INT C C INF, P629; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Ding Y, 2009, J AM SOC INF SCI TEC, V60, P2229, DOI 10.1002/asi.21171; DOMINGOS P., 2001, P 7 ACM SIGKDD INT C; Goyal A., DAT MIN ICDM 2011 IE, P211; Goyal A, P 3 ACM INT C WEB SE, P241; Goyal A, 2011, P WWW; Goyal A, 2011, PROC VLDB ENDOW, V5, P73, DOI 10.14778/2047485.2047492; Hoppenstaedt F., 1975, MATH THEORIES POPULA; Hsu WH, 2006, AAAI SPRING S COMP A, V6; Jiang CR, 2010, INT ASIA CONF INFORM, P88, DOI 10.1109/CAR.2010.5456772; Jiang Q, AAAI, V11, P127; Jung K, 2012, IEEE DATA MINING, P918, DOI 10.1109/ICDM.2012.79; Kempe D, 2003, P 9 ACM SIGKDD INT C; KERMACK WO, 1991, B MATH BIOL, V53, P57, DOI 10.1016/S0092-8240(05)80041-2; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Leskovec J., SNAP DATASETS STANFO; Leskovec J., 2007, P 13 ACM SIGKDD INT; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2016, PHYS REP, V650, P1, DOI 10.1016/j.physrep.2016.06.007; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Malliaros FD, 2016, SCI REP-UK, V6, DOI 10.1038/srep19307; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Ohsaka N, AAAI, P138; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Rossi G Maria-Evgenia, P 24 INT C WORLD WID, P101; Tang Y, P 2014 ACM SIGMOD IN, P75; Tang Y., 2015, P 2015 ACM SIGMOD IN; Taskar B., 2004, ADV NEURAL INFORM PR; Trusov M, 2009, J MARKETING, V73, P90, DOI 10.1509/jmkg.73.5.90; van der Plank J.E., 2013, PLANT DIS EPIDEMICS; Wang Y., 2010, P 16 ACM SIGKDD INT; Williams D., 1991, PROBABILITY MARTINGA; Zeng D, 2010, IEEE INTELL SYST, V25, P13, DOI 10.1109/MIS.2010.151; Zhou YB, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/3/033033	45	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206318	10.1371/journal.pone.0206318	http://dx.doi.org/10.1371/journal.pone.0206318			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383770	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600037
J	Schimmelmann, A; Fernandez-Cortes, A; Cuezva, S; Streil, T; Lennon, JT				Schimmelmann, Arndt; Fernandez-Cortes, Angel; Cuezva, Soledad; Streil, Thomas; Lennon, Jay T.			Radiolysis via radioactivity is not responsible for rapid methane oxidation in subterranean air	PLOS ONE			English	Article							RADON EMANATION; SOIL-GAS; ION; IMPACT; DEEP	Atmospheric methane is rapidly lost when it enters humid subterranean critical and vadose zones (e.g., air in soils and caves). Because methane is a source of carbon and energy, it can be consumed by methanotrophic methane-oxidizing bacteria. As an additional subterranean sink, it has been hypothesized that methane is oxidized by natural radioactivity-induced radiolysis that produces energetic ions and radicals, which then trigger abiotic oxidation and consumption of methane within a few hours. Using controlled laboratory experiments, we tested whether radiolysis could rapidly oxidize methane in sealed air with different relative humidities while being exposed to elevated levels of radiation (more than 535 kBq m(-3)) from radon isotopes Rn-222 and Rn-220 (i.e., thoron). We found no evidence that radiolysis contributed to methane oxidation. In contrast, we observed the rapid loss of methane when moist soil was added to the same apparatus in the absence of elevated radon abundance. Together, our findings are consistent with the view that methane oxidizing bacteria are responsible for the widespread observations of methane depletion in subterranean environments. Further studies are needed on the ability of microbes to consume trace amounts of methane in poorly ventilated caves, even though the trophic and energetic benefits become marginal at very low partial pressures of methane.	[Schimmelmann, Arndt] Indiana Univ, Dept Earth & Atmospher Sci, Bloomington, IN 47405 USA; [Fernandez-Cortes, Angel; Cuezva, Soledad] Univ Almeria, Dept Biol & Geol, Almeria, Spain; [Fernandez-Cortes, Angel] Royal Holloway Univ London, Dept Earth Sci, Egham, Surrey, England; [Streil, Thomas] SARAD GmbH, Dresden, Germany; [Lennon, Jay T.] Indiana Univ, Dept Biol, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Universidad de Almeria; University of London; Royal Holloway University London; Indiana University System; Indiana University Bloomington	Schimmelmann, A (corresponding author), Indiana Univ, Dept Earth & Atmospher Sci, Bloomington, IN 47405 USA.	aschimme@indiana.edu	Fernandez-Cortes, Angel/AGK-5192-2022; Lennon, Jay T./ABE-6120-2020; Cuezva, Soledad/M-4131-2015; Fernandez-Cortes, Angel/I-5489-2012	Fernandez-Cortes, Angel/0000-0002-8482-3308; Lennon, Jay T./0000-0003-3126-6111; Cuezva, Soledad/0000-0002-2439-4767; Fernandez-Cortes, Angel/0000-0002-8482-3308; Schimmelmann, Arndt/0000-0003-4648-5253	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division [DE-SC0006978]; Spanish Ministry of Economy and Competitiveness [CGL2016-78318-C2-1R, CGL2016-78318-C2-2R]; U.S. National Science Foundation [1442246]; U.S. Army Research Office [W911NF-14-1-0411]; Indiana University Office of the Vice President of International Affairs; project SMACKS (IEF-Marie Curie Actions) [624204]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Spanish Ministry of Economy and Competitiveness(Spanish Government); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Army Research Office; Indiana University Office of the Vice President of International Affairs; project SMACKS (IEF-Marie Curie Actions)	This study is based upon work at Indiana University supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division under Award Number DE-SC0006978 awarded to Arndt Schimmelmann. Work at the Royal Holloway University of London (RHUL) was supported by the Spanish Ministry of Economy and Competitiveness projects CGL2016-78318-C2-1R and CGL2016-78318-C2-2R AEI/FEDER/UE awarded to Angel Fernandez-Cortes. Jay T. Lennon was supported by the U.S. National Science Foundation (1442246) and the U.S. Army Research Office (W911NF-14-1-0411). Jay T. Lennon further acknowledges support from the Indiana University Office of the Vice President of International Affairs. Angel Fernandez-Cortes' work was further supported by project SMACKS (IEF-Marie Curie Actions no 624204, FP7/2007-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cigna A., 2005, INT J SPELEOL, V34, P1, DOI [10.5038/1827-806x.34.1.1, DOI 10.5038/1827-806X.34.1.1]; Colman DR, 2017, P NATL ACAD SCI USA, V114, P6895, DOI 10.1073/pnas.1701266114; Colwell FS, 2013, REV MINERAL GEOCHEM, V75, P547, DOI 10.2138/rmg.2013.75.17; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; Cosma C, 2008, INT J MOL SCI, V9, P1024, DOI 10.3390/ijms9061024; Du'o'ng NT, 2017, CHEM GEOL, V466, P229, DOI 10.1016/j.chemgeo.2017.06.014; Edwards CR, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.00047-17, 10.1128/genomea.00047-17]; Farhan Ul Haque M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0500-x; Fernandez-Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8003; Greenwood PF, 2018, ORG GEOCHEM, V123, P103, DOI 10.1016/j.orggeochem.2018.06.013; HAYNES RM, 1966, J CHEM PHYS, V45, P3899, DOI 10.1063/1.1727435; HURSH JB, 1966, J INORG NUCL CHEM, V28, P2771, DOI 10.1016/0022-1902(66)80001-5; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Kolarz PM, 2009, APPL RADIAT ISOTOPES, V67, P2062, DOI 10.1016/j.apradiso.2009.07.023; Lefticariu L, 2010, EARTH PLANET SC LETT, V292, P57, DOI 10.1016/j.epsl.2010.01.020; Lennon JT, 2017, GEOBIOLOGY, V15, P254, DOI 10.1111/gbi.12214; LINDMARK A, 1985, SCI TOTAL ENVIRON, V45, P397, DOI 10.1016/0048-9697(85)90243-8; MANCINELLI RL, 1995, ANNU REV MICROBIOL, V49, P581, DOI 10.1146/annurev.mi.49.100195.003053; Mattey DP, 2013, EARTH PLANET SC LETT, V374, P71, DOI 10.1016/j.epsl.2013.05.011; McDonough LK, 2016, ENVIRON EARTH SCI, V75, DOI 10.1007/s12665-016-5497-5; Meisenberg O, 2017, SCI TOTAL ENVIRON, V579, P1855, DOI 10.1016/j.scitotenv.2016.11.170; MORAWSKA L, 1993, GEOCHIM COSMOCHIM AC, V57, P1783, DOI 10.1016/0016-7037(93)90113-B; Oremland RS, 1988, ADVANCES IN MICROBIA, V10, P335, DOI [10.1007/978-1-4684-5409-3_8, DOI 10.1007/978-1-4684-5409-3_8]; Papastefanou C, 2007, ANN GEOPHYS-ITALY, V50, P569; Prather MJ, 2017, P NATL ACAD SCI USA, V114, P5324, DOI 10.1073/pnas.1704884114; Rasul G, 1997, P NATL ACAD SCI USA, V94, P11159, DOI 10.1073/pnas.94.21.11159; Seyis C, 2010, ACTA GEOPHYS, V58, P939, DOI 10.2478/s11600-010-0012-y; Tammet H, 2006, ATMOS CHEM PHYS, V6, P3377, DOI 10.5194/acp-6-3377-2006; Wang J, 2011, SCI TOTAL ENVIRON, V409, P3613, DOI 10.1016/j.scitotenv.2011.06.030; Waring CL, 2009, GEOCHIM COSMOCHIM AC, V73, pA1419; Waring CL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07769-6; Webster KD, 2018, EARTH PLANET SC LETT, V485, P9, DOI 10.1016/j.epsl.2017.12.025; Webster KD, 2016, CHEM GEOL, V443, P1, DOI 10.1016/j.chemgeo.2016.09.020; Wismut GmbH and MECSEK-KO, 2011, ANN REP 2010 COOP WI, P24; Xu XF, 2016, BIOGEOSCIENCES, V13, P3735, DOI 10.5194/bg-13-3735-2016; Yan ZF, 2017, WATER RESOUR RES, V53, P8698, DOI 10.1002/2017WR020570	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206506	10.1371/journal.pone.0206506	http://dx.doi.org/10.1371/journal.pone.0206506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383783	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600056
J	Yadav, P; Goyal, VD; Gaur, NK; Kumar, A; Gokhale, SM; Jamdar, SN; Makde, RD				Yadav, Pooja; Goyal, Venuka Durani; Gaur, Neeraj Kailash; Kumar, Ashwani; Gokhale, Sadashiv M.; Jamdar, Sahayog N.; Makde, Ravindra D.			Carboxypeptidase in prolyl oligopeptidase family: Unique enzyme activation and substrate-screening mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oligomerization; substrate specificity; carboxypeptidase; enzyme catalysis; peptidase; active site regulation; catalytic triad; POP family; serine carboxypeptidase; substrate screening; S9 peptidase; oligopeptidase; structure-function; S9C subfamily	PRELIMINARY-X-RAY; CRYSTAL-STRUCTURE; ACTIVE-SITE; ACYLPEPTIDE HYDROLASE; INDUCED-FIT; CRYSTALLIZATION; PEPTIDASE; SYSTEM; CRYSTALLOGRAPHY; EXPRESSION	Serine peptidases of the prolyl oligopeptidase (POP) family are of substantial therapeutic importance because of their involvement in diseases such as diabetes, cancer, neurological diseases, and autoimmune disorders. Proper annotation and knowledge of substrate specificity mechanisms in this family are highly valuable. Although endopeptidase, dipeptidyl peptidase, tripeptidyl peptidase, and acylaminoacyl peptidase activities have been reported previously, here we report the first instance of carboxypeptidase activity in a POP family member. We determined the crystal structures of this carboxypeptidase, an S9C subfamily member from Deinococcus radiodurans, in its active and inactive states at 2.3- resolution, providing an unprecedented view of assembly and disassembly of the active site mediated by an arginine residue. We observed that this residue is poised to bind substrate in the active structure and disrupts the catalytic triad in the inactive structure. The assembly of the active site is accompanied by the ordering of gating loops, which reduces the effective size of the oligomeric pore. This prevents the entry of larger peptides and constitutes a novel mechanism for substrate screening. Furthermore, we observed structural adaptations that enable its carboxypeptidase activity, with a unique loop and two arginine residues in the active site cavity orienting the peptide substrate for catalysis. Using these structural features, we identified homologs of this enzyme in the POP family and confirmed the presence of carboxypeptidase activity in one of them. In conclusion, we have identified a new type within POP enzymes that exhibits not only unique activity but also a novel substrate-screening mechanism.	[Yadav, Pooja; Goyal, Venuka Durani; Gaur, Neeraj Kailash; Kumar, Ashwani; Makde, Ravindra D.] Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India; [Jamdar, Sahayog N.] Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India; [Yadav, Pooja; Gokhale, Sadashiv M.] Devi Ahilya Univ, Sch Biochem, Indore 452001, Madhya Pradesh, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); Devi Ahilya University	Makde, RD (corresponding author), Bhabha Atom Res Ctr, High Pressure & Synchrotron Radiat Phys Div, Bombay 400085, Maharashtra, India.; Jamdar, SN (corresponding author), Bhabha Atom Res Ctr, Food Technol Div, Bombay 400085, Maharashtra, India.	snjam@barc.gov.in; ravimakde@rrcat.gov.in	Goyal, Venuka/AAR-7525-2020	Goyal, Venuka/0000-0001-7838-572X; kumar, ashwani/0000-0002-7526-1569; Gaur, Neeraj/0000-0002-5926-9966; Makde, Ravindra D./0000-0001-7020-0065	University Grants Commission National Fellowship for Other Backward Classes (UGC-NF-OBC) scholarship; Department of Science and Technology Innovation in Science Pursuit for Inspired Research (DST INSPIRE) faculty award	University Grants Commission National Fellowship for Other Backward Classes (UGC-NF-OBC) scholarship; Department of Science and Technology Innovation in Science Pursuit for Inspired Research (DST INSPIRE) faculty award	Supported by a University Grants Commission National Fellowship for Other Backward Classes (UGC-NF-OBC) scholarship.; Supported by a Department of Science and Technology Innovation in Science Pursuit for Inspired Research (DST INSPIRE) faculty award.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Are VN, 2014, ACTA CRYSTALLOGR F, V70, P1292, DOI 10.1107/S2053230X14017944; Banbula A, 1999, J BIOL CHEM, V274, P9246, DOI 10.1074/jbc.274.14.9246; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Canning P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079349; CHAYEN NE, 1992, J CRYST GROWTH, V122, P176, DOI 10.1016/0022-0248(92)90241-A; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; D'Arcy A, 2007, ACTA CRYSTALLOGR D, V63, P550, DOI 10.1107/S0907444907007652; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; DOI E, 1981, ANAL BIOCHEM, V118, P173, DOI 10.1016/0003-2697(81)90175-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FEESE M, 1993, J MOL BIOL, V233, P546, DOI 10.1006/jmbi.1993.1531; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Hughes TE, 1999, BIOCHEMISTRY-US, V38, P11597, DOI 10.1021/bi990852f; JONES WM, 1986, BIOCHEM BIOPH RES CO, V139, P244, DOI 10.1016/S0006-291X(86)80105-X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; KENNY AJ, 1976, BIOCHEM J, V157, P169, DOI 10.1042/bj1570169; KOBAYASHI K, 1987, J BIOL CHEM, V262, P11435; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar A, 2016, J SYNCHROTRON RADIAT, V23, P629, DOI 10.1107/S160057751600076X; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Menyhard DK, 2013, J BIOL CHEM, V288, P17884, DOI 10.1074/jbc.M113.451534; Morty RE, 2000, BIOCHEM PHARMACOL, V60, P1497, DOI 10.1016/S0006-2952(00)00459-7; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Polgar L, 2002, CELL MOL LIFE SCI, V59, P349, DOI 10.1007/s00018-002-8427-5; Polgar L, 1997, PROTEINS, V28, P375; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Santhoshkumar P, 2014, J BIOL CHEM, V289, P9039, DOI 10.1074/jbc.M113.510677; SCALONI A, 1992, J LAB CLIN MED, V120, P546; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Szeltner Z, 2003, J BIOL CHEM, V278, P48786, DOI 10.1074/jbc.M309555200; Szeltner Z, 2008, CURR PROTEIN PEPT SC, V9, P96; Szeltner Z, 2013, BBA-PROTEINS PROTEOM, V1834, P98, DOI 10.1016/j.bbapap.2012.08.012; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; WILK S, 1983, LIFE SCI, V33, P2149, DOI 10.1016/0024-3205(83)90285-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wright H, 2005, ACTA CRYSTALLOGR F, V61, P942, DOI 10.1107/S1744309105029222; Yamin R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-33; Zeng Zhihong, 2017, DNA Repair (Amst), V58, P52, DOI 10.1016/j.dnarep.2017.08.008	50	12	12	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2019	294	1					89	100		10.1074/jbc.RA118.004254	http://dx.doi.org/10.1074/jbc.RA118.004254			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG6PT	30409909	Green Published, hybrid			2022-12-26	WOS:000455105500015
J	Jing, YP; An, HL; Zhang, SJ; Wang, NB; Zhou, ST				Jing, Yu-Pu; An, Hongli; Zhang, Shanjing; Wang, Ningbo; Zhou, Shutang			Protein kinase C mediates juvenile hormone-dependent phosphorylation of Na+/K+-ATPase to induce ovarian follicular patency for yolk protein uptake	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						juvenile hormone (JH); Na; K plus -ATPase; reproduction; insect; ovary; Vitellogenesis; vitellogenin	K+-ATPASE; ALPHA-1 SUBUNIT; TRANSCRIPTIONAL ACTIVATION; NA+,K+-ATPASE ACTIVITY; RHODNIUS-PROLIXUS; CELLS; INHIBITION; IDENTIFICATION; PATHWAY; VITELLOGENESIS	In oviparous animals, vitellogenesis is prerequisite to egg production and embryonic growth after oviposition. For successful insect vitellogenesis and oogenesis, vitellogenin (Vg) synthesized in the fat body (homologue to vertebrate liver and adipose tissue) must pass through the intercellular channels, a condition known as patency in the follicular epithelium, to reach the surface of oocytes. This process is controlled by juvenile hormone (JH) in many insect species, but the underlying mechanisms remain elusive. Previous work has suggested the possible involvement of Na+/K+-ATPase in patency initiation, but again, the regulatory cascade of Na+/K+-ATPase for patency initiation has been lacking. Using the migratory locust Locusta migratoria as a model system, we report here that RNAi-mediated knockdown of gene coding for Na+/K+-ATPase, inhibition of its phosphorylation, or suppression of its activity causes loss of patency, resulting in blocked Vg uptake, arrested oocyte maturation, and impaired ovarian growth. JH triggers G protein-coupled receptor (GPCR), receptor tyrosine kinase (RTK), phospholipase C (PLC), inositol trisphosphate receptor (IP3R), and protein kinase C (PKC) to phosphorylate Na+/K+-ATPase -subunit at amino acid residue Ser(8), consequently activating Na+/K+-ATPase for the induction of patency in vitellogenic follicular epithelium. Our results thus point to a previously unidentified mechanism by which JH induces the phosphorylation and activation of Na+/K+-ATPase via a signaling cascade of GPCR, RTK, PLC, IP3R, and PKC. The findings advance our understanding of JH regulation in insect vitellogenesis and oogenesis.	[Jing, Yu-Pu; An, Hongli; Zhang, Shanjing; Wang, Ningbo; Zhou, Shutang] Henan Univ, Sch Life Sci, State Key Lab Cotton Biol, Key Lab Plant Stress Biol, Kaifeng 475004, Peoples R China	Henan University	Zhou, ST (corresponding author), Henan Univ, Sch Life Sci, State Key Lab Cotton Biol, Key Lab Plant Stress Biol, Kaifeng 475004, Peoples R China.	szhou@henu.edu.cn	Jing, Yu-Pu/AAE-3531-2022		National Natural Science Foundation of China [31601896, 31630070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China Grants 31601896 and 31630070. The authors declare that they have no conflicts of interest with the contents of this article.	ABUHAKIMA R, 1979, INSECT BIOCHEM, V9, P195, DOI 10.1016/0020-1790(79)90050-7; Agrahari S, 2008, PESTIC BIOCHEM PHYS, V92, P57, DOI 10.1016/j.pestbp.2008.06.003; Alevizopoulos K, 2014, CURR DRUG TARGETS, V15, P988, DOI 10.2174/1389450115666140908125025; BEGUIN P, 1994, J BIOL CHEM, V269, P24437; Belles X, 2005, REPRO BIOL, V12, P157; Cai MJ, 2014, J BIOL CHEM, V289, P26630, DOI 10.1074/jbc.M114.581876; Chakraborti S., 2016, NA K ATPASE PERSPECT, P3; [常静 Chang Jing], 2017, [农药, Agrochemicals], V56, P692; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; DAVEY KG, 1993, INVERTEBR REPROD DEV, V24, P39, DOI 10.1080/07924259.1993.9672329; Davies TGE, 2007, INSECT MOL BIOL, V16, P361, DOI 10.1111/j.1365-2583.2007.00733.x; FAMBROUGH DM, 1994, AM J PHYSIOL, V266, pC579, DOI 10.1152/ajpcell.1994.266.3.C579; Feraille E, 2000, MOL BIOL CELL, V11, P39, DOI 10.1091/mbc.11.1.39; FISONE G, 1994, J BIOL CHEM, V269, P9368; Geletiova J., 2016, FASEB J, V30; GLINKA AV, 1995, BIOCHEM MOL BIOL INT, V35, P323; Guo W, 2019, FASEB J, V33, P917, DOI 10.1096/fj.201801068R; Guo W, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004702; Hall J. E., 2006, TXB MED PHYSL, P365; HURD H, 1997, J Insect Physiol, V43, P337; ILENCHUK TT, 1987, INSECT BIOCHEM, V17, P1085, DOI 10.1016/0020-1790(87)90125-9; Jindra M, 2015, CURR OPIN INSECT SCI, V11, P39, DOI 10.1016/j.cois.2015.08.004; Jindra M, 2013, ANNU REV ENTOMOL, V58, P181, DOI 10.1146/annurev-ento-120811-153700; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KOCH RB, 1969, LIFE SCI PT 1 PHYSI, V8, P289, DOI 10.1016/0024-3205(69)90133-7; KUNKEL JG, 1995, BIOL BULL, V189, P197, DOI 10.1086/BBLv189n2p197; Li K, 2019, INSECT SCI, V26, P600, DOI 10.1111/1744-7917.12614; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu PC, 2015, P NATL ACAD SCI USA, V112, pE1871, DOI 10.1073/pnas.1423204112; Liu TB, 2016, AM J PHYSIOL-ENDOC M, V310, pE565, DOI 10.1152/ajpendo.00360.2015; Liu W, 2013, BBA-GEN SUBJECTS, V1830, P5184, DOI 10.1016/j.bbagen.2013.06.037; Liu X, 1998, AM J PHYSIOL-HEART C, V274, pH83, DOI 10.1152/ajpheart.1998.274.1.H83; LOCKE J, 1987, DNA-J MOLEC CELL BIO, V6, P331, DOI 10.1089/dna.1987.6.331; Logvinenko NS, 1996, P NATL ACAD SCI USA, V93, P9132, DOI 10.1073/pnas.93.17.9132; Luo MW, 2017, J BIOL CHEM, V292, P8823, DOI 10.1074/jbc.M117.780957; Marquezan BP, 2013, EPILEPSY RES, V105, P396, DOI 10.1016/j.eplepsyres.2013.03.007; McCormick Stephen D., 1995, V14, P285, DOI 10.1016/S1546-5098(08)60250-2; Nishikawa K, 1997, J BIOL CHEM, V272, P952, DOI 10.1074/jbc.272.2.952; Ojani R, 2016, INSECT BIOCHEM MOLEC, V70, P44, DOI 10.1016/j.ibmb.2015.12.001; Orlov SN, 2019, CURR MED CHEM, V26, P564, DOI 10.2174/0929867324666170619105407; Pedemonte CH, 1997, MOL PHARMACOL, V52, P88, DOI 10.1124/mol.52.1.88; Pham B, 2017, ECOTOX ENVIRON SAFE, V143, P283, DOI 10.1016/j.ecoenv.2017.05.035; Pham D, 2016, COMP BIOCHEM PHYS B, V196, P27, DOI 10.1016/j.cbpb.2015.12.007; PRATT GE, 1972, J EXP BIOL, V56, P201; Pszczolkowski M. A., 2005, Pestycydy, P161; Pszczolkowski MA, 2005, J INSECT PHYSIOL, V51, P445, DOI 10.1016/j.jinsphys.2005.01.008; Pszczolkowski MA, 2008, J INSECT PHYSIOL, V54, P358, DOI 10.1016/j.jinsphys.2007.10.005; Raikhel A.S., 2005, P433; Rocco-Machado N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129604; Roy S, 2018, ANNU REV ENTOMOL, V63, P489, DOI 10.1146/annurev-ento-020117-043258; Sancho E, 1997, ECOTOX ENVIRON SAFE, V38, P132, DOI 10.1006/eesa.1997.1573; Sandtner W, 2011, J BIOL CHEM, V286, P38177, DOI 10.1074/jbc.M111.267682; SATOH T, 1993, AM J PHYSIOL, V265, pF399, DOI 10.1152/ajprenal.1993.265.3.F399; SEVALA VL, 1993, INVERTEBR REPROD DEV, V23, P189, DOI 10.1080/07924259.1993.9672314; SEVALA VL, 1989, EXPERIENTIA, V45, P355, DOI 10.1007/BF01957476; Silva LND, 2016, J MEMBRANE BIOL, V249, P459, DOI 10.1007/s00232-016-9886-1; SKOU JC, 1992, J BIOENERG BIOMEMBR, V24, P249; Soltoff SP, 2010, J BIOL CHEM, V285, P36330, DOI 10.1074/jbc.M110.136465; Sun BH, 1998, J NEUROCHEM, V71, P142; Wang YR, 1997, J INSECT PHYSIOL, V43, P675, DOI 10.1016/S0022-1910(97)00009-7; Wang ZM, 2017, INSECT BIOCHEM MOLEC, V82, P31, DOI 10.1016/j.ibmb.2017.01.009; Wu ZX, 2016, J BIOL CHEM, V291, P5418, DOI 10.1074/jbc.M115.698936; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; YADWAD VB, 1990, B ENVIRON CONTAM TOX, V44, P585, DOI 10.1007/BF01700880	64	30	31	2	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20112	20122		10.1074/jbc.RA118.005692	http://dx.doi.org/10.1074/jbc.RA118.005692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385509	Green Published, hybrid			2022-12-26	WOS:000454685900020
J	Crawford, R; Gizzi, L; Dieterich, A; Mhuiris, AN; Falla, D				Crawford, Rebecca; Gizzi, Leonardo; Dieterich, Angela; Mhuiris, Aine Ni; Falla, Deborah			Age-related changes in trunk muscle activity and spinal and lower limb kinematics during gait	PLOS ONE			English	Article							LUMBAR BACK MUSCLES; STEP WIDTH VARIABILITY; PARASPINAL MUSCLES; OLDER-ADULTS; FATTY INFILTRATION; SPEED; WALKING; YOUNG; ASSOCIATION; ACTIVATION	The influence of age on spinal muscle activation patterns and its relation to kinematics is poorly understood. We aimed at understanding age-related changes to spine and trunk muscle activity in addition to spinal and lower limb kinematics during treadmill walking under various conditions. An observational study was conducted evaluating asymptomatic young (n = 10; 3F, 7M; 26.3 +/- 2.5yrs) and older (n = 9; 3F, 6M; 67.1 +/- 4.2yrs) adults' treadmill walking at 2km/h and 4km/h, each at 0, 1, 5, and 10% inclination. Unilateral (right side) electromyography (EMG) was recorded from deep and superficial multifidus (intramuscular) and erector spinae and abdominal obliques (surface); trunk and leg kinematics were also measured. Muscle activity was characterised by peak amplitude and duration of activity, and the time-point of peak amplitude in the gait cycle (0-100%). Peak activation in older adults was lower for the superficial multifidus (p<0.0001) and higher for the thoracolumbar (p<0.001) and lumbar erector spinae (p<0.01). The duration of activation was longer in older adults for all muscles (p<0.05) except the superficial multifidus, and longer during faster walking for all participants. The time-point of peak amplitude in the gait cycle was earlier in older participants for the external obliques (p<0.05). Walking speed appeared to influence muscle activity more than inclination. Older adults used less spine, trunk and lower limb motion, except at the ankle. Age-related differences within multifidus and between paravertebral and trunk muscles were inconsistent. Walking at 4km/h at 5-10% inclination may specifically target the lumbar paravertebral muscles.	[Crawford, Rebecca; Mhuiris, Aine Ni] Zurich Univ Appl Sci, Inst Hlth Sci, Winterthur, Switzerland; [Gizzi, Leonardo; Dieterich, Angela; Falla, Deborah] Univ Med Ctr Gottingen, Gottingen, Niedersachsen, Germany; [Crawford, Rebecca] Curtin Univ, Fac Hlth Sci, Perth, WA, Australia; [Gizzi, Leonardo] Univ Stuttgart, Continuum Biomech & Mech Res Grp, Baden, Switzerland; [Dieterich, Angela] Furtwangen Univ, Fac Hlth Safety & Soc, Furtwangen, Germany; [Mhuiris, Aine Ni] Physio & Co GmbH, Zurich, Switzerland; [Falla, Deborah] Univ Birmingham, Ctr Precis Rehabil Spinal Pain CPR Spine, Sch Sport Exercise & Rehabil Sci, Coll Life & Environm Sci, Birmingham, W Midlands, England	Zurich University of Applied Sciences; University of Gottingen; Curtin University; University of Birmingham	Falla, D (corresponding author), Univ Med Ctr Gottingen, Gottingen, Niedersachsen, Germany.; Falla, D (corresponding author), Univ Birmingham, Ctr Precis Rehabil Spinal Pain CPR Spine, Sch Sport Exercise & Rehabil Sci, Coll Life & Environm Sci, Birmingham, W Midlands, England.	d.falla@bham.ac.uk	Gizzi, Leonardo/B-5691-2013; Falla, Deborah/ABA-7734-2021; Crawford, Rebecca/F-3120-2017	Gizzi, Leonardo/0000-0003-3009-6261; Falla, Deborah/0000-0003-1689-6190; Crawford, Rebecca/0000-0001-9153-6684; Dieterich, Angela V./0000-0002-8522-8746	ZUAS	ZUAS	This study was undertaken as a joint collaboration between researchers then at The University of Gottingen, Germany (UG; DF, LG, AD) and the Zurich University of Applied Sciences, Switzerland (ZUAS; RC, ANM). Authors were employed (ranging from 20-100%) by their respective institutions at the time. All subject recruitment and data collection activities were undertaken at UG in two discreet sessions where all authors were onsite and participating. Internal travel-grant support (5000 total) was provided by ZUAS for ANM and RC (together) under a skills exchange scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders C, 2009, EUR J APPL PHYSIOL, V105, P585, DOI 10.1007/s00421-008-0938-9; Belavy DL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45975; BOGDUK N, 1980, J ANAT, V131, P525; BOGDUK N, 1992, SPINE, V17, P897, DOI 10.1097/00007632-199208000-00007; Brach JS, 2008, GAIT POSTURE, V27, P431, DOI 10.1016/j.gaitpost.2007.05.016; Cooley JR, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2266-5; Cornwall J, 2011, SPINE, V36, pE1053, DOI 10.1097/BRS.0b013e3181f79629; Crawford RJ, 2016, AM J NEURORADIOL, V37, P742, DOI 10.3174/ajnr.A4596; Crawford RJ, 2017, EUR SPINE J, V26, P3059, DOI 10.1007/s00586-017-5212-6; Crawford RJ, 2016, J ELECTROMYOGR KINES, V30, P177, DOI 10.1016/j.jelekin.2016.07.006; Crawford RJ, 2016, SCOLIOSIS SPINAL DIS, V11, DOI 10.1186/s13013-016-0080-0; Dahlqvist JR, 2017, MED SCI SPORT EXER, V49, P595, DOI 10.1249/MSS.0000000000001119; DeVita P, 2000, J GERONTOL A-BIOL, V55, pB593, DOI 10.1093/gerona/55.12.B593; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; DIFABIO RP, 1987, PHYS THER, V67, P43, DOI 10.1093/ptj/67.1.43; DONISCH EW, 1972, AM J ANAT, V133, P25, DOI 10.1002/aja.1001330103; FALLA D, 2017, THE JOURNAL OF ORTHO, V47, P268, DOI DOI 10.2519/JOSPT.2017.6768; Falla D, 2017, EXERC SPORT SCI REV, V45, P105, DOI 10.1249/JES.0000000000000103; Gizzi L, 2011, J NEUROPHYSIOL, V106, P202, DOI 10.1152/jn.00727.2010; Goubert D, 2017, SPINE J, V17, P1285, DOI 10.1016/j.spinee.2017.04.025; Goubert D, 2016, PAIN PHYSICIAN, V19, pE985; Haig Andrew J, 2002, Spine J, V2, P372, DOI 10.1016/S1529-9430(02)00201-2; Hermens HJ, 1999, EUROPEAN RECOMMENDAT, DOI [10.1152/jn.00727.2010, DOI 10.1152/JN.00727.2010]; Hides JA, 1998, MANUAL THERAPY, V3, P125, DOI DOI 10.1016/S1356-689X(98)80002-7; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Hortobagyi T, 2011, J GERONTOL A-BIOL, V66, P541, DOI 10.1093/gerona/glr008; KIRKALDY-WILLIS W H, 1978, Spine, V3, P319, DOI 10.1097/00007632-197812000-00004; Ko SU, 2010, AGE AGEING, V39, P688, DOI 10.1093/ageing/afq113; Lee HS, 2014, ANN REHABIL MED-ARM, V38, P514, DOI 10.5535/arm.2014.38.4.514; Lee HJ, 2017, J AGING PHYS ACTIV, V25, P247, DOI 10.1123/japa.2015-0325; MacDonald D, 2009, PAIN, V142, P183, DOI 10.1016/j.pain.2008.12.002; MACINTOSH JE, 1986, CLIN BIOMECH, V1, P205, DOI 10.1016/0268-0033(86)90147-6; MACINTOSH JE, 1986, CLIN BIOMECH, V1, P196, DOI 10.1016/0268-0033(86)90146-4; MACINTOSH JE, 1993, AUST NZ J SURG, V63, P205, DOI 10.1111/j.1445-2197.1993.tb00520.x; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Mannion AF, 1997, J ORTHOPAED RES, V15, P881, DOI 10.1002/jor.1100150614; Masaki M, 2016, AGING CLIN EXP RES, V28, P429, DOI 10.1007/s40520-015-0442-0; Mazaheri R., 2016, ASIAN J SPORTS MED, V7, pe35308, DOI [10.5812/asjsm.35308, DOI 10.5812/ASJSM.35308]; Meakin JR, 2013, J ANAT, V222, P608, DOI 10.1111/joa.12047; Muriuki MG, 2016, J ORTHOP RES, V34, P1389, DOI 10.1002/jor.23232; Oliveira AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059029; Owings TM, 2004, GAIT POSTURE, V20, P26, DOI 10.1016/S0966-6362(03)00088-2; Owings TM, 2004, J BIOMECH, V37, P935, DOI 10.1016/j.jbiomech.2003.11.012; Pezolato A, 2012, EUR SPINE J, V21, P2158, DOI 10.1007/s00586-012-2286-z; Ranger TA, 2017, SPINE J, V17, P1729, DOI 10.1016/j.spinee.2017.07.002; Regev GJ, 2010, SPINE, V35, P1265, DOI 10.1097/BRS.0b013e3181bfcd98; Saunders SW, 2005, CLIN BIOMECH, V20, P784, DOI 10.1016/j.clinbiomech.2005.04.004; Saunders SW, 2004, GAIT POSTURE, V20, P280, DOI 10.1016/j.gaitpost.2003.10.003; Schmid S, 2017, HUM MOVEMENT SCI, V54, P73, DOI 10.1016/j.humov.2017.04.001; THORSTENSSON A, 1982, ACTA PHYSIOL SCAND, V116, P13, DOI 10.1111/j.1748-1716.1982.tb10593.x; Valentin S, 2015, MANUAL THER, V20, P90, DOI 10.1016/j.math.2014.07.007; van den Hoorn W, 2012, J BIOMECH, V45, P342, DOI 10.1016/j.jbiomech.2011.10.024; Van K, 2006, J ORTHOP SPORT PHYS, V36, P920, DOI 10.2519/jospt.2006.2304; Weber T, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13188	54	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206514	10.1371/journal.pone.0206514	http://dx.doi.org/10.1371/journal.pone.0206514			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408111	Green Submitted, gold, Green Published			2022-12-26	WOS:000449512300022
J	Harihar, A; Chanchani, P; Borah, J; Crouthers, RJ; Darman, Y; Gray, TNE; Mohamad, S; Rawson, BM; Rayan, MD; Roberts, JL; Steinmetz, R; Sunarto, S; Widodo, FA; Anwar, M; Bhatta, SR; Chakravarthi, JPP; Chang, YD; Congdon, G; Dave, C; Dey, S; Durairaj, B; Fomenko, P; Guleria, H; Gupta, M; Gurung, G; Ittira, B; Jena, J; Kostyria, A; Kumar, K; Kumar, V; Lhendup, P; Liu, PQ; Malla, S; Maurya, K; Moktan, V; Van, NDN; Parakkasi, K; Phoonjampa, R; Phumanee, W; Singh, AK; Stengel, C; Subba, SA; Thapa, K; Thomas, TC; Wong, C; Baltzer, M; Ghose, D; Worah, S; Vattakaven, J				Harihar, Abishek; Chanchani, Pranav; Borah, Jimmy; Crouthers, Rachel Jane; Darman, Yury; Gray, Thomas N. E.; Mohamad, Shariff; Rawson, Benjamin Miles; Rayan, Mark Darmaraj; Roberts, Jennifer Lucy; Steinmetz, Robert; Sunarto, Sunarto; Widodo, Febri Anggriawan; Anwar, Meraj; Bhatta, Shiv Raj; Chakravarthi, Jayam Peter Prem; Chang, Youde; Congdon, Gordon; Dave, Chittaranjan; Dey, Soumen; Durairaj, Boominathan; Fomenko, Pavel; Guleria, Harish; Gupta, Mudit; Gurung, Ghana; Ittira, Bopanna; Jena, Jyotirmay; Kostyria, Alexey; Kumar, Krishna; Kumar, Vijay; Lhendup, Phurba; Liu, Peiqi; Malla, Sabita; Maurya, Kamlesh; Moktan, Vijay; Nguyen Dao Ngoc Van; Parakkasi, Karmila; Phoonjampa, Rungnapa; Phumanee, Worrapan; Singh, Anil Kumar; Stengel, Carrie; Subba, Samundra Ambuhang; Thapa, Kanchan; Thomas, Tiju C.; Wong, Christopher; Baltzer, Michael; Ghose, Dipankar; Worah, Sejal; Vattakaven, Joseph			Recovery planning towards doubling wild tiger Panthera tigris numbers: Detailing 18 recovery sites from across the range	PLOS ONE			English	Article							HUMAN-DOMINATED LANDSCAPE; LAW-ENFORCEMENT; CONSERVING TIGERS; PROTECTED AREAS; HOME-RANGE; POPULATION; DENSITY; CONSERVATION; PREY; ALTAICA	With less than 3200 wild tigers in 2010, the heads of 13 tiger-range countries committed to doubling the global population of wild tigers by 2022. This goal represents the highest level of ambition and commitment required to turn the tide for tigers in the wild. Yet, ensuring efficient and targeted implementation of conservation actions alongside systematic monitoring of progress towards this goal requires that we set site-specific recovery targets and timelines that are ecologically realistic. In this study, we assess the recovery potential of 18 sites identified under WWF's Tigers Alive Initiative. We delineated recovery systems comprising a source, recovery site, and support region, which need to be managed synergistically to meet these targets. By using the best available data on tiger and prey numbers, and adapting existing species recovery frameworks, we show that these sites, which currently support 165 (118-277) tigers, have the potential to harbour 585 (454-739) individuals. This would constitute a 15% increase in the global population and represent over a three-fold increase within these specific sites, on an average. However, it may not be realistic to achieve this target by 2022, since tiger recovery in 15 of these 18 sites is contingent on the initial recovery of prey populations, which is a slow process. We conclude that while sustained conservation efforts can yield significant recoveries, it is critical that we commit our resources to achieving the biologically realistic targets for these sites even if the timelines are extended.	[Harihar, Abishek; Vattakaven, Joseph] WWF Tigers Alive Initiat, New Delhi, India; [Chanchani, Pranav; Ghose, Dipankar; Worah, Sejal] WWF India, New Delhi, India; [Borah, Jimmy] WWF India, Tezpur, Assam, India; [Borah, Jimmy; Crouthers, Rachel Jane; Gray, Thomas N. E.; Congdon, Gordon] WWF Greater Mekong Program, Phnom Penh, Cambodia; [Darman, Yury; Fomenko, Pavel; Kostyria, Alexey] WWF Russia, Amur Branch, Vladivostok, Russia; [Mohamad, Shariff; Rayan, Mark Darmaraj; Wong, Christopher] WWF Malaysia, Kuala Lumpur, Selangor, Malaysia; [Rawson, Benjamin Miles; Nguyen Dao Ngoc Van] WWF Vietnam, Hanoi, Vietnam; [Rayan, Mark Darmaraj] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Roberts, Jennifer Lucy] WWF Tigers Alive Initiat, Phnom Penh, Cambodia; [Steinmetz, Robert; Phoonjampa, Rungnapa; Phumanee, Worrapan] WWF Thailand, Bangkok, Thailand; [Sunarto, Sunarto] WWF Indonesia, Jakarta, Indonesia; [Widodo, Febri Anggriawan] WWF Indonesia, Cent Sumatra Program, Pekanbaru, Riau, Indonesia; [Anwar, Meraj; Guleria, Harish] WWF India, Terai Arc Landscape Off, Haldwani, Uttarakhand, India; [Bhatta, Shiv Raj; Gurung, Ghana; Malla, Sabita; Subba, Samundra Ambuhang; Thapa, Kanchan] WWF Nepal, Programme Off, Kathmandu, Nepal; [Chakravarthi, Jayam Peter Prem; Durairaj, Boominathan; Kumar, Krishna; Thomas, Tiju C.] WWF India, Western Ghats Nilgiris Landscape Off, Coimbatore, Tamil Nadu, India; [Chang, Youde; Liu, Peiqi] WWF China, Changchun, Jilin, Peoples R China; [Dave, Chittaranjan] WWF India, Satpura Maikal Landscape Off, Mandla, Madhya Pradesh, India; [Dey, Soumen] WWF India, Satpura Maikal Landscape Off, Jabalpur, Madhya Pradesh, India; [Gupta, Mudit; Maurya, Kamlesh] WWF India, Terai Arc Landscape Off, Pilibhit, Uttar Pradesh, India; [Ittira, Bopanna; Singh, Anil Kumar] WWF India, Programme Off, Dehra Dun, Uttarakhand, India; [Jena, Jyotirmay] WWF India, Satpura Maikal Landscape Off, Balaghat, Madhya Pradesh, India; [Kumar, Vijay] WWF India, Western Ghats Nilgiris Landscape Off, Bhavanisagar, Tamil Nadu, India; [Lhendup, Phurba; Moktan, Vijay] WWF Bhutan, Program Off, Thimphu, Bhutan; [Parakkasi, Karmila] WWF Tigers Alive Initiat, Jakarta, Indonesia; [Stengel, Carrie] WWF Tigers Alive Initiat, Washington, DC USA; [Baltzer, Michael] WWF Tigers Alive Initiat, Singapore, Singapore; [Harihar, Abishek; Borah, Jimmy] Panthera, New York, NY 10018 USA; [Harihar, Abishek] Nat Conservat Fdn, Mysore, Karnataka, India; [Gray, Thomas N. E.] Wildlife Alliance, Phnom Penh, Cambodia; [Chakravarthi, Jayam Peter Prem] Tamil Nadu Forest Dept, Udumalpet, Tamil Nadu, India; [Parakkasi, Karmila] PT Royal Lestari Utama, Jakarta, Indonesia	World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; University of Kent; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund; World Wildlife Fund	Harihar, A; Vattakaven, J (corresponding author), WWF Tigers Alive Initiat, New Delhi, India.; Harihar, A (corresponding author), Panthera, New York, NY 10018 USA.; Harihar, A (corresponding author), Nat Conservat Fdn, Mysore, Karnataka, India.	harihar.abishek@gmail.com; josephvattax@gmail.com	Darman, Yury/HGC-9072-2022; Thapa, Kanchan/AGU-3365-2022; Harihar, Abishek/AAY-5092-2020; Dave, Chittaranjan/GPX-0631-2022; Borah, Jimmy/E-7502-2011; Burton, Anissa/AAC-9711-2021	Harihar, Abishek/0000-0002-2446-6345; Crouthers, Rachel/0000-0002-8156-8188; Widodo, Febri Anggriawan/0000-0002-8084-6836; Dave, Chittaranjan/0000-0002-2006-383X	WWF Tigers Alive Initiative team; WWF- Network offices; WWF-National offices; NGO	WWF Tigers Alive Initiative team; WWF- Network offices; WWF-National offices; NGO	WWF Tigers Alive Initiative team, WWF- Network offices and WWF-National offices, the funders, provided support in the form of salaries for all authors when the work was carried out. AH & JB, TNEG and JPPC are currently employed by Panthera, Wildlife Alliance and Tamil Nadu Forest Department, respectively and receive salary support. Additionally, one of the authors (KP) is currently employed by PT. Royal Lestari Utama (a commercial venture) and receives salary support from the venture. Neither of the funders had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work and the roles of these authors are articulated in the 'author contributions' section.; We would like to thank the respective Departments of Nature Conservation of all the nations for permitting us to carry out field surveys, WWF Tigers Alive Initiative team, WWF-Network offices, WWF- National offices and NGO partners for enabling and supporting this work. In particular, AH would like to thank Christopher Hallam for comments and Mousumi Ghosh-Harihar for her help at various stages in the preparation of this manuscript. We also thank James L.D. Smith and anonymous reviewers who helped refocus our paper.	[Anonymous], 2012, SCIENCE, DOI DOI 10.1126/science.1215904; Athreya V, 2014, TROP CONSERV SCI, V7, P75, DOI 10.1177/194008291400700111; Balmford A, 1995, CONSERV BIOL, V9, P1539, DOI 10.1046/j.1523-1739.1995.09061539.x; Bhagabati NK, 2014, BIOL CONSERV, V169, P147, DOI 10.1016/j.biocon.2013.11.010; Carroll C, 2006, J APPL ECOL, V43, P1056, DOI 10.1111/j.1365-2664.2006.01237.x; Chanchani P, 2016, CONSERV BIOL, V30, P649, DOI 10.1111/cobi.12633; Chapron G, 2008, J APPL ECOL, V45, P1667, DOI 10.1111/j.1365-2664.2008.01538.x; Chundawat RS, 2016, BIOL CONSERV, V197, P146, DOI 10.1016/j.biocon.2016.03.004; Dutta T, 2016, REG ENVIRON CHANGE, V16, P53, DOI 10.1007/s10113-015-0877-z; Flather, 2016, SPECIES RECOVERY US; Gilbert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110811; Global Tiger Initiative Secretariat, 2013, GLOB TIG REC PROGR I; Global Tiger Initiative Secretariat, 2011, GLOB TIG REC PROGR 2; Goble DD, 2009, NAT RESOUR J, V49, P1; Goodrich J., 2015, IUCN RED LIST THREAT, V2015, DOI [10.2305/IUCN.UK.2015-2.RLTS.T15955A50659951, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15955A50659951, DOI 10.2305/IUCN.UK.2015-2.RLTS.T15955A50659951.EN, 10.2305/]; Gray TNE, 2017, BIODIVERS CONSERV, V26, P2383, DOI 10.1007/s10531-017-1365-1; Harihar A, 2018, ORYX, V52, P78, DOI 10.1017/S0030605317001156; Harihar A, 2017, CONSERV LETT, V10, P502, DOI 10.1111/conl.12406; Harihar A, 2015, GLOBAL ENVIRON CHANG, V33, P122, DOI 10.1016/j.gloenvcha.2015.05.004; Harihar A, 2014, DIVERS DISTRIB, V20, P567, DOI 10.1111/ddi.12174; Harihar A, 2009, EUR J WILDLIFE RES, V55, P97, DOI 10.1007/s10344-008-0219-2; Hotte MHH, 2016, INTEGR ZOOL, V11, P2, DOI 10.1111/1749-4877.12168; Horev A, 2012, BIOL CONSERV, V147, P22, DOI 10.1016/j.biocon.2012.01.012; Hutchings JA, 2012, TRENDS ECOL EVOL, V27, P542, DOI 10.1016/j.tree.2012.06.005; Ivan JS, 2013, ECOLOGY, V94, P817, DOI 10.1890/12-0102.1; Johnson A, 2016, BIOL CONSERV, V202, P99, DOI 10.1016/j.biocon.2016.08.018; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joshi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077980; Karanth K.U., 2002, MONITORING TIGERS TH, DOI [10.1111/j.1523-1739.2003.01769.x, DOI 10.1111/J.1523-1739.2003.01769.X]; Karanth K. U., 2017, METHODS MONITORING T, P191, DOI DOI 10.1007/978-981-10-5436-5_10; Karanth K. Ullas, 1999, P100; Karanth KU, 2004, P NATL ACAD SCI USA, V101, P4854, DOI 10.1073/pnas.0306210101; Karanth KU, 1998, ECOLOGY, V79, P2852; Karanth KU, LONG TERM MONITORING; KENNEY JS, 1995, CONSERV BIOL, V9, P1127, DOI 10.1046/j.1523-1739.1995.9051116.x-i1; Lacy R.C., 2014, VORTEX STOCHASTIC SI; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; Lacy Robert C., 2000, Ecological Bulletins, V48, P191; Linkie M, 2015, J APPL ECOL, V52, P851, DOI 10.1111/1365-2664.12461; Luskin MS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01656-4; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McCarthy DP, 2012, SCIENCE, V338, P946, DOI 10.1126/science.1229803; McRae B., 2013, NAT CONSERV; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Miquelle DG, 2015, INTEGR ZOOL, V10, P315, DOI 10.1111/1749-4877.12141; NatureServe IUCN (International Union for Conservation of Nature), 2015, IUCN RED LIST THREAT; Nichols JD, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P45, DOI 10.1007/978-4-431-99495-4_4; O'Grady JJ, 2006, BIOL CONSERV, V133, P42, DOI 10.1016/j.biocon.2006.05.016; Obbard ME, 2010, J APPL ECOL, V47, P76, DOI 10.1111/j.1365-2664.2009.01758.x; Ranganathan J, 2008, BIOL CONSERV, V141, P67, DOI 10.1016/j.biocon.2007.09.003; Rathore CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039996; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; RoelkeParker ME, 1996, NATURE, V379, P441, DOI 10.1038/379441a0; Sanderson E., 2006, SETTING PRIORITIES C; Sankar K, 2010, TROP CONSERV SCI, V3, P301, DOI 10.1177/194008291000300305; Sarkar MS, 2016, EUR J WILDLIFE RES, V62, P537, DOI 10.1007/s10344-016-1026-9; Seidensticker J, 2010, INTEGR ZOOL, V5, P285, DOI 10.1111/j.1749-4877.2010.00214.x; Seimon TA, 2013, MBIO, V4, DOI 10.1128/mBio.00410-13; Shah S, 2015, CATNEWS; Sharma RK, 2010, ANIM CONSERV, V13, P94, DOI 10.1111/j.1469-1795.2009.00305.x; Sharma S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1506; Sharma S, 2013, ECOL EVOL, V3, P48, DOI 10.1002/ece3.432; Shukla R, 2013, SUGARCANE TIGER PHEN; Singh R, 2013, J ARID ENVIRON, V98, P105, DOI 10.1016/j.jaridenv.2013.08.005; SMITH JLD, 1993, BEHAVIOUR, V124, P165, DOI 10.1163/156853993X00560; SMITH JLD, 1991, CONSERV BIOL, V5, P484, DOI 10.1111/j.1523-1739.1991.tb00355.x; Smith JLD, 1999, RIDING TIGER TIGER C, P178; Steinmetz R, 2014, J APPL ECOL, V51, P1469, DOI 10.1111/1365-2664.12239; Stephens PA, 2006, ANIM CONSERV, V9, P339, DOI 10.1111/j.1469-1795.2006.00044.x; STOCKLI R., 2005, BLUE MARBLE NEXT GEN; Stokes EJ, 2010, INTEGR ZOOL, V5, P363, DOI 10.1111/j.1749-4877.2010.00223.x; Sunarto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030859; Sunquist M. E., 1981, SOCIAL ORG TIGERS PA; Thatte P, 2018, BIOL CONSERV, V218, P181, DOI [10.1016/j.biocon.2017.12.022, 10.1016/j.biocon.]; Tucker MA, 2018, SCIENCE, V359, P466, DOI 10.1126/science.aam9712; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wikramanayake E, 2011, CONSERV LETT, V4, P219, DOI 10.1111/j.1755-263X.2010.00162.x; Wolf C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170052; Yumnam B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111207; Zhang CZ, 2013, WILDLIFE BIOL, V19, P452, DOI 10.2981/12-090	82	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207114	10.1371/journal.pone.0207114	http://dx.doi.org/10.1371/journal.pone.0207114			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408090	gold, Green Published, Green Submitted			2022-12-26	WOS:000449512300077
J	Wang, W; Zhang, C; Cui, L; Xie, QY; Jia, ZY; Zheng, W				Wang, Wei; Zhang, Chen; Cui, Lin; Xie, Qing-yun; Jia, Zhen-yu; Zheng, Wei			Reliability, validity and responsiveness of the Chinese version of the Rotator Cuff Quality of Life Index (RC-QOL) in patients with rotator cuff disorders	PLOS ONE			English	Article							CROSS-CULTURAL ADAPTATION; SF-36 HEALTH SURVEY; SHOULDER SCORE; VALIDATION; QUESTIONNAIRE; TRANSLATION; REPRODUCIBILITY; OSTEOARTHRITIS; KNEE; AGREEMENT	Background The Rotator Cuff Quality of Life Index (RC-QOL) is a scale designed to evaluate the impact of rotator cuff (RC) disorders on the general quality of life of patients. Our study aims to adapt the RC-QOL into Chinese and to assess its reliability, validity and responsiveness in Chinese patients with RC disorders. Methods First, we developed the Chinese version of RC-QOL (C-RC-QOL) through a five-step procedure. Next, the recruited patients gave three rounds of responses to the C-RC-QOL, Medical Outcomes Study Short Form 36 (SF-36) and Oxford Shoulder Score scales (OSS). Then, we calculated the Cronbach's alpha, standard error of measurement (SEM), minimally detectable change (MDC), intra-class correlation coefficient (ICC), Pearson's correlation coefficient (r), effect size (ES) and standardized response mean (SRM) to evaluate the reliability, validity and responsiveness of the C-RC-QOL respectively. The unidimensionality of each subscale was assessed by principal component analysis (PCA) of the residuals. Results Overall, 124 patients with RC disorders successfully completed the first two rounds of the scales, and 108 patients completed the last round of the scales. Good or excellent internal consistency (Cronbach's alpha = 0.953) was found in the overall scale and subscales of the C-RC-QOL, and good or excellent test-retest reliability (ICC = 0.854) was found as well. The SEM and MDC values of the C-RC-QOL were 4.6 and 12.8 respectively. Moderate, good or excellent correlations (r = 0.452-0.839) were obtained between the physical subscales of the C-RC-QOL and the OSS, as well as the physical subscales of the SF-36; similar results were obtained between the emotion subscale of the C-RC-QOL and the mental subscales of the SF-36 (r = 0.490-0.733), which, illustrated the good validity of the C-RC-QOL. In addition, high responsiveness was observed in the overall scale and subscales of the C-RC-QOL (ES = 1.77, SRM = 1.98). The unidimensionality of five subscales was respected according to PCA of the residuals. Conclusions The C-RC-QOL scale is reliable, valid and responsive for the evaluation of Chinese-speaking patients with RC disorders and it would be an effective instrument.	[Wang, Wei; Cui, Lin; Xie, Qing-yun; Zheng, Wei] Chengdu Mil Gen Hosp, Dept Orthoped, Chengdu, Sichuan, Peoples R China; [Zhang, Chen; Jia, Zhen-yu] Changhai Hosp, Dept Orthoped, Shanghai, Peoples R China	Naval Medical University	Xie, QY; Zheng, W (corresponding author), Chengdu Mil Gen Hosp, Dept Orthoped, Chengdu, Sichuan, Peoples R China.	xqingyun@163.com; zw770880@126.com			Department of Science and Technology of Sichuan Province; Chengdu Military General Hospital [41732C112];  [2017SZ0128]	Department of Science and Technology of Sichuan Province; Chengdu Military General Hospital; 	This work was funded by Department of Science and Technology of Sichuan Province and 2017SZ0128 to QX and Chengdu Military General Hospital 41732C112 to WW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Charles A., 2009, SHOULDER; Cohen J., 1983, APPL MULTIPLE REGRES; COSTE J, 1995, STAT MED, V14, P331, DOI 10.1002/sim.4780140402; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P593, DOI 10.1302/0301-620X.78B4.0780593; Dawson J, 2009, ARCH ORTHOP TRAUM SU, V129, P119, DOI 10.1007/s00402-007-0549-7; El O, 2006, RHEUMATOL INT, V26, P1101, DOI 10.1007/s00296-006-0151-2; Eubank BH, 2017, J SHOULDER ELB SURG, V26, P314, DOI 10.1016/j.jse.2016.07.030; Franchignoni F, 2015, EUR J PHYS REHAB MED, V51, P429; Goetz C, 2011, RHEUMATOLOGY, V50, P500, DOI 10.1093/rheumatology/keq357; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Hollinshead RM, 2000, J SHOULDER ELB SURG, V9, P373, DOI 10.1067/mse.2000.108389; Huber W, 2005, Z RHEUMATOL, V64, P188, DOI 10.1007/s00393-005-0646-3; Husted JA, 2000, J CLIN EPIDEMIOL, V53, P459, DOI 10.1016/S0895-4356(99)00206-1; Kawabata M, 2013, J ORTHOP SCI, V18, P705, DOI 10.1007/s00776-013-0426-x; Kirkley A, 2003, CLIN J SPORT MED, V13, P84, DOI 10.1097/00042752-200303000-00004; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee Edwin W C, 2004, J Hand Ther, V17, P417, DOI 10.1016/S0894-1130(04)00183-8; Leggin BG, 2006, J ORTHOP SPORT PHYS, V36, P138, DOI 10.2519/jospt.2006.36.3.138; Li L, 2003, J EPIDEMIOL COMMUN H, V57, P259, DOI 10.1136/jech.57.4.259; Linacre JM, USERS GUIDE WINSTEPS; Lo IKY, 2001, OSTEOARTHR CARTILAGE, V9, P771, DOI 10.1053/joca.2001.0474; LYSHOLM J, 1982, AM J SPORT MED, V10, P150, DOI 10.1177/036354658201000306; MacDermid JC, 2004, J SHOULDER ELB SURG, V13, P593, DOI 10.1016/j.jse.2004.03.009; Mokkink LB, 2010, BMC MED RES METHODOL, V10; Mousavi SJ, 2009, CLIN RHEUMATOL, V28, P293, DOI 10.1007/s10067-008-1042-6; Naal FD, 2011, ARTHROSCOPY, V27, P339, DOI 10.1016/j.arthro.2010.07.021; Oliva F, 2015, MLTJ-MUSCLE LIGAMENT, V5, P227, DOI 10.11138/mltj/2015.5.4.227; Oliva Francesco, 2014, Muscles Ligaments Tendons J, V4, P309; Ostor AJK, 2004, ANN RHEUM DIS, V63, P1288, DOI 10.1136/ard.2003.014712; Papalia R, 2010, KNEE SURG SPORT TR A, V18, P1417, DOI 10.1007/s00167-009-0943-5; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Pynsent PB, 2001, J BONE JOINT SURG BR, V83B, P792, DOI 10.1302/0301-620X.83B6.11973; Razmjou H, 2006, BMC MUSCULOSKEL DIS, V7, DOI 10.1186/1471-2474-7-26; St-Pierre C, 2016, DISABIL REHABIL, V38, P103, DOI 10.3109/09638288.2015.1027004; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Wang W, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1283-5; Wei X, 2012, OSTEOARTHR CARTILAGE, V20, P1563, DOI 10.1016/j.joca.2012.08.018; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WHO, 1984, CONST WHO; Xu XM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0383-5; Zhaeentan S, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1014-y; Zheng W, 2014, CLIN ORTHOP RELAT R, V472, P1545, DOI 10.1007/s11999-013-3403-y	48	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0206347	10.1371/journal.pone.0206347	http://dx.doi.org/10.1371/journal.pone.0206347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ5ZX	30408054	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300018
J	Winter, M; Haynert, K; Scheu, S; Maraun, M				Winter, Marlene; Haynert, Kristin; Scheu, Stefan; Maraun, Mark			Seasonal dynamics and changing sea level as determinants of the community and trophic structure of oribatid mites in a salt marsh of the Wadden Sea	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; INTERTIDAL MITES; STABLE-ISOTOPE; SOIL; ECOLOGY; ACARI; PATTERNS; TERRESTRIAL; COLLEMBOLA; PROFILES	Global change processes affect seasonal dynamics of salt marshes and thereby their plant and animal communities. However, these changes have been little investigated for microarthropod communities. We studied the effect of seasonality and changes in sea level on oribatid mites in the natural salt marsh and on artificial islands in the back-barrier environment of the island Spiekeroog (Wadden Sea, Germany). Three zones of the artificial islands were filled with transplanted sods from the lower salt marsh zone and thereby exposed to three different inundation frequencies. We hypothesized that oribatid mite communities will differ along the natural salt marsh vegetation zones [ upper salt marsh (USM), lower salt marsh (LSM), pioneer zone (PZ)], which are influenced by different tidal regimes. Accordingly, total oribatid mite densities declined from the USM and LSM to the PZ. Similarly, oribatid mite species compositions changed along the salt marsh transect and also responded to variations in inundation frequency in LSM on artificial islands with typical species of the USM, LSM and PZ being Multioppia neglecta (USM), Hermannia pulchella (LSM), Zachvatkinibates quadrivertex (LSM, PZ) and Ameronothrus schneideri (LSM, PZ). Oribatid mite density in the salt marsh and on the artificial islands was at a maximum in winter and spring; this was due in part to high density of juveniles, pointing to two reproductive periods. We hypothesized that oribatid mite trophic structure changes due to variations in abiotic (e.g., tidal dynamics, temperature) and biotic conditions (e.g., resource availability). Stable isotope (N-15, C-13) and neutral lipid fatty acid analyses indicated that oribatid mite species have different diets with e.g., Z. quadrivertex feeding on macroalgae and fungi, A. schneideri feeding on microalgae and bacteria, and Scheloribates laevigatus and M. neglecta feeding on dead organic matter, bacteria and fungi. Overall, the results indicate that oribatid mite species in salt marshes are affected by changes in environmental factors such as inundation intensity, with the effects being most pronounced in species with narrow trophic niches and limited niche plasticity. The results also indicate that oribatid mite communities of the LSM respond little to short-term (one year) changes in inundation frequency.	[Winter, Marlene; Haynert, Kristin; Scheu, Stefan; Maraun, Mark] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Scheu, Stefan] Univ Gottingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; [Haynert, Kristin] Marine Res Dept, Wilhelmshaven, Germany	University of Gottingen; University of Gottingen	Maraun, M (corresponding author), Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany.	mmaraun@gwdg.de		Maraun, Mark/0000-0002-2736-8548	Volkswagen Foundation within the funding initiative of the Ministry for Science and Culture of Lower Saxony, Germany	Volkswagen Foundation within the funding initiative of the Ministry for Science and Culture of Lower Saxony, Germany	This study was funded by the Volkswagen Foundation within the funding initiative of the Ministry for Science and Culture of Lower Saxony, Germany. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baath E, 2003, MICROBIAL ECOL, V45, P373, DOI 10.1007/s00248-003-2002-y; Balke T, 2017, ESTUAR COAST SHELF S, V198, P288, DOI 10.1016/j.ecss.2017.09.021; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Coulson SJ, 2002, FUNCT ECOL, V16, P353, DOI 10.1046/j.1365-2435.2002.00636.x; Craft C, 2009, FRONT ECOL ENVIRON, V7, P73, DOI 10.1890/070219; Crosby SC, 2016, ESTUAR COAST SHELF S, V181, P93, DOI 10.1016/j.ecss.2016.08.018; Ermilov SG, 2012, ZOOTAXA, P1; Ermilov SG, 2012, ENTOMOL REV, V92, P815; FERNANDEZ R, 2014, PLOS ONE, V9; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Harwood J. L., 1984, Lipids in plants and microbes.; Haubert D, 2004, COMP BIOCHEM PHYS B, V138, P41, DOI 10.1016/j.cbpc.2004.02.009; Haynert K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189645; Illig J, 2010, EXP APPL ACAROL, V52, P49, DOI 10.1007/s10493-010-9348-x; Langel R, 2014, RAPID COMMUN MASS SP, V28, P1019, DOI 10.1002/rcm.6878; LUXTON M, 1990, J ROY SOC NEW ZEAL, V20, P367, DOI 10.1080/03036758.1990.10426719; LUXTON M, 1967, PEDOBIOLOGIA, V7, P55; LUXTON M, 1967, J ANIM ECOL, V36, P257, DOI 10.2307/2911; LUXTON MALCOLM, 1966, ACAROLOGIA, V8, P163; MABERLY SC, 1992, OECOLOGIA, V91, P481, DOI 10.1007/BF00650320; MACFADYEN A, 1961, J ANIM ECOL, V30, P171, DOI 10.2307/2120; Maraun M, 2000, ECOGRAPHY, V23, P374, DOI 10.1111/j.1600-0587.2000.tb00294.x; Maraun M, 2011, SOIL BIOL BIOCHEM, V43, P877, DOI 10.1016/j.soilbio.2011.01.003; Maraun M, 2007, ECOGRAPHY, V30, P209, DOI [10.1111/j.2007.0906-7590.04994.x, 10.1111/j.0906-7590.2007.04994.x]; Maraun M, 2012, EVOL ECOL RES, V14, P311; Niedrighaus R, 2009, SPIEKEROOG; Niedrighaus R., 2009, PRIMARBIOTOPE HALO S; Ohmes A., 2010, INSELINFO SPIEKEROOG; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Penuelas J, 2002, GLOBAL CHANGE BIOL, V8, P531, DOI 10.1046/j.1365-2486.2002.00489.x; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Pfingstl T, 2014, ZOOMORPHOLOGY, V133, P359, DOI 10.1007/s00435-014-0228-5; Pfingstl T, 2013, ACAROLOGIA, V53, P369, DOI 10.1051/acarologia/20132101; Pfingstl T, 2013, EXP APPL ACAROL, V61, P87, DOI 10.1007/s10493-013-9681-y; POLDERMAN P J G, 1974, Netherlands Journal of Sea Research, V8, P49, DOI 10.1016/0077-7579(74)90026-X; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Reinfelder JR, 2004, PLANT PHYSIOL, V135, P2106, DOI 10.1104/pp.104.041319; Roberts K, 2007, PLANT PHYSIOL, V145, P230, DOI 10.1104/pp.107.102616; Roper T, 2012, J HYDROL, V454, P173, DOI 10.1016/j.jhydrol.2012.06.011; Ruess L, 2004, OECOLOGIA, V139, P336, DOI 10.1007/s00442-004-1514-6; Ruess L, 2007, SOIL BIOL BIOCHEM, V39, P1990, DOI 10.1016/j.soilbio.2007.03.002; Ruess L, 2010, SOIL BIOL BIOCHEM, V42, P1898, DOI 10.1016/j.soilbio.2010.07.020; Sahu A, 2013, PHYTOCHEMISTRY, V89, P53, DOI 10.1016/j.phytochem.2013.02.001; Sakamoto K, 2004, SOIL BIOL BIOCHEM, V36, P1827, DOI 10.1016/j.soilbio.2004.04.037; Sanchez JM, 1996, J VEG SCI, V7, P695, DOI 10.2307/3236381; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Schluter MH, 2012, J SEA RES, V67, P91, DOI 10.1016/j.seares.2011.11.001; SCHULTE G, 1976, PEDOBIOLOGIA, V16, P332; SCHULTE G, 1973, Netherlands Journal of Sea Research, V7, P68, DOI 10.1016/0077-7579(73)90033-1; Schumacher J, 2014, HELGOLAND MAR RES, V68, P289, DOI 10.1007/s10152-014-0389-0; Stief Peter, 2013, PLoS One, V8, pe73257, DOI 10.1371/journal.pone.0073257; Suh SS, 2015, ASIAN PAC J TROP MED, V8, P191, DOI 10.1016/S1995-7645(14)60313-8; Traugott M, 2013, ADV ECOL RES, V49, P177, DOI 10.1016/B978-0-12-420002-9.00003-2; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; WEIGMANN G, 1973, Z WISS ZOOL ABT A, V186, P295; Weigmann G., 2008, INTEGRATIVE ACAROLOG, P275; Weigmann G., 2006, SERIES FOUNDER TIERW; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; ZHUKOVA NV, 1995, PHYTOCHEMISTRY, V39, P351, DOI 10.1016/0031-9422(94)00913-E	63	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207141	10.1371/journal.pone.0207141	http://dx.doi.org/10.1371/journal.pone.0207141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408121	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300082
J	Martinez-Marquez, JY; Duncan, MC				Martinez-Marquez, Jorge Y.; Duncan, Mara C.			Investigation of Ldb19/Art1 localization and function at the late Golgi	PLOS ONE			English	Article							REGULATES CLATHRIN ADAPTERS; SACCHAROMYCES-CEREVISIAE; YEAST; UBIQUITIN; PROTEINS; ENDOCYTOSIS; MEMBRANE; PERMEASE; BINDING; FAMILY	The arrestin-related family of proteins (ARTs) are potent regulators of membrane traffic at multiple cellular locations in the yeast Saccharomyces cerevisiae. Several ARTs act at multiple locations, suggesting that ARTs with well-established functions at one location may have additional, as of yet, uncharacterized roles at other locations in the cell. To more fully understand the spectrum of cellular functions regulated by ART proteins, we explored the localization and function of Ldb19/Art1, which has previously been shown to function at the plasma membrane, yet is reported to localize to the trans-Golgi network (TGN). We report that the C-terminal fusion of Ldb19 with GFP is functional and, as previously reported, localizes to the TGN. We further establish that Ldb19 associates with late stages of TGN maturation that are enriched in the clathrin adaptor protein complex-1 (AP-1). Additionally, we present genetic interaction assays that suggest Ldb19 acts at the late TGN in a mechanism related to that of AP-1. However, Ldb19 and AP-1 have dissimilar phenotypes in a subset of assays of membrane traffic, suggesting Ldb19 functions at the TGN are distinct from those of AP-1. Together these results indicate Ldb19 functions at the TGN, in addition to its well-established role in endocytosis.	[Martinez-Marquez, Jorge Y.; Duncan, Mara C.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Duncan, MC (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	mcduncan@umich.edu		Duncan, Mara/0000-0002-2383-0109; Martinez-Marquez, Jorge/0000-0003-1485-4800	National Institutes of Health [F31-GM112470, R01-GM092741]; Michigan Protein Folding Disease Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM112470] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Protein Folding Disease Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by the National Institutes of Health to J.Y.M.M. (F31-GM112470) and M.C.D. (R01-GM092741), and by the Michigan Protein Folding Disease Initiative (M.C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvaro CG, 2014, MOL CELL BIOL, V34, P2660, DOI 10.1128/MCB.00230-14; Aoh QL, 2013, MOL BIOL CELL, V24, P832, DOI 10.1091/mbc.E12-10-0750; Aoh QL, 2011, MOL BIOL CELL, V22, P3671, DOI 10.1091/mbc.E11-04-0309; Becuwe M, 2014, ELIFE, V3, DOI 10.7554/eLife.03307; Bensen ES, 2000, GENETICS, V154, P83; Boman AL, 2002, MOL BIOL CELL, V13, P3078, DOI 10.1091/mbc.E02-02-0078; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Chong YT, 2015, CELL, V161, P1413, DOI 10.1016/j.cell.2015.04.051; Conibear E, 2002, METHOD ENZYMOL, V351, P408; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Costaguta G, 2001, MOL BIOL CELL, V12, P1885, DOI 10.1091/mbc.12.6.1885; Crapeau M, 2014, J BIOL CHEM, V289, P22103, DOI 10.1074/jbc.M114.582320; Daboussi L, 2012, NAT CELL BIOL, V14, P239, DOI 10.1038/ncb2427; Day KJ, 2018, DEV CELL, V44, P56, DOI 10.1016/j.devcel.2017.12.014; Dong B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30963; Faini M, 2013, TRENDS CELL BIOL, V23, P279, DOI 10.1016/j.tcb.2013.01.005; Gournas C, 2017, MOL BIOL CELL, V28, P2819, DOI 10.1091/mbc.E17-02-0104; Guiney EL, 2016, MOL BIOL CELL, V27, P4043, DOI 10.1091/mbc.E16-08-0570; Hager NA, 2018, J BIOL CHEM, V293, P11006, DOI 10.1074/jbc.RA117.001293; Hatakeyama R, 2010, MOL CELL BIOL, V30, P5598, DOI 10.1128/MCB.00464-10; Herranz S, 2005, P NATL ACAD SCI USA, V102, P12141, DOI 10.1073/pnas.0504776102; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hovsepian J, 2018, MOL BIOL CELL, V29, P1012, DOI 10.1091/mbc.E17-07-0466; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Hung CW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30305-z; Hung CW, 2016, MOL BIOL CELL, V27, P1143, DOI 10.1091/mbc.E15-08-0588; Hung CW, 2012, J BIOL CHEM, V287, P17398, DOI 10.1074/jbc.M112.349035; Huser S, 2013, BIOCHEM J, V450, P73, DOI 10.1042/BJ20121373; Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2; Karachaliou M, 2013, MOL MICROBIOL, V88, P301, DOI 10.1111/mmi.12184; Kim JJ, 2016, DEV CELL, V36, P440, DOI 10.1016/j.devcel.2016.01.016; Kita A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016842; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Lund FW, 2014, TRAFFIC, V15, P1406, DOI 10.1111/tra.12228; MacGurn JA, 2011, CELL, V147, P1104, DOI 10.1016/j.cell.2011.09.054; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; McDonold CM, 2014, DEV CELL, V30, P759, DOI 10.1016/j.devcel.2014.07.016; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; Nakase Y, 2013, J CELL SCI, V126, P3972, DOI 10.1242/jcs.128355; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; O'Donnell AF, 2010, MOL BIOL CELL, V21, P3552, DOI 10.1091/mbc.E10-07-0636; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; PEARSE BMF, 1976, P NATL ACAD SCI USA, V73, P1255, DOI 10.1073/pnas.73.4.1255; PHAN HL, 1994, EMBO J, V13, P1706, DOI 10.1002/j.1460-2075.1994.tb06435.x; Prosser DC, 2015, J CELL SCI; RAD MR, 1995, J CELL SCI, V108, P1605; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Tanaka M, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00592-17; Valdivia RH, 2002, DEV CELL, V2, P283, DOI 10.1016/S1534-5807(02)00127-2; VOLLAND C, 1994, J BIOL CHEM, V269, P9833; WILSBACH K, 1993, EMBO J, V12, P3049, DOI 10.1002/j.1460-2075.1993.tb05974.x; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Yeung BG, 2001, TRAFFIC, V2, P565, DOI 10.1034/j.1600-0854.2001.20806.x; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459; Zhdankina O, 2001, YEAST, V18, P1, DOI 10.1002/1097-0061(200101)18:1<1::AID-YEA644>3.0.CO;2-5; Ziman M, 1998, MOL BIOL CELL, V9, P1565, DOI 10.1091/mbc.9.6.1565	64	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206944	10.1371/journal.pone.0206944	http://dx.doi.org/10.1371/journal.pone.0206944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403748	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500084
J	Somda, NSB; Rode, BS; Sawadogo, PS; Gnankine, O; Maiga, H; Fournet, F; Lees, RS; Bouyer, J; Gilles, J; Sanon, A; Diabate, A; Dabire, KR				Somda, Nanwintoum Severin Bimbile; Rode, Bewadeyir Serge; Sawadogo, Peguedwinde Simon; Gnankine, Olivier; Maiga, Hamidou; Fournet, Florence; Lees, Rosemary Susan; Bouyer, Jeremy; Gilles, Jeremie; Sanon, Antoine; Diabate, Abdoulaye; Dabire, Kounbobr Roch			Ecology of reproduction of Anopheles arabiensis in an urban area of Bobo-Dioulasso, Burkina Faso (West Africa): Monthly swarming and mating frequency and their relation to environmental factors	PLOS ONE			English	Article							MOLECULAR M-FORM; DIPTERA-CULICIDAE; GAMBIAE DIPTERA; CLIMATE-CHANGE; MOSQUITO; BEHAVIOR; DYNAMICS; MALES; SL	Swarming is a key part of the natural system of reproduction of anopheline mosquito populations, and a better understanding of swarming and mating systems in a targeted species in its natural habitat would contribute to better design control strategies with a greater chance of success. Our study investigated the monthly occurrence of swarming and the mating frequency (within swarms) of Anopheles arabiensis in Dioulassoba, Burkina Faso and their relationship with local environmental factors. Mosquitoes collected from swarms were described in terms of body size, recent sugar meal intake, and female repletion, insemination, and Plasmodium falciparum infection status. Swarms of An. arabiensis were found in each month of the year. Both start and end times of swarming varied significantly between months, correlating with the time of sunset. Swarming mostly started after or coincided with sunset from late July to early October but occurred before sunset from late October to early July. Swarming duration, the number of mosquitoes and mating pairs per swarm, and time to first mating were significantly different between months in an inverse relationship with the monthly rainfall. The number of mating pairs was strongly and positively correlated with swarm size. Almost all the females caught in copula were inseminated but a very few were blood fed; no P. falciparum infection was observed. Males caught in copula and in solo were similar in body size and in the proportion which had taken a recent sugar meal. Our investigations showed that An. arabiensis reproductive activities are most frequent during the dry season, suggesting either the species' preference for dry climatic conditions or a lack of available breeding sites during the rainy season due to the seasonal flooding in this area. Targeting interventions to kill mosquitoes in swarms or to achieve an over-flooding ratio of sterile males during the rainy season would increase their efficiency in reducing the population density of this vector.	[Somda, Nanwintoum Severin Bimbile; Rode, Bewadeyir Serge; Sawadogo, Peguedwinde Simon; Maiga, Hamidou; Diabate, Abdoulaye; Dabire, Kounbobr Roch] IRSS DRO, Bobo Dioulasso, Burkina Faso; [Somda, Nanwintoum Severin Bimbile; Rode, Bewadeyir Serge; Gnankine, Olivier; Sanon, Antoine] Univ Ouaga 1 Joseph Ki Zerbo, Lab Entomol Fondamentale & Appl, Ouagadougou 1, Burkina Faso; [Fournet, Florence] IRD, Unite Malad Infect & Vecteurs, Ecol Genet Evolut & Controle, Montpellier, France; [Lees, Rosemary Susan] Univ Liverpool Liverpool Sch Trop Med, Liverpool Insect Testing Estab, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England; [Bouyer, Jeremy; Gilles, Jeremie] Joint FAO IAEA, Insect Pest Control Lab, Int Atom Energy Agcy, Vienna, Austria	Institut de Recherche pour le Developpement (IRD); Liverpool School of Tropical Medicine; International Atomic Energy Agency	Somda, NSB (corresponding author), IRSS DRO, Bobo Dioulasso, Burkina Faso.; Somda, NSB (corresponding author), Univ Ouaga 1 Joseph Ki Zerbo, Lab Entomol Fondamentale & Appl, Ouagadougou 1, Burkina Faso.	nansevbis@gmail.com	Lees, Rosemary Susan/H-3425-2019; MAIGA, Hamidou/AAR-3023-2020; Gnankine, Olivier/AAH-4974-2019; Bouyer, Jérémy/AAK-7370-2020; Sanon, Antoine/H-7203-2016; Dabire, Roch Kounbobr/ABF-3525-2020; SOMDA, Nanwintoum Severin BIMBILE/T-5918-2019	Lees, Rosemary Susan/0000-0002-4232-9125; MAIGA, Hamidou/0000-0001-8662-4700; Gnankine, Olivier/0000-0002-6006-6533; Bouyer, Jérémy/0000-0002-1913-416X; Sanon, Antoine/0000-0002-2046-8503; PODA, Bewadeyir Serge/0000-0002-8982-2355; Bimbile Somda, Nanwintoum Severin/0000-0002-3546-3078; Sawadogo, Simon Peguedwinde/0000-0002-9414-4659				Afrane YA, 2012, ANN NY ACAD SCI, V1249, P204, DOI 10.1111/j.1749-6632.2011.06432.x; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; BURKOT TR, 1984, AM J TROP MED HYG, V33, P783, DOI 10.4269/ajtmh.1984.33.783; Charlwood JD, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-2; Charlwood JD, 2002, J VECTOR ECOL, V27, P178; CHARLWOOD JD, 1979, PHYSIOL ENTOMOL, V4, P111, DOI 10.1111/j.1365-3032.1979.tb00185.x; Charlwood JD, 2002, MED VET ENTOMOL, V16, P109, DOI 10.1046/j.0269-283x.2002.00342.x; CHARLWOOD JD, 1980, PHYSIOL ENTOMOL, V5, P315, DOI 10.1111/j.1365-3032.1980.tb00241.x; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Dabire KR, 2014, ACTA TROP, V132, pS35, DOI 10.1016/j.actatropica.2013.12.012; Dabire KR, 2013, MED VET ENTOMOL, V27, P298, DOI 10.1111/j.1365-2915.2012.01049.x; Dabire RK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-127; Diabate A, 2003, T ROY SOC TROP MED H, V97, P713, DOI 10.1016/S0035-9203(03)80110-4; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Diabate A, 2006, J MED ENTOMOL, V43, P480, DOI 10.1603/0022-2585(2006)43[480:MSOTMM]2.0.CO;2; Diabate A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0961-8; DOWNES JA, 1969, ANNU REV ENTOMOL, V14, P271, DOI 10.1146/annurev.en.14.010169.001415; GIBSON G, 1985, PHYSIOL ENTOMOL, V10, P283, DOI 10.1111/j.1365-3032.1985.tb00049.x; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Gouagna LC, 2010, J VECTOR ECOL, V35, P267, DOI 10.1111/j.1948-7134.2010.00082.x; GUBLER DJ, 1972, MOSQ NEWS, V32, P219; Hassan MM, 2014, ACTA TROP, V132, pS64, DOI 10.1016/j.actatropica.2013.11.013; Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2; Helinski MEH, 2008, REPROD BIOL INDUCED, P1; Helinski MEH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-65; Hien DFDS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005773; James MC, 1996, MED MICROBIOLOGY; LOFGREN CS, 1974, B WORLD HEALTH ORGAN, V50, P323; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Sawadogo SP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-275; Sawadogo SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173273; SEAWRIGHT JA, 1978, SCIENCE, V200, P1303, DOI 10.1126/science.663614; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1984, MOSQ NEWS, V44, P573; Vrzal EM, 2010, J INSECT PHYSIOL, V56, P1659, DOI 10.1016/j.jinsphys.2010.06.011; WEIDHAAS DE, 1974, AM J TROP MED HYG, V23, P298, DOI 10.4269/ajtmh.1974.23.298; WHO, 2016, WORLD MAL REP 2016; WHO, 1982, MAN ENV MAN MOSQ CON; Wirth DF., 2017, MALARIA BIOL ERA ERA; Yamana TK, 2013, ENVIRON HEALTH PERSP, V121, P1179, DOI 10.1289/ehp.1206174; Yuval B, 2006, ANNU REV ENTOMOL, V51, P413, DOI 10.1146/annurev.ento.51.110104.151058; YUVAL B, 1993, OECOLOGIA, V95, P65, DOI 10.1007/BF00649508; YUVAL B, 1994, ECOL ENTOMOL, V19, P74, DOI 10.1111/j.1365-2311.1994.tb00392.x	46	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205966	10.1371/journal.pone.0205966	http://dx.doi.org/10.1371/journal.pone.0205966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403762	gold, Green Published, Green Accepted			2022-12-26	WOS:000449379500037
J	Springmann, M; Mason-D'Coz, D; Robinson, S; Wiebe, K; Godfrey, HCJ; Rayner, M; Scarborough, P				Springmann, Marco; Mason-D'Coz, Daniel; Robinson, Sherman; Wiebe, Keith; Godfrey, H. Charles J.; Rayner, Mike; Scarborough, Peter			Health-motivated taxes on red and processed meat: A modelling study on optimal tax levels and associated health impacts	PLOS ONE			English	Article							COMPARATIVE RISK-ASSESSMENT; DIABETES-MELLITUS; ECONOMIC BURDEN; CONSUMPTION; MORTALITY; METAANALYSIS; DISEASE; FOOD; STROKE	Background The consumption of red and processed meat has been associated with increased mortality from chronic diseases, and as a result, it has been classified by the World Health Organization as carcinogenic (processed meat) and probably carcinogenic (red meat) to humans. One policy response is to regulate red and processed meat consumption similar to other carcinogens and foods of public health concerns. Here we describe a market-based approach of taxing red and processed meat according to its health impacts. Methods We calculated economically optimal tax levels for 149 world regions that would account for (internalize) the health costs associated with ill-health from red and processed meat consumption, and we used a coupled modelling framework to estimate the impacts of optimal taxation on consumption, health costs, and non-communicable disease mortality. Health impacts were estimated using a global comparative risk assessment framework, and economic responses were estimated using international data on health costs, prices, and price elasticities. Findings The health-related costs to society attributable to red and processed meat consumption in 2020 amounted to USD 285 billion (sensitivity intervals based on epidemiological uncertainty (SI), 93-431), three quarters of which were due to processed meat consumption. Under optimal taxation, prices for processed meat increased by 25% on average, ranging from 1% in low-income countries to over 100% in high-income countries, and prices for red meat increased by 4%, ranging from 0.2% to over 20%. Consumption of processed meat decreased by 16% on average, ranging from 1% to 25%, whilst red meat consumption remained stable as substitution for processed meat compensated price-related reductions. The number of deaths attributable to red and processed meat consumption decreased by 9% (222,000; SI, 38,000-357,000), and attributable health costs decreased by 14% (USD 41 billion; SI, 10-57) globally, in each case with greatest reductions in high and middle-income countries. Interpretation Including the social health cost of red and processed meat consumption in the price of red and processed meat could lead to significant health and environmental benefits, in particular in high and middle-income countries. The optimal tax levels estimated in this study are context-specific and can complement the simple rules of thumb currently used for setting health-motivated tax levels.	[Springmann, Marco; Godfrey, H. Charles J.; Rayner, Mike; Scarborough, Peter] Univ Oxford, Oxford Martin Programme Future Food, Oxford, England; [Springmann, Marco; Rayner, Mike; Scarborough, Peter] Univ Oxford, Nuffield Dept Populat Hlth, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England; [Mason-D'Coz, Daniel; Robinson, Sherman; Wiebe, Keith] IFPRI, Environm & Prod Technol Div, Washington, DC USA; [Mason-D'Coz, Daniel] CSIRO, Agr & Food, St Lucia, Qld, Australia; [Godfrey, H. Charles J.] Univ Oxford, Dept Zool, Oxford, England	University of Oxford; University of Oxford; CGIAR; International Food Policy Research Institute (IFPRI); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Oxford	Springmann, M (corresponding author), Univ Oxford, Oxford Martin Programme Future Food, Oxford, England.; Springmann, M (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Ctr Populat Approaches Noncommunicable Dis Preven, Oxford, England.	marco.springmann@dph.ox.ac.uk	Scarborough, Peter/ABD-6111-2021; Mason-D'Croz, Daniel/M-4254-2016	Scarborough, Peter/0000-0002-2378-2944; Mason-D'Croz, Daniel/0000-0003-0673-2301; Wiebe, Keith/0000-0001-6035-620X	Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP) [205212/Z/16/Z]; CGIAR Research Program on Policies, Institutions, and Markets (PIM); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS); BHF Intermediate Basic Science Research Fellowship [FS/15/34/31656]; British Heart Foundation [006/PSS/CORE/2016/OXFORD]; NERC [NE/M021386/1] Funding Source: UKRI	Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP); CGIAR Research Program on Policies, Institutions, and Markets (PIM)(CGIAR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR); BHF Intermediate Basic Science Research Fellowship; British Heart Foundation(British Heart Foundation); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Wellcome Trust, Our Planet Our Health (Livestock, Environment and People - LEAP), award number 205212/Z/16/Z to MS, HCJG; the CGIAR Research Programs on Policies, Institutions, and Markets (PIM) and on Climate Change, Agriculture and Food Security (CCAFS) to KW, SR, DMD; a BHF Intermediate Basic Science Research Fellowship FS/15/34/31656 to PS; the British Heart Foundation, grant number 006/PSS/CORE/2016/OXFORD to MR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abete I, 2014, BRIT J NUTR, V112, P762, DOI 10.1017/S000711451400124X; Alexandratos N, 2012, 1203 ESA FA3; Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; BAUMOL WJ, 1972, AM ECON REV, V62, P307; Bergenstal RM, 2013, DIABETES CARE, V36, pE107, DOI 10.2337/dc13-0295; Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1; Chan DSM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020456, 10.1371/journal.pone.0027218]; Chen GC, 2013, EUR J CLIN NUTR, V67, P91, DOI 10.1038/ejcn.2012.180; Cornelsen L, 2015, FOOD RES COLLAB POLI; Cornelsen L, 2015, HEALTH ECON, V24, P1548, DOI 10.1002/hec.3107; Eyles H, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001353; Feskens EJM, 2013, CURR DIABETES REP, V13, P298, DOI 10.1007/s11892-013-0365-0; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; GARNETT T, 2015, POLICIES ACTIONS SHI; Green R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3703; Gustavsson J., 2011, Global food losses and food waste: extent, causes and prevention; Herrero M, 2016, NAT CLIM CHANGE, V6, P452, DOI [10.1038/nclimate2925, 10.1038/NCLIMATE2925]; IEA, 2015, CO2 EM FUEL COMB HIG; Koster I, 2011, EXP CLIN ENDOCR DIAB, V119, P377, DOI 10.1055/s-0030-1269847; Larsson SC, 2013, AM J EPIDEMIOL; Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Melina V, 2016, J ACAD NUTR DIET, V116, P1970, DOI 10.1016/j.jand.2016.09.025; Micha R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008705; Micha R, 2012, CURR ATHEROSCLER REP, V14, P515, DOI 10.1007/s11883-012-0282-8; Micha R, 2010, CIRCULATION, V121, P2271, DOI 10.1161/CIRCULATIONAHA.109.924977; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Mytton OT, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2931; Nghiem N, 2013, AM J PUBLIC HEALTH, V103, P1954, DOI 10.2105/AJPH.2013.301337; Nichols M., 2012, EUROPEAN CARDIOVASCU; Pan A, 2012, ARCH INTERN MED, V172, P555, DOI 10.1001/archinternmed.2011.2287; Pigou A., 1932, EC WELFARE; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Smed S, 2016, EUR J CLIN NUTR, V70, P681, DOI 10.1038/ejcn.2016.6; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Springmann M, 2017, NAT CLIM CHANGE, V7, P69, DOI [10.1038/NCLIMATE3155, 10.1038/nclimate3155]; Springmann M, 2016, LANCET, V387, P1937, DOI 10.1016/S0140-6736(15)01156-3; Springmann M, 2016, P NATL ACAD SCI USA, V113, P4146, DOI 10.1073/pnas.1523119113; Steinfeld H., 2006, Livestock's long shadow: environmental issues and options; Thow AM, 2014, NUTR REV, V72, P551, DOI 10.1111/nure.12123; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Wang X, 2016, PUBLIC HEALTH NUTR, V19, P893, DOI 10.1017/S1368980015002062; WCRF/AICR, 2007, FOOD NUTR PHYS ACT P; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; Wollenberg E, 2016, GLOBAL CHANGE BIOL, V22, P3859, DOI 10.1111/gcb.13340; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	49	56	56	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0204139	10.1371/journal.pone.0204139	http://dx.doi.org/10.1371/journal.pone.0204139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ4NU	30399152	Green Published, gold, Green Submitted			2022-12-26	WOS:000449374000001
J	Clark, SG; Graybeal, LL; Bhattacharjee, S; Thomas, C; Bhattacharya, S; Cox, DN				Clark, Sarah G.; Graybeal, Lacey L.; Bhattacharjee, Shatabdi; Thomas, Caroline; Bhattacharya, Surajit; Cox, Daniel N.			Basal autophagy is required for promoting dendritic terminal branching in Drosophila sensory neurons	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NEURODEGENERATIVE DISEASES; MULTIDENDRITIC NEURONS; CELL-GROWTH; MECHANISMS; DEATH; DEGENERATION; MORPHOLOGY; CUT; DEGRADATION	Dendrites function as the primary sites for synaptic input and integration with impairments in dendritic arborization being associated with dysfunctional neuronal circuitry. Post-mitotic neurons require high levels of basal autophagy to clear cytotoxic materials and autophagic dysfunction under native or cellular stress conditions has been linked to neuronal cell death as well as axo-dendritic degeneration. However, relatively little is known regarding the developmental role of basal autophagy in directing aspects of dendritic arborization or the mechanisms by which the autophagic machinery may be transcriptionally regulated to promote dendritic diversification. We demonstrate that autophagy-related (Atg) genes are positively regulated by the homeodomain transcription factor Cut, and that basal autophagy functions as a downstream effector pathway for Cut-mediated dendritic terminal branching in Drosophila multidendritic (md) sensory neurons. Further, loss of function analyses implicate Atg genes in promoting cell type-specific dendritic arborization and terminal branching, while gain of function studies suggest that excessive autophagy leads to dramatic reductions in dendritic complexity. We demonstrate that the Atg1 initiator kinase interacts with the dual leucine zipper kinase (DLK) pathway by negatively regulating the E3 ubiquitin ligase Highwire and positively regulating the MAPKKK Wallenda. Finally, autophagic induction partially rescues dendritic atrophy defects observed in a model of polyglutamine toxicity. Collectively, these studies implicate transcriptional control of basal autophagy in directing dendritic terminal branching and demonstrate the importance of homeostatic control of autophagic levels for dendritic arbor complexity under native or cellular stress conditions.	[Clark, Sarah G.; Bhattacharjee, Shatabdi; Bhattacharya, Surajit; Cox, Daniel N.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Graybeal, Lacey L.; Thomas, Caroline; Cox, Daniel N.] George Mason Univ, Sch Syst Biol, Krasnow Inst Adv Study, Fairfax, VA 22030 USA	University System of Georgia; Georgia State University; George Mason University	Cox, DN (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.; Cox, DN (corresponding author), George Mason Univ, Sch Syst Biol, Krasnow Inst Adv Study, Fairfax, VA 22030 USA.	dcox18@gsu.edu	Bhattacharya, Surajit/AAH-8132-2019	Cox, Daniel/0000-0001-9191-9212; Bhattacharjee, Shatabdi/0000-0003-0850-7319	National Institute of Mental Health [R15 MH086928]; National Institute of Neurological Disease and Stroke grant from the National Institutes of Health [R01 NS086082]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086082] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disease and Stroke grant from the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a National Institute of Mental Health grant (R15 MH086928) and National Institute of Neurological Disease and Stroke grant (R01 NS086082) from the National Institutes of Health to DNC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsley JA, 2003, CURR BIOL, V13, P1557, DOI 10.1016/S0960-9822(03)00596-7; Bhattacharya Surajit, 2014, Genom Data, V2, P378; Bilen J, 2007, PLOS GENET, V3, P1950, DOI 10.1371/journal.pgen.003177; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Chang YY, 2010, FEBS LETT, V584, P1342, DOI 10.1016/j.febslet.2010.01.006; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Chung CG, 2017, CELL REP, V20, P356, DOI 10.1016/j.celrep.2017.06.059; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Corty MM, 2016, DEVELOPMENT, V143, P1351, DOI 10.1242/dev.130906; Das R, 2017, GENETICS, V207, P1401, DOI 10.1534/genetics.117.300393; Grueber WB, 2003, CELL, V112, P805, DOI 10.1016/S0092-8674(03)00160-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Han C, 2011, P NATL ACAD SCI USA, V108, P9673, DOI 10.1073/pnas.1106386108; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang J, 2007, CELL CYCLE, V6, P1837, DOI 10.4161/cc.6.15.4511; Iyer E. P. R., 2009, JOVE-J VIS EXP, V34, P1599, DOI DOI 10.3791/1599; Iyer EPR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072434; Iyer SC, 2013, J CELL SCI, V126, P4732, DOI 10.1242/jcs.131144; Iyer SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033634; Jan YN, 2010, NAT REV NEUROSCI, V11, P316, DOI 10.1038/nrn2836; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kadandale P, 2010, P NATL ACAD SCI USA, V107, P10502, DOI 10.1073/pnas.0914168107; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lee JA, 2009, BMB REP, V42, P324, DOI 10.5483/BMBRep.2009.42.6.324; Lee SB, 2011, P NATL ACAD SCI USA, V108, P16795, DOI 10.1073/pnas.1113573108; Lefebvre JL, 2015, ANNU REV CELL DEV BI, V31, P741, DOI 10.1146/annurev-cellbio-100913-013020; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; McPhee CK, 2009, BBA-MOL CELL RES, V1793, P1452, DOI 10.1016/j.bbamcr.2009.02.009; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Nagel J, 2012, DEVELOPMENT, V139, P2999, DOI 10.1242/dev.077800; Nanda S, 2017, CONT CLIN NEUROSCIEN, DOI [10.1007/9783-319-52067-4_1, DOI 10.1007/9783-319-52067-4_1]; Nascimento-Ferreira I, 2011, BRAIN, V134, P1400, DOI 10.1093/brain/awr047; Neufeld TP, 2008, AUTOPHAGY, V4, P557, DOI 10.4161/auto.5782; Parrish JZ, 2009, NEURON, V63, P788, DOI 10.1016/j.neuron.2009.08.006; Petersen LK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024531; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Poe AR, 2017, P NATL ACAD SCI USA, V114, pE8062, DOI 10.1073/pnas.1707467114; Puram SV, 2013, DEVELOPMENT, V140, P4657, DOI 10.1242/dev.087676; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rubinsztein DC, 2012, CURR BIOL, V22, pR29, DOI 10.1016/j.cub.2011.11.034; Saitoh Y, 2015, J BIOL CHEM, V290, P1442, DOI 10.1074/jbc.M114.590281; Santiago C, 2014, DEVELOPMENT, V141, P4667, DOI 10.1242/dev.110817; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Shen W, 2009, J CELL BIOL, V187, P71, DOI 10.1083/jcb.200907109; Son JH, 2012, EXP MOL MED, V44, P89, DOI 10.3858/emm.2012.44.2.031; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Stewart A, 2012, J NEUROSCI, V32, P11631, DOI 10.1523/JNEUROSCI.0729-12.2012; Sulkowski MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022611; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Turner HN, 2016, CURR BIOL, V26, P3116, DOI 10.1016/j.cub.2016.09.038; Wang X, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001572; Wen YH, 2013, MOL CELL NEUROSCI, V52, P140, DOI 10.1016/j.mcn.2012.11.008; Winslow AR, 2008, BBA-MOL BASIS DIS, V1782, P723, DOI 10.1016/j.bbadis.2008.06.010; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Yang Y, 2013, TRENDS NEUROSCI, V36, P418, DOI 10.1016/j.tins.2013.04.001; Yang ZF, 2009, CURR TOP MICROBIOL, V335, P1, DOI 10.1007/978-3-642-00302-8_1; Yue ZY, 2009, BBA-MOL CELL RES, V1793, P1496, DOI 10.1016/j.bbamcr.2009.01.016; Zirin J, 2010, SEMIN IMMUNOPATHOL, V32, P363, DOI 10.1007/s00281-010-0223-y	66	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206743	10.1371/journal.pone.0206743	http://dx.doi.org/10.1371/journal.pone.0206743			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395636	Green Submitted, Green Published, gold			2022-12-26	WOS:000449291400048
J	Telfer, E; Graham, N; Macdonald, L; Sturrock, S; Wilcox, P; Stanbra, L				Telfer, Emily; Graham, Natalie; Macdonald, Lucy; Sturrock, Shane; Wilcox, Phillip; Stanbra, Lisa			Approaches to variant discovery for conifer transcriptome sequencing	PLOS ONE			English	Article							CROSS-SPECIES TRANSFERABILITY; READ ALIGNMENT; PINUS-RADIATA; SNP DISCOVERY; GENOME SIZE; FRAMEWORK	There is a wide diversity of bioinformatic tools available for the assembly of next generation sequence and subsequence variant calling to identify genetic markers at scale. Integration of genomics tools such as genomic selection, association studies, pedigree analysis and analysis of genetic diversity, into operational breeding is a goal for New Zealand's most widely planted exotic tree species, Pinus radiata. In the absence of full reference genomes for large megagenomes such as in conifers, RNA sequencing in a range of genotypes and tissue types, offers a rich source of genetic markers for downstream application. We compared nine different assembler and variant calling software combinations in a single transcriptomic library and found that Single Nucleotide Polymorphism (SNPs) discovery could vary by as much as an order of magnitude (8,061 SNPs up to 86,815 SNPs). The assembler with the best realignment of the packages trialled, Trinity, in combination with several variant callers was then applied to a much larger multi-genotype, multi-tissue transcriptome and identified 683,135 in silico SNPs across a predicted 449,951 exons when mapped to the Pinus taeda ver 1.01e reference.	[Telfer, Emily; Graham, Natalie; Macdonald, Lucy; Sturrock, Shane; Stanbra, Lisa] New Zealand Forest Res Inst LTD, Scion, Rotorua, New Zealand; [Sturrock, Shane] Real Time Genom, Hamilton, New Zealand; [Wilcox, Phillip] Univ Otago, Dept Math & Stat, Dunedin, New Zealand	Scion; University of Otago	Telfer, E (corresponding author), New Zealand Forest Res Inst LTD, Scion, Rotorua, New Zealand.	emily.telfer@scionresearch.com		Graham, Natalie/0000-0002-0676-8403; Telfer, Emily/0000-0001-5269-6589	Foundation for Research, Science and Technology (FRST) [CO4X0703]; Strategic Science Investment Fund (SSIF)	Foundation for Research, Science and Technology (FRST)(New Zealand Foundation for Research, Science and Technology); Strategic Science Investment Fund (SSIF)	The financial support for this project has come from an agency that has since undergone a name change. The original financial support came from Foundation for Research, Science and Technology (FRST) Contract number CO4X0703 and has since been supported by our internally allocated Strategic Science Investment Fund (SSIF), allocated to New Zealand Forest Research Institute LTD, trading as Scion from the Ministry of Business, Innovation and Employment.	AppliedBiosystems, 2011, SOLID SYST NEXT GEN; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Canales J, 2014, PLANT BIOTECHNOL J, V12, P286, DOI 10.1111/pbi.12136; Cato S, 2006, PLANT MOL BIOL, V60, P565, DOI 10.1007/s11103-005-5022-9; Chagne D, 2004, THEOR APPL GENET, V109, P1204, DOI 10.1007/s00122-004-1683-z; Chopra R, 2015, MOL GENET GENOMICS, V290, P1169, DOI 10.1007/s00438-014-0976-4; Cokus SJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1761-4; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; De La Torre AR, 2014, PLANT PHYSIOL, V166, P1724, DOI 10.1104/pp.114.248708; De Wit P, 2015, MOL ECOL, V24, P2310, DOI 10.1111/mec.13165; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dillon SK, 2012, NEW PHYTOL, V195, P596, DOI 10.1111/j.1469-8137.2012.04200.x; Du J, 2017, BIOTECHNOLOGY BIOTEC, P1, DOI DOI 10.1080/13102818.2017.1335176; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fernandez-Pozo N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-366; Garrison, 2010, FREEBAYES; Geraldes A, 2011, MOL ECOL RESOUR, V11, P81, DOI 10.1111/j.1755-0998.2010.02960.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Honaas LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146062; Humble Emily, 2016, BMC Research Notes, V9, P418, DOI 10.1186/s13104-016-2209-x; Illumina, 2013, ILL CUST GEN OPT; Illumina, 2016, HISEQ 2500 PERF SPEC; Illumina, 2011, TECHN SOL TECHN; Isik F, 2014, NEW FOREST, V45, P379, DOI 10.1007/s11056-014-9422-z; Lamara M, 2016, NEW PHYTOL, V210, P240, DOI 10.1111/nph.13762; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee W., 2010, MOSAIK ALIGNER; Leonarduzzi C, 2016, PLANT MOL BIOL REP, V34, P993, DOI 10.1007/s11105-016-0980-4; Lesser MR, 2012, MOL ECOL RESOUR, V12, P448, DOI 10.1111/j.1755-0998.2011.03102.x; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li Y, 2017, SIMULATION IMPACT GE; Li YJ, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1019-6; Liu JJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3079-2; Liu JJ, 2014, CONSERV GENET RESOUR, V6, P647, DOI 10.1007/s12686-014-0168-x; Liu L, 2015, INT J MOL SCI, V16, P29047, DOI 10.3390/ijms161226139; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Mann IK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-702; Mast S, 2010, TREE PHYSIOL, V30, P1456, DOI 10.1093/treephys/tpq084; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meuwissen THE, 2001, GENETICS, V157, P1819; Ministry for Primary Industries & Forest Owners Association, 2016, FACTS FIG; Neves LG, 2013, PLANT J, V75, P146, DOI 10.1111/tpj.12193; Raj M, 2005, SILVAE GENET, V54, P126, DOI 10.1515/sg-2005-0020; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Silva OB, 2015, NEW PHYTOL, V206, P1527, DOI 10.1111/nph.13322; WAKAMIYA I, 1993, AM J BOT, V80, P1235, DOI 10.2307/2445706; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wegrzyn JL, 2014, GENETICS, V196, P891, DOI 10.1534/genetics.113.159996; Yang Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-328; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	55	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0205835	10.1371/journal.pone.0205835	http://dx.doi.org/10.1371/journal.pone.0205835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395612	Green Submitted, gold, Green Published			2022-12-26	WOS:000449291400012
J	Garcia-Tejero, S; Spence, JR; O'Halloran, J; Bourassa, S; Oxbrough, A				Garcia-Tejero, Sergio; Spence, John R.; O'Halloran, John; Bourassa, Stephane; Oxbrough, Anne			Natural succession and clearcutting as drivers of environmental heterogeneity and beta diversity in North American boreal forests	PLOS ONE			English	Article							BEETLES COLEOPTERA; SPECIES-DIVERSITY; MIXEDWOOD; DISTURBANCE; LITTER; MANAGEMENT; SELECTION	Clear-cutting alters natural ecosystem processes by reducing landscape heterogeneity. It is the dominant harvesting technique across the boreal zone, yet understanding of how environmental heterogeneity and beta diversity are structured in forest ecosystems and post-clear cut is lacking. We use ground-dwelling arthropods as models to determine how natural succession (progression from deciduous to mixed to coniferous cover types) and clear-cutting change boreal forests, exploring the role of environmental heterogeneity in shaping beta diversity across multiple spatial scales (between-cover types and between-stands of the same cover type (1600 to 8500 m), between-plots (100 to 400 m) and within-plots (20 to 40 m)). We characterise environmental heterogeneity as variability in combined structural, vegetational and soil parameters, and beta diversity, as variability in assemblage composition. Clear-cutting homogenised forest environments across all spatial scales, reducing total environmental heterogeneity by 35%. Arthropod beta diversity reflected these changes at larger scales suggesting that environmental heterogeneity is useful in explaining beta diversity both between-cover types and between-stands of the same cover type. However, at smaller scales, within- and between-plots spider beta diversity reflected the lower environmental heterogeneity in regenerating stands, whereas staphylinid and carabids assemblages were not homogenised 12 years post-harvest. Differences in environmental heterogeneity and staphylinid beta diversity between cover types were also important at small scales. In regenerating stands, we detected a subtle yet notable effect of pre-felling cover type on environmental heterogeneity and arthropods, where pre-felling cover type accounted for a significant amount of variance in beta diversity, indicating that biological legacies (e.g. soil pH reflecting pre-harvest conditions) may have a role in driving beta diversity even 12 years post-harvest. This study highlights the importance of understanding site history when predicting impacts of change in forest ecosystems. Further, to understand drivers of beta diversity we must identify biological legacies shaping community structure.	[Garcia-Tejero, Sergio; Oxbrough, Anne] Edge Hill Univ, Dept Biol, Ormskirk, Lancs, England; [Spence, John R.] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [O'Halloran, John] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Bourassa, Stephane] Laurentian Forestry Ctr, Quebec City, PQ, Canada	Edge Hill University; University of Alberta; University College Cork	Oxbrough, A (corresponding author), Edge Hill Univ, Dept Biol, Ormskirk, Lancs, England.	anne.oxbrough@edgehill.ac.uk	Oxbrough, Anne/ABB-5473-2020	Oxbrough, Anne/0000-0001-8065-7085	COFUND IRCSET-Marie Curie International Mobility Fellowship 2009-2014; Edge Hill University Research Investment Fund; Daishowa-Marubeni International Ltd.; Canadian Forest Products Ltd.; Alberta Ministry of Agriculture and Forestry; Foothills Research Institute	COFUND IRCSET-Marie Curie International Mobility Fellowship 2009-2014; Edge Hill University Research Investment Fund; Daishowa-Marubeni International Ltd.; Canadian Forest Products Ltd.(Natural Resources CanadaCanadian Forest Service); Alberta Ministry of Agriculture and Forestry; Foothills Research Institute	This research was funded through a COFUND IRCSET-Marie Curie International Mobility Fellowship 2009-2014 (https://cordis.europa.eu/project/rcn/90290_en. html) and an Edge Hill University Research Investment Fund Grant 2012-2014 (https://www.edgehill.ac.uk/), to AO. The data was collected at the EMEND project which receives some funding from Daishowa-Marubeni International Ltd., Canadian Forest Products Ltd., Alberta Ministry of Agriculture and Forestry and the Foothills Research Institute. The funders of the research and the EMEND project had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclerc A, 2012, ECOL ENG, V42, P260, DOI 10.1016/j.ecoleng.2012.02.024; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; Bergeron JAC, 2017, OIKOS, V126, P1738, DOI 10.1111/oik.04208; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Bohac J, 1999, AGR ECOSYST ENVIRON, V74, P357, DOI 10.1016/S0167-8809(99)00043-2; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; BULTMAN TL, 1984, AM MIDL NAT, V111, P165, DOI 10.2307/2425555; CCFM Canadian Council of Forest Ministers, 2016, SILV NAT TABL; Chaudhary A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23954; Digweed SC, 1995, PEDOBIOLOGIA, V39, P561; Gradowski T, 2010, FOREST ECOL MANAG, V259, P383, DOI 10.1016/j.foreco.2009.10.033; GREENSTONE MH, 1984, OECOLOGIA, V62, P299, DOI 10.1007/BF00384260; Horn H. S., 1974, Annual Review of Ecology and Systematics, V5, P25, DOI 10.1146/annurev.es.05.110174.000325; Hunter M.L., 1999, J WILDLIFE MANAGE; Johansson T, 2016, FOREST ECOL MANAG, V359, P65, DOI 10.1016/j.foreco.2015.09.041; Kembel SW, 2006, J VEG SCI, V17, P783, DOI 10.1111/j.1654-1103.2006.tb02501.x; Kimmins H, 1997, BALANCING ACT ENV IS; Koivula M, 1999, ECOGRAPHY, V22, P424, DOI 10.1111/j.1600-0587.1999.tb00579.x; Kuuluvainen T, 2002, SILVA FENN, V36, P97, DOI 10.14214/sf.552; Legendre P, 2013, ECOL LETT, V16, P951, DOI 10.1111/ele.12141; Lieffers VJ, 1996, FOREST CHRON, V72, P286, DOI 10.5558/tfc72286-3; Lindenmayer DB, 2006, BIOL CONSERV, V131, P433, DOI 10.1016/j.biocon.2006.02.019; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Macdonald SE, 2007, FOREST ECOL MANAG, V242, P34, DOI 10.1016/j.foreco.2007.01.029; Niemela J, 1996, ECOGRAPHY, V19, P352, DOI 10.1111/j.1600-0587.1996.tb01264.x; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Oksanen J, 2010, R PACKAGE VERSION 1; PAJE F, 1984, OECOLOGIA, V64, P41, DOI 10.1007/BF00377541; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pinzon J, 2012, FOREST ECOL MANAG, V266, P42, DOI 10.1016/j.foreco.2011.10.045; R-Core-Team, 2015, LANG ENV STAT COMP; Rodriguez A, 2017, ECOL APPL, V27, P589, DOI 10.1002/eap.1468; Rudolphi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018639; Spence JR, 2008, CAN ENTOMOL, V140, P510, DOI 10.4039/N07-Ls05; Spence JR, 2001, TRENDS ECOL EVOL, V16, P591, DOI 10.1016/S0169-5347(01)02335-7; Statbank, 2017, STAT NORW NAT FOR IN; Swanson ME, 2011, FRONT ECOL ENVIRON, V9, P117, DOI 10.1890/090157; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; THAYER MK, 2005, HDB ZOOLOGY, V4, P296, DOI 10.1515/9783110904550; Thiele H, 1977, CARABID BEETLES THEI; Thomas PA, 2007, ECOLOGY OF WOODLANDS AND FORESTS: DESCRIPTION, DYNAMICS AND DIVERSITY, P1, DOI 10.1017/CBO9780511805578; Uetz G.W., 1991, P325; UETZ GW, 1979, OECOLOGIA, V40, P29, DOI 10.1007/BF00388808; VanStraalen NM, 1997, J APPL ECOL, V34, P217, DOI 10.2307/2404860; Victorsson J, 2013, INSECT CONSERV DIVER, V6, P483, DOI 10.1111/icad.12005; Wise DH, 1993, SPIDERS ECOLOGICAL W; Woodcock BA, 2005, METH ECOL, P37, DOI 10.1002/9780470750513.ch3; Work TT, 2013, ZOOKEYS, P31, DOI 10.3897/zookeys.258.4174; Work TT, 2004, CAN J FOREST RES, V34, P417, DOI 10.1139/X03-238	49	9	9	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206931	10.1371/journal.pone.0206931	http://dx.doi.org/10.1371/journal.pone.0206931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388175	gold, Green Submitted, Green Published			2022-12-26	WOS:000449289800074
J	Mettananda, S; Suranjan, M; Fernando, R; Dias, T; Mettananda, C; Rodrigo, R; Perera, L; Gibbons, R; Premawardhena, A; Higgs, D				Mettananda, Sachith; Suranjan, Marius; Fernando, Roshale; Dias, Tiran; Mettananda, Chamila; Rodrigo, Rexan; Perera, Lakshman; Gibbons, Richard; Premawardhena, Anuja; Higgs, Douglas			Anaemia among females in child-bearing age: Relative contributions, effects and interactions of alpha- and beta-thalassaemia	PLOS ONE			English	Article							GLOBIN; PREVENTION; PREGNANCY; OUTCOMES; BURDEN	Introduction Anaemia in women during pregnancy and child bearing age is one of the most common global health problems. Reasons are numerous, but in many cases only minimal attempts are made to elucidate the underlying causes. In this study we aim to identify aetiology of anaemia in women of child bearing age and to determine the relative contributions, effects and interactions of alpha- and beta-thalassaemia in a region of the world where thalassaemia is endemic. Methods A cross sectional study was conducted at the Colombo North Teaching Hospital of Sri Lanka. The patient database of deliveries between January 2015 and September 2016 at University Obstetrics Unit was screened to identify women with anaemia during pregnancy and 253 anaemic females were randomly re-called for the study. Data were collected using an interviewer-administered questionnaire and haematological investigations were done to identify aetiologies. Results Out of the 253 females who were anaemic during pregnancy and were re-called, 8 were excluded due to being currently pregnant. Of the remaining 245 females, 117(47.8%) remained anaemic and another 22(9.0%) had non-anaemic microcytosis. Of anaemic females, 28(24.8%) were iron deficient, 40(35.4%) had low-normal serum ferritin without fulfilling the criteria for iron deficiency,18(15.3%) had beta-haemoglobinopathy trait and 20 (17.0%) had alpha-thalassaemia trait. Of females who had non-anaemic microcytosis, 14 (66.0%) had alpha-thalassaemia trait. In 4 females, both alpha- and beta-thalassaemia trait coexist. These females had higher levels of haemoglobin (p = 0.06), MCV (p<0.05) and MCH (p<0.01) compared to individuals with only beta-thalassaemia trait. A significantly higher proportion of premature births (p<0.01) and lower mean birth weights (p<0.05) were observed in patients with alpha-thalassaemia trait. Conclusions Nearly one third of anaemic females in child bearing age had thalassaemia trait of which alpha-thalassemia contributes to a majority. Both alpha- and beta-thalassaemia trait can co-exist and have ameliorating effects on red cell indices in heterozygous states. alpha-Thalassaemia trait was significantly associated with premature births and low birth weight. It is of paramount importance to investigate the causes of anaemia in women of child bearing age and during pregnancy in addition to providing universal iron supplementation.	[Mettananda, Sachith; Suranjan, Marius; Fernando, Roshale] Univ Kelaniya, Fac Med, Dept Paediat, Ragama, Sri Lanka; [Mettananda, Sachith; Dias, Tiran; Premawardhena, Anuja] Colombo North Teaching Hosp, Ragama, Sri Lanka; [Dias, Tiran] Univ Kelaniya, Fac Med, Dept Obstet & Gynaecol, Ragama, Sri Lanka; [Mettananda, Chamila] Univ Kelaniya, Fac Med, Dept Pharmacol, Ragama, Sri Lanka; [Rodrigo, Rexan; Perera, Lakshman; Premawardhena, Anuja] Univ Kelaniya, Fac Med, Dept Med, Ragama, Sri Lanka; [Gibbons, Richard; Higgs, Douglas] Univ Oxford, MRC Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford, England	University Kelaniya; University of Colombo; Colombo North Teaching Hospital; University Kelaniya; University Kelaniya; University Kelaniya; University of Oxford	Mettananda, S (corresponding author), Univ Kelaniya, Fac Med, Dept Paediat, Ragama, Sri Lanka.; Mettananda, S (corresponding author), Colombo North Teaching Hosp, Ragama, Sri Lanka.	sachith.mettananda@kln.ac.lk	Mettananda, Kukulege Chamila Dinushi/Y-3222-2019; Mettananda, Sachith/H-4640-2019; Premawardhena, Anuja/GLN-5388-2022	Mettananda, Kukulege Chamila Dinushi/0000-0002-3328-1553; Mettananda, Sachith/0000-0002-0760-0418; Premawardhena, Anuja/0000-0003-0605-9081; Rodrigo, Rexan/0000-0002-2194-8453	Medical Research Council UK Discovery Award [MC_PC_15069]; MRC [MC_UU_12009/4, MC_U137961144, G1000801, MC_PC_15069, MC_U137961145, MC_UU_00016/4] Funding Source: UKRI	Medical Research Council UK Discovery Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council UK Discovery Award Grant to DRH (MC_PC_15069). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188110; Goonewardene M, 2012, BEST PRACT RES CL OB, V26, P3, DOI 10.1016/j.bpobgyn.2011.10.010; Gunawardena K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001341; Hanprasertpong T, 2013, ARCH GYNECOL OBSTET, V288, P1051, DOI 10.1007/s00404-013-2886-9; Harteveld CL, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-13; KANAVAKIS E, 1982, BRIT J HAEMATOL, V52, P465, DOI 10.1111/j.1365-2141.1982.tb03916.x; Kassebaum NJ, 2016, HEMATOL ONCOL CLIN N, V30, P247, DOI 10.1016/j.hoc.2015.11.002; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; Li DZ, 2006, HAEMATOLOGICA, V91, P649; Mettananda S, 2017, CEYLON MED J, V62, P73, DOI 10.4038/cmj.v62i2.8469; Mettananda S, 2017, SRI LANKA J CHILD HL, V46, P203, DOI DOI 10.4038/sljch.v46i3.8318; Mettananda S, 2017, SRI LANKA J CHILD HL, V46, P307; Mettananda S, 2018, HEMATOL ONCOL CLIN N, V32, P177, DOI 10.1016/j.hoc.2017.11.003; Mettananda S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00479-7; Mettananda S, 2017, HAEMATOLOGICA, V102, pE80, DOI 10.3324/haematol.2016.155655; Mettananda S, 2016, ANN NY ACAD SCI, V1368, P16, DOI 10.1111/nyas.12988; Mettananda S, 2015, BLOOD, V125, P3694, DOI 10.1182/blood-2015-03-633594; Neuberger A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006589.pub4; Paganini D, 2017, GUT, V66, P1956, DOI 10.1136/gutjnl-2017-314418; Premawardhena A, 2017, BRIT J HAEMATOL, V176, P475, DOI 10.1111/bjh.14437; Rodrigo R, 2018, BLOOD CELLS MOL DIS; Shretta R, 2017, MAJOR INFECT DIS, DOI 10.1596/978-1-4648-0524-0_ch12; Smithers LG, 2014, PAEDIATR PERINAT EP, V28, P381, DOI 10.1111/ppe.12149; Weatherall DJ, 2011, TRANSFUSION MED, V21, P218, DOI 10.1111/j.1365-3148.2011.01090.x; Weatherall DJ., 2001, THALASSAEMIA SYNDROM, V4th ed; WHO, 2016, WHO TECH REP SER, V997, P1; Wijesundere DA, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00212	27	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206928	10.1371/journal.pone.0206928	http://dx.doi.org/10.1371/journal.pone.0206928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388173	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800073
J	Harshman, SW; Pitsch, RL; Smith, ZK; O'Connor, ML; Geier, BA; Qualley, AV; Schaeublin, NM; Fischer, MV; Eckerle, JJ; Strang, AJ; Martin, JA				Harshman, Sean W.; Pitsch, Rhonda L.; Smith, Zachary K.; O'Connor, Maegan L.; Geier, Brian A.; Qualley, Anthony, V; Schaeublin, Nicole M.; Fischer, Molly, V; Eckerle, Jason J.; Strang, Adam J.; Martin, Jennifer A.			The proteomic and metabolomic characterization of exercise-induced sweat for human performance monitoring: A pilot investigation	PLOS ONE			English	Article							WHOLE-BODY WASHDOWN; MASS-SPECTROMETRY; LACTATE; AMMONIA; METLIN; HMDB; COLLECTION; IDENTIFICATION; EXCRETION; RETENTION	Sweat is a biofluid with several attractive attributes. However, investigation into sweat for biomarker discovery applications is still in its infancy. To add support for the use of sweat as a non-invasive media for human performance monitoring, volunteer participants were subjected to a physical exertion model using a treadmill. Following exercise, sweat was collected, aliquotted, and analyzed for metabolite and protein content via high-resolution mass spectrometry. Overall, the proteomic analysis illustrates significant enrichment steps will be required for proteomic biomarker discovery from single sweat samples as protein abundance is low in this medium. Furthermore, the results indicate a potential for protein degradation, or a large number of low molecular weight protein/peptides, in these samples. Metabolomic analysis shows a strong correlation in the overall abundance among sweat metabolites. Finally, hierarchical clustering of participant metabolite abundances show trends emerging, although no significant trends were observed (alpha = 0.8, lambda = 1 standard error via cross validation). However, these data suggest with a greater number of biological replicates, stronger, statistically significant results, can be obtained. Collectively, this study represents the first to simultaneously use both proteomic and metabolomic analysis to investigate sweat. These data highlight several pitfalls of sweat analysis for biomarker discovery applications.	[Harshman, Sean W.; Smith, Zachary K.; Qualley, Anthony, V; Schaeublin, Nicole M.] UES Inc, Air Force Res Lab, Wright Patterson AFB, OH 45433 USA; [Pitsch, Rhonda L.] Henry M Jackson Fdn Adv Mil Med, Air Force Res Lab, Wright Patterson AFB, OH USA; [O'Connor, Maegan L.; Fischer, Molly, V] Oak Ridge Inst Sci & Educ, Air Force Res Lab, Wright Patterson AFB, OH USA; [Geier, Brian A.; Strang, Adam J.; Martin, Jennifer A.] Air Force Res Lab, Wright Patterson AFB, OH USA; [Eckerle, Jason J.] Air Force Res Lab, InfoSciTex Corp, Wright Patterson AFB, OH USA	UES, Inc.; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; United States Department of Defense; United States Air Force; US Air Force Research Laboratory; United States Department of Defense; United States Air Force; US Air Force Research Laboratory	Harshman, SW (corresponding author), UES Inc, Air Force Res Lab, Wright Patterson AFB, OH 45433 USA.	sean.harshman.ctr@us.af.mil	Schaeublin, Nicole/AAK-3760-2020	Pitsch, Rhonda/0000-0002-9218-274X	UES Inc.; InfoSciTex Corp.; United States Air Force [FA8650-14-D-6516]	UES Inc.; InfoSciTex Corp.; United States Air Force(United States Department of Defense)	The funders, UES Inc. and InfoSciTex Corp., are commercial companies who provided support in the form of salaries for authors, SWH, ZKS, AVQ, NMS, JJE. United States Air Force provided support for this work via subcontract to UES Inc. (FA8650-14-D-6516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; United States Air Force provided support for this work via subcontract to UES Inc. (FA8650-14-D-6516). Opinions, interpretations, conclusions and recommendations are those of the authors and not necessarily endorsed by the United States Government. The authors would like to thank Dr. Heather Pangburn, Mr. Gregory Sudberry and Ms. Tenika Dearmond for their scholarly help for this manuscript.	Adewole OO, 2016, PROTEOM CLIN APPL, V10, P547, DOI 10.1002/prca.201500071; Agrawal K, 2017, J LIPID RES, V58, P188, DOI 10.1194/jlr.M071738; ALLAN JR, 1971, J APPL PHYSIOL, V30, P708, DOI 10.1152/jappl.1971.30.5.708; Alpert AJ, 2018, J CHROMATOGR A, V1538, P45, DOI 10.1016/j.chroma.2018.01.038; Alvear-Ordenes I, 2005, INT J SPORTS MED, V26, P632, DOI 10.1055/s-2004-830380; Baker LB, 2009, J APPL PHYSIOL, V107, P887, DOI 10.1152/japplphysiol.00197.2009; Benton HP, 2015, ANAL CHEM, V87, P884, DOI 10.1021/ac5025649; Benton HP, 2010, BIOINFORMATICS; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOYSEN TC, 1984, J APPL PHYSIOL, V56, P1302, DOI 10.1152/jappl.1984.56.5.1302; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUCE RA, 1949, J CLIN INVEST, V28, P1431, DOI 10.1172/JCI102208; BRUCE RA, 1949, J CLIN INVEST, V28, P1423, DOI 10.1172/JCI102207; BRUSILOW SW, 1968, AM J PHYSIOL, V214, P513, DOI 10.1152/ajplegacy.1968.214.3.513; Burian M, 2015, J INVEST DERMATOL, V135, P759, DOI 10.1038/jid.2014.462; Calderon-Santiago M, 2014, J CHROMATOGR A, V1333, P70, DOI 10.1016/j.chroma.2014.01.071; Calderon-Santiago M, 2015, ANAL BIOANAL CHEM, V407, P5381, DOI 10.1007/s00216-015-8700-8; Clarys P, 2017, SKIN RES TECHNOL, V23, P30, DOI 10.1111/srt.12297; Csosz E, 2015, J EUR ACAD DERMATOL, V29, P2024, DOI 10.1111/jdv.13221; Delgado-Povedano MD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1116-4; Delgado-Povedano MM, 2018, TALANTA, V177, P47, DOI 10.1016/j.talanta.2017.09.028; de Castro MDL, 2016, BIOANALYSIS, V8, P85, DOI 10.4155/bio.15.229; Dutkiewicz EP, 2014, ANAL CHEM, V86, P2337, DOI 10.1021/ac4039338; FALK B, 1991, J APPL PHYSIOL, V71, P1735, DOI 10.1152/jappl.1991.71.5.1735; FELLMANN N, 1983, J APPL PHYSIOL, V54, P355, DOI 10.1152/jappl.1983.54.2.355; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; FUKUMOTO T, 1988, CLIN CARDIOL, V11, P707, DOI 10.1002/clc.4960111010; GORSKI J, 1985, EUR J APPL PHYSIOL, V54, P416, DOI 10.1007/BF02337187; Gowda H, 2014, ANAL CHEM, V86, P6931, DOI 10.1021/ac500734c; Guijas C, 2018, ANAL CHEM, V90, P3156, DOI 10.1021/acs.analchem.7b04424; Guo Y, 2005, J CHROMATOGR A, V1074, P71, DOI 10.1016/j.chroma.2005.03.058; Harshman SW, 2016, J PROTEOMICS, V136, P89, DOI 10.1016/j.jprot.2015.12.016; Harshman SW, 2013, PROTEOMICS, V13, P3013, DOI 10.1002/pmic.201300142; Hayden G, 2004, EUR J APPL PHYSIOL, V91, P748, DOI 10.1007/s00421-004-1057-x; HERRMANN F, 1955, J INVEST DERMATOL, V24, P225, DOI 10.1038/jid.1955.36; Hooton K, 2016, ANAL CHEM, V88, P7378, DOI 10.1021/acs.analchem.6b01930; Jadoon S, 2015, INT J ANAL CHEM, V2015, DOI 10.1155/2015/164974; KAISER D, 1974, PFLUG ARCH EUR J PHY, V349, P63, DOI 10.1007/BF00587917; Kutyshenko VP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028824; LEMON PWR, 1986, J APPL PHYSIOL, V61, P1967, DOI 10.1152/jappl.1986.61.5.1967; LIAPPIS N, 1979, EUR J APPL PHYSIOL, V42, P227, DOI 10.1007/BF00423292; Luetkemeier MJ, 2017, MED SCI SPORT EXER, V49, P1432, DOI 10.1249/MSS.0000000000001244; Macedo AN, 2017, ACS CENTRAL SCI, V3, P904, DOI 10.1021/acscentsci.7b00299; Mark H, 2013, INT J COSMETIC SCI, V35, P163, DOI 10.1111/ics.12019; Mena-Bravo A, 2014, J PHARMACEUT BIOMED, V90, P139, DOI 10.1016/j.jpba.2013.10.048; Meyer F, 2007, BRAZ J MED BIOL RES, V40, P135, DOI 10.1590/S0100-879X2006005000044; Mi H, 2013, NATURECOM; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Morgan RM, 2004, ACTA PHYSIOL SCAND, V182, P37, DOI 10.1111/j.1365-201X.2004.01305.x; MORIMOTO T, 1967, NATURE, V216, P813, DOI 10.1038/216813a0; Park JH, 2011, J DERMATOL, V38, P1012, DOI 10.1111/j.1346-8138.2010.01186.x; Patterson MJ, 2000, EXP PHYSIOL, V85, P869, DOI 10.1017/S0958067000020583; Patterson MJ, 2002, ACTA PHYSIOL SCAND, V174, P41, DOI 10.1046/j.1365-201x.2002.00927.x; Patti GJ, 2013, ANAL CHEM, V85, P798, DOI 10.1021/ac3029745; Pilardeau P, 1979, Br J Sports Med, V13, P118; Pires FO, 2011, PSYCHOPHYSIOLOGY, V48, P1284, DOI 10.1111/j.1469-8986.2011.01187.x; Raiszadeh MM, 2012, J PROTEOME RES, V11, P2127, DOI 10.1021/pr2007957; Rinehart D, 2014, NAT BIOTECHNOL, V32, P524, DOI 10.1038/nbt.2927; Saat Mohamed, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P541, DOI 10.2114/jpa.24.541; Sakharov DA, 2010, B EXP BIOL MED+, V150, P83, DOI 10.1007/s10517-010-1075-0; SATO K, 1970, J INVEST DERMATOL, V54, P443, DOI 10.1111/1523-1747.ep12259272; Shirreffs SM, 1997, J APPL PHYSIOL, V82, P336, DOI 10.1152/jappl.1997.82.1.336; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; XU H, 2007, BMC BIOINFORMATICS, V8; Xu H, 2008, J PROTEOME RES, V7, P2605, DOI 10.1021/pr800002u; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Xu H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-347; YOSIPOVITCH G, 1994, J LAB CLIN MED, V124, P808; Yu YJ, 2017, J PROTEOMICS, V155, P40, DOI 10.1016/j.jprot.2017.01.005; Zhu ZJ, 2013, NAT PROTOC, V8, P451, DOI 10.1038/nprot.2013.004; 2009, METHODS MOL BIOL, V563, P1	78	22	23	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0203133	10.1371/journal.pone.0203133	http://dx.doi.org/10.1371/journal.pone.0203133			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383773	Green Published, gold			2022-12-26	WOS:000449027600007
J	Linton, SS; Abraham, T; Liao, J; Clawson, GA; Butler, PJ; Fox, T; Kester, M; Matters, GL				Linton, Samuel S.; Abraham, Thomas; Liao, Jason; Clawson, Gary A.; Butler, Peter J.; Fox, Todd; Kester, Mark; Matters, Gail L.			Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages	PLOS ONE			English	Article							PROSTAGLANDIN E-2; PD-L1 EXPRESSION; POOR-PROGNOSIS; FUSION; CHEMORESISTANCE; METASTASIS; INTEGRINS; MONOCYTES; MEMBRANE; CONFERS	Pancreatic ductal adenocarcinoma (PDAC) tumor growth is enhanced by tumor-associated macrophages (TAMs), yet the mechanisms by which tumor cells and TAMs communicate are not fully understood. Here we show that exosomes secreted by PDAC cell lines differed in their surface proteins, lipid composition, and efficiency of fusing with THP-1-derived macrophages in vitro. Exosomes from AsPC-1, an ascites-derived human PDAC cell line, were enriched in ICAM-1, which mediated their docking to macrophages through interactions with surface-exposed CD11c on macrophages. AsPC-1 exosomes also contained much higher levels of arachidonic acid (AA), and they fused at a higher rate with THP-1-derived macrophages than did exosomes from other PDAC cell lines or from an immortalized normal pancreatic ductal epithelial cell line (HPDE) H6c7. Phospholipase A(2) enzymatic cleavage of arachidonic acid from AsPC-1 exosomes reduced fusion efficiency. PGE(2) secretion was elevated in macrophages treated with AsPC-1 exosomes but not in macrophages treated with exosomes from other cell lines, suggesting a functional role for the AsPC-1 exosome-delivered arachidonic acid in macrophages. Non-polarized (M0) macrophages treated with AsPC-1 exosomes had increased levels of surface markers indicative of polarization to an immunosuppressive M2-like phenotype (CD14(hi) CD163(hi) CD206(hi)). Furthermore, macrophages treated with AsPC-1 exosomes had significantly increased secretion of pro-tumoral, bioactive molecules including VEGF, MCP-1, IL-6, IL-1 beta, MMP-9, and TNF alpha. Together, these results demonstrate that compared to exosomes from other primary tumor-derived PDAC cell lines, AsPC-1 exosomes alter THP-1-derived macrophage phenotype and function. AsPC-1 exosomes mediate communication between tumor cells and TAMs that contributes to tumor progression.	[Linton, Samuel S.; Matters, Gail L.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Abraham, Thomas] Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA USA; [Liao, Jason] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Clawson, Gary A.] Penn State Univ, Coll Med, Dept Pathol, Hershey, PA USA; [Butler, Peter J.] Penn State Univ, Dept Engn, University Pk, PA 16802 USA; [Fox, Todd; Kester, Mark] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Linton, Samuel S.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Virginia; Rockefeller University	Matters, GL (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.	gmatters@pennstatehealth.psu.edu	Abraham, Thomas/AAJ-7950-2020; Kester, Mark/ABG-4615-2020; Abraham, Thomas/J-7080-2014	Abraham, Thomas/0000-0003-0750-8774; Matters, Gail/0000-0001-8613-8649	NIH [1S10OD010756, 1S10OD018124, R01 CA167535]; Pennsylvania Department of Health, Tobacco CURE funds; Department of Pharmacology at Penn State Hershey College of Medicine; NATIONAL CANCER INSTITUTE [R01CA167535] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health, Tobacco CURE funds; Department of Pharmacology at Penn State Hershey College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NIH R01 CA167535. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This project was also funded in part under a grant from the Pennsylvania Department of Health, Tobacco CURE funds. The Department of Health specifically disclaims responsibility for any analysis, interpretations or conclusions. Work contributed by T. Abraham was supported in part by NIH 1S10OD010756 and 1S10OD018124.; The Penn State Hershey College of Medicine shared-service core research facilities contributed to many aspects of this project. We thank members of the Lukacher laboratory at Penn State Hershey College of Medicine for training in flow cytometry, Jade Vogel of the Flow Cytometry Core Facility for help with acquiring flow cytometry samples, and members of the Kester lab for their technical support and advice. We thank Roland Myers, formerly of the Microscopy Imaging Core, for his assistance with sample preparation and acquiring the TEM images and Dr. M.S. Tsao, University Health Network in Toronto, for the gift of HPDE H6c7 cells. We also wish to thank Christopher McGovern for contributing to many fruitful discussions. The generous support of Dr. Kent Vrana and the Department of Pharmacology at Penn State Hershey College of Medicine is gratefully acknowledged.	Ahmadi M, 2008, CANCER RES, V68, P7520, DOI 10.1158/0008-5472.CAN-08-1060; Angst E, 2008, SURGERY, V144, P57, DOI 10.1016/j.surg.2008.03.024; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chalmin F, 2010, J CLIN INVEST, V120, P457, DOI 10.1172/JCI40483; Charo C, 2013, PANCREAS, V42, P467, DOI 10.1097/MPA.0b013e318264d0f8; Chattopadhyay S, 2003, J BIOL CHEM, V278, P39675, DOI 10.1074/jbc.M212594200; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cui Y, 2017, INT J CANCER, V141, P2423, DOI 10.1002/ijc.31007; Gatto F, 2016, CELL REP, V16, P878, DOI 10.1016/j.celrep.2016.06.038; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Golan T, 2017, ONCOTARGET, V8, P40778, DOI 10.18632/oncotarget.17253; Grekova SP, 2011, J ONCOL, V2011, DOI 10.1155/2011/741868; Hang JJ, 2016, ONCOTARGET, V7, P28207, DOI 10.18632/oncotarget.8593; Hartley G, 2017, CANCER IMMUNOL IMMUN, V66, P523, DOI 10.1007/s00262-017-1955-5; Hicks AM, 2016, CLIN COLORECTAL CANC, V15, P360, DOI 10.1016/j.clcc.2016.04.014; Hiraide T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29935; Hogendorf P, 2012, J INVEST SURG, V25, P8, DOI 10.3109/08941939.2011.592569; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hu H, 2016, TUMOR BIOL, V37, P8657, DOI 10.1007/s13277-015-4741-z; Hull MA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06253-5; Janakiram NB, 2017, IMMUNOLOGY, V152, P36, DOI 10.1111/imm.12746; Javeed N, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1252013; Karnevi E, 2014, IMMUNOL CELL BIOL, V92, P543, DOI 10.1038/icb.2014.22; Kenkel JA, 2017, CANCER RES, V77, P4158, DOI 10.1158/0008-5472.CAN-16-2212; Kim HY, 2016, ONCOTARGET, V7, P67111, DOI 10.18632/oncotarget.11560; Knab LM, 2014, WORLD J GASTROENTERO, V20, P10729, DOI 10.3748/wjg.v20.i31.10729; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Li HL, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4299-4; Liou GY, 2015, CANCER DISCOV, V5, P52, DOI 10.1158/2159-8290.CD-14-0474; Liu N, 1998, AM J PATHOL, V153, P263, DOI 10.1016/S0002-9440(10)65567-8; Logsdon CD, 2015, AM J PHYSIOL-GASTR L, V309, pG283, DOI 10.1152/ajpgi.00169.2015; Long KB, 2017, MOL CANCER THER, V16, P1898, DOI 10.1158/1535-7163.MCT-16-0899; Maia J, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00018; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; MAYORGA LS, 1993, P NATL ACAD SCI USA, V90, P10255, DOI 10.1073/pnas.90.21.10255; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Moore GY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020236; Nandi P, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-3018-2; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Prima V, 2017, P NATL ACAD SCI USA, V114, P1117, DOI 10.1073/pnas.1612920114; Rana S, 2012, INT J BIOCHEM CELL B, V44, P1574, DOI 10.1016/j.biocel.2012.06.018; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Satake T, 2018, ANTICANCER RES, V38, P1927, DOI 10.21873/anticanres.12430; Segura E, 2005, BLOOD, V106, P216, DOI 10.1182/blood-2005-01-0220; Sharma R, 2017, BRIT J CANCER, V117, P545, DOI 10.1038/bjc.2017.183; Smyth TJ, 2014, BBA-BIOMEMBRANES, V1838, P2954, DOI 10.1016/j.bbamem.2014.07.026; Su MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30110; Subra C, 2010, J LIPID RES, V51, P2105, DOI 10.1194/jlr.M003657; Suemizu H, 2007, INT J ONCOL, V31, P741; Wang DZ, 2013, CANCER J, V19, P502, DOI 10.1097/PPO.0000000000000003; Whiteside TL, 2017, CLIN EXP IMMUNOL, V189, P259, DOI 10.1111/cei.12974; Xiang XY, 2009, INT J CANCER, V124, P2621, DOI 10.1002/ijc.24249; Yan GF, 2018, CANCER RES, V78, P5586, DOI 10.1158/0008-5472.CAN-17-3962; Yang M, 2018, CANCER RES, V78, P5492, DOI 10.1158/0008-5472.CAN-18-1367; Zhang CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021233; Zhang DX, 2018, CANCER RES, V78, P1700, DOI 10.1158/0008-5472.CAN-17-1366; Zhang YS, 2011, BLOOD, V118, P5355, DOI 10.1182/blood-2011-04-350587	62	53	57	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206759	10.1371/journal.pone.0206759	http://dx.doi.org/10.1371/journal.pone.0206759			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383833	Green Submitted, Green Published, gold			2022-12-26	WOS:000449027600095
J	Wong, MJ; Liao, LH; Berenbaum, MR				Wong, Michael J.; Liao, Ling-Hsiu; Berenbaum, May R.			Biphasic concentration-dependent interaction between imidacloprid and dietary phytochemicals in honey bees (Apis mellifera)	PLOS ONE			English	Article							OXIDATIVE STRESS; NEONICOTINOID INSECTICIDES; SYSTEMIC INSECTICIDES; PESTICIDE; EXPOSURE; DETOXIFICATION; HORMESIS; RISKS; METABOLISM; MECHANISMS	Background The presence of the neonicotinoid imidacloprid in nectar, honey, pollen, beebread and beeswax has been implicated in declines worldwide in the health of the western honey bee Apis mellifera. Certain phytochemicals, including quercetin and p-coumaric acid, are ubiquitous in the honey bee diet and are known to upregulate cytochrome P450 genes encoding enzymes that detoxify insecticides. Thus, the possibility exists that these dietary phytochemicals interact with ingested imidacloprid to ameliorate toxicity by enhancing its detoxification. Approach Quercetin and p-coumaric acid were incorporated in a phytochemical-free artificial diet individually and together along with imidacloprid at a range of field-realistic concentrations. In acute toxicity bioassays, honey bee 24- and 48- hour imidacloprid LC50 values were determined in the presence of the phytochemicals. Additionally, chronic toxicity bioassays were conducted using varying concentrations of imidacloprid in diets with the phytochemicals to test impacts of phytochemicals on longevity. Results In acute toxicity bioassays, the phytochemicals had no effect on imidacloprid LC50 values. In chronic toxicity longevity bioassays, phytochemicals enhanced honey bee survival at low imidacloprid concentrations (15 and 45 ppb) but had a negative effect at higher concentrations (105 ppb and 135 ppb). p-Coumaric acid alone increased honey bee longevity at concentrations of 15 and 45 ppb imidacloprid (hazard ratio (HR): 0.83 and 0.70, respectively). Quercetin alone and in combination with p-coumaric acid similarly enhanced longevity at 45 ppb imidacloprid (HR: 0.81 and HR: 0.77, respectively). However, p-coumaric acid in combination with 105 ppb imidacloprid and quercetin in combination with 135 ppb imidacloprid increased honey bee HR by approximately 30% (HR: 1.33 and HR: 1.30, respectively). Conclusions The biphasic concentration-dependent response of honey bees to imidacloprid in the presence of two ubiquitous dietary phytochemicals indicates that there are limits to the protective effects of the natural diet of honey bees against neonicotinoids based on their own inherent toxicity.	[Wong, Michael J.; Liao, Ling-Hsiu; Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Liao, LH (corresponding author), Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.	liao19@illinois.edu	Liao, LH/AAB-1547-2019	Liao, LH/0000-0003-1776-9564	National Honey Board; National Institute of Food and Agriculture [2017-67013]	National Honey Board; National Institute of Food and Agriculture(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded by National Honey Board and National Institute of Food and Agriculture 2017-67013 to MB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir FNE, 2017, BIOMEDICINES, V5, DOI 10.3390/biomedicines5020018; Alkassab AT, 2017, J PLANT DIS PROTECT, V124, P1, DOI 10.1007/s41348-016-0041-0; Altaye SZ, 2010, J EXP BIOL, V213, P3311, DOI 10.1242/jeb.046953; Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044; [Anonymous], 2000, CROP POLLINATION BEE; BAI DL, 1991, PESTIC SCI, V33, P197, DOI 10.1002/ps.2780330208; Berenbaum MR, 2016, J AGR FOOD CHEM, V64, P13, DOI 10.1021/acs.jafc.5b01067; Berenbaum MR, 2015, CURR OPIN INSECT SCI, V10, P51, DOI 10.1016/j.cois.2015.03.005; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Bonvehi JS, 2001, J AGR FOOD CHEM, V49, P1848, DOI 10.1021/jf0012300; Calabrese EJ, 2013, ENVIRON POLLUT, V182, P452, DOI 10.1016/j.envpol.2013.07.046; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Carreck NL, 2014, J APICULT RES, V53, P607, DOI 10.3896/IBRA.1.53.5.08; Ceksteryte V., 2006, Biologija, P28; Chagnon M, 2015, ENVIRON SCI POLLUT R, V22, P119, DOI 10.1007/s11356-014-3277-x; Chaimanee V, 2016, J INSECT PHYSIOL, V89, P1, DOI 10.1016/j.jinsphys.2016.03.004; Costa LG, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2986796; COX DR, 1972, J R STAT SOC B, V34, P187; Cressey D, 2017, NATURE, V551, P156, DOI 10.1038/551156a; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Cutler GC, 2015, PEST MANAG SCI, V71, P1368, DOI 10.1002/ps.4042; Cutler GC, 2013, DOSE-RESPONSE, V11, P154, DOI 10.2203/dose-response.12-008.Cutler; De Smet L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171529; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Derecka K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068191; Dubecke A, 2011, FOOD ADDIT CONTAM A, V28, P348, DOI 10.1080/19440049.2010.541594; Duzguner V, 2012, PESTIC BIOCHEM PHYS, V104, P58, DOI 10.1016/j.pestbp.2012.06.011; Ekinci-Akdemir FN, 2017, J ANIM PLANT SCI-PAK, V27, P1560; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Fischer DL, 2007, NEONICOTINOID INSECT, P1; Ge WL, 2015, J AGR FOOD CHEM, V63, P1856, DOI 10.1021/jf504895h; Gheldof N, 2002, J AGR FOOD CHEM, V50, P3050, DOI 10.1021/jf0114637; GODFRAY HCJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI DOI 10.1098/RSPB.2015.1821; Guedes RNC, 2014, PEST MANAG SCI, V70, P690, DOI 10.1002/ps.3669; Guseman AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148242; Haith DA, 2010, ENVIRON SCI TECHNOL, V44, P6496, DOI 10.1021/es101636y; Hawthorne DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026796; HOEKSTRA JA, 1991, ENVIRONMETRICS, V2, P139, DOI 10.1002/env.3770020203; Hoffmann EJ, 2012, J ECON ENTOMOL, V105, P67, DOI 10.1603/EC11251; Ince S, 2013, TOXICOL ENVIRON CHEM, V95, P318, DOI 10.1080/02772248.2013.764672; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jerkovic I, 2017, MOLECULES, V22, DOI 10.3390/molecules22111909; Johnson RM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031051, 10.1371/journal.pone.0033479]; Kaiser J, 2003, SCIENCE, V302, P376, DOI 10.1126/science.302.5644.376; Kaskoniene V, 2015, FOOD ANAL METHOD, V8, P1150, DOI 10.1007/s12161-014-9996-2; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kulhanek K, 2017, J APICULT RES, V56, P328, DOI 10.1080/00218839.2017.1344496; Lambin M, 2001, ARCH INSECT BIOCHEM, V48, P129, DOI 10.1002/arch.1065; Lee KP, 2007, J EXP BIOL, V210, P3236, DOI 10.1242/jeb.008060; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liao LH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15066-5; Liao LH, 2017, INSECTS, V8, DOI 10.3390/insects8010022; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Mao WF, 2017, P NATL ACAD SCI USA, V114, P2538, DOI 10.1073/pnas.1614864114; Mao WF, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500795; Mao W, 2013, P NATL ACAD SCI USA, V110, P8842, DOI 10.1073/pnas.1303884110; Mao WF, 2011, P NATL ACAD SCI USA, V108, P12657, DOI 10.1073/pnas.1109535108; Mao WF, 2009, COMP BIOCHEM PHYS B, V154, P427, DOI 10.1016/j.cbpb.2009.08.008; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x; Poquet Y, 2016, APIDOLOGIE, V47, P412, DOI 10.1007/s13592-016-0429-7; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Seitz N, 2016, J APICULT RES, V54, P292, DOI 10.1080/00218839.2016.1153294; Shimanuki H, 2000, AGR HDB, V690; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Tosi S, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1711; Tosi S, 2016, J INSECT PHYSIOL, V93-94, P56, DOI 10.1016/j.jinsphys.2016.08.010; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vannette RL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16224; Wheeler MW, 2006, ENVIRON TOXICOL CHEM, V25, P1441, DOI 10.1897/05-320R.1; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049472; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	82	18	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206625	10.1371/journal.pone.0206625	http://dx.doi.org/10.1371/journal.pone.0206625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383869	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600074
J	Matyszewski, M; Zheng, WL; Lueck, J; Antiochos, B; Egelman, EH; Sohn, J				Matyszewski, Mariusz; Zheng, Weili; Lueck, Jacob; Antiochos, Brendan; Egelman, Edward H.; Sohn, Jungsan			Cryo-EM structure of the NLRC4(CARD) filament provides insights into how symmetric and asymmetric supramolecular structures drive inflammasome assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; cryo-electron microscopy; nod-like receptor (NLR); inflammasome; biophysics; caspase; Monte Carlo simulation; NLRC4; pyroptosis	AIM2 INFLAMMASOME; SIGNAL-ACTIVATION; CRYSTAL-STRUCTURE; MECHANISM; NLRP3; VISUALIZATION; AUTOIMMUNITY; RECRUITMENT; REVEALS; SYSTEM	Inflammasomes are supramolecular signaling platforms integral to innate immune defense against invading pathogens. The NOD-like receptor (NLR) family apoptosis inhibitory protein (NAIP)NLR family caspase-recruiting domain (CARD) domain-containing 4 (NLRC4) inflammasome recognizes intracellular bacteria and induces the polymerization of the caspase-1 protease, which in turn executes maturation of interleukin-1 (IL-1) and pyroptosis. Several high-resolution structures of the fully assembled NAIPNLRC4 complex are available, but these structures do not resolve the architecture of the CARD filament in atomic detail. Here, we present the cryo-EM structure of the filament assembled by the CARD of human NLRC4 (NLRC4(CARD)) at 3.4 resolution. The structure revealed that the helical architecture of the NLRC4(CARD) filament is essentially identical to that of the downstream filament assembled by the CARD of caspase-1 (casp1(CARD)), but deviates from the split washer-like assembly of the NAIPNLRC4 oligomer. Our results suggest that architectural complementarity is a major driver for the recognition between upstream and downstream CARD assemblies in inflammasomes. Furthermore, a Monte Carlo simulation of the NLRC4(CARD) filament assembly rationalized why an (un)decameric NLRC4 oligomer is optimal for assembling the helical base of the NLRC4(CARD) filament. Together, our results explain how symmetric and asymmetric supramolecular assemblies enable high-fidelity signaling in inflammasomes.	[Matyszewski, Mariusz; Lueck, Jacob; Sohn, Jungsan] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zheng, Weili; Egelman, Edward H.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Antiochos, Brendan] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Virginia; Johns Hopkins University	Sohn, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.; Egelman, EH (corresponding author), Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.	egelman@virginia.edu; jsohn@jhmi.edu		Matyszewski, Mariusz/0000-0003-1033-9270	National Institutes of Health [S10 OD016734]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122510, R01GM035269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Sohn lab members for discussion and the staff at NCI NCEF for cryo-EM data collection. The Johns Hopkins Microscope Facility was supported by National Institutes of Health Grant S10 OD016734.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bandera A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00214; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; David L, 2018, P NATL ACAD SCI USA, V115, P1499, DOI 10.1073/pnas.1721967115; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Diebolder CA, 2015, STRUCTURE, V23, P2349, DOI 10.1016/j.str.2015.10.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Henao-Mejia J, 2014, ANNU REV PHYSIOL, V76, P57, DOI 10.1146/annurev-physiol-021113-170324; Hu ZH, 2015, SCIENCE, V350, P399, DOI 10.1126/science.aac5489; Hu ZH, 2013, SCIENCE, V341, P172, DOI 10.1126/science.1236381; Jin TC, 2013, ACTA CRYSTALLOGR F, V69, P482, DOI 10.1107/S1744309113010075; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Lee S, 2017, AM J RESP CRIT CARE, V196, P713, DOI 10.1164/rccm.201604-0892OC; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li Y, 2018, P NATL ACAD SCI USA, V115, P10845, DOI 10.1073/pnas.1810524115; Lin C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00271; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Lu A, 2016, NAT STRUCT MOL BIOL, V23, P416, DOI 10.1038/nsmb.3199; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Man SM, 2016, EUR J IMMUNOL, V46, P269, DOI 10.1002/eji.201545839; Maruzuru Y, 2018, CELL HOST MICROBE, V23, P254, DOI 10.1016/j.chom.2017.12.014; Matyszewski M, 2018, P NATL ACAD SCI USA, V115, pE1963, DOI 10.1073/pnas.1712860115; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Morrone SR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8827; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Peisley A, 2014, NATURE, V509, P110, DOI 10.1038/nature13140; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Ruiz VMR, 2017, P NATL ACAD SCI USA, V114, P13242, DOI 10.1073/pnas.1710433114; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Sohn J, 2004, P NATL ACAD SCI USA, V101, P16437, DOI 10.1073/pnas.0407663101; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tenthorey JL, 2017, SCIENCE, V358, P888, DOI 10.1126/science.aao1140; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Vance RE, 2015, CURR OPIN IMMUNOL, V32, P84, DOI 10.1016/j.coi.2015.01.010; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wu B, 2014, MOL CELL, V55, P511, DOI 10.1016/j.molcel.2014.06.010; Yang CA, 2015, J AUTOIMMUN, V61, P1, DOI 10.1016/j.jaut.2015.05.001; Yi YS, 2018, KOREAN J PHYSIOL PHA, V22, P1, DOI 10.4196/kjpp.2018.22.1.1; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	45	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2018	293	52					20240	20248		10.1074/jbc.RA118.006050	http://dx.doi.org/10.1074/jbc.RA118.006050			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HG1BW	30385506	Green Published, hybrid			2022-12-26	WOS:000454685900029
J	Tomo, S; Mohan, S; Ramachandrappa, VS; Samadanam, DM; Suresh, S; Pillai, AB; Tamilarasu, K; Ramachandran, R; Rajendiran, S				Tomo, Sojit; Mohan, Sindhujadevi; Ramachandrappa, Vijaykumar Shettikothanuru; Samadanam, Daisy Mariya; Suresh, Sevanthy; Pillai, Agieshkumar Balakrishna; Tamilarasu, Kadhiravan; Ramachandran, Rameshkumar; Rajendiran, Soundravally			Dynamic modulation of DC-SIGN and FcYR2A receptors expression on platelets in dengue	PLOS ONE			English	Article							HUMAN DENDRITIC CELLS; VIRUS-INFECTION; PRODUCTIVE INFECTION; HEMORRHAGIC-FEVER; ACTIVATION; THROMBOCYTOPENIA; ANTIBODIES; REPLICATION; SEVERITY; LEVEL	Platelet activation has been reported to play a major role in inflammatory response and thrombocytopenia during dengue viral infection. Cells expressing FcYR2Aand DC-SIGN receptors are reported to be involved in dengue virulence. The present study is designed to assess the expression level of these two receptors on platelet surface collected from dengue patients and to study its association in patients with platelet RNA positive for dengue virus. This was an analytical cross-sectional study carried out in JIPMER hospital, Puducherry. Forty-four patients with dengue infection as cases and 44 patients with non dengue acute other febrile illness(OFI) as controls were recruited. Peripheral venous blood was withdrawn on day of admission, day 3 post admission and day of discharge and serological tests for NS1 dengue antigen and anti IgM antibody were analyzed for diagnosis of dengue infection. Platelet rich plasma was assessed for DC SIGN, FcYR2A levels and platelets separated from dengue patients were subjected to RNA extraction and detection of presence of viral RNA. The study observed a decreased expression of DC-SIGN and FcYR2A on platelets in dengue patients compared to OFI group on all the time points. Further, cells expressing DC-SIGN and FcYR2A were found to be decreased on platelets in dengue patients who were positive for NS1 antigen. DC-SIGN and FcYR2A expression was also found to be notably decreased in patients positive for platelet DENV RNA when compared with patients negative for platelet DENV RNA. Our results suggest that DC-SIGN and FcYR2A, which are receptors for viral capture and immune mediated clearance respectively, might be down regulated on platelets in patients with dengue infection. The decreased receptor expression diminishes platelet activation and subsequently has protective action on the host from the ongoing conflict between immune system and dengue virus.	[Tomo, Sojit; Mohan, Sindhujadevi; Ramachandrappa, Vijaykumar Shettikothanuru; Samadanam, Daisy Mariya; Suresh, Sevanthy; Rajendiran, Soundravally] JIPMER, Dept Biochem, Pondicherry, India; [Pillai, Agieshkumar Balakrishna] CIDRF, Pondicherry, India; [Tamilarasu, Kadhiravan] JIPMER, Dept Med, Pondicherry, India; [Ramachandran, Rameshkumar] JIPMER, Dept Paediat, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research	Rajendiran, S (corresponding author), JIPMER, Dept Biochem, Pondicherry, India.	soundy27@gmail.com	TOMO, SOJIT/AAO-9380-2021	TOMO, SOJIT/0000-0001-5381-4348; Balakrishna Pillai, Agieshkumar/0000-0002-6543-2977; Rameshkumar, Ramachandran/0000-0002-1911-3473	Intramural Fund of Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry; Department of Biotechnology (DBT), India; DBT; JIPMER	Intramural Fund of Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); JIPMER	This work was supported by a grant from the Intramural Fund of Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry and Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors sincerely thank all patients who actively participated in this study as well all the staff in the Department of Medicine and Pediatrics, JIPMER. We thank DBT and intramural grant of the parent institute JIPMER for funding this project.	Arepally G, 1997, BLOOD, V89, P370, DOI 10.1182/blood.V89.2.370; Beltran D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00192; Bray PF, 2013, BLOOD, V122, P3400, DOI 10.1182/blood-2013-09-526418; Brown GT, 2011, J IMMUNOL BALTIM MD, V1950, DOI [10.1016/j.cell.2005.06.015, DOI 10.1016/J.CELL.2005.06.015]; Canobbio I, 2001, J BIOL CHEM, V276, P26022, DOI 10.1074/jbc.M102639200; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Chawla T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065231; Chen YC, 2002, J VIROL, V76, P9877, DOI 10.1128/JVI.76.19.9877-9887.2002; Chizzolini C, 1997, EUR J IMMUNOL, V27, P171, DOI 10.1002/eji.1830270125; Trugilho MRD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006385; Denis MM, 2005, CELL, V122, P379, DOI 10.1016/j.cell.2005.06.015; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Hottz ED, 2013, J THROMB HAEMOST, V11, P951, DOI 10.1111/jth.12178; Kar M, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx051; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07; Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866; Noisakran S, 2009, SE ASIAN J TROP MED, V40, P253; Ojha A, 2017, SCI REP-UK, V7, DOI 10.1038/srep41697; Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06; Rondina MT, 2015, BLOOD, V126, P286, DOI 10.1182/blood-2015-05-647362; Saito M, 2004, CLIN EXP IMMUNOL, V138, P299, DOI 10.1111/j.1365-2249.2004.02626.x; Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647; Simon AY, 2015, BLOOD, V126, P378, DOI 10.1182/blood-2014-09-598029; Soundravally R, 2015, INFECTION, V43, P13, DOI 10.1007/s15010-014-0683-4; Sutherland MR, 2016, TRANSFUSION, V56, P1129, DOI 10.1111/trf.13454; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; TOMIYAMA Y, 1992, BLOOD, V80, P2261; Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15; Worth RG, 2006, EXP HEMATOL, V34, P1490, DOI 10.1016/j.exphem.2006.06.015	31	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2018	13	11							e0206346	10.1371/journal.pone.0206346	http://dx.doi.org/10.1371/journal.pone.0206346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ8VH	30412591	gold, Green Published, Green Submitted			2022-12-26	WOS:000449772600014
J	Lima, DBC; da Silva, LDM; Comizzoli, P				Cruvinel Lima, David Baruc; Machado da Silva, Lucia Daniel; Comizzoli, Pierre			Influence of warming and reanimation conditions on seminiferous tubule morphology, mitochondrial activity, and cell composition of vitrified testicular tissues in the domestic cat model	PLOS ONE			English	Article							SPERMATOGONIAL STEM-CELLS; EPIDERMAL-GROWTH-FACTOR; IN-VITRO CULTURE; PREPUBERTAL CATS; OVARIAN TISSUE; MOUSE; CRYOPRESERVATION; VITRIFICATION; MEMBRANE; SPERM	Understanding critical roles of warming and reanimation is critical to improve the survival of vitrified testicular tissue in domestic cats. The objective was to study structural and functional properties of testicular tissues from prepubertal domestic cats after standard vitrification followed by two warming protocols (directly at 37 degrees C or with a 5-second pre-exposure to 50 degrees C) and three reanimation time points (immediately, 24 h and 5 days post-warming). In Experiment 1, tissues were evaluated for histo-morphology and mitochondrial activity immediately or 24 h after warming protocols. In Experiment 2, cell viability, DNA fragmentation, and germ cell composition were assessed immediately, 24 h, or 5 days after optimal warming. Preservation of seminiferous tubule structure was better using warming at 50 degrees C for five seconds, and survival of somatic as well as germinal cells was higher compared to direct warming at 37 degrees C for one minute. Short term in vitro culture (for reanimation) also proved that cellular composition and functionality were better preserved when warmed for a short time at 50 degrees C. Collective data showed that short warming at 50 degrees C led to better quality of seminiferous tubule structure and cell composition after vitrification and short-term culture. In addition, data suggest clear directions to further understand and optimize testicular tissue survival after fertility preservation procedures.	[Cruvinel Lima, David Baruc; Machado da Silva, Lucia Daniel] Univ Estadual Ceara, Sch Vet Med, Lab Carnivore Reprod, UECE, Fortaleza, CE, Brazil; [Comizzoli, Pierre] Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20008 USA	Universidade Estadual do Ceara; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Comizzoli, P (corresponding author), Smithsonian Conservat Biol Inst, Natl Zool Pk, Washington, DC 20008 USA.	comizzolip@si.edu		Silva, Lucia/0000-0001-9793-1968	CNPq; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq; CAPES to M.Sc. David Baruc Cruvinel Lima. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrishami M, 2010, THERIOGENOLOGY, V73, P86, DOI 10.1016/j.theriogenology.2009.08.004; Alam MS, 2014, ACTA HISTOCHEM, V116, P682, DOI 10.1016/j.acthis.2013.12.006; Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Baert Y, 2012, FERTIL STERIL, V97, P1152, DOI 10.1016/j.fertnstert.2012.02.010; Bagkos G, 2014, MED HYPOTHESES, V83, P175, DOI 10.1016/j.mehy.2014.05.001; Berghe FV, 2018, CRYOBIOLOGY, V80, P18, DOI [10.1016/j.cryobiol.2017.12.095, DOI 10.1016/J.CRYOBIOL.2017.12.095]; Boni R, 2017, ANDROLOGY-US, V5, P133, DOI 10.1111/andr.12259; Buarpung S, 2013, THERIOGENOLOGY, V79, P149, DOI 10.1016/j.theriogenology.2012.09.022; Buarpung S, 2012, ANIM REPROD SCI, V131, P219, DOI 10.1016/j.anireprosci.2012.03.011; Calle-Guisado V, 2017, ANIM REPROD SCI, V187, P13, DOI 10.1016/j.anireprosci.2017.09.009; Caturla-Sanchez E, 2018, CRYOBIOLOGY, V80, P126, DOI 10.1016/j.cryobiol.2017.11.001; Comizzoli P, 2018, J ASSIST REPROD GEN, V35, P551, DOI 10.1007/s10815-018-1136-2; Comizzoli P, 2015, ASIAN J ANDROL, V17, P640, DOI 10.4103/1008-682X.153849; Lima DBC, 2018, THERIOGENOLOGY, V110, P110, DOI 10.1016/j.theriogenology.2017.12.037; Dores C, 2012, CELL TISSUE RES, V349, P691, DOI 10.1007/s00441-012-1457-x; Dube E, 2012, HUM REPROD, V27, P2285, DOI 10.1093/humrep/des164; Fu XF, 2015, INT J BIOL SCI, V11, P1226, DOI 10.7150/ijbs.11536; Giese S, 2012, DIS MODEL MECH, V5, P895, DOI 10.1242/dmm.008649; Giudice MG, 2017, STEM CELL RES, V21, P171, DOI 10.1016/j.scr.2017.01.009; Hajiaghalou S, 2016, THERIOGENOLOGY, V86, P2073, DOI 10.1016/j.theriogenology.2016.06.027; He DW, 2007, J ANDROL, V28, P389, DOI 10.2164/jandrol.106.000455; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Keros V, 2007, HUM REPROD, V22, P1384, DOI 10.1093/humrep/del508; Lee PC, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.129106; Li Z, 2016, TOXICOLOGY, V355, P39, DOI 10.1016/j.tox.2016.05.016; Lima DBC, 2017, REPROD DOMEST ANIM, V52, P235, DOI 10.1111/rda.12833; Lima DBC, 2017, RURAL, V47, P1, DOI [10.1590/0103-8478cr20170135, DOI 10.1590/0103-8478CR20170135]; Mota PC, 2012, THERIOGENOLOGY, V77, P299, DOI 10.1016/j.theriogenology.2011.07.042; Nabi A, 2014, ANDROLOGIA, V46, P374, DOI 10.1111/and.12088; Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009; Nishimura H, 2017, CURR BIOL, V27, pR979, DOI [10.1016/j.cub.2017.09.010, DOI 10.1016/J.CUB.2017.09.010]; Nohalez A, 2015, THERIOGENOLOGY, V84, P545, DOI 10.1016/j.theriogenology.2015.04.004; Paoli D, 2011, FERTIL STERIL, V95, P2315, DOI 10.1016/j.fertnstert.2011.03.059; Poels J, 2012, THERIOGENOLOGY, V77, P1008, DOI 10.1016/j.theriogenology.2011.10.015; Pointis Georges, 2011, Spermatogenesis, V1, P303; Pukazhenthi BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123957; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rowlison T, 2017, REPROD DOMEST ANIM, V52, P193, DOI 10.1111/rda.12831; Sadri-Ardekani H, 2016, METHODS, V99, P120, DOI 10.1016/j.ymeth.2016.02.013; Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850; Seki S, 2008, CRYOBIOLOGY, V56, P171, DOI 10.1016/j.cryobiol.2008.02.001; Seki S, 2014, CRYOBIOLOGY, V68, P71, DOI 10.1016/j.cryobiol.2013.12.001; Seki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036058; Silva AF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191912; Succu S, 2018, THERIOGENOLOGY, V110, P18, DOI 10.1016/j.theriogenology.2017.12.031; Tanpradit N, 2016, J ASSIST REPROD GEN, V33, P1621, DOI 10.1007/s10815-016-0810-5; Thongkittidilok C, 2017, REPROD DOMEST ANIM, V52, P114, DOI 10.1111/rda.12852; Thuwanut P, 2012, REPROD DOMEST ANIM, V47, P777, DOI 10.1111/j.1439-0531.2011.01967.x; Thuwanut P, 2013, CRYOBIOLOGY, V67, P244, DOI 10.1016/j.cryobiol.2013.07.002; Travers A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082819; Unni S, 2012, FERTIL STERIL, V97, P200, DOI 10.1016/j.fertnstert.2011.10.018; Vansandt LM, 2012, REPROD DOMEST ANIM, V47, P256, DOI 10.1111/rda.12079; Wang Y, 2008, HUM REPROD, V23, P2256, DOI 10.1093/humrep/den255; Wu JY, 2011, CRYOLETTERS, V32, P402; Yango P, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1250; Yildiz C, 2013, CRYOBIOLOGY, V67, P70, DOI 10.1016/j.cryobiol.2013.05.004; Yokonishi T., 2014, NATURE COMMUNICATION, V5, P1, DOI DOI 10.1038/NC0MMS5320; Zeineddine D, 2014, AM J STEM CELLS, V3, P74; Zeng W, 2017, ANDROLOGY-US, V5, P336, DOI 10.1111/andr.12308	59	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207317	10.1371/journal.pone.0207317	http://dx.doi.org/10.1371/journal.pone.0207317			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408126	Green Published, gold, Green Submitted			2022-12-26	WOS:000449512300097
J	Nagahisa, H; Miyata, H				Nagahisa, Hiroshi; Miyata, Hirofumi			Influence of hypoxic stimulation on angiogenesis and satellite cells in mouse skeletal muscle	PLOS ONE			English	Article							NITRIC-OXIDE; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; EXERCISE; VEGF; EXPRESSION; ATROPHY; BRAIN; MICE; CAPILLARIZATION	We clarified in our previous study that hypoxic training promotes angiogenesis in skeletal muscle, but the mechanism of angiogenesis in skeletal muscle remains unknown. In this study, we investigated the influence of differences in hypoxia exposure on angiogenesis in skeletal muscles at differing ages and metabolic characteristics at which the production of reactive oxygen species and nitric oxide may differ. Ten-week-old (young) and 20-monthold (old) mice were separated into control (N), continuous hypoxia (H), and intermittent hypoxia (IH) groups. The H group was exposed to 16% O-2 hypoxia for 5 days and the IH group was exposed to 16% O-2 hypoxia at one-hour intervals during the light period for 5 days. After completion of hypoxia exposure, the soleus and gastrocnemius muscles were immediately excised, and mRNA expression of angiogenesis-and satellite cell-related genes was investigated using real-time RT-PCR. In addition, muscle fiber type composition, muscle fiber area, number of satellite cells, and capillary density were measured immunohistochemically. In the young soleus muscle, the muscle fiber area was decreased in the H group, and mRNA expression of satellite cell activation-related MyoD, MHCe, and BDNF was significantly increased. On the other hand, in the old soleus muscle, nNOS and VEGFA mRNA expression, and the capillary density were significantly increased in the H group. In the superficial portion of the gastrocnemius, mRNA expression of FGF2, an angiogenic factor secreted by satellite cells, was significantly increased in the young IH group. In addition, a positive correlation between VEGF-A mRNA expression and nNOS mRNA expression in the soleus muscle and eNOS mRNA expression in the superficial portion of the gastrocnemius was noted. These data demonstrated that age, hypoxia exposure method and muscle metabolic characteristics are related, which results in significant differences in angiogenesis.	[Nagahisa, Hiroshi; Miyata, Hirofumi] Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Biol Sci, Yamaguchi, Japan	Yamaguchi University	Miyata, H (corresponding author), Yamaguchi Univ, Grad Sch Sci & Technol Innovat, Biol Sci, Yamaguchi, Japan.	hiro@yamaguchi-u.ac.jp			Japanese Ministry of Education, Science and Culture [17J08086, 16H03221]	Japanese Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant from The Japanese Ministry of Education, Science and Culture (17J08086, HN and 16H03221. HM).; This work was supported in part by a grant from The Japanese Ministry of Education, Science and Culture (nos. 17J08086 and 16H03221).	Baum O, 2013, AM J PHYSIOL-REG I, V304, pR1175, DOI 10.1152/ajpregu.00434.2012; Carberry JC, 2014, EUR RESPIR J, V43, P1149, DOI 10.1183/09031936.00139512; Casey DP, 2011, J PHYSIOL-LONDON, V589, P1477, DOI 10.1113/jphysiol.2010.203539; Chen CY, 2010, CHINESE J PHYSIOL, V53, P62, DOI 10.4077/CJP.2010.AMK078; Clow C, 2010, MOL BIOL CELL, V21, P2182, DOI 10.1091/mbc.E10-02-0154; Cocks M, 2013, J PHYSIOL-LONDON, V591, P641, DOI 10.1113/jphysiol.2012.239566; Croley AN, 2005, J APPL PHYSIOL, V99, P1872, DOI 10.1152/japplphysiol.00498.2005; De Palma C, 2012, MOL NEUROBIOL, V46, P682, DOI 10.1007/s12035-012-8311-8; de Theije CC, 2015, J APPL PHYSIOL, V118, P200, DOI 10.1152/japplphysiol.00624.2014; Egginton S, 2016, ACTA PHYSIOL, V218, P153, DOI 10.1111/apha.12728; Fujimaki S, 2014, J BIOL CHEM, V289, P7399, DOI 10.1074/jbc.M113.539247; Gavin TP, 2006, ACTA PHYSIOL, V188, P113, DOI 10.1111/j.1748-1716.2006.01609.x; Gliemann L, 2016, FREE RADICAL BIO MED, V98, P165, DOI 10.1016/j.freeradbiomed.2016.03.037; Ho JJD, 2012, J MOL MED, V90, P217, DOI 10.1007/s00109-012-0880-5; Hoshino S, 2002, J MUSCLE RES CELL M, V23, P139, DOI 10.1023/A:1020268700730; Huber-Abel FAM, 2012, EUR J APPL PHYSIOL, V112, P155, DOI 10.1007/s00421-011-1960-x; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Lavie L, 2015, SLEEP MED REV, V20, P27, DOI 10.1016/j.smrv.2014.07.003; Mateika JH, 2015, J APPL PHYSIOL, V118, P520, DOI 10.1152/japplphysiol.00564.2014; Merry TL, 2016, J PHYSIOL-LONDON, V594, P5135, DOI 10.1113/JP270654; Murach KA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0132-z; Nagahisa H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1535367; Naumenko VS, 2015, NEUROSCIENCE, V284, P730, DOI 10.1016/j.neuroscience.2014.10.045; Olfert IM, 2001, J APPL PHYSIOL, V90, P1532, DOI 10.1152/jappl.2001.90.4.1532; Radak Z, 2013, ANTIOXID REDOX SIGN, V18, P1208, DOI 10.1089/ars.2011.4498; Razeghi P, 2006, BIOCHEM BIOPH RES CO, V342, P361, DOI 10.1016/j.bbrc.2006.01.163; Rhoads RP, 2013, BIOCHEM BIOPH RES CO, V440, P399, DOI 10.1016/j.bbrc.2013.09.085; Rhoads RP, 2009, AM J PHYSIOL-CELL PH, V296, pC1321, DOI 10.1152/ajpcell.00391.2008; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Sriram S, 2011, AGING CELL, V10, P931, DOI 10.1111/j.1474-9726.2011.00734.x; Suzuki J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12744; Verdijk LB, 2016, MED SCI SPORT EXER, V48, P2157, DOI 10.1249/MSS.0000000000001019; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Williams JL, 2006, MICROCIRCULATION, V13, P499, DOI 10.1080/10739680600785717; Williams JL, 2006, J PHYSIOL-LONDON, V570, P445, DOI 10.1113/jphysiol.2005.095596; Yu T, 2017, INT J SPORTS MED, V38, P959, DOI 10.1055/s-0043-118343; Zuo L, 2013, AM J PHYSIOL-REG I, V304, pR1009, DOI 10.1152/ajpregu.00563.2012	38	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0207040	10.1371/journal.pone.0207040	http://dx.doi.org/10.1371/journal.pone.0207040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408093	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300070
J	Peng, YY; Zhou, PP; Zhao, J; Li, JZ; Lai, SK; Tinker, NA; Liao, S; Yan, HH				Peng, Yuanying; Zhou, Pingping; Zhao, Jun; Li, Junzhuo; Lai, Shikui; Tinker, Nicholas A.; Liao, Shu; Yan, Honghai			Phylogenetic relationships in the genus Avena based on the nuclear Pgk1 gene	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; REPETITIVE DNA-SEQUENCES; C-GENOME; HEXAPLOID OAT; SPECIES RELATIONSHIPS; MONOSOMIC LINES; DIPLOID AVENA; SATIVA L.; A-GENOME; B-GENOME	The phylogenetic relationships among 76 Avena taxa, representing 14 diploids, eight tetraploids, and four hexaploids were investigated by using the nuclear plastid 3-phosphoglycerate kinase gene (Pgk1). A significant deletion (131 bp) was detected in all the C genome homoeologues which reconfirmed a major structural divergence between the A and C genomes. Phylogenetic analysis indicated the C-p genome is more closely related to the polyploid species than is the C-v genome. Two haplotypes of Pgk1 gene were obtained from most of the AB genome tetraploids. Both types of the barbata group showed a close relationship with the A(s) genome diploid species, supporting the hypothesis that both the A and B genomes are derived from an A(s) genome. Two haplotypes were also detected in A. agadiriana, which showed close relationships with the A(s) genome diploid and the A(c) genome diploid, respectively, emphasizing the important role of the A(c) genome in the evolution of A. agadiriana. Three homoeologues of the Pgk1 gene were detected in five hexaploid accessions. The homoeologues that might represent the D genome were tightly clustered with the tetraploids A. maroccana and A. murphyi, but did not show a close relationship with any extant diploid species.	[Peng, Yuanying; Zhou, Pingping; Zhao, Jun; Li, Junzhuo; Lai, Shikui; Liao, Shu; Yan, Honghai] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China; [Zhou, Pingping; Yan, Honghai] China West Normal Univ, Collaborat Innovat Ctr Tissue Repair Mat Sichuan, Nanchong, Peoples R China; [Tinker, Nicholas A.] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada	Sichuan Agricultural University; China West Normal University; Agriculture & Agri Food Canada	Yan, HH (corresponding author), Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China.; Yan, HH (corresponding author), China West Normal Univ, Collaborat Innovat Ctr Tissue Repair Mat Sichuan, Nanchong, Peoples R China.	Honghai_yan@outlook.com		Tinker, Nicholas/0000-0002-2452-4779; honghai, yan/0000-0001-7360-0670; Peng, Yuanying/0000-0002-3304-3301	National Natural Science Foundation of China [31101152, 31571739]; Earmarked Fund for China Agriculture Research System [CARS-08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for China Agriculture Research System	This work was financially supported by the National Natural Science Foundation of China (Grant No. 31101152, 31571739) and the Earmarked Fund for China Agriculture Research System (CARS-08) to YP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badaeva E, 2010, J BOT; Badaeva ED, 2005, RUSSIAN J GENETICS, V41, P1728; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baum B.R., 1977, MONOGRAPH GENUS AVEN; BAUM BR, 1973, CAN J BOT, V51, P759, DOI 10.1139/b73-095; BAUM BR, 1985, CAN J BOT, V63, P1379, DOI 10.1139/b85-191; BAUM BR, 1985, CAN J BOT, V63, P1057, DOI 10.1139/b85-144; CHEN QF, 1994, GENOME, V37, P607, DOI 10.1139/g94-086; Chen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071139; Cheng DW, 2003, GENOME, V46, P119, DOI [10.1139/g02-111, 10.1139/G02-111]; Chew P, 2016, THEOR APPL GENET, V129, P1405, DOI 10.1007/s00122-016-2712-4; Doyle J. J., 1987, PHYTOCHEM B, P11; Fan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031122; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FOMINAYA A, 1988, GENOME, V30, P627, DOI 10.1139/g88-106; FOMINAYA A, 1988, GENOME, V30, P633, DOI 10.1139/g88-107; Fu YB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22478-4; HOLDEN JHW, 1966, CHROMOSOMA, V20, P75, DOI 10.1007/BF00331899; Huang SX, 2002, PLANT MOL BIOL, V48, P805, DOI 10.1023/A:1014868320552; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irigoyen ML, 2002, GENOME, V45, P1230, DOI 10.1139/G02-076; Irigoyen ML, 2001, THEOR APPL GENET, V103, P1160, DOI 10.1007/s001220100723; JELLEN EN, 1994, GENOME, V37, P613, DOI 10.1139/g94-087; Jellen EN, 1996, THEOR APPL GENET, V92, P726, DOI 10.1007/BF00226095; Katsiotis A, 1997, ANN BOT-LONDON, V79, P103, DOI 10.1006/anbo.1996.0312; Kilian B, 2007, MOL BIOL EVOL, V24, P217, DOI 10.1093/molbev/msl151; Ladizinsky G, 1998, GENET RESOUR CROP EV, V45, P263, DOI 10.1023/A:1008657530466; LADIZINSKY G, 1971, EUPHYTICA, V20, P380, DOI 10.1007/BF00035663; LADIZINSKY G, 1971, ISRAEL J BOT, V20, P297; Ladizinsky G, 1999, GENET RESOUR CROP EV, V46, P501, DOI 10.1023/A:1008728316354; Leggett J, 1995, P KEW CHROM C 4; Leggett J. Mike, 1995, P120; Lin Lei, 2015, Journal of Tropical and Subtropical Botany, V23, P111; Linares C, 1996, GENOME, V39, P535, DOI 10.1139/g96-068; Linares C, 1998, P NATL ACAD SCI USA, V95, P12450, DOI 10.1073/pnas.95.21.12450; Liu Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41944; Loskutov IG, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P109, DOI 10.1007/978-3-642-14228-4_3; Nikoloudakis N, 2008, THEOR APPL GENET, V117, P273, DOI 10.1007/s00122-008-0772-9; Oliver RE, 2011, THEOR APPL GENET, V123, P1159, DOI 10.1007/s00122-011-1656-y; Peng YY, 2010, THEOR APPL GENET, V121, P985, DOI 10.1007/s00122-010-1367-9; PERCHUK IN, 2002, AGRARN ROSS, V3, P41; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; RAJHATHY T, 1967, CAN J GENET CYTOL, V9, P52, DOI 10.1139/g67-007; Rajhathy T., 1974, CYTOGENETICS OATS AV; Sanz MJ, 2010, THEOR APPL GENET, V121, P1541, DOI 10.1007/s00122-010-1409-3; Sha LN, 2017, ANN BOT-LONDON, V119, P95, DOI 10.1093/aob/mcw222; Shelukhina OY, 2007, RUSS J GENET+, V43, P613, DOI 10.1134/S102279540706004X; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Thomas H., 1992, Oat science and technology., P473; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Xia XH, 2013, MOL BIOL EVOL, V30, P1720, DOI 10.1093/molbev/mst064; Yan HH, 2014, GENOME, V57, P267, DOI 10.1139/gen-2014-0075; Yan HH, 2016, THEOR APPL GENET, V129, P2133, DOI 10.1007/s00122-016-2762-7; Yan HH, 2016, GENOME, V59, P209, DOI 10.1139/gen-2015-0132	54	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2018	13	11							e0200047	10.1371/journal.pone.0200047	http://dx.doi.org/10.1371/journal.pone.0200047			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ5ZX	30408035	Green Published, Green Submitted, gold			2022-12-26	WOS:000449512300002
J	Boggie, MA; Collins, DP; Donnelly, JP; Carleton, SA				Boggie, Matthew A.; Collins, Daniel P.; Donnelly, J. Patrick; Carleton, Scott A.			Land Use, anthropogenic disturbance, and riverine features drive patterns of habitat selection by a wintering waterbird in a semiarid environment	PLOS ONE			English	Article							GREATER SANDHILL CRANES; MIDDLE RIO-GRANDE; CLIMATE-CHANGE; AGRICULTURAL PRACTICES; ACTIVITY BUDGETS; MIGRATORY BIRD; UNITED-STATES; DYNAMICS; ECOSYSTEMS; BEHAVIOR	River ecosystems in semi-arid environments provide an array of resources that concentrate biodiversity, but also attract human settlement and support economic development. In the southwestern United States, land-use change, drought, and anthropogenic disturbance are compounding factors which have led to departures from historical conditions of river ecosystems, consequently affecting wildlife habitat, including important wintering areas for migratory birds. The Rio Grande (River) in central New Mexico is the lifeblood of the Middle Rio Grande Valley (MRGV), maintaining large urban and agricultural centers and riparian and wetland resources, which disproportionately support a diversity of wildlife. The MRGV has been identified as the most important wintering area for the Rocky Mountain Population of greater sandhill cranes (Antigone canadensis tabida). Presently, however, changes in the hydrogeomorphology of the Rio Grande and landscape modification by humans have reshaped the MRGV and winter habitat for sandhill cranes. To evaluate these impacts, we investigated how land-use practices, anthropogenic disturbance, and river morphology influenced patterns of diurnal and roosting habitat selection by sandhill cranes. During the diurnal period, sandhill cranes relied heavily on managed public lands selecting agriculture crops, such as corn fields, and wetlands for foraging and loafing while avoiding areas with increasing densities of human structures. Sandhill cranes selected areas for roosting in the Rio Grande characterized by shallower water interspersed with sandbars, wide channel width, low bank vegetation, and farther away from disturbances associated with bridges. Our results establish and identify the central processes driving patterns of diel habitat selection by wintering sandhill cranes. Land use and riverine trends have likely gradually reduced winter habitat to managed public lands and limited reaches of the Rio Grande, underscoring the importance of natural resources agencies in supporting migratory birds and challenges involved when managing for wildlife in highly pressured semi-arid environments.	[Boggie, Matthew A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Collins, Daniel P.; Carleton, Scott A.] US Fish & Wildlife Serv, Div Migratory Birds, Albuquerque, NM USA; [Donnelly, J. Patrick] Univ Montana, Intermt West Joint Venture, Missoula, MT 59812 USA; [Donnelly, J. Patrick] Univ Montana, US Fish & Wildlife Serv, Missoula, MT 59812 USA	New Mexico State University; United States Department of the Interior; US Fish & Wildlife Service; University of Montana System; University of Montana; United States Department of the Interior; US Fish & Wildlife Service; University of Montana System; University of Montana	Boggie, MA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	boggie@nmsu.edu			U.S. Fish and Wildlife Service, Division of Migratory Birds	U.S. Fish and Wildlife Service, Division of Migratory Birds(US Fish & Wildlife Service)	This work was funded by the U.S. Fish and Wildlife Service, Division of Migratory Birds.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anteau MJ, 2011, J WILDLIFE MANAGE, V75, P1004, DOI 10.1002/jwmg.135; Archer Steven R., 2008, Rangelands, V30, P23, DOI 10.2111/1551-501X(2008)30[23:CCAEOT]2.0.CO;2; Austin JE., 2012, P WORKSH CRAN AGR CL, P131; Basille M, 2015, HAB HABITAT MOVEMENT; Basille M, 2015, ECOLOGY, V96, P2622, DOI 10.1890/14-1706.1; Blackburn E, 2016, J ORNITHOL, V157, P93, DOI 10.1007/s10336-015-1252-z; Boggie MA, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2083; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Brook BW, 2013, TRENDS ECOL EVOL, V28, P396, DOI 10.1016/j.tree.2013.01.016; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Carlisle JD, 2009, CONDOR, V111, P211, DOI 10.1525/cond.2009.080096; Case D, 2009, SPECIAL REPORT FILES; Collins DP, 2016, J FISH WILDL MANAG, V7, P141, DOI 10.3996/042015-JFWM-036; Congalton RG, 1998, PHOTOGRAMM ENG REM S, V64, P1107; Copeland SM, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1823; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; Darrah AJ, 2017, ECOL ENG, V106, P784, DOI 10.1016/j.ecoleng.2016.06.001; Dettinger M, 2015, ECOL APPL, V25, P2069, DOI 10.1890/15-0938.1; DREWIEN RC, 1995, J WILDLIFE MANAGE, V59, P339, DOI 10.2307/3808948; DREWIEN RC, 1974, J WILDLIFE MANAGE, V38, P720, DOI 10.2307/3800039; Finch DM, 2000, STUD AVIAN BIOL-SER, P88; Foga S, 2017, REMOTE SENS ENVIRON, V194, P379, DOI 10.1016/j.rse.2017.03.026; Foody GM, 2009, INT J REMOTE SENS, V30, P5273, DOI 10.1080/01431160903130937; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Fox AD, 1995, WILSON BULL, V107, P752; Friggens MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144089; Garfin G, 2013, NCA REGION INPUT REP, P1, DOI 10.5822/978-1-61091-484-0; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Grimm NB, 2016, CLIMATIC CHANGE, V135, P97, DOI 10.1007/s10584-015-1547-3; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; HOWE WH, 1991, SOUTHWEST NAT, V36, P218, DOI 10.2307/3671924; Huang JP, 2016, CLIM DYNAM, V46, P1131, DOI 10.1007/s00382-015-2636-8; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; Iriarte DP., 2011, THESIS; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Johnson WP, 2014, AVIAN CONSERV ECOL, V9, DOI 10.5751/ACE-00683-090202; Keshava N, 2002, IEEE SIGNAL PROC MAG, V19, P44, DOI 10.1109/79.974727; Kessler AC, 2011, INVAS PLANT SCI MANA, V4, P369, DOI 10.1614/IPSM-D-11-00036.1; Kinzel PJ, 2009, RIVER RES APPL, V25, P135, DOI 10.1002/rra.1103; Krapu GL, 2014, WILDLIFE MONOGR, V189, P1, DOI 10.1002/wmon.1013; KRAPU GL, 1984, J WILDLIFE MANAGE, V48, P407, DOI 10.2307/3801172; Kruse KL, 2017, J FISH WILDL MANAG, V8, P436, DOI [10.3996/042017-JFWM-037, 10.3996/042017-jfwm-037]; Kutner M., 2004, APPL LINEAR REGRESSI; Leu M, 2008, ECOL APPL, V18, P1119, DOI 10.1890/07-0480.1; Li CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118928; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Masek JG, 2006, IEEE GEOSCI REMOTE S, V3, P68, DOI 10.1109/LGRS.2005.857030; Mason THE, 2017, J ANIM ECOL, V86, P960, DOI 10.1111/1365-2656.12682; Maxwell S, 2016, NATURE, V536, P143, DOI 10.1038/536143a; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Medley CN, 2013, ECOHYDROLOGY, V6, P491, DOI 10.1002/eco.1373; Merritt DM, 2012, ECOL APPL, V22, P1973, DOI 10.1890/12-0303.1; Molles MC, 1998, BIOSCIENCE, V48, P749, DOI 10.2307/1313337; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Newton I., 1998, POPULATION LIMITATIO; Noojipady Praveen, 2015, Ecosystem Health and Sustainability, V1, P27, DOI 10.1890/EHS15-0020.1; NORLING BS, 1992, GREAT BASIN NAT, V52, P253; Norris DR, 2007, CONDOR, V109, P535; Northrup JM, 2013, ECOLOGY, V94, P1456, DOI 10.1890/12-1688.1; ODUM EP, 1960, AM J CLIN NUTR, V8, P621, DOI 10.1093/ajcn/8.5.621; Pacific Flyway Council and Central Flyway Council, 2016, PAC CENTR FLYW MAN P; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Pearse AT, 2017, J WILDLIFE MANAGE, V81, P477, DOI 10.1002/jwmg.21215; Pearse AT, 2016, CONDOR, V118, P391, DOI 10.1650/CONDOR-15-99.1; Pearse AT, 2010, J WILDLIFE MANAGE, V74, P479, DOI 10.2193/2008-539; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Petrakis RE, 2017, LAND-BASEL, V6, DOI 10.3390/land6020029; Petrie MJ, 1998, J WILDLIFE MANAGE, V62, P1147, DOI 10.2307/3802570; Prima MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169779; Pyne MI, 2017, GLOBAL CHANGE BIOL, V23, P77, DOI 10.1111/gcb.13437; R Core Team, 2021, R LANGUAGE ENV STAT; Rappole J., 2013, AVIAN MIGRANT BIOL B; Robb GN, 2008, BIOL LETTERS, V4, P220, DOI 10.1098/rsbl.2007.0622; Ruth JM, 2012, CONDOR, V114, P698, DOI 10.1525/cond.2012.120020; Schmitt C.G., 1997, P 7 N AM CRAN WORKSH, P219; Schroeder RL, 2004, NAT RESOUR J, V44, P1185; Sedinger James S., 2014, Wildfowl, P277; Sherfy MH, 2011, J WILDLIFE MANAGE, V75, P995, DOI 10.1002/jwmg.157; Smith DM, 2016, J ARID ENVIRON, V135, P120, DOI 10.1016/j.jaridenv.2016.08.016; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Swanson BJ, 2011, EARTH SURF PROC LAND, V36, P885, DOI 10.1002/esp.2119; TACHA TC, 1987, J WILDLIFE MANAGE, V51, P440, DOI 10.2307/3801032; Tacha Thomas C., 1994, P77; Taylor JP, 2005, WILDLIFE SOC B, V33, P574, DOI 10.2193/0091-7648(2005)33[574:MBUOBF]2.0.CO;2; Taylor JP, 1999, WETLANDS, V19, P372, DOI 10.1007/BF03161769; Thorpe PP, 2016, SPECIAL REPORT FILES; Tietjen B, 2017, GLOBAL CHANGE BIOL, V23, P2743, DOI 10.1111/gcb.13598; U. S. Bureau of Land Management, 2012, NEW MEX SURF LAND OW; U. S. Department of the Interior Fish and Wildlife Service U. S. Department of Commerce U. S. Census Bureau., 2011, 2011 NAT SURV FISH H; Urbanek RP, 1991, P 1987 INT CRAN WORK, P241; van Wijk RE, 2016, ECOL EVOL, V6, P8679, DOI 10.1002/ece3.2578; Walsh J., 2014, CLIMATE CHANGE IMPAC, P19, DOI [10.7930/J0KW5CXT, DOI 10.7930/J0KW5CXT]; Wheeler RH, 1972, TRAPPING TECHNIQUES; Wright GD, 2015, J FISH WILDL MANAG, V6, P112, DOI 10.3996/062014-JFWM-044; Yamamoto T, 2014, BEHAVIOUR, V151, P683, DOI 10.1163/1568539X-00003163; Zhou B, 2010, WATERBIRDS, V33, P110, DOI 10.1675/063.033.0114	98	7	7	5	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206222	10.1371/journal.pone.0206222	http://dx.doi.org/10.1371/journal.pone.0206222			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403712	Green Published, Green Submitted, gold			2022-12-26	WOS:000449379500058
J	Liu, CJ; Wang, L; Xie, HZ; Zhang, LY; Wang, BS; Luo, C; Wang, SQ; Tang, ML; Fu, ZB; Ruan, HL; Liu, ZJ; Wei, L; Yi, WY; Xie, YQ				Liu, Changjiang; Wang, Li; Xie, Huizhong; Zhang, Liyuan; Wang, Bingshu; Luo, Chun; Wang, Suiqun; Tang, Mingliang; Fu, Zhongbiao; Ruan, Hailan; Liu, Zhengjin; Wei, Ling; Yi, Wenyi; Xie, Yunqian			The relationship between serum hepatitis B virus DNA level and liver histology in patients with chronic HBV infection	PLOS ONE			English	Article							LAENNEC STAGING SYSTEM; NATURAL-HISTORY; CLINICAL STAGE; VIRAL LOAD; CIRRHOSIS; FIBROSIS; PARAMETERS; MANAGEMENT; THERAPY; UPDATE	Background There is no consensus regarding the relationship between HBV DNA and liver fibrosis, and the relationship between HBV DNA and the degree of liver cirrhosis has not been reported in patients with chronic HBV infection. Methods From January 2011 to December 2016, liver biopsies were performed on 396 patients with chronic hepatitis B and cirrhosis. Assessments of liver fibrosis and cirrhosis were based on the Laennec staging system. Results Serum levels of HBV DNA were correlated with fibrosis and cirrhosis (KW = 73.946, P<0.001). Serum HBV DNA level was correlated with mild fibrosis, moderate to severe fibrosis and cirrhosis (P = 0.009, P<0.001, and P<0.001, respectively). The HBeAg-positive group and HBeAg-negative group showed significant differences in HBV DNA levels, and the rates of mild fibrosis, severe fibrosis and cirrhosis were significantly different between these two groups (F = 17.585, P<0.001 and F = 6.017, P = 0.003, respectively). The replication status of the serum HBV DNA affected fibrosis formation as well as cirrhosis (chi(2) = 53.76, P<0.001). In the HBeAg-positive group, the sensitivity, specificity and AUC values of HBV DNA as a predictor for mild fibrosis and cirrhosis were 64.3%, 78.94% and 0.818, respectively, and 81.0%, 69.2%, and 0.871, respectively. In the HBeAg-negative group, the sensitivity, specificity and AUC values of HBV DNA for liver sclerosis prediction were 48%, 76.8% and 0.697, respectively. Conclusions Different HBV DNA levels had different effects on the formation of fibrosis and sclerosis in liver tissues. HBV DNA levels can predict mild fibrosis and cirrhosis in liver tissue, which is enhanced in HBeAg-positive patients.	[Liu, Changjiang; Xie, Huizhong; Tang, Mingliang; Fu, Zhongbiao; Ruan, Hailan; Liu, Zhengjin; Wei, Ling; Yi, Wenyi; Xie, Yunqian] Hainan Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Haikou, Hainan, Peoples R China; [Wang, Li; Wang, Bingshu; Luo, Chun; Wang, Suiqun] Hainan Med Univ, Affiliated Hosp 2, Dept Pathol, Haikou, Hainan, Peoples R China; [Zhang, Liyuan] Hainan Med Univ, Affiliated Hosp 2, Dept Infect Dis, Haikou, Hainan, Peoples R China	Hainan Medical University; Hainan Medical University; Hainan Medical University	Xie, HZ (corresponding author), Hainan Med Univ, Affiliated Hosp 2, Dept Gastroenterol, Haikou, Hainan, Peoples R China.	hnxiehuizhong@163.com		huizhong, xie/0000-0002-7477-3327				Abdo AA, 2014, J CLIN GASTROENTEROL, V48, pE50, DOI 10.1097/MCG.0b013e3182a9a2e1; Alam M M, 2014, Bangladesh Med Res Counc Bull, V40, P92; Alavian SM, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.34790; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; de Oliveira VOB, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658065, 10.1590/S1678-9946201658065]; Brown A, 2012, EXPERT REV GASTROENT, V6, P187, DOI [10.1586/EGH.12.4, 10.1586/egh.12.4]; Chen JD, 2010, GASTROENTEROLOGY, V138, P1747, DOI 10.1053/j.gastro.2010.01.042; Chung GE, 2014, WORLD J GASTROENTERO, V20, P7306, DOI 10.3748/wjg.v20.i23.7306; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Diktas H, 2016, POSTGRAD MED J, V92, P693, DOI 10.1136/postgradmedj-2016-134069; European Assoc Study Liver, 2017, J HEPATOL, V67, P370, DOI 10.1016/j.jhep.2017.03.021; Fung J, 2007, ALIMENT PHARM THER, V26, P377, DOI 10.1111/j.1365-2036.2007.03390.x; Gao Yufeng, 2015, Zhonghua Gan Zang Bing Za Zhi, V23, P254, DOI 10.3760/cma.j.issn.1007-3418.2015.04.005; Gish RG, 2015, ANTIVIR RES, V121, P47, DOI 10.1016/j.antiviral.2015.06.008; Harkisoen S, 2014, INT J INFECT DIS, V29, P133, DOI 10.1016/j.ijid.2014.08.005; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Ke WM, 2011, J VIRAL HEPATITIS, V18, P637, DOI 10.1111/j.1365-2893.2011.01444.x; Kim JD, 2010, CLIN GASTROENTEROL H, V8, P60, DOI 10.1016/j.cgh.2009.09.026; Kim MY, 2011, J HEPATOL, V55, P1004, DOI 10.1016/j.jhep.2011.02.012; Lee CZ, 2002, LIVER, V22, P130, DOI 10.1034/j.1600-0676.2002.01525.x; Mancuso A, 2015, ALIMENT PHARM THER, V41, P707, DOI 10.1111/apt.13118; Mancuso A, 2016, MED HYPOTHESES, V94, P4, DOI 10.1016/j.mehy.2016.06.008; Mancuso A, 2014, MED HYPOTHESES, V82, P244, DOI 10.1016/j.mehy.2013.11.044; Mani H, 2009, HEPATOLOGY, V49, pS61, DOI 10.1002/hep.22930; Pan AN, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006465; Praneenararat S, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0218-6; Rastogi A, 2013, HISTOPATHOLOGY, V62, P731, DOI 10.1111/his.12070; Sanai FM, 2011, J VIRAL HEPATITIS, V18, pE217, DOI 10.1111/j.1365-2893.2011.01437.x; Sanai FM, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0658-x; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Tseng TC, 2015, J VIRAL HEPATITIS, V22, P77, DOI 10.1111/jvh.12370; Vardar R, 2010, HEPATO-GASTROENTEROL, V57, P908; Wang J, 2017, ONCOTARGET, V8, P59257, DOI 10.18632/oncotarget.19501; Wang W, 2015, HEPATOL INT, V9, P621, DOI 10.1007/s12072-015-9648-7; Wanless IR, 2002, BLOOD, V100, P1566, DOI 10.1182/blood-2002-01-0306; Wu JF, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0199-y; Xie QX, 2014, J MED VIROL, V86, P1828, DOI 10.1002/jmv.24000; Zhang EL, 2016, J SURG RES, V204, P274, DOI 10.1016/j.jss.2016.04.036	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0206060	10.1371/journal.pone.0206060	http://dx.doi.org/10.1371/journal.pone.0206060			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403735	Green Submitted, Green Published, gold			2022-12-26	WOS:000449379500047
J	Magrassi, L; Zippo, AG; Azzalin, A; Bastianello, S; Imberti, R; Biella, GEM				Magrassi, Lorenzo; Zippo, Antonio G.; Azzalin, Alberto; Bastianello, Stefano; Imberti, Roberto; Biella, Gabriele E. M.			Single unit activities recorded in the thalamus and the overlying parietal cortex of subjects affected by disorders of consciousness	PLOS ONE			English	Article							CEREBRAL-CORTEX; SLEEP SPINDLES; BRAIN; EEG; STATE; STIMULATION; NEURONS; MECHANISMS; INSIGHTS; NUCLEUS	The lack of direct neurophysiological recordings from the thalamus and the cortex hampers our understanding of vegetative state/unresponsive wakefulness syndrome and minimally conscious state in humans. We obtained microelectrode recordings from the thalami and the homolateral parietal cortex of two vegetative state/unresponsive wakefulness syndrome and one minimally conscious state patients during surgery for implantation of electrodes in both thalami for chronic deep brain stimulation. We found that activity of the thalamo-cortical networks differed among the two conditions. There were half the number of active neurons in the thalami of patients in vegetative state/unresponsive wakefulness syndrome than in minimally conscious state. Coupling of thalamic neuron discharge with EEG phases also differed in the two conditions and thalamo-cortical cross-frequency coupling was limited to the minimally conscious state patient. When consciousness is physiologically or pharmacologically reversibly suspended there is a significant increase in bursting activity of the thalamic neurons. By contrast, in the thalami of our patients in both conditions fewer than 17% of the recorded neurons showed bursting activity. This indicates that these conditions differ from physiological suspension of consciousness and that increased thalamic inhibition is not prominent. Our findings, albeit obtained in a limited number of patients, unveil the neurophysiology of these conditions at single unit resolution and might be relevant for inspiring novel therapeutic options.	[Magrassi, Lorenzo; Azzalin, Alberto] Univ Pavia, Fdn IRCCS Policlin S Matteo, Dipartimento Sci Clin Chirurg Diagnost & Pediat, Neurochirurg, Pavia, Italy; [Magrassi, Lorenzo; Azzalin, Alberto] CNR, IGM, Pavia, Italy; [Zippo, Antonio G.; Biella, Gabriele E. M.] CNR, Ist Bioimmagini & Fisiol Mol, LITA Bldg, Segrate, Italy; [Bastianello, Stefano] State Univ Pavia, Dept Brain & Behav Sci, Neuroradiol Dept, C Mondino Natl Neurol Inst, Pavia, Italy; [Imberti, Roberto] Fdn IRCCS Policlin S Matteo, Phase Clin Trial Unit & Expt Therapy 1, Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR); IRCCS Fondazione Casimiro Mondino; IRCCS Fondazione San Matteo	Magrassi, L (corresponding author), Univ Pavia, Fdn IRCCS Policlin S Matteo, Dipartimento Sci Clin Chirurg Diagnost & Pediat, Neurochirurg, Pavia, Italy.; Magrassi, L (corresponding author), CNR, IGM, Pavia, Italy.	lorenzo.magrassi@unipv.it	Magrassi, Lorenzo/AAJ-3105-2020	Bastianello, Stefano/0000-0002-8414-9077; Magrassi, Lorenzo/0000-0002-8308-2720	Fondazione I.R.C. C.S. Policlinico S. Matteo [08019701/08]	Fondazione I.R.C. C.S. Policlinico S. Matteo	This study was supported by a grant (ricerca corrente 08019701/08) to Roberto Imberti and Lorenzo Magrassi from the Fondazione I.R.C. C.S. Policlinico S. Matteo. The funding source had no role in the study design or implementation.	Andrillon T, 2011, J NEUROSCI, V31, P17821, DOI 10.1523/JNEUROSCI.2604-11.2011; Bakkum DJ, 2014, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00193; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Constantinople CM, 2011, NEURON, V69, P1061, DOI 10.1016/j.neuron.2011.02.040; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Crone JS, 2017, CEREB CORTEX, V27, P2727, DOI 10.1093/cercor/bhw112; Crone JS, 2014, NEUROIMAGE-CLIN, V4, P240, DOI 10.1016/j.nicl.2013.12.005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Di Perri C, 2016, LANCET NEUROL, V15, P830, DOI 10.1016/S1474-4422(16)00111-3; Fernandez-Espejo D, 2015, JAMA NEUROL, V72, P1442, DOI 10.1001/jamaneurol.2015.2614; Fernandez-Espejo D, 2010, J NEUROTRAUM, V27, P1187, DOI 10.1089/neu.2010.1297; FitzGerald THB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00084; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Galvan A, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00005; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Guldenmund P, 2016, BRAIN INJURY, V30, P343, DOI 10.3109/02699052.2015.1118765; JANG SH, 2016, MEDICINE, V95, DOI DOI 10.1097/MD.0000000000005234; Jeanmonod D, 1996, BRAIN, V119, P363, DOI 10.1093/brain/119.2.363; Kirsch M, 2017, ANESTH ANALG, V124, P588, DOI 10.1213/ANE.0000000000001721; Krishna V, 2015, EUR J NEUROSCI, V42, P2070, DOI 10.1111/ejn.13004; Lacey CJ, 2007, J NEUROSCI, V27, P4374, DOI 10.1523/JNEUROSCI.5519-06.2007; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lee J, 2013, P NATL ACAD SCI USA, V110, P20266, DOI 10.1073/pnas.1320572110; Lenz FA, 2002, J NEUROPHYSIOL, V87, P2084, DOI 10.1152/jn.00049.2001; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Lombardi F, 2007, FUNCT NEUROL, V22, P47; Lutkenhoff ES, 2015, ANN NEUROL, V78, P68, DOI 10.1002/ana.24423; Lutkenhoff ES, 2013, NEUROIMAGE-CLIN, V3, P396, DOI 10.1016/j.nicl.2013.09.010; Magnin M, 2000, NEUROSCIENCE, V96, P549, DOI 10.1016/S0306-4522(99)00583-7; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; Magrassi L, 2016, J NEUROSURG, V125, P972, DOI 10.3171/2015.7.JNS15700; Montemurro MA, 2008, CURR BIOL, V18, P375, DOI 10.1016/j.cub.2008.02.023; Monti MM, 2015, NEUROLOGY, V84, P167, DOI 10.1212/WNL.0000000000001123; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Ojemann GA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00034; Owen AM, 2006, SCIENCE, V313, P1402, DOI 10.1126/science.1130197; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Raeva S N, 2006, Neurosci Behav Physiol, V36, P287, DOI 10.1007/s11055-006-0015-y; Ranft A, 2016, ANESTHESIOLOGY, V125, P861, DOI 10.1097/ALN.0000000000001322; Roux F, 2013, J NEUROSCI, V33, P17827, DOI 10.1523/JNEUROSCI.5778-12.2013; Schiff ND, 2008, NATURE, V452, P120, DOI 10.1038/nature06818; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schwalm M, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0096-16.2016; Sheroziya M, 2015, J NEUROSCI, V35, P13006, DOI 10.1523/JNEUROSCI.1359-15.2015; Simons DJ, 2015, J NEUROPHYSIOL, V114, P1912, DOI 10.1152/jn.00488.2015; Storchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035850; Tsoukatos J, 1997, EXP BRAIN RES, V113, P273, DOI 10.1007/BF02450325; Yamamoto T, 2010, EUR J NEUROSCI, V32, P1145, DOI 10.1111/j.1460-9568.2010.07412.x; Zar JH., 2010, BIOSTAT ANAL, V5th; Zheng ZS, 2017, HUM BRAIN MAPP, V38, P431, DOI 10.1002/hbm.23370	56	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205967	10.1371/journal.pone.0205967	http://dx.doi.org/10.1371/journal.pone.0205967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403761	Green Submitted, gold, Green Published			2022-12-26	WOS:000449379500038
J	Tatsumi, D; Hayashi, Y; Endo, M; Kobayashi, H; Yoshioka, T; Kiso, K; Kanno, S; Nakai, Y; Maeda, I; Mochizuki, K; Tachibana, M; Koseki, H; Okuda, A; Yasui, A; Kono, T; Matsui, Y				Tatsumi, Daiki; Hayashi, Yohei; Endo, Mai; Kobayashi, Hisato; Yoshioka, Takumi; Kiso, Kohei; Kanno, Shinichiro; Nakai, Yuji; Maeda, Ikuma; Mochizuki, Kentaro; Tachibana, Makoto; Koseki, Haruhiko; Okuda, Akihiko; Yasui, Akira; Kono, Tomohiro; Matsui, Yasuhisa			DNMTs and SETDB1 function as co-repressors in MAX-mediated repression of germ cell-related genes in mouse embryonic stem cells	PLOS ONE			English	Article							DNA METHYLATION; SELF-RENEWAL; RNA-SEQ; IN-VIVO; CHROMATIN; POLYCOMB; COMPLEX; DIFFERENTIATION; MAINTENANCE; MECHANISMS	In embryonic stem cells (ESCs), the expression of development-related genes, including germ cell-related genes, is globally repressed. The transcription factor MAX represses germ cell-related gene expression in ESCs via PCGF6-polycomb repressive complex 1 (PRC1), which consists of several epigenetic factors. However, we predicted that MAX represses germ cell-related gene expression through several additional mechanisms because PCGF6-PRC1 regulates the expression of only a subset of genes repressed by MAX. Here, we report that MAX associated with DNA methyltransferases (DNMTs) and the histone methyltransferase SETDB1 cooperatively control germ cell-related gene expression in ESCs. Both DNA methylation and histone H3 lysine 9 tri-methylation of the promoter regions of several germ cell-related genes were not affected by knockout of the PRC1 components, indicating that the MAX-DNMT and MAX-SETDB1 pathways are independent of the PCGF6-PRC1 pathway. Our findings provide insights into our understanding of MAX-based repressive mechanisms of germ cell-related genes in ESCs.	[Tatsumi, Daiki; Hayashi, Yohei; Endo, Mai; Kiso, Kohei; Maeda, Ikuma; Mochizuki, Kentaro; Matsui, Yasuhisa] Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan; [Tatsumi, Daiki; Hayashi, Yohei; Endo, Mai; Mochizuki, Kentaro; Matsui, Yasuhisa] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Hayashi, Yohei; Matsui, Yasuhisa] Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chuo Ku, Tokyo, Japan; [Kobayashi, Hisato] Tokyo Univ Agr, NODAI Genome Res Ctr, Setagaya Ku, Tokyo, Japan; [Yoshioka, Takumi; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo, Japan; [Kiso, Kohei] Tohoku Univ, Sch Med, Sendai, Miyagi, Japan; [Kanno, Shinichiro; Yasui, Akira] Tohoku Univ, Inst Dev Aging & Canc, Div Dynam Proteome Canc & Aging, Sendai, Miyagi, Japan; [Nakai, Yuji] Hirosaki Univ, Inst Food Sci, Hirosaki, Aomori, Japan; [Mochizuki, Kentaro] Tohoku Univ, Ctr Environm Conservat & Res Safety, Sendai, Miyagi, Japan; [Tachibana, Makoto] Tokushima Univ, Inst Enzyme Res, Dept Enzyme Chem, Shinkura Cho, Tokushima, Japan; [Koseki, Haruhiko] RIKEN, Ctr Integrat Med Sci, Lab Dev Genet, Yokohama, Kanagawa, Japan; [Koseki, Haruhiko] Core Res Evolut Sci & Technol, Yokohama, Kanagawa, Japan; [Okuda, Akihiko] Saitama Med Univ, Res Ctr Genom Med, Div Dev Biol, Yamane Hidaka, Saitama, Japan; [Matsui, Yasuhisa] Tohoku Univ, Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan; [Maeda, Ikuma] HaploPharma Inc, Chuo Ku, Tokyo, Japan	Tohoku University; Tohoku University; Tokyo University of Agriculture; Tokyo University of Agriculture; Tohoku University; Tohoku University; Hirosaki University; Tohoku University; Tokushima University; RIKEN; Saitama Medical University; Tohoku University	Matsui, Y (corresponding author), Tohoku Univ, IDAC, Cell Resource Ctr Biomed Res, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.; Matsui, Y (corresponding author), Japan Agcy Med Res & Dev Core Res Evolut Sci & Te, Chuo Ku, Tokyo, Japan.; Matsui, Y (corresponding author), Tohoku Univ, Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan.	yasuhisa.matsui.d3@tohoku.ac.jp	Kobayashi, Hisato/AAP-7910-2020; NAKAI, Yuji/G-3433-2014	NAKAI, Yuji/0000-0002-2458-3875; Matsui, Yasuhisa/0000-0001-7026-6355; Kobayashi, Hisato/0000-0003-3800-4691; Hayashi, Yohei/0000-0003-3914-9999	Ministry of Education, Culture, Sports, Science and Technology of Japan [18H04875, 25114003]; AMED-CREST from the Japan Agency for Medical Research and Development [17gm0510017h0005]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); AMED-CREST from the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported by a Grant-in-Aid (KAKENHI)(http://www.mext.go.jp/en/policy/science_ technology/researchpromotion/title01/detail01/1374077. htm) in the Innovative Areas, "Sex spectrum" (grant #18H04875) to YH, KAKENHI in the Innovative Areas, "Mechanisms regulating gamete formation in animals"(grant #25114003) to YM from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and by AMED-CREST grant #17gm0510017h0005 to YM from the Japan Agency for Medical Research and Development (https://www.amed.go.jp/en/index.html).IM is employed by and received salary from HaploPharma Inc., Chuo-ku, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Endoh M, 2017, ELIFE, V6, DOI 10.7554/eLife.21064; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Hackett JA, 2012, DEVELOPMENT, V139, P3623, DOI 10.1242/dev.081661; Halpern KB, 2014, J BIOL CHEM, V289, P23882, DOI 10.1074/jbc.M114.573469; Hargan-Calvopina J, 2016, DEV CELL, V39, P75, DOI 10.1016/j.devcel.2016.07.019; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Karimi MM, 2011, CELL STEM CELL, V8, P676, DOI 10.1016/j.stem.2011.04.004; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kobayashi H, 2013, GENOME RES, V23, P616, DOI 10.1101/gr.148023.112; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Koike T, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.116.138677; Li Z., 2015, IEEE T SERV COMPUT, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0124949; Liu S, 2014, GENE DEV, V28, P2041, DOI 10.1101/gad.244848.114; Lohmann F, 2010, STEM CELLS, V28, P201, DOI 10.1002/stem.278; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Maeda I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2780; Maksakova IA, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-15; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; Matsumura Y, 2015, MOL CELL, V60, P584, DOI 10.1016/j.molcel.2015.10.025; Luis NM, 2012, CELL STEM CELL, V11, P16, DOI 10.1016/j.stem.2012.06.005; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miura F, 2015, DNA RES, V22, P13, DOI 10.1093/dnares/dsu034; Monk D, 2015, INT J BIOCHEM CELL B, V67, P128, DOI 10.1016/j.biocel.2015.04.014; Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Sachs M, 2013, CELL REP, V3, P1777, DOI 10.1016/j.celrep.2013.04.032; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sekinaka T, 2016, SCI REP-UK, V6, DOI 10.1038/srep32932; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun DQ, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r38; Suzuki A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11056; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tang WWC, 2015, CELL, V161, P1453, DOI 10.1016/j.cell.2015.04.053; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Yang BX, 2015, CELL, V163, P230, DOI 10.1016/j.cell.2015.08.037; Yokobayashi S, 2013, NATURE, V190, P1954; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhang T, 2016, CELL REP, V15, P77, DOI 10.1016/j.celrep.2016.03.007	49	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2018	13	11							e0205969	10.1371/journal.pone.0205969	http://dx.doi.org/10.1371/journal.pone.0205969			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4PQ	30403691	gold, Green Submitted, Green Published			2022-12-26	WOS:000449379500039
J	Crosby, K; Crown, AM; Roberts, BL; Brown, H; Ayers, JI; Borchelt, DR				Crosby, Keith; Crown, Anthony M.; Roberts, Brittany L.; Brown, Hilda; Ayers, Jacob, I; Borchelt, David R.			Loss of charge mutations in solvent exposed Lys residues of superoxide dismutase 1 do not induce inclusion formation in cultured cell models	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOLECULAR-WEIGHT COMPLEXES; MOTOR-NEURON DISEASE; WILD-TYPE; MUTANT SOD1; HYALINE INCLUSIONS; CLINICAL-FEATURES; TRANSGENIC MICE; AGGREGATION; SUPEROXIDE-DISMUTASE-1	Mutations in superoxide dismutase 1 (SOD1) associated with familial amyotrophic lateral sclerosis (fALS) induce the protein to misfold and aggregate. Missense mutations at more than 80 different amino acid positions have been associated with disease. How these mutations heighten the propensity of SOD1 to misfold and aggregate is unclear. With so many mutations, it is possible that more than one mechanism of aggregation may be involved. Of many possible mechanisms to explain heightened aggregation, one that has been suggested is that mutations that eliminate charged amino acids could diminish repulsive forces that would inhibit aberrant protein:protein interactions. Mutations at twenty-one charged residues in SOD1 have been associated with fALS, but of the 11 Lys residues in the protein, only 1 has been identified as mutated in ALS patients. Here, we examined whether loss of positively charged surface Lys residues in SOD1 would induce misfolding and formation of intracellular inclusions. We mutated four different Lys residues (K30, K36, K75, K91) in SOD1 that are not particularly well conserved, and expressed these variants as fusion proteins with yellow fluorescent protein (YFP) to assess inclusion formation. We also assessed whether these mutations induced binding to a conformation-restricted SOD1 antibody, designated C4F6, which recognizes non-natively folded protein. Although we observed some mutations to cause enhanced C4F6 binding, we did not observe that mutations that reduce charge at these positions caused the protein to form intracellular inclusions. Our findings may have implications for the low frequency of mutations at Lys residues SOD1 in ALS patients.	[Crosby, Keith; Brown, Hilda; Ayers, Jacob, I; Borchelt, David R.] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Crown, Anthony M.; Roberts, Brittany L.; Borchelt, David R.] Univ Florida, Coll Arts & Sci, Gainesville, FL 32611 USA; [Brown, Hilda; Borchelt, David R.] Univ Florida, McKnight Brain Inst, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Borchelt, DR (corresponding author), Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.; Borchelt, DR (corresponding author), Univ Florida, Coll Arts & Sci, Gainesville, FL 32611 USA.; Borchelt, DR (corresponding author), Univ Florida, McKnight Brain Inst, SantaFe HealthCare Alzheimers Dis Res Ctr, Gainesville, FL 32611 USA.	drb1@ufl.edu	Ayers, Jacob/AAQ-7158-2021	Ayers, Jacob/0000-0003-4544-2366	National Institutes of Neurological Disease and Stroke [P01 NS049134]; University of Florida	National Institutes of Neurological Disease and Stroke; University of Florida(University of Florida)	This work was supported by a grant from the National Institutes of Neurological Disease and Stroke (P01 NS049134 to DB) and by the University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayers J, 2014, J NEUROCHEM, V128, P305, DOI 10.1111/jnc.12451; Ayers JI, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-55; BORCHELT DR, 1994, P NATL ACAD SCI USA, V91, P8292, DOI 10.1073/pnas.91.17.8292; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brotherton TE, 2012, P NATL ACAD SCI USA, V109, P5505, DOI 10.1073/pnas.1115009109; Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891; Corcoran LJ, 2004, CURR BIOL, V14, P488, DOI 10.1016/j.cub.2004.03.003; Da Cruz S, 2017, ACTA NEUROPATHOL, V134, P97, DOI 10.1007/s00401-017-1688-8; Elam JS, 2003, NAT STRUCT BIOL, V10, P461, DOI 10.1038/nsb935; Fei EK, 2006, BIOCHEM BIOPH RES CO, V347, P406, DOI 10.1016/j.bbrc.2006.06.092; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; FRIDOVICH I, 1974, ADV ENZYMOL RAMB, V41, P35; Grad LI, 2014, P NATL ACAD SCI USA, V111, P3620, DOI 10.1073/pnas.1312245111; Graffmo KS, 2013, HUM MOL GENET, V22, P51, DOI 10.1093/hmg/dds399; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hineno A, 2012, J NEUROL SCI, V319, P63, DOI 10.1016/j.jns.2012.05.014; Ivanova MI, 2014, P NATL ACAD SCI USA, V111, P197, DOI 10.1073/pnas.1320786110; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2008, ANN NEUROL, V63, P671, DOI 10.1002/ana.21356; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Karch CM, 2008, J BIOL CHEM, V283, P13528, DOI 10.1074/jbc.M800564200; Karch CM, 2009, P NATL ACAD SCI USA, V106, P7774, DOI 10.1073/pnas.0902505106; Kato S, 2001, ACTA NEUROPATHOL, V102, P233; Kerman A, 2010, ACTA NEUROPATHOL, V119, P335, DOI 10.1007/s00401-010-0646-5; Knibb JA, 2016, J NEUROL NEUROSURG P; Kokubo Y, 1999, ARCH NEUROL-CHICAGO, V56, P1506, DOI 10.1001/archneur.56.12.1506; Matsumoto G, 2005, J CELL BIOL, V171, P75, DOI 10.1083/jcb.200504050; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Monsellier E, 2007, BIOPHYS J, V93, P4382, DOI 10.1529/biophysj.107.111336; Monsellier E, 2007, EMBO REP, V8, P737, DOI 10.1038/sj.embor.7401034; Nakamura S, 2014, NEUROPATHOLOGY, V34, P58, DOI 10.1111/neup.12049; NISHIDA CR, 1994, P NATL ACAD SCI USA, V91, P9906, DOI 10.1073/pnas.91.21.9906; Ogihara NL, 1996, BIOCHEMISTRY-US, V35, P2316, DOI 10.1021/bi951930b; Ohi T, 2004, J NEUROL SCI, V225, P19, DOI 10.1016/j.jns.2004.06.008; OKAMOTO K, 1991, NEUROSCI LETT, V129, P233, DOI 10.1016/0304-3940(91)90469-A; PARGE HE, 1992, P NATL ACAD SCI USA, V89, P6109, DOI 10.1073/pnas.89.13.6109; Prudencio M, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-77; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; Ratovitski T, 1999, HUM MOL GENET, V8, P1451, DOI 10.1093/hmg/8.8.1451; Roberts BLT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047838; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rotunno MS, 2014, J BIOL CHEM, V289, P28527, DOI 10.1074/jbc.M114.581801; Sabado J, 2013, J NEUROPATH EXP NEUR, V72, P646, DOI 10.1097/NEN.0b013e318297fd10; Sangwan Smriti, 2016, Postepy Biochem, V62, P362; Sasaki S, 1998, NEUROLOGY, V51, P871, DOI 10.1212/WNL.51.3.871; Shaw CE, 1997, NEUROLOGY, V49, P1612, DOI 10.1212/WNL.49.6.1612; Shibata N, 1996, DEV NEUROSCI-BASEL, V18, P492, DOI 10.1159/000111445; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Shinder GA, 2001, J BIOL CHEM, V276, P12791, DOI 10.1074/jbc.M010759200; Steinacker P, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0130-x; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; Suzuki M, 2008, J NEUROL SCI, V268, P140, DOI 10.1016/j.jns.2007.11.020; Takehisa Y, 2001, ARCH NEUROL-CHICAGO, V58, P736, DOI 10.1001/archneur.58.5.736; Tan CF, 2004, ACTA NEUROPATHOL, V108, P332, DOI 10.1007/s00401-004-0893-4; Turner BJ, 2005, J NEUROSCI, V25, P108, DOI 10.1523/JNEUROSCI.4253-04.2005; Urushitani M, 2008, FASEB J, V22, P2476, DOI 10.1096/fj.07-092783; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, HUM MOL GENET, V14, P2335, DOI 10.1093/hmg/ddi236; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x; Wang J, 2002, NEUROBIOL DIS, V9, P139, DOI 10.1006/nbdi.2001.0471; Wang J, 2009, P NATL ACAD SCI USA, V106, P1392, DOI 10.1073/pnas.0813045106; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Witan H, 2009, NEUROBIOL DIS, V36, P331, DOI 10.1016/j.nbd.2009.07.024; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Zhang FJ, 2006, BBA-GEN SUBJECTS, V1760, P404, DOI 10.1016/j.bbagen.2005.11.024	71	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2018	13	11							e0206751	10.1371/journal.pone.0206751	http://dx.doi.org/10.1371/journal.pone.0206751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ4NU	30399166	Green Submitted, gold, Green Published			2022-12-26	WOS:000449374000019
J	Laino, J; Villena, J; Suvorov, A; Zelaya, H; Moyano, RO; Salva, S; Alvarez, S				Laino, Jonathan; Villena, Julio; Suvorov, Alexander; Zelaya, Hortensia; Moyano, Ramiro Ortiz; Salva, Susana; Alvarez, Susana			Nasal immunization with recombinant chimeric pneumococcal protein and cell wall from immunobiotic bacteria improve resistance of infant mice to Streptococcus pneumoniae infection	PLOS ONE			English	Article							INFLAMMATION-COAGULATION INTERACTIONS; MUCOSAL ADJUVANT ACTIVITY; LACTOCOCCUS-LACTIS; PULMONARY DAMAGE; VACCINE; INTERLEUKIN-12; PEPTIDOGLYCAN; CHALLENGE; IMMUNITY; FUSION	Respiratory tract infections and invasive disease caused by Streptococcus pneumoniae in high-risk groups are a major global health problem. Available human vaccines have reduced immunogenicity and low immunological memory in these populations, as well as high cost as a public health strategy in poor communities. In addition, no single pneumococcal protein antigen has been able to elicit protection comparable to that achieved using protein-polysaccharide conjugate vaccines. In this context, chimeric pneumococcal proteins raise as potential good vaccine candidates because of their simplicity of production and reduced cost. The aim of this work was to study whether the nasal immunization of infant mice with the recombinant chimeric pneumococcal protein (PSFP) was able to improve resistance to S. pneumoniae, and whether the immunomodulatory strain Lactobacillus rhamnosus CRL1505 or its cell wall (CW1505) could be used as effective mucosal adjuvants. Our results showed that the nasal immunization with PSPF improved pneumococcal-specific IgA and IgG levels in broncho-alveolar lavage (BAL), reduced lung bacterial counts, and avoided dissemination of pneumococci into the blood. Of interest, immunization with PSPF elicited cross-protective immunity against different pneumococcal serotypes. It was also observed that the nasal immunization of infant mice with PSPF+CW1505 significantly increased the production of pneumococcal-specific IgA and IgG in BAL, as well as IgM and IgG in serum when compared with PSPF alone. PSPF+CW1505 immunization also improved the reduction of pneumococcal lung colonization and its dissemination in to the bloodstream when compared to PSPF alone. Our results suggest that immunization with PSPF together with the cell wall of the immunomodulatory strain L. rhamnosus CRL1505 as a mucosal adjuvant could be an interesting alternative to improve protection against pneumococcal infection in children.	[Laino, Jonathan; Villena, Julio; Zelaya, Hortensia; Moyano, Ramiro Ortiz; Salva, Susana; Alvarez, Susana] Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Tucuman, Argentina; [Suvorov, Alexander] Fed State Budgetary Sci Inst, Inst Expt Med, St Petersburg, Russia; [Suvorov, Alexander] St Petersburg State Univ, St Petersburg, Russia	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Experimental Medicine; Saint Petersburg State University	Villena, J; Alvarez, S (corresponding author), Reference Ctr Lactobacilli CERELA CONICET, Lab Immunobiotechnol, San Miguel De Tucuman, Tucuman, Argentina.; Suvorov, A (corresponding author), Fed State Budgetary Sci Inst, Inst Expt Med, St Petersburg, Russia.; Suvorov, A (corresponding author), St Petersburg State Univ, St Petersburg, Russia.	jcvillena@cerela.org.ar; Alexander_suvorov1@hotmail.com; salvarez@cerela.org.ar	; Suvorov, Alexander/J-6921-2013	Salva, Susana/0000-0001-9571-1259; Suvorov, Alexander/0000-0003-2312-5589; Laino, Jonathan Emiliano/0000-0003-0739-8384	ANPCyT-FONCyT [PICT-2013-3219, PICT-201-0410]	ANPCyT-FONCyT(ANPCyTFONCyT)	This study was supported by ANPCyT-FONCyT Grants PICT-2013-3219 and PICT-201-0410 to Julio Villena.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Alicino C, 2017, VACCINE, V35, P5776, DOI 10.1016/j.vaccine.2017.09.005; Boyaka PN, 2017, J IMMUNOL, V199, P9, DOI 10.4049/jimmunol.1601775; Cafiero-Fonseca ET, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186903; Clua P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00948; Converso TR, 2017, VACCINE, V35, P5140, DOI 10.1016/j.vaccine.2017.08.010; Feldman Charles, 2016, F1000Res, V5, P2320; Fougeron D, 2015, VACCINE, V33, P3331, DOI 10.1016/j.vaccine.2015.05.022; Goulart C, 2017, VACCINE, V35, P1683, DOI 10.1016/j.vaccine.2017.02.029; Kolling Y, 2015, INT IMMUNOPHARMACOL, V25, P474, DOI 10.1016/j.intimp.2015.02.006; Medina M, 2008, INFECT IMMUN, V76, P2696, DOI 10.1128/IAI.00119-08; Miyaji EN, 2015, CLIN VACCINE IMMUNOL, V22, P213, DOI 10.1128/CVI.00692-14; Ogunniyi AD, 2007, INFECT IMMUN, V75, P350, DOI 10.1128/IAI.01103-06; Okrozub VV, 2015, EPMA J, V6, DOI 10.1186/s13167-015-0035-1; Principi N, 2017, EXPERT OPIN BIOL TH, V12, P1; Salva S, 2010, INT J FOOD MICROBIOL, V141, P82, DOI 10.1016/j.ijfoodmicro.2010.03.013; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7; Suvorov A, 2015, J VACCINES VACCIN, V6, P6, DOI [10.1139/w08-077, DOI 10.1139/W08-077]; Tomosada Y, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-40; Twigg Homer L 3rd, 2005, Proc Am Thorac Soc, V2, P417, DOI 10.1513/pats.200508-089JS; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Villena J, 2008, CAN J MICROBIOL, V54, P845, DOI [10.1139/W08-077, 10.1139/w08-077]; Villena J, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00563; Villena J, 2010, J MICROBIOL IMMUNOL, V43, P1, DOI 10.1016/S1684-1182(10)60001-1; Zelaya H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00633; Zelaya H, 2015, INFLAMM RES, V64, P589, DOI 10.1007/s00011-015-0837-6; Zelaya H, 2014, INT IMMUNOPHARMACOL, V19, P161, DOI 10.1016/j.intimp.2013.12.020	29	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0206661	10.1371/journal.pone.0206661	http://dx.doi.org/10.1371/journal.pone.0206661			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395582	gold, Green Submitted, Green Published			2022-12-26	WOS:000449291400040
J	Sanchez-Vidal, A; Thompson, RC; Canals, M; de Haan, WP				Sanchez-Vidal, Anna; Thompson, Richard C.; Canals, Miguel; de Haan, William P.			The imprint of microfibres in southern European deep seas	PLOS ONE			English	Article							PLASTIC DEBRIS; MICROPLASTIC POLLUTION; SEDIMENT-TRANSPORT; MARINE-ENVIRONMENT; SUBMARINE CANYONS; SYNTHETIC-FIBERS; MYTILUS-EDULIS; PACIFIC-OCEAN; INGESTION; CONTAMINATION	Pollution of the marine environment by large and microscopic plastic fragments and their potential impacts on organisms has stimulated considerable research interest and has received widespread publicity. However, relatively little attention has been paid to the fate and effects of microplastic particles that are fibrous in shape, also referred as microfibres, which are mostly shed from synthetic textiles during production or washing. Here we assess composition and abundance of microfibres in seafloor sediments in southern European seas, filling gaps in the limited understanding of the long-range transport and magnitude of this type of microplastic pollution. We report abundances of 10-70 microfibres in 50 ml of sediment, including both natural and regenerated cellulose, and synthetic plastic (polyester, acrylic, polyamide, polyethylene, and polypropylene) fibres. Following a shelf-slope-deep basin continuum approach, based on the relative abundance of fibres it would appear that coastal seas retain around 33% of the sea floor microfibres, but greater quantities of the fibres are exported to the open sea, where they accumulate in sediments. Submarine canyons act as preferential conduits for downslope transport of microfibres, with 29% of the seafloor microfibres compared to 18% found on the open slope. Around 20% of the microfibres found had accumulated in the deep open sea beyond 2000m of water depth. The remoteness of the deep sea does not prevent the accumulation of microfibres, being available to become integrated into deep sea organisms.	[Sanchez-Vidal, Anna; Canals, Miguel; de Haan, William P.] Univ Barcelona, Dept Dinam Terra & Ocea, GRC Geociencies Marines, Barcelona, Spain; [Thompson, Richard C.] Plymouth Univ, Marine Biol & Ecol Res Ctr, Plymouth, Devon, England	University of Barcelona; University of Plymouth	Sanchez-Vidal, A (corresponding author), Univ Barcelona, Dept Dinam Terra & Ocea, GRC Geociencies Marines, Barcelona, Spain.	anna.sanchez@ub.edu	Sanchez-Vidal, Anna/B-6919-2016; de Haan, William P./R-1939-2019; Canals, Miquel/F-4922-2013	Sanchez-Vidal, Anna/0000-0002-8209-1959; de Haan, William P./0000-0002-4192-191X; Canals, Miquel/0000-0001-5267-7601; Thompson, Richard/0000-0003-2262-6621	Ministerio de Economia, Industria y Competitividad [CGL2016-81854-REDT]; Ministerio de Educacion, Cultura y Deporte [CAS15/00227]; Agencia de Gestio d'Ajuts Universitaris i de Recerca [2017 SGR 315]; Institut d'Estudis Catalans (I-MarCat); Directorate-General for the Environment [11.0661/2017/750680/SUB/ENV.C2]	Ministerio de Economia, Industria y Competitividad; Ministerio de Educacion, Cultura y Deporte; Agencia de Gestio d'Ajuts Universitaris i de Recerca(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Institut d'Estudis Catalans (I-MarCat); Directorate-General for the Environment	This research has been supported by Ministerio de Economia, Industria y Competitividad (CGL2016-81854-REDT), Ministerio de Educacion, Cultura y Deporte (CAS15/00227), Agencia de Gestio d'Ajuts Universitaris i de Recerca (2017 SGR 315), Institut d'Estudis Catalans (I-MarCat) and Directorate-General for the Environment (11.0661/2017/750680/SUB/ENV.C2). The funders had no role in study design, data collection and	Almroth BMC, 2018, ENVIRON SCI POLLUT R, V25, P1191, DOI 10.1007/s11356-017-0528-7; Andrady AL, 2015, MARINE ANTHROPOGENIC LITTER, P57, DOI 10.1007/978-3-319-16510-3_3; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Bergmann M, 2015, MARINE ANTHROPOGENIC LITTER, P1, DOI 10.1007/978-3-319-16510-3; Browne MA, 2015, MARINE ANTHROPOGENIC LITTER, P229, DOI 10.1007/978-3-319-16510-3_9; Browne MA, 2010, ENVIRON SCI TECHNOL, V44, P3404, DOI 10.1021/es903784e; Browne MA, 2011, ENVIRON SCI TECHNOL, V45, P9175, DOI 10.1021/es201811s; Canals M, 2013, PROG OCEANOGR, V118, P1, DOI 10.1016/j.pocean.2013.09.004; Canals M, 2006, NATURE, V444, P354, DOI 10.1038/nature05271; Carmichael A., 2015, TEXT WORLD; Chen R, 2001, J AM INST CONSERV, V40, P91, DOI 10.2307/3180024; CIRFS European man-made fibres association, 2016, WORLD MAN MAD FIBR P; Claessens M, 2011, MAR POLLUT BULL, V62, P2199, DOI 10.1016/j.marpolbul.2011.06.030; Collard F, 2015, ARCH ENVIRON CON TOX, V69, P331, DOI 10.1007/s00244-015-0221-0; Cooper DA, 2010, MAR POLLUT BULL, V60, P650, DOI 10.1016/j.marpolbul.2009.12.026; Cossa D, 2014, CHEM GEOL, V380, P61, DOI 10.1016/j.chemgeo.2014.04.015; Costa MF, 2010, ENVIRON MONIT ASSESS, V168, P299, DOI 10.1007/s10661-009-1113-4; Cozar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121762; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; De Witte B, 2014, MAR POLLUT BULL, V85, P146, DOI 10.1016/j.marpolbul.2014.06.006; Desforges JPW, 2015, ARCH ENVIRON CON TOX, V69, P320, DOI 10.1007/s00244-015-0172-5; Desforges JPW, 2014, MAR POLLUT BULL, V79, P94, DOI 10.1016/j.marpolbul.2013.12.035; Devriese LI, 2015, MAR POLLUT BULL, V98, P179, DOI 10.1016/j.marpolbul.2015.06.051; Dris R, 2018, SCI TOTAL ENVIRON, V618, P157, DOI 10.1016/j.scitotenv.2017.11.009; Dris R, 2016, MAR POLLUT BULL, V104, P290, DOI 10.1016/j.marpolbul.2016.01.006; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Fischer V, 2015, DEEP-SEA RES PT II, V111, P399, DOI 10.1016/j.dsr2.2014.08.012; Hidalgo-Ruz V, 2012, ENVIRON SCI TECHNOL, V46, P3060, DOI 10.1021/es2031505; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Jemec A, 2016, ENVIRON POLLUT, V219, P201, DOI 10.1016/j.envpol.2016.10.037; Kaiser D, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8e8b; Koelmans AA, 2015, MARINE ANTHROPOGENIC, P313; Law KL, 2014, SCIENCE, V345, P144, DOI 10.1126/science.1254065; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Lusher AL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14947; Lusher AL, 2015, ENVIRON POLLUT, V199, P185, DOI 10.1016/j.envpol.2015.01.023; Lusher AL, 2014, MAR POLLUT BULL, V88, P325, DOI 10.1016/j.marpolbul.2014.08.023; Masson DG, 2010, GEOLOGY, V38, P831, DOI 10.1130/G30895.1; Mathalon A, 2014, MARINE POLLUTION B, V81, P67; Monosson E, 2016, SCIENCE, V354, P977, DOI 10.1126/science.aak9834; Moore CJ, 2001, MAR POLLUT BULL, V42, P1297, DOI 10.1016/S0025-326X(01)00114-X; Murphy F, 2016, ENVIRON SCI TECHNOL, V50, P5800, DOI 10.1021/acs.est.5b05416; Murray F, 2011, MAR POLLUT BULL, V62, P1207, DOI 10.1016/j.marpolbul.2011.03.032; Napper IE, 2016, MAR POLLUT BULL, V112, P39, DOI 10.1016/j.marpolbul.2016.09.025; Napper IE, 2015, MAR POLLUT BULL, V99, P178, DOI 10.1016/j.marpolbul.2015.07.029; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; Park CH, 2004, J APPL POLYM SCI, V94, P248, DOI 10.1002/app.20879; Paull CK, 2003, GEO-MAR LETT, V22, P227, DOI 10.1007/s00367-003-0117-2; Pirc U, 2016, ENVIRON SCI POLLUT R, V23, P22206, DOI 10.1007/s11356-016-7703-0; Puig P, 2014, ANNU REV MAR SCI, V6, P53, DOI 10.1146/annurev-marine-010213-135037; Remy F, 2015, ENVIRON SCI TECHNOL, V49, P11158, DOI 10.1021/acs.est.5b02005; Rochman CM, 2015, MARINE ANTHROPOGENIC LITTER, P117, DOI 10.1007/978-3-319-16510-3_5; Rong XY, 2008, COMPUT MATH APPL, V55, P1560, DOI 10.1016/j.camwa.2007.08.014; RYAN PG, 1990, S AFR J SCI, V86, P450; Sadri SS, 2014, MAR POLLUT BULL, V81, P55, DOI 10.1016/j.marpolbul.2014.02.020; Salvado JA, 2013, PROG OCEANOGR, V118, P235, DOI 10.1016/j.pocean.2013.07.014; Salvado JA, 2012, ENVIRON POLLUT, V168, P87, DOI 10.1016/j.envpol.2012.04.019; Sanchez-Vidal A, 2015, SCI TOTAL ENVIRON, V526, P41, DOI 10.1016/j.scitotenv.2015.04.080; Sanchez-Vidal A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030395, 10.1371/journal.pone.0043943]; Stolte A, 2015, MAR POLLUT BULL, V99, P216, DOI 10.1016/j.marpolbul.2015.07.022; Suaria G, 2016, SCI REP-UK, V6, DOI 10.1038/srep37551; Talvitie J, 2017, WATER RES, V123, P401, DOI 10.1016/j.watres.2017.07.005; Taylor ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep33997; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; UNEP, 2014, PLAST DEBR OC UNEP Y, P49; Van Cauwenberghe L, 2015, ENVIRON POLLUT, V199, P10, DOI 10.1016/j.envpol.2015.01.008; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; Woodall LC, 2015, MAR POLLUT BULL, V95, P40, DOI 10.1016/j.marpolbul.2015.04.044; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317; Yoshida S, 2016, SCIENCE, V351, P1196, DOI 10.1126/science.aad6359; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x; Zubris KAV, 2005, ENVIRON POLLUT, V138, P201, DOI 10.1016/j.envpol.2005.04.013	74	94	94	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2018	13	11							e0207033	10.1371/journal.pone.0207033	http://dx.doi.org/10.1371/journal.pone.0207033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MT	30395638	Green Published, gold, Green Submitted			2022-12-26	WOS:000449291400076
J	Babalyan, K; Sultanov, R; Generozov, E; Sharova, E; Kostryukova, E; Lanrin, A; Kanygina, A; Govorun, V; Arapidi, G				Babalyan, K.; Sultanov, R.; Generozov, E.; Sharova, E.; Kostryukova, E.; Lanrin, A.; Kanygina, A.; Govorun, V; Arapidi, G.			LogLoss-BERAF: An ensemble-based machine learning model for constructing highly accurate diagnostic sets of methylation sites accounting for heterogeneity in prostate cancer	PLOS ONE			English	Article							DNA METHYLATION; COLORECTAL-CANCER; FEATURE-SELECTION; GENES; EXPRESSION; BIOMARKERS; GSTP1; HYPERMETHYLATION; IDENTIFICATION; MARKERS	Although modern methods of whole genome DNA methylation analysis have a wide range of applications, they are not suitable for clinical diagnostics due to their high cost and complexity and due to the large amount of sample DNA required for the analysis. Therefore, it is crucial to be able to identify a relatively small number of methylation sites that provide high precision and sensitivity for the diagnosis of pathological states. We propose an algorithm for constructing limited subsamples from high-dimensional data to form diagnostic panels. We have developed a tool that utilizes different methods of selection to find an optimal, minimum necessary combination of factors using cross-entropy loss metrics (LogLoss) to identify a subset of methylation sites. We show that the algorithm can work effectively with different genome methylation patterns using ensemble-based machine learning methods. Algorithm efficiency, precision and robustness were evaluated using five genome-wide DNA methylation datasets (totaling 626 samples), and each dataset was classified into tumor and non-tumor samples. The algorithm produced an AUC of 0.97 (95% CI: 0.94-0.99, 9 sites) for prostate adenocarcinoma and an AUC of 1.0 (from 2 to 6 sites) for urothelial bladder carcinoma, two types of kidney carcinoma and colorectal carcinoma. For prostate adenocarcinoma we showed that identified differential variability methylation patterns distinguish cluster of samples with higher recurrence rate (hazard ratio for recurrence = 0.48, 95% CI: 0.05-0.92; log-rank test, p-value < 0.03). We also identified several clusters of correlated interchangeable methylation sites that can be used for the elaboration of biological interpretation of the resulting models and for further selection of the sites most suitable for designing diagnostic panels. LogLoss-BERAF is implemented as a standalone python code and open-source code is freely available from https://github.com/bioinformatics-IBCH/logloss-beraf along with the models described in this article.	[Babalyan, K.; Sultanov, R.; Generozov, E.; Sharova, E.; Kostryukova, E.; Lanrin, A.; Kanygina, A.; Govorun, V; Arapidi, G.] Fed Med Biol Agcy, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Babalyan, K.; Sultanov, R.; Kanygina, A.; Govorun, V; Arapidi, G.] State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia; [Babalyan, K.; Sultanov, R.; Govorun, V; Arapidi, G.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Moscow Institute of Physics & Technology; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Babalyan, K (corresponding author), Fed Med Biol Agcy, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia.; Babalyan, K (corresponding author), State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia.; Babalyan, K (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	babalyan@phystech.edu	Sharova, Elena/AAE-1330-2022; Govorun, Vadim M/A-9043-2018; Arapidi, Georgij/H-7616-2014; Kanygina, Alexandra V/E-6604-2017; Generozov, Edward V/U-3431-2017; Sultanov, Rinat I/L-5394-2018	Sharova, Elena/0000-0003-3208-9719; Arapidi, Georgij/0000-0003-2323-1859; Kanygina, Alexandra V/0000-0003-4993-9492; Generozov, Edward V/0000-0002-6314-4883; Sultanov, Rinat I/0000-0003-3918-708X	Russian Science Foundation [14-50-00131]; Ministry of Education and Science of Russian Federation [14.607.21.0068, RFMEFI60714x0068]; Russian Foundation for Basic Research [17-29-06076\17, 17-29-06063]	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Education and Science of Russian Federation(Ministry of Education and Science, Russian Federation); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Science Foundation project no. 14-50-00131 (for the machine learning and final framework), by the Ministry of Education and Science of Russian Federation no. 14.607.21.0068, unique ID RFMEFI60714x0068 (for the FRCC PCM dataset formation (GSE74013)), by the Russian Foundation for Basic Research projects no. 17-29-06076\17 (for the final model sites analysis) and no. 17-29-06063 (for the comparison with previously published models). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Adeola HA, 2016, ONCOTARGET, V7, P13945, DOI 10.18632/oncotarget.7359; Alkuhlani A, 2017, SOFT COMPUT, V21, P6895, DOI 10.1007/s00500-016-2439-9; Almeida M, 2014, J CELL MOL MED, V18, P2287, DOI 10.1111/jcmm.12394; Aslibekyan S, 2014, CHRONOBIOL INT, V31, P1034, DOI 10.3109/07420528.2014.944266; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Berdasco M, 2010, DEV CELL, V19, P698, DOI 10.1016/j.devcel.2010.10.005; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Bibikova M, 2009, EPIGENOMICS-UK, V1, P177, DOI [10.2217/epi.09.14, 10.2217/EPI.09.14]; Bijnsdorp IV, 2017, MOL DIAGN THER, V21, P385, DOI 10.1007/s40291-017-0271-2; Bishop CM., 2006, PATTERN RECOGN, P209; Blum AL, 1997, ARTIF INTELL, V97, P245, DOI 10.1016/S0004-3702(97)00063-5; Bock C, 2016, NAT BIOTECHNOL, V34, P726, DOI 10.1038/nbt.3605; Bose M, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-312; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brikun I, 2014, BIOMARK RES, V2, DOI 10.1186/s40364-014-0025-9; Cairns P, 2001, CLIN CANCER RES, V7, P2727; Chen F, 2016, BMC UROL, V16, DOI 10.1186/s12894-016-0171-5; Chihara Y, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-275; Cho SB, 2007, APPL INTELL, V26, P243, DOI 10.1007/s10489-006-0020-4; Chuang LY, 2008, COMPUT BIOL CHEM, V32, P29, DOI 10.1016/j.compbiolchem.2007.09.005; Chung W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002079; Ciccarese C, 2017, CANCER TREAT REV, V54, P68, DOI 10.1016/j.ctrv.2017.02.001; Cornford P, 1999, AM J PATHOL, V154, P137, DOI 10.1016/S0002-9440(10)65260-1; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; Dammann R, 2005, EUR J CANCER, V41, P1223, DOI 10.1016/j.ejca.2005.02.020; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Giacinti L, 2008, CLIN TER, V159, P347; Henry LA, 2011, ONCOGENE, V30, P1046, DOI 10.1038/onc.2010.488; Hessels D, 2013, ASIAN J ANDROL, V15, P333, DOI 10.1038/aja.2013.6; Kirby MK, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3252-2; Kok-Sin T, 2015, ONCOL REP, V34, P22, DOI 10.3892/or.2015.3993; Kuncheva LI, 2007, PROCEEDINGS OF THE IASTED INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND APPLICATIONS, P390; Labuzzetta CJ, 2016, BIOINFORMATICS, V32, P421, DOI 10.1093/bioinformatics/btw430; Lazar C, 2012, IEEE ACM T COMPUT BI, V9, P1106, DOI 10.1109/TCBB.2012.33; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Li LC, 2007, FRONT BIOSCI, V12; Lin PC, 2013, NEOPLASIA, V15, P373, DOI 10.1593/neo.122146; Liu J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2819-7; de Maturana EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083745; Calle ML, 2011, HUM HERED, V72, P121, DOI 10.1159/000330778; Ma SS, 2006, INTEGRATIVE ANAL CAN, P82; Ma ZY, 2013, J BIOINF COMPUT BIOL, V11, DOI 10.1142/S0219720013500054; Majer W, 2015, J CANCER, V6, P1105, DOI 10.7150/jca.12145; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Nakayama M, 2004, J CELL BIOCHEM, V91, P540, DOI 10.1002/jcb.10740; Naumov VA, 2013, EPIGENETICS-US, V8, P921, DOI 10.4161/epi.25577; Oster B, 2011, INT J CANCER, V129, P2855, DOI 10.1002/ijc.25951; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pisanic T, 2016, SEMIN CELL DEV BIOL, DOI [10.1016/j.matchemphys.2008.10.020, DOI 10.1016/J.MATCHEMPHYS.2008.10.020]; Puthiyedth N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127702; Radovic M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1423-9; Rodriguez JD, 2013, PATTERN RECOGN, V46, P855, DOI 10.1016/j.patcog.2012.09.007; Sertkaya S, 2015, TUMOR BIOL, V36, P799, DOI 10.1007/s13277-014-2703-5; Skorodumova LO, 2017, BIOCHEM MOSC-SUPPL S, V11, P194, DOI 10.1134/S199075081702007X; Stewart GD, 2013, J UROLOGY, V189, P1110, DOI 10.1016/j.juro.2012.08.219; Tang YY, 2017, ONCOTARGET, V8, P58199, DOI 10.18632/oncotarget.16437; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Teschendorff AE, 2012, BIOINFORMATICS, V28, P1487, DOI 10.1093/bioinformatics/bts170; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Wilinski A, 2009, COMPEL, V28, P231, DOI 10.1108/03321640910919020; Woodson K, 2008, J UROLOGY, V179, P508, DOI 10.1016/j.juro.2007.09.073; Yao S, 2012, BRIT J CANCER, V107, P388, DOI 10.1038/bjc.2012.162; Zou L, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/721493	69	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0204371	10.1371/journal.pone.0204371	http://dx.doi.org/10.1371/journal.pone.0204371			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388122	Green Published, Green Submitted, gold			2022-12-26	WOS:000449289800006
J	Courtney, AL; PeConga, EK; Wagner, DD; Rapuano, KM				Courtney, Andrea L.; PeConga, Emma K.; Wagner, Dylan D.; Rapuano, Kristina M.			Calorie information and dieting status modulate reward and control activation during the evaluation of food images	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; ORBITOFRONTAL CORTEX; SYSTEM ACTIVATION; OBESE CHILDREN; BRAIN NETWORKS; SELF-CONTROL; WEIGHT; IMPACT; CONSUMER; LABELS	Several public health departments throughout North America have responded to the obesity epidemic by mandating that restaurants publish calories at the point of purchase-with the intention of encouraging healthier food decisions. To help determine whether accompanying calorie information successfully changes a food's appetitive value, this study investigated the influence of calorie information on brain responses to food images. During functional magnetic resonance imaging (fMRI) scanning, dieting (N = 22) and non-dieting (N = 20) participants viewed pictures of food with and without calorie information and rated their desire to eat the food. When food images were paired with calorie information, not only did self-reported desire to eat the food decrease, but reward system activation (Neurosynth-defined from the term "food") decreased and control system activation (the fronto-parietal [FP] control system) increased. Additionally, a parametric modulation of reward activation by food preferences was attenuated in the context of calorie information. Finally, whole brain multivariate pattern analysis (MVPA) revealed patterns of activation in a region of the reward system-the orbitofrontal cortex (OFC)-that were more similar for food images presented with and without calorie information in dieting than non-dieting participants, suggesting that dieters may spontaneously consider calorie information when viewing food. Taken together, these results suggest that calorie information may alter brain responses to food cues by simultaneously reducing reward system activation and increasing control system activation. Moreover, individuals with greater experience or stronger motivations to consider calorie information (i.e., dieters) may more naturally do so, as evidenced by a greater degree of representational similarity between food images with and without calorie information. Combining an awareness of calories with the motivation to control them may more effectively elicit diet-related behavior change.	[Courtney, Andrea L.; PeConga, Emma K.; Rapuano, Kristina M.] Dartmouth Coll, Psychol & Brain Sci, Hanover, NH 03755 USA; [Courtney, Andrea L.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Wagner, Dylan D.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Rapuano, Kristina M.] Yale Univ, Dept Psychol, New Haven, CT USA	Dartmouth College; Stanford University; University System of Ohio; Ohio State University; Yale University	Courtney, AL (corresponding author), Dartmouth Coll, Psychol & Brain Sci, Hanover, NH 03755 USA.; Courtney, AL (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	acourtne@stanford.edu	Rapuano, Kristina/J-6489-2019; Courtney, Andrea/K-5013-2019; Wagner, Dylan/AAP-4728-2020	Wagner, Dylan/0000-0002-1062-8163; Courtney, Andrea/0000-0003-1214-9649				Adamo KB, 2012, INT J ENV RES PUB HE, V9, P1263, DOI 10.3390/ijerph9041263; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berman M, 2008, JAMA-J AM MED ASSOC, V300, P433, DOI 10.1001/jama.300.4.433; Blechert J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00617; Bleich SN, 2017, OBESITY, V25, P2018, DOI 10.1002/oby.21940; Block Jason P, 2013, BMJ, V346, pf2907, DOI 10.1136/bmj.f2907; Bruce AS, 2010, INT J OBESITY, V34, P1494, DOI 10.1038/ijo.2010.84; Cantor J, 2015, HEALTH AFFAIR, V34, P1893, DOI 10.1377/hlthaff.2015.0623; Carels RA, 2007, APPETITE, V49, P450, DOI 10.1016/j.appet.2007.02.009; Chandon P, 2007, J MARKETING RES, V44, P84, DOI 10.1509/jmkr.44.1.84; Coelho JS, 2008, APPETITE, V51, P347, DOI 10.1016/j.appet.2008.04.001; Courtney AL, 2018, J STUD ALCOHOL DRUGS, V79, P29; Cox RW, 2017, BRAIN CONNECT, V7, P152, DOI 10.1089/brain.2016.0475; Davids S, 2010, INT J OBESITY, V34, P94, DOI 10.1038/ijo.2009.193; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Demos KE, 2011, J COGNITIVE NEUROSCI, V23, P1952, DOI 10.1162/jocn.2010.21568; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Fishbach A, 2003, J PERS SOC PSYCHOL, V84, P296, DOI 10.1037/0022-3514.84.2.296; Girz L, 2012, INT J OBESITY, V36, P1340, DOI 10.1038/ijo.2011.135; Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hare TA, 2011, J NEUROSCI, V31, P11077, DOI 10.1523/JNEUROSCI.6383-10.2011; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; HEATHERTON TF, 1991, J ABNORM PSYCHOL, V100, P78, DOI 10.1037/0021-843X.100.1.78; HEATHERTON TF, 1988, J ABNORM PSYCHOL, V97, P19, DOI 10.1037/0021-843X.97.1.19; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Holsen LM, 2018, INT J OBESITY, V42, P785, DOI 10.1038/ijo.2017.190; Joint FAO/WHO Codex Alimentarius Commission, 2001, COD AL FOOD LAB COMP; Krieger JW, 2013, AM J PREV MED, V44, P595, DOI 10.1016/j.amepre.2013.01.031; Kriegeskorte Nikolaus, 2008, Front Syst Neurosci, V2, P4, DOI 10.3389/neuro.06.004.2008; Long MW, 2015, AM J PUBLIC HEALTH, V105, pE11, DOI 10.2105/AJPH.2015.302570; Lopez RB, 2017, SOC COGN AFFECT NEUR, V12, P832, DOI 10.1093/scan/nsx004; Lopez RB, 2016, APPETITE, V103, P192, DOI 10.1016/j.appet.2016.03.027; Lopez RB, 2014, PSYCHOL SCI, V25, P1337, DOI 10.1177/0956797614531492; Mandle J, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.25912; Marcus Daniel S, 2011, Front Neuroinform, V5, P4, DOI 10.3389/fninf.2011.00004; Mhurchu CN, 2007, AUST NZ J PUBL HEAL, V31, P105, DOI 10.1111/j.1753-6405.2007.00026.x; Moodie C, 2015, TOB CONTROL, V24, pE93, DOI 10.1136/tobaccocontrol-2013-050999; Mur M, 2009, SOC COGN AFFECT NEUR, V4, P101, DOI 10.1093/scan/nsn044; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Platkin Charles, 2014, BMC Obes, V1, P21, DOI 10.1186/s40608-014-0021-5; POLIVY J, 1976, ADDICT BEHAV, V1, P237, DOI 10.1016/0306-4603(76)90016-2; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Pursey Kirrilly M, 2014, Front Nutr, V1, P7, DOI 10.3389/fnut.2014.00007; Rapuano KM, 2016, CEREB CORTEX, V26, P2602, DOI 10.1093/cercor/bhv097; Rendell SL, 2014, CURR OBES REP, V3, P368, DOI 10.1007/s13679-014-0116-9; Riddle PJ, 2016, SOC COGN AFFECT NEUR, V11, P1802, DOI 10.1093/scan/nsw087; Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Sentyrz SM, 1998, J APPL PSYCHOL, V83, P944, DOI 10.1037/0021-9010.83.6.944; Simmons WK, 2014, BRAIN STRUCT FUNCT, V219, P473, DOI 10.1007/s00429-013-0511-0; Sinclair SE, 2014, J ACAD NUTR DIET, V114, P1375, DOI 10.1016/j.jand.2014.05.014; Sisnowski J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182581; Stampfli AE, 2017, APPETITE, V110, P94, DOI 10.1016/j.appet.2016.11.037; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Tandon PS, 2010, PEDIATRICS, V125, P244, DOI 10.1542/peds.2009-1117; Thrasher JF, 2011, HEALTH POLICY, V102, P41, DOI 10.1016/j.healthpol.2011.06.003; van der Laan LN, 2011, NEUROIMAGE, V55, P296, DOI 10.1016/j.neuroimage.2010.11.055; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; van Meer F, 2015, NEUROIMAGE, V104, P35, DOI 10.1016/j.neuroimage.2014.09.069; Wagner DD, 2013, PSYCHOL SCI, V24, P2262, DOI 10.1177/0956797613492985; Wang AL, 2015, ADDICT BIOL, V20, P368, DOI 10.1111/adb.12117; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]	67	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0204744	10.1371/journal.pone.0204744	http://dx.doi.org/10.1371/journal.pone.0204744			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ3MD	30388113	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800009
J	Nakagawa, S; Nakaishi, M; Hashimoto, M; Ito, H; Yamamoto, W; Nakashima, R; Tanaka, M; Fujii, T; Omura, T; Imai, S; Nakagawa, T; Yonezawa, A; Imai, H; Mimori, T; Matsubara, K				Nakagawa, Shunsaku; Nakaishi, Mayumi; Hashimoto, Motomu; Ito, Hiromu; Yamamoto, Wataru; Nakashima, Ran; Tanaka, Masao; Fujii, Takao; Omura, Tomohiro; Imai, Satoshi; Nakagawa, Takayuki; Yonezawa, Atsushi; Imai, Hirohisa; Mimori, Tsuneyo; Matsubara, Kazuo			Effect of medication adherence on disease activity among Japanese patients with rheumatoid arthritis	PLOS ONE			English	Article							ANTIRHEUMATIC DRUGS; SERIOUS INFECTION; VALIDITY; CRITERIA; THERAPY; IMPACT; COHORT	For the optimum efficacy of disease-modifying anti-rheumatic drugs (DMARDs), patients need to be adherent to their medication regimen. To clarify the effects of medication adherence on disease activity in Japanese patients with rheumatoid arthritis (RA), we conducted a cohort study in patients with various stages of RA. Patients were enrolled from the Kyoto University RA Management Alliance cohort, and followed up prospectively for 12 months. In this study, a total of 475 patients were analyzed and divided into 9 groups according to their medication adherence and the RA disease duration. The primary outcomes were based on the rate of a disease flare. The secondary outcomes were the changes in disease activity score using 28 joints (DAS28-ESR), simplified disease activity index (SDAI) and physical disability by health assessment questionnaire-disability index (HAQ). The changes in DAS28-ESR, HAQ, and the risk of disease flare in the highly adherent patients were significantly lower than those of the less adherent patients among the groups with RA <= 4.6 years but not those among the other groups. Taken together, this study identified a significant association between medication adherence and the disease flare during early-stage RA or short disease duration. These results emphasize the need to pay more attention to medication adherence in preventing the disease progression of RA.	[Nakagawa, Shunsaku; Nakaishi, Mayumi; Omura, Tomohiro; Imai, Satoshi; Nakagawa, Takayuki; Yonezawa, Atsushi; Matsubara, Kazuo] Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto, Japan; [Hashimoto, Motomu; Tanaka, Masao] Kyoto Univ, Grad Sch Med, Dept Adv Med Rheumat Dis, Kyoto, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan; [Nakashima, Ran; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Fujii, Takao] Wakayama Med Univ, Dept Clin Immunol & Rheumatol, Wakayama, Japan; [Imai, Hirohisa] Univ Tokyo, Grad Sch Med, Dept Med & Pharmaceut Community Healthcare, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Wakayama Medical University; University of Tokyo	Nakagawa, S (corresponding author), Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto, Japan.	nakashun@kuhp.kyoto-u.ac.jp	Yonezawa, Atsushi/AAS-8423-2020; Tomohiro, Omura/AAR-8420-2021	Yonezawa, Atsushi/0000-0002-8057-6768; Imai, Satoshi/0000-0003-4737-8695; Nakagawa, Shunsaku/0000-0002-1285-122X; Nakagawa, Takayuki/0000-0003-1890-0843	Japan Health Labour Sciences Research Grant [H29-Medicine and Pharmacy-008]	Japan Health Labour Sciences Research Grant	This work was supported by Japan Health Labour Sciences Research Grant (H29-Medicine and Pharmacy-008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; [Anonymous], 2003, ADHERENCE LONG TERM; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Bluett J, 2015, RHEUMATOLOGY, V54, P494, DOI 10.1093/rheumatology/keu358; Contreras-Yanez I, 2010, AM J MED SCI, V340, P282, DOI 10.1097/MAJ.0b013e3181e8bcb0; Cramer J, 2003, VALUE HEALTH, V6, P566, DOI 10.1046/j.1524-4733.2003.65269.x; Curtis JR, 2016, J RHEUMATOL, V43, P1997, DOI 10.3899/jrheum.151212; de Klerk E, 2003, J RHEUMATOL, V30, P2469; de Klerk E, 2003, J RHEUMATOL, V30, P44; Hashimoto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098202; Iguchi-Hashimoto M, 2016, CLIN RHEUMATOL, V35, P213, DOI 10.1007/s10067-015-3143-3; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawakami A, 2012, GASTROENTEROL NURS, V35, P24, DOI 10.1097/SGA.0b013e31824033f7; Komano Y, 2011, J RHEUMATOL, V38, P1258, DOI 10.3899/jrheum.101009; Li L, 2017, PATIENT PREFER ADHER, V11, P1343, DOI 10.2147/PPA.S140457; Matsui T, 2007, ANN RHEUM DIS, V66, P1221, DOI 10.1136/ard.2006.063834; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Munro R, 1998, ANN RHEUM DIS, V57, P88, DOI 10.1136/ard.57.2.88; Pascual-Ramos V, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2620; Pasma A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0801-4; Pasma A, 2013, SEMIN ARTHRITIS RHEU, V43, P18, DOI 10.1016/j.semarthrit.2012.12.001; Salt E, 2010, ORTHOP NURS, V29, P260, DOI 10.1097/NOR.0b013e3181e5c2c9; Scheiman-Elazary A, 2016, J RHEUMATOL, V43, P512, DOI 10.3899/jrheum.141371; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; Tanaka S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5397; van der Maas A, 2013, ANN RHEUM DIS, V72, P1800, DOI 10.1136/annrheumdis-2012-202281; vanderHeide A, 1996, ANN INTERN MED, V124, P699, DOI 10.7326/0003-4819-124-8-199604150-00001; Wabe N, 2017, RHEUMATOL INT, V37, P897, DOI 10.1007/s00296-017-3655-z; Waimann CA, 2013, ARTHRITIS RHEUM-US, V65, P1421, DOI 10.1002/art.37917; Yaku A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39180	30	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206943	10.1371/journal.pone.0206943	http://dx.doi.org/10.1371/journal.pone.0206943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388179	Green Published, gold, Green Submitted			2022-12-26	WOS:000449289800075
J	Pascual, G; Mesa-Ciller, C; Rodriguez, M; Perez-Kohler, B; Gomez-Gil, V; Fernandez-Gutierrez, M; San Roman, J; Bellon, JM				Pascual, Gemma; Mesa-Ciller, Claudia; Rodriguez, Marta; Perez-Kohler, Barbara; Gomez-Gil, Veronica; Fernandez-Gutierrez, Mar; San Roman, Julio; Bellon, Juan M.			Pre-clinical assay of the tissue integration and mechanical adhesion of several types of cyanoacrylate adhesives in the fixation of lightweight polypropylene meshes for abdominal hernia repair	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; N-BUTYL CYANOACRYLATE; LONG-TERM; VENTRAL HERNIA; INGUINAL HERNIORRHAPHY; LICHTENSTEIN TECHNIQUE; EXPERIMENTAL-MODEL; WALL DEFECTS; CHRONIC PAIN; FIBRIN GLUE	Introduction Lightweight (LW) polypropylene (PP) meshes better adapt to host tissue, causing less fibrosis and inflammatory responses than high-density meshes. Mesh fixation using tissue adhesives (TA) that replace conventional sutures may improve the process of hernia repair and tissue trauma. This preclinical study compares the behavior of different cyanoacrylate-based adhesives in the fixation of LW-PP meshes for hernia repair. Methods Partial abdominal wall defects were repaired using LW-PP Optilene meshes in New Zealand rabbits. The following groups were established according to the mesh fixation method: Suture (control), Glubran 2 (n-butyl), Ifabond (n-hexyl), SafetySeal (n-butyl) and Evobond (n-octyl). At 14, 90 and 180 days after surgery, the recovered implants were examined to assess the host tissue integration, the macrophage response and the biomechanical strength. Results All the groups showed optimal host tissue incorporation regardless of the fixation procedure. Significantly increased levels of collagen 1 and collagen 3 gene expression (p<0.001) were observed at 14 days compared to the medium- and long-term durations, where the Suture and Glubran groups showed the highest expression of collagen 1. All the adhesives increased the macrophage reaction (p<0.001) compared to sutures at all implant times. Maximal macrophage response was observed in the short-term Glubran group (p<0.01) compared to the rest of the groups. Although SafetySeal and Evobond did not reach the biomechanical resistance of sutures at 14 days, all the adhesives did reach this level in the medium- to long-term periods, providing significantly higher resistance (p<0.05). Conclusions All the cyanoacrylates, despite inducing a significantly increased macrophage response versus sutures, showed optimal host tissue integration and long-term mechanical behavior; thus, they might be good choices for LW-PP mesh hernia repairs.	[Pascual, Gemma] Univ Alcala De Henares, Fac Med & Hlth Sci, Dept Med & Med Specialties, Madrid, Spain; [Pascual, Gemma; Rodriguez, Marta; Perez-Kohler, Barbara; Gomez-Gil, Veronica; Fernandez-Gutierrez, Mar; San Roman, Julio; Bellon, Juan M.] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Ramon y Cajal Hlth Res Inst IRYCIS, Madrid, Spain; [Mesa-Ciller, Claudia; Rodriguez, Marta; Perez-Kohler, Barbara; Gomez-Gil, Veronica; Bellon, Juan M.] Univ Alcala De Henares, Fac Med & Hlth Sci, Dept Surg Med & Social Sci, Madrid, Spain; [Fernandez-Gutierrez, Mar; San Roman, Julio] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Polymer Sci & Technol Inst, ICTP, Polymer Biomat Grp,CSIC, Madrid, Spain	Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universidad de Alcala; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia & Tecnologia de Polimeros (ICTP)	Pascual, G (corresponding author), Univ Alcala De Henares, Fac Med & Hlth Sci, Dept Med & Med Specialties, Madrid, Spain.; Pascual, G (corresponding author), Networking Biomed Res Ctr Bioengn Biomat & Nanome, Ramon y Cajal Hlth Res Inst IRYCIS, Madrid, Spain.	gemma.pascual@uah.es	Gil, Verónica Gómez/J-7960-2019; Köhler, Bárbara Pérez/M-1858-2019; Fernandez-gutierrez, Mar/AAV-1378-2020; PASCUAL, GEMMA/M-6564-2016; Fernandez-gutierrez, Mar/D-3860-2014	Gil, Verónica Gómez/0000-0002-6642-5912; Köhler, Bárbara Pérez/0000-0002-5061-1526; Mesa Ciller, Claudia/0000-0001-9807-5550; PASCUAL, GEMMA/0000-0002-1623-4384; Fernandez-gutierrez, Mar/0000-0003-1739-1987	Spanish Ministry of Economy and Competitiveness [SAF2014-55022-P, SAF2017-89481-P]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	The study was supported by Grant "SAF2014-55022-P" and "SAF2017-89481-P" from the Spanish Ministry of Economy and Competitiveness.	Agresta F, 2010, HERNIA, V14, P471, DOI 10.1007/s10029-010-0677-9; Bellon JM, 2009, J BIOMED MATER RES B, V89B, P448, DOI 10.1002/jbm.b.31234; Bellon JM, 2017, J SURG RES, V208, P68, DOI 10.1016/j.jss.2016.09.021; Bjurstrom MF, 2014, J PAIN RES, V7, P277, DOI 10.2147/JPR.S47005; Bona S, 2018, UPDATES SURG, V70, P77, DOI 10.1007/s13304-017-0483-3; Campanelli G, 2012, ANN SURG, V255, P650, DOI 10.1097/SLA.0b013e31824b32bf; Chen DC, 2014, WORLD J SURG, V38, P2571, DOI 10.1007/s00268-014-2626-8; Chowbey PK, 2010, SURG ENDOSC, V24, P3073, DOI 10.1007/s00464-010-1092-0; Cobb WS, 2006, J SURG RES, V136, P1, DOI 10.1016/j.jss.2006.05.022; Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109; Colvin HS, 2013, WORLD J SURG, V37, P2282, DOI 10.1007/s00268-013-2140-4; Conze J., 1999, BIOCOMPATIBILITY BIO, pChapter 14; de Goede B, 2013, BRIT J SURG, V100, P735, DOI 10.1002/bjs.9072; Dilege E, 2010, J INVEST SURG, V23, P262, DOI 10.3109/08941939.2010.481008; Fernandez-Gutierrez M, 2016, MACROMOL BIOSCI, V16, P1803, DOI 10.1002/mabi.201600246; Greca F H, 2001, Hernia, V5, P59; Hernandez B, 2011, J MECH BEHAV BIOMED, V4, P392, DOI 10.1016/j.jmbbm.2010.11.012; Hernandez-Gascon B, 2013, ANN BIOMED ENG, V41, P433, DOI 10.1007/s10439-012-0672-7; Hernandez-Gascon B, 2012, J MECH BEHAV BIOMED, V5, P257, DOI 10.1016/j.jmbbm.2011.09.005; Hernandez-Gascon B, 2011, ACTA BIOMATER, V7, P3905, DOI 10.1016/j.actbio.2011.06.033; Junge K, 2001, Hernia, V5, P113; Khaleal F, 2011, ANZ J SURG, V81, P154, DOI 10.1111/j.1445-2197.2010.05438.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim-Fuchs C, 2012, HERNIA, V16, P21, DOI 10.1007/s10029-011-0856-3; Klinge U, 2007, WORLD J SURG, V31, P867, DOI 10.1007/s00268-006-0670-8; Klinge U, 2002, J BIOMED MATER RES, V63, P129, DOI 10.1002/jbm.10119; Kukleta JF, 2012, HERNIA, V16, P153, DOI 10.1007/s10029-011-0887-9; Leggat PA, 2007, ANZ J SURG, V77, P209, DOI 10.1111/j.1445-2197.2007.04020.x; Li JS, 2015, SURG LAPARO ENDO PER, V25, P238, DOI 10.1097/SLE.0000000000000144; Montanaro L, 2001, BIOMATERIALS, V22, P59, DOI 10.1016/S0142-9612(00)00163-0; Moreno-Egea A, 2014, SURG INNOV, V21, P590, DOI 10.1177/1553350613517944; Negro P, 2011, HERNIA, V15, P7, DOI 10.1007/s10029-010-0706-8; O'Dwyer PJ, 2005, BRIT J SURG, V92, P166, DOI 10.1002/bjs.4833; Paajanen H, 2011, BRIT J SURG, V98, P1245, DOI 10.1002/bjs.7598; Pascual G, 2008, SURGERY, V144, P427, DOI 10.1016/j.surg.2008.04.005; Pascual G, 2017, J SURG RES, V220, P30, DOI 10.1016/j.jss.2017.06.074; Pascual G, 2017, J MATER SCI-MATER M, V28, DOI 10.1007/s10856-017-5869-8; Pascual G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157920; Pascual G, 2012, SURGERY, V152, P886, DOI 10.1016/j.surg.2012.03.009; Ronka K, 2015, ANN SURG, V262, P714, DOI 10.1097/SLA.0000000000001458; Sanders Lindsey, 2014, Critical Reviews in Biomedical Engineering, V42, P271, DOI 10.1615/CritRevBiomedEng.2014011676; Scognamiglio F, 2016, J BIOMED MATER RES B, V104, P626, DOI 10.1002/jbm.b.33409; Shen YM, 2012, SURGERY, V151, P550, DOI 10.1016/j.surg.2011.09.031; Simon-Allue R, 2016, HERNIA, V20, P839, DOI 10.1007/s10029-016-1525-3; Stefano O, 2010, JSLS-J SOC LAPAROEND, V14, P240, DOI 10.4293/108680810X12785289144359; Weyhe D, 2006, WORLD J SURG, V30, P1586, DOI 10.1007/s00268-005-0601-0	46	6	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2018	13	11							e0206515	10.1371/journal.pone.0206515	http://dx.doi.org/10.1371/journal.pone.0206515			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ3MD	30388135	Green Submitted, Green Published, gold			2022-12-26	WOS:000449289800036
J	Ahmad, S; ul Haq, I; Caceres, C; Tomas, US; Dammalage, T; Gembinsky, K; Paulus, H; Vreysen, MJB; Rempoulakis, P				Ahmad, Sohel; ul Haq, Ihsan; Caceres, Carlos; Tomas, Ulysses Sto; Dammalage, Thilakasiri; Gembinsky, Keke; Paulus, Hannes; Vreysen, Marc J. B.; Rempoulakis, Polychronis			One for all: Mating compatibility among various populations of olive fruit fly (Diptera: Tephritidae) for application of the sterile insect technique	PLOS ONE			English	Article							SEXUAL COMPATIBILITY; ERADICATION; PERFORMANCE; RELEASE; COLONIZATION; LEPIDOPTERA; STRAINS; QUALITY; SIT	The olive fruit fly, Bactrocera oleae (Rossi), is the most important insect pest for the cultivation of olives worldwide. Considerable research efforts have been invested in the past decades to develop eradication or suppression tactics for use within an area-wide integrated pest management (AW-IPM) approach that includes a sterile insect technique (SIT) component. One of the major obstacles encountered in the development of SIT for olive fruit fly was the inferior quality of the mass-reared flies, expressed among others evident primarily by sterile males having a different timing of peak mating and a lower mating propensity in comparison with their wild counterparts. In this study we assessed the mating behaviour and mating compatibility of olive fruit flies originating from four countries of the Mediterranean region (Croatia, France, Italy, Spain) in walk-in field cages and post zygotic compatibility (expressed as% egg hatch) under laboratory conditions. Furthermore, we tested the hypothesis whether a hybrid strain (Greece (domesticated)/Israel (wild)) adapted to laboratory rearing conditions showed any mating barriers with all the four "wild" populations. Finally, we examined the effect of colonization on the mating compatibility of the four newly established populations over three consecutive generations. The results showed no prezygotic (mating barriers) or post-zygotic isolations (measured by egg hatch%) among the olive fruit fly populations from the four countries tested. Also, there was no evidence of mating barriers between the hybrid strain and the wild populations of the Mediterranean region.	[Ahmad, Sohel; Caceres, Carlos; Tomas, Ulysses Sto; Dammalage, Thilakasiri; Gembinsky, Keke; Vreysen, Marc J. B.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Ahmad, Sohel; Paulus, Hannes] Univ Vienna, Vienna, Austria; [ul Haq, Ihsan] Natl Agr Res Ctr, Islamabad, Pakistan; [Rempoulakis, Polychronis] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; University of Vienna; National Agricultural Research Council - Pakistan; Macquarie University	Ahmad, S (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.; Ahmad, S (corresponding author), Univ Vienna, Vienna, Austria.	sohel.ahmad@iaea.org	Rempoulakis, Polychronis/P-2731-2019	Rempoulakis, Polychronis/0000-0002-3947-0064; Ahmad, Sohel/0000-0002-5404-1874				Ahmad Sohel, 2014, International Journal of Industrial Entomology, V29, P198; Bjelis M, 2013, J APPL ENTOMOL, V137, P154, DOI 10.1111/j.1439-0418.2011.01660.x; Bueno AM, 2002, IOBC WPRS B, V25, P1; BUSH GL, 1976, SCIENCE, V193, P491, DOI 10.1126/science.941019; BUSHLAND RC, 1955, SCIENCE, V122, P287, DOI 10.1126/science.122.3163.287; Cayol JP, 1999, J ECON ENTOMOL, V92, P140, DOI 10.1093/jee/92.1.140; Cayol JP, 2002, FLA ENTOMOL, V85, P51, DOI 10.1653/0015-4040(2002)085[0051:SCIMDT]2.0.CO;2; Cayol JP, 1999, J APPL ENTOMOL, V123, P613, DOI 10.1046/j.1439-0418.1999.00359.x; Cayol JP., 2002, P 2 INT C ALT CONTR, P593; Dimou I, 2010, J APPL ENTOMOL, V134, P72, DOI 10.1111/j.1439-0418.2009.01433.x; Dyck V.A., 2006, STERILE INSECT TECHN; Enkerlin WR, 2017, ENTOMOL EXP APPL, V164, P188, DOI 10.1111/eea.12611; Estes AM, 2012, J APPL ENTOMOL, V136, P1, DOI 10.1111/j.1439-0418.2011.01620.x; FERREIRA JR, 1983, PESTIC SCI, V14, P167, DOI 10.1002/ps.2780140211; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Hendrichs J, 2003, ENCY INSECTS, P1074; Hendrichs J., 2009, ENCY INSECTS, V2nd ed., P953, DOI DOI 10.1016/B978-0-12-374144-8.00252-6; Hood-Nowotny R, 2016, FLA ENTOMOL, V99, P166, DOI 10.1653/024.099.sp120; Kakani EG, 2009, SOC CHEM IND, P1; Katsoyannos P., 1992, OLIVE PESTS THEIR CO; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LOHER W, 1979, Z ANGEW ENTOMOL, V88, P425; Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Meats AW, 2003, AUST J EXP AGR, V43, P389, DOI 10.1071/EA02064; Mutika GN, 2001, B ENTOMOL RES, V91, P281, DOI 10.1079/BER2001102; Nardi F, 2005, MOL ECOL, V14, P2729, DOI 10.1111/j.1365-294X.2005.02610.x; NESTEL D, 2016, ADV INSECT CONTROL R, P47, DOI DOI 10.1007/978-3-319-31800-4; NEUENSCHWANDER P, 1978, Z ANGEW ENTOMOL, V86, P420; Pereira R, 2007, FLA ENTOMOL, V90, P10, DOI 10.1653/0015-4040(2007)90[10:SPOMRA]2.0.CO;2; Rice R., 2000, U CALIF PLANT PROT Q, P1; Rull J, 2007, J ECON ENTOMOL, V100, P752, DOI 10.1603/0022-0493(2007)100[752:COAHST]2.0.CO;2; Rull J, 2013, ENTOMOL EXP APPL, V148, P213, DOI 10.1111/eea.12094; SCHROEDER WJ, 1981, P HAWAII ENTOMOL SOC, V23, P437; Schutze MK, 2015, SYST ENTOMOL, V40, P456, DOI 10.1111/syen.12113; Taret G, 2010, J APPL ENTOMOL, V134, P207, DOI 10.1111/j.1439-0418.2008.01375.x; Tsitsipis JA, 1987, FRUIT FLIES EC IMPOR, P203; TZANAKAKIS ME, 1967, J ECON ENTOMOL, V60, P660, DOI 10.1093/jee/60.3.660; Vera MT, 2006, ANN ENTOMOL SOC AM, V99, P387, DOI 10.1603/0013-8746(2006)099[0387:MIAPOT]2.0.CO;2; Zervas, 1982, IAEASM25539, P357; Zygouridis NE, 2014, J APPL ENTOMOL, V138, P423, DOI 10.1111/jen.12042	41	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206739	10.1371/journal.pone.0206739	http://dx.doi.org/10.1371/journal.pone.0206739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383856	Green Submitted, gold, Green Published			2022-12-26	WOS:000449027600089
J	Cole, JW; Xu, HC; Ryan, K; Jaworek, T; Dueker, N; McArdle, P; Gaynor, B; Cheng, YC; O'Connell, J; Bevan, S; Malik, R; Ahmed, NU; Amouyel, P; Anjum, S; Bis, JC; Crosslin, D; Danesh, J; Engelter, ST; Fornage, M; Frossard, P; Gieger, C; Giese, AK; Grond-Ginsbach, C; Ho, WK; Holliday, E; Hopewell, J; Hussain, M; Iqbal, W; Jabeen, S; Jannes, J; Kamal, A; Kamatani, Y; Kanse, S; Kloss, M; Lathrop, M; Leys, D; Lindgren, A; Longstreth, WT; Mahmood, K; Meisinger, C; Metso, TM; Mosley, T; Mueller-Nurasyid, M; Norrving, B; Parati, E; Peters, A; Pezzini, A; Quereshi, I; Rasheed, A; Rauf, A; Salam, T; Shen, J; Slowik, A; Stanne, T; Strauch, K; Tatlisumak, T; Thijs, VN; Tiedt, S; Traylor, M; Waldenberger, M; Walters, M; Zhao, W; Boncoraglio, G; Debette, S; Jern, C; Levi, C; Markus, H; Meschia, J; Rolfs, A; Rothwell, P; Saleheen, D; Seshadri, S; Sharma, P; Sudlow, C; Worrall, B; Stine, OC; Kittner, SJ; Mitchell, BD				Cole, John W.; Xu, Huichun; Ryan, Kathleen; Jaworek, Thomas; Dueker, Nicole; McArdle, Patrick; Gaynor, Brady; Cheng, Yu-Ching; O'Connell, Jeffrey; Bevan, Steve; Malik, Rainer; Ahmed, Naveed Uddin; Amouyel, Philippe; Anjum, Sheraz; Bis, Joshua C.; Crosslin, David; Danesh, John; Engelter, Stefan T.; Fornage, Myriam; Frossard, Philippe; Gieger, Christian; Giese, Anne-Katrin; Grond-Ginsbach, Caspar; Ho, Weang Kee; Holliday, Elizabeth; Hopewell, Jemma; Hussain, M.; Iqbal, W.; Jabeen, S.; Jannes, Jim; Kamal, Ayeesha; Kamatani, Yoichiro; Kanse, Sandip; Kloss, Manja; Lathrop, Mark; Leys, Didier; Lindgren, Arne; Longstreth, W. T., Jr.; Mahmood, Khalid; Meisinger, Christa; Metso, Tiina M.; Mosley, Thomas, Jr.; Mueller-Nurasyid, Martina; Norrving, Bo; Parati, Eugenio; Peters, Annette; Pezzini, Alessandro; Quereshi, I; Rasheed, Asif; Rauf, A.; Salam, T.; Shen, Jess; Slowik, Agnieszka; Stanne, Tara; Strauch, Konstantin; Tatlisumak, Turgut; Thijs, Vincent N.; Tiedt, Steffen; Traylor, Matthew; Waldenberger, Melanie; Walters, Matthew; Zhao, Wei; Boncoraglio, Giorgio; Debette, Stephanie; Jern, Christina; Levi, Christopher; Markus, Hugh; Meschia, James; Rolfs, Arndt; Rothwell, Peter; Saleheen, Danish; Seshadri, Sudha; Sharma, Pankaj; Sudlow, Cathie; Worrall, Bradford; Stine, O. Colin; Kittner, Steven J.; Mitchell, Braxton D.		METASTROKE Consortium ISGC; WTCCC-2 Consortium	Genetics of the thrombomodulin-endothelial cell protein C receptor system and the risk of early-onset ischemic stroke	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FACTOR-V-LEIDEN; YOUNG-ADULTS; MYOCARDIAL-INFARCTION; CLASSIFICATION; POLYMORPHISMS; METAANALYSIS; POPULATION; MECHANISMS; MORTALITY	Background and purpose Polymorphisms in coagulation genes have been associated with early-onset ischemic stroke. Here we pursue an a priori hypothesis that genetic variation in the endothelial-based receptors of the thrombomodulin-protein C system (THBD and PROCR) may similarly be associated with early-onset ischemic stroke. We explored this hypothesis utilizing a multi-tage design of discovery and replication. Methods Discovery was performed in the Genetics-of-Early-Onset Stroke (GEOS) Study, a biracial population-based case-control study of ischemic stroke among men and women aged 1549 including 829 cases of first ischemic stroke (42.2% African-American) and 850 age-comparable stroke-free controls (38.1% African-American). Twenty-four single-nucleotide-polymorphisms (SNPs) in THBD and 22 SNPs in PROCR were evaluated. Following LD pruning (r(2)>= 0.8), we advanced uncorrelated SNPs forward for association analyses. Associated SNPs were evaluated for replication in an early-onset ischemic stroke population (onset-ge<60 years) consisting of 3676 cases and 21118 non-stroke controls from 6 case-control studies. Lastly, we determined if the replicated SNPs also associated with older-onset ischemic stroke in the METASTROKE data-base. Results Among GEOS Caucasians, PROCR rs9574, which was in strong LD with 8 other SNPs, and one additional independent SNP rs2069951, were significantly associated with ischemic stroke (rs9574, OR = 1.33, p = 0.003; rs2069951, OR = 1.80, p = 0.006) using an additive-model adjusting for age, gender and population-structure. Adjusting for risk factors did not change the associations; however, associations were strengthened among those without risk factors. PROCR rs9574 also associated with early-onset ischemic stroke in the replication sample (OR = 1.08, p = 0.015), but not older-onset stroke. There were no PROCR associations in African-Americans, nor were there any THBD associations in either ethnicity. Conclusion PROCR polymorphisms are associated with early-onset ischemic stroke in Caucasians.	[Cole, John W.; Kittner, Steven J.] Univ Maryland, Sch Med, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; [Xu, Huichun; Ryan, Kathleen; Jaworek, Thomas; McArdle, Patrick; Gaynor, Brady; O'Connell, Jeffrey; Stine, O. Colin; Mitchell, Braxton D.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Dueker, Nicole] Univ Miami, Miami, FL USA; [Cheng, Yu-Ching] US FDA, White Oak, MD USA; [Bevan, Steve] Univ Lincoln, Lincoln, England; [Malik, Rainer] Klinikum Univ Munchen, Munich, Germany; [Ahmed, Naveed Uddin] Liaquat Natl Hosp, Karachi, Pakistan; [Amouyel, Philippe] Inserm, Lille, France; [Anjum, Sheraz; Frossard, Philippe; Hussain, M.; Jabeen, S.; Rasheed, Asif; Rauf, A.] Ctr Noncommunicable Dis, Karachi, Pakistan; [Bis, Joshua C.; Crosslin, David] Univ Washington, Seattle, WA 98195 USA; [Danesh, John; Ho, Weang Kee; Traylor, Matthew; Markus, Hugh] Univ Cambridge, Cambridge, England; [Engelter, Stefan T.] Univ Hosp Basel, Basel, Switzerland; [Fornage, Myriam] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Gieger, Christian; Waldenberger, Melanie] Helmholtz Zentrum Munchen, Munich, Germany; [Giese, Anne-Katrin] Massachusetts Gen Hosp, Boston, MA USA; [Grond-Ginsbach, Caspar; Kloss, Manja] Heidelberg Univ, Heidelberg, Germany; [Holliday, Elizabeth] Univ Newcastle, Newcastle, NSW, Australia; [Hopewell, Jemma] Univ Oxford, Oxford, England; [Iqbal, W.; Salam, T.] Lahore Gen Hosp, Lahore, Pakistan; [Jannes, Jim] Univ Adelaide, Adelaide, SA, Australia; [Kamal, Ayeesha] Aga Khan Univ Hosp, Karachi, Pakistan; [Kamatani, Yoichiro] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Kanse, Sandip] Inst Basic Med Sci, Oslo, Norway; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Lathrop, Mark] Quebec Innovat Ctr, Montreal, PQ, Canada; [Leys, Didier] Univ Lille, INSERM, Lille, France; [Lindgren, Arne; Norrving, Bo] Lund Univ, Lund, Sweden; [Longstreth, W. T., Jr.] Harborview Med Ctr, Seattle, WA USA; [Mahmood, Khalid] Dow Univ Hlth Sci, Civil Hosp, Karachi, Pakistan; [Meisinger, Christa] Cent Hosp Augsburg, Augsburg, Germany; [Metso, Tiina M.; Tatlisumak, Turgut] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Mosley, Thomas, Jr.] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Mueller-Nurasyid, Martina] Ludwig Maximilians Univ Munchen, Inst Med Informat, Munich, Germany; [Parati, Eugenio; Boncoraglio, Giorgio] Fdn IRCCS Ist Neurol, Milan, Italy; [Peters, Annette] GSF Natl Res Ctr Environm & Hlth, Munich, Germany; [Pezzini, Alessandro] Univ Brescia, Brescia, Italy; [Quereshi, I] King Edward Med Univ, Lahore, Pakistan; [Quereshi, I] Mayo Hosp, Lahore, Pakistan; [Shen, Jess] Lunenfeld Tenubaum Res Inst, Toronto, ON, Canada; [Slowik, Agnieszka] Jagiellonian Univ, Med Coll, Krakow, Poland; [Stanne, Tara; Jern, Christina] Inst Biomed, Gothenburg, Sweden; [Strauch, Konstantin] Ludwig Maximilians Univ Munchen, Munich, Germany; [Thijs, Vincent N.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Tiedt, Steffen] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Walters, Matthew] Univ Glasgow, Glasgow, Lanark, Scotland; [Zhao, Wei] Translat Med & Human Genet, Philadelphia, PA USA; [Debette, Stephanie] Bordeaux Univ, Bordeaux, France; [Levi, Christopher] John Hunter Hosp, New Lambton Hts, NSW, Australia; [Meschia, James] Mayo Clin, Jacksonville, FL 32224 USA; [Rolfs, Arndt] Univ Rostock, Rostock, Mecklenburg Vor, Germany; [Rothwell, Peter] John Radcliffe Hosp, Oxford, England; [Saleheen, Danish] Univ Penn, Philadelphia, PA 19104 USA; [Seshadri, Sudha] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sharma, Pankaj] Royal Holloway Univ London, London, England; [Sudlow, Cathie] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Worrall, Bradford] Univ Virginia, Charlottesville, VA USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Miami; US Food & Drug Administration (FDA); University of Lincoln; University of Munich; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Washington; University of Washington Seattle; University of Cambridge; University of Basel; University of Texas System; University of Texas Health Science Center Houston; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Massachusetts General Hospital; Ruprecht Karls University Heidelberg; University of Newcastle; University of Oxford; University of Adelaide; Aga Khan University; RIKEN; McGill University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Lund University; Harborview Medical Center; Dow University of Health Sciences; University of Helsinki; Helsinki University Central Hospital; University of Mississippi; University of Mississippi Medical Center; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Brescia; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Munich; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Munich; University of Glasgow; John Hunter Hospital; Mayo Clinic; University of Rostock; University of Oxford; University of Pennsylvania; Boston University; University of London; Royal Holloway University London; University of Edinburgh; University of Virginia	Cole, JW (corresponding author), Univ Maryland, Sch Med, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA.	jcole@som.umaryland.edu	Rothwell, Peter/ABE-5913-2020; Peters, Annette/A-6117-2011; Mitchell, Braxton/CAF-0876-2022; sharma, pankaj/HGE-4423-2022; Parati, Eugenio Agostino/AAN-5893-2021; Waldenberger, Melanie/B-5355-2014; Shao, Ruitai/AAU-7642-2021; Meschia, James/GPP-1636-2022; Meisinger, Christine/B-5358-2014; Sander-Effron, Samuel/AAX-2231-2020; Thijs, Vincent/C-3647-2009; Müller-Nurasyid, Martina/I-8735-2018; Jabeen, Sehrish/AAH-4233-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Boncoraglio, Giorgio Battista/B-8647-2011; Debette, Stephanie/T-4946-2019	Rothwell, Peter/0000-0001-9739-9211; Peters, Annette/0000-0001-6645-0985; Parati, Eugenio Agostino/0000-0001-5020-6523; Waldenberger, Melanie/0000-0003-0583-5093; Meschia, James/0000-0002-4475-8142; Thijs, Vincent/0000-0002-6614-8417; Müller-Nurasyid, Martina/0000-0003-3793-5910; Boncoraglio, Giorgio Battista/0000-0002-2551-525X; Debette, Stephanie/0000-0001-8675-7968; Hopewell, Jemma/0000-0002-3870-8018; Kanse, Sandip/0000-0003-0782-9957; Seshadri, Sudha/0000-0001-6135-2622; Giese, A.K./0000-0002-8500-2376; Sudlow, Cathie/0000-0002-7725-7520; Levi, Christopher/0000-0002-9474-796X; Malik, Rainer/0000-0001-9212-2520; Cole, John/0000-0001-9263-8930; Gaynor, Brady/0000-0002-4142-0613	Epidemiology of Aging Training Program Grant, NIH/NIA [T32 AG000262]; U.S. Department of Veterans Affairs; American Heart Association Cardiovascular Genome-Phenome Study [15GPSPG23770000]; American Heart Association Discovery Grant - Bayer Group [17IBDG33700328]; National Institutes of Health Genes, Environment and Health Initiative (GEI), as part of the GENEVA consortium under GEI [U01 HG004436]; Mid-Atlantic Nutrition and Obesity Research Center [P30 DK072488]; Office of Research and Development, Medical Research Service; Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs; National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS069208]; NIH Office of Research on Women's Health [R01 NS45012, U01 NS069208-01]; Australian National and Medical Health Research Council (NHMRC) [569257]; Australian National Heart Foundation (NHF) [G 04S 1623]; University of Newcastle; National Heart Foundation; National Stroke Foundation of Australia [100071]; Department of Health (UK); Henry Smith Charity; UK-India Education Research Institutive (UKIERI) from the British Council; UK Medical Research Council (MRC) [ISRCTN48489393]; British Heart Foundation [ISRCTN48489393]; Roche Vitamins Ltd [ISRCTN48489393]; Merck and Co.; Intramural Research Program of the NIA, NIH [Z01 AG-000015-50]; American Heart Association/Bugher Foundation Centers for Stroke Prevention Research [0775010N]; National Center for Research Resources [U54 RR020278]; Italian Ministry of Health [RC 2007/LR6, RC 2008/LR6, RC 2009/LR8, RC 2010/LR8, GR-2011-02347041]; Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project [085475/B/08/Z, 085475/Z/08/Z, WT084724MA]; Stroke Association; National Institute of Health Research (NIHR); NIHR Biomedical Research Centre, Oxford; Binks Trust; Chief Scientist Office; Vascular Dementia Research Foundation; BHF Centre of Research Excellence in Oxford; United States National Human Genome Research Institute (NHGRI), as part of the Genomics and Randomized Trials Network (GARNET) [U01 HG005160]; United States National Center for Biotechnology Information; NHGRI GARNET [U01 HG005152]; NIH Genes, Environment, and Health Initiative (GEI) [U01 HG004424]; National Institutes of Health (NIH) [U01 NS069208, HHSN268200782096C, R01 NS100178, R01 NS105150, U01 HG005157, R01 NS34447]; University of Maryland School of Medicine; German Federal Ministry of Education and Research (BMBF); FP7 European Union project CVgenes@target [261123]; DFG [CRC 1123]; Corona Foundation; Fondation Leducq; Division of Adult and Community Health, Centers for Disease Control; Gladys M Brawn Fellowship scheme; Vincent Fairfax Family Foundation in Australia; Merck and Co [ISRCTN48489393]; British Heart Foundation; NIH-NINDS [R01 NS-42733, R01 NS-39987]; NIH and NHLBI's STAMPEED genomics research program [R01 HL087676]; MRC; Dunhill Medical Trust; Scottish Funding Council; Wellcome Trust [090532/Z/09/Z]; United States Public Health Service, NINDS, Bethesda, Maryland [R01 NS34447]; US National Library of Medicine; MRC [MR/L003120/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100178, R01NS105150, R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000262, R01AG054076] Funding Source: NIH RePORTER	Epidemiology of Aging Training Program Grant, NIH/NIA; U.S. Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association Cardiovascular Genome-Phenome Study(American Heart Association); American Heart Association Discovery Grant - Bayer Group; National Institutes of Health Genes, Environment and Health Initiative (GEI), as part of the GENEVA consortium under GEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mid-Atlantic Nutrition and Obesity Research Center; Office of Research and Development, Medical Research Service(US Department of Veterans Affairs); Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); Australian National and Medical Health Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian National Heart Foundation (NHF)(National Heart Foundation of Australia); University of Newcastle; National Heart Foundation(National Heart Foundation of Australia); National Stroke Foundation of Australia; Department of Health (UK); Henry Smith Charity; UK-India Education Research Institutive (UKIERI) from the British Council(The British Council in India); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Roche Vitamins Ltd; Merck and Co.(Merck & Company); Intramural Research Program of the NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association/Bugher Foundation Centers for Stroke Prevention Research(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Italian Ministry of Health(Ministry of Health, Italy); Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project; Stroke Association; National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); Binks Trust; Chief Scientist Office; Vascular Dementia Research Foundation; BHF Centre of Research Excellence in Oxford; United States National Human Genome Research Institute (NHGRI), as part of the Genomics and Randomized Trials Network (GARNET); United States National Center for Biotechnology Information; NHGRI GARNET; NIH Genes, Environment, and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland School of Medicine; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); FP7 European Union project CVgenes@target; DFG(German Research Foundation (DFG)); Corona Foundation; Fondation Leducq(Leducq Foundation); Division of Adult and Community Health, Centers for Disease Control; Gladys M Brawn Fellowship scheme; Vincent Fairfax Family Foundation in Australia; Merck and Co(Merck & Company); British Heart Foundation(British Heart Foundation); NIH-NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH and NHLBI's STAMPEED genomics research program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); Scottish Funding Council; Wellcome Trust(Wellcome Trust); United States Public Health Service, NINDS, Bethesda, Maryland; US National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by NIH grants U01 NS069208, R01 NS100178, and R01 NS105150; an Epidemiology of Aging Training Program Grant, NIH/NIA T32 AG000262; the U.S. Department of Veterans Affairs, and the American Heart Association Cardiovascular Genome-Phenome Study (grant# 15GPSPG23770000), and an American Heart Association Discovery Grant supported by Bayer Group (grant# 17IBDG33700328). Further details regarding the data collection, organization, funding and relationships between METASTROKE and the other studies involved can be found below. Genetics of Early Onset Stroke (GEOS) Study (Baltimore, USA): GWAS data for the GEOS Study was supported by the National Institutes of Health Genes, Environment and Health Initiative (GEI) grant U01 HG004436, as part of the GENEVA consortium under GEI, with additional support provided by the Mid-Atlantic Nutrition and Obesity Research Center (P30 DK072488); and the Office of Research and Development, Medical Research Service, and the Baltimore Geriatrics Research, Education, and Clinical Center of the Department of Veterans Affairs. Genotyping services were provided by the Johns Hopkins University Center for Inherited Disease Research (CIDR), which is fully funded through a federal contract from the National Institutes of Health to the Johns Hopkins University (contract number HHSN268200782096C). Assistance with data cleaning was provided by the GENEVA Coordinating Center (U01 HG 004446; PI Bruce S Weir). Study recruitment and collection of datasets were supported by a cooperative agreement with the Division of Adult and Community Health, Centers for Disease Control and by grants from the National Institute of Neurological Disorders and Stroke (NINDS) and the NIH Office of Research on Women's Health (R01 NS45012, U01 NS069208-01). METASTROKE: METASTROKE is a collaboration of numerous international studies with the aim of validating associations from previous GWAS and identifying novel genetic associations through meta-analysis of GWAS datasets for ischemic stroke and its subtypes. Included studies are as follows: ASGC: Australian population control data were derived from the Hunter Community Study. We also thank the University of Newcastle for funding and the men and women of the Hunter region who participated in this study. This research was funded by grants from the Australian National and Medical Health Research Council (NHMRC Project Grant ID: 569257), the Australian National Heart Foundation (NHF Project Grant ID: G 04S 1623), the University of Newcastle, the Gladys M Brawn Fellowship scheme, and the Vincent Fairfax Family Foundation in Australia. Elizabeth G Holliday was supported by a Fellowship from the National Heart Foundation and National Stroke Foundation of Australia (ID: 100071). BRAINS: Bio-Repository of DNA in Stroke (BRAINS) is partly funded by a Senior Fellowship from the Department of Health (UK) to P Sharma, the Henry Smith Charity and the UK-India Education Research Institutive (UKIERI) from the British Council. HPS: Heart Protection Study (HPS) (ISRCTN48489393) was supported by the UK Medical Research Council (MRC), British Heart Foundation, Merck and Co (manufacturers of simvastatin), and Roche Vitamins Ltd (manufacturers of vitamins). Genotyping was supported by a grant to Oxford University and CNG from Merck and Co. Jemma C Hopewell acknowledges support from the British Heart Foundation (FS/14/55/30806).; ISGS: Ischemic Stroke Genetics Study (ISGS)/Siblings With Ischemic Stroke Study (SWISS) was supported in part by the Intramural Research Program of the NIA, NIH project Z01 AG-000954-06. ISGS/SWISS used samples and clinical data from the NIH-NINDS Human Genetics Resource Center DNA and Cell Line Repository (http://ccr.coriell.org/ninds), human subjects protocol numbers 2003-081 and 2004-147. ISGS/SWISS used stroke-free participants from the Baltimore Longitudinal Study of Aging (BLSA) as controls. The inclusion of BLSA samples was supported in part by the Intramural Research Program of the NIA, NIH project Z01 AG-000015-50, human subjects protocol number 2003-078. The ISGS study was funded by NIH-NINDS grant R01 NS-42733 (JF Meschia). The SWISS study was funded by NIH-NINDS grant R01 NS-39987 (J F Meschia). This study used the high-performance computational capabilities of the Biowulf Linux cluster at the NIH (http://biowulf.nih.gov). MGH-GASROS: MGH Genes Affecting Stroke Risk and Outcome Study (MGH-GASROS) was supported by NINDS (U01 NS069208), the American Heart Association/Bugher Foundation Centers for Stroke Prevention Research 0775010N, the NIH and NHLBI's STAMPEED genomics research program (R01 HL087676), and a grant from the National Center for Research Resources. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research resources. MILANO: Milano - Besta Stroke Register Collection and genotyping of the Milan cases within CEDIR were supported by the Italian Ministry of Health (grant numbers: RC 2007/LR6, RC 2008/LR6; RC 2009/LR8; RC 2010/LR8; GR-2011-02347041). FP6 LSHM-CT-2007-037273 for the PROCARDIS control samples. WTCCC2: Wellcome Trust Case-Control Consortium 2 (WTCCC2) was principally funded by the Wellcome Trust, as part of the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z and 085475/Z/08/Z and WT084724MA). The Stroke Association provided additional support for collection of some of the St George's, London cases. The Oxford cases were collected as part of the Oxford Vascular Study which is funded by the MRC, Stroke Association, Dunhill Medical Trust, National Institute of Health Research (NIHR) and the NIHR Biomedical Research Centre, Oxford. The Edinburgh Stroke Study was supported by the Wellcome Trust (clinician scientist award to C Sudlow), and the Binks Trust. Sample processing occurred in the Genetics Core Laboratory of the Wellcome Trust Clinical Research Facility, Western General Hospital, Edinburgh. Much of the neuroimaging occurred in the Scottish Funding Council Brain Imaging Research Centre (www.sbirc.ed.ac.uk), Division of Clinical Neurosciences, University of Edinburgh, a core area of the Wellcome Trust Clinical Research Facility and part of the SINAPSE (Scottish Imaging Network-A Platform for Scientific Excellence) collaboration (www.sinapse.ac.uk), funded by the Scottish Funding Council and the Chief Scientist Office. Collection of the Munich cases and data analysis was supported by the Vascular Dementia Research Foundation. M Farrall and A Helgadottir acknowledge support from the BHF Centre of Research Excellence in Oxford and the Wellcome Trust core award (090532/Z/09/Z). VISP: The GWAS component of the Vitamin Intervention for Stroke Prevention (VISP) study was supported by the United States National Human Genome Research Institute (NHGRI), grant U01 HG005160 (PI Michele Sale & Bradford Worrall), as part of the Genomics and Randomized Trials Network (GARNET).; Genotyping services were provided by the Johns Hopkins University Center for Inherited Disease Research (CIDR), which is fully funded through a federal contract from the NIH to the Johns Hopkins University. Assistance with data cleaning was provided by the GARNET Coordinating Center (U01 HG005157; PI Bruce S Weir). Study recruitment and collection of datasets for the VISP clinical trial were supported by an investigator-initiated research grant (R01 NS34447; PI James Toole) from the United States Public Health Service, NINDS, Bethesda, Maryland. Control data obtained through the database of genotypes and phenotypes (dbGAP) maintained and supported by the United States National Center for Biotechnology Information, US National Library of Medicine. WHI: Funding support for WHI-GARNET was provided through the NHGRI GARNET (Grant Number U01 HG005152). Assistance with phenotype harmonisation and genotype cleaning, as well as with general study coordination, was provided by the GARNET Coordinating Center (U01 HG005157). Funding support for genotyping, which was performed at the Broad Institute of MIT and Harvard, was provided by the NIH Genes, Environment, and Health Initiative (GEI; U01 HG004424). SiGN: The Stroke Genetics Network (SiGN) study was funded by a cooperative agreement grant from the National Institute of Neurological Disorders and Stroke (NINDS) U01 NS069208. Genotyping services were provided by the Johns Hopkins University Center for Inherited Disease Research (CIDR), which is fully funded through a federal contract from the National Institutes of Health (NIH) to the Johns Hopkins University (contract no. HHSN268200782096C). The Biostatistics Department Genetics Coordinating Center at the University of Washington (Seattle) provided more extensive quality control of the genotype data through a subcontract with CIDR. Additional support to the Administrative Core of SiGN was provided by the Dean's Office, University of Maryland School of Medicine. This work was supported by grants received from the German Federal Ministry of Education and Research (BMBF) in the context of the e:Med program (e:AtheroSysMed), the FP7 European Union project CVgenes@target (261123), the DFG as part of the CRC 1123 (B3), the Corona Foundation and the Fondation Leducq (Transatlantic Network of Excellence on the Pathogenesis of Small Vessel Disease of the Brain).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Cheng YC, 2016, STROKE, V47, P307, DOI 10.1161/STROKEAHA.115.011328; Cheng YC, 2014, CIRC-CARDIOVASC GENE, V7, P383, DOI 10.1161/CIRCGENETICS.113.000390; Cheng YC, 2011, G3-GENES GENOM GENET, V1, P505, DOI 10.1534/g3.111.001164; Debette S, 2015, NAT GENET, V47, P78, DOI 10.1038/ng.3154; ESMON CT, 1981, P NATL ACAD SCI-BIOL, V78, P2249, DOI 10.1073/pnas.78.4.2249; ESMON CT, 1987, SCIENCE, V235, P1348, DOI 10.1126/science.3029867; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; Esmon CT, 2001, THROMB HAEMOSTASIS, V86, P51; Franchi F, 2001, BRIT J HAEMATOL, V114, P641, DOI 10.1046/j.1365-2141.2001.02964.x; Guella I, 2011, THROMB HAEMOSTASIS, V106, P655, DOI 10.1160/TH11-04-0247; Hamedani AG, 2013, J STROKE CEREBROVASC, V22, P419, DOI 10.1016/j.jstrokecerebrovasdis.2011.10.007; Hanson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075286; Hinds DA, 2016, HUM MOL GENET, V25, P1867, DOI 10.1093/hmg/ddw037; Jiang BJ, 2014, STROKE, V45, P961, DOI 10.1161/STROKEAHA.113.004063; JOHNSON CJ, 1995, STROKE, V26, P46, DOI 10.1161/01.STR.26.1.46; Kittner SJ, 1996, NEW ENGL J MED, V335, P768, DOI 10.1056/NEJM199609123351102; Medina P, 2008, HAEMATOL-HEMATOL J, V93, P1358, DOI 10.3324/haematol.13066; Naess H, 2002, STROKE, V33, P2105, DOI 10.1161/01.STR.0000023888.43488.10; Olson NC, 2018, J THROMB HAEMOST, V16, P19, DOI 10.1111/jth.13899; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reiner AP, 2008, J THROMB HAEMOST, V6, P1625, DOI 10.1111/j.1538-7836.2008.03118.x; Ridker PM, 1997, ANN INTERN MED, V126, P528, DOI 10.7326/0003-4819-126-7-199704010-00005; Sayed-Tabatabaei FA, 2005, J MED GENET, V42, P26, DOI 10.1136/jmg.2004.022756; Traylor M, 2012, LANCET NEUROL, V11, P951, DOI 10.1016/S1474-4422(12)70234-X	26	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206554	10.1371/journal.pone.0206554	http://dx.doi.org/10.1371/journal.pone.0206554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383853	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000449027600064
J	Nishio, A; Horita, R; Marutani, T; Yamamoto, M				Nishio, Akihiro; Horita, Ryo; Marutani, Toshiyuki; Yamamoto, Mayumi			Factors that influence delaying initial psychiatric treatment in rural Cambodia: A pilot study	PLOS ONE			English	Article							UNTREATED PSYCHOSIS; 1ST-EPISODE PSYCHOSIS; DURATION; POPULATION; CARE	Background The WHO reported the gap between the need for treatment and its provision is huge in low- and middle-income countries. It is estimated there are lots of burden to obtain treatment in these countries. This survey intended to show the delay of their first visit to a psychiatric department and the factors that influence the delay. To elucidate the factors affecting medical accessibility for people with mental illness, we propose the concept of duration of untreated mental illness (DUM), which is the duration between the onset or first symptom of mental illness and the first visit to a psychiatric department or clinic. Methods Participants were 109 Cambodian adults (18 years old and up) who had a psychiatric consultation in one of the following hospitals. We analyzed the relationships between DUM and patients' background; age, gender, economic status, education level, occupation, hospital access, and diagnosis. Results The average DUM of all participants was 34.8 +/- 42.4 months, ranging from 0 to 240 There was no significant difference in DUM by difference in hospital, gender, age, hospital access, education level, occupation, or economic status. Only patient diagnosis was related to DUM. The DUM for patients with schizophrenia and epilepsy was long, while the DUM for patients with neurosis and substance use were short. Conclusion To compare DUM with that of other low- and middle-income countries, DUM of our survey is extremely long. However, those reports were from urban areas within the low- and middle-income countries. We considered our report to include a very important sample showing the condition of psychiatric services in rural areas of low-income countries.	[Nishio, Akihiro; Horita, Ryo; Marutani, Toshiyuki; Yamamoto, Mayumi] Gifu Univ, Hlth Adm Ctr, Gifu, Japan; [Nishio, Akihiro] Gifu Univ, Grad Sch Med, Dept Psychopathol, Div Neurosci, Gifu, Japan; [Marutani, Toshiyuki] Tokyo Inst Technol, Hlth Support Ctr, Yokohama, Kanagawa, Japan; [Yamamoto, Mayumi] Gifu Univ, United Grad Sch Drug Discovery & Med Informat Sci, Gifu, Japan	Gifu University; Gifu University; Tokyo Institute of Technology; Gifu University	Nishio, A (corresponding author), Gifu Univ, Hlth Adm Ctr, Gifu, Japan.; Nishio, A (corresponding author), Gifu Univ, Grad Sch Med, Dept Psychopathol, Div Neurosci, Gifu, Japan.	a_nishio@gifu-u.ac.jp			Gifu University	Gifu University	This survey was supported by Gifu University.	Al Fayez H, 2017, EARLY INTERV PSYCHIA, V11, P47, DOI 10.1111/eip.12214; Apiquian R, 2002, SCHIZOPHR RES, V53, P161, DOI 10.1016/S0920-9964(00)00087-6; Ayres AM, 2007, SCHIZOPHR RES, V90, P338, DOI 10.1016/j.schres.2006.09.026; Bora E, 2017, SCHIZOPHR RES; Burns JK, 2010, AFR J PSYCHIATRY, V13, P395; Dong H, 2016, DURATION UNTREATED P, V11, DOI [10.1371/journal.pone.0157083, DOI 10.1371/JOURNAL.PONE.0157083]; Hui CLM, 2015, EARLY INTERV PSYCHIA, V9, P118, DOI 10.1111/eip.12094; Naqvi HA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007409; Norman RMG, 2004, PSYCHOL MED, V34, P255, DOI 10.1017/S0033291703001119; Oosthuizen P, 2005, ACTA PSYCHIAT SCAND, V111, P214, DOI 10.1111/j.1600-0447.2004.00448.x; Padilla E, 2015, SCHIZOPHR RES, V161, P184, DOI 10.1016/j.schres.2014.10.039; Penttila M, 2013, SCHIZOPHR RES, V143, P3, DOI 10.1016/j.schres.2012.10.029; Sharifi V, 2009, EARLY INTERV PSYCHIA, V3, P131, DOI 10.1111/j.1751-7893.2009.00119.x; Tang JY, 2009, SCHIZOPHR RES, V109, P15, DOI [10.1016/j.schres.2009.01.008, DOI 10.1016/J.SCHRES.2009.01.008]; Tomita A, 2015, J NERV MENT DIS, V203, P222, DOI 10.1097/NMD.0000000000000268; WHO-AIMS, MENT HLTH SYST SEL L; World Bank, WORLD BANK DAT	17	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206882	10.1371/journal.pone.0206882	http://dx.doi.org/10.1371/journal.pone.0206882			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GZ0DG	30383851	Green Published, Green Submitted, gold			2022-12-26	WOS:000449027600103
J	Thordardottir, M; Lindqvist, EK; Lund, SH; Costello, R; Burton, D; Steingrimsdottir, L; Korde, N; Mailankody, S; Eiriksdottir, G; Launer, LJ; Gudnason, V; Harris, TB; Landgren, O; Torfadottir, JE; Kristinsson, SY				Thordardottir, Marianna; Lindqvist, Ebba K.; Lund, Sigrun H.; Costello, Rene; Burton, Debra; Steingrimsdottir, Laufey; Korde, Neha; Mailankody, Sham; Eiriksdottir, Gudny; Launer, Lenore J.; Gudnason, Vilmundur; Harris, Tamara B.; Landgren, Ola; Torfadottir, Johanna E.; Kristinsson, Sigurdur Y.			Dietary intake is associated with risk of multiple myeloma and its precursor disease	PLOS ONE			English	Article							UNDETERMINED SIGNIFICANCE MGUS; MONOCLONAL GAMMOPATHY; CANCER-RISK; PREVALENCE; PROGRESSION; VETERANS; MEN; CONSUMPTION; DISORDERS; NUTRITION	The etiology of monoclonal gammopathy of undetermined significance (MGUS), the precursor state of multiple myeloma (MM), is mostly unknown and no studies have been conducted on the effect of diet on MGUS or progression from MGUS to MM. We aimed to explore the association between common foods and MGUS and progression to MM. Data from the population-based AGES Study (N = 5,764) were utilized. Food frequency questionnaire was used to assess dietary intake during adolescence, midlife, and late life. Serum protein electrophoresis and serum free light-chain assay was performed to identify MGUS (n = 300) and LC-MGUS cases (n = 275). We cross linked our data with the Icelandic Cancer Registry to find cases of MM in the study group. We found that intake of fruit at least three times per week during adolescence was associated with lower risk of MGUS when compared to lower fruit consumption (OR = 0.62, 95% CI 0.41-0.95). We additionally found that intake of fruit at least three times per week during the late life period was associated with decreased risk of progressing from MGUS to MM (HR = 0.34, 95% CI 0.13-0.89) when compared to lower intake. Adolescent intake of fruit may reduce risk of MGUS, whereas fruit intake after MGUS onset may reduce risk of progressing to MM. Our findings suggest that diet might alter the risk of developing MGUS and progression to MM.	[Thordardottir, Marianna; Gudnason, Vilmundur; Kristinsson, Sigurdur Y.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Lindqvist, Ebba K.; Kristinsson, Sigurdur Y.] Karolinska Univ Hosp, Dept Med, Div Hematol, Stockholm, Sweden; [Lindqvist, Ebba K.; Kristinsson, Sigurdur Y.] Karolinska Inst, Stockholm, Sweden; [Lund, Sigrun H.; Torfadottir, Johanna E.] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Costello, Rene; Burton, Debra] NCI, Multiple Myeloma Sect, NIH, Bethesda, MD 20892 USA; [Steingrimsdottir, Laufey] Univ Iceland, Fac Food Sci & Human Nutr, Reykjavik, Iceland; [Korde, Neha; Mailankody, Sham; Landgren, Ola] Mem Sloan Kettering Canc Ctr, Myeloma Serv, Div Hematol Oncol, 1275 York Ave, New York, NY 10021 USA; [Eiriksdottir, Gudny; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Launer, Lenore J.; Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, Bethesda, MD 20892 USA; [Torfadottir, Johanna E.] Iceland Canc Soc, Reykjavik, Iceland	University of Iceland; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Iceland; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Iceland; Memorial Sloan Kettering Cancer Center; Icelandic Heart Association; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Thordardottir, M (corresponding author), Univ Iceland, Fac Med, Reykjavik, Iceland.	mthordar@hi.is	Gudnason, Vilmundur/AAE-7126-2019; Lindqvist, Ebba/AAE-6477-2022; Lund, Sigrun Helga/K-9144-2015; Lund, Sigrún Helga/AAG-6042-2019; Þórðardóttir, Maríanna/Q-6096-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Lund, Sigrun Helga/0000-0002-3806-2296; Lund, Sigrún Helga/0000-0002-3806-2296; Thordardottir, Marianna/0000-0002-1273-3493; Lindqvist, Ebba K/0000-0001-7662-1338	NIH [N01-AG-012100]; Intramural Research Program of the National Institute on Aging; Icelandic Heart Association; Icelandic Parliament; Icelandic Centre for Research, RANNIS; Landspitali University Hospital Research Fund; Karolinska Instituted Foundations; Marie Curie CIG; Memorial Sloan Kettering Core Grant [P30 CA008748]; National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG007380] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Icelandic Heart Association; Icelandic Parliament; Icelandic Centre for Research, RANNIS; Landspitali University Hospital Research Fund; Karolinska Instituted Foundations; Marie Curie CIG; Memorial Sloan Kettering Core Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The AGES-Reykjavik Study was funded by NIH contract N01-AG-012100, the Intramural Research Program of the National Institute on Aging, by the Icelandic Heart Association, and the Icelandic Parliament. This work was supported by the Icelandic Centre for Research, RANNIS (S.Y. Kristinsson), the Landspitali University Hospital Research Fund (S.Y. Kristinsson), the Karolinska Instituted Foundations (S.Y. Kristinsson), the Marie Curie CIG (S.Y. Kristinsson), and the Memorial Sloan Kettering Core Grant (P30 CA008748) from the National Cancer Institute (O. Landgren). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie JM, 2006, ANN CLIN LAB SCI, V36, P157; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Baris D, 2000, AM J PUBLIC HEALTH, V90, P1277, DOI 10.2105/AJPH.90.8.1277; Bradbury KE, 2014, AM J CLIN NUTR, V100, p394S, DOI 10.3945/ajcn.113.071357; Brown LM, 2008, BLOOD, V111, P3388, DOI 10.1182/blood-2007-10-121285; Brown LM, 2001, CANCER CAUSE CONTROL, V12, P117, DOI 10.1023/A:1008937901586; Chatenoud L, 1998, INT J CANCER, V77, P24, DOI 10.1002/(SICI)1097-0215(19980703)77:1&lt;24::AID-IJC5&gt;3.0.CO;2-1; Darmon N, 2008, AM J CLIN NUTR, V87, P1107, DOI 10.1093/ajcn/87.5.1107; Dispenzieri A, 2010, LANCET, V375, P1721, DOI 10.1016/S0140-6736(10)60482-5; Dwyer JT, 1997, AM J CLIN NUTR, V65, P1153; Eisele L, 2012, ANN HEMATOL, V91, P243, DOI 10.1007/s00277-011-1293-1; Eysteinsdottir T, 2011, J NUTR HEALTH AGING, V15, P809, DOI 10.1007/s12603-011-0067-8; Eysteinsdottir T, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-12; Ferlin M, 2000, BRIT J HAEMATOL, V111, P626, DOI 10.1046/j.1365-2141.2000.02364.x; Fernandez E, 1999, AM J CLIN NUTR, V70, P85; Fritschi L, 2004, CANCER EPIDEM BIOMAR, V13, P532; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Harris TB, 2015, AM J CLIN NUTR, V101, P947, DOI 10.3945/ajcn.114.087502; Hofmann JN, 2013, AM J EPIDEMIOL, V177, P776, DOI 10.1093/aje/kws295; Hosgood HD, 2007, CANCER CAUSE CONTROL, V18, P1065, DOI 10.1007/s10552-007-9047-z; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Katzmann JA, 2002, CLIN CHEM, V48, P1437; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; Landgren O, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.97; Landgren O, 2006, BLOOD, V107, P904, DOI 10.1182/blood-2005-08-3449; Landgren O, 2007, MAYO CLIN PROC, V82, P1468, DOI 10.4065/82.12.1468; Landgren O, 2015, JAMA ONCOL, V1, P1061, DOI 10.1001/jamaoncol.2015.2938; Landgren O, 2009, BLOOD, V114, P791, DOI 10.1182/blood-2008-12-191676; Landgren O, 2009, BLOOD, V113, P5412, DOI 10.1182/blood-2008-12-194241; Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602; Lindqvist EK, 2011, BLOOD, V118, P6284, DOI 10.1182/blood-2011-04-347559; Lutsenko EA, 2002, J BIOL CHEM, V277, P16895, DOI 10.1074/jbc.M201151200; Mirmiran P, 2014, WORLD J DIABETES, V5, P267, DOI 10.4239/wjd.v5.i3.267; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Rose DP, 1999, PHARMACOL THERAPEUT, V83, P217, DOI 10.1016/S0163-7258(99)00026-1; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Sigurdardottir LG, 2012, ACTA ONCOL, V51, P880, DOI 10.3109/0284186X.2012.698751; SIGURDSSON E, 1993, EUR HEART J, V14, P584, DOI 10.1093/eurheartj/14.5.584; Sigurjonsson J, 1943, SURVEY DIET HLTH ICE; Steingrimsdottir L, 2003, DIET ICELANDERS DIET; Swerdlov S. H., 2008, WHO CLASSIFICATION T; Tavani A, 2000, INT J CANCER, V86, P425, DOI 10.1002/(SICI)1097-0215(20000501)86:3&lt;425::AID-IJC19&gt;3.0.CO;2-S; Tavani A, 1997, NUTR CANCER, V27, P256, DOI 10.1080/01635589709514535; Thordardottir M, 2017, BLOOD ADV, V1, P2186, DOI 10.1182/bloodadvances.2017007609; Thorsteinsdottir S, 2017, BLOOD ADV, V1, P2790, DOI 10.1182/bloodadvances.2017010454; Torfadottir JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059799; Torfadottir JE, 2012, AM J EPIDEMIOL, V175, P144, DOI 10.1093/aje/kwr289; Turati F, 2015, BRIT J NUTR, V113, pS102, DOI 10.1017/S0007114515000148; Turesson I, 2014, BLOOD, V123, P338, DOI 10.1182/blood-2013-05-505487; Vlajinac HD, 2003, NEOPLASMA, V50, P79; Wallin A, 2011, EUR J CANCER, V47, P1606, DOI 10.1016/j.ejca.2011.01.020; Weiss BM, 2009, BLOOD, V113, P5418, DOI 10.1182/blood-2008-12-195008	54	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2018	13	11							e0206047	10.1371/journal.pone.0206047	http://dx.doi.org/10.1371/journal.pone.0206047			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GZ0DG	30383820	Green Published, gold, Green Submitted			2022-12-26	WOS:000449027600025
